Citrus Sinensis ID: 012014
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 473 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGP4 | 1010 | Probable LRR receptor-lik | yes | no | 0.649 | 0.303 | 0.428 | 8e-74 | |
| C0LGT6 | 1031 | LRR receptor-like serine/ | no | no | 0.636 | 0.291 | 0.416 | 3e-68 | |
| Q9SD62 | 1025 | Putative receptor-like pr | no | no | 0.638 | 0.294 | 0.415 | 2e-66 | |
| Q9ZUI0 | 980 | Putative leucine-rich rep | no | no | 0.659 | 0.318 | 0.345 | 3e-47 | |
| O22476 | 1196 | Protein BRASSINOSTEROID I | no | no | 0.511 | 0.202 | 0.400 | 1e-42 | |
| Q8L899 | 1207 | Systemin receptor SR160 O | N/A | no | 0.524 | 0.205 | 0.383 | 2e-42 | |
| Q9FL28 | 1173 | LRR receptor-like serine/ | no | no | 0.621 | 0.250 | 0.334 | 8e-42 | |
| Q8GUQ5 | 1207 | Brassinosteroid LRR recep | N/A | no | 0.524 | 0.205 | 0.379 | 8e-42 | |
| Q9ZPS9 | 1143 | Serine/threonine-protein | no | no | 0.680 | 0.281 | 0.337 | 3e-41 | |
| Q9SYM9 | 355 | Receptor-like serine/thre | no | no | 0.613 | 0.816 | 0.332 | 1e-39 |
| >sp|C0LGP4|Y3475_ARATH Probable LRR receptor-like serine/threonine-protein kinase At3g47570 OS=Arabidopsis thaliana GN=At3g47570 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 278 bits (710), Expect = 8e-74, Method: Compositional matrix adjust.
Identities = 141/329 (42%), Positives = 205/329 (62%), Gaps = 22/329 (6%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGSKSFKSECKA 194
S+ DL NATNGFSS+N++G+G+FG+VY L + +AVKV N+ R G KSF +EC++
Sbjct: 691 SYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECES 750
Query: 195 AINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLI 254
+I+HRN+V++ TA S +D+QG F+A++Y+FMPNGSL+ WL ++ + +
Sbjct: 751 LKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLTL 810
Query: 255 KKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQ 314
++L+IAIDVA L YLH C PIAHC+LKPSNVLLDD++ HV DFG+AR L D++
Sbjct: 811 LERLNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDEE 870
Query: 315 NRF-----ICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMN 369
+ F ++G+ GY PEY +G + S GDVYSFGILLLEMFTG RP++ +F G
Sbjct: 871 SFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFTGKRPTNELFGGNFT 930
Query: 370 LRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGV 429
L ++ K ALP+R ++VD+ L + + V ++EC + E+G+
Sbjct: 931 LNSYTKSALPERILDIVDESILH-------IGLRVGFP---------VVECLTMVFEVGL 974
Query: 430 ACSAERPRERMKINDVESRLRLIRRKLLE 458
C E P R+ + V L IR + +
Sbjct: 975 RCCEESPMNRLATSIVVKELISIRERFFK 1003
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGT6|EFR_ARATH LRR receptor-like serine/threonine-protein kinase EFR OS=Arabidopsis thaliana GN=EFR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 259 bits (662), Expect = 3e-68, Method: Compositional matrix adjust.
Identities = 139/334 (41%), Positives = 205/334 (61%), Gaps = 33/334 (9%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGSKSFKSECKA 194
S+++L++AT+ FSS NLIG+GNFG+V+ G L + +AVKV NL++ G +KSF +EC+
Sbjct: 701 SYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECET 760
Query: 195 AINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLI 254
I+HRN+V++ T S +D +G F+A+VY+FMP GSL+ WL+ +D + +
Sbjct: 761 FKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTP 820
Query: 255 KKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQ 314
+KL+IAIDVA AL YLH C P+AHC++KPSN+LLDD++ HV DFG+A+ L D++
Sbjct: 821 AEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRE 880
Query: 315 ---NRFIC--IKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMN 369
N+F ++G+ GY PEY +G + S GDVYSFGILLLEMF+G +P+D F G N
Sbjct: 881 SFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYN 940
Query: 370 LRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGV 429
L ++ K L + C +SS GS+A I E + ++G+
Sbjct: 941 LHSYTKSIL--------------------SGC---TSSGGSNA----IDEGLRLVLQVGI 973
Query: 430 ACSAERPRERMKINDVESRLRLIRRKLLETPACL 463
CS E PR+RM+ ++ L IR K + +
Sbjct: 974 KCSEEYPRDRMRTDEAVRELISIRSKFFSSKTTI 1007
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of elongation factor Tu (EF-Tu), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Reduces transformation by Rhizobium radiobacter probably by inducing plant defense during the interaction. Binding to the effector AvrPto1 from P.syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SD62|Y3471_ARATH Putative receptor-like protein kinase At3g47110 OS=Arabidopsis thaliana GN=At3g47110 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 254 bits (648), Expect = 2e-66, Method: Compositional matrix adjust.
Identities = 135/325 (41%), Positives = 197/325 (60%), Gaps = 23/325 (7%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTLFD-GTTIAVKVFNLIRPGGSKSFKSECKA 194
S+ +LY T GFSS+NLIG+GNFG+V+ G L +A+KV NL + G +KSF +EC+A
Sbjct: 708 SYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEA 767
Query: 195 AINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLI 254
I+HRN+V++ T S D++G F+A+VY+FMPNG+L+ WL + + +
Sbjct: 768 LGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPSRTLGL 827
Query: 255 KKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQ 314
+L+IAIDVA AL YLH C PIAHC++KPSN+LLD ++ HV DFG+A+ L D+
Sbjct: 828 FARLNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDRD 887
Query: 315 NRFI-----CIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMN 369
I ++G+ GY PEY +G S GDVYSFGI+LLE+FTG RP++ +F +
Sbjct: 888 TFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGLT 947
Query: 370 LRNFVKMALPQR-AEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIG 428
L +F K AL +R A ++ D+ L+ G+ A ++EC + +G
Sbjct: 948 LHSFTKSALQKRQALDITDETILR----------------GAYAQHFNMVECLTLVFRVG 991
Query: 429 VACSAERPRERMKINDVESRLRLIR 453
V+CS E P R+ + + S+L IR
Sbjct: 992 VSCSEESPVNRISMAEAISKLVSIR 1016
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUI0|Y2241_ARATH Putative leucine-rich repeat receptor-like serine/threonine-protein kinase At2g24130 OS=Arabidopsis thaliana GN=At2g24130 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 190 bits (482), Expect = 3e-47, Method: Compositional matrix adjust.
Identities = 124/359 (34%), Positives = 185/359 (51%), Gaps = 47/359 (13%)
Query: 127 EGKQTINNP-----SFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIR 181
E KQ N+P S++ L AT GF++++LIG+G FG VY G L + T +AVKV +
Sbjct: 636 EEKQNQNDPKYPRISYQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVLD--- 692
Query: 182 PGG----SKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWL 237
P S SFK EC+ +HRN++R+ T S F A+V MPNGSLE L
Sbjct: 693 PKTALEFSGSFKRECQILKRTRHRNLIRIITTCSK-----PGFNALVLPLMPNGSLERHL 747
Query: 238 RGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297
+ ++ N + + ++I DVA + YLH + HC+LKPSN+LLDDEM
Sbjct: 748 YPGEYSSK-----NLDLIQLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTA 802
Query: 298 HVGDFGMARFLPAIDKQ------------NRFICIKGSTGYIPPEYDLGCEASTYGDVYS 345
V DFG++R + +++ + +C GS GYI PEY +G AST+GDVYS
Sbjct: 803 LVTDFGISRLVQGVEETVSTDDSVSFGSTDGLLC--GSVGYIAPEYGMGKRASTHGDVYS 860
Query: 346 FGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVS 405
FG+LLLE+ +G RP+D + +L F+K P E +++ + +G+ E
Sbjct: 861 FGVLLLEIVSGRRPTDVLVNEGSSLHEFMKSHYPDSLEGIIEQALSRWKPQGKPEKCE-- 918
Query: 406 SSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRKLLETPACLE 464
+ILE + E+G+ C+ P R + DV + ++ L P+ L
Sbjct: 919 -----KLWREVILE----MIELGLVCTQYNPSTRPDMLDVAHEMGRLKEYLFACPSLLH 968
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O22476|BRI1_ARATH Protein BRASSINOSTEROID INSENSITIVE 1 OS=Arabidopsis thaliana GN=BRI1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 174 bits (441), Expect = 1e-42, Method: Compositional matrix adjust.
Identities = 101/252 (40%), Positives = 142/252 (56%), Gaps = 10/252 (3%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAA 195
+F DL ATNGF + +LIG+G FG VY L DG+ +A+K + G + F +E +
Sbjct: 872 TFADLLQATNGFHNDSLIGSGGFGDVYKAILKDGSAVAIKKLIHVSGQGDREFMAEMETI 931
Query: 196 INIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIK 255
IKHRN+V + + V + + +VY+FM GSLE+ L D + N+ +
Sbjct: 932 GKIKHRNLVPLL-GYCKVGDE----RLLVYEFMKYGSLEDVLH---DPKKAGVKLNWSTR 983
Query: 256 KKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQN 315
+K IAI A L +LH +C P I H ++K SNVLLD+ + V DFGMAR + A+D
Sbjct: 984 RK--IAIGSARGLAFLHHNCSPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHL 1041
Query: 316 RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVK 375
+ G+ GY+PPEY ST GDVYS+G++LLE+ TG RP+D G NL +VK
Sbjct: 1042 SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSPDFGDNNLVGWVK 1101
Query: 376 MALPQRAEEVVD 387
R +V D
Sbjct: 1102 QHAKLRISDVFD 1113
|
Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. Binds brassinolide, and less effectively castasterone, but not 2,3,22,23-O-tetramethylbrassinolide or ecdysone. May be involved in a feedback regulation of brassinosteroid biosynthesis. Phosphorylates BRI1-associated receptor kinase 1 (BAK1), Transthyretin-Like protein (TTL) and SERK1 on 'Ser-299' and 'Thr-462' in vitro. May have a guanylyl cyclase activity. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8L899|BRI1_SOLPE Systemin receptor SR160 OS=Solanum peruvianum PE=1 SV=1 | Back alignment and function description |
|---|
Score = 173 bits (439), Expect = 2e-42, Method: Compositional matrix adjust.
Identities = 99/258 (38%), Positives = 147/258 (56%), Gaps = 10/258 (3%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAA 195
+F DL ATNGF + +L+G+G FG VY L DG+ +A+K + G + F +E +
Sbjct: 877 TFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVAIKKLIHVSGQGDREFTAEMETI 936
Query: 196 INIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIK 255
IKHRN+V + + V + + +VY++M GSLE+ L + T + N+ +
Sbjct: 937 GKIKHRNLVPLL-GYCKVGEE----RLLVYEYMKYGSLEDVLHDRKKTG---IKLNWPAR 988
Query: 256 KKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQN 315
+K IAI A L +LH +C P I H ++K SNVLLD+ + V DFGMAR + A+D
Sbjct: 989 RK--IAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHL 1046
Query: 316 RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVK 375
+ G+ GY+PPEY ST GDVYS+G++LLE+ TG +P+D G NL +VK
Sbjct: 1047 SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKQPTDSADFGDNNLVGWVK 1106
Query: 376 MALPQRAEEVVDDFNLQE 393
+ + +V D L+E
Sbjct: 1107 LHAKGKITDVFDRELLKE 1124
|
Receptor with a serine/threonine-protein kinase activity. Involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. May also regulate, in response to brassinosteroid binding, a signaling cascade involved in plant development. Solanum peruvianum (taxid: 4082) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FL28|FLS2_ARATH LRR receptor-like serine/threonine-protein kinase FLS2 OS=Arabidopsis thaliana GN=FLS2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 171 bits (434), Expect = 8e-42, Method: Compositional matrix adjust.
Identities = 108/323 (33%), Positives = 173/323 (53%), Gaps = 29/323 (8%)
Query: 138 KDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNL--IRPGGSKSFKSECKAA 195
K+L AT+ F+SAN+IG+ + +VY G L DGT IAVKV NL K F +E K
Sbjct: 861 KELEQATDSFNSANIIGSSSLSTVYKGQLEDGTVIAVKVLNLKEFSAESDKWFYTEAKTL 920
Query: 196 INIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIK 255
+KHRN+V++ G ++ + KA+V FM NG+LE+ + G + P+ +
Sbjct: 921 SQLKHRNLVKIL----GFAWESGKTKALVLPFMENGNLEDTIHG----SAAPIGS---LL 969
Query: 256 KKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQN 315
+K+D+ + +A + YLH PI HC+LKP+N+LLD + + HV DFG AR L + +
Sbjct: 970 EKIDLCVHIASGIDYLHSGYGFPIVHCDLKPANILLDSDRVAHVSDFGTARILGFREDGS 1029
Query: 316 RFI---CIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRN 372
+G+ GY+ PE+ + +T DV+SFGI+++E+ T RP+ +N +
Sbjct: 1030 TTASTSAFEGTIGYLAPEFAYMRKVTTKADVFSFGIIMMELMTKQRPT------SLNDED 1083
Query: 373 FVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACS 432
M L Q E+ + + + R + ME+ S S I E F +C + C+
Sbjct: 1084 SQDMTLRQLVEKSIGNGRKGMV---RVLDMELGDSIVSLKQEEAI-EDFLKLC---LFCT 1136
Query: 433 AERPRERMKINDVESRLRLIRRK 455
+ RP +R +N++ + L +R K
Sbjct: 1137 SSRPEDRPDMNEILTHLMKLRGK 1159
|
Constitutes the pattern-recognition receptor (PPR) that determines the specific perception of flagellin (flg22), a potent elicitor of the defense response to pathogen-associated molecular patterns (PAMPs). Flagellin-binding to the receptor is the first step to initiate the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6), resulting in enhanced resistance against pathogens. Binding to the effector AvrPto1 from Pseudomonas syringae blocks the downstream plant immune response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GUQ5|BRI1_SOLLC Brassinosteroid LRR receptor kinase OS=Solanum lycopersicum GN=CURL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 171 bits (434), Expect = 8e-42, Method: Compositional matrix adjust.
Identities = 98/258 (37%), Positives = 146/258 (56%), Gaps = 10/258 (3%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAA 195
+F DL ATNGF + +L+G+G FG VY L DG+ +A+K + G + F +E +
Sbjct: 877 TFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVAIKKLIHVSGQGDREFTAEMETI 936
Query: 196 INIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIK 255
IKHRN+V + + V + + +VY++M GSLE+ L + + N+ +
Sbjct: 937 GKIKHRNLVPLL-GYCKVGEE----RLLVYEYMKYGSLEDVLHDRKKIG---IKLNWPAR 988
Query: 256 KKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQN 315
+K IAI A L +LH +C P I H ++K SNVLLD+ + V DFGMAR + A+D
Sbjct: 989 RK--IAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHL 1046
Query: 316 RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVK 375
+ G+ GY+PPEY ST GDVYS+G++LLE+ TG +P+D G NL +VK
Sbjct: 1047 SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKQPTDSADFGDNNLVGWVK 1106
Query: 376 MALPQRAEEVVDDFNLQE 393
+ + +V D L+E
Sbjct: 1107 LHAKGKITDVFDRELLKE 1124
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. May be involved in a feedback regulation of brassinosteroid biosynthesis. May be also involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. Solanum lycopersicum (taxid: 4081) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZPS9|BRL2_ARATH Serine/threonine-protein kinase BRI1-like 2 OS=Arabidopsis thaliana GN=BRL2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 170 bits (430), Expect = 3e-41, Method: Compositional matrix adjust.
Identities = 114/338 (33%), Positives = 177/338 (52%), Gaps = 16/338 (4%)
Query: 117 KKKLLKTPVYEGKQTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKV 176
+K+ L V ++ + F L ATNGFS+A++IG G FG V+ TL DG+++A+K
Sbjct: 808 EKEPLSINVATFQRQLRKLKFSQLIEATNGFSAASMIGHGGFGEVFKATLKDGSSVAIKK 867
Query: 177 FNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEW 236
+ G + F +E + IKHRN+V + + + + + +VY+FM GSLEE
Sbjct: 868 LIRLSCQGDREFMAEMETLGKIKHRNLVPLL-GYCKIGEE----RLLVYEFMQYGSLEEV 922
Query: 237 LRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI 296
L G R + + +KK IA A L +LH +C P I H ++K SNVLLD +M
Sbjct: 923 LHGPRTGEKRRI-LGWEERKK--IAKGAAKGLCFLHHNCIPHIIHRDMKSSNVLLDQDME 979
Query: 297 GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTG 356
V DFGMAR + A+D + G+ GY+PPEY + GDVYS G+++LE+ +G
Sbjct: 980 ARVSDFGMARLISALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSIGVVMLEILSG 1039
Query: 357 IRPSDGIFTGKMNLRNFVKM-ALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHAS 415
RP+D G NL + KM A + EV+D+ ++EG + + +
Sbjct: 1040 KRPTDKEEFGDTNLVGWSKMKAREGKHMEVIDE---DLLKEGSSESL----NEKEGFEGG 1092
Query: 416 IILECFNSICEIGVACSAERPRERMKINDVESRLRLIR 453
+I++ EI + C + P +R + V + LR +R
Sbjct: 1093 VIVKEMLRYLEIALRCVDDFPSKRPNMLQVVASLRELR 1130
|
Receptor with a serine/threonine-protein kinase activity, which may transduce extracellular spatial and temporal signals into downstream cell differentiation responses in provascular and procambial cells. In contrast to BRI1, BRL1 and BRL3, it does not bind brassinolide. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SYM9|Y1853_ARATH Receptor-like serine/threonine-protein kinase At1g78530 OS=Arabidopsis thaliana GN=At1g78530 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 164 bits (416), Expect = 1e-39, Method: Compositional matrix adjust.
Identities = 108/325 (33%), Positives = 159/325 (48%), Gaps = 35/325 (10%)
Query: 130 QTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFK 189
Q +N+ S T+ S+ +++G+G FG+VY + D TT AVK N + F
Sbjct: 58 QLLNSVSSDMFMKKTHKLSNKDILGSGGFGTVYRLVIDDSTTFAVKRLNRGTSERDRGFH 117
Query: 190 SECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLN 249
E +A +IKHRNIV + F+ Y ++Y+ MPNGSL+ +L G+ +W
Sbjct: 118 RELEAMADIKHRNIVTLHGYFTSPHYN-----LLIYELMPNGSLDSFLHGRKALDW---- 168
Query: 250 FNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLP 309
+ IA+ A + YLH DC P I H ++K SN+LLD M V DFG+A +
Sbjct: 169 -----ASRYRIAVGAARGISYLHHDCIPHIIHRDIKSSNILLDHNMEARVSDFGLATLME 223
Query: 310 AIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG-IFTGKM 368
DK + + G+ GY+ PEY +A+ GDVYSFG++LLE+ TG +P+D F
Sbjct: 224 P-DKTHVSTFVAGTFGYLAPEYFDTGKATMKGDVYSFGVVLLELLTGRKPTDDEFFEEGT 282
Query: 369 NLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIG 428
L +VK + + EEVV D L+ GSS + E N + I
Sbjct: 283 KLVTWVKGVVRDQREEVVIDNRLR----------------GSSVQEN---EEMNDVFGIA 323
Query: 429 VACSAERPRERMKINDVESRLRLIR 453
+ C P R + +V L I+
Sbjct: 324 MMCLEPEPAIRPAMTEVVKLLEYIK 348
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 473 | ||||||
| 359486510 | 965 | PREDICTED: probable LRR receptor-like se | 0.670 | 0.328 | 0.561 | 1e-93 | |
| 255586722 | 936 | serine-threonine protein kinase, plant-t | 0.665 | 0.336 | 0.563 | 9e-93 | |
| 224097752 | 1025 | predicted protein [Populus trichocarpa] | 0.682 | 0.315 | 0.534 | 1e-91 | |
| 224097750 | 1023 | predicted protein [Populus trichocarpa] | 0.682 | 0.315 | 0.531 | 2e-91 | |
| 224119022 | 1021 | predicted protein [Populus trichocarpa] | 0.670 | 0.310 | 0.524 | 4e-89 | |
| 359482058 | 1040 | PREDICTED: probable LRR receptor-like se | 0.723 | 0.328 | 0.506 | 1e-88 | |
| 224135241 | 985 | predicted protein [Populus trichocarpa] | 0.691 | 0.331 | 0.507 | 1e-88 | |
| 147853780 | 1904 | hypothetical protein VITISV_030954 [Viti | 0.723 | 0.179 | 0.506 | 2e-88 | |
| 224113117 | 1006 | predicted protein [Populus trichocarpa] | 0.668 | 0.314 | 0.514 | 3e-88 | |
| 224121306 | 966 | predicted protein [Populus trichocarpa] | 0.701 | 0.343 | 0.491 | 3e-88 |
| >gi|359486510|ref|XP_002271317.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like, partial [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 350 bits (897), Expect = 1e-93, Method: Compositional matrix adjust.
Identities = 187/333 (56%), Positives = 226/333 (67%), Gaps = 16/333 (4%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKA 194
S++ L AT+GFSS+NLIG G+FGSVY G L DGT IAVKV NL+R G SKSF +EC+A
Sbjct: 627 SYQSLLRATDGFSSSNLIGVGSFGSVYKGILDHDGTAIAVKVLNLLRKGASKSFIAECEA 686
Query: 195 AINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDT---NWRPLNFN 251
NI+HRN+V+V TA SGVDYQG FKAVVY+FM NGSLE+WL T + P N
Sbjct: 687 LRNIRHRNLVKVLTACSGVDYQGNDFKAVVYEFMVNGSLEQWLHPTPTTAEASAPPRKLN 746
Query: 252 FLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAI 311
FL ++L+IAIDVACAL YLH CQ PI HC+LKPSNVLLD EM GHVGDFG+A+FLP
Sbjct: 747 FL--QRLNIAIDVACALDYLHHQCQTPIVHCDLKPSNVLLDTEMTGHVGDFGIAKFLPEA 804
Query: 312 -----DKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTG 366
+ Q+ I I+G+ GY PEY +G E ST GDVYSFGILLLEMFTG RP++ +F
Sbjct: 805 ATRVPEIQSSSIGIRGTIGYAAPEYGMGSEVSTSGDVYSFGILLLEMFTGKRPTEDMFKD 864
Query: 367 KMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICE 426
+N+ NFVK A+P+R E+ D LQ EG M S +S+H + EC SI
Sbjct: 865 SLNIHNFVKTAVPERVAEIADPVLLQ---EGVEMDNTTSQRRMASSHDA--QECLISIFG 919
Query: 427 IGVACSAERPRERMKINDVESRLRLIRRKLLET 459
IG+ACSAE PRER I D + L +R L T
Sbjct: 920 IGLACSAELPRERKNITDAAAELNSVRDIFLGT 952
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255586722|ref|XP_002533985.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223526036|gb|EEF28405.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 347 bits (890), Expect = 9e-93, Method: Compositional matrix adjust.
Identities = 182/323 (56%), Positives = 225/323 (69%), Gaps = 8/323 (2%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDG-TTIAVKVFNLIRPGGSKSFKSECKA 194
S+ LY AT+GFSSAN +GAG+FG+V+ G L G T+IAVKVFNL+R G KSF +EC+A
Sbjct: 619 SYHTLYKATDGFSSANTLGAGSFGTVFKGELGGGETSIAVKVFNLMRHGAFKSFIAECEA 678
Query: 195 AINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLI 254
NI+HRN+V+V TA S VDYQG FKA+VY+FM NGSLEEWL D+ P N N I
Sbjct: 679 LRNIRHRNLVKVLTACSSVDYQGNEFKALVYEFMVNGSLEEWLHPPDEAKAIPRN-NLNI 737
Query: 255 KKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQ 314
++L+IA+DVACAL YLH C+ PI HC+LKPSN+LLD+EM GHVGDFG+A+F Q
Sbjct: 738 LQRLNIAVDVACALDYLHNHCETPIIHCDLKPSNILLDNEMTGHVGDFGLAKFYRERSHQ 797
Query: 315 NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFV 374
+ I I+GS GY P EY G E ST GDVYS+GILLLE+FTG RP D F ++L N+V
Sbjct: 798 SSSIGIRGSLGYAPAEYGTGNEVSTSGDVYSYGILLLEIFTGKRPMDDWFNEDVSLHNYV 857
Query: 375 KMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAE 434
K ALP++ E++D QE E G ++ S+A + +EC SICEIGVACSAE
Sbjct: 858 KNALPEQVVEILDPTLFQEGEGGISLIRR------SNASINRTMECLISICEIGVACSAE 911
Query: 435 RPRERMKINDVESRLRLIRRKLL 457
P ERM I DV +L IR KLL
Sbjct: 912 TPGERMNICDVAGQLVSIRNKLL 934
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224097752|ref|XP_002311067.1| predicted protein [Populus trichocarpa] gi|222850887|gb|EEE88434.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 343 bits (880), Expect = 1e-91, Method: Compositional matrix adjust.
Identities = 179/335 (53%), Positives = 222/335 (66%), Gaps = 12/335 (3%)
Query: 129 KQTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKS 187
+ T +++DL ATNGFS ANLIGAG+FGSVY G L DG +AVKVFNL+R G SKS
Sbjct: 689 ESTFQRVAYEDLLQATNGFSPANLIGAGSFGSVYKGILRSDGAAVAVKVFNLLREGASKS 748
Query: 188 FKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRP 247
F +EC A INI+HRN+V+V TA SG+D+QG FKA+VY+FM NGSLEEWL ++
Sbjct: 749 FMAECAALINIRHRNLVKVLTACSGIDFQGNDFKALVYEFMVNGSLEEWLHPAQISDEAH 808
Query: 248 LNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF 307
+ + ++L+IAIDVA AL YLH CQ I HC+LKPSNVLLD ++ HVGDFG+AR
Sbjct: 809 RRRDLSLLQRLNIAIDVASALDYLHNHCQIAIVHCDLKPSNVLLDGDLTAHVGDFGLARL 868
Query: 308 LPAIDK-----QNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
LP Q I +KG+ GY PEY LG E S YGDVYS+GILLLE+FTG RP+DG
Sbjct: 869 LPQASHQLCLDQTSSIGLKGTIGYAAPEYGLGSEVSPYGDVYSYGILLLEVFTGRRPTDG 928
Query: 363 IFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFN 422
+F +NL NF K ALP EV+D + E EE +S +H +EC
Sbjct: 929 LFKDGLNLHNFAKTALPISVAEVLDPVLVTEAEE------TSGDASRRMSHIGNHMECLA 982
Query: 423 SICEIGVACSAERPRERMKINDVESRLRLIRRKLL 457
+I ++GVACSAE PRERM+I+ V LR IR LL
Sbjct: 983 AIVKVGVACSAEFPRERMEISSVAVELRRIRHILL 1017
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224097750|ref|XP_002311066.1| predicted protein [Populus trichocarpa] gi|222850886|gb|EEE88433.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 342 bits (878), Expect = 2e-91, Method: Compositional matrix adjust.
Identities = 178/335 (53%), Positives = 223/335 (66%), Gaps = 12/335 (3%)
Query: 129 KQTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKS 187
+ T +++DL AT GFS ANLIGAG+FGSVY G L DG +AVKVFNL+R G SKS
Sbjct: 687 ESTFQRVAYEDLLQATKGFSPANLIGAGSFGSVYKGILRSDGAAVAVKVFNLLREGASKS 746
Query: 188 FKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRP 247
F +EC A INI+HRN+V+V TA SG+D+QG FKA+VY+FM NGSLEEWL ++
Sbjct: 747 FMAECAALINIRHRNLVKVLTACSGIDFQGNDFKALVYEFMVNGSLEEWLHPVQISDEAH 806
Query: 248 LNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF 307
+ + + ++L+IAIDVA AL YLH CQ +AHC+LKPSNVLLD +M HVGDFG+AR
Sbjct: 807 VRRDLSLLQRLNIAIDVASALDYLHNHCQIAVAHCDLKPSNVLLDGDMTAHVGDFGLARL 866
Query: 308 LPAIDK-----QNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
LP Q I +KG+ GY PEY LG E S YGDVYS+GILLLE+FTG RP++G
Sbjct: 867 LPQASHQLCLDQTSSIGLKGTIGYAAPEYGLGSEVSPYGDVYSYGILLLEVFTGRRPTNG 926
Query: 363 IFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFN 422
+F +NL NF K ALP EV+D + E EE +S +H +EC
Sbjct: 927 LFKDGLNLHNFAKTALPISVAEVLDPVLVTEAEE------TSGDASRRMSHIGNHMECLA 980
Query: 423 SICEIGVACSAERPRERMKINDVESRLRLIRRKLL 457
+I ++GVACSAE PRERM+I+ V LR IR LL
Sbjct: 981 AIVKVGVACSAEFPRERMEISSVAVELRRIRHILL 1015
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224119022|ref|XP_002331306.1| predicted protein [Populus trichocarpa] gi|222873889|gb|EEF11020.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 335 bits (858), Expect = 4e-89, Method: Compositional matrix adjust.
Identities = 173/330 (52%), Positives = 222/330 (67%), Gaps = 13/330 (3%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKA 194
S++ L ATNGFSS+NL+G G+FGSVY G L +G IAVKV NL+R G S+SF +EC+A
Sbjct: 688 SYQILLKATNGFSSSNLVGIGSFGSVYKGMLDQNGMVIAVKVLNLMRQGASRSFIAECEA 747
Query: 195 AINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLI 254
NI+HRN+V+V TA S +DY G FKA+VY+FM NGSLE+WL +
Sbjct: 748 LRNIRHRNLVKVLTACSSIDYHGNDFKAIVYEFMANGSLEDWLHPTGTGGGT--TLTLNL 805
Query: 255 KKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAID-- 312
++L+IAIDVACAL YLH C+ PIAHC+LKPSNVLLDDE+ GHVGDFG+A+FL
Sbjct: 806 LQRLNIAIDVACALEYLHHHCEMPIAHCDLKPSNVLLDDELTGHVGDFGLAKFLSGASLD 865
Query: 313 ---KQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMN 369
++ I ++G+ GY PPEY +G E S YGD YS+GILLLEMFTG RP+D +F N
Sbjct: 866 YPTNESTSIGVRGTIGYAPPEYGVGGEVSAYGDTYSYGILLLEMFTGKRPTDEMFREGSN 925
Query: 370 LRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGV 429
L NFVK A+P++ +++ D LQE G E+SS S LEC NSI IG+
Sbjct: 926 LHNFVKRAVPEQVKQITDPTLLQEEPTGDDDKHEISSMRNSRP-----LECLNSILRIGI 980
Query: 430 ACSAERPRERMKINDVESRLRLIRRKLLET 459
+CS E PRERMKI+D ++L +R +L T
Sbjct: 981 SCSVEFPRERMKISDAVAQLHSVRNELQST 1010
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359482058|ref|XP_002274540.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At3g47570-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 333 bits (853), Expect = 1e-88, Method: Compositional matrix adjust.
Identities = 183/361 (50%), Positives = 237/361 (65%), Gaps = 19/361 (5%)
Query: 109 VESRLRLIKKKLLKTPVYEGKQTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGTLF- 167
V +RLR +K++ +T K I N S+ L+ AT GFSSANLIG G FGSVY G L
Sbjct: 676 VINRLRRVKREPSQTSA-SSKDLILNVSYDGLFKATGGFSSANLIGTGGFGSVYKGILGQ 734
Query: 168 DGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKF 227
D T +AVKV L + G KSFK+EC+A NI+HRN+V+V T S VDYQG FKA+VY+F
Sbjct: 735 DETVVAVKVIQLHQRGAVKSFKAECEALRNIRHRNLVKVLTTCSSVDYQGNDFKALVYEF 794
Query: 228 MPNGSLEEWLR---GKDDTN--WRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHC 282
MPNGSLE WL D+ N R L+ + ++L+IAIDVA AL YLH C PI HC
Sbjct: 795 MPNGSLENWLHPVPTPDEINDVLRILS----LPQRLNIAIDVASALDYLHHHCHKPIVHC 850
Query: 283 NLKPSNVLLDDEMIGHVGDFGMARFLP-----AIDKQNRFICIKGSTGYIPPEYDLGCEA 337
+LKPSN+LLD++M HVGDFG+ARF+P + Q+ I +KG+ GY PEY +G +
Sbjct: 851 DLKPSNILLDNDMTAHVGDFGLARFIPEAAGRSHPSQSSSIGLKGTIGYAAPEYGMGTKV 910
Query: 338 STYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNL-QEIEE 396
S GD YS+GILLLEMFTG RP++ +F+ ++NL NFVKMALP+R +++D F L E +E
Sbjct: 911 SALGDTYSYGILLLEMFTGKRPTESMFSDQLNLHNFVKMALPERIADIIDPFFLSSEAKE 970
Query: 397 GRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRKL 456
T + SS+ + + EC SI IGV+CS E PRERM I + L+LIR+ L
Sbjct: 971 EETTAAD--SSNLAHMKREKMHECLISILRIGVSCSLESPRERMAITEAIKELQLIRKIL 1028
Query: 457 L 457
L
Sbjct: 1029 L 1029
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224135241|ref|XP_002327600.1| predicted protein [Populus trichocarpa] gi|222836154|gb|EEE74575.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 333 bits (853), Expect = 1e-88, Method: Compositional matrix adjust.
Identities = 180/355 (50%), Positives = 230/355 (64%), Gaps = 28/355 (7%)
Query: 109 VESRLRLIKKKLLKTPVYEGKQTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGTLF- 167
++ LR K L + ++G ++KDL ATNGFSS NLIGAG+FGSVY G L
Sbjct: 633 LKKSLRKTKNDLAREIPFQGV------AYKDLRQATNGFSSENLIGAGSFGSVYKGLLAS 686
Query: 168 DGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKF 227
DG +AVKVFNL+R G SKSF EC A NI+HRN+V+V A++GVD QG FKA+VY+F
Sbjct: 687 DGVIVAVKVFNLLREGASKSFMRECAALTNIRHRNLVKVLCAYAGVDVQGKDFKALVYEF 746
Query: 228 MPNGSLEEWLRGKDDTNWR----PLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCN 283
M NGSLEEWL + T ++ P N N + ++L+IAIDVA AL YLH C+ PIAHC+
Sbjct: 747 MINGSLEEWLH-PNQTLYQEVHEPRNLNLI--QRLNIAIDVANALDYLHNHCKTPIAHCD 803
Query: 284 LKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDV 343
LKPSNVLLD +M HVGDFG+ +FL Q + +KG+ GY PEY +G E ST GDV
Sbjct: 804 LKPSNVLLDGDMTAHVGDFGLLKFLSEASCQTSSVGLKGTVGYAAPEYGIGSEVSTLGDV 863
Query: 344 YSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCME 403
YS+GILLLEM TG RP+D +F + L N+VKMALP R +V D + E+++G+
Sbjct: 864 YSYGILLLEMITGKRPTDSMFKDGIELHNYVKMALPDRVVDVADPKLVIEVDQGK----- 918
Query: 404 VSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRKLLE 458
AH ILEC SI ++GV CS + PRERM I++V + L R LE
Sbjct: 919 -------DAHQ--ILECLISISKVGVFCSEKFPRERMGISNVVAVLNRTRANFLE 964
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147853780|emb|CAN83822.1| hypothetical protein VITISV_030954 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 332 bits (852), Expect = 2e-88, Method: Compositional matrix adjust.
Identities = 183/361 (50%), Positives = 237/361 (65%), Gaps = 19/361 (5%)
Query: 109 VESRLRLIKKKLLKTPVYEGKQTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGTLF- 167
V +RLR +K++ +T K I N S+ L+ AT GFSSANLIG G FGSVY G L
Sbjct: 707 VINRLRRVKREPSQTSA-SSKDLILNVSYDGLFKATGGFSSANLIGTGGFGSVYKGXLGQ 765
Query: 168 DGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKF 227
D T +AVKV L + G KSFK+EC+A NI+HRN+V+V T S VDYQG FKA+VY+F
Sbjct: 766 DETVVAVKVIQLHQRGAVKSFKAECEALRNIRHRNLVKVLTTCSSVDYQGNDFKALVYEF 825
Query: 228 MPNGSLEEWLR---GKDDTN--WRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHC 282
MPNGSLE WL D+ N R L+ + ++L+IAIDVA AL YLH C PI HC
Sbjct: 826 MPNGSLENWLHPVPTPDEINDVLRILS----LPQRLNIAIDVASALDYLHHHCHKPIVHC 881
Query: 283 NLKPSNVLLDDEMIGHVGDFGMARFLP-----AIDKQNRFICIKGSTGYIPPEYDLGCEA 337
+LKPSN+LLD++M HVGDFG+ARF+P + Q+ I +KG+ GY PEY +G +
Sbjct: 882 DLKPSNILLDNDMTAHVGDFGLARFIPEAAGRSHPSQSSSIGLKGTIGYAAPEYGMGTKV 941
Query: 338 STYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNL-QEIEE 396
S GD YS+GILLLEMFTG RP++ +F+ ++NL NFVKMALP+R +++D F L E +E
Sbjct: 942 SALGDTYSYGILLLEMFTGKRPTESMFSDQLNLHNFVKMALPERIADIIDPFFLSSEAKE 1001
Query: 397 GRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRKL 456
T + SS+ + + EC SI IGV+CS E PRERM I + L+LIR+ L
Sbjct: 1002 EETTAAD--SSNLAHMKREKMHECLISILRIGVSCSLESPRERMAITEAIKELQLIRKIL 1059
Query: 457 L 457
L
Sbjct: 1060 L 1060
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224113117|ref|XP_002316396.1| predicted protein [Populus trichocarpa] gi|222865436|gb|EEF02567.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 332 bits (851), Expect = 3e-88, Method: Compositional matrix adjust.
Identities = 172/334 (51%), Positives = 222/334 (66%), Gaps = 18/334 (5%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGSKSFKSECKA 194
++++LY AT GFSS+N IG G+FGSVY L DG +AVKVFNL+R G SKS+ +EC A
Sbjct: 677 TYEELYQATGGFSSSNFIGGGSFGSVYKAILAPDGMIVAVKVFNLLRKGASKSYMAECAA 736
Query: 195 AINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLI 254
INI+HRN+V++ TA S +D++G FKA+VY+FM NGSLEEWL ++ N +
Sbjct: 737 LINIRHRNLVKILTACSSLDFRGNDFKALVYEFMVNGSLEEWLHPVHTSDEEREQGNLNL 796
Query: 255 KKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAI--- 311
++L++AIDVA AL YLH CQ + HC+LKPSNVLLD +M HVGDFG+ARF P
Sbjct: 797 IQRLNVAIDVASALDYLHYHCQMAVVHCDLKPSNVLLDGDMTAHVGDFGLARFRPEASVQ 856
Query: 312 --DKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMN 369
QN I +KG+ GY PEY +G E STYGDVYS+GILLLE+ TG P+DG F +N
Sbjct: 857 LSSNQNSSIGLKGTVGYAAPEYGIGNEVSTYGDVYSYGILLLEILTGKTPTDGSFKEGLN 916
Query: 370 LRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASI----ILECFNSIC 425
L +VKMALP R EVVD L+EIE+ +S++ S I +LEC SI
Sbjct: 917 LHKYVKMALPDRVVEVVDPILLREIEQ--------TSANASDGMKRIGNDKVLECLVSIM 968
Query: 426 EIGVACSAERPRERMKINDVESRLRLIRRKLLET 459
E+GV+CS + PRER I++V + L IR LL T
Sbjct: 969 EVGVSCSVDLPRERTNISNVVAELHRIRGILLGT 1002
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224121306|ref|XP_002330794.1| predicted protein [Populus trichocarpa] gi|222872596|gb|EEF09727.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 332 bits (850), Expect = 3e-88, Method: Compositional matrix adjust.
Identities = 174/354 (49%), Positives = 233/354 (65%), Gaps = 22/354 (6%)
Query: 116 IKKKLLKTPVYEGKQTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAV 174
++KK+ TP + ++ S++ L AT+GFS NL+G G FGSVY G L D +AV
Sbjct: 611 LRKKVEPTPTSP-ENSVFQMSYRSLLKATDGFSLTNLLGVGGFGSVYKGILDNDEKLVAV 669
Query: 175 KVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLE 234
KV NL+ P SKSFK+EC+ N++HRN+V++ TA SG DYQG FKA+VY+FM NGSLE
Sbjct: 670 KVLNLLNPRASKSFKAECEVLRNVRHRNLVKLLTACSGSDYQGNDFKALVYEFMVNGSLE 729
Query: 235 EWLR----GKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVL 290
EWL G D+ + NF+ ++L+IAID++CAL YLH C+ PI HC+LKPSNVL
Sbjct: 730 EWLHPITPGIDEARESSRSLNFV--QRLNIAIDISCALEYLHRGCRTPIVHCDLKPSNVL 787
Query: 291 LDDEMIGHVGDFGMARFLPAIDKQNRF-----ICIKGSTGYIPPEYDLGCEASTYGDVYS 345
LDDEMIGHVGDFG+ARF P F ++G+ GY PEY +G E ST GDV+S
Sbjct: 788 LDDEMIGHVGDFGLARFFPEATNNLSFNRSSTNGVRGTIGYTAPEYGMGNEVSTSGDVFS 847
Query: 346 FGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVS 405
+GILLLEMF+G RP+D IF +NL ++K ALP + EE++D +QEI+ R
Sbjct: 848 YGILLLEMFSGKRPTDVIFEDSLNLHTYMKAALPGKVEEILDPILVQEIKGER------- 900
Query: 406 SSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRKLLET 459
S S S + +C S+ E+G+ACSAE P ERM I++V + L+ I+ KLL +
Sbjct: 901 --SSSYMWNSKVQDCVVSVFEVGIACSAELPSERMDISEVTAELQAIKEKLLRS 952
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 473 | ||||||
| TAIR|locus:2075631 | 1009 | AT3G47090 [Arabidopsis thalian | 0.649 | 0.304 | 0.419 | 1.4e-67 | |
| TAIR|locus:2079142 | 1010 | AT3G47570 [Arabidopsis thalian | 0.646 | 0.302 | 0.436 | 1e-66 | |
| TAIR|locus:2079157 | 1011 | AT3G47580 [Arabidopsis thalian | 0.651 | 0.304 | 0.409 | 2.7e-66 | |
| TAIR|locus:2175703 | 502 | AT5G39390 [Arabidopsis thalian | 0.513 | 0.484 | 0.489 | 4.8e-66 | |
| TAIR|locus:2149922 | 1031 | EFR "EF-TU receptor" [Arabidop | 0.513 | 0.235 | 0.477 | 2.3e-65 | |
| UNIPROTKB|Q40640 | 1025 | Xa21 "Receptor kinase-like pro | 0.665 | 0.307 | 0.407 | 3.8e-60 | |
| TAIR|locus:2075661 | 1025 | AT3G47110 [Arabidopsis thalian | 0.636 | 0.293 | 0.414 | 1e-58 | |
| TAIR|locus:2047525 | 980 | AT2G24130 [Arabidopsis thalian | 0.663 | 0.320 | 0.349 | 6.3e-42 | |
| TAIR|locus:2132168 | 725 | AT4G02010 [Arabidopsis thalian | 0.515 | 0.336 | 0.372 | 1.2e-40 | |
| TAIR|locus:2005498 | 1196 | BRI1 "BRASSINOSTEROID INSENSIT | 0.524 | 0.207 | 0.399 | 6.6e-40 |
| TAIR|locus:2075631 AT3G47090 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 676 (243.0 bits), Expect = 1.4e-67, Sum P(2) = 1.4e-67
Identities = 139/331 (41%), Positives = 208/331 (62%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKA 194
S+ DL NAT+GFSS+N++G+G+FG+V+ L + +AVKV N+ R G KSF +EC++
Sbjct: 690 SYGDLRNATDGFSSSNIVGSGSFGTVFKALLQTENKIVAVKVLNMQRRGAMKSFMAECES 749
Query: 195 AINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKD-DTNWRPLNFNFL 253
+I+HRN+V++ TA + +D+QG F+A++Y+FMPNGSL++WL ++ + RP L
Sbjct: 750 LKDIRHRNLVKLLTACASIDFQGNEFRALIYEFMPNGSLDKWLHPEEVEEIHRPSRTLTL 809
Query: 254 IKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDK 313
+++ L+IAIDVA L YLH C PIAHC+LKPSN+LLDD++ HV DFG+AR L D+
Sbjct: 810 LER-LNIAIDVASVLDYLHVHCHEPIAHCDLKPSNILLDDDLTAHVSDFGLARLLLKFDQ 868
Query: 314 QNRF-----ICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKM 368
++ F ++G+ GY PEY +G + S +GDVYSFG+L+LEMFTG RP++ +F G
Sbjct: 869 ESFFNQLSSAGVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLVLEMFTGKRPTNELFGGNF 928
Query: 369 NLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVXXXXXXXXXXXIILECFNSICEIG 428
L ++ K ALP+R ++ D L G + V LEC I ++G
Sbjct: 929 TLNSYTKAALPERVLDIADKSILHS---GLRVGFPV-------------LECLKGILDVG 972
Query: 429 VACSAERPRERMKINDVESRLRLIRRKLLET 459
+ C E P R+ ++ L IR + +T
Sbjct: 973 LRCCEESPLNRLATSEAAKELISIRERFFKT 1003
|
|
| TAIR|locus:2079142 AT3G47570 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 682 (245.1 bits), Expect = 1.0e-66, P = 1.0e-66
Identities = 144/330 (43%), Positives = 208/330 (63%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGSKSFKSECKA 194
S+ DL NATNGFSS+N++G+G+FG+VY L + +AVKV N+ R G KSF +EC++
Sbjct: 691 SYGDLRNATNGFSSSNMVGSGSFGTVYKALLLTEKKVVAVKVLNMQRRGAMKSFMAECES 750
Query: 195 AINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKD-DTNWRPLNFNFL 253
+I+HRN+V++ TA S +D+QG F+A++Y+FMPNGSL+ WL ++ + RP L
Sbjct: 751 LKDIRHRNLVKLLTACSSIDFQGNEFRALIYEFMPNGSLDMWLHPEEVEEIHRPSRTLTL 810
Query: 254 IKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDK 313
+++ L+IAIDVA L YLH C PIAHC+LKPSNVLLDD++ HV DFG+AR L D+
Sbjct: 811 LER-LNIAIDVASVLDYLHVHCHEPIAHCDLKPSNVLLDDDLTAHVSDFGLARLLLKFDE 869
Query: 314 QNRF-----ICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKM 368
++ F ++G+ GY PEY +G + S GDVYSFGILLLEMFTG RP++ +F G
Sbjct: 870 ESFFNQLSSAGVRGTIGYAAPEYGVGGQPSINGDVYSFGILLLEMFTGKRPTNELFGGNF 929
Query: 369 NLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVXXXXXXXXXXXIILECFNSICEIG 428
L ++ K ALP+R ++VD+ L + + V ++EC + E+G
Sbjct: 930 TLNSYTKSALPERILDIVDESILH-------IGLRVGFP---------VVECLTMVFEVG 973
Query: 429 VACSAERPRERMKINDVESRLRLIRRKLLE 458
+ C E P R+ + V L IR + +
Sbjct: 974 LRCCEESPMNRLATSIVVKELISIRERFFK 1003
|
|
| TAIR|locus:2079157 AT3G47580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 665 (239.2 bits), Expect = 2.7e-66, Sum P(2) = 2.7e-66
Identities = 135/330 (40%), Positives = 203/330 (61%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKA 194
S+ DL NATNGFSS+N++G+G+FG+V+ L + +AVKV N+ R G KSF +EC++
Sbjct: 692 SYGDLRNATNGFSSSNMVGSGSFGTVFKALLPTESKIVAVKVLNMQRRGAMKSFMAECES 751
Query: 195 AINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLI 254
+ +HRN+V++ TA + D+QG F+A++Y+++PNGS++ WL ++ R +
Sbjct: 752 LKDTRHRNLVKLLTACASTDFQGNEFRALIYEYLPNGSVDMWLHPEEVEEIRRPPRTLTL 811
Query: 255 KKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQ 314
++L+I IDVA L YLH C PIAHC+LKPSNVLL+D++ HV DFG+AR L DK+
Sbjct: 812 LERLNIVIDVASVLDYLHVHCHEPIAHCDLKPSNVLLEDDLTAHVSDFGLARLLLKFDKE 871
Query: 315 ---NRFIC--IKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMN 369
N+ ++G+ GY PEY +G + S +GDVYSFG+LLLEMFTG RP+D +F G +
Sbjct: 872 SFLNQLSSAGVRGTIGYAAPEYGMGGQPSIHGDVYSFGVLLLEMFTGKRPTDELFGGNLT 931
Query: 370 LRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVXXXXXXXXXXXIILECFNSICEIGV 429
L ++ K+ALP++ E+ D L + + V EC + E+G+
Sbjct: 932 LHSYTKLALPEKVFEIADKAILH-------IGLRVGFRTA---------ECLTLVLEVGL 975
Query: 430 ACSAERPRERMKINDVESRLRLIRRKLLET 459
C E P R+ ++V L IR + +T
Sbjct: 976 RCCEEYPTNRLATSEVAKELISIRERFFKT 1005
|
|
| TAIR|locus:2175703 AT5G39390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 627 (225.8 bits), Expect = 4.8e-66, Sum P(2) = 4.8e-66
Identities = 122/249 (48%), Positives = 172/249 (69%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKA 194
S+++LYNAT+GFSS+NLIG+GNF V+ G L + +AVKV NL++ G +KSF +EC++
Sbjct: 198 SYEELYNATSGFSSSNLIGSGNFSDVFKGLLGLEEKLVAVKVLNLLKHGATKSFIAECES 257
Query: 195 AINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLI 254
I+HRN+ ++ T S +D QG F+A+VY+FMP GSL+ WL+ +D + + +
Sbjct: 258 FKGIRHRNLAKLITVCSSLDSQGNDFRALVYEFMPKGSLDMWLQPEDLESANNHSRSLTF 317
Query: 255 KKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQ 314
+K++IAIDVA AL YLH C P+AHC++KPSNVLLDD++ HV DFG+AR L D++
Sbjct: 318 AEKVNIAIDVASALEYLHVYCHDPVAHCDIKPSNVLLDDDLTAHVSDFGLARLLYNFDEK 377
Query: 315 ---NRFIC--IKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMN 369
N+F ++G+ GY PEY +G + S GDVYSFG+LLLEMFTG +P+D F G N
Sbjct: 378 TFLNQFSSAGVRGTIGYAAPEYGMGSKPSIQGDVYSFGVLLLEMFTGKKPTDNSFGGGYN 437
Query: 370 LRNFVKMAL 378
L + K L
Sbjct: 438 LHGYTKSVL 446
|
|
| TAIR|locus:2149922 EFR "EF-TU receptor" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 610 (219.8 bits), Expect = 2.3e-65, Sum P(3) = 2.3e-65
Identities = 119/249 (47%), Positives = 172/249 (69%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGSKSFKSECKA 194
S+++L++AT+ FSS NLIG+GNFG+V+ G L + +AVKV NL++ G +KSF +EC+
Sbjct: 701 SYEELHSATSRFSSTNLIGSGNFGNVFKGLLGPENKLVAVKVLNLLKHGATKSFMAECET 760
Query: 195 AINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLI 254
I+HRN+V++ T S +D +G F+A+VY+FMP GSL+ WL+ +D + +
Sbjct: 761 FKGIRHRNLVKLITVCSSLDSEGNDFRALVYEFMPKGSLDMWLQLEDLERVNDHSRSLTP 820
Query: 255 KKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQ 314
+KL+IAIDVA AL YLH C P+AHC++KPSN+LLDD++ HV DFG+A+ L D++
Sbjct: 821 AEKLNIAIDVASALEYLHVHCHDPVAHCDIKPSNILLDDDLTAHVSDFGLAQLLYKYDRE 880
Query: 315 ---NRFIC--IKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMN 369
N+F ++G+ GY PEY +G + S GDVYSFGILLLEMF+G +P+D F G N
Sbjct: 881 SFLNQFSSAGVRGTIGYAAPEYGMGGQPSIQGDVYSFGILLLEMFSGKKPTDESFAGDYN 940
Query: 370 LRNFVKMAL 378
L ++ K L
Sbjct: 941 LHSYTKSIL 949
|
|
| UNIPROTKB|Q40640 Xa21 "Receptor kinase-like protein" [Oryza sativa (taxid:4530)] | Back alignment and assigned GO terms |
|---|
Score = 623 (224.4 bits), Expect = 3.8e-60, P = 3.8e-60
Identities = 136/334 (40%), Positives = 192/334 (57%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAA 195
S+ L AT+GF+ NL+G+G+FGSVY G L +AVKV L P KSF +EC+A
Sbjct: 697 SYSQLVKATDGFAPTNLLGSGSFGSVYKGKLNIQDHVAVKVLKLENPKALKSFTAECEAL 756
Query: 196 INIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGK--DDTNWRPLNFNFL 253
N++HRN+V++ T S +D +G FKA+VY FMPNGSLE+W+ + D + R LN +
Sbjct: 757 RNMRHRNLVKIVTICSSIDNRGNDFKAIVYDFMPNGSLEDWIHPETNDQADQRHLNLH-- 814
Query: 254 IKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL----P 309
+++ I +DVACAL YLH P+ HC++K SNVLLD +M+ HVGDFG+AR L
Sbjct: 815 --RRVTILLDVACALDYLHRHGPEPVVHCDIKSSNVLLDSDMVAHVGDFGLARILVDGTS 872
Query: 310 AIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMN 369
I + + G+ GY PEY +G AST+GD+YS+GIL+LE+ TG RP+D F +
Sbjct: 873 LIQQSTSSMGFIGTIGYAAPEYGVGLIASTHGDIYSYGILVLEIVTGKRPTDSTFRPDLG 932
Query: 370 LRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVXXXXXXXXXXXIILECFNSICEIGV 429
LR +V++ L R +VVD + + E I EC + +G+
Sbjct: 933 LRQYVELGLHGRVTDVVDTKLILDSENWLN--------STNNSPCRRITECIVWLLRLGL 984
Query: 430 ACSAERPRERMKINDVESRLRLIRRKLLET-PAC 462
+CS E P R D+ L I++ L P C
Sbjct: 985 SCSQELPSSRTPTGDIIDELNAIKQNLSGLFPVC 1018
|
|
| TAIR|locus:2075661 AT3G47110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 610 (219.8 bits), Expect = 1.0e-58, P = 1.0e-58
Identities = 135/326 (41%), Positives = 195/326 (59%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTLFD-GTTIAVKVFNLIRPGGSKSFKSECKA 194
S+ +LY T GFSS+NLIG+GNFG+V+ G L +A+KV NL + G +KSF +EC+A
Sbjct: 708 SYDELYKTTGGFSSSNLIGSGNFGAVFKGFLGSKNKAVAIKVLNLCKRGAAKSFIAECEA 767
Query: 195 AINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKD-DTNWRPLNFNFL 253
I+HRN+V++ T S D++G F+A+VY+FMPNG+L+ WL + + P L
Sbjct: 768 LGGIRHRNLVKLVTICSSSDFEGNDFRALVYEFMPNGNLDMWLHPDEIEETGNPSRTLGL 827
Query: 254 IKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDK 313
+ L+IAIDVA AL YLH C PIAHC++KPSN+LLD ++ HV DFG+A+ L D+
Sbjct: 828 FAR-LNIAIDVASALVYLHTYCHNPIAHCDIKPSNILLDKDLTAHVSDFGLAQLLLKFDR 886
Query: 314 QNRFIC-----IKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKM 368
I ++G+ GY PEY +G S GDVYSFGI+LLE+FTG RP++ +F +
Sbjct: 887 DTFHIQFSSAGVRGTIGYAAPEYGMGGHPSIMGDVYSFGIVLLEIFTGKRPTNKLFVDGL 946
Query: 369 NLRNFVKMALPQR-AEEVVDDFNLQEIEEGRTMCMEVXXXXXXXXXXXIILECFNSICEI 427
L +F K AL +R A ++ D+ L+ ++EC + +
Sbjct: 947 TLHSFTKSALQKRQALDITDETILR----------------GAYAQHFNMVECLTLVFRV 990
Query: 428 GVACSAERPRERMKINDVESRLRLIR 453
GV+CS E P R+ + + S+L IR
Sbjct: 991 GVSCSEESPVNRISMAEAISKLVSIR 1016
|
|
| TAIR|locus:2047525 AT2G24130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 454 (164.9 bits), Expect = 6.3e-42, P = 6.3e-42
Identities = 124/355 (34%), Positives = 185/355 (52%)
Query: 127 EGKQTINNP-----SFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFN-LI 180
E KQ N+P S++ L AT GF++++LIG+G FG VY G L + T +AVKV +
Sbjct: 636 EEKQNQNDPKYPRISYQQLIAATGGFNASSLIGSGRFGHVYKGVLRNNTKVAVKVLDPKT 695
Query: 181 RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGK 240
S SFK EC+ +HRN++R+ T S G F A+V MPNGSLE L
Sbjct: 696 ALEFSGSFKRECQILKRTRHRNLIRIITTCSK---PG--FNALVLPLMPNGSLERHLYPG 750
Query: 241 DDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300
+ + N + + + ++I DVA + YLH + HC+LKPSN+LLDDEM V
Sbjct: 751 E---YSSKNLDLI--QLVNICSDVAEGIAYLHHYSPVKVVHCDLKPSNILLDDEMTALVT 805
Query: 301 DFGMARFLPAIDKQ------------NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGI 348
DFG++R + +++ + +C GS GYI PEY +G AST+GDVYSFG+
Sbjct: 806 DFGISRLVQGVEETVSTDDSVSFGSTDGLLC--GSVGYIAPEYGMGKRASTHGDVYSFGV 863
Query: 349 LLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVXXXX 408
LLLE+ +G RP+D + +L F+K P E +++ + +G+ E
Sbjct: 864 LLLEIVSGRRPTDVLVNEGSSLHEFMKSHYPDSLEGIIEQALSRWKPQGKPEKCE----- 918
Query: 409 XXXXXXXIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRKLLETPACL 463
+ILE + E+G+ C+ P R + DV + ++ L P+ L
Sbjct: 919 --KLWREVILE----MIELGLVCTQYNPSTRPDMLDVAHEMGRLKEYLFACPSLL 967
|
|
| TAIR|locus:2132168 AT4G02010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 406 (148.0 bits), Expect = 1.2e-40, Sum P(2) = 1.2e-40
Identities = 95/255 (37%), Positives = 141/255 (55%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAA 195
S+++L AT+ F SA+++G G FG VY G L DGT +A+K P G K F+ E
Sbjct: 369 SYEELKEATSNFESASILGEGGFGKVYRGILADGTAVAIKKLTSGGPQGDKEFQVEIDML 428
Query: 196 INIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIK 255
+ HRN+V++ +S D + + Y+ +PNGSLE WL G N PL+++ +K
Sbjct: 429 SRLHHRNLVKLVGYYSSRD---SSQHLLCYELVPNGSLEAWLHGPLGLNC-PLDWDTRMK 484
Query: 256 KKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQN 315
IA+D A L YLH D QP + H + K SN+LL++ V DFG+A+ P +
Sbjct: 485 ----IALDAARGLAYLHEDSQPSVIHRDFKASNILLENNFNAKVADFGLAKQAPEGRGNH 540
Query: 316 RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSD-GIFTGKMNLRNFV 374
+ G+ GY+ PEY + DVYS+G++LLE+ TG +P D +G+ NL +
Sbjct: 541 LSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPSGQENLVTWT 600
Query: 375 KMAL--PQRAEEVVD 387
+ L R EE+VD
Sbjct: 601 RPVLRDKDRLEELVD 615
|
|
| TAIR|locus:2005498 BRI1 "BRASSINOSTEROID INSENSITIVE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 437 (158.9 bits), Expect = 6.6e-40, P = 6.6e-40
Identities = 103/258 (39%), Positives = 144/258 (55%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAA 195
+F DL ATNGF + +LIG+G FG VY L DG+ +A+K + G + F +E +
Sbjct: 872 TFADLLQATNGFHNDSLIGSGGFGDVYKAILKDGSAVAIKKLIHVSGQGDREFMAEMETI 931
Query: 196 INIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIK 255
IKHRN+V + G G + +VY+FM GSLE+ L D + N+ +
Sbjct: 932 GKIKHRNLVPLL----GYCKVGDE-RLLVYEFMKYGSLEDVLH---DPKKAGVKLNWSTR 983
Query: 256 KKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQN 315
+K IAI A L +LH +C P I H ++K SNVLLD+ + V DFGMAR + A+D
Sbjct: 984 RK--IAIGSARGLAFLHHNCSPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHL 1041
Query: 316 RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVK 375
+ G+ GY+PPEY ST GDVYS+G++LLE+ TG RP+D G NL +VK
Sbjct: 1042 SVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTDSPDFGDNNLVGWVK 1101
Query: 376 MALPQRAEEVVDDFNLQE 393
R +V D ++E
Sbjct: 1102 QHAKLRISDVFDPELMKE 1119
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
No EC number assignment, probably not an enzyme!
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 473 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-33 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-29 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-29 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 8e-27 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-26 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-26 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-26 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-25 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-21 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-20 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-18 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-18 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-18 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-18 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-17 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-17 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-16 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-16 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-16 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-16 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-15 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-15 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-14 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-14 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-14 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-14 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-14 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-14 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-14 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-14 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-13 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-13 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-13 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-13 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-13 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 9e-13 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-12 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-12 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-12 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-12 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-12 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-12 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-12 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-12 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 9e-12 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-11 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-11 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-11 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-11 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-11 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-11 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 5e-11 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-11 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-10 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-10 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-10 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-10 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-10 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-10 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-10 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 5e-10 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-10 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 8e-10 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 9e-10 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-09 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-09 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-09 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-09 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-09 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-09 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 7e-09 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-08 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-08 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-08 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-08 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-08 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-08 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-08 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-08 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-08 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-08 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 7e-08 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-08 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 9e-08 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 9e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-07 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-07 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-07 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-07 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-07 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-07 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-07 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-07 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-07 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-07 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-07 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-07 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-07 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-07 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-07 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 6e-07 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-07 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-07 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-07 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 9e-07 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 9e-07 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-06 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-06 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-06 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-06 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-06 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-06 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-06 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-06 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-06 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-06 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-06 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-06 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-06 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-06 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-06 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-06 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-06 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-06 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-06 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-06 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-05 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-05 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-05 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-05 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-05 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-05 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-05 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-05 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-05 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-05 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-05 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-05 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-05 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-05 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-05 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-05 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-05 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-05 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-05 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-05 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-05 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-05 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-05 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 7e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 7e-05 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-05 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 9e-05 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 9e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-04 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-04 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-04 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-04 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-04 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-04 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-04 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-04 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-04 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-04 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-04 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-04 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-04 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-04 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-04 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-04 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-04 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-04 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-04 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-04 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-04 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-04 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-04 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-04 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 8e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 8e-04 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 0.001 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 0.001 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 0.001 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 0.001 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 0.001 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.001 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.001 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 0.002 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 0.002 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.002 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 0.002 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 0.002 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 0.002 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 0.003 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 0.003 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 0.003 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 0.003 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 0.003 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 0.003 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 0.004 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 5e-33
Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSK-SFKSECKAAINIKHRNIVRVFTAF 210
+G G FG+VY G +A+K+ E + + H NIV+++ F
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
+ +V ++ GSL++ L+ N L+ + +++ I + + L Y
Sbjct: 61 -----EDENHLYLVMEYCEGGSLKDLLK----ENEGKLSEDEILR----ILLQILEGLEY 107
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIKGSTGYIP 328
LH I H +LKP N+LLD + G V DFG+++ L ++ I G+ Y+
Sbjct: 108 LH---SNGIIHRDLKPENILLDSD-NGKVKLADFGLSKLLT--SDKSLLKTIVGTPAYMA 161
Query: 329 PEYDLGCEASTY-GDVYSFGILLLEM 353
PE LG + D++S G++L E+
Sbjct: 162 PEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 4e-29
Identities = 66/230 (28%), Positives = 97/230 (42%), Gaps = 42/230 (18%)
Query: 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFT 208
+G G+FG VY G +A+KV + + E K +KH NIVR++
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 209 AFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACAL 268
F D +V ++ G L + L+ L+ + + AL
Sbjct: 65 VFEDEDKL-----YLVMEYCEGGDLFDLLK-----KRGRLSEDEARF----YLRQILSAL 110
Query: 269 RYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIKGSTGY 326
YLH I H +LKP N+LLD++ GHV DFG+AR L +K F+ G+ Y
Sbjct: 111 EYLHSKG---IVHRDLKPENILLDED--GHVKLADFGLARQLDPGEKLTTFV---GTPEY 162
Query: 327 IPPE------YDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNL 370
+ PE Y D++S G++L E+ TG P F G L
Sbjct: 163 MAPEVLLGKGYGKAV------DIWSLGVILYELLTGKPP----FPGDDQL 202
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 7e-29
Identities = 60/214 (28%), Positives = 94/214 (43%), Gaps = 30/214 (14%)
Query: 153 IGAGNFGSVYNGTLFD-----GTTIAVKVFNLI-RPGGSKSFKSECKAAINIKHRNIVRV 206
+G G FG VY GTL T +AVK + F E + H NIVR
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR- 65
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVAC 266
GV QG +V ++MP G L ++LR + +K L +A+ +A
Sbjct: 66 ---LLGVCTQGEPLY-IVTEYMPGGDLLDFLRKHGE--------KLTLKDLLQMALQIAK 113
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAID----KQNRFICIKG 322
+ YL H +L N L+ + ++ + DFG++R + D + + IK
Sbjct: 114 GMEYLE---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIK- 169
Query: 323 STGYIPPEYDLGCEASTYGDVYSFGILLLEMFTG 356
++ PE + ++ DV+SFG+LL E+FT
Sbjct: 170 ---WMAPESLKDGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 8e-27
Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 23/215 (10%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNL--IRPGGSKSFKSECKAAINIKHRNIVRVFTA 209
+G+G+FG+VY G +AVK+ + ++ + E + + H NIVR+
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI-- 64
Query: 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALR 269
+V ++ G L ++L PL+ + KK IA+ + L
Sbjct: 65 --DAFEDKDHL-YLVMEYCEGGDLFDYLSRG-----GPLSED-EAKK---IALQILRGLE 112
Query: 270 YLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPP 329
YLH + I H +LKP N+LLD+ + + DFG+A+ L G+ Y+ P
Sbjct: 113 YLHSN---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV--GTPWYMAP 167
Query: 330 EYDLGCEASTYG-DVYSFGILLLEMFTGIRPSDGI 363
E LG DV+S G++L E+ TG P G
Sbjct: 168 EVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGE 202
|
Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 56/224 (25%), Positives = 95/224 (42%), Gaps = 36/224 (16%)
Query: 153 IGAGNFGSVYNGTLFD-----GTTIAVKVFNLIRPGGS----KSFKSECKAAINIKHRNI 203
+G G FG VY G L +AVK ++ S + F E + + H N+
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKT---LKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 204 VRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAID 263
V+ GV + +V ++M G L +LR + L A+
Sbjct: 64 VK----LLGVCTEEEPLY-IVMEYMEGGDLLSYLRKNRP--------KLSLSDLLSFALQ 110
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPA---IDKQNRFICI 320
+A + YL H +L N L+ + ++ + DFG++R L K+ + I
Sbjct: 111 IARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPI 167
Query: 321 KGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363
+ ++ PE + ++ DV+SFG+LL E+FT G +P G+
Sbjct: 168 R----WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM 207
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 61/226 (26%), Positives = 95/226 (42%), Gaps = 39/226 (17%)
Query: 153 IGAGNFGSVYNGTLFDG-----TTIAVKVFNLIRPGGS----KSFKSECKAAINIKHRNI 203
+G G FG VY GTL +AVK ++ S + F E + + H NI
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKT---LKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 204 VRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAID 263
V+ GV + +V ++MP G L ++LR + L A+
Sbjct: 64 VK----LLGVCTEEEPLM-IVMEYMPGGDLLDYLRKNRPKE-------LSLSDLLSFALQ 111
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGS 323
+A + YL H +L N L+ + ++ + DFG++R L D K
Sbjct: 112 IARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY------YKVK 162
Query: 324 TGYIP-----PEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363
G +P PE + ++ DV+SFG+LL E+FT G P G+
Sbjct: 163 GGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGM 208
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 3e-26
Identities = 62/227 (27%), Positives = 98/227 (43%), Gaps = 30/227 (13%)
Query: 151 NLIGAGNFGSVYNGTLFDG----TTIAVKVFNLIRPGGSKS----FKSECKAAINIKHRN 202
+G G FG VY G L T +AVK ++ S+ F E + + H N
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKT---LKEDASEEERKDFLKEARVMKKLGHPN 57
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAI 262
+VR+ GV + +V ++M G L ++LR P +K L AI
Sbjct: 58 VVRLL----GVCTEEEPLY-LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAI 112
Query: 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKG 322
+A + YL H +L N L+ ++++ + DFG++R + D K
Sbjct: 113 QIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYY-----RKK 164
Query: 323 STGYIP-----PEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363
+ G +P PE ++ DV+SFG+LL E+FT G P G+
Sbjct: 165 TGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL 211
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 7e-25
Identities = 59/215 (27%), Positives = 97/215 (45%), Gaps = 24/215 (11%)
Query: 151 NLIGAGNFGSVYNGTLFD-GTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVF 207
L+G G+FGSVY D G +AVK L ++ + E + +++H NIVR +
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 208 TAFSGVDYQGARFKAVVYKFM---PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDV 264
G + K + F+ GSL L+ + L +I+K +
Sbjct: 66 ----GSERD--EEKNTLNIFLEYVSGGSLSSLLK-----KFGKLP-EPVIRK---YTRQI 110
Query: 265 ACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGST 324
L YLH I H ++K +N+L+D + + + DFG A+ L I+ ++G+
Sbjct: 111 LEGLAYLH-SNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTP 167
Query: 325 GYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
++ PE G E D++S G ++EM TG P
Sbjct: 168 YWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 95.2 bits (235), Expect = 3e-21
Identities = 63/224 (28%), Positives = 98/224 (43%), Gaps = 28/224 (12%)
Query: 152 LIGAGNFGSVYNGTLFDGTTIAVKVFNL---IRPGGSKSFKSECKAAINIKH-RNIVRVF 207
+G G+FG VY D +A+KV + + F E + ++ H NIV+++
Sbjct: 7 KLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 208 TAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACA 267
F Q +V +++ GSLE+ L+ + L I + A
Sbjct: 65 DFF-----QDEGSLYLVMEYVDGGSLEDLLK------KIGRKGPLSESEALFILAQILSA 113
Query: 268 LRYLHCDCQPPIAHCNLKPSNVLLD-DEMIGHVGDFGMARFLPAID----KQNRFICIKG 322
L YLH I H ++KP N+LLD D + + DFG+A+ LP G
Sbjct: 114 LEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVG 170
Query: 323 STGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDGI 363
+ GY+ PE LG + D++S GI L E+ TG+ P +G
Sbjct: 171 TPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGE 214
|
Length = 384 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 1e-20
Identities = 77/318 (24%), Positives = 131/318 (41%), Gaps = 58/318 (18%)
Query: 151 NLIGAGNFGSVYNGT---LFDGTT--IAVKVFNLIRPGGSKS-FKSECKAAINIKHRNIV 204
+G G+FG V L D T +AVK N +S F+ E + + H NIV
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 205 RVFTAFSGVDY-QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIA-- 261
+ + GV G R ++ +++P+GSL ++L+ D L+ I
Sbjct: 70 K----YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKR----LLLFSSQICKG 121
Query: 262 IDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIK 321
+D + RY+H D L N+L++ E + + DFG+A+ LP DK ++
Sbjct: 122 MDYLGSQRYIHRD---------LAARNILVESEDLVKISDFGLAKVLPE-DKDYYYV--- 168
Query: 322 GSTGYIP-----PEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKM 376
G P PE + S+ DV+SFG+ L E+FT PS + F++M
Sbjct: 169 KEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPS------QSPPAEFLRM 222
Query: 377 ALPQRAEEVVDDFNLQEIEEG-RTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAER 435
+ + +V L+ ++EG R C + + ++ C
Sbjct: 223 IGIAQGQMIVTRL-LELLKEGERLPRPP---------------SCPDEVYDLMKLCWEAE 266
Query: 436 PRERMKINDVESRLRLIR 453
P++R D+ + +R
Sbjct: 267 PQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 1e-18
Identities = 56/222 (25%), Positives = 92/222 (41%), Gaps = 42/222 (18%)
Query: 147 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVR 205
F IG G FG VY G +A+KV L + +E + KH NIV+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIA---I 262
+ ++ + + +V +F GSL++ L+ + L + IA
Sbjct: 62 YYGSY---LKKDELW--IVMEFCSGGSLKDLLKST----NQTLT-------ESQIAYVCK 105
Query: 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICI 320
++ L YLH I H ++K +N+LL + G V DFG++ L +N +
Sbjct: 106 ELLKGLEYLH---SNGIIHRDIKAANILLTSD--GEVKLIDFGLSAQLSDTKARNTMV-- 158
Query: 321 KGSTGYIPPE------YDLGCEASTYGDVYSFGILLLEMFTG 356
G+ ++ PE YD D++S GI +E+ G
Sbjct: 159 -GTPYWMAPEVINGKPYDYKA------DIWSLGITAIELAEG 193
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 1e-18
Identities = 64/212 (30%), Positives = 93/212 (43%), Gaps = 29/212 (13%)
Query: 152 LIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSK-SFKSECKAAINIKHRNIVRVFTAF 210
IG GNFG VY G L T +AVK P K F E + H NIV++
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLI--- 58
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
GV Q +V + +P GSL +LR K + +KK L +++D A + Y
Sbjct: 59 -GVCVQKQPI-YIVMELVPGGSLLTFLRKKKN--------RLTVKKLLQMSLDAAAGMEY 108
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPE 330
L H +L N L+ + + + DFGM+R +++ + IP +
Sbjct: 109 LESKN---CIHRDLAARNCLVGENNVLKISDFGMSR-----EEEGGIYTVSDGLKQIPIK 160
Query: 331 YDLGCEASTYG------DVYSFGILLLEMFTG 356
+ EA YG DV+S+GILL E F+
Sbjct: 161 WT-APEALNYGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 3e-18
Identities = 83/325 (25%), Positives = 136/325 (41%), Gaps = 85/325 (26%)
Query: 153 IGAGNFGSVYNGTLF------DGTTIAVKVF-NLIRPGGSKSFKSECKAAINIKHRNIVR 205
+G G FG V+ G + D +AVK K F+ E + N +H NIV+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK-------- 257
F GV +G +V+++M +G L ++LR + FL
Sbjct: 73 ----FYGVCTEGDPP-IMVFEYMEHGDLNKFLRSHGP------DAAFLKSPDSPMGELTL 121
Query: 258 ---LDIAIDVACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAI 311
L IA+ +A + YL H H +L N L+ +++ +GDFGM+R +
Sbjct: 122 SQLLQIAVQIASGMVYLASQH------FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTT 175
Query: 312 DKQNRFICIKGST----GYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTG 366
D + + G T ++PPE + + +T DV+SFG++L E+FT G +P G
Sbjct: 176 D----YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYG---- 227
Query: 367 KMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTM-CMEVSSSSGSSAHASIILECFNSIC 425
L N EEV+ + I +GR + C + +
Sbjct: 228 ---LSN----------EEVI-----ECITQGRLLQRPRT---------------CPSEVY 254
Query: 426 EIGVACSAERPRERMKINDVESRLR 450
+I + C P++R+ I D+ RL+
Sbjct: 255 DIMLGCWKRDPQQRINIKDIHERLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 7e-18
Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 34/210 (16%)
Query: 152 LIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSK-SFKSECKAAINIKHRNIVRVFTAF 210
IG G FG V G + G +AVK L + +F +E ++H N+V+
Sbjct: 13 TIGKGEFGDVMLGD-YRGQKVAVK--CLKDDSTAAQAFLAEASVMTTLRHPNLVQ----L 65
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
GV QG +V ++M GSL ++LR + R + + ++L A+DV + Y
Sbjct: 66 LGVVLQGNPL-YIVTEYMAKGSLVDYLR----SRGRAVI---TLAQQLGFALDVCEGMEY 117
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIP-- 328
L + H +L NVL+ ++++ V DFG+A + +G +P
Sbjct: 118 LE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLA----------KEASQGQDSGKLPVK 164
Query: 329 ---PEYDLGCEASTYGDVYSFGILLLEMFT 355
PE + ST DV+SFGILL E+++
Sbjct: 165 WTAPEALREKKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 4e-17
Identities = 66/222 (29%), Positives = 94/222 (42%), Gaps = 35/222 (15%)
Query: 151 NLIGAGNFGSVYNG-TLFDGTTIAVKVFNLIRPGGS--KSFKSECKAAINIKHRNIVRVF 207
N IG G FG VY L G +AVK + K E K +KH N+V+ +
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 208 TAFSGVDYQGARFKAVVYKFMP---NGSLEEWLRGK--DDTNWRPLNFNFLIKKKLDIAI 262
GV+ + VY FM G+LEE L D + + L++
Sbjct: 66 ----GVEVHREK----VYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLE------- 110
Query: 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL--PAIDKQNRFICI 320
L YLH I H ++KP+N+ LD + +GDFG A L +
Sbjct: 111 ----GLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSL 163
Query: 321 KGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
G+ Y+ PE G + +G D++S G ++LEM TG RP
Sbjct: 164 AGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 8e-17
Identities = 59/225 (26%), Positives = 102/225 (45%), Gaps = 26/225 (11%)
Query: 147 FSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRV 206
F+ +G+G FG V+ G + +A+K+ + F+ E +A ++H++++ +
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 207 FTAFSGVD--YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDV 264
F S + Y ++ + M GSL +LR + + +D+A V
Sbjct: 68 FAVCSVGEPVY-------IITELMEKGSLLAFLRSPEGQVLP-------VASLIDMACQV 113
Query: 265 ACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL--PAIDKQNRFICIKG 322
A + YL + H +L N+L+ ++++ V DFG+AR + ++ I K
Sbjct: 114 AEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK- 169
Query: 323 STGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTG 366
+ PE ST DV+SFGILL EMFT G P G+
Sbjct: 170 ---WTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH 211
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 1e-16
Identities = 65/246 (26%), Positives = 108/246 (43%), Gaps = 50/246 (20%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAF 210
IG+G FG V+ G + +A+K IR G + F E + + + H +V+++
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKT---IREGAMSEEDFIEEAQVMMKLSHPKLVQLY--- 65
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
GV + + +V++FM +G L ++LR + F + L + +DV + Y
Sbjct: 66 -GVCTERSPI-CLVFEFMEHGCLSDYLRAQRGK--------FSQETLLGMCLDVCEGMAY 115
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTG----- 325
L + H +L N L+ + + V DFGM RF+ +D Q STG
Sbjct: 116 LESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFV--LDDQ-----YTSSTGTKFPV 165
Query: 326 -YIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEE 384
+ PE + S+ DV+SFG+L+ E+F+ GK N + E
Sbjct: 166 KWSSPEVFSFSKYSSKSDVWSFGVLMWEVFS---------EGKTPYEN-------RSNSE 209
Query: 385 VVDDFN 390
VV+ N
Sbjct: 210 VVETIN 215
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 4e-16
Identities = 62/248 (25%), Positives = 116/248 (46%), Gaps = 31/248 (12%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAF 210
+G G FG V+ GT T +A+K ++PG ++F E + ++H +V+++
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 70
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
S +V ++M GSL ++L+G+ R + + +D+A +A + Y
Sbjct: 71 SEEPIY------IVTEYMSKGSLLDFLKGEMGKYLR-------LPQLVDMAAQIASGMAY 117
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGST---GYI 327
+ + H +L+ +N+L+ + ++ V DFG+AR + + N + +G+ +
Sbjct: 118 VE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI----EDNEYTARQGAKFPIKWT 170
Query: 328 PPEYDLGCEASTYGDVYSFGILLLEMFTGIR-PSDGIFTGKM--NLRNFVKMALPQRAEE 384
PE L + DV+SFGILL E+ T R P G+ ++ + +M P E
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPE 230
Query: 385 VVDDFNLQ 392
+ D Q
Sbjct: 231 SLHDLMCQ 238
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 4e-16
Identities = 59/213 (27%), Positives = 103/213 (48%), Gaps = 37/213 (17%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAF 210
+GAG FG V+ GT T +AVK ++PG ++F E + ++H +V+++
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKT---LKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVC 70
Query: 211 SGVD--YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACAL 268
S + Y +V ++M GSL ++L K + L L+ D+A +A +
Sbjct: 71 SEEEPIY-------IVTEYMSKGSLLDFL--KSGEG-KKLRLPQLV----DMAAQIAEGM 116
Query: 269 RYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIP 328
YL H +L N+L+ + ++ + DFG+AR + + + + +G+ P
Sbjct: 117 AYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLI----EDDEYTAREGAK--FP 167
Query: 329 PEYDLGCEASTYG------DVYSFGILLLEMFT 355
++ EA+ YG DV+SFGILL E+ T
Sbjct: 168 IKWT-APEAANYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 5e-16
Identities = 73/246 (29%), Positives = 110/246 (44%), Gaps = 35/246 (14%)
Query: 152 LIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSK-SFKSECKAAINIKHRNIVRVFTAF 210
L+G GNFG V+ GTL D T +AVK P K F SE + H NIV++
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLI--- 58
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
GV Q +V + +P G +LR K D K+ + A+D A + Y
Sbjct: 59 -GVCTQRQPI-YIVMELVPGGDFLSFLRKKKD--------ELKTKQLVKFALDAAAGMAY 108
Query: 271 LHC-DCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPP 329
L +C H +L N L+ + + + DFGM+R +++ I IP
Sbjct: 109 LESKNC----IHRDLAARNCLVGENNVLKISDFGMSR------QEDDGIYSSSGLKQIPI 158
Query: 330 EYDLGCEASTYG------DVYSFGILLLEMFT-GIRPSDGIFT--GKMNLRNFVKMALPQ 380
++ EA YG DV+S+GILL E F+ G+ P G+ + + +M+ PQ
Sbjct: 159 KWT-APEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQ 217
Query: 381 RAEEVV 386
+ + V
Sbjct: 218 KCPDDV 223
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 3e-15
Identities = 66/229 (28%), Positives = 105/229 (45%), Gaps = 43/229 (18%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAF 210
+G+G FG V+ G +A+K +IR G F E K + + H N+V+++
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIK---MIREGAMSEDDFIEEAKVMMKLSHPNLVQLY--- 65
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLR---GKDDTNWRPLNFNFLIKKKLDIAIDVACA 267
GV + +V ++M NG L +LR GK T W LD+ DV A
Sbjct: 66 -GVCTKQRPIF-IVTEYMANGCLLNYLRERKGKLGTEWL-----------LDMCSDVCEA 112
Query: 268 LRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYI 327
+ YL + H +L N L+ ++ + V DFG+AR++ +D Q + +G+ +
Sbjct: 113 MEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYV--LDDQ--YTSSQGTKFPV 165
Query: 328 ---PPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNF 373
PPE S+ DV+SFG+L+ E+F+ GKM F
Sbjct: 166 KWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSE---------GKMPYERF 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 4e-15
Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 28/211 (13%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAF 210
+G G FG V+ GT T +AVK ++PG +SF E + ++H +V+++
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKT---LKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVV 70
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
S +V ++M GSL ++L+ D R L L+ D+A VA + Y
Sbjct: 71 S------EEPIYIVTEYMSKGSLLDFLK---DGEGRALKLPNLV----DMAAQVAAGMAY 117
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGST---GYI 327
+ + H +L+ +N+L+ D ++ + DFG+AR + + N + +G+ +
Sbjct: 118 IE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLI----EDNEYTARQGAKFPIKWT 170
Query: 328 PPEYDLGCEASTYGDVYSFGILLLEMFTGIR 358
PE L + DV+SFGILL E+ T R
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 79/319 (24%), Positives = 133/319 (41%), Gaps = 73/319 (22%)
Query: 153 IGAGNFGSVYNGTLF------DGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRV 206
+G G FG V+ D +AVK + F+ E + ++H++IVR
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR- 71
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLR----------GKDDTNWRPLNFNFLIKK 256
F GV +G R +V+++M +G L +LR G +D L +
Sbjct: 72 ---FYGVCTEG-RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQM--- 124
Query: 257 KLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNR 316
L IA +A + YL H +L N L+ ++ +GDFGM+R + + D
Sbjct: 125 -LAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD---- 176
Query: 317 FICIKGST----GYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLR 371
+ + G T ++PPE L + +T D++SFG++L E+FT G +P
Sbjct: 177 YYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP------------ 224
Query: 372 NFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVAC 431
+ +++ + E + +E+E RT C + I C
Sbjct: 225 -WYQLSNTEAIECITQG---RELERPRT--------------------CPPEVYAIMQGC 260
Query: 432 SAERPRERMKINDVESRLR 450
P++RM I D+ SRL+
Sbjct: 261 WQREPQQRMVIKDIHSRLQ 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 30/225 (13%)
Query: 153 IGAGNFGSVYNGTLF------DGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRV 206
+G G FG V+ + D +AVK K F+ E + N++H +IV+
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK- 71
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLR--GKD-----DTNWRPLNFNFLIKKKLD 259
F GV G +V+++M +G L ++LR G D D R + + L
Sbjct: 72 ---FYGVCGDGDPL-IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 260 IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFIC 319
IA +A + YL H +L N L+ ++ +GDFGM+R + + D +
Sbjct: 128 IASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD----YYR 180
Query: 320 IKGST----GYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRP 359
+ G T ++PPE + + +T DV+SFG++L E+FT G +P
Sbjct: 181 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 1e-14
Identities = 68/208 (32%), Positives = 102/208 (49%), Gaps = 27/208 (12%)
Query: 153 IGAGNFGSVYNGTLFDGTT-IAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTA 209
+GAG FG V+ G L++ TT +AVK ++PG K F +E + ++H +++++
Sbjct: 14 LGAGQFGEVWEG-LWNNTTPVAVKT---LKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAV 69
Query: 210 FSGVD--YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACA 267
+ + Y +V + M GSL E+L+G R L LI D+A VA
Sbjct: 70 CTLEEPIY-------IVTELMKYGSLLEYLQGGAG---RALKLPQLI----DMAAQVASG 115
Query: 268 LRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYI 327
+ YL + Q I H +L NVL+ + I V DFG+AR + + R K +
Sbjct: 116 MAYL--EAQNYI-HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAR-EGAKFPIKWT 171
Query: 328 PPEYDLGCEASTYGDVYSFGILLLEMFT 355
PE L S DV+SFGILL E+ T
Sbjct: 172 APEAALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 2e-14
Identities = 64/225 (28%), Positives = 94/225 (41%), Gaps = 51/225 (22%)
Query: 153 IGAGNFGSVY------NGTLFDGTTIAVKVFN---LIRPGGSKSFKSECKAAINIKHRNI 203
+G G+FG V G L+ A+KV +I+ + +E I H I
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLY-----AMKVLKKKKIIKRKEVEHTLTERNILSRINHPFI 55
Query: 204 VRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIK-KKLD--- 259
V++ AF Q +V ++ P G L F+ L K +
Sbjct: 56 VKLHYAF-----QTEEKLYLVLEYAPGGEL----------------FSHLSKEGRFSEER 94
Query: 260 ---IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQ 314
A ++ AL YLH I + +LKP N+LLD + GH+ DFG+A+ L + +
Sbjct: 95 ARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDAD--GHIKLTDFGLAKELSSEGSR 149
Query: 315 NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
C G+ Y+ PE LG D +S G+LL EM TG P
Sbjct: 150 TNTFC--GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 2e-14
Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 22/210 (10%)
Query: 153 IGAGNFGSVYNGTL-FDGTTIAVKVFNL-IRPGGSKSFKSECKAAINIKHRNIVRVFTAF 210
+G G+ G VY G A+K ++ K E K + + +V+ + AF
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
Y+ ++V ++M GSL + L+ + L IA + L Y
Sbjct: 69 ----YKEGEI-SIVLEYMDGGSLADLLKKV-----GKIPEPVLAY----IARQILKGLDY 114
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLP-AIDKQNRFICIKGSTGYIPP 329
LH I H ++KPSN+L++ + + DFG+++ L +D+ N F+ G+ Y+ P
Sbjct: 115 LHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV---GTVTYMSP 169
Query: 330 EYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
E G S D++S G+ LLE G P
Sbjct: 170 ERIQGESYSYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 3e-14
Identities = 67/221 (30%), Positives = 100/221 (45%), Gaps = 39/221 (17%)
Query: 152 LIGAGNFGSVYNG-TLFDGTTIAVKVFNLIRPGGS-----KSFKSECKAAINIKHRNIVR 205
L+G+G+FGSVY G L DG AVK +L G + K + E ++H NIV+
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 206 VFTAFSGVDYQG-ARFKAVVYKFM---PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIA 261
Y G R + +Y F+ P GSL + L+ K + P+ + ++ L
Sbjct: 67 ---------YLGTEREEDNLYIFLELVPGGSLAKLLK-KYGSFPEPVIRLY-TRQILL-- 113
Query: 262 IDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIK 321
L YLH H ++K +N+L+D + + DFGMA+ + F K
Sbjct: 114 -----GLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSF---K 162
Query: 322 GSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
GS ++ PE YG D++S G +LEM TG P
Sbjct: 163 GSPYWMAPEVIAQQGG--YGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 4e-14
Identities = 58/237 (24%), Positives = 97/237 (40%), Gaps = 46/237 (19%)
Query: 152 LIGAGNFGSVYNGTLF-DGTTIAVKVFN---LIRPGGSKSFKSECKAAIN--IKHRNIVR 205
+IG G+F +V A+K+ + LI+ K K E K + H I++
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIE-KEVLTRLNGHPGIIK 66
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVA 265
++ F D + F V ++ PNG L +++R + + + + A ++
Sbjct: 67 LYYTFQ--DEENLYF---VLEYAPNGELLQYIR-------KYGSLDEKCTRF--YAAEIL 112
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDK-QNRFICIK- 321
AL YLH I H +LKP N+LLD +M H+ DFG A+ L ++
Sbjct: 113 LALEYLH---SKGIIHRDLKPENILLDKDM--HIKITDFGTAKVLDPNSSPESNKGDATN 167
Query: 322 ----------------GSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
G+ Y+ PE A D+++ G ++ +M TG P G
Sbjct: 168 IDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRG 224
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (176), Expect = 5e-14
Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 32/221 (14%)
Query: 147 FSSANLIGAGNFGSVYNG-TLFDGTTIAVKVFNL--IRPGGSKSFKSECKAAINIKHRNI 203
+ +LIG G FG VY G L G +A+K +L I+ KS E N+KH NI
Sbjct: 2 YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61
Query: 204 VRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFL---IKKKLDI 260
V+ + + + ++ ++ NGSL + ++ + P + + + + L
Sbjct: 62 VKYIGSI-----ETSDSLYIILEYAENGSLRQIIK-----KFGPFPESLVAVYVYQVLQ- 110
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFI 318
L YLH + + H ++K +N+L + G V DFG+A L + K +
Sbjct: 111 ------GLAYLH---EQGVIHRDIKAANILTTKD--GVVKLADFGVATKLNDVSKDDA-- 157
Query: 319 CIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
+ G+ ++ PE AST D++S G ++E+ TG P
Sbjct: 158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 1e-13
Identities = 55/203 (27%), Positives = 97/203 (47%), Gaps = 22/203 (10%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSG 212
IG G FG V G + G +AVK +++F +E ++H N+V++
Sbjct: 14 IGKGEFGDVMLGD-YRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI-- 68
Query: 213 VDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLH 272
V+ +G + +V ++M GSL ++LR + + L + L+K ++DV A+ YL
Sbjct: 69 VEEKGGLY--IVTEYMAKGSLVDYLRSRGRS---VLGGDCLLK----FSLDVCEAMEYLE 119
Query: 273 CDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYD 332
+ H +L NVL+ ++ + V DFG+ + + + + PE
Sbjct: 120 AN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL-----PVKWTAPEAL 171
Query: 333 LGCEASTYGDVYSFGILLLEMFT 355
+ ST DV+SFGILL E+++
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 3e-13
Identities = 56/204 (27%), Positives = 97/204 (47%), Gaps = 26/204 (12%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSG 212
IG G FG+V G + G +AVK N+ +++F E + H+N+VR+ G
Sbjct: 14 IGEGEFGAVLQGE-YTGQKVAVK--NIKCDVTAQAFLEETAVMTKLHHKNLVRLL----G 66
Query: 213 VDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLH 272
V + +V + M G+L +LR + + + L ++DVA + YL
Sbjct: 67 VILHNGLY--IVMELMSKGNLVNFLRTRG-------RALVSVIQLLQFSLDVAEGMEYLE 117
Query: 273 CDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLP-AIDKQNRFICIKGSTGYIPPEY 331
+ H +L N+L+ ++ + V DFG+AR +D N + +K + PE
Sbjct: 118 ---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD--NSKLPVK----WTAPEA 168
Query: 332 DLGCEASTYGDVYSFGILLLEMFT 355
+ S+ DV+S+G+LL E+F+
Sbjct: 169 LKHKKFSSKSDVWSYGVLLWEVFS 192
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 3e-13
Identities = 54/211 (25%), Positives = 102/211 (48%), Gaps = 33/211 (15%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAF 210
+GAG FG V+ G + T +AVK ++PG ++F E ++H +VR++
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKT---LKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 211 SGVD--YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACAL 268
+ + Y ++ ++M GSL ++L+ + L+ K +D + +A +
Sbjct: 71 TKEEPIY-------IITEYMAKGSLLDFLKSDEGGK-------VLLPKLIDFSAQIAEGM 116
Query: 269 RYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYI- 327
Y+ + H +L+ +NVL+ + ++ + DFG+AR + + N + +G+ I
Sbjct: 117 AYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVI----EDNEYTAREGAKFPIK 169
Query: 328 ---PPEYDLGCEASTYGDVYSFGILLLEMFT 355
P + G + DV+SFGILL E+ T
Sbjct: 170 WTAPEAINFGS-FTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 4e-13
Identities = 65/216 (30%), Positives = 104/216 (48%), Gaps = 32/216 (14%)
Query: 152 LIGAGNFGSV----YNGTLFDGT--TIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVR 205
+G GNFGSV Y+ L D T +AVK + F+ E + +++H NIV+
Sbjct: 11 QLGKGNFGSVELCRYD-PLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 206 VFTAFSGVDYQ-GARFKAVVYKFMPNGSLEEWL---RGKDDTNWRPLNFNFLIKKKLDIA 261
+ GV Y G R +V +++P GSL ++L R + D + L + I K
Sbjct: 70 ----YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHR-KLLLYASQICK----G 120
Query: 262 IDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIK 321
++ + RY+H D L N+L++ E +GDFG+ + LP DK+ +
Sbjct: 121 MEYLGSKRYVHRD---------LATRNILVESENRVKIGDFGLTKVLPQ-DKEYYKVREP 170
Query: 322 GSTG--YIPPEYDLGCEASTYGDVYSFGILLLEMFT 355
G + + PE + S DV+SFG++L E+FT
Sbjct: 171 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 5e-13
Identities = 57/223 (25%), Positives = 96/223 (43%), Gaps = 30/223 (13%)
Query: 152 LIGAGNFGSVYNGTLF---DGTTIAVKVFNLIRPGGSKSFKSECKAAINI---KHRNIVR 205
L+G+G FG+V+ G D I V + + G ++F+ + + H IVR
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVA 265
+ G Q +V + P GSL + +R D+ L+ L L+ + +A
Sbjct: 74 LLGICPGASLQ------LVTQLSPLGSLLDHVRQHRDS----LDPQRL----LNWCVQIA 119
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTG 325
+ YL + H NL N+LL + I + DFG+A L DK+ + K
Sbjct: 120 KGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIK 176
Query: 326 YIPPEYDLGCEASTYGDVYSFGILLLEMFT-------GIRPSD 361
++ E L + DV+S+G+ + EM + G+RP +
Sbjct: 177 WMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE 219
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 6e-13
Identities = 62/222 (27%), Positives = 103/222 (46%), Gaps = 27/222 (12%)
Query: 153 IGAGNFGSVYNGTLF------DGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRV 206
+G G FG V+ + D +AVK K F E + N++H +IV+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK- 71
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLR--GKDDTNWRPLN--FNFLIKKKLDIAI 262
F GV +G +V+++M +G L ++LR G D N + L IA
Sbjct: 72 ---FYGVCVEGDPL-IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKG 322
+A + YL H +L N L+ + ++ +GDFGM+R + + D + + G
Sbjct: 128 QIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD----YYRVGG 180
Query: 323 ST----GYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRP 359
T ++PPE + + +T DV+S G++L E+FT G +P
Sbjct: 181 HTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 8e-13
Identities = 80/282 (28%), Positives = 116/282 (41%), Gaps = 59/282 (20%)
Query: 152 LIGAGNFGSVYNG-TLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAF 210
++G G +G VY L IA+K + E +KHRNIV+ +
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQ----Y 70
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFN-----FLIKKKLDIAIDVA 265
G D + FK + + +P GSL LR K W PL N F K+ L+
Sbjct: 71 LGSDSENGFFK-IFMEQVPGGSLSALLRSK----WGPLKDNEQTIIFYTKQILE------ 119
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDD-EMIGHVGDFGMARFLPAIDKQNRFICIKGST 324
L+YLH I H ++K NVL++ + + DFG ++ L I+ G+
Sbjct: 120 -GLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTE--TFTGTL 173
Query: 325 GYIPPEY-DLGCEASTYG---DVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQ 380
Y+ PE D G YG D++S G ++EM TG P F+++ PQ
Sbjct: 174 QYMAPEVIDKGPRG--YGAPADIWSLGCTIVEMATGKPP-------------FIELGEPQ 218
Query: 381 RAEEVVDDFNLQ-EIEEGRTMCMEVSSSSGSSAHASIILECF 421
A V F + EI E S S+ + IL CF
Sbjct: 219 AAMFKVGMFKIHPEIPE-----------SLSAEAKNFILRCF 249
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (167), Expect = 9e-13
Identities = 56/227 (24%), Positives = 95/227 (41%), Gaps = 42/227 (18%)
Query: 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAIN-------IKHRN 202
IG G+FG VY DG +K +L S + E + A+N + H N
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDL-----SNMSEKEREDALNEVKILKKLNHPN 60
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFM---PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLD 259
I++ + +F + M G L + ++ + F ++ LD
Sbjct: 61 IIKYYESFEEKGK--------LCIVMEYADGGDLSQKIK-----KQKKEGKPFPEEQILD 107
Query: 260 IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL-PAIDKQNRFI 318
+ + AL+YLH I H ++KP N+ L + +GDFG+++ L +D +
Sbjct: 108 WFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV 164
Query: 319 CIKGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDG 362
G+ Y+ PE C+ Y D++S G +L E+ T P +G
Sbjct: 165 ---GTPYYLSPEL---CQNKPYNYKSDIWSLGCVLYELCTLKHPFEG 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 1e-12
Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 23/217 (10%)
Query: 151 NLIGAGNFGSVYNGTLFD-GTTIAVKVF--NLIRPGGSKSFKSECKAAINIKHRNIVRVF 207
+ +G G +G VY G T+AVK + + + F E IKH N+V++
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLL 68
Query: 208 TAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACA 267
GV + F ++ +FM G+L ++LR + + L +A ++ A
Sbjct: 69 ----GVCTREPPF-YIITEFMTYGNLLDYLRECNRQEVNAVVL-------LYMATQISSA 116
Query: 268 LRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYI 327
+ YL + H +L N L+ + + V DFG++R + D K +
Sbjct: 117 MEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWT 172
Query: 328 PPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363
PE + S DV++FG+LL E+ T G+ P GI
Sbjct: 173 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 209
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 61/240 (25%), Positives = 112/240 (46%), Gaps = 31/240 (12%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAF 210
+G G FG V+ GT T +A+K ++PG ++F E + ++H +V ++
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKT---LKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV 70
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
S +V +FM GSL ++L+ D + + + +D+A +A + Y
Sbjct: 71 SEEPIY------IVTEFMGKGSLLDFLKEGDGKYLK-------LPQLVDMAAQIADGMAY 117
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGST---GYI 327
+ + H +L+ +N+L+ D ++ + DFG+AR + + N + +G+ +
Sbjct: 118 IE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLI----EDNEYTARQGAKFPIKWT 170
Query: 328 PPEYDLGCEASTYGDVYSFGILLLEMFTGIR-PSDGIFTGKM--NLRNFVKMALPQRAEE 384
PE L + DV+SFGILL E+ T R P G+ ++ + +M PQ E
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPE 230
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 3e-12
Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 22/205 (10%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGG--SKSFKSECKAAINIKHRNIVRVFTAF 210
+G G FG V G +A+K +I+ G F E K + + H +V+++
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIK---MIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
+ R +V ++M NG L +LR F + L++ DV + Y
Sbjct: 69 TK-----QRPIYIVTEYMSNGCLLNYLREHGK--------RFQPSQLLEMCKDVCEGMAY 115
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPE 330
L H +L N L+DD+ V DFG++R++ D+ + K + PPE
Sbjct: 116 LE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPE 171
Query: 331 YDLGCEASTYGDVYSFGILLLEMFT 355
L + S+ DV++FG+L+ E+++
Sbjct: 172 VLLYSKFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 3e-12
Identities = 61/224 (27%), Positives = 92/224 (41%), Gaps = 37/224 (16%)
Query: 153 IGAGNFGSVYNGTLF--DGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVF 207
+G GNFGSV G G + V V L + G K F E + H IVR+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 208 TAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACA 267
GV +G +V + P G L ++L+ + + + ++A VA
Sbjct: 63 ----GV-CKGEPL-MLVMELAPLGPLLKYLKKRREIP---------VSDLKELAHQVAMG 107
Query: 268 LRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTG-- 325
+ YL H +L NVLL + + DFGM+R L A R +T
Sbjct: 108 MAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA-----TTAGR 159
Query: 326 -----YIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363
Y P + G + S+ DV+S+G+ L E F+ G +P +
Sbjct: 160 WPLKWYAPECINYG-KFSSKSDVWSYGVTLWEAFSYGAKPYGEM 202
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 56/214 (26%), Positives = 87/214 (40%), Gaps = 30/214 (14%)
Query: 152 LIGAGNFGSVYNGT----LFDGTTIAVKVFNLIRPGG-SKSFKSECKAAINIKHRNIVRV 206
+G G+FG V G +AVK + F E ++ H N++R+
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVAC 266
+ GV +V + P GSL + LR + +FLI D A+ +A
Sbjct: 62 Y----GVVLTHPLM--MVTELAPLGSLLDRLR-------KDALGHFLISTLCDYAVQIAN 108
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAID-----KQNRFICIK 321
+RYL H +L N+LL + +GDFG+ R LP + +++ +
Sbjct: 109 GMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPF- 164
Query: 322 GSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT 355
+ PE S DV+ FG+ L EMFT
Sbjct: 165 ---AWCAPESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 4e-12
Identities = 62/226 (27%), Positives = 97/226 (42%), Gaps = 45/226 (19%)
Query: 153 IGAGNFGSVY----NGTLFDGTTIAVKVFN---LIRPGGSKSFKSECKAAINIKHRNIVR 205
I G +G V+ T G A+KV +IR +E + +V+
Sbjct: 1 ISKGAYGRVFLAKKKST---GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKK--KLDIAID 263
++ +F QG + +V +++P G L L N L + ++ IA +
Sbjct: 58 LYYSF-----QGKKNLYLVMEYLPGGDLASLLE----------NVGSLDEDVARIYIA-E 101
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARF--------LPAIDK 313
+ AL YLH I H +LKP N+L+D GH+ DFG+++ L +K
Sbjct: 102 IVLALEYLH---SNGIIHRDLKPDNILIDSN--GHLKLTDFGLSKVGLVRRQINLNDDEK 156
Query: 314 QNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
+++ I G+ YI PE LG S D +S G +L E GI P
Sbjct: 157 EDKRIV--GTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-12
Identities = 58/220 (26%), Positives = 108/220 (49%), Gaps = 35/220 (15%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAF 210
+GAG FG V+ T T +AVK ++PG ++F +E ++H +V++
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKT---MKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 70
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
+ ++ +FM GSL ++L+ D+ + +PL K +D + +A + +
Sbjct: 71 TKEPIY------IITEFMAKGSLLDFLK-SDEGSKQPL------PKLIDFSAQIAEGMAF 117
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPE 330
+ Q H +L+ +N+L+ ++ + DFG+AR + + N + +G+ P +
Sbjct: 118 IE---QRNYIHRDLRAANILVSASLVCKIADFGLARVI----EDNEYTAREGAK--FPIK 168
Query: 331 YDLGCEASTYG------DVYSFGILLLEMFT-GIRPSDGI 363
+ EA +G DV+SFGILL+E+ T G P G+
Sbjct: 169 WT-APEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 207
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 6e-12
Identities = 74/309 (23%), Positives = 131/309 (42%), Gaps = 60/309 (19%)
Query: 151 NLIGAGNFGSVYNG-TLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTA 209
N+I G G+ Y G ++ +G VK N + S ++ ++H NIV++
Sbjct: 696 NVISRGKKGASYKGKSIKNGMQFVVKEINDVN-SIPSSEIADMG---KLQHPNIVKLIGL 751
Query: 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALR 269
+ + ++++++ +L E LR +W +++ IAI +A ALR
Sbjct: 752 C-----RSEKGAYLIHEYIEGKNLSEVLRN---LSW---------ERRRKIAIGIAKALR 794
Query: 270 YLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKG----STG 325
+LHC C P + NL P +++D + H + LP + +C S+
Sbjct: 795 FLHCRCSPAVVVGNLSPEKIIIDGKDEPH-----LRLSLPGL------LCTDTKCFISSA 843
Query: 326 YIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEV 385
Y+ PE + + D+Y FG++L+E+ TG P+D F ++ + A
Sbjct: 844 YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEW--------ARYC 895
Query: 386 VDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDV 445
D +L M ++ S S + + I+E N + + C+A P R NDV
Sbjct: 896 YSDCHLD-------MWIDPSIRGDVSVNQNEIVEVMN----LALHCTATDPTARPCANDV 944
Query: 446 ----ESRLR 450
ES R
Sbjct: 945 LKTLESASR 953
|
Length = 968 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (161), Expect = 6e-12
Identities = 64/236 (27%), Positives = 99/236 (41%), Gaps = 58/236 (24%)
Query: 153 IGAGNFGSVYNG-TLFDGTTIAVKVFNL--IRPGGSKSFKSECKAAINIKHRNIVR---- 205
IG G +G VY G +A+K + + G + E K ++H NIVR
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEI 66
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAID-V 264
V + G Y +V+++M + L G L ++ +
Sbjct: 67 VTSKGKGSIY-------MVFEYMDHD-----LTG------------LLDSPEVKFTESQI 102
Query: 265 AC-------ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL---PAIDKQ 314
C L+YLH I H ++K SN+L++++ + + DFG+AR + D
Sbjct: 103 KCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159
Query: 315 NRFICIKGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDGIFTGK 367
NR I + Y PPE LG YG D++S G +L E+F G +P IF G
Sbjct: 160 NRVITL----WYRPPELLLGAT--RYGPEVDMWSVGCILAELFLG-KP---IFQGS 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 7e-12
Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 24/206 (11%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGG--SKSFKSECKAAINIKHRNIVRVFTAF 210
+G+G FG V+ G +A+K I G + F E K + + H +V+++
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKA---INEGAMSEEDFIEEAKVMMKLSHPKLVQLY--- 65
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
GV Q + +V +FM NG L +LR + + + L + DV + Y
Sbjct: 66 -GVCTQ-QKPLYIVTEFMENGCLLNYLRQRQGKLSKDM--------LLSMCQDVCEGMEY 115
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFIC-IKGSTGYIPP 329
L + H +L N L+ + V DFGM R++ +D + K + PP
Sbjct: 116 LE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYV--LDDEYTSSSGAKFPVKWSPP 170
Query: 330 EYDLGCEASTYGDVYSFGILLLEMFT 355
E + S+ DV+SFG+L+ E+FT
Sbjct: 171 EVFNFSKYSSKSDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 8e-12
Identities = 61/229 (26%), Positives = 97/229 (42%), Gaps = 50/229 (21%)
Query: 151 NLIGAGNFGSVYNGTLF----DGTTIAVKVFNLIRPGGSKS----FKSECKAAINIKHRN 202
+IG G FG V G L +A+K ++ G S F +E H N
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKT---LKAGSSDKQRLDFLTEASIMGQFDHPN 66
Query: 203 IVR---VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLD 259
I+R V T V ++ ++M NGSL+++LR D F + + +
Sbjct: 67 IIRLEGVVTKSRPV--------MIITEYMENGSLDKFLRENDG--------KFTVGQLVG 110
Query: 260 IAIDVACALRYL--HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRF 317
+ +A ++YL H +L N+L++ ++ V DFG++R L +
Sbjct: 111 MLRGIASGMKYLSEMN-----YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT--- 162
Query: 318 ICIKGSTGYIPPEYDLGCEASTYG------DVYSFGILLLEMFT-GIRP 359
KG G IP + EA Y DV+SFGI++ E+ + G RP
Sbjct: 163 YTTKG--GKIPIRWT-APEAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 9e-12
Identities = 69/233 (29%), Positives = 98/233 (42%), Gaps = 31/233 (13%)
Query: 151 NLIGAGNFGSVYNGTL----FDGTTIAVKVFNL---IRPGGSKSFKSECKAAINIK--HR 201
+G G FG VY G D + V V L F E A I K H+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLME--ALIMSKFNHQ 69
Query: 202 NIVRVFTAFSGVDYQG-ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDI 260
NIVR GV ++ RF ++ + M G L+ +LR RP + +K L
Sbjct: 70 NIVR----LIGVSFERLPRF--ILLELMAGGDLKSFLRENRPRPERP--SSLTMKDLLFC 121
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV---GDFGMARFLPAIDKQNRF 317
A DVA +YL + H ++ N LL + G V DFGMAR + +
Sbjct: 122 ARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178
Query: 318 ICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMN 369
++PPE L ++ DV+SFG+LL E+F+ G P + G+ N
Sbjct: 179 GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP----YPGRTN 227
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 53/226 (23%), Positives = 92/226 (40%), Gaps = 16/226 (7%)
Query: 147 FSSANLIGAGNFGSVYNGTLF--DGTTIAVKVFNLIRPGGSKS----FKSECKAAINIKH 200
++G G FGSV G L DG+ + V V + + S F SE + H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 201 RNIVRVF-TAFSGVDYQGARFKAVVYKFMPNGSLEEWL-RGKDDTNWRPLNFNFLIKKKL 258
N++++ F Q V+ FM +G L +L + ++ L
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGL----PEKLPLQTLL 116
Query: 259 DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFI 318
+D+A + YL H +L N +L ++M V DFG+++ + + D +
Sbjct: 117 KFMVDIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGR 173
Query: 319 CIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363
K +I E ++ DV++FG+ + E+ T G P G+
Sbjct: 174 IAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV 219
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 59/214 (27%), Positives = 92/214 (42%), Gaps = 30/214 (14%)
Query: 152 LIGAGNFGSVY-NGTLFDGTTIAVKVFNL---IRPGGSKSFKSECKAAINIKHRNIVRVF 207
+G G FG V+ A+KV + IR + +E + + H I+R+F
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLF 67
Query: 208 TAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACA 267
RF ++ +++P G L +LR + F A ++ CA
Sbjct: 68 WT-----EHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLF---------YASEIVCA 113
Query: 268 LRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIKGSTG 325
L YLH I + +LKP N+LLD E GH+ DFG A+ L ++R + G+
Sbjct: 114 LEYLH---SKEIVYRDLKPENILLDKE--GHIKLTDFGFAKKL-----RDRTWTLCGTPE 163
Query: 326 YIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
Y+ PE + D ++ GIL+ EM G P
Sbjct: 164 YLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 61/225 (27%), Positives = 102/225 (45%), Gaps = 43/225 (19%)
Query: 152 LIGAGNFGSVYNGTL----FDGTTIAVKVFNLIRPGGSKS----FKSECKAAINIKHRNI 203
+IGAG FG V+ G L +A+K ++PG ++ F SE H NI
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKT---LKPGYTEKQRQDFLSEASIMGQFSHHNI 68
Query: 204 VRVFTAFSGVDYQGARFK--AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIA 261
+R+ + +FK ++ ++M NG+L+++LR D F + + +
Sbjct: 69 IRLEGVVT-------KFKPAMIITEYMENGALDKYLRDHDG--------EFSSYQLVGML 113
Query: 262 IDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIK 321
+A ++YL H +L N+L++ + V DFG++R L D + +
Sbjct: 114 RGIAAGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED-DPEGTYTT-- 167
Query: 322 GSTGYIPPEYDLGCEASTY------GDVYSFGILLLEMFT-GIRP 359
S G IP + EA Y DV+SFGI++ E+ + G RP
Sbjct: 168 -SGGKIPIRWT-APEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 62/227 (27%), Positives = 97/227 (42%), Gaps = 38/227 (16%)
Query: 147 FSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAIN-------I 198
F N IG G+FG V+ D A+K +L SK + E + AI+ +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDL-----SKMNRREREEAIDEARVLAKL 56
Query: 199 KHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKL 258
I+R + +F +D +V ++ NG L + L+ + RPL + + +
Sbjct: 57 DSSYIIRYYESF--LDKGKL---NIVMEYAENGDLHKLLKMQRG---RPLPEDQVWR--- 105
Query: 259 DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFI 318
I + L +LH I H ++K N+ LD +GD G+A+ L F
Sbjct: 106 -FFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD---NTNFA 158
Query: 319 -CIKGSTGYIPPEYDLGCEASTY---GDVYSFGILLLEMFTGIRPSD 361
I G+ Y+ PE CE Y DV++ G++L E TG P D
Sbjct: 159 NTIVGTPYYLSPEL---CEDKPYNEKSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 65/283 (22%), Positives = 116/283 (40%), Gaps = 57/283 (20%)
Query: 153 IGAGNFGSVYNG-TLFDGTTIAVKVF---NLIRPGGSKSFKSECKAAINIKHR--NIVRV 206
I G FGSVY G A+KV ++I + K+E +A + I+ + ++
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAE-RAIMMIQGESPYVAKL 62
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLR--GKDDTNWRPLNFNFLIKKKLDIAIDV 264
+ +F DY +V +++ G ++ G +W K+ +V
Sbjct: 63 YYSFQSKDYL-----YLVMEYLNGGDCASLIKTLGGLPEDW--------AKQ---YIAEV 106
Query: 265 ACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIKG 322
+ LH Q I H ++KP N+L+D GH+ DFG++R + +F+ G
Sbjct: 107 VLGVEDLH---QRGIIHRDIKPENLLIDQT--GHLKLTDFGLSR---NGLENKKFV---G 155
Query: 323 STGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPS---------DGIFTGKMNLRNF 373
+ Y+ PE LG D +S G ++ E G P D I + ++N
Sbjct: 156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEE 215
Query: 374 VKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASI 416
VK A ++++ R +CM+ + G++ + I
Sbjct: 216 VKEFCSPEAVDLIN----------RLLCMDPAKRLGANGYQEI 248
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-11
Identities = 57/211 (27%), Positives = 104/211 (49%), Gaps = 34/211 (16%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAF 210
+GAG FG V+ G T +A+K ++ G ++F +E ++H +VR++
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKS---LKQGSMSPEAFLAEANLMKQLQHPRLVRLY--- 67
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
V Q + ++ ++M NGSL ++L+ + L N LI D+A +A + +
Sbjct: 68 -AVVTQEPIY--IITEYMENGSLVDFLKTPEGIK---LTINKLI----DMAAQIAEGMAF 117
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPE 330
+ + H +L+ +N+L+ + + + DFG+AR + + N + +G+ P +
Sbjct: 118 IE---RKNYIHRDLRAANILVSETLCCKIADFGLARLI----EDNEYTAREGAK--FPIK 168
Query: 331 YDLGCEASTYG------DVYSFGILLLEMFT 355
+ EA YG DV+SFGILL E+ T
Sbjct: 169 WT-APEAINYGTFTIKSDVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-11
Identities = 69/227 (30%), Positives = 103/227 (45%), Gaps = 41/227 (18%)
Query: 151 NLIGAGNFGSVYNGTLFD----GT---TIAVKVFNLIRPGGSKSFKSE--CKAAI--NIK 199
N +G+G FG VY GT D G+ +AVK +R G + K E +A + N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKT---LRKGATDQEKKEFLKEAHLMSNFN 57
Query: 200 HRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRG-KDDTNWRPLNFNFLIKKKL 258
H NIV++ + Q ++ + M G L +LR + + PL +K+ L
Sbjct: 58 HPNIVKLLGVCLLNEPQ-----YIIMELMEGGDLLSYLRDARVERFGPPL---LTLKELL 109
Query: 259 DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL-----DDEMIGHVGDFGMARFLPAIDK 313
DI +DVA YL Q H +L N L+ D + + +GDFG+AR + D
Sbjct: 110 DICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDY 166
Query: 314 QNRFICIKGSTGYIP-----PEYDLGCEASTYGDVYSFGILLLEMFT 355
K G +P PE L + +T DV+SFG+L+ E+ T
Sbjct: 167 YR-----KEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 60/220 (27%), Positives = 89/220 (40%), Gaps = 34/220 (15%)
Query: 153 IGAGNFGSVYNGTLFD------GTTIAVKVFNLIRPGGSKS----FKSECKAAINIKHRN 202
+G G+FG VY G T +A+K N S F +E +
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVN---ENASMRERIEFLNEASVMKEFNCHH 70
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGK--DDTNWRPLNFNFLIKKKLDI 260
+VR GV G VV + M G L+ +LR + + N L L K + +
Sbjct: 71 VVR----LLGVVSTGQP-TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKF-IQM 124
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICI 320
A ++A + YL H +L N ++ +++ +GDFGM R D
Sbjct: 125 AAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTR-----DIYETDYYR 176
Query: 321 KGSTGYIP-----PEYDLGCEASTYGDVYSFGILLLEMFT 355
KG G +P PE +T DV+SFG++L EM T
Sbjct: 177 KGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (154), Expect = 5e-11
Identities = 59/220 (26%), Positives = 96/220 (43%), Gaps = 44/220 (20%)
Query: 153 IGAGNFGSV----YNGTLFDGTTIAVKVFN---LIRPGGSKSFKSECKAAINIKHRNIVR 205
+G G+FG V + G+ G A+K+ + +++ + +E + +I+H +V
Sbjct: 9 LGTGSFGRVMLVRHKGS---GKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVN 65
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVA 265
++ +F Q +V +++P G L LR F A V
Sbjct: 66 LYGSF-----QDDSNLYLVMEYVPGGELFSHLRKSG---------RFPEPVARFYAAQVV 111
Query: 266 CALRYLH-CDCQPPIAHCNLKPSNVLLDDEMIGH--VGDFGMARFLPAIDKQNRFICIKG 322
AL YLH D I + +LKP N+LLD + G+ + DFG A+ + R + G
Sbjct: 112 LALEYLHSLD----IVYRDLKPENLLLDSD--GYIKITDFGFAKRVK-----GRTYTLCG 160
Query: 323 STGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
+ Y+ PE L YG D ++ GIL+ EM G P
Sbjct: 161 TPEYLAPEIILS---KGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 7e-11
Identities = 75/322 (23%), Positives = 136/322 (42%), Gaps = 77/322 (23%)
Query: 153 IGAGNFGSVYNGTLF------DGTTIAVKVF-NLIRPGGSKSFKSECKAAINIKHRNIVR 205
+G G FG VY G L T++A+K P + F+ E + +++H NIV
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWL-----------RGKDDTNWRPLNFNFLI 254
+ GV + ++++++ +G L E+L D+T L+ +
Sbjct: 73 LL----GVCTKEQPT-CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF- 126
Query: 255 KKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAID-- 312
L IAI +A + YL H +L N L+ + + + DFG++R + + D
Sbjct: 127 ---LHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYY 180
Query: 313 --KQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMN 369
+ + ++ ++PPE L + +T D++SFG++L E+F+ G++P G
Sbjct: 181 RVQSKSLLPVR----WMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYG------- 229
Query: 370 LRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHA-SIILECFNSICEIG 428
F+ QE+ E + A ++++EC+N I
Sbjct: 230 -------------------FSNQEVIEMIRSRQLLPCPEDCPARVYALMIECWNEI---- 266
Query: 429 VACSAERPRERMKINDVESRLR 450
A RPR + D+ +RLR
Sbjct: 267 ---PARRPRFK----DIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 7e-11
Identities = 60/237 (25%), Positives = 103/237 (43%), Gaps = 47/237 (19%)
Query: 153 IGAGNFGSVYNGTLF------DGTTIAVKVFNLIRPGGS----KSFKSECKAAINIKHRN 202
IG G FG V+ T +AVK +++ S F+ E H N
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVK---MLKEEASADMQADFQREAALMAEFDHPN 69
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW---------------RP 247
IV++ GV G + +++++M G L E+LR + P
Sbjct: 70 IVKLL----GVCAVG-KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 248 LNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF 307
L + + L IA VA + YL + H +L N L+ + M+ + DFG++R
Sbjct: 125 LPLSCTEQ--LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRN 179
Query: 308 LPAID----KQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRP 359
+ + D +N I I+ ++PPE +T DV+++G++L E+F+ G++P
Sbjct: 180 IYSADYYKASENDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 32/104 (30%), Positives = 46/104 (44%), Gaps = 6/104 (5%)
Query: 260 IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFIC 319
++ AL YLH I H ++KP N+LLD++ H+ DF +A + D
Sbjct: 105 WICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP-DTLTTSTS 160
Query: 320 IKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363
G+ GY+ PE S D +S G+ E G RP G
Sbjct: 161 --GTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGH 202
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 67/259 (25%), Positives = 109/259 (42%), Gaps = 49/259 (18%)
Query: 153 IGAGNFGSVYNGTLF----DGTTIAVKVFNLIRPGGSKSFK----SECKAAINI-KHRNI 203
+GAG FG V T + + V V +++P S + SE K ++ H NI
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAV-KMLKPTAHSSEREALMSELKIMSHLGNHENI 101
Query: 204 VRVFTA--FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDD---TNWRPLNFNFLIKKKL 258
V + A G V+ ++ G L +LR K + T L+F++ + K +
Sbjct: 102 VNLLGACTIGGPIL-------VITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGM 154
Query: 259 DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFI 318
C H +L NVLL I + DFG+AR I + ++
Sbjct: 155 AFLASKNCI-------------HRDLAARNVLLTHGKIVKICDFGLAR---DIMNDSNYV 198
Query: 319 CIKGST----GYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTG----KMN 369
+KG+ ++ PE C + DV+S+GILL E+F+ G P G+ K+
Sbjct: 199 -VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKL- 256
Query: 370 LRNFVKMALPQRAEEVVDD 388
++ +MA P+ A + D
Sbjct: 257 IKEGYRMAQPEHAPAEIYD 275
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 52/224 (23%), Positives = 97/224 (43%), Gaps = 36/224 (16%)
Query: 153 IGAGNFGSVYNGT---LFDGTTIAVKVFNLIRPGGSKSFKS---ECKAAINIKHRNIVRV 206
+G+G FG+VY G + I V + L K+ K E ++ H ++VR+
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVAC 266
Q ++ + MP G L +++R D + +L L+ + +A
Sbjct: 75 LGICLSSQVQ------LITQLMPLGCLLDYVRNHKDN----IGSQYL----LNWCVQIAK 120
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGY 326
+ YL + + H +L NVL+ + DFG+A+ L +K+ G
Sbjct: 121 GMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKE-----YHAEGGK 172
Query: 327 IPPEYDLGCEASTYG------DVYSFGILLLEMFT-GIRPSDGI 363
+P ++ + E+ + DV+S+G+ + E+ T G +P +GI
Sbjct: 173 VPIKW-MALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI 215
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (149), Expect = 3e-10
Identities = 60/230 (26%), Positives = 91/230 (39%), Gaps = 49/230 (21%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVR---V 206
+G G +G VY G +A+K L G + E +KH NIV+ V
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDV 66
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVAC 266
+ +V+++ + L+ D PL+ N LIK I +
Sbjct: 67 IHTERKL--------YLVFEYC-----DMDLKKYLDKRPGPLSPN-LIKS---IMYQLLR 109
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTG- 325
L Y H I H +LKP N+L++ + + + DFG+AR I ++ T
Sbjct: 110 GLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAF--------GIPLRTYTHE 158
Query: 326 -----YIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDGIFTGK 367
Y PE LG Y D++S G + EM TG +P +F G
Sbjct: 159 VVTLWYRAPEILLGS--KHYSTAVDIWSVGCIFAEMITG-KP---LFPGD 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 3e-10
Identities = 61/216 (28%), Positives = 93/216 (43%), Gaps = 30/216 (13%)
Query: 151 NLIGAGNFGSVYNGTLFDG----TTIAVKVFNLIRPGGSKS-FKSECKAAINIKHRNIVR 205
+IG G+FG VY+GTL D AVK N I F E + H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVL- 59
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVA 265
+ G+ VV +M +G L ++R +T+ N +K + + VA
Sbjct: 60 ---SLLGICLPSEGSPLVVLPYMKHGDLRNFIR--SETH------NPTVKDLIGFGLQVA 108
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTG 325
+ YL H +L N +LD+ V DFG+AR + DK+ + + TG
Sbjct: 109 KGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDI--YDKE--YYSVHNHTG 161
Query: 326 YIPPEYDLGCEA------STYGDVYSFGILLLEMFT 355
P + E+ +T DV+SFG+LL E+ T
Sbjct: 162 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-10
Identities = 62/239 (25%), Positives = 96/239 (40%), Gaps = 58/239 (24%)
Query: 146 GFSSANLIGAGNFGSVYN-GTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAIN------- 197
F +G G++GSVY L D A+K +L GS S + E + A+N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDL----GSMS-QKEREDAVNEIRILAS 55
Query: 198 IKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRG--------KDDTNWRPLN 249
+ H NI+ AF G + +V ++ P G L + + + WR
Sbjct: 56 VNHPNIISYKEAF----LDGNKL-CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR--- 107
Query: 250 FNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLP 309
I I + L+ LH + I H +LK +N+LL + +GD G+++ L
Sbjct: 108 ----------IFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVL- 153
Query: 310 AIDKQNRFICIKGSTGYIPPE------YDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
K+N G+ Y+ PE Y D++S G LL EM T P +
Sbjct: 154 ---KKNMAKTQIGTPHYMAPEVWKGRPYSYKS------DIWSLGCLLYEMATFAPPFEA 203
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 4e-10
Identities = 64/212 (30%), Positives = 94/212 (44%), Gaps = 32/212 (15%)
Query: 153 IGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKS-FKSECKAAINIKHRNIVRVFTAF 210
IG GNFG V++G L D T +AVK P K+ F E + H NIVR+
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLI--- 59
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKD-DTNWRPLNFNFLIKKKLDIAIDVACALR 269
GV Q K +Y M E ++G D T R +K+ + + + A +
Sbjct: 60 -GVCTQ----KQPIYIVM------ELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGME 108
Query: 270 YLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPP 329
YL H +L N L+ ++ + + DFGM+R ++++ G IP
Sbjct: 109 YLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSR-----EEEDGVYASTGGMKQIPV 160
Query: 330 EYDLGCEASTYG------DVYSFGILLLEMFT 355
++ EA YG DV+SFGILL E F+
Sbjct: 161 KWT-APEALNYGRYSSESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 5e-10
Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 35/222 (15%)
Query: 152 LIGAGNFGSVYNGTL----FDGTTIAVKVFNLIRPGGS----KSFKSECKAAINIKHRNI 203
+IGAG FG V G L +A+K ++ G + + F SE H NI
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKT---LKSGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 204 VRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAID 263
+ + GV +R ++ +FM NG+L+ +LR D F + + + +
Sbjct: 68 IHL----EGV-VTKSRPVMIITEFMENGALDSFLRQNDG--------QFTVIQLVGMLRG 114
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGS 323
+A ++YL + H +L N+L++ ++ V DFG++RFL + G
Sbjct: 115 IAAGMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLG- 170
Query: 324 TGYIP-----PEYDLGCEASTYGDVYSFGILLLE-MFTGIRP 359
G IP PE + ++ DV+S+GI++ E M G RP
Sbjct: 171 -GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 6e-10
Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 39/219 (17%)
Query: 153 IGAGNFGSVYNGTLFD------GTTIAVKVFNLIRPGGSKSFKSECKAAI----NIKHRN 202
+G G+FG V +D G +AVK ++P + ++ K I N+ H N
Sbjct: 12 LGEGHFGKV-ELCRYDPEGDNTGEQVAVKS---LKPESGGNHIADLKKEIEILRNLYHEN 67
Query: 203 IVRVFTAFSGV-DYQGARFKAVVYKFMPNGSLEEWL-RGKDDTNWRPLNFNFLIKKKLDI 260
IV+ + G+ G ++ +F+P+GSL+E+L R K+ N +K++L
Sbjct: 68 IVK----YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKIN---------LKQQLKY 114
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICI 320
A+ + + YL H +L NVL++ E +GDFG+ + AI+ + +
Sbjct: 115 AVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTK---AIETDKEYYTV 168
Query: 321 KGSTG----YIPPEYDLGCEASTYGDVYSFGILLLEMFT 355
K + PE + + DV+SFG+ L E+ T
Sbjct: 169 KDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 7e-10
Identities = 42/125 (33%), Positives = 65/125 (52%), Gaps = 18/125 (14%)
Query: 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG--DFGMARFLPAIDKQNRFICI 320
++A AL +LH I + +LKP N+LLD+E GH+ DFG+++ +ID + +
Sbjct: 106 ELALALDHLH---SLGIIYRDLKPENILLDEE--GHIKLTDFGLSK--ESIDHEKKAYSF 158
Query: 321 KGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGK-----MNLRNFVK 375
G+ Y+ PE + D +SFG+L+ EM TG P F GK M + K
Sbjct: 159 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP----FQGKDRKETMTMILKAK 214
Query: 376 MALPQ 380
+ +PQ
Sbjct: 215 LGMPQ 219
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 8e-10
Identities = 57/214 (26%), Positives = 92/214 (42%), Gaps = 30/214 (14%)
Query: 152 LIGAGNFGSVYNGTLFD-GTTIAVKVFNLIR--PGGSKSFKS-ECKAAI--NIKHRNIVR 205
L+G G FG VY D G +AVK P K + EC+ + N++H IV+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVA 265
+ + ++ ++MP GS+++ L+ + L K I V
Sbjct: 69 YYGCL-----RDDETLSIFMEYMPGGSVKDQLKA-----YGALTETVTRKYTRQILEGVE 118
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFI-CIKGST 324
YLH + I H ++K +N+L D +GDFG ++ L I + + G+
Sbjct: 119 ----YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTP 171
Query: 325 GYIPPEYDLGCEASTYG---DVYSFGILLLEMFT 355
++ PE G YG DV+S G ++EM T
Sbjct: 172 YWMSPEVISG---EGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.5 bits (145), Expect = 9e-10
Identities = 53/247 (21%), Positives = 93/247 (37%), Gaps = 72/247 (29%)
Query: 151 NLIGAGNFGSV---YNGTLFDGTTIAVKVFNLIRPGGSKSFKS---------ECKAAINI 198
IG+G +G V + G +A+K + + F E K ++
Sbjct: 6 KPIGSGAYGVVCSAVDKRT--GRKVAIKKISNV-------FDDLIDAKRILREIKLLRHL 56
Query: 199 KHRNIVRVFTAFSGVDYQGARFKAV--VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKK 256
+H NI+ + F V V + M +T+ + +IK
Sbjct: 57 RHENIIGLLDIL--RPPSPEDFNDVYIVTELM-------------ETD-----LHKVIKS 96
Query: 257 KLDIAID--------VACALRYLH-CDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF 307
+ D + L+YLH + + H +LKPSN+L++ + DFG+AR
Sbjct: 97 PQPLTDDHIQYFLYQILRGLKYLHSAN----VIHRDLKPSNILVNSNCDLKICDFGLARG 152
Query: 308 LPAIDKQNRFICIKGSTGYI------PPEYDLGCEASTYG-DVYSFGILLLEMFTGIRPS 360
+ + + F+ T Y+ PE L T D++S G + E+ T +P
Sbjct: 153 VDPDEDEKGFL-----TEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR-KP- 205
Query: 361 DGIFTGK 367
+F G+
Sbjct: 206 --LFPGR 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 66/225 (29%), Positives = 93/225 (41%), Gaps = 36/225 (16%)
Query: 153 IGAGNFGSVYNGTLF--DGTTIAVKVFNL-IRPGGSKSFKSECKAAINIKHRNIVRVFTA 209
+GAGN G V L G +AVK L I K E IV + A
Sbjct: 9 LGAGNSGVVSK-VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 210 FSGVDYQGARFKAVVYKFMPNGSLEEWL-RGKDDTNWRPLNFNFLIKKKLDIAIDVACAL 268
F G + Y M GSL++ L + R L IA+ V L
Sbjct: 68 FY---NNGDISICMEY--MDGGSLDKILKEVQGRIPERILGK---------IAVAVLKGL 113
Query: 269 RYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG--DFGMARFLPAIDKQNRFICIKGSTGY 326
YLH + I H ++KPSN+L++ G + DFG++ L F+ G++ Y
Sbjct: 114 TYLHEKHK--IIHRDVKPSNILVNSR--GQIKLCDFGVSGQLVN-SLAKTFV---GTSSY 165
Query: 327 IPPEYDLGCEASTYGDVYSFGILLLEMFTG-------IRPSDGIF 364
+ PE G + S D++S G+ L+E+ TG P DGIF
Sbjct: 166 MAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIF 210
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 58/227 (25%), Positives = 101/227 (44%), Gaps = 36/227 (15%)
Query: 152 LIGAGNFGSVYNGTLF-DGTTI----AVKVFN-LIRPGGSKSFKSECKAAINIKHRNIVR 205
++G+G FG+VY G +G T+ A+K+ N P + F E ++ H ++VR
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVA 265
+ Q +V + MP+G L +++ D L N+ ++ +A
Sbjct: 74 LLGVCLSPTIQ------LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ--------IA 119
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTG 325
+ YL + + H +L NVL+ + DFG+AR L +K+ G
Sbjct: 120 KGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE-----YNADGG 171
Query: 326 YIPPEYDLGCEASTY------GDVYSFGILLLEMFT-GIRPSDGIFT 365
+P ++ + E Y DV+S+G+ + E+ T G +P DGI T
Sbjct: 172 KMPIKW-MALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT 217
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 29/218 (13%)
Query: 153 IGAGNFGSV----YNGTLFDGTTIAVKVFNLIRPGGSK---SFKSECKAAINIKHRNIVR 205
+G G+FG V Y+ DGT V V L R G + +K E + H NIV+
Sbjct: 12 LGEGHFGKVSLYCYDPA-NDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVK 70
Query: 206 VFTAFSGV-DYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDV 264
+ G QG + ++ +++P GSL ++L P + + + L A +
Sbjct: 71 ----YKGCCSEQGGKGLQLIMEYVPLGSLRDYL---------PKH-KLNLAQLLLFAQQI 116
Query: 265 ACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGST 324
+ YLH Q I H +L NVLLD++ + +GDFG+A+ +P + R + G +
Sbjct: 117 CEGMAYLHS--QHYI-HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR-VREDGDS 172
Query: 325 G--YIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPS 360
+ E + S DV+SFG+ L E+ T
Sbjct: 173 PVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSK 210
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 61/229 (26%), Positives = 103/229 (44%), Gaps = 45/229 (19%)
Query: 152 LIGAGNFGSVYNG-TLFDGTTIAVKVFNLIRPGGSKSFKSECKAAIN-----------IK 199
LIG+G+FGSVY G G +AVK + P S S K ++ ++ ++
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVK--QVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 200 HRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW----RPLNFNFLIK 255
H NIV+ + D+ + +++P GS+ L N+ L NF ++
Sbjct: 65 HENIVQYLGSSLDADHLN-----IFLEYVPGGSVAALL-----NNYGAFEETLVRNF-VR 113
Query: 256 KKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPA----- 310
+ L L YLH I H ++K +N+L+D++ + DFG+++ L A
Sbjct: 114 QILK-------GLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLST 163
Query: 311 IDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
R ++GS ++ PE + D++S G L++EM TG P
Sbjct: 164 KTNGAR-PSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 28/217 (12%)
Query: 153 IGAGNFGSVYNGTLFDG-------TTIAVKVFNLIRPGGSK-SFKSECKAAINIKHRNIV 204
+G G+FG VY G + G T +A+K N + F +E ++V
Sbjct: 14 LGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 205 RVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRG-KDDTNWRPLNFNFLIKKKLDIAID 263
R+ GV QG + V+ + M G L+ +LR + + P+ +KK + +A +
Sbjct: 73 RLL----GVVSQG-QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGE 127
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGS 323
+A + YL+ + H +L N ++ ++ +GDFGM R + D KG
Sbjct: 128 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR-----KGG 179
Query: 324 TGYIP-----PEYDLGCEASTYGDVYSFGILLLEMFT 355
G +P PE +TY DV+SFG++L E+ T
Sbjct: 180 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 47/137 (34%), Positives = 66/137 (48%), Gaps = 21/137 (15%)
Query: 235 EWLRGKDDTNWRPLNFNFLIKKKLDI------AIDVACALRYLHCDCQPPIAHCNLKPSN 288
E+L G D L F+ K D+ A ++ C L++LH I + +LK N
Sbjct: 76 EYLNGGD------LMFHIQSCHKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDN 126
Query: 289 VLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSF 346
+LLD + GH+ DFGM + D + C G+ YI PE LG + +T D +SF
Sbjct: 127 ILLDTD--GHIKIADFGMCKENMLGDAKTCTFC--GTPDYIAPEILLGQKYNTSVDWWSF 182
Query: 347 GILLLEMFTGIRPSDGI 363
G+LL EM G P G
Sbjct: 183 GVLLYEMLIGQSPFHGH 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 4e-09
Identities = 67/237 (28%), Positives = 99/237 (41%), Gaps = 52/237 (21%)
Query: 152 LIGAGNFGSVYNGTLFD---GTTIAVKV-------FNLIRPGGSKSFKSECKAAINIKHR 201
LIG G G VY +D +A+K L++ K F E K A ++ H
Sbjct: 9 LIGKGGMGEVYLA--YDPVCSRRVALKKIREDLSENPLLK----KRFLREAKIAADLIHP 62
Query: 202 NIVRVFTAFSGVDYQGARFKAVVYKFMP---NGSLEEWLRG--KDDTNWRPLNFNFLIKK 256
IV V++ S D VY MP +L+ L+ + ++ + L +
Sbjct: 63 GIVPVYSICSDGD--------PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGA 114
Query: 257 KLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG--DFGMARF------- 307
L I + + Y+H + H +LKP N+LL + G V D+G A F
Sbjct: 115 FLSIFHKICATIEYVH---SKGVLHRDLKPDNILLG--LFGEVVILDWGAAIFKKLEEED 169
Query: 308 LPAIDKQNRFIC---------IKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT 355
L ID R IC I G+ Y+ PE LG AS D+Y+ G++L +M T
Sbjct: 170 LLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 4e-09
Identities = 44/136 (32%), Positives = 64/136 (47%), Gaps = 21/136 (15%)
Query: 235 EWLRGKDDTNWRPLNFNFLIKKKLDI------AIDVACALRYLHCDCQPPIAHCNLKPSN 288
E+L G D L F+ + D A ++ C L++LH + I + +LK N
Sbjct: 76 EYLNGGD------LMFHIQSSGRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDN 126
Query: 289 VLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSF 346
VLLD + GH+ DFGM + + + C G+ YI PE G + + D +SF
Sbjct: 127 VLLDKD--GHIKIADFGMCKENMNGEGKASTFC--GTPDYIAPEILKGQKYNESVDWWSF 182
Query: 347 GILLLEMFTGIRPSDG 362
G+LL EM G P G
Sbjct: 183 GVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 5e-09
Identities = 63/227 (27%), Positives = 104/227 (45%), Gaps = 42/227 (18%)
Query: 152 LIGAGNFGSVY---NGTLFDGTTIAVKVFNL----------IRPGGSKSFKSECKAAINI 198
LIG G +G VY N T G +AVK L + K+ +SE + ++
Sbjct: 8 LIGKGTYGRVYLALNVT--TGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 199 KHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLR--GKDDTNWRPLNFNFLIKK 256
H NIV+ + +Y ++ +++P GS+ LR G+ + F ++
Sbjct: 66 DHLNIVQYLGFETTEEYL-----SIFLEYVPGGSIGSCLRTYGR----FEEQLVRFFTEQ 116
Query: 257 KLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNR 316
L+ L YLH I H +LK N+L+D + I + DFG+++ I ++
Sbjct: 117 VLE-------GLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQ 166
Query: 317 FICIKGSTGYIPPE----YDLGCEASTYGDVYSFGILLLEMFTGIRP 359
+ ++GS ++ PE Y G A D++S G ++LEMF G RP
Sbjct: 167 NMSMQGSVFWMAPEVIHSYSQGYSAKV--DIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 7e-09
Identities = 68/260 (26%), Positives = 113/260 (43%), Gaps = 52/260 (20%)
Query: 152 LIGAGNFGSVYNGTLFD------GTTIAVKVFNLIRPGGSKSFK---SECKAAINI-KHR 201
+G G FG V +T+AVK+ L K SE + I KH+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKHK 76
Query: 202 NIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRP------LNFNFLIK 255
NI+ + + +G + VV ++ +G+L ++LR + RP + +
Sbjct: 77 NIINLLGVCTQ---EGPLY--VVVEYAAHGNLRDFLRAR-----RPPGEYASPDDPRPPE 126
Query: 256 KKL---DI---AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLP 309
+ L D+ A VA + +L H +L NVL+ ++ + + DFG+AR +
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIH 183
Query: 310 AIDKQNRFICIKGSTGYIPPEYDLGCEA------STYGDVYSFGILLLEMFT-GIRPSDG 362
ID K + G +P ++ + EA + DV+SFG+LL E+FT G P G
Sbjct: 184 HIDYYR-----KTTNGRLPVKW-MAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 237
Query: 363 IFTGKM--NLRNFVKMALPQ 380
I ++ L+ +M PQ
Sbjct: 238 IPVEELFKLLKEGYRMEKPQ 257
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 8e-09
Identities = 61/217 (28%), Positives = 91/217 (41%), Gaps = 33/217 (15%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNL-IRPGGSKSFKSECKAAINIKHRNIVRVFTAF 210
+G GN G+VY L +AVKV L I K SE + I+ + AF
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
+ R ++ +FM GSL+ + + + R IA+ V L Y
Sbjct: 69 ----FVENRI-SICTEFMDGGSLDVYRKIPEHVLGR-------------IAVAVVKGLTY 110
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHVG--DFGMARFL-PAIDKQNRFICIKGSTGYI 327
L I H ++KPSN+L++ G V DFG++ L +I K G+ Y+
Sbjct: 111 L---WSLKILHRDVKPSNMLVNTR--GQVKLCDFGVSTQLVNSIAKT-----YVGTNAYM 160
Query: 328 PPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364
PE G + + DV+S GI +E+ G P I
Sbjct: 161 APERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQ 197
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 43/134 (32%), Positives = 63/134 (47%), Gaps = 17/134 (12%)
Query: 235 EWLRGKDDTNWRPLNFNFLIKKKLDI------AIDVACALRYLHCDCQPPIAHCNLKPSN 288
E+L G D L F+ K + D+ A ++ C L++LH I + +LK N
Sbjct: 76 EFLNGGD------LMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDN 126
Query: 289 VLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGI 348
V+LD + + DFGM + + NR G+ YI PE G + + D +SFG+
Sbjct: 127 VMLDRDGHIKIADFGMCK--ENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGV 184
Query: 349 LLLEMFTGIRPSDG 362
LL EM G P G
Sbjct: 185 LLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 59/223 (26%), Positives = 92/223 (41%), Gaps = 35/223 (15%)
Query: 153 IGAGNFGSVYNG-TLFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVR---V 206
IG G +G VY G +A+K L G K+ E K + H NI++ V
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVAC 266
F + +V++FM + L + ++ R L LIK +
Sbjct: 67 FRHKGDL--------YLVFEFM-DTDLYKLIKD----RQRGLP-ESLIKS---YLYQLLQ 109
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTG- 325
L + H I H +LKP N+L++ E + + DFG+AR + R T
Sbjct: 110 GLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLAR---SFGSPVRPYTHYVVTRW 163
Query: 326 YIPPEYDLGCEASTYG-DVYSFGILLLEMFTGIRPSDGIFTGK 367
Y PE LG + + D++S G + E+ + RP +F GK
Sbjct: 164 YRAPELLLGDKGYSTPVDIWSVGCIFAELLSR-RP---LFPGK 202
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 56/226 (24%), Positives = 101/226 (44%), Gaps = 34/226 (15%)
Query: 146 GFSSANLIGAGNFGSVYNGTLFD---GTTIAVKVFNLIRPGGSKS----FKSECKAAINI 198
+ ++L+ G FG ++ G L D G V V + S+ E +
Sbjct: 7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD-HASEIQVTLLLQESCLLYGL 65
Query: 199 KHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWL---RGKDDTNWRPLNFNFLIK 255
H+NI+ + V + V+Y +M G+L+ +L R + N + L+ L+
Sbjct: 66 SHQNILPI----LHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV- 120
Query: 256 KKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL-PAI--- 311
+AI +AC + YLH + + H ++ N ++D+E+ + D ++R L P
Sbjct: 121 ---HMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHC 174
Query: 312 --DKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT 355
D +NR + ++ E + E S+ DV+SFG+LL E+ T
Sbjct: 175 LGDNENRPV------KWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 1e-08
Identities = 61/248 (24%), Positives = 98/248 (39%), Gaps = 59/248 (23%)
Query: 140 LYNATNGFSSANLIGAGNFGSVYNGTLFD-GTTIAVKVFNLIRPGGSKSFKSECKAAINI 198
L + T F +IG G +G VY G +A+K+ ++I + + E K NI
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII-----EDEEEEIKEEYNI 55
Query: 199 -----KHRNIVRVFTAFSGVDYQGARFKAV----------VYKFMPNGSLEEWLRGKDDT 243
H NI + GA K V + GS+ + ++G
Sbjct: 56 LRKYSNHPNI---------ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKK 106
Query: 244 NWRPLNFNFLIKKKLDIAI---DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300
R K+ IA + L YLH + + H ++K N+LL V
Sbjct: 107 GKR--------LKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKN--AEVK 153
Query: 301 --DFGMARFLP-AIDKQNRFICIKGSTGYIPPEYDLGCEAS---TY---GDVYSFGILLL 351
DFG++ L + ++N FI G+ ++ PE + C+ +Y DV+S GI +
Sbjct: 154 LVDFGVSAQLDSTLGRRNTFI---GTPYWMAPEV-IACDEQPDASYDARSDVWSLGITAI 209
Query: 352 EMFTGIRP 359
E+ G P
Sbjct: 210 ELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 58/222 (26%), Positives = 94/222 (42%), Gaps = 32/222 (14%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTA 209
IG G G V+ G T+A+K L R G E KA +H +V++
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALR 269
F G+ F +V ++MP L E LR ++ RPL +K + + + +
Sbjct: 68 FP----HGSGF-VLVMEYMP-SDLSEVLRDEE----RPLP-EAQVKSYMRMLLK---GVA 113
Query: 270 YLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMAR-FLPAIDKQNRFICIKGSTGYIP 328
Y+H I H +LKP+N+L+ + + + DFG+AR F + + Y
Sbjct: 114 YMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV--ATRWYRA 168
Query: 329 PEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDGIFTGK 367
PE G Y D+++ G + E+ G P +F G+
Sbjct: 169 PELLYGAR--KYDPGVDLWAVGCIFAELLNG-SP---LFPGE 204
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-08
Identities = 55/223 (24%), Positives = 93/223 (41%), Gaps = 40/223 (17%)
Query: 152 LIGAGNFGSVYN--GTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI----------- 198
+G+G FG VY +A+K N+ P K + K+ +I
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 199 KHRNIVRVFTAFSGVDYQGARFKAVVYKFM------PNGSLEEWLRGKDDTNWRPLNFNF 252
+H NIVR + F + R +Y M P G L+ K F
Sbjct: 67 RHPNIVRYYKTFL----ENDR----LYIVMDLIEGAPLGEHFNSLKEKKQ--------RF 110
Query: 253 LIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAID 312
++ +I + + ALRYLH + + I H +L P+N++L ++ + DFG+A+
Sbjct: 111 TEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQ 165
Query: 313 KQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT 355
+++ + G+ Y PE DV++FG +L +M T
Sbjct: 166 PESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 45/180 (25%), Positives = 82/180 (45%), Gaps = 25/180 (13%)
Query: 187 SFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWR 246
+ ++EC+ + H NI+ + F D +V ++ P G+L E+++ +
Sbjct: 45 AAQNECQVLKLLSHPNIIEYYENFL-EDKA----LMIVMEYAPGGTLAEYIQKR------ 93
Query: 247 PLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD-EMIGHVGDFGMA 305
N L + + AL ++H I H +LK N+LLD +M+ +GDFG++
Sbjct: 94 -CNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGIS 149
Query: 306 RFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTY---GDVYSFGILLLEMFTGIRPSDG 362
+ L + K + G+ YI PE CE Y D+++ G +L E+ + R +
Sbjct: 150 KILSSKSKAYTVV---GTPCYISPEL---CEGKPYNQKSDIWALGCVLYELASLKRAFEA 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 57/219 (26%), Positives = 98/219 (44%), Gaps = 18/219 (8%)
Query: 152 LIGAGNFGSV-YNGTLFDGTTIAVKVFNL--IRPGGSKSFKSECKAAINIKHRNIVRVFT 208
++G+G G+V + DG AVKV ++ + ++E +N +IV+
Sbjct: 39 VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHE 98
Query: 209 AFSGVDYQG---ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVA 265
F+ D + A+V + G L + ++ + TN R F + + I V
Sbjct: 99 DFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTN-RT----FREHEAGLLFIQVL 153
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAI--DKQNRFICIKGS 323
A+ ++H + H ++K +N+LL + +GDFG ++ A D R C G+
Sbjct: 154 LAVHHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC--GT 208
Query: 324 TGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
Y+ PE S D++S G+LL E+ T RP DG
Sbjct: 209 PYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG 247
|
Length = 496 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 69/318 (21%), Positives = 128/318 (40%), Gaps = 69/318 (21%)
Query: 153 IGAGNFGSVYNGTLF-----DGTTIAVKVF-NLIRPGGSKSFKSECKAAINIKHRNIVRV 206
+G FG +Y G L+ +A+K ++ P F+ E + H NIV +
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWL--RGKDDTNWRPLNFNFLIKKKLD----- 259
+ + ++++++ G L E+L R + + +K LD
Sbjct: 73 LGVVTQ-----EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127
Query: 260 -IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAID----KQ 314
IAI +A + YL H +L N+L+ +++ + D G++R + + D +
Sbjct: 128 HIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQP 184
Query: 315 NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNF 373
+ I+ ++PPE + + S+ D++SFG++L E+F+ G++P G
Sbjct: 185 KSLLPIR----WMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYG----------- 229
Query: 374 VKMALPQRAEEVVDDFNLQE-IEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACS 432
F+ QE IE R + S S++ EC+
Sbjct: 230 ---------------FSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQ---------- 264
Query: 433 AERPRERMKINDVESRLR 450
E P R + D+ +RLR
Sbjct: 265 -EGPSRRPRFKDIHTRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (132), Expect = 3e-08
Identities = 56/210 (26%), Positives = 87/210 (41%), Gaps = 30/210 (14%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFS 211
IG G G VY T G +A+K L + + +E + KH NIV + ++
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQN-KELIINEILIMKDCKHPNIVDYYDSYL 85
Query: 212 GVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAI---DVACAL 268
+ VV ++M GSL + + NF+ + IA +V L
Sbjct: 86 ---VGDELW--VVMEYMDGGSLTDIIT-----------QNFVRMNEPQIAYVCREVLQGL 129
Query: 269 RYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIKGSTGY 326
YLH + H ++K N+LL G V DFG A L +K R + G+ +
Sbjct: 130 EYLH---SQNVIHRDIKSDNILLS--KDGSVKLADFGFAAQLTK-EKSKR-NSVVGTPYW 182
Query: 327 IPPEYDLGCEASTYGDVYSFGILLLEMFTG 356
+ PE + D++S GI+ +EM G
Sbjct: 183 MAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 55/219 (25%), Positives = 94/219 (42%), Gaps = 32/219 (14%)
Query: 153 IGAGNFGSVYNGTLFD------GTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRV 206
+G G+FG VY G D T +AVK N S S + + + ++++
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN-----ESASLRERIEF---LNEASVMKG 65
Query: 207 FTAFSGVDYQGARFKA----VVYKFMPNGSLEEWLRG-KDDTNWRPLNFNFLIKKKLDIA 261
FT V G K VV + M +G L+ +LR + + P +++ + +A
Sbjct: 66 FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 125
Query: 262 IDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIK 321
++A + YL+ H +L N ++ + +GDFGM R + D K
Sbjct: 126 AEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR-----K 177
Query: 322 GSTGYIP-----PEYDLGCEASTYGDVYSFGILLLEMFT 355
G G +P PE +T D++SFG++L E+ +
Sbjct: 178 GGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 4e-08
Identities = 60/267 (22%), Positives = 105/267 (39%), Gaps = 36/267 (13%)
Query: 147 FSSANLIGAGNFGSVYNGT-LFDGTTIAVK---VFNLIRPGGSKSFKSECKAAINIKHRN 202
F IG G F VY T L DG +A+K +F+L+ E + H N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKL---- 258
+++ + +F + +V + G L ++ +F +K+L
Sbjct: 64 VIKYYASFIEDNELN-----IVLELADAGDLSRMIK------------HFKKQKRLIPEK 106
Query: 259 ---DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQN 315
+ + AL ++H + H ++KP+NV + + +GD G+ RF + K
Sbjct: 107 TVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTT 161
Query: 316 RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVK 375
+ G+ Y+ PE + D++S G LL EM P + KMNL + K
Sbjct: 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNLYSLCK 218
Query: 376 MALPQRAEEVVDDFNLQEIEEGRTMCM 402
+ D +E+ + MC+
Sbjct: 219 KIEQCDYPPLPSDHYSEELRQLVNMCI 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 4e-08
Identities = 55/226 (24%), Positives = 95/226 (42%), Gaps = 43/226 (19%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGS------KSFKSECKAAINIKHRNIV 204
+G G F S Y + GT +AVK +R S ++ + E + + H +I+
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 205 RVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDV 264
R+ G + + F + ++M GS+ L + +I + +
Sbjct: 67 RML----GATCEDSHFN-LFVEWMAGGSVSHLLS-----KYGAFKEAVIINYTEQLLRGL 116
Query: 265 ACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH---VGDFGMARFLPAI-----DKQNR 316
+ YLH + Q I H ++K +N+L+D G + DFG A L A + Q +
Sbjct: 117 S----YLH-ENQ--IIHRDVKGANLLIDS--TGQRLRIADFGAAARLAAKGTGAGEFQGQ 167
Query: 317 FICIKGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
+ G+ ++ PE G YG DV+S G +++EM T P
Sbjct: 168 LL---GTIAFMAPEVLRG---EQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 5e-08
Identities = 52/218 (23%), Positives = 89/218 (40%), Gaps = 31/218 (14%)
Query: 153 IGAGNFGSVYNG-TLFDGTTIAVKVFNLIRPGGS-KSFKSECKAAINIKHRNIVRVFTAF 210
IG G VY L + +A+K +L + S + E +A H N+V+ +T+F
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
V + +V ++ GSL + ++ + K +V L Y
Sbjct: 69 V-VGDE----LWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLK------EVLKGLEY 117
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL--PAIDKQNRFICIKGSTGYIP 328
LH + Q H ++K N+LL ++ + DFG++ L + G+ ++
Sbjct: 118 LHSNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMA 174
Query: 329 PE-------YDLGCEASTYGDVYSFGILLLEMFTGIRP 359
PE YD D++SFGI +E+ TG P
Sbjct: 175 PEVMEQVHGYDFK------ADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 6e-08
Identities = 49/178 (27%), Positives = 81/178 (45%), Gaps = 26/178 (14%)
Query: 199 KHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRP--LNFNF---- 252
KH+NI+ + A + Q +V ++ G+L E+LR + RP ++++F
Sbjct: 76 KHKNIINLLGACT----QDGPLYVLV-EYASKGNLREYLRAR-----RPPGMDYSFDTCK 125
Query: 253 ------LIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMAR 306
K + A VA + YL H +L NVL+ ++ + + DFG+AR
Sbjct: 126 LPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR 182
Query: 307 FLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363
+ ID + + ++ PE + DV+SFG+LL E+FT G P GI
Sbjct: 183 DVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 7e-08
Identities = 59/216 (27%), Positives = 90/216 (41%), Gaps = 25/216 (11%)
Query: 147 FSSANLIGAGNFGSVYNG-TLFDGTTIAVKV--FNLIRPGGSKSFKSECKAAINIKHRNI 203
F N IG G +G VY G +A+K + R G S E +N++H NI
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNI 68
Query: 204 VRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAID 263
V + G ++ F+ E+ L D P F + + +
Sbjct: 69 VELKEVV-----VGKHLDSI---FLVMEYCEQDLASLLDNMPTP----FSESQVKCLMLQ 116
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF--LPAIDKQNRFICIK 321
+ L+YLH + I H +LK SN+LL D+ + DFG+AR LPA + +
Sbjct: 117 LLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV--- 170
Query: 322 GSTGYIPPEYDLGCEASTYG-DVYSFGILLLEMFTG 356
+ Y PE LGC T D+++ G +L E+
Sbjct: 171 -TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 7e-08
Identities = 36/106 (33%), Positives = 51/106 (48%), Gaps = 13/106 (12%)
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMAR--FLPAIDKQNR 316
A ++ L++LH + I + +LK NVLLD E GH+ DFGM + L +
Sbjct: 102 AAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSE--GHIKIADFGMCKEGILGG-VTTST 155
Query: 317 FICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
F C G+ YI PE D ++ G+LL EM G P +G
Sbjct: 156 F-C--GTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEG 198
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 9e-08
Identities = 69/273 (25%), Positives = 109/273 (39%), Gaps = 61/273 (22%)
Query: 153 IGAGNFGSVYNGTLFD------GTTIAVKVFNLIRPGGSKS----FKSECKAAINIKHRN 202
+G G FG V T F TT+AVK +++ S S SE + H +
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVK---MLKENASSSELRDLLSEFNLLKQVNHPH 64
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLR-------------------GKDDT 243
+++++ A S G ++ ++ GSL +LR D+
Sbjct: 65 VIKLYGACSQ---DGPLL--LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119
Query: 244 NWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303
+ R L LI A ++ ++YL + + H +L NVL+ + + DFG
Sbjct: 120 DERALTMGDLIS----FAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFG 172
Query: 304 MARFLPAIDKQNRFICIKGSTGYIP-----PEYDLGCEASTYGDVYSFGILLLEMFT-GI 357
++R + D +K S G IP E +T DV+SFG+LL E+ T G
Sbjct: 173 LSRDVYEEDSY-----VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG 227
Query: 358 RPSDGIFTGKMNLRNFVK----MALPQRAEEVV 386
P GI L N +K M P+ E +
Sbjct: 228 NPYPGI--APERLFNLLKTGYRMERPENCSEEM 258
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 9e-08
Identities = 57/233 (24%), Positives = 85/233 (36%), Gaps = 45/233 (19%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTA 209
IG G+FG+V DG + K + + SE +KH NIVR +
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDR 67
Query: 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK------------ 257
+D R +Y M E+ G D LI+K
Sbjct: 68 I--ID----RSNQTLYIVM------EYCEGGDLAQ--------LIQKCKKERKYIEEEFI 107
Query: 258 LDIAIDVACALRYLH--CDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLP-AIDKQ 314
I + AL H D + H +LKP+N+ LD +GDFG+A+ L
Sbjct: 108 WRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA 167
Query: 315 NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGK 367
++ G+ Y+ PE D++S G L+ E+ P FT +
Sbjct: 168 KTYV---GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP----FTAR 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 1e-07
Identities = 61/231 (26%), Positives = 103/231 (44%), Gaps = 41/231 (17%)
Query: 147 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-----KH 200
F L+G G +G VY G + G A+KV ++ + + E K IN+ H
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-----TGDEEEEIKQEINMLKKYSHH 62
Query: 201 RNIVRVFTAF-----SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIK 255
RNI + AF G+D Q +V +F GS+ + ++ + ++ +
Sbjct: 63 RNIATYYGAFIKKNPPGMDDQ----LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR 118
Query: 256 KKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM-ARFLPAIDKQ 314
+ L L +LH Q + H ++K NVLL + + DFG+ A+ + ++
Sbjct: 119 EILR-------GLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR 168
Query: 315 NRFICIKGSTGYIPPEYDLGCEA---STY---GDVYSFGILLLEMFTGIRP 359
N FI G+ ++ PE + C+ +TY D++S GI +EM G P
Sbjct: 169 NTFI---GTPYWMAPEV-IACDENPDATYDFKSDLWSLGITAIEMAEGAPP 215
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 58/184 (31%), Positives = 83/184 (45%), Gaps = 38/184 (20%)
Query: 199 KHRNIVRVFTAFSGVDYQ-GARFKAVVYKFMPNGSLEEWLR-----GKDDT------NWR 246
KH+NI+ + GV Q G + V+ ++ G+L E+LR G D T
Sbjct: 76 KHKNIINLL----GVCTQEGPLY--VIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEE 129
Query: 247 PLNFNFLIKKKLDIAIDVACALRYLHCD-CQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305
L+F L+ A VA + YL C H +L NVL+ ++ + + DFG+A
Sbjct: 130 QLSFKDLVS----CAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLA 181
Query: 306 RFLPAIDKQNRFICIKGSTGYIP-----PEYDLGCEASTYGDVYSFGILLLEMFT-GIRP 359
R + ID K S G +P PE + DV+SFGIL+ E+FT G P
Sbjct: 182 RGVHDIDYYK-----KTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP 236
Query: 360 SDGI 363
GI
Sbjct: 237 YPGI 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 1e-07
Identities = 61/222 (27%), Positives = 101/222 (45%), Gaps = 37/222 (16%)
Query: 152 LIGAGNFGSVYNGTL-FDG---TTIAVKVFNLIRPGGS----KSFKSECKAAINIKHRNI 203
+IGAG FG V +G L G +A+K ++ G + + F SE H NI
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKT---LKAGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 204 VRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAID 263
+ + GV + + +V ++M NGSL+ +LR D F + + + +
Sbjct: 68 IHL----EGVVTKS-KPVMIVTEYMENGSLDAFLRKHDG--------QFTVIQLVGMLRG 114
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGS 323
+A ++YL H +L N+L++ ++ V DFG++R L D +G
Sbjct: 115 IASGMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE--DDPEAAYTTRG- 168
Query: 324 TGYIP-----PEYDLGCEASTYGDVYSFGILLLE-MFTGIRP 359
G IP PE + ++ DV+S+GI++ E M G RP
Sbjct: 169 -GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 59/242 (24%), Positives = 95/242 (39%), Gaps = 69/242 (28%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI----KHRNIVRV 206
+G G++GSVY G +A+KV + + E I+I IV+
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKE----ISILKQCDSPYIVK- 62
Query: 207 FTAFSGVDYQGARFKA----VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLD--- 259
Y G+ FK +V ++ GS+ + ++ + K L
Sbjct: 63 --------YYGSYFKNTDLWIVMEYCGAGSVSDIMK--------------ITNKTLTEEE 100
Query: 260 IAI---DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLP-AIDKQN 315
IA L YLH H ++K N+LL++E + DFG++ L + K+N
Sbjct: 101 IAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRN 157
Query: 316 RFICIKGSTGYIPPE------YDLGCEASTYGDVYSFGILLLEMFTG------IRPSDGI 363
I G+ ++ PE Y+ +A D++S GI +EM G I P I
Sbjct: 158 TVI---GTPFWMAPEVIQEIGYN--NKA----DIWSLGITAIEMAEGKPPYSDIHPMRAI 208
Query: 364 FT 365
F
Sbjct: 209 FM 210
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 40/108 (37%), Positives = 52/108 (48%), Gaps = 15/108 (13%)
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFI 318
A ++A L +LH I + +LK NV+LD E GH+ DFGM + K R
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAE--GHIKIADFGMCKENIFGGKTTRTF 161
Query: 319 CIKGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDGI 363
C G+ YI PE YG D ++FG+LL EM G P DG
Sbjct: 162 C--GTPDYIAPEIIA---YQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 204
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 43/143 (30%), Positives = 60/143 (41%), Gaps = 16/143 (11%)
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFI 318
A + C L +LH Q I + +LKP NVLLDD G+V D G+A L K
Sbjct: 101 AAQIICGLEHLH---QRRIVYRDLKPENVLLDDH--GNVRISDLGLAVELKGGKKIKGRA 155
Query: 319 CIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMAL 378
G+ GY+ PE G D ++ G L EM G P + + +K
Sbjct: 156 ---GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQ--RKEKVEKEELKRRT 210
Query: 379 PQRAEEVVDDFNLQEIEEGRTMC 401
+ A E D F+ E + +C
Sbjct: 211 LEMAVEYPDKFS----PEAKDLC 229
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 16/173 (9%)
Query: 199 KHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKD----DTNWRPLNF---N 251
KH+NI+ + A + G + V+ ++ G+L E+LR + + + P
Sbjct: 82 KHKNIINLLGACT---QDGPLY--VIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQ 136
Query: 252 FLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAI 311
K + A VA + YL H +L NVL+ ++ + + DFG+AR + I
Sbjct: 137 LSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 193
Query: 312 DKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363
D + + ++ PE + DV+SFG+LL E+FT G P G+
Sbjct: 194 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 65/253 (25%), Positives = 100/253 (39%), Gaps = 65/253 (25%)
Query: 128 GKQTINNPSFKDLYNATNGFSSANLIGAGNFGSVY------NGTLFDGTTIAVKVFNLIR 181
G S +L N IG+G G+VY G L+ A+KV I
Sbjct: 64 GSAPSAAKSLSEL-------ERVNRIGSGAGGTVYKVIHRPTGRLY-----ALKV---IY 108
Query: 182 PGGSKSFKSECKAAINI----KHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWL 237
+ + + I I H N+V+ F + V+ +FM GSLE
Sbjct: 109 GNHEDTVRRQICREIEILRDVNHPNVVKCHDMFD----HNGEIQ-VLLEFMDGGSLE--- 160
Query: 238 RGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297
+ FL D+A + + YLH + I H ++KPSN+L++
Sbjct: 161 ------GTHIADEQFLA----DVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNV 207
Query: 298 HVGDFGMARFLP-AIDKQNRFICIKGSTGYIPPE----------YDLGCEASTYGDVYSF 346
+ DFG++R L +D N + G+ Y+ PE YD G GD++S
Sbjct: 208 KIADFGVSRILAQTMDPCNSSV---GTIAYMSPERINTDLNHGAYD-GYA----GDIWSL 259
Query: 347 GILLLEMFTGIRP 359
G+ +LE + G P
Sbjct: 260 GVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 52.6 bits (127), Expect = 2e-07
Identities = 36/107 (33%), Positives = 55/107 (51%), Gaps = 17/107 (15%)
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGY 326
AL+Y+H + H +LKPSN+LL+ + + DFG+AR L +++ + T Y
Sbjct: 119 ALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVL---TDY 172
Query: 327 I------PPEYDLGCEASTYG-DVYSFGILLLEMFTGIRPSDGIFTG 366
+ PE LG T G D++S G +L EM G +P +F G
Sbjct: 173 VATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG-KP---LFPG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 43/131 (32%), Positives = 64/131 (48%), Gaps = 13/131 (9%)
Query: 260 IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG--DFGMARFLPAIDKQNRF 317
IA+ + AL YLH + + H ++KPSNVL++ G V DFG++ +L +D +
Sbjct: 108 IAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRN--GQVKLCDFGISGYL--VDSVAKT 161
Query: 318 ICIKGSTGYIPPE-YDLGCEASTY---GDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNF 373
I G Y+ PE + Y DV+S GI ++E+ TG P D T L+
Sbjct: 162 IDA-GCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQV 220
Query: 374 VKMALPQRAEE 384
V+ PQ E
Sbjct: 221 VEEPSPQLPAE 231
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 60/222 (27%), Positives = 85/222 (38%), Gaps = 46/222 (20%)
Query: 153 IGAGNFGSVYNGTL-FDGTTIAVKVFN---LIRPGGSKSFKSECKAAINIKHRNIVRVFT 208
+G G FG V + T A+K ++ G + SE + H IV+++
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 209 AFSGVDYQGARFKAVVY---KFMPNGSLEEWLRGKDDTNWRPLNFN-----FLIKKKLDI 260
F Y +Y ++ G L LR + F+ F I
Sbjct: 61 TFKDKKY--------IYMLMEYCLGGELWTILRDRG-------LFDEYTARFYI------ 99
Query: 261 AIDVAC---ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRF 317
AC A YLH I + +LKP N+LLD + DFG A+ L + K F
Sbjct: 100 ----ACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTF 152
Query: 318 ICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
G+ Y+ PE L D +S GILL E+ TG P
Sbjct: 153 C---GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 54/230 (23%), Positives = 99/230 (43%), Gaps = 36/230 (15%)
Query: 147 FSSANLIGAGNFGSVYNGTLF-DGTTI----AVKVF-NLIRPGGSKSFKSECKAAINIKH 200
F ++G+G FG+VY G +G + A+K P +K E ++ +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 201 RNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDI 260
++ R+ Q ++ + MP G L +++R D N + L+
Sbjct: 69 PHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKD--------NIGSQYLLNW 114
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICI 320
+ +A + YL + + H +L NVL+ + DFG+A+ L A +K+
Sbjct: 115 CVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE-----Y 166
Query: 321 KGSTGYIPPEYDLGCEA---STY---GDVYSFGILLLEMFT-GIRPSDGI 363
G +P ++ + E+ Y DV+S+G+ + E+ T G +P DGI
Sbjct: 167 HAEGGKVPIKW-MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 215
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 3e-07
Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 32/217 (14%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKS-FKSECKAAINIKH---RNIVRV 206
LIG G +G+VY G + G +A+K+ NL P S + E ++ NI +
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAI--DV 264
+ G +G R ++ ++ GS+ ++ I +K I +V
Sbjct: 68 Y----GSYLKGPRL-WIIMEYAEGGSVRTLMKAGP------------IAEKYISVIIREV 110
Query: 265 ACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAID-KQNRFICIKGS 323
AL+Y+H + H ++K +N+L+ + + DFG+A L K++ F+ G+
Sbjct: 111 LVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV---GT 164
Query: 324 TGYIPPEYDL-GCEASTYGDVYSFGILLLEMFTGIRP 359
++ PE G T D++S GI + EM TG P
Sbjct: 165 PYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 58/229 (25%), Positives = 101/229 (44%), Gaps = 28/229 (12%)
Query: 141 YNATNGFSSANLIGAGNFGSVYNG-TLFDGTTIAVKVFNLIRPGGSKSFKSECKAAI--N 197
+ + + +G G++ +VY G + +G +A+KV L G+ F + +A++
Sbjct: 1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGT-PFTAIREASLLKG 59
Query: 198 IKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK 257
+KH NIV + + F+ V + L +++ K P N + +
Sbjct: 60 LKHANIVLLHDIIHTKETLTLVFEYV------HTDLCQYM-DKHPGGLHPENVKLFLFQL 112
Query: 258 LDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF--LPAIDKQN 315
L L Y+H Q I H +LKP N+L+ D + DFG+AR +P+ N
Sbjct: 113 LR-------GLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSN 162
Query: 316 RFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGI 363
+ + Y PP+ LG E ST D++ G + +EM G+ G+
Sbjct: 163 EVVTL----WYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 37/97 (38%), Positives = 53/97 (54%), Gaps = 11/97 (11%)
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG--DFGMARF-LPAIDKQNRFICIKG 322
CAL LH + + + +LKP N+LLD GH+ DFG+ + + DK N F C G
Sbjct: 104 CALENLH---KFNVIYRDLKPENILLD--YQGHIALCDFGLCKLNMKDDDKTNTF-C--G 155
Query: 323 STGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
+ Y+ PE LG + D ++ G+LL EM TG+ P
Sbjct: 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 59/231 (25%), Positives = 102/231 (44%), Gaps = 41/231 (17%)
Query: 147 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-----KH 200
F ++G G +G VY G + G A+KV ++ ++ + E K IN+ H
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDV-----TEDEEEEIKLEINMLKKYSHH 72
Query: 201 RNIVRVFTAF-----SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIK 255
RNI + AF G D Q +V +F GS+ + ++ + ++ +
Sbjct: 73 RNIATYYGAFIKKSPPGHDDQ----LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICR 128
Query: 256 KKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM-ARFLPAIDKQ 314
+ L L +LH + H ++K NVLL + + DFG+ A+ + ++
Sbjct: 129 EILR-------GLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR 178
Query: 315 NRFICIKGSTGYIPPEYDLGCEA---STY---GDVYSFGILLLEMFTGIRP 359
N FI G+ ++ PE + C+ +TY D++S GI +EM G P
Sbjct: 179 NTFI---GTPYWMAPEV-IACDENPDATYDYRSDIWSLGITAIEMAEGAPP 225
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 6e-07
Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 22/215 (10%)
Query: 152 LIGAGNFGSVYNGTLFD-GTTIAVKV--FNLIRPGGSKSFKS-ECKAAI--NIKHRNIVR 205
L+G G FG VY D G +A K F+ P SK + EC+ + N++H IV+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVA 265
+ + + + ++MP GS+++ L+ + L + K I
Sbjct: 69 YYGCLRD---RAEKTLTIFMEYMPGGSVKDQLKA-----YGALTESVTRKYTRQILE--- 117
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFI-CIKGST 324
+ YLH + I H ++K +N+L D +GDFG ++ L I I + G+
Sbjct: 118 -GMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTP 173
Query: 325 GYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
++ PE G DV+S G ++EM T P
Sbjct: 174 YWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 6e-07
Identities = 55/223 (24%), Positives = 97/223 (43%), Gaps = 35/223 (15%)
Query: 151 NLIGAGNFGSVYNGTLF-DGTTI--AVKVFN-LIRPGGSKSFKSECKAAINI-KHRNIVR 205
++IG GNFG V + DG + A+K+ + F E + + H NI+
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRP-------LNFNFLIKKKL 258
+ A + +G + A+ Y P G+L ++LR P ++ L
Sbjct: 68 LLGA---CENRGYLYIAIEYA--PYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122
Query: 259 DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFI 318
A DVA ++YL + H +L NVL+ + + + DFG++R +
Sbjct: 123 QFASDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR--------GEEV 171
Query: 319 CIKGSTGYIPPEYDLGCEA------STYGDVYSFGILLLEMFT 355
+K + G +P + + E+ +T DV+SFG+LL E+ +
Sbjct: 172 YVKKTMGRLPVRW-MAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 6e-07
Identities = 65/228 (28%), Positives = 103/228 (45%), Gaps = 42/228 (18%)
Query: 147 FSSANLIGAGNFGSVYNGTLFD-GTTIAVKVFNLI--RPGGSKSFKSECKAAINIKHRNI 203
F IG G +G VY D G +A+K L + G + E K + HRNI
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 204 VR----VFTAFSGVDY---QGARFKAVVYKFMPN---GSLEEWLRGKDDTNWRPLNFNFL 253
V V +D+ +GA + +V+++M + G LE L ++ +
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFY--LVFEYMDHDLMGLLESGL-----VHFSEDHIKSF 121
Query: 254 IKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDK 313
+K+ L+ L Y H + H ++K SN+LL+++ + DFG+AR + +
Sbjct: 122 MKQLLE-------GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES 171
Query: 314 Q---NRFICIKGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFT 355
+ N+ I + Y PPE LG E YG DV+S G +L E+FT
Sbjct: 172 RPYTNKVITL----WYRPPELLLGEE--RYGPAIDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 6e-07
Identities = 31/96 (32%), Positives = 47/96 (48%), Gaps = 5/96 (5%)
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGS 323
+ L +LH Q I + +LKP NVLLD++ + D G+A L D Q++ G+
Sbjct: 106 IISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVEL--KDGQSKTKGYAGT 160
Query: 324 TGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
G++ PE G E D ++ G+ L EM P
Sbjct: 161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 9e-07
Identities = 61/226 (26%), Positives = 93/226 (41%), Gaps = 33/226 (14%)
Query: 147 FSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNL------IRPGGSKSFKSECKAAINIKH 200
++ ++G G +G+VY G G IAVK L + + E ++KH
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 201 RNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDI 260
NIV + G ++ +F+P GS+ L + PL K I
Sbjct: 62 VNIV----QYLGTCLDDNTI-SIFMEFVPGGSISSILN-----RFGPLPEPVFCKYTKQI 111
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAI----DKQNR 316
VA YLH +C + H ++K +NV+L I + DFG AR L + N
Sbjct: 112 LDGVA----YLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNM 164
Query: 317 FICIKGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
+ G+ ++ PE S YG D++S G + EM TG P
Sbjct: 165 LKSMHGTPYWMAPEV---INESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 9e-07
Identities = 46/178 (25%), Positives = 75/178 (42%), Gaps = 26/178 (14%)
Query: 199 KHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNF------ 252
KH+NI+ + A + Q +V ++ G+L E+LR + RP +
Sbjct: 79 KHKNIINLLGACT----QDGPLYVIV-EYASKGNLREYLRAR-----RPPGMEYSYDIAR 128
Query: 253 ------LIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMAR 306
K + VA + YL H +L NVL+ + + + DFG+AR
Sbjct: 129 VPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 185
Query: 307 FLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363
+ ID + + ++ PE + DV+SFG+L+ E+FT G P GI
Sbjct: 186 DVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 9e-07
Identities = 63/258 (24%), Positives = 95/258 (36%), Gaps = 72/258 (27%)
Query: 145 NGFSSANLIGAGNFGSVYNGTLFDGTT---IAVKVFN---LIRPGGSKSFKSECKAAINI 198
+ F +IG G FG V+ + D T A+KV +I+ ++E +
Sbjct: 1 DDFEVIKVIGRGAFGEVW--LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA 58
Query: 199 KHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKD--DTNWRPLNFNFLIKK 256
IV+++ +F Q +V ++MP G L L KD F I +
Sbjct: 59 DSPWIVKLYYSF-----QDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETA----RFYIAE 109
Query: 257 KLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMA--------R 306
L +A+D L ++H D +KP N+L+D + GH+ DFG+ R
Sbjct: 110 -LVLALDSVHKLGFIHRD---------IKPDNILIDAD--GHIKLADFGLCKKMNKAKDR 157
Query: 307 FLPAIDKQNRFICIK-------------------GSTGYIPPE------YDLGCEASTYG 341
D N G+ YI PE Y L C
Sbjct: 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLEC------ 211
Query: 342 DVYSFGILLLEMFTGIRP 359
D +S G++L EM G P
Sbjct: 212 DWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 59/244 (24%), Positives = 91/244 (37%), Gaps = 48/244 (19%)
Query: 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIA---VKVFNLIRPGGSKSFKSECKAAINIK 199
F IG G F VY L DG +A V++F ++ + E +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 200 HRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIK--KK 257
H N+++ +F + N LE G + + +IK KK
Sbjct: 61 HPNVIKYLASF-------------IENNELNIVLELADAG---------DLSRMIKHFKK 98
Query: 258 LDIAID----------VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF 307
I + AL ++H I H ++KP+NV + + +GD G+ RF
Sbjct: 99 QKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRF 155
Query: 308 LPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTG- 366
+ K + G+ Y+ PE + D++S G LL EM P F G
Sbjct: 156 FSS--KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP----FYGD 209
Query: 367 KMNL 370
KMNL
Sbjct: 210 KMNL 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 34/213 (15%)
Query: 153 IGAGNFGS---VYNGTLFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVF 207
IG G+FG V + DG +K N+ + P + + E N+KH NIV+
Sbjct: 8 IGEGSFGKAILVKSKE--DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65
Query: 208 TAF--SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVA 265
+F +G Y +V + G L + + + F + LD + +
Sbjct: 66 ESFEENGNLY-------IVMDYCEGGDLYKKINAQR-------GVLFPEDQILDWFVQIC 111
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTG 325
AL+++H I H ++K N+ L + +GDFG+AR L + + R CI G+
Sbjct: 112 LALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR-TCI-GTPY 166
Query: 326 YIPPEYDLGCEASTY---GDVYSFGILLLEMFT 355
Y+ PE CE Y D+++ G +L EM T
Sbjct: 167 YLSPEI---CENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 58/218 (26%), Positives = 93/218 (42%), Gaps = 48/218 (22%)
Query: 153 IGAGNFGSVYNG-TLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFS 211
IG+G +G VY + G +A+KV L + + E +H NIV F ++
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 212 GVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVAC----A 267
D +V ++ GSL++ PL+ +L IA V
Sbjct: 71 RRDKL-----WIVMEYCGGGSLQDIY----QVTRGPLS-------ELQIAY-VCRETLKG 113
Query: 268 LRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPA-IDKQNRFICIKGST 324
L YLH + H ++K +N+LL ++ G V DFG++ L A I K+ FI G+
Sbjct: 114 LAYLH---ETGKIHRDIKGANILLTED--GDVKLADFGVSAQLTATIAKRKSFI---GTP 165
Query: 325 GYIPPE---------YDLGCEASTYGDVYSFGILLLEM 353
++ PE YD C D+++ GI +E+
Sbjct: 166 YWMAPEVAAVERKGGYDGKC------DIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 57/225 (25%), Positives = 89/225 (39%), Gaps = 29/225 (12%)
Query: 169 GTTIAVKVFNLIRPGGS---KSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVY 225
G +A+K+ P F+ E + H NIV + SG G F V+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLD--SGEAPPGLLF--AVF 58
Query: 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLK 285
+++P +L E L D L+ + LD +ACA I H +LK
Sbjct: 59 EYVPGRTLREVL--AADGALPAGETGRLMLQVLD---ALACAHN-------QGIVHRDLK 106
Query: 286 PSNVLL---DDEMIGHVGDFGMARFLP---AIDKQ--NRFICIKGSTGYIPPEYDLGCEA 337
P N+++ V DFG+ LP D R + G+ Y PE G
Sbjct: 107 PQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPV 166
Query: 338 STYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNF--VKMALPQ 380
+ D+Y++G++ LE TG R G ++ + V ++LP
Sbjct: 167 TPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLPP 211
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 68/260 (26%), Positives = 106/260 (40%), Gaps = 40/260 (15%)
Query: 129 KQTINNPSFKDLYNATNGFSSANLIGAGNFGSV-YNGTLFDGTTIAVKV---FNLIRPGG 184
K TIN +DL + +IG G FG V A+K+ F +I+
Sbjct: 29 KDTINK--IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSD 86
Query: 185 SKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTN 244
S F E +V++F AF Q R+ +V ++MP G L + D
Sbjct: 87 SAFFWEERDIMAFANSPWVVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMSNYD--- 138
Query: 245 WRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM 304
P + ++ +A+D ++ ++H D +KP N+LLD + DFG
Sbjct: 139 -VPEKWARFYTAEVVLALDAIHSMGFIHRD---------VKPDNMLLDKSGHLKLADFGT 188
Query: 305 ARFLPAIDKQNRFIC--IKGSTGYIPPEYDLGCEAST--YG---DVYSFGILLLEMFTGI 357
++K+ C G+ YI PE L + YG D +S G+ L EM G
Sbjct: 189 CM---KMNKEGMVRCDTAVGTPDYISPEV-LKSQGGDGYYGRECDWWSVGVFLYEMLVGD 244
Query: 358 RP--SD---GIFTGKMNLRN 372
P +D G ++ MN +N
Sbjct: 245 TPFYADSLVGTYSKIMNHKN 264
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 22/215 (10%)
Query: 152 LIGAGNFGSVYNGTLFD-GTTIAVKV--FNLIRPGGSKSFKS-ECKAAI--NIKHRNIVR 205
L+G G FG VY D G +AVK F+ P SK + EC+ + N+ H IV+
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVA 265
+ D R ++ + MP GS+++ L+ ++ L N K I V+
Sbjct: 69 YYGCLR--DPM-ERTLSIFMEHMPGGSIKDQLK-----SYGALTENVTRKYTRQILEGVS 120
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFI-CIKGST 324
YLH + I H ++K +N+L D +GDFG ++ L I + + G+
Sbjct: 121 ----YLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTP 173
Query: 325 GYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
++ PE G D++S G ++EM T P
Sbjct: 174 YWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 54/228 (23%), Positives = 99/228 (43%), Gaps = 45/228 (19%)
Query: 151 NLIGAGNFGSVY------NGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-KHRNI 203
++IG GNFG V +G D +K + + F E + + H NI
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNI 70
Query: 204 VRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLI--------- 254
+ + A +++G + A+ ++ P+G+L ++LR P F I
Sbjct: 71 INLLGA---CEHRGYLYLAI--EYAPHGNLLDFLRKSRVLETDPA---FAIANSTASTLS 122
Query: 255 -KKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDK 313
++ L A DVA + YL Q H +L N+L+ + + + DFG++R
Sbjct: 123 SQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR------- 172
Query: 314 QNRFICIKGSTGYIPPEYDLGCEASTY------GDVYSFGILLLEMFT 355
+ + +K + G +P + + E+ Y DV+S+G+LL E+ +
Sbjct: 173 -GQEVYVKKTMGRLPVRW-MAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 39/153 (25%), Positives = 68/153 (44%), Gaps = 12/153 (7%)
Query: 249 NFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL 308
N F ++ L A ++ C L LH + + +LKP N+LLDD + D G+A +
Sbjct: 96 NPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKI 152
Query: 309 PAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKM 368
P + + G+ GY+ PE + D + G L+ EM G P F G+
Sbjct: 153 PEGESIRGRV---GTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP----FRGRK 205
Query: 369 NLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMC 401
+ + +R E + ++ + EE +++C
Sbjct: 206 --EKVKREEVDRRVLETEEVYSAKFSEEAKSIC 236
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 60/221 (27%), Positives = 92/221 (41%), Gaps = 19/221 (8%)
Query: 153 IGAGNFGSVYNGTLFDGTTI---AVKVFNLIRPGGSK--SFKSECKAAINIKHRNIVRVF 207
+G G FGSV G L +I AVK + S+ F SE H N++R+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 208 -TAFSGVDYQGARFKAVVYKFMPNGSLEEWL---RGKDDTNWRPLNFNFLIKKKLDIAID 263
V+ +G V+ FM +G L +L R D + P L+K D
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQM--LVK----FMTD 120
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGS 323
+A + YL H +L N +L++ M V DFG+++ + D + K
Sbjct: 121 IASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177
Query: 324 TGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363
+I E +T DV+SFG+ + E+ T G P G+
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV 218
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 50/172 (29%), Positives = 78/172 (45%), Gaps = 31/172 (18%)
Query: 240 KDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHC-DCQPPIAHCNLKPSNVLLDDEMIGH 298
+D + PL+ + L L + VA + +L +C H ++ NVLL D +
Sbjct: 201 EDTEDSWPLDLDDL----LRFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAK 252
Query: 299 VGDFGMARFLPAIDKQNRFICIKGST----GYIPPEYDLGCEASTYGDVYSFGILLLEMF 354
+ DFG+AR I + ++ +KG+ ++ PE C + DV+S+GILL E+F
Sbjct: 253 ICDFGLAR---DIMNDSNYV-VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 308
Query: 355 T-GIRPSDGIFTG----KMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMC 401
+ G P GI KM R + +M+ P DF EI MC
Sbjct: 309 SLGKSPYPGILVNSKFYKMVKRGY-QMSRP--------DFAPPEIYSIMKMC 351
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 3e-06
Identities = 59/241 (24%), Positives = 98/241 (40%), Gaps = 74/241 (30%)
Query: 147 FSSANLIGAGNFGSVYNGTLFD---GTTIAVKVFNL-------------IRPGGSKSFKS 190
F+ IG G+FG VY D +A+KV +L I F S
Sbjct: 3 FTLLECIGKGSFGEVYKA--IDKRTNQVVAIKVIDLEEAEDEIEDIQQEI------QFLS 54
Query: 191 ECKAAINIKHRNIVRVFTAFSGVDYQGARFK-AVVYKFMPNGSLEEWLR-GKDDTNWRPL 248
+C++ I + + +F K ++ ++ GS + L+ GK D +
Sbjct: 55 QCRSP------YITKYYGSFLK------GSKLWIIMEYCGGGSCLDLLKPGKLDETY--- 99
Query: 249 NFNFLIKKKLDIAI---DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305
IA +V L YLH + I H ++K +N+LL +E + DFG++
Sbjct: 100 -----------IAFILREVLLGLEYLHE--EGKI-HRDIKAANILLSEEGDVKLADFGVS 145
Query: 306 RFLPA-IDKQNRFICIKGSTGYIPPE------YDLGCEASTYGDVYSFGILLLEMFTGIR 358
L + + K+N F+ G+ ++ PE YD D++S GI +E+ G
Sbjct: 146 GQLTSTMSKRNTFV---GTPFWMAPEVIKQSGYDEKA------DIWSLGITAIELAKGEP 196
Query: 359 P 359
P
Sbjct: 197 P 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 58/239 (24%), Positives = 105/239 (43%), Gaps = 42/239 (17%)
Query: 147 FSSANLIGAGNFGSVYNGTLF--DGT--TIAVKVF--NLIRPGGSKSFKSECKAAINIKH 200
F+ ++G G FGSV L DG+ +AVK+ ++ + F E H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 201 RNIVRVFTAFSGVDYQGARFKA------VVYKFMPNGSLEEWL---RGKDDTNWRPLNFN 251
N++++ GV + +R K V+ FM +G L +L R ++ F
Sbjct: 61 PNVIKLI----GVSLR-SRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEP------FT 109
Query: 252 FLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAI 311
++ + ID+A + YL H +L N +L++ M V DFG+++ + +
Sbjct: 110 LPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSG 166
Query: 312 DKQNRFICIKGSTGYIPPEYDLGCEA------STYGDVYSFGILLLEMFT-GIRPSDGI 363
D +G +P ++ L E+ +T+ DV++FG+ + E+ T G P G+
Sbjct: 167 DYYR-----QGCASKLPVKW-LALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV 219
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 60/214 (28%), Positives = 89/214 (41%), Gaps = 28/214 (13%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFN---LIRPGGSKSFKSECKAAI-NIKHRNIVRVF 207
IG G+FG V DG AVKV +++ K +E + N+KH +V +
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 208 TAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACA 267
+F Q A V ++ G L L+ + +F + A ++A A
Sbjct: 63 YSF-----QTADKLYFVLDYVNGGELFFHLQRER---------SFPEPRARFYAAEIASA 108
Query: 268 LRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIKGSTG 325
L YLH I + +LKP N+LLD + GHV DFG+ + K C G+
Sbjct: 109 LGYLH---SLNIIYRDLKPENILLDSQ--GHVVLTDFGLCKEGIEHSKTTSTFC--GTPE 161
Query: 326 YIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
Y+ PE D + G +L EM G+ P
Sbjct: 162 YLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 55/244 (22%), Positives = 93/244 (38%), Gaps = 56/244 (22%)
Query: 153 IGAGNFGSVYNGTLFD-GTTIAVKVFN---LIRPGGSKSFKSECKAAINIKHRNIVRVFT 208
+G G +G V+ D G +A+K L + + +E K +V++
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 209 AFSGVDYQGARFKAVVY---KFMPNGSLEEWLRGKDDTNWRPLNFN---FLIKKKLDIAI 262
AF +Y +Y +++P G L N L+ + F +
Sbjct: 69 AFQDDEY--------LYLAMEYVPGGDFRTLL-----NNLGVLSEDHARFYM-------A 108
Query: 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICI 320
++ A+ LH + H +LKP N L+D GH+ DFG+++ + N +
Sbjct: 109 EMFEAVDALH---ELGYIHRDLKPENFLIDAS--GHIKLTDFGLSK--GIVTYANS---V 158
Query: 321 KGSTGYIPPE------YDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKM--NLRN 372
GS Y+ PE YD D +S G +L E G P G + NL+
Sbjct: 159 VGSPDYMAPEVLRGKGYDFTV------DYWSLGCMLYEFLCGFPPFSGSTPNETWENLKY 212
Query: 373 FVKM 376
+ +
Sbjct: 213 WKET 216
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 34/98 (34%), Positives = 50/98 (51%), Gaps = 14/98 (14%)
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG--DFGMARFLPAIDKQNRFICIKGST 324
AL +LH + I + +LKP N+LLD GH+ DFG+++ +K C G+T
Sbjct: 108 ALEHLH---KYDIVYRDLKPENILLDAT--GHIALCDFGLSKANLTDNKTTNTFC--GTT 160
Query: 325 GYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
Y+ PE L + Y D +S G+L+ EM G P
Sbjct: 161 EYLAPEVLL--DEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 65/241 (26%), Positives = 113/241 (46%), Gaps = 26/241 (10%)
Query: 142 NATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHR 201
+ + N+IG G+FG VY D T+ V + +++ K+ E N+ H
Sbjct: 63 SPNKSYKLGNIIGNGSFGVVYEAICID-TSEKVAIKKVLQDPQYKN--RELLIMKNLNHI 119
Query: 202 NIVRVFTAFSGVDYQGAR---FKAVVYKFMPNGSLEEWLRGKDDTNWR-PLNFNFLIKKK 257
NI+ + + ++ F VV +F+P ++ ++++ N PL FL+K
Sbjct: 120 NIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPL---FLVKL- 174
Query: 258 LDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD-DEMIGHVGDFGMARFLPAIDKQNR 316
+ + AL Y+H I H +LKP N+L+D + + DFG A+ L A +
Sbjct: 175 --YSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVS 229
Query: 317 FICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVK 375
+IC S Y PE LG +T+ D++S G ++ EM G IF+G+ ++ V+
Sbjct: 230 YIC---SRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYP----IFSGQSSVDQLVR 282
Query: 376 M 376
+
Sbjct: 283 I 283
|
Length = 440 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 4e-06
Identities = 58/211 (27%), Positives = 90/211 (42%), Gaps = 29/211 (13%)
Query: 153 IGAGNFGSVYNGTLF----DGTTIAVKVFNLIRPGGSKSFKSECKAAI--NIKHRNIVRV 206
+G G++G V +L DG +K NL + +E +A + +KH NIV
Sbjct: 8 VGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK-LDIAIDVA 265
++ G D +V F G L L+ + L + + ++ + +A
Sbjct: 65 RESWEGEDGL----LYIVMGFCEGGDLYHKLKEQKG--------KLLPENQVVEWFVQIA 112
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPA-IDKQNRFICIKGST 324
AL+YLH + I H +LK NV L I VGD G+AR L D + I G+
Sbjct: 113 MALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI---GTP 166
Query: 325 GYIPPEYDLGCEASTYGDVYSFGILLLEMFT 355
Y+ PE + DV++ G + EM T
Sbjct: 167 YYMSPELFSNKPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 36/105 (34%), Positives = 55/105 (52%), Gaps = 10/105 (9%)
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL-PAIDKQNRFICIKGST 324
L+Y+H + H +LKPSN+L++++ +GDFGMAR L + + F+ +T
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174
Query: 325 -GYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGK 367
Y PE L E +T D++S G + EM G R +F GK
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQ---LFPGK 215
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 10/94 (10%)
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMAR--FLPAIDKQNRFICIKGST 324
L Y+H + I H ++K +N+L+ + I + DFG+AR L K NR+ +
Sbjct: 131 GLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTL 187
Query: 325 GYIPPEYDLGCEASTYG---DVYSFGILLLEMFT 355
Y PPE LG YG D++ G ++ EM+T
Sbjct: 188 WYRPPELLLGER--DYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 4e-06
Identities = 58/227 (25%), Positives = 98/227 (43%), Gaps = 37/227 (16%)
Query: 153 IGAGNFGSVY-------------NGTLFDGTTIAVKVFNLIRPGGSKS----FKSECKAA 195
+G G FG V+ FDG + V V ++R +K+ F E K
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAV-KMLRADVTKTARNDFLKEIKIM 71
Query: 196 INIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNF--- 252
+K+ NI+R+ GV ++ ++M NG L ++L ++ + N
Sbjct: 72 SRLKNPNIIRLL----GVCVSDDPL-CMITEYMENGDLNQFLSQREIESTFTHANNIPSV 126
Query: 253 LIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAID 312
I L +A+ +A ++YL H +L N L+ + + DFGM+R L + D
Sbjct: 127 SIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGD 183
Query: 313 KQNRFICIKGST----GYIPPEYDLGCEASTYGDVYSFGILLLEMFT 355
+ I+G ++ E L + +T DV++FG+ L EMFT
Sbjct: 184 ----YYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 5e-06
Identities = 41/145 (28%), Positives = 70/145 (48%), Gaps = 20/145 (13%)
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICI 320
A ++ C L LH Q I + +LKP N+LLDD + D G+A +P + Q I
Sbjct: 108 AAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVP--EGQT----I 158
Query: 321 K---GSTGYIPPEYDLGCEASTYG-DVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKM 376
K G+ GY+ PE + E T+ D ++ G LL EM G P + + +
Sbjct: 159 KGRVGTVGYMAPEV-VKNERYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIKRE 211
Query: 377 ALPQRAEEVVDDFNLQEIEEGRTMC 401
+ + +EV ++++ + + R++C
Sbjct: 212 EVERLVKEVQEEYSEKFSPDARSLC 236
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 7e-06
Identities = 55/234 (23%), Positives = 94/234 (40%), Gaps = 50/234 (21%)
Query: 153 IGAGNFGSVY------------NGTLFDG-----TTIAVKVFNLIRPGGSKS----FKSE 191
+G G FG V+ + +AVKV +RP S + F E
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKV---LRPDASDNAREDFLKE 69
Query: 192 CKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLR---GKDDT---NW 245
K + NI R+ + ++ ++M NG L ++L+ + N
Sbjct: 70 VKILSRLSDPNIARLLGVCTVDPPL-----CMIMEYMENGDLNQFLQKHVAETSGLACNS 124
Query: 246 RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305
+ L+F+ L L +A +A +RYL H +L N L+ + DFGM+
Sbjct: 125 KSLSFSTL----LYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
Query: 306 RFLPAIDKQNRFICIKGST----GYIPPEYDLGCEASTYGDVYSFGILLLEMFT 355
R L + D + ++G ++ E L + +T DV++FG+ L E+ T
Sbjct: 178 RNLYSSD----YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 47.6 bits (114), Expect = 7e-06
Identities = 54/228 (23%), Positives = 84/228 (36%), Gaps = 64/228 (28%)
Query: 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAIN------------ 197
+G G + VY G +A+K I+ G + E K IN
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKK---IKLGE----RKEAKDGINFTALREIKLLQE 58
Query: 198 IKHRNIVR---VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLI 254
+KH NI+ VF S ++ +V++FM LE+ +I
Sbjct: 59 LKHPNIIGLLDVFGHKSNIN--------LVFEFME-TDLEK-----------------VI 92
Query: 255 KKKLDI--AIDVAC-------ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305
K K + D+ L YLH I H +LKP+N+L+ + + + DFG+A
Sbjct: 93 KDKSIVLTPADIKSYMLMTLRGLEYLH-SNW--ILHRDLKPNNLLIASDGVLKLADFGLA 149
Query: 306 RFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYG-DVYSFGILLLE 352
R + + Y PE G G D++S G + E
Sbjct: 150 RSFG--SPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAE 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 43/148 (29%), Positives = 72/148 (48%), Gaps = 26/148 (17%)
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFI 318
A ++ C L LH + I + +LKP N+LLDD GH+ D G+A +P +
Sbjct: 108 AAEITCGLEDLH---RERIVYRDLKPENILLDDY--GHIRISDLGLAVEIPEGET----- 157
Query: 319 CIK---GSTGYIPPEYDLGCEASTYG-DVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFV 374
I+ G+ GY+ PE + E T+ D + G L+ EM G P F + + V
Sbjct: 158 -IRGRVGTVGYMAPEV-VKNERYTFSPDWWGLGCLIYEMIEGKSP----FRQR---KEKV 208
Query: 375 KM-ALPQRAEEVVDDFNLQEIEEGRTMC 401
K + +R +E ++++ + E R++C
Sbjct: 209 KREEVERRVKEDQEEYSEKFSEAARSIC 236
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 1e-05
Identities = 60/257 (23%), Positives = 111/257 (43%), Gaps = 38/257 (14%)
Query: 151 NLIGAGNFGSVYNGTLF-DGTTI--AVKVFN-LIRPGGSKSFKSECKAAINIKHR-NIVR 205
++IG GNFG V + DG + A+K + F E + + H NI+
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRP-------LNFNFLIKKKL 258
+ A +++G + A+ Y P+G+L ++LR P ++ L
Sbjct: 61 LLGA---CEHRGYLYLAIEYA--PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115
Query: 259 DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFI 318
A DVA + YL Q H +L N+L+ + + + DFG++R + +
Sbjct: 116 HFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR--------GQEV 164
Query: 319 CIKGSTGYIPPEYDLGCEA------STYGDVYSFGILLLEMFT-GIRPSDGIFTGKM--N 369
+K + G +P + + E+ +T DV+S+G+LL E+ + G P G+ ++
Sbjct: 165 YVKKTMGRLPVRW-MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 223
Query: 370 LRNFVKMALPQRAEEVV 386
L ++ P ++ V
Sbjct: 224 LPQGYRLEKPLNCDDEV 240
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 55/218 (25%), Positives = 85/218 (38%), Gaps = 27/218 (12%)
Query: 147 FSSANLIGAGNFGSVYNGTLFDGT--TIAVKVF---NLIRPGGSKSFKSECKAAINIKHR 201
F+ +G G+FG V T + +A+K F +I+ SE K I H
Sbjct: 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHP 91
Query: 202 NIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIA 261
V ++ +F Y +V +F+ G +LR N F A
Sbjct: 92 FCVNLYGSFKDESYL-----YLVLEFVIGGEFFTFLR---------RNKRFPNDVGCFYA 137
Query: 262 IDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIK 321
+ YL I + +LKP N+LLD + + DFG A+ +D + +C
Sbjct: 138 AQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV---VDTRTYTLC-- 189
Query: 322 GSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
G+ YI PE L D ++ GI + E+ G P
Sbjct: 190 GTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 33/101 (32%), Positives = 47/101 (46%), Gaps = 9/101 (8%)
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH--VGDFGMARFLPAIDKQNRFI 318
A +V AL +LH + + + +LK N+LLD E GH + DFGM +
Sbjct: 102 AAEVTLALMFLH---RHGVIYRDLKLDNILLDAE--GHCKLADFGMCKEGILNGVTTTTF 156
Query: 319 CIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
C G+ YI PE E D ++ G+L+ EM G P
Sbjct: 157 C--GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 39/147 (26%), Positives = 52/147 (35%), Gaps = 41/147 (27%)
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFI 318
A +V AL YLH I + +LKP N+LL + GH+ DF +++
Sbjct: 109 AAEVLLALEYLHLL---GIVYRDLKPENILLHES--GHIMLSDFDLSKQSDVEPPPVSKA 163
Query: 319 CIKGSTG---------------------------YIPPEYDLGCEASTYGDVYSFGILLL 351
KGS YI PE G + D ++ GILL
Sbjct: 164 LRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLY 223
Query: 352 EMFTGIRPSDGIFTGK---MNLRNFVK 375
EM G P F G N +K
Sbjct: 224 EMLYGTTP----FKGSNRDETFSNILK 246
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 40/142 (28%), Positives = 65/142 (45%), Gaps = 33/142 (23%)
Query: 263 DVACALRYLH-CDCQPPIAHCNLKPSNVLLDDEMIGHVG--DFGMARFLPAIDKQNRFIC 319
++ A YLH D I + +LKP N+LLD++ GHV DFG A+ +P +R
Sbjct: 126 ELVLAFEYLHSKD----IIYRDLKPENLLLDNK--GHVKVTDFGFAKKVP-----DRTFT 174
Query: 320 IKGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTG---------IRPSDGIFTGK 367
+ G+ Y+ PE ++ +G D ++ G+LL E G R + I G+
Sbjct: 175 LCGTPEYLAPEV---IQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR 231
Query: 368 MNLRNFVKMALPQRAEEVVDDF 389
+ N+ RA ++V
Sbjct: 232 LKFPNWFDG----RARDLVKGL 249
|
Length = 329 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 28/209 (13%)
Query: 153 IGAGNFGSVYNGTLFD-GTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFS 211
+G G FG VY + G A KV + + E + H IV++ AF
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF- 78
Query: 212 GVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYL 271
Y + ++ +F P G+++ + D P + ++ L+ AL+YL
Sbjct: 79 ---YWDGKL-WIMIEFCPGGAVDAIMLELDRGLTEP-QIQVICRQMLE-------ALQYL 126
Query: 272 HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM-ARFLPAIDKQNRFICIKGSTGYIPPE 330
H I H +LK NVLL + + DFG+ A+ + + +++ FI G+ ++ PE
Sbjct: 127 H---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI---GTPYWMAPE 180
Query: 331 YDLGCEA---STY---GDVYSFGILLLEM 353
+ CE + Y D++S GI L+EM
Sbjct: 181 VVM-CETMKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 54/220 (24%), Positives = 93/220 (42%), Gaps = 26/220 (11%)
Query: 152 LIGAGNFGSVYNGTLF-DGTTIAVKV-FNLIR----PGGSKSFKSECKAAINIKHRNIVR 205
++G+G FG+VY G DG + + V ++R P +K E + + R
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLR-GKDDTNWRPLNFNFLIKKKLDIAIDV 264
+ Q +V + MP G L +++R KD + L L+ + +
Sbjct: 74 LLGICLTSTVQ------LVTQLMPYGCLLDYVRENKDRIGSQDL---------LNWCVQI 118
Query: 265 ACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGST 324
A + YL + + H +L NVL+ + DFG+AR L + + K
Sbjct: 119 AKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPI 175
Query: 325 GYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363
++ E L + DV+S+G+ + E+ T G +P DGI
Sbjct: 176 KWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI 215
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 37/107 (34%), Positives = 52/107 (48%), Gaps = 15/107 (14%)
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFI 318
A +++ L +LH + I + +LK NV+LD E GH+ DFGM + R
Sbjct: 107 AAEISVGLFFLH---RRGIIYRDLKLDNVMLDSE--GHIKIADFGMCKEHMVDGVTTRTF 161
Query: 319 CIKGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDG 362
C G+ YI PE YG D +++G+LL EM G P DG
Sbjct: 162 C--GTPDYIAPEI---IAYQPYGKSVDWWAYGVLLYEMLAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 24/216 (11%)
Query: 147 FSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNL-IRPGGSKSFKSECKAAINIKHRNIV 204
F + +GAGN G V+ + G +A K+ +L I+P + +++ + + H
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKP----AIRNQIIRELQVLHECNS 62
Query: 205 RVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDV 264
F G Y ++ + M GSL++ L+ + L ++I V
Sbjct: 63 PYIVGFYGAFYSDGEI-SICMEHMDGGSLDQVLKKAGRIPEQILG---------KVSIAV 112
Query: 265 ACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQ-NRFICIKGS 323
L YL + I H ++KPSN+L++ + DFG++ L ID N F+ G+
Sbjct: 113 IKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV---GT 165
Query: 324 TGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
Y+ PE G S D++S G+ L+EM G P
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 33/107 (30%), Positives = 50/107 (46%), Gaps = 9/107 (8%)
Query: 260 IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFIC 319
+ + + AL YL + H ++KPSN+LLD + DFG++ L +D + +
Sbjct: 119 MTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRL--VDSKAKTRS 174
Query: 320 IKGSTGYIPPE-YDLGCEASTY---GDVYSFGILLLEMFTGIRPSDG 362
G Y+ PE D Y DV+S GI L+E+ TG P
Sbjct: 175 -AGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 64/256 (25%), Positives = 109/256 (42%), Gaps = 57/256 (22%)
Query: 129 KQTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKS 187
++ +N K ++ ++S +G+G +GSV + G +A+K L RP S+
Sbjct: 3 REEVN----KTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIK--KLSRPFQSEI 56
Query: 188 FKS----ECKAAINIKHRNIVR---VFT-AFSGVDYQGARFKAVVYKFMPNGSLE-EWLR 238
F E +++H N++ VFT A SG ++Q Y MP + + +
Sbjct: 57 FAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD------FYLVMPYMQTDLQKIM 110
Query: 239 GKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298
G + + +L+ + L C L+Y+H I H +LKP N+ ++++
Sbjct: 111 GHPLSEDK---VQYLVYQML-------CGLKYIH---SAGIIHRDLKPGNLAVNEDCELK 157
Query: 299 VGDFGMARFLPAIDKQNRFICIKGSTGYI------PPEYDLGCEASTYG-DVYSFGILLL 351
+ DFG+AR A TGY+ PE L D++S G ++
Sbjct: 158 ILDFGLARHADA-----------EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMA 206
Query: 352 EMFTGIRPSDGIFTGK 367
EM TG +F GK
Sbjct: 207 EMLTG----KTLFKGK 218
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 70/324 (21%), Positives = 129/324 (39%), Gaps = 81/324 (25%)
Query: 153 IGAGNFGSVYNGTLFDGT------TIAVKVFNLIRPGG-SKSFKSECKAAINIKHRNIVR 205
+G FG VY G LF +A+K G + FK E ++H NIV
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWL----------RGKDD----TNWRPLNFN 251
+ + + ++++ + + L E+L DD + P +F
Sbjct: 73 LLGVVTK-----EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADF- 126
Query: 252 FLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAI 311
+ I +A + +L + H +L NVL+ D++ + D G+ R + A
Sbjct: 127 ------VHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAA 177
Query: 312 D----KQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTG 366
D N + I+ ++ PE + + S D++S+G++L E+F+ G++P + G
Sbjct: 178 DYYKLMGNSLLPIR----WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP----YCG 229
Query: 367 KMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICE 426
N ++ ++M ++ DD C + +++LEC+N
Sbjct: 230 YSN-QDVIEMIRNRQVLPCPDD------------C--------PAWVYTLMLECWN---- 264
Query: 427 IGVACSAERPRERMKINDVESRLR 450
E P R + D+ SRLR
Sbjct: 265 -------EFPSRRPRFKDIHSRLR 281
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 35/103 (33%), Positives = 54/103 (52%), Gaps = 15/103 (14%)
Query: 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMAR-FLPAIDKQNRFIC 319
++ AL +LH + I + ++K N+LLD E GHV DFG+++ FL ++ C
Sbjct: 113 EIILALEHLH---KLGIVYRDIKLENILLDSE--GHVVLTDFGLSKEFLSEEKERTYSFC 167
Query: 320 IKGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
G+ Y+ PE G +G D +S GIL+ E+ TG P
Sbjct: 168 --GTIEYMAPEIIRG--KGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 54/243 (22%), Positives = 95/243 (39%), Gaps = 41/243 (16%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVK---VFNLIRPGGSKSFKSECKAAINIKHRNIVRVFT 208
IG G F VY T L D +A+K +F ++ + E + H N+++
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 209 AFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKL-------DIA 261
+F + + L L D + + F +K+L
Sbjct: 70 SF-----------------IEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYF 112
Query: 262 IDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIK 321
+ + A+ ++H + H ++KP+NV + + +GD G+ RF + K +
Sbjct: 113 VQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLV 167
Query: 322 GSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQR 381
G+ Y+ PE + D++S G LL EM P + KMNL +L Q+
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP---FYGDKMNL-----FSLCQK 219
Query: 382 AEE 384
E+
Sbjct: 220 IEQ 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 57/216 (26%), Positives = 94/216 (43%), Gaps = 24/216 (11%)
Query: 152 LIGAGNFGSVYNGTLFD-GTTIAVKVFNLIRPGGSKSFKS----ECKAAI--NIKHRNIV 204
L+G G FG VY D G +AVK P ++ K EC+ + N++H IV
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPF-DPDSQETSKEVNALECEIQLLKNLRHDRIV 67
Query: 205 RVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDV 264
+ + D + + V ++MP GS+++ L+ + L N + I V
Sbjct: 68 QYYGCLR--DPEEKKLSIFV-EYMPGGSIKDQLKA-----YGALTENVTRRYTRQILQGV 119
Query: 265 ACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFI-CIKGS 323
+ YLH + I H ++K +N+L D +GDFG ++ + I I + G+
Sbjct: 120 S----YLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGT 172
Query: 324 TGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
++ PE G DV+S ++EM T P
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 4e-05
Identities = 60/221 (27%), Positives = 93/221 (42%), Gaps = 40/221 (18%)
Query: 152 LIGAGNFGSVYNGTL-FDGTTIAVKVFN---LIRPGGSKSFKSECKAAI-NIKHRNIVRV 206
+IG G+FG V DG+ AVKV +++ +E + N+KH +V +
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVAC 266
+F Q A V ++ G L L+ + FL + A +VA
Sbjct: 62 HYSF-----QTAEKLYFVLDYVNGGELFFHLQRER---------CFLEPRARFYAAEVAS 107
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIKGST 324
A+ YLH I + +LKP N+LLD + GHV DFG+ + ++ + G+
Sbjct: 108 AIGYLH---SLNIIYRDLKPENILLDSQ--GHVVLTDFGLCK--EGVEPEETTSTFCGTP 160
Query: 325 GYIPPE------YDLGCEASTYGDVYSFGILLLEMFTGIRP 359
Y+ PE YD D + G +L EM G+ P
Sbjct: 161 EYLAPEVLRKEPYDRTV------DWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 36/102 (35%), Positives = 52/102 (50%), Gaps = 11/102 (10%)
Query: 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG--DFGMAR-FLPAIDKQNRFIC 319
+++ AL YLH + I + +LK NVLLD E GH+ D+GM + L D + F
Sbjct: 104 EISLALNYLH---ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTTSTFC- 157
Query: 320 IKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSD 361
G+ YI PE G + D ++ G+L+ EM G P D
Sbjct: 158 --GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 54/220 (24%), Positives = 85/220 (38%), Gaps = 35/220 (15%)
Query: 145 NGFSSANLIGAGNFGSVY------NGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI 198
+ +G G GSV G +F TI P K E + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP----NPDLQKQILRELEINKSC 56
Query: 199 KHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLE----EWLRGKDDTNWRPLNFNFLI 254
K IV+ + AF +D + + ++ GSL+ + + + L
Sbjct: 57 KSPYIVKYYGAF--LDESSSSIG-IAMEYCEGGSLDSIYKKVKKRGGRIGEKVL------ 107
Query: 255 KKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQ 314
IA V L YLH I H ++KPSN+LL + + DFG++ ++
Sbjct: 108 ---GKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSG--ELVNSL 159
Query: 315 -NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEM 353
F G++ Y+ PE G S DV+S G+ LLE+
Sbjct: 160 AGTFT---GTSFYMAPERIQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 4e-05
Identities = 59/245 (24%), Positives = 94/245 (38%), Gaps = 54/245 (22%)
Query: 153 IGAGNFGSVYNG-TLFDGTTIAVKVFNLIRPGGSKSFKS--------ECKAAINIKHRNI 203
+G G FG VY + G +A+K + + K E K +KH N+
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVALKKILM------HNEKDGFPITALREIKILKKLKHPNV 69
Query: 204 VRVFTAFSGVDY--QGARFKAVVYKFMP------NGSLEEWLRGKDDTNWRPLNFNFLIK 255
V + V+ + R + VY P +G LE +
Sbjct: 70 VPLIDMA--VERPDKSKRKRGSVYMVTPYMDHDLSGLLE-----NPSVKLTESQIKCYML 122
Query: 256 KKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQN 315
+ L+ + YLH + I H ++K +N+L+D++ I + DFG+AR
Sbjct: 123 QLLE-------GINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNP 172
Query: 316 RFICIKGSTGYI---------PPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFT 365
+ G+ Y PPE LG +T D++ G + EMFT RP I
Sbjct: 173 KGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR-RP---ILQ 228
Query: 366 GKMNL 370
GK ++
Sbjct: 229 GKSDI 233
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 61/233 (26%), Positives = 96/233 (41%), Gaps = 38/233 (16%)
Query: 147 FSSANL-----IGAGNFGSVYNGTLFD--GTTIAVKVFNLIRPGGS-KSFKSECKAAINI 198
F++ +L IG G FG+V N L GT +AVK K + +
Sbjct: 1 FTAEDLKDLGEIGRGAFGTV-NKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVM-- 57
Query: 199 KHRNIVRVFTAFSGVDYQGARFKA----VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLI 254
+ + + V + GA F+ + + M + SL+++ + + + L
Sbjct: 58 RSSDCPYI------VKFYGALFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPEEILG 110
Query: 255 KKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG--DFGMARFLPAID 312
K IA+ AL YL + + I H ++KPSN+LLD G++ DFG++ L
Sbjct: 111 K----IAVATVKALNYLKEELK--IIHRDVKPSNILLDRN--GNIKLCDFGISGQLVDSI 162
Query: 313 KQNRFICIKGSTGYIPPEYDLGCEASTY---GDVYSFGILLLEMFTGIRPSDG 362
+ R G Y+ PE Y DV+S GI L E+ TG P
Sbjct: 163 AKTRDA---GCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK 212
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 34/215 (15%)
Query: 153 IGAGNFGSVYN-GTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHR----NIVRVF 207
+GAGN GSV + GT +A KV + G S + + + I H IV +
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKV---VHIGAKSSVRKQILRELQIMHECRSPYIVSFY 69
Query: 208 TAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACA 267
AF + +FM GSL+ + P+ L K IA+ V
Sbjct: 70 GAF-----LNENNICMCMEFMDCGSLDRIYK-----KGGPIPVEILGK----IAVAVVEG 115
Query: 268 LRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG--DFGMARFLPAIDK-QNRFICIKGST 324
L YL+ + I H ++KPSN+L++ G + DFG++ L I+ + F+ G++
Sbjct: 116 LTYLYNVHR--IMHRDIKPSNILVNSR--GQIKLCDFGVSGEL--INSIADTFV---GTS 166
Query: 325 GYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
Y+ PE G + + DV+S GI ++E+ G P
Sbjct: 167 TYMSPERIQGGKYTVKSDVWSLGISIIELALGKFP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 52/215 (24%), Positives = 94/215 (43%), Gaps = 20/215 (9%)
Query: 147 FSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRV 206
F+ IG G+FG V+ G D T V +I ++ + + I + +
Sbjct: 6 FTKLERIGKGSFGEVFKG--IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPY 63
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVAC 266
T + G +G + ++ +++ GS + LR P + F I L ++
Sbjct: 64 VTKYYGSYLKGTKL-WIIMEYLGGGSALDLLRAG------PFD-EFQIATMLK---EILK 112
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAID-KQNRFICIKGSTG 325
L YLH + + H ++K +NVLL ++ + DFG+A L K+N F+ G+
Sbjct: 113 GLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV---GTPF 166
Query: 326 YIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPS 360
++ PE + D++S GI +E+ G P+
Sbjct: 167 WMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPN 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 5e-05
Identities = 52/228 (22%), Positives = 94/228 (41%), Gaps = 35/228 (15%)
Query: 147 FSSANL-----IGAGNFGSVY----NGTLFDG--TTIAVKVFNLIRPGGSKS-FKSECKA 194
F +NL +G G FG V+ G +G T + VK + +S F+ E
Sbjct: 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61
Query: 195 AINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLR---GKDDTNWRPLNFN 251
+ H+N+VR+ G+ + ++ ++ G L+++LR KD+ P
Sbjct: 62 FRKLSHKNVVRLL----GLCREAEPH-YMILEYTDLGDLKQFLRATKSKDEKLKPP---P 113
Query: 252 FLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAI 311
K+K+ + +A + +L H +L N L+ + V +++
Sbjct: 114 LSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSK----- 165
Query: 312 DKQNRFICIKGST----GYIPPEYDLGCEASTYGDVYSFGILLLEMFT 355
D N + ++ PE + ST DV+SFG+L+ E+FT
Sbjct: 166 DVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 5e-05
Identities = 51/225 (22%), Positives = 92/225 (40%), Gaps = 36/225 (16%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIR----PGGSKSFKSECKAAINIKHRNIVR-VF 207
IG G FG V G G + A V +R P F E + + H N+++ +
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 208 TAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACA 267
+ Y +V +F P G L+ +LR + + L + +A +VA
Sbjct: 63 QCIESIPY------LLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQR----MACEVASG 112
Query: 268 LRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA--RFLPAIDKQNRFI---CIKG 322
L +LH Q H +L N L ++ +GD+G+A ++ ++ +I C
Sbjct: 113 LLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQY-----PEDYYITKDCHAV 164
Query: 323 STGYIPPEYD-------LGCEASTYGDVYSFGILLLEMFT-GIRP 359
++ PE L + + +++S G+ + E+FT +P
Sbjct: 165 PLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 6e-05
Identities = 56/220 (25%), Positives = 91/220 (41%), Gaps = 37/220 (16%)
Query: 153 IGAGNFGSVYNGTL---FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHR----NIVR 205
+G+GNFG V G +A+KV ++ KS + E I H+ IVR
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKV---LKNENEKSVRDEMMREAEIMHQLDNPYIVR 59
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVA 265
+ A +V + G L ++L GK D + +++ V+
Sbjct: 60 MIGVCE------AEALMLVMEMASGGPLNKFLSGKKDE--------ITVSNVVELMHQVS 105
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTG 325
++YL H +L NVLL ++ + DFG+++ L A D + S G
Sbjct: 106 MGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK----ARSAG 158
Query: 326 YIP-----PEYDLGCEASTYGDVYSFGILLLEMFT-GIRP 359
P PE + S+ DV+S+GI + E F+ G +P
Sbjct: 159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 6e-05
Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 27/217 (12%)
Query: 153 IGAGNFGSVY-NGTLFDGTTIAVKVFNLIR-PGGSK-SFKSECKAAINIKHRNIVRVFTA 209
IG G+FG +Y D +K +L + P K + K E +KH NIV F +
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALR 269
F G F +V ++ G L + + R F + L + ++ L+
Sbjct: 68 FQ---ENGRLF--IVMEYCDGGDLMKRIN-------RQRGVLFSEDQILSWFVQISLGLK 115
Query: 270 YLHCDCQPPIAHCNLKPSNVLLDDE-MIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIP 328
++H I H ++K N+ L M+ +GDFG+AR L + C+ G+ Y+
Sbjct: 116 HIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY-TCV-GTPYYLS 170
Query: 329 PEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDG 362
PE C+ Y D++S G +L E+ T P +G
Sbjct: 171 PEI---CQNRPYNNKTDIWSLGCVLYELCTLKHPFEG 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 6e-05
Identities = 34/101 (33%), Positives = 52/101 (51%), Gaps = 8/101 (7%)
Query: 260 IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQ-NRFI 318
I+I V L YL + I H ++KPSN+L++ + DFG++ L ID N F+
Sbjct: 104 ISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV 159
Query: 319 CIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
G+ Y+ PE G + D++S G+ L+EM G P
Sbjct: 160 ---GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 7e-05
Identities = 63/226 (27%), Positives = 97/226 (42%), Gaps = 36/226 (15%)
Query: 153 IGAGNFGSVYNG-TLFDGTTIAVKVFNLIRPGGSKSFK-SECKAAINIKHRNIVRVFTAF 210
+G G + +VY G G +A+K +L G+ S E +KH NIVR+
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLH--- 64
Query: 211 SGVDYQGARFKAV-VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKK---KLDIAIDVAC 266
D K + V+++M + L++++ L+ N +K +L I
Sbjct: 65 ---DVIHTENKLMLVFEYM-DKDLKKYM--DTHGVRGALDPN-TVKSFTYQLLKGIAFCH 117
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF--LPAIDKQNRFICIKGST 324
R LH D LKP N+L++ + DFG+AR +P N F +
Sbjct: 118 ENRVLHRD---------LKPQNLLINKRGELKLADFGLARAFGIPV----NTFSNEVVTL 164
Query: 325 GYIPPEYDLGCEA-STYGDVYSFGILLLEMFTGIRPSDGIFTGKMN 369
Y P+ LG ST D++S G ++ EM TG RP +F G N
Sbjct: 165 WYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITG-RP---LFPGTNN 206
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 7e-05
Identities = 34/95 (35%), Positives = 50/95 (52%), Gaps = 11/95 (11%)
Query: 268 LRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF--LPAIDKQNRFICIKGSTG 325
L Y H + I H +LKP N+L++++ + DFG+AR +P N + +
Sbjct: 116 LSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTL----W 168
Query: 326 YIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRP 359
Y PP+ LG E ST D++ G +L EM TG RP
Sbjct: 169 YRPPDVLLGSTEYSTPIDMWGVGCILYEMATG-RP 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 7e-05
Identities = 70/272 (25%), Positives = 107/272 (39%), Gaps = 50/272 (18%)
Query: 152 LIGAGNFGSVYNGTL-FDGTTIAVKVFN---LIRPGGSKSFKSECKAAI-NIKHRNIVRV 206
+IG G+FG V DG AVKV ++ K +E + N+KH +V +
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVAC 266
+F + V F+ G L L+ ++ + P + + A ++A
Sbjct: 62 HYSFQTTEKL-----YFVLDFVNGGELFFHLQ-RERSFPEP-------RARFYAA-EIAS 107
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIKGST 324
AL YLH I + +LKP N+LLD + GHV DFG+ + A C G+
Sbjct: 108 ALGYLH---SINIVYRDLKPENILLDSQ--GHVVLTDFGLCKEGIAQSDTTTTFC--GTP 160
Query: 325 GYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP---------SDGIFTGKMNLRNFVK 375
Y+ PE D + G +L EM G+ P D I + LR
Sbjct: 161 EYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGAS 220
Query: 376 MALPQRAEEVV-----------DDFNLQEIEE 396
+ EE++ +DF EI+E
Sbjct: 221 LTAWSILEELLEKDRQRRLGAKEDFL--EIQE 250
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 51/227 (22%), Positives = 90/227 (39%), Gaps = 43/227 (18%)
Query: 152 LIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAIN-----------IKH 200
LI + S+Y G +F+ + ++ F K F K I+ I
Sbjct: 27 LIKENDQNSIYKG-IFNNKEVIIRTF--------KKFHKGHKVLIDITENEIKNLRRIDS 77
Query: 201 RNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDI 260
NI++++ + R +++ ++ G L E L + L+F K KLD+
Sbjct: 78 NNILKIYGFIIDIVDDLPRL-SLILEYCTRGYLREVLD-----KEKDLSF----KTKLDM 127
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL--PAIDKQNRFI 318
AID L L+ P + NL + L+ + + G+ + L P N +
Sbjct: 128 AIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV 185
Query: 319 CIKGSTGYIPPEY--DLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363
Y + D+ E + D+YS G++L E+FTG P + +
Sbjct: 186 -------YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL 225
|
Length = 283 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 7e-05
Identities = 35/104 (33%), Positives = 54/104 (51%), Gaps = 11/104 (10%)
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG--DFGMAR-FLPAIDKQNRF 317
+ +++ AL +LH + I + +LK NVLLD E GH+ D+GM + + D + F
Sbjct: 102 SAEISLALNFLH---ERGIIYRDLKLDNVLLDAE--GHIKLTDYGMCKEGIRPGDTTSTF 156
Query: 318 ICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSD 361
C G+ YI PE G + D ++ G+L+ EM G P D
Sbjct: 157 -C--GTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 9e-05
Identities = 41/127 (32%), Positives = 55/127 (43%), Gaps = 26/127 (20%)
Query: 263 DVAC--------ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAID 312
D AC AL +LH Q I + +LKP N+LLD + GHV DFG+ +
Sbjct: 100 DTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQ--GHVKLTDFGLCKESIHEG 154
Query: 313 KQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP---------SDGI 363
C G+ Y+ PE + D +S G L+ +M TG P D I
Sbjct: 155 TVTHTFC--GTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI 212
Query: 364 FTGKMNL 370
GK+NL
Sbjct: 213 LKGKLNL 219
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 9e-05
Identities = 59/241 (24%), Positives = 105/241 (43%), Gaps = 44/241 (18%)
Query: 129 KQTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTT-IAVKVFNLIRPGGS-- 185
+Q +N K ++ + + + +G+G +GSV FD T + V V L RP S
Sbjct: 5 RQELN----KTIWEVPERYQNLSPVGSGAYGSVCAA--FDTKTGLRVAVKKLSRPFQSII 58
Query: 186 --KSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDT 243
K E + ++KH N++ + F+ P SLEE+ T
Sbjct: 59 HAKRTYRELRLLKHMKHENVIGLLDVFT-----------------PARSLEEFNDVYLVT 101
Query: 244 NWRPLNFNFLIK-KKLD------IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI 296
+ + N ++K +KL + + L+Y+H I H +LKPSN+ ++++
Sbjct: 102 HLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCE 158
Query: 297 GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFT 355
+ DFG+AR D+ ++ + Y PE L + D++S G ++ E+ T
Sbjct: 159 LKILDFGLARH--TDDEMTGYVATR---WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 213
Query: 356 G 356
G
Sbjct: 214 G 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 9e-05
Identities = 58/216 (26%), Positives = 96/216 (44%), Gaps = 24/216 (11%)
Query: 147 FSSANLIGAGNFGSVYN-GTLFDGTTIAVKVFNL-IRPGGSKSFKSECKAAINIKHRNIV 204
F + +GAGN G V G +A K+ +L I+P + +++ + + H
Sbjct: 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKP----AIRNQIIRELQVLHECNS 62
Query: 205 RVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDV 264
F G Y ++ + M GSL++ L+ + + L K ++I V
Sbjct: 63 PYIVGFYGAFYSDGEI-SICMEHMDGGSLDQVLK-----EAKRIPEEILGK----VSIAV 112
Query: 265 ACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQ-NRFICIKGS 323
L YL Q I H ++KPSN+L++ + DFG++ L ID N F+ G+
Sbjct: 113 LRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSFV---GT 165
Query: 324 TGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
Y+ PE G S D++S G+ L+E+ G P
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-04
Identities = 38/116 (32%), Positives = 57/116 (49%), Gaps = 12/116 (10%)
Query: 281 HCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGST----GYIPPEYDLGCE 336
H +L NVLL I + DFG+AR I + ++ KGST ++ PE
Sbjct: 260 HRDLAARNVLLAQGKIVKICDFGLAR---DIMHDSNYVS-KGSTFLPVKWMAPESIFDNL 315
Query: 337 ASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKM---NLRNFVKMALPQRAEEVVDD 388
+T DV+S+GILL E+F+ G P G+ +++ +MA P A + V D
Sbjct: 316 YTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYD 371
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 52/220 (23%), Positives = 87/220 (39%), Gaps = 28/220 (12%)
Query: 159 GSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKA-----AINIKHRNIVRVF---TAF 210
Y+ + D T +K + ++P GS + C A IN+ + + R F T
Sbjct: 5 SQFYSVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHA 64
Query: 211 SGVDYQGARFKAVVYK--------FMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLD--- 259
+ K V +K F P SLEE+ N +I +LD
Sbjct: 65 KRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHER 124
Query: 260 ---IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNR 316
+ + C +++LH I H +LKPSN+++ + + DFG+AR
Sbjct: 125 MSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTP 181
Query: 317 FICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTG 356
++ + Y PE LG D++S G ++ E+ G
Sbjct: 182 YVVTR---YYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 34/212 (16%)
Query: 153 IGAGNFGSVYNGTLFD-GTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFS 211
+G G FG VY + G A KV + + + E + H NIV++ AF
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 212 GVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPL---NFNFLIKKKLDIAIDVACAL 268
Y+ + ++ +F G+++ + + RPL + K+ L+ AL
Sbjct: 73 ---YENNLW--ILIEFCAGGAVDAVMLELE----RPLTEPQIRVVCKQTLE-------AL 116
Query: 269 RYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM-ARFLPAIDKQNRFICIKGSTGYI 327
YLH + I H +LK N+L + + DFG+ A+ I +++ FI G+ ++
Sbjct: 117 NYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI---GTPYWM 170
Query: 328 PPEYDLGCEAST------YGDVYSFGILLLEM 353
PE + CE S DV+S GI L+EM
Sbjct: 171 APEVVM-CETSKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 41/164 (25%), Positives = 70/164 (42%), Gaps = 34/164 (20%)
Query: 197 NIKHRNIVRVF-TAFSGVDYQGA------RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLN 249
N+ H +++R+ T SG + + +Y ++ S RPL
Sbjct: 113 NVNHPSVIRMKDTLVSG----AITCMVLPHYSSDLYTYLTKRS-------------RPLP 155
Query: 250 FNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLP 309
I + L I + LRYLH I H ++K N+ ++D +GD G A+F P
Sbjct: 156 ----IDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQF-P 207
Query: 310 AIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEM 353
+ F+ + G+ PE + ++ D++S GI+L EM
Sbjct: 208 VVAPA--FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 37/106 (34%), Positives = 53/106 (50%), Gaps = 11/106 (10%)
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG--DFGMAR-FLPAIDKQNRF 317
A ++ AL +LH + I + +LK NVLLD + GH+ D+GM + L D + F
Sbjct: 102 AAEICIALNFLH---ERGIIYRDLKLDNVLLDAD--GHIKLTDYGMCKEGLGPGDTTSTF 156
Query: 318 ICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363
G+ YI PE G E D ++ G+L+ EM G P D I
Sbjct: 157 C---GTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDII 199
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 51/210 (24%), Positives = 83/210 (39%), Gaps = 20/210 (9%)
Query: 151 NLIGAGNFGSVYNGT-LFDGTTIAVK--VFNLIRPGGSKSFKSEC---KAAINIKHRNIV 204
IG G +G+VY L G +A+K L G S E K + +H NIV
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 205 RVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDV 264
R+ G +V++ + + L +L P L+++ L
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQLLR----- 118
Query: 265 ACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGST 324
+ +LH I H +LKP N+L+ + + DFG+AR + + +
Sbjct: 119 --GVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIY---SFEMALTSVVVTL 170
Query: 325 GYIPPEYDLGCEASTYGDVYSFGILLLEMF 354
Y PE L +T D++S G + E+F
Sbjct: 171 WYRAPEVLLQSSYATPVDMWSVGCIFAELF 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 37/107 (34%), Positives = 51/107 (47%), Gaps = 15/107 (14%)
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFI 318
A ++A L +LH I + +LK NV+LD E GH+ DFGM + +
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCKENMWDGVTTKTF 161
Query: 319 CIKGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDG 362
C G+ YI PE YG D ++FG+LL EM G P +G
Sbjct: 162 C--GTPDYIAPEI---IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 1e-04
Identities = 65/252 (25%), Positives = 102/252 (40%), Gaps = 58/252 (23%)
Query: 147 FSSANLIGAGNFGSVYNGTLFDGTTI-AVKV---FNLIRPGGSKSFKSECKAAINIKHRN 202
F +IG G FG V + A+K+ F +I+ S F E +
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEW 104
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSL----------EEWLRGKDDTNWRPLNFNF 252
IV++ AF Q ++ +V ++MP G L E+W R F
Sbjct: 105 IVQLHYAF-----QDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWAR-------------F 146
Query: 253 LIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPA 310
+ + +A+D ++ ++H D +KP N+LLD GH+ DFG + A
Sbjct: 147 YTAE-VVLALDAIHSMGFIHRD---------VKPDNMLLDKS--GHLKLADFGTCMKMDA 194
Query: 311 IDKQNRFICIKGSTGYIPPEYDLGCEAST--YG---DVYSFGILLLEMFTGIRP--SD-- 361
+ R G+ YI PE L + YG D +S G+ L EM G P +D
Sbjct: 195 -NGMVRCDTAVGTPDYISPEV-LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 252
Query: 362 -GIFTGKMNLRN 372
G ++ M+ +N
Sbjct: 253 VGTYSKIMDHKN 264
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 55/240 (22%), Positives = 100/240 (41%), Gaps = 53/240 (22%)
Query: 134 NPSFKDLYNATNG---FSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFK 189
+P +L++ + F+ IG G+FG+VY + +A+K + G +S +
Sbjct: 1 DPEIAELFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSY---SGKQSNE 57
Query: 190 S------ECKAAINIKHRNIVRVFTAFSGVDYQGARFK-AVVYKFMPN--GSLEEWLRGK 240
E + ++H N + +Y+G + + M GS + L
Sbjct: 58 KWQDIIKEVRFLQQLRHPNTI---------EYKGCYLREHTAWLVMEYCLGSASDIL--- 105
Query: 241 DDTNWRPLNFNFLIKKKLDIAI---DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297
+ + +PL ++++IA L YLH + H ++K N+LL +
Sbjct: 106 -EVHKKPL-------QEVEIAAICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTV 154
Query: 298 HVGDFGMARFL-PAIDKQNRFICIKGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEM 353
+ DFG A + PA N F+ G+ ++ PE L + Y DV+S GI +E+
Sbjct: 155 KLADFGSASLVSPA----NSFV---GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 29/96 (30%), Positives = 43/96 (44%), Gaps = 6/96 (6%)
Query: 259 DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFI 318
D+ L +LH +C I H +LKP N+L+ + DFG+AR Q
Sbjct: 112 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSC---QMALT 165
Query: 319 CIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMF 354
+ + Y PE L +T D++S G + EMF
Sbjct: 166 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 30/79 (37%), Positives = 44/79 (55%), Gaps = 8/79 (10%)
Query: 281 HCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGST----GYIPPEYDLGCE 336
H +L NVL+ + + + DFG+AR I + + +I KGST ++ PE
Sbjct: 262 HRDLAARNVLICEGKLVKICDFGLAR---DIMRDSNYIS-KGSTFLPLKWMAPESIFNNL 317
Query: 337 ASTYGDVYSFGILLLEMFT 355
+T DV+SFGILL E+FT
Sbjct: 318 YTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 56/234 (23%), Positives = 90/234 (38%), Gaps = 54/234 (23%)
Query: 152 LIGAGNFGSVYNGTLFD-GTTIAVKVFNLIRPGGSKSFKS---ECKAAINIKHRNIVRVF 207
++G G +G V G +A+K F K+ E K ++H NIV +
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKF-KESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 208 TAF--SGVDYQGARFKAVVYKFMPNG---SLEEWLRGKDDTNWRPLNFNFLIKKKLDIAI 262
AF G Y +V++++ LE G R + L++
Sbjct: 67 EAFRRKGRLY-------LVFEYVERTLLELLEASPGGLPPDAVRSYIWQ-LLQ------- 111
Query: 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKG 322
A+ Y H I H ++KP N+L+ + + + DFG AR L A
Sbjct: 112 ----AIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP------- 157
Query: 323 STGYI------PPEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDGIFTGK 367
T Y+ PE +G + YG DV++ G ++ E+ G P +F G
Sbjct: 158 LTDYVATRWYRAPELLVG--DTNYGKPVDVWAIGCIMAELLDG-EP---LFPGD 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 44/139 (31%), Positives = 61/139 (43%), Gaps = 20/139 (14%)
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH--VGDFGMARFLPAIDKQNRFI 318
A ++ AL +LH I + +LK NVLLD E GH + DFGM + K
Sbjct: 102 AAEITSALMFLH---DKGIIYRDLKLDNVLLDHE--GHCKLADFGMCKEGIFNGKTTSTF 156
Query: 319 CIKGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRP-----SDGIFTGKMNL 370
C G+ YI PE + YG D ++ G+LL EM G P D +F +N
Sbjct: 157 C--GTPDYIAPEI---LQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND 211
Query: 371 RNFVKMALPQRAEEVVDDF 389
L Q A +++ F
Sbjct: 212 EVVYPTWLSQDAVDILKAF 230
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 34/104 (32%), Positives = 52/104 (50%), Gaps = 16/104 (15%)
Query: 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMAR-FLP-AIDKQNRFI 318
++ AL +LH Q I + ++K N+LLD E GHV DFG+++ FL ++ F
Sbjct: 113 EIVLALDHLH---QLGIIYRDIKLENILLDSE--GHVVLTDFGLSKEFLAEEEERAYSF- 166
Query: 319 CIKGSTGYIPPEYDLGCEASTYGDV---YSFGILLLEMFTGIRP 359
C G+ Y+ PE G + +S G+L E+ TG P
Sbjct: 167 C--GTIEYMAPEVIRGGS-GGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 34/110 (30%), Positives = 53/110 (48%), Gaps = 20/110 (18%)
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMAR-FLPAIDKQNRFICIKGST 324
C L+Y+H + H +LKP N+L++ + + DFG+AR F + F+ T
Sbjct: 116 CGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-----T 167
Query: 325 GYI------PPEYDLGCEASTYG-DVYSFGILLLEMFTGIRPSDGIFTGK 367
Y+ PE L ++ T DV+S G +L E G +P +F GK
Sbjct: 168 EYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAE-LLGRKP---VFKGK 213
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 2e-04
Identities = 59/224 (26%), Positives = 90/224 (40%), Gaps = 30/224 (13%)
Query: 147 FSSANLIGAGNFGSVYNGTLFDGTTI-AVKVFN---LIRPGGSKSFKSECKAAINIKHRN 202
F +IG G FG V L + + A+K+ N +++ + F+ E +N ++
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAI 262
I + AF Q +V + G L L +D P + ++ IAI
Sbjct: 63 ITTLHYAF-----QDENNLYLVMDYYVGGDLLTLLSKFEDR--LPEDMARFYLAEMVIAI 115
Query: 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICI 320
D L Y+H D +KP N+L+D M GH+ DFG L + +
Sbjct: 116 DSVHQLHYVHRD---------IKPDNILMD--MNGHIRLADFGSCLKLMEDGTVQSSVAV 164
Query: 321 KGSTGYIPPEYDLGCE--ASTYG---DVYSFGILLLEMFTGIRP 359
G+ YI PE E YG D +S G+ + EM G P
Sbjct: 165 -GTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 31/100 (31%), Positives = 48/100 (48%), Gaps = 8/100 (8%)
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICI 320
A ++ C L L + I + +LKP N+LLDD + D G+A +P + +
Sbjct: 108 AAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV-- 162
Query: 321 KGSTGYIPPEYDLGCEASTYG-DVYSFGILLLEMFTGIRP 359
G+ GY+ PE + E T+ D + G L+ EM G P
Sbjct: 163 -GTVGYMAPEV-INNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 56/227 (24%), Positives = 91/227 (40%), Gaps = 41/227 (18%)
Query: 157 NFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKA--AINIKHRNIVRVFTAFSGVD 214
NF SV G D T +K + ++P GS + C A AI ++ I ++ F
Sbjct: 9 NFYSVEIG---DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT 65
Query: 215 YQGARFKAVVYK--------------FMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLD- 259
+ ++ +V F P SLEE+ N +I+ +LD
Sbjct: 66 HAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH 125
Query: 260 -----IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMAR-----FLP 309
+ + C +++LH I H +LKPSN+++ + + DFG+AR F+
Sbjct: 126 ERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 182
Query: 310 AIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTG 356
R+ Y PE LG D++S G ++ EM G
Sbjct: 183 TPYVVTRY--------YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 61/255 (23%), Positives = 106/255 (41%), Gaps = 40/255 (15%)
Query: 153 IGAGNFGSVYNG---TLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHR----NIVR 205
+G+GNFG+V G T+AVK+ L + K E N+ + IVR
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKI--LKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVA 265
+ + +V + G L ++L+ N + K ++ V+
Sbjct: 61 MIGICEAESWM------LVMELAELGPLNKFLQK---------NKHVTEKNITELVHQVS 105
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTG 325
++YL + H +L NVLL + + DFG+++ L A + + + G
Sbjct: 106 MGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK----AKTHG 158
Query: 326 YIP-----PEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMN--LRNFVKMA 377
P PE + S+ DV+SFG+L+ E F+ G +P G+ ++ + + +M
Sbjct: 159 KWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERME 218
Query: 378 LPQRAE-EVVDDFNL 391
PQR E+ D L
Sbjct: 219 CPQRCPPEMYDLMKL 233
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 31/96 (32%), Positives = 48/96 (50%), Gaps = 11/96 (11%)
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF--LPAIDKQNRFICIKGST 324
L Y H + + H +LKP N+L+++ + DFG+AR +P N + +
Sbjct: 116 GLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTL---- 168
Query: 325 GYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRP 359
Y PP+ LG + ST D++ G + EM TG RP
Sbjct: 169 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTG-RP 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 60/226 (26%), Positives = 97/226 (42%), Gaps = 30/226 (13%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSG 212
+G GN+GSVY + T IR +S ++ ++I H+ + F G
Sbjct: 9 LGKGNYGSVYK--VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYG 66
Query: 213 VDYQ-GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYL 271
+ GA + + Y M GSL++ G T P + ++++ I V L++L
Sbjct: 67 AFFIEGAVYMCMEY--MDAGSLDKLYAGGVATEGIPED---VLRR---ITYAVVKGLKFL 118
Query: 272 HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPA-IDKQNRFICIKGSTGYIPPE 330
+ I H ++KP+NVL++ + DFG++ L A + K N G Y+ PE
Sbjct: 119 KEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN-----IGCQSYMAPE 171
Query: 331 YDLG---CEASTY---GDVYSFGILLLEMFTGIRP-----SDGIFT 365
+ TY DV+S G+ +LEM G P IF
Sbjct: 172 RIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFA 217
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 37/108 (34%), Positives = 46/108 (42%), Gaps = 21/108 (19%)
Query: 260 IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMA-RFLPAIDKQNR 316
+AID L Y+H D +KP NVLLD GH+ DFG R L D +
Sbjct: 113 LAIDSVHQLGYVHRD---------IKPDNVLLD--KNGHIRLADFGSCLRLLA--DGTVQ 159
Query: 317 FICIKGSTGYIPPEYDLGCEAST--YG---DVYSFGILLLEMFTGIRP 359
G+ YI PE E YG D +S G+ + EM G P
Sbjct: 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 53/214 (24%), Positives = 94/214 (43%), Gaps = 38/214 (17%)
Query: 153 IGAGNFGSVY---NGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTA 209
+G G FG VY + G A K+ + + F E KH NIV ++ A
Sbjct: 13 LGDGAFGKVYKAQHKE--TGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEA 70
Query: 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLN---FNFLIKKKLDIAIDVAC 266
+ Y+ + ++ +F G+L+ + + R L ++ ++ L+
Sbjct: 71 YF---YENKLW--ILIEFCDGGALDSIMLELE----RGLTEPQIRYVCRQMLE------- 114
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM-ARFLPAIDKQNRFICIKGSTG 325
AL +LH + H +LK N+LL + + DFG+ A+ + K++ FI G+
Sbjct: 115 ALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI---GTPY 168
Query: 326 YIPPEYDLGCEAST---Y---GDVYSFGILLLEM 353
++ PE + CE Y D++S GI L+E+
Sbjct: 169 WMAPEV-VACETFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (100), Expect = 4e-04
Identities = 42/164 (25%), Positives = 73/164 (44%), Gaps = 33/164 (20%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKS--EC------KAAINIK-HRN 202
+G G FGSVY G +A+K K F S EC K+ + H N
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMK-------KKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAI 262
IV++ F + F V+++M G+L + ++ + +P + + +I+ I
Sbjct: 60 IVKLKEVF--RENDELYF---VFEYM-EGNLYQLMKDRKG---KPFSES-VIR---SIIY 106
Query: 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMAR 306
+ L ++H + H +LKP N+L+ + + DFG+AR
Sbjct: 107 QILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 33/108 (30%), Positives = 49/108 (45%), Gaps = 19/108 (17%)
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGY 326
L+Y+H + H +LKPSN+LL+ + DFG+AR F+ T Y
Sbjct: 118 GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFL-----TEY 169
Query: 327 I------PPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGK 367
+ PE L + D++S G +L EM + RP +F GK
Sbjct: 170 VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RP---LFPGK 213
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 35/130 (26%), Positives = 62/130 (47%), Gaps = 13/130 (10%)
Query: 268 LRYLHCDCQPPIAHCNLKPSNVLLD-DEMIGHVGDFGMARFL-PAIDKQNRFICIKGSTG 325
L+Y+H + H +LKP+NV ++ ++++ +GDFG+AR + P + +
Sbjct: 127 LKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW 183
Query: 326 YIPPEYDLGCEASTYG-DVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEE 384
Y P L T D+++ G + EM TG +P +F G L +M L +
Sbjct: 184 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KP---LFAGAHELE---QMQLILESVP 236
Query: 385 VVDDFNLQEI 394
VV + + E+
Sbjct: 237 VVREEDRNEL 246
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 5e-04
Identities = 57/227 (25%), Positives = 96/227 (42%), Gaps = 46/227 (20%)
Query: 147 FSSANLIGAGNFGSVYNGTLFDGTT---IAVKVFNLIRPGGSKSFKSECKAAINIKHRNI 203
F+ IG G+FG VY G D T +A+K+ +L E + I +I
Sbjct: 6 FTKLERIGKGSFGEVYKG--IDNRTKEVVAIKIIDL----------EEAEDEI----EDI 49
Query: 204 VRVFTAFSGVD------YQGARFKA----VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFL 253
+ T S D Y G+ K ++ +++ GS + L+ PL ++
Sbjct: 50 QQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPG------PLEETYI 103
Query: 254 IKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAID- 312
I ++ L YLH + + H ++K +NVLL ++ + DFG+A L
Sbjct: 104 AT----ILREILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156
Query: 313 KQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
K+N F+ G+ ++ PE D++S GI +E+ G P
Sbjct: 157 KRNTFV---GTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 6e-04
Identities = 49/221 (22%), Positives = 90/221 (40%), Gaps = 39/221 (17%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGS----KSFKSECKAAINIKHRNIVRVFT 208
IG G FG V G + G T A V +R S F E + +++H N+++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 209 AFSGV-DYQGARFKAVVYKFMPNGSLEEWLRGK---DDTNWRPLNFNFLIKKKLDIAIDV 264
+ V Y +V +F P G L+ +LR + P +A ++
Sbjct: 63 QCTEVTPY------LLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQ-------RMACEI 109
Query: 265 ACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA----RFLPAIDKQNRFICI 320
A L +LH + H +L N LL ++ +GD+G++ + + ++ +
Sbjct: 110 ALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPL 166
Query: 321 KGSTGYIPPEYD-------LGCEASTYGDVYSFGILLLEMF 354
+ +I PE L + + +V+S G+ + E+F
Sbjct: 167 R----WIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 6e-04
Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 52/223 (23%)
Query: 153 IGAGNFGSV-YNGTLFDGTTIAVKVFNLIRPGGSKSFKS----ECKAAINIKHRNI---V 204
+G+G +G+V G +A+K L RP S+ F E + ++KH N+ +
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIK--KLYRPFQSELFAKRAYRELRLLKHMKHENVIGLL 80
Query: 205 RVFTAFSGVDYQGARFKA--VVYKFMPN--GSLEEWLRGKDDTNWRPLNFNFLIKKKLDI 260
VFT +D RF +V FM G L + + +D FL+ + L
Sbjct: 81 DVFTPDLSLD----RFHDFYLVMPFMGTDLGKLMKHEKLSED------RIQFLVYQMLK- 129
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICI 320
L+Y+H I H +LKP N+ ++++ + DFG+AR D +
Sbjct: 130 ------GLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSE------ 171
Query: 321 KGSTGYI------PPEYDLGCEASTYG-DVYSFGILLLEMFTG 356
TGY+ PE L T D++S G ++ EM TG
Sbjct: 172 --MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTG 212
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 6e-04
Identities = 34/109 (31%), Positives = 49/109 (44%), Gaps = 10/109 (9%)
Query: 251 NFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPA 310
N I L I V A++YLH + I H ++K N+ ++ +GDFG A F P
Sbjct: 178 NIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACF-PV 233
Query: 311 IDKQNRFICIKGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTG 356
N++ G+ PE YG D++S GI+L EM T
Sbjct: 234 DINANKYYGWAGTIATNAPEL---LARDPYGPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 6e-04
Identities = 51/216 (23%), Positives = 90/216 (41%), Gaps = 27/216 (12%)
Query: 152 LIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGS----KSFKSECKAAINIKHRNIVRV 206
++G G FG + G L + +R G S + F +E H NIVR+
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVAC 266
GV +G +V ++M NG+L+ +LR + + + + + +A
Sbjct: 72 ----EGVITRGNTM-MIVTEYMSNGALDSFLRKHEG--------QLVAGQLMGMLPGLAS 118
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTG- 325
++YL + H L VL++ +++ + F R L + + + G +
Sbjct: 119 GMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGF---RRLQEDKSEAIYTTMSGKSPV 172
Query: 326 -YIPPEYDLGCEASTYGDVYSFGILLLE-MFTGIRP 359
+ PE S+ DV+SFGI++ E M G RP
Sbjct: 173 LWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 8e-04
Identities = 30/101 (29%), Positives = 50/101 (49%), Gaps = 10/101 (9%)
Query: 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICI 320
++ AL +LH + I + ++K N+LLD GHV DFG+++ D+ R
Sbjct: 113 EIVLALEHLH---KLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFHE-DEVERAYSF 166
Query: 321 KGSTGYIPPEYDLGCEA--STYGDVYSFGILLLEMFTGIRP 359
G+ Y+ P+ G + D +S G+L+ E+ TG P
Sbjct: 167 CGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 8e-04
Identities = 61/252 (24%), Positives = 96/252 (38%), Gaps = 58/252 (23%)
Query: 147 FSSANLIGAGNFGSVYNGTLFD-GTTIAVKVF---NLIRPGGSKSFKSECKAAINIKHRN 202
F S +IG G FG V D G A+K+ +++ ++E +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAI 262
+V++F +F Q R ++ +F+P G + L KD + F + +AI
Sbjct: 63 VVKMFYSF-----QDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYI---AETVLAI 114
Query: 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFL------------ 308
D L ++H D +KP N+LLD + GHV DFG+ L
Sbjct: 115 DAIHQLGFIHRD---------IKPDNLLLDAK--GHVKLSDFGLCTGLKKAHRTEFYRNL 163
Query: 309 ---PAID---------------KQNR---FICIKGSTGYIPPEYDLGCEASTYGDVYSFG 347
P D K+NR G+ YI PE + + D +S G
Sbjct: 164 THNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLG 223
Query: 348 ILLLEMFTGIRP 359
+++ EM G P
Sbjct: 224 VIMYEMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.001
Identities = 61/234 (26%), Positives = 92/234 (39%), Gaps = 58/234 (24%)
Query: 153 IGAGNFGSVYNG-TLFDGTTIAVKVFNL-----------IRPGGSKSFKSECKAAINIKH 200
IG G +G VY G +A+K L IR E + H
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR---------EISLLKELNH 57
Query: 201 RNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDI 260
NIVR+ V + + +V++F+ + L++++ T P LIK L
Sbjct: 58 PNIVRLLD----VVHSENKL-YLVFEFL-DLDLKKYMDSSPLTGLDPP----LIKSYLYQ 107
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRF-IC 319
+ + Y H + H +LKP N+L+D E + DFG+AR F +
Sbjct: 108 LLQ---GIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLAR---------AFGVP 152
Query: 320 IKGSTG------YIPPEYDLGCEA-STYGDVYSFGILLLEMFTGIRPSDGIFTG 366
++ T Y PE LG ST D++S G + EM RP +F G
Sbjct: 153 VRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNR-RP---LFPG 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 40.5 bits (94), Expect = 0.001
Identities = 55/218 (25%), Positives = 91/218 (41%), Gaps = 41/218 (18%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFS 211
IG G G+V+ + G +A+K NL + + +E +K+ NIV +F
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 212 GVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIA-IDVAC---- 266
D VV +++ GSL + + + +D A I C
Sbjct: 87 VGDEL-----FVVMEYLAGGSLTD----------------VVTETCMDEAQIAAVCRECL 125
Query: 267 -ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM-ARFLPAIDKQNRFICIKGST 324
AL +LH + + H ++K NVLL + + DFG A+ P K++ + G+
Sbjct: 126 QALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV---GTP 179
Query: 325 GYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
++ PE YG D++S GI+ +EM G P
Sbjct: 180 YWMAPEV---VTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 23/91 (25%), Positives = 43/91 (47%), Gaps = 13/91 (14%)
Query: 279 IAHCNLKPSNVLLDDEMIGHVGDFGMAR---FLPAIDKQNRFICIKG---------STGY 326
H +L P+N+ ++ + I + DFG+AR + P D ++ ++ + Y
Sbjct: 140 FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWY 199
Query: 327 IPPEYDLGCEASTYG-DVYSFGILLLEMFTG 356
PE +G E + D++S G + E+ TG
Sbjct: 200 RAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230
|
Length = 335 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 24/98 (24%), Positives = 48/98 (48%), Gaps = 5/98 (5%)
Query: 258 LDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRF 317
L + A+ Y+H + I H ++K N+ L + +GDFG+++ L + +
Sbjct: 104 LWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGS-EYSMAE 159
Query: 318 ICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT 355
+ G+ Y+ PE G + + D+++ G +L E+ T
Sbjct: 160 TVV-GTPYYMSPELCQGVKYNFKSDIWALGCVLYELLT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 39/126 (30%), Positives = 58/126 (46%), Gaps = 23/126 (18%)
Query: 248 LNFNFL---IKKKLDIA----IDVACALRYLHCDCQPPIAHC--------NLKPSNVLLD 292
L F FL +KK +D + I + YL Q +A C +LKP N+L++
Sbjct: 76 LVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQG-LAFCHSHRVLHRDLKPQNLLIN 134
Query: 293 DEMIGHVGDFGMARF--LPAIDKQNRFICIKGSTGYIPPEYDLGCE-ASTYGDVYSFGIL 349
E + DFG+AR +P + + + Y PE LGC+ ST D++S G +
Sbjct: 135 TEGAIKLADFGLARAFGVPVRTYTHEVVTL----WYRAPEILLGCKYYSTAVDIWSLGCI 190
Query: 350 LLEMFT 355
EM T
Sbjct: 191 FAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 9/88 (10%)
Query: 281 HCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGST----GYIPPEYDLGCE 336
H +L N+LL I + DFG+AR I + ++ +KG+ ++ PE C
Sbjct: 237 HRDLAARNILLTHGRITKICDFGLAR---DIRNDSNYV-VKGNARLPVKWMAPESIFNCV 292
Query: 337 ASTYGDVYSFGILLLEMFT-GIRPSDGI 363
+ DV+S+GILL E+F+ G P G+
Sbjct: 293 YTFESDVWSYGILLWEIFSLGSSPYPGM 320
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 33/117 (28%), Positives = 56/117 (47%), Gaps = 18/117 (15%)
Query: 281 HCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGST----GYIPPEYDLGCE 336
H +L N+LL + + + DFG+AR I K ++ KG ++ PE
Sbjct: 196 HRDLAARNILLSENNVVKICDFGLAR---DIYKDPDYV-RKGDARLPLKWMAPESIFDKV 251
Query: 337 ASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMN------LRNFVKMALPQRAEEVV 386
+T DV+SFG+LL E+F+ G P G+ +++ L+ +M P+ A +
Sbjct: 252 YTTQSDVWSFGVLLWEIFSLGASPYPGV---QIDEEFCRRLKEGTRMRAPEYATPEI 305
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 40.5 bits (94), Expect = 0.002
Identities = 48/214 (22%), Positives = 86/214 (40%), Gaps = 28/214 (13%)
Query: 162 YNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIV--RVFTAFSGVDYQGAR 219
Y+ + D T +K + ++P GS + C A + RN+ ++ F +
Sbjct: 4 YSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRA 63
Query: 220 FKAVVYK--------------FMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLD------ 259
++ +V F P SLEE+ N +I+ +LD
Sbjct: 64 YRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSY 123
Query: 260 IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFIC 319
+ + C +++LH I H +LKPSN+++ + + DFG+AR ++
Sbjct: 124 LLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV 180
Query: 320 IKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEM 353
+ Y PE LG D++S G ++ EM
Sbjct: 181 TR---YYRAPEVILGMGYKENVDIWSVGCIMGEM 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 58/224 (25%), Positives = 88/224 (39%), Gaps = 30/224 (13%)
Query: 147 FSSANLIGAGNFGSVYNGTLFDGTTI-AVKVFN---LIRPGGSKSFKSECKAAINIKHRN 202
F +IG G FG V + I A+K+ N +++ + F+ E +N +
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAI 262
I + AF Q + +V + G L L +D P + ++ +AI
Sbjct: 63 ITTLHYAF-----QDENYLYLVMDYYVGGDLLTLLSKFEDR--LPEDMARFYIAEMVLAI 115
Query: 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICI 320
L Y+H D +KP NVLLD M GH+ DFG + + +
Sbjct: 116 HSIHQLHYVHRD---------IKPDNVLLD--MNGHIRLADFGSCLKMNQDGTVQSSVAV 164
Query: 321 KGSTGYIPPEYDLGCE--ASTYG---DVYSFGILLLEMFTGIRP 359
G+ YI PE E YG D +S G+ + EM G P
Sbjct: 165 -GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 34/110 (30%), Positives = 55/110 (50%), Gaps = 12/110 (10%)
Query: 281 HCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGST----GYIPPEYDLGCE 336
H +L N+LL + + + DFG+AR I K ++ KGS ++ PE
Sbjct: 197 HRDLAARNILLSENNVVKICDFGLAR---DIYKDPDYV-RKGSARLPLKWMAPESIFDKV 252
Query: 337 ASTYGDVYSFGILLLEMFT-GIRPSDGIFTGK---MNLRNFVKMALPQRA 382
+T DV+SFG+LL E+F+ G P G+ + L++ +M P+ A
Sbjct: 253 YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENA 302
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 31/96 (32%), Positives = 48/96 (50%), Gaps = 11/96 (11%)
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF--LPAIDKQNRFICIKGST 324
L Y H + + H +LKP N+L+++ + DFG+AR +P N + +
Sbjct: 116 GLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTL---- 168
Query: 325 GYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRP 359
Y PP+ LG E ST D++ G + EM +G RP
Sbjct: 169 WYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASG-RP 203
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 54/219 (24%), Positives = 95/219 (43%), Gaps = 46/219 (21%)
Query: 153 IGAGNFGSVYNG-TLFDGTTIAVKVFNLIRPGGSKSFKSECKAAI--NIKHRNIVRVFTA 209
+G G++ +VY G + +G +A+KV ++ G F + +A++ +KH NIV +
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGV-PFTAIREASLLKGLKHANIVLLHDI 71
Query: 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLR----GKDDTNWRPLNFNFLIKKKLDIAIDVA 265
V+++M + L +++ G N R F L
Sbjct: 72 I-----HTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLR----------- 114
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG-----DFGMARF--LPAIDKQNRFI 318
L Y+H I H +LKP N+L I ++G DFG+AR +P+ + +
Sbjct: 115 -GLAYIH---GQHILHRDLKPQNLL-----ISYLGELKLADFGLARAKSIPSQTYSSEVV 165
Query: 319 CIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTG 356
+ Y PP+ LG + S+ D++ G + +EM G
Sbjct: 166 TL----WYRPPDVLLGATDYSSALDIWGAGCIFIEMLQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 33/95 (34%), Positives = 48/95 (50%), Gaps = 11/95 (11%)
Query: 268 LRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF--LPAIDKQNRFICIKGSTG 325
L Y H Q + H +LKP N+L+ + + DFG+AR +P+ N + +
Sbjct: 116 LAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTL----W 168
Query: 326 YIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRP 359
Y PP+ LG E ST D++ G + EM TG RP
Sbjct: 169 YRPPDVLLGSTEYSTSLDMWGVGCIFYEMATG-RP 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.003
Identities = 34/113 (30%), Positives = 52/113 (46%), Gaps = 25/113 (22%)
Query: 268 LRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYI 327
L+Y+H + H +LKPSN+L+++ + DFG+AR D Q TGY+
Sbjct: 121 LKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQ---DPQ--------MTGYV 166
Query: 328 PPEYDLGCEA----STYG---DVYSFGILLLEMFTGIRPSDGIFTGKMNLRNF 373
Y E Y D++S G + EM G +P +F GK ++ F
Sbjct: 167 STRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KP---LFPGKDHVNQF 215
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 32/101 (31%), Positives = 47/101 (46%), Gaps = 9/101 (8%)
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFI 318
A ++A AL YLH I + +LKP N+LLD + GH+ DFG+ + I+
Sbjct: 102 AAEIASALGYLH---SLNIVYRDLKPENILLDSQ--GHIVLTDFGLCK--ENIEHNGTTS 154
Query: 319 CIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
G+ Y+ PE D + G +L EM G+ P
Sbjct: 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.003
Identities = 33/103 (32%), Positives = 49/103 (47%), Gaps = 14/103 (13%)
Query: 268 LRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYI 327
L+Y+H + H +LKPSN+LL+ + DFG+AR +K + + Y
Sbjct: 121 LKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRWYR 175
Query: 328 PPEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDGIFTGK 367
PE L C S Y DV+S G + E+ +P +F GK
Sbjct: 176 APELLLNC--SEYTTAIDVWSVGCIFAELLGR-KP---LFPGK 212
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 56/219 (25%), Positives = 94/219 (42%), Gaps = 29/219 (13%)
Query: 142 NATNGFSSANLIGAGNFGSVYNG-TLFDGTTIAVKVFNLIRPGGSKSF-KSECKAAINIK 199
N + + +G+G +G VY L G AVK+ L PG S + E K
Sbjct: 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKL-EPGDDFSLIQQEIFMVKECK 64
Query: 200 HRNIVRVFTAFSGVDYQGARFKA-VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKL 258
H NIV F ++ +R K + ++ GSL++ + L ++ ++ L
Sbjct: 65 HCNIVAYFGSYL------SREKLWICMEYCGGGSLQDIYHVTGPLS--ELQIAYVCRETL 116
Query: 259 DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPA-IDKQNRF 317
L YLH + H ++K +N+LL D + DFG+A + A I K+ F
Sbjct: 117 Q-------GLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSF 166
Query: 318 ICIKGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEM 353
I G+ ++ PE + Y D+++ GI +E+
Sbjct: 167 I---GTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 49/193 (25%), Positives = 82/193 (42%), Gaps = 36/193 (18%)
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAI 262
+V++F AF Q ++ +V ++MP G L + D P + ++ +A+
Sbjct: 105 VVQLFCAF-----QDDKYLYMVMEYMPGGDLVNLMSNYD----VPEKWAKFYTAEVVLAL 155
Query: 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFIC--I 320
D ++ +H D +KP N+LLD + DFG +D+ C
Sbjct: 156 DAIHSMGLIHRD---------VKPDNMLLDKHGHLKLADFGTCM---KMDETGMVRCDTA 203
Query: 321 KGSTGYIPPEYDLGCEAST--YG---DVYSFGILLLEMFTGIRP--SD---GIFTGKMNL 370
G+ YI PE L + YG D +S G+ L EM G P +D G ++ M+
Sbjct: 204 VGTPDYISPEV-LKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDH 262
Query: 371 RNFVKMALPQRAE 383
+N + P+ E
Sbjct: 263 KN--SLNFPEDVE 273
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 29/97 (29%), Positives = 45/97 (46%), Gaps = 8/97 (8%)
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIK-G 322
+ C + +LH I + ++KP NVLLDD+ + D G+A L + I + G
Sbjct: 104 ITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELK----DGKTITQRAG 156
Query: 323 STGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
+ GY+ PE S D ++ G + EM G P
Sbjct: 157 TNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.004
Identities = 54/220 (24%), Positives = 98/220 (44%), Gaps = 46/220 (20%)
Query: 153 IGAGNFGSVYNGTLFDGTT---IAVKVFNLIRPGGS-----KSFKSECKAAINIKHRNIV 204
+G+G +GSV + +D +AVK L RP S ++++ E + ++KH N++
Sbjct: 23 VGSGAYGSVCSA--YDTRLRQKVAVK--KLSRPFQSLIHARRTYR-ELRLLKHMKHENVI 77
Query: 205 RVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIK-KKLD---- 259
+ F+ P S+E + TN + N ++K +KL
Sbjct: 78 GLLDVFT-----------------PATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHV 120
Query: 260 --IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRF 317
+ + L+Y+H I H +LKPSNV ++++ + DFG+AR A D+ +
Sbjct: 121 QFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLAR--QADDEMTGY 175
Query: 318 ICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTG 356
+ + Y PE L + D++S G ++ E+ G
Sbjct: 176 VATR---WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKG 212
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.004
Identities = 41/168 (24%), Positives = 71/168 (42%), Gaps = 21/168 (12%)
Query: 152 LIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFS 211
LIG G FG VY I + I +++ E NI + + ++
Sbjct: 19 LIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIH 78
Query: 212 GVDYQG-------ARFK--AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKL--DI 260
+D+ G FK + Y+F+ LE+ + + R N KKL +I
Sbjct: 79 NIDHLGIPKYYGCGSFKRCRMYYRFI---LLEKLVENTKEIFKRIKCKN----KKLIKNI 131
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL 308
D+ L Y+H + I+H ++KP N+++D G++ D+G+A
Sbjct: 132 MKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYIIDYGIASHF 176
|
Length = 294 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 473 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.98 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.98 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.93 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.9 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.87 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.87 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.86 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.86 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.86 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.86 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.85 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.82 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.81 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.81 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.8 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.79 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.77 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.76 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.72 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.71 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.69 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.67 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.66 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.6 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.57 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.52 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.45 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.41 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.38 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.35 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.28 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.26 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.25 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.24 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.21 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.17 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.15 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.03 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.02 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.01 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.96 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.81 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.81 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.79 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 98.73 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 98.7 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.69 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.66 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 98.63 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 98.62 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 98.55 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.53 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.49 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.48 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 98.46 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.45 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.43 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 98.42 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 98.4 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.36 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 98.35 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.3 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 98.28 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.26 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 98.26 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 98.21 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 98.21 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.2 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 98.19 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 98.18 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 98.18 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 98.17 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 98.17 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 98.16 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 98.16 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 98.15 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 98.15 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 98.15 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 98.13 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 98.13 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 98.13 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 98.13 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.12 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 98.12 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 98.12 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 98.11 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 98.11 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 98.11 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-54 Score=410.06 Aligned_cols=290 Identities=34% Similarity=0.584 Sum_probs=240.9
Q ss_pred ccCCCchhhhhcccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeee
Q 012014 131 TINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAF 210 (473)
Q Consensus 131 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 210 (473)
....+++.++..+|++|...++||+|+||.||+|...+++.||||++.........+|.+|+.++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45668999999999999999999999999999999988999999988754432145699999999999999999999999
Q ss_pred eccccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEE
Q 012014 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVL 290 (473)
Q Consensus 211 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil 290 (473)
.+.+ ...+||+||+++|+|.++|...... .++|.++++|+.++|+||+|||+.+...||||||||+|||
T Consensus 141 ~e~~----~~~~LVYEym~nGsL~d~L~~~~~~-------~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNIL 209 (361)
T KOG1187|consen 141 LEGG----EHRLLVYEYMPNGSLEDHLHGKKGE-------PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNIL 209 (361)
T ss_pred ecCC----ceEEEEEEccCCCCHHHHhCCCCCC-------CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHee
Confidence 7543 1579999999999999999886542 3679999999999999999999877778999999999999
Q ss_pred ecCCccEEEeecccccccCccccccceeec-cCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCC-CCcc
Q 012014 291 LDDEMIGHVGDFGMARFLPAIDKQNRFICI-KGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF-TGKM 368 (473)
Q Consensus 291 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~-~~~~ 368 (473)
+|+++++||+|||+|+..+.. ....... .||.+|+|||+...+..+.|+|||||||+++||+||+.|.+... ....
T Consensus 210 LD~~~~aKlsDFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~ 287 (361)
T KOG1187|consen 210 LDEDFNAKLSDFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGEL 287 (361)
T ss_pred ECCCCCEEccCccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccc
Confidence 999999999999999765431 1111112 69999999999999999999999999999999999999987643 3444
Q ss_pred cHHHHHHhhcC-cchhhhccccchH-HHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHH
Q 012014 369 NLRNFVKMALP-QRAEEVVDDFNLQ-EIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVE 446 (473)
Q Consensus 369 ~~~~~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~ 446 (473)
.+..|...... ..+.+++|+.+.. ... .......+..++.+|++.+|.+||+|.||+
T Consensus 288 ~l~~w~~~~~~~~~~~eiiD~~l~~~~~~---------------------~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv 346 (361)
T KOG1187|consen 288 SLVEWAKPLLEEGKLREIVDPRLKEGEYP---------------------DEKEVKKLAELALRCLRPDPKERPTMSQVV 346 (361)
T ss_pred cHHHHHHHHHHCcchhheeCCCccCCCCC---------------------hHHHHHHHHHHHHHHcCcCCCcCcCHHHHH
Confidence 57777655544 3677888876542 111 014667799999999999999999999999
Q ss_pred HHHHHHHH
Q 012014 447 SRLRLIRR 454 (473)
Q Consensus 447 ~~L~~l~~ 454 (473)
+.|+.+..
T Consensus 347 ~~L~~~~~ 354 (361)
T KOG1187|consen 347 KELEGILS 354 (361)
T ss_pred HHHHhhcc
Confidence 99966644
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-53 Score=380.36 Aligned_cols=253 Identities=24% Similarity=0.312 Sum_probs=207.8
Q ss_pred CCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeec-cCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNL-IRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
++.+..+.||+|+.|+||+++ ..+++.+|+|++.. ......+++.+|+++++..+||+||++||.|.... . ...
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~---~-~is 154 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNG---E-EIS 154 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC---c-eEE
Confidence 356678899999999999999 56789999999953 33445678899999999999999999999997532 2 589
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
|+||||++|||++++...+ .+++....+|+.+|++||.|||. .++||||||||+|||++..|.+|||||
T Consensus 155 I~mEYMDgGSLd~~~k~~g---------~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDF 223 (364)
T KOG0581|consen 155 ICMEYMDGGSLDDILKRVG---------RIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDF 223 (364)
T ss_pred eehhhcCCCCHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccc
Confidence 9999999999999998764 35688899999999999999993 389999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcch
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRA 382 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 382 (473)
|.++.+... ...++.||..|||||.+.+..|+.++||||||++++|+++|+.||.............+.....+..
T Consensus 224 GVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~pp 299 (364)
T KOG0581|consen 224 GVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPP 299 (364)
T ss_pred cccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCC
Confidence 999877543 4456789999999999999999999999999999999999999998653323332322222211111
Q ss_pred hhhccccchHHHHhhhhhhcccccCCCCcchhhHHH-HHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 383 EEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIIL-ECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
..+ +. .++++++.++..||++||.+|||+.|+++
T Consensus 300 P~l-------------------------------P~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 300 PRL-------------------------------PEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CCC-------------------------------CcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 111 11 36778999999999999999999999875
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-52 Score=394.35 Aligned_cols=265 Identities=27% Similarity=0.428 Sum_probs=212.9
Q ss_pred ccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCC--chhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGG--SKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
....+...+.||+|+||+||+|.+.....||||++....... .+.|.+|+.+|.+++|||||+++|+|.+.. ..
T Consensus 39 ~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~----~~ 114 (362)
T KOG0192|consen 39 DPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPP----GS 114 (362)
T ss_pred ChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC----Cc
Confidence 344555667799999999999997554559999997543222 458999999999999999999999996542 15
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCC-eeeccCCCCcEEecCCc-cEE
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPP-IAHCNLKPSNVLLDDEM-IGH 298 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~-iiH~Dlkp~Nil~~~~~-~~k 298 (473)
.++||||+++|+|.+++..... ..+++..++.++.|||+||.||| +++ ||||||||+|||++.++ ++|
T Consensus 115 ~~iVtEy~~~GsL~~~l~~~~~-------~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~K 184 (362)
T KOG0192|consen 115 LCIVTEYMPGGSLSVLLHKKRK-------RKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLK 184 (362)
T ss_pred eEEEEEeCCCCcHHHHHhhccc-------CCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEE
Confidence 7999999999999999987411 14779999999999999999999 888 99999999999999997 999
Q ss_pred EeecccccccCccccccceeeccCCCCcCCCcccc--CCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 012014 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDL--GCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKM 376 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~ 376 (473)
|+|||+++...... ...+...||+.|||||++. ...|+.|+||||||+++|||+||..||.+....... ...+..
T Consensus 185 I~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~-~~v~~~ 261 (362)
T KOG0192|consen 185 IADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVA-SAVVVG 261 (362)
T ss_pred ECCCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHH-HHHHhc
Confidence 99999998764321 2233367999999999999 568999999999999999999999999876542111 111100
Q ss_pred hcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHHhh
Q 012014 377 ALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRKL 456 (473)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~~ 456 (473)
. .++..+..+++.+..|+.+||+.||..||++.+|+..|+.+...+
T Consensus 262 ~----------------------------------~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 262 G----------------------------------LRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred C----------------------------------CCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 0 011222347788999999999999999999999999999998766
Q ss_pred cc
Q 012014 457 LE 458 (473)
Q Consensus 457 ~~ 458 (473)
..
T Consensus 308 ~~ 309 (362)
T KOG0192|consen 308 SS 309 (362)
T ss_pred cc
Confidence 54
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-52 Score=377.83 Aligned_cols=252 Identities=19% Similarity=0.275 Sum_probs=202.6
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCC-------CchhHHHHHHHHHhcCCCCceeeeeeeecccc
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPG-------GSKSFKSECKAAINIKHRNIVRVFTAFSGVDY 215 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 215 (473)
.+.|.+.+.||+|+||.|-+|. ..+|+.||||++++.... ......+|+++|++|+|||||+++++|...+
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d- 249 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD- 249 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC-
Confidence 4567889999999999999998 678999999999743211 1233579999999999999999999986654
Q ss_pred CCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCC-
Q 012014 216 QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE- 294 (473)
Q Consensus 216 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~- 294 (473)
..|+||||+.||+|.+++-.+.. +.+.....+++|++.|+.||| ++||+||||||+|||+..+
T Consensus 250 ----s~YmVlE~v~GGeLfd~vv~nk~---------l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~ 313 (475)
T KOG0615|consen 250 ----SSYMVLEYVEGGELFDKVVANKY---------LREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDA 313 (475)
T ss_pred ----ceEEEEEEecCccHHHHHHhccc---------cccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCC
Confidence 56999999999999999987763 336667789999999999999 9999999999999999766
Q ss_pred --ccEEEeecccccccCccccccceeeccCCCCcCCCccccCCC---CCcccchhhHhHHHHHHHhCCCCCCCCCCCccc
Q 012014 295 --MIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE---ASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMN 369 (473)
Q Consensus 295 --~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~ 369 (473)
..+||+|||+|+..+. .....+.+|||.|.|||++.+.. +..++|+||+||+||-+++|.+||.+.......
T Consensus 314 e~~llKItDFGlAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl 390 (475)
T KOG0615|consen 314 EDCLLKITDFGLAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSL 390 (475)
T ss_pred cceEEEecccchhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccH
Confidence 7899999999998753 44456788999999999998765 334789999999999999999999876554432
Q ss_pred HHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 370 LRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
..++.+....-. +..-....++..+|+.+||..||++|||+.|++.
T Consensus 391 ~eQI~~G~y~f~--------------------------------p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 391 KEQILKGRYAFG--------------------------------PLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred HHHHhcCccccc--------------------------------ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 222222211110 0111246678889999999999999999999864
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-51 Score=393.49 Aligned_cols=247 Identities=24% Similarity=0.357 Sum_probs=209.3
Q ss_pred CCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeec---cCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNL---IRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
.+|...++||+|||+.||.++. .+|+.||+|++.+ .+....+.+.+|+++.+.|+|||||+++++|.+ ..+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FED-----s~n 92 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFED-----SNN 92 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeec-----CCc
Confidence 5799999999999999999995 8899999999974 345567789999999999999999999999865 448
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
+|||+|+|+.++|..+++... .+++.++..+++||+.||.||| +++|||||||..|+|++++.++||+
T Consensus 93 VYivLELC~~~sL~el~Krrk---------~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIg 160 (592)
T KOG0575|consen 93 VYIVLELCHRGSLMELLKRRK---------PLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIG 160 (592)
T ss_pred eEEEEEecCCccHHHHHHhcC---------CCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEec
Confidence 999999999999999998654 4779999999999999999999 9999999999999999999999999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCc
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQ 380 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 380 (473)
|||+|..+.... ....+.+|||.|.|||++....++..+||||+||+||-|+.|++||... .+....
T Consensus 161 DFGLAt~le~~~--Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk-----~vkety------ 227 (592)
T KOG0575|consen 161 DFGLATQLEYDG--ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK-----TVKETY------ 227 (592)
T ss_pred ccceeeeecCcc--cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc-----hHHHHH------
Confidence 999999886533 3445678999999999999999999999999999999999999999752 111111
Q ss_pred chhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 381 RAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
+.....++ ..+.....+..+||..+|+.||.+|||+++|+.
T Consensus 228 ------~~Ik~~~Y--------------------~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 228 ------NKIKLNEY--------------------SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ------HHHHhcCc--------------------ccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11111110 112234567789999999999999999999975
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-52 Score=360.98 Aligned_cols=263 Identities=22% Similarity=0.289 Sum_probs=207.0
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC--CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
-.+|.+.++||+|.||+||++. ..+|..+|.|.++... ......+..|+.+|++|+|||||++++.-.. ++...
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~---~~~ev 94 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI---EDNEV 94 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh---ccchh
Confidence 3468899999999999999998 7899999999987322 2334568899999999999999999984322 33445
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCC-CCCeeeccCCCCcEEecCCccEEE
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDC-QPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~-~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
++||||||.+|+|.+.++...... ..+++..+++++.|++.||.++|+.. ..-|+||||||.||+++.+|.+||
T Consensus 95 lnivmE~c~~GDLsqmIk~~K~qk-----r~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKL 169 (375)
T KOG0591|consen 95 LNIVMELCDAGDLSQMIKHFKKQK-----RLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKL 169 (375)
T ss_pred hHHHHHhhcccCHHHHHHHHHhcc-----ccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceee
Confidence 899999999999999997654321 24779999999999999999999422 123999999999999999999999
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcC
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP 379 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 379 (473)
+|||+++.+.... ....+.+|||.||+||.+.+.+|+.+|||||+||++|||+.-++||.+. ++.+.-+....
T Consensus 170 GDfGL~r~l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~-----n~~~L~~KI~q 242 (375)
T KOG0591|consen 170 GDFGLGRFLSSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD-----NLLSLCKKIEQ 242 (375)
T ss_pred ccchhHhHhcchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc-----cHHHHHHHHHc
Confidence 9999999886543 3334567999999999999999999999999999999999999999873 22222222111
Q ss_pred cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHH
Q 012014 380 QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRL 451 (473)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 451 (473)
.....+. ....+..+..|+..|+..||+.||+...++..+..
T Consensus 243 gd~~~~p------------------------------~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 243 GDYPPLP------------------------------DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred CCCCCCc------------------------------HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 1111111 13467788999999999999999996555544443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-51 Score=370.46 Aligned_cols=201 Identities=29% Similarity=0.467 Sum_probs=178.2
Q ss_pred ccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeecc--CCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCce
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI--RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (473)
...+|...+.||.|+||+||+|+ ..++..||||.+... .....+.+..|+.+|+.++|||||++++++... .
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~-----~ 82 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDD-----D 82 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC-----C
Confidence 34689999999999999999999 556899999999755 334456788999999999999999999998654 4
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCC-----
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE----- 294 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~----- 294 (473)
+.|||||||.||||.+||+.++ .+++..+..++.||+.||++|| +++||||||||+|||++..
T Consensus 83 ~i~lVMEyC~gGDLs~yi~~~~---------~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~ 150 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYIRRRG---------RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDT 150 (429)
T ss_pred eEEEEEEeCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCC
Confidence 8999999999999999999886 3568999999999999999999 9999999999999999764
Q ss_pred -ccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCC
Q 012014 295 -MIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (473)
Q Consensus 295 -~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 363 (473)
-.+||+|||+|+.+.. .....+.+|++.|||||++....|+.|+|+||+|+|+|+|++|+.||+..
T Consensus 151 ~~~LKIADFGfAR~L~~---~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~ 217 (429)
T KOG0595|consen 151 SPVLKIADFGFARFLQP---GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE 217 (429)
T ss_pred CceEEecccchhhhCCc---hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 4689999999998864 33445678999999999999999999999999999999999999999853
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-51 Score=384.35 Aligned_cols=262 Identities=25% Similarity=0.396 Sum_probs=214.9
Q ss_pred hhcccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCce
Q 012014 140 LYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 140 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (473)
+......+...+.||+|-||.||.|.+.....||+|.++... -..+.|.+|+++|++|+|+|||+++++|....
T Consensus 201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~----- 274 (468)
T KOG0197|consen 201 WEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE----- 274 (468)
T ss_pred eeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCC-----
Confidence 333444567788999999999999998777899999998542 34577899999999999999999999996532
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
.++||||||+.|+|.+||+..... .+...+.+.++.|||+|++||+ ++++|||||.+.|||++++..+||
T Consensus 275 piyIVtE~m~~GsLl~yLr~~~~~-------~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKI 344 (468)
T KOG0197|consen 275 PIYIVTEYMPKGSLLDYLRTREGG-------LLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKI 344 (468)
T ss_pred ceEEEEEecccCcHHHHhhhcCCC-------ccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEE
Confidence 689999999999999999973322 3567899999999999999999 999999999999999999999999
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhc
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMAL 378 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 378 (473)
+|||+|+...+.. ........-...|.|||.+..+.++.|||||||||+||||+| |+.||.++...+
T Consensus 345 sDFGLAr~~~d~~-Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e----------- 412 (468)
T KOG0197|consen 345 SDFGLARLIGDDE-YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE----------- 412 (468)
T ss_pred cccccccccCCCc-eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH-----------
Confidence 9999999544332 111222223567999999999999999999999999999999 999988754322
Q ss_pred CcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHH
Q 012014 379 PQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRR 454 (473)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~ 454 (473)
+...++.|.++ +.+..||..+.+||..||+.+|++|||+..+...|+.+..
T Consensus 413 -----------v~~~le~GyRl--------------p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 413 -----------VLELLERGYRL--------------PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred -----------HHHHHhccCcC--------------CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 12233333333 3445689999999999999999999999999999988854
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-49 Score=358.02 Aligned_cols=244 Identities=25% Similarity=0.298 Sum_probs=200.9
Q ss_pred ccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC---CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
..++|++.++||+|+||.||.++ ..+++.+|+|++++.. ....+....|..+|..++||+||+++..|. +.
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQ-----t~ 97 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQ-----TE 97 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecc-----cC
Confidence 45789999999999999999999 5678999999997533 334567889999999999999999998874 45
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
..+|+|+||+.||.|..+|++.+ .|++..+.-++.+|+.||.||| ++|||||||||+|||+|.+|+++
T Consensus 98 ~kLylVld~~~GGeLf~hL~~eg---------~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~ 165 (357)
T KOG0598|consen 98 EKLYLVLDYLNGGELFYHLQREG---------RFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIK 165 (357)
T ss_pred CeEEEEEeccCCccHHHHHHhcC---------CcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEE
Confidence 58999999999999999999776 4778889999999999999999 99999999999999999999999
Q ss_pred EeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 012014 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMAL 378 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~ 378 (473)
|+|||+++..-.. .....+.+||+.|||||++.+..|+..+|+||||+++|||++|.+||.+.... .+.+...
T Consensus 166 LtDFgL~k~~~~~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~-----~~~~~I~ 238 (357)
T KOG0598|consen 166 LTDFGLCKEDLKD--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK-----KMYDKIL 238 (357)
T ss_pred EeccccchhcccC--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH-----HHHHHHh
Confidence 9999999854332 33445578999999999999999999999999999999999999999864322 2222221
Q ss_pred CcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCC
Q 012014 379 PQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMK 441 (473)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt 441 (473)
...... .+.-...+..+|+...|+.||++|..
T Consensus 239 ~~k~~~-------------------------------~p~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 239 KGKLPL-------------------------------PPGYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred cCcCCC-------------------------------CCccCCHHHHHHHHHHhccCHHHhcC
Confidence 111000 00113446678999999999999963
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=366.87 Aligned_cols=253 Identities=23% Similarity=0.346 Sum_probs=209.0
Q ss_pred hcccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeec---cCCCCchhHHHHHHHHHhc-CCCCceeeeeeeecccc
Q 012014 141 YNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNL---IRPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDY 215 (473)
Q Consensus 141 ~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 215 (473)
....++|..++.||+|+|++|++|+ ..+++.||||++.+ .+....+....|-.+|.+| .||.|++||..|.+
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD--- 145 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD--- 145 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec---
Confidence 4566899999999999999999999 67899999999963 3344556678899999999 89999999999854
Q ss_pred CCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCc
Q 012014 216 QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM 295 (473)
Q Consensus 216 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~ 295 (473)
...+|+|+||+++|+|.++|++.+ .|.+..+..++.+|+.||+||| ++|||||||||+|||+|+++
T Consensus 146 --~~sLYFvLe~A~nGdll~~i~K~G---------sfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dm 211 (604)
T KOG0592|consen 146 --EESLYFVLEYAPNGDLLDLIKKYG---------SFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDG 211 (604)
T ss_pred --ccceEEEEEecCCCcHHHHHHHhC---------cchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCC
Confidence 447899999999999999999886 4668888999999999999999 99999999999999999999
Q ss_pred cEEEeecccccccCccccc---------cce--eeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCC
Q 012014 296 IGHVGDFGMARFLPAIDKQ---------NRF--ICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (473)
Q Consensus 296 ~~kl~Dfg~~~~~~~~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~ 364 (473)
++||+|||.|+.+...... ... .+++||..|.+||++.....+..+|||+||||+|.|+.|.+||.+..
T Consensus 212 hikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N 291 (604)
T KOG0592|consen 212 HIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN 291 (604)
T ss_pred cEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc
Confidence 9999999999987654322 112 56889999999999999999999999999999999999999998632
Q ss_pred CCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHH
Q 012014 365 TGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKIND 444 (473)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 444 (473)
.-- .+..++.. ..+.+...++.+.+|+.+.|..||.+|+|+++
T Consensus 292 eyl-iFqkI~~l------------------------------------~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~q 334 (604)
T KOG0592|consen 292 EYL-IFQKIQAL------------------------------------DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQ 334 (604)
T ss_pred HHH-HHHHHHHh------------------------------------cccCCCCCCHHHHHHHHHHHccCccccccHHH
Confidence 211 01111100 11123345667888999999999999999977
Q ss_pred HHH
Q 012014 445 VES 447 (473)
Q Consensus 445 v~~ 447 (473)
|-+
T Consensus 335 Ik~ 337 (604)
T KOG0592|consen 335 IKA 337 (604)
T ss_pred Hhh
Confidence 754
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-48 Score=354.22 Aligned_cols=261 Identities=25% Similarity=0.382 Sum_probs=204.5
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
..+|...+.||+|+||.||++.. .+|...|||.+........+.+.+|+.+|.+++|||||+++|...... + ..++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~--~-~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRE--N-DEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCcccccc--C-eeeE
Confidence 45678899999999999999994 458999999987654333667899999999999999999999743321 1 4679
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecC-CccEEEee
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD-EMIGHVGD 301 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~-~~~~kl~D 301 (473)
++|||+++|+|.+++...+. .+++..+..+++||++||+||| ++|||||||||+|||++. ++.+||+|
T Consensus 93 i~mEy~~~GsL~~~~~~~g~--------~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaD 161 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGG--------KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLAD 161 (313)
T ss_pred eeeeccCCCcHHHHHHHcCC--------CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEecc
Confidence 99999999999999998763 2668999999999999999999 999999999999999999 79999999
Q ss_pred cccccccCc-cccccceeeccCCCCcCCCccccCC-CCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcC
Q 012014 302 FGMARFLPA-IDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP 379 (473)
Q Consensus 302 fg~~~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 379 (473)
||+++.... ...........||+.|||||++..+ ....++|||||||++.||+||++||....... .........
T Consensus 162 FG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~---~~~~~ig~~ 238 (313)
T KOG0198|consen 162 FGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEA---EALLLIGRE 238 (313)
T ss_pred CccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchH---HHHHHHhcc
Confidence 999987653 1112233456799999999999863 33459999999999999999999998641111 111111111
Q ss_pred cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHH
Q 012014 380 QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLI 452 (473)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l 452 (473)
.... ..+...+.+..+++..|+..||++||||.++++.--..
T Consensus 239 ~~~P-------------------------------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~ 280 (313)
T KOG0198|consen 239 DSLP-------------------------------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLK 280 (313)
T ss_pred CCCC-------------------------------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhh
Confidence 1111 12233566788999999999999999999998765443
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-48 Score=338.64 Aligned_cols=276 Identities=17% Similarity=0.244 Sum_probs=203.9
Q ss_pred CCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCC--CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
+.|+...++|+|+||.||+++ ..+|+.||||++..... .-.+-..+|++.|++++|||+|.++.+|.. ....
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr-----krkl 76 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR-----KRKL 76 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh-----ccee
Confidence 357788899999999999999 56799999999974332 223456899999999999999999999843 4578
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEee
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~D 301 (473)
+||+|||+. ++.+-|..... .++......++.|++.|+.|+| ++++|||||||+|||++.+|.+||||
T Consensus 77 hLVFE~~dh-TvL~eLe~~p~--------G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCD 144 (396)
T KOG0593|consen 77 HLVFEYCDH-TVLHELERYPN--------GVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCD 144 (396)
T ss_pred EEEeeecch-HHHHHHHhccC--------CCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEecc
Confidence 999999976 44455554432 3557888999999999999999 99999999999999999999999999
Q ss_pred cccccccCccccccceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHH--HHHhhc
Q 012014 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRN--FVKMAL 378 (473)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~--~~~~~~ 378 (473)
||+|+.+.. .....+....|.+|+|||.+.+ .+|+..+||||+||++.||++|.+-|.|..+-+..+.. .+....
T Consensus 145 FGFAR~L~~--pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~ 222 (396)
T KOG0593|consen 145 FGFARTLSA--PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLI 222 (396)
T ss_pred chhhHhhcC--CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccC
Confidence 999998864 2334444567999999999988 67999999999999999999999999876544322111 111111
Q ss_pred CcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 379 PQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
| +-.+++...- +- ...-.+............+....-+.+|+..||+.||++|+|.+|++.
T Consensus 223 p-rhq~iF~~N~---~F----~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 223 P-RHQSIFSSNP---FF----HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred H-HHHHHhccCC---ce----eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1 1111111100 00 000111111112222233455668899999999999999999999874
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=348.80 Aligned_cols=266 Identities=23% Similarity=0.262 Sum_probs=214.6
Q ss_pred hhcccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCC-CchhHHHHHHHHHhcCCCCceeeeeeeeccccCC
Q 012014 140 LYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPG-GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (473)
Q Consensus 140 ~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (473)
+-...++|++..+||.|..++||+|+ ...+..||||+++..... ..+.+++|+..|+.++||||++++..|...
T Consensus 21 ~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~---- 96 (516)
T KOG0582|consen 21 FPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD---- 96 (516)
T ss_pred CCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEec----
Confidence 34456789999999999999999999 678899999999865543 358899999999999999999999998653
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccE
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~ 297 (473)
..+|+||.||.+||+.+.++..... .|.+..+..|++++++||.||| .+|.||||||+.||||+.+|.+
T Consensus 97 -~~LWvVmpfMa~GS~ldIik~~~~~-------Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~V 165 (516)
T KOG0582|consen 97 -SELWVVMPFMAGGSLLDIIKTYYPD-------GLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTV 165 (516)
T ss_pred -ceeEEeehhhcCCcHHHHHHHHccc-------cccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcE
Confidence 3789999999999999999877643 4678889999999999999999 9999999999999999999999
Q ss_pred EEeecccccccCccccccc-e-eeccCCCCcCCCccccC--CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHH
Q 012014 298 HVGDFGMARFLPAIDKQNR-F-ICIKGSTGYIPPEYDLG--CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNF 373 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~-~-~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~ 373 (473)
||+|||.+..+........ . ....||+.|||||++.. ..|+.|+||||||++..||.+|..||......++.+...
T Consensus 166 kLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL 245 (516)
T KOG0582|consen 166 KLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL 245 (516)
T ss_pred EEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh
Confidence 9999999877654332211 1 45679999999999543 359999999999999999999999998765444322211
Q ss_pred HHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 374 VKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
+...|... .+....+........+.+++..||.+||.+|||++++++
T Consensus 246 -qn~pp~~~--------------------------t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 246 -QNDPPTLL--------------------------TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred -cCCCCCcc--------------------------cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 11111111 111222334456778999999999999999999999975
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-48 Score=358.93 Aligned_cols=279 Identities=19% Similarity=0.241 Sum_probs=211.5
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchh-HHHHHHHHHhcC-CCCceeeeeeeeccccCCcee
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKS-FKSECKAAINIK-HRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~-~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 220 (473)
-++|.+.++||.|.||.||+|+ ..+|..||||+++..-....+. -.+|+..|++|+ ||||+++.+++.+.+ ..
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~----~~ 84 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDND----RI 84 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC----ce
Confidence 4678999999999999999999 6779999999998654433332 358999999998 999999999986533 37
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
+++||||| ..+|.++++.+.. .|++.++..|+.||+.||+|+| .+|+.|||+||+|||+..+..+||+
T Consensus 85 L~fVfE~M-d~NLYqLmK~R~r--------~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKia 152 (538)
T KOG0661|consen 85 LYFVFEFM-DCNLYQLMKDRNR--------LFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIA 152 (538)
T ss_pred EeeeHHhh-hhhHHHHHhhcCC--------cCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEec
Confidence 89999999 5699999988743 5889999999999999999999 9999999999999999999999999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcC
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP 379 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 379 (473)
|||+|+.+.... ..+..+.|..|+|||++.. +.|+.+.|+||+|||++|+.+-++.|.|....+..+. +....-.
T Consensus 153 DFGLARev~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~K-Ic~VLGt 228 (538)
T KOG0661|consen 153 DFGLAREVRSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYK-ICEVLGT 228 (538)
T ss_pred ccccccccccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHH-HHHHhCC
Confidence 999999875533 3344557999999998765 5699999999999999999999999988654443222 2222211
Q ss_pred cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 380 QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
.....+.....+ ...+ ....+.-.+.........++.+..+|+.+|+.+||.+||||+|.++.
T Consensus 229 P~~~~~~eg~~L-----a~~m-nf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 229 PDKDSWPEGYNL-----ASAM-NFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred CccccchhHHHH-----HHHh-ccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 111111110000 0001 01111112222333344578889999999999999999999998753
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-47 Score=358.36 Aligned_cols=250 Identities=20% Similarity=0.273 Sum_probs=211.0
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
...|....+||+|+.|.||.|. ..+++.||||++........+-+.+|+.+|+..+|+|||++++.|... ..+|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~-----deLW 346 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG-----DELW 346 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc-----ceeE
Confidence 4568888899999999999998 677899999999987777788899999999999999999999988543 4789
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
+||||++||+|.+.+.... +++.++..|+++++.||+||| .+||+|||||.+|||++.+|.+||+||
T Consensus 347 VVMEym~ggsLTDvVt~~~----------~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDF 413 (550)
T KOG0578|consen 347 VVMEYMEGGSLTDVVTKTR----------MTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDF 413 (550)
T ss_pred EEEeecCCCchhhhhhccc----------ccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeee
Confidence 9999999999999987663 669999999999999999999 999999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcch
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRA 382 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 382 (473)
|++..+.... ....+..|||.|||||+.....|++++||||||++++||+-|.+||-. +..+..+......+..
T Consensus 414 GFcaqi~~~~--~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYln----E~PlrAlyLIa~ng~P 487 (550)
T KOG0578|consen 414 GFCAQISEEQ--SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLN----ENPLRALYLIATNGTP 487 (550)
T ss_pred eeeecccccc--CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccC----CChHHHHHHHhhcCCC
Confidence 9998775533 245567799999999999999999999999999999999999999964 2222222222111111
Q ss_pred hhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 383 EEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
++ .........+.+++.+||..|+.+|||+.|+|+
T Consensus 488 -~l-----------------------------k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 488 -KL-----------------------------KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred -Cc-----------------------------CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 00 112345678899999999999999999999986
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=363.50 Aligned_cols=270 Identities=25% Similarity=0.346 Sum_probs=219.3
Q ss_pred CchhhhhcccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCC--CCchhHHHHHHHHHhcCCCCceeeeeeeec
Q 012014 135 PSFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSG 212 (473)
Q Consensus 135 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 212 (473)
.+..+|....+.+.+...||+|.||+||+|.|.. .||||+++.... ...+.|++|+..+++-+|.||+-+.|+|..
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 3457777888888999999999999999999753 699999985443 345789999999999999999999999865
Q ss_pred cccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEec
Q 012014 213 VDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD 292 (473)
Q Consensus 213 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~ 292 (473)
.. ..||+.+|.|.+|+.+|+-... .|...+.++|+.||+.|+.||| .++|||||||..|||+.
T Consensus 460 p~------~AIiTqwCeGsSLY~hlHv~et--------kfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~ 522 (678)
T KOG0193|consen 460 PP------LAIITQWCEGSSLYTHLHVQET--------KFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLH 522 (678)
T ss_pred Cc------eeeeehhccCchhhhhccchhh--------hhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEc
Confidence 43 3899999999999999987653 4778899999999999999999 99999999999999999
Q ss_pred CCccEEEeecccccccCccccccceeeccCCCCcCCCccccC---CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCccc
Q 012014 293 DEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG---CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMN 369 (473)
Q Consensus 293 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~ 369 (473)
+++.|||+|||++..-.............|...|||||++.. .+|+..+||||||+|+|||++|..||.. ...+..
T Consensus 523 ~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~dqI 601 (678)
T KOG0193|consen 523 EDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNRDQI 601 (678)
T ss_pred cCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CChhhe
Confidence 999999999999976554444444555668899999999864 4699999999999999999999999983 222211
Q ss_pred HHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHH
Q 012014 370 LRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRL 449 (473)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L 449 (473)
+-..-+.+...+.. ....++++++.+|+..||+.++++||++.+|+..|
T Consensus 602 ifmVGrG~l~pd~s-------------------------------~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l 650 (678)
T KOG0193|consen 602 IFMVGRGYLMPDLS-------------------------------KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKL 650 (678)
T ss_pred EEEecccccCccch-------------------------------hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHH
Confidence 11111111111111 11245889999999999999999999999999999
Q ss_pred HHHHHh
Q 012014 450 RLIRRK 455 (473)
Q Consensus 450 ~~l~~~ 455 (473)
+.+..+
T Consensus 651 ~~l~~~ 656 (678)
T KOG0193|consen 651 EELLPS 656 (678)
T ss_pred HHhhhc
Confidence 888764
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-48 Score=381.46 Aligned_cols=275 Identities=24% Similarity=0.382 Sum_probs=220.4
Q ss_pred hhhhhcccCCCCccceeecCCCeEEEEEEec------CCCEEEEEEeeccCCC-CchhHHHHHHHHHhcCCCCceeeeee
Q 012014 137 FKDLYNATNGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRPG-GSKSFKSECKAAINIKHRNIVRVFTA 209 (473)
Q Consensus 137 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~ 209 (473)
..-......+.+..+.||+|+||.||+|+.. +...||||.++..... ...+|++|++++..++|||||+++|+
T Consensus 478 ~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGV 557 (774)
T KOG1026|consen 478 LKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGV 557 (774)
T ss_pred cceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence 3334445566777889999999999999843 2467999999866555 66789999999999999999999999
Q ss_pred eeccccCCceeeEEEEEecCCCCHHHHhcCCCCCCCC-----CcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccC
Q 012014 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWR-----PLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNL 284 (473)
Q Consensus 210 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~-----~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dl 284 (473)
|... ...++|+|||..|||.+||......... +.+..++..+.+.|+.|||.|+.||- ++.+|||||
T Consensus 558 C~~~-----~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDL 629 (774)
T KOG1026|consen 558 CREG-----DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDL 629 (774)
T ss_pred EccC-----CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccch
Confidence 9654 3679999999999999999876543211 11334788999999999999999999 999999999
Q ss_pred CCCcEEecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCC
Q 012014 285 KPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363 (473)
Q Consensus 285 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~ 363 (473)
...|+||.++..|||+|||+++..-..+.........-..+|||||.+..+.||++||||||||+|||+++ |..||.+.
T Consensus 630 ATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~gl 709 (774)
T KOG1026|consen 630 ATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGL 709 (774)
T ss_pred hhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCccccc
Confidence 99999999999999999999986644332222111122568999999999999999999999999999999 99999986
Q ss_pred CCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChH
Q 012014 364 FTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKIN 443 (473)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 443 (473)
.+++.. +. +.... . .+.+.+||.++++||..||+.+|.+|||++
T Consensus 710 Sn~EVI--e~-----------i~~g~----------------------l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~ 753 (774)
T KOG1026|consen 710 SNQEVI--EC-----------IRAGQ----------------------L-LSCPENCPTEVYSLMLECWNENPKRRPSFK 753 (774)
T ss_pred chHHHH--HH-----------HHcCC----------------------c-ccCCCCCCHHHHHHHHHHhhcCcccCCCHH
Confidence 654320 00 00111 1 234567999999999999999999999999
Q ss_pred HHHHHHHHHHHh
Q 012014 444 DVESRLRLIRRK 455 (473)
Q Consensus 444 ev~~~L~~l~~~ 455 (473)
||-.+|+.+-..
T Consensus 754 eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 754 EIHSRLQAWAQA 765 (774)
T ss_pred HHHHHHHHHHhc
Confidence 999999988543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=350.61 Aligned_cols=280 Identities=21% Similarity=0.265 Sum_probs=210.6
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC--CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
.+.|+.+++||+|.||.||+|+ ..+|+.||+|++.... ........+||.||++|+||||+++.+...+. ....
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~~~s 192 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---LSGS 192 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---CCce
Confidence 4568889999999999999999 6789999999998544 45566788999999999999999999998764 2457
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
+|||+|||+. ||..++.... ..|++.++..++.||+.||+|+| ++||+|||||.+|||||++|.+||+
T Consensus 193 iYlVFeYMdh-DL~GLl~~p~--------vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKia 260 (560)
T KOG0600|consen 193 IYLVFEYMDH-DLSGLLSSPG--------VKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIA 260 (560)
T ss_pred EEEEEecccc-hhhhhhcCCC--------cccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEec
Confidence 8999999965 8988887653 25889999999999999999999 9999999999999999999999999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCccccCC-CCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcC
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP 379 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 379 (473)
|||+|+++.... ....+..+-|..|.|||++.|. .|+.++|+||.||||.||++|++.|.+...-+ .+..+.+..-.
T Consensus 261 DFGLAr~y~~~~-~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEve-Ql~kIfklcGS 338 (560)
T KOG0600|consen 261 DFGLARFYTPSG-SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVE-QLHKIFKLCGS 338 (560)
T ss_pred cccceeeccCCC-CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHH-HHHHHHHHhCC
Confidence 999999876544 2335555679999999999885 59999999999999999999999998743221 11222211111
Q ss_pred cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 380 QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.....+. ...+..+. .......-.....+.....+....+|+..+|..||.+|.|+.+++.
T Consensus 339 P~e~~W~-~~kLP~~~------~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 339 PTEDYWP-VSKLPHAT------IFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CChhccc-cccCCccc------ccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 1111010 00000000 0000000011122223456778889999999999999999988753
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-46 Score=320.70 Aligned_cols=276 Identities=19% Similarity=0.277 Sum_probs=209.5
Q ss_pred CCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCC--CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
.+|...++||+|.||.||+|+ ..+|+.||||+++.... +-.....+|++.|+.++|+||+.++++|.+.+ ..
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~-----~l 76 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKS-----NL 76 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCC-----ce
Confidence 468889999999999999999 67899999999985432 33456789999999999999999999986543 67
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEee
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~D 301 (473)
.||+||++ .+|...++.... .++..++..++.++++||+||| ++.|+||||||.|+|++.+|.+||+|
T Consensus 77 ~lVfEfm~-tdLe~vIkd~~i--------~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiAD 144 (318)
T KOG0659|consen 77 SLVFEFMP-TDLEVVIKDKNI--------ILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIAD 144 (318)
T ss_pred EEEEEecc-ccHHHHhccccc--------ccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeec
Confidence 89999995 599999987753 4778999999999999999999 99999999999999999999999999
Q ss_pred cccccccCccccccceeeccCCCCcCCCccccCC-CCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCc
Q 012014 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQ 380 (473)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 380 (473)
||+++.+........ ..+-|..|.|||.+.|. .|+..+|+||.|||+.||+.|.+-|.|..+-+ .+..+.+..-..
T Consensus 145 FGLAr~f~~p~~~~~--~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDid-QL~~If~~LGTP 221 (318)
T KOG0659|consen 145 FGLARFFGSPNRIQT--HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDID-QLSKIFRALGTP 221 (318)
T ss_pred ccchhccCCCCcccc--cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHH-HHHHHHHHcCCC
Confidence 999999876543322 22569999999998875 49999999999999999999988877644332 223333333222
Q ss_pred chhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 381 RAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
...++.+-.-+..+...+ ..+.+.... .-..+.....+|+..++.+||.+|+|++|.++.
T Consensus 222 ~~~~WP~~~~lpdY~~~~---~~P~~~~~~-----lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 222 TPDQWPEMTSLPDYVKIQ---QFPKPPLNN-----LFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred CcccCccccccccHHHHh---cCCCCcccc-----ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 222222211122222111 111111110 112345566899999999999999999998653
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-46 Score=355.40 Aligned_cols=256 Identities=21% Similarity=0.329 Sum_probs=206.5
Q ss_pred cccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeecc----CC-CCchhHHHHHHHHHhcC-CCCceeeeeeeeccc
Q 012014 142 NATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI----RP-GGSKSFKSECKAAINIK-HRNIVRVFTAFSGVD 214 (473)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~ 214 (473)
...++|.+.+.||+|+||.|+.|. ..++..||+|+++.. .. ...+.+.+|+.++++++ ||||++++.++...
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~- 92 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP- 92 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC-
Confidence 345789999999999999999998 567899999977643 11 23456778999999999 99999999998553
Q ss_pred cCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCC
Q 012014 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE 294 (473)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~ 294 (473)
...++|||||.||+|.+++.... .+.+.++..++.|+++|++||| ++||+||||||+|||++.+
T Consensus 93 ----~~~~ivmEy~~gGdL~~~i~~~g---------~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~ 156 (370)
T KOG0583|consen 93 ----TKIYIVMEYCSGGDLFDYIVNKG---------RLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGN 156 (370)
T ss_pred ----CeEEEEEEecCCccHHHHHHHcC---------CCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCC
Confidence 35899999999999999998854 3558899999999999999999 9999999999999999999
Q ss_pred -ccEEEeecccccccCccccccceeeccCCCCcCCCccccCCC-CC-cccchhhHhHHHHHHHhCCCCCCCCCCCcccHH
Q 012014 295 -MIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE-AS-TYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLR 371 (473)
Q Consensus 295 -~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~ 371 (473)
+++||+|||++.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|..||+.. +..
T Consensus 157 ~~~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~-----~~~ 229 (370)
T KOG0583|consen 157 EGNLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS-----NVP 229 (370)
T ss_pred CCCEEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc-----cHH
Confidence 999999999998764 2234455678999999999999977 75 7789999999999999999999862 111
Q ss_pred HHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHH-HHHHHHHhhhcccCCCCCCCChHHHHHHHH
Q 012014 372 NFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILEC-FNSICEIGVACSAERPRERMKINDVESRLR 450 (473)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 450 (473)
...+...... ...+... ..++..|+.+||..||.+|+|+.+|+ .-.
T Consensus 230 ~l~~ki~~~~--------------------------------~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~ 276 (370)
T KOG0583|consen 230 NLYRKIRKGE--------------------------------FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHP 276 (370)
T ss_pred HHHHHHhcCC--------------------------------ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hCh
Confidence 1111110000 0011112 55778999999999999999999998 555
Q ss_pred HHHH
Q 012014 451 LIRR 454 (473)
Q Consensus 451 ~l~~ 454 (473)
-++.
T Consensus 277 w~~~ 280 (370)
T KOG0583|consen 277 WFQK 280 (370)
T ss_pred hhcc
Confidence 5554
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=352.78 Aligned_cols=249 Identities=20% Similarity=0.294 Sum_probs=199.5
Q ss_pred cccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC---CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCC
Q 012014 142 NATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (473)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (473)
...++|+++++||+|+||.||+|+ ..+|..+|+|++++.. .+..+..+.|-.+|...++|+||++|..|.+
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD----- 212 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD----- 212 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC-----
Confidence 356899999999999999999999 5679999999998543 3455678899999999999999999999855
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccE
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~ 297 (473)
..++||||||++||++..+|...+ .|++..+..++.+++.|+..|| +.|+|||||||+|+|||..|++
T Consensus 213 ~~~LYLiMEylPGGD~mTLL~~~~---------~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHi 280 (550)
T KOG0605|consen 213 KEYLYLIMEYLPGGDMMTLLMRKD---------TLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHI 280 (550)
T ss_pred CCeeEEEEEecCCccHHHHHHhcC---------cCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCE
Confidence 448999999999999999998876 4668899999999999999999 9999999999999999999999
Q ss_pred EEeecccccccCcc----------------------ccc-----c------------------ceeeccCCCCcCCCccc
Q 012014 298 HVGDFGMARFLPAI----------------------DKQ-----N------------------RFICIKGSTGYIPPEYD 332 (473)
Q Consensus 298 kl~Dfg~~~~~~~~----------------------~~~-----~------------------~~~~~~gt~~y~aPE~~ 332 (473)
||+|||+++.+... ... . ...+.+|||.|||||++
T Consensus 281 KLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVl 360 (550)
T KOG0605|consen 281 KLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVL 360 (550)
T ss_pred eeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHH
Confidence 99999998543210 000 0 01235699999999999
Q ss_pred cCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcc
Q 012014 333 LGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSA 412 (473)
Q Consensus 333 ~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (473)
.+..|+..+|+||||||+||||.|.+||.+.....+ +..++..... +
T Consensus 361 l~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T-~rkI~nwr~~------l-------------------------- 407 (550)
T KOG0605|consen 361 LGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQET-YRKIVNWRET------L-------------------------- 407 (550)
T ss_pred hcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhhh------c--------------------------
Confidence 999999999999999999999999999987543321 1111111100 0
Q ss_pred hhhHHHHHHHHHHHHhhhcccCCCCCCCC
Q 012014 413 HASIILECFNSICEIGVACSAERPRERMK 441 (473)
Q Consensus 413 ~~~~~~~~~~~l~~l~~~cl~~dP~~RPt 441 (473)
..+....+..+..+||.+|+. ||+.|.-
T Consensus 408 ~fP~~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 408 KFPEEVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred cCCCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence 000111234677899999999 9999976
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-46 Score=359.21 Aligned_cols=270 Identities=24% Similarity=0.316 Sum_probs=204.8
Q ss_pred ccCCCCccceeecCCCeEEEEEEe------cCCCEEEEEEeeccCC-CCchhHHHHHHHHHhc-CCCCceeeeeeeeccc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTL------FDGTTIAVKVFNLIRP-GGSKSFKSECKAAINI-KHRNIVRVFTAFSGVD 214 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 214 (473)
..++|.+.++||+|+||.||+|.. .+++.||+|+++.... .....+.+|+.++..+ +||||++++++|...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP- 83 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC-
Confidence 456899999999999999999973 2356899999874322 2345688999999999 899999999987532
Q ss_pred cCCceeeEEEEEecCCCCHHHHhcCCCCCCC-------------------------------------------------
Q 012014 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTNW------------------------------------------------- 245 (473)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~------------------------------------------------- 245 (473)
....+++|||+++|+|.+++........
T Consensus 84 ---~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 84 ---NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred ---CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 2357899999999999999975421100
Q ss_pred ----CCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecccccccCccccccceeecc
Q 012014 246 ----RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIK 321 (473)
Q Consensus 246 ----~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 321 (473)
......+++.++..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++...............
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~ 237 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSAR 237 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCC
Confidence 000123668889999999999999999 9999999999999999999999999999998653322112222334
Q ss_pred CCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhh
Q 012014 322 GSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTM 400 (473)
Q Consensus 322 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (473)
+++.|+|||++.+..++.++|||||||++|||++ |..||.+...... +..... .....
T Consensus 238 ~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-~~~~~~---~~~~~----------------- 296 (338)
T cd05102 238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-FCQRLK---DGTRM----------------- 296 (338)
T ss_pred CCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-HHHHHh---cCCCC-----------------
Confidence 6788999999998899999999999999999997 9999976432211 000000 00000
Q ss_pred hcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHH
Q 012014 401 CMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRR 454 (473)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~ 454 (473)
..+..++..+.+|+.+||+.||++|||+.||++.|+.+..
T Consensus 297 --------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 297 --------------RAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred --------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0011245578899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=327.89 Aligned_cols=198 Identities=26% Similarity=0.386 Sum_probs=177.9
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCC---CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCce
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP---GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (473)
.++|+..+.||.|+||.|.+++ ..+|.-+|+|++++..- ...+...+|..+|+.+.||+++++++.|.+. .
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~-----~ 117 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDN-----S 117 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccC-----C
Confidence 3578899999999999999999 66789999999975332 2345678999999999999999999998654 4
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
.+++||||++||.|..++++.+ .|++..+.-++.||+.||+||| +++|++|||||+|||+|.+|.+||
T Consensus 118 ~lymvmeyv~GGElFS~Lrk~~---------rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKi 185 (355)
T KOG0616|consen 118 NLYMVMEYVPGGELFSYLRKSG---------RFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKI 185 (355)
T ss_pred eEEEEEeccCCccHHHHHHhcC---------CCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEE
Confidence 7899999999999999999876 4778899999999999999999 999999999999999999999999
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCC
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 363 (473)
+|||+|+... ..+.+.+|||.|+|||++...+|+.++|.|||||++|||+.|.+||...
T Consensus 186 tDFGFAK~v~-----~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~ 244 (355)
T KOG0616|consen 186 TDFGFAKRVS-----GRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDD 244 (355)
T ss_pred EeccceEEec-----CcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCC
Confidence 9999999763 3366789999999999999999999999999999999999999999764
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=354.55 Aligned_cols=257 Identities=24% Similarity=0.365 Sum_probs=210.9
Q ss_pred cccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 142 NATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
.........+-||+|+.|.||+|++ .++.||||+++.. -..+|+-|++|+||||+.+.|+|... ..+
T Consensus 121 iPFe~IsELeWlGSGaQGAVF~Grl-~netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqs-----Pcy 187 (904)
T KOG4721|consen 121 IPFEEISELEWLGSGAQGAVFLGRL-HNETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQS-----PCY 187 (904)
T ss_pred CCHHHhhhhhhhccCcccceeeeec-cCceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCC-----cee
Confidence 3333344567799999999999996 5689999987632 24678889999999999999999653 478
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEee
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~D 301 (473)
|||||||+.|-|...|+.... ++......|..+||.|+.||| .+.|||||||.-||||..+..+||+|
T Consensus 188 CIiMEfCa~GqL~~VLka~~~---------itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsD 255 (904)
T KOG4721|consen 188 CIIMEFCAQGQLYEVLKAGRP---------ITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISD 255 (904)
T ss_pred EEeeeccccccHHHHHhccCc---------cCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEecc
Confidence 999999999999999988763 446778899999999999999 99999999999999999999999999
Q ss_pred cccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcc
Q 012014 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQR 381 (473)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 381 (473)
||.++..... .....++||..|||||++.+.+.+.|+||||||||||||+||..||.........
T Consensus 256 FGTS~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII------------ 320 (904)
T KOG4721|consen 256 FGTSKELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII------------ 320 (904)
T ss_pred ccchHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE------------
Confidence 9999877553 3345678999999999999999999999999999999999999999764332210
Q ss_pred hhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHHhhccCCc
Q 012014 382 AEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRKLLETPA 461 (473)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~~~~~~~ 461 (473)
.+.-.-++.-..+..|++.+.=|++.||+-.|..|||+.+|+..|+-....+.....
T Consensus 321 -----------------------wGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell~~te 377 (904)
T KOG4721|consen 321 -----------------------WGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELLSTTE 377 (904)
T ss_pred -----------------------EeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHhcccH
Confidence 001111222334557899999999999999999999999999999888766655543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=351.69 Aligned_cols=246 Identities=25% Similarity=0.393 Sum_probs=205.3
Q ss_pred CCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCC--CchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
++|.+.+.||+|+||.||+|+ ..+.+.||+|.+.+.... ..+.+.+|++|++.++|||||.++++| ++..+.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~~ 76 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAHL 76 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccceE
Confidence 478888999999999999999 667899999998754332 345689999999999999999999997 445689
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEee
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~D 301 (473)
|+|+|||.| +|..+|...+ .++++.+..++.|++.||.||| +++|+|||+||.|||++.+|++|++|
T Consensus 77 ~vVte~a~g-~L~~il~~d~---------~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~Klcd 143 (808)
T KOG0597|consen 77 WVVTEYAVG-DLFTILEQDG---------KLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCD 143 (808)
T ss_pred EEEehhhhh-hHHHHHHhcc---------CCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeech
Confidence 999999965 9999998776 4679999999999999999999 99999999999999999999999999
Q ss_pred cccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcc
Q 012014 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQR 381 (473)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 381 (473)
||+|+.... .....+...|||-|||||+..+.+|+..+|.||+||++||+++|++||... .+.+.++....+.
T Consensus 144 Fg~Ar~m~~--~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-----si~~Lv~~I~~d~ 216 (808)
T KOG0597|consen 144 FGLARAMST--NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-----SITQLVKSILKDP 216 (808)
T ss_pred hhhhhhccc--CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-----HHHHHHHHHhcCC
Confidence 999997654 344566788999999999999999999999999999999999999999641 1222222221111
Q ss_pred hhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 382 AEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
+ ..+......+..++...|.+||..|.|..+++.
T Consensus 217 v--------------------------------~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 217 V--------------------------------KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred C--------------------------------CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 0 011245667888999999999999999999864
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=344.29 Aligned_cols=249 Identities=22% Similarity=0.300 Sum_probs=205.3
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
...|...++||+|+||.||+|. ..+++.||+|++..... ...+.+++|+.++..++++||.++|+.|... ..+
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g-----~~L 86 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG-----TKL 86 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeec-----ccH
Confidence 3457777999999999999999 66789999999986543 3457789999999999999999999998653 378
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEee
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~D 301 (473)
+++||||.||++.+.++.... +.+..+.-++++++.||.||| .++.+|||||+.|||+..+|.+||+|
T Consensus 87 wiiMey~~gGsv~~lL~~~~~---------~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~D 154 (467)
T KOG0201|consen 87 WIIMEYCGGGSVLDLLKSGNI---------LDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLAD 154 (467)
T ss_pred HHHHHHhcCcchhhhhccCCC---------CccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEe
Confidence 999999999999999987653 235556668999999999999 99999999999999999999999999
Q ss_pred cccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcc
Q 012014 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQR 381 (473)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 381 (473)
||.+..+..... ...++.||+.|||||++.+..|+.|+||||||++.+||++|.+|+........ ...+|..
T Consensus 155 fgVa~ql~~~~~--rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv------lflIpk~ 226 (467)
T KOG0201|consen 155 FGVAGQLTNTVK--RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV------LFLIPKS 226 (467)
T ss_pred cceeeeeechhh--ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE------EEeccCC
Confidence 999987755432 22567899999999999988999999999999999999999999987544221 1112222
Q ss_pred hhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 382 AEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
....++ ..+...+++++..||++||+.||||.++++
T Consensus 227 ~PP~L~------------------------------~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 227 APPRLD------------------------------GDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CCCccc------------------------------cccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 222222 135667899999999999999999999875
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=340.37 Aligned_cols=261 Identities=20% Similarity=0.299 Sum_probs=199.7
Q ss_pred cccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCC--------------CCchhHHHHHHHHHhcCCCCceee
Q 012014 142 NATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--------------GGSKSFKSECKAAINIKHRNIVRV 206 (473)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~~ 206 (473)
...|+|++.+.||+|.||.|-+|. ..+++.||||++.+... ...+...+|+.+|+++.|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 456889999999999999999999 56799999999964221 112478899999999999999999
Q ss_pred eeeeeccccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCC
Q 012014 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKP 286 (473)
Q Consensus 207 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp 286 (473)
+.+..+.. ...+|||+|||..|.+...=... ..+++.++++++++++.||+||| .+|||||||||
T Consensus 174 iEvLDDP~---s~~~YlVley~s~G~v~w~p~d~---------~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKP 238 (576)
T KOG0585|consen 174 IEVLDDPE---SDKLYLVLEYCSKGEVKWCPPDK---------PELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKP 238 (576)
T ss_pred EEeecCcc---cCceEEEEEeccCCccccCCCCc---------ccccHHHHHHHHHHHHHHHHHHH---hcCeeccccch
Confidence 99976543 56789999999888774321111 12779999999999999999999 99999999999
Q ss_pred CcEEecCCccEEEeecccccccCcccc---ccceeeccCCCCcCCCccccCCC----CCcccchhhHhHHHHHHHhCCCC
Q 012014 287 SNVLLDDEMIGHVGDFGMARFLPAIDK---QNRFICIKGSTGYIPPEYDLGCE----ASTYGDVYSFGILLLEMFTGIRP 359 (473)
Q Consensus 287 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~elltg~~P 359 (473)
+|+|++++|++||+|||.+........ ........|||.|+|||...++. -+.+.||||+||+||.|+.|+.|
T Consensus 239 sNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~P 318 (576)
T KOG0585|consen 239 SNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLP 318 (576)
T ss_pred hheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCC
Confidence 999999999999999999987633211 11223367999999999987732 35677999999999999999999
Q ss_pred CCCCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCC
Q 012014 360 SDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRER 439 (473)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 439 (473)
|.+.+.-+ .+ ..+....+ ..+...+....+.+|+.++|.+||+.|
T Consensus 319 F~~~~~~~----l~---------~KIvn~pL----------------------~fP~~pe~~e~~kDli~~lL~KdP~~R 363 (576)
T KOG0585|consen 319 FFDDFELE----LF---------DKIVNDPL----------------------EFPENPEINEDLKDLIKRLLEKDPEQR 363 (576)
T ss_pred cccchHHH----HH---------HHHhcCcc----------------------cCCCcccccHHHHHHHHHHhhcChhhe
Confidence 97532111 00 11111100 001112456688899999999999999
Q ss_pred CChHHHHHHHHHH
Q 012014 440 MKINDVESRLRLI 452 (473)
Q Consensus 440 Pt~~ev~~~L~~l 452 (473)
.+..+|....--.
T Consensus 364 i~l~~ik~Hpwvt 376 (576)
T KOG0585|consen 364 ITLPDIKLHPWVT 376 (576)
T ss_pred eehhhheecceec
Confidence 9999987655433
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=338.03 Aligned_cols=251 Identities=21% Similarity=0.315 Sum_probs=199.6
Q ss_pred cceeecCCCeEEEEEEecCCCEEEEEEeeccCCCC---chhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEEEE
Q 012014 150 ANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGG---SKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYK 226 (473)
Q Consensus 150 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 226 (473)
...||+|++|.||+|.. +|+.||||.++...... .+.+.+|+.++.+++||||+++++++.+.. ......++|||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~E 102 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILE 102 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEE
Confidence 36799999999999986 78999999997544333 356789999999999999999999986521 22346799999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCC-CCeeeccCCCCcEEecCCccEEEeecccc
Q 012014 227 FMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQ-PPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (473)
Q Consensus 227 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~ 305 (473)
|+++|+|.+++.... .+++.....++.|++.||.||| + .+++||||||+||++++++.+||+|||++
T Consensus 103 y~~~g~L~~~l~~~~---------~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~ 170 (283)
T PHA02988 103 YCTRGYLREVLDKEK---------DLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTENYKLKIICHGLE 170 (283)
T ss_pred eCCCCcHHHHHhhCC---------CCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCCCcEEEcccchH
Confidence 999999999997654 3557888999999999999999 6 48999999999999999999999999999
Q ss_pred cccCccccccceeeccCCCCcCCCccccC--CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchh
Q 012014 306 RFLPAIDKQNRFICIKGSTGYIPPEYDLG--CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAE 383 (473)
Q Consensus 306 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 383 (473)
+...... ....||..|+|||++.+ ..++.++|||||||++|||++|..||.+.... ............
T Consensus 171 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~-----~~~~~i~~~~~~ 240 (283)
T PHA02988 171 KILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK-----EIYDLIINKNNS 240 (283)
T ss_pred hhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHhcCCC
Confidence 8653321 23457899999999876 67999999999999999999999999754211 111111000000
Q ss_pred hhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHH
Q 012014 384 EVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRR 454 (473)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~ 454 (473)
...+..++..+.+|+.+||+.||++|||++||++.|+.++.
T Consensus 241 ------------------------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 241 ------------------------------LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred ------------------------------CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 00111356688999999999999999999999999998853
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=329.25 Aligned_cols=290 Identities=20% Similarity=0.269 Sum_probs=215.4
Q ss_pred hhhcccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEee--ccCCCCchhHHHHHHHHHhcCCCCceeeeeeeecccc
Q 012014 139 DLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFN--LIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY 215 (473)
Q Consensus 139 ~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 215 (473)
+.......|...+.||+|+||.|+.|. ..+|+.||||++. .......++..+|+++|+.++|+||+.+++++.....
T Consensus 16 ~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 16 ELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR 95 (359)
T ss_pred eEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence 444556677778999999999999998 6689999999987 3444456778899999999999999999999977555
Q ss_pred CCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCc
Q 012014 216 QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM 295 (473)
Q Consensus 216 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~ 295 (473)
..-...|+|+|+| +.+|.+.++... .++...+..++.||++||.|+| +.+|+||||||+|+|++.+.
T Consensus 96 ~~f~DvYiV~elM-etDL~~iik~~~---------~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c 162 (359)
T KOG0660|consen 96 DKFNDVYLVFELM-ETDLHQIIKSQQ---------DLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADC 162 (359)
T ss_pred cccceeEEehhHH-hhHHHHHHHcCc---------cccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCC
Confidence 6677899999999 779999998875 3668888999999999999999 99999999999999999999
Q ss_pred cEEEeecccccccCccccccceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 012014 296 IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFV 374 (473)
Q Consensus 296 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~ 374 (473)
.+||+|||+|+...........+...-|..|.|||++.. ..|+.+.||||.|||+.||++|++-|.|...-. .+..+
T Consensus 163 ~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~-Ql~lI- 240 (359)
T KOG0660|consen 163 DLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVH-QLQLI- 240 (359)
T ss_pred CEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHH-HHHHH-
Confidence 999999999998754322233344557999999998765 569999999999999999999999998743221 11212
Q ss_pred HhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 375 KMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
....+..-.+.+............+..+...... ....-........+|+.+||..||.+|+|++|.++
T Consensus 241 ~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~----f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 241 LELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQP----FSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCC----HHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 2222211111111111111111111111111111 11222345667889999999999999999999865
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=353.20 Aligned_cols=244 Identities=23% Similarity=0.271 Sum_probs=201.0
Q ss_pred cccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC---CCCchhHHHHHHHHHhcC-CCCceeeeeeeeccccC
Q 012014 142 NATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQ 216 (473)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 216 (473)
...++|...++||+|+||.|+++. ..+++.+|||++++.. ..+.+....|.+|+...+ ||++++++.+| +
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f-----Q 439 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF-----Q 439 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc-----c
Confidence 345789999999999999999999 5678999999998543 445677889999988775 99999999997 4
Q ss_pred CceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCcc
Q 012014 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI 296 (473)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~ 296 (473)
+..++|+||||+.||++..+.+.. .|++..+.-+++.|+.||.||| ++||||||||.+|||+|.+|+
T Consensus 440 T~~~l~fvmey~~Ggdm~~~~~~~----------~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh 506 (694)
T KOG0694|consen 440 TKEHLFFVMEYVAGGDLMHHIHTD----------VFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGH 506 (694)
T ss_pred cCCeEEEEEEecCCCcEEEEEecc----------cccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCc
Confidence 556899999999999955444433 4779999999999999999999 999999999999999999999
Q ss_pred EEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 012014 297 GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKM 376 (473)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~ 376 (473)
+||+|||+++..- .....+.+++|||.|||||++.+..|+.++|+|||||+||||+.|..||.+....
T Consensus 507 ~kiADFGlcKe~m--~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe---------- 574 (694)
T KOG0694|consen 507 VKIADFGLCKEGM--GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE---------- 574 (694)
T ss_pred EEecccccccccC--CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH----------
Confidence 9999999998643 2345667889999999999999999999999999999999999999999874322
Q ss_pred hcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCCh
Q 012014 377 ALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKI 442 (473)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 442 (473)
++.+..+.... -.+..++.+..+++.+.|..||++|.-+
T Consensus 575 -------e~FdsI~~d~~--------------------~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 575 -------EVFDSIVNDEV--------------------RYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -------HHHHHHhcCCC--------------------CCCCcccHHHHHHHHHHhccCcccccCC
Confidence 12221111110 0122356678899999999999999866
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=349.66 Aligned_cols=248 Identities=21% Similarity=0.303 Sum_probs=207.3
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC---CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCce
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (473)
.+-|++++.||.|+-|.|-+|+ ..+|+.+|||++.+.. ......+.+|+.+|+.+.|||++++|+++ ++..
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-----e~~~ 85 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-----ENKQ 85 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-----ccCc
Confidence 3568899999999999999999 5689999999997542 22345688999999999999999999996 4456
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
++|+|.||+++|.|++++..++ .+++.++.+++.||+.|+.|+| ..+|+||||||+|+|+|..+++||
T Consensus 86 ~lylvlEyv~gGELFdylv~kG---------~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKI 153 (786)
T KOG0588|consen 86 HLYLVLEYVPGGELFDYLVRKG---------PLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKI 153 (786)
T ss_pred eEEEEEEecCCchhHHHHHhhC---------CCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEee
Confidence 8999999999999999998887 4668999999999999999999 999999999999999999999999
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccCCCC-CcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEA-STYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMAL 378 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~ 378 (473)
+|||+|..-.. .....+.||+|.|.|||++.|.+| +.++||||.|||||.|+||+.||++ .+++..+....
T Consensus 154 ADFGMAsLe~~---gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD-----dNir~LLlKV~ 225 (786)
T KOG0588|consen 154 ADFGMASLEVP---GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD-----DNIRVLLLKVQ 225 (786)
T ss_pred eccceeecccC---CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC-----ccHHHHHHHHH
Confidence 99999976432 344556789999999999999887 5789999999999999999999984 33444332221
Q ss_pred CcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 379 PQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
.+. .+.+...+.+..+|+.+|+..||+.|.|++||++.
T Consensus 226 ~G~--------------------------------f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 226 RGV--------------------------------FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred cCc--------------------------------ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 111 11223456677899999999999999999999764
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-45 Score=374.14 Aligned_cols=278 Identities=24% Similarity=0.351 Sum_probs=219.1
Q ss_pred cCCCCccceeecCCCeEEEEEEecC--CC----EEEEEEeeccC-CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccC
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTLFD--GT----TIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQ 216 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 216 (473)
..+......||+|+||.||.|...+ +. .||+|.++... ......|.+|..+|+.++|||||+++|++.+.
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~--- 767 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS--- 767 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC---
Confidence 3445677889999999999998432 33 48889887543 34456799999999999999999999999763
Q ss_pred CceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCcc
Q 012014 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI 296 (473)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~ 296 (473)
...+|++|||++|+|..||++.+.....+ ..++..+.+.++.|||+|+.||+ ++++|||||..+|+|++....
T Consensus 768 --~~~~i~leyM~gGDL~sflr~~r~~~~~~--~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~ 840 (1025)
T KOG1095|consen 768 --GPPLILLEYMEGGDLLSFLRESRPAPFQP--SNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRV 840 (1025)
T ss_pred --CCcEEEehhcccCcHHHHHHhcccccCCC--CCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCc
Confidence 36799999999999999999886554442 35778999999999999999999 999999999999999999999
Q ss_pred EEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHH
Q 012014 297 GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVK 375 (473)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~ 375 (473)
+||+|||+|+.+-..+.........-...|||||.+..+.++.|+|||||||++||++| |..||.+..+.+.. .
T Consensus 841 VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~--~--- 915 (1025)
T KOG1095|consen 841 VKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVL--L--- 915 (1025)
T ss_pred EEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHH--H---
Confidence 99999999995433221111111112357999999999999999999999999999999 99999864332210 0
Q ss_pred hhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHHh
Q 012014 376 MALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRK 455 (473)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~ 455 (473)
....+. +-+.+..|+..++++|..||+.+|++||++..|++++..+...
T Consensus 916 ~~~~gg-------------------------------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 916 DVLEGG-------------------------------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred HHHhCC-------------------------------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 000000 1223457999999999999999999999999999999999887
Q ss_pred hccCCcccccCC
Q 012014 456 LLETPACLEVKQ 467 (473)
Q Consensus 456 ~~~~~~~~~~~~ 467 (473)
............
T Consensus 965 ~~~~~~~~~~a~ 976 (1025)
T KOG1095|consen 965 ALGTIYGPLPAD 976 (1025)
T ss_pred hccCcccccccc
Confidence 776655444333
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-45 Score=329.37 Aligned_cols=248 Identities=20% Similarity=0.324 Sum_probs=207.1
Q ss_pred ccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCC---CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP---GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
...+|++.+.||+|.||.|-+|. ...|+.||||.+++... .+.-.+++|++||+.|+||||+.+|.+|.. .
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFEN-----k 125 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFEN-----K 125 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcC-----C
Confidence 34679999999999999999998 57899999999975433 334568899999999999999999999854 4
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
....|||||..+|.|.+|+...+ .+++.++..+++||.+|+.|+| .++++|||||.+|||+|.++++|
T Consensus 126 dKIvivMEYaS~GeLYDYiSer~---------~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiK 193 (668)
T KOG0611|consen 126 DKIVIVMEYASGGELYDYISERG---------SLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIK 193 (668)
T ss_pred ceEEEEEEecCCccHHHHHHHhc---------cccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCee
Confidence 47899999999999999998876 5779999999999999999999 99999999999999999999999
Q ss_pred EeecccccccCccccccceeeccCCCCcCCCccccCCCC-CcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEA-STYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
|+|||++..+.. .....+++|+|-|.+||+..+.+| ++.+|-|||||+||-|+.|..||+|.. ...+++..
T Consensus 194 IADFGLSNly~~---~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D-----hk~lvrQI 265 (668)
T KOG0611|consen 194 IADFGLSNLYAD---KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD-----HKRLVRQI 265 (668)
T ss_pred eeccchhhhhcc---ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch-----HHHHHHHh
Confidence 999999987754 344567889999999999999887 578999999999999999999999842 22222222
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
..+...+ ++.+....-||.+||..||++|-|+.+|+..
T Consensus 266 s~GaYrE---------------------------------P~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 266 SRGAYRE---------------------------------PETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred hcccccC---------------------------------CCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 2111111 1234455679999999999999999998764
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=320.54 Aligned_cols=278 Identities=21% Similarity=0.228 Sum_probs=206.0
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC--CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
.+.|+..+.|++|+||.||+|+ ..+++.||+|+++... .+..-.-.+|+.+|.+++|||||.+-.+..+.+. ..
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~---d~ 151 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNM---DK 151 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccc---ce
Confidence 3568889999999999999999 6779999999998433 2223346899999999999999999999887553 35
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.|+|||||+. +|..++..... .|+..++..++.|+++|++||| .+.|+||||||+|+|+++.|.+||+
T Consensus 152 iy~VMe~~Eh-DLksl~d~m~q--------~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKia 219 (419)
T KOG0663|consen 152 IYIVMEYVEH-DLKSLMETMKQ--------PFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIA 219 (419)
T ss_pred eeeeHHHHHh-hHHHHHHhccC--------CCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEec
Confidence 8999999965 99999987652 4778999999999999999999 9999999999999999999999999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCccccCCC-CCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc-
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE-ASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMAL- 378 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~- 378 (473)
|||+|+.++... ...+...-|..|.|||.+.+.. |+++.|+||+|||+.||+++++-|.|...-+. +..+.+..-
T Consensus 220 DFGLAR~ygsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQ-l~~If~llGt 296 (419)
T KOG0663|consen 220 DFGLAREYGSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQ-LDKIFKLLGT 296 (419)
T ss_pred ccchhhhhcCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHH-HHHHHHHhCC
Confidence 999999886642 2344455699999999988864 99999999999999999999999988544332 222222221
Q ss_pred C-cc-hhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHH-HHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 379 P-QR-AEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILE-CFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 379 ~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
| +. +...........+... ...-..++..+... ..+.-.+|+...|.+||.+|.|+.|-++
T Consensus 297 Pte~iwpg~~~lp~~k~~~f~--------~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 297 PSEAIWPGYSELPAVKKMTFS--------EHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred CccccCCCccccchhhccccC--------CCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 1 11 1111110000000000 00000111111111 3456678999999999999999998754
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=329.07 Aligned_cols=285 Identities=21% Similarity=0.256 Sum_probs=206.7
Q ss_pred CCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEE
Q 012014 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVV 224 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 224 (473)
.|...+++|.|+||.||+|. ..+++.||||++-.. .+.-.+|+++|+.++|||||++..+|......+.-+..+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d----~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQD----KRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCC----CCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 46778999999999999999 456799999997532 2233579999999999999999998876543324467799
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCC-ccEEEeecc
Q 012014 225 YKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE-MIGHVGDFG 303 (473)
Q Consensus 225 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~-~~~kl~Dfg 303 (473)
|||++. +|.++++.....+ ..++.-.+.-+..||.+||.||| +.||+||||||.|+|+|.+ |.+||||||
T Consensus 101 leymP~-tL~~~~r~~~~~~-----~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFG 171 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRAN-----QRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFG 171 (364)
T ss_pred HHhchH-HHHHHHHHHhhcC-----CCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCC
Confidence 999976 9999998532111 13445667779999999999999 8999999999999999976 899999999
Q ss_pred cccccCccccccceeeccCCCCcCCCccccCC-CCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcch
Q 012014 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRA 382 (473)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 382 (473)
.|+.+........ ...|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|.|.. +...+..+++..-.+..
T Consensus 172 SAK~L~~~epniS---YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s-~~dQL~eIik~lG~Pt~ 247 (364)
T KOG0658|consen 172 SAKVLVKGEPNIS---YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDS-SVDQLVEIIKVLGTPTR 247 (364)
T ss_pred cceeeccCCCcee---EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCC-HHHHHHHHHHHhCCCCH
Confidence 9998876554432 3358999999998875 59999999999999999999999999843 33445555555443333
Q ss_pred hhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH--HHHHHHH
Q 012014 383 EEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES--RLRLIRR 454 (473)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~--~L~~l~~ 454 (473)
+++..-..... + ...+......+.. -.....+++..+|+.++|.++|.+|.|+.|++. ....++.
T Consensus 248 e~I~~mn~~y~-~---~~~p~ik~~~~~~---~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 248 EDIKSMNPNYT-E---FKFPQIKAHPWHK---VFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred HHHhhcCcccc-c---ccCccccccccee---ecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 33221110000 0 0000011111000 122346778899999999999999999998873 3444443
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-44 Score=348.08 Aligned_cols=268 Identities=24% Similarity=0.293 Sum_probs=202.6
Q ss_pred cccCCCCccceeecCCCeEEEEEEe------cCCCEEEEEEeeccC-CCCchhHHHHHHHHHhc-CCCCceeeeeeeecc
Q 012014 142 NATNGFSSANLIGAGNFGSVYNGTL------FDGTTIAVKVFNLIR-PGGSKSFKSECKAAINI-KHRNIVRVFTAFSGV 213 (473)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 213 (473)
...++|++.+.||+|+||.||+|.+ .++..||||+++... ....+.+.+|+.++..+ +||||++++++|.+.
T Consensus 32 ~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 32 FPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred cchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 3456799999999999999999963 235689999987432 22345688999999999 899999999998553
Q ss_pred ccCCceeeEEEEEecCCCCHHHHhcCCCCCCC------------------------------------------------
Q 012014 214 DYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW------------------------------------------------ 245 (473)
Q Consensus 214 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~------------------------------------------------ 245 (473)
...++|||||++|+|.+++........
T Consensus 112 -----~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 186 (375)
T cd05104 112 -----GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKR 186 (375)
T ss_pred -----CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccc
Confidence 357999999999999999975431100
Q ss_pred ------------------CCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecccccc
Q 012014 246 ------------------RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF 307 (473)
Q Consensus 246 ------------------~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 307 (473)
......+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++.
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~ 263 (375)
T cd05104 187 RSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARD 263 (375)
T ss_pred cccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCcccee
Confidence 000123668889999999999999999 99999999999999999999999999999986
Q ss_pred cCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcCcchhhhc
Q 012014 308 LPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMALPQRAEEVV 386 (473)
Q Consensus 308 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (473)
..............++..|+|||++.+..++.++|||||||++|||++ |..||........ +...+......
T Consensus 264 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~-~~~~~~~~~~~------ 336 (375)
T cd05104 264 IRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK-FYKMIKEGYRM------ 336 (375)
T ss_pred ccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH-HHHHHHhCccC------
Confidence 543322111122335677999999999999999999999999999998 8999876432211 11111100000
Q ss_pred cccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHH
Q 012014 387 DDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLI 452 (473)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l 452 (473)
..+...+.++.+|+.+||+.||++|||+.||++.|+..
T Consensus 337 ----------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 337 ----------------------------LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ----------------------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 00011345788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-45 Score=349.16 Aligned_cols=270 Identities=23% Similarity=0.352 Sum_probs=213.2
Q ss_pred chhhhhcccCCCCccceeecCCCeEEEEEEecC--C---CEEEEEEeeccC---CCCchhHHHHHHHHHhcCCCCceeee
Q 012014 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTLFD--G---TTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVF 207 (473)
Q Consensus 136 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~--~---~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~ 207 (473)
.-+.|+...++-...++||+|+||.||+|.+.. + ..||+|..+... ......|.+|+++|++++|||||++|
T Consensus 148 ~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~y 227 (474)
T KOG0194|consen 148 PRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFY 227 (474)
T ss_pred cccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence 344566677778888999999999999998432 2 238999987422 34456799999999999999999999
Q ss_pred eeeeccccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCC
Q 012014 208 TAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPS 287 (473)
Q Consensus 208 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~ 287 (473)
|++... ..+++|||+|+||+|.++|+.... .++..+++.++.+.|.||+||| ++++|||||-.+
T Consensus 228 GVa~~~-----~Pl~ivmEl~~gGsL~~~L~k~~~--------~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAAR 291 (474)
T KOG0194|consen 228 GVAVLE-----EPLMLVMELCNGGSLDDYLKKNKK--------SLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAAR 291 (474)
T ss_pred EEEcCC-----CccEEEEEecCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHH
Confidence 998653 367999999999999999998764 3668999999999999999999 999999999999
Q ss_pred cEEecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCC
Q 012014 288 NVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTG 366 (473)
Q Consensus 288 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~ 366 (473)
|+|++.++.+||+|||+++.-....... ....-...|+|||.+....|+.++|||||||++||+++ |..||.+....
T Consensus 292 NcL~~~~~~vKISDFGLs~~~~~~~~~~--~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~ 369 (474)
T KOG0194|consen 292 NCLYSKKGVVKISDFGLSRAGSQYVMKK--FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY 369 (474)
T ss_pred HheecCCCeEEeCccccccCCcceeecc--ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH
Confidence 9999999999999999987543111111 01123578999999999999999999999999999999 89999875432
Q ss_pred cccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHH
Q 012014 367 KMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVE 446 (473)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~ 446 (473)
+ ....+. ..+.++ ..+...+..+..++..||..||++||||.++.
T Consensus 370 ~--v~~kI~-------------------~~~~r~--------------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~ 414 (474)
T KOG0194|consen 370 E--VKAKIV-------------------KNGYRM--------------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIK 414 (474)
T ss_pred H--HHHHHH-------------------hcCccC--------------CCCCCCHHHHHHHHHHhccCChhhccCHHHHH
Confidence 1 111110 000100 11224577888999999999999999999999
Q ss_pred HHHHHHHHhhcc
Q 012014 447 SRLRLIRRKLLE 458 (473)
Q Consensus 447 ~~L~~l~~~~~~ 458 (473)
+.|+.+......
T Consensus 415 ~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 415 KKLEALEKKKEA 426 (474)
T ss_pred HHHHHHHhcccc
Confidence 999999876553
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-44 Score=348.01 Aligned_cols=269 Identities=24% Similarity=0.323 Sum_probs=203.3
Q ss_pred hcccCCCCccceeecCCCeEEEEEEec------CCCEEEEEEeeccCC-CCchhHHHHHHHHHhc-CCCCceeeeeeeec
Q 012014 141 YNATNGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRP-GGSKSFKSECKAAINI-KHRNIVRVFTAFSG 212 (473)
Q Consensus 141 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 212 (473)
....++|++.+.||+|+||.||+|+.. ++..||+|+++.... .....+.+|+.+++.+ +||||++++++|.+
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 344567999999999999999998731 235799999874332 2345688999999999 89999999999854
Q ss_pred cccCCceeeEEEEEecCCCCHHHHhcCCCCCC------------------------------------------------
Q 012014 213 VDYQGARFKAVVYKFMPNGSLEEWLRGKDDTN------------------------------------------------ 244 (473)
Q Consensus 213 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~------------------------------------------------ 244 (473)
. ...++||||+++|+|.+++.......
T Consensus 114 ~-----~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (374)
T cd05106 114 G-----GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS 188 (374)
T ss_pred C-----CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcc
Confidence 3 36799999999999999986432100
Q ss_pred -------------CCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecccccccCcc
Q 012014 245 -------------WRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAI 311 (473)
Q Consensus 245 -------------~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 311 (473)
.......+++.+++.++.||+.||.||| +++|+||||||+|||+++++.+||+|||+++.....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~ 265 (374)
T cd05106 189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265 (374)
T ss_pred ccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCC
Confidence 0011124678889999999999999999 999999999999999999999999999999865432
Q ss_pred ccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcCcchhhhccccc
Q 012014 312 DKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDDFN 390 (473)
Q Consensus 312 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (473)
..........++..|+|||++.+..++.++|||||||++|+|++ |..||....... .+...........
T Consensus 266 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~~~~~~~~--------- 335 (374)
T cd05106 266 SNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMVKRGYQMS--------- 335 (374)
T ss_pred cceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHHHcccCcc---------
Confidence 21111122235678999999988899999999999999999997 999997643221 1111111000000
Q ss_pred hHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHH
Q 012014 391 LQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLI 452 (473)
Q Consensus 391 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l 452 (473)
.+...+.++.+++.+||+.||++|||+.+|++.|+.+
T Consensus 336 -------------------------~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 336 -------------------------RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred -------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0011245788999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=307.64 Aligned_cols=249 Identities=22% Similarity=0.369 Sum_probs=207.3
Q ss_pred ccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeecc---CCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
..++|++++.||+|.||.||.|+ ..++..||+|++.+. ......++.+|++|-+.|+||||+++|++|.+ .
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd-----~ 94 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD-----S 94 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheec-----c
Confidence 45789999999999999999999 667889999998643 23445678999999999999999999999865 3
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...||++||.++|+|...|...... .|.+.....++.|+|.||.|+| .+++|||||||+|+|++..+.+|
T Consensus 95 ~riyLilEya~~gel~k~L~~~~~~-------~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lk 164 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQEGRMK-------RFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELK 164 (281)
T ss_pred ceeEEEEEecCCchHHHHHHhcccc-------cccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCee
Confidence 4789999999999999999855433 3667888899999999999999 99999999999999999999999
Q ss_pred EeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 012014 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMAL 378 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~ 378 (473)
|+|||.+...+ .....+.+||..|.+||+..+..++..+|+|++|++.||++.|.+||.... ....+..+.+...
T Consensus 165 iAdfGwsV~~p----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k~~~ 239 (281)
T KOG0580|consen 165 IADFGWSVHAP----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRKVDL 239 (281)
T ss_pred ccCCCceeecC----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHHccc
Confidence 99999997543 344566789999999999999999999999999999999999999998754 2222222222111
Q ss_pred CcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 379 PQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
. .+...+....+|+.+|+..+|.+|.+..|++.
T Consensus 240 ~------------------------------------~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 240 K------------------------------------FPSTISGGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred c------------------------------------CCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence 0 11234557778999999999999999999875
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=337.39 Aligned_cols=270 Identities=21% Similarity=0.270 Sum_probs=199.8
Q ss_pred cCCCCccceeecCCCeEEEEEEecC-----------------CCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCcee
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTLFD-----------------GTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVR 205 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~ 205 (473)
.++|.+.++||+|+||.||+|.+.+ +..||+|.+..... .....+.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 4578899999999999999997432 34699999874322 22356889999999999999999
Q ss_pred eeeeeeccccCCceeeEEEEEecCCCCHHHHhcCCCCCCC----------CCcchhhcHHHHHHHHHHHHHHHHHHhhCC
Q 012014 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW----------RPLNFNFLIKKKLDIAIDVACALRYLHCDC 275 (473)
Q Consensus 206 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~----------~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~ 275 (473)
+++++.+. ...++||||+++|+|.+++........ ......+++..+..++.||+.||.|||
T Consensus 84 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH--- 155 (304)
T cd05096 84 LLGVCVDE-----DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS--- 155 (304)
T ss_pred EEEEEecC-----CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---
Confidence 99998653 357999999999999999865432110 011124667889999999999999999
Q ss_pred CCCeeeccCCCCcEEecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh
Q 012014 276 QPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT 355 (473)
Q Consensus 276 ~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt 355 (473)
+++|+||||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++
T Consensus 156 ~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~ 235 (304)
T cd05096 156 SLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235 (304)
T ss_pred HCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHH
Confidence 89999999999999999999999999999986543322112222345788999999988889999999999999999987
Q ss_pred --CCCCCCCCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhccc
Q 012014 356 --GIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSA 433 (473)
Q Consensus 356 --g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~ 433 (473)
+..||.+....+ ................. ...+..++..+.+|+.+||+
T Consensus 236 ~~~~~p~~~~~~~~--~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~li~~cl~ 286 (304)
T cd05096 236 LCKEQPYGELTDEQ--VIENAGEFFRDQGRQVY---------------------------LFRPPPCPQGLYELMLQCWS 286 (304)
T ss_pred ccCCCCCCcCCHHH--HHHHHHHHhhhcccccc---------------------------ccCCCCCCHHHHHHHHHHcc
Confidence 567776542211 01100000000000000 00012346688999999999
Q ss_pred CCCCCCCChHHHHHHHH
Q 012014 434 ERPRERMKINDVESRLR 450 (473)
Q Consensus 434 ~dP~~RPt~~ev~~~L~ 450 (473)
.||++|||+.||.+.|+
T Consensus 287 ~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 287 RDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCchhCcCHHHHHHHHh
Confidence 99999999999988875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=331.96 Aligned_cols=251 Identities=22% Similarity=0.288 Sum_probs=196.2
Q ss_pred CCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC---CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
.|+..+.||+|+||.||+|. ..+++.||+|.+.... ......+.+|+.++.+++|+||+++++++.+. ...
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~-----~~~ 75 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETK-----DAL 75 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC-----CeE
Confidence 37788999999999999998 5679999999986432 12234578899999999999999999987543 368
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEee
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~D 301 (473)
++||||+++|+|.+++...... .+++..+..++.|++.||.||| +++|+||||||+|||+++++.+||+|
T Consensus 76 ~lv~e~~~~g~L~~~~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~D 145 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYNMGNP-------GFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISD 145 (285)
T ss_pred EEEEEecCCCcHHHHHHhhCCC-------CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEee
Confidence 9999999999999888643321 3568889999999999999999 99999999999999999999999999
Q ss_pred cccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcc
Q 012014 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQR 381 (473)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 381 (473)
||++....... ......||..|+|||++.+..++.++|||||||++|+|++|..||.+...... ...... .....
T Consensus 146 fg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~-~~~~~~-~~~~~ 220 (285)
T cd05631 146 LGLAVQIPEGE---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK-REEVDR-RVKED 220 (285)
T ss_pred CCCcEEcCCCC---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh-HHHHHH-Hhhcc
Confidence 99998654322 22334689999999999999999999999999999999999999986432110 000000 00000
Q ss_pred hhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCC-----hHHHHH
Q 012014 382 AEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMK-----INDVES 447 (473)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~ 447 (473)
.. ......+..+.+|+.+||+.||.+||| ++++++
T Consensus 221 ~~-------------------------------~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 221 QE-------------------------------EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cc-------------------------------cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 00 001124557889999999999999997 677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=337.69 Aligned_cols=252 Identities=20% Similarity=0.277 Sum_probs=210.2
Q ss_pred CCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCC--CchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
++|..++++|+|+||.++.++ ..+++.+++|.+...... ..+...+|+.+++++.|||||.+.+.|.. +....
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~----~~~~l 79 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEE----DGQLL 79 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhc----CCceE
Confidence 578999999999999999998 557889999999854433 34467899999999999999999999854 34568
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEee
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~D 301 (473)
+|||+||+||+|.+.|.+.... .|+++.+..++.|++.|+.||| +++|+|||||+.|||++.++.+||+|
T Consensus 80 ~Ivm~Y~eGg~l~~~i~~~k~~-------~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgD 149 (426)
T KOG0589|consen 80 CIVMEYCEGGDLAQLIKEQKGV-------LFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGD 149 (426)
T ss_pred EEEEeecCCCCHHHHHHHHhhc-------cccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecc
Confidence 9999999999999999887632 5789999999999999999999 99999999999999999999999999
Q ss_pred cccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcc
Q 012014 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQR 381 (473)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 381 (473)
||+|+.+.... ....+..||+.||+||++.+.+|+.|+|||||||++|||++-+++|.... ....+.......
T Consensus 150 fGlaK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~-----m~~Li~ki~~~~ 222 (426)
T KOG0589|consen 150 FGLAKILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASN-----MSELILKINRGL 222 (426)
T ss_pred hhhhhhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccc-----hHHHHHHHhhcc
Confidence 99999886643 23445679999999999999999999999999999999999999998632 222221111111
Q ss_pred hhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 382 AEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
. .+.+.....++..|+..|+..+|..||++.+++..
T Consensus 223 ~-------------------------------~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 Y-------------------------------SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred C-------------------------------CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 0 01123456788899999999999999999999987
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=338.71 Aligned_cols=245 Identities=24% Similarity=0.320 Sum_probs=195.8
Q ss_pred CCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccC---CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+ ...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD-----QRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc-----CCe
Confidence 4788999999999999999994 468999999986432 1234568899999999999999999988644 347
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.++||||+++|+|.+++.... .+++..+..++.|++.||.||| ++||+||||||+|||++.++.+||+
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~ 143 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRNSG---------RFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLT 143 (291)
T ss_pred EEEEEeCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEE
Confidence 899999999999999997654 3557888999999999999999 9999999999999999999999999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCc
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQ 380 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 380 (473)
|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.... .........
T Consensus 144 Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-----~~~~~i~~~ 213 (291)
T cd05612 144 DFGFAKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF-----GIYEKILAG 213 (291)
T ss_pred ecCcchhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhC
Confidence 99999865321 22346899999999999988999999999999999999999999753211 111110000
Q ss_pred chhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCC-----hHHHHHH
Q 012014 381 RAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMK-----INDVESR 448 (473)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~~ 448 (473)
.. ..+......+.+|+.+||+.||.+||+ ++|+++.
T Consensus 214 ~~--------------------------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 214 KL--------------------------------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred Cc--------------------------------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 00 001122456789999999999999995 7777643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=342.43 Aligned_cols=280 Identities=18% Similarity=0.235 Sum_probs=200.5
Q ss_pred CCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC--CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
+|++.++||+|+||.||+|. ..+++.||+|+++... ......+.+|+.+++.++||||+++++++...+.......+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 47889999999999999998 4578999999986422 22345688999999999999999999988654434445689
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
+||||+ +++|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+||
T Consensus 81 lv~e~~-~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Df 147 (338)
T cd07859 81 VVFELM-ESDLHQVIKAND---------DLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDF 147 (338)
T ss_pred EEEecC-CCCHHHHHHhcc---------cCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccC
Confidence 999999 579999987553 3568899999999999999999 999999999999999999999999999
Q ss_pred ccccccCccccc-cceeeccCCCCcCCCccccC--CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcC
Q 012014 303 GMARFLPAIDKQ-NRFICIKGSTGYIPPEYDLG--CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP 379 (473)
Q Consensus 303 g~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 379 (473)
|+++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+..... .+ ..+.....
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~-~~-~~~~~~~~ 225 (338)
T cd07859 148 GLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH-QL-DLITDLLG 225 (338)
T ss_pred ccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH-HH-HHHHHHhC
Confidence 999764332211 12233468999999999876 578999999999999999999999997642211 01 11111111
Q ss_pred cch----hhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 380 QRA----EEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 380 ~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
... ..+........+.. . .. .............+..+.+++.+||+.||++|||+.|+++.
T Consensus 226 ~~~~~~~~~i~~~~~~~~~~~---~--~~---~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 226 TPSPETISRVRNEKARRYLSS---M--RK---KQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred CCCHHHHHHhhhhhHHHHHHh---h--cc---cCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000 01100000000000 0 00 00000001111245677899999999999999999999853
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=305.86 Aligned_cols=271 Identities=19% Similarity=0.201 Sum_probs=216.1
Q ss_pred hcccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCce
Q 012014 141 YNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 141 ~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (473)
..+.++|.+.+.||+|||+-||+++ ..+++.+|+|++......+.+...+|++..++++|||+++++++......+...
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 4456789999999999999999999 778999999999877767788899999999999999999999998766666778
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCC--eeeccCCCCcEEecCCccE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPP--IAHCNLKPSNVLLDDEMIG 297 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~Dlkp~Nil~~~~~~~ 297 (473)
..||+++|...|+|.+.+........ .+++.+.+.|+.+|++||++|| ... +.||||||.|||+.+++.+
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~-----~~sE~~iL~if~gic~gL~~lH---~~~~~yAH~DiKP~NILls~~~~~ 168 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGN-----FVSEAQILWIFLGICRGLEALH---EKEPPYAHRDIKPANILLSDSGLP 168 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCC-----ccCHHHHHHHHHHHHHHHHHHh---ccCCcccccCCCcceeEecCCCce
Confidence 89999999999999999976543321 4779999999999999999999 665 9999999999999999999
Q ss_pred EEeecccccccCcccccc-------ceeeccCCCCcCCCccccC---CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCc
Q 012014 298 HVGDFGMARFLPAIDKQN-------RFICIKGSTGYIPPEYDLG---CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGK 367 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~ 367 (473)
+|.|||.++...-..... .......|..|.|||.+.- ...+.++|||||||+||.|+.|..||+......
T Consensus 169 vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G 248 (302)
T KOG2345|consen 169 VLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG 248 (302)
T ss_pred EEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC
Confidence 999999987653321111 1122346899999998763 457899999999999999999999997643322
Q ss_pred ccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 368 MNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
..+.- .+..... ..+.....++.+.+|+.+|++.||.+||++.+++.
T Consensus 249 gSlaL-----------Av~n~q~----------------------s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~ 295 (302)
T KOG2345|consen 249 GSLAL-----------AVQNAQI----------------------SIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLS 295 (302)
T ss_pred CeEEE-----------eeecccc----------------------ccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 11000 0000000 00001125778999999999999999999999999
Q ss_pred HHHHH
Q 012014 448 RLRLI 452 (473)
Q Consensus 448 ~L~~l 452 (473)
.++.+
T Consensus 296 ~~d~L 300 (302)
T KOG2345|consen 296 KLDDL 300 (302)
T ss_pred HHHhh
Confidence 99876
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=334.64 Aligned_cols=280 Identities=21% Similarity=0.287 Sum_probs=198.4
Q ss_pred ccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
..++|.+.+.||+|+||.||+|.. .+++.||+|+++.... .....+.+|+.+++.++||||+++++++.+. ..
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~ 77 (303)
T cd07869 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTK-----ET 77 (303)
T ss_pred ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecC-----Ce
Confidence 457899999999999999999994 4789999999874332 2334678999999999999999999998543 46
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.++||||++ ++|.+++..... .++...+..++.|++.||.||| +++|+||||||+|||++.++.+||+
T Consensus 78 ~~lv~e~~~-~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~ 145 (303)
T cd07869 78 LTLVFEYVH-TDLCQYMDKHPG--------GLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLA 145 (303)
T ss_pred EEEEEECCC-cCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEC
Confidence 899999994 688888865432 2557888999999999999999 9999999999999999999999999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcC
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP 379 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 379 (473)
|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..+....+.........
T Consensus 146 Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 223 (303)
T cd07869 146 DFGLARAKSVPS--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGT 223 (303)
T ss_pred CCCcceeccCCC--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCC
Confidence 999987543221 12233458999999999865 458889999999999999999999998754322222222211111
Q ss_pred cchhhhccccchHHHHhhhhhhcccccCCCCcchhh--HHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 380 QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHAS--IILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
..............+ ..+............ .....+..+.+|+.+||+.||++|||+.|+++
T Consensus 224 ~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 224 PNEDTWPGVHSLPHF------KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred CChhhccchhhcccc------ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000000000000 000000000000000 00112356789999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=341.04 Aligned_cols=276 Identities=20% Similarity=0.187 Sum_probs=199.9
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
.++|++.+.||+|+||.||+|. ..+++.||+|... ...+.+|+.++++++||||++++++|... ...+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~ 159 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYN-----KFTC 159 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEEC-----CeeE
Confidence 3579999999999999999998 4678999999743 34578999999999999999999998543 3679
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
+|||++ +++|..++.... .+++.+++.++.||+.||.||| +++|+||||||+|||++.++.+||+||
T Consensus 160 lv~e~~-~~~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DF 226 (391)
T PHA03212 160 LILPRY-KTDLYCYLAAKR---------NIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDF 226 (391)
T ss_pred EEEecC-CCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeC
Confidence 999999 578999886653 3558889999999999999999 899999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCC------cccHHHHHHh
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTG------KMNLRNFVKM 376 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~------~~~~~~~~~~ 376 (473)
|+++...... ........||+.|+|||++.+..++.++|||||||++|||++|..||...... ...+...+..
T Consensus 227 G~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~ 305 (391)
T PHA03212 227 GAACFPVDIN-ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRR 305 (391)
T ss_pred Cccccccccc-ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHH
Confidence 9997543221 22233456999999999999989999999999999999999999887543211 1122222221
Q ss_pred hcCcchhhhccc--cchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 377 ALPQRAEEVVDD--FNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 377 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
..+.......+. .+...+.. ..............+......+.++.+|+.+||+.||++|||+.|+++
T Consensus 306 ~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 306 SGTHPNEFPIDAQANLDEIYIG---LAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hcCChhhcCcchhHHHHHHHHH---HHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 111000000000 00000000 000000001111112233356778999999999999999999999974
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=330.88 Aligned_cols=279 Identities=20% Similarity=0.264 Sum_probs=200.0
Q ss_pred CCCCccceeecCCCeEEEEEEe--cCCCEEEEEEeeccCC--CCchhHHHHHHHHHhc---CCCCceeeeeeeeccccCC
Q 012014 145 NGFSSANLIGAGNFGSVYNGTL--FDGTTIAVKVFNLIRP--GGSKSFKSECKAAINI---KHRNIVRVFTAFSGVDYQG 217 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~ 217 (473)
++|++.+.||+|+||.||+|+. .+++.||+|+++.... .....+.+|+.++..+ +||||++++++|.......
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 4688999999999999999984 3468899999874332 2234567788877766 6999999999986443344
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccE
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~ 297 (473)
....++||||++ ++|.+++...... .+++..+..++.|++.||.||| +++|+||||||+|||++.++.+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~-------~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~ 149 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEP-------GVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQI 149 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCC-------CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCE
Confidence 556899999995 6999998754322 3568899999999999999999 9999999999999999999999
Q ss_pred EEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|.+||.+....+ .+.......
T Consensus 150 kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~-~~~~i~~~~ 225 (290)
T cd07862 150 KLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVI 225 (290)
T ss_pred EEccccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHh
Confidence 99999999865432 22234458999999999988889999999999999999999999998643321 122222111
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
............... . ..................+..+.+|+.+||+.||++|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~~~---~------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 226 GLPGEEDWPRDVALP---R------QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred CCCChhhchhhhccc---c------hhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 100000000000000 0 000000000011112235667889999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=342.17 Aligned_cols=245 Identities=22% Similarity=0.272 Sum_probs=195.8
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccC---CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCce
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (473)
.++|.+.+.||+|+||.||+|+. .+++.||+|+++... ....+.+.+|+.++.+++||||+++++++.+. .
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~ 91 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE-----N 91 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC-----C
Confidence 46789999999999999999994 468999999987432 23345688999999999999999999998543 4
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
..++||||+++|+|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||
T Consensus 92 ~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl 159 (329)
T PTZ00263 92 RVYFLLEFVVGGELFTHLRKAG---------RFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKV 159 (329)
T ss_pred EEEEEEcCCCCChHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEE
Confidence 6899999999999999997654 3557888889999999999999 999999999999999999999999
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcC
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP 379 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 379 (473)
+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.... ........
T Consensus 160 ~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-----~~~~~i~~ 229 (329)
T PTZ00263 160 TDFGFAKKVPDR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF-----RIYEKILA 229 (329)
T ss_pred eeccCceEcCCC-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH-----HHHHHHhc
Confidence 999999865332 12346899999999999988999999999999999999999999653211 11110000
Q ss_pred cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCC-----hHHHHH
Q 012014 380 QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMK-----INDVES 447 (473)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~ 447 (473)
... ..+......+.+|+.+||+.||.+||+ +.+++.
T Consensus 230 ~~~--------------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 230 GRL--------------------------------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred CCc--------------------------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 000 000112346779999999999999997 566653
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=329.64 Aligned_cols=278 Identities=19% Similarity=0.197 Sum_probs=199.7
Q ss_pred CCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccC--CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
++|++.+.||+|+||.||+|+. .+++.||+|+++... ....+.+.+|+.++..++||||+++++++.. ....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 75 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR-----RGKL 75 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec-----CCEE
Confidence 4789999999999999999995 468899999997532 2234568899999999999999999998754 3468
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEee
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~D 301 (473)
++||||++++++..+..... .+++..+..++.|++.||.||| +++|+||||||+||+++.++.+||+|
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~D 143 (287)
T cd07848 76 YLVFEYVEKNMLELLEEMPN---------GVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCD 143 (287)
T ss_pred EEEEecCCCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEee
Confidence 99999999877765543322 3568889999999999999999 99999999999999999999999999
Q ss_pred cccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcC--
Q 012014 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP-- 379 (473)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~-- 379 (473)
||++....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+. +........+
T Consensus 144 fg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~ 221 (287)
T cd07848 144 FGFARNLSEGS-NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ-LFTIQKVLGPLP 221 (287)
T ss_pred ccCcccccccc-cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhCCCC
Confidence 99998764322 1122234689999999999988899999999999999999999999976432211 1111111100
Q ss_pred cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 380 QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.......... ..+.. ....................+..+.+|+.+||+.||++|||++|+++
T Consensus 222 ~~~~~~~~~~--~~~~~----~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 222 AEQMKLFYSN--PRFHG----LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred HHHHHhhhcc--chhcc----cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000 00000 00000000000111112235678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=340.41 Aligned_cols=241 Identities=18% Similarity=0.227 Sum_probs=191.3
Q ss_pred ceeecCCCeEEEEEE-ecCCCEEEEEEeeccC---CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEEEE
Q 012014 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYK 226 (473)
Q Consensus 151 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 226 (473)
++||+|+||.||+|. ..+|+.||+|+++... ......+.+|+.++.+++||||+++++++.. ....++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT-----HDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc-----CCEEEEEEe
Confidence 469999999999998 4578999999997432 2233567889999999999999999998754 347899999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeeccccc
Q 012014 227 FMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMAR 306 (473)
Q Consensus 227 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~ 306 (473)
|+++|+|.+++.... .+++.++..++.||+.||+||| ++||+||||||+|||++.++.+||+|||+++
T Consensus 76 ~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~ 143 (323)
T cd05571 76 YANGGELFFHLSRER---------VFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK 143 (323)
T ss_pred CCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 999999999987654 3568889999999999999999 9999999999999999999999999999987
Q ss_pred ccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchhhhc
Q 012014 307 FLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVV 386 (473)
Q Consensus 307 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (473)
..... ........||+.|+|||++.+..++.++|||||||++|||++|..||.+.... ...........
T Consensus 144 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-----~~~~~~~~~~~---- 212 (323)
T cd05571 144 EGISD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELILMEEI---- 212 (323)
T ss_pred ccccC--CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH-----HHHHHHHcCCC----
Confidence 53221 12223456999999999999989999999999999999999999999652211 11110000000
Q ss_pred cccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCC-----ChHHHHH
Q 012014 387 DDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERM-----KINDVES 447 (473)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~ 447 (473)
..+...+..+.+|+.+||+.||++|| ++.++++
T Consensus 213 ----------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 213 ----------------------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred ----------------------------CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 00112355778999999999999999 7888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=313.03 Aligned_cols=250 Identities=20% Similarity=0.279 Sum_probs=201.1
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeec--cCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNL--IRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
++.|++.++||+|.|+.|+++. ..+|+.+|+|+++. .+..+.+.+.+|++|-+.|+|||||++.+.+ ....+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-----~~~~~ 84 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESF 84 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-----cccce
Confidence 4678889999999999999987 56799999998863 3445677899999999999999999999885 44568
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEec---CCccE
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD---DEMIG 297 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~---~~~~~ 297 (473)
.++|+|++.|++|..-|-.. +.+++..+..+++||++||.|+| .++|||||+||+|+++. ..--+
T Consensus 85 ~ylvFe~m~G~dl~~eIV~R---------~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~v 152 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVAR---------EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAV 152 (355)
T ss_pred eEEEEecccchHHHHHHHHH---------HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCce
Confidence 89999999999998766543 25788999999999999999999 99999999999999994 34578
Q ss_pred EEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
||+|||++..+. .+.......|||+|||||++...+|+..+|||+.|||||-|+.|.+||.+..... .+.++....
T Consensus 153 KL~~FGvAi~l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r-lye~I~~g~ 228 (355)
T KOG0033|consen 153 KLADFGLAIEVN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-LYEQIKAGA 228 (355)
T ss_pred eecccceEEEeC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH-HHHHHhccc
Confidence 999999999876 2445566789999999999999999999999999999999999999998632221 111111111
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHH
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVE 446 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~ 446 (473)
..-.. ..-....++..+|+.+||..||.+|.|+.|.+
T Consensus 229 yd~~~--------------------------------~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 229 YDYPS--------------------------------PEWDTVTPEAKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred cCCCC--------------------------------cccCcCCHHHHHHHHHHhccChhhhccHHHHh
Confidence 00000 00112455778899999999999999998865
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=329.39 Aligned_cols=263 Identities=23% Similarity=0.418 Sum_probs=203.5
Q ss_pred CCCCccceeecCCCeEEEEEEecC-C-----CEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCC
Q 012014 145 NGFSSANLIGAGNFGSVYNGTLFD-G-----TTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (473)
++|++.+.||+|+||.||+|.... + ..||+|.++.... .....+.+|+.++..++||||+++++++...
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~---- 80 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE---- 80 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC----
Confidence 478889999999999999998432 2 5799998864322 2235688999999999999999999997542
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCCCC-------CcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEE
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWR-------PLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVL 290 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~-------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil 290 (473)
...+++|||+++|+|.+++......... .....+++.+++.++.|++.||.||| +++++||||||+||+
T Consensus 81 -~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil 156 (283)
T cd05048 81 -QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCL 156 (283)
T ss_pred -CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEE
Confidence 3579999999999999999765332110 11124678889999999999999999 999999999999999
Q ss_pred ecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCccc
Q 012014 291 LDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMN 369 (473)
Q Consensus 291 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~ 369 (473)
+++++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....+
T Consensus 157 ~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~-- 234 (283)
T cd05048 157 VGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE-- 234 (283)
T ss_pred EcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH--
Confidence 99999999999999976543322222233446788999999988889999999999999999998 999997643211
Q ss_pred HHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHH
Q 012014 370 LRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRL 449 (473)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L 449 (473)
+...+. .... ...+..++..+.+|+.+||+.||++|||++||++.|
T Consensus 235 ~~~~i~---~~~~-------------------------------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l 280 (283)
T cd05048 235 VIEMIR---SRQL-------------------------------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRL 280 (283)
T ss_pred HHHHHH---cCCc-------------------------------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 111100 0000 001224677899999999999999999999999999
Q ss_pred HH
Q 012014 450 RL 451 (473)
Q Consensus 450 ~~ 451 (473)
++
T Consensus 281 ~~ 282 (283)
T cd05048 281 RS 282 (283)
T ss_pred hc
Confidence 75
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=338.91 Aligned_cols=253 Identities=19% Similarity=0.260 Sum_probs=199.2
Q ss_pred CCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccC---CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
++|++.+.||+|+||.||+|+. .+++.||+|+++... ......+.+|+.++..++||||+++++++.. ...
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-----~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD-----DEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc-----CCE
Confidence 4789999999999999999995 468999999997432 2234568899999999999999999998754 347
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.++||||+++|+|.+++.... .+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~ 143 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNNLG---------VLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLT 143 (333)
T ss_pred EEEEEeCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEE
Confidence 899999999999999997653 3558889999999999999999 9999999999999999999999999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCc
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQ 380 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 380 (473)
|||++..... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+....+. +.......
T Consensus 144 Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~i~~~~--- 214 (333)
T cd05600 144 DFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET-WENLKYWK--- 214 (333)
T ss_pred eCcCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH-HHHHHhcc---
Confidence 9999976533 22345689999999999998999999999999999999999999975322110 01000000
Q ss_pred chhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 381 RAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
....... ........+.++.+|+.+||..+|.+|||+.++++.
T Consensus 215 ---~~~~~~~----------------------~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 215 ---ETLQRPV----------------------YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred ---ccccCCC----------------------CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0000000 000001245678899999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=335.02 Aligned_cols=199 Identities=25% Similarity=0.310 Sum_probs=170.6
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
.++|++.+.||+|+||.||+++. .++..+|+|.+..... .....+.+|++++.+++||||+++++++... ...
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 78 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEI 78 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-----CEE
Confidence 46899999999999999999994 4688999999875322 2345688999999999999999999998543 367
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCC-CeeeccCCCCcEEecCCccEEEe
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQP-PIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~-~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
++||||+++|+|.+++.... .+++..+..++.|++.||.||| ++ +|+||||||+|||++.++.+||+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~ 146 (331)
T cd06649 79 SICMEHMDGGSLDQVLKEAK---------RIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLC 146 (331)
T ss_pred EEEeecCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEc
Confidence 99999999999999997654 2557888999999999999999 64 69999999999999999999999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCC
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 363 (473)
|||++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 147 Dfg~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 147 DFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred cCcccccccccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 999987653321 22345899999999999989999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=336.39 Aligned_cols=253 Identities=23% Similarity=0.404 Sum_probs=211.3
Q ss_pred CccceeecCCCeEEEEEEec---CC--CEEEEEEeec-cCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 148 SSANLIGAGNFGSVYNGTLF---DG--TTIAVKVFNL-IRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 148 ~~~~~lg~G~~g~V~~~~~~---~~--~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
...++||.|-||.||+|... .| -.||||.++. ..+.+.+.|..|+.+|+.++||||++++|+|.+. ..
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~------P~ 465 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ------PM 465 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc------ce
Confidence 34677999999999999832 23 3589999986 4455678899999999999999999999999764 47
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEee
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~D 301 (473)
|||||+++.|.|..||+.+.. .++......++.||+.||.||| ++++|||||...|||+.....+||+|
T Consensus 466 WivmEL~~~GELr~yLq~nk~--------sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaD 534 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQNKD--------SLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLAD 534 (974)
T ss_pred eEEEecccchhHHHHHHhccc--------cchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecc
Confidence 999999999999999988764 4667888899999999999999 99999999999999999999999999
Q ss_pred cccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcCc
Q 012014 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMALPQ 380 (473)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~ 380 (473)
||+++.+......... ...-...|||||.+.-.+++.+||||-|||.+||++. |..||.+..+.+..
T Consensus 535 FGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI----------- 602 (974)
T KOG4257|consen 535 FGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI----------- 602 (974)
T ss_pred cchhhhccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE-----------
Confidence 9999988765533332 2233567999999999999999999999999999988 99999986554421
Q ss_pred chhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHH
Q 012014 381 RAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRR 454 (473)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~ 454 (473)
..++.|. +.+.++.||+.|+.|+.+||.+||.+||++.||...|..+..
T Consensus 603 -----------~~iEnGe--------------RlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 603 -----------GHIENGE--------------RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred -----------EEecCCC--------------CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 1111111 224556799999999999999999999999999999998875
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=341.39 Aligned_cols=271 Identities=22% Similarity=0.299 Sum_probs=205.4
Q ss_pred hhcccCCCCccceeecCCCeEEEEEEec------CCCEEEEEEeeccCC-CCchhHHHHHHHHHhcC-CCCceeeeeeee
Q 012014 140 LYNATNGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRP-GGSKSFKSECKAAINIK-HRNIVRVFTAFS 211 (473)
Q Consensus 140 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 211 (473)
+....++|.+.++||+|+||.||+|... .+..||||+++.... ...+.+.+|+.++.++. ||||++++++|.
T Consensus 32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 3445678999999999999999999842 134699999864322 23457889999999996 999999999985
Q ss_pred ccccCCceeeEEEEEecCCCCHHHHhcCCCCCCC----------------------------------------------
Q 012014 212 GVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW---------------------------------------------- 245 (473)
Q Consensus 212 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~---------------------------------------------- 245 (473)
+. ...++|||||++|+|.+++........
T Consensus 112 ~~-----~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (400)
T cd05105 112 KS-----GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTT 186 (400)
T ss_pred cC-----CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccc
Confidence 43 367999999999999999865321000
Q ss_pred -----------------------------------------CCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccC
Q 012014 246 -----------------------------------------RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNL 284 (473)
Q Consensus 246 -----------------------------------------~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dl 284 (473)
......+++.++..++.|++.||.||| +++|+||||
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~di 263 (400)
T cd05105 187 QYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDL 263 (400)
T ss_pred ccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCC
Confidence 000113667888999999999999999 999999999
Q ss_pred CCCcEEecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCC
Q 012014 285 KPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363 (473)
Q Consensus 285 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~ 363 (473)
||+|||++.++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||...
T Consensus 264 kp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~ 343 (400)
T cd05105 264 AARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM 343 (400)
T ss_pred ChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence 99999999999999999999986543322222223346788999999998889999999999999999997 99998754
Q ss_pred CCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChH
Q 012014 364 FTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKIN 443 (473)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 443 (473)
......... ..... ....+..++..+.+++.+||+.||++|||+.
T Consensus 344 ~~~~~~~~~-~~~~~----------------------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 388 (400)
T cd05105 344 IVDSTFYNK-IKSGY----------------------------------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFL 388 (400)
T ss_pred chhHHHHHH-HhcCC----------------------------------CCCCCccCCHHHHHHHHHHCccCHhHCcCHH
Confidence 222111000 00000 0001123466788999999999999999999
Q ss_pred HHHHHHHHHH
Q 012014 444 DVESRLRLIR 453 (473)
Q Consensus 444 ev~~~L~~l~ 453 (473)
+|.+.|+.+.
T Consensus 389 ~l~~~l~~l~ 398 (400)
T cd05105 389 HLSDIVESLL 398 (400)
T ss_pred HHHHHHHHHc
Confidence 9999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=327.29 Aligned_cols=277 Identities=20% Similarity=0.272 Sum_probs=197.6
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC-CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
.++|.+.++||+|+||.||+|. ..+++.||+|+++... ......+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~ 78 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHT-----ERCL 78 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcC-----CCeE
Confidence 3579999999999999999998 4578999999987433 2234567899999999999999999999754 3467
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEee
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~D 301 (473)
++||||++ |+|.+++..... .+++..+..++.||+.||.||| ++||+||||||+|||++.++.+||+|
T Consensus 79 ~lv~e~~~-~~l~~~l~~~~~--------~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~D 146 (288)
T cd07871 79 TLVFEYLD-SDLKQYLDNCGN--------LMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLAD 146 (288)
T ss_pred EEEEeCCC-cCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECc
Confidence 99999996 599998865432 2457888999999999999999 99999999999999999999999999
Q ss_pred cccccccCccccccceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCc
Q 012014 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQ 380 (473)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 380 (473)
||+++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+ .+....... ..
T Consensus 147 fG~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~-~~ 222 (288)
T cd07871 147 FGLARAKSVPT--KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE-ELHLIFRLL-GT 222 (288)
T ss_pred CcceeeccCCC--ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHh-CC
Confidence 99997643322 11223457999999998865 468999999999999999999999997643221 111111111 11
Q ss_pred chhhhccccc-hHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 381 RAEEVVDDFN-LQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 381 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
...+...... ...+.. ...+................+..+|+.+||+.||.+|||+.|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 223 PTEETWPGITSNEEFRS------YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred CChHHhhccccchhhhc------cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0111000000 000000 000000000000011123456789999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=350.71 Aligned_cols=264 Identities=23% Similarity=0.319 Sum_probs=205.6
Q ss_pred hcccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCC--CCchhHHHHHHHHHhcCCCCceeeeeeeecccc--
Q 012014 141 YNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY-- 215 (473)
Q Consensus 141 ~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-- 215 (473)
....++|.+.++||+|+||.||+|. ..+++.||||++..... .....+.+|+..+..++|+||++++..+...+.
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 4456799999999999999999998 56799999999875332 233567889999999999999999887754321
Q ss_pred -CCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCC
Q 012014 216 -QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE 294 (473)
Q Consensus 216 -~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~ 294 (473)
......++||||+++|+|.+++....... ..+++..+..++.|++.||.||| +++|+||||||+|||++.+
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~-----~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~ 179 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTN-----RTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSN 179 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCC
Confidence 11224689999999999999997543211 13668889999999999999999 9999999999999999999
Q ss_pred ccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 012014 295 MIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFV 374 (473)
Q Consensus 295 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~ 374 (473)
+.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|..||.+.. .....
T Consensus 180 ~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~-----~~~~~ 254 (496)
T PTZ00283 180 GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-----MEEVM 254 (496)
T ss_pred CCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----HHHHH
Confidence 9999999999987654332233344569999999999999899999999999999999999999997532 11111
Q ss_pred HhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 375 KMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
......... ..+...+..+.+|+.+||+.||.+|||+.+++..
T Consensus 255 ~~~~~~~~~-------------------------------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 255 HKTLAGRYD-------------------------------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHHhcCCCC-------------------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111111000 0112345678899999999999999999999763
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=331.86 Aligned_cols=259 Identities=23% Similarity=0.375 Sum_probs=201.7
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCC----EEEEEEeeccC-CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCC
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGT----TIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (473)
.++|+..+.||+|+||.||+|.+ .++. .||+|.++... ......+.+|+.+++.++||||+++++++...
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~---- 81 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---- 81 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC----
Confidence 35799999999999999999984 3343 48999986432 23346788999999999999999999998542
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccE
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~ 297 (473)
..++++||+++|+|.+++..... .+++..++.++.||+.||+||| +++|+||||||+|||++.++.+
T Consensus 82 --~~~~v~e~~~~g~l~~~l~~~~~--------~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~ 148 (316)
T cd05108 82 --TVQLITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHV 148 (316)
T ss_pred --CceeeeecCCCCCHHHHHHhccc--------cCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcE
Confidence 35799999999999999986532 2557888999999999999999 9999999999999999999999
Q ss_pred EEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHh
Q 012014 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKM 376 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~ 376 (473)
||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.+..... +......
T Consensus 149 kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~--~~~~~~~ 226 (316)
T cd05108 149 KITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEK 226 (316)
T ss_pred EEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHhC
Confidence 9999999987654332222222334678999999999899999999999999999998 999997532111 1111100
Q ss_pred hcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHHh
Q 012014 377 ALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRK 455 (473)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~ 455 (473)
.. . ...+..++..+.+++.+||..||++|||+.+|+..|..+...
T Consensus 227 ~~--~--------------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 227 GE--R--------------------------------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred CC--C--------------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 00 0 000112345678999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=324.03 Aligned_cols=256 Identities=20% Similarity=0.317 Sum_probs=199.5
Q ss_pred cCCCCccceeecCCCeEEEEEEec----CCCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTLF----DGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
.++|++.+.||+|+||.||+|.+. .+..||+|.++.... .....+.+|+.++.+++||||+++++++.. .
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~ 78 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR-----G 78 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec-----C
Confidence 356889999999999999999742 356899999875322 223568899999999999999999999754 3
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...++||||+++|+|.+++..... .+++.+++.++.|++.||+||| +++++||||||+||+++.++.+|
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~~~~--------~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~ 147 (266)
T cd05064 79 NTMMIVTEYMSNGALDSFLRKHEG--------QLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCK 147 (266)
T ss_pred CCcEEEEEeCCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEE
Confidence 467999999999999999976431 3568899999999999999999 99999999999999999999999
Q ss_pred EeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhh
Q 012014 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~ 377 (473)
++|||.+....... ........++..|+|||.+.+..++.++|||||||++||+++ |..||.+..... .....
T Consensus 148 l~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~-----~~~~~ 221 (266)
T cd05064 148 ISGFRRLQEDKSEA-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD-----VIKAV 221 (266)
T ss_pred ECCCcccccccccc-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-----HHHHH
Confidence 99999876532211 111112335678999999998899999999999999999775 999997542211 11100
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHH
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLI 452 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l 452 (473)
.... ....+..++..+.+++.+||+.+|.+|||+.+|.+.|+++
T Consensus 222 ~~~~-------------------------------~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 222 EDGF-------------------------------RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HCCC-------------------------------CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0000 0001123566789999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=349.84 Aligned_cols=266 Identities=20% Similarity=0.226 Sum_probs=210.0
Q ss_pred ccCCCCccceeecCCCeEEEEEEecCC-CEEEEEEeeccCCCCchhHHHHHHHHHhcC-CCCceeeeeeeeccc-cCC-c
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTLFDG-TTIAVKVFNLIRPGGSKSFKSECKAAINIK-HRNIVRVFTAFSGVD-YQG-A 218 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~-~~~-~ 218 (473)
...++++.++|.+|||+.||.|....+ ..||+|++-.......+.+.+|+.+|+.|. |+|||.+++...... ..+ .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 445678899999999999999996555 999999998777677788999999999996 999999999432222 223 4
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
..++|+||||.||+|-+++..+... .|++.++++|+.|+++|+.+||.. ..+|||||||-+||||+.+++.|
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~-------~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~K 186 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQT-------RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYK 186 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhc-------cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEE
Confidence 6788999999999999999866533 488999999999999999999944 56799999999999999999999
Q ss_pred EeecccccccCccccccc-------eeeccCCCCcCCCccc---cCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcc
Q 012014 299 VGDFGMARFLPAIDKQNR-------FICIKGSTGYIPPEYD---LGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKM 368 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~-------~~~~~gt~~y~aPE~~---~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~ 368 (473)
|||||.+.-......... .....-|+.|+|||++ .+.+.+.|+|||||||+||.|+....||++...-
T Consensus 187 LCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-- 264 (738)
T KOG1989|consen 187 LCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-- 264 (738)
T ss_pred eCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce--
Confidence 999999864322111110 0112358999999975 4677999999999999999999999999753111
Q ss_pred cHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 369 NLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
.+++. . ...+....+...+.+||..||+.||.+||++-+|++.
T Consensus 265 ---------------aIlng----~------------------Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 265 ---------------AILNG----N------------------YSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred ---------------eEEec----c------------------ccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 11110 0 0001113477889999999999999999999999999
Q ss_pred HHHHHHh
Q 012014 449 LRLIRRK 455 (473)
Q Consensus 449 L~~l~~~ 455 (473)
+-.|..+
T Consensus 308 ~~~l~~~ 314 (738)
T KOG1989|consen 308 IFELANK 314 (738)
T ss_pred HHHHhcC
Confidence 9998744
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=353.50 Aligned_cols=253 Identities=19% Similarity=0.227 Sum_probs=198.2
Q ss_pred CCCccceeecCCCeEEEEEEe-cC-CCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEE
Q 012014 146 GFSSANLIGAGNFGSVYNGTL-FD-GTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~~-~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (473)
.|.+.+.||+|+||.||+|.. .+ +..||+|.+..........+.+|+.++..++|||||+++++|... ...++
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~-----~~~~l 142 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSD-----DKLLL 142 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC-----CEEEE
Confidence 488899999999999999983 33 678899877544433445678899999999999999999998553 36899
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecc
Q 012014 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (473)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg 303 (473)
||||+++|+|.+++...... ...+++.++..++.||+.||.||| +++|+||||||+|||++.++.+||+|||
T Consensus 143 v~E~~~gg~L~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFg 214 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKE-----HLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFG 214 (478)
T ss_pred EEECCCCCCHHHHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCc
Confidence 99999999999988643211 113668889999999999999999 9999999999999999999999999999
Q ss_pred cccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchh
Q 012014 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAE 383 (473)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 383 (473)
+++.+.............||+.|+|||++.+..++.++|||||||++|+|++|..||.+... .............
T Consensus 215 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-----~~~~~~~~~~~~~ 289 (478)
T PTZ00267 215 FSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-----REIMQQVLYGKYD 289 (478)
T ss_pred CceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCCC
Confidence 99876543322233445699999999999998999999999999999999999999975321 1111111000000
Q ss_pred hhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 384 EVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
. .+...+..+.+|+.+||..||++|||+.+++.
T Consensus 290 ~-------------------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 P-------------------------------FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred C-------------------------------CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 0 01123457889999999999999999999864
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=336.17 Aligned_cols=236 Identities=22% Similarity=0.291 Sum_probs=186.9
Q ss_pred eecCCCeEEEEEEe-cCCCEEEEEEeecc---CCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEEEEec
Q 012014 153 IGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFM 228 (473)
Q Consensus 153 lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 228 (473)
||+|+||.||+|.. .+++.||+|+++.. .......+.+|+.++.+++||||+++++++.. ....++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS-----PEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec-----CCeEEEEEcCC
Confidence 69999999999994 46889999998742 22334567889999999999999999998754 34689999999
Q ss_pred CCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeeccccccc
Q 012014 229 PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL 308 (473)
Q Consensus 229 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 308 (473)
++|+|.+++.... .+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||+++..
T Consensus 76 ~~g~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~ 143 (312)
T cd05585 76 NGGELFHHLQREG---------RFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLN 143 (312)
T ss_pred CCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccC
Confidence 9999999997653 3568888999999999999999 999999999999999999999999999999754
Q ss_pred CccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchhhhccc
Q 012014 309 PAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDD 388 (473)
Q Consensus 309 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (473)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+... ............
T Consensus 144 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-----~~~~~~~~~~~~------ 210 (312)
T cd05585 144 MKDD--DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-----NEMYRKILQEPL------ 210 (312)
T ss_pred ccCC--CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-----HHHHHHHHcCCC------
Confidence 3221 222345699999999999998999999999999999999999999975321 111111110000
Q ss_pred cchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHH
Q 012014 389 FNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKIND 444 (473)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 444 (473)
..+...+..+.+|+.+||+.||.+||++..
T Consensus 211 --------------------------~~~~~~~~~~~~li~~~L~~dp~~R~~~~~ 240 (312)
T cd05585 211 --------------------------RFPDGFDRDAKDLLIGLLSRDPTRRLGYNG 240 (312)
T ss_pred --------------------------CCCCcCCHHHHHHHHHHcCCCHHHcCCCCC
Confidence 001124457789999999999999986433
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=334.14 Aligned_cols=270 Identities=23% Similarity=0.312 Sum_probs=204.1
Q ss_pred ccCCCCccceeecCCCeEEEEEEec------CCCEEEEEEeeccCC-CCchhHHHHHHHHHhc-CCCCceeeeeeeeccc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRP-GGSKSFKSECKAAINI-KHRNIVRVFTAFSGVD 214 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 214 (473)
..++|++.++||+|+||.||+|... +++.||+|+++.... ...+.+.+|+.++.++ +||||++++++|...
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~- 83 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP- 83 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC-
Confidence 3458999999999999999999632 347899999864321 1234577899999999 899999999988542
Q ss_pred cCCceeeEEEEEecCCCCHHHHhcCCCCCCC-------------------------------------------------
Q 012014 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTNW------------------------------------------------- 245 (473)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~------------------------------------------------- 245 (473)
....+++|||+++|+|.+++........
T Consensus 84 ---~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 84 ---GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ---CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 3467899999999999999865321100
Q ss_pred ---CCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecccccccCccccccceeeccC
Q 012014 246 ---RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKG 322 (473)
Q Consensus 246 ---~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g 322 (473)
......+++..+..++.||+.||.||| +++|+||||||+||+++.++.+||+|||+++.+.............+
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~ 237 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 237 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCC
Confidence 000114678899999999999999999 99999999999999999999999999999987643322222223446
Q ss_pred CCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhh
Q 012014 323 STGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMC 401 (473)
Q Consensus 323 t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 401 (473)
+..|+|||++.+..++.++|||||||++|||++ |..||.+....+. +......... .
T Consensus 238 ~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~----~----------------- 295 (337)
T cd05054 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-FCRRLKEGTR----M----------------- 295 (337)
T ss_pred CccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-HHHHHhccCC----C-----------------
Confidence 778999999999999999999999999999998 9999976322111 1111000000 0
Q ss_pred cccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHH
Q 012014 402 MEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRR 454 (473)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~ 454 (473)
..+...+.++.+++.+||+.+|++|||+.||++.|+.+..
T Consensus 296 -------------~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 296 -------------RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred -------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0011234578899999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=313.90 Aligned_cols=283 Identities=21% Similarity=0.251 Sum_probs=205.9
Q ss_pred CCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCC--CCchhHHHHHHHHHhcCCCC-ceeeeeeeecccc-CCce
Q 012014 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRN-IVRVFTAFSGVDY-QGAR 219 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~-~~~~ 219 (473)
..|...++||+|+||+||+|+ ..+|+.||+|+++.... +......+|+.++++++|+| ||.+++++...+. ....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 356777889999999999999 67899999999986543 34456789999999999999 9999999865431 2233
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
..++|+||+ .-+|.+++....... ..++...+..++.||+.||+||| +++|+||||||+|||++++|.+||
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~-----~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKl 161 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKP-----QGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKL 161 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccc-----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEee
Confidence 678999999 569999998766321 12445788999999999999999 999999999999999999999999
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccCC-CCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMAL 378 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~ 378 (473)
+|||+|+.+.-.. ...+...+|..|.|||++.+. .|+...||||+|||++||++++.-|.+..+.+.....+.....
T Consensus 162 aDFGlAra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGt 239 (323)
T KOG0594|consen 162 ADFGLARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGT 239 (323)
T ss_pred eccchHHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCC
Confidence 9999999654322 224455689999999999887 6999999999999999999999999886653322222211112
Q ss_pred C--cchhhhccccchHHHHhhhhhhcccccCCC-CcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 379 P--QRAEEVVDDFNLQEIEEGRTMCMEVSSSSG-SSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 379 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
| ..++.+..- ..+.. ..+... ................+++..||+++|.+|.|++..++.
T Consensus 240 P~e~~Wp~v~~~---~~~k~-------~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 240 PNEKDWPGVSSL---PDYKA-------PFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCccCCCCcccc---ccccc-------cCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 2 111111110 00000 000000 000000111112477899999999999999999998774
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=326.12 Aligned_cols=268 Identities=23% Similarity=0.374 Sum_probs=206.3
Q ss_pred cCCCCccceeecCCCeEEEEEEe------cCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCC
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL------FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (473)
.++|.+.+.||+|+||.||++.. .++..+|+|.+..........+.+|+.++.+++||||+++++++...
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---- 79 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG---- 79 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC----
Confidence 35788999999999999999973 23456899988754444456789999999999999999999998543
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCCC----CCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecC
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNW----RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD 293 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~----~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~ 293 (473)
...+++|||+++++|.+++........ ......+++.+++.++.|++.||+||| ++|++||||||+||++++
T Consensus 80 -~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~ 155 (288)
T cd05093 80 -DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGE 155 (288)
T ss_pred -CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEcc
Confidence 467999999999999999975432110 011124778999999999999999999 999999999999999999
Q ss_pred CccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHH
Q 012014 294 EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRN 372 (473)
Q Consensus 294 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~ 372 (473)
++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus 156 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~----- 230 (288)
T cd05093 156 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE----- 230 (288)
T ss_pred CCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----
Confidence 99999999999986543222111222335778999999998889999999999999999998 999987543211
Q ss_pred HHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHH
Q 012014 373 FVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLI 452 (473)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l 452 (473)
............ .....+..+.+|+.+||+.||.+|||+.||++.|+.+
T Consensus 231 ~~~~i~~~~~~~-------------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~ 279 (288)
T cd05093 231 VIECITQGRVLQ-------------------------------RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL 279 (288)
T ss_pred HHHHHHcCCcCC-------------------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 111000000000 0012345789999999999999999999999999999
Q ss_pred HHh
Q 012014 453 RRK 455 (473)
Q Consensus 453 ~~~ 455 (473)
..+
T Consensus 280 ~~~ 282 (288)
T cd05093 280 AKA 282 (288)
T ss_pred HHh
Confidence 754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=338.25 Aligned_cols=246 Identities=22% Similarity=0.268 Sum_probs=195.8
Q ss_pred ccCCCCccceeecCCCeEEEEEEec-C-CCEEEEEEeeccC---CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCC
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTLF-D-GTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (473)
..++|.+.+.||+|+||.||+|... + +..||+|++.... ......+.+|+.++..++||||+++++++.+.
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~---- 103 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE---- 103 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC----
Confidence 4467999999999999999999843 3 3689999986422 23345688999999999999999999998543
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccE
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~ 297 (473)
...++||||+++|+|.+++.... .+++..+..++.|++.||.||| +++|+||||||+|||++.++.+
T Consensus 104 -~~~~lv~Ey~~~g~L~~~i~~~~---------~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~i 170 (340)
T PTZ00426 104 -SYLYLVLEFVIGGEFFTFLRRNK---------RFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFI 170 (340)
T ss_pred -CEEEEEEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCE
Confidence 46899999999999999997654 3568888999999999999999 9999999999999999999999
Q ss_pred EEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|..||.+.... ......
T Consensus 171 kL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~~~~i 240 (340)
T PTZ00426 171 KMTDFGFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-----LIYQKI 240 (340)
T ss_pred EEecCCCCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-----HHHHHH
Confidence 99999999865321 23456999999999999888999999999999999999999999753211 000100
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCC-----ChHHHHH
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERM-----KINDVES 447 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~ 447 (473)
..... . .+...+..+.+++.+||+.||++|+ |++++++
T Consensus 241 ~~~~~-~-------------------------------~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 241 LEGII-Y-------------------------------FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred hcCCC-C-------------------------------CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 00000 0 0011234567899999999999995 7888765
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=335.22 Aligned_cols=242 Identities=19% Similarity=0.231 Sum_probs=191.8
Q ss_pred ceeecCCCeEEEEEE-ecCCCEEEEEEeeccC---CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEEEE
Q 012014 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYK 226 (473)
Q Consensus 151 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 226 (473)
++||+|+||.||++. ..+++.||+|++.... ......+.+|+.+++.++||||+++++++.. ....++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT-----KDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-----CCEEEEEEe
Confidence 469999999999998 4578999999997432 2234567889999999999999999988754 346899999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeeccccc
Q 012014 227 FMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMAR 306 (473)
Q Consensus 227 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~ 306 (473)
|+++|+|.+++.... .+++.++..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++
T Consensus 76 y~~~g~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~ 143 (328)
T cd05593 76 YVNGGELFFHLSRER---------VFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCK 143 (328)
T ss_pred CCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCc
Confidence 999999999987653 3568899999999999999999 9999999999999999999999999999987
Q ss_pred ccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchhhhc
Q 012014 307 FLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVV 386 (473)
Q Consensus 307 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (473)
..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.... ...........
T Consensus 144 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-----~~~~~~~~~~~---- 212 (328)
T cd05593 144 EGITD--AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELILMEDI---- 212 (328)
T ss_pred cCCCc--ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-----HHHHHhccCCc----
Confidence 53221 12223456999999999999889999999999999999999999999753211 11111000000
Q ss_pred cccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCC-----ChHHHHHH
Q 012014 387 DDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERM-----KINDVESR 448 (473)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~~ 448 (473)
..+...+..+.+|+.+||+.||++|| ++.|+++.
T Consensus 213 ----------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 213 ----------------------------KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred ----------------------------cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 00112345778999999999999997 88888753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=335.62 Aligned_cols=241 Identities=19% Similarity=0.232 Sum_probs=190.8
Q ss_pred ceeecCCCeEEEEEE-ecCCCEEEEEEeeccC---CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEEEE
Q 012014 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYK 226 (473)
Q Consensus 151 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 226 (473)
+.||+|+||.||++. ..+|+.||+|+++... ......+.+|+.++..++||||++++++|... ...++|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~-----~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-----DRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecC-----CEEEEEEe
Confidence 469999999999998 4578999999997432 22344677899999999999999999988543 36899999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeeccccc
Q 012014 227 FMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMAR 306 (473)
Q Consensus 227 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~ 306 (473)
|+++|+|..++.... .+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++
T Consensus 76 ~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~ 143 (323)
T cd05595 76 YANGGELFFHLSRER---------VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK 143 (323)
T ss_pred CCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhc
Confidence 999999999887653 3568899999999999999999 9999999999999999999999999999987
Q ss_pred ccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchhhhc
Q 012014 307 FLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVV 386 (473)
Q Consensus 307 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 386 (473)
..... ........||+.|+|||++.+..++.++|||||||++|||++|..||...... ...........
T Consensus 144 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-----~~~~~~~~~~~---- 212 (323)
T cd05595 144 EGISD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----RLFELILMEEI---- 212 (323)
T ss_pred cccCC--CCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-----HHHHHHhcCCC----
Confidence 53221 11223356899999999999989999999999999999999999999753211 11110000000
Q ss_pred cccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCC-----ChHHHHH
Q 012014 387 DDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERM-----KINDVES 447 (473)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~ 447 (473)
..+...+..+.+|+.+||+.||++|| ++.++++
T Consensus 213 ----------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 213 ----------------------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred ----------------------------CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 00112355778999999999999998 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=323.46 Aligned_cols=256 Identities=23% Similarity=0.397 Sum_probs=202.2
Q ss_pred ccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
..++|++.++||+|+||.||+|...++..||+|.+.... ...+.+.+|+.+++.++|+||+++++.+.+ ....+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 77 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTK-----EEPIY 77 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcC-----CCCcE
Confidence 346789999999999999999997778899999876432 235678999999999999999999988754 33579
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
++|||+++|+|.+++...... .+++.++..++.|++.||.||| +++++||||||+||+++.++.+||+||
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df 147 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGG-------KVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADF 147 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCC
Confidence 999999999999999764322 3557888999999999999999 899999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcCcc
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMALPQR 381 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 381 (473)
|++........ .......++..|+|||++.+..++.++|||||||++|+|++ |..||....... .........+
T Consensus 148 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~~~~~~~~~-- 222 (261)
T cd05072 148 GLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD--VMSALQRGYR-- 222 (261)
T ss_pred ccceecCCCce-eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH--HHHHHHcCCC--
Confidence 99987643221 11122335678999999988889999999999999999998 999997532111 0000000000
Q ss_pred hhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHH
Q 012014 382 AEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRL 451 (473)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 451 (473)
.+.....+..+.+++.+||+.||++|||+++|.+.|+.
T Consensus 223 --------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 223 --------------------------------MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred --------------------------------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 00001245578899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=324.16 Aligned_cols=263 Identities=25% Similarity=0.434 Sum_probs=203.3
Q ss_pred cCCCCccceeecCCCeEEEEEEec------CCCEEEEEEeeccCCC-CchhHHHHHHHHHhcCCCCceeeeeeeeccccC
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRPG-GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQ 216 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 216 (473)
.++|.+.+.||+|+||.||+|... +++.||+|.++..... ..+.+.+|++++..++||||+++++++...
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--- 80 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG--- 80 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC---
Confidence 356888999999999999999853 3478999998754433 346789999999999999999999998553
Q ss_pred CceeeEEEEEecCCCCHHHHhcCCCCCCC-----CCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEe
Q 012014 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNW-----RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL 291 (473)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~-----~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~ 291 (473)
...+++|||+++++|.+++........ ......+++.++..++.|++.||.||| +++++||||||+||++
T Consensus 81 --~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili 155 (280)
T cd05049 81 --DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLV 155 (280)
T ss_pred --CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEE
Confidence 467999999999999999976542110 111224678899999999999999999 9999999999999999
Q ss_pred cCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccH
Q 012014 292 DDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNL 370 (473)
Q Consensus 292 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~ 370 (473)
+.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |..||.+.....
T Consensus 156 ~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~--- 232 (280)
T cd05049 156 GYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE--- 232 (280)
T ss_pred cCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---
Confidence 9999999999999976533221111122335788999999999999999999999999999998 999986532211
Q ss_pred HHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHH
Q 012014 371 RNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLR 450 (473)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 450 (473)
........... ..+...+..+.+++.+||+.||++|||+.||++.|+
T Consensus 233 --~~~~~~~~~~~-------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 233 --VIECITQGRLL-------------------------------QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred --HHHHHHcCCcC-------------------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 11000000000 001124567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-43 Score=324.84 Aligned_cols=257 Identities=26% Similarity=0.405 Sum_probs=206.5
Q ss_pred ccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
...+|.+.++||.|+||.||+|...++..+|+|.+..........+.+|+.+++.++||||+++++++.+. ...+
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 78 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVG-----EPVY 78 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecC-----CCeE
Confidence 34578899999999999999999777899999998765554567889999999999999999999987543 3679
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
+||||+++++|.+++...... .+++.++..++.|++.||.||| +++++|+||||+||++++++.+||+||
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~ 148 (261)
T cd05148 79 IITELMEKGSLLAFLRSPEGQ-------VLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADF 148 (261)
T ss_pred EEEeecccCCHHHHHhcCCCC-------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccc
Confidence 999999999999999765322 3568889999999999999999 899999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcCcc
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMALPQR 381 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 381 (473)
|.+......... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+ .+.... ....
T Consensus 149 g~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~-~~~~~~-~~~~-- 222 (261)
T cd05148 149 GLARLIKEDVYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE-VYDQIT-AGYR-- 222 (261)
T ss_pred cchhhcCCcccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH-HHHHHH-hCCc--
Confidence 999766432211 113345778999999988889999999999999999998 899997533111 001000 0000
Q ss_pred hhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHH
Q 012014 382 AEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLI 452 (473)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l 452 (473)
...+..++..+.+++.+||+.||.+|||+.+|++.|+.+
T Consensus 223 --------------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 223 --------------------------------MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred --------------------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 001123456788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=324.44 Aligned_cols=250 Identities=28% Similarity=0.438 Sum_probs=189.4
Q ss_pred ccceeecCCCeEEEEEEec-----CCCEEEEEEeeccCCC-CchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 149 SANLIGAGNFGSVYNGTLF-----DGTTIAVKVFNLIRPG-GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 149 ~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
+.+.||.|.||.||+|.+. .+..|+||.++..... ..+.+.+|++.+.+++||||++++|++... ...+
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~-----~~~~ 77 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIEN-----EPLF 77 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESS-----SSEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccc-----cccc
Confidence 4578999999999999965 3578999999643222 357899999999999999999999999732 2479
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
+||||+++|+|.++|...... .+++.++..|+.||+.||.||| +++++|+||+++||+++.++.+||+||
T Consensus 78 lv~e~~~~g~L~~~L~~~~~~-------~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f 147 (259)
T PF07714_consen 78 LVMEYCPGGSLDDYLKSKNKE-------PLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDF 147 (259)
T ss_dssp EEEE--TTEBHHHHHHHTCTT-------TSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEEST
T ss_pred ccccccccccccccccccccc-------cccccccccccccccccccccc---ccccccccccccccccccccccccccc
Confidence 999999999999999887222 4678999999999999999999 899999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcCcc
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMALPQR 381 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 381 (473)
|++................+...|+|||.+.+..++.++||||||+++|||++ |..||...... .+........
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~-----~~~~~~~~~~ 222 (259)
T PF07714_consen 148 GLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE-----EIIEKLKQGQ 222 (259)
T ss_dssp TTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH-----HHHHHHHTTE
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-----cccccccccc
Confidence 99987632222222222336778999999998889999999999999999999 78998654211 1111111110
Q ss_pred hhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHH
Q 012014 382 AEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRL 449 (473)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L 449 (473)
.. ..+..++..+.+++..||+.||++|||+.+|++.|
T Consensus 223 ~~-------------------------------~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 223 RL-------------------------------PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ET-------------------------------TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cc-------------------------------eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 00 01123466788999999999999999999999887
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=324.30 Aligned_cols=267 Identities=24% Similarity=0.391 Sum_probs=205.8
Q ss_pred CCCCccceeecCCCeEEEEEEec------CCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 145 NGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
.+|.+.+.||+|+||.||+|... ++..+++|.++.......+.+.+|+.++++++||||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 79 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDG----- 79 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC-----
Confidence 46788899999999999999732 3456899988654444446789999999999999999999998543
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCC-------CCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEe
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTN-------WRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL 291 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~-------~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~ 291 (473)
...++||||+++++|.+++....... .......+++..++.++.||+.||.||| +++|+||||||+||++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~ 156 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLV 156 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEE
Confidence 36799999999999999997653210 0011123678999999999999999999 9999999999999999
Q ss_pred cCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccH
Q 012014 292 DDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNL 370 (473)
Q Consensus 292 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~ 370 (473)
+.++.+||+|||++................|+..|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus 157 ~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--- 233 (291)
T cd05094 157 GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--- 233 (291)
T ss_pred ccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence 9999999999999976543322222223346788999999998889999999999999999999 999986532211
Q ss_pred HHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHH
Q 012014 371 RNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLR 450 (473)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 450 (473)
............ ....++..+.+++.+||+.||++|||+.+|++.|+
T Consensus 234 --~~~~~~~~~~~~-------------------------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~ 280 (291)
T cd05094 234 --VIECITQGRVLE-------------------------------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILH 280 (291)
T ss_pred --HHHHHhCCCCCC-------------------------------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 111000000000 01124567889999999999999999999999999
Q ss_pred HHHHh
Q 012014 451 LIRRK 455 (473)
Q Consensus 451 ~l~~~ 455 (473)
.+...
T Consensus 281 ~~~~~ 285 (291)
T cd05094 281 ALGKA 285 (291)
T ss_pred HHHhh
Confidence 99653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=317.32 Aligned_cols=251 Identities=24% Similarity=0.346 Sum_probs=197.4
Q ss_pred CCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEE
Q 012014 145 NGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVV 224 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 224 (473)
++|++.+.||+|+||.||++.+.++..+|+|.+.... .....+.+|+.++++++||||+++++++... ...++|
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~iv 77 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ-----KPLYIV 77 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccC-----CCEEEE
Confidence 4688889999999999999998777899999876332 2346788999999999999999999997543 367999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeeccc
Q 012014 225 YKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM 304 (473)
Q Consensus 225 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~ 304 (473)
|||+++|+|.+++..... .+++..+..++.|++.||.||| +++|+||||||+||+++.++.+||+|||.
T Consensus 78 ~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~ 146 (256)
T cd05114 78 TEFMENGCLLNYLRQRQG--------KLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGM 146 (256)
T ss_pred EEcCCCCcHHHHHHhCcc--------CCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCC
Confidence 999999999999875432 2568889999999999999999 99999999999999999999999999999
Q ss_pred ccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcCcchh
Q 012014 305 ARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMALPQRAE 383 (473)
Q Consensus 305 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 383 (473)
++........ ......++..|+|||++.+..++.++||||||+++|+|++ |+.||...... ...........
T Consensus 147 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~-----~~~~~i~~~~~- 219 (256)
T cd05114 147 TRYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-----EVVEMISRGFR- 219 (256)
T ss_pred ccccCCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHHHHCCCC-
Confidence 8765332211 1122235668999999988889999999999999999999 89999653211 11111100000
Q ss_pred hhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHH
Q 012014 384 EVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRL 449 (473)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L 449 (473)
... +...+..+.+++.+||+.||++|||+.++++.|
T Consensus 220 -~~~-----------------------------~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 220 -LYR-----------------------------PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred -CCC-----------------------------CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 000 011234688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=321.23 Aligned_cols=257 Identities=23% Similarity=0.347 Sum_probs=198.0
Q ss_pred CCCCccceeecCCCeEEEEEEe-cCCC----EEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 145 NGFSSANLIGAGNFGSVYNGTL-FDGT----TIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~-~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
++|++.+.||+|+||.||+|.+ .+++ .+++|.+..... .....+..|+..+.+++||||+++++++..
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~------ 80 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG------ 80 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC------
Confidence 4688899999999999999984 3444 477777653221 123457778888999999999999998743
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...++++||+++|+|.+++..... .+++..+..++.||+.||.||| +++++||||||+||+++.++.+|
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~k 149 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHRD--------SLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQ 149 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEE
Confidence 235789999999999999976432 3568899999999999999999 89999999999999999999999
Q ss_pred EeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhh
Q 012014 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~ 377 (473)
|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.+..... +...+...
T Consensus 150 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--~~~~~~~~ 227 (279)
T cd05111 150 IADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE--VPDLLEKG 227 (279)
T ss_pred EcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHCC
Confidence 999999986644332222233456788999999988889999999999999999998 999997642111 11111100
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHH
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRR 454 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~ 454 (473)
.. .. .+..++..+.+++.+||..||++|||+.|+++.|..+..
T Consensus 228 ~~-----~~-----------------------------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 228 ER-----LA-----------------------------QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred Cc-----CC-----------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 00 00 001134467789999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=322.86 Aligned_cols=265 Identities=23% Similarity=0.348 Sum_probs=200.1
Q ss_pred cccCCCCccceeecCCCeEEEEEEec------CCCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccc
Q 012014 142 NATNGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVD 214 (473)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 214 (473)
...++|++.+.||+|+||.||+|... .+..||+|+++.... .....+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~-- 80 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-- 80 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC--
Confidence 35678999999999999999998742 246799998863221 223468899999999999999999999743
Q ss_pred cCCceeeEEEEEecCCCCHHHHhcCCCCCC-CCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecC
Q 012014 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTN-WRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD 293 (473)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~ 293 (473)
....++||||+++|+|.+++....... ..+....+++..+..++.|++.||.||| +++++||||||+||++++
T Consensus 81 ---~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~ 154 (277)
T cd05062 81 ---GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAE 154 (277)
T ss_pred ---CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcC
Confidence 336799999999999999997543211 0111123557888999999999999999 899999999999999999
Q ss_pred CccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHH
Q 012014 294 EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRN 372 (473)
Q Consensus 294 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~ 372 (473)
++.++|+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.+.... .
T Consensus 155 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~-----~ 229 (277)
T cd05062 155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE-----Q 229 (277)
T ss_pred CCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----H
Confidence 99999999999876543222111122345778999999998889999999999999999999 78898753221 1
Q ss_pred HHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHH
Q 012014 373 FVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLR 450 (473)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 450 (473)
............ .+..++..+.+++.+||+.||++|||+.|+++.|+
T Consensus 230 ~~~~~~~~~~~~-------------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 230 VLRFVMEGGLLD-------------------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHHHHHcCCcCC-------------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 111000000000 01123557889999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=317.87 Aligned_cols=256 Identities=23% Similarity=0.342 Sum_probs=200.9
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
..+|.+.+.||+|+||.||+|.. .+++.||+|.+... ......+.+|++++..++||||+++++++... ...+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 78 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-----PPFY 78 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCC-----CCcE
Confidence 34688889999999999999984 46889999998643 23346788999999999999999999987543 3579
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
++|||+++++|.+++...... .+++..++.++.|++.||.||| +++++||||||+||++++++.+||+||
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~-------~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df 148 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNRQ-------EVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADF 148 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCCC-------CCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCC
Confidence 999999999999999754322 3568888999999999999999 999999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcCcc
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMALPQR 381 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 381 (473)
|++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||.+.... ..........
T Consensus 149 ~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-----~~~~~~~~~~ 222 (263)
T cd05052 149 GLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----QVYELLEKGY 222 (263)
T ss_pred cccccccccee-eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHHHHCCC
Confidence 99986543221 11112224667999999998899999999999999999998 99998753211 1110000000
Q ss_pred hhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHH
Q 012014 382 AEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLI 452 (473)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l 452 (473)
. ...+..++..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 223 -----~--------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 223 -----R--------------------------MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -----C--------------------------CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 0 000112456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=322.17 Aligned_cols=264 Identities=22% Similarity=0.355 Sum_probs=201.7
Q ss_pred CCccceeecCCCeEEEEEEec-C---CCEEEEEEeeccCC--CCchhHHHHHHHHHhcCCCCceeeeeeeecccc-CCce
Q 012014 147 FSSANLIGAGNFGSVYNGTLF-D---GTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY-QGAR 219 (473)
Q Consensus 147 ~~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 219 (473)
|.+.+.||+|+||.||+|... + +..||+|+++.... .....+.+|+..++.++||||+++++++..... ....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567889999999999999843 2 36799999874332 223578899999999999999999998765442 2334
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
..+++|||+++|+|..++........ ...+++..+..++.|++.||.||| +++++||||||+||++++++.+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~---~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl 154 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGL---PEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCV 154 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCC---cccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEE
Confidence 57999999999999999865432111 124668899999999999999999 899999999999999999999999
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhc
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMAL 378 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 378 (473)
+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+ +.....
T Consensus 155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~--~~~~~~--- 229 (273)
T cd05035 155 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE--IYDYLR--- 229 (273)
T ss_pred CCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHH---
Confidence 99999986644322222222335678999999988889999999999999999999 889986532211 000000
Q ss_pred CcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHH
Q 012014 379 PQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLI 452 (473)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l 452 (473)
.... ...+..++..+.+++.+||+.||++|||+.||++.|+.+
T Consensus 230 ~~~~-------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 230 HGNR-------------------------------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred cCCC-------------------------------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0000 000123456789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=318.54 Aligned_cols=261 Identities=19% Similarity=0.278 Sum_probs=203.9
Q ss_pred CCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCC---CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP---GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
++|++.+.||+|+||.||+|+ ..+++.||+|.++.... .....+.+|+.+++.++||||+++++++.+. ..
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED-----NE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC-----Ce
Confidence 578999999999999999998 45789999998864322 2234678999999999999999999987643 36
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.++++||+++|+|.+++...... ...++...+..++.|++.||.||| +++++|+||||+||+++.++.++|+
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~ 148 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQ-----KRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLG 148 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhc-----cCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEEC
Confidence 79999999999999988643211 113567889999999999999999 9999999999999999999999999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCc
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQ 380 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 380 (473)
|||++........ ......|++.|+|||.+.+..++.++||||||+++|+|++|..||....... ..+.......
T Consensus 149 d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~---~~~~~~~~~~ 223 (267)
T cd08228 149 DLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL---FSLCQKIEQC 223 (267)
T ss_pred ccccceeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH---HHHHHHHhcC
Confidence 9999887643221 1223458899999999988889999999999999999999999986532211 1111110000
Q ss_pred chhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHH
Q 012014 381 RAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIR 453 (473)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~ 453 (473)
.... ......+..+.+++.+||+.+|++|||+.+|++.|+.++
T Consensus 224 ~~~~------------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 224 DYPP------------------------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CCCC------------------------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 0000 001134567899999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=338.53 Aligned_cols=201 Identities=21% Similarity=0.280 Sum_probs=169.3
Q ss_pred CCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC---CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
.|...+.||+|+||.||+|+ ..+++.||+|++.... ......+.+|+.++..++||||+++++++.+. ...
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~-----~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDK-----DNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecC-----CEE
Confidence 58889999999999999998 4578999999997432 22345688999999999999999999998643 368
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEee
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~D 301 (473)
++||||+++|+|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~---------~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~D 144 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIRME---------VFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTD 144 (381)
T ss_pred EEEEecCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEee
Confidence 99999999999999997654 3557888889999999999999 99999999999999999999999999
Q ss_pred cccccccCccccc---------------------------------------------cceeeccCCCCcCCCccccCCC
Q 012014 302 FGMARFLPAIDKQ---------------------------------------------NRFICIKGSTGYIPPEYDLGCE 336 (473)
Q Consensus 302 fg~~~~~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~ 336 (473)
||+++.+...... .......||+.|+|||++.+..
T Consensus 145 FGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~ 224 (381)
T cd05626 145 FGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG 224 (381)
T ss_pred CcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCC
Confidence 9997643210000 0012346999999999999888
Q ss_pred CCcccchhhHhHHHHHHHhCCCCCCCC
Q 012014 337 ASTYGDVYSFGILLLEMFTGIRPSDGI 363 (473)
Q Consensus 337 ~~~~~DiwSlG~il~elltg~~P~~~~ 363 (473)
++.++|||||||++|||++|..||...
T Consensus 225 ~~~~~DiwSlG~il~elltG~~Pf~~~ 251 (381)
T cd05626 225 YTQLCDWWSVGVILFEMLVGQPPFLAP 251 (381)
T ss_pred CCCccceeehhhHHHHHHhCCCCCcCC
Confidence 999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=324.60 Aligned_cols=272 Identities=21% Similarity=0.281 Sum_probs=202.2
Q ss_pred CCC-CccceeecCCCeEEEEEE-----ecCCCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCC
Q 012014 145 NGF-SSANLIGAGNFGSVYNGT-----LFDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (473)
Q Consensus 145 ~~~-~~~~~lg~G~~g~V~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (473)
++| ...+.||+|+||.||++. ..++..||+|.++.... .....+.+|+.++++++||||+++++++... .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~ 79 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ---G 79 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---C
Confidence 344 888999999999998864 23578899999875332 2346788999999999999999999987542 2
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccE
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~ 297 (473)
....+++|||+++++|.+++... .+++.++..++.|++.||.||| +++|+||||||+||+++.++.+
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~~----------~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~ 146 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPKH----------KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLV 146 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHHc----------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcE
Confidence 34678999999999999999754 2568999999999999999999 9999999999999999999999
Q ss_pred EEeecccccccCccccccc-eeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 012014 298 HVGDFGMARFLPAIDKQNR-FICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKM 376 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~ 376 (473)
||+|||+++.......... .....++..|+|||.+.+..++.++||||||+++|+|++|..||......- ......
T Consensus 147 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~---~~~~~~ 223 (283)
T cd05080 147 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF---EEMIGP 223 (283)
T ss_pred EEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh---hhhhcc
Confidence 9999999986644221111 112235667999999988889999999999999999999999986532211 111100
Q ss_pred hcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHH
Q 012014 377 ALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIR 453 (473)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~ 453 (473)
.. ............... ...+.+..++..+.+++.+||+.||++|||+++|++.|+.+.
T Consensus 224 ~~----~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 224 KQ----GQMTVVRLIELLERG--------------MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred cc----cccchhhhhhhhhcC--------------CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 00 000000000000000 000111235678999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=323.80 Aligned_cols=275 Identities=23% Similarity=0.338 Sum_probs=203.0
Q ss_pred cCCCCccceeecCCCeEEEEEEe-----cCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-----FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
.++|++.+.||+|+||.||++.. .++..||+|.+........+.+.+|++++..++||||+++++++... +.
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~ 79 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GR 79 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC---CC
Confidence 35788999999999999999873 35789999998755444456789999999999999999999987542 23
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...++||||+++|+|.+++..... .+++..+..++.|++.||.||| ++|++||||||+||+++.++.+|
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~--------~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~ 148 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRE--------RLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVK 148 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCc--------CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEE
Confidence 457999999999999999975432 2558889999999999999999 99999999999999999999999
Q ss_pred EeecccccccCccccccce-eeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 299 VGDFGMARFLPAIDKQNRF-ICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
|+|||++............ ....++..|+|||++.+..++.++||||||+++|||++|..|+..... .+....
T Consensus 149 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~------~~~~~~ 222 (284)
T cd05081 149 IGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA------EFMRMM 222 (284)
T ss_pred ECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch------hhhhhc
Confidence 9999999876443221111 112234569999999888899999999999999999998877643211 011100
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHH
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLI 452 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l 452 (473)
............+........ .......++..+.+|+.+||+.+|++|||+.||++.|+.+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 223 GNDKQGQMIVYHLIELLKNNG--------------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred ccccccccchHHHHHHHhcCC--------------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 000000000000000000000 0001123456799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=320.03 Aligned_cols=257 Identities=26% Similarity=0.387 Sum_probs=202.3
Q ss_pred ccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
..++|++.+.||+|+||.||+|...+++.||+|.++... ...+.+.+|+.++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 77 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE-----EPIY 77 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecC-----CCee
Confidence 346789999999999999999997677889999986433 2356788999999999999999999987543 3679
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
++|||+++++|.+++...... .+++..+..++.|++.||.||| +++++||||||+||+++.++.+||+||
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~df 147 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGR-------ALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADF 147 (261)
T ss_pred eeeecccCCcHHHHHhccCCC-------CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCc
Confidence 999999999999999765311 3568899999999999999999 999999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcCcc
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMALPQR 381 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 381 (473)
|+++....... .......++..|+|||++.+..++.++||||||+++|+|++ |..||.+..... .+... .....
T Consensus 148 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~~-~~~~~-- 222 (261)
T cd05068 148 GLARVIKEDIY-EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-VLQQV-DQGYR-- 222 (261)
T ss_pred ceEEEccCCcc-cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH-HHHHH-HcCCC--
Confidence 99987653211 11111223457999999998889999999999999999999 999997532111 00000 00000
Q ss_pred hhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHH
Q 012014 382 AEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLI 452 (473)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l 452 (473)
...+...+..+.+++.+||+.||.+||++.+|.+.|+.+
T Consensus 223 --------------------------------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 223 --------------------------------MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred --------------------------------CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 000112456788999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=325.93 Aligned_cols=252 Identities=23% Similarity=0.334 Sum_probs=207.0
Q ss_pred cccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCC---chhHHHHHHHHHhcC-CCCceeeeeeeeccccC
Q 012014 142 NATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGG---SKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQ 216 (473)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 216 (473)
.....|.+.+.||+|.||.||+++ ..+|+.+|+|.+.+..... ...+.+|+.+|+++. |||||.++++|.+.
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~--- 108 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP--- 108 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC---
Confidence 345678889999999999999999 4569999999997655433 358999999999998 99999999998654
Q ss_pred CceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCC--
Q 012014 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE-- 294 (473)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~-- 294 (473)
...++|||+|.||.|.+.+... .+++..+..++.|++.|+.||| +.||+||||||+|+|+...
T Consensus 109 --~~~~lvmEL~~GGeLfd~i~~~----------~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~ 173 (382)
T KOG0032|consen 109 --DSVYLVMELCEGGELFDRIVKK----------HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDE 173 (382)
T ss_pred --CeEEEEEEecCCchHHHHHHHc----------cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccC
Confidence 3789999999999999999875 1669999999999999999999 9999999999999999533
Q ss_pred --ccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHH
Q 012014 295 --MIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRN 372 (473)
Q Consensus 295 --~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~ 372 (473)
+.+|++|||++..... .......+||+.|+|||++....|+..+||||+||++|.|++|.+||.+........ .
T Consensus 174 ~~~~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-~ 249 (382)
T KOG0032|consen 174 GSGRIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-A 249 (382)
T ss_pred CCCcEEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-H
Confidence 5799999999998755 445667889999999999999999999999999999999999999998754333211 1
Q ss_pred HHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 373 FVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
...... .. . . +.-......+.+++..|+..||..|+|+.++++
T Consensus 250 i~~~~~-----~f-~---~-----------------------~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 250 ILRGDF-----DF-T---S-----------------------EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred HHcCCC-----CC-C---C-----------------------CCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 111110 00 0 0 001234667889999999999999999999988
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=334.04 Aligned_cols=249 Identities=22% Similarity=0.296 Sum_probs=189.6
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
.++|+..++||+|+||.||+|+ ..+++.||||++..... .....+.+|+++++.++|+||+++++++.. ....
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 147 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDH-----NGEI 147 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEecc-----CCeE
Confidence 3567788999999999999998 45689999999864322 223568899999999999999999999754 3467
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEee
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~D 301 (473)
++||||+++|+|.+... ..+..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|
T Consensus 148 ~lv~e~~~~~~L~~~~~-------------~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~D 211 (353)
T PLN00034 148 QVLLEFMDGGSLEGTHI-------------ADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIAD 211 (353)
T ss_pred EEEEecCCCCccccccc-------------CCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcc
Confidence 99999999999865321 225677889999999999999 99999999999999999999999999
Q ss_pred cccccccCccccccceeeccCCCCcCCCccccC-----CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 012014 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-----CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKM 376 (473)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~ 376 (473)
||+++.+.... .......||..|+|||++.. ...+.++|||||||++|||++|+.||......+ +......
T Consensus 212 fG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~~~~ 287 (353)
T PLN00034 212 FGVSRILAQTM--DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD--WASLMCA 287 (353)
T ss_pred cccceeccccc--ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHHHH
Confidence 99998654321 11233468999999998743 234568999999999999999999997322111 1111100
Q ss_pred hcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 377 ALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
...... .......+.++.+|+.+||+.||++|||+.||++.
T Consensus 288 ~~~~~~-------------------------------~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 288 ICMSQP-------------------------------PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HhccCC-------------------------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 00012345678899999999999999999999864
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=329.29 Aligned_cols=199 Identities=26% Similarity=0.339 Sum_probs=169.8
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccC-CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
.++|++.++||+|+||.||++.. .++..+|+|.+.... ......+.+|++++..++||||++++++|... ...
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 78 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEI 78 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC-----CEE
Confidence 46899999999999999999994 468899999887532 22335688999999999999999999998653 378
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCC-CCeeeccCCCCcEEecCCccEEEe
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQ-PPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
++||||+++|+|.+++.... .+++..+..++.|++.||.||| + .+|+||||||+|||++.++.+||+
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dlkp~Nili~~~~~~kL~ 146 (333)
T cd06650 79 SICMEHMDGGSLDQVLKKAG---------RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLC 146 (333)
T ss_pred EEEEecCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChhhEEEcCCCCEEEe
Confidence 99999999999999997643 2457788899999999999999 6 479999999999999999999999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCC
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 363 (473)
|||++....... .....||..|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 147 Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 147 DFGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred eCCcchhhhhhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 999987553221 12345899999999999888999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=321.00 Aligned_cols=263 Identities=22% Similarity=0.375 Sum_probs=200.7
Q ss_pred CCCCccceeecCCCeEEEEEEe-----cCCCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 145 NGFSSANLIGAGNFGSVYNGTL-----FDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
++|++.+.||+|+||.||+|.. .++..+|+|.++.... .....+.+|+.+++.++||||+++++++...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----- 79 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE----- 79 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC-----
Confidence 4688889999999999999973 2457899999874332 2235688999999999999999999987543
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCC--------CCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTN--------WRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVL 290 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~--------~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil 290 (473)
...+++|||+++++|.+++....... .......+++.+++.++.|++.||.||| +++++||||||+||+
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nil 156 (283)
T cd05090 80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNIL 156 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEE
Confidence 36799999999999999986432110 0111224668889999999999999999 999999999999999
Q ss_pred ecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCccc
Q 012014 291 LDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMN 369 (473)
Q Consensus 291 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~ 369 (473)
++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.+.... .
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~--~ 234 (283)
T cd05090 157 IGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ--E 234 (283)
T ss_pred EcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--H
Confidence 99999999999999986543322222233445778999999988889999999999999999998 99998753211 1
Q ss_pred HHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHH
Q 012014 370 LRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRL 449 (473)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L 449 (473)
+...+... ... ..+..++..+.+++.+||+.||++||++.+|++.|
T Consensus 235 ~~~~~~~~---~~~-------------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 280 (283)
T cd05090 235 VIEMVRKR---QLL-------------------------------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280 (283)
T ss_pred HHHHHHcC---CcC-------------------------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHh
Confidence 11111100 000 00112456788999999999999999999999988
Q ss_pred HH
Q 012014 450 RL 451 (473)
Q Consensus 450 ~~ 451 (473)
.+
T Consensus 281 ~~ 282 (283)
T cd05090 281 RS 282 (283)
T ss_pred hc
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=339.18 Aligned_cols=202 Identities=23% Similarity=0.350 Sum_probs=171.4
Q ss_pred CCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC---CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
++|++.++||+|+||.||+|+ ..+++.||||+++... ......+.+|+.++..++||||++++++|.+ ...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-----~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD-----ENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-----CCe
Confidence 478999999999999999999 4568999999997432 2234567889999999999999999999854 347
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.++||||+++|+|.+++.... .+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+
T Consensus 76 ~~lv~E~~~~g~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~ 143 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMKKD---------TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLS 143 (364)
T ss_pred EEEEECCCCCcHHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEe
Confidence 899999999999999997654 3668899999999999999999 9999999999999999999999999
Q ss_pred ecccccccCcccccc------------------------------------ceeeccCCCCcCCCccccCCCCCcccchh
Q 012014 301 DFGMARFLPAIDKQN------------------------------------RFICIKGSTGYIPPEYDLGCEASTYGDVY 344 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 344 (473)
|||+++.+....... ......||+.|+|||++.+..++.++|||
T Consensus 144 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 223 (364)
T cd05599 144 DFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWW 223 (364)
T ss_pred ecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeee
Confidence 999987543211000 01124599999999999998999999999
Q ss_pred hHhHHHHHHHhCCCCCCCC
Q 012014 345 SFGILLLEMFTGIRPSDGI 363 (473)
Q Consensus 345 SlG~il~elltg~~P~~~~ 363 (473)
||||++|||++|..||.+.
T Consensus 224 SlG~il~el~~G~~Pf~~~ 242 (364)
T cd05599 224 SLGVIMYEMLVGYPPFCSD 242 (364)
T ss_pred cchhHHHHhhcCCCCCCCC
Confidence 9999999999999999753
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=320.39 Aligned_cols=257 Identities=23% Similarity=0.379 Sum_probs=201.3
Q ss_pred cCCCCccceeecCCCeEEEEEEec----CCCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTLF----DGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
.++|++.+.||+|+||.||+|.+. +...||+|.++.... .....+.+|+.++..++||||+++++++.+ .
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 77 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK-----S 77 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEec-----C
Confidence 467899999999999999999853 245799998864332 233568899999999999999999998754 3
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...+++|||+++++|.+++..... .+++.++..++.|++.||.||| +++|+|+||||+||+++.++.++
T Consensus 78 ~~~~iv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~ 146 (266)
T cd05033 78 RPVMIITEYMENGSLDKFLRENDG--------KFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCK 146 (266)
T ss_pred CceEEEEEcCCCCCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEE
Confidence 357999999999999999976432 3568899999999999999999 99999999999999999999999
Q ss_pred EeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhh
Q 012014 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~ 377 (473)
|+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||....... +.......
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~~~~ 224 (266)
T cd05033 147 VSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD--VIKAVEDG 224 (266)
T ss_pred ECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH--HHHHHHcC
Confidence 999999987752222222222335678999999998889999999999999999998 999986432111 00000000
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHH
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLI 452 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l 452 (473)
... +.+..++..+.+|+.+||+.||++|||+.||++.|+++
T Consensus 225 ~~~----------------------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 225 YRL----------------------------------PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCC----------------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 000 00112456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=313.95 Aligned_cols=254 Identities=24% Similarity=0.332 Sum_probs=202.9
Q ss_pred ccCCCCccceeecCCCeEEEEEEec-CCCEEEEEEeeccC---CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
..++|++.+.||+|.-|+||+++.. ++..+|+|++.+.. .....+.+.|-+||+.++||.++.+|..|.. .
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet-----~ 149 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET-----D 149 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec-----c
Confidence 3467888999999999999999954 46899999997533 2334567889999999999999999999854 5
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
.+.|++||||+||+|..+++.+... .|++..+.-++.+++.||+||| -.|||+|||||+||||.++|++.
T Consensus 150 ~~~cl~meyCpGGdL~~LrqkQp~~-------~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIM 219 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQKQPGK-------RFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIM 219 (459)
T ss_pred ceeEEEEecCCCccHHHHHhhCCCC-------ccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEE
Confidence 5889999999999999998877644 5889999999999999999999 99999999999999999999999
Q ss_pred EeecccccccCc---------------------------------ccc---------------------ccceeeccCCC
Q 012014 299 VGDFGMARFLPA---------------------------------IDK---------------------QNRFICIKGST 324 (473)
Q Consensus 299 l~Dfg~~~~~~~---------------------------------~~~---------------------~~~~~~~~gt~ 324 (473)
|+||.++..... ... .....+++||-
T Consensus 220 LsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGTh 299 (459)
T KOG0610|consen 220 LSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTH 299 (459)
T ss_pred eeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccc
Confidence 999998743211 000 01123467999
Q ss_pred CcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhccc
Q 012014 325 GYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEV 404 (473)
Q Consensus 325 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (473)
.|.|||++.|...+.++|+|+|||++|||+.|..||.|....++ +.+.+.....
T Consensus 300 EYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T-l~NIv~~~l~------------------------- 353 (459)
T KOG0610|consen 300 EYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET-LRNIVGQPLK------------------------- 353 (459)
T ss_pred ccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh-HHHHhcCCCc-------------------------
Confidence 99999999999999999999999999999999999998655443 2222211100
Q ss_pred ccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCC----hHHHH
Q 012014 405 SSSSGSSAHASIILECFNSICEIGVACSAERPRERMK----INDVE 446 (473)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt----~~ev~ 446 (473)
.+...+....+.+||.+.|.+||.+|.. +.||-
T Consensus 354 ---------Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 354 ---------FPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK 390 (459)
T ss_pred ---------CCCCCcchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence 0001134457789999999999999998 66664
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=341.43 Aligned_cols=287 Identities=20% Similarity=0.265 Sum_probs=199.0
Q ss_pred ccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeecccc---CCc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY---QGA 218 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~ 218 (473)
...+|.+.++||+|+||.||+|.. .+++.||||++... .....+|+.+++.++||||++++++|..... ...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 346799999999999999999984 56899999988532 2345679999999999999999988754322 223
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCc-cE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM-IG 297 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~-~~ 297 (473)
.+.++||||++ ++|.+++...... ...+++..+..++.||+.||.||| +++|+||||||+|||++.++ .+
T Consensus 140 ~~l~lvmE~~~-~~l~~~~~~~~~~-----~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~v 210 (440)
T PTZ00036 140 IFLNVVMEFIP-QTVHKYMKHYARN-----NHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTL 210 (440)
T ss_pred eEEEEEEecCC-ccHHHHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCce
Confidence 45789999996 5787776532111 113668889999999999999999 99999999999999998664 79
Q ss_pred EEeecccccccCccccccceeeccCCCCcCCCccccCC-CCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 012014 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKM 376 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~ 376 (473)
||+|||+++.+.... ......||+.|+|||++.+. .++.++|||||||++|||++|.+||.+....+ .+......
T Consensus 211 kL~DFGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-~~~~i~~~ 286 (440)
T PTZ00036 211 KLCDFGSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD-QLVRIIQV 286 (440)
T ss_pred eeeccccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHH
Confidence 999999998664322 22234689999999998764 68999999999999999999999998643322 12222211
Q ss_pred hcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHH--HHHHHHH
Q 012014 377 ALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVE--SRLRLIR 453 (473)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~--~~L~~l~ 453 (473)
........... . ...+.. ...............+...+.++.+|+.+||..||.+|||+.|++ ..++.++
T Consensus 287 ~~~p~~~~~~~-~-~~~~~~-----~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 287 LGTPTEDQLKE-M-NPNYAD-----IKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred hCCCCHHHHHH-h-chhhhc-----ccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 11111000000 0 000000 000000000011111223456889999999999999999999998 3455444
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=331.68 Aligned_cols=244 Identities=22% Similarity=0.284 Sum_probs=189.7
Q ss_pred CCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC---CCCchhHHHHHHHH---HhcCCCCceeeeeeeeccccCCce
Q 012014 147 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAA---INIKHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 147 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~~~ 219 (473)
|++.+.||+|+||.||+|. ..+++.||||+++... ....+.+.+|++++ ..++||||+++++++.. ..
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~-----~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT-----ED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc-----CC
Confidence 6678899999999999998 4568999999997432 22335567776665 45689999999999754 34
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
..++||||+++|+|..++... .+++..+..++.||+.||.||| +++|+||||||+||+++.++.+||
T Consensus 76 ~~~lv~E~~~~~~L~~~~~~~----------~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL 142 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIHTD----------VFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKI 142 (324)
T ss_pred EEEEEEcCCCCCcHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEe
Confidence 789999999999999988653 3668899999999999999999 999999999999999999999999
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcC
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP 379 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 379 (473)
+|||+++..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.... ........
T Consensus 143 ~Dfg~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~-----~~~~~i~~ 215 (324)
T cd05589 143 ADFGLCKEGMGF--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-----EVFDSIVN 215 (324)
T ss_pred CcccCCccCCCC--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHh
Confidence 999998753221 12223456999999999999989999999999999999999999999753211 11100000
Q ss_pred cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCC-----hHHHHH
Q 012014 380 QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMK-----INDVES 447 (473)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~ 447 (473)
... ..+...+..+.+++.+||+.||.+||+ +.++++
T Consensus 216 ~~~--------------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 216 DEV--------------------------------RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CCC--------------------------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 000 001123557789999999999999994 555544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=336.01 Aligned_cols=255 Identities=22% Similarity=0.265 Sum_probs=196.7
Q ss_pred cccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC---CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCC
Q 012014 142 NATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (473)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (473)
...++|++.++||+|+||.||+|+ ..+++.||+|+++... ......+.+|+.+++.++||||+++++++.+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~----- 114 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD----- 114 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec-----
Confidence 345689999999999999999998 4568999999996422 2233457889999999999999999998754
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccE
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~ 297 (473)
....++||||+++|+|.+++.... +++..+..++.||+.||.||| +++|+||||||+|||++.++.+
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~~~~----------l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~ 181 (370)
T cd05596 115 DKYLYMVMEYMPGGDLVNLMSNYD----------IPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHL 181 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCE
Confidence 347899999999999999986542 457788889999999999999 9999999999999999999999
Q ss_pred EEeecccccccCccccccceeeccCCCCcCCCccccCC----CCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHH
Q 012014 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC----EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNF 373 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~ 373 (473)
||+|||++....... ........||+.|+|||++.+. .++.++|||||||++|||++|..||.+..... .+...
T Consensus 182 kL~DfG~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~i 259 (370)
T cd05596 182 KLADFGTCMKMDANG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-TYSKI 259 (370)
T ss_pred EEEeccceeeccCCC-cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH-HHHHH
Confidence 999999998654322 1122345699999999998653 37899999999999999999999997532110 01111
Q ss_pred HHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCC--CCChHHHHHH
Q 012014 374 VKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRE--RMKINDVESR 448 (473)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~ev~~~ 448 (473)
.. ... .+ ..+.....+..+.+|+.+||+.+|.+ |||+.|+++.
T Consensus 260 ~~----~~~-~~---------------------------~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 260 MD----HKN-SL---------------------------TFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred Hc----CCC-cC---------------------------CCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 00 000 00 00000123567789999999999988 9999999653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=320.94 Aligned_cols=278 Identities=21% Similarity=0.258 Sum_probs=198.8
Q ss_pred CCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCC--CCchhHHHHHHHHHhc---CCCCceeeeeeeeccccCCce
Q 012014 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINI---KHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~ 219 (473)
+|++.+.||+|+||.||+|. ..+++.||+|.++.... .....+.+|+.+++.+ +||||+++++++.........
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 47888999999999999998 45789999999874322 2234566788777665 799999999998665444455
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
..+++|||++ ++|.+++...... .+++..+..++.|++.||.||| +++|+||||||+||+++.++.+||
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~-------~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl 149 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPP-------GLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKL 149 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEE
Confidence 6899999996 5899988764322 3668899999999999999999 999999999999999999999999
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcC
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP 379 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 379 (473)
+|||+++...... ......||..|+|||++.+..++.++|||||||++|+|++|.+||.+....+ .+.........
T Consensus 150 ~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~ 225 (288)
T cd07863 150 ADFGLARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLIGL 225 (288)
T ss_pred CccCccccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH-HHHHHHHHhCC
Confidence 9999998654321 1223457999999999998889999999999999999999999997543221 11111111100
Q ss_pred cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 380 QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
............. . ..................+..+.+|+.+||+.||++|||+.|++.
T Consensus 226 ~~~~~~~~~~~~~---~------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 226 PPEDDWPRDVTLP---R------GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CChhhCccccccc---c------cccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000000000 0 000000000011111235667889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=333.78 Aligned_cols=202 Identities=23% Similarity=0.356 Sum_probs=171.5
Q ss_pred CCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC---CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
++|++.+.||+|+||.||+|. ..+++.||+|+++... ......+.+|+.++.+++||||+++++.+.+ ...
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~-----~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD-----KLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec-----CCe
Confidence 478899999999999999998 4568999999997432 2233567889999999999999999999754 347
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.++||||+++|+|.+++.... .+++..+..++.|++.||.||| ++||+||||||+|||++.++.+||+
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~ 143 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMKKD---------TLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLS 143 (363)
T ss_pred EEEEEcCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEe
Confidence 899999999999999997654 3568899999999999999999 9999999999999999999999999
Q ss_pred ecccccccCccccc---------------------------------cceeeccCCCCcCCCccccCCCCCcccchhhHh
Q 012014 301 DFGMARFLPAIDKQ---------------------------------NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFG 347 (473)
Q Consensus 301 Dfg~~~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 347 (473)
|||+++.+...... .......||+.|+|||++.+..++.++||||||
T Consensus 144 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlG 223 (363)
T cd05628 144 DFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLG 223 (363)
T ss_pred eccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhH
Confidence 99998754321100 011235699999999999998999999999999
Q ss_pred HHHHHHHhCCCCCCCC
Q 012014 348 ILLLEMFTGIRPSDGI 363 (473)
Q Consensus 348 ~il~elltg~~P~~~~ 363 (473)
|++|||++|..||.+.
T Consensus 224 vil~ell~G~~Pf~~~ 239 (363)
T cd05628 224 VIMYEMLIGYPPFCSE 239 (363)
T ss_pred HHHHHHHhCCCCCCCC
Confidence 9999999999999753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=335.63 Aligned_cols=253 Identities=21% Similarity=0.317 Sum_probs=199.0
Q ss_pred CCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccC---CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
++|.+.+.||+|+||.||+|.. .+++.||+|+++... ......+.+|+.++..++||||+++++++.+ ...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD-----EEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheec-----CCe
Confidence 4789999999999999999994 478999999997432 2344568899999999999999999998754 347
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.++||||+++|+|.+++.... .+++..+..++.||+.||.||| ++||+||||||+|||++.++.+||+
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~ 143 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRKD---------VFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLA 143 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEee
Confidence 899999999999999997653 3568889999999999999999 8999999999999999999999999
Q ss_pred ecccccccCccc---------------------------cccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHH
Q 012014 301 DFGMARFLPAID---------------------------KQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEM 353 (473)
Q Consensus 301 Dfg~~~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 353 (473)
|||++....... .........||+.|+|||++.+..++.++|||||||++|||
T Consensus 144 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 223 (350)
T cd05573 144 DFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEM 223 (350)
T ss_pred cCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhh
Confidence 999998654322 00122345689999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhccc
Q 012014 354 FTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSA 433 (473)
Q Consensus 354 ltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~ 433 (473)
++|..||........ ....... .... .. +.....+..+.+|+.+||.
T Consensus 224 l~g~~Pf~~~~~~~~-~~~i~~~--~~~~-~~-----------------------------p~~~~~~~~~~~li~~ll~ 270 (350)
T cd05573 224 LYGFPPFYSDTLQET-YNKIINW--KESL-RF-----------------------------PPDPPVSPEAIDLICRLLC 270 (350)
T ss_pred ccCCCCCCCCCHHHH-HHHHhcc--CCcc-cC-----------------------------CCCCCCCHHHHHHHHHHcc
Confidence 999999976431110 0000000 0000 00 0000135678899999997
Q ss_pred CCCCCCCC-hHHHHHH
Q 012014 434 ERPRERMK-INDVESR 448 (473)
Q Consensus 434 ~dP~~RPt-~~ev~~~ 448 (473)
||.+||+ +.|+++.
T Consensus 271 -dp~~R~~s~~~ll~h 285 (350)
T cd05573 271 -DPEDRLGSFEEIKSH 285 (350)
T ss_pred -ChhhcCCCHHHHhcC
Confidence 9999999 9999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=302.28 Aligned_cols=252 Identities=21% Similarity=0.324 Sum_probs=200.3
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCC----CCc----hhHHHHHHHHHhc-CCCCceeeeeeeecc
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP----GGS----KSFKSECKAAINI-KHRNIVRVFTAFSGV 213 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~----~~~----~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 213 (473)
.+.|...+.||.|..+.|-++. ..+|..+|+|++..... ... +.-.+|+.||+++ .||+|+++.++|
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y--- 92 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY--- 92 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec---
Confidence 3467788899999999999887 56789999999974322 112 3356799999998 699999999996
Q ss_pred ccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecC
Q 012014 214 DYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD 293 (473)
Q Consensus 214 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~ 293 (473)
++..+.++|+|.|+.|.|.++|...- .+++++..+|++|+..|++||| .++||||||||+|||+++
T Consensus 93 --es~sF~FlVFdl~prGELFDyLts~V---------tlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILldd 158 (411)
T KOG0599|consen 93 --ESDAFVFLVFDLMPRGELFDYLTSKV---------TLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDD 158 (411)
T ss_pred --cCcchhhhhhhhcccchHHHHhhhhe---------eecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeecc
Confidence 44568999999999999999998765 5779999999999999999999 999999999999999999
Q ss_pred CccEEEeecccccccCccccccceeeccCCCCcCCCccccC------CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCc
Q 012014 294 EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG------CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGK 367 (473)
Q Consensus 294 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~ 367 (473)
+.++||+|||+|+.+..+ ......+|||+|.|||.+.. ..|+..+|+||+|||+|.|+.|.+||-... +
T Consensus 159 n~~i~isDFGFa~~l~~G---ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk--Q 233 (411)
T KOG0599|consen 159 NMNIKISDFGFACQLEPG---EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK--Q 233 (411)
T ss_pred ccceEEeccceeeccCCc---hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH--H
Confidence 999999999999988653 44556789999999998753 358889999999999999999999996411 0
Q ss_pred ccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 368 MNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
+ -+++....+.... ..+.=.+......+|+.+||+.||.+|.|++|.+.
T Consensus 234 m---lMLR~ImeGkyqF----------------------------~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 234 M---LMLRMIMEGKYQF----------------------------RSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred H---HHHHHHHhccccc----------------------------CCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 0 1111111111100 00111245678889999999999999999999875
Q ss_pred H
Q 012014 448 R 448 (473)
Q Consensus 448 ~ 448 (473)
.
T Consensus 283 H 283 (411)
T KOG0599|consen 283 H 283 (411)
T ss_pred C
Confidence 3
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=329.62 Aligned_cols=240 Identities=21% Similarity=0.245 Sum_probs=192.3
Q ss_pred ccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhc-CCCCceeeeeeeeccccCCcee
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 220 (473)
.+..|.....+|.|+|+.|-.+. ..+++..++|++... ...-.+|+.++... +||||+++.+.+.+ ...
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~-----~~~ 390 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYED-----GKE 390 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecC-----Cce
Confidence 35678888889999999999988 667899999998754 22345677665555 79999999999743 557
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEe-cCCccEEE
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL-DDEMIGHV 299 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~-~~~~~~kl 299 (473)
.|+|||++.++-|.+.+.... .+ ..++..|+++|+.|+.||| ++|+|||||||+|||+ ++.++++|
T Consensus 391 ~~~v~e~l~g~ell~ri~~~~---------~~-~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrl 457 (612)
T KOG0603|consen 391 IYLVMELLDGGELLRRIRSKP---------EF-CSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRL 457 (612)
T ss_pred eeeeehhccccHHHHHHHhcc---------hh-HHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEE
Confidence 899999999999988887654 23 3677889999999999999 9999999999999999 68999999
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcC
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP 379 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 379 (473)
+|||.++..... ....+-|..|.|||++....|+.++||||||++||+|++|+.||.....+. +.......
T Consensus 458 tyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~----ei~~~i~~ 528 (612)
T KOG0603|consen 458 TYFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI----EIHTRIQM 528 (612)
T ss_pred EEechhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH----HHHHhhcC
Confidence 999999876543 233445889999999999999999999999999999999999998654441 11111111
Q ss_pred cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 380 QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
+.. ....+...++|+..||+.||.+||++.++..
T Consensus 529 ~~~----------------------------------s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 529 PKF----------------------------------SECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred Ccc----------------------------------ccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 111 1235567789999999999999999999854
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=337.37 Aligned_cols=202 Identities=22% Similarity=0.311 Sum_probs=169.6
Q ss_pred CCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC---CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
++|.+.++||+|+||.||++. ..+++.||+|++.... ......+.+|++++..++||||++++++|.+ ...
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-----~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD-----AQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc-----CCe
Confidence 478899999999999999998 4578999999986422 2234567889999999999999999999854 347
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.++||||+++|+|.+++.... .+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~ 143 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIKYD---------TFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLS 143 (377)
T ss_pred eEEEEeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEe
Confidence 899999999999999997653 3557888899999999999999 9999999999999999999999999
Q ss_pred ecccccccCccccc------------c---------------------------------ceeeccCCCCcCCCccccCC
Q 012014 301 DFGMARFLPAIDKQ------------N---------------------------------RFICIKGSTGYIPPEYDLGC 335 (473)
Q Consensus 301 Dfg~~~~~~~~~~~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~ 335 (473)
|||+++.+...... . ......||+.|+|||++.+.
T Consensus 144 DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 223 (377)
T cd05629 144 DFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQ 223 (377)
T ss_pred ecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccC
Confidence 99999643211000 0 00124699999999999998
Q ss_pred CCCcccchhhHhHHHHHHHhCCCCCCCC
Q 012014 336 EASTYGDVYSFGILLLEMFTGIRPSDGI 363 (473)
Q Consensus 336 ~~~~~~DiwSlG~il~elltg~~P~~~~ 363 (473)
.++.++|||||||++|||++|..||.+.
T Consensus 224 ~~~~~~DiwSlGvil~elltG~~Pf~~~ 251 (377)
T cd05629 224 GYGQECDWWSLGAIMFECLIGWPPFCSE 251 (377)
T ss_pred CCCCceeeEecchhhhhhhcCCCCCCCC
Confidence 9999999999999999999999999753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=333.51 Aligned_cols=241 Identities=18% Similarity=0.225 Sum_probs=190.0
Q ss_pred ceeecCCCeEEEEEE-ecCCCEEEEEEeeccC---CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEEEE
Q 012014 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYK 226 (473)
Q Consensus 151 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 226 (473)
+.||+|+||.||++. ..+++.||+|+++... ......+.+|++++..++||||+++++++.. ....++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~-----~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-----HDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc-----CCEEEEEEe
Confidence 469999999999998 4578999999997432 2233567789999999999999999998754 346899999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCC-CCeeeccCCCCcEEecCCccEEEeecccc
Q 012014 227 FMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQ-PPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (473)
Q Consensus 227 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~ 305 (473)
|+++|+|.+++.... .+++..+..++.||+.||.||| + ++|+||||||+|||++.++.+||+|||++
T Consensus 76 ~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~ 143 (325)
T cd05594 76 YANGGELFFHLSRER---------VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLC 143 (325)
T ss_pred CCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCC
Confidence 999999999987653 3568899999999999999999 7 79999999999999999999999999998
Q ss_pred cccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchhhh
Q 012014 306 RFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEV 385 (473)
Q Consensus 306 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (473)
+...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.... ...........
T Consensus 144 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~-----~~~~~i~~~~~--- 213 (325)
T cd05594 144 KEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELILMEEI--- 213 (325)
T ss_pred eecCCCC--cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH-----HHHHHHhcCCC---
Confidence 7532211 1223356999999999999989999999999999999999999999753211 11100000000
Q ss_pred ccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCC-----ChHHHHH
Q 012014 386 VDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERM-----KINDVES 447 (473)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~ 447 (473)
..+...+..+.+|+.+||+.||++|+ ++.++++
T Consensus 214 -----------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 214 -----------------------------RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred -----------------------------CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 00012345678899999999999997 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=330.74 Aligned_cols=266 Identities=24% Similarity=0.345 Sum_probs=216.2
Q ss_pred CchhhhhcccCCCCccceeecCCCeEEEEEEecC-CCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeecc
Q 012014 135 PSFKDLYNATNGFSSANLIGAGNFGSVYNGTLFD-GTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGV 213 (473)
Q Consensus 135 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 213 (473)
+.+++|+..-.+....++||-|.||.||.|.|.. .-.||||.++.. .-..++|..|+.+|+.++|||+|+++|+|...
T Consensus 257 Pn~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~E 335 (1157)
T KOG4278|consen 257 PNADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE 335 (1157)
T ss_pred CCcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence 3456677777777788999999999999999654 567999998742 23467899999999999999999999999653
Q ss_pred ccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecC
Q 012014 214 DYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD 293 (473)
Q Consensus 214 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~ 293 (473)
...|||+|||..|+|.+||+..... .++.-..+.++.||++|++||. .+++|||||...|+|+.+
T Consensus 336 -----pPFYIiTEfM~yGNLLdYLRecnr~-------ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgE 400 (1157)
T KOG4278|consen 336 -----PPFYIITEFMCYGNLLDYLRECNRS-------EVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGE 400 (1157)
T ss_pred -----CCeEEEEecccCccHHHHHHHhchh-------hcchhHHHHHHHHHHHHHHHHH---Hhhhhhhhhhhhhccccc
Confidence 3579999999999999999877543 2334556788999999999999 999999999999999999
Q ss_pred CccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHH
Q 012014 294 EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRN 372 (473)
Q Consensus 294 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~ 372 (473)
+..+|++|||+++++...... ......-...|.|||-+....++.|+|||+|||+|||+.| |..||.++.- .+
T Consensus 401 nhiVKvADFGLsRlMtgDTYT-AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl-----Sq 474 (1157)
T KOG4278|consen 401 NHIVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQ 474 (1157)
T ss_pred cceEEeeccchhhhhcCCcee-cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH-----HH
Confidence 999999999999987543322 1122223567999999999999999999999999999999 9999987422 11
Q ss_pred HHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHH
Q 012014 373 FVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLI 452 (473)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l 452 (473)
+...++.+.+| +.+..|++.+++||..||+++|.+||++.||-+.++.+
T Consensus 475 -----------------VY~LLEkgyRM--------------~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 475 -----------------VYGLLEKGYRM--------------DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred -----------------HHHHHhccccc--------------cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 11222333333 34456899999999999999999999999999999988
Q ss_pred H
Q 012014 453 R 453 (473)
Q Consensus 453 ~ 453 (473)
.
T Consensus 524 f 524 (1157)
T KOG4278|consen 524 F 524 (1157)
T ss_pred h
Confidence 5
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=330.09 Aligned_cols=241 Identities=22% Similarity=0.280 Sum_probs=189.4
Q ss_pred ceeecCCCeEEEEEEe----cCCCEEEEEEeeccC----CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 151 NLIGAGNFGSVYNGTL----FDGTTIAVKVFNLIR----PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 151 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
++||+|+||.||+++. .+++.||+|+++... ......+.+|+.++..++||||++++++|... ...+
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~-----~~~~ 76 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTG-----GKLY 76 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecC-----CeEE
Confidence 5799999999999984 357899999987422 22334577899999999999999999998543 3679
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
+||||+++|+|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+||
T Consensus 77 lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Df 144 (323)
T cd05584 77 LILEYLSGGELFMHLEREG---------IFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDF 144 (323)
T ss_pred EEEeCCCCchHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeC
Confidence 9999999999999997654 2457788889999999999999 999999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcch
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRA 382 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 382 (473)
|+++...... .......||+.|+|||++.+..++.++|||||||++|||++|..||.+.... ...........
T Consensus 145 g~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-----~~~~~~~~~~~ 217 (323)
T cd05584 145 GLCKESIHEG--TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-----KTIDKILKGKL 217 (323)
T ss_pred cCCeecccCC--CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-----HHHHHHHcCCC
Confidence 9987542221 1223356899999999999888999999999999999999999999753211 11111100000
Q ss_pred hhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCC-----ChHHHHH
Q 012014 383 EEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERM-----KINDVES 447 (473)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~ 447 (473)
..+...+..+.+|+.+||+.||++|| ++.++++
T Consensus 218 --------------------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 218 --------------------------------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred --------------------------------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 00112345678999999999999999 7777765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=344.54 Aligned_cols=259 Identities=24% Similarity=0.444 Sum_probs=214.8
Q ss_pred cCCCCccceeecCCCeEEEEEEec----CCCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTLF----DGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
.+...+.++||.|.||+||+|+++ ....||||.++.... .....|+.|+.||.+++||||+++-|+... .
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk-----s 702 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK-----S 702 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEec-----C
Confidence 344568899999999999999843 245799999986543 345679999999999999999999999743 4
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...+||+|||++|+|+.||+.+.. .|++-+...+++.|+.|+.||- +.++|||||...|||++.+..+|
T Consensus 703 ~PvMIiTEyMENGsLDsFLR~~DG--------qftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCK 771 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLRQNDG--------QFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCK 771 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHhhcCC--------ceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEE
Confidence 578999999999999999998864 3778899999999999999999 99999999999999999999999
Q ss_pred EeecccccccCccccccceeeccC--CCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHH
Q 012014 299 VGDFGMARFLPAIDKQNRFICIKG--STGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVK 375 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~ 375 (473)
++|||+++.+.+.. ....++.-| ..+|.|||.+....++.+|||||||++|||.++ |..||-.+.+.+.
T Consensus 772 VsDFGLSRvledd~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV------- 843 (996)
T KOG0196|consen 772 VSDFGLSRVLEDDP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV------- 843 (996)
T ss_pred eccccceeecccCC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH-------
Confidence 99999999886544 222222223 367999999999999999999999999999888 9999976544331
Q ss_pred hhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHHh
Q 012014 376 MALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRK 455 (473)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~ 455 (473)
...++.+.+. +.+++||..|.+||..||++|-.+||++.+|+..|.++-+.
T Consensus 844 ---------------IkaIe~gyRL--------------PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 844 ---------------IKAIEQGYRL--------------PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred ---------------HHHHHhccCC--------------CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 1122222221 34578999999999999999999999999999999999654
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=316.63 Aligned_cols=264 Identities=22% Similarity=0.338 Sum_probs=198.0
Q ss_pred CCccceeecCCCeEEEEEEecC-CC--EEEEEEeeccC--CCCchhHHHHHHHHHhcCCCCceeeeeeeecccc-CCcee
Q 012014 147 FSSANLIGAGNFGSVYNGTLFD-GT--TIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY-QGARF 220 (473)
Q Consensus 147 ~~~~~~lg~G~~g~V~~~~~~~-~~--~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 220 (473)
|.+.++||+|+||.||+|...+ +. .+|+|.++... ....+.+.+|+.++..++||||+++++++..... .....
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4567899999999999998543 33 68999886432 2234568899999999999999999998754321 22235
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.+++|||+++|+|.+++....... ....+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~ 154 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGD---CPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVA 154 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccC---CcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEEC
Confidence 789999999999999885332111 0113668889999999999999999 8999999999999999999999999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcC
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMALP 379 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 379 (473)
|||+++...............+++.|+|||...+..++.++||||||+++|||++ |..||.+.... .+......
T Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~--- 229 (272)
T cd05075 155 DFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--EIYDYLRQ--- 229 (272)
T ss_pred CCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHc---
Confidence 9999987643322111222345778999999998889999999999999999999 88998753221 11111100
Q ss_pred cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHH
Q 012014 380 QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLI 452 (473)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l 452 (473)
.... .....++..+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 230 ~~~~-------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 230 GNRL-------------------------------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCC-------------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0000 00112345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=319.05 Aligned_cols=260 Identities=22% Similarity=0.348 Sum_probs=201.7
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCC----EEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCC
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGT----TIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (473)
.++|...++||+|+||.||+|.+ .+++ .||+|+++.... .....+.+|+.++..++||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---- 81 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS---- 81 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC----
Confidence 45788999999999999999984 3444 489999864322 2345688999999999999999999987532
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccE
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~ 297 (473)
..++++||+++|+|.+++..... .+++..++.++.|++.||.||| +++|+||||||+||++++++.+
T Consensus 82 --~~~l~~~~~~~g~l~~~l~~~~~--------~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~ 148 (279)
T cd05109 82 --TVQLVTQLMPYGCLLDYVRENKD--------RIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHV 148 (279)
T ss_pred --CcEEEEEcCCCCCHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcE
Confidence 35799999999999999976432 3568899999999999999999 9999999999999999999999
Q ss_pred EEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHh
Q 012014 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKM 376 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~ 376 (473)
||+|||+++...............+++.|+|||...+..++.++|||||||++|||++ |..||....... +...+..
T Consensus 149 kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~ 226 (279)
T cd05109 149 KITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE--IPDLLEK 226 (279)
T ss_pred EECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHC
Confidence 9999999987643322211222235678999999988889999999999999999998 999986532111 1111110
Q ss_pred hcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHHhh
Q 012014 377 ALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRKL 456 (473)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~~ 456 (473)
.... .....++..+.+++.+||+.||++|||+.++++.|+.+..+.
T Consensus 227 ~~~~----------------------------------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 227 GERL----------------------------------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred CCcC----------------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 0000 001124557889999999999999999999999998886543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=328.45 Aligned_cols=251 Identities=20% Similarity=0.258 Sum_probs=193.2
Q ss_pred CCCccceeecCCCeEEEEEEe----cCCCEEEEEEeeccC----CCCchhHHHHHHHHHhc-CCCCceeeeeeeeccccC
Q 012014 146 GFSSANLIGAGNFGSVYNGTL----FDGTTIAVKVFNLIR----PGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQ 216 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 216 (473)
+|++.+.||+|+||.||+++. .+++.||+|++.... ....+.+.+|+.++..+ +||||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~---- 76 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT---- 76 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec----
Confidence 488899999999999999874 357899999987422 22345678899999999 59999999988754
Q ss_pred CceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCcc
Q 012014 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI 296 (473)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~ 296 (473)
....++||||+++|+|.+++.... .+++.++..++.||+.||.||| +++|+||||||+|||++.++.
T Consensus 77 -~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~ 143 (332)
T cd05614 77 -EAKLHLILDYVSGGEMFTHLYQRD---------NFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGH 143 (332)
T ss_pred -CCEEEEEEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCC
Confidence 346799999999999999997653 3568889999999999999999 999999999999999999999
Q ss_pred EEEeecccccccCccccccceeeccCCCCcCCCccccCC-CCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 012014 297 GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVK 375 (473)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~ 375 (473)
+||+|||+++...... ........||+.|+|||++.+. .++.++|||||||++|||++|..||........ ...+..
T Consensus 144 ~kl~DfG~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-~~~~~~ 221 (332)
T cd05614 144 VVLTDFGLSKEFLSEE-KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT-QSEVSR 221 (332)
T ss_pred EEEeeCcCCccccccC-CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC-HHHHHH
Confidence 9999999998653322 1222345699999999998865 478899999999999999999999975322111 111111
Q ss_pred hhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCC-----ChHHHHH
Q 012014 376 MALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERM-----KINDVES 447 (473)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~ 447 (473)
...... ...+...+..+.+++.+||+.||++|| +++++++
T Consensus 222 ~~~~~~--------------------------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 222 RILKCD--------------------------------PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred HHhcCC--------------------------------CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 000000 000112345678899999999999999 6667764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=327.98 Aligned_cols=264 Identities=23% Similarity=0.281 Sum_probs=209.2
Q ss_pred CCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCC-CchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEE
Q 012014 145 NGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG-GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (473)
+...+.++||+|-||+|.++....+..||||.++..... ....|.+|+++|.+|+|||||+++|+|...+ .+++
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De-----Picm 612 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD-----PLCM 612 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC-----chHH
Confidence 445678899999999999999877899999999854433 3478999999999999999999999997644 6799
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecc
Q 012014 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (473)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg 303 (473)
++||+++|+|.+|+..+.... ........|+.||+.|++||. +.++|||||.+.|+|++.++++||+|||
T Consensus 613 I~EYmEnGDLnqFl~aheapt-------~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfg 682 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHELPT-------AETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFG 682 (807)
T ss_pred HHHHHhcCcHHHHHHhccCcc-------cccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcc
Confidence 999999999999999885432 224456679999999999999 9999999999999999999999999999
Q ss_pred cccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh--CCCCCCCCCCCcccHHHHHHhhcCcc
Q 012014 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT--GIRPSDGIFTGKMNLRNFVKMALPQR 381 (473)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt--g~~P~~~~~~~~~~~~~~~~~~~~~~ 381 (473)
+++-+-..+.........-..+|||||.+.-++++++||||+||+++||+++ ...||....+.+.. +.
T Consensus 683 msR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv----------en 752 (807)
T KOG1094|consen 683 MSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV----------EN 752 (807)
T ss_pred cccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH----------Hh
Confidence 9996654443333222334678999999999999999999999999999876 78899765443310 11
Q ss_pred hhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHH
Q 012014 382 AEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLI 452 (473)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l 452 (473)
..++++..-.+ .-...+.-|+..+.+|+.+||+.|-.+|||+++|...|+..
T Consensus 753 ~~~~~~~~~~~-------------------~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 753 AGEFFRDQGRQ-------------------VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred hhhhcCCCCcc-------------------eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 11111111000 00112345889999999999999999999999999888764
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=320.07 Aligned_cols=251 Identities=22% Similarity=0.281 Sum_probs=195.5
Q ss_pred CCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCC---CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP---GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
+|++.++||+|+||.||++. ..+++.||+|++..... .....+.+|+.+++.++||||+++++.+.. ....
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-----KDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC-----CCeE
Confidence 47888999999999999998 45689999999864321 223457789999999999999999998754 3368
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEee
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~D 301 (473)
++||||+++|+|.+++...... .+++..+..++.|++.||.||| +++|+||||||+||++++++.++|+|
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~D 145 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNMGNP-------GFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISD 145 (285)
T ss_pred EEEEeccCCCcHHHHHHhcCcC-------CCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEee
Confidence 9999999999999988654321 3668899999999999999999 89999999999999999999999999
Q ss_pred cccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcc
Q 012014 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQR 381 (473)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 381 (473)
||++....... ......|++.|+|||++.+..++.++||||+||++|+|++|..||.+..... ....+... ....
T Consensus 146 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~-~~~~~~~~-~~~~ 220 (285)
T cd05605 146 LGLAVEIPEGE---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-KREEVERR-VKED 220 (285)
T ss_pred CCCceecCCCC---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh-HHHHHHHH-hhhc
Confidence 99998654322 1223468999999999998889999999999999999999999997532211 00011000 0000
Q ss_pred hhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCC-----ChHHHHH
Q 012014 382 AEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERM-----KINDVES 447 (473)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~ 447 (473)
. ...+...+..+.+|+.+||+.||++|| ++.++++
T Consensus 221 ~-------------------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 221 Q-------------------------------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred c-------------------------------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 0 000122456788999999999999999 7777754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=319.10 Aligned_cols=254 Identities=19% Similarity=0.234 Sum_probs=197.3
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
.++|++.+.||+|+||.||+|. ..+++.||+|++..........+.+|+.++.+++||||+++++++... ...+
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~-----~~~~ 82 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR-----EKLW 82 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC-----CEEE
Confidence 3579999999999999999999 467899999999755444556788999999999999999999998543 3679
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
+||||+++++|.+++.... .+++.++..++.|++.||.||| +++|+||||||+||+++.++.+||+||
T Consensus 83 iv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~df 150 (267)
T cd06646 83 ICMEYCGGGSLQDIYHVTG---------PLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADF 150 (267)
T ss_pred EEEeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcC
Confidence 9999999999999986543 2558889999999999999999 899999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCcccc---CCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcC
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDL---GCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP 379 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 379 (473)
|++....... .......|++.|+|||.+. ...++.++|||||||++|||++|..||.......... .+..
T Consensus 151 g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-~~~~---- 223 (267)
T cd06646 151 GVAAKITATI--AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-LMSK---- 223 (267)
T ss_pred ccceeecccc--cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-eeec----
Confidence 9998653321 1122345889999999874 3457889999999999999999999986432111000 0000
Q ss_pred cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 380 QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
.. ...+. .......+..+.+++.+||+.||++|||+++|++.
T Consensus 224 ~~---~~~~~------------------------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 224 SN---FQPPK------------------------LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred CC---CCCCC------------------------CccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 00 00000 00001234678899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=314.90 Aligned_cols=252 Identities=24% Similarity=0.371 Sum_probs=197.9
Q ss_pred CCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEE
Q 012014 145 NGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVV 224 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 224 (473)
++|.+.+.||+|+||.||+|...++..+|+|.++... ...+.+.+|+.++.+++||||+++++++... ...+++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv 77 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ-----RPIYIV 77 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccC-----CCcEEE
Confidence 4688889999999999999987677789999886432 3356789999999999999999999998543 356999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeeccc
Q 012014 225 YKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM 304 (473)
Q Consensus 225 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~ 304 (473)
|||+.+|+|.+++..... .+++.+++.++.||+.||.||| +++++|+||||+||+++.++.+||+|||.
T Consensus 78 ~e~~~~~~l~~~i~~~~~--------~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~ 146 (256)
T cd05113 78 TEYMSNGCLLNYLREHGK--------RFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGL 146 (256)
T ss_pred EEcCCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCcc
Confidence 999999999999976432 3568899999999999999999 99999999999999999999999999999
Q ss_pred ccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcCcchh
Q 012014 305 ARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMALPQRAE 383 (473)
Q Consensus 305 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 383 (473)
++....... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ...........
T Consensus 147 ~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~~~~~~~--- 220 (256)
T cd05113 147 SRYVLDDEY-TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE--TVEKVSQGLRL--- 220 (256)
T ss_pred ceecCCCce-eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHHhcCCCC---
Confidence 876533221 11122235678999999988889999999999999999998 999986532211 00000000000
Q ss_pred hhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHH
Q 012014 384 EVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLR 450 (473)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 450 (473)
..+...+..+.+++.+||+.||.+|||+.+|++.|+
T Consensus 221 -------------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 221 -------------------------------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -------------------------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 000113467889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=331.97 Aligned_cols=270 Identities=21% Similarity=0.250 Sum_probs=204.8
Q ss_pred hhcccCCCCccceeecCCCeEEEEEEec------CCCEEEEEEeeccCC-CCchhHHHHHHHHHhcC-CCCceeeeeeee
Q 012014 140 LYNATNGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRP-GGSKSFKSECKAAINIK-HRNIVRVFTAFS 211 (473)
Q Consensus 140 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 211 (473)
+....++|.+.++||+|+||.||+|++. .++.||+|+++.... .....+.+|+.++.++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 4555667889999999999999999853 246899999975322 22346889999999997 999999999985
Q ss_pred ccccCCceeeEEEEEecCCCCHHHHhcCCCCCCC----------------------------------------------
Q 012014 212 GVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW---------------------------------------------- 245 (473)
Q Consensus 212 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~---------------------------------------------- 245 (473)
.. ...++||||+++|+|.+++........
T Consensus 112 ~~-----~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (401)
T cd05107 112 KG-----GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDES 186 (401)
T ss_pred cC-----CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccc
Confidence 43 367999999999999999975432000
Q ss_pred -------------------------------------------CCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeec
Q 012014 246 -------------------------------------------RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHC 282 (473)
Q Consensus 246 -------------------------------------------~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~ 282 (473)
......+++..++.++.|++.||.||| +++++||
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHr 263 (401)
T cd05107 187 ADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHR 263 (401)
T ss_pred cCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcc
Confidence 001123667788999999999999999 9999999
Q ss_pred cCCCCcEEecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCC
Q 012014 283 NLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSD 361 (473)
Q Consensus 283 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~ 361 (473)
||||+|||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.
T Consensus 264 dlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~ 343 (401)
T cd05107 264 DLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYP 343 (401)
T ss_pred cCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCC
Confidence 9999999999999999999999986533221111223346788999999998889999999999999999998 889986
Q ss_pred CCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCC
Q 012014 362 GIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMK 441 (473)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt 441 (473)
.....+. +...+. .+. ....+..++..+.+|+.+||+.||.+||+
T Consensus 344 ~~~~~~~-~~~~~~---~~~-------------------------------~~~~p~~~~~~l~~li~~cl~~~P~~RPs 388 (401)
T cd05107 344 ELPMNEQ-FYNAIK---RGY-------------------------------RMAKPAHASDEIYEIMQKCWEEKFEIRPD 388 (401)
T ss_pred CCCchHH-HHHHHH---cCC-------------------------------CCCCCCCCCHHHHHHHHHHcCCChhHCcC
Confidence 5322111 000000 000 00001124567899999999999999999
Q ss_pred hHHHHHHHHHH
Q 012014 442 INDVESRLRLI 452 (473)
Q Consensus 442 ~~ev~~~L~~l 452 (473)
++||++.|+.+
T Consensus 389 ~~ell~~L~~~ 399 (401)
T cd05107 389 FSQLVHLVGDL 399 (401)
T ss_pred HHHHHHHHHHH
Confidence 99999999886
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=324.79 Aligned_cols=269 Identities=23% Similarity=0.340 Sum_probs=204.0
Q ss_pred hcccCCCCccceeecCCCeEEEEEEec------CCCEEEEEEeeccCC-CCchhHHHHHHHHHhc-CCCCceeeeeeeec
Q 012014 141 YNATNGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRP-GGSKSFKSECKAAINI-KHRNIVRVFTAFSG 212 (473)
Q Consensus 141 ~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 212 (473)
....++|++.+.||+|+||.||++... ....+|+|.+..... .....+.+|+.++.++ +||||+++++++..
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 344567899999999999999999843 236799998874321 2234588999999999 89999999998754
Q ss_pred cccCCceeeEEEEEecCCCCHHHHhcCCCCCCCC-------CcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCC
Q 012014 213 VDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWR-------PLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLK 285 (473)
Q Consensus 213 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~-------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlk 285 (473)
. ...+++|||+++|+|.+++......... .....+++..++.++.|++.||.||| +++|+|||||
T Consensus 88 ~-----~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlk 159 (293)
T cd05053 88 E-----GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLA 159 (293)
T ss_pred C-----CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccc
Confidence 3 3679999999999999999754311000 11224778999999999999999999 9999999999
Q ss_pred CCcEEecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCC
Q 012014 286 PSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (473)
Q Consensus 286 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~ 364 (473)
|+||+++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus 160 p~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 239 (293)
T cd05053 160 ARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 239 (293)
T ss_pred eeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC
Confidence 9999999999999999999987654322222222335678999999988889999999999999999998 999987532
Q ss_pred CCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHH
Q 012014 365 TGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKIND 444 (473)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 444 (473)
..+ .......... ...+..++..+.+|+.+||+.||++|||+.|
T Consensus 240 ~~~-----~~~~~~~~~~-------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e 283 (293)
T cd05053 240 VEE-----LFKLLKEGYR-------------------------------MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQ 283 (293)
T ss_pred HHH-----HHHHHHcCCc-------------------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHH
Confidence 111 1100000000 0001124567889999999999999999999
Q ss_pred HHHHHHHHH
Q 012014 445 VESRLRLIR 453 (473)
Q Consensus 445 v~~~L~~l~ 453 (473)
|++.|+.+.
T Consensus 284 il~~l~~~~ 292 (293)
T cd05053 284 LVEDLDRML 292 (293)
T ss_pred HHHHHHHhh
Confidence 999998873
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=329.45 Aligned_cols=241 Identities=21% Similarity=0.243 Sum_probs=188.9
Q ss_pred CCCccceeecCCCeEEEEEEe-cCCCEEEEEEeecc---CCCCchhHHHHHHHHHhcCCC-CceeeeeeeeccccCCcee
Q 012014 146 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHR-NIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~~~ 220 (473)
+|++.+.||+|+||.||+|.. .+++.||+|+++.. .....+.+..|..++..++|+ +|+++++++.+. ..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM-----DR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcC-----CE
Confidence 578899999999999999984 46789999999743 223445678899999999765 588888887543 36
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.++||||+++|+|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~---------~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~ 143 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQVG---------KFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIA 143 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEe
Confidence 899999999999999997654 3558889999999999999999 9999999999999999999999999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCc
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQ 380 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 380 (473)
|||+++..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..... ........
T Consensus 144 Dfg~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~-----~~~~i~~~ 216 (324)
T cd05587 144 DFGMCKENIFG--GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-----LFQSIMEH 216 (324)
T ss_pred ecCcceecCCC--CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-----HHHHHHcC
Confidence 99998743221 122334569999999999999899999999999999999999999997532111 11100000
Q ss_pred chhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCCh
Q 012014 381 RAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKI 442 (473)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 442 (473)
.. ..+...+..+.+++.+||..||.+||+.
T Consensus 217 ~~--------------------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 217 NV--------------------------------SYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CC--------------------------------CCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 00 0001234567899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=319.50 Aligned_cols=269 Identities=21% Similarity=0.308 Sum_probs=207.5
Q ss_pred ccCCCCccceeecCCCeEEEEEEecC-----CCEEEEEEeeccC-CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccC
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTLFD-----GTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQ 216 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 216 (473)
..++|.+.++||+|+||.||+|.... +..|++|+++... ......+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--- 80 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED--- 80 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC---
Confidence 34678999999999999999999654 6889999886432 22345688999999999999999999987542
Q ss_pred CceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCcc
Q 012014 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI 296 (473)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~ 296 (473)
....++++||+++|+|.+++......... ....+++.++..++.|++.||.||| +++++||||||+||++++++.
T Consensus 81 -~~~~~~~~~~~~~~~L~~~l~~~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~ 155 (280)
T cd05043 81 -GEPPFVLYPYMNWGNLKLFLQQCRLGEAN-NPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQ 155 (280)
T ss_pred -CCCCEEEEEcCCCCcHHHHHHhccccccc-cccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCc
Confidence 34678999999999999999765322110 1124778999999999999999999 999999999999999999999
Q ss_pred EEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHH
Q 012014 297 GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVK 375 (473)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~ 375 (473)
+||+|||+++.+.............++..|+|||++.+..++.++||||||+++||+++ |..||...... .+.....
T Consensus 156 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~ 233 (280)
T cd05043 156 VKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF--EMAAYLK 233 (280)
T ss_pred EEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH--HHHHHHH
Confidence 99999999986543222111122345778999999988889999999999999999999 99999753211 1111111
Q ss_pred hhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHHh
Q 012014 376 MALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRK 455 (473)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~ 455 (473)
.... ......++..+.+++.+||+.||++|||+.++++.|+.+.++
T Consensus 234 ~~~~----------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 234 DGYR----------------------------------LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred cCCC----------------------------------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 1000 000112456788999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=329.32 Aligned_cols=238 Identities=23% Similarity=0.259 Sum_probs=186.8
Q ss_pred ceeecCCCeEEEEEEe-cCCCEEEEEEeecc---CCCCchhHHHHHHHHHhc-CCCCceeeeeeeeccccCCceeeEEEE
Q 012014 151 NLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGARFKAVVY 225 (473)
Q Consensus 151 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (473)
++||+|+||.||+|+. .+++.||+|+++.. .......+..|..++..+ +||||+++++++... ...++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~-----~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTP-----DRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcC-----CEEEEEE
Confidence 4699999999999984 56899999998742 223345677888888876 699999999997543 4689999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecccc
Q 012014 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (473)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~ 305 (473)
||+++|+|.+++.... .+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||++
T Consensus 76 Ey~~~g~L~~~i~~~~---------~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~ 143 (320)
T cd05590 76 EFVNGGDLMFHIQKSR---------RFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMC 143 (320)
T ss_pred cCCCCchHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCC
Confidence 9999999999987654 3558889999999999999999 999999999999999999999999999998
Q ss_pred cccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchhhh
Q 012014 306 RFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEV 385 (473)
Q Consensus 306 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (473)
+..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.... ...........
T Consensus 144 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-----~~~~~i~~~~~--- 213 (320)
T cd05590 144 KEGIFN--GKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED-----DLFEAILNDEV--- 213 (320)
T ss_pred eecCcC--CCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-----HHHHHHhcCCC---
Confidence 753221 12223456899999999999889999999999999999999999999753211 11111100000
Q ss_pred ccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHH
Q 012014 386 VDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKIND 444 (473)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 444 (473)
..+...+..+.+|+.+||+.||++||++.+
T Consensus 214 -----------------------------~~~~~~~~~~~~li~~~L~~dP~~R~~~~~ 243 (320)
T cd05590 214 -----------------------------VYPTWLSQDAVDILKAFMTKNPTMRLGSLT 243 (320)
T ss_pred -----------------------------CCCCCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 000113456789999999999999999833
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=326.55 Aligned_cols=193 Identities=23% Similarity=0.271 Sum_probs=164.1
Q ss_pred ceeecCCCeEEEEEE-ecCCCEEEEEEeeccC---CCCchhHHHHHHHHHhc-CCCCceeeeeeeeccccCCceeeEEEE
Q 012014 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGARFKAVVY 225 (473)
Q Consensus 151 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (473)
++||+|+||.||+|. ..+++.||+|+++... ......+.+|..++..+ +||||++++++|... ...++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~-----~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE-----SRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC-----CEEEEEE
Confidence 469999999999998 4568999999997532 22335578899999888 799999999998543 4689999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecccc
Q 012014 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (473)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~ 305 (473)
||+++|+|.+++.... .+++..+..++.|++.||.||| +++|+||||||+||+++.++.+||+|||++
T Consensus 76 e~~~~g~L~~~~~~~~---------~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~ 143 (329)
T cd05588 76 EFVSGGDLMFHMQRQR---------KLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMC 143 (329)
T ss_pred eCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccc
Confidence 9999999999886543 3668999999999999999999 999999999999999999999999999998
Q ss_pred cccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCC
Q 012014 306 RFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362 (473)
Q Consensus 306 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 362 (473)
+..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus 144 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 144 KEGIRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred cccccC--CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 743221 1222345689999999999998999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=332.63 Aligned_cols=203 Identities=25% Similarity=0.319 Sum_probs=170.5
Q ss_pred cccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccC---CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCC
Q 012014 142 NATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (473)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (473)
...++|++.+.||+|+||.||++.. .+++.+|+|++.... ......+.+|+.+++.++||||+++++++.+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~----- 114 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD----- 114 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----
Confidence 3456899999999999999999994 468899999986422 2234457899999999999999999999754
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccE
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~ 297 (473)
....++||||+++|+|.+++.... +++..+..++.||+.||.||| +++|+||||||+|||++.++.+
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~~~~----------~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~ 181 (370)
T cd05621 115 DKYLYMVMEYMPGGDLVNLMSNYD----------VPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHL 181 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCE
Confidence 347899999999999999996542 457888999999999999999 9999999999999999999999
Q ss_pred EEeecccccccCccccccceeeccCCCCcCCCccccCCC----CCcccchhhHhHHHHHHHhCCCCCCCC
Q 012014 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE----ASTYGDVYSFGILLLEMFTGIRPSDGI 363 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~elltg~~P~~~~ 363 (473)
||+|||++....... ........||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.
T Consensus 182 kL~DFG~a~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~ 250 (370)
T cd05621 182 KLADFGTCMKMDETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD 250 (370)
T ss_pred EEEecccceecccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence 999999998664322 11223456999999999987543 788999999999999999999999753
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=324.70 Aligned_cols=270 Identities=24% Similarity=0.329 Sum_probs=204.5
Q ss_pred cccCCCCccceeecCCCeEEEEEEec--------CCCEEEEEEeeccC-CCCchhHHHHHHHHHhc-CCCCceeeeeeee
Q 012014 142 NATNGFSSANLIGAGNFGSVYNGTLF--------DGTTIAVKVFNLIR-PGGSKSFKSECKAAINI-KHRNIVRVFTAFS 211 (473)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 211 (473)
...++|.+.+.||+|+||.||++... +...+|+|.++... ......+.+|+.++..+ +||||+++++++.
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 34568999999999999999999732 23569999987432 22335688899999999 7999999999985
Q ss_pred ccccCCceeeEEEEEecCCCCHHHHhcCCCCCCC-------CCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccC
Q 012014 212 GVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW-------RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNL 284 (473)
Q Consensus 212 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~-------~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dl 284 (473)
.. ...++||||+++|+|.+++........ ......+++.+++.++.|++.||+||| ++|++||||
T Consensus 95 ~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dl 166 (307)
T cd05098 95 QD-----GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDL 166 (307)
T ss_pred cC-----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccc
Confidence 43 367999999999999999976532110 001123678899999999999999999 999999999
Q ss_pred CCCcEEecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCC
Q 012014 285 KPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363 (473)
Q Consensus 285 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~ 363 (473)
||+||+++.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|+|++ |..||.+.
T Consensus 167 kp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~ 246 (307)
T cd05098 167 AARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 246 (307)
T ss_pred cHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 99999999999999999999976543221111222234578999999988889999999999999999998 88888642
Q ss_pred CCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChH
Q 012014 364 FTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKIN 443 (473)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 443 (473)
.. ........... ....+...+..+.+|+.+||+.+|++|||+.
T Consensus 247 ~~-----~~~~~~~~~~~-------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 290 (307)
T cd05098 247 PV-----EELFKLLKEGH-------------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFK 290 (307)
T ss_pred CH-----HHHHHHHHcCC-------------------------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHH
Confidence 11 11111000000 0001123456888999999999999999999
Q ss_pred HHHHHHHHHHHh
Q 012014 444 DVESRLRLIRRK 455 (473)
Q Consensus 444 ev~~~L~~l~~~ 455 (473)
+|++.|+.+...
T Consensus 291 evl~~l~~~~~~ 302 (307)
T cd05098 291 QLVEDLDRILAL 302 (307)
T ss_pred HHHHHHHHHHHH
Confidence 999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=315.54 Aligned_cols=255 Identities=24% Similarity=0.399 Sum_probs=201.1
Q ss_pred cCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEE
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (473)
.++|.+.++||+|+||.||+|...+...||+|+++... ...+.+.+|+.++..++||||+++++.+.. ...++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~~~l 77 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIYI 77 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC------CCcEE
Confidence 45799999999999999999987666789999987432 234678999999999999999999987632 24689
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecc
Q 012014 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (473)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg 303 (473)
||||+++|+|.+++...... .+++..+..++.|++.||.||| +++++||||||+||++++++.+||+|||
T Consensus 78 v~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg 147 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGK-------YLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFG 147 (262)
T ss_pred EEEcCCCCcHHHHHhhcccc-------CCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCC
Confidence 99999999999999754321 3568889999999999999999 9999999999999999999999999999
Q ss_pred cccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcCcch
Q 012014 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMALPQRA 382 (473)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 382 (473)
.++....... .......++..|+|||+..+..++.++||||||+++|+|++ |..||.+..... .........
T Consensus 148 ~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~-----~~~~~~~~~- 220 (262)
T cd05071 148 LARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-----VLDQVERGY- 220 (262)
T ss_pred ceeecccccc-ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH-----HHHHHhcCC-
Confidence 9986643321 11122346778999999988889999999999999999999 888986532111 000000000
Q ss_pred hhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHH
Q 012014 383 EEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLI 452 (473)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l 452 (473)
........+..+.+|+.+||+.||++|||+.++++.|+..
T Consensus 221 ------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 221 ------------------------------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ------------------------------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0001123566788999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=316.33 Aligned_cols=254 Identities=25% Similarity=0.405 Sum_probs=200.5
Q ss_pred cCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEE
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (473)
.++|++.++||+|+||.||+|...++..+|+|.++.... ..+.+.+|+.++++++|||++++++++.. ...++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~~~l 77 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE------EPIYI 77 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC------CCcEE
Confidence 457899999999999999999977788899999875332 34678999999999999999999988632 24689
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecc
Q 012014 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (473)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg 303 (473)
+|||+++++|.+++...... .+++.++..++.|++.||.||| +++++||||||+||++++++.++|+|||
T Consensus 78 v~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg 147 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGEGR-------ALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFG 147 (260)
T ss_pred EEEecCCCcHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCce
Confidence 99999999999999764321 3568899999999999999999 8999999999999999999999999999
Q ss_pred cccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcCcch
Q 012014 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMALPQRA 382 (473)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 382 (473)
++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+....+ ..........
T Consensus 148 ~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-----~~~~~~~~~~ 221 (260)
T cd05070 148 LARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE-----VLEQVERGYR 221 (260)
T ss_pred eeeeccCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH-----HHHHHHcCCC
Confidence 99865432211 1112235668999999988889999999999999999999 899997532111 1110000000
Q ss_pred hhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHH
Q 012014 383 EEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRL 451 (473)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 451 (473)
.+.+...+..+.+|+.+||+.||++|||+.++.+.|+.
T Consensus 222 -------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 -------------------------------MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -------------------------------CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 00011245678899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=319.80 Aligned_cols=263 Identities=22% Similarity=0.362 Sum_probs=200.6
Q ss_pred CCCCccceeecCCCeEEEEEEec------CCCEEEEEEeeccCCC-CchhHHHHHHHHHhcCCCCceeeeeeeeccccCC
Q 012014 145 NGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRPG-GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (473)
.+|.+.+.||+|+||.||+|... +++.||+|+++..... ....+.+|+.++..++||||+++++++.+.
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~---- 80 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE---- 80 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC----
Confidence 35778899999999999999843 2478999998743322 235688999999999999999999998543
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCC-------CCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEE
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDT-------NWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVL 290 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~-------~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil 290 (473)
...++++||+++++|.+++...... ........+++..+..++.|++.||.||| +++|+||||||+||+
T Consensus 81 -~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil 156 (283)
T cd05091 81 -QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVL 156 (283)
T ss_pred -CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheE
Confidence 3578999999999999998543211 00111224668889999999999999999 999999999999999
Q ss_pred ecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCccc
Q 012014 291 LDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMN 369 (473)
Q Consensus 291 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~ 369 (473)
+++++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||.+....
T Consensus 157 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--- 233 (283)
T cd05091 157 VFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--- 233 (283)
T ss_pred ecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH---
Confidence 99999999999999886544332222233346788999999988889999999999999999998 88888753221
Q ss_pred HHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHH
Q 012014 370 LRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRL 449 (473)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L 449 (473)
............ ..+..++..+.+|+..||+.||++|||+.+|+..|
T Consensus 234 --~~~~~i~~~~~~-------------------------------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l 280 (283)
T cd05091 234 --DVIEMIRNRQVL-------------------------------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRL 280 (283)
T ss_pred --HHHHHHHcCCcC-------------------------------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHh
Confidence 111111111000 01123566788999999999999999999999998
Q ss_pred HH
Q 012014 450 RL 451 (473)
Q Consensus 450 ~~ 451 (473)
+.
T Consensus 281 ~~ 282 (283)
T cd05091 281 RT 282 (283)
T ss_pred hC
Confidence 74
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=317.16 Aligned_cols=246 Identities=22% Similarity=0.275 Sum_probs=189.4
Q ss_pred eecCCCeEEEEEE-ecCCCEEEEEEeeccC---CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEEEEec
Q 012014 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFM 228 (473)
Q Consensus 153 lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 228 (473)
||+|+||.||++. ..+|+.||+|.+.... ......+..|++++.+++||||+++++++.. ....++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~-----~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES-----KTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec-----CCeEEEEEecC
Confidence 6999999999998 4568999999986322 1223445679999999999999999998754 34789999999
Q ss_pred CCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeeccccccc
Q 012014 229 PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL 308 (473)
Q Consensus 229 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 308 (473)
++++|.+++...... .+++..+..++.|++.||.||| +++|+||||||+||+++.++.++|+|||++...
T Consensus 76 ~g~~L~~~~~~~~~~-------~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~ 145 (277)
T cd05607 76 NGGDLKYHIYNVGER-------GLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVEL 145 (277)
T ss_pred CCCCHHHHHHhcccc-------CCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeec
Confidence 999999988654322 3557888999999999999999 999999999999999999999999999999765
Q ss_pred CccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchhhhccc
Q 012014 309 PAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDD 388 (473)
Q Consensus 309 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (473)
.... ......||..|+|||++.+..++.++|||||||++|+|++|..||........ ...............
T Consensus 146 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~---- 217 (277)
T cd05607 146 KDGK---TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA-KEELKRRTLEDEVKF---- 217 (277)
T ss_pred CCCc---eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh-HHHHHHHhhcccccc----
Confidence 4321 22334689999999999988899999999999999999999999975322111 011111000000000
Q ss_pred cchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 389 FNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
.....+.++.+|+..||+.||++|||++|+++.
T Consensus 218 ---------------------------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 218 ---------------------------EHQNFTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred ---------------------------ccccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 001235578899999999999999999887643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=326.30 Aligned_cols=193 Identities=23% Similarity=0.271 Sum_probs=163.2
Q ss_pred ceeecCCCeEEEEEE-ecCCCEEEEEEeeccC---CCCchhHHHHHHHHHhc-CCCCceeeeeeeeccccCCceeeEEEE
Q 012014 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGARFKAVVY 225 (473)
Q Consensus 151 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (473)
+.||+|+||.||+|. ..+++.||+|+++... ......+.+|+.++.++ +||||+++++++... ...++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~-----~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-----SRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC-----CEEEEEE
Confidence 469999999999998 4568899999997532 22334577888888776 899999999997543 4689999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecccc
Q 012014 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (473)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~ 305 (473)
||+++|+|..++.... .+++..+..++.|++.||.||| +++|+||||||+||+++.++.+||+|||++
T Consensus 76 E~~~~~~L~~~~~~~~---------~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~ 143 (329)
T cd05618 76 EYVNGGDLMFHMQRQR---------KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 143 (329)
T ss_pred eCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCcc
Confidence 9999999999886553 3568899999999999999999 999999999999999999999999999998
Q ss_pred cccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCC
Q 012014 306 RFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362 (473)
Q Consensus 306 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 362 (473)
+..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 144 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 144 KEGLRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ccccCC--CCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 753221 1122345689999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=322.12 Aligned_cols=260 Identities=24% Similarity=0.333 Sum_probs=201.0
Q ss_pred ccCCCCccceeecCCCeEEEEEEec------CCCEEEEEEeeccC-CCCchhHHHHHHHHHhc-CCCCceeeeeeeeccc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIR-PGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVD 214 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 214 (473)
..++|.+.+.||+|+||.||+|... .+..||+|.++... ....+.+.+|+.+++++ +||||+++++++...
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~- 111 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG- 111 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC-
Confidence 3457999999999999999999731 24579999887432 22335688999999999 799999999998543
Q ss_pred cCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCC
Q 012014 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE 294 (473)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~ 294 (473)
...+++|||+++|+|.+++...... .+++.++..++.|++.||.||| +++|+|+||||+||+++.+
T Consensus 112 ----~~~~lv~e~~~~~~L~~~i~~~~~~-------~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~ 177 (302)
T cd05055 112 ----GPILVITEYCCYGDLLNFLRRKRES-------FLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHG 177 (302)
T ss_pred ----CceEEEEEcCCCCcHHHHHHhCCCC-------CCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCC
Confidence 3579999999999999999754321 2568899999999999999999 8999999999999999999
Q ss_pred ccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHH
Q 012014 295 MIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNF 373 (473)
Q Consensus 295 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~ 373 (473)
+.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|+|++ |..||.+...... +...
T Consensus 178 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~-~~~~ 256 (302)
T cd05055 178 KIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK-FYKL 256 (302)
T ss_pred CeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH-HHHH
Confidence 9999999999986543321111122345778999999998889999999999999999998 9999875432111 1010
Q ss_pred HHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHH
Q 012014 374 VKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLI 452 (473)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l 452 (473)
.....+. ..+...+..+.+++.+||+.+|++|||+.||++.|+.+
T Consensus 257 ~~~~~~~----------------------------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 257 IKEGYRM----------------------------------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HHcCCcC----------------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0000000 00011245788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=331.57 Aligned_cols=286 Identities=17% Similarity=0.192 Sum_probs=198.9
Q ss_pred ccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC--CCCchhHHHHHHHHHhcCCCCceeeeeeeecccc-CCc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY-QGA 218 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~ 218 (473)
..++|++.+.||+|+||.||++. ..+|+.||+|++.... ......+.+|+.++..++||||+++++++..... ...
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 45789999999999999999998 4568999999986432 2334567899999999999999999999854331 122
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...++||||++ ++|.+.+.. .++...+..++.|++.||.||| +++|+||||||+|||++.++.+|
T Consensus 99 ~~~~lv~e~~~-~~l~~~~~~-----------~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~k 163 (359)
T cd07876 99 QDVYLVMELMD-ANLCQVIHM-----------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLK 163 (359)
T ss_pred ceeEEEEeCCC-cCHHHHHhc-----------cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEE
Confidence 35799999995 467776643 2447788899999999999999 99999999999999999999999
Q ss_pred EeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 012014 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMAL 378 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~ 378 (473)
|+|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+..... .+........
T Consensus 164 l~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~ 239 (359)
T cd07876 164 ILDFGLARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID-QWNKVIEQLG 239 (359)
T ss_pred EecCCCccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcC
Confidence 9999999754321 12233458999999999999899999999999999999999999998643211 1111111111
Q ss_pred Ccchhhhccccc--hHHHHhhhhhhcccc-----cCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 379 PQRAEEVVDDFN--LQEIEEGRTMCMEVS-----SSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 379 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
. ...+..+... ...+........... ..................+.+|+.+||..||++|||+.|+++.
T Consensus 240 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 240 T-PSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred C-CcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1 0011100000 000000000000000 0000000000111235678899999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=325.37 Aligned_cols=240 Identities=23% Similarity=0.314 Sum_probs=185.9
Q ss_pred ceeecCCCeEEEEEEe-cCCCEEEEEEeeccC---CCCchhHHHHHHHHHh-cCCCCceeeeeeeeccccCCceeeEEEE
Q 012014 151 NLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGSKSFKSECKAAIN-IKHRNIVRVFTAFSGVDYQGARFKAVVY 225 (473)
Q Consensus 151 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (473)
++||+|+||.||+|.. .+++.||+|+++... ....+.+..|..++.. .+||||+++++++.. ....++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~-----~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT-----KEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc-----CCEEEEEE
Confidence 4699999999999984 568899999997432 2233455667777665 489999999998754 34689999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecccc
Q 012014 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (473)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~ 305 (473)
||+++|+|.+++.... .+++..+..++.||+.||.||| +++|+||||||+||+++.++.+||+|||++
T Consensus 76 e~~~gg~L~~~~~~~~---------~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a 143 (316)
T cd05592 76 EYLNGGDLMFHIQSSG---------RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMC 143 (316)
T ss_pred cCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCC
Confidence 9999999999987653 3568888999999999999999 899999999999999999999999999999
Q ss_pred cccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchhhh
Q 012014 306 RFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEV 385 (473)
Q Consensus 306 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (473)
+...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.... ..........
T Consensus 144 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~-----~~~~~i~~~~---- 212 (316)
T cd05592 144 KENMNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED-----ELFDSILNDR---- 212 (316)
T ss_pred eECCCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHcCC----
Confidence 7543222 2223456899999999999988999999999999999999999999763221 1111000000
Q ss_pred ccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChH-HHH
Q 012014 386 VDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKIN-DVE 446 (473)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-ev~ 446 (473)
+..+...+..+.+|+.+||+.||.+||++. +++
T Consensus 213 ----------------------------~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 213 ----------------------------PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred ----------------------------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 000112345677899999999999999975 453
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=327.12 Aligned_cols=270 Identities=21% Similarity=0.283 Sum_probs=202.1
Q ss_pred ccCCCCccceeecCCCeEEEEEEe------cCCCEEEEEEeeccCC-CCchhHHHHHHHHHhc-CCCCceeeeeeeeccc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTL------FDGTTIAVKVFNLIRP-GGSKSFKSECKAAINI-KHRNIVRVFTAFSGVD 214 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 214 (473)
..++|++.++||+|+||.||+|.. .+++.||||+++.... .....+.+|+.++.++ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~- 83 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 83 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC-
Confidence 346899999999999999999973 3468899999874322 2234678999999999 689999999987542
Q ss_pred cCCceeeEEEEEecCCCCHHHHhcCCCCCCCC------------------------------------------------
Q 012014 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWR------------------------------------------------ 246 (473)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~------------------------------------------------ 246 (473)
....+++|||+++|+|.+++.........
T Consensus 84 ---~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 84 ---GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ---CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 23578999999999999999754210000
Q ss_pred ----------CcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecccccccCccccccc
Q 012014 247 ----------PLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNR 316 (473)
Q Consensus 247 ----------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 316 (473)
.....+++.++..++.|++.||.||| +++|+||||||+||+++.++.+||+|||++...........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 237 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR 237 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhh
Confidence 00113567888999999999999999 99999999999999999999999999999976533222112
Q ss_pred eeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcCcchhhhccccchHHHH
Q 012014 317 FICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIE 395 (473)
Q Consensus 317 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 395 (473)
.....++..|+|||.+.+..++.++||||||+++|+|++ |..||........ +...... .....
T Consensus 238 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~~~~~~---~~~~~----------- 302 (343)
T cd05103 238 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-FCRRLKE---GTRMR----------- 302 (343)
T ss_pred cCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-HHHHHhc---cCCCC-----------
Confidence 222345678999999988889999999999999999997 9999875322111 0000000 00000
Q ss_pred hhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHH
Q 012014 396 EGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRR 454 (473)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~ 454 (473)
.+...+..+.+++.+||+.||++|||+.||++.|+.+..
T Consensus 303 --------------------~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 303 --------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred --------------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 000123467899999999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=327.60 Aligned_cols=242 Identities=21% Similarity=0.245 Sum_probs=189.1
Q ss_pred ceeecCCCeEEEEEEe-cCCCEEEEEEeeccC---CCCchhHHHHHHHHHhc-CCCCceeeeeeeeccccCCceeeEEEE
Q 012014 151 NLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGARFKAVVY 225 (473)
Q Consensus 151 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (473)
++||+|+||.||+|+. .+++.||+|+++... ......+..|.+++..+ +||||++++++|... ...++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~-----~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK-----DRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC-----CeEEEEE
Confidence 4699999999999984 468899999987432 23345577888888866 799999999998543 3689999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecccc
Q 012014 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (473)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~ 305 (473)
||+++|+|..++.... .+++..+..++.||+.||.||| +++|+||||||+||+++.++.+||+|||++
T Consensus 76 E~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~ 143 (321)
T cd05591 76 EYVNGGDLMFQIQRSR---------KFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMC 143 (321)
T ss_pred eCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccc
Confidence 9999999999987654 3558888999999999999999 999999999999999999999999999998
Q ss_pred cccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchhhh
Q 012014 306 RFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEV 385 (473)
Q Consensus 306 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (473)
+...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+..... ..........
T Consensus 144 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~-----~~~~i~~~~~--- 213 (321)
T cd05591 144 KEGILNG--VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD-----LFESILHDDV--- 213 (321)
T ss_pred eecccCC--ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH-----HHHHHHcCCC---
Confidence 7543221 22234568999999999998899999999999999999999999997532211 1111000000
Q ss_pred ccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCC-------ChHHHHHH
Q 012014 386 VDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERM-------KINDVESR 448 (473)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-------t~~ev~~~ 448 (473)
..+...+.++.+|+.+||+.||++|| +++++++.
T Consensus 214 -----------------------------~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 214 -----------------------------LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred -----------------------------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 00011345778999999999999999 77777643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=310.88 Aligned_cols=261 Identities=20% Similarity=0.297 Sum_probs=205.4
Q ss_pred CCCCccceeecCCCeEEEEEEec-CCCEEEEEEeeccC---CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 145 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
++|++.+.||+|+||.||+|... +++.||+|.++... ......+.+|++++++++|+||+++++++... ..
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~-----~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN-----NE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC-----Ce
Confidence 67999999999999999999954 78999999886422 22356788999999999999999999998653 36
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.+++|||+++|+|.+++...... ...+++.++..++.|++.||.||| +.|++||||+|+||+++.++.++|+
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~ 148 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQ-----KRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLG 148 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhccc-----CCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEe
Confidence 79999999999999998653221 113568899999999999999999 9999999999999999999999999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCc
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQ 380 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 380 (473)
|||++........ ......|++.|+|||.+.+..++.++||||||+++|+|++|..||..... ............
T Consensus 149 d~~~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~ 223 (267)
T cd08224 149 DLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLYSLCKKIEKC 223 (267)
T ss_pred ccceeeeccCCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc---cHHHHHhhhhcC
Confidence 9999876543221 12234588999999999888899999999999999999999999864321 111111110000
Q ss_pred chhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHH
Q 012014 381 RAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIR 453 (473)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~ 453 (473)
.... ......+..+.+++.+||+.+|++|||+.+|++.|+.+.
T Consensus 224 ~~~~------------------------------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 224 DYPP------------------------------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCCC------------------------------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0000 001134567889999999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=336.74 Aligned_cols=202 Identities=22% Similarity=0.311 Sum_probs=169.6
Q ss_pred CCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC---CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
++|++.+.||+|+||.||+|+ ..+++.||+|++.... ......+.+|+.++..++||||+++++.|.+ ...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-----~~~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD-----KDN 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc-----CCE
Confidence 478999999999999999998 4568999999986422 2234568899999999999999999999854 347
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.++||||+++|+|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+
T Consensus 76 ~~lv~E~~~~g~L~~~i~~~~---------~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~ 143 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIRLG---------IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLT 143 (376)
T ss_pred EEEEEeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEE
Confidence 899999999999999997654 2557888889999999999999 9999999999999999999999999
Q ss_pred ecccccccCcccc-----------------------------------------ccceeeccCCCCcCCCccccCCCCCc
Q 012014 301 DFGMARFLPAIDK-----------------------------------------QNRFICIKGSTGYIPPEYDLGCEAST 339 (473)
Q Consensus 301 Dfg~~~~~~~~~~-----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~ 339 (473)
|||++..+..... ........||+.|+|||++.+..++.
T Consensus 144 DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 223 (376)
T cd05598 144 DFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ 223 (376)
T ss_pred eCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCc
Confidence 9999753311000 00011346999999999999989999
Q ss_pred ccchhhHhHHHHHHHhCCCCCCCC
Q 012014 340 YGDVYSFGILLLEMFTGIRPSDGI 363 (473)
Q Consensus 340 ~~DiwSlG~il~elltg~~P~~~~ 363 (473)
++|||||||++|||++|..||.+.
T Consensus 224 ~~DiwSlGvilyell~G~~Pf~~~ 247 (376)
T cd05598 224 LCDWWSVGVILYEMLVGQPPFLAD 247 (376)
T ss_pred ceeeeeccceeeehhhCCCCCCCC
Confidence 999999999999999999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=336.29 Aligned_cols=201 Identities=22% Similarity=0.312 Sum_probs=168.8
Q ss_pred CCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC---CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
+|+..++||+|+||.||+|+ ..+++.||+|++.... ......+.+|+.++..++||||+++++.|.+. ...
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~-----~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDK-----DNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeC-----CEE
Confidence 58899999999999999998 4578899999987432 22345688999999999999999999998543 468
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEee
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~D 301 (473)
++|||||++|+|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~---------~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~D 144 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIRMG---------IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTD 144 (382)
T ss_pred EEEEeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeE
Confidence 99999999999999997653 2557888899999999999999 99999999999999999999999999
Q ss_pred cccccccCcccc---------------------------------------------ccceeeccCCCCcCCCccccCCC
Q 012014 302 FGMARFLPAIDK---------------------------------------------QNRFICIKGSTGYIPPEYDLGCE 336 (473)
Q Consensus 302 fg~~~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~ 336 (473)
||++..+..... ........||+.|+|||++.+..
T Consensus 145 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~ 224 (382)
T cd05625 145 FGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG 224 (382)
T ss_pred CCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCC
Confidence 999753311000 00012346999999999999989
Q ss_pred CCcccchhhHhHHHHHHHhCCCCCCCC
Q 012014 337 ASTYGDVYSFGILLLEMFTGIRPSDGI 363 (473)
Q Consensus 337 ~~~~~DiwSlG~il~elltg~~P~~~~ 363 (473)
++.++|||||||++|||++|..||.+.
T Consensus 225 ~~~~~DiwSlGvil~elltG~~Pf~~~ 251 (382)
T cd05625 225 YTQLCDWWSVGVILYEMLVGQPPFLAQ 251 (382)
T ss_pred CCCeeeEEechHHHHHHHhCCCCCCCC
Confidence 999999999999999999999999763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=330.91 Aligned_cols=252 Identities=23% Similarity=0.240 Sum_probs=196.1
Q ss_pred CCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC---CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
++|.+.+.||+|+||.||++. ..+++.||+|+++... ......+.+|+.++..++||||+++++++.+ ...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~-----~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD-----KDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec-----CCe
Confidence 478899999999999999998 4578999999997432 2234567899999999999999999998754 346
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.++||||+++|+|.+++..... .+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~--------~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~ 144 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRYED--------QFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLA 144 (330)
T ss_pred EEEEECCCCCCCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEec
Confidence 8999999999999999976522 3668888999999999999999 9999999999999999999999999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCcccc------CCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDL------GCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFV 374 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~ 374 (473)
|||++..+...... ......||+.|+|||++. +..++.++|||||||++|+|++|..||....... .+....
T Consensus 145 Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~-~~~~i~ 222 (330)
T cd05601 145 DFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK-TYNNIM 222 (330)
T ss_pred cCCCCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH-HHHHHH
Confidence 99999876433211 223346899999999986 4567899999999999999999999997532211 011100
Q ss_pred HhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 375 KMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.. ...... +.....+..+.+|+..||+ ||.+|||+.+++.
T Consensus 223 ~~---~~~~~~-----------------------------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 223 NF---QRFLKF-----------------------------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred cC---CCccCC-----------------------------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 00 000000 0001234567889999998 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=311.75 Aligned_cols=248 Identities=25% Similarity=0.350 Sum_probs=191.2
Q ss_pred ceeecCCCeEEEEEEe-cCCCEEEEEEeeccC-CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEEEEec
Q 012014 151 NLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFM 228 (473)
Q Consensus 151 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 228 (473)
+.||+|+||.||+|.. .+++.+|+|.+.... ......+.+|+++++.++||||+++++++... ...++||||+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~ 75 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-----QPIYIVMELV 75 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-----CCeEEEEeec
Confidence 3699999999999984 578999999876332 22345689999999999999999999998543 3679999999
Q ss_pred CCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeeccccccc
Q 012014 229 PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL 308 (473)
Q Consensus 229 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 308 (473)
++++|.+++..... .+++.+++.++.|++.||.||| +++++||||||+||+++.++.+||+|||++...
T Consensus 76 ~~~~L~~~~~~~~~--------~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 144 (252)
T cd05084 76 QGGDFLTFLRTEGP--------RLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREE 144 (252)
T ss_pred cCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCccc
Confidence 99999999965432 2558889999999999999999 999999999999999999999999999998754
Q ss_pred CccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcCcchhhhcc
Q 012014 309 PAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMALPQRAEEVVD 387 (473)
Q Consensus 309 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (473)
.............++..|+|||.+.+..++.++||||||+++|+|++ |..||....... .........+
T Consensus 145 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~--~~~~~~~~~~-------- 214 (252)
T cd05084 145 EDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ--TREAIEQGVR-------- 214 (252)
T ss_pred ccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH--HHHHHHcCCC--------
Confidence 32211111111123456999999998889999999999999999998 888886432110 0000000000
Q ss_pred ccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHH
Q 012014 388 DFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLR 450 (473)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 450 (473)
...+..++..+.+|+.+||+.||++|||+.+|++.|+
T Consensus 215 --------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 215 --------------------------LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred --------------------------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 0001124567889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=322.88 Aligned_cols=270 Identities=23% Similarity=0.334 Sum_probs=205.9
Q ss_pred cccCCCCccceeecCCCeEEEEEEec--------CCCEEEEEEeeccC-CCCchhHHHHHHHHHhc-CCCCceeeeeeee
Q 012014 142 NATNGFSSANLIGAGNFGSVYNGTLF--------DGTTIAVKVFNLIR-PGGSKSFKSECKAAINI-KHRNIVRVFTAFS 211 (473)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 211 (473)
...++|.+.+.||+|+||.||+|+.. ++..||+|.+.... ......+.+|+.++..+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 34567889999999999999999731 23579999886432 23345788999999999 8999999999975
Q ss_pred ccccCCceeeEEEEEecCCCCHHHHhcCCCCCCCC-------CcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccC
Q 012014 212 GVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWR-------PLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNL 284 (473)
Q Consensus 212 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~-------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dl 284 (473)
.. ...+++|||+++|+|.+++......... .....+++.++..++.||+.||.||| ++|++||||
T Consensus 92 ~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dl 163 (304)
T cd05101 92 QD-----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDL 163 (304)
T ss_pred cC-----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeeccc
Confidence 43 3679999999999999999765322110 01124678889999999999999999 999999999
Q ss_pred CCCcEEecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCC
Q 012014 285 KPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363 (473)
Q Consensus 285 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~ 363 (473)
||+||+++.++.+||+|||+++...............+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.
T Consensus 164 kp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 164 AARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred ccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999999987654332222233346778999999988889999999999999999998 78888653
Q ss_pred CCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChH
Q 012014 364 FTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKIN 443 (473)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 443 (473)
.. ..+......... ...+..++..+.+|+.+||+.+|.+|||+.
T Consensus 244 ~~-----~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~ 287 (304)
T cd05101 244 PV-----EELFKLLKEGHR-------------------------------MDKPANCTNELYMMMRDCWHAIPSHRPTFK 287 (304)
T ss_pred CH-----HHHHHHHHcCCc-------------------------------CCCCCCCCHHHHHHHHHHcccChhhCCCHH
Confidence 21 111111000000 000113456788999999999999999999
Q ss_pred HHHHHHHHHHHh
Q 012014 444 DVESRLRLIRRK 455 (473)
Q Consensus 444 ev~~~L~~l~~~ 455 (473)
||++.|+.+...
T Consensus 288 e~l~~l~~~~~~ 299 (304)
T cd05101 288 QLVEDLDRILTL 299 (304)
T ss_pred HHHHHHHHHHHh
Confidence 999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=329.85 Aligned_cols=279 Identities=23% Similarity=0.296 Sum_probs=203.1
Q ss_pred CCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcC-C-----CCceeeeeeeeccccCCc
Q 012014 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK-H-----RNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~~~~~~~~~~~~~~ 218 (473)
+|.+.++||+|+||.|.+|. ..+++.||||+++... ....+-..|+.+|..|+ | -|+|+++++|...
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr----- 260 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR----- 260 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc-----
Confidence 68899999999999999998 5679999999998533 23455678999999996 3 4899999998653
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCC--cc
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE--MI 296 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~--~~ 296 (473)
.+.|||+|.+ ..+|.++|+.+.-. .|+...+..++.||+.||.+|| ..+|||+||||+|||+.+. ..
T Consensus 261 ~HlciVfELL-~~NLYellK~n~f~-------Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~ 329 (586)
T KOG0667|consen 261 NHLCIVFELL-STNLYELLKNNKFR-------GLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSR 329 (586)
T ss_pred cceeeeehhh-hhhHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCc
Confidence 4789999999 66999999988754 4778999999999999999999 9999999999999999643 37
Q ss_pred EEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 012014 297 GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKM 376 (473)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~ 376 (473)
+||+|||.|+..... ..+..-+..|+|||++.|.+|+.+.||||||||++||++|.+.|.|....+ .+..+...
T Consensus 330 vKVIDFGSSc~~~q~-----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~D-Ql~~I~e~ 403 (586)
T KOG0667|consen 330 IKVIDFGSSCFESQR-----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYD-QLARIIEV 403 (586)
T ss_pred eeEEecccccccCCc-----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHH-HHHHHHHH
Confidence 999999999875332 224456889999999999999999999999999999999988888753322 22222211
Q ss_pred h-cC-c-------chhhhccc-------cchHH---------HHhhhhh-hcccccC-CCCcchhhHHHHHHHHHHHHhh
Q 012014 377 A-LP-Q-------RAEEVVDD-------FNLQE---------IEEGRTM-CMEVSSS-SGSSAHASIILECFNSICEIGV 429 (473)
Q Consensus 377 ~-~~-~-------~~~~~~~~-------~~~~~---------~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~l~~l~~ 429 (473)
. .| . ......+. ..... ....... ....... ...+............+.+++.
T Consensus 404 lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk 483 (586)
T KOG0667|consen 404 LGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLK 483 (586)
T ss_pred hCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHH
Confidence 1 11 0 00000110 00000 0000000 0000011 1122222333345678899999
Q ss_pred hcccCCCCCCCChHHHHH
Q 012014 430 ACSAERPRERMKINDVES 447 (473)
Q Consensus 430 ~cl~~dP~~RPt~~ev~~ 447 (473)
+||.+||.+|+|..|.++
T Consensus 484 ~~L~~dP~~R~tp~qal~ 501 (586)
T KOG0667|consen 484 RCLEWDPAERITPAQALN 501 (586)
T ss_pred HHhccCchhcCCHHHHhc
Confidence 999999999999988764
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=330.96 Aligned_cols=278 Identities=18% Similarity=0.146 Sum_probs=199.4
Q ss_pred cCCCCccceeecCCCeEEEEEEec---CCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTLF---DGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
..+|.+.+.||+|+||.||++... .+..||+|.+.. .....+|+.++++++||||+++++++.. ...
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~-----~~~~~~E~~il~~l~h~~iv~~~~~~~~-----~~~ 160 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTG-----GKTPGREIDILKTISHRAIINLIHAYRW-----KST 160 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccc-----cccHHHHHHHHHhcCCCCccceeeeEee-----CCE
Confidence 357999999999999999999742 357899998753 2345789999999999999999998754 346
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.+++||++ +++|.+++.... .+++.+++.++.||+.||.||| +++|+||||||+|||++.++.+||+
T Consensus 161 ~~lv~e~~-~~~l~~~l~~~~---------~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~ 227 (392)
T PHA03207 161 VCMVMPKY-KCDLFTYVDRSG---------PLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLG 227 (392)
T ss_pred EEEEehhc-CCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEc
Confidence 79999999 478999885433 3668999999999999999999 9999999999999999999999999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCc--ccHHHHHHhhc
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGK--MNLRNFVKMAL 378 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~--~~~~~~~~~~~ 378 (473)
|||+++...............||+.|+|||++.+..++.++|||||||++|||++|..||.+..... ..+....+...
T Consensus 228 DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~ 307 (392)
T PHA03207 228 DFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQ 307 (392)
T ss_pred cCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhc
Confidence 9999986654433333345679999999999999899999999999999999999999997653321 12222222211
Q ss_pred Ccchh--hhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 379 PQRAE--EVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 379 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
..... .-........+.... .........+.. -........+.+++.+||..||++|||+.|++..
T Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~--~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 308 VHPLEFPQNGSTNLCKHFKQYA--IVLRPPYTIPPV--IRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred cCccccCCccchhHHHHHHhhc--ccccCCccccch--hhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 11000 000000000100000 000000000000 0001234577889999999999999999999764
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=327.53 Aligned_cols=241 Identities=21% Similarity=0.235 Sum_probs=188.7
Q ss_pred CCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccC---CCCchhHHHHHHHHHhc-CCCCceeeeeeeeccccCCcee
Q 012014 146 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 220 (473)
+|.+.+.||+|+||.||+|.. .+++.||+|+++... ......+..|..++..+ +|++|+++++++.+. ..
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-----~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM-----DR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC-----CE
Confidence 578899999999999999984 467899999987432 22234566788888777 589999999887543 36
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.++||||+++|+|.+++.... .+++.++..++.||+.||.||| +++|+||||||+|||++.++.+||+
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~---------~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~ 143 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQVG---------RFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIA 143 (323)
T ss_pred EEEEEcCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEc
Confidence 899999999999999987654 3558889999999999999999 9999999999999999999999999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCc
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQ 380 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 380 (473)
|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|..||.+..... ........
T Consensus 144 DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~-----~~~~i~~~ 216 (323)
T cd05616 144 DFGMCKENMWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-----LFQSIMEH 216 (323)
T ss_pred cCCCceecCCCC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH-----HHHHHHhC
Confidence 999997543211 12234568999999999999999999999999999999999999997532211 11100000
Q ss_pred chhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCCh
Q 012014 381 RAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKI 442 (473)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 442 (473)
.. ..+...+.++.+|+.+||+.||.+|++.
T Consensus 217 ~~--------------------------------~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 217 NV--------------------------------AYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CC--------------------------------CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 00 0011234567899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=316.66 Aligned_cols=265 Identities=23% Similarity=0.341 Sum_probs=201.0
Q ss_pred CCCccceeecCCCeEEEEEEec------CCCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 146 GFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
+|.+.+.||+|+||.||+|... ....+++|.+..... .....+.+|+.++..++||||+++++.+...
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----- 75 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQD----- 75 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecC-----
Confidence 4778899999999999999842 235688888764332 2235688999999999999999999987543
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCC---------------CCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeecc
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNW---------------RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCN 283 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~---------------~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~D 283 (473)
...+++|||+.+|+|.+++........ ......+++..++.++.|++.||.||| +++++|||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~d 152 (290)
T cd05045 76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRD 152 (290)
T ss_pred CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhh
Confidence 357999999999999999875422110 011124678899999999999999999 99999999
Q ss_pred CCCCcEEecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCC
Q 012014 284 LKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDG 362 (473)
Q Consensus 284 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~ 362 (473)
|||+||++++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||.+
T Consensus 153 ikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 232 (290)
T cd05045 153 LAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 232 (290)
T ss_pred hhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999976543322222223345778999999988889999999999999999998 9999975
Q ss_pred CCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCCh
Q 012014 363 IFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKI 442 (473)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 442 (473)
..... +......... ...+..++..+.+++.+||+.||++|||+
T Consensus 233 ~~~~~--~~~~~~~~~~----------------------------------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~ 276 (290)
T cd05045 233 IAPER--LFNLLKTGYR----------------------------------MERPENCSEEMYNLMLTCWKQEPDKRPTF 276 (290)
T ss_pred CCHHH--HHHHHhCCCC----------------------------------CCCCCCCCHHHHHHHHHHccCCcccCCCH
Confidence 32111 1111100000 00011245678899999999999999999
Q ss_pred HHHHHHHHHHHH
Q 012014 443 NDVESRLRLIRR 454 (473)
Q Consensus 443 ~ev~~~L~~l~~ 454 (473)
.|+++.|+.+-.
T Consensus 277 ~~i~~~l~~~~~ 288 (290)
T cd05045 277 ADISKELEKMMV 288 (290)
T ss_pred HHHHHHHHHHHh
Confidence 999999998854
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=331.86 Aligned_cols=284 Identities=17% Similarity=0.189 Sum_probs=199.5
Q ss_pred CCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC--CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
+|++.+.||+|+||.||++. ..+++.||+|++.... ....+.+.+|+.++..++||||+++++++...+.......+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 47889999999999999998 4578999999986422 12345688999999999999999999998654433334679
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
+||||+. ++|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+||
T Consensus 81 lv~e~~~-~~l~~~~~~~~---------~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Df 147 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ---------PLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDF 147 (372)
T ss_pred EEeeccc-cCHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccc
Confidence 9999995 68888886543 3568899999999999999999 999999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCC-CCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcc
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQR 381 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 381 (473)
|+++...... ........+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+..... .+..+........
T Consensus 148 g~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~g~~~ 225 (372)
T cd07853 148 GLARVEEPDE-SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ-QLDLITDLLGTPS 225 (372)
T ss_pred cceeecccCc-cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHcCCCC
Confidence 9998654322 1122234578999999998774 47899999999999999999999997643221 1111111111111
Q ss_pred hhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 382 AEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
...+... . ......... ..................+..+.+|+.+||+.||++|||+.|+++.
T Consensus 226 ~~~~~~~-~-~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 226 LEAMRSA-C-EGARAHILR--GPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHh-h-HHHHHHHHh--CCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 1111000 0 000000000 0000000000000111235678899999999999999999999763
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=313.60 Aligned_cols=260 Identities=20% Similarity=0.292 Sum_probs=203.5
Q ss_pred CCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCC---CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP---GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
++|++.+.||+|+||.||+|. ..+++.+|||.+..... .....+.+|+.+++.++||||+++++++... ..
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-----NE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeC-----Ce
Confidence 468889999999999999999 46889999998864322 2235688999999999999999999998543 36
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.+++|||+++++|.+++...... ...+++..+..++.||+.||.||| +++++|+||||+||+++.++.++|+
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~ 148 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQ-----KRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLG 148 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhcc-----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEC
Confidence 79999999999999998643211 113568899999999999999999 9999999999999999999999999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCc
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQ 380 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 380 (473)
|||++........ ......|+..|+|||.+.+..++.++||||||+++|+|++|..||.+..... ........
T Consensus 149 dfg~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~-- 221 (267)
T cd08229 149 DLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL---YSLCKKIE-- 221 (267)
T ss_pred cchhhhccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH---HHHhhhhh--
Confidence 9999876543221 1223458899999999988889999999999999999999999996532211 11110000
Q ss_pred chhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHH
Q 012014 381 RAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLI 452 (473)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l 452 (473)
..... +......+..+.+++.+||+.||.+|||+.+|++.++++
T Consensus 222 ---~~~~~-------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 222 ---QCDYP-------------------------PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred ---cCCCC-------------------------CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 00000 000112566888999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=317.48 Aligned_cols=267 Identities=21% Similarity=0.295 Sum_probs=200.6
Q ss_pred cccCCCCccceeecCCCeEEEEEEec------CCCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccc
Q 012014 142 NATNGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVD 214 (473)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 214 (473)
...++|++.++||+|+||.||+|... .+..||+|.++.... .....+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~- 81 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG- 81 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-
Confidence 45678999999999999999999632 245799998763321 2234578899999999999999999987543
Q ss_pred cCCceeeEEEEEecCCCCHHHHhcCCCCCCCC-CcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecC
Q 012014 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWR-PLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD 293 (473)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~-~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~ 293 (473)
...++||||+++|+|.+++......... .....+++..+..++.|++.||.||| +++|+||||||+||+++.
T Consensus 82 ----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~ 154 (288)
T cd05061 82 ----QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAH 154 (288)
T ss_pred ----CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcC
Confidence 3579999999999999999754321110 00112446788899999999999999 999999999999999999
Q ss_pred CccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHH
Q 012014 294 EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRN 372 (473)
Q Consensus 294 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~ 372 (473)
++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.+.... .
T Consensus 155 ~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~-----~ 229 (288)
T cd05061 155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE-----Q 229 (288)
T ss_pred CCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH-----H
Confidence 99999999999986543222221222235678999999998889999999999999999998 78898653221 1
Q ss_pred HHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHH
Q 012014 373 FVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLI 452 (473)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l 452 (473)
........... ..+..++..+.+++.+||+.||++|||+.++++.|+..
T Consensus 230 ~~~~~~~~~~~-------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 230 VLKFVMDGGYL-------------------------------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HHHHHHcCCCC-------------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 11110000000 00112356889999999999999999999999888876
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=331.34 Aligned_cols=287 Identities=16% Similarity=0.153 Sum_probs=199.6
Q ss_pred ccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCC--CCchhHHHHHHHHHhcCCCCceeeeeeeecccc-CCc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY-QGA 218 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~ 218 (473)
..++|.+.+.||+|+||.||++. ...++.||+|++..... .....+.+|+.+++.++||||+++++++..... ...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 45789999999999999999998 45689999999874322 233567789999999999999999998864331 223
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...++||||++ ++|.+++... ++...+..++.|++.||.||| ++||+||||||+|||++.++.+|
T Consensus 95 ~~~~lv~e~~~-~~l~~~~~~~-----------l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~k 159 (355)
T cd07874 95 QDVYLVMELMD-ANLCQVIQME-----------LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLK 159 (355)
T ss_pred ceeEEEhhhhc-ccHHHHHhhc-----------CCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEE
Confidence 45799999995 5777776532 447788899999999999999 99999999999999999999999
Q ss_pred EeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 012014 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMAL 378 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~ 378 (473)
|+|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+ .+...+....
T Consensus 160 l~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~ 235 (355)
T cd07874 160 ILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLG 235 (355)
T ss_pred EeeCcccccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhC
Confidence 9999999865332 12233468999999999999899999999999999999999999997642211 1111111111
Q ss_pred Cc--chhhhccccchHHHHhhhhhh----cccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 379 PQ--RAEEVVDDFNLQEIEEGRTMC----MEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 379 ~~--~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
.. .....+............... ......................+.+|+.+||+.||++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 236 TPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred CCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00 000000000000000000000 00000000000001111235678899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=319.00 Aligned_cols=262 Identities=25% Similarity=0.341 Sum_probs=198.9
Q ss_pred ccCCCCccceeecCCCeEEEEEEec------CCCEEEEEEeeccCCC-CchhHHHHHHHHHhcCCCCceeeeeeeecccc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRPG-GSKSFKSECKAAINIKHRNIVRVFTAFSGVDY 215 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 215 (473)
.+++|.+.+.||+|+||.||+|... .+..||+|.+...... ....+.+|+.+++.++|+||+++++++.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-- 81 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFER-- 81 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC--
Confidence 3467899999999999999999853 3567899987643322 234688999999999999999999987543
Q ss_pred CCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCc
Q 012014 216 QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM 295 (473)
Q Consensus 216 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~ 295 (473)
...++||||+++++|.+++......... ...+++.+++.++.||+.||.||| +++++||||||+||+++.++
T Consensus 82 ---~~~~lv~e~~~g~~L~~~i~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~ 153 (277)
T cd05036 82 ---LPRFILLELMAGGDLKSFLRENRPRPER--PSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKG 153 (277)
T ss_pred ---CCcEEEEecCCCCCHHHHHHHhCCCCCC--CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccC
Confidence 3568999999999999999776432211 124678999999999999999999 89999999999999998654
Q ss_pred ---cEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHH
Q 012014 296 ---IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLR 371 (473)
Q Consensus 296 ---~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~ 371 (473)
.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||.+..... +.
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~--~~ 231 (277)
T cd05036 154 PGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE--VM 231 (277)
T ss_pred CCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HH
Confidence 689999999986632221111112223567999999998889999999999999999997 999997532211 11
Q ss_pred HHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHH
Q 012014 372 NFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLR 450 (473)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 450 (473)
..+.. ... ...+..++..+.+++.+||+.||++|||+.+|++.|+
T Consensus 232 ~~~~~---~~~-------------------------------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 232 EFVTG---GGR-------------------------------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHHc---CCc-------------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11000 000 0001124567889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=320.81 Aligned_cols=280 Identities=17% Similarity=0.250 Sum_probs=200.1
Q ss_pred CCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
++|.+.+.||+|+||.||+|. ..+++.||+|.++.... .....+.+|+.++++++||||+++++++... ...+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 80 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTD-----KSLT 80 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeC-----CeEE
Confidence 579999999999999999998 44688999999875432 2334678999999999999999999997543 3679
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
+||||++ ++|.+++..... .+++..+..++.|++.||.||| +++|+||||||+||+++.++.+||+||
T Consensus 81 lv~e~~~-~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Df 148 (309)
T cd07872 81 LVFEYLD-KDLKQYMDDCGN--------IMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADF 148 (309)
T ss_pred EEEeCCC-CCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcc
Confidence 9999996 589888865432 2457888899999999999999 999999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcC--
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP-- 379 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~-- 379 (473)
|+++...... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+ .+....+....
T Consensus 149 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~ 225 (309)
T cd07872 149 GLARAKSVPT--KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED-ELHLIFRLLGTPT 225 (309)
T ss_pred ccceecCCCc--cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCC
Confidence 9997543322 11223457899999998865 458899999999999999999999997643221 11111111111
Q ss_pred -cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH--HHHHHH
Q 012014 380 -QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES--RLRLIR 453 (473)
Q Consensus 380 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~--~L~~l~ 453 (473)
.....+.......... .. ..............+..+.+|+.+||+.||.+|||+.|+++ .++.+.
T Consensus 226 ~~~~~~~~~~~~~~~~~-------~~--~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 226 EETWPGISSNDEFKNYN-------FP--KYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred HHHHhhhcchhhhhhhh-------cC--ccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 0011110000000000 00 00000001111234567889999999999999999999987 444443
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=331.61 Aligned_cols=279 Identities=15% Similarity=0.124 Sum_probs=197.6
Q ss_pred ccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
...+|.+.+.||+|+||.||+|.. ..++.||||... ...+.+|++++++++|||||++++++... ...
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~-----~~~ 235 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVG-----GLT 235 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEEC-----CEE
Confidence 345799999999999999999994 457899999632 34567899999999999999999987543 367
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEee
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~D 301 (473)
++|||++ .++|.+++..... .+++.+++.++.||+.||.||| ++||+||||||+|||++.++.+||+|
T Consensus 236 ~lv~e~~-~~~L~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~D 303 (461)
T PHA03211 236 CLVLPKY-RSDLYTYLGARLR--------PLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGD 303 (461)
T ss_pred EEEEEcc-CCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcc
Confidence 9999999 5799998865432 3668999999999999999999 99999999999999999999999999
Q ss_pred cccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCc------ccHHHHHH
Q 012014 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGK------MNLRNFVK 375 (473)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~------~~~~~~~~ 375 (473)
||+++...............||+.|+|||++.+..++.++|||||||++|||++|..|+....... ..+...+.
T Consensus 304 FGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~ 383 (461)
T PHA03211 304 FGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIR 383 (461)
T ss_pred cCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHH
Confidence 999986643322222234569999999999999899999999999999999999887654322111 11222221
Q ss_pred hhcC--cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 376 MALP--QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 376 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.... ..........+...+... ..... ........+.........+.+|+.+||+.||.+|||+.|+++
T Consensus 384 ~~~~~~~~~~~~~~~~l~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 384 QAQVHVDEFPQHAGSRLVSQYRHR--AARNR-RPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred hhccccccCCCCcchHHHHHHHhh--hhccc-CCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 1100 000000000111111000 00000 000000111112233457889999999999999999999976
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=320.55 Aligned_cols=205 Identities=20% Similarity=0.251 Sum_probs=163.3
Q ss_pred cceeecCCCeEEEEEEec---CCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEEEE
Q 012014 150 ANLIGAGNFGSVYNGTLF---DGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYK 226 (473)
Q Consensus 150 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 226 (473)
..+||+|+||.||+|+.. +++.||+|.+... .....+.+|+.++++++||||+++++++... .....+++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSH---ADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecC---CCcEEEEEEe
Confidence 468999999999999843 4678999998643 2345678999999999999999999988542 2346799999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEe----cCCccEEEeec
Q 012014 227 FMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL----DDEMIGHVGDF 302 (473)
Q Consensus 227 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~----~~~~~~kl~Df 302 (473)
|+ +++|.+++..............+++..+..++.||+.||.||| +++|+||||||+|||+ +.++.+||+||
T Consensus 81 ~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07868 81 YA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred cc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence 99 4689888764432211111224678899999999999999999 9999999999999999 45678999999
Q ss_pred ccccccCcccc-ccceeeccCCCCcCCCccccCC-CCCcccchhhHhHHHHHHHhCCCCCCCC
Q 012014 303 GMARFLPAIDK-QNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGI 363 (473)
Q Consensus 303 g~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~ 363 (473)
|+++....... ........||+.|+|||++.+. .++.++||||+||++|+|++|.+||.+.
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 99987643221 1222345689999999998774 5899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=346.88 Aligned_cols=268 Identities=24% Similarity=0.276 Sum_probs=202.7
Q ss_pred CCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCC---CchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG---GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
++|++.++||+|+||.||+|.. .+++.||+|++...... ..+.+.+|++++.+++||||+++++++.+. ..
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~-----~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG-----DP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC-----CE
Confidence 5799999999999999999984 46899999998643221 235688999999999999999999997543 36
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCC--CCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTN--WRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
.+++|||++||+|.+++....... .......+++..++.++.||+.||.||| ++||+||||||+||+++.++.+|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vK 153 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVV 153 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEE
Confidence 799999999999999986532111 0111123456788999999999999999 89999999999999999999999
Q ss_pred EeecccccccCccccc----------------cceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCC
Q 012014 299 VGDFGMARFLPAIDKQ----------------NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 362 (473)
|+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus 154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~ 233 (932)
T PRK13184 154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR 233 (932)
T ss_pred EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 9999999865211100 011124599999999999999999999999999999999999999975
Q ss_pred CCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCC-C
Q 012014 363 IFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERM-K 441 (473)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t 441 (473)
......... .... ..... ....+.+..+.+++.+||..||++|| +
T Consensus 234 ~~~~ki~~~----~~i~-~P~~~-----------------------------~p~~~iP~~L~~LI~rcL~~DP~kR~ss 279 (932)
T PRK13184 234 KKGRKISYR----DVIL-SPIEV-----------------------------APYREIPPFLSQIAMKALAVDPAERYSS 279 (932)
T ss_pred cchhhhhhh----hhcc-Chhhc-----------------------------cccccCCHHHHHHHHHHccCChhhCcCH
Confidence 322111000 0000 00000 00113456788999999999999996 6
Q ss_pred hHHHHHHHHHHHH
Q 012014 442 INDVESRLRLIRR 454 (473)
Q Consensus 442 ~~ev~~~L~~l~~ 454 (473)
++++.+.|+....
T Consensus 280 ~eeLl~~Le~~lq 292 (932)
T PRK13184 280 VQELKQDLEPHLQ 292 (932)
T ss_pred HHHHHHHHHHHHh
Confidence 7888888887754
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=330.32 Aligned_cols=238 Identities=24% Similarity=0.287 Sum_probs=188.6
Q ss_pred ceeecCCCeEEEEEEe----cCCCEEEEEEeeccCC--CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEE
Q 012014 151 NLIGAGNFGSVYNGTL----FDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVV 224 (473)
Q Consensus 151 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 224 (473)
+.||+|+||.||++.. .+|+.||+|+++.... .....+.+|++++.+++||||+++++++.+ ....++|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~lv 76 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT-----EGKLYLI 76 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CCEEEEE
Confidence 5799999999999873 3578999999974322 233457789999999999999999999854 3467999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeeccc
Q 012014 225 YKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM 304 (473)
Q Consensus 225 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~ 304 (473)
|||+++|+|.+++.... .+++..+..++.||+.||.||| +++|+||||||+||+++.++.+||+|||+
T Consensus 77 ~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~ 144 (318)
T cd05582 77 LDFLRGGDLFTRLSKEV---------MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGL 144 (318)
T ss_pred EcCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccC
Confidence 99999999999996543 3568899999999999999999 99999999999999999999999999999
Q ss_pred ccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchhh
Q 012014 305 ARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEE 384 (473)
Q Consensus 305 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (473)
++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.... ...........
T Consensus 145 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-----~~~~~i~~~~~-- 215 (318)
T cd05582 145 SKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK-----ETMTMILKAKL-- 215 (318)
T ss_pred CcccCCCC--CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH-----HHHHHHHcCCC--
Confidence 87653321 2233456899999999999888999999999999999999999999753211 11110000000
Q ss_pred hccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHH
Q 012014 385 VVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKIND 444 (473)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 444 (473)
..+...+..+.+|+.+||+.||++|||+.+
T Consensus 216 ------------------------------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 216 ------------------------------GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred ------------------------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 001123456789999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=323.95 Aligned_cols=240 Identities=24% Similarity=0.335 Sum_probs=186.6
Q ss_pred ceeecCCCeEEEEEEe-cCCCEEEEEEeeccC---CCCchhHHHHHHHHHh-cCCCCceeeeeeeeccccCCceeeEEEE
Q 012014 151 NLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGSKSFKSECKAAIN-IKHRNIVRVFTAFSGVDYQGARFKAVVY 225 (473)
Q Consensus 151 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (473)
+.||+|+||.||+|.. .+++.||+|+++... ......+..|..++.. ++||||+++++++.+. ...++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~-----~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK-----ENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC-----CEEEEEE
Confidence 4699999999999994 467899999997532 2234456678888776 4899999999998543 3689999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecccc
Q 012014 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (473)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~ 305 (473)
||+++|+|.+++.... .+++.++..++.|++.||.||| +++|+||||||+|||++.++.+||+|||++
T Consensus 76 ey~~~g~L~~~l~~~~---------~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~ 143 (316)
T cd05619 76 EYLNGGDLMFHIQSCH---------KFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMC 143 (316)
T ss_pred eCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcc
Confidence 9999999999997643 3557888999999999999999 999999999999999999999999999998
Q ss_pred cccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchhhh
Q 012014 306 RFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEV 385 (473)
Q Consensus 306 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (473)
+..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+..... +...+....+.
T Consensus 144 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~--~~~~i~~~~~~----- 214 (316)
T cd05619 144 KENMLG--DAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE--LFQSIRMDNPC----- 214 (316)
T ss_pred eECCCC--CCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhCCCC-----
Confidence 753221 122234568999999999999899999999999999999999999997532110 00000000000
Q ss_pred ccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChH-HHH
Q 012014 386 VDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKIN-DVE 446 (473)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-ev~ 446 (473)
.+......+.+++.+||+.||++||++. ++.
T Consensus 215 ------------------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 215 ------------------------------YPRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred ------------------------------CCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 0011344678899999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=319.44 Aligned_cols=272 Identities=23% Similarity=0.332 Sum_probs=205.3
Q ss_pred ccCCCCccceeecCCCeEEEEEEec--------CCCEEEEEEeeccCC-CCchhHHHHHHHHHhc-CCCCceeeeeeeec
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTLF--------DGTTIAVKVFNLIRP-GGSKSFKSECKAAINI-KHRNIVRVFTAFSG 212 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 212 (473)
...+|.+.++||+|+||.||+|... ....+|+|.++.... .....+.+|+.++.++ +||||+++++++..
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 4467889999999999999999731 245789998874322 2234678999999999 69999999998854
Q ss_pred cccCCceeeEEEEEecCCCCHHHHhcCCCCCCC-------CCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCC
Q 012014 213 VDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW-------RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLK 285 (473)
Q Consensus 213 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~-------~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlk 285 (473)
. ...+++|||+++|+|.+++........ ......+++.++..++.|++.||.||| ++|++|||||
T Consensus 90 ~-----~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlk 161 (314)
T cd05099 90 E-----GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLA 161 (314)
T ss_pred C-----CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecccc
Confidence 2 357999999999999999976432110 001124678899999999999999999 9999999999
Q ss_pred CCcEEecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCC
Q 012014 286 PSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (473)
Q Consensus 286 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~ 364 (473)
|+||+++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..||.+..
T Consensus 162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 241 (314)
T cd05099 162 ARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP 241 (314)
T ss_pred ceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999986643222221222234567999999988889999999999999999999 889986532
Q ss_pred CCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHH
Q 012014 365 TGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKIND 444 (473)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 444 (473)
.. ........... ...+..++.++.+|+.+||+.||++|||+.|
T Consensus 242 ~~-----~~~~~~~~~~~-------------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ 285 (314)
T cd05099 242 VE-----ELFKLLREGHR-------------------------------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQ 285 (314)
T ss_pred HH-----HHHHHHHcCCC-------------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence 11 11110000000 0001234567889999999999999999999
Q ss_pred HHHHHHHHHHhhcc
Q 012014 445 VESRLRLIRRKLLE 458 (473)
Q Consensus 445 v~~~L~~l~~~~~~ 458 (473)
+++.|+.+......
T Consensus 286 ll~~l~~~~~~~~~ 299 (314)
T cd05099 286 LVEALDKVLAAVSE 299 (314)
T ss_pred HHHHHHHHHHHhcC
Confidence 99999999765543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-41 Score=310.99 Aligned_cols=251 Identities=25% Similarity=0.357 Sum_probs=198.3
Q ss_pred cCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEE
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (473)
-++|.+.+.||+|+||.||++.. .+..+|+|.++.. ...+.+.+|+.++++++|+|++++++++.. .....++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~l 77 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLYI 77 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEc----CCCceEE
Confidence 35788899999999999999975 5788999998632 235678999999999999999999997643 2345799
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecc
Q 012014 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (473)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg 303 (473)
+|||+++++|.+++...... .+++..++.++.|++.||.||| +++++||||||+||++++++.+||+|||
T Consensus 78 v~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg 147 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGRS-------VLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFG 147 (256)
T ss_pred EEECCCCCcHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCc
Confidence 99999999999999765422 2558889999999999999999 9999999999999999999999999999
Q ss_pred cccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcCcch
Q 012014 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMALPQRA 382 (473)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 382 (473)
++....... ....++..|+|||++.+..++.++|||||||++|+|++ |..||.... .............
T Consensus 148 ~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~-----~~~~~~~~~~~~~ 217 (256)
T cd05082 148 LTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKDVVPRVEKGYK 217 (256)
T ss_pred cceeccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHhcCCC
Confidence 987543221 12234668999999988889999999999999999998 999986421 1111111000000
Q ss_pred hhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHH
Q 012014 383 EEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLI 452 (473)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l 452 (473)
. .....++..+.+++.+||+.||++|||+.++++.|+.+
T Consensus 218 ~-------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 218 M-------------------------------DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred C-------------------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 0 00112456788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=325.62 Aligned_cols=241 Identities=22% Similarity=0.250 Sum_probs=189.8
Q ss_pred ceeecCCCeEEEEEEe-cCCCEEEEEEeeccC---CCCchhHHHHHHHHHhc-CCCCceeeeeeeeccccCCceeeEEEE
Q 012014 151 NLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGARFKAVVY 225 (473)
Q Consensus 151 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (473)
+.||+|+||.||+|.. .+++.||+|+++... ......+.+|..++..+ +||||+++++++.. ....++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~-----~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT-----KDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-----CCEEEEEE
Confidence 4699999999999984 468899999997432 23345677888998888 69999999999754 33689999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecccc
Q 012014 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (473)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~ 305 (473)
||+++|+|..++.... .+++.++..++.|++.||.||| +++|+||||||+||+++.++.+||+|||++
T Consensus 76 e~~~~~~L~~~~~~~~---------~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~ 143 (318)
T cd05570 76 EYVNGGDLMFHIQRSG---------RFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMC 143 (318)
T ss_pred cCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCC
Confidence 9999999999987654 3668899999999999999999 999999999999999999999999999998
Q ss_pred cccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchhhh
Q 012014 306 RFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEV 385 (473)
Q Consensus 306 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (473)
+..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.... ...........
T Consensus 144 ~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~-----~~~~~i~~~~~--- 213 (318)
T cd05570 144 KEGILG--GVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED-----ELFQSILEDEV--- 213 (318)
T ss_pred eecCcC--CCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH-----HHHHHHHcCCC---
Confidence 753221 11223346899999999999999999999999999999999999999753211 11110000000
Q ss_pred ccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCCh-----HHHHH
Q 012014 386 VDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKI-----NDVES 447 (473)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~-----~ev~~ 447 (473)
..+...+..+.+|+.+||..||++|||+ .++++
T Consensus 214 -----------------------------~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 214 -----------------------------RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred -----------------------------CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 0011234578899999999999999999 77754
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=310.71 Aligned_cols=255 Identities=24% Similarity=0.380 Sum_probs=202.0
Q ss_pred ccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
..++|++.++||+|+||.||+|...+++.||+|.+.... .....+.+|+.++++++||||+++++++.. ...+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~ 76 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVTQ------EPIY 76 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEcc------CCcE
Confidence 346789999999999999999998788999999987433 235678999999999999999999988632 2479
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
++|||+++++|.+++...... .+++.++..++.|++.||+||| +.+++||||||+||++++++.++|+||
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~df 146 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGI-------KLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADF 146 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccC
Confidence 999999999999998754322 3568889999999999999999 999999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcCcc
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMALPQR 381 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 381 (473)
|++........ .......++..|+|||++.+..++.++||||||+++|+|++ |..||.+..... ...........
T Consensus 147 g~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~~~- 222 (260)
T cd05067 147 GLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE--VIQNLERGYRM- 222 (260)
T ss_pred cceeecCCCCc-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH--HHHHHHcCCCC-
Confidence 99976642221 11122335678999999988889999999999999999999 999997543211 00000000000
Q ss_pred hhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHH
Q 012014 382 AEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRL 451 (473)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 451 (473)
+.....+.++.+++.+||+.||++|||++++++.|+.
T Consensus 223 ---------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 ---------------------------------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ---------------------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0011234578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=320.28 Aligned_cols=262 Identities=25% Similarity=0.388 Sum_probs=200.5
Q ss_pred CCCCccceeecCCCeEEEEEEec------CCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 145 NGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
.+|...++||+|+||.||++... ++..+|+|.+..........+.+|++++..++|+||+++++++.+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 79 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEG----- 79 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC-----
Confidence 56788899999999999999632 3568899988755544556799999999999999999999987543
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCC------CCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEec
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNW------RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD 292 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~ 292 (473)
...+++|||+++|+|.+++........ ......+++..++.++.|++.||.||| +++++||||||+||+++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~ 156 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVG 156 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEc
Confidence 357999999999999999976542100 001123678899999999999999999 99999999999999999
Q ss_pred CCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHH
Q 012014 293 DEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLR 371 (473)
Q Consensus 293 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~ 371 (473)
+++.+||+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |.+||........ +.
T Consensus 157 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-~~ 235 (280)
T cd05092 157 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA-IE 235 (280)
T ss_pred CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH-HH
Confidence 999999999999975533221111122235678999999998899999999999999999998 9999864322110 00
Q ss_pred HHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHH
Q 012014 372 NFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLR 450 (473)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 450 (473)
... .... ...+..++..+.+|+.+||+.||.+||+++||++.|+
T Consensus 236 ~~~----~~~~-------------------------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 236 CIT----QGRE-------------------------------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHH----cCcc-------------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 000 0000 0001124567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=323.72 Aligned_cols=240 Identities=24% Similarity=0.323 Sum_probs=186.9
Q ss_pred ceeecCCCeEEEEEEe-cCCCEEEEEEeeccC---CCCchhHHHHHHHHHhc-CCCCceeeeeeeeccccCCceeeEEEE
Q 012014 151 NLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGARFKAVVY 225 (473)
Q Consensus 151 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (473)
++||+|+||.||+|.. .+++.||+|+++... ......+..|..++..+ +||||+++++++.. ....++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT-----KEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe-----CCEEEEEE
Confidence 4699999999999994 468999999997432 23345567788887754 89999999999854 34789999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecccc
Q 012014 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (473)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~ 305 (473)
||+++|+|.+++.... .+++.++..++.|++.||+||| ++||+||||||+|||++.++.+||+|||++
T Consensus 76 E~~~~g~L~~~i~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~ 143 (316)
T cd05620 76 EFLNGGDLMFHIQDKG---------RFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMC 143 (316)
T ss_pred CCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCC
Confidence 9999999999987653 3558888999999999999999 999999999999999999999999999998
Q ss_pred cccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchhhh
Q 012014 306 RFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEV 385 (473)
Q Consensus 306 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (473)
+..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+..... +...+....+
T Consensus 144 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~--~~~~~~~~~~------ 213 (316)
T cd05620 144 KENVFG--DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE--LFESIRVDTP------ 213 (316)
T ss_pred eecccC--CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--HHHHHHhCCC------
Confidence 743221 122334569999999999999899999999999999999999999997532110 0000000000
Q ss_pred ccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChH-HHH
Q 012014 386 VDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKIN-DVE 446 (473)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-ev~ 446 (473)
..+.....++.+|+.+||+.||++||++. ++.
T Consensus 214 -----------------------------~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 214 -----------------------------HYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred -----------------------------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 00011345678899999999999999984 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=330.68 Aligned_cols=246 Identities=24% Similarity=0.336 Sum_probs=200.3
Q ss_pred eeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEEEEecCC
Q 012014 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPN 230 (473)
Q Consensus 152 ~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~ 230 (473)
+||+|.||+||-|+ ..+...+|||-+..........+..|+...++|+|.|||+++|.+.+ +.+.-|.||-++|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~se-----nGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSE-----NGFFKIFMEQVPG 656 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCC-----CCeEEEEeecCCC
Confidence 69999999999999 55677899999876666667778999999999999999999999743 3477899999999
Q ss_pred CCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEec-CCccEEEeecccccccC
Q 012014 231 GSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD-DEMIGHVGDFGMARFLP 309 (473)
Q Consensus 231 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~-~~~~~kl~Dfg~~~~~~ 309 (473)
|+|.++|+..- .+.. =.+.+.-.+.+||++||.||| .+.|||||||-+|||++ -.|.+||+|||.++.+.
T Consensus 657 GSLSsLLrskW----GPlK--DNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA 727 (1226)
T KOG4279|consen 657 GSLSSLLRSKW----GPLK--DNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA 727 (1226)
T ss_pred CcHHHHHHhcc----CCCc--cchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhc
Confidence 99999998653 2221 136777789999999999999 99999999999999996 47899999999998775
Q ss_pred ccccccceeeccCCCCcCCCccccCCC--CCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchhhhcc
Q 012014 310 AIDKQNRFICIKGSTGYIPPEYDLGCE--ASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVVD 387 (473)
Q Consensus 310 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (473)
... ....++.||..|||||++..++ |+.++|||||||++.||.||++||.........+-.. -
T Consensus 728 gin--P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkV---G---------- 792 (1226)
T KOG4279|consen 728 GIN--PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKV---G---------- 792 (1226)
T ss_pred cCC--ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhh---c----------
Confidence 433 2334566999999999998764 8999999999999999999999997653332111100 0
Q ss_pred ccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 388 DFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
. -..+++.+.+...+...++.+|+.+||.+||+++++++
T Consensus 793 --m-------------------yKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 793 --M-------------------YKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred --c-------------------eecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 0 01244566778889999999999999999999999975
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=317.86 Aligned_cols=250 Identities=19% Similarity=0.242 Sum_probs=200.0
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
..+|++.+.||+|+||.||+|. ..+++.||+|.+..........+.+|+.+++.++||||+++++.|... ...+
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~-----~~~~ 93 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELW 93 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeC-----CEEE
Confidence 4578999999999999999998 457899999999865555567889999999999999999999988642 3689
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
+||||+++++|.+++.... +++.++..++.|++.||.||| +.+|+||||||+||+++.++.+||+||
T Consensus 94 lv~e~~~~~~L~~~~~~~~----------~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~df 160 (296)
T cd06654 94 VVMEYLAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDF 160 (296)
T ss_pred EeecccCCCCHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECcc
Confidence 9999999999999986532 457888999999999999999 999999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcch
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRA 382 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 382 (473)
|++....... .......|++.|+|||.+.+..++.++|||||||++|+|++|..||....... ...... ....
T Consensus 161 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~----~~~~~~-~~~~ 233 (296)
T cd06654 161 GFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR----ALYLIA-TNGT 233 (296)
T ss_pred ccchhccccc--cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH----hHHHHh-cCCC
Confidence 9987653322 11223458899999999988889999999999999999999999997532211 100000 0000
Q ss_pred hhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 383 EEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
..+ ..+...+..+.+++.+||..||++|||+.||+.
T Consensus 234 ~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 234 PEL-----------------------------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCC-----------------------------CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 000 001124557889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=318.70 Aligned_cols=270 Identities=22% Similarity=0.269 Sum_probs=197.6
Q ss_pred cCCCCccceeecCCCeEEEEEEecC---------------CCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeee
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTLFD---------------GTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVF 207 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~~~---------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~ 207 (473)
.++|++.+.||+|+||.||++.... ...||+|.++.... .....+.+|++++.+++||||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3579999999999999999987422 23589999864322 2235688999999999999999999
Q ss_pred eeeeccccCCceeeEEEEEecCCCCHHHHhcCCCCCC---CCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccC
Q 012014 208 TAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTN---WRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNL 284 (473)
Q Consensus 208 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dl 284 (473)
+++... ...++||||+++++|.+++....... .......+++..++.++.|++.||.||| +++++||||
T Consensus 84 ~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dl 155 (295)
T cd05097 84 GVCVSD-----DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDL 155 (295)
T ss_pred EEEcCC-----CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeecccc
Confidence 998543 36799999999999999996543110 0001113568889999999999999999 999999999
Q ss_pred CCCcEEecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh--CCCCCCC
Q 012014 285 KPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT--GIRPSDG 362 (473)
Q Consensus 285 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt--g~~P~~~ 362 (473)
||+||++++++.+||+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus 156 kp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 156 ATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred ChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 99999999999999999999976543221111222335678999999988889999999999999999998 6677765
Q ss_pred CCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCCh
Q 012014 363 IFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKI 442 (473)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 442 (473)
....+ .+........... ... ........+..+.+|+.+||..||++|||+
T Consensus 236 ~~~~~-~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~~~l~~li~~~l~~~p~~RPs~ 286 (295)
T cd05097 236 LSDEQ-VIENTGEFFRNQG-RQI---------------------------YLSQTPLCPSPVFKLMMRCWSRDIKDRPTF 286 (295)
T ss_pred cChHH-HHHHHHHhhhhcc-ccc---------------------------cCCCCCCCCHHHHHHHHHHcCCCchhCcCH
Confidence 32211 1111000000000 000 000011245689999999999999999999
Q ss_pred HHHHHHHH
Q 012014 443 NDVESRLR 450 (473)
Q Consensus 443 ~ev~~~L~ 450 (473)
.+|++.|+
T Consensus 287 ~~i~~~l~ 294 (295)
T cd05097 287 NKIHHFLR 294 (295)
T ss_pred HHHHHHHh
Confidence 99999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=315.36 Aligned_cols=264 Identities=23% Similarity=0.330 Sum_probs=201.1
Q ss_pred ccCCCCccceeecCCCeEEEEEEec------CCCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeecccc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY 215 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 215 (473)
..++|.+.+.||+|+||.||+|... .+..||+|.+..... .....+.+|+.++..++||||+++++++...
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-- 81 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG-- 81 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC--
Confidence 3467889999999999999999843 236899999864321 2234688999999999999999999997543
Q ss_pred CCceeeEEEEEecCCCCHHHHhcCCCCCCCC-CcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCC
Q 012014 216 QGARFKAVVYKFMPNGSLEEWLRGKDDTNWR-PLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE 294 (473)
Q Consensus 216 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~-~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~ 294 (473)
...++||||+++|+|.+++......... .....+++..+..++.|++.||.||| +++++||||||+||+++.+
T Consensus 82 ---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~ 155 (277)
T cd05032 82 ---QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAED 155 (277)
T ss_pred ---CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCC
Confidence 4679999999999999999764321110 00113567889999999999999999 9999999999999999999
Q ss_pred ccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHH
Q 012014 295 MIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNF 373 (473)
Q Consensus 295 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~ 373 (473)
+.+||+|||+++...............++..|+|||.+.+..++.++|||||||++||+++ |..||.+..... ....
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~ 233 (277)
T cd05032 156 LTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE--VLKF 233 (277)
T ss_pred CCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH--HHHH
Confidence 9999999999976543322222233346788999999988889999999999999999998 999986532111 1111
Q ss_pred HHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHH
Q 012014 374 VKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLR 450 (473)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 450 (473)
.. ..... ..+..++..+.+++.+||+.+|++|||+.+|++.|+
T Consensus 234 ~~---~~~~~-------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 234 VI---DGGHL-------------------------------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred Hh---cCCCC-------------------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 10 00000 001123568889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=319.68 Aligned_cols=267 Identities=22% Similarity=0.343 Sum_probs=201.4
Q ss_pred CCCCccceeecCCCeEEEEEEec-CCC--EEEEEEeeccC-CCCchhHHHHHHHHHhc-CCCCceeeeeeeeccccCCce
Q 012014 145 NGFSSANLIGAGNFGSVYNGTLF-DGT--TIAVKVFNLIR-PGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 219 (473)
++|++.++||+|+||.||+|... ++. .+++|.++... ....+.+.+|+.++.++ +||||+++++++... .
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-----~ 76 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENR-----G 76 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC-----C
Confidence 57899999999999999999853 333 47888876322 22345688999999999 799999999987543 3
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCC-------CcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEec
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWR-------PLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD 292 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~-------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~ 292 (473)
..+++|||+++|+|.+++......... .....+++..+..++.|++.||+||| +++|+||||||+||+++
T Consensus 77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~ 153 (297)
T cd05089 77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVG 153 (297)
T ss_pred cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEEC
Confidence 679999999999999999764321110 01124678899999999999999999 99999999999999999
Q ss_pred CCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHH
Q 012014 293 DEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLR 371 (473)
Q Consensus 293 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~ 371 (473)
.++.+||+|||++....... .......+..|+|||++.+..++.++|||||||++|||++ |..||.+.....
T Consensus 154 ~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~---- 226 (297)
T cd05089 154 ENLASKIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE---- 226 (297)
T ss_pred CCCeEEECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH----
Confidence 99999999999986432111 1111123557999999988889999999999999999997 999997532211
Q ss_pred HHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHH
Q 012014 372 NFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRL 451 (473)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 451 (473)
........ . ....+..++..+.+|+.+||+.||.+|||+.+|++.|+.
T Consensus 227 -~~~~~~~~-~------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 274 (297)
T cd05089 227 -LYEKLPQG-Y------------------------------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSR 274 (297)
T ss_pred -HHHHHhcC-C------------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence 11100000 0 000011245678899999999999999999999999999
Q ss_pred HHHhhcc
Q 012014 452 IRRKLLE 458 (473)
Q Consensus 452 l~~~~~~ 458 (473)
+..+...
T Consensus 275 ~~~~~~~ 281 (297)
T cd05089 275 MLEARKA 281 (297)
T ss_pred HHHhhcc
Confidence 9876543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=309.98 Aligned_cols=246 Identities=24% Similarity=0.343 Sum_probs=192.3
Q ss_pred eeecCCCeEEEEEEe---cCCCEEEEEEeeccCC--CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEEEE
Q 012014 152 LIGAGNFGSVYNGTL---FDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYK 226 (473)
Q Consensus 152 ~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 226 (473)
.||+|+||.||+|.+ .++..+|+|+++.... ...+.+.+|+.++..++||||+++++++.. ...++|||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~lv~e 75 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA------ESWMLVME 75 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC------CCcEEEEe
Confidence 589999999999963 3578899999864332 234568899999999999999999998632 24589999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeeccccc
Q 012014 227 FMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMAR 306 (473)
Q Consensus 227 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~ 306 (473)
|+++|+|.+++.... .+++..+..++.|++.||.||| +++|+||||||+||+++.++.+||+|||++.
T Consensus 76 ~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~ 143 (257)
T cd05116 76 LAELGPLNKFLQKNK---------HVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSK 143 (257)
T ss_pred cCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCcccc
Confidence 999999999997543 3568889999999999999999 9999999999999999999999999999998
Q ss_pred ccCcccccc-ceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcCcchhh
Q 012014 307 FLPAIDKQN-RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMALPQRAEE 384 (473)
Q Consensus 307 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (473)
......... ......++..|+|||.+....++.++||||||+++|||++ |..||....... +...+.. ...
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~i~~---~~~-- 216 (257)
T cd05116 144 ALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE--VTQMIES---GER-- 216 (257)
T ss_pred ccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHC---CCC--
Confidence 664332111 1122234678999999988889999999999999999998 999997532211 1111110 000
Q ss_pred hccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHH
Q 012014 385 VVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRL 451 (473)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 451 (473)
.+.+..++.++.+|+.+||+.||++|||+++|.+.|+.
T Consensus 217 -----------------------------~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 217 -----------------------------MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred -----------------------------CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 00111245678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=310.78 Aligned_cols=251 Identities=21% Similarity=0.306 Sum_probs=197.7
Q ss_pred CCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCC-----CchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPG-----GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
++|.+.+.||+|++|.||+|. ..+++.+|+|.+...... ....+.+|+.++.+++||||+++++++...
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----- 76 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD----- 76 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC-----
Confidence 579999999999999999998 456899999998643221 234678899999999999999999998543
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...++++||+++++|.+++.... .++...+..++.|++.||.||| +.+++||||+|+||+++.++.++
T Consensus 77 ~~~~~v~e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~ 144 (263)
T cd06625 77 ETLSIFMEYMPGGSVKDQLKAYG---------ALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVK 144 (263)
T ss_pred CeEEEEEEECCCCcHHHHHHHhC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEE
Confidence 37899999999999999987653 2557888999999999999999 99999999999999999999999
Q ss_pred EeecccccccCccccccc-eeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 299 VGDFGMARFLPAIDKQNR-FICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
|+|||+++.......... .....|+..|+|||++.+..++.++||||||+++|+|++|+.||...... .......
T Consensus 145 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~ 220 (263)
T cd06625 145 LGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM----AAIFKIA 220 (263)
T ss_pred EeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH----HHHHHHh
Confidence 999999976543221111 12345788999999999988999999999999999999999999653111 1110000
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.... ....+...+..+.+++.+||+.||.+|||+.|+++
T Consensus 221 ~~~~-------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 221 TQPT-------------------------------NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred ccCC-------------------------------CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence 0000 00111234557889999999999999999999976
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=315.37 Aligned_cols=247 Identities=23% Similarity=0.265 Sum_probs=189.3
Q ss_pred eecCCCeEEEEEE-ecCCCEEEEEEeeccCC---CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEEEEec
Q 012014 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP---GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFM 228 (473)
Q Consensus 153 lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 228 (473)
||+|+||+||++. ..+++.||+|.+..... ...+.+..|+.+++.++||||+++++++.. ....++||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT-----KTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC-----CCeEEEEEeCC
Confidence 6999999999998 45789999999864322 123457789999999999999999988754 34689999999
Q ss_pred CCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeeccccccc
Q 012014 229 PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL 308 (473)
Q Consensus 229 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 308 (473)
++|+|.+++...... ...+++..+..++.||+.||.||| +++|+||||||+||+++.++.+||+|||++..+
T Consensus 76 ~~g~L~~~~~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 147 (280)
T cd05608 76 NGGDLRYHIYNVDEE-----NPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVEL 147 (280)
T ss_pred CCCCHHHHHHhcccc-----CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceec
Confidence 999999887543211 114668899999999999999999 999999999999999999999999999999765
Q ss_pred CccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchhhhccc
Q 012014 309 PAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDD 388 (473)
Q Consensus 309 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (473)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........ .............
T Consensus 148 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~------ 218 (280)
T cd05608 148 KDGQS--KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELKQRILNDSV------ 218 (280)
T ss_pred CCCCc--cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-HHHHHHhhcccCC------
Confidence 43221 22334689999999999999999999999999999999999999975322110 0000000000000
Q ss_pred cchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCC-----ChHHHHH
Q 012014 389 FNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERM-----KINDVES 447 (473)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~ 447 (473)
..+...+..+.+++.+||+.||++|| |++++++
T Consensus 219 --------------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 219 --------------------------TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred --------------------------CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 01123456788999999999999999 5566654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=315.16 Aligned_cols=253 Identities=20% Similarity=0.255 Sum_probs=196.7
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
.++|.+.+.||+|+||.||+|. ..+++.||+|.++.........+.+|+.+++.++||||+++++.+... ...+
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~-----~~~~ 82 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR-----DKLW 82 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC-----CEEE
Confidence 3578889999999999999998 456899999998765444455688999999999999999999987543 4679
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
++|||+++++|.+++.... .+++.++..++.|++.||.||| ++|++|+||||+||+++.++.+||+||
T Consensus 83 lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~df 150 (267)
T cd06645 83 ICMEFCGGGSLQDIYHVTG---------PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADF 150 (267)
T ss_pred EEEeccCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcc
Confidence 9999999999999987554 3568899999999999999999 899999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCcccc---CCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcC
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDL---GCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP 379 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 379 (473)
|++....... .......|+..|+|||++. ...++.++|||||||++|+|++|..||......... ........
T Consensus 151 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~-~~~~~~~~- 226 (267)
T cd06645 151 GVSAQITATI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-FLMTKSNF- 226 (267)
T ss_pred eeeeEccCcc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH-HhhhccCC-
Confidence 9987653321 1223346899999999874 456889999999999999999999998643221110 00000000
Q ss_pred cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 380 QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
..... . .....+..+.+++.+||+.||++|||+++|++
T Consensus 227 -~~~~~-~----------------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 227 -QPPKL-K----------------------------DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred -CCCcc-c----------------------------ccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 00000 0 00113446789999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=309.79 Aligned_cols=251 Identities=25% Similarity=0.364 Sum_probs=196.8
Q ss_pred CCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEE
Q 012014 145 NGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVV 224 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 224 (473)
.+|++.+.||+|+||.||+|.+.++..+|+|.+.... .....+.+|+.+++.++||||+++++++... ...++|
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv 77 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ-----RPIFIV 77 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCC-----CceEEE
Confidence 4588899999999999999997777789999986322 2345688999999999999999999987543 367999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeeccc
Q 012014 225 YKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM 304 (473)
Q Consensus 225 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~ 304 (473)
|||+++++|.+++..... .+++..+..++.|++.||.||| +++++||||||+||+++.++.+||+|||+
T Consensus 78 ~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~ 146 (256)
T cd05059 78 TEYMANGCLLNYLRERKG--------KLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGL 146 (256)
T ss_pred EecCCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCccc
Confidence 999999999999975432 3568889999999999999999 99999999999999999999999999999
Q ss_pred ccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcCcchh
Q 012014 305 ARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMALPQRAE 383 (473)
Q Consensus 305 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 383 (473)
++....... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+. .........
T Consensus 147 ~~~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~~~~~~~~~---- 219 (256)
T cd05059 147 ARYVLDDQY-TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV--VESVSAGYR---- 219 (256)
T ss_pred ceecccccc-cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH--HHHHHcCCc----
Confidence 876533211 11111123457999999998889999999999999999999 8999975322110 000000000
Q ss_pred hhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHH
Q 012014 384 EVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRL 449 (473)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L 449 (473)
...+..++..+.+++.+||+.+|++|||+.||++.|
T Consensus 220 ------------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 220 ------------------------------LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred ------------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 000112456788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=329.47 Aligned_cols=205 Identities=26% Similarity=0.321 Sum_probs=171.6
Q ss_pred hhhcccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC---CCCchhHHHHHHHHHhcCCCCceeeeeeeeccc
Q 012014 139 DLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVD 214 (473)
Q Consensus 139 ~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 214 (473)
++....++|++.+.||+|+||.||++. ..+++.+|+|++.... ......+.+|+.++..++||||+++++++.+
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-- 114 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD-- 114 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc--
Confidence 344456899999999999999999999 4568899999986422 2233457789999999999999999999754
Q ss_pred cCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCC
Q 012014 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE 294 (473)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~ 294 (473)
....++||||+++|+|.+++.... ++...+..++.||+.||.||| +++|+||||||+|||++.+
T Consensus 115 ---~~~~~lv~Ey~~gg~L~~~~~~~~----------~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~ 178 (371)
T cd05622 115 ---DRYLYMVMEYMPGGDLVNLMSNYD----------VPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKS 178 (371)
T ss_pred ---CCEEEEEEcCCCCCcHHHHHHhcC----------CCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCC
Confidence 347899999999999999997542 457788889999999999999 9999999999999999999
Q ss_pred ccEEEeecccccccCccccccceeeccCCCCcCCCccccCCC----CCcccchhhHhHHHHHHHhCCCCCCC
Q 012014 295 MIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE----ASTYGDVYSFGILLLEMFTGIRPSDG 362 (473)
Q Consensus 295 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~elltg~~P~~~ 362 (473)
+.+||+|||+++...... ........||+.|+|||++.+.. ++.++|||||||++|||++|..||.+
T Consensus 179 ~~ikL~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 249 (371)
T cd05622 179 GHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249 (371)
T ss_pred CCEEEEeCCceeEcCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCC
Confidence 999999999998664322 11223456999999999987543 78999999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=329.52 Aligned_cols=286 Identities=16% Similarity=0.147 Sum_probs=199.9
Q ss_pred ccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC--CCCchhHHHHHHHHHhcCCCCceeeeeeeecccc-CCc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY-QGA 218 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~ 218 (473)
..++|.+.+.||+|+||.||+|. ...++.||||++.... ......+.+|+.+++.++||||+++++++..... ...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 45789999999999999999998 4568899999987432 2234567899999999999999999998754321 223
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...++||||++ ++|.+++... +++..+..++.|++.||.||| +++|+||||||+|||++.++.+|
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~~-----------~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~k 166 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQME-----------LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLK 166 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHhc-----------CCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEE
Confidence 45799999995 5787777532 447788899999999999999 99999999999999999999999
Q ss_pred EeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 012014 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMAL 378 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~ 378 (473)
|+|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+ .+........
T Consensus 167 L~DfG~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~ 242 (364)
T cd07875 167 ILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQLG 242 (364)
T ss_pred EEeCCCccccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcC
Confidence 9999999865332 12233468999999999999999999999999999999999999997643221 1122211111
Q ss_pred Cc--chhhhccccchHHHHhhhhhhcc----cccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 379 PQ--RAEEVVDDFNLQEIEEGRTMCME----VSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 379 ~~--~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.. .....+................. ....................+.+|+.+||+.||.+|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 243 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred CCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 10 00011111000000000000000 00000000000111123457889999999999999999999976
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=314.09 Aligned_cols=258 Identities=21% Similarity=0.304 Sum_probs=199.3
Q ss_pred cccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhc-CCCCceeeeeeeeccccCC-c
Q 012014 142 NATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQG-A 218 (473)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~-~ 218 (473)
.+++.|++.+.||+|+||.||+|. ..+++.||+|.+.... .....+.+|+.++.++ +||||++++++|....... .
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 456789999999999999999998 4568899999987433 3446788999999998 7999999999987543221 3
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...+++|||+++++|.+++...... .+++..+..++.|++.||.||| +++|+||||||+||+++.++.+|
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~-------~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~ 151 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGN-------TLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVK 151 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEE
Confidence 4679999999999999999764321 3568889999999999999999 89999999999999999999999
Q ss_pred EeecccccccCccccccceeeccCCCCcCCCcccc-----CCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHH
Q 012014 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDL-----GCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNF 373 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~ 373 (473)
|+|||++....... .......|+..|+|||++. +..++.++|||||||++|||++|..||....... ..
T Consensus 152 l~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~----~~ 225 (272)
T cd06637 152 LVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR----AL 225 (272)
T ss_pred EccCCCceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH----HH
Confidence 99999997653322 1223456899999999986 3357889999999999999999999996432111 00
Q ss_pred HHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 374 VKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
... ........ .....+..+.+|+.+||..||.+|||+.||++
T Consensus 226 ~~~-~~~~~~~~------------------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 226 FLI-PRNPAPRL------------------------------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred HHH-hcCCCCCC------------------------------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 000 00000000 00123457889999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=314.16 Aligned_cols=273 Identities=23% Similarity=0.346 Sum_probs=201.3
Q ss_pred CCCCccceeecCCCeEEEEEEe-----cCCCEEEEEEeeccC-CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 145 NGFSSANLIGAGNFGSVYNGTL-----FDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
..|++.+.||+|+||.||++.. .++..||+|.++... ......+.+|+.+++.++||||+++++++... +.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~ 80 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GG 80 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CC
Confidence 3578899999999999999973 357889999986432 22345788999999999999999999988543 23
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...++||||+++++|.+++..... .+++.++..++.|++.||.||| ++|++||||||+||+++.++.+|
T Consensus 81 ~~~~lv~e~~~g~~L~~~l~~~~~--------~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~ 149 (284)
T cd05079 81 NGIKLIMEFLPSGSLKEYLPRNKN--------KINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVK 149 (284)
T ss_pred CceEEEEEccCCCCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEE
Confidence 457999999999999999865431 2568889999999999999999 99999999999999999999999
Q ss_pred EeecccccccCccccc-cceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 299 VGDFGMARFLPAIDKQ-NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
|+|||+++.+...... .......|+..|+|||++.+..++.++||||||+++|+|+++..|+...... .....
T Consensus 150 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~------~~~~~ 223 (284)
T cd05079 150 IGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTL------FLKMI 223 (284)
T ss_pred ECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccch------hhhhc
Confidence 9999999866432211 1112344677899999998888999999999999999999988775432110 00000
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHH
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLI 452 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l 452 (473)
.+........ ........+. ..+....++..+.+|+.+||+.||++|||+.+|++.|+.+
T Consensus 224 ~~~~~~~~~~-~~~~~~~~~~--------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 224 GPTHGQMTVT-RLVRVLEEGK--------------RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred ccccccccHH-HHHHHHHcCc--------------cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0000000000 0000000000 0001123567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=327.38 Aligned_cols=237 Identities=24% Similarity=0.262 Sum_probs=183.7
Q ss_pred ceeecCCCeEEEEEEe-cCCCEEEEEEeeccC---CCCchhHHHHHH-HHHhcCCCCceeeeeeeeccccCCceeeEEEE
Q 012014 151 NLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGSKSFKSECK-AAINIKHRNIVRVFTAFSGVDYQGARFKAVVY 225 (473)
Q Consensus 151 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (473)
++||+|+||.||+|.. .+|+.||+|++.... ......+.+|.. +++.++||||+++++.+.. ....++||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~-----~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-----ADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe-----CCEEEEEE
Confidence 4699999999999994 578999999987432 122234455554 4678999999999998754 34679999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecccc
Q 012014 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (473)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~ 305 (473)
||+++|+|.+++.... .+++..+..++.||+.||.||| ++||+||||||+|||++.++.+||+|||++
T Consensus 76 e~~~~g~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~ 143 (323)
T cd05575 76 DYVNGGELFFHLQRER---------SFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLC 143 (323)
T ss_pred cCCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCC
Confidence 9999999999987653 3558888999999999999999 999999999999999999999999999998
Q ss_pred cccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchhhh
Q 012014 306 RFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEV 385 (473)
Q Consensus 306 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (473)
+..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+... ............
T Consensus 144 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-----~~~~~~i~~~~~--- 213 (323)
T cd05575 144 KEGIEH--SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-----AEMYDNILNKPL--- 213 (323)
T ss_pred cccccC--CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-----HHHHHHHHcCCC---
Confidence 753221 1222345689999999999998999999999999999999999999975321 111111100000
Q ss_pred ccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChH
Q 012014 386 VDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKIN 443 (473)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 443 (473)
......+..+.+++.+||+.||.+||++.
T Consensus 214 -----------------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 214 -----------------------------RLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred -----------------------------CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 00012355778999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=336.56 Aligned_cols=203 Identities=22% Similarity=0.306 Sum_probs=164.8
Q ss_pred hhhcccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCC------CCceeeeeeee
Q 012014 139 DLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKH------RNIVRVFTAFS 211 (473)
Q Consensus 139 ~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~~~~~~~ 211 (473)
++...+++|++.++||+|+||.||+|. ..+++.||||+++... ........|+.++..++| +++++++++|.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 344456889999999999999999998 4568899999986422 223456678888877754 45888888875
Q ss_pred ccccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCC-CCeeeccCCCCcEE
Q 012014 212 GVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQ-PPIAHCNLKPSNVL 290 (473)
Q Consensus 212 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~iiH~Dlkp~Nil 290 (473)
. ...+.++|||++ +++|.+++.... .+++..+..|+.||+.||.||| + .|||||||||+|||
T Consensus 202 ~----~~~~~~iv~~~~-g~~l~~~l~~~~---------~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NIL 264 (467)
T PTZ00284 202 N----ETGHMCIVMPKY-GPCLLDWIMKHG---------PFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENIL 264 (467)
T ss_pred c----CCceEEEEEecc-CCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEE
Confidence 3 234679999998 789999887653 3568889999999999999999 7 59999999999999
Q ss_pred ecCCc----------------cEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHH
Q 012014 291 LDDEM----------------IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMF 354 (473)
Q Consensus 291 ~~~~~----------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 354 (473)
++.++ .+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||+
T Consensus 265 l~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~ell 339 (467)
T PTZ00284 265 METSDTVVDPVTNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELY 339 (467)
T ss_pred EecCCcccccccccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHH
Confidence 98765 49999999876432 1223456999999999999999999999999999999999
Q ss_pred hCCCCCCCCC
Q 012014 355 TGIRPSDGIF 364 (473)
Q Consensus 355 tg~~P~~~~~ 364 (473)
+|+.||.+..
T Consensus 340 tG~~pf~~~~ 349 (467)
T PTZ00284 340 TGKLLYDTHD 349 (467)
T ss_pred hCCCCCCCCC
Confidence 9999997643
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=315.89 Aligned_cols=270 Identities=20% Similarity=0.271 Sum_probs=199.1
Q ss_pred cCCCCccceeecCCCeEEEEEEec-----------------CCCEEEEEEeeccC-CCCchhHHHHHHHHHhcCCCCcee
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTLF-----------------DGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVR 205 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 205 (473)
.++|++.+.||+|+||.||++... +...+|+|+++... ......+.+|+.++..++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 357999999999999999998532 23468999987432 223457889999999999999999
Q ss_pred eeeeeeccccCCceeeEEEEEecCCCCHHHHhcCCCCCCC--CCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeecc
Q 012014 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW--RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCN 283 (473)
Q Consensus 206 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~D 283 (473)
+++++... ...+++|||+++|+|.+++........ ......+++.++..++.|++.||.||| +++++|||
T Consensus 84 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~d 155 (296)
T cd05095 84 LLAVCITS-----DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRD 155 (296)
T ss_pred EEEEEecC-----CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeeccc
Confidence 99998543 357999999999999999976543211 111123668889999999999999999 99999999
Q ss_pred CCCCcEEecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh--CCCCCC
Q 012014 284 LKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT--GIRPSD 361 (473)
Q Consensus 284 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt--g~~P~~ 361 (473)
|||+||+++.++.++|+|||+++.+.............++..|+|||...+..++.++|||||||++|||++ |..||.
T Consensus 156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~ 235 (296)
T cd05095 156 LATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYS 235 (296)
T ss_pred CChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcc
Confidence 999999999999999999999986533221111122234678999999888889999999999999999998 778886
Q ss_pred CCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCC
Q 012014 362 GIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMK 441 (473)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt 441 (473)
.....+. +.......... .... ..+.+..++..+.+|+.+||+.||++|||
T Consensus 236 ~~~~~~~-~~~~~~~~~~~-~~~~---------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~ 286 (296)
T cd05095 236 QLSDEQV-IENTGEFFRDQ-GRQV---------------------------YLPKPALCPDSLYKLMLSCWRRNAKERPS 286 (296)
T ss_pred ccChHHH-HHHHHHHHhhc-cccc---------------------------cCCCCCCCCHHHHHHHHHHcCCCcccCCC
Confidence 5322111 00000000000 0000 00001124568889999999999999999
Q ss_pred hHHHHHHHH
Q 012014 442 INDVESRLR 450 (473)
Q Consensus 442 ~~ev~~~L~ 450 (473)
+.||++.|+
T Consensus 287 ~~~i~~~l~ 295 (296)
T cd05095 287 FQEIHATLL 295 (296)
T ss_pred HHHHHHHHh
Confidence 999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=309.02 Aligned_cols=248 Identities=23% Similarity=0.364 Sum_probs=192.4
Q ss_pred eeecCCCeEEEEEEec---CCCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEEEEe
Q 012014 152 LIGAGNFGSVYNGTLF---DGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKF 227 (473)
Q Consensus 152 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 227 (473)
.||+|+||.||+|.+. ++..||+|++..... ...+.+.+|+.++++++||||+++++++.. ...++||||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~------~~~~lv~e~ 75 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA------EALMLVMEM 75 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC------CCeEEEEEe
Confidence 3899999999999743 355799999875432 224568899999999999999999998732 256899999
Q ss_pred cCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecccccc
Q 012014 228 MPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF 307 (473)
Q Consensus 228 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 307 (473)
+++|+|.+++..... .+++..++.++.|++.||.||| +++++||||||+||+++.++.+||+|||++..
T Consensus 76 ~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~ 144 (257)
T cd05115 76 ASGGPLNKFLSGKKD--------EITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKA 144 (257)
T ss_pred CCCCCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCcccc
Confidence 999999999975432 3668999999999999999999 89999999999999999999999999999986
Q ss_pred cCccccccc-eeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcCcchhhh
Q 012014 308 LPAIDKQNR-FICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMALPQRAEEV 385 (473)
Q Consensus 308 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (473)
......... .....++..|+|||.+.+..++.++||||||+++|++++ |..||....... ....+....+
T Consensus 145 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~~------ 216 (257)
T cd05115 145 LGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE--VMSFIEQGKR------ 216 (257)
T ss_pred ccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHHHCCCC------
Confidence 543322111 111223578999999988889999999999999999996 999997642211 1111100000
Q ss_pred ccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHH
Q 012014 386 VDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLI 452 (473)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l 452 (473)
...+..++.++.+++.+||..||++||++.+|.+.|+.+
T Consensus 217 ----------------------------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 217 ----------------------------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred ----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 001123456888999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=320.25 Aligned_cols=267 Identities=23% Similarity=0.362 Sum_probs=200.6
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCC--EEEEEEeeccC-CCCchhHHHHHHHHHhc-CCCCceeeeeeeeccccCCc
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGT--TIAVKVFNLIR-PGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 218 (473)
.++|++.+.||+|+||.||+|.. .++. .+|+|.++... ......+.+|+.++.++ +||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~----- 80 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR----- 80 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC-----
Confidence 46789999999999999999984 3454 45777665322 22335688899999999 899999999997543
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCC-------cchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEe
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRP-------LNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL 291 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~-------~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~ 291 (473)
...++||||+++|+|.+++.........+ ....+++.+++.++.|++.||+||| ++|++||||||+|||+
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili 157 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILV 157 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEe
Confidence 36799999999999999997654221110 1124678899999999999999999 9999999999999999
Q ss_pred cCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccH
Q 012014 292 DDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNL 370 (473)
Q Consensus 292 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~ 370 (473)
+.++.+||+|||++...... .......++..|+|||++.+..++.++|||||||++|||+| |..||.+....+
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--- 231 (303)
T cd05088 158 GENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE--- 231 (303)
T ss_pred cCCCcEEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH---
Confidence 99999999999998643211 11111224667999999988889999999999999999998 999996532211
Q ss_pred HHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHH
Q 012014 371 RNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLR 450 (473)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 450 (473)
..... +... . ...+...+..+.+|+.+||+.||++|||+.++++.|+
T Consensus 232 --~~~~~-~~~~----~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~ 278 (303)
T cd05088 232 --LYEKL-PQGY----R--------------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 278 (303)
T ss_pred --HHHHH-hcCC----c--------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 11000 0000 0 0001123456789999999999999999999999999
Q ss_pred HHHHhhc
Q 012014 451 LIRRKLL 457 (473)
Q Consensus 451 ~l~~~~~ 457 (473)
.+.+.-.
T Consensus 279 ~~~~~~~ 285 (303)
T cd05088 279 RMLEERK 285 (303)
T ss_pred HHHHhhh
Confidence 8865543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=311.42 Aligned_cols=256 Identities=20% Similarity=0.290 Sum_probs=186.5
Q ss_pred ceeecCCCeEEEEEEecC---CCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEEEE
Q 012014 151 NLIGAGNFGSVYNGTLFD---GTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYK 226 (473)
Q Consensus 151 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 226 (473)
+.||+|+||.||+|...+ +..+|+|.++.... .....+.+|+.++.+++||||+++++++.+. ...++|||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e 75 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV-----TPYLLVME 75 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC-----CCcEEEEE
Confidence 358999999999998533 45789998864332 2234688899999999999999999987543 35799999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeeccccc
Q 012014 227 FMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMAR 306 (473)
Q Consensus 227 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~ 306 (473)
|+++|+|.+++....... ....++..+..++.|++.||.||| +++++||||||+||+++.++.+||+|||+++
T Consensus 76 ~~~~g~L~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~ 148 (269)
T cd05087 76 FCPLGDLKGYLRSCRKAE----LMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSH 148 (269)
T ss_pred CCCCCcHHHHHHHhhhcc----cccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccc
Confidence 999999999997543211 112346677889999999999999 9999999999999999999999999999997
Q ss_pred ccCccccccceeeccCCCCcCCCccccCC-------CCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhc
Q 012014 307 FLPAIDKQNRFICIKGSTGYIPPEYDLGC-------EASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMAL 378 (473)
Q Consensus 307 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 378 (473)
...............|+..|+|||++.+. .++.++||||||+++|||++ |..||......+. ..+. .
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~--~~~~---~ 223 (269)
T cd05087 149 NKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV--LTYT---V 223 (269)
T ss_pred cccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH--HHHH---h
Confidence 54332221222234578889999987642 35789999999999999996 9999975432211 0000 0
Q ss_pred CcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHH
Q 012014 379 PQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLR 450 (473)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 450 (473)
........++. .....+..+.+++..|| .+|++|||++||+..|+
T Consensus 224 ~~~~~~~~~~~--------------------------~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 224 REQQLKLPKPR--------------------------LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred hcccCCCCCCc--------------------------cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 00000000000 00113445778999999 68999999999998774
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=308.42 Aligned_cols=250 Identities=20% Similarity=0.280 Sum_probs=197.9
Q ss_pred CCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC-CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEE
Q 012014 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (473)
+|++.+.||+|+||.||++. ..+++.+|+|.++... ....+.+.+|+.+++.++||||+++++.+.+ ....++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 75 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEA-----DGHLYI 75 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEE-----CCEEEE
Confidence 47888999999999999998 4578999999986432 3345678899999999999999999999754 347899
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecc
Q 012014 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (473)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg 303 (473)
+|||+++|+|.+++...... .++...+..++.|++.||.||| +++|+|+||||+||+++.++.++|+|||
T Consensus 76 v~e~~~~~~l~~~~~~~~~~-------~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg 145 (255)
T cd08219 76 VMEYCDGGDLMQKIKLQRGK-------LFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFG 145 (255)
T ss_pred EEeeCCCCcHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccC
Confidence 99999999999998654321 3568889999999999999999 9999999999999999999999999999
Q ss_pred cccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchh
Q 012014 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAE 383 (473)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 383 (473)
.+........ ......|++.|+|||++.+..++.++|+||||+++|+|++|..||..... .............
T Consensus 146 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~ 218 (255)
T cd08219 146 SARLLTSPGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-----KNLILKVCQGSYK 218 (255)
T ss_pred cceeeccccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-----HHHHHHHhcCCCC
Confidence 9976543221 12234588999999999988899999999999999999999999975211 1111111000000
Q ss_pred hhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 384 EVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
. .+...+..+.+|+.+||+.||++|||+.||+.+
T Consensus 219 ~-------------------------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 P-------------------------------LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred C-------------------------------CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0 011234567899999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=321.22 Aligned_cols=243 Identities=21% Similarity=0.244 Sum_probs=187.5
Q ss_pred ceeecCCCeEEEEEE-ecCCCEEEEEEeeccC---CCCchhHHHHHHHHHhc-CCCCceeeeeeeeccccCCceeeEEEE
Q 012014 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGARFKAVVY 225 (473)
Q Consensus 151 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (473)
++||+|+||.||+|. ..+++.||+|+++... ....+.+.+|+.++.++ +||||+++++++.. ....++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT-----TSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe-----CCEEEEEE
Confidence 469999999999998 4567899999997532 22335578899999888 69999999998754 34689999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecccc
Q 012014 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (473)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~ 305 (473)
||+++|+|..++.... .+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||++
T Consensus 76 e~~~~~~L~~~~~~~~---------~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~ 143 (327)
T cd05617 76 EYVNGGDLMFHMQRQR---------KLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMC 143 (327)
T ss_pred eCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccc
Confidence 9999999999887543 3668899999999999999999 999999999999999999999999999998
Q ss_pred cccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCc-ccHHHHHHhhcCcchhh
Q 012014 306 RFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGK-MNLRNFVKMALPQRAEE 384 (473)
Q Consensus 306 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~-~~~~~~~~~~~~~~~~~ 384 (473)
+..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||....... ................
T Consensus 144 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~- 220 (327)
T cd05617 144 KEGLGP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI- 220 (327)
T ss_pred eeccCC--CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC-
Confidence 753221 122334569999999999999999999999999999999999999997543221 1111111000000000
Q ss_pred hccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChH
Q 012014 385 VVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKIN 443 (473)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 443 (473)
..+...+..+.+++.+||+.||++||++.
T Consensus 221 ------------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 221 ------------------------------RIPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred ------------------------------CCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 00112345678899999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=308.45 Aligned_cols=254 Identities=25% Similarity=0.397 Sum_probs=199.4
Q ss_pred cCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEE
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (473)
.++|.+...||+|+||.||+|....+..+|+|.+.... ...+.+.+|+.+++.++|||++++++++.. ...++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------~~~~~ 77 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE------EPIYI 77 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC------CCcEE
Confidence 35688899999999999999997666789999876432 234678899999999999999999988632 24689
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecc
Q 012014 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (473)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg 303 (473)
+|||+++|+|.+++...... .+++..+..++.|++.||.||| +.+++|+||||+||++++++.++|+|||
T Consensus 78 v~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg 147 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDGK-------YLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFG 147 (260)
T ss_pred EEEcCCCCCHHHHHhhCCCC-------CCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCc
Confidence 99999999999999764321 2558889999999999999999 9999999999999999999999999999
Q ss_pred cccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcCcch
Q 012014 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMALPQRA 382 (473)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 382 (473)
++........ .......++..|+|||...+..++.++||||||+++|+|++ |..||.+...... .... .....
T Consensus 148 ~~~~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-~~~~-~~~~~--- 221 (260)
T cd05069 148 LARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV-LEQV-ERGYR--- 221 (260)
T ss_pred cceEccCCcc-cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHH-HcCCC---
Confidence 9976543221 11122335778999999988889999999999999999999 8999975322110 0000 00000
Q ss_pred hhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHH
Q 012014 383 EEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRL 451 (473)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 451 (473)
...+...+..+.+++.+||+.||++|||+++|++.|+.
T Consensus 222 -------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 222 -------------------------------MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -------------------------------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 00011345678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=306.93 Aligned_cols=251 Identities=25% Similarity=0.415 Sum_probs=200.9
Q ss_pred cCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEE
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (473)
.++|++.+.||+|+||.||+|.. .|+.||+|.++.... ..+.+.+|+.++..++|+||+++++++.. ....++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~ 77 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-----GNPLYI 77 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcC-----CCCeEE
Confidence 46788999999999999999985 579999999975433 45678999999999999999999999754 336799
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecc
Q 012014 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (473)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg 303 (473)
||||+++++|.+++...... .+++..+..++.|++.||.||| +++++|+||||+||+++.++.+||+|||
T Consensus 78 v~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g 147 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRA-------VITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFG 147 (256)
T ss_pred EEEecCCCcHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccc
Confidence 99999999999999765421 3568899999999999999999 9999999999999999999999999999
Q ss_pred cccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcCcch
Q 012014 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMALPQRA 382 (473)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 382 (473)
.++....... ...++..|+|||.+.+..++.++||||||+++|+|++ |..||....... +.........
T Consensus 148 ~~~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~~~~~--- 217 (256)
T cd05039 148 LAKEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPHVEKGYR--- 217 (256)
T ss_pred cccccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHhcCCC---
Confidence 9986632211 2234667999999988889999999999999999997 999986432110 0000000000
Q ss_pred hhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHH
Q 012014 383 EEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLI 452 (473)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l 452 (473)
...+...+..+.+++.+||+.+|++|||+.|+++.|+.+
T Consensus 218 -------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 218 -------------------------------MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred -------------------------------CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 000112456788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=325.93 Aligned_cols=240 Identities=25% Similarity=0.264 Sum_probs=184.1
Q ss_pred ceeecCCCeEEEEEEe-cCCCEEEEEEeeccC---CCCchhHHHHHH-HHHhcCCCCceeeeeeeeccccCCceeeEEEE
Q 012014 151 NLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGSKSFKSECK-AAINIKHRNIVRVFTAFSGVDYQGARFKAVVY 225 (473)
Q Consensus 151 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (473)
+.||+|+||.||+|+. .+++.||+|++.... ......+..|.. +++.++||||+++++++... ...++||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~-----~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA-----DKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcC-----CeEEEEE
Confidence 4699999999999984 467889999987432 112233444444 46778999999999987543 3679999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecccc
Q 012014 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (473)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~ 305 (473)
||+++|+|.+++.... .+++..+..++.||+.||.||| ++||+||||||+|||++.++.+||+|||++
T Consensus 76 e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a 143 (325)
T cd05602 76 DYINGGELFYHLQRER---------CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLC 143 (325)
T ss_pred eCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCC
Confidence 9999999999997643 3557788889999999999999 999999999999999999999999999999
Q ss_pred cccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchhhh
Q 012014 306 RFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEV 385 (473)
Q Consensus 306 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (473)
+..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||.+..... ..........
T Consensus 144 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~~~i~~~~~--- 213 (325)
T cd05602 144 KENIEH--NGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-----MYDNILNKPL--- 213 (325)
T ss_pred cccccC--CCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH-----HHHHHHhCCc---
Confidence 754221 122334569999999999999899999999999999999999999997532111 1110000000
Q ss_pred ccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHH
Q 012014 386 VDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVE 446 (473)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~ 446 (473)
......+..+.+++.+||+.||.+||++.+.+
T Consensus 214 -----------------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 214 -----------------------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred -----------------------------CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 00012345778999999999999999987543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=316.91 Aligned_cols=270 Identities=20% Similarity=0.248 Sum_probs=200.5
Q ss_pred cCCCCccceeecCCCeEEEEEEecC-----------------CCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCcee
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTLFD-----------------GTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVR 205 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~ 205 (473)
.++|++.+.||+|+||.||+|.... +..||+|.+..... .....+.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578999999999999999987432 24589999874332 23457889999999999999999
Q ss_pred eeeeeeccccCCceeeEEEEEecCCCCHHHHhcCCCCCCCC--CcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeecc
Q 012014 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWR--PLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCN 283 (473)
Q Consensus 206 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~--~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~D 283 (473)
+++++... ...+++|||+++++|.+++......... .....+++..++.++.|++.||.||| +++++|||
T Consensus 84 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~d 155 (296)
T cd05051 84 LLGVCTVD-----PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRD 155 (296)
T ss_pred EEEEEecC-----CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccc
Confidence 99998543 3679999999999999999765421100 01113668899999999999999999 89999999
Q ss_pred CCCCcEEecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh--CCCCCC
Q 012014 284 LKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT--GIRPSD 361 (473)
Q Consensus 284 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt--g~~P~~ 361 (473)
|||+||+++.++.++|+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.
T Consensus 156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 235 (296)
T cd05051 156 LATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE 235 (296)
T ss_pred cchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999976543322222223446788999999988889999999999999999998 777876
Q ss_pred CCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCC
Q 012014 362 GIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMK 441 (473)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt 441 (473)
...... .+............... ...+..++.++.+|+.+||+.||.+|||
T Consensus 236 ~~~~~~-~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rpt 286 (296)
T cd05051 236 HLTDQQ-VIENAGHFFRDDGRQIY----------------------------LPRPPNCPKDIYELMLECWRRDEEDRPT 286 (296)
T ss_pred CcChHH-HHHHHHhcccccccccc----------------------------CCCccCCCHHHHHHHHHHhccChhcCCC
Confidence 532111 01111000000000000 0001124568899999999999999999
Q ss_pred hHHHHHHHH
Q 012014 442 INDVESRLR 450 (473)
Q Consensus 442 ~~ev~~~L~ 450 (473)
+.||++.|+
T Consensus 287 ~~el~~~L~ 295 (296)
T cd05051 287 FREIHLFLQ 295 (296)
T ss_pred HHHHHHHhc
Confidence 999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=323.22 Aligned_cols=242 Identities=20% Similarity=0.243 Sum_probs=189.0
Q ss_pred CCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC---CCCchhHHHHHHHHHhcC-CCCceeeeeeeeccccCCcee
Q 012014 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 220 (473)
+|...+.||+|+||.||+|. ..+++.||+|+++... ....+.+..|..++..+. |++|+++++++.+ ...
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT-----VDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec-----CCE
Confidence 47778999999999999998 4578999999987432 233456778888888885 5778888888754 336
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.++||||+++|+|.+++.... .+++.++..++.||+.||.||| +++|+||||||+|||++.++.+||+
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~~~---------~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~ 143 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQVG---------KFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIA 143 (323)
T ss_pred EEEEEcCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEe
Confidence 899999999999999997654 3668899999999999999999 9999999999999999999999999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCc
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQ 380 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 380 (473)
|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+..... ........
T Consensus 144 Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~-----~~~~i~~~ 216 (323)
T cd05615 144 DFGMCKEHMVDG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE-----LFQSIMEH 216 (323)
T ss_pred ccccccccCCCC--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhC
Confidence 999987543221 12234568999999999998889999999999999999999999997642211 11100000
Q ss_pred chhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChH
Q 012014 381 RAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKIN 443 (473)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 443 (473)
.. ..+...+..+.+++.+||+.||.+|++..
T Consensus 217 ~~--------------------------------~~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 217 NV--------------------------------SYPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred CC--------------------------------CCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 00 00112345678899999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=307.44 Aligned_cols=249 Identities=22% Similarity=0.309 Sum_probs=198.7
Q ss_pred CCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccC--CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 146 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
+|.+.+.||+|++|.||+|.. .+++.|++|.+.... ......+.+|+.+++.++||||+++++++.+. ...+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 75 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK-----GKLN 75 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC-----CEEE
Confidence 477889999999999999984 568999999987432 33456788999999999999999999997543 4679
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
+||||+++++|.+++...... .+++..+..++.|++.||.||| +++++|+||||+||+++.++.++|+||
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df 145 (256)
T cd08529 76 IVMEYAENGDLHKLLKMQRGR-------PLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDL 145 (256)
T ss_pred EEEEeCCCCcHHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEccc
Confidence 999999999999999764221 3568888999999999999999 899999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcch
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRA 382 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 382 (473)
|+++...... .......|++.|+|||+..+..++.++||||||+++|+|++|..||....... ..........
T Consensus 146 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~ 218 (256)
T cd08529 146 GVAKLLSDNT--NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA-----LILKIIRGVF 218 (256)
T ss_pred ccceeccCcc--chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHcCCC
Confidence 9988664422 11223458899999999999889999999999999999999999997543111 1110000000
Q ss_pred hhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 383 EEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
. ......+..+.+++.+||+.+|++||++.+|++
T Consensus 219 ~-------------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 219 P-------------------------------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred C-------------------------------CCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 0 001134567889999999999999999999976
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=307.05 Aligned_cols=248 Identities=21% Similarity=0.307 Sum_probs=205.1
Q ss_pred CCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEE
Q 012014 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVV 224 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 224 (473)
-|.+..+||+|+||.||+|. ...|+.+|||.+.. ..+..++.+|+.+|++++.|++|++||.|... ..+|+|
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~-----sDLWIV 106 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKH-----SDLWIV 106 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccC-----CceEee
Confidence 47788999999999999998 56799999999753 34678899999999999999999999987543 368999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeeccc
Q 012014 225 YKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM 304 (473)
Q Consensus 225 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~ 304 (473)
||||..|++.+.++.+.. .+++.++..+++..++||+||| ...-||||||..|||++.+|.+||+|||.
T Consensus 107 MEYCGAGSiSDI~R~R~K--------~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGV 175 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRARRK--------PLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGV 175 (502)
T ss_pred hhhcCCCcHHHHHHHhcC--------CccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccc
Confidence 999999999999976643 4779999999999999999999 88899999999999999999999999999
Q ss_pred ccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchhh
Q 012014 305 ARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEE 384 (473)
Q Consensus 305 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (473)
+..+.+. -....+..|||.|||||++..-.|+.++||||||++..||..|++||..+...... ..+|.....
T Consensus 176 AGQLTDT--MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI------FMIPT~PPP 247 (502)
T KOG0574|consen 176 AGQLTDT--MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI------FMIPTKPPP 247 (502)
T ss_pred cchhhhh--HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee------EeccCCCCC
Confidence 9766432 23344567999999999999999999999999999999999999999875433211 112222222
Q ss_pred hccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 385 VVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.++ .+..-+.++.+++..||-++|++|-|+-++++
T Consensus 248 TF~----------------------------KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 248 TFK----------------------------KPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CCC----------------------------ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 111 13345667889999999999999999988875
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=326.53 Aligned_cols=240 Identities=25% Similarity=0.270 Sum_probs=184.6
Q ss_pred ceeecCCCeEEEEEE-ecCCCEEEEEEeeccC---CCCchhHHHHHH-HHHhcCCCCceeeeeeeeccccCCceeeEEEE
Q 012014 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECK-AAINIKHRNIVRVFTAFSGVDYQGARFKAVVY 225 (473)
Q Consensus 151 ~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (473)
++||+|+||.||+|+ ..+|+.||+|++.... ......+..|.. +++.++||||+++++++.. ....++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~-----~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-----TEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec-----CCEEEEEE
Confidence 469999999999998 4578999999987432 122334555554 4677899999999998754 34679999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecccc
Q 012014 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (473)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~ 305 (473)
||+++|+|..++.... .+++..+..++.||+.||.||| ++||+||||||+|||++.++.+||+|||++
T Consensus 76 e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~ 143 (325)
T cd05604 76 DFVNGGELFFHLQRER---------SFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLC 143 (325)
T ss_pred cCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCc
Confidence 9999999999887543 3568889999999999999999 999999999999999999999999999998
Q ss_pred cccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchhhh
Q 012014 306 RFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEV 385 (473)
Q Consensus 306 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (473)
+..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||...... ........... .
T Consensus 144 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-----~~~~~~~~~~~--~ 214 (325)
T cd05604 144 KEGIAQ--SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA-----EMYDNILHKPL--V 214 (325)
T ss_pred ccCCCC--CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH-----HHHHHHHcCCc--c
Confidence 753221 12223456899999999999999999999999999999999999999753211 11111100000 0
Q ss_pred ccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHH
Q 012014 386 VDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVE 446 (473)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~ 446 (473)
.....+..+.+++.+||+.||.+||++.+.+
T Consensus 215 ------------------------------~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 215 ------------------------------LRPGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred ------------------------------CCCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 0011344677899999999999999986433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=314.38 Aligned_cols=264 Identities=22% Similarity=0.349 Sum_probs=200.7
Q ss_pred ccCCCCccceeecCCCeEEEEEEec------CCCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeecccc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY 215 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 215 (473)
..++|++.+.||+|+||.||+|... ++..||+|++..... .....+.+|+.++.+++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~-- 80 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVG-- 80 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC--
Confidence 3467999999999999999999842 467899999864322 2235688999999999999999999987543
Q ss_pred CCceeeEEEEEecCCCCHHHHhcCCCCCCCC-------------CcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeec
Q 012014 216 QGARFKAVVYKFMPNGSLEEWLRGKDDTNWR-------------PLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHC 282 (473)
Q Consensus 216 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~-------------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~ 282 (473)
...+++|||+++|+|.+++......... .....+++.+++.++.|++.||.||| +++++||
T Consensus 81 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~ 154 (288)
T cd05050 81 ---KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHR 154 (288)
T ss_pred ---CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecc
Confidence 3579999999999999999754321100 11124678889999999999999999 9999999
Q ss_pred cCCCCcEEecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCC
Q 012014 283 NLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSD 361 (473)
Q Consensus 283 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~ 361 (473)
||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||.
T Consensus 155 dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~ 234 (288)
T cd05050 155 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYY 234 (288)
T ss_pred cccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999876533221111122234667999999988899999999999999999998 888986
Q ss_pred CCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCC
Q 012014 362 GIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMK 441 (473)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt 441 (473)
+.... ............ ..+...+..+.+|+.+||+.||.+|||
T Consensus 235 ~~~~~-----~~~~~~~~~~~~-------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt 278 (288)
T cd05050 235 GMAHE-----EVIYYVRDGNVL-------------------------------SCPDNCPLELYNLMRLCWSKLPSDRPS 278 (288)
T ss_pred CCCHH-----HHHHHHhcCCCC-------------------------------CCCCCCCHHHHHHHHHHcccCcccCCC
Confidence 53221 111111000000 001124567889999999999999999
Q ss_pred hHHHHHHHH
Q 012014 442 INDVESRLR 450 (473)
Q Consensus 442 ~~ev~~~L~ 450 (473)
+.||+..|+
T Consensus 279 ~~el~~~l~ 287 (288)
T cd05050 279 FASINRILQ 287 (288)
T ss_pred HHHHHHHhh
Confidence 999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=311.99 Aligned_cols=251 Identities=23% Similarity=0.304 Sum_probs=195.0
Q ss_pred CCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCC---CchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPG---GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
.|+..++||+|+||.||++. ..+++.||+|.+...... ....+.+|+.++.+++|+||+++++.+.+. ...
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-----~~~ 75 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETK-----DAL 75 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC-----CEE
Confidence 36778899999999999998 457899999998643221 224577899999999999999999987543 368
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEee
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~D 301 (473)
++||||+++++|.+++...... .+++.++..++.|++.||.||| +++|+||||||+||+++.++.++|+|
T Consensus 76 ~lv~e~~~g~~L~~~l~~~~~~-------~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~D 145 (285)
T cd05630 76 CLVLTLMNGGDLKFHIYHMGEA-------GFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISD 145 (285)
T ss_pred EEEEEecCCCcHHHHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEee
Confidence 9999999999999998654321 3668889999999999999999 99999999999999999999999999
Q ss_pred cccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcc
Q 012014 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQR 381 (473)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 381 (473)
||++....... ......||..|+|||++.+..++.++||||||+++|+|++|..||........ ... ...... .
T Consensus 146 fg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~-~~~-~~~~~~-~ 219 (285)
T cd05630 146 LGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-REE-VERLVK-E 219 (285)
T ss_pred ccceeecCCCc---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch-HHH-HHhhhh-h
Confidence 99987653322 12234689999999999998999999999999999999999999975322110 000 000000 0
Q ss_pred hhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCC-----hHHHHH
Q 012014 382 AEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMK-----INDVES 447 (473)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~ 447 (473)
... ......+..+.+|+..||+.||++||| +.|+++
T Consensus 220 ~~~------------------------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 220 VQE------------------------------EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhh------------------------------hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 000 001123456789999999999999999 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=313.09 Aligned_cols=268 Identities=19% Similarity=0.248 Sum_probs=204.3
Q ss_pred chhhhhcccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhc-CCCCceeeeeeeecc
Q 012014 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGV 213 (473)
Q Consensus 136 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 213 (473)
.++.+....++|++.+.||+|+||.||+|. ..+++.+|+|+++... .....+.+|+.++..+ +||||+++++++...
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 456667788999999999999999999998 4568899999876422 2345688899999999 699999999998655
Q ss_pred ccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecC
Q 012014 214 DYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD 293 (473)
Q Consensus 214 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~ 293 (473)
........++||||+++++|.+++...... ...+++..+..++.|++.||.||| +++++||||||+||+++.
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~ 159 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKR-----GERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTT 159 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhcc-----CccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECC
Confidence 444556789999999999999987643211 013567888999999999999999 899999999999999999
Q ss_pred CccEEEeecccccccCccccccceeeccCCCCcCCCccccC-----CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcc
Q 012014 294 EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-----CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKM 368 (473)
Q Consensus 294 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~ 368 (473)
++.+||+|||+++...... .......|++.|+|||++.. ..++.++|||||||++|+|++|..||.......
T Consensus 160 ~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~- 236 (286)
T cd06638 160 EGGVKLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR- 236 (286)
T ss_pred CCCEEEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-
Confidence 9999999999998654322 12223458999999998753 347889999999999999999999987532111
Q ss_pred cHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 369 NLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
...... ........ .+...+..+.+|+.+||+.||++|||+.||++.
T Consensus 237 ---~~~~~~-~~~~~~~~-----------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 237 ---ALFKIP-RNPPPTLH-----------------------------QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred ---HHhhcc-ccCCCccc-----------------------------CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 000000 00000000 001134568899999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=308.50 Aligned_cols=254 Identities=19% Similarity=0.248 Sum_probs=201.2
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
.++|.+.+.||+|+||.||+|.. .+++.+++|.+........+.+.+|+.++++++||||+++++++.. ....+
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~ 76 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLR-----RDKLW 76 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEe-----CCEEE
Confidence 46789999999999999999984 4678999999986555566789999999999999999999998754 33689
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
++|||+++++|.+++..... .++..++..++.|++.||.||| +++++|+||+|+||+++.++.+||+||
T Consensus 77 l~~e~~~~~~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~ 145 (262)
T cd06613 77 IVMEYCGGGSLQDIYQVTRG--------PLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADF 145 (262)
T ss_pred EEEeCCCCCcHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECcc
Confidence 99999999999999876521 3568889999999999999999 999999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCC---CCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcC
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC---EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP 379 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 379 (473)
|++....... .......|+..|+|||.+.+. .++.++||||||+++|+|++|..||.......... .......+
T Consensus 146 g~~~~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~-~~~~~~~~ 222 (262)
T cd06613 146 GVSAQLTATI--AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF-LISKSNFP 222 (262)
T ss_pred ccchhhhhhh--hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHhccCC
Confidence 9997654321 122234578899999998776 78999999999999999999999997533211100 00000000
Q ss_pred cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 380 QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
. .. .......+..+.+++.+||+.||.+|||+++|+.
T Consensus 223 ~-------~~------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 223 P-------PK------------------------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred C-------cc------------------------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 00 0011234567899999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=322.08 Aligned_cols=281 Identities=17% Similarity=0.213 Sum_probs=198.2
Q ss_pred ccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCC--CCchhHHHHHHHHHhcCCCCceeeeeeeecccc-CCc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY-QGA 218 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~ 218 (473)
..++|.+.+.||+|+||.||+|. ..+++.||+|++..... .....+.+|+.+++.++||||++++++|..... ...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 45789999999999999999998 45788999999864321 233557789999999999999999998754321 122
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...+++++++ +++|.+++... .+++..+..++.||+.||.||| +++|+||||||+||+++.++.+|
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~~----------~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~k 158 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKCQ----------KLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELR 158 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEE
Confidence 3568999988 88999888643 3668899999999999999999 99999999999999999999999
Q ss_pred EeecccccccCccccccceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
|+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+ .+..+....
T Consensus 159 l~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~ 232 (343)
T cd07878 159 ILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID-QLKRIMEVV 232 (343)
T ss_pred EcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHh
Confidence 9999999865332 223458999999999877 468999999999999999999999997532111 111111111
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
.. ...+............... ...... ..............+.+|+.+||+.||++|||+.|+++.
T Consensus 233 ~~-~~~~~~~~~~~~~~~~~~~---~~~~~~-~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 233 GT-PSPEVLKKISSEHARKYIQ---SLPHMP-QQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CC-CCHHHHHhcchhhHHHHhh---cccccc-chhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 0111111000000000000 000000 000000001123457899999999999999999999853
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=310.71 Aligned_cols=256 Identities=24% Similarity=0.385 Sum_probs=202.4
Q ss_pred ccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
.-++|.+.++||+|+||.||+|...+++.+|+|.+.... .....+.+|+.++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 77 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSE-----EEPIY 77 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeec-----CCceE
Confidence 346899999999999999999997777889999987433 345678999999999999999999998754 23579
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
++|||+++++|.+++...... .+++.++..++.|++.||.||| +++++|+||||+||+++.++.+||+||
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~-------~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~ 147 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGK-------KLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADF 147 (261)
T ss_pred EEEeccCCCCHHHHHhccccC-------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECcc
Confidence 999999999999999765422 3568899999999999999999 999999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcCcc
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMALPQR 381 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 381 (473)
|++....... ........++..|+|||.+.+..++.++||||||+++|+|++ |+.||.+..... .+....... .
T Consensus 148 g~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-~~~~~~~~~-~-- 222 (261)
T cd05034 148 GLARLIEDDE-YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE-VLEQVERGY-R-- 222 (261)
T ss_pred ccceeccchh-hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHcCC-C--
Confidence 9998664321 111112234678999999998889999999999999999999 999996532111 111100000 0
Q ss_pred hhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHH
Q 012014 382 AEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRL 451 (473)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 451 (473)
...+...+..+.+++.+||+.||++|||+.++.+.|+.
T Consensus 223 --------------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 --------------------------------MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred --------------------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 00011235578899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=329.05 Aligned_cols=202 Identities=24% Similarity=0.362 Sum_probs=171.1
Q ss_pred CCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC---CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
++|+..+.||+|+||.||++. ..+++.||+|+++... ......+.+|+.++..++||||+++++.+.+ ...
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~-----~~~ 75 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD-----KRN 75 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----CCE
Confidence 468889999999999999998 4568999999997422 2334567889999999999999999998754 347
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.++||||+++|+|.+++.... .+++..+..++.|++.||.||| ++||+||||||+|||++.++.+||+
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~ 143 (360)
T cd05627 76 LYLIMEFLPGGDMMTLLMKKD---------TLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLS 143 (360)
T ss_pred EEEEEeCCCCccHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEe
Confidence 899999999999999997654 3568889999999999999999 9999999999999999999999999
Q ss_pred ecccccccCccccc---------------------------------cceeeccCCCCcCCCccccCCCCCcccchhhHh
Q 012014 301 DFGMARFLPAIDKQ---------------------------------NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFG 347 (473)
Q Consensus 301 Dfg~~~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 347 (473)
|||+++.+...... .......||+.|+|||++.+..++.++||||||
T Consensus 144 DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlG 223 (360)
T cd05627 144 DFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLG 223 (360)
T ss_pred eccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceecccc
Confidence 99998754321100 011234699999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCC
Q 012014 348 ILLLEMFTGIRPSDGI 363 (473)
Q Consensus 348 ~il~elltg~~P~~~~ 363 (473)
|++|||++|..||.+.
T Consensus 224 vilyel~tG~~Pf~~~ 239 (360)
T cd05627 224 VIMYEMLIGYPPFCSE 239 (360)
T ss_pred ceeeecccCCCCCCCC
Confidence 9999999999999753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=313.87 Aligned_cols=250 Identities=20% Similarity=0.257 Sum_probs=200.5
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
..+|++.+.||.|+||.||+|. ..+++.|++|.+........+.+.+|+.+++.++||||+++++++.. ....+
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~ 92 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLV-----GDELF 92 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEec-----CceEE
Confidence 3568999999999999999998 46789999999976555556788999999999999999999999854 34689
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
+|+||+++++|.+++... .+++.++..++.|++.||.||| +++++||||||+||+++.++.+||+||
T Consensus 93 lv~e~~~~~~L~~~~~~~----------~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~df 159 (296)
T cd06655 93 VVMEYLAGGSLTDVVTET----------CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDF 159 (296)
T ss_pred EEEEecCCCcHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccC
Confidence 999999999999998653 2558899999999999999999 999999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcch
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRA 382 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 382 (473)
|++........ ......|+..|+|||.+.+..++.++|||||||++|+|++|..||.+...... ...... ...
T Consensus 160 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~----~~~~~~-~~~ 232 (296)
T cd06655 160 GFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA----LYLIAT-NGT 232 (296)
T ss_pred ccchhcccccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHh-cCC
Confidence 99876543221 12234588999999999988899999999999999999999999976322111 000000 000
Q ss_pred hhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 383 EEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
... ..+...+..+.+++.+||..||.+|||+.+|+.
T Consensus 233 ~~~-----------------------------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 233 PEL-----------------------------QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred ccc-----------------------------CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 000 001224557888999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=311.32 Aligned_cols=257 Identities=23% Similarity=0.382 Sum_probs=198.5
Q ss_pred cCCCCccceeecCCCeEEEEEEec-CCC---EEEEEEeeccC-CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTLF-DGT---TIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
.++|+..+.||+|+||.||+|... ++. .+|+|.++... ......+.+|++++.+++||||+++++++.+.
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 78 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF----- 78 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC-----
Confidence 457888999999999999999853 333 68999886432 22345688999999999999999999998543
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...++||||+++++|.+++..... .+++.++..++.|++.||.||| +.+++||||||+||+++.++.+|
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~k 147 (268)
T cd05063 79 KPAMIITEYMENGALDKYLRDHDG--------EFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECK 147 (268)
T ss_pred CCcEEEEEcCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEE
Confidence 357999999999999999975432 3568889999999999999999 89999999999999999999999
Q ss_pred EeecccccccCccccccce-eeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHh
Q 012014 299 VGDFGMARFLPAIDKQNRF-ICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKM 376 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~ 376 (473)
|+|||++............ .....+..|+|||++.+..++.++|||||||++|||++ |..||...... .....
T Consensus 148 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~-----~~~~~ 222 (268)
T cd05063 148 VSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH-----EVMKA 222 (268)
T ss_pred ECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH-----HHHHH
Confidence 9999999766432211111 11123457999999988889999999999999999998 99999653211 11111
Q ss_pred hcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHH
Q 012014 377 ALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLI 452 (473)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l 452 (473)
..... ..+...+++..+.+++.+||+.||++||++.+|++.|+++
T Consensus 223 i~~~~-------------------------------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 223 INDGF-------------------------------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HhcCC-------------------------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00000 0000112456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=308.18 Aligned_cols=258 Identities=22% Similarity=0.272 Sum_probs=197.2
Q ss_pred hhcccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 140 LYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 140 ~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
++..++++.....||+|+||.||+|. ..++..||+|.+........+.+.+|+.+++.++|+||+++++++...
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----- 77 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN----- 77 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC-----
Confidence 34456677777899999999999998 456788999998755544556789999999999999999999997543
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecC-CccE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD-EMIG 297 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~-~~~~ 297 (473)
...++++||+++++|.+++...... .......+..++.||+.||.||| +++|+||||||+||+++. ++.+
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~ 148 (268)
T cd06624 78 GFFKIFMEQVPGGSLSALLRSKWGP------LKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVV 148 (268)
T ss_pred CEEEEEEecCCCCCHHHHHHHhccc------CCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeE
Confidence 4679999999999999999754211 01146778889999999999999 999999999999999976 6799
Q ss_pred EEeecccccccCccccccceeeccCCCCcCCCccccCCC--CCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 012014 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE--ASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVK 375 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~ 375 (473)
+|+|||++........ ......|++.|+|||++.+.. ++.++||||||+++|+|++|..||............ .
T Consensus 149 ~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~--~ 224 (268)
T cd06624 149 KISDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK--V 224 (268)
T ss_pred EEecchhheecccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh--h
Confidence 9999999876543221 122335789999999986643 788999999999999999999999653221110000 0
Q ss_pred hhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 376 MALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.. ... .+..+......+.+++.+||+.+|++|||+.||++
T Consensus 225 ~~-~~~-------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 225 GM-FKI-------------------------------HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred hh-hcc-------------------------------CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 00 000 00011234567889999999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=311.89 Aligned_cols=256 Identities=23% Similarity=0.406 Sum_probs=197.7
Q ss_pred CCCCccceeecCCCeEEEEEEec-CC---CEEEEEEeeccC-CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCce
Q 012014 145 NGFSSANLIGAGNFGSVYNGTLF-DG---TTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (473)
++|++.+.||+|+||.||+|... ++ ..||+|.++... ......+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-----~~ 78 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-----SR 78 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECC-----CC
Confidence 45788999999999999999843 33 369999986432 2234578999999999999999999998743 34
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
..++||||+++|+|.+++..... .+++.+++.++.|++.||.||| +++++|+||||+||+++.++.+||
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl 147 (269)
T cd05065 79 PVMIITEFMENGALDSFLRQNDG--------QFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKV 147 (269)
T ss_pred ceEEEEecCCCCcHHHHHhhCCC--------CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEE
Confidence 67999999999999999976432 3568889999999999999999 999999999999999999999999
Q ss_pred eecccccccCccccccceeecc---CCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHH
Q 012014 300 GDFGMARFLPAIDKQNRFICIK---GSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVK 375 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~---gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~ 375 (473)
+|||++................ ++..|+|||.+.+..++.++||||||+++|||++ |..||......+ ....+.
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~--~~~~i~ 225 (269)
T cd05065 148 SDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--VINAIE 225 (269)
T ss_pred CCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH--HHHHHH
Confidence 9999987654322111111111 2457999999998899999999999999999886 999996532111 111110
Q ss_pred hhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHH
Q 012014 376 MALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLI 452 (473)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l 452 (473)
...+ .+...+++..+.+++.+||+.+|++||++.+|+..|+.+
T Consensus 226 ~~~~----------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 226 QDYR----------------------------------LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred cCCc----------------------------------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0000 000123456788999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=314.72 Aligned_cols=259 Identities=23% Similarity=0.382 Sum_probs=199.7
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCC----EEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCC
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGT----TIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (473)
.++|+..+.||+|+||.||+|.+ .++. .+|+|.+..... .....+.+|+.++..++||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~---- 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP---- 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC----
Confidence 35688889999999999999984 3454 578888764322 1233678999999999999999999987532
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccE
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~ 297 (473)
..++++||+++|+|.+++..... .+++..+..++.|++.||.||| +++|+||||||+||+++.++.+
T Consensus 82 --~~~~v~e~~~~g~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~ 148 (303)
T cd05110 82 --TIQLVTQLMPHGCLLDYVHEHKD--------NIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHV 148 (303)
T ss_pred --CceeeehhcCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCce
Confidence 34789999999999999876532 2557889999999999999999 9999999999999999999999
Q ss_pred EEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHh
Q 012014 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKM 376 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~ 376 (473)
||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||.+..... ...+...
T Consensus 149 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~--~~~~~~~ 226 (303)
T cd05110 149 KITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE--IPDLLEK 226 (303)
T ss_pred EEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHC
Confidence 9999999987644322222223345778999999998889999999999999999997 999997532111 1111110
Q ss_pred hcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHHh
Q 012014 377 ALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRK 455 (473)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~ 455 (473)
.. .. ..+..++..+.+++..||..||++|||+.+|++.|+.+.+.
T Consensus 227 ~~--~~--------------------------------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 227 GE--RL--------------------------------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred CC--CC--------------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 00 00 00011345678999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=306.22 Aligned_cols=248 Identities=27% Similarity=0.393 Sum_probs=193.5
Q ss_pred ceeecCCCeEEEEEEe-cC---CCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEEE
Q 012014 151 NLIGAGNFGSVYNGTL-FD---GTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVY 225 (473)
Q Consensus 151 ~~lg~G~~g~V~~~~~-~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (473)
++||+|+||.||+|.. .. +..+|+|.+..... ...+.+.+|+.+++.++||||+++++++.. ...++||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~ 74 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG------EPLMLVM 74 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC------CceEEEE
Confidence 4699999999999973 22 26899999874432 234578899999999999999999998642 2468999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecccc
Q 012014 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (473)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~ 305 (473)
||+++|+|.+++.... .+++..+..++.|++.||.||| ..+++|+||||+||+++.++.+||+|||++
T Consensus 75 e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~ 142 (257)
T cd05060 75 ELAPLGPLLKYLKKRR---------EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMS 142 (257)
T ss_pred EeCCCCcHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEecccccc
Confidence 9999999999997654 3558899999999999999999 899999999999999999999999999999
Q ss_pred cccCcccccc-ceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcCcchh
Q 012014 306 RFLPAIDKQN-RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMALPQRAE 383 (473)
Q Consensus 306 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 383 (473)
+......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+ +...+....+ .
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~--~~~~~~~~~~---~ 217 (257)
T cd05060 143 RALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE--VIAMLESGER---L 217 (257)
T ss_pred ceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH--HHHHHHcCCc---C
Confidence 8664332111 1111223567999999998889999999999999999998 999997532211 1111110000 0
Q ss_pred hhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHH
Q 012014 384 EVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLI 452 (473)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l 452 (473)
..+..++..+.+++.+||+.||++|||+.+|++.|+++
T Consensus 218 -------------------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 218 -------------------------------PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred -------------------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 00112456788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=316.83 Aligned_cols=205 Identities=20% Similarity=0.253 Sum_probs=162.5
Q ss_pred cceeecCCCeEEEEEEec---CCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEEEE
Q 012014 150 ANLIGAGNFGSVYNGTLF---DGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYK 226 (473)
Q Consensus 150 ~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 226 (473)
..+||+|+||.||+|... ++..||+|.++.. .....+.+|+.+++.++||||+++++++... .....++|||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT--GISMSACREIALLRELKHPNVIALQKVFLSH---SDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCC--CCcHHHHHHHHHHHhCCCCCeeeEEEEEecc---CCCeEEEEEe
Confidence 468999999999999853 4578999988643 2345678999999999999999999988542 2346799999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEe----cCCccEEEeec
Q 012014 227 FMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL----DDEMIGHVGDF 302 (473)
Q Consensus 227 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~----~~~~~~kl~Df 302 (473)
|+. ++|.+++..............+++..+..++.||+.||.||| +++|+||||||+|||+ +.++.+||+||
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df 156 (317)
T cd07867 81 YAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADM 156 (317)
T ss_pred eeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence 985 588888764332211112224678889999999999999999 9999999999999999 56679999999
Q ss_pred ccccccCccccc-cceeeccCCCCcCCCccccCC-CCCcccchhhHhHHHHHHHhCCCCCCCC
Q 012014 303 GMARFLPAIDKQ-NRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGI 363 (473)
Q Consensus 303 g~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~ 363 (473)
|+++........ .......||+.|+|||++.+. .++.++|||||||++|||+||.+||...
T Consensus 157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 999876443211 122344689999999998764 5899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=312.22 Aligned_cols=273 Identities=23% Similarity=0.334 Sum_probs=203.8
Q ss_pred CCCCccceeecCCCeEEEEEEec-----CCCEEEEEEeeccCCC-CchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 145 NGFSSANLIGAGNFGSVYNGTLF-----DGTTIAVKVFNLIRPG-GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
.+|...+.||+|+||.||+|... +++.+|+|+++..... ....+.+|+++++.++||||+++++++... +.
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~---~~ 80 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKP---GG 80 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecC---CC
Confidence 45778899999999999999843 3688999998754432 356799999999999999999999987542 24
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...+++|||+++++|.+++..... .+++..+..++.|++.||.||| +++++|+||||+||+++.++.++
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~--------~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~ 149 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRD--------QINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVK 149 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCcc--------ccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEE
Confidence 567999999999999999976542 3568899999999999999999 89999999999999999999999
Q ss_pred EeecccccccCcccccc-ceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 299 VGDFGMARFLPAIDKQN-RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
|+|||++.......... ......++..|+|||.+.+..++.++||||||+++|||++|..|+......... +....
T Consensus 150 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~---~~~~~ 226 (284)
T cd05038 150 ISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR---MIGIA 226 (284)
T ss_pred EcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc---ccccc
Confidence 99999998765322111 111223456799999998888999999999999999999999998653222110 00000
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHH
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLI 452 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l 452 (473)
..... .......+.... ....+..++.++.+|+.+||+.||++|||+.||++.|+.+
T Consensus 227 ~~~~~----~~~~~~~~~~~~--------------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 227 QGQMI----VTRLLELLKEGE--------------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred ccccc----HHHHHHHHHcCC--------------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 00000 000000000000 0001123457899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=314.83 Aligned_cols=250 Identities=19% Similarity=0.227 Sum_probs=200.0
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
..+|.+.+.||+|+||.||+|. ..+++.||+|.+........+.+.+|+.+++.++||||++++++|... ...+
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~ 92 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELW 92 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----CEEE
Confidence 3679999999999999999998 457999999999765555567788999999999999999999998543 3679
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
+||||+++++|.+++... .+++.++..++.|++.||.||| +.+++||||||+||+++.++.++|+||
T Consensus 93 lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Df 159 (297)
T cd06656 93 VVMEYLAGGSLTDVVTET----------CMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDF 159 (297)
T ss_pred EeecccCCCCHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcC
Confidence 999999999999998653 2457888999999999999999 899999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcch
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRA 382 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 382 (473)
|++........ ......|++.|+|||.+.+..++.++|||||||++|+|++|..||.+......... ... ...
T Consensus 160 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-~~~----~~~ 232 (297)
T cd06656 160 GFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-IAT----NGT 232 (297)
T ss_pred ccceEccCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-ecc----CCC
Confidence 99876543221 12234588999999999988899999999999999999999999965322111000 000 000
Q ss_pred hhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 383 EEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.. ...+...+..+.+|+.+||..||++|||+.+|++
T Consensus 233 ~~-----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 233 PE-----------------------------LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CC-----------------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 0001224556789999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=307.21 Aligned_cols=250 Identities=21% Similarity=0.284 Sum_probs=196.7
Q ss_pred CCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCC------CchhHHHHHHHHHhcCCCCceeeeeeeeccccCCce
Q 012014 146 GFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG------GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (473)
+|.+.+.||+|+||.||+|...+++.+|+|.++..... ....+.+|+.++++++|+||+++++++.+. .
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~ 75 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD-----N 75 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC-----C
Confidence 47888999999999999999778999999998743221 124588899999999999999999998543 4
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
..+++|||+++++|.+++.... .+++..+..++.|++.||+||| +.+|+|+||+|+||+++.++.++|
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l 143 (265)
T cd06631 76 TISIFMEFVPGGSISSILNRFG---------PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKL 143 (265)
T ss_pred eEEEEEecCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEe
Confidence 7899999999999999997643 2557888899999999999999 899999999999999999999999
Q ss_pred eecccccccCccc----cccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 012014 300 GDFGMARFLPAID----KQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVK 375 (473)
Q Consensus 300 ~Dfg~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~ 375 (473)
+|||++....... .........|+..|+|||++.+..++.++||||||+++|+|++|..||....... ....
T Consensus 144 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~----~~~~ 219 (265)
T cd06631 144 IDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA----AMFY 219 (265)
T ss_pred ccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH----HHHH
Confidence 9999987653211 1112223458999999999998889999999999999999999999997532111 1000
Q ss_pred hhcC-cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 376 MALP-QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 376 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.... .... ..+...+..+.+++.+||+.||.+|||+.|+++
T Consensus 220 ~~~~~~~~~-------------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 220 IGAHRGLMP-------------------------------RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred hhhccCCCC-------------------------------CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000 0000 001124567889999999999999999999874
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=311.98 Aligned_cols=250 Identities=22% Similarity=0.295 Sum_probs=193.3
Q ss_pred CCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCC---CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 147 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP---GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 147 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
|+..++||+|+||+||+|. ..+++.+|+|.+..... .....+.+|+.++..++|+||+++++.+.. ....+
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-----~~~~~ 76 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET-----KDALC 76 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec-----CCEEE
Confidence 6677899999999999998 45789999999864322 223457789999999999999999988754 33689
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
++|||+++++|.+++...... .+++..+..++.|++.||.||| +++|+||||||+||++++++.+||+||
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Df 146 (285)
T cd05632 77 LVLTIMNGGDLKFHIYNMGNP-------GFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDL 146 (285)
T ss_pred EEEEeccCccHHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecC
Confidence 999999999999988654321 3668999999999999999999 999999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcch
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRA 382 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 382 (473)
|++....... ......|+..|+|||++.+..++.++|+||||+++|+|++|..||.+...... ...... ......
T Consensus 147 g~~~~~~~~~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~~~~~~-~~~~~~ 221 (285)
T cd05632 147 GLAVKIPEGE---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-REEVDR-RVLETE 221 (285)
T ss_pred CcceecCCCC---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH-hhhccc
Confidence 9987653321 12234689999999999888899999999999999999999999975321110 000000 000000
Q ss_pred hhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCC-----hHHHHH
Q 012014 383 EEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMK-----INDVES 447 (473)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~ 447 (473)
.. .....+..+.+|+.+||+.||++||| +.+++.
T Consensus 222 ~~-------------------------------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 222 EV-------------------------------YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred cc-------------------------------cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 00 01123456788999999999999999 556655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=310.61 Aligned_cols=256 Identities=21% Similarity=0.368 Sum_probs=200.1
Q ss_pred CCCCccceeecCCCeEEEEEEecC----CCEEEEEEeeccC-CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCce
Q 012014 145 NGFSSANLIGAGNFGSVYNGTLFD----GTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (473)
++|.+.++||+|+||.||+|...+ ...||+|...... ....+.+.+|+.+++.++||||+++++++.+ .
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~------~ 79 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE------N 79 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC------C
Confidence 468889999999999999998433 2468999886443 2334578899999999999999999998753 2
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
..++||||+++|+|.+++..... .+++..++.++.|++.||.||| +++++||||||+||+++.++.+||
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l 148 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNKY--------SLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKL 148 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEE
Confidence 35899999999999999976432 2568899999999999999999 999999999999999999999999
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhc
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMAL 378 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 378 (473)
+|||+++........ ......++..|+|||.+....++.++||||||+++|+|++ |..||.+...... ........
T Consensus 149 ~d~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~-~~~~~~~~- 225 (270)
T cd05056 149 GDFGLSRYLEDESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV-IGRIENGE- 225 (270)
T ss_pred ccCceeeecccccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHcCC-
Confidence 999999865443211 1112234568999999988889999999999999999996 9999976432211 00000000
Q ss_pred CcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHH
Q 012014 379 PQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRR 454 (473)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~ 454 (473)
. ...+..++..+.+++.+||..+|.+|||+.++++.|+.+..
T Consensus 226 --~--------------------------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 226 --R--------------------------------LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred --c--------------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0 00012345678899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=323.30 Aligned_cols=237 Identities=24% Similarity=0.287 Sum_probs=182.6
Q ss_pred ceeecCCCeEEEEEEe-cCCCEEEEEEeeccC---CCCchhHHHHHH-HHHhcCCCCceeeeeeeeccccCCceeeEEEE
Q 012014 151 NLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGSKSFKSECK-AAINIKHRNIVRVFTAFSGVDYQGARFKAVVY 225 (473)
Q Consensus 151 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (473)
++||+|+||.||+|+. .+++.||+|++.... ......+..|.. +++.++||||+++++++.+. ...++||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~-----~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTA-----EKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcC-----CEEEEEE
Confidence 4699999999999994 568999999987432 122334555554 57889999999999887543 4689999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecccc
Q 012014 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (473)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~ 305 (473)
||+++|+|..++.... .+++..+..++.||+.||.||| +++|+||||||+||+++.++.+||+|||++
T Consensus 76 e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~ 143 (321)
T cd05603 76 DYVNGGELFFHLQRER---------CFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLC 143 (321)
T ss_pred cCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCC
Confidence 9999999999886543 3557888899999999999999 999999999999999999999999999998
Q ss_pred cccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchhhh
Q 012014 306 RFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEV 385 (473)
Q Consensus 306 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (473)
+..... ........||+.|+|||++.+..++.++|||||||++|||++|..||.+... ............
T Consensus 144 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~~~~--- 213 (321)
T cd05603 144 KEGVEP--EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-----SQMYDNILHKPL--- 213 (321)
T ss_pred ccCCCC--CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-----HHHHHHHhcCCC---
Confidence 753221 1222345689999999999988899999999999999999999999975321 111111000000
Q ss_pred ccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChH
Q 012014 386 VDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKIN 443 (473)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 443 (473)
..+......+.+++.+||+.||.+||++.
T Consensus 214 -----------------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 214 -----------------------------QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred -----------------------------CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 00112345678999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=346.57 Aligned_cols=263 Identities=19% Similarity=0.222 Sum_probs=197.9
Q ss_pred hhhhcccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC--CCCchhHHHHHHHHHhcCCCCceeeeeeeeccc
Q 012014 138 KDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVD 214 (473)
Q Consensus 138 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 214 (473)
.......++|.+.+.||+|+||.||+|. ..++..+|+|++.... ......+..|+.++..++|||||+++++|.+.
T Consensus 6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de- 84 (1021)
T PTZ00266 6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK- 84 (1021)
T ss_pred cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec-
Confidence 3344556789999999999999999999 4567889999987432 22345688999999999999999999988643
Q ss_pred cCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCC----CCCeeeccCCCCcEE
Q 012014 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDC----QPPIAHCNLKPSNVL 290 (473)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~----~~~iiH~Dlkp~Nil 290 (473)
.....+|||||+++|+|.++|...... ...+++..++.|+.||+.||.|||+.. .++||||||||+|||
T Consensus 85 --~~~~lyIVMEY~~gGSL~~lL~k~~~~-----~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNIL 157 (1021)
T PTZ00266 85 --ANQKLYILMEFCDAGDLSRNIQKCYKM-----FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIF 157 (1021)
T ss_pred --CCCEEEEEEeCCCCCcHHHHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeE
Confidence 234679999999999999999753211 013668899999999999999999321 146999999999999
Q ss_pred ecC-----------------CccEEEeecccccccCccccccceeeccCCCCcCCCccccC--CCCCcccchhhHhHHHH
Q 012014 291 LDD-----------------EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG--CEASTYGDVYSFGILLL 351 (473)
Q Consensus 291 ~~~-----------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ 351 (473)
++. .+.+||+|||++..+.... ......||+.|+|||++.+ ..++.++||||||||+|
T Consensus 158 L~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILY 234 (1021)
T PTZ00266 158 LSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234 (1021)
T ss_pred eecCccccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHH
Confidence 964 3358999999998654322 1233468999999999864 45889999999999999
Q ss_pred HHHhCCCCCCCCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhc
Q 012014 352 EMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVAC 431 (473)
Q Consensus 352 elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c 431 (473)
+|++|..||..... ...+........ .+ .....+..+.+|+..|
T Consensus 235 ELLTGk~PF~~~~~----~~qli~~lk~~p--~l------------------------------pi~~~S~eL~dLI~~~ 278 (1021)
T PTZ00266 235 ELCSGKTPFHKANN----FSQLISELKRGP--DL------------------------------PIKGKSKELNILIKNL 278 (1021)
T ss_pred HHHHCCCCCCcCCc----HHHHHHHHhcCC--CC------------------------------CcCCCCHHHHHHHHHH
Confidence 99999999975321 111111110000 00 0011345788999999
Q ss_pred ccCCCCCCCChHHHHH
Q 012014 432 SAERPRERMKINDVES 447 (473)
Q Consensus 432 l~~dP~~RPt~~ev~~ 447 (473)
|..+|.+|||+.|++.
T Consensus 279 L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 279 LNLSAKERPSALQCLG 294 (1021)
T ss_pred hcCChhHCcCHHHHhc
Confidence 9999999999999984
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=317.70 Aligned_cols=268 Identities=24% Similarity=0.338 Sum_probs=203.0
Q ss_pred ccCCCCccceeecCCCeEEEEEEec--------CCCEEEEEEeeccC-CCCchhHHHHHHHHHhc-CCCCceeeeeeeec
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTLF--------DGTTIAVKVFNLIR-PGGSKSFKSECKAAINI-KHRNIVRVFTAFSG 212 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 212 (473)
...+|.+.+.||+|+||.||+|... .+..||+|.++... ......+.+|+.++.++ +||||++++++|..
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 89 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence 3457899999999999999999732 12368999886432 22345788999999999 79999999999854
Q ss_pred cccCCceeeEEEEEecCCCCHHHHhcCCCCCCC-------CCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCC
Q 012014 213 VDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW-------RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLK 285 (473)
Q Consensus 213 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~-------~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlk 285 (473)
. ...+++|||+++|+|.+++........ ......+++.+++.++.|++.||.||| +++++|||||
T Consensus 90 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlk 161 (334)
T cd05100 90 D-----GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLA 161 (334)
T ss_pred C-----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccc
Confidence 3 367999999999999999976432110 001123668889999999999999999 9999999999
Q ss_pred CCcEEecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCC
Q 012014 286 PSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (473)
Q Consensus 286 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~ 364 (473)
|+||+++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||.+..
T Consensus 162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 162 ARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred cceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999999999986543322222222334567999999998889999999999999999998 888986532
Q ss_pred CCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHH
Q 012014 365 TGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKIND 444 (473)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 444 (473)
. ............. ..+..++..+.+|+.+||+.+|++|||+.|
T Consensus 242 ~-----~~~~~~~~~~~~~-------------------------------~~~~~~~~~l~~li~~cl~~~p~~Rps~~e 285 (334)
T cd05100 242 V-----EELFKLLKEGHRM-------------------------------DKPANCTHELYMIMRECWHAVPSQRPTFKQ 285 (334)
T ss_pred H-----HHHHHHHHcCCCC-------------------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHH
Confidence 1 1111111000000 001124557889999999999999999999
Q ss_pred HHHHHHHHHH
Q 012014 445 VESRLRLIRR 454 (473)
Q Consensus 445 v~~~L~~l~~ 454 (473)
|++.|+.+..
T Consensus 286 ll~~l~~~~~ 295 (334)
T cd05100 286 LVEDLDRVLT 295 (334)
T ss_pred HHHHHHHHhh
Confidence 9999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=305.50 Aligned_cols=256 Identities=25% Similarity=0.398 Sum_probs=199.4
Q ss_pred ceeecCCCeEEEEEEecC----CCEEEEEEeeccCCCC-chhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEEE
Q 012014 151 NLIGAGNFGSVYNGTLFD----GTTIAVKVFNLIRPGG-SKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVY 225 (473)
Q Consensus 151 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (473)
+.||+|+||.||+|.... +..|++|.++...... ...+.+|++.+..++|+||+++++++.. ....+++|
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~lv~ 75 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-----EEPLYLVL 75 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-----CCceEEEE
Confidence 469999999999999543 7899999987544332 5678899999999999999999999754 34689999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecccc
Q 012014 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (473)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~ 305 (473)
||+++++|.+++..............+++.++..++.|++.||.||| +++++||||||+||+++.++.+||+|||.+
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~ 152 (262)
T cd00192 76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLS 152 (262)
T ss_pred EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEcccccc
Confidence 99999999999987521100000114679999999999999999999 999999999999999999999999999999
Q ss_pred cccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcCcchhh
Q 012014 306 RFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMALPQRAEE 384 (473)
Q Consensus 306 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (473)
................++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ..........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~~~~~~--- 224 (262)
T cd00192 153 RDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE-----EVLEYLRKGY--- 224 (262)
T ss_pred cccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH-----HHHHHHHcCC---
Confidence 87654332222334457889999999988889999999999999999999 69999764211 1111000000
Q ss_pred hccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHH
Q 012014 385 VVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLR 450 (473)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 450 (473)
....+...+..+.+++.+||+.||.+|||+.|+++.|+
T Consensus 225 ----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 ----------------------------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ----------------------------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 00011234668889999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=314.13 Aligned_cols=198 Identities=26% Similarity=0.311 Sum_probs=168.5
Q ss_pred CCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
++|++.+.||+|+||.||++. ..++..+|+|.++.... .....+.+|++++.+++||||++++++|... ...+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 75 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD-----GEIS 75 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-----CEEE
Confidence 468999999999999999998 44688899998864322 2234688999999999999999999998543 3789
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCC-CCeeeccCCCCcEEecCCccEEEee
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQ-PPIAHCNLKPSNVLLDDEMIGHVGD 301 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~iiH~Dlkp~Nil~~~~~~~kl~D 301 (473)
+||||+++++|.+++.... .+++..+..++.|++.||.||| + .+++||||||+||+++.++.+||+|
T Consensus 76 lv~ey~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~d 143 (308)
T cd06615 76 ICMEHMDGGSLDQVLKKAG---------RIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCD 143 (308)
T ss_pred EEeeccCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEcc
Confidence 9999999999999997653 3557888999999999999999 6 5899999999999999999999999
Q ss_pred cccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCC
Q 012014 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (473)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 363 (473)
||++....... .....|+..|+|||.+.+..++.++||||||+++|+|++|..||...
T Consensus 144 fg~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~ 201 (308)
T cd06615 144 FGVSGQLIDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPP 201 (308)
T ss_pred CCCcccccccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCc
Confidence 99987553221 22346899999999998888999999999999999999999999653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=303.91 Aligned_cols=247 Identities=27% Similarity=0.386 Sum_probs=192.5
Q ss_pred ceeecCCCeEEEEEEecCCCEEEEEEeeccCCC-CchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEEEEecC
Q 012014 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG-GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMP 229 (473)
Q Consensus 151 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~ 229 (473)
++||+|+||.||+|...+++.+|+|.++..... ....+.+|+.++..++||||+++++++... ...++||||++
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~~ 75 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQR-----QPIYIVMELVP 75 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecC-----CccEEEEECCC
Confidence 368999999999999778899999998643322 234688999999999999999999998543 35799999999
Q ss_pred CCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecccccccC
Q 012014 230 NGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLP 309 (473)
Q Consensus 230 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 309 (473)
+++|.+++..... .+.+..+..++.|++.||.||| +++++||||||+||+++.++.+||+|||++....
T Consensus 76 ~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 144 (250)
T cd05085 76 GGDFLSFLRKKKD--------ELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQED 144 (250)
T ss_pred CCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceecc
Confidence 9999999865432 2558889999999999999999 9999999999999999999999999999987543
Q ss_pred ccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcCcchhhhccc
Q 012014 310 AIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDD 388 (473)
Q Consensus 310 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (473)
.... .......++..|+|||++.+..++.++||||||+++|++++ |..||.+..... ......... ..
T Consensus 145 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~-----~~~~~~~~~-----~~ 213 (250)
T cd05085 145 DGIY-SSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ-----AREQVEKGY-----RM 213 (250)
T ss_pred cccc-ccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH-----HHHHHHcCC-----CC
Confidence 2211 11112234677999999988889999999999999999998 999997532111 000000000 00
Q ss_pred cchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHH
Q 012014 389 FNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLR 450 (473)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 450 (473)
..+...+..+.+++.+||+.+|++|||+.|+++.|.
T Consensus 214 --------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 214 --------------------------SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred --------------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 001124567889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=314.88 Aligned_cols=289 Identities=19% Similarity=0.263 Sum_probs=203.2
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccC-CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
-++|.+.+.||+|+||.||+|.. .+++.||+|.++... ......+.+|+.+++.++||||+++++++... ...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~-----~~~ 79 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE-----KSL 79 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecC-----CeE
Confidence 35789999999999999999984 468899999987433 22345678999999999999999999998543 368
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEee
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~D 301 (473)
++||||++ ++|.+++..... .+++..+..++.|++.||.||| +++|+|+||||+||+++.++.+||+|
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~--------~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~d 147 (301)
T cd07873 80 TLVFEYLD-KDLKQYLDDCGN--------SINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLAD 147 (301)
T ss_pred EEEEeccc-cCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECc
Confidence 99999996 699998865432 2557889999999999999999 99999999999999999999999999
Q ss_pred cccccccCccccccceeeccCCCCcCCCccccCC-CCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCc
Q 012014 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQ 380 (473)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 380 (473)
||++....... .......+++.|+|||++.+. .++.++|||||||++|+|++|.+||.+....+ .+..... ....
T Consensus 148 fg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~-~~~~~~~-~~~~ 223 (301)
T cd07873 148 FGLARAKSIPT--KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE-QLHFIFR-ILGT 223 (301)
T ss_pred CcchhccCCCC--CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH-HcCC
Confidence 99997543221 112233468899999987654 47889999999999999999999997643211 1111111 1110
Q ss_pred chhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH--HHHHHHHhhcc
Q 012014 381 RAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES--RLRLIRRKLLE 458 (473)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~--~L~~l~~~~~~ 458 (473)
............. ....... +..............+..+.+|+.+||+.||.+|||+.|+++ .++.+.+.+..
T Consensus 224 ~~~~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~~~~ 298 (301)
T cd07873 224 PTEETWPGILSNE----EFKSYNY-PKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGERIHK 298 (301)
T ss_pred CChhhchhhhccc----ccccccc-CccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccchhhc
Confidence 0000000000000 0000000 000000001111234567889999999999999999999987 56555555443
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=308.69 Aligned_cols=249 Identities=24% Similarity=0.308 Sum_probs=193.0
Q ss_pred CCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC-CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
++|++.++||+|+||.||+|. ..+++.||+|.+.... ......+.+|+.++.+++||||+++++.|... ...+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 75 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE-----NRIS 75 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC-----CEEE
Confidence 367888999999999999998 4678999999986432 22335688999999999999999999998653 3678
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
+||||+++++|..+. .+++..+..++.|++.||.||| +++|+|+||||+||+++.++.++|+||
T Consensus 76 lv~e~~~~~~l~~~~-------------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~df 139 (279)
T cd06619 76 ICTEFMDGGSLDVYR-------------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDF 139 (279)
T ss_pred EEEecCCCCChHHhh-------------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeC
Confidence 999999999997652 1346778899999999999999 999999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccH--HHHHHhhcCc
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNL--RNFVKMALPQ 380 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~--~~~~~~~~~~ 380 (473)
|++...... ......||..|+|||++.+..++.++||||||+++|+|++|..||.......... ..........
T Consensus 140 g~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 215 (279)
T cd06619 140 GVSTQLVNS----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE 215 (279)
T ss_pred Ccceecccc----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc
Confidence 999765332 1223468999999999998889999999999999999999999997643221110 0000000000
Q ss_pred chhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 381 RAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
..... .....+.++.+++.+||+.||++||++.|+++.
T Consensus 216 ~~~~~------------------------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 216 DPPVL------------------------------PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCCC------------------------------CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00000 001134567899999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=319.59 Aligned_cols=201 Identities=25% Similarity=0.309 Sum_probs=168.4
Q ss_pred CCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeecc---CCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
++|++.+.||+|+||.||+++ ..+++.||+|+++.. .......+.+|+.++..++|+||++++++|.+ ...
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD-----ENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec-----CCe
Confidence 478999999999999999999 456899999998742 22234568899999999999999999998754 347
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.++||||+++|+|.+++..... .+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~ 144 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKFED--------RLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLA 144 (331)
T ss_pred EEEEEecCCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEE
Confidence 8999999999999999975321 3568889999999999999999 9999999999999999999999999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCccccC-----CCCCcccchhhHhHHHHHHHhCCCCCCC
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-----CEASTYGDVYSFGILLLEMFTGIRPSDG 362 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~P~~~ 362 (473)
|||++........ .......||+.|+|||++.. ..++.++|||||||++|+|++|+.||.+
T Consensus 145 Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 145 DFGSCLRLLADGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred ECCceeecCCCCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 9999876543221 11223458999999999863 4578899999999999999999999975
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=307.90 Aligned_cols=257 Identities=22% Similarity=0.374 Sum_probs=200.4
Q ss_pred CCCCccceeecCCCeEEEEEEec-CCC----EEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 145 NGFSSANLIGAGNFGSVYNGTLF-DGT----TIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
.+|.+.+.||+|+||.||+|... ++. .+|+|.+..... .....+.+|+.++.+++||||+++++++..
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------ 80 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS------ 80 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec------
Confidence 56888999999999999999843 333 589998764432 234578899999999999999999999854
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...++||||+++|+|.+++..... .+++..+..++.|++.||+||| +++++||||||+||+++.++.+|
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~k 149 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHKD--------NIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVK 149 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEE
Confidence 357899999999999999976532 2568899999999999999999 89999999999999999999999
Q ss_pred EeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhh
Q 012014 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~ 377 (473)
|+|||+++...............++..|+|||.+....++.++||||||+++||+++ |..||.+....+ +...+...
T Consensus 150 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~ 227 (279)
T cd05057 150 ITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE--IPDLLEKG 227 (279)
T ss_pred ECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHHhCC
Confidence 999999987653322211122224568999999988889999999999999999998 999997642211 11111100
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHH
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRR 454 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~ 454 (473)
... ..+..+...+.+++.+||..||.+|||+.++++.|+.+..
T Consensus 228 ~~~----------------------------------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 228 ERL----------------------------------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred CCC----------------------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 000 0011133467889999999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=305.54 Aligned_cols=249 Identities=23% Similarity=0.312 Sum_probs=196.1
Q ss_pred CCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCc---------hhHHHHHHHHHhcCCCCceeeeeeeecccc
Q 012014 146 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGS---------KSFKSECKAAINIKHRNIVRVFTAFSGVDY 215 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~---------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 215 (473)
+|.+...||+|+||.||+|.. .+++.+|+|.+........ +.+.+|+.++++++||||+++++++.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 78 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA-- 78 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC--
Confidence 477888999999999999984 5688999998875433222 4578899999999999999999997543
Q ss_pred CCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCc
Q 012014 216 QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM 295 (473)
Q Consensus 216 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~ 295 (473)
...+++|||+++++|.+++.... .+++..+..++.|++.||.||| +++++||||+|+||++++++
T Consensus 79 ---~~~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~ 143 (267)
T cd06628 79 ---DHLNIFLEYVPGGSVAALLNNYG---------AFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKG 143 (267)
T ss_pred ---CccEEEEEecCCCCHHHHHHhcc---------CccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCC
Confidence 36799999999999999997653 3557888899999999999999 89999999999999999999
Q ss_pred cEEEeecccccccCccccc----cceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHH
Q 012014 296 IGHVGDFGMARFLPAIDKQ----NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLR 371 (473)
Q Consensus 296 ~~kl~Dfg~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~ 371 (473)
.+||+|||+++........ .......|+..|+|||.+.+..++.++||||||+++|+|++|..||.......
T Consensus 144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---- 219 (267)
T cd06628 144 GIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ---- 219 (267)
T ss_pred CEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH----
Confidence 9999999999876432111 11123458899999999998889999999999999999999999997532111
Q ss_pred HHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 372 NFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
....... .. .+..+...+..+.+++.+||+.||.+||++.||++
T Consensus 220 ~~~~~~~------~~--------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 220 AIFKIGE------NA--------------------------SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HHHHHhc------cC--------------------------CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 1100000 00 00011234567889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=306.62 Aligned_cols=253 Identities=26% Similarity=0.376 Sum_probs=189.9
Q ss_pred ceeecCCCeEEEEEEec----CCCEEEEEEeeccC-CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEEE
Q 012014 151 NLIGAGNFGSVYNGTLF----DGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVY 225 (473)
Q Consensus 151 ~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (473)
+.||+|+||.||+|... ++..+|+|.+.... ......+.+|+.+++.++||||+++++++... ....+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~~~~lv~ 76 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS----EGSPLVVL 76 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC----CCCcEEEE
Confidence 46899999999999843 23579999875322 22345788899999999999999999977432 23568999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecccc
Q 012014 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (473)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~ 305 (473)
||+++|+|.+++..... ..++.....++.|++.||.||| +.+++||||||+|||+++++.+||+|||++
T Consensus 77 e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~ 145 (262)
T cd05058 77 PYMKHGDLRNFIRSETH--------NPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLA 145 (262)
T ss_pred ecCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCcccc
Confidence 99999999999975432 1346677889999999999999 999999999999999999999999999999
Q ss_pred cccCcccc--ccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhC-CCCCCCCCCCcccHHHHHHhhcCcch
Q 012014 306 RFLPAIDK--QNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTG-IRPSDGIFTGKMNLRNFVKMALPQRA 382 (473)
Q Consensus 306 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg-~~P~~~~~~~~~~~~~~~~~~~~~~~ 382 (473)
+....... ........++..|+|||.+.+..++.++||||||+++|||++| .+||...... ...........
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~-----~~~~~~~~~~~ 220 (262)
T cd05058 146 RDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF-----DITVYLLQGRR 220 (262)
T ss_pred ccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHHHhcCCC
Confidence 75532211 1111223457789999999888899999999999999999995 5566532111 11100000000
Q ss_pred hhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHH
Q 012014 383 EEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRR 454 (473)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~ 454 (473)
...+...+..+.+++..||+.+|++|||+.||++.|+.+..
T Consensus 221 -------------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 221 -------------------------------LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred -------------------------------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 00011234578899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=308.13 Aligned_cols=255 Identities=21% Similarity=0.277 Sum_probs=184.3
Q ss_pred ceeecCCCeEEEEEEecC---CCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEEEE
Q 012014 151 NLIGAGNFGSVYNGTLFD---GTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYK 226 (473)
Q Consensus 151 ~~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 226 (473)
+.||+|+||.||+|...+ ...+|+|.+..... .....+.+|+.+++.++||||+++++.+.+. ...++|||
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~-----~~~~lv~e 75 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES-----IPYLLVLE 75 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCC-----CceEEEEE
Confidence 358999999999997433 34678887653322 2234678999999999999999999987543 36799999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeeccccc
Q 012014 227 FMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMAR 306 (473)
Q Consensus 227 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~ 306 (473)
|+++|+|.+++........ ..+++.....++.||+.||.||| +++|+||||||+|||++.++.+||+|||++.
T Consensus 76 ~~~~g~L~~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 148 (269)
T cd05042 76 FCPLGDLKNYLRSNRGMVA----QMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLAL 148 (269)
T ss_pred eCCCCcHHHHHHhcccccc----ccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEecccccc
Confidence 9999999999976543211 12346778899999999999999 9999999999999999999999999999987
Q ss_pred ccCccccccceeeccCCCCcCCCccccC-------CCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhc
Q 012014 307 FLPAIDKQNRFICIKGSTGYIPPEYDLG-------CEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMAL 378 (473)
Q Consensus 307 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 378 (473)
...............++..|+|||++.. ..++.++|||||||++|||++ |..||......+ .+.......
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~~~- 226 (269)
T cd05042 149 EQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLKQVVREQ- 226 (269)
T ss_pred ccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHhhcc-
Confidence 5432221111223345778999998643 356889999999999999999 788886532211 111111100
Q ss_pred CcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHH
Q 012014 379 PQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRL 449 (473)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L 449 (473)
...+..+ ......+..+.+++..|| .||++|||++||++.|
T Consensus 227 ---~~~~~~~--------------------------~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 227 ---DIKLPKP--------------------------QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred ---CccCCCC--------------------------cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 0000000 001124456677888898 5999999999999887
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=306.47 Aligned_cols=240 Identities=21% Similarity=0.277 Sum_probs=183.6
Q ss_pred ceeecCCCeEEEEEEecC-------------CCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCC
Q 012014 151 NLIGAGNFGSVYNGTLFD-------------GTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (473)
Q Consensus 151 ~~lg~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (473)
+.||+|+||.||+|.+.. ...|++|.+..........+.+|+.++..++||||+++++++...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~---- 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRD---- 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecC----
Confidence 368999999999998432 235888987654444455788899999999999999999998543
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCcc-
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI- 296 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~- 296 (473)
...+++|||+++|+|..++..... .+++..++.++.||+.||.||| +++|+||||||+|||++.++.
T Consensus 77 -~~~~lv~e~~~~~~l~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~ 144 (262)
T cd05077 77 -VENIMVEEFVEFGPLDLFMHRKSD--------VLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGID 144 (262)
T ss_pred -CCCEEEEecccCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCcc
Confidence 356899999999999998875432 3568889999999999999999 999999999999999987654
Q ss_pred ------EEEeecccccccCccccccceeeccCCCCcCCCcccc-CCCCCcccchhhHhHHHHHHH-hCCCCCCCCCCCcc
Q 012014 297 ------GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDL-GCEASTYGDVYSFGILLLEMF-TGIRPSDGIFTGKM 368 (473)
Q Consensus 297 ------~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~ell-tg~~P~~~~~~~~~ 368 (473)
+|++|||++...... ....|+..|+|||.+. +..++.++|||||||++|||+ +|..||.......
T Consensus 145 ~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~- 217 (262)
T cd05077 145 GECGPFIKLSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE- 217 (262)
T ss_pred CCCCceeEeCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-
Confidence 899999998754321 1234788999999886 456899999999999999998 5888876421110
Q ss_pred cHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 369 NLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
...+.. .. ... .......+.+|+.+||+.||.+||++.+|++.
T Consensus 218 -~~~~~~----~~-~~~-------------------------------~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 218 -KERFYE----GQ-CML-------------------------------VTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred -HHHHHh----cC-ccC-------------------------------CCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 000000 00 000 00123567899999999999999999999887
Q ss_pred HH
Q 012014 449 LR 450 (473)
Q Consensus 449 L~ 450 (473)
|+
T Consensus 261 ~~ 262 (262)
T cd05077 261 IN 262 (262)
T ss_pred cC
Confidence 63
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=304.13 Aligned_cols=255 Identities=23% Similarity=0.372 Sum_probs=200.7
Q ss_pred ccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
...+|.+.+.||+|+||.||++...++..+|+|.+.... .....+.+|+.+++.++|+||+++++.+.. ...+
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~ 76 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIY 76 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CCeE
Confidence 346789999999999999999987777889999876432 234678899999999999999999998743 3569
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
++|||+++++|.+++...... .+++.++..++.|++.||.||| +.+++|+||||+||+++.++.+||+||
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~ 146 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGS-------KQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADF 146 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCcc-------ccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCC
Confidence 999999999999999764322 3557888999999999999999 899999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcCcc
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMALPQR 381 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 381 (473)
|.+....... ........++..|+|||++....++.++|+||||+++|++++ |..||.+..... +.........
T Consensus 147 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~~~~~~~~~-- 221 (260)
T cd05073 147 GLARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--VIRALERGYR-- 221 (260)
T ss_pred cceeeccCCC-cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHhCCCC--
Confidence 9997654322 111122335678999999988889999999999999999999 999997532211 0110000000
Q ss_pred hhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHH
Q 012014 382 AEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRL 451 (473)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 451 (473)
. +.....+..+.+++.+||+.||++||++.++.+.|+.
T Consensus 222 -~-------------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 222 -M-------------------------------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred -C-------------------------------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0 0011245678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=309.69 Aligned_cols=257 Identities=23% Similarity=0.372 Sum_probs=198.5
Q ss_pred cCCCCccceeecCCCeEEEEEEec-C---CCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTLF-D---GTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~~-~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
..+|++.+.||+|+||.||+|... + +..+|+|.++.... .....+.+|+.++.+++||||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~ 77 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-----S 77 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----C
Confidence 357888999999999999999842 2 33789998864321 224578899999999999999999999754 2
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...++||||+++++|.+++..... .+++.++..++.|++.||.||| +++++||||||+||+++.++.++
T Consensus 78 ~~~~lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~ 146 (267)
T cd05066 78 KPVMIVTEYMENGSLDAFLRKHDG--------QFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCK 146 (267)
T ss_pred CccEEEEEcCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEE
Confidence 367999999999999999976532 2568889999999999999999 99999999999999999999999
Q ss_pred EeecccccccCccccccc-eeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHh
Q 012014 299 VGDFGMARFLPAIDKQNR-FICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKM 376 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~ 376 (473)
|+|||++........... .....++..|+|||.+.+..++.++||||||+++|++++ |..||......+ ....+..
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--~~~~~~~ 224 (267)
T cd05066 147 VSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--VIKAIEE 224 (267)
T ss_pred eCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--HHHHHhC
Confidence 999999987644321111 111223567999999998889999999999999999887 999987532211 0000000
Q ss_pred hcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHH
Q 012014 377 ALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLI 452 (473)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l 452 (473)
... .+.....+..+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus 225 ~~~----------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 225 GYR----------------------------------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CCc----------------------------------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 000 000112356788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=309.35 Aligned_cols=252 Identities=25% Similarity=0.407 Sum_probs=193.9
Q ss_pred CCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCch--hHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEE
Q 012014 147 FSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSK--SFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (473)
Q Consensus 147 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (473)
|++.+.||+|+||.||++.. .+++.+|+|++......... ...+|+.++.+++||||+++++++.. ....++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~ 75 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI 75 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence 56788999999999999994 45678999999854432222 23459999999999999999999865 346789
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecc
Q 012014 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (473)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg 303 (473)
+|||+++++|.+++.... .+++..+..++.|++.||.+|| +++++|+||||+||+++.++.++|+|||
T Consensus 76 v~~~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg 143 (260)
T PF00069_consen 76 VMEYCPGGSLQDYLQKNK---------PLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFG 143 (260)
T ss_dssp EEEEETTEBHHHHHHHHS---------SBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGT
T ss_pred cccccccccccccccccc---------cccccccccccccccccccccc---cccccccccccccccccccccccccccc
Confidence 999999999999998322 3668999999999999999999 8999999999999999999999999999
Q ss_pred cccccCccccccceeeccCCCCcCCCcccc-CCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcch
Q 012014 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDL-GCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRA 382 (473)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 382 (473)
.+..... .........++..|+|||++. +..++.++||||+|+++|+|++|..||......+ .............
T Consensus 144 ~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~--~~~~~~~~~~~~~ 219 (260)
T PF00069_consen 144 SSVKLSE--NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD--QLEIIEKILKRPL 219 (260)
T ss_dssp TTEESTS--TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH--HHHHHHHHHHTHH
T ss_pred ccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccchh--hhhhhhhcccccc
Confidence 9975411 122334456899999999998 7889999999999999999999999998641000 0000000000000
Q ss_pred hhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 383 EEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.... .........+.+++.+||+.||++|||+.++++
T Consensus 220 ~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 220 PSSS----------------------------QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHT----------------------------TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cccc----------------------------cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 000011368899999999999999999999874
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=308.03 Aligned_cols=277 Identities=19% Similarity=0.220 Sum_probs=196.0
Q ss_pred CCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCC--CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 146 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
+|++.+.||+|+||.||+|.. .+++.||+|+++.... .....+.+|+.++..++||||+++++++.. ....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ-----ESRLY 75 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee-----CCeEE
Confidence 478889999999999999984 4689999999864322 234568899999999999999999999854 34679
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
+||||++ ++|.+++...... ..+++..+..++.|++.||.||| +++++||||||+||+++.++.+||+||
T Consensus 76 ~v~e~~~-~~l~~~~~~~~~~------~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~df 145 (285)
T cd07861 76 LIFEFLS-MDLKKYLDSLPKG------QYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADF 145 (285)
T ss_pred EEEecCC-CCHHHHHhcCCCC------CcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcc
Confidence 9999996 6899988654321 13668899999999999999999 999999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCC-CCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcc
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQR 381 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 381 (473)
|++....... .......+++.|+|||++.+. .++.++||||||+++|+|++|+.||.+...... ............
T Consensus 146 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~-~~~~~~~~~~~~ 222 (285)
T cd07861 146 GLARAFGIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ-LFRIFRILGTPT 222 (285)
T ss_pred cceeecCCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHhCCCC
Confidence 9997653321 112233468899999988654 478899999999999999999999976432211 111111110000
Q ss_pred hhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 382 AEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
....-.......+.. .... .............+.++.+++.+||+.||++|||+.+|++
T Consensus 223 ~~~~~~~~~~~~~~~------~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 223 EDVWPGVTSLPDYKN------TFPK-WKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hhhhhcchhhHHHHh------hccc-cCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000000000 0000 0000000111224667889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=305.41 Aligned_cols=249 Identities=27% Similarity=0.402 Sum_probs=195.2
Q ss_pred ceeecCCCeEEEEEEecC--C--CEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEEE
Q 012014 151 NLIGAGNFGSVYNGTLFD--G--TTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVY 225 (473)
Q Consensus 151 ~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (473)
++||+|++|.||+|.+.+ + ..||+|.+..... ...+.+.+|+.++++++||||+++++.+.+ ...+++|
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~ 74 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMVT 74 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEEE
Confidence 468999999999998533 3 3689999876544 445678999999999999999999998754 4679999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecccc
Q 012014 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (473)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~ 305 (473)
||+++|+|.+++...... .+++..+..++.|++.||.||| +++++|+||||+||+++.++.+||+|||++
T Consensus 75 e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~ 144 (257)
T cd05040 75 ELAPLGSLLDRLRKDALG-------HFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLM 144 (257)
T ss_pred EecCCCcHHHHHHhcccc-------cCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEecccccc
Confidence 999999999999765421 3568899999999999999999 999999999999999999999999999999
Q ss_pred cccCccccc-cceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcCcchh
Q 012014 306 RFLPAIDKQ-NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMALPQRAE 383 (473)
Q Consensus 306 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 383 (473)
+.+...... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+. .... .. ...
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-~~~~-~~--~~~-- 218 (257)
T cd05040 145 RALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI-LKKI-DK--EGE-- 218 (257)
T ss_pred ccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHH-Hh--cCC--
Confidence 876542211 11123446788999999998889999999999999999999 9999965322110 0000 00 000
Q ss_pred hhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHH
Q 012014 384 EVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLR 450 (473)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 450 (473)
. ...+...+..+.+++.+||+.+|++|||+.+|++.|.
T Consensus 219 ~-----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 219 R-----------------------------LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred c-----------------------------CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0 0001124567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=305.68 Aligned_cols=256 Identities=23% Similarity=0.355 Sum_probs=192.4
Q ss_pred ceeecCCCeEEEEEEec-CCC--EEEEEEeeccC-CCCchhHHHHHHHHHhc-CCCCceeeeeeeeccccCCceeeEEEE
Q 012014 151 NLIGAGNFGSVYNGTLF-DGT--TIAVKVFNLIR-PGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGARFKAVVY 225 (473)
Q Consensus 151 ~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (473)
++||+|+||.||+|... ++. .+++|.++... ......+.+|+.++.++ +||||+++++++... ...+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-----~~~~lv~ 75 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----GYLYLAI 75 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecC-----CCceEEE
Confidence 36899999999999853 444 46888876432 23345788999999999 799999999998543 3579999
Q ss_pred EecCCCCHHHHhcCCCCCCCC-------CcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 226 KFMPNGSLEEWLRGKDDTNWR-------PLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~-------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
||+++|+|.+++......... .....+++.++..++.|++.||+||| +++++||||||+||+++.++.+|
T Consensus 76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~k 152 (270)
T cd05047 76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAK 152 (270)
T ss_pred EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEE
Confidence 999999999999765321110 01123678899999999999999999 89999999999999999999999
Q ss_pred EeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhh
Q 012014 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~ 377 (473)
|+|||++...... ........+..|+|||++.+..++.++||||||+++|||++ |..||.+.... ......
T Consensus 153 l~dfgl~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-----~~~~~~ 224 (270)
T cd05047 153 IADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----ELYEKL 224 (270)
T ss_pred ECCCCCccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH-----HHHHHH
Confidence 9999998632211 11111224567999999988889999999999999999997 99999653211 111110
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHH
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIR 453 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~ 453 (473)
...... ..+...+..+.+|+.+||+.||.+|||+.+++..|+.+.
T Consensus 225 ~~~~~~-------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 225 PQGYRL-------------------------------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred hCCCCC-------------------------------CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 000000 001123457889999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=310.04 Aligned_cols=249 Identities=20% Similarity=0.246 Sum_probs=193.0
Q ss_pred CCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEEE
Q 012014 147 FSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVY 225 (473)
Q Consensus 147 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (473)
|++.+.||+|+||.||+|.. .++..+++|.+..........+.+|+.+++.++||||+++++++... ...++||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-----~~~~~v~ 81 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-----NNLWILI 81 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC-----CEEEEEE
Confidence 56788899999999999994 45788899988654444456788999999999999999999998543 3679999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecccc
Q 012014 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (473)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~ 305 (473)
||+++++|..++..... .+++..+..++.|++.||.||| +.+++||||||+||+++.++.+||+|||++
T Consensus 82 e~~~~~~l~~~~~~~~~--------~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~ 150 (282)
T cd06643 82 EFCAGGAVDAVMLELER--------PLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVS 150 (282)
T ss_pred EecCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccc
Confidence 99999999998765321 3568899999999999999999 899999999999999999999999999998
Q ss_pred cccCccccccceeeccCCCCcCCCcccc-----CCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCc
Q 012014 306 RFLPAIDKQNRFICIKGSTGYIPPEYDL-----GCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQ 380 (473)
Q Consensus 306 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 380 (473)
....... .......|+..|+|||++. +..++.++|||||||++|+|++|..||........ ........
T Consensus 151 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~~~~~~~--- 224 (282)
T cd06643 151 AKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV-LLKIAKSE--- 224 (282)
T ss_pred ccccccc--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH-HHHHhhcC---
Confidence 7653321 1222345899999999874 34578899999999999999999999975322110 00000000
Q ss_pred chhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 381 RAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
..... .+...+..+.+++.+||+.||.+|||+.++++
T Consensus 225 -~~~~~-----------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 225 -PPTLA-----------------------------QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred -CCCCC-----------------------------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 01123457889999999999999999998864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=302.40 Aligned_cols=250 Identities=23% Similarity=0.317 Sum_probs=197.3
Q ss_pred CCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCC--CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
+|++.+.||+|++|.||++. ..+++.||+|.+..... ...+.+.+|+.++++++|||++++++.+.. .....+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~ 76 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG----EDGLLY 76 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC----CCCEEE
Confidence 48889999999999999998 45678999999864332 234568899999999999999999987642 233579
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
++|||+++++|.+++...... .+++.++..++.|++.||.+|| +++++||||||+||+++.++.++|+||
T Consensus 77 lv~e~~~~~~l~~~l~~~~~~-------~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df 146 (257)
T cd08223 77 IVMGFCEGGDLYHKLKEQKGK-------LLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDL 146 (257)
T ss_pred EEecccCCCcHHHHHHHhcCC-------CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecc
Confidence 999999999999999764321 3568899999999999999999 999999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcch
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRA 382 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 382 (473)
|++....... .......|++.|+|||++.+..++.++||||||+++|+|++|..||..... ............
T Consensus 147 ~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~-----~~~~~~~~~~~~ 219 (257)
T cd08223 147 GIARVLENQC--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM-----NSLVYRIIEGKL 219 (257)
T ss_pred cceEEecccC--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHHHhcCC
Confidence 9998664322 222334589999999999998899999999999999999999999874321 111111100000
Q ss_pred hhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 383 EEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
. ..+...+..+.+++.+||+.||++|||+.++++
T Consensus 220 ~-------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 220 P-------------------------------PMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred C-------------------------------CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 001134567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=308.89 Aligned_cols=238 Identities=21% Similarity=0.260 Sum_probs=181.3
Q ss_pred eeecCCCeEEEEEEecC-------------------------CCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceee
Q 012014 152 LIGAGNFGSVYNGTLFD-------------------------GTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRV 206 (473)
Q Consensus 152 ~lg~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 206 (473)
.||+|+||.||+|.+.. ...|++|++..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997321 13588898864433334568889999999999999999
Q ss_pred eeeeeccccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCC
Q 012014 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKP 286 (473)
Q Consensus 207 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp 286 (473)
++++... ...++||||+++|+|..++..... .+++..+..++.||+.||.||| +++|+||||||
T Consensus 82 ~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp 145 (274)
T cd05076 82 HGVCVRG-----SENIMVEEFVEHGPLDVCLRKEKG--------RVPVAWKITVAQQLASALSYLE---DKNLVHGNVCA 145 (274)
T ss_pred EEEEEeC-----CceEEEEecCCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCc
Confidence 9998653 367999999999999999865332 2557888999999999999999 99999999999
Q ss_pred CcEEecCCc-------cEEEeecccccccCccccccceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHH-hCC
Q 012014 287 SNVLLDDEM-------IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMF-TGI 357 (473)
Q Consensus 287 ~Nil~~~~~-------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell-tg~ 357 (473)
+||+++..+ .+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|.
T Consensus 146 ~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~ 219 (274)
T cd05076 146 KNILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGE 219 (274)
T ss_pred ccEEEeccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 999997643 4899999988643221 12246888999998865 56899999999999999995 699
Q ss_pred CCCCCCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCC
Q 012014 358 RPSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPR 437 (473)
Q Consensus 358 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~ 437 (473)
.||........ ..+...... .+......+.+++.+||+.+|+
T Consensus 220 ~p~~~~~~~~~--~~~~~~~~~------------------------------------~~~~~~~~~~~li~~cl~~~p~ 261 (274)
T cd05076 220 VPLKERTPSEK--ERFYEKKHR------------------------------------LPEPSCKELATLISQCLTYEPT 261 (274)
T ss_pred CCccccChHHH--HHHHHhccC------------------------------------CCCCCChHHHHHHHHHcccChh
Confidence 99875322110 111000000 0001124678899999999999
Q ss_pred CCCChHHHHHHH
Q 012014 438 ERMKINDVESRL 449 (473)
Q Consensus 438 ~RPt~~ev~~~L 449 (473)
+|||+.+|++.|
T Consensus 262 ~Rps~~~il~~L 273 (274)
T cd05076 262 QRPSFRTILRDL 273 (274)
T ss_pred hCcCHHHHHHhh
Confidence 999999999877
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=309.49 Aligned_cols=266 Identities=22% Similarity=0.243 Sum_probs=202.9
Q ss_pred hhhhhcccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHHHHHHhc-CCCCceeeeeeeeccc
Q 012014 137 FKDLYNATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVD 214 (473)
Q Consensus 137 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 214 (473)
+.++...+++|.+.+.||+|+||.||++.. .+++.+|+|.+.... .....+.+|+.++.++ +|||++++++++...+
T Consensus 14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~ 92 (291)
T cd06639 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKAD 92 (291)
T ss_pred cccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecc
Confidence 455666789999999999999999999984 578999999986432 2345678899999998 8999999999987654
Q ss_pred cCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCC
Q 012014 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE 294 (473)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~ 294 (473)
.......++||||+++++|.+++....... ..+++..+..++.|++.||.||| +++++||||||+||+++.+
T Consensus 93 ~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~ 164 (291)
T cd06639 93 KLVGGQLWLVLELCNGGSVTELVKGLLICG-----QRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTE 164 (291)
T ss_pred ccCCCeeEEEEEECCCCcHHHHHHHhhhcC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCC
Confidence 333456899999999999999886432110 13568889999999999999999 8999999999999999999
Q ss_pred ccEEEeecccccccCccccccceeeccCCCCcCCCccccCC-----CCCcccchhhHhHHHHHHHhCCCCCCCCCCCccc
Q 012014 295 MIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-----EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMN 369 (473)
Q Consensus 295 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~ 369 (473)
+.+||+|||++........ ......|+..|+|||.+... .++.++|||||||++|+|++|+.||........
T Consensus 165 ~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~- 241 (291)
T cd06639 165 GGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT- 241 (291)
T ss_pred CCEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH-
Confidence 9999999999886543221 11234588999999987643 368899999999999999999999975322111
Q ss_pred HHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 370 LRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
+....+ .....+. ........+.+|+.+||+.||++|||+.||++
T Consensus 242 ~~~~~~----~~~~~~~-----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 242 LFKIPR----NPPPTLL-----------------------------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHHHhc----CCCCCCC-----------------------------cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 000000 0000000 01123456889999999999999999999975
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=311.12 Aligned_cols=254 Identities=19% Similarity=0.259 Sum_probs=199.1
Q ss_pred ccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
..++|.+.+.||.|+||.||+|.. .++..+|+|.++.......+.+.+|+.++++++||||+++++.+.. ....
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 77 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFY-----ENKL 77 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEec-----CCeE
Confidence 456799999999999999999984 4689999999876554455678899999999999999999999854 3367
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEee
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~D 301 (473)
++||||+++++|.+++..... .+++..+..++.|++.||.||| +++|+|+||||+||+++.++.++|+|
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d 146 (280)
T cd06611 78 WILIEFCDGGALDSIMLELER--------GLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLAD 146 (280)
T ss_pred EEEeeccCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEcc
Confidence 999999999999999876432 3668899999999999999999 99999999999999999999999999
Q ss_pred cccccccCccccccceeeccCCCCcCCCcccc-----CCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 012014 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDL-----GCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKM 376 (473)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~ 376 (473)
||++....... .......|++.|+|||.+. +..++.++||||||+++|+|++|..||....... .....
T Consensus 147 ~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~----~~~~~ 220 (280)
T cd06611 147 FGVSAKNKSTL--QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR----VLLKI 220 (280)
T ss_pred Cccchhhcccc--cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH----HHHHH
Confidence 99987653322 1223345899999999874 3457789999999999999999999997532211 01000
Q ss_pred hcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 377 ALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
. ......+ ..+...+..+.+++.+||+.||.+|||+.+|++.
T Consensus 221 ~-~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 221 L-KSEPPTL-----------------------------DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred h-cCCCCCc-----------------------------CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0 0000000 0011234577889999999999999999999653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=319.12 Aligned_cols=201 Identities=23% Similarity=0.300 Sum_probs=168.7
Q ss_pred CCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC---CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
++|.+.+.||+|+||.||+++ ..+++.||+|++.... ......+.+|..++..++|+||+++++++.+ ...
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~-----~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD-----ENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----CCE
Confidence 478999999999999999998 4568899999986421 2233457889999999999999999999754 347
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.++||||+++|+|.+++..... .+++..+..++.|++.||.||| +++|+||||||+|||++.++.+||+
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~~~--------~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~ 144 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKFED--------RLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLA 144 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEE
Confidence 8999999999999999976321 3557888899999999999999 9999999999999999999999999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCccccC-----CCCCcccchhhHhHHHHHHHhCCCCCCC
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-----CEASTYGDVYSFGILLLEMFTGIRPSDG 362 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~P~~~ 362 (473)
|||+++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..
T Consensus 145 DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 145 DFGSCLKMNQDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred eccceeeccCCCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 9999976543221 12223569999999999875 4678899999999999999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=302.29 Aligned_cols=252 Identities=24% Similarity=0.395 Sum_probs=197.4
Q ss_pred cCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEE
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (473)
..+|++.+.||+|+||.||+|.+.++..+|+|.+.... .....+.+|++++++++||||+++++++... ...++
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~ 76 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTER-----SPICL 76 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccC-----CceEE
Confidence 35688889999999999999987678899999886432 2346789999999999999999999987543 36799
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecc
Q 012014 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (473)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg 303 (473)
+|||+++++|.+++..... .+++..+..++.|++.||.||| +++++|+||||+||+++.++.+||+|||
T Consensus 77 v~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g 145 (256)
T cd05112 77 VFEFMEHGCLSDYLRAQRG--------KFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFG 145 (256)
T ss_pred EEEcCCCCcHHHHHHhCcc--------CCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCc
Confidence 9999999999999875432 2558889999999999999999 8999999999999999999999999999
Q ss_pred cccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcCcch
Q 012014 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMALPQRA 382 (473)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 382 (473)
++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||...... ......... .
T Consensus 146 ~~~~~~~~~~-~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~~~~~~~~~-~ 218 (256)
T cd05112 146 MTRFVLDDQY-TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS-----EVVETINAG-F 218 (256)
T ss_pred ceeecccCcc-cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH-----HHHHHHhCC-C
Confidence 9876533211 11112234678999999988889999999999999999998 99998753211 111111000 0
Q ss_pred hhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHH
Q 012014 383 EEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRL 449 (473)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L 449 (473)
.... +...+..+.+|+.+||+.+|++|||+.|+++.|
T Consensus 219 -~~~~-----------------------------~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 219 -RLYK-----------------------------PRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred -CCCC-----------------------------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 0000 001245788999999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=309.73 Aligned_cols=253 Identities=21% Similarity=0.241 Sum_probs=196.6
Q ss_pred ccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
..+.|++.++||.|+||.||+|.. .+++.+++|.+..........+.+|+.+++.++||||+++++.+... ...
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 84 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWD-----GKL 84 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC-----CeE
Confidence 346799999999999999999984 45899999998765544556788999999999999999999987542 367
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEee
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~D 301 (473)
++||||+++++|..++..... .+++..+..++.|++.||.||| +++++||||||+||+++.++.+||+|
T Consensus 85 ~lv~e~~~~~~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~d 153 (292)
T cd06644 85 WIMIEFCPGGAVDAIMLELDR--------GLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLAD 153 (292)
T ss_pred EEEEecCCCCcHHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEcc
Confidence 999999999999988765432 3568899999999999999999 99999999999999999999999999
Q ss_pred cccccccCccccccceeeccCCCCcCCCcccc-----CCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 012014 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDL-----GCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKM 376 (473)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~ 376 (473)
||++...... ........|++.|+|||++. ...++.++|||||||++|+|++|..||....... .+..+..
T Consensus 154 fg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-~~~~~~~- 229 (292)
T cd06644 154 FGVSAKNVKT--LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKIAK- 229 (292)
T ss_pred Cccceecccc--ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH-HHHHHhc-
Confidence 9998754322 11223345889999999984 3457889999999999999999999986532111 0011000
Q ss_pred hcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 377 ALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
....... .+...+..+.+++.+||+.||++||++.||++
T Consensus 230 ---~~~~~~~-----------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 230 ---SEPPTLS-----------------------------QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ---CCCccCC-----------------------------CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000 01123456788999999999999999999965
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=309.62 Aligned_cols=248 Identities=19% Similarity=0.321 Sum_probs=205.2
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCC--CchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
..=|.+.+.||+|-|+.|-+|+ ..+|..||||++.+.... ....+.+|++-|+.++|||||++|.+. ++...
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi-----DTQTK 91 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-----DTQTK 91 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh-----cccce
Confidence 3458888999999999999998 679999999999754433 345788999999999999999999995 45567
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEe-cCCccEEE
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL-DDEMIGHV 299 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~-~~~~~~kl 299 (473)
+|||+|+-++|+|++||.++.. .+.+..+.+++.||+.|+.|+| ...+|||||||+||.+ ..-|-+||
T Consensus 92 lyLiLELGD~GDl~DyImKHe~--------Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKL 160 (864)
T KOG4717|consen 92 LYLILELGDGGDLFDYIMKHEE--------GLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKL 160 (864)
T ss_pred EEEEEEecCCchHHHHHHhhhc--------cccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEe
Confidence 8999999999999999988764 3668889999999999999999 9999999999999876 56689999
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccCCCCC-cccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEAS-TYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMAL 378 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~ 378 (473)
.|||++..+.+ .....+.+|+..|.|||++.+..|+ +++||||||||||.|++|+.||....+.+..
T Consensus 161 TDFGFSNkf~P---G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL--------- 228 (864)
T KOG4717|consen 161 TDFGFSNKFQP---GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL--------- 228 (864)
T ss_pred eeccccccCCC---cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh---------
Confidence 99999977654 4455677899999999999998886 5679999999999999999999876554321
Q ss_pred CcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 379 PQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
..++|-. ...+.....+..+||..||..||.+|-|.+||+.
T Consensus 229 ----TmImDCK------------------------YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 229 ----TMIMDCK------------------------YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred ----hhhhccc------------------------ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 1111110 0122345667789999999999999999998864
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=317.81 Aligned_cols=278 Identities=18% Similarity=0.138 Sum_probs=193.6
Q ss_pred ccceeecC--CCeEEEEEE-ecCCCEEEEEEeeccCC--CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEE
Q 012014 149 SANLIGAG--NFGSVYNGT-LFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (473)
Q Consensus 149 ~~~~lg~G--~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (473)
+.++||+| +||+||++. ..+|+.||+|+++.... .....+.+|+.+++.++||||++++++|... ...++
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-----~~~~l 76 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-----NELWV 76 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC-----CEEEE
Confidence 45789999 788999998 56789999999875322 2234677899999999999999999998653 36799
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecc
Q 012014 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (473)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg 303 (473)
||||+++|+|.+++...... .+++..+..++.|++.||.||| +++|+||||||+|||++.++.++++|||
T Consensus 77 v~e~~~~~~l~~~~~~~~~~-------~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~ 146 (327)
T cd08227 77 VTSFMAYGSAKDLICTHFMD-------GMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLR 146 (327)
T ss_pred EEeccCCCcHHHHHHhhccC-------CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccc
Confidence 99999999999999654321 3568889999999999999999 9999999999999999999999999998
Q ss_pred cccccCcccccc-----ceeeccCCCCcCCCccccC--CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 012014 304 MARFLPAIDKQN-----RFICIKGSTGYIPPEYDLG--CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKM 376 (473)
Q Consensus 304 ~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~ 376 (473)
.+.......... ......++..|+|||++.+ ..++.++|||||||++|||++|..||......... .....
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~~~~- 224 (327)
T cd08227 147 SNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML-LEKLN- 224 (327)
T ss_pred hhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH-HHHhc-
Confidence 754332111100 1112346778999999876 45899999999999999999999999764332211 11111
Q ss_pred hcCcchhhhccccchHH---------------HHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCC
Q 012014 377 ALPQRAEEVVDDFNLQE---------------IEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMK 441 (473)
Q Consensus 377 ~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt 441 (473)
.......+...... ...+... .............+........+.+|+.+||+.||++|||
T Consensus 225 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt 300 (327)
T cd08227 225 ---GTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTV-STPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPS 300 (327)
T ss_pred ---CCccccccccchhhhhcccCCcccCCcCCCCccccc-CCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCC
Confidence 11111111000000 0000000 0000000001111122235668899999999999999999
Q ss_pred hHHHHH
Q 012014 442 INDVES 447 (473)
Q Consensus 442 ~~ev~~ 447 (473)
++||++
T Consensus 301 ~~ell~ 306 (327)
T cd08227 301 ASTLLN 306 (327)
T ss_pred HHHHhc
Confidence 999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=304.08 Aligned_cols=252 Identities=21% Similarity=0.310 Sum_probs=193.5
Q ss_pred CCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCC-----CchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG-----GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
.+|...+.||+|+||.||+|.. .++..||+|.+...... ....+.+|+.+++.++||||+++++++.+. ..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR---AE 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC---CC
Confidence 5789999999999999999984 56899999998643221 224578899999999999999999987542 23
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...++++||+++++|.+++.... .+++...+.++.|++.||.||| +.+|+||||||+||+++.++.+|
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~ 146 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKAYG---------ALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVK 146 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEE
Confidence 46789999999999999997643 2457888899999999999999 99999999999999999999999
Q ss_pred EeecccccccCcccc-ccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 299 VGDFGMARFLPAIDK-QNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
|+|||++........ ........|+..|+|||.+.+..++.++|||||||++|+|++|..||....... ......
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~----~~~~~~ 222 (266)
T cd06651 147 LGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA----AIFKIA 222 (266)
T ss_pred EccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH----HHHHHh
Confidence 999999876533211 111223457899999999998889999999999999999999999997532111 110000
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.... .+..+......+.+++ +||..||++|||++||++
T Consensus 223 -~~~~------------------------------~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 223 -TQPT------------------------------NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred -cCCC------------------------------CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 0000 0001122344566676 788899999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=304.44 Aligned_cols=250 Identities=20% Similarity=0.289 Sum_probs=200.1
Q ss_pred cCCCCccceeecCCCeEEEEEEec-CCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
.++|+..+.||+|+||.||+|... +++.+++|.+..... ...+.+|++++++++||||+++++++... ...+
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~ 74 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKN-----TDLW 74 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecC-----CcEE
Confidence 468999999999999999999954 478999999874432 67899999999999999999999998543 4689
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
+++||+++++|.+++..... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.+||+||
T Consensus 75 l~~e~~~~~~L~~~l~~~~~--------~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~df 143 (256)
T cd06612 75 IVMEYCGAGSVSDIMKITNK--------TLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADF 143 (256)
T ss_pred EEEecCCCCcHHHHHHhCcc--------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEccc
Confidence 99999999999999865432 3568899999999999999999 899999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcch
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRA 382 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 382 (473)
|++........ ......|+..|+|||++.+..++.++||||||+++|+|++|..||........... .....
T Consensus 144 g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~------~~~~~ 215 (256)
T cd06612 144 GVSGQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM------IPNKP 215 (256)
T ss_pred ccchhcccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh------hccCC
Confidence 99986644321 22234478999999999988899999999999999999999999975322211000 00000
Q ss_pred hhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 383 EEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.. ....+...+..+.+++.+||+.||++|||+.||++
T Consensus 216 ~~----------------------------~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 216 PP----------------------------TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CC----------------------------CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 00 00011234567889999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=301.65 Aligned_cols=250 Identities=19% Similarity=0.278 Sum_probs=199.8
Q ss_pred CCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC--CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
+|+..++||.|+||.||.++ ..+++.+++|.+.... ......+.+|+.++++++|+||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~ 75 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD-----NTLL 75 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC-----CeEE
Confidence 58889999999999999998 5668999999987432 33456788999999999999999999998553 4689
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
++|||+++++|.+++...... .+++.++..++.|++.||.||| +.+++|+||+|+||+++.++.+||+||
T Consensus 76 ~~~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~ 145 (256)
T cd08221 76 IEMEYANGGTLYDKIVRQKGQ-------LFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDF 145 (256)
T ss_pred EEEEecCCCcHHHHHHhcccc-------CCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcC
Confidence 999999999999999765321 3568899999999999999999 899999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcch
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRA 382 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 382 (473)
|++........ ......|++.|+|||.+.+..++.++||||||+++|+|++|..||...... ...........
T Consensus 146 ~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-----~~~~~~~~~~~ 218 (256)
T cd08221 146 GISKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL-----NLVVKIVQGNY 218 (256)
T ss_pred cceEEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHcCCC
Confidence 99986644321 223345899999999998888899999999999999999999999652211 11111111100
Q ss_pred hhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 383 EEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
.. .....+..+.+++.+||+.||.+|||+.++++.
T Consensus 219 ~~-------------------------------~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 219 TP-------------------------------VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CC-------------------------------CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 00 012245678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=301.44 Aligned_cols=248 Identities=27% Similarity=0.388 Sum_probs=193.7
Q ss_pred ceeecCCCeEEEEEEecCCCEEEEEEeeccCCC-CchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEEEEecC
Q 012014 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG-GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMP 229 (473)
Q Consensus 151 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~ 229 (473)
++||+|+||.||++...+++.||+|.++..... ....+.+|++++++++||||+++++++.+. ...++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~v~e~~~ 75 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQK-----QPIYIVMELVP 75 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecC-----CCeEEEEEcCC
Confidence 469999999999999666999999998754433 345789999999999999999999987543 36799999999
Q ss_pred CCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecccccccC
Q 012014 230 NGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLP 309 (473)
Q Consensus 230 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 309 (473)
+++|.+++..... .+++..+..++.+++.||.||| +++++||||||+||+++.++.+||+|||++....
T Consensus 76 ~~~l~~~l~~~~~--------~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 144 (251)
T cd05041 76 GGSLLTFLRKKKN--------RLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEE 144 (251)
T ss_pred CCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeecccccccc
Confidence 9999999965432 2457888999999999999999 9999999999999999999999999999997654
Q ss_pred ccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcCcchhhhccc
Q 012014 310 AIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDD 388 (473)
Q Consensus 310 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (473)
............++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ..........
T Consensus 145 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~--~~~~~~~~~~--------- 213 (251)
T cd05041 145 GGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ--TRERIESGYR--------- 213 (251)
T ss_pred CCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH--HHHHHhcCCC---------
Confidence 2211111111223567999999988889999999999999999999 888886542211 0110000000
Q ss_pred cchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHH
Q 012014 389 FNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLR 450 (473)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 450 (473)
...+...+..+.+++.+||+.+|.+|||+.||++.|+
T Consensus 214 -------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 214 -------------------------MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred -------------------------CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 0001124567889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=319.51 Aligned_cols=191 Identities=22% Similarity=0.330 Sum_probs=160.3
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
..+|.+.+.||+|+||.||+|.. .+++.||+|+.. ......|+.++++++||||+++++++... ...+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~------~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 133 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQ------KGTTLIEAMLLQNVNHPSVIRMKDTLVSG-----AITC 133 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCC------ccccHHHHHHHHhCCCCCCcChhheEEeC-----CeeE
Confidence 35799999999999999999994 457889999743 22346799999999999999999998653 3679
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
+|||++ .++|.+++..... .+++..+..|+.||+.||.||| +++|+||||||+|||++.++.+||+||
T Consensus 134 lv~e~~-~~~l~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~Df 201 (357)
T PHA03209 134 MVLPHY-SSDLYTYLTKRSR--------PLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDL 201 (357)
T ss_pred EEEEcc-CCcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecC
Confidence 999999 5689998865432 3668899999999999999999 899999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCC
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPS 360 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~ 360 (473)
|+++..... .......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 202 G~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 202 GAAQFPVVA---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ccccccccC---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 999753221 1223456899999999999989999999999999999999865554
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=322.98 Aligned_cols=252 Identities=20% Similarity=0.255 Sum_probs=199.7
Q ss_pred cCCCCccceeecCCCeEEEEEEec-CCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
.+.|.++..||.|+||.||+|... ++-..|-|++........+.+.-|+.||..++||+||++++.|.. .+.+|
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~-----enkLw 105 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYF-----ENKLW 105 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhc-----cCceE
Confidence 345778888999999999999844 344557788877777778889999999999999999999998753 23679
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
++.|||.||-.+..+-.-+. .+.+.++.-+++|++.||.||| +++|||||||..|||++-+|.++|+||
T Consensus 106 iliEFC~GGAVDaimlEL~r--------~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADF 174 (1187)
T KOG0579|consen 106 ILIEFCGGGAVDAIMLELGR--------VLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADF 174 (1187)
T ss_pred EEEeecCCchHhHHHHHhcc--------ccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecc
Confidence 99999999999988866543 4778999999999999999999 999999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccc-----cCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYD-----LGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
|.+..... ......++.|||+|||||+. ...+|+.++||||||++|.||..+.+|....... +-+++..
T Consensus 175 GVSAKn~~--t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM----RVllKia 248 (1187)
T KOG0579|consen 175 GVSAKNKS--TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM----RVLLKIA 248 (1187)
T ss_pred cccccchh--HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH----HHHHHHh
Confidence 99865422 23344567899999999974 4568999999999999999999999997653221 1111111
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
. ....-++.+ ..-...+.+++.+||..||..||++.++++
T Consensus 249 K-SePPTLlqP-----------------------------S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 249 K-SEPPTLLQP-----------------------------SHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred h-cCCCcccCc-----------------------------chhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 1 111111111 122446788999999999999999999875
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=309.64 Aligned_cols=276 Identities=17% Similarity=0.231 Sum_probs=195.8
Q ss_pred CCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccC--CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 146 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
+|+..+.||+|+||.||+|.. .+|+.||+|.++... ......+.+|+.++++++||||+++++++.+ ....+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS-----DKKLT 75 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc-----CCceE
Confidence 478889999999999999994 578999999987432 2233567889999999999999999999754 34689
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
+++||++ ++|.+++..... .+++..+..++.||+.||.||| +++|+||||||+||+++.++.+||+||
T Consensus 76 lv~e~~~-~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~df 143 (284)
T cd07839 76 LVFEYCD-QDLKKYFDSCNG--------DIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADF 143 (284)
T ss_pred EEEecCC-CCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECcc
Confidence 9999996 588888765321 3568899999999999999999 899999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCC-CCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcc
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQR 381 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 381 (473)
|+++...... .......+++.|+|||++.+. .++.++|||||||++|+|++|..||....+....+....+......
T Consensus 144 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 221 (284)
T cd07839 144 GLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT 221 (284)
T ss_pred chhhccCCCC--CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCC
Confidence 9998654322 112234578899999998764 4789999999999999999999886543322222222111111100
Q ss_pred hhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 382 AEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.... ........ ..............+.....+..+.+|+.+||+.||.+|||+.|+++
T Consensus 222 ~~~~------~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 222 EESW------PGVSKLPD-YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hHHh------HHhhhccc-ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000 00000000 00000000000011122235678889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=310.10 Aligned_cols=264 Identities=23% Similarity=0.256 Sum_probs=201.3
Q ss_pred CCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccC-CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
++|++.+.||+|+||+||++.. .+++.||+|++.... ....+.+.+|++++..++||||+++++++... ...+
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 79 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE-----NNIC 79 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecC-----CEEE
Confidence 5788899999999999999984 468899999886433 23356788999999999999999999998653 4789
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCC-CCeeeccCCCCcEEecCCccEEEee
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQ-PPIAHCNLKPSNVLLDDEMIGHVGD 301 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~iiH~Dlkp~Nil~~~~~~~kl~D 301 (473)
+||||+++++|.+++.... .+++..+..++.+++.||.||| + ++++||||||+||++++++.++|+|
T Consensus 80 lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~LH---~~~~i~H~dl~p~nil~~~~~~~~l~d 147 (284)
T cd06620 80 MCMEFMDCGSLDRIYKKGG---------PIPVEILGKIAVAVVEGLTYLY---NVHRIMHRDIKPSNILVNSRGQIKLCD 147 (284)
T ss_pred EEEecCCCCCHHHHHHhcc---------CCCHHHHHHHHHHHHHHHHHHH---HhcCeeccCCCHHHEEECCCCcEEEcc
Confidence 9999999999999987643 3558889999999999999999 5 5899999999999999999999999
Q ss_pred cccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcc
Q 012014 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQR 381 (473)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 381 (473)
||++....... .....|+..|+|||++.+..++.++|||||||++|+|++|..||.......... ..+..
T Consensus 148 ~gl~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~------~~~~~ 217 (284)
T cd06620 148 FGVSGELINSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ------DDPMG 217 (284)
T ss_pred CCcccchhhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhh------hhhhH
Confidence 99986542211 123458999999999988889999999999999999999999998643321100 00000
Q ss_pred hhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHH
Q 012014 382 AEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIR 453 (473)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~ 453 (473)
..+....... +... . . ....++..+.+|+.+||+.||++|||+.||++..--++
T Consensus 218 ~~~~~~~~~~-----------~~~~-~---~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 218 ILDLLQQIVQ-----------EPPP-R---L---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred HHHHHHHHhh-----------ccCC-C---C---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 0000000000 0000 0 0 00125567889999999999999999999988654443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=320.42 Aligned_cols=245 Identities=21% Similarity=0.273 Sum_probs=193.6
Q ss_pred CCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCC---CchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPG---GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
..|...+.||.|+||.||.|+ ..+.+.||||+++-.... ....+.+|+..|.+++|||++.+-|+|... ..
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre-----~T 100 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLRE-----HT 100 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeecc-----ch
Confidence 347778899999999999999 667899999999743332 234688999999999999999999998542 35
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.||||||| -|+-.|++.-+.. .+.+-++..|+.+.+.||+||| +.+.||||||..|||+++.|.|||+
T Consensus 101 aWLVMEYC-lGSAsDlleVhkK--------plqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLa 168 (948)
T KOG0577|consen 101 AWLVMEYC-LGSASDLLEVHKK--------PLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLA 168 (948)
T ss_pred HHHHHHHH-hccHHHHHHHHhc--------cchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeec
Confidence 69999999 6688887755432 3557889999999999999999 9999999999999999999999999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCcccc---CCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDL---GCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
|||.|....+ ..+++|||.|||||++. .+.|+-++||||||++..||...++|+..+.... .+..+....
T Consensus 169 DFGSAsi~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS-ALYHIAQNe 241 (948)
T KOG0577|consen 169 DFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNE 241 (948)
T ss_pred cccchhhcCc------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH-HHHHHHhcC
Confidence 9999976533 23567999999999875 4679999999999999999999999976532111 011111111
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.| .+. + .+-...+++++..||++-|.+|||..+++.
T Consensus 242 sP-----tLq-----------------------s------~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 242 SP-----TLQ-----------------------S------NEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CC-----CCC-----------------------C------chhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 11 111 1 123557889999999999999999998865
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=321.70 Aligned_cols=247 Identities=23% Similarity=0.372 Sum_probs=196.4
Q ss_pred CccceeecCCCeEEEEEE-ecCCCEEEEEEee----ccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 148 SSANLIGAGNFGSVYNGT-LFDGTTIAVKVFN----LIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 148 ~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~----~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
+...+||+|+|-+||+|. ..+|..||=-.++ ...+...++|..|+.+|+.|+||||+++|.++.+.. .....
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~---n~~in 119 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTD---NKTIN 119 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCC---Cceee
Confidence 445679999999999998 3456666532222 123344578999999999999999999999988754 35678
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecC-CccEEEee
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD-EMIGHVGD 301 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~-~~~~kl~D 301 (473)
+|+|++..|+|..|+++.+. ...+....|++||++||.|||++ ..+|||||||-+||||+. .|.|||+|
T Consensus 120 ~iTEL~TSGtLr~Y~kk~~~---------vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGD 189 (632)
T KOG0584|consen 120 FITELFTSGTLREYRKKHRR---------VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGD 189 (632)
T ss_pred eeeecccCCcHHHHHHHhcc---------CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecc
Confidence 99999999999999998874 44778899999999999999977 789999999999999975 48999999
Q ss_pred cccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcc
Q 012014 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQR 381 (473)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 381 (473)
+|+|+.... .......|||.|||||+.. ..|+..+||||||++++||+|+.+||..-.+....++.......|..
T Consensus 190 LGLAtl~r~----s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~s 264 (632)
T KOG0584|consen 190 LGLATLLRK----SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAA 264 (632)
T ss_pred hhHHHHhhc----cccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHH
Confidence 999987643 2233467999999999988 58999999999999999999999999754333333333333333333
Q ss_pred hhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 382 AEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
+..+-| +++.++|.+||.. .++|||+.|++.
T Consensus 265 l~kV~d----------------------------------Pevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 265 LSKVKD----------------------------------PEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred hhccCC----------------------------------HHHHHHHHHHhcC-chhccCHHHHhh
Confidence 333332 3677899999999 999999999874
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=317.23 Aligned_cols=202 Identities=23% Similarity=0.287 Sum_probs=167.8
Q ss_pred CCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeecc---CCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
++|.+.++||+|+||.||+++. .+++.+|+|++... .......+.+|+.++..++|+||+++++++.+ ...
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD-----ENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec-----CCE
Confidence 4788999999999999999984 45788999998632 12233457889999999999999999998754 346
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.++||||+++|+|.+++..... .+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~--------~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~ 144 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKFED--------RLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLA 144 (332)
T ss_pred EEEEEeccCCCcHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEe
Confidence 8999999999999999976322 3567888999999999999999 9999999999999999999999999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCcccc-----CCCCCcccchhhHhHHHHHHHhCCCCCCCC
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDL-----GCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~P~~~~ 363 (473)
|||++....... ........||+.|+|||++. ...++.++|||||||++|||++|..||...
T Consensus 145 DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~ 211 (332)
T cd05623 145 DFGSCLKLMEDG-TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (332)
T ss_pred ecchheecccCC-cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence 999987653322 11222346999999999986 345889999999999999999999999753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=305.48 Aligned_cols=254 Identities=25% Similarity=0.371 Sum_probs=194.4
Q ss_pred CCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCC----------CchhHHHHHHHHHhcCCCCceeeeeeeeccc
Q 012014 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPG----------GSKSFKSECKAAINIKHRNIVRVFTAFSGVD 214 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 214 (473)
+|...+.||+|+||.||+|. ..+++.+|+|.++..... ..+.+.+|+.++..++||||+++++++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~- 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE- 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC-
Confidence 47788999999999999998 456899999988632111 123577899999999999999999987543
Q ss_pred cCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCC
Q 012014 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE 294 (473)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~ 294 (473)
...++||||+++++|.+++.... .+++..+..++.|++.||.||| +++++||||+|+||+++.+
T Consensus 81 ----~~~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~ 144 (272)
T cd06629 81 ----EYLSIFLEYVPGGSIGSCLRTYG---------RFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDAD 144 (272)
T ss_pred ----CceEEEEecCCCCcHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCC
Confidence 46799999999999999997653 3557888899999999999999 8999999999999999999
Q ss_pred ccEEEeecccccccCccccccceeeccCCCCcCCCccccCCC--CCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHH
Q 012014 295 MIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE--ASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRN 372 (473)
Q Consensus 295 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~ 372 (473)
+.++|+|||+++...............|+..|+|||.+.... ++.++|+||||+++|++++|..||...... ..
T Consensus 145 ~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~----~~ 220 (272)
T cd06629 145 GICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI----AA 220 (272)
T ss_pred CeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH----HH
Confidence 999999999997654322222223445889999999987654 789999999999999999999998642111 11
Q ss_pred HHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 373 FVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
..... ......... .......+..+.+++.+||+.||++|||+.+|++
T Consensus 221 ~~~~~-~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 221 MFKLG-NKRSAPPIP--------------------------PDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred HHHhh-ccccCCcCC--------------------------ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 10000 000000000 0011234678889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=307.67 Aligned_cols=264 Identities=20% Similarity=0.269 Sum_probs=201.5
Q ss_pred chhhhhcccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHHHHHHhc-CCCCceeeeeeeecc
Q 012014 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGV 213 (473)
Q Consensus 136 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 213 (473)
...++....+.|++.+.||.|+||.||+|.. .+++.+|+|++.... .....+..|+.++.++ +||||+++++++...
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 3445556678899999999999999999994 568899999986432 2345688899999998 799999999998643
Q ss_pred cc-CCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEec
Q 012014 214 DY-QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD 292 (473)
Q Consensus 214 ~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~ 292 (473)
.. ......+++|||+++|+|.+++...... .+++..+..++.||+.||.||| +++|+|+||||+||+++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~ 155 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKGN-------ALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLT 155 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccCC-------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEC
Confidence 21 2245789999999999999999764322 2557788899999999999999 89999999999999999
Q ss_pred CCccEEEeecccccccCccccccceeeccCCCCcCCCcccc-----CCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCc
Q 012014 293 DEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDL-----GCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGK 367 (473)
Q Consensus 293 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~ 367 (473)
.++.++|+|||++....... .......|++.|+|||.+. +..++.++|||||||++|+|++|..||.......
T Consensus 156 ~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~ 233 (282)
T cd06636 156 ENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR 233 (282)
T ss_pred CCCCEEEeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh
Confidence 99999999999987553221 1223345899999999875 3457889999999999999999999996532111
Q ss_pred ccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 368 MNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
. ..... ...... ......+..+.+|+.+||+.||.+|||+.||++
T Consensus 234 ~----~~~~~-~~~~~~------------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 234 A----LFLIP-RNPPPK------------------------------LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred h----hhhHh-hCCCCC------------------------------CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 00000 000000 000124567899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=304.70 Aligned_cols=248 Identities=20% Similarity=0.281 Sum_probs=198.1
Q ss_pred CCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccC-CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
++|++.+.||.|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.++||||+++++++.+. ...+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 75 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG-----SKLW 75 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC-----CeEE
Confidence 4688899999999999999984 468999999987543 23345688999999999999999999987543 4789
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
+|+||+++++|.+++... .+++..+..++.|++.||.||| +++++|+||+|+||++++++.++|+||
T Consensus 76 ~v~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~ 142 (274)
T cd06609 76 IIMEYCGGGSCLDLLKPG----------KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADF 142 (274)
T ss_pred EEEEeeCCCcHHHHHhhc----------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccc
Confidence 999999999999999764 2558899999999999999999 999999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcch
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRA 382 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 382 (473)
|+++...... .......|++.|+|||.+.+..++.++||||||+++|+|++|..||........ ........+
T Consensus 143 g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~--- 215 (274)
T cd06609 143 GVSGQLTSTM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV--LFLIPKNNP--- 215 (274)
T ss_pred ccceeecccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH--HHHhhhcCC---
Confidence 9998765432 122334588899999999988899999999999999999999999975321110 000000000
Q ss_pred hhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 383 EEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
..+.. ...+..+.+++.+||..||++|||++++++
T Consensus 216 ~~~~~------------------------------~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 216 PSLEG------------------------------NKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred CCCcc------------------------------cccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 00000 014557889999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=308.12 Aligned_cols=240 Identities=22% Similarity=0.314 Sum_probs=183.7
Q ss_pred ceeecCCCeEEEEEEecC--------CCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 151 NLIGAGNFGSVYNGTLFD--------GTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 151 ~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
+.||+|+||.||+|.... ...+|+|.+........+.+.+|+.+++.++||||+++++++... ...+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-----~~~~ 75 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG-----DESI 75 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC-----CCcE
Confidence 369999999999998422 235888887654444456788999999999999999999998643 3568
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCcc------
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI------ 296 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~------ 296 (473)
+||||+++|+|.+++..... .+++..++.++.||+.||.||| +++|+||||||+||+++.++.
T Consensus 76 lv~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~ 144 (258)
T cd05078 76 MVQEYVKFGSLDTYLKKNKN--------LINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNP 144 (258)
T ss_pred EEEecCCCCcHHHHHhcCCC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCC
Confidence 99999999999999976542 2557888999999999999999 999999999999999987664
Q ss_pred --EEEeecccccccCccccccceeeccCCCCcCCCccccCC-CCCcccchhhHhHHHHHHHhCC-CCCCCCCCCcccHHH
Q 012014 297 --GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGI-RPSDGIFTGKMNLRN 372 (473)
Q Consensus 297 --~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~-~P~~~~~~~~~~~~~ 372 (473)
++++|||++...... ....++..|+|||++.+. .++.++||||||+++|+|++|. .||........ ..
T Consensus 145 ~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~--~~ 216 (258)
T cd05078 145 PFIKLSDPGISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK--LQ 216 (258)
T ss_pred ceEEecccccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH--HH
Confidence 699999988654321 223478899999999874 5799999999999999999985 55543211100 00
Q ss_pred HHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHH
Q 012014 373 FVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLR 450 (473)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 450 (473)
.... .. . .+.....++.+|+.+||+.||++|||+++|++.|+
T Consensus 217 ~~~~--~~---~-------------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 217 FYED--RH---Q-------------------------------LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred HHHc--cc---c-------------------------------CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000 00 0 00112346889999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=305.63 Aligned_cols=262 Identities=19% Similarity=0.306 Sum_probs=199.5
Q ss_pred CCCCccceeecCCCeEEEEEEec------CCCEEEEEEeeccCCC-CchhHHHHHHHHHhcCCCCceeeeeeeeccccCC
Q 012014 145 NGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRPG-GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (473)
++|+....||+|+||.||+|+.. +.+.|++|.+...... ....+.+|++++++++||||+++++++.+.
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---- 80 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA---- 80 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC----
Confidence 57888999999999999999843 2467999988654332 346789999999999999999999987543
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccE
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~ 297 (473)
...++||||+++|+|.+++..............+++..+..++.|++.||.||| +++|+||||||+||+++.++.+
T Consensus 81 -~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~ 156 (275)
T cd05046 81 -EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREV 156 (275)
T ss_pred -CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcE
Confidence 357999999999999999976542211111113678999999999999999999 9999999999999999999999
Q ss_pred EEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHh
Q 012014 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKM 376 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~ 376 (473)
+++|||++....... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ....
T Consensus 157 ~l~~~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~-----~~~~ 230 (275)
T cd05046 157 KVSLLSLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-----VLNR 230 (275)
T ss_pred EEcccccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH-----HHHH
Confidence 999999987543211 111222345778999999988888999999999999999999 888986532211 1111
Q ss_pred hcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHH
Q 012014 377 ALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLR 450 (473)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 450 (473)
....... +.....++..+.+++.+||+.||.+|||+.|++..|.
T Consensus 231 ~~~~~~~------------------------------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 231 LQAGKLE------------------------------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHcCCcC------------------------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1000000 0001124568889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=304.91 Aligned_cols=263 Identities=22% Similarity=0.222 Sum_probs=198.4
Q ss_pred CCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
++|...+.||.|++|.||++.. .+++.+|+|.+..... .....+.+|++++++++||||++++++|.... ....+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDES---SSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccC---CCeEE
Confidence 4688899999999999999994 5688999999874332 23456889999999999999999999885432 34579
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
+||||+++++|.+++...... ...++...+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+||
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~df 149 (287)
T cd06621 78 IAMEYCEGGSLDSIYKKVKKR-----GGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDF 149 (287)
T ss_pred EEEEecCCCCHHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeec
Confidence 999999999999987542211 113567889999999999999999 999999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcch
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRA 382 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 382 (473)
|++....... .....++..|+|||.+.+..++.++||||||+++|+|++|..||......................
T Consensus 150 g~~~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 225 (287)
T cd06621 150 GVSGELVNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN 225 (287)
T ss_pred cccccccccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCc
Confidence 9987543221 112347889999999998889999999999999999999999997643211111111111000000
Q ss_pred hhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 383 EEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
..+.+. .......++.+.+++.+||+.||.+|||+.||++
T Consensus 226 ~~~~~~-------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 226 PELKDE-------------------------PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred hhhccC-------------------------CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 000000 0000123567889999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=305.96 Aligned_cols=264 Identities=23% Similarity=0.382 Sum_probs=198.6
Q ss_pred CCccceeecCCCeEEEEEEec----CCCEEEEEEeeccC--CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCC-ce
Q 012014 147 FSSANLIGAGNFGSVYNGTLF----DGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG-AR 219 (473)
Q Consensus 147 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~-~~ 219 (473)
|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+++++.++||||+++++++......+ ..
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999742 36889999986432 223456889999999999999999999876533221 12
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
..+++++|+.+|+|.+++....... ....+++..+..++.|++.||+||| +++|+||||||+||+++.++.+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl 154 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGE---EPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCV 154 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccC---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEE
Confidence 3578999999999998875432111 0123668889999999999999999 899999999999999999999999
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhc
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMAL 378 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 378 (473)
+|||+++...............+++.|++||.+.+..++.++||||||+++|+|++ |..||.+..... +.......
T Consensus 155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~--~~~~~~~~- 231 (273)
T cd05074 155 ADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE--IYNYLIKG- 231 (273)
T ss_pred CcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH--HHHHHHcC-
Confidence 99999986543221112222335678999999988889999999999999999999 889987532211 11111000
Q ss_pred CcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHH
Q 012014 379 PQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLI 452 (473)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l 452 (473)
... ......+..+.+++.+||+.+|++|||+.||++.|+++
T Consensus 232 -~~~--------------------------------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 -NRL--------------------------------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred -CcC--------------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 000 00012456788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=301.50 Aligned_cols=247 Identities=24% Similarity=0.390 Sum_probs=195.5
Q ss_pred CCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEE
Q 012014 145 NGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVV 224 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 224 (473)
++|.+.+.||+|+||.||++. .+++.||+|.++.. .....+.+|+.++.+++||||+++++++... ..+++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~-~~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~------~~~~v 76 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGE-YTGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN------GLYIV 76 (254)
T ss_pred HHceeeeeeccCCCCceEecc-cCCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC------CcEEE
Confidence 568899999999999999997 47788999998642 2346789999999999999999999987532 35899
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeeccc
Q 012014 225 YKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM 304 (473)
Q Consensus 225 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~ 304 (473)
|||+++++|.+++...... .+++..++.++.|++.||.||| ++|++||||||+||+++.++.+||+|||+
T Consensus 77 ~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~ 146 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRA-------LVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGL 146 (254)
T ss_pred EECCCCCCHHHHHHhcCcC-------CCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCcc
Confidence 9999999999999765321 3558888999999999999999 99999999999999999999999999999
Q ss_pred ccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcCcchh
Q 012014 305 ARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMALPQRAE 383 (473)
Q Consensus 305 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 383 (473)
+....... .....+..|+|||.+.+..++.++|+||||+++|+|++ |..||...... .........
T Consensus 147 ~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-----~~~~~~~~~--- 213 (254)
T cd05083 147 ARVGSMGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK-----EVKECVEKG--- 213 (254)
T ss_pred ceeccccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH-----HHHHHHhCC---
Confidence 87543211 11224567999999988889999999999999999998 99998753211 111000000
Q ss_pred hhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHH
Q 012014 384 EVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRL 451 (473)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 451 (473)
... ......+..+.+++.+||+.+|++|||+++|++.|+.
T Consensus 214 --------------~~~--------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 214 --------------YRM--------------EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred --------------CCC--------------CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 000 0011245678899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=315.60 Aligned_cols=283 Identities=17% Similarity=0.212 Sum_probs=202.9
Q ss_pred ccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC-CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
.+++|++.++||+|+||.||+|. ..+|+.||+|.++... ......+.+|+.++++++||||+++++++..........
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 45789999999999999999998 5578999999986422 223456788999999999999999999886655555557
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.++++||+. ++|.+++... .+++..+..++.|++.||.||| +++|+||||||+||+++.++.+||+
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~----------~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~ 148 (336)
T cd07849 83 VYIVQELME-TDLYKLIKTQ----------HLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKIC 148 (336)
T ss_pred EEEEehhcc-cCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEC
Confidence 899999995 5898888654 3668889999999999999999 9999999999999999999999999
Q ss_pred ecccccccCccccc-cceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 012014 301 DFGMARFLPAIDKQ-NRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMAL 378 (473)
Q Consensus 301 Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~ 378 (473)
|||++......... .......||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.... ..+..+.....
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~-~~~~~~~~~~~ 227 (336)
T cd07849 149 DFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL-HQLNLILGVLG 227 (336)
T ss_pred cccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcC
Confidence 99999765432211 11223458999999998654 46899999999999999999999999753211 11111111111
Q ss_pred ---CcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 379 ---PQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 379 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
++....+.+......... . ...............+..+.+++.+||+.||++|||+.|+++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~-------~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 228 TPSQEDLNCIISLRARNYIKS-------L-PFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred CCCHHHHHHhhchhhhhHHhh-------c-CcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 011111111110000000 0 0000000001112346678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=306.70 Aligned_cols=276 Identities=20% Similarity=0.263 Sum_probs=198.3
Q ss_pred CCCCccceeecCCCeEEEEEEec-CCCEEEEEEeeccC--CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 145 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.. ....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~ 75 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR-----KRKL 75 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee-----CCEE
Confidence 46888999999999999999854 68999999986432 2234567899999999999999999999854 3467
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEee
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~D 301 (473)
++||||+++++|..++.... .+++..+..++.|++.||.||| +++++||||||+||+++.++.+||+|
T Consensus 76 ~~v~e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~d 143 (286)
T cd07847 76 HLVFEYCDHTVLNELEKNPR---------GVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCD 143 (286)
T ss_pred EEEEeccCccHHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECc
Confidence 99999999988888775433 3568899999999999999999 89999999999999999999999999
Q ss_pred cccccccCccccccceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcC-
Q 012014 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP- 379 (473)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~- 379 (473)
||++........ ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||.+....+. +.........
T Consensus 144 fg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~ 220 (286)
T cd07847 144 FGFARILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ-LYLIRKTLGDL 220 (286)
T ss_pred cccceecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCC
Confidence 999987644321 1223347889999999876 4578999999999999999999999986543221 1111110000
Q ss_pred -cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 380 -QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 380 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.......+.... .. .. ..................+..+.+|+.+||+.||++|||+.|++.
T Consensus 221 ~~~~~~~~~~~~~---~~--~~--~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 221 IPRHQQIFSTNQF---FK--GL--SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ChHHhhhcccccc---cc--cc--cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 000000000000 00 00 000000000000111234678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=339.71 Aligned_cols=259 Identities=22% Similarity=0.303 Sum_probs=191.3
Q ss_pred ccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC-CCCchhHHHHHHHHHhcCCCCceeeeeeeeccc------
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVD------ 214 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------ 214 (473)
..++|+...+||+||||.||+++ .-+|+.||||++.... ......+.+|+..+++|+|||||++|..+.+..
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 34678999999999999999999 5689999999997543 223456889999999999999999984432110
Q ss_pred ----------------------------------------------------------------------c---------
Q 012014 215 ----------------------------------------------------------------------Y--------- 215 (473)
Q Consensus 215 ----------------------------------------------------------------------~--------- 215 (473)
+
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence 0
Q ss_pred ----------------------CC-------ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHH
Q 012014 216 ----------------------QG-------ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVAC 266 (473)
Q Consensus 216 ----------------------~~-------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~ 266 (473)
.. ...+||-||||+..+|.+++..+.... .....++++++|++
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--------~~d~~wrLFreIlE 708 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--------QRDEAWRLFREILE 708 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--------hhHHHHHHHHHHHH
Confidence 00 135689999999988888887664211 25678899999999
Q ss_pred HHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecccccccC----c------------cccccceeeccCCCCcCCCc
Q 012014 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLP----A------------IDKQNRFICIKGSTGYIPPE 330 (473)
Q Consensus 267 ~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~----~------------~~~~~~~~~~~gt~~y~aPE 330 (473)
||.|+| ++|||||||||.||+++.+..|||+|||+|+... . .......+...||.-|+|||
T Consensus 709 GLaYIH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPE 785 (1351)
T KOG1035|consen 709 GLAYIH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPE 785 (1351)
T ss_pred HHHHHH---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHH
Confidence 999999 9999999999999999999999999999998621 0 01122446678999999999
Q ss_pred cccCCC---CCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccC
Q 012014 331 YDLGCE---ASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSS 407 (473)
Q Consensus 331 ~~~~~~---~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (473)
++.+.. |+.|+|+||||+|++||+. ||..... -...+.....+.++.- ..+
T Consensus 786 ll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME----Ra~iL~~LR~g~iP~~-~~f------------------ 839 (1351)
T KOG1035|consen 786 LLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME----RASILTNLRKGSIPEP-ADF------------------ 839 (1351)
T ss_pred HhcccccccccchhhhHHHHHHHHHHhc---cCCchHH----HHHHHHhcccCCCCCC-ccc------------------
Confidence 988754 9999999999999999985 5653211 1122222212211111 000
Q ss_pred CCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 408 SGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 408 ~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
..+....=.+++.++++.||.+||||.|++.
T Consensus 840 ---------~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 840 ---------FDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred ---------ccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 0112223457999999999999999999874
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=320.85 Aligned_cols=257 Identities=25% Similarity=0.373 Sum_probs=206.2
Q ss_pred CCCCccceeecCCCeEEEEEEec--CCC--EEEEEEeeccCCC-CchhHHHHHHHHHhcCCCCceeeeeeeeccccCCce
Q 012014 145 NGFSSANLIGAGNFGSVYNGTLF--DGT--TIAVKVFNLIRPG-GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (473)
......++||+|.||.|++|.|. +|+ .||||.++..... ....|++|+.+|.+|+|||++++||+..+.
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~q------ 183 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQ------ 183 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccc------
Confidence 34566788999999999999864 344 5899999865544 678899999999999999999999998652
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
...+|||+++.|+|.+.|+..... .|.......++.|||.|+.||. ++++|||||...|+|+...-.+||
T Consensus 184 p~mMV~ELaplGSLldrLrka~~~-------~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI 253 (1039)
T KOG0199|consen 184 PAMMVFELAPLGSLLDRLRKAKKA-------ILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKI 253 (1039)
T ss_pred hhhHHhhhcccchHHHHHhhcccc-------ceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeee
Confidence 468999999999999999883322 4668888899999999999999 999999999999999999999999
Q ss_pred eecccccccCcccccccee-eccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhh
Q 012014 300 GDFGMARFLPAIDKQNRFI-CIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~ 377 (473)
+|||+.+.++......... ...-...|.|||.+....++.+||||+|||++|||+| |..||-|....+.
T Consensus 254 ~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qI--------- 324 (1039)
T KOG0199|consen 254 CDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQI--------- 324 (1039)
T ss_pred ecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHH---------
Confidence 9999999887654322111 1223567999999999999999999999999999999 8999987432211
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHH
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIR 453 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~ 453 (473)
-+.+|. + .+-..+..|++.+++++..||..+|++|||+..|.+.+-...
T Consensus 325 -----L~~iD~--------~--------------erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~e 373 (1039)
T KOG0199|consen 325 -----LKNIDA--------G--------------ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE 373 (1039)
T ss_pred -----HHhccc--------c--------------ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence 011110 0 011234568999999999999999999999999986655443
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=302.74 Aligned_cols=252 Identities=20% Similarity=0.275 Sum_probs=193.8
Q ss_pred CCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCC--C---CchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--G---GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
++|++.++||+|+||.||+|.. .+++.||+|.+..... . ....+.+|+.++.+++||||+++++++.+.. .
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPM---E 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCC---C
Confidence 5789999999999999999984 5689999998863221 1 1346788999999999999999999875422 2
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...+++|||+++++|.+++.... .+++..+..++.|++.||.||| +++++|+||||+||+++.++.++
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~ 146 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSYG---------ALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVK 146 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEE
Confidence 45789999999999999987543 2457788899999999999999 99999999999999999999999
Q ss_pred EeecccccccCcccc-ccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 299 VGDFGMARFLPAIDK-QNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
|+|||++........ ........|+..|+|||.+.+..++.++||||||+++|+|++|..||...... .......
T Consensus 147 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~~~~~~~ 222 (265)
T cd06652 147 LGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM----AAIFKIA 222 (265)
T ss_pred ECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH----HHHHHHh
Confidence 999999976533211 11122345889999999998888999999999999999999999999643111 1111000
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.... .+..+......+.+++.+||. +|++|||++||++
T Consensus 223 ~~~~-------------------------------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 223 TQPT-------------------------------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred cCCC-------------------------------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 0000 000112345567788999985 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=307.66 Aligned_cols=263 Identities=18% Similarity=0.182 Sum_probs=185.9
Q ss_pred cCCCCccceeecCCCeEEEEEEecC----CCEEEEEEeeccCCCCc-h----------hHHHHHHHHHhcCCCCceeeee
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTLFD----GTTIAVKVFNLIRPGGS-K----------SFKSECKAAINIKHRNIVRVFT 208 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~-~----------~~~~E~~~l~~l~h~niv~~~~ 208 (473)
.++|.+.++||+|+||.||+|...+ +..+|+|+......... + ....+...+..+.|+||+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 4689999999999999999998543 34566665432221110 0 1122334455678999999998
Q ss_pred eeeccccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCc
Q 012014 209 AFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSN 288 (473)
Q Consensus 209 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~N 288 (473)
++.... ......+++++++ ..++.+.+.... .+++..+..++.|++.||.||| +++|+||||||+|
T Consensus 91 ~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~N 156 (294)
T PHA02882 91 CGSFKR-CRMYYRFILLEKL-VENTKEIFKRIK---------CKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPEN 156 (294)
T ss_pred eeeEec-CCceEEEEEEehh-ccCHHHHHHhhc---------cCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHH
Confidence 764332 2223557888887 446777665432 1336778899999999999999 9999999999999
Q ss_pred EEecCCccEEEeecccccccCccccc-----cceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCC
Q 012014 289 VLLDDEMIGHVGDFGMARFLPAIDKQ-----NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (473)
Q Consensus 289 il~~~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 363 (473)
||++.++.++|+|||+|+.+...... .......||+.|+|||+..+..++.++|||||||++|||++|..||.+.
T Consensus 157 ill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 157 IMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred EEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 99999999999999999866432211 1122346999999999999999999999999999999999999999875
Q ss_pred CCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChH
Q 012014 364 FTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKIN 443 (473)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 443 (473)
.............. ...+... . .....++..+.+++..||+.+|++||+++
T Consensus 237 ~~~~~~~~~~~~~~----~~~~~~~----~---------------------~~~~~~~~~~~~~~~~~~~~~~~~rp~~~ 287 (294)
T PHA02882 237 GHNGNLIHAAKCDF----IKRLHEG----K---------------------IKIKNANKFIYDFIECVTKLSYEEKPDYD 287 (294)
T ss_pred ccchHHHHHhHHHH----HHHhhhh----h---------------------hccCCCCHHHHHHHHHHHhCCCCCCCCHH
Confidence 33221111110000 0000000 0 00123467889999999999999999999
Q ss_pred HHHHHH
Q 012014 444 DVESRL 449 (473)
Q Consensus 444 ev~~~L 449 (473)
+|.+.|
T Consensus 288 ~l~~~~ 293 (294)
T PHA02882 288 ALIKIF 293 (294)
T ss_pred HHHHhh
Confidence 998876
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=317.15 Aligned_cols=191 Identities=26% Similarity=0.283 Sum_probs=157.4
Q ss_pred eecCCCeEEEEEE-ecCCCEEEEEEeeccCC---CCchhHHHHHHHHHhc---CCCCceeeeeeeeccccCCceeeEEEE
Q 012014 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP---GGSKSFKSECKAAINI---KHRNIVRVFTAFSGVDYQGARFKAVVY 225 (473)
Q Consensus 153 lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (473)
||+|+||.||+|+ ..+++.||+|++..... .....+..|..++... +||||+++++++... ...++||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~-----~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD-----SDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC-----CeEEEEE
Confidence 6999999999998 45689999999864221 1223455666776655 699999999987543 4689999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecccc
Q 012014 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (473)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~ 305 (473)
||+++|+|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+|||++
T Consensus 76 e~~~~g~L~~~l~~~~---------~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a 143 (330)
T cd05586 76 DYMSGGELFWHLQKEG---------RFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLS 143 (330)
T ss_pred cCCCCChHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcC
Confidence 9999999999987654 3568899999999999999999 999999999999999999999999999998
Q ss_pred cccCccccccceeeccCCCCcCCCccccCC-CCCcccchhhHhHHHHHHHhCCCCCCC
Q 012014 306 RFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDG 362 (473)
Q Consensus 306 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~ 362 (473)
+...... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+
T Consensus 144 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~ 199 (330)
T cd05586 144 KANLTDN--KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA 199 (330)
T ss_pred cCCCCCC--CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC
Confidence 7543221 222345699999999998764 489999999999999999999999975
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=308.86 Aligned_cols=249 Identities=21% Similarity=0.273 Sum_probs=194.6
Q ss_pred CCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEE
Q 012014 146 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVV 224 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 224 (473)
.|.....||+|+||.||++.. .++..||||.+........+.+.+|+.++..++||||+++++.+... ...++|
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-----~~~~lv 97 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVG-----DELWVV 97 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecC-----CeEEEE
Confidence 344456799999999999984 56899999998754444556788999999999999999999987543 467999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeeccc
Q 012014 225 YKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM 304 (473)
Q Consensus 225 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~ 304 (473)
|||+++++|.+++... .+++.++..++.||+.||.||| +++|+||||||+||++++++.++|+|||+
T Consensus 98 ~e~~~~~~L~~~~~~~----------~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~ 164 (292)
T cd06658 98 MEFLEGGALTDIVTHT----------RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGF 164 (292)
T ss_pred EeCCCCCcHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcc
Confidence 9999999999988543 2457889999999999999999 89999999999999999999999999999
Q ss_pred ccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchhh
Q 012014 305 ARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEE 384 (473)
Q Consensus 305 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (473)
+........ ......|+..|+|||.+.+..++.++||||||+++|||++|..||....... .+. ......+....
T Consensus 165 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~-~~~~~~~~~~~- 239 (292)
T cd06658 165 CAQVSKEVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ-AMR-RIRDNLPPRVK- 239 (292)
T ss_pred hhhcccccc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHH-HHHhcCCCccc-
Confidence 876543221 1223458999999999988889999999999999999999999997532110 000 00000000000
Q ss_pred hccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 385 VVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
.....+..+.+++.+||..||.+|||+.|+++.
T Consensus 240 -------------------------------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 240 -------------------------------DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred -------------------------------cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 001234567889999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=308.91 Aligned_cols=256 Identities=20% Similarity=0.212 Sum_probs=196.1
Q ss_pred CCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCC---CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP---GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
++|.+.+.||+|+||.||++. ..+++.|++|.+..... .....+.+|+.++..++||||+++++.+.. ...
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~ 75 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET-----KRH 75 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec-----CCE
Confidence 478899999999999999998 45678999999874331 233567899999999999999999998754 347
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.++||||+++++|.+++.... .+++..+..++.|++.||.||| +++++||||||+||+++.++.+||+
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~ 143 (305)
T cd05609 76 LCMVMEYVEGGDCATLLKNIG---------ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLT 143 (305)
T ss_pred EEEEEecCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEe
Confidence 899999999999999997653 3558888899999999999999 8999999999999999999999999
Q ss_pred ecccccccCccc-------------cccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCc
Q 012014 301 DFGMARFLPAID-------------KQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGK 367 (473)
Q Consensus 301 Dfg~~~~~~~~~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~ 367 (473)
|||+++...... .........|+..|+|||.+.+..++.++||||||+++|+|++|..||.+....
T Consensus 144 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~- 222 (305)
T cd05609 144 DFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE- 222 (305)
T ss_pred eCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence 999986421100 000111235788999999998888999999999999999999999999753211
Q ss_pred ccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 368 MNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
............ .. ......+..+.+++.+||+.||++|||+.++.+
T Consensus 223 ----~~~~~~~~~~~~---~~--------------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ 269 (305)
T cd05609 223 ----ELFGQVISDDIE---WP--------------------------EGDEALPADAQDLISRLLRQNPLERLGTGGAFE 269 (305)
T ss_pred ----HHHHHHHhcccC---CC--------------------------CccccCCHHHHHHHHHHhccChhhccCccCHHH
Confidence 111110000000 00 000124567889999999999999999776666
Q ss_pred HHHH
Q 012014 448 RLRL 451 (473)
Q Consensus 448 ~L~~ 451 (473)
.|+.
T Consensus 270 ll~~ 273 (305)
T cd05609 270 VKQH 273 (305)
T ss_pred HHhC
Confidence 5554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=305.39 Aligned_cols=252 Identities=22% Similarity=0.247 Sum_probs=194.7
Q ss_pred CCCCccceeecCCCeEEEEEEec-CCCEEEEEEeeccC-CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 145 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
++|++.+.||+|+||.||++... +++.||+|.++... ......+.+|+.++.+++||||+++++.+.. ....+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~ 75 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI-----EGAVY 75 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec-----CCeEE
Confidence 36888999999999999999954 78999999886432 2224578899999999999999999998754 34789
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCC-CCeeeccCCCCcEEecCCccEEEee
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQ-PPIAHCNLKPSNVLLDDEMIGHVGD 301 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~iiH~Dlkp~Nil~~~~~~~kl~D 301 (473)
+||||+++++|..++...... ..+++..+..++.|++.||.||| + .+|+||||||+||+++.++.+||+|
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~LH---~~~~i~H~dl~p~nil~~~~~~~~l~d 146 (286)
T cd06622 76 MCMEYMDAGSLDKLYAGGVAT------EGIPEDVLRRITYAVVKGLKFLK---EEHNIIHRDVKPTNVLVNGNGQVKLCD 146 (286)
T ss_pred EEEeecCCCCHHHHHHhcccc------CCCCHHHHHHHHHHHHHHHHHHH---hcCCEeeCCCCHHHEEECCCCCEEEee
Confidence 999999999999998764211 13668899999999999999999 5 5999999999999999999999999
Q ss_pred cccccccCccccccceeeccCCCCcCCCccccCCC------CCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 012014 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE------ASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVK 375 (473)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~ 375 (473)
||++..+.... .....|++.|+|||.+.+.. ++.++|||||||++|+|++|..||....... ......
T Consensus 147 fg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~ 220 (286)
T cd06622 147 FGVSGNLVASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN--IFAQLS 220 (286)
T ss_pred cCCcccccCCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh--HHHHHH
Confidence 99987653221 22345788999999985543 5889999999999999999999996532111 000000
Q ss_pred hhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 376 MALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
....... ...+...+..+.+++.+||+.+|++||++.+++.
T Consensus 221 ~~~~~~~-------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 221 AIVDGDP-------------------------------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred HHhhcCC-------------------------------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 0000000 0011235667889999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=300.37 Aligned_cols=254 Identities=19% Similarity=0.250 Sum_probs=182.1
Q ss_pred eeecCCCeEEEEEEecCCC---EEEEEEeeccC-CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEEEEe
Q 012014 152 LIGAGNFGSVYNGTLFDGT---TIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKF 227 (473)
Q Consensus 152 ~lg~G~~g~V~~~~~~~~~---~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 227 (473)
.||+|+||.||+|...++. .+++|.++... ....+.+.+|+.++..++||||+++++.|... ...++||||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~-----~~~~lv~e~ 76 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEA-----IPYLLVFEY 76 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCC-----CccEEEEec
Confidence 5999999999999854433 45666655332 22346789999999999999999999998643 367999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecccccc
Q 012014 228 MPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF 307 (473)
Q Consensus 228 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 307 (473)
+++|+|.+++....... ..+....+..++.||+.||.||| +++++||||||+|||++.++.+||+|||++..
T Consensus 77 ~~~~~L~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~ 148 (268)
T cd05086 77 CELGDLKSYLSQEQWHR-----RNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPS 148 (268)
T ss_pred CCCCcHHHHHHhhhccc-----ccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccc
Confidence 99999999997643211 12346677889999999999999 89999999999999999999999999999864
Q ss_pred cCccccccceeeccCCCCcCCCccccC-------CCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcC
Q 012014 308 LPAIDKQNRFICIKGSTGYIPPEYDLG-------CEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMALP 379 (473)
Q Consensus 308 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 379 (473)
..............|+..|+|||++.. ..++.++||||||+++|||++ |..||......+ .+.... .
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~----~ 223 (268)
T cd05086 149 RYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE-VLNHVI----K 223 (268)
T ss_pred cCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHH----h
Confidence 322111112223457889999998753 245788999999999999997 577876432211 111111 1
Q ss_pred cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHH
Q 012014 380 QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLR 450 (473)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 450 (473)
.....+.++.. .......+.+++..|| .+|++|||+++|++.|.
T Consensus 224 ~~~~~~~~~~~--------------------------~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 224 DQQVKLFKPQL--------------------------ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred hcccccCCCcc--------------------------CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 11111111100 0113346778999999 68999999999988773
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=305.35 Aligned_cols=254 Identities=28% Similarity=0.397 Sum_probs=193.4
Q ss_pred ceeecCCCeEEEEEEecC-------CCEEEEEEeeccC-CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 151 NLIGAGNFGSVYNGTLFD-------GTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 151 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
+.||+|+||.||+|+..+ +..+|+|.+.... ......+.+|+.+++.++||||+++++++... ...+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 75 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLN-----EPQY 75 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCC-----CCeE
Confidence 368999999999998432 2579999876432 23456788999999999999999999997543 3579
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCc-----cE
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM-----IG 297 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~-----~~ 297 (473)
++|||+++++|.+++......... ...+++.+++.++.|++.||.||| +++++|+||||+||+++.++ .+
T Consensus 76 ~v~e~~~~~~L~~~l~~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~ 150 (269)
T cd05044 76 IIMELMEGGDLLSYLRDARVERFG--PPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVV 150 (269)
T ss_pred EEEeccCCCcHHHHHHHhhhcccC--CccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcce
Confidence 999999999999999754322111 113568899999999999999999 89999999999999999877 89
Q ss_pred EEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHh
Q 012014 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKM 376 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~ 376 (473)
+|+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..||......+ ....+..
T Consensus 151 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~--~~~~~~~ 228 (269)
T cd05044 151 KIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE--VLQHVTA 228 (269)
T ss_pred EECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH--HHHHHhc
Confidence 9999999976543222122222345788999999998899999999999999999998 999986432111 1111000
Q ss_pred hcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHH
Q 012014 377 ALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLR 450 (473)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 450 (473)
.. ........+..+.+++.+||+.+|.+|||+.+|++.|+
T Consensus 229 ---~~-------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 229 ---GG-------------------------------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ---CC-------------------------------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 00 00001234567889999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=302.75 Aligned_cols=249 Identities=22% Similarity=0.310 Sum_probs=197.5
Q ss_pred CCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC--CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
+|++.+.||+|+||.||++. ..+++.||+|.+.... ......+.+|+.++++++||||+++++++.. ....+
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 75 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE-----NGNLY 75 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC-----CCeEE
Confidence 48889999999999999998 4578999999987432 2334578899999999999999999998754 34789
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
+||||+++++|.+++...... .+++.+++.++.|++.||.||| +++++|+||+|+||+++.++.++|+||
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~-------~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~ 145 (256)
T cd08218 76 IVMDYCEGGDLYKKINAQRGV-------LFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDF 145 (256)
T ss_pred EEEecCCCCcHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeec
Confidence 999999999999998754321 3558889999999999999999 899999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcch
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRA 382 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 382 (473)
|++........ ......|++.|+|||++.+..++.++|+||||+++|+|++|..||..... .........+..
T Consensus 146 ~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----~~~~~~~~~~~~ 218 (256)
T cd08218 146 GIARVLNSTVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM-----KNLVLKIIRGSY 218 (256)
T ss_pred cceeecCcchh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH-----HHHHHHHhcCCC
Confidence 99976543221 11223478899999999888899999999999999999999999864211 111111110000
Q ss_pred hhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 383 EEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
. ..+...+..+.+++.+||+.+|.+||++.||++
T Consensus 219 ~-------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 219 P-------------------------------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred C-------------------------------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 0 011234567889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=312.19 Aligned_cols=254 Identities=21% Similarity=0.257 Sum_probs=196.7
Q ss_pred ccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeecc--CCCCchhHHHHHHHHHhc-CCCCceeeeeeeeccccCCce
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLI--RPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 219 (473)
....|++.++||+||.+.||++...+.+.+|+|++... .......|.+|+..|.+| .|.+||++|+|-.. ..
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~-----d~ 433 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT-----DG 433 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc-----Cc
Confidence 44569999999999999999999878889999987632 334456799999999999 59999999999654 45
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
++|+||||= ..+|..+|+...... +...+..+..|++.|+.++| .+||||.||||.|+|+- .|.+||
T Consensus 434 ~lYmvmE~G-d~DL~kiL~k~~~~~--------~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlV-kG~LKL 500 (677)
T KOG0596|consen 434 YLYMVMECG-DIDLNKILKKKKSID--------PDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLV-KGRLKL 500 (677)
T ss_pred eEEEEeecc-cccHHHHHHhccCCC--------chHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEE-eeeEEe
Confidence 899999975 679999998876432 11256778899999999999 99999999999999986 478999
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccCCC-----------CCcccchhhHhHHHHHHHhCCCCCCCCCCCcc
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE-----------ASTYGDVYSFGILLLEMFTGIRPSDGIFTGKM 368 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DiwSlG~il~elltg~~P~~~~~~~~~ 368 (473)
+|||+|..+......-.....+||+.||+||.+.... .+.+|||||||||||+|+.|+.||......
T Consensus 501 IDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~-- 578 (677)
T KOG0596|consen 501 IDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ-- 578 (677)
T ss_pred eeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH--
Confidence 9999999887766666667788999999999875432 567899999999999999999999753211
Q ss_pred cHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 369 NLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
+.+. ..+.++.. ++.... .+ ...++.++|+.||..||++|||..||++
T Consensus 579 ----~aKl------~aI~~P~~------------~Iefp~-------~~--~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 579 ----IAKL------HAITDPNH------------EIEFPD-------IP--ENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred ----HHHH------HhhcCCCc------------cccccC-------CC--CchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 1111 11111100 000000 00 1123889999999999999999999975
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=302.85 Aligned_cols=253 Identities=23% Similarity=0.290 Sum_probs=198.5
Q ss_pred CCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
++|+..+.||+|+||.||++.. .+++.+|+|.+..... .....+.+|++++++++||||+++++.+... ...+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~ 75 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN-----GDIS 75 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecC-----CEEE
Confidence 4678889999999999999984 4689999999875432 3345688999999999999999999987543 4789
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCC-CCeeeccCCCCcEEecCCccEEEee
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQ-PPIAHCNLKPSNVLLDDEMIGHVGD 301 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~iiH~Dlkp~Nil~~~~~~~kl~D 301 (473)
+++||+++++|.+++..... .+++..+..++.|++.||.||| + .+++|+||||+||+++.++.++|+|
T Consensus 76 lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d 144 (265)
T cd06605 76 ICMEYMDGGSLDKILKEVQG--------RIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCD 144 (265)
T ss_pred EEEEecCCCcHHHHHHHccC--------CCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEee
Confidence 99999999999999976531 3557888899999999999999 8 9999999999999999999999999
Q ss_pred cccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcc
Q 012014 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQR 381 (473)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 381 (473)
||.+......... ...|+..|+|||.+.+..++.++||||||+++|+|++|..||.....................
T Consensus 145 ~g~~~~~~~~~~~----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 220 (265)
T cd06605 145 FGVSGQLVNSLAK----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP 220 (265)
T ss_pred cccchhhHHHHhh----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC
Confidence 9998765322111 155889999999999889999999999999999999999999754322111111111111000
Q ss_pred hhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 382 AEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
...+ .....+..+.+++.+||..||++|||+.+++.
T Consensus 221 ~~~~------------------------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 221 PPRL------------------------------PSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CCCC------------------------------ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 0000 00014567889999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=303.51 Aligned_cols=282 Identities=19% Similarity=0.242 Sum_probs=194.9
Q ss_pred ccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
++++|.+.+.||+|+||.||+|. ..+++.||+|.+..... .....+.+|+.+++.++|+||+++++++.. ...
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-----~~~ 77 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT-----KET 77 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec-----CCe
Confidence 46789999999999999999998 45789999999864432 223467899999999999999999999754 336
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.++||||+. ++|.+++..... .+++.++..++.|++.||.||| +++|+|+||||+||+++.++.+||+
T Consensus 78 ~~lv~e~~~-~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~ 145 (291)
T cd07870 78 LTFVFEYMH-TDLAQYMIQHPG--------GLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLA 145 (291)
T ss_pred EEEEEeccc-CCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEe
Confidence 799999995 788777754321 2446778889999999999999 8999999999999999999999999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCccccCC-CCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcC
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP 379 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 379 (473)
|||+++....... ......+++.|+|||.+.+. .++.++||||||+++|+|++|..||.+.......+.........
T Consensus 146 Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~ 223 (291)
T cd07870 146 DFGLARAKSIPSQ--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGV 223 (291)
T ss_pred ccccccccCCCCC--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCC
Confidence 9999875433221 12233478999999998754 47889999999999999999999998654322222211111100
Q ss_pred cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 380 QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
. ...... .+. ........ ...................+..+.+++.+|+..||++|||+.|++.
T Consensus 224 ~-~~~~~~-~~~-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 224 P-TEDTWP-GVS-KLPNYKPE-WFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred C-Chhhhh-hhh-hcccccch-hccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0 000000 000 00000000 0000000000000000112467789999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=300.88 Aligned_cols=258 Identities=21% Similarity=0.299 Sum_probs=200.5
Q ss_pred CCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC-CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
++|++.+.||.|+||+||+|. ..++..+|+|++.... ......+.+|+.+++.++|+||+++++.+.. ....+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 75 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV-----GDELW 75 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEee-----CCEEE
Confidence 478999999999999999998 4468899999986433 2245678999999999999999999998754 34679
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
++||++++++|.+++....... .+++..+..++.|++.||.||| +++++||||+|+||++++++.++|+||
T Consensus 76 iv~e~~~~~~l~~~~~~~~~~~------~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df 146 (267)
T cd06610 76 LVMPYLSGGSLLDIMKSSYPRG------GLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADF 146 (267)
T ss_pred EEEeccCCCcHHHHHHHhcccC------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEccc
Confidence 9999999999999997643211 3568889999999999999999 999999999999999999999999999
Q ss_pred ccccccCcccccc--ceeeccCCCCcCCCccccCC-CCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcC
Q 012014 303 GMARFLPAIDKQN--RFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP 379 (473)
Q Consensus 303 g~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 379 (473)
|++..+....... ......|+..|+|||++... .++.++|+||||+++|+|++|..||........ +....... +
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~~~~-~ 224 (267)
T cd06610 147 GVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV-LMLTLQND-P 224 (267)
T ss_pred chHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh-HHHHhcCC-C
Confidence 9998765433221 22334588999999998776 789999999999999999999999975432211 11111100 0
Q ss_pred cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 380 QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
...... ......+..+.+++.+||..||++|||+.+|++
T Consensus 225 ~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 225 PSLETG-----------------------------ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCcCCc-----------------------------cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000000 001234567889999999999999999999975
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=303.65 Aligned_cols=248 Identities=20% Similarity=0.297 Sum_probs=197.9
Q ss_pred CCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccC-CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
..|+..+.||.|+||.||+|.. .++..||+|.+.... ......+.+|+.++++++||||+++++++.+. ...+
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 78 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG-----TKLW 78 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----CEEE
Confidence 3577888999999999999984 468899999987432 22345688999999999999999999998543 4789
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
+||||+++|+|.+++... .+++.++..++.|++.||.||| +++++|+||+|+||+++.++.++|+||
T Consensus 79 lv~e~~~~~~L~~~i~~~----------~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~df 145 (277)
T cd06640 79 IIMEYLGGGSALDLLRAG----------PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADF 145 (277)
T ss_pred EEEecCCCCcHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEccc
Confidence 999999999999998753 2457788899999999999999 999999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcch
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRA 382 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 382 (473)
|++........ ......++..|+|||++.+..++.++|+||||+++|||++|..||......... . ..+..
T Consensus 146 g~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-----~-~~~~~- 216 (277)
T cd06640 146 GVAGQLTDTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL-----F-LIPKN- 216 (277)
T ss_pred ccceeccCCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh-----h-hhhcC-
Confidence 99976543221 122345788999999998888999999999999999999999999753221100 0 00000
Q ss_pred hhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 383 EEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
. .+......+..+.+++.+||+.||++|||+.+++..
T Consensus 217 ---~--------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 217 ---N--------------------------PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred ---C--------------------------CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 0 001122456788999999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=297.61 Aligned_cols=251 Identities=25% Similarity=0.406 Sum_probs=196.3
Q ss_pred CCccceeecCCCeEEEEEEecC-----CCEEEEEEeeccCCC-CchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 147 FSSANLIGAGNFGSVYNGTLFD-----GTTIAVKVFNLIRPG-GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 147 ~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
|.+.+.||.|+||.||++.... +..||+|.++..... ....+.+|+..+..++|+||+++++++.+. ..
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~ 75 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE-----EP 75 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-----Ce
Confidence 4567889999999999998543 388999998654332 456789999999999999999999998553 46
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.+++|||+++++|.+++...... .+++.++..++.|++.||.||| +.+++|+||||+||+++.++.++|+
T Consensus 76 ~~~i~e~~~~~~l~~~~~~~~~~-------~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~ 145 (258)
T smart00219 76 LMIVMEYMEGGDLLDYLRKNRPK-------ELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKIS 145 (258)
T ss_pred eEEEEeccCCCCHHHHHHhhhhc-------cCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEc
Confidence 79999999999999999765421 1568899999999999999999 9999999999999999999999999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcC
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMALP 379 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 379 (473)
|||+++........... ...+++.|+|||.+.+..++.++||||||+++|+|++ |..||..... .........
T Consensus 146 dfg~~~~~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-----~~~~~~~~~ 219 (258)
T smart00219 146 DFGLSRDLYDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-----EEVLEYLKK 219 (258)
T ss_pred ccCCceecccccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHhc
Confidence 99999876543211111 2236789999999988889999999999999999998 7888865211 111110000
Q ss_pred cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHH
Q 012014 380 QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRL 449 (473)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L 449 (473)
.... ..+...+..+.+++.+||+.||++|||+.|+++.|
T Consensus 220 ~~~~-------------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 220 GYRL-------------------------------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCC-------------------------------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0000 00112456788999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=300.42 Aligned_cols=238 Identities=21% Similarity=0.330 Sum_probs=185.4
Q ss_pred ceeecCCCeEEEEEEecC-C----------CEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCce
Q 012014 151 NLIGAGNFGSVYNGTLFD-G----------TTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 151 ~~lg~G~~g~V~~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (473)
+.||+|+||.||+|...+ + ..+++|.+...... ...+.+|+.+++.++||||+++++++.. .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~ 73 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR------D 73 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec------C
Confidence 468999999999999543 3 25788877643332 6788999999999999999999998754 2
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCc----
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM---- 295 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~---- 295 (473)
..++||||+++|+|.+++..... .+++..+..++.||+.||.||| +++|+||||||+||+++.++
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~ 142 (259)
T cd05037 74 ENIMVEEYVKFGPLDVFLHREKN--------NVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEG 142 (259)
T ss_pred CcEEEEEcCCCCcHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccC
Confidence 45899999999999999986542 3557889999999999999999 99999999999999999887
Q ss_pred ---cEEEeecccccccCccccccceeeccCCCCcCCCccccCC--CCCcccchhhHhHHHHHHHh-CCCCCCCCCCCccc
Q 012014 296 ---IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC--EASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMN 369 (473)
Q Consensus 296 ---~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~ 369 (473)
.+||+|||++..... .....++..|+|||++.+. .++.++||||||+++|+|++ |..||.......
T Consensus 143 ~~~~~kl~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~-- 214 (259)
T cd05037 143 YVPFIKLSDPGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE-- 214 (259)
T ss_pred CceeEEeCCCCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh--
Confidence 799999999986533 1123467789999998876 78999999999999999999 577776532111
Q ss_pred HHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHH
Q 012014 370 LRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRL 449 (473)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L 449 (473)
...... ... .. . ......+.+++.+||..||.+|||+.+|++.|
T Consensus 215 ~~~~~~---~~~--~~----------------------~---------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 215 KERFYQ---DQH--RL----------------------P---------MPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred HHHHHh---cCC--CC----------------------C---------CCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 000000 000 00 0 00115788999999999999999999999887
Q ss_pred H
Q 012014 450 R 450 (473)
Q Consensus 450 ~ 450 (473)
+
T Consensus 259 ~ 259 (259)
T cd05037 259 N 259 (259)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=304.76 Aligned_cols=202 Identities=24% Similarity=0.381 Sum_probs=166.8
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
.++|++.+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|+.+++.++||||+++++++.+ ....
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~ 78 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHT-----KKTL 78 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEec-----CCeE
Confidence 36789999999999999999984 4689999999874332 233457789999999999999999999754 3478
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEee
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~D 301 (473)
++||||++ ++|.+++..... .+++..+..++.|++.||.||| +++|+||||||+||+++.++.+||+|
T Consensus 79 ~lv~e~~~-~~L~~~~~~~~~--------~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~d 146 (291)
T cd07844 79 TLVFEYLD-TDLKQYMDDCGG--------GLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLAD 146 (291)
T ss_pred EEEEecCC-CCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECc
Confidence 99999997 599998875432 2558889999999999999999 99999999999999999999999999
Q ss_pred cccccccCccccccceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHHhCCCCCCCCC
Q 012014 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (473)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~ 364 (473)
||+++...... .......++..|+|||++.+ ..++.++||||||+++|+|++|..||.+..
T Consensus 147 fg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 147 FGLARAKSVPS--KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred cccccccCCCC--ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 99987543211 11122346888999999875 458899999999999999999999997643
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=302.95 Aligned_cols=261 Identities=20% Similarity=0.286 Sum_probs=201.0
Q ss_pred cccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHHHHHHhc-CCCCceeeeeeeecccc-CCc
Q 012014 142 NATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDY-QGA 218 (473)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~-~~~ 218 (473)
..+++|++.+.||+|+||.||+|.. .+++.+++|++..... ..+.+.+|+.+++++ +|+||+++++++..... ...
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 4578999999999999999999995 4678999999875432 346789999999999 79999999999876442 234
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...++||||+++++|.+++...... ...+++..+..++.|++.||.||| +++++|+||+|+||+++.++.+|
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~ 153 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKK-----GKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVK 153 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhc-----CCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEE
Confidence 5689999999999999998653311 013568889999999999999999 99999999999999999999999
Q ss_pred EeecccccccCccccccceeeccCCCCcCCCccccC-----CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHH
Q 012014 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-----CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNF 373 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~ 373 (473)
|+|||++....... .......|+..|+|||++.. ..++.++||||||+++|+|++|..||....... .+...
T Consensus 154 l~d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~ 230 (275)
T cd06608 154 LVDFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-ALFKI 230 (275)
T ss_pred ECCCccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-HHHHh
Confidence 99999987654322 22233458999999998753 346788999999999999999999997432111 11110
Q ss_pred HHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 374 VKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.. .....+ ......+..+.+|+.+||..||++|||+.||++
T Consensus 231 ~~----~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 231 PR----NPPPTL-----------------------------KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hc----cCCCCC-----------------------------CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00 000000 001224567889999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=306.71 Aligned_cols=248 Identities=19% Similarity=0.272 Sum_probs=195.0
Q ss_pred CCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEEE
Q 012014 147 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVY 225 (473)
Q Consensus 147 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (473)
|.....||+|+||.||+|. ..+++.||+|.+........+.+.+|+.++..++||||+++++++.. ....+++|
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~iv~ 97 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLV-----GEELWVLM 97 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheee-----CCeEEEEE
Confidence 3445579999999999998 45789999999876554556678899999999999999999998754 34679999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecccc
Q 012014 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (473)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~ 305 (473)
||+++++|.+++... .+++..+..++.|++.||.||| +++++||||||+||+++.++.+||+|||++
T Consensus 98 e~~~~~~L~~~~~~~----------~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~ 164 (297)
T cd06659 98 EFLQGGALTDIVSQT----------RLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFC 164 (297)
T ss_pred ecCCCCCHHHHHhhc----------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhH
Confidence 999999999987553 2558889999999999999999 999999999999999999999999999998
Q ss_pred cccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchhhh
Q 012014 306 RFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEV 385 (473)
Q Consensus 306 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (473)
....... .......|+..|+|||++.+..++.++|||||||++|||++|..||....... .+. ......+.. .
T Consensus 165 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-~~~-~~~~~~~~~---~ 237 (297)
T cd06659 165 AQISKDV--PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-AMK-RLRDSPPPK---L 237 (297)
T ss_pred hhccccc--ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHH-HHhccCCCC---c
Confidence 7554322 11223458999999999998889999999999999999999999997432111 000 000000000 0
Q ss_pred ccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 386 VDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
......+..+.+++.+||+.||++|||+.+|++.
T Consensus 238 -----------------------------~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 238 -----------------------------KNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred -----------------------------cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0001234567889999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=302.84 Aligned_cols=281 Identities=26% Similarity=0.348 Sum_probs=208.1
Q ss_pred CCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHh--cCCCCceeeeeeeeccccCCceeeE
Q 012014 145 NGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAIN--IKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
......++||+|+||.||+|.+ +++.||||++.. .....|++|-+|.+. +.|+||++++++-...+.. ...++
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~-~~eyw 284 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD-RMEYW 284 (534)
T ss_pred CchhhHHHhhcCccceeehhhc-cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcc-cccee
Confidence 4556778899999999999996 559999999863 346678888888765 4899999999886554422 55789
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhC------CCCCeeeccCCCCcEEecCCcc
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCD------CQPPIAHCNLKPSNVLLDDEMI 296 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~------~~~~iiH~Dlkp~Nil~~~~~~ 296 (473)
||++|.+.|+|.+||..+. ++|....+++..+++||+|||+. ...+|+|||||+.|||+.++++
T Consensus 285 LVt~fh~kGsL~dyL~~nt----------isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlT 354 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLKANT----------ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLT 354 (534)
T ss_pred EEeeeccCCcHHHHHHhcc----------ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCc
Confidence 9999999999999999874 66999999999999999999953 2457999999999999999999
Q ss_pred EEEeecccccccCccccccceeeccCCCCcCCCccccCCC-CC-----cccchhhHhHHHHHHHhCCCCCC-C-CCCCcc
Q 012014 297 GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE-AS-----TYGDVYSFGILLLEMFTGIRPSD-G-IFTGKM 368 (473)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DiwSlG~il~elltg~~P~~-~-~~~~~~ 368 (473)
+.|+|||+|..+............+||.+|||||++.+.. +. .+.||||+|.|||||+++..-++ + ...-+.
T Consensus 355 ccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yql 434 (534)
T KOG3653|consen 355 CCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQL 434 (534)
T ss_pred EEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccC
Confidence 9999999999887766666666688999999999988743 22 34799999999999999654432 1 111111
Q ss_pred cHHHHHHhhcC-cchh-hhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHH
Q 012014 369 NLRNFVKMALP-QRAE-EVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVE 446 (473)
Q Consensus 369 ~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~ 446 (473)
.+..-+..... ++.. -++.......+.+.++. .....-|++.+..||..||+.|.|+.=+.
T Consensus 435 pfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~-----------------h~~~~~l~et~EeCWDhDaeARLTA~Cv~ 497 (534)
T KOG3653|consen 435 PFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRK-----------------HAGMAVLCETIEECWDHDAEARLTAGCVE 497 (534)
T ss_pred chhHHhcCCCCHHHHHHHHHhhccCCCChhhhhc-----------------CccHHHHHHHHHHHcCCchhhhhhhHHHH
Confidence 11111110000 0000 11111111111111111 13567899999999999999999999999
Q ss_pred HHHHHHHHhhc
Q 012014 447 SRLRLIRRKLL 457 (473)
Q Consensus 447 ~~L~~l~~~~~ 457 (473)
+++..+.....
T Consensus 498 eR~~~l~~~~~ 508 (534)
T KOG3653|consen 498 ERMAELMMLWE 508 (534)
T ss_pred HHHHHHhccCC
Confidence 99999965443
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=314.21 Aligned_cols=250 Identities=22% Similarity=0.323 Sum_probs=202.7
Q ss_pred hcccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCC--CchhHHHHHHHHHhcCCCCceeeeeeeeccccCC
Q 012014 141 YNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (473)
Q Consensus 141 ~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (473)
......|.+.+.||+|.|+.|.+|+ ..++..||||.+.+...+ ....+.+|+++|..++|||||+++.+.. .
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~-----t 126 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIE-----T 126 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeee-----e
Confidence 3456789999999999999999999 567999999999754433 2345889999999999999999999964 3
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccE
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~ 297 (473)
...+|+||||+.+|.+.+|+..++. ..+..+..++.|+.+|++||| +++|+|||||++|||++.+.++
T Consensus 127 ~~~lylV~eya~~ge~~~yl~~~gr---------~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mni 194 (596)
T KOG0586|consen 127 EATLYLVMEYASGGELFDYLVKHGR---------MKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNI 194 (596)
T ss_pred cceeEEEEEeccCchhHHHHHhccc---------chhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccce
Confidence 4578999999999999999998874 335778889999999999999 9999999999999999999999
Q ss_pred EEeecccccccCccccccceeeccCCCCcCCCccccCCCC-CcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 012014 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEA-STYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKM 376 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~ 376 (473)
||+|||++..+.. .....+.+|++.|.|||++.+..| ++++|+||+|+++|-|+.|..||++..-
T Consensus 195 kIaDfgfS~~~~~---~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l----------- 260 (596)
T KOG0586|consen 195 KIADFGFSTFFDY---GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL----------- 260 (596)
T ss_pred eeeccccceeecc---cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc-----------
Confidence 9999999998753 444556789999999999998776 6789999999999999999999987321
Q ss_pred hcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 377 ALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.++-++.+...+. .+.-...+..+|++++|-.+|.+|+++++|.+
T Consensus 261 ------k~Lr~rvl~gk~r--------------------Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 261 ------KELRPRVLRGKYR--------------------IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred ------ccccchheeeeec--------------------ccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 1111111111100 01112334557889999999999999999865
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=316.57 Aligned_cols=208 Identities=29% Similarity=0.408 Sum_probs=175.9
Q ss_pred CCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC-CCCchhHHHHHHHHHhcCCCCceeeeeeeeccc-cCCceeeEE
Q 012014 147 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVD-YQGARFKAV 223 (473)
Q Consensus 147 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~~~~~l 223 (473)
|...+.||+||||.||+|+ ..+|+.||||.++... ....+...+|+++|++++|||||+++++-.+.. +.......+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 4567789999999999999 6789999999998533 345677889999999999999999998854322 111445789
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEec--CCc--cEEE
Q 012014 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD--DEM--IGHV 299 (473)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~--~~~--~~kl 299 (473)
|||||++|||..+|+..... ..+++.+.+.++.+++.||.||| .+||+||||||.||++- .+| ..||
T Consensus 95 vmEyC~gGsL~~~L~~PEN~------~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKL 165 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENA------YGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKL 165 (732)
T ss_pred EEeecCCCcHHHHhcCcccc------cCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEee
Confidence 99999999999999876543 26889999999999999999999 99999999999999983 323 5699
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHHhCCCCCCCCCCC
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFTG 366 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~ 366 (473)
+|||.|+.+++. ....+..||..|.+||+... ..|+..+|.|||||++|+++||..||-.....
T Consensus 166 tDfG~Arel~d~---s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 166 TDFGAARELDDN---SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred ecccccccCCCC---CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 999999988653 36677889999999999984 78999999999999999999999999765444
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=306.06 Aligned_cols=249 Identities=24% Similarity=0.294 Sum_probs=199.1
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC---CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCce
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (473)
.+.|+.-++||+||||.||-++ ..+|+.+|+|.+.+.+ ........+|-.+|.+++.++||.+-..|.+ ..
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT-----kd 258 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFET-----KD 258 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC-----CC
Confidence 4668899999999999999998 5679999999886432 2233456799999999999999999887644 44
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
.+|+||..|.||+|.-+|.+.+.. .|++..++-++.+|+.||++|| +.+||+||+||+|||+|+.|+++|
T Consensus 259 ~LClVLtlMNGGDLkfHiyn~g~~-------gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRI 328 (591)
T KOG0986|consen 259 ALCLVLTLMNGGDLKFHIYNHGNP-------GFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRI 328 (591)
T ss_pred ceEEEEEeecCCceeEEeeccCCC-------CCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEe
Confidence 789999999999999999887643 4779999999999999999999 999999999999999999999999
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcC
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP 379 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 379 (473)
+|+|+|..++... ......||.+|||||++.+..|+...|+|||||++|||+.|..||........
T Consensus 329 SDLGLAvei~~g~---~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk----------- 394 (591)
T KOG0986|consen 329 SDLGLAVEIPEGK---PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK----------- 394 (591)
T ss_pred eccceEEecCCCC---ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh-----------
Confidence 9999999876543 33344799999999999999999999999999999999999999964321110
Q ss_pred cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChH
Q 012014 380 QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKIN 443 (473)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 443 (473)
.+-++...... .-..+...+++..+|....|..||.+|....
T Consensus 395 ---~eEvdrr~~~~-------------------~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 395 ---REEVDRRTLED-------------------PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred ---HHHHHHHHhcc-------------------hhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 00011111100 0011234566778888899999999997644
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=305.07 Aligned_cols=251 Identities=19% Similarity=0.222 Sum_probs=199.3
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
.++|.+.+.||+|+||.||++. ..+++.||+|.+........+.+.+|+.+++.++||||+++++.|... ...+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-----~~~~ 92 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVG-----DELW 92 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeC-----CcEE
Confidence 3678999999999999999998 456889999998755545566789999999999999999999987543 3679
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
+|+||+++++|.+++.... +++.++..++.|++.||.||| +++++|+||||+||+++.++.+||+||
T Consensus 93 lv~e~~~~~~L~~~~~~~~----------l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~df 159 (293)
T cd06647 93 VVMEYLAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDF 159 (293)
T ss_pred EEEecCCCCcHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccC
Confidence 9999999999999997542 457888999999999999999 999999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcch
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRA 382 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 382 (473)
|++........ ......|++.|+|||.+.+..++.++||||||+++|++++|..||......... ..... ...
T Consensus 160 g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~-~~~~~---~~~- 232 (293)
T cd06647 160 GFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-YLIAT---NGT- 232 (293)
T ss_pred cceeccccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe-eehhc---CCC-
Confidence 99876543321 222345889999999998888999999999999999999999999753221100 00000 000
Q ss_pred hhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 383 EEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
. ........+..+.+++.+||..+|++||++.+++..
T Consensus 233 ~-----------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 233 P-----------------------------ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred C-----------------------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 000011245578899999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=297.83 Aligned_cols=247 Identities=24% Similarity=0.338 Sum_probs=195.0
Q ss_pred CCCccceeecCCCeEEEEEEec-CCCEEEEEEeeccCC-----CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCce
Q 012014 146 GFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRP-----GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (473)
+|+..+.||+|+||.||+|... +++.|++|.+..... ...+.+.+|+.+++.++||||+++++++.. ..
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~ 75 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE-----ED 75 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec-----CC
Confidence 4777889999999999999954 789999999875332 133568899999999999999999998754 34
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
..++++||+++++|.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.+||
T Consensus 76 ~~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl 143 (258)
T cd06632 76 NLYIFLELVPGGSLAKLLKKYG---------SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKL 143 (258)
T ss_pred eEEEEEEecCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEE
Confidence 6799999999999999997653 2457888899999999999999 899999999999999999999999
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccCCC-CCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE-ASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMAL 378 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~ 378 (473)
+|||++....... ......|+..|+|||.+.... ++.++|+||||+++|+|++|..||....... .......
T Consensus 144 ~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~----~~~~~~~ 216 (258)
T cd06632 144 ADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA----AVFKIGR 216 (258)
T ss_pred ccCccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH----HHHHHHh
Confidence 9999987654322 223445889999999987766 8999999999999999999999997532111 0000000
Q ss_pred CcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 379 PQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.... +..+......+.+++.+||+.||.+|||+.+++.
T Consensus 217 ~~~~-------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 217 SKEL-------------------------------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred cccC-------------------------------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 0000 0001123567788999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=296.66 Aligned_cols=248 Identities=21% Similarity=0.354 Sum_probs=195.5
Q ss_pred CCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC--CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
+|+..+.||+|+||.||++. ..+++.+|+|.+.... ......+.+|+.+++.++||||+++++.+.. ....+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~ 75 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE-----DKALM 75 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec-----CCEEE
Confidence 47888999999999999998 4578899999987432 2234578899999999999999999998753 34679
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCC-ccEEEee
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE-MIGHVGD 301 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~-~~~kl~D 301 (473)
+||||+++++|.+++...... .+++..+..++.|++.||.||| +++++|+||+|+||+++.+ +.+||+|
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d 145 (256)
T cd08220 76 IVMEYAPGGTLAEYIQKRCNS-------LLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGD 145 (256)
T ss_pred EEEecCCCCCHHHHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEcc
Confidence 999999999999999764321 3568889999999999999999 9999999999999999754 4689999
Q ss_pred cccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcc
Q 012014 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQR 381 (473)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 381 (473)
||++....... ......|+..|+|||.+.+..++.++||||||+++|+|++|..||.+.... ..........
T Consensus 146 ~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-----~~~~~~~~~~ 217 (256)
T cd08220 146 FGISKILSSKS---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP-----ALVLKIMSGT 217 (256)
T ss_pred CCCceecCCCc---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH-----HHHHHHHhcC
Confidence 99998764322 122345789999999999888999999999999999999999998653211 1111000000
Q ss_pred hhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 382 AEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.. +.+...+..+.+++.+||+.||++|||+.|++.
T Consensus 218 ~~-------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 218 FA-------------------------------PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CC-------------------------------CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 00 001124557889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=304.70 Aligned_cols=246 Identities=21% Similarity=0.311 Sum_probs=195.1
Q ss_pred CCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC-CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEE
Q 012014 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (473)
.|+..+.||+|+||.||+|. ..+++.||+|.++... ....+.+.+|+.++++++||||+++++++.. ....++
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l 79 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLK-----GTKLWI 79 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccccc-----CCceEE
Confidence 46677889999999999998 4567899999986432 2234568899999999999999999999754 346799
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecc
Q 012014 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (473)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg 303 (473)
||||+++++|.+++... .+++..+..++.|++.||.||| +++++|+||+|+||+++.++.++|+|||
T Consensus 80 v~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg 146 (277)
T cd06642 80 IMEYLGGGSALDLLKPG----------PLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFG 146 (277)
T ss_pred EEEccCCCcHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEcccc
Confidence 99999999999998653 2557888999999999999999 9999999999999999999999999999
Q ss_pred cccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchh
Q 012014 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAE 383 (473)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 383 (473)
++..+.... .......|+..|+|||++.+..++.++||||||+++|||++|..||........ ... .....
T Consensus 147 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~----~~~~~- 217 (277)
T cd06642 147 VAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV--LFL----IPKNS- 217 (277)
T ss_pred ccccccCcc--hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH--Hhh----hhcCC-
Confidence 997654322 112234578899999999988899999999999999999999999865322110 000 00000
Q ss_pred hhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 384 EVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
. +......+..+.+++.+||+.+|++|||+.+|+.
T Consensus 218 ---~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 218 ---P--------------------------PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred ---C--------------------------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0 0001124567889999999999999999999987
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=301.98 Aligned_cols=276 Identities=20% Similarity=0.251 Sum_probs=195.6
Q ss_pred CCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccC--CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 146 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
+|+..+.||.|++|.||+|+. .+++.||||.++... ......+.+|++++++++||||+++++++.+ ....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 75 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-----ENKLY 75 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc-----CCcEE
Confidence 488899999999999999984 468999999886432 2233568899999999999999999999754 34679
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
+||||+. ++|.+++...... .+++..+..++.|++.||.||| +++++|+||+|+||+++.++.+||+||
T Consensus 76 ~v~e~~~-~~l~~~~~~~~~~-------~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~df 144 (284)
T cd07860 76 LVFEFLH-QDLKKFMDASPLS-------GIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADF 144 (284)
T ss_pred EEeeccc-cCHHHHHHhCCCC-------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeec
Confidence 9999995 6899988654322 3568899999999999999999 999999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCCC-CCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcc
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE-ASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQR 381 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 381 (473)
|++....... .......+++.|+|||++.+.. ++.++||||||+++|+|+||..||.+..... .+...........
T Consensus 145 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~ 221 (284)
T cd07860 145 GLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPD 221 (284)
T ss_pred cchhhcccCc--cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCC
Confidence 9987654322 1122334688999999887644 6889999999999999999999997533211 1111111111000
Q ss_pred hhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 382 AEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
... .+... .+..... ....................+.+++.+||+.||.+|||+.++++
T Consensus 222 -~~~-~~~~~-~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 222 -EVV-WPGVT-SLPDYKP----SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred -hhh-hhhhh-HHHHHHh----hcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 000 00000 0000000 00000000000111224567889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=287.58 Aligned_cols=259 Identities=22% Similarity=0.301 Sum_probs=203.8
Q ss_pred hcccCCCCcc-ceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhc-CCCCceeeeeeeeccccCC
Q 012014 141 YNATNGFSSA-NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQG 217 (473)
Q Consensus 141 ~~~~~~~~~~-~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 217 (473)
+..+++|++. ++||-|-.|.|..+. ..+++++|+|++. +....++|++..-.. .|||||.++++|.. .+++
T Consensus 57 ~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-----Ds~KARrEVeLHw~~s~h~~iV~IidVyeN-s~~~ 130 (400)
T KOG0604|consen 57 YSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-----DSPKARREVELHWMASGHPHIVSIIDVYEN-SYQG 130 (400)
T ss_pred ccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-----cCHHHHhHhhhhhhhcCCCceEEeehhhhh-hccC
Confidence 4466777654 679999999999988 6689999999986 345677888875544 69999999999854 4577
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecC---C
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD---E 294 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~---~ 294 (473)
...+.+|||.|+||.|...++.++.. .|+++++..|+.||+.|+.||| +.+|.||||||+|+|... |
T Consensus 131 rkcLLiVmE~meGGeLfsriq~~g~~-------afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~n 200 (400)
T KOG0604|consen 131 RKCLLIVMECMEGGELFSRIQDRGDQ-------AFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPN 200 (400)
T ss_pred ceeeEeeeecccchHHHHHHHHcccc-------cchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCC
Confidence 78889999999999999999988754 5889999999999999999999 999999999999999954 4
Q ss_pred ccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 012014 295 MIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFV 374 (473)
Q Consensus 295 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~ 374 (473)
..+||+|||+|+.-.. .....+.+-||.|.|||++....|+..+|+||+||++|-|++|.+||........ .
T Consensus 201 a~lKLtDfGFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai--s--- 272 (400)
T KOG0604|consen 201 APLKLTDFGFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--S--- 272 (400)
T ss_pred cceEecccccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC--C---
Confidence 5799999999986432 3444566789999999999999999999999999999999999999986543211 0
Q ss_pred HhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 375 KMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
+.....+..++- .+..++=...++...+++...|+.+|.+|.|+.|+..
T Consensus 273 -------------pgMk~rI~~gqy-----------~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 273 -------------PGMKRRIRTGQY-----------EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred -------------hhHHhHhhccCc-----------cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 000000000000 0000111346778889999999999999999999864
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=349.38 Aligned_cols=262 Identities=24% Similarity=0.410 Sum_probs=203.6
Q ss_pred CCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEE
Q 012014 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (473)
..|...++||+|+||.||+|.. .++..||+|+++.... ....|++.+++++|||||+++++|.+. ...++
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~-----~~~~l 760 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSE-----KGAYL 760 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcC-----CCCEE
Confidence 4577788999999999999984 6789999999864321 224568899999999999999998653 35799
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecc
Q 012014 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (473)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg 303 (473)
||||+++|+|.++++. +++.++..++.|++.||+|||+.++.+|+||||||+||+++.++..++. ||
T Consensus 761 v~Ey~~~g~L~~~l~~------------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~ 827 (968)
T PLN00113 761 IHEYIEGKNLSEVLRN------------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LS 827 (968)
T ss_pred EEeCCCCCcHHHHHhc------------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ec
Confidence 9999999999999963 3488899999999999999996666799999999999999998888775 66
Q ss_pred cccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCc-ch
Q 012014 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQ-RA 382 (473)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~-~~ 382 (473)
........ ....||+.|+|||++.+..++.++|||||||++|||+||+.||+........+..+.+..... ..
T Consensus 828 ~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 901 (968)
T PLN00113 828 LPGLLCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHL 901 (968)
T ss_pred cccccccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccch
Confidence 55432111 122578999999999998999999999999999999999999976555444555555433221 12
Q ss_pred hhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHH
Q 012014 383 EEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRR 454 (473)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~ 454 (473)
..+.++..... .....+...++.+++.+||+.||++||||.||++.|+.+.+
T Consensus 902 ~~~~~~~~~~~--------------------~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 902 DMWIDPSIRGD--------------------VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred hheeCccccCC--------------------CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 22222221110 01123456678899999999999999999999999998855
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=305.86 Aligned_cols=209 Identities=22% Similarity=0.313 Sum_probs=168.7
Q ss_pred CCCccceeecCCCeEEEEEEe-c--CCCEEEEEEeeccC---CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCce
Q 012014 146 GFSSANLIGAGNFGSVYNGTL-F--DGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~~-~--~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (473)
+|.+.++||+|+||.||+|.. . +++.||+|.+.... ......+.+|+.++..++||||+++++++.+. ...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~ 77 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK 77 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence 478889999999999999994 3 57999999997533 33446778999999999999999999998653 234
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecC----Cc
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD----EM 295 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~----~~ 295 (473)
..++||||++ ++|.+++........ ..+++..+..++.|++.||.||| +++|+||||||+||+++. ++
T Consensus 78 ~~~lv~e~~~-~~l~~~~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~ 149 (316)
T cd07842 78 SVYLLFDYAE-HDLWQIIKFHRQAKR----VSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERG 149 (316)
T ss_pred eEEEEEeCCC-cCHHHHHHhhccCCC----cCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccc
Confidence 7899999996 578777754332211 14668889999999999999999 999999999999999999 99
Q ss_pred cEEEeecccccccCcccc-ccceeeccCCCCcCCCccccCC-CCCcccchhhHhHHHHHHHhCCCCCCCCCC
Q 012014 296 IGHVGDFGMARFLPAIDK-QNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFT 365 (473)
Q Consensus 296 ~~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~ 365 (473)
.+||+|||++........ ........+|+.|+|||++.+. .++.++||||||+++|+|++|.+||.+...
T Consensus 150 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 150 VVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred eEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 999999999986643322 1112234578899999987664 578999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=301.95 Aligned_cols=252 Identities=21% Similarity=0.258 Sum_probs=189.3
Q ss_pred CCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCC-CCchhHHHHHHH-HHhcCCCCceeeeeeeeccccCCceee
Q 012014 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP-GGSKSFKSECKA-AINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
++|++.+.||+|+||.||+|.. .+|+.||+|+++.... .....+..|+.+ ++.++||||+++++++... ...
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~-----~~~ 75 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFRE-----GDV 75 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecC-----CcE
Confidence 4788999999999999999984 5699999999875322 223345566665 5667899999999998543 367
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCC-CeeeccCCCCcEEecCCccEEEe
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQP-PIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~-~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
+++|||++ |+|.+++....... ..+++..++.++.|++.||.||| ++ +++||||||+||+++.++.+||+
T Consensus 76 ~lv~e~~~-~~l~~~l~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~ 146 (283)
T cd06617 76 WICMEVMD-TSLDKFYKKVYDKG-----LTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLC 146 (283)
T ss_pred EEEhhhhc-ccHHHHHHHhccCC-----CCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEe
Confidence 99999995 78988876532211 14678999999999999999999 76 99999999999999999999999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCccccC----CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG----CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKM 376 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~ 376 (473)
|||++....... ......|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||.........+.....
T Consensus 147 dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~- 222 (283)
T cd06617 147 DFGISGYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE- 222 (283)
T ss_pred eccccccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh-
Confidence 999998653321 1122457899999998865 45688999999999999999999999642211111111100
Q ss_pred hcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 377 ALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
....... ....+..+.+++.+||..+|++|||+.+|++
T Consensus 223 ---~~~~~~~------------------------------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 223 ---EPSPQLP------------------------------AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred ---cCCCCCC------------------------------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000000 0124567889999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=305.98 Aligned_cols=276 Identities=20% Similarity=0.295 Sum_probs=197.0
Q ss_pred CCCCccceeecCCCeEEEEEEec-CCCEEEEEEeeccCC--CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 145 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
++|++.++||+|+||.||+|... +++.||+|++..... ...+.+.+|++++..++||||+++++++.. ....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 75 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR-----KKRL 75 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc-----CCeE
Confidence 46888999999999999999954 589999999864322 234568899999999999999999999853 3468
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEee
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~D 301 (473)
++||||+++++|..+..... .+++.++..++.|++.||.||| +.+++|+||+|+||++++++.++|+|
T Consensus 76 ~lv~e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~d 143 (286)
T cd07846 76 YLVFEFVDHTVLDDLEKYPN---------GLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCD 143 (286)
T ss_pred EEEEecCCccHHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEe
Confidence 99999999999988775432 2558899999999999999999 89999999999999999999999999
Q ss_pred cccccccCccccccceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh--c
Q 012014 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA--L 378 (473)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~--~ 378 (473)
||++....... .......|+..|+|||++.+ ..++.++||||||+++|+|++|.+||......+ .+....... .
T Consensus 144 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~-~~~~~~~~~~~~ 220 (286)
T cd07846 144 FGFARTLAAPG--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID-QLYHIIKCLGNL 220 (286)
T ss_pred eeeeeeccCCc--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH-HHHHHHHHhCCC
Confidence 99988654322 11223457889999999875 347889999999999999999999986532111 111111000 0
Q ss_pred CcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 379 PQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
........+.... ... ...................+..+.+|+.+||+.||++|||+.+|++
T Consensus 221 ~~~~~~~~~~~~~---~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 221 IPRHQEIFQKNPL---FAG----MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred chhhHHHhccchH---hhc----cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000000000000 000 0000000000001112235678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=300.95 Aligned_cols=273 Identities=19% Similarity=0.244 Sum_probs=199.6
Q ss_pred CCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccC--CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 146 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
+|++.+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+.++++++||||+++++++.. ....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~ 75 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH-----GSGFV 75 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec-----CCeeE
Confidence 478889999999999999984 578999999987543 2334678999999999999999999999854 34679
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
+||||+ +++|.+++..... .+++.++..++.||+.||.||| +++++|+||||+||+++.++.++|+||
T Consensus 76 ~v~e~~-~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~df 143 (286)
T cd07832 76 LVMEYM-PSDLSEVLRDEER--------PLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADF 143 (286)
T ss_pred EEeccc-CCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeee
Confidence 999999 9999999875431 3668899999999999999999 899999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCC-CCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCc-
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQ- 380 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~- 380 (473)
|++........ .......|+..|+|||.+.+. .++.++||||+|+++|+|++|.+||.+.... ..+..........
T Consensus 144 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~~~~~~~ 221 (286)
T cd07832 144 GLARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-EQLAIVFRTLGTPN 221 (286)
T ss_pred eecccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-HHHHHHHHHcCCCC
Confidence 99987644321 122334589999999998654 4689999999999999999998888653321 1111111111100
Q ss_pred --chhhhccccchHHHHhhhhhhcccccCCC-CcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 381 --RAEEVVDDFNLQEIEEGRTMCMEVSSSSG-SSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 381 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
...+..+.. .+. ....... .........+.+..+.+|+.+||+.||++|||+.++++
T Consensus 222 ~~~~~~~~~~~---~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 222 EETWPGLTSLP---DYN-------KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred hHHHhhccCcc---hhh-------cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 000000000 000 0000000 00011111234578999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=310.71 Aligned_cols=289 Identities=18% Similarity=0.208 Sum_probs=206.9
Q ss_pred ccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeecc--CCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCce
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI--RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (473)
..++|.+.+.||+|+||.||+|. ..+++.||+|.++.. .......+.+|+.++..++||||+++++++.........
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 34679999999999999999998 457899999998643 222345677899999999999999999988655433334
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
..+++|||+. ++|.+++.... .+++..+..++.|++.||.||| +++++||||||+||+++.++.+||
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~~---------~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL 149 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSSQ---------TLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKI 149 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEE
Confidence 6899999995 79999987653 3568899999999999999999 999999999999999999999999
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMAL 378 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~ 378 (473)
+|||+++...... .......|+..|+|||.+.+ ..++.++|||||||++|+|++|..||.+.... ..+........
T Consensus 150 ~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~ 226 (337)
T cd07858 150 CDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV-HQLKLITELLG 226 (337)
T ss_pred CcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH-HHHHHHHHHhC
Confidence 9999998654322 11223457889999998765 46899999999999999999999999764211 11111111110
Q ss_pred C---cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH--HHHHH
Q 012014 379 P---QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR--LRLIR 453 (473)
Q Consensus 379 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~--L~~l~ 453 (473)
+ .....+.+........ ........ .........+..+.+++.+||+.||++|||+.|+++. ++.+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 227 SPSEEDLGFIRNEKARRYIR-------SLPYTPRQ-SFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred CCChHHhhhcCchhhhHHHH-------hcCccccc-CHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 0 0010111100000000 00000000 0011122456788999999999999999999999877 76664
Q ss_pred Hh
Q 012014 454 RK 455 (473)
Q Consensus 454 ~~ 455 (473)
..
T Consensus 299 ~~ 300 (337)
T cd07858 299 DP 300 (337)
T ss_pred Cc
Confidence 43
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=308.36 Aligned_cols=284 Identities=21% Similarity=0.256 Sum_probs=203.5
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC--CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
.++|++.+.||+|+||.||+|. ..+++.||+|++.... ......+.+|+.++.+++||||++++++|.... .....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCce
Confidence 4689999999999999999998 4579999999987432 233456788999999999999999999876543 33456
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.++||||+. |+|.+++.... .+++..+..++.||+.||.||| +++|+||||||+||+++.++.+||+
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~~---------~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~ 149 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSDQ---------PLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIG 149 (334)
T ss_pred EEEEEehhh-hhHHHHhccCC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEec
Confidence 899999995 69999987543 3568899999999999999999 8999999999999999999999999
Q ss_pred ecccccccCccccc--cceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 301 DFGMARFLPAIDKQ--NRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 301 Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
|||++......... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+..... .+.... ..
T Consensus 150 dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~-~~~~~~-~~ 227 (334)
T cd07855 150 DFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH-QLKLIL-SV 227 (334)
T ss_pred ccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH-HHHHHH-HH
Confidence 99999765432211 11123468899999998765 458899999999999999999999997643211 111111 11
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
......+..+............ .................+..+.+++.+||+.||++|||+.+++.
T Consensus 228 ~g~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 228 LGSPSEEVLNRIGSDRVRKYIQ----NLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hCCChhHhhhhhchhhHHHHHh----hcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 1111111111111111000000 00000011111122335778999999999999999999999876
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=295.96 Aligned_cols=252 Identities=23% Similarity=0.296 Sum_probs=201.4
Q ss_pred CCCCccceeecCCCeEEEEEEec-CCCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 145 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
++|++.+.||+|++|.||+|... +++.|++|++..... .....+.+|+..+.+++|+||+++++++... ...+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 75 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKE-----GEIS 75 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC-----CeEE
Confidence 46888999999999999999954 589999999875443 3456789999999999999999999998543 4789
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCC-CCeeeccCCCCcEEecCCccEEEee
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQ-PPIAHCNLKPSNVLLDDEMIGHVGD 301 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~iiH~Dlkp~Nil~~~~~~~kl~D 301 (473)
++|||+++++|.+++.... .+++..++.++.|++.||.||| + .+++|+||+|+||+++.++.++|+|
T Consensus 76 lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~d 143 (264)
T cd06623 76 IVLEYMDGGSLADLLKKVG---------KIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIAD 143 (264)
T ss_pred EEEEecCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEcc
Confidence 9999999999999997653 3568899999999999999999 8 9999999999999999999999999
Q ss_pred cccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcc
Q 012014 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQR 381 (473)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 381 (473)
||.+......... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...... .............
T Consensus 144 f~~~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~ 219 (264)
T cd06623 144 FGISKVLENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP--SFFELMQAICDGP 219 (264)
T ss_pred CccceecccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc--CHHHHHHHHhcCC
Confidence 9999866433222 12344788999999999888999999999999999999999999764321 1111111111000
Q ss_pred hhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHH-HHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 382 AEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILE-CFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
.. ..... .+..+.+++.+||+.+|++|||+.|+++.
T Consensus 220 ~~-------------------------------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 220 PP-------------------------------SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CC-------------------------------CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 00 00112 45688899999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=297.12 Aligned_cols=252 Identities=24% Similarity=0.327 Sum_probs=196.7
Q ss_pred CCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCC--CchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 146 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
+|...+.||+|+||.||+|.. .+++.|++|.++..... ....+.+|+.+++.++|+||+++++.+.. ....+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~ 75 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH-----REKVY 75 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec-----CCEEE
Confidence 578889999999999999984 47899999998755433 45678899999999999999999998643 34679
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
+|+||+++++|.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||++++++.+||+||
T Consensus 76 lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~ 143 (264)
T cd06626 76 IFMEYCSGGTLEELLEHGR---------ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDF 143 (264)
T ss_pred EEEecCCCCcHHHHHhhcC---------CCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccc
Confidence 9999999999999997653 2447788899999999999999 999999999999999999999999999
Q ss_pred ccccccCccccccc--eeeccCCCCcCCCccccCCC---CCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 303 GMARFLPAIDKQNR--FICIKGSTGYIPPEYDLGCE---ASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 303 g~~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
|++........... .....++..|+|||++.+.. ++.++||||||+++|+|++|..||........ .......
T Consensus 144 g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~-~~~~~~~- 221 (264)
T cd06626 144 GCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ-IMFHVGA- 221 (264)
T ss_pred ccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH-HHHHHhc-
Confidence 99987644322111 12345788999999988766 88999999999999999999999975321110 0000000
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.....+ . .....+..+.+++.+||+.||.+|||+.|++.
T Consensus 222 --~~~~~~-~----------------------------~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 222 --GHKPPI-P----------------------------DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred --CCCCCC-C----------------------------cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000 0 00123556789999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=304.93 Aligned_cols=243 Identities=23% Similarity=0.299 Sum_probs=194.6
Q ss_pred CCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccC---CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
++|.+.+.||+|+||.||++.. .+++.+|+|++.... ....+.+.+|++++++++||||+++++++.. ...
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD-----DSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc-----CCe
Confidence 4788999999999999999984 468999999986432 2334668899999999999999999999754 346
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.++||||+++++|.+++.... .++...+..++.|++.||.||| +++++|+||+|+||+++.++.+||+
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~~---------~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~ 143 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKSG---------RFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKIT 143 (290)
T ss_pred EEEEEecCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEe
Confidence 899999999999999997653 3568889999999999999999 8999999999999999999999999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCc
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQ 380 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 380 (473)
|||++...... .....|++.|+|||.+.+...+.++||||||+++|+|++|..||...... .........
T Consensus 144 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~ 213 (290)
T cd05580 144 DFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI-----QIYEKILEG 213 (290)
T ss_pred eCCCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHhcC
Confidence 99999865432 22345899999999998888899999999999999999999999753210 000000000
Q ss_pred chhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCC-----ChHHHH
Q 012014 381 RAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERM-----KINDVE 446 (473)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~ 446 (473)
.. ..+...+..+.+++.+||..||.+|| +++|++
T Consensus 214 ~~--------------------------------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 214 KV--------------------------------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred Cc--------------------------------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 00 00112345778999999999999999 666665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=297.13 Aligned_cols=256 Identities=20% Similarity=0.242 Sum_probs=199.5
Q ss_pred CCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC--CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
+|++.+.||.|+||.||++. ..+++.+|+|.+.... ....+.+.+|+.+++.++||||+++++++... .....+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~ 77 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR---SNQTLY 77 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC---CCCEEE
Confidence 47888999999999999998 4578899999986432 22345688899999999999999999987542 234679
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCC--CCCeeeccCCCCcEEecCCccEEEe
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDC--QPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~--~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
++|||+++++|.+++...... ...+++..++.++.|++.||.|||... +.+++|+||||+||+++.++.+||+
T Consensus 78 ~~~e~~~~~~L~~~l~~~~~~-----~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~ 152 (265)
T cd08217 78 IVMEYCEGGDLAQLIQKCKKE-----RKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLG 152 (265)
T ss_pred EEehhccCCCHHHHHHHHhhc-----ccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEe
Confidence 999999999999999754211 113668899999999999999999432 5689999999999999999999999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCc
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQ 380 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 380 (473)
|||++........ ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ..+.......
T Consensus 153 d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~ 225 (265)
T cd08217 153 DFGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ-----LQLASKIKEG 225 (265)
T ss_pred cccccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH-----HHHHHHHhcC
Confidence 9999987654321 12234589999999999988899999999999999999999999976321 1111111000
Q ss_pred chhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 381 RAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
... ..+...+..+.+++.+||+.+|++|||+.+|++
T Consensus 226 ~~~-------------------------------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 226 KFR-------------------------------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred CCC-------------------------------CCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 000 011234567889999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=300.60 Aligned_cols=248 Identities=20% Similarity=0.241 Sum_probs=195.6
Q ss_pred CCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEE
Q 012014 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVV 224 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 224 (473)
.|...+.||+|++|.||++. ..+++.+++|+++.......+.+.+|+.++..++||||+++++++... ...+++
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~-----~~~~~v 94 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG-----DELWVV 94 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcC-----CeEEEE
Confidence 35556799999999999998 457899999998755444556788999999999999999999987543 367999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeeccc
Q 012014 225 YKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM 304 (473)
Q Consensus 225 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~ 304 (473)
+||+++++|.+++... .+++.++..++.|++.||.||| +++++||||+|+||+++.++.++|+|||+
T Consensus 95 ~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~ 161 (285)
T cd06648 95 MEFLEGGALTDIVTHT----------RMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGF 161 (285)
T ss_pred EeccCCCCHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEccccc
Confidence 9999999999998763 2557888999999999999999 99999999999999999999999999998
Q ss_pred ccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchhh
Q 012014 305 ARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEE 384 (473)
Q Consensus 305 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (473)
+........ ......|++.|+|||.+.+..++.++||||||+++|+|++|..||...... . ............
T Consensus 162 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~----~-~~~~~~~~~~~~ 234 (285)
T cd06648 162 CAQVSKEVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL----Q-AMKRIRDNLPPK 234 (285)
T ss_pred chhhccCCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH----H-HHHHHHhcCCCC
Confidence 875543221 122345899999999998888999999999999999999999998652111 0 000000000000
Q ss_pred hccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 385 VVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
. ......+..+.+++.+||+.||++|||+.++++
T Consensus 235 ~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 235 L-----------------------------KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred C-----------------------------cccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 0 000123457889999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=311.74 Aligned_cols=286 Identities=17% Similarity=0.173 Sum_probs=200.1
Q ss_pred ccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC--CCCchhHHHHHHHHHhcCCCCceeeeeeeecccc-CCc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY-QGA 218 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~ 218 (473)
..++|+..+.||+|+||.||+|. ..+++.||+|.+.... ......+.+|+.++++++||||++++++|..... .+.
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 45789999999999999999998 4578999999986422 2233567789999999999999999998864321 223
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...++||||+. ++|.+++... ++...+..++.|++.||.||| ++||+||||||+||+++.++.+|
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~-----------l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~k 158 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD-----------LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLK 158 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc-----------CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEE
Confidence 45799999995 5888887543 447788899999999999999 89999999999999999999999
Q ss_pred EeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 012014 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMAL 378 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~ 378 (473)
|+|||+++...... ......|+..|+|||.+.+..++.++|||||||++|+|++|..||...... ..+........
T Consensus 159 L~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~ 234 (353)
T cd07850 159 ILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI-DQWNKIIEQLG 234 (353)
T ss_pred EccCccceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhcC
Confidence 99999998654322 122345789999999999989999999999999999999999999754221 11111111111
Q ss_pred C--cchhhhccccchHHHHhhhhhhc----cc-ccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 379 P--QRAEEVVDDFNLQEIEEGRTMCM----EV-SSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 379 ~--~~~~~~~~~~~~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
. ......++............... .. ................+..+.+++.+||+.||++|||+.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 235 TPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred CCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 01111111110000000000000 00 0000000000001234667889999999999999999999985
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=306.53 Aligned_cols=253 Identities=23% Similarity=0.300 Sum_probs=196.2
Q ss_pred CCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCC---CchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG---GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
++|+..+.||+|+||.||+|.. .+++.+|+|.+...... ....+.+|++++..++||||+++++.+.+ ...
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT-----ETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec-----CCE
Confidence 4688899999999999999984 45899999999754322 34568899999999999999999998754 346
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.+++|||+.+++|.+++...... .+++..+..++.|++.||.||| +.+++|+||||+||+++.++.++|+
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~-------~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~ 145 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQPGK-------CLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLS 145 (316)
T ss_pred EEEEEEecCCCCHHHHHHhCCCC-------ccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEe
Confidence 89999999999999998754321 3668888999999999999999 9999999999999999999999999
Q ss_pred ecccccccCccccc---------------------------cceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHH
Q 012014 301 DFGMARFLPAIDKQ---------------------------NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEM 353 (473)
Q Consensus 301 Dfg~~~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 353 (473)
|||++......... .......||..|+|||++.+..++.++||||||+++|+|
T Consensus 146 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l 225 (316)
T cd05574 146 DFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEM 225 (316)
T ss_pred ecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHH
Confidence 99998754322110 011123578899999999988899999999999999999
Q ss_pred HhCCCCCCCCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhccc
Q 012014 354 FTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSA 433 (473)
Q Consensus 354 ltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~ 433 (473)
++|..||.+...... +.... ..... .......+..+.+++.+||.
T Consensus 226 ~~g~~pf~~~~~~~~-~~~~~----~~~~~------------------------------~~~~~~~~~~~~~li~~~l~ 270 (316)
T cd05574 226 LYGTTPFKGSNRDET-FSNIL----KKEVT------------------------------FPGSPPVSSSARDLIRKLLV 270 (316)
T ss_pred hhCCCCCCCCchHHH-HHHHh----cCCcc------------------------------CCCccccCHHHHHHHHHHcc
Confidence 999999975432110 11000 00000 00001146688999999999
Q ss_pred CCCCCCCC----hHHHHH
Q 012014 434 ERPRERMK----INDVES 447 (473)
Q Consensus 434 ~dP~~RPt----~~ev~~ 447 (473)
.||++||| +.|++.
T Consensus 271 ~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 271 KDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred CCHhHCCCchhhHHHHHc
Confidence 99999999 555554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=298.51 Aligned_cols=253 Identities=23% Similarity=0.324 Sum_probs=196.5
Q ss_pred CCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCC------CchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPG------GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
+|+..+.||+|+||.||+|. ..+++.+|+|++...... ..+.+.+|++++++++||||+++++++.+ .
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~ 75 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE-----D 75 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc-----C
Confidence 47888999999999999998 467899999998743321 23568899999999999999999999854 3
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCc-cE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM-IG 297 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~-~~ 297 (473)
...++||||+++++|.+++.... .+++..+..++.|++.||.||| +++++|+||+|+||+++.++ .+
T Consensus 76 ~~~~~v~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~ 143 (268)
T cd06630 76 SHFNLFVEWMAGGSVSHLLSKYG---------AFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRL 143 (268)
T ss_pred CeEEEEEeccCCCcHHHHHHHhC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEE
Confidence 46799999999999999997643 3557889999999999999999 99999999999999998775 69
Q ss_pred EEeecccccccCccccc--cceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 012014 298 HVGDFGMARFLPAIDKQ--NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVK 375 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~ 375 (473)
||+|||.+......... .......|+..|+|||.+.+..++.++||||+|+++|+|++|..||........ ......
T Consensus 144 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~ 222 (268)
T cd06630 144 RIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH-LALIFK 222 (268)
T ss_pred EEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch-HHHHHH
Confidence 99999999776543211 111234578899999999888899999999999999999999999964321110 000000
Q ss_pred hhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 376 MALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
..... .....+...+..+.+++.+||..||.+|||+.|+++
T Consensus 223 ~~~~~-------------------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 223 IASAT-------------------------------TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HhccC-------------------------------CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00000 001112235677889999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=301.48 Aligned_cols=281 Identities=18% Similarity=0.195 Sum_probs=198.0
Q ss_pred CCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCC--CCchhHHHHHHHHHhcC-CCCceeeeeeeeccccCCcee
Q 012014 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 220 (473)
++|++.+.||+|+||.||+|.. .+++.||+|.++.... .....+.+|+.++..+. ||||+++++++...+......
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4688999999999999999994 5689999999864332 23456889999999995 699999999986654333445
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecC-CccEEE
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD-EMIGHV 299 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~-~~~~kl 299 (473)
.+++|||+++ +|.+++....... ...+++..++.++.||+.||.||| +++|+||||||+||+++. ++.+||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl 152 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGP----GRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKI 152 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccC----CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEE
Confidence 7999999975 8999886543221 113668999999999999999999 999999999999999998 899999
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMAL 378 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~ 378 (473)
+|||+++.+.... .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||.+...... +..+.....
T Consensus 153 ~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~ 229 (295)
T cd07837 153 ADLGLGRAFSIPV--KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ-LLHIFKLLG 229 (295)
T ss_pred eecccceecCCCc--cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHHHhC
Confidence 9999987653321 11122346888999998765 4578999999999999999999999976432211 111111100
Q ss_pred -Ccc--hhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 379 -PQR--AEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 379 -~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
+.. .............. ..............+..+.+++.+||..||.+|||+.|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 230 TPTEQVWPGVSKLRDWHEFP-----------QWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred CCChhhCcchhhccchhhcC-----------cccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 000 00000000000000 00000000111235677899999999999999999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=302.79 Aligned_cols=274 Identities=19% Similarity=0.233 Sum_probs=196.6
Q ss_pred CCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCC-----CchhHHHHHHHHHhcCCCCceeeeeeeeccccCCce
Q 012014 146 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG-----GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (473)
+|...+.||+|+||.||+|.. .+++.||+|.++..... ....+.+|+.++..++|+||+++++++.+ ..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~ 75 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-----KS 75 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-----CC
Confidence 477888999999999999984 46899999999754322 23456789999999999999999999855 34
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
..++||||+ +|+|.+++..... .+++..+..++.||++||.||| +++++|+||||+||+++.++.++|
T Consensus 76 ~~~lv~e~~-~~~L~~~i~~~~~--------~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l 143 (298)
T cd07841 76 NINLVFEFM-ETDLEKVIKDKSI--------VLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKL 143 (298)
T ss_pred EEEEEEccc-CCCHHHHHhccCC--------CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEE
Confidence 789999999 9999999976531 3668899999999999999999 999999999999999999999999
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMAL 378 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~ 378 (473)
+|||+++...... .......+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||.+....+ .+........
T Consensus 144 ~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~-~~~~~~~~~~ 220 (298)
T cd07841 144 ADFGLARSFGSPN--RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID-QLGKIFEALG 220 (298)
T ss_pred ccceeeeeccCCC--ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH-HHHHHHHHcC
Confidence 9999998764432 11222346788999998855 457899999999999999999988876533211 1111111110
Q ss_pred CcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 379 PQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
........+...... .... ...............+..+.+++.+||+.||++|||+.||++
T Consensus 221 ~~~~~~~~~~~~~~~------~~~~--~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 221 TPTEENWPGVTSLPD------YVEF--KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred CCchhhhhhcccccc------cccc--cccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 000000000000000 0000 000000001112234678899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=296.88 Aligned_cols=254 Identities=22% Similarity=0.332 Sum_probs=194.5
Q ss_pred CCCccceeecCCCeEEEEEEecC--CCEEEEEEeeccCC----------CCchhHHHHHHHHHh-cCCCCceeeeeeeec
Q 012014 146 GFSSANLIGAGNFGSVYNGTLFD--GTTIAVKVFNLIRP----------GGSKSFKSECKAAIN-IKHRNIVRVFTAFSG 212 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~ 212 (473)
+|++.+.||+|+||.||+|.... ++.+|+|.+..... .....+.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999543 78899998863221 122346778888765 799999999999854
Q ss_pred cccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCC-CCeeeccCCCCcEEe
Q 012014 213 VDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQ-PPIAHCNLKPSNVLL 291 (473)
Q Consensus 213 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~iiH~Dlkp~Nil~ 291 (473)
. ...+++|||+++++|.+++...... ...+++..++.++.|++.||.||| + .+++|+||+|+||++
T Consensus 81 ~-----~~~~lv~e~~~~~~l~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh---~~~~i~H~dl~~~nil~ 147 (269)
T cd08528 81 N-----DRLYIVMDLIEGAPLGEHFNSLKEK-----KQRFTEERIWNIFVQMVLALRYLH---KEKRIVHRDLTPNNIML 147 (269)
T ss_pred C-----CeEEEEEecCCCCcHHHHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHhc---cCCceeecCCCHHHEEE
Confidence 3 4789999999999999988542111 113668889999999999999999 6 689999999999999
Q ss_pred cCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHH
Q 012014 292 DDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLR 371 (473)
Q Consensus 292 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~ 371 (473)
+.++.+||+|||.+....... ......|+..|+|||.+.+..++.++||||||+++|+|++|..||..... .
T Consensus 148 ~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~-----~ 219 (269)
T cd08528 148 GEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM-----L 219 (269)
T ss_pred CCCCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH-----H
Confidence 999999999999998654322 23345589999999999988899999999999999999999999864211 1
Q ss_pred HHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHH
Q 012014 372 NFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLR 450 (473)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 450 (473)
.............. .....+..+.+++.+||+.||++|||+.||.++|+
T Consensus 220 ~~~~~~~~~~~~~~------------------------------~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 220 SLATKIVEAVYEPL------------------------------PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred HHHHHHhhccCCcC------------------------------CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 11110000000000 00123457889999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=322.99 Aligned_cols=286 Identities=17% Similarity=0.121 Sum_probs=186.9
Q ss_pred cCCCCccceeecCCCeEEEEEEec--CCCEEEEEEee---------------c--cCCCCchhHHHHHHHHHhcCCCCce
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTLF--DGTTIAVKVFN---------------L--IRPGGSKSFKSECKAAINIKHRNIV 204 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~---------------~--~~~~~~~~~~~E~~~l~~l~h~niv 204 (473)
.++|++.+.||+|+||.||++... .+...+.|.+. . ........+.+|+.++.+++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 468999999999999999998632 22222222110 0 0111234578999999999999999
Q ss_pred eeeeeeeccccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccC
Q 012014 205 RVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNL 284 (473)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dl 284 (473)
++++++... ...+++++++ +++|.+++........ ......++..++.||+.||.||| +++|+||||
T Consensus 227 ~l~~~~~~~-----~~~~lv~e~~-~~~l~~~l~~~~~~~~----~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDL 293 (501)
T PHA03210 227 KIEEILRSE-----ANTYMITQKY-DFDLYSFMYDEAFDWK----DRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDI 293 (501)
T ss_pred cEeEEEEEC-----CeeEEEEecc-ccCHHHHHhhcccccc----ccccHHHHHHHHHHHHHHHHHHH---hCCeecCCC
Confidence 999998653 3578999998 5688888765432110 01235677889999999999999 999999999
Q ss_pred CCCcEEecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCC
Q 012014 285 KPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (473)
Q Consensus 285 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~ 364 (473)
||+|||++.++.+||+|||+++.+.... ........||..|+|||++.+..++.++|||||||++|||++|..|+.+..
T Consensus 294 KP~NILl~~~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~ 372 (501)
T PHA03210 294 KLENIFLNCDGKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDG 372 (501)
T ss_pred CHHHEEECCCCCEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCC
Confidence 9999999999999999999998764422 112233569999999999999899999999999999999999876443222
Q ss_pred CC--cccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCCh
Q 012014 365 TG--KMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKI 442 (473)
Q Consensus 365 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 442 (473)
.. ...+...+..... ...+..+ .....+................... .....+..+.+++.+||+.||.+|||+
T Consensus 373 ~~~~~~~~~~~~~~~~~-~~~~~p~-~~~~~~~~i~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~kmL~~DP~~Rpsa 448 (501)
T PHA03210 373 GGKPGKQLLKIIDSLSV-CDEEFPD-PPCKLFDYIDSAEIDHAGHSVPPLI--RNLGLPADFEYPLVKMLTFDWHLRPGA 448 (501)
T ss_pred CCCHHHHHHHHHHhccc-ChhhcCC-cHHHHHHHhhhhhcccCccchhhHH--HhcCCChHHHHHHHHHhccCcccCcCH
Confidence 11 1122222211100 0000100 0000000000000000000000000 011234567888999999999999999
Q ss_pred HHHHH
Q 012014 443 NDVES 447 (473)
Q Consensus 443 ~ev~~ 447 (473)
.|++.
T Consensus 449 ~elL~ 453 (501)
T PHA03210 449 AELLA 453 (501)
T ss_pred HHHhh
Confidence 99975
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=301.05 Aligned_cols=277 Identities=21% Similarity=0.269 Sum_probs=198.5
Q ss_pred CCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccC--CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
++|++.+.||+|+||.||+|.. .+++.||+|.++... ....+.+.+|++++++++|+||+++++++.. ....
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~ 75 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-----KGRL 75 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-----CCEE
Confidence 4688999999999999999984 468899999987432 2334678999999999999999999999865 3367
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEee
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~D 301 (473)
+++|||++++.+..+..... .+++.++..++.||+.||.||| .++++|+||+|+||++++++.+||+|
T Consensus 76 ~iv~e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d 143 (288)
T cd07833 76 YLVFEYVERTLLELLEASPG---------GLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCD 143 (288)
T ss_pred EEEEecCCCCHHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEe
Confidence 99999998877766654432 2558899999999999999999 89999999999999999999999999
Q ss_pred cccccccCccccccceeeccCCCCcCCCccccCC-CCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh--c
Q 012014 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA--L 378 (473)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~--~ 378 (473)
||++........ .......++..|+|||++.+. .++.++||||||+++|+|++|..||.+....+. +....... .
T Consensus 144 ~g~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~ 221 (288)
T cd07833 144 FGFARALRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQ-LYLIQKCLGPL 221 (288)
T ss_pred eecccccCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCC
Confidence 999987654332 122334578899999999887 789999999999999999999999975432111 11100000 0
Q ss_pred CcchhhhccccchHHHHhhhhhhcccccCCCCc-chhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 379 PQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSS-AHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
+.......... ..+ . ........... .....+...+.++.+|+.+||+.||++|||+++|++
T Consensus 222 ~~~~~~~~~~~--~~~-~----~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 222 PPSHQELFSSN--PRF-A----GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred CHHHhhhcccC--ccc-c----ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000000000 000 0 00000000000 000011124788999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=298.35 Aligned_cols=247 Identities=22% Similarity=0.349 Sum_probs=194.4
Q ss_pred CCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC-CCCchhHHHHHHHHHhcC---CCCceeeeeeeeccccCCcee
Q 012014 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIK---HRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~~~ 220 (473)
.|+..+.||+|+||.||+|. ..+++.||+|.++... ......+.+|+.+++.++ |||++++++++.. ...
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~-----~~~ 76 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK-----GPR 76 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee-----CCE
Confidence 57788999999999999999 4678999999986432 334467889999999996 9999999998754 346
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.++||||+++++|.+++... .+++..++.++.|++.||.||| +.+|+|+||+|+||+++.++.++|+
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~----------~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~ 143 (277)
T cd06917 77 LWIIMEYAEGGSVRTLMKAG----------PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLC 143 (277)
T ss_pred EEEEEecCCCCcHHHHHHcc----------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEc
Confidence 79999999999999998654 2558889999999999999999 9999999999999999999999999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCccccCC-CCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcC
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP 379 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 379 (473)
|||++....... .......|+..|+|||.+.++ .++.++|+||||+++|+|++|..||.+...... ......
T Consensus 144 dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~-----~~~~~~ 216 (277)
T cd06917 144 DFGVAALLNQNS--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA-----MMLIPK 216 (277)
T ss_pred cCCceeecCCCc--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh-----hhcccc
Confidence 999998765433 222334589999999988654 478999999999999999999999975322110 000000
Q ss_pred cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 380 QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.....+. ....+..+.+++.+||+.||++|||+.|+++
T Consensus 217 ~~~~~~~------------------------------~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 217 SKPPRLE------------------------------DNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCCCCC------------------------------cccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 0000000 0013457889999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=302.38 Aligned_cols=209 Identities=23% Similarity=0.315 Sum_probs=168.3
Q ss_pred ccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCC--CCchhHHHHHHHHHhcCCCCceeeeeeeeccccC---
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQ--- 216 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~--- 216 (473)
..++|++.+.||+|+||.||+|.. .+++.||+|.+..... .....+.+|+.++++++||||+++++++......
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 345799999999999999999984 5689999999864322 2233567899999999999999999988654321
Q ss_pred CceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCcc
Q 012014 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI 296 (473)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~ 296 (473)
.....++||||+. ++|.+++..... .+++.++..++.|++.||.||| +++++|+||||+||+++.++.
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~ 157 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSNKNV--------KFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGI 157 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCc
Confidence 2345699999995 588888865421 3668899999999999999999 899999999999999999999
Q ss_pred EEEeecccccccCccccc--cceeeccCCCCcCCCccccCCC-CCcccchhhHhHHHHHHHhCCCCCCCC
Q 012014 297 GHVGDFGMARFLPAIDKQ--NRFICIKGSTGYIPPEYDLGCE-ASTYGDVYSFGILLLEMFTGIRPSDGI 363 (473)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~P~~~~ 363 (473)
+||+|||++......... .......++..|+|||.+.+.. ++.++||||||+++|+|++|..||.+.
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~ 227 (310)
T cd07865 158 LKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGN 227 (310)
T ss_pred EEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 999999999866432211 1122345788999999876643 788999999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=339.51 Aligned_cols=256 Identities=25% Similarity=0.306 Sum_probs=199.9
Q ss_pred hhcccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC--CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccC
Q 012014 140 LYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQ 216 (473)
Q Consensus 140 ~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 216 (473)
+...+-++.....||.|.||.||.|. ..+|...|+|-++... ....+.+.+|..++..++|||+|++||+-.+.
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR--- 1306 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR--- 1306 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecH---
Confidence 44556778889999999999999999 6679999999887432 34456788999999999999999999996553
Q ss_pred CceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCcc
Q 012014 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI 296 (473)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~ 296 (473)
...+|.||||.+|+|.+.+...+. ..+.....+..|++.|+.||| ++|||||||||+||+++.+|.
T Consensus 1307 --ekv~IFMEyC~~GsLa~ll~~gri---------~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~ 1372 (1509)
T KOG4645|consen 1307 --EKVYIFMEYCEGGSLASLLEHGRI---------EDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGL 1372 (1509)
T ss_pred --HHHHHHHHHhccCcHHHHHHhcch---------hhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCc
Confidence 367899999999999999987642 224445567889999999999 999999999999999999999
Q ss_pred EEEeecccccccCccc--cccceeeccCCCCcCCCccccCCC---CCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHH
Q 012014 297 GHVGDFGMARFLPAID--KQNRFICIKGSTGYIPPEYDLGCE---ASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLR 371 (473)
Q Consensus 297 ~kl~Dfg~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~ 371 (473)
+|++|||.|..+.... .........||+.|||||++.+.. ...+.||||+|||+.||+||+.||......-..+-
T Consensus 1373 iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy 1452 (1509)
T KOG4645|consen 1373 IKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMY 1452 (1509)
T ss_pred EEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHh
Confidence 9999999998775432 112233456999999999987643 56789999999999999999999987543321111
Q ss_pred HHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 372 NFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.......| +.+.....+-.+++.+||..||+.|.++.||++
T Consensus 1453 ~V~~gh~P-----------------------------------q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1453 HVAAGHKP-----------------------------------QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred HHhccCCC-----------------------------------CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 11111111 122234455668999999999999998887754
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=295.62 Aligned_cols=247 Identities=19% Similarity=0.279 Sum_probs=195.5
Q ss_pred CCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccC-CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEE
Q 012014 146 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (473)
-|+..+.||+|+||.||+|.. .+++.+|+|.+.... ......+.+|+.++.+++||||+++++++... ...++
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~l 79 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-----TKLWI 79 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC-----CeEEE
Confidence 367788999999999999984 568899999876432 22335688999999999999999999998543 46799
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecc
Q 012014 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (473)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg 303 (473)
||||+++++|.+++... .+++..+..++.|++.|+.||| +++++|+||+|+||+++.++.++|+|||
T Consensus 80 v~e~~~~~~l~~~i~~~----------~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg 146 (277)
T cd06641 80 IMEYLGGGSALDLLEPG----------PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFG 146 (277)
T ss_pred EEEeCCCCcHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecc
Confidence 99999999999998643 2558889999999999999999 9999999999999999999999999999
Q ss_pred cccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchh
Q 012014 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAE 383 (473)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 383 (473)
++..+.... .......|+..|+|||.+.+..++.++|+|||||++|+|++|..||....... ...........
T Consensus 147 ~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~ 219 (277)
T cd06641 147 VAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK-----VLFLIPKNNPP 219 (277)
T ss_pred cceecccch--hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH-----HHHHHhcCCCC
Confidence 987654322 11223457889999999988888999999999999999999999996532111 00000000000
Q ss_pred hhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 384 EVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
......+..+.+++.+||+.+|.+||++.++++.
T Consensus 220 -------------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 220 -------------------------------TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred -------------------------------CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0011245678899999999999999999999884
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=295.92 Aligned_cols=247 Identities=22% Similarity=0.271 Sum_probs=197.0
Q ss_pred CCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCC---CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 146 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP---GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
+|++.+.||.|+||.||+|.. .+++.||+|.+..... ...+.+.+|++++++++||||+++++++.+ ....
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD-----EENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC-----CCeE
Confidence 588899999999999999994 4689999999974332 335678899999999999999999988743 3478
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEee
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~D 301 (473)
++|+||+.+++|.+++.... .+++.++..++.|++.||.||| +++++|+||+|+||++++++.++|+|
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d 143 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQKV---------KFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITD 143 (258)
T ss_pred EEEEeCCCCCCHHHHHHhcC---------CcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEee
Confidence 99999999999999997652 3558889999999999999999 99999999999999999999999999
Q ss_pred cccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcc
Q 012014 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQR 381 (473)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 381 (473)
||++....... ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||....... ...+..... ..
T Consensus 144 ~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~-~~ 217 (258)
T cd05578 144 FNIATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI--RDQIRAKQE-TA 217 (258)
T ss_pred cccccccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH--HHHHHHHhc-cc
Confidence 99988654322 2233458889999999988889999999999999999999999997643221 111111000 00
Q ss_pred hhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCCh--HHHH
Q 012014 382 AEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKI--NDVE 446 (473)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~--~ev~ 446 (473)
....+...+..+.+++.+||+.||.+||++ +|++
T Consensus 218 -------------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 218 -------------------------------DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -------------------------------cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 001112345788899999999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=293.78 Aligned_cols=249 Identities=22% Similarity=0.317 Sum_probs=195.9
Q ss_pred CCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccC--CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 146 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
+|.+.+.||+|+||.||+|.. .+|..+|+|.+.... ....+.+.+|+.+++.++|+||+++++.+.. ....+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~-----~~~~~ 75 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE-----NGRLF 75 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc-----CCeEE
Confidence 478889999999999999994 468899999987532 2344578899999999999999999998754 34789
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCc-cEEEee
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM-IGHVGD 301 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~-~~kl~D 301 (473)
+++||+++++|.+++...... .+++..+..++.|++.||.||| +.+++|+||||+||++++++ .+||+|
T Consensus 76 lv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d 145 (257)
T cd08225 76 IVMEYCDGGDLMKRINRQRGV-------LFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGD 145 (257)
T ss_pred EEEecCCCCcHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecc
Confidence 999999999999999764321 3568889999999999999999 89999999999999998875 569999
Q ss_pred cccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcc
Q 012014 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQR 381 (473)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 381 (473)
||.+....... .......|++.|+|||++.+..++.++|+||||+++|+|++|..||..... ...........
T Consensus 146 ~~~~~~~~~~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~ 218 (257)
T cd08225 146 FGIARQLNDSM--ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL-----HQLVLKICQGY 218 (257)
T ss_pred cccchhccCCc--ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHhccc
Confidence 99997664322 112234589999999999888899999999999999999999999865321 11111111110
Q ss_pred hhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 382 AEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.... ....+..+.+++.+||..+|++|||+.||+.
T Consensus 219 ~~~~-------------------------------~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 219 FAPI-------------------------------SPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCCC-------------------------------CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0000 0123457889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=281.97 Aligned_cols=252 Identities=23% Similarity=0.273 Sum_probs=191.8
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeecc-CCCCchhHHHHHHHHHhc-CCCCceeeeeeeeccccCCcee
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI-RPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 220 (473)
.++...+..||.|..|.|++++ ..+|..+|||.+... .....+++...+.++... +.|.||+.+|+|.... .
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~-----d 165 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT-----D 165 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc-----h
Confidence 3455567789999999999999 566899999999743 334456677777776655 4899999999997533 5
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.++.||.| ...++.+++.-.. .+++.-+-++...+++||.||.. .++|||||+||+|||+|+.|++|||
T Consensus 166 V~IcMelM-s~C~ekLlkrik~--------piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlC 234 (391)
T KOG0983|consen 166 VFICMELM-STCAEKLLKRIKG--------PIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLC 234 (391)
T ss_pred HHHHHHHH-HHHHHHHHHHhcC--------CchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEee
Confidence 78899988 3456666654432 35677777889999999999985 6899999999999999999999999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCccccC---CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG---CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
|||++..+.+. ...+...|-+.|||||.+.- ..|+..+||||||++++||.||+.||.+-..+-..+...+...
T Consensus 235 DFGIsGrlvdS---kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~e 311 (391)
T KOG0983|consen 235 DFGISGRLVDS---KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEE 311 (391)
T ss_pred cccccceeecc---cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcC
Confidence 99999776442 22334458999999998764 3589999999999999999999999987433333333332211
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
|.. ++. ...++..+.+++..||.+|+.+||...++++
T Consensus 312 -PP~----L~~----------------------------~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 312 -PPL----LPG----------------------------HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred -CCC----CCc----------------------------ccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 111 110 0125668889999999999999999998875
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=290.85 Aligned_cols=202 Identities=22% Similarity=0.270 Sum_probs=175.8
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCC---CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCce
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP---GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (473)
-++|...++||+|.||.|-+++ ..+++.+|+|++++.-. .....-..|-++|+..+||.+..+-..| +...
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF-----Qt~d 241 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF-----QTQD 241 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh-----ccCc
Confidence 4689999999999999999998 67899999999985332 2233457899999999999999887766 4455
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
.+|+||||..||.|.-+|.... .|++....-+-.+|+.||.||| +++||.||||.+|+|+|.+|++||
T Consensus 242 rlCFVMeyanGGeLf~HLsrer---------~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKi 309 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSRER---------VFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKI 309 (516)
T ss_pred eEEEEEEEccCceEeeehhhhh---------cccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEe
Confidence 8899999999999999988755 4778888889999999999999 999999999999999999999999
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCC
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~ 364 (473)
+|||+++.- ........+++|||.|.|||++....|+.++|+|.+||++|||++|+.||....
T Consensus 310 tDFGLCKE~--I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d 372 (516)
T KOG0690|consen 310 TDFGLCKEE--IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD 372 (516)
T ss_pred eecccchhc--ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc
Confidence 999999853 233455667899999999999999999999999999999999999999998643
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=296.09 Aligned_cols=241 Identities=22% Similarity=0.251 Sum_probs=181.8
Q ss_pred eeecCCCeEEEEEEe-cCCCEEEEEEeeccCCC---CchhHHHHHHHHH---hcCCCCceeeeeeeeccccCCceeeEEE
Q 012014 152 LIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG---GSKSFKSECKAAI---NIKHRNIVRVFTAFSGVDYQGARFKAVV 224 (473)
Q Consensus 152 ~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~---~l~h~niv~~~~~~~~~~~~~~~~~~lv 224 (473)
+||+|+||.||++.. .+++.+|+|.+...... ....+.+|..++. ..+||||+.+++++... ...++|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-----~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP-----DKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC-----CeEEEE
Confidence 489999999999984 56899999998643321 1223444544333 34799999999887542 367999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeeccc
Q 012014 225 YKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM 304 (473)
Q Consensus 225 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~ 304 (473)
|||+++|+|.+++.... .+++..+..++.|++.||.||| +++|+||||||+||+++.++.++|+|||+
T Consensus 76 ~e~~~~~~L~~~i~~~~---------~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~ 143 (279)
T cd05633 76 LDLMNGGDLHYHLSQHG---------VFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGL 143 (279)
T ss_pred EecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCc
Confidence 99999999999987553 3668899999999999999999 99999999999999999999999999999
Q ss_pred ccccCccccccceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchh
Q 012014 305 ARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAE 383 (473)
Q Consensus 305 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 383 (473)
+....... .....||..|+|||.+.+ ..++.++|||||||++|+|++|..||........ ..........
T Consensus 144 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~--- 214 (279)
T cd05633 144 ACDFSKKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTLTV--- 214 (279)
T ss_pred ceeccccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH--HHHHHHhhcC---
Confidence 87553321 123458999999999864 5689999999999999999999999975432211 0000000000
Q ss_pred hhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCC-----ChHHHHH
Q 012014 384 EVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERM-----KINDVES 447 (473)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~ 447 (473)
. ...+...+..+.+++.+||+.||++|| |++|+++
T Consensus 215 ---~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 215 ---N--------------------------VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred ---C--------------------------cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 0 001123456788999999999999999 5888866
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=285.35 Aligned_cols=273 Identities=21% Similarity=0.302 Sum_probs=208.2
Q ss_pred CchhhhhcccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhc-CCCCceeeeeeeec
Q 012014 135 PSFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-KHRNIVRVFTAFSG 212 (473)
Q Consensus 135 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 212 (473)
..|.+.|..| .+.||+|+|+.|-.+. ..+|..+|||++.+.......+..+|++++.+. .|+||++++++|.+
T Consensus 73 g~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd 147 (463)
T KOG0607|consen 73 GKFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFED 147 (463)
T ss_pred chHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence 3588888777 4689999999999998 789999999999887777778899999999998 59999999999865
Q ss_pred cccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEec
Q 012014 213 VDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD 292 (473)
Q Consensus 213 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~ 292 (473)
. ...|||||-|.||+|..+|+.+. .|++.++.++..+|+.||.||| .+||.|||+||+|||..
T Consensus 148 d-----~~FYLVfEKm~GGplLshI~~~~---------~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~ 210 (463)
T KOG0607|consen 148 D-----TRFYLVFEKMRGGPLLSHIQKRK---------HFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCE 210 (463)
T ss_pred c-----ceEEEEEecccCchHHHHHHHhh---------hccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeec
Confidence 3 36799999999999999998775 6889999999999999999999 99999999999999996
Q ss_pred CCc---cEEEeecccccccCcc-----ccccceeeccCCCCcCCCcccc---C--CCCCcccchhhHhHHHHHHHhCCCC
Q 012014 293 DEM---IGHVGDFGMARFLPAI-----DKQNRFICIKGSTGYIPPEYDL---G--CEASTYGDVYSFGILLLEMFTGIRP 359 (473)
Q Consensus 293 ~~~---~~kl~Dfg~~~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~---~--~~~~~~~DiwSlG~il~elltg~~P 359 (473)
+.. -+||+||.+..-.... .......+.+|+..|||||+.. + ..|+.++|.||||||+|-|++|.+|
T Consensus 211 ~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpP 290 (463)
T KOG0607|consen 211 SPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPP 290 (463)
T ss_pred CCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCC
Confidence 544 5799999887543221 1233345678999999999743 2 3589999999999999999999999
Q ss_pred CCCCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCC
Q 012014 360 SDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRER 439 (473)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 439 (473)
|.|..+.+-.+. .+.+-..-...+...+++|.-- -+...| ...+.+..+|+...+..||.+|
T Consensus 291 FvG~Cg~dCGWd-------rGe~Cr~CQ~~LFesIQEGkYe--------FPdkdW---ahIS~eakdlisnLlvrda~~r 352 (463)
T KOG0607|consen 291 FVGHCGADCGWD-------RGEVCRVCQNKLFESIQEGKYE--------FPDKDW---AHISSEAKDLISNLLVRDAKQR 352 (463)
T ss_pred ccCccCCcCCcc-------CCCccHHHHHHHHHHHhccCCc--------CChhhh---HHhhHHHHHHHHHHHhccHHhh
Confidence 998765442111 1111111111222222221100 000111 2356677788888889999999
Q ss_pred CChHHHHH
Q 012014 440 MKINDVES 447 (473)
Q Consensus 440 Pt~~ev~~ 447 (473)
.++.+++.
T Consensus 353 lsa~~vln 360 (463)
T KOG0607|consen 353 LSAAQVLN 360 (463)
T ss_pred hhhhhccC
Confidence 99988876
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=297.56 Aligned_cols=248 Identities=18% Similarity=0.228 Sum_probs=192.0
Q ss_pred ccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCC---CchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG---GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
....|...+.||+|+||.||+|.. .+++.||+|.+...... ....+.+|+.+++.++||||++++++|.+.
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~----- 87 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE----- 87 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC-----
Confidence 345688999999999999999984 46899999998643322 224678999999999999999999998653
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...++||||+. |+|.+++..... .+++..+..++.|++.||.||| +.+++||||+|+||+++.++.+|
T Consensus 88 ~~~~lv~e~~~-g~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~k 155 (307)
T cd06607 88 HTAWLVMEYCL-GSASDILEVHKK--------PLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVK 155 (307)
T ss_pred CeEEEEHHhhC-CCHHHHHHHccc--------CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEE
Confidence 35799999996 678777754321 2568889999999999999999 89999999999999999999999
Q ss_pred EeecccccccCccccccceeeccCCCCcCCCcccc---CCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 012014 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDL---GCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVK 375 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~ 375 (473)
|+|||++...... ....|++.|+|||++. ...++.++||||||+++|+|++|..||.+...... ..
T Consensus 156 L~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~-----~~ 224 (307)
T cd06607 156 LADFGSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----LY 224 (307)
T ss_pred EeecCcceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH-----HH
Confidence 9999998754322 1235788999999874 35688999999999999999999999865321110 00
Q ss_pred hhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 376 MALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
.......... .....+..+.+++.+||+.||++|||+.+|+..
T Consensus 225 ~~~~~~~~~~------------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 225 HIAQNDSPTL------------------------------SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred HHhcCCCCCC------------------------------CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000000000 011245678999999999999999999999873
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=298.03 Aligned_cols=275 Identities=19% Similarity=0.237 Sum_probs=195.5
Q ss_pred CCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC--CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEE
Q 012014 147 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (473)
Q Consensus 147 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (473)
|++.+.||.|++|.||+|. ..+|+.||+|++.... ......+.+|+.+++.++|||++++++++.+ ....++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~-----~~~~~i 75 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS-----ENKLYL 75 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc-----CCeEEE
Confidence 6678899999999999998 4579999999987433 2233568899999999999999999999754 347899
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecc
Q 012014 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (473)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg 303 (473)
+|||+ +++|.+++...... .+++..+..++.|++.||.||| +++++||||+|+||+++.++.++|+|||
T Consensus 76 v~e~~-~~~l~~~~~~~~~~-------~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~ 144 (283)
T cd07835 76 VFEFL-DLDLKKYMDSSPLT-------GLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFG 144 (283)
T ss_pred EEecc-CcCHHHHHhhCCCC-------CCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecc
Confidence 99999 46999998765421 3568899999999999999999 8999999999999999999999999999
Q ss_pred cccccCccccccceeeccCCCCcCCCccccCC-CCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcch
Q 012014 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRA 382 (473)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 382 (473)
++....... .......++..|+|||++.+. .++.++||||||+++|+|++|..||........ +....+.......
T Consensus 145 ~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~ 221 (283)
T cd07835 145 LARAFGVPV--RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ-LFRIFRTLGTPDE 221 (283)
T ss_pred cccccCCCc--cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCCh
Confidence 997653321 111223468899999987664 578899999999999999999999975432111 1111111100000
Q ss_pred hhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 383 EEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
...........+... . .. .............+..+.+++.+||+.||++|||+.|+++
T Consensus 222 ~~~~~~~~~~~~~~~--~---~~--~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 222 DVWPGVTSLPDYKPT--F---PK--WARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred HHhhhhhhchhhhhh--c---cc--ccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000000000000 0 00 0000011112234567889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=292.53 Aligned_cols=244 Identities=17% Similarity=0.242 Sum_probs=186.7
Q ss_pred ccCCCCcccee--ecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhc-CCCCceeeeeeeeccccCCc
Q 012014 143 ATNGFSSANLI--GAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 143 ~~~~~~~~~~l--g~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 218 (473)
..++|++.+.+ |+|+||.||++. ..++..+|+|.+....... .|+.....+ +||||+++++.|...
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~----- 81 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTL----- 81 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecC-----
Confidence 34566666666 999999999998 4578899999986432211 122222222 799999999998653
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCc-cE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM-IG 297 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~-~~ 297 (473)
...++||||+++++|.+++.... .+++.++..++.|++.||.||| +.+++||||||+||+++.++ .+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~ 149 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKEG---------KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRI 149 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeE
Confidence 36899999999999999997653 3568999999999999999999 99999999999999999988 99
Q ss_pred EEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
+|+|||++...... ....|+..|+|||++.+..++.++||||||+++|+|++|..||............+....
T Consensus 150 ~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 223 (267)
T PHA03390 150 YLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ 223 (267)
T ss_pred EEecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh
Confidence 99999998765322 123589999999999988899999999999999999999999985433322222221111
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCC-hHHHHH
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMK-INDVES 447 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~ev~~ 447 (473)
.... ......+..+.+++.+||+.||.+||+ ++|+++
T Consensus 224 -~~~~--------------------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 224 -QKKL--------------------------------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred -cccC--------------------------------CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0000 001134567889999999999999996 588863
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=299.47 Aligned_cols=281 Identities=21% Similarity=0.228 Sum_probs=197.4
Q ss_pred ccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCC--CchhHHHHHHHHHhcCCCCceeeeeeeeccccCCce
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (473)
..++|++.+.||+|+||.||+|.. .+|+.||+|.++..... ....+.+|+.++.+++|+||+++++++.+.. ..
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~---~~ 81 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH---LD 81 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC---CC
Confidence 356899999999999999999994 56899999998743322 2335678999999999999999999986432 23
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
..++||||+. ++|.+++..... .+++.++..++.|++.||.||| +.+++||||||+||+++.++.+||
T Consensus 82 ~~~lv~e~~~-~~l~~~l~~~~~--------~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL 149 (309)
T cd07845 82 SIFLVMEYCE-QDLASLLDNMPT--------PFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKI 149 (309)
T ss_pred eEEEEEecCC-CCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEE
Confidence 5799999995 589888875421 3668899999999999999999 999999999999999999999999
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMAL 378 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~ 378 (473)
+|||++........ ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||....... .+...... .
T Consensus 150 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~-~~~~~~~~-~ 225 (309)
T cd07845 150 ADFGLARTYGLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE-QLDLIIQL-L 225 (309)
T ss_pred CccceeeecCCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHh-c
Confidence 99999987644321 1122235788999999865 457899999999999999999999997532211 11111111 1
Q ss_pred CcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 379 PQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
............ ........ ....... ..........+..+.+++.+||+.||++|||+.|++.
T Consensus 226 ~~~~~~~~~~~~--~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 226 GTPNESIWPGFS--DLPLVGKF--TLPKQPY-NNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred CCCChhhchhhh--cccccccc--cccCCCC-CchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 100000000000 00000000 0000000 0000011123667789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=295.20 Aligned_cols=274 Identities=20% Similarity=0.247 Sum_probs=198.2
Q ss_pred CCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEE
Q 012014 146 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (473)
+|++.+.||.|++|.||+|+. .+++.||+|.++.... .....+.+|+.++++++||||+++++++.+. ...++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~~l 75 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTE-----NKLML 75 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeC-----CcEEE
Confidence 588899999999999999995 4689999999875432 2345678899999999999999999998653 36799
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecc
Q 012014 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (473)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg 303 (473)
||||++ ++|.+++...... ..+++..+..++.|++.||.||| +++++||||||+||++++++.++|+|||
T Consensus 76 v~e~~~-~~l~~~~~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g 145 (284)
T cd07836 76 VFEYMD-KDLKKYMDTHGVR------GALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFG 145 (284)
T ss_pred EEecCC-ccHHHHHHhcCCC------CCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecc
Confidence 999997 5899988754321 13668999999999999999999 8999999999999999999999999999
Q ss_pred cccccCccccccceeeccCCCCcCCCccccCC-CCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCc--
Q 012014 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQ-- 380 (473)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~-- 380 (473)
++....... .......++..|+|||++.+. .++.++||||||+++|+|++|..||.+....+ .+..........
T Consensus 146 ~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~ 222 (284)
T cd07836 146 LARAFGIPV--NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED-QLLKIFRIMGTPTE 222 (284)
T ss_pred hhhhhcCCc--cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCCh
Confidence 997653321 112233478899999988664 47889999999999999999999997643321 111111111100
Q ss_pred -chhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 381 -RAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 381 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
....+... ..+. ..................+..+.+++.+||+.||.+|||+.||++
T Consensus 223 ~~~~~~~~~---~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 223 STWPGISQL---PEYK-------PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hhHHHHhcC---chhc-------ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000 0000 000000000011122235678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=296.52 Aligned_cols=253 Identities=21% Similarity=0.259 Sum_probs=201.3
Q ss_pred cccCCCCccceeecCCCeEEEEEEec-CCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 142 NATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
..++.|+..+.||+|+||.||+|... ++..+++|++..... ....+.+|++.+..++|+||+++++.+... ..
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~ 89 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVG-----DE 89 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-----CE
Confidence 45677999999999999999999954 689999999975443 456788999999999999999999998653 46
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.++++||+++++|.+++..... .+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.++|+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~--------~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~ 158 (286)
T cd06614 90 LWVVMEYMDGGSLTDIITQNFV--------RMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLA 158 (286)
T ss_pred EEEEEeccCCCcHHHHHHHhcc--------CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEEC
Confidence 8999999999999999987541 3568889999999999999999 8999999999999999999999999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCc
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQ 380 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 380 (473)
|||++........ ......++..|+|||.+.+..++.++||||||+++|+|++|..||....... .... ....
T Consensus 159 d~~~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~----~~~~-~~~~ 231 (286)
T cd06614 159 DFGFAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR----ALFL-ITTK 231 (286)
T ss_pred ccchhhhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH----HHHH-HHhc
Confidence 9999875543221 1223347889999999988889999999999999999999999986432111 0000 0000
Q ss_pred chhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 381 RAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
..... ......+..+.+++.+||+.+|.+|||+.+|++
T Consensus 232 ~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 232 GIPPL-----------------------------KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred CCCCC-----------------------------cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 00000 001124567889999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=297.65 Aligned_cols=277 Identities=20% Similarity=0.231 Sum_probs=196.8
Q ss_pred CCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCC--CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
++|++.+.||+|+||.||+|.. .+++.+|+|.++.... .....+.+|+.++.+++||||+++++++...+ ....
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---~~~~ 81 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN---LDKI 81 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC---CCcE
Confidence 5788999999999999999995 4688999999974332 22335678999999999999999999886532 2578
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEee
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~D 301 (473)
++||||++ ++|.+++..... .+++.++..++.|++.||.||| +++++|+||||+||+++.++.+||+|
T Consensus 82 ~lv~e~~~-~~L~~~~~~~~~--------~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d 149 (293)
T cd07843 82 YMVMEYVE-HDLKSLMETMKQ--------PFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICD 149 (293)
T ss_pred EEEehhcC-cCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEee
Confidence 99999996 599998876432 3668999999999999999999 89999999999999999999999999
Q ss_pred cccccccCccccccceeeccCCCCcCCCccccCCC-CCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCc
Q 012014 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE-ASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQ 380 (473)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 380 (473)
||++....... .......+++.|+|||.+.+.. ++.++||||||+++|+|++|..||....... .+..........
T Consensus 150 ~g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~ 226 (293)
T cd07843 150 FGLAREYGSPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID-QLNKIFKLLGTP 226 (293)
T ss_pred cCceeeccCCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCC
Confidence 99998664432 1122344788999999987644 6899999999999999999999997643221 111111110000
Q ss_pred ---chhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHH-HHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 381 ---RAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILE-CFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 381 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
....... ...... ..... ..........+.. ....+.+++.+||+.||++|||+.|+++
T Consensus 227 ~~~~~~~~~~---~~~~~~--~~~~~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 227 TEKIWPGFSE---LPGAKK--KTFTK---YPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred chHHHHHhhc---cchhcc--ccccc---ccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000000 000000 00000 0000000000001 3567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=292.44 Aligned_cols=252 Identities=19% Similarity=0.267 Sum_probs=194.7
Q ss_pred CCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC-----CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-----PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
.+|.+.+.||+|+||.||+|. ..+++.||+|.+.... ......+.+|+.++++++||||+++++++.+.. .
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~---~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPE---E 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCC---C
Confidence 478999999999999999998 4568999999875321 122346889999999999999999999875422 3
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...++++||+++++|.+++.... .+++.....++.|++.||.||| +++++|+||||+||+++.++.++
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~~---------~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~ 146 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAYG---------ALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVK 146 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEE
Confidence 45789999999999999987543 2457788899999999999999 99999999999999999999999
Q ss_pred EeecccccccCcccc-ccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 299 VGDFGMARFLPAIDK-QNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
|+|||+++....... ........|+..|+|||++.+..++.++|+|||||++|+|++|..||...... .......
T Consensus 147 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~ 222 (264)
T cd06653 147 LGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM----AAIFKIA 222 (264)
T ss_pred ECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH----HHHHHHH
Confidence 999999986533211 11122345889999999998888999999999999999999999999753111 1111100
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
..... ...+......+.+++.+||+ +|..|||+.+++.
T Consensus 223 ~~~~~-------------------------------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 223 TQPTK-------------------------------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred cCCCC-------------------------------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 00000 00112345678899999999 5799999998864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=301.23 Aligned_cols=257 Identities=22% Similarity=0.199 Sum_probs=189.0
Q ss_pred CCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCC-CCchhHHHHHHHHHhcC-CCCceeeeeeeeccccCCceee
Q 012014 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~ 221 (473)
++|.....||+|+||.||++. ..+++.+|+|.+..... .....+.+|+.++.++. ||||+++++++... ...
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~-----~~~ 78 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE-----GDC 78 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC-----CcE
Confidence 356677899999999999998 45689999999874332 23456889999999996 99999999987542 356
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCC-CCeeeccCCCCcEEecCCccEEEe
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQ-PPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
+++|||+. ++|.++........ ...+++..+..++.|++.||+||| + .+++||||||+||+++.++.+||+
T Consensus 79 ~~~~e~~~-~~l~~l~~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~ 150 (288)
T cd06616 79 WICMELMD-ISLDKFYKYVYEVL----KSVIPEEILGKIAVATVKALNYLK---EELKIIHRDVKPSNILLDRNGNIKLC 150 (288)
T ss_pred EEEEeccc-CCHHHHHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHh---hcCCeeccCCCHHHEEEccCCcEEEe
Confidence 89999985 46655432110000 013668889999999999999999 5 599999999999999999999999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCccccCC---CCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC---EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
|||++....... ......|+..|+|||++.+. .++.++||||||+++|+|++|..||..... ........
T Consensus 151 dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~ 223 (288)
T cd06616 151 DFGISGQLVDSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS----VFDQLTQV 223 (288)
T ss_pred ecchhHHhccCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch----HHHHHhhh
Confidence 999997654322 11223578999999998776 689999999999999999999999975321 01111111
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
.......+. .......+..+.+|+.+||+.||++|||+.+|++.
T Consensus 224 ~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 224 VKGDPPILS---------------------------NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred cCCCCCcCC---------------------------CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000 00012356678999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=297.42 Aligned_cols=245 Identities=20% Similarity=0.268 Sum_probs=193.0
Q ss_pred ccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEEEEe
Q 012014 149 SANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKF 227 (473)
Q Consensus 149 ~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 227 (473)
...+||+|+||.||++.. .+++.||+|++..........+.+|+.+++.++|+||+++++.+... ...+++|||
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~lv~e~ 98 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DELWVVMEF 98 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeC-----CEEEEEEec
Confidence 346799999999999984 57899999998654444556788999999999999999999998653 367999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecccccc
Q 012014 228 MPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF 307 (473)
Q Consensus 228 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 307 (473)
+++++|.+++... .+++..+..++.|++.||+||| ++|++|+||+|+||+++.++.++|+|||++..
T Consensus 99 ~~~~~L~~~~~~~----------~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~ 165 (292)
T cd06657 99 LEGGALTDIVTHT----------RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ 165 (292)
T ss_pred CCCCcHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEccccccee
Confidence 9999999987543 2457888999999999999999 89999999999999999999999999999876
Q ss_pred cCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchhhhcc
Q 012014 308 LPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVVD 387 (473)
Q Consensus 308 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (473)
..... .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||.+..... .........+.....
T Consensus 166 ~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~--- 238 (292)
T cd06657 166 VSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--AMKMIRDNLPPKLKN--- 238 (292)
T ss_pred ccccc--ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhhCCcccCC---
Confidence 54322 12233458899999999988889999999999999999999999997532110 011111111111000
Q ss_pred ccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 388 DFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
....+..+.+++.+||+.||.+||++.+|++
T Consensus 239 -----------------------------~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 239 -----------------------------LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred -----------------------------cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 0123456778999999999999999999887
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=290.13 Aligned_cols=272 Identities=21% Similarity=0.306 Sum_probs=208.0
Q ss_pred ccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHh--cCCCCceeeeeeeeccccCCcee
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAIN--IKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
...+..+.+.||+|.||+||+|.| .|+.||||+|.. .+...+.+|.+|.+. |+|+||+.+++.-.... .....
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~-gs~TQ 283 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDN-GSWTQ 283 (513)
T ss_pred hhheeEEEEEecCccccceeeccc-cCCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCC-CceEE
Confidence 445677889999999999999996 689999999974 345667788888765 59999999987743322 34556
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhh-----CCCCCeeeccCCCCcEEecCCc
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHC-----DCQPPIAHCNLKPSNVLLDDEM 295 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~-----~~~~~iiH~Dlkp~Nil~~~~~ 295 (473)
+|||++|.+.|||.|||... .++.+..++++..+|.||+|||. +....|.|||||+.|||+.+++
T Consensus 284 LwLvTdYHe~GSL~DyL~r~----------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~ 353 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNRN----------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 353 (513)
T ss_pred EEEeeecccCCcHHHHHhhc----------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC
Confidence 89999999999999999986 36688999999999999999994 2356799999999999999999
Q ss_pred cEEEeecccccccCccccc--cceeeccCCCCcCCCccccCCCC------CcccchhhHhHHHHHHHhC----------C
Q 012014 296 IGHVGDFGMARFLPAIDKQ--NRFICIKGSTGYIPPEYDLGCEA------STYGDVYSFGILLLEMFTG----------I 357 (473)
Q Consensus 296 ~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~------~~~~DiwSlG~il~elltg----------~ 357 (473)
.+-|+|+|+|......... ......+||-+|||||++..... -..+||||||.|+||++.+ +
T Consensus 354 ~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~ 433 (513)
T KOG2052|consen 354 TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQ 433 (513)
T ss_pred cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhc
Confidence 9999999999766544221 22345679999999999865321 2347999999999999862 4
Q ss_pred CCCCCCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCC
Q 012014 358 RPSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPR 437 (473)
Q Consensus 358 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~ 437 (473)
.||.+....+..+.++.....-.+....++.. | ...+....+.+||+.||..||.
T Consensus 434 ~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnr------------------------W-~s~~~l~~m~klMkeCW~~Np~ 488 (513)
T KOG2052|consen 434 LPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNR------------------------W-KSDPALRVMAKLMKECWYANPA 488 (513)
T ss_pred CCcccCCCCCCCHHHHhcceeecccCCCCCcc------------------------c-ccCHHHHHHHHHHHHhhcCCch
Confidence 78887766665555544332222222111110 0 1134677889999999999999
Q ss_pred CCCChHHHHHHHHHHHH
Q 012014 438 ERMKINDVESRLRLIRR 454 (473)
Q Consensus 438 ~RPt~~ev~~~L~~l~~ 454 (473)
-|.|+--|-+.|.++.+
T Consensus 489 aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 489 ARLTALRIKKTLAKLSN 505 (513)
T ss_pred hhhHHHHHHHHHHHHhc
Confidence 99999999999988864
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=289.00 Aligned_cols=253 Identities=23% Similarity=0.338 Sum_probs=201.3
Q ss_pred CCCccceeecCCCeEEEEEEec-CCCEEEEEEeeccCC--CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 146 GFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
+|...+.||+|++|.||+|... +++.|++|++..... ...+.+.+|+.++++++||||+++++.+.... ....+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~ 77 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN 77 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence 4778899999999999999954 689999999875432 34567899999999999999999999986531 24679
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
+++||+++++|.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+||
T Consensus 78 lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~ 145 (260)
T cd06606 78 IFLEYVSGGSLSSLLKKFG---------KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADF 145 (260)
T ss_pred EEEEecCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccc
Confidence 9999999999999997654 3568899999999999999999 899999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcch
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRA 382 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 382 (473)
|.+................++..|+|||.+.+...+.++||||||+++|+|++|..||....... ............
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~ 222 (260)
T cd06606 146 GCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM---AALYKIGSSGEP 222 (260)
T ss_pred ccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH---HHHHhccccCCC
Confidence 99987655432111233458899999999988889999999999999999999999997643111 000000000000
Q ss_pred hhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 383 EEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
...+...+..+.+++.+||..||++|||+.|++.
T Consensus 223 -------------------------------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 223 -------------------------------PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred -------------------------------cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 0111233678899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=292.73 Aligned_cols=274 Identities=19% Similarity=0.225 Sum_probs=193.0
Q ss_pred CCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC-CCCchhHHHHHHHHHhcC-CCCceeeeeeeeccccCCceeeEE
Q 012014 147 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQGARFKAV 223 (473)
Q Consensus 147 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l 223 (473)
|++.+.||+|+||.||+|. ..+++.||+|+++... ........+|+.++.++. ||||+++++++.+. .....++
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~l 77 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLAL 77 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEEE
Confidence 5678899999999999998 4578999999987432 222234457888898885 99999999998653 1246799
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecc
Q 012014 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (473)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg 303 (473)
||||++ |+|.+++..... .+++.++..++.|++.||.||| +++++||||||+||+++. +.+||+|||
T Consensus 78 v~e~~~-~~l~~~l~~~~~--------~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg 144 (282)
T cd07831 78 VFELMD-MNLYELIKGRKR--------PLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFG 144 (282)
T ss_pred EEecCC-ccHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecc
Confidence 999996 588888865431 3568999999999999999999 899999999999999999 999999999
Q ss_pred cccccCccccccceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcch
Q 012014 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRA 382 (473)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 382 (473)
+++....... .....++..|+|||.+.. ..++.++|||||||++|||++|..||.+....+ .+... ........
T Consensus 145 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~-~~~~~-~~~~~~~~ 219 (282)
T cd07831 145 SCRGIYSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD-QIAKI-HDVLGTPD 219 (282)
T ss_pred cccccccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH-HHHHH-HHHcCCCC
Confidence 9986643221 122347889999997644 457889999999999999999999997643211 11111 11111111
Q ss_pred hhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 383 EEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
..+.. ........ ........+..........+..+.+|+.+||+.||++|||+.++++
T Consensus 220 ~~~~~-----~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 220 AEVLK-----KFRKSRHM-NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred HHHHH-----hhcccccc-cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 11100 00000000 0000000011111222345789999999999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=292.35 Aligned_cols=275 Identities=20% Similarity=0.257 Sum_probs=199.0
Q ss_pred CCccceeecCCCeEEEEEEec-CCCEEEEEEeeccCC--CCchhHHHHHHHHHhc---CCCCceeeeeeeeccccCCcee
Q 012014 147 FSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRP--GGSKSFKSECKAAINI---KHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 147 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~~~~ 220 (473)
|++.+.||+|+||.||+|+.. +++.||+|.++.... .....+.+|+.++.++ +||||+++++++...+......
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567889999999999999954 589999999974322 2234566788777666 6999999999997765444445
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.+++|||+. ++|.+++...... .+++..+..++.|++.||.||| +++++|+||+|+||+++.++.+||+
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~-------~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~ 149 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKP-------GLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIA 149 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCC-------CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEe
Confidence 899999996 5899988764321 3668899999999999999999 8999999999999999999999999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCc
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQ 380 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 380 (473)
|||++........ .....++..|+|||++.+..++.++||||||+++|+|++|.+||.+....+ .+..+.......
T Consensus 150 dfg~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~ 225 (287)
T cd07838 150 DFGLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD-QLDKIFDVIGLP 225 (287)
T ss_pred ccCcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH-HHHHHHHHcCCC
Confidence 9999977643221 122347889999999998889999999999999999999999987643221 122222111110
Q ss_pred chhhhccccc--hHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 381 RAEEVVDDFN--LQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 381 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.......... ...+ ...............+..+.+++.+||+.||.+||++.|++.
T Consensus 226 ~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 226 SEEEWPRNVSLPRSSF-----------PSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred ChHhcCCCcccchhhc-----------ccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000000000 0000 000000111222345678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=304.95 Aligned_cols=283 Identities=20% Similarity=0.269 Sum_probs=199.0
Q ss_pred ccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeecc--CCCCchhHHHHHHHHHhc-CCCCceeeeeeeeccccCCc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI--RPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 218 (473)
..++|.+.+.||+|+||.||+|.. .+++.+|+|++... .......+.+|+.++.++ +||||++++++|... ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~---~~ 81 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE---ND 81 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccC---CC
Confidence 356799999999999999999984 46889999988532 222345577899999999 999999999987542 23
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...++||||++ ++|.+++... .+.+..+..++.|++.||.||| ++||+||||||+||+++.++.+|
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~----------~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~k 147 (337)
T cd07852 82 KDIYLVFEYME-TDLHAVIRAN----------ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVK 147 (337)
T ss_pred ceEEEEecccc-cCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEE
Confidence 46799999996 5999998754 2447788889999999999999 99999999999999999999999
Q ss_pred EeecccccccCccccc---cceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 012014 299 VGDFGMARFLPAIDKQ---NRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFV 374 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~ 374 (473)
|+|||++......... .......||..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+...... .....
T Consensus 148 l~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~~ 226 (337)
T cd07852 148 LADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKII 226 (337)
T ss_pred EeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHH
Confidence 9999999866443221 12233458999999998765 4578899999999999999999999976432211 11111
Q ss_pred HhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 375 KMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
... .....+..... ..... ....... ...............+..+.+++.+||+.||++|||+.++++.
T Consensus 227 ~~~-~~~~~~~~~~~-~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 227 EVI-GPPSAEDIESI-KSPFA--ATMLDSL-PSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHh-CCCCHHHHHHH-HhhhH--HHhhhhc-ccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 111 00000000000 00000 0000000 0000000111112256788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=304.65 Aligned_cols=283 Identities=19% Similarity=0.248 Sum_probs=197.7
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccC------
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQ------ 216 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~------ 216 (473)
.++|.+.+.||.|+||.||+|. ..+++.||+|.+........+.+.+|+.+++.++||||+++++++......
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 4789999999999999999998 456899999999766655667789999999999999999999887543211
Q ss_pred ---CceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEec-
Q 012014 217 ---GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD- 292 (473)
Q Consensus 217 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~- 292 (473)
.....++||||++ ++|.+++... .+++..+..++.||+.||.||| +.||+||||||+||+++
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~----------~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~ 149 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG----------PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINT 149 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcC
Confidence 1135789999996 6999888643 2558889999999999999999 99999999999999997
Q ss_pred CCccEEEeecccccccCcccccc-ceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccH
Q 012014 293 DEMIGHVGDFGMARFLPAIDKQN-RFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNL 370 (473)
Q Consensus 293 ~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~ 370 (473)
.++.+||+|||+++......... ......|+..|+|||.+.+ ..++.++|||||||++|+|++|..||.+...... .
T Consensus 150 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-~ 228 (342)
T cd07854 150 EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ-M 228 (342)
T ss_pred CCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-H
Confidence 45678999999997653321111 1122347889999998654 4588899999999999999999999975432111 1
Q ss_pred HHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 371 RNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
...... .+.......... .......... .......+ ..........++.+|+.+||+.||.+|||+.|++.
T Consensus 229 ~~~~~~-~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 229 QLILES-VPVVREEDRNEL-LNVIPSFVRN--DGGEPRRP--LRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HHHHHh-cCCCChHHhhhh-hhhhhhhhhh--cccccCCC--HHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 111111 110000000000 0000000000 00000000 00111234567889999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=313.42 Aligned_cols=256 Identities=24% Similarity=0.397 Sum_probs=210.8
Q ss_pred CCccceeecCCCeEEEEEEe-cCC----CEEEEEEeecc-CCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 147 FSSANLIGAGNFGSVYNGTL-FDG----TTIAVKVFNLI-RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 147 ~~~~~~lg~G~~g~V~~~~~-~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
.+..++||+|+||+||+|.| ..| -+||+|++... ......++..|+-+|.+++|||+++++++|... .
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s------~ 771 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS------T 771 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc------h
Confidence 45678999999999999984 333 47899998643 344567899999999999999999999998653 3
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
+.||++|++.|+|.+|++.++. .+-.+..+.|+.||++||.||| .++++||||-..|||+..-..+||.
T Consensus 772 ~qlvtq~mP~G~LlDyvr~hr~--------~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkit 840 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREHRD--------NIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKIT 840 (1177)
T ss_pred HHHHHHhcccchHHHHHHHhhc--------cccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEE
Confidence 6899999999999999988764 2447888999999999999999 9999999999999999999999999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcC
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMALP 379 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 379 (473)
|||+++.+.............-.+.|||-|.+....|+.++|||||||++||++| |..|++++...+.
T Consensus 841 dfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI----------- 909 (1177)
T KOG1025|consen 841 DFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI----------- 909 (1177)
T ss_pred ecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh-----------
Confidence 9999999877665544444444678999999999999999999999999999999 9999988643321
Q ss_pred cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHHh
Q 012014 380 QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRK 455 (473)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~ 455 (473)
.+++. .+.+ -+.++.|+.+++-++.+||..|+..||+++++.+.+..+-+.
T Consensus 910 ---~dlle--------~geR--------------LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 910 ---PDLLE--------KGER--------------LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred ---hHHHh--------cccc--------------CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 11111 1111 122345888999999999999999999999999999888543
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=293.79 Aligned_cols=276 Identities=20% Similarity=0.239 Sum_probs=193.7
Q ss_pred CCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCC--CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
++|++.+.||+|++|.||+|.. .+++.||+|.+..... ...+.+.+|++++++++||||+++++++.. ....
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~ 76 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS-----EKRL 76 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec-----CCeE
Confidence 5788999999999999999984 4789999999864322 233568899999999999999999999854 3478
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecC-CccEEEe
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD-EMIGHVG 300 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~-~~~~kl~ 300 (473)
++||||++ ++|.+++...... .+++..+..++.||+.||.||| +++++||||+|+||+++. ++.+||+
T Consensus 77 ~lv~e~~~-~~l~~~~~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~ 145 (294)
T PLN00009 77 YLVFEYLD-LDLKKHMDSSPDF-------AKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLA 145 (294)
T ss_pred EEEEeccc-ccHHHHHHhCCCC-------CcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEc
Confidence 99999995 5888887654322 2457788899999999999999 899999999999999985 5679999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCccccCC-CCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcC
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP 379 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 379 (473)
|||++....... .......|++.|+|||++.+. .++.++||||||+++|+|++|..||......+ .+........
T Consensus 146 dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~-~~~~~~~~~~- 221 (294)
T PLN00009 146 DFGLARAFGIPV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID-ELFKIFRILG- 221 (294)
T ss_pred ccccccccCCCc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhC-
Confidence 999997653321 112233468899999988664 57899999999999999999999997632211 1111111100
Q ss_pred cchhhhcccc-chHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 380 QRAEEVVDDF-NLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 380 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.......+.. ....+.... .. .............+..+.+++.+||+.||++||++.++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~------~~-~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 222 TPNEETWPGVTSLPDYKSAF------PK-WPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred CCChhhccccccchhhhhhc------cc-CCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000000000 000000000 00 0000000111234567889999999999999999999986
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=302.27 Aligned_cols=287 Identities=17% Similarity=0.215 Sum_probs=208.0
Q ss_pred CCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccC--CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 146 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
+|.+.+.||.|+||.||+|.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++...........+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 588899999999999999995 458999999987533 33456789999999999999999999998665433345679
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
++|||++ ++|.+++.... .+++..+..++.|++.||.||| ++||+||||||+||+++.++.++|+||
T Consensus 81 lv~e~~~-~~l~~~l~~~~---------~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~df 147 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ---------PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDF 147 (330)
T ss_pred EEecchh-hhHHHHHhCCC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEccc
Confidence 9999996 58999987653 3668899999999999999999 999999999999999999999999999
Q ss_pred ccccccCccccc-cceeeccCCCCcCCCccccCC-CCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCc
Q 012014 303 GMARFLPAIDKQ-NRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQ 380 (473)
Q Consensus 303 g~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 380 (473)
|++......... .......++..|+|||.+.+. .++.++||||||+++|+|++|..||.+....+. +..........
T Consensus 148 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~-~~~i~~~~~~~ 226 (330)
T cd07834 148 GLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ-LNLIVEVLGTP 226 (330)
T ss_pred CceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH-HHHHHHhcCCC
Confidence 999876543210 112334578899999999887 789999999999999999999999976542211 11111111000
Q ss_pred chhh---hccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH--HHHHHH
Q 012014 381 RAEE---VVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR--LRLIRR 454 (473)
Q Consensus 381 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~--L~~l~~ 454 (473)
.... ............ ................+..+.+++.+||+.||.+|||+.+++.. ++.++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 227 SEEDLKFITSEKARNYLKS--------LPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred ChhHhhhccccchhhHHhh--------cccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 0000 000000000000 00000001111122356788999999999999999999999874 666543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=292.28 Aligned_cols=241 Identities=25% Similarity=0.297 Sum_probs=186.0
Q ss_pred eecCCCeEEEEEE-ecCCCEEEEEEeeccC---CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEEEEec
Q 012014 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFM 228 (473)
Q Consensus 153 lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 228 (473)
||+|+||+||+|. ..+|+.||+|.+.... ......+.+|+.+++.++||||+++++.+.. ....++||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET-----KDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec-----CCeEEEEEecC
Confidence 6899999999998 4578999999986432 1223456789999999999999999998754 33679999999
Q ss_pred CCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeeccccccc
Q 012014 229 PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL 308 (473)
Q Consensus 229 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 308 (473)
++++|.+++...... .+++.++..++.|++.||.||| +++++||||+|+||++++++.+||+|||.+...
T Consensus 76 ~~~~L~~~l~~~~~~-------~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~ 145 (277)
T cd05577 76 NGGDLKYHIYNVGEP-------GFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVEL 145 (277)
T ss_pred CCCcHHHHHHHcCcC-------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhh
Confidence 999999999765421 3668899999999999999999 999999999999999999999999999998765
Q ss_pred CccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchhhhccc
Q 012014 309 PAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDD 388 (473)
Q Consensus 309 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (473)
.. ........|+..|+|||++.+..++.++||||||+++|+|++|..||........ ......... ...
T Consensus 146 ~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~-~~~------ 214 (277)
T cd05577 146 KG---GKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-KEELKRRTL-EMA------ 214 (277)
T ss_pred cc---CCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-HHHHHhccc-ccc------
Confidence 43 1122234578899999999888899999999999999999999999975432110 000000000 000
Q ss_pred cchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHH
Q 012014 389 FNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKIND 444 (473)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 444 (473)
...+...+..+.+++.+||+.||.+||++.+
T Consensus 215 -------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 215 -------------------------VEYPDKFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred -------------------------ccCCccCCHHHHHHHHHHccCChhHccCCCc
Confidence 0001123567889999999999999994444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=293.26 Aligned_cols=278 Identities=21% Similarity=0.261 Sum_probs=197.3
Q ss_pred CCccceeecCCCeEEEEEEec-CCCEEEEEEeeccC--CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEE
Q 012014 147 FSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (473)
Q Consensus 147 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (473)
|.+.+.||+|+||.||+|... +++.+|+|++.... ......+.+|+.+++.++|||++++++++.... ....++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~l 77 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKG---KGSIYM 77 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCC---CCcEEE
Confidence 567889999999999999854 58899999998653 333456889999999999999999999986531 347899
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecc
Q 012014 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (473)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg 303 (473)
||||++ ++|.+++..... .+++.+++.++.||+.||+||| +++++|+||+|+||++++++.+||+|||
T Consensus 78 v~e~~~-~~l~~~~~~~~~--------~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g 145 (287)
T cd07840 78 VFEYMD-HDLTGLLDSPEV--------KFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFG 145 (287)
T ss_pred Eecccc-ccHHHHHhccCC--------CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEcccc
Confidence 999996 589998865521 3668899999999999999999 8999999999999999999999999999
Q ss_pred cccccCccccccceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcch
Q 012014 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRA 382 (473)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 382 (473)
++........ .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||...... ..+............
T Consensus 146 ~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~-~~~~~~~~~~~~~~~ 223 (287)
T cd07840 146 LARPYTKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL-EQLEKIFELCGSPTD 223 (287)
T ss_pred ceeeccCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCch
Confidence 9987644321 11223346888999998765 45789999999999999999999999764321 111111111110000
Q ss_pred hhhccccchHHHHhhhhhhcccccCCCCcchhhHHHH-HHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 383 EEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILE-CFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.............. ..... ............ ++..+.+++.+||+.||.+|||+.++++
T Consensus 224 ~~~~~~~~~~~~~~-----~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 224 ENWPGVSKLPWFEN-----LKPKK-PYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhccccccchhhhh-----ccccc-cchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000000000000 00000 000000111112 3778999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=298.77 Aligned_cols=281 Identities=19% Similarity=0.237 Sum_probs=199.3
Q ss_pred hhhcccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC--CCCchhHHHHHHHHHhcCCCCceeeeeeeecccc
Q 012014 139 DLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY 215 (473)
Q Consensus 139 ~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 215 (473)
++...+++|++.+.||.|+||.||+|. ..+++.||+|++.... ......+.+|+.++..++||||++++++|...
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-- 81 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP-- 81 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC--
Confidence 455678899999999999999999998 5578999999885322 22346788999999999999999999988532
Q ss_pred CCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCc
Q 012014 216 QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM 295 (473)
Q Consensus 216 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~ 295 (473)
....++++||+ +++|.+++.... ++...+..++.|++.||.||| +++|+||||+|+||+++.++
T Consensus 82 --~~~~~lv~e~~-~~~L~~~~~~~~----------~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~ 145 (328)
T cd07856 82 --LEDIYFVTELL-GTDLHRLLTSRP----------LEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENC 145 (328)
T ss_pred --CCcEEEEeehh-ccCHHHHHhcCC----------CCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCC
Confidence 23578999998 679999886532 446777889999999999999 99999999999999999999
Q ss_pred cEEEeecccccccCccccccceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 012014 296 IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFV 374 (473)
Q Consensus 296 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~ 374 (473)
.+||+|||++...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||....... .... .
T Consensus 146 ~~~l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~-~~~~-~ 218 (328)
T cd07856 146 DLKICDFGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN-QFSI-I 218 (328)
T ss_pred CEEeCccccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHH-H
Confidence 9999999998754321 122347889999998766 568999999999999999999999997543211 1111 1
Q ss_pred HhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 375 KMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
.........++.............. .. ...............+..+.+++.+||+.+|++|||+.+++..
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 219 TDLLGTPPDDVINTICSENTLRFVQ---SL-PKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHhCCCCHHHHHhccchhhHHHHh---hc-cccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1111111111111100000000000 00 0000000011112345788999999999999999999998654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=285.03 Aligned_cols=249 Identities=22% Similarity=0.323 Sum_probs=198.8
Q ss_pred CCCccceeecCCCeEEEEEEec-CCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEE
Q 012014 146 GFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVV 224 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 224 (473)
+|...+.||+|++|.||++... +++.+++|++..........+.+|+..++.++|||++++++++... ...+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~l~ 75 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKK-----DELWIV 75 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeEEEE
Confidence 4778899999999999999954 6899999999765444567899999999999999999999987543 467999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeeccc
Q 012014 225 YKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM 304 (473)
Q Consensus 225 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~ 304 (473)
+||+++++|.+++..... .+++..+..++.|++.||.||| .++++|+||+|+||+++.++.++|+|||.
T Consensus 76 ~e~~~~~~L~~~~~~~~~--------~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~ 144 (253)
T cd05122 76 MEFCSGGSLKDLLKSTNQ--------TLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGL 144 (253)
T ss_pred EecCCCCcHHHHHhhcCC--------CCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeeccc
Confidence 999999999999876531 3568889999999999999999 89999999999999999999999999999
Q ss_pred ccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchhh
Q 012014 305 ARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEE 384 (473)
Q Consensus 305 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 384 (473)
+........ .....|+..|+|||.+.+..++.++||||||+++|+|++|..||........ ... ........
T Consensus 145 ~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~~~-~~~~~~~~ 216 (253)
T cd05122 145 SAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA----LFK-IATNGPPG 216 (253)
T ss_pred ccccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH----HHH-HHhcCCCC
Confidence 987654321 2334588999999999888899999999999999999999999975321110 000 00000000
Q ss_pred hccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 385 VVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
... ....+..+.+++.+||+.||++|||+.|+++
T Consensus 217 ~~~-----------------------------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 217 LRN-----------------------------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred cCc-----------------------------ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000 0112557889999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=299.49 Aligned_cols=288 Identities=19% Similarity=0.235 Sum_probs=194.6
Q ss_pred ceeecC--CCeEEEEEEe-cCCCEEEEEEeeccCCC--CchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEEE
Q 012014 151 NLIGAG--NFGSVYNGTL-FDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVY 225 (473)
Q Consensus 151 ~~lg~G--~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (473)
..||+| +||+||++.. .+++.||+|++...... ..+.+.+|+.+++.++||||++++++|... ...++||
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-----~~~~~v~ 78 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTG-----SWLWVIS 78 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecC-----CceEEEE
Confidence 356666 9999999984 57999999998743322 235688999999999999999999998653 3679999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecccc
Q 012014 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (473)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~ 305 (473)
||+.+++|.+++...... .+++..+..++.|++.||+||| +++|+||||||+||+++.++.++++||+.+
T Consensus 79 e~~~~~~l~~~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~ 148 (328)
T cd08226 79 PFMAYGSANSLLKTYFPE-------GMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHL 148 (328)
T ss_pred ecccCCCHHHHHHhhccc-------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHH
Confidence 999999999998765422 3568888899999999999999 999999999999999999999999999865
Q ss_pred cccCccccccc-----eeeccCCCCcCCCccccCC--CCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 012014 306 RFLPAIDKQNR-----FICIKGSTGYIPPEYDLGC--EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMAL 378 (473)
Q Consensus 306 ~~~~~~~~~~~-----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~ 378 (473)
........... .....++..|+|||++.+. .++.++|||||||++|+|++|..||..................
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 228 (328)
T cd08226 149 YSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPY 228 (328)
T ss_pred hhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCC
Confidence 43322111110 0112346679999998763 4789999999999999999999999764322111111000000
Q ss_pred --------CcchhhhccccchHHHHhhhhhhc----ccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHH
Q 012014 379 --------PQRAEEVVDDFNLQEIEEGRTMCM----EVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVE 446 (473)
Q Consensus 379 --------~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~ 446 (473)
+.......... .....+..... .................+...+.+|+.+||+.||++|||+.|++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l 306 (328)
T cd08226 229 SPLDITTFPCEESRMKNSQ--SGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLL 306 (328)
T ss_pred CCccccccchhhhhhccch--hhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHh
Confidence 00000000000 00000000000 00000001112223345678899999999999999999999996
Q ss_pred H--HHHHHHHh
Q 012014 447 S--RLRLIRRK 455 (473)
Q Consensus 447 ~--~L~~l~~~ 455 (473)
+ .++.+++.
T Consensus 307 ~~~~~~~~~~~ 317 (328)
T cd08226 307 SHAFFKQVKEQ 317 (328)
T ss_pred hCHHHHHHHHh
Confidence 3 45555543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=297.02 Aligned_cols=250 Identities=20% Similarity=0.253 Sum_probs=192.5
Q ss_pred CCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCC---CchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPG---GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
..|...+.||+|+||.||+|. ..++..+|+|.+...... ....+.+|+++++.++|||++++++++.+. ..
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~ 99 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE-----HT 99 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC-----Ce
Confidence 347788999999999999998 456899999998643222 234688899999999999999999998553 36
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.++||||++ |+|.+++..... .+++.++..++.|++.||.||| +++|+||||+|+||+++.++.+||+
T Consensus 100 ~~lv~e~~~-g~l~~~~~~~~~--------~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~ 167 (317)
T cd06635 100 AWLVMEYCL-GSASDLLEVHKK--------PLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLA 167 (317)
T ss_pred EEEEEeCCC-CCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEe
Confidence 799999996 588887754321 3568899999999999999999 9999999999999999999999999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCcccc---CCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDL---GCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
|||++...... ....|++.|+|||++. ...++.++|||||||++|+|++|..||........ +.......
T Consensus 168 dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~~~~~~~ 240 (317)
T cd06635 168 DFGSASIASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNE 240 (317)
T ss_pred cCCCccccCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-HHHHHhcc
Confidence 99998754321 2235889999999874 45688999999999999999999999865321110 11111000
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHH
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLI 452 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l 452 (473)
.+. ......+..+.+++.+||+.+|.+|||+.+|++.+-.+
T Consensus 241 ~~~----------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 241 SPT----------------------------------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred CCC----------------------------------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 000 00112445788999999999999999999999865443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=288.96 Aligned_cols=242 Identities=24% Similarity=0.289 Sum_probs=189.8
Q ss_pred eecCCCeEEEEEEe-cCCCEEEEEEeeccCC---CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEEEEec
Q 012014 153 IGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP---GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFM 228 (473)
Q Consensus 153 lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 228 (473)
||.|+||.||+|.. .+++.+|+|++..... ...+.+.+|+.+++.++||||+++++.+.+. ...+++|||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDK-----KYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcC-----CccEEEEecC
Confidence 69999999999994 4589999999874332 2345788999999999999999999987543 3679999999
Q ss_pred CCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeeccccccc
Q 012014 229 PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL 308 (473)
Q Consensus 229 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 308 (473)
++++|.+++.... .++...+..++.|++.||.||| +++++|+||+|+||+++.++.++|+|||++...
T Consensus 76 ~~~~L~~~l~~~~---------~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~ 143 (262)
T cd05572 76 LGGELWTILRDRG---------LFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKL 143 (262)
T ss_pred CCCcHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCccccc
Confidence 9999999997654 2557888999999999999999 899999999999999999999999999999876
Q ss_pred CccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchhhhccc
Q 012014 309 PAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDD 388 (473)
Q Consensus 309 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (473)
.... ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||........ ...... .+.
T Consensus 144 ~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~--------~~~ 209 (262)
T cd05572 144 KSGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM---EIYNDI--------LKG 209 (262)
T ss_pred Cccc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH---HHHHHH--------hcc
Confidence 4432 22234588999999999888899999999999999999999999976432111 110000 000
Q ss_pred cchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCC-----hHHHHH
Q 012014 389 FNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMK-----INDVES 447 (473)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~ 447 (473)
. .....+...+..+.+++.+||+.||++||| +.|+++
T Consensus 210 ~----------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 210 N----------------------GKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred C----------------------CCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 0 000011123568899999999999999999 666554
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=298.10 Aligned_cols=279 Identities=19% Similarity=0.144 Sum_probs=190.7
Q ss_pred CccceeecCCCeEEEEEEecCCCEEEEEEeecc--CCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEEE
Q 012014 148 SSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLI--RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVY 225 (473)
Q Consensus 148 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (473)
.+.+.+|.|+++.||++. .+++.||+|+++.. .......+.+|+.+++.++||||+++++++... ...+++|
T Consensus 5 ~i~~~~~~~~~v~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~-----~~~~~~~ 78 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD-----SELYVVS 78 (314)
T ss_pred hhhHhhcCCceEEEEEec-CCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecC-----CeEEEEE
Confidence 344445555565555554 47899999999754 233456789999999999999999999988543 3679999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecccc
Q 012014 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (473)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~ 305 (473)
||+++|+|.+++...... .+++..+..++.|++.||.||| +++|+||||||+||+++.++.+||+|||.+
T Consensus 79 e~~~~~~l~~~l~~~~~~-------~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~ 148 (314)
T cd08216 79 PLMAYGSCEDLLKTHFPE-------GLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYS 148 (314)
T ss_pred eccCCCCHHHHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccc
Confidence 999999999999765322 3557888899999999999999 999999999999999999999999999988
Q ss_pred cccCcccc-----ccceeeccCCCCcCCCccccC--CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 012014 306 RFLPAIDK-----QNRFICIKGSTGYIPPEYDLG--CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMAL 378 (473)
Q Consensus 306 ~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~ 378 (473)
........ ........++..|+|||++.+ ..++.++|||||||++|+|++|..||.........+. ...
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~-~~~--- 224 (314)
T cd08216 149 VSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLE-KVR--- 224 (314)
T ss_pred eeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHh---
Confidence 75532211 111123346788999999876 3588999999999999999999999976432221111 111
Q ss_pred CcchhhhccccchHHHHhhhhh--hcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 379 PQRAEEVVDDFNLQEIEEGRTM--CMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.....+++............. .......................+.+|+.+||+.||++|||++++++
T Consensus 225 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 225 -GTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred -ccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 111111110000000000000 00000000000111122334568899999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=289.21 Aligned_cols=241 Identities=21% Similarity=0.245 Sum_probs=182.1
Q ss_pred eeecCCCeEEEEEE-ecCCCEEEEEEeeccCCC---CchhHHHHHH---HHHhcCCCCceeeeeeeeccccCCceeeEEE
Q 012014 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPG---GSKSFKSECK---AAINIKHRNIVRVFTAFSGVDYQGARFKAVV 224 (473)
Q Consensus 152 ~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~---~~~~~~~E~~---~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 224 (473)
+||+|+||.||+|. ..+++.||+|.+...... ....+..|.. .+....||||+++++++.+. ...++|
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-----~~~~~v 75 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP-----DKLSFI 75 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC-----CEEEEE
Confidence 48999999999998 456899999998643221 1122344443 34445899999999887543 367999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeeccc
Q 012014 225 YKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM 304 (473)
Q Consensus 225 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~ 304 (473)
|||+++|+|.+++.... .+++..+..++.|++.||.||| +++|+||||||+||+++.++.+||+|||+
T Consensus 76 ~e~~~g~~L~~~l~~~~---------~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~ 143 (278)
T cd05606 76 LDLMNGGDLHYHLSQHG---------VFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGL 143 (278)
T ss_pred EecCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcC
Confidence 99999999999986543 3668999999999999999999 89999999999999999999999999999
Q ss_pred ccccCccccccceeeccCCCCcCCCccccCC-CCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchh
Q 012014 305 ARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAE 383 (473)
Q Consensus 305 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 383 (473)
+....... .....|+..|+|||.+.++ .++.++||||+|+++|+|++|..||......... .........
T Consensus 144 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~--~~~~~~~~~--- 214 (278)
T cd05606 144 ACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRMTLTM--- 214 (278)
T ss_pred ccccCccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH--HHHHHhhcc---
Confidence 87553321 1234589999999998754 5899999999999999999999999764221110 000000000
Q ss_pred hhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCC-----ChHHHHH
Q 012014 384 EVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERM-----KINDVES 447 (473)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~ 447 (473)
. ...+...+..+.+++.+||..||.+|| ++.++++
T Consensus 215 ---~--------------------------~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 215 ---A--------------------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred ---C--------------------------CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 0 000112356788999999999999999 8988874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=296.67 Aligned_cols=285 Identities=20% Similarity=0.204 Sum_probs=197.3
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCC--CchhHHHHHHHHHhcCCCCceeeeeeeecccc---CC
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAFSGVDY---QG 217 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~ 217 (473)
.++|.+.++||+|+||.||+|. ..+++.+|+|++...... ....+.+|+++++.++||||+++++++..... ..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 5789999999999999999999 446899999998643322 23467889999999999999999998755331 12
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccE
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~ 297 (473)
....++||||+. ++|...+..... .+++..+..++.|+++||.||| +++|+|+||||+||++++++.+
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~~~--------~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~ 154 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENPSV--------KLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGIL 154 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhcccc--------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCE
Confidence 346799999995 578777765321 3668999999999999999999 9999999999999999999999
Q ss_pred EEeecccccccCccccc---------cceeeccCCCCcCCCccccCC-CCCcccchhhHhHHHHHHHhCCCCCCCCCCCc
Q 012014 298 HVGDFGMARFLPAIDKQ---------NRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGK 367 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~ 367 (473)
||+|||++......... .......|++.|+|||.+.+. .++.++||||||+++|+|++|.+||.+.....
T Consensus 155 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~ 234 (311)
T cd07866 155 KIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID 234 (311)
T ss_pred EECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999765432211 111234568889999987654 58899999999999999999999997643321
Q ss_pred ccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 368 MNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
..................+...... ........................+.+++.+||+.||.+|||+.|++.
T Consensus 235 -~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 235 -QLHLIFKLCGTPTEETWPGWRSLPG------CEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred -HHHHHHHHhCCCChhhchhhhhccc------ccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 1111111100000000000000000 000000000000001111223467889999999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=294.46 Aligned_cols=282 Identities=20% Similarity=0.219 Sum_probs=197.7
Q ss_pred ccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccC--CCCchhHHHHHHHHHhcCCCCceeeeeeeeccc-----
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVD----- 214 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----- 214 (473)
..++|++.+.||+|+||.||+|.. .+++.||+|.++... ......+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 456899999999999999999995 468999999997533 223356778999999999999999999886533
Q ss_pred cCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCC
Q 012014 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE 294 (473)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~ 294 (473)
.......++|+||+++ +|.+++..... .+++..+..++.|++.||.||| +.+|+|+||||+||+++++
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~ 152 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESGLV--------HFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNK 152 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcCCC--------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCC
Confidence 0122368999999975 77777765421 3668999999999999999999 9999999999999999999
Q ss_pred ccEEEeecccccccCccccccceeeccCCCCcCCCccccCC-CCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHH
Q 012014 295 MIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNF 373 (473)
Q Consensus 295 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~ 373 (473)
+.+||+|||++........ .......++..|+|||.+.+. .++.++|||||||++|+|++|++||...... ..+..+
T Consensus 153 ~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~-~~~~~~ 230 (302)
T cd07864 153 GQIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL-AQLELI 230 (302)
T ss_pred CcEEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHH
Confidence 9999999999986644321 111223457889999987653 5788999999999999999999999753211 111111
Q ss_pred HHhh---cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 374 VKMA---LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 374 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.... .+.....+......... . ...... . .........+..+.+++.+||+.||.+|||+.+|++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~---~----~~~~~~-~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 231 SRLCGSPCPAVWPDVIKLPYFNTM---K----PKKQYR-R-RLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHHhCCCChhhccccccccccccc---c----cccccc-c-chhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111 00000000000000000 0 000000 0 000011124678899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=285.75 Aligned_cols=251 Identities=23% Similarity=0.352 Sum_probs=199.7
Q ss_pred CCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCC--CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 146 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
+|.+.+.||.|+||.||++.. .++..+++|++..... .....+.+|+++++.++|||++++++.+... ...+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-----~~~~ 75 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK-----GKLC 75 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC-----CEEE
Confidence 578889999999999999994 4689999999975433 3456788999999999999999999987543 4789
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
+++||+++++|.+++...... ...+++.++..++.+++.||.||| +++++|+||+|+||+++.++.++|+||
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~ 147 (258)
T cd08215 76 IVMEYADGGDLSQKIKKQKKE-----GKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDF 147 (258)
T ss_pred EEEEecCCCcHHHHHHHhhcc-----CCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCc
Confidence 999999999999999765311 114678999999999999999999 899999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcch
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRA 382 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 382 (473)
|++....... .......|++.|+|||...+..++.++|+||+|+++|+|++|..||..... ............
T Consensus 148 ~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~~~~ 220 (258)
T cd08215 148 GISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-----LELALKILKGQY 220 (258)
T ss_pred cceeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-----HHHHHHHhcCCC
Confidence 9998664432 122234588899999999888899999999999999999999999865321 111111111000
Q ss_pred hhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 383 EEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.. .+...+..+.+++.+||+.+|++|||+.|+++
T Consensus 221 ~~-------------------------------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 221 PP-------------------------------IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CC-------------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 01124567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=291.47 Aligned_cols=243 Identities=21% Similarity=0.285 Sum_probs=183.7
Q ss_pred ceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCC---CchhHHHHHHHH-HhcCCCCceeeeeeeeccccCCceeeEEEE
Q 012014 151 NLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG---GSKSFKSECKAA-INIKHRNIVRVFTAFSGVDYQGARFKAVVY 225 (473)
Q Consensus 151 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (473)
+.||+|+||.||+|.. .+++.||+|.+...... ....+..|..++ ...+|||++++++++.. ....+++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS-----KDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc-----CCeEEEEE
Confidence 5689999999999984 56899999998643221 112344454443 44589999999999854 34789999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecccc
Q 012014 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (473)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~ 305 (473)
||+++++|.+++.... .+++..+..++.|++.||.||| +.+++||||+|+||+++.++.+||+|||++
T Consensus 77 e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 144 (260)
T cd05611 77 EYLNGGDCASLIKTLG---------GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLS 144 (260)
T ss_pred eccCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccc
Confidence 9999999999997653 2558888999999999999999 899999999999999999999999999998
Q ss_pred cccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchhhh
Q 012014 306 RFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEV 385 (473)
Q Consensus 306 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (473)
..... .....|+..|+|||.+.+..++.++||||||+++|+|++|..||....... ...........
T Consensus 145 ~~~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~-- 211 (260)
T cd05611 145 RNGLE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-----VFDNILSRRIN-- 211 (260)
T ss_pred eeccc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-----HHHHHHhcccC--
Confidence 75432 123457889999999988888999999999999999999999997532211 11000000000
Q ss_pred ccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHH
Q 012014 386 VDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRL 449 (473)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L 449 (473)
........++..+.+++.+||+.||++|||+.++.+.|
T Consensus 212 --------------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 212 --------------------------WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred --------------------------CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 00001113467889999999999999999887665543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=299.72 Aligned_cols=283 Identities=18% Similarity=0.247 Sum_probs=198.3
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC--CCCchhHHHHHHHHHhcCCCCceeeeeeeecccc-CCce
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY-QGAR 219 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~ 219 (473)
.++|...+.||+|+||.||+|. ..+++.||+|++.... ......+.+|+.++..++||||+++++++..... ....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 4789999999999999999998 4578999999986432 2223467899999999999999999999865432 1223
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
..++|+||+. .+|..++.. .+++..+..++.|++.||.||| +++++||||||+||+++.++.+||
T Consensus 94 ~~~lv~e~~~-~~l~~~~~~-----------~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL 158 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMGH-----------PLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKI 158 (342)
T ss_pred eEEEEecccc-cCHHHHHcC-----------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEE
Confidence 5689999995 478776532 2557889999999999999999 999999999999999999999999
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMAL 378 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~ 378 (473)
+|||+++..... .....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.+..... .+........
T Consensus 159 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~ 232 (342)
T cd07879 159 LDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTG 232 (342)
T ss_pred eeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcC
Confidence 999998754321 122347889999999876 458899999999999999999999997532111 1111111100
Q ss_pred -C-cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH--HHHHHHH
Q 012014 379 -P-QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES--RLRLIRR 454 (473)
Q Consensus 379 -~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~--~L~~l~~ 454 (473)
+ ....+............. . +..............+..+.+|+.+||+.||.+|||+.|++. .++.++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~------~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 233 VPGPEFVQKLEDKAAKSYIKS------L-PKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred CCCHHHHHHhcccchHHHHhh------c-CCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 0 000011110000000000 0 000000000011124567889999999999999999999984 4766653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=285.51 Aligned_cols=247 Identities=23% Similarity=0.350 Sum_probs=197.5
Q ss_pred CCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCC--CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 146 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
+|++.+.||+|++|.||++.. .+++.|++|.+..... .....+.+|++++.+++|||++++++++.+ ....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~ 75 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET-----SDSLY 75 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe-----CCEEE
Confidence 478889999999999999984 4678999999975443 344678999999999999999999998754 34689
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
++|||+++++|.+++.... .+++..+..++.|++.||.||| ++|++||||+|+||+++.++.++|+||
T Consensus 76 ~v~e~~~~~~L~~~~~~~~---------~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~ 143 (254)
T cd06627 76 IILEYAENGSLRQIIKKFG---------PFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADF 143 (254)
T ss_pred EEEecCCCCcHHHHHHhcc---------CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEecc
Confidence 9999999999999987653 3568899999999999999999 999999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcch
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRA 382 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 382 (473)
|++......... .....|+..|+|||...+..++.++||||||+++|+|++|..||...... ....... ....
T Consensus 144 ~~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~----~~~~~~~-~~~~ 216 (254)
T cd06627 144 GVATKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM----AALFRIV-QDDH 216 (254)
T ss_pred ccceecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH----HHHHHHh-ccCC
Confidence 999876543321 22345789999999998888899999999999999999999999753211 1111000 0000
Q ss_pred hhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 383 EEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
...+...+..+.+++.+||+.+|++|||+.+++.
T Consensus 217 -------------------------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 217 -------------------------------PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred -------------------------------CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 0001123567889999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=290.93 Aligned_cols=275 Identities=20% Similarity=0.256 Sum_probs=198.6
Q ss_pred CCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCC--CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEE
Q 012014 147 FSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (473)
Q Consensus 147 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (473)
|++.+.||+|++|.||+|.. .+++.+++|.++.... .....+.+|+.++++++||||+++++++... ...++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~~ 75 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK-----GDLYL 75 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC-----CCEEE
Confidence 56778999999999999984 5789999999874332 2346788999999999999999999997543 46899
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecc
Q 012014 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (473)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg 303 (473)
++||+++ +|.+++..... .+++..+..++.|++.||.||| +++|+|+||||+||+++.++.+||+|||
T Consensus 76 v~e~~~~-~l~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~ 143 (283)
T cd05118 76 VFEFMDT-DLYKLIKDRQR--------GLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFG 143 (283)
T ss_pred EEeccCC-CHHHHHHhhcc--------cCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeee
Confidence 9999964 89888876431 3568899999999999999999 9999999999999999999999999999
Q ss_pred cccccCccccccceeeccCCCCcCCCccccCC-CCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcch
Q 012014 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRA 382 (473)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 382 (473)
.+....... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+ .+......... ..
T Consensus 144 ~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~~~~~~~~-~~ 219 (283)
T cd05118 144 LARSFGSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID-QLFKIFRTLGT-PD 219 (283)
T ss_pred eeEecCCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCC-Cc
Confidence 997765432 112234578899999998776 68999999999999999999999997543211 11111111100 00
Q ss_pred hhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 383 EEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
........ ..... ....................+.++.+++.+||+.||.+||++.+++.
T Consensus 220 ~~~~~~~~-~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 220 PEVWPKFT-SLARN----YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hHhcccch-hhhhh----hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00000000 00000 00000000011112223456789999999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=324.94 Aligned_cols=207 Identities=28% Similarity=0.356 Sum_probs=180.5
Q ss_pred hhhhcccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeec---cCCCCchhHHHHHHHHHhcCCCCceeeeeeeecc
Q 012014 138 KDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNL---IRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGV 213 (473)
Q Consensus 138 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 213 (473)
.++....++|.+.++||+|+||.|..++ ..+++.||+|++++ ........|..|-.+|..-+.+-|++++..|.+
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD- 146 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD- 146 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC-
Confidence 3455567899999999999999999999 56789999999986 334456678999999999999999999988744
Q ss_pred ccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecC
Q 012014 214 DYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD 293 (473)
Q Consensus 214 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~ 293 (473)
..++|+||||++||+|..++.... .+++.-+..++..|+.||.-|| +.|+|||||||+|||+|.
T Consensus 147 ----~~~LYlVMdY~pGGDlltLlSk~~---------~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~ 210 (1317)
T KOG0612|consen 147 ----ERYLYLVMDYMPGGDLLTLLSKFD---------RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDK 210 (1317)
T ss_pred ----ccceEEEEecccCchHHHHHhhcC---------CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecc
Confidence 558999999999999999998775 3668888899999999999999 999999999999999999
Q ss_pred CccEEEeecccccccCccccccceeeccCCCCcCCCcccc----C-CCCCcccchhhHhHHHHHHHhCCCCCCC
Q 012014 294 EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDL----G-CEASTYGDVYSFGILLLEMFTGIRPSDG 362 (473)
Q Consensus 294 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DiwSlG~il~elltg~~P~~~ 362 (473)
.|++||+|||.+-.+...+ .-.....+|||.|.+||++. + +.|+..+|+||+||++|||+.|..||..
T Consensus 211 ~GHikLADFGsClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 211 SGHIKLADFGSCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred cCcEeeccchhHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 9999999999998776543 44556678999999999875 2 5699999999999999999999999974
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=298.58 Aligned_cols=285 Identities=16% Similarity=0.210 Sum_probs=201.3
Q ss_pred hcccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCC--CCchhHHHHHHHHHhcCCCCceeeeeeeecccc-C
Q 012014 141 YNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY-Q 216 (473)
Q Consensus 141 ~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~ 216 (473)
....++|++.+.||+|+||.||+|. ..+++.||+|++..... .....+.+|+.+++.++||||+++++++..... .
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 3356789999999999999999998 55789999999864221 123467899999999999999999998864331 1
Q ss_pred CceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCcc
Q 012014 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI 296 (473)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~ 296 (473)
.....++||||+ +++|.+++... .+++..+..++.|++.||.||| +.+|+||||||+||+++.++.
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~~----------~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~ 156 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKHE----------KLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCE 156 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCC
Confidence 123468999999 78999988643 3568899999999999999999 999999999999999999999
Q ss_pred EEEeecccccccCccccccceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 012014 297 GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVK 375 (473)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~ 375 (473)
+||+|||++...... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+..... .+.....
T Consensus 157 ~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-~~~~~~~ 230 (343)
T cd07880 157 LKILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD-QLMEIMK 230 (343)
T ss_pred EEEeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHH
Confidence 999999999765321 123357889999999876 458899999999999999999999997542211 1111111
Q ss_pred hhcC--cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHH--HHHHH
Q 012014 376 MALP--QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVE--SRLRL 451 (473)
Q Consensus 376 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~--~~L~~ 451 (473)
.... ......+.......+.. ...... ..............+.+++.+|++.||++|||+.+++ ..++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~ 303 (343)
T cd07880 231 VTGTPSKEFVQKLQSEDAKNYVK------KLPRFR-KKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEE 303 (343)
T ss_pred hcCCCCHHHHHhhcchhHHHHHH------hccccC-cchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhh
Confidence 1100 00111111000000000 000000 0000111123456788999999999999999999998 34444
Q ss_pred H
Q 012014 452 I 452 (473)
Q Consensus 452 l 452 (473)
.
T Consensus 304 ~ 304 (343)
T cd07880 304 F 304 (343)
T ss_pred h
Confidence 3
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=296.51 Aligned_cols=282 Identities=18% Similarity=0.194 Sum_probs=193.9
Q ss_pred CCCccceeecCCCeEEEEEEe-cC--CCEEEEEEeeccC--CCCchhHHHHHHHHHhc-CCCCceeeeeeeeccccCCce
Q 012014 146 GFSSANLIGAGNFGSVYNGTL-FD--GTTIAVKVFNLIR--PGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~~-~~--~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 219 (473)
+|.+.+.||+|+||.||++.. .+ +..||+|++.... ......+.+|+.++.++ +||||+++++.+.... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence 477889999999999999994 34 7799999986422 12245678899999999 5999999998754321 2234
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
..+++++|+. ++|.+++.... .+++..+..++.||+.||.||| ++|++||||||+||+++.++.+||
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl 146 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQ---------PLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKI 146 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEe
Confidence 5788999985 79999986543 3568899999999999999999 999999999999999999999999
Q ss_pred eecccccccCccccc--cceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 012014 300 GDFGMARFLPAIDKQ--NRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKM 376 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~ 376 (473)
+|||+++........ .......||..|+|||++.+ ..++.++||||||+++|+|++|..||.+.... ..+......
T Consensus 147 ~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~-~~~~~~~~~ 225 (332)
T cd07857 147 CDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV-DQLNQILQV 225 (332)
T ss_pred CcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH-HHHHHHHHH
Confidence 999999865432211 11223468999999998765 46899999999999999999999999753221 111111111
Q ss_pred hcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 377 ALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.. ....+................ ..... ..............+.+++.+||+.||++|||+.|++.
T Consensus 226 ~~-~~~~~~~~~~~~~~~~~~~~~---~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 226 LG-TPDEETLSRIGSPKAQNYIRS---LPNIP-KKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred hC-CCCHHHHHhhhhhhHHHHHHh---ccccC-CcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 10 000111110000000000000 00000 00000011123567889999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=297.69 Aligned_cols=277 Identities=18% Similarity=0.243 Sum_probs=194.6
Q ss_pred cCCCCc-cceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCC--------------chhHHHHHHHHHhcCCCCceeee
Q 012014 144 TNGFSS-ANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGG--------------SKSFKSECKAAINIKHRNIVRVF 207 (473)
Q Consensus 144 ~~~~~~-~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~~~ 207 (473)
.++|.. .+.||.|+||.||+|. ..+++.||+|.++...... ...+.+|+.++..++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 456654 5779999999999998 4578999999986432221 12477899999999999999999
Q ss_pred eeeeccccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCC
Q 012014 208 TAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPS 287 (473)
Q Consensus 208 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~ 287 (473)
+++... ...+++|||+. |+|.+++.... .+++.....++.|++.||.||| +++++|+||+|+
T Consensus 87 ~~~~~~-----~~~~lv~e~~~-~~l~~~l~~~~---------~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~ 148 (335)
T PTZ00024 87 DVYVEG-----DFINLVMDIMA-SDLKKVVDRKI---------RLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPA 148 (335)
T ss_pred EEEecC-----CcEEEEEeccc-cCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHH
Confidence 998543 46799999996 69999986543 3568889999999999999999 999999999999
Q ss_pred cEEecCCccEEEeecccccccCccc------------cccceeeccCCCCcCCCccccCC-CCCcccchhhHhHHHHHHH
Q 012014 288 NVLLDDEMIGHVGDFGMARFLPAID------------KQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMF 354 (473)
Q Consensus 288 Nil~~~~~~~kl~Dfg~~~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell 354 (473)
||+++.++.+||+|||++....... .........+++.|+|||.+.+. .++.++|||||||++|+|+
T Consensus 149 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~ 228 (335)
T PTZ00024 149 NIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELL 228 (335)
T ss_pred HeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHH
Confidence 9999999999999999997654111 01112223468889999998764 4789999999999999999
Q ss_pred hCCCCCCCCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccC
Q 012014 355 TGIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAE 434 (473)
Q Consensus 355 tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~ 434 (473)
+|..||.+....+. +....................... ... ................+..+.+++.+||+.
T Consensus 229 tg~~p~~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~------~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 299 (335)
T PTZ00024 229 TGKPLFPGENEIDQ-LGRIFELLGTPNEDNWPQAKKLPL------YTE--FTPRKPKDLKTIFPNASDDAIDLLQSLLKL 299 (335)
T ss_pred hCCCCCCCCCHHHH-HHHHHHHhCCCchhhCcchhhccc------ccc--cCcCCcccHHHhCcCCChHHHHHHHHHcCC
Confidence 99999976432211 111111110000000000000000 000 000000011111223467788999999999
Q ss_pred CCCCCCChHHHHH
Q 012014 435 RPRERMKINDVES 447 (473)
Q Consensus 435 dP~~RPt~~ev~~ 447 (473)
||++|||+.|++.
T Consensus 300 ~P~~R~s~~~~l~ 312 (335)
T PTZ00024 300 NPLERISAKEALK 312 (335)
T ss_pred CchhccCHHHHhc
Confidence 9999999999975
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=293.87 Aligned_cols=253 Identities=22% Similarity=0.277 Sum_probs=189.6
Q ss_pred ccCCCCccceeecCCCeEEEEEEec-CCCEEEEEEeeccCC-CCchhHHHHHHHHHhc-CCCCceeeeeeeeccccCCce
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRP-GGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 219 (473)
..++|.+.+.||+|+||.||+|... +++.||||.++.... .....+..|+.++.+. .||||+++++++.+ ..
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~ 87 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT-----DS 87 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec-----CC
Confidence 3467899999999999999999954 489999999875332 2334566777777666 49999999999854 33
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCC-CCeeeccCCCCcEEecCCccEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQ-PPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
..+++|||+ +++|.+++..... .+++..+..++.|++.||.||| + .+|+||||+|+||++++++.+|
T Consensus 88 ~~~~v~e~~-~~~l~~l~~~~~~--------~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~k 155 (296)
T cd06618 88 DVFICMELM-STCLDKLLKRIQG--------PIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVK 155 (296)
T ss_pred eEEEEeecc-CcCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEE
Confidence 689999998 4578777755321 3568888999999999999999 6 5999999999999999999999
Q ss_pred EeecccccccCccccccceeeccCCCCcCCCccccCCC----CCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 012014 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE----ASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFV 374 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~ 374 (473)
|+|||++..+..... .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||.........+....
T Consensus 156 L~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~ 232 (296)
T cd06618 156 LCDFGISGRLVDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKIL 232 (296)
T ss_pred ECccccchhccCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHh
Confidence 999999876543221 12234788999999987553 78899999999999999999999964211111011100
Q ss_pred HhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 375 KMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
. ....... ....++.++.+|+.+||+.||++|||+.++++.
T Consensus 233 ~----~~~~~~~-----------------------------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 233 Q----EEPPSLP-----------------------------PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred c----CCCCCCC-----------------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 0000000 000235578899999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=279.22 Aligned_cols=207 Identities=22% Similarity=0.281 Sum_probs=170.2
Q ss_pred CCCCccceeecCCCeEEEEEEec---C--CCEEEEEEeeccCC--CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCC
Q 012014 145 NGFSSANLIGAGNFGSVYNGTLF---D--GTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~~---~--~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (473)
..|+.+..||+|.||.||+|... + .+.+|+|.++..+. +-.....+|+.+++.++|||++.+..+|...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~---- 99 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH---- 99 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc----
Confidence 46888999999999999999622 2 23789999985432 3345678999999999999999999998653
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCC---
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE--- 294 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~--- 294 (473)
...+++++||.+. +|...|+-+.....+ .++......|+.||+.|+.||| ++-|+||||||.|||+..+
T Consensus 100 d~~v~l~fdYAEh-DL~~II~fHr~~~~~----~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgpe 171 (438)
T KOG0666|consen 100 DKKVWLLFDYAEH-DLWHIIKFHRASKAK----QLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPE 171 (438)
T ss_pred CceEEEEehhhhh-hHHHHHHHhccchhc----cCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCc
Confidence 4578999999965 999999877654332 4557778899999999999999 8999999999999999877
Q ss_pred -ccEEEeecccccccCcccccc-ceeeccCCCCcCCCccccCCC-CCcccchhhHhHHHHHHHhCCCCCCCC
Q 012014 295 -MIGHVGDFGMARFLPAIDKQN-RFICIKGSTGYIPPEYDLGCE-ASTYGDVYSFGILLLEMFTGIRPSDGI 363 (473)
Q Consensus 295 -~~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~P~~~~ 363 (473)
|.+||+|||+++.+...-... .....+-|..|.|||.+.|.. |+.+.||||.|||+.||+|-.+-|.+.
T Consensus 172 rG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 172 RGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred cCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 899999999999876543221 233445699999999998865 899999999999999999999988764
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=291.65 Aligned_cols=246 Identities=23% Similarity=0.330 Sum_probs=190.3
Q ss_pred eecCCCeEEEEEEec-CCCEEEEEEeeccCC---CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEEEEec
Q 012014 153 IGAGNFGSVYNGTLF-DGTTIAVKVFNLIRP---GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFM 228 (473)
Q Consensus 153 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 228 (473)
||.|+||.||++... +++.+++|.+..... .....+.+|++++.+++||||+++++.+.. ....+++|||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG-----KKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec-----CcEEEEEEecC
Confidence 689999999999954 589999999864332 344578899999999999999999988743 34689999999
Q ss_pred CCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeeccccccc
Q 012014 229 PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL 308 (473)
Q Consensus 229 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 308 (473)
++++|.+++.... .+++..+..++.|++.||.||| +++++|+||+|+||+++.++.++|+|||++...
T Consensus 76 ~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~ 143 (265)
T cd05579 76 PGGDLASLLENVG---------SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVG 143 (265)
T ss_pred CCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhc
Confidence 9999999997643 3568899999999999999999 999999999999999999999999999998754
Q ss_pred Ccccc------ccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcch
Q 012014 309 PAIDK------QNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRA 382 (473)
Q Consensus 309 ~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 382 (473)
..... ........++..|+|||...+...+.++||||||+++|+|++|..||...... ...........
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~-----~~~~~~~~~~~ 218 (265)
T cd05579 144 LVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE-----EIFQNILNGKI 218 (265)
T ss_pred ccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHhcCCc
Confidence 33211 11223345788999999998888999999999999999999999999753211 11100000000
Q ss_pred hhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHH
Q 012014 383 EEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLR 450 (473)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 450 (473)
.+......+..+.+++.+||+.+|.+|||+.++.+.|+
T Consensus 219 ------------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 219 ------------------------------EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred ------------------------------CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 00000012567889999999999999999966655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=286.10 Aligned_cols=205 Identities=24% Similarity=0.274 Sum_probs=174.7
Q ss_pred hcccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeecc---CCCCchhHHHHHHHHHhc-CCCCceeeeeeeecccc
Q 012014 141 YNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI---RPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDY 215 (473)
Q Consensus 141 ~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~ 215 (473)
.....+|....+||+|+||.|.+|. ..+.+.+|||++++. ...+.+--..|-++|... +.|.+++++.+|...+
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD- 423 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD- 423 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh-
Confidence 3445689999999999999999998 445788999999742 234445556788887766 5789999999986554
Q ss_pred CCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCc
Q 012014 216 QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM 295 (473)
Q Consensus 216 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~ 295 (473)
.+|+||||+.||+|--+++.-+. |-+..+.-++.+|+-||-+|| ++|||.||||.+||++|.+|
T Consensus 424 ----RLyFVMEyvnGGDLMyhiQQ~Gk---------FKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eG 487 (683)
T KOG0696|consen 424 ----RLYFVMEYVNGGDLMYHIQQVGK---------FKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEG 487 (683)
T ss_pred ----heeeEEEEecCchhhhHHHHhcc---------cCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCC
Confidence 78999999999999999987763 446778889999999999999 99999999999999999999
Q ss_pred cEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCC
Q 012014 296 IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (473)
Q Consensus 296 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~ 364 (473)
++||+|||+++.-- -......+.+|||.|+|||++...+|+.++|+|||||+||||+.|++||++..
T Consensus 488 HiKi~DFGmcKEni--~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeD 554 (683)
T KOG0696|consen 488 HIKIADFGMCKENI--FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 554 (683)
T ss_pred ceEeeecccccccc--cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999998532 23445667889999999999999999999999999999999999999999843
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=284.99 Aligned_cols=249 Identities=22% Similarity=0.276 Sum_probs=197.4
Q ss_pred CCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC--CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
+|++.+.||+|+||.||++. ..+++.+|+|.+.... ......+.+|+.+++.++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~ 75 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG-----NKLC 75 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC-----CEEE
Confidence 57888999999999999998 4578899999987432 22345678899999999999999999987543 4689
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
+||||+++++|.+++...... ...+++..+..++.|++.||.||| +.|++|+||+|+||+++.++.+||+||
T Consensus 76 ~v~e~~~~~~L~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~ 147 (256)
T cd08530 76 IVMEYAPFGDLSKAISKRKKK-----RKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDL 147 (256)
T ss_pred EEehhcCCCCHHHHHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeec
Confidence 999999999999998763211 113568889999999999999999 999999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcch
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRA 382 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 382 (473)
|++...... ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||...... ...........
T Consensus 148 g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-----~~~~~~~~~~~ 218 (256)
T cd08530 148 GISKVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-----DLRYKVQRGKY 218 (256)
T ss_pred cchhhhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHhcCCC
Confidence 999876543 122345788999999999888999999999999999999999999753211 11100000000
Q ss_pred hhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 383 EEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
...+...+..+.+++.+||+.+|++|||+.|+++
T Consensus 219 -------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 219 -------------------------------PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred -------------------------------CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0011234567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=290.43 Aligned_cols=256 Identities=20% Similarity=0.253 Sum_probs=195.2
Q ss_pred CCCccceeecCCCeEEEEEEe----cCCCEEEEEEeeccC----CCCchhHHHHHHHHHhc-CCCCceeeeeeeeccccC
Q 012014 146 GFSSANLIGAGNFGSVYNGTL----FDGTTIAVKVFNLIR----PGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQ 216 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 216 (473)
+|.+.+.||+|+||.||+++. .+++.||+|.++... ....+.+.+|+.++.++ +||||+++++.+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~---- 76 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT---- 76 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec----
Confidence 477889999999999999873 356889999987432 22345678999999999 59999999988743
Q ss_pred CceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCcc
Q 012014 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI 296 (473)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~ 296 (473)
....++||||+++|+|.+++.... .+++..+..++.|++.||.||| +.+++||||||+||+++.++.
T Consensus 77 -~~~~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~ 143 (288)
T cd05583 77 -DTKLHLILDYVNGGELFTHLYQRE---------HFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGH 143 (288)
T ss_pred -CCEEEEEEecCCCCcHHHHHhhcC---------CcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCC
Confidence 346799999999999999987543 3557888999999999999999 899999999999999999999
Q ss_pred EEEeecccccccCccccccceeeccCCCCcCCCccccCCC--CCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 012014 297 GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE--ASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFV 374 (473)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~ 374 (473)
++|+|||+++...... ........|+..|+|||.+.+.. .+.++||||||+++|+|++|..||...... .....+.
T Consensus 144 ~~l~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~~~~ 221 (288)
T cd05583 144 VVLTDFGLSKEFLAEE-EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQSEIS 221 (288)
T ss_pred EEEEECcccccccccc-ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-chHHHHH
Confidence 9999999987654322 11222345899999999987654 788999999999999999999998642111 1111111
Q ss_pred HhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHH
Q 012014 375 KMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLI 452 (473)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l 452 (473)
....... ...+...+..+.+++.+||+.||++|||+.++.+.|+..
T Consensus 222 ~~~~~~~--------------------------------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 222 RRILKSK--------------------------------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred HHHHccC--------------------------------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 1100000 000112345778999999999999999999887776654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=298.31 Aligned_cols=284 Identities=17% Similarity=0.230 Sum_probs=200.6
Q ss_pred hhhhcccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC--CCCchhHHHHHHHHHhcCCCCceeeeeeeeccc
Q 012014 138 KDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVD 214 (473)
Q Consensus 138 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 214 (473)
.++...+++|.+.+.||+|+||.||+|. ..+++.||+|+++... ....+.+.+|+.++.+++||||+++++++....
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 4456677899999999999999999998 4578999999986432 122456788999999999999999999875432
Q ss_pred c-CCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecC
Q 012014 215 Y-QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD 293 (473)
Q Consensus 215 ~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~ 293 (473)
. ......+++++++ +++|.+++... .+++..+..++.|++.||.||| +++|+||||||+||+++.
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~~----------~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~ 155 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKCQ----------KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNE 155 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcC
Confidence 1 1223468888887 88999888653 2558889999999999999999 999999999999999999
Q ss_pred CccEEEeecccccccCccccccceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHH
Q 012014 294 EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRN 372 (473)
Q Consensus 294 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~ 372 (473)
++.+||+|||++..... ......|+..|+|||.+.+ ..++.++|||||||++|+|++|..||...... ..+..
T Consensus 156 ~~~~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~-~~~~~ 229 (345)
T cd07877 156 DCELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKL 229 (345)
T ss_pred CCCEEEecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHH
Confidence 99999999999875432 1223457899999998866 46889999999999999999999999653221 11222
Q ss_pred HHHhhc--CcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 373 FVKMAL--PQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 373 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
...... +......+.......+.. ...... . ..........+..+.+++.+||+.||.+|||+.+++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~---~-~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 230 ILRLVGTPGAELLKKISSESARNYIQ---SLTQMP---K-MNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHHhCCCCHHHHhhcccHhHHHHHH---HhcccC---C-cchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 211111 001100011000000000 000000 0 00000001235578899999999999999999998764
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=287.84 Aligned_cols=251 Identities=20% Similarity=0.269 Sum_probs=190.8
Q ss_pred CCCccceeecCCCeEEEEEEe----cCCCEEEEEEeeccC----CCCchhHHHHHHHHHhc-CCCCceeeeeeeeccccC
Q 012014 146 GFSSANLIGAGNFGSVYNGTL----FDGTTIAVKVFNLIR----PGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQ 216 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 216 (473)
+|++.+.||+|+||.||+|.. .+|+.||+|+++... ....+.+.+|+.++.++ +|+||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~---- 76 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT---- 76 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec----
Confidence 478889999999999999984 368999999987432 22345678899999999 59999999988754
Q ss_pred CceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCcc
Q 012014 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI 296 (473)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~ 296 (473)
....++||||+++++|.+++.... .+++..+..++.|++.||.||| +.+++||||+|+||+++.++.
T Consensus 77 -~~~~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~ 143 (290)
T cd05613 77 -DTKLHLILDYINGGELFTHLSQRE---------RFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGH 143 (290)
T ss_pred -CCeEEEEEecCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCC
Confidence 346789999999999999997653 2557888889999999999999 999999999999999999999
Q ss_pred EEEeecccccccCccccccceeeccCCCCcCCCccccCC--CCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 012014 297 GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC--EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFV 374 (473)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~ 374 (473)
+||+|||++....... ........|+..|+|||.+.+. .++.++||||||+++|+|++|..||...... .....+.
T Consensus 144 ~kl~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~~~~~~ 221 (290)
T cd05613 144 VVLTDFGLSKEFHEDE-VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-NSQAEIS 221 (290)
T ss_pred EEEeeCccceeccccc-ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-ccHHHHH
Confidence 9999999997654322 1122234589999999998753 4678999999999999999999998642111 1111111
Q ss_pred HhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCC-----ChHHHHH
Q 012014 375 KMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERM-----KINDVES 447 (473)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~ 447 (473)
........ ..+...+..+.+++.+||+.||++|| ++.++++
T Consensus 222 ~~~~~~~~--------------------------------~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 222 RRILKSEP--------------------------------PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred HHhhccCC--------------------------------CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 11000000 00112345778999999999999997 5666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=316.18 Aligned_cols=271 Identities=27% Similarity=0.371 Sum_probs=209.9
Q ss_pred hhhcccCCCCccceeecCCCeEEEEEEec----C----CCEEEEEEeeccCC-CCchhHHHHHHHHHhc-CCCCceeeee
Q 012014 139 DLYNATNGFSSANLIGAGNFGSVYNGTLF----D----GTTIAVKVFNLIRP-GGSKSFKSECKAAINI-KHRNIVRVFT 208 (473)
Q Consensus 139 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~ 208 (473)
.++...++..+.+.||+|.||.|++|... . ...||||.++.... ...+.+..|+++|..+ .||||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 45555666677789999999999999732 1 45799999874332 3456799999999999 5999999999
Q ss_pred eeeccccCCceeeEEEEEecCCCCHHHHhcCCC-CCCCCCc----c--hhhcHHHHHHHHHHHHHHHHHHhhCCCCCeee
Q 012014 209 AFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKD-DTNWRPL----N--FNFLIKKKLDIAIDVACALRYLHCDCQPPIAH 281 (473)
Q Consensus 209 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~----~--~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH 281 (473)
+|.. ....++|+||+..|+|.++++..+ ....... . ..++..+.+.++.|||.|++||+ +.++||
T Consensus 370 ~~t~-----~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vH 441 (609)
T KOG0200|consen 370 ACTQ-----DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVH 441 (609)
T ss_pred eecc-----CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccc
Confidence 9865 346799999999999999998877 1110000 0 13778999999999999999999 999999
Q ss_pred ccCCCCcEEecCCccEEEeecccccccCccccccceeeccC--CCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCC
Q 012014 282 CNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKG--STGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIR 358 (473)
Q Consensus 282 ~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~ 358 (473)
|||-..|||+..+..+||+|||+|+......... .....| ...|||||.+....|+.+||||||||+|||++| |..
T Consensus 442 RDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~-~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~ 520 (609)
T KOG0200|consen 442 RDLAARNVLITKNKVIKIADFGLARDHYNKDYYR-TKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGT 520 (609)
T ss_pred hhhhhhhEEecCCCEEEEccccceeccCCCCceE-ecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCC
Confidence 9999999999999999999999998654433221 111122 334999999999999999999999999999999 999
Q ss_pred CCCCCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCC
Q 012014 359 PSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRE 438 (473)
Q Consensus 359 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~ 438 (473)
||.+...... +.+ .+..|.++ +.+..|..+++++|..||+.+|++
T Consensus 521 PYp~~~~~~~-l~~--------------------~l~~G~r~--------------~~P~~c~~eiY~iM~~CW~~~p~~ 565 (609)
T KOG0200|consen 521 PYPGIPPTEE-LLE--------------------FLKEGNRM--------------EQPEHCSDEIYDLMKSCWNADPED 565 (609)
T ss_pred CCCCCCcHHH-HHH--------------------HHhcCCCC--------------CCCCCCCHHHHHHHHHHhCCCccc
Confidence 9976321111 111 11122211 234567889999999999999999
Q ss_pred CCChHHHHHHHHHHH
Q 012014 439 RMKINDVESRLRLIR 453 (473)
Q Consensus 439 RPt~~ev~~~L~~l~ 453 (473)
||++.++.+.++.+.
T Consensus 566 RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 566 RPTFSECVEFFEKHL 580 (609)
T ss_pred CCCHHHHHHHHHHHH
Confidence 999999999999964
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=292.13 Aligned_cols=250 Identities=19% Similarity=0.247 Sum_probs=191.4
Q ss_pred ccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCC---CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP---GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
..+.|...+.||+|+||.||+|+ ..+++.+|+|.+..... .....+.+|+.+++.++|+|++++++++...
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 87 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE----- 87 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC-----
Confidence 34457788899999999999999 45688999999864222 2234577899999999999999999998653
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...++||||+. |+|.+++..... .+++.++..++.|++.||.||| +++++||||||+||+++.++.+|
T Consensus 88 ~~~~lv~e~~~-~~l~~~~~~~~~--------~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~k 155 (308)
T cd06634 88 HTAWLVMEYCL-GSASDLLEVHKK--------PLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVK 155 (308)
T ss_pred CeeEEEEEccC-CCHHHHHHHcCC--------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEE
Confidence 36799999996 688887754321 2558888999999999999999 89999999999999999999999
Q ss_pred EeecccccccCccccccceeeccCCCCcCCCcccc---CCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 012014 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDL---GCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVK 375 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~ 375 (473)
|+|||++...... ....|++.|+|||.+. ...++.++|||||||++|+|++|..||........ ......
T Consensus 156 l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~ 228 (308)
T cd06634 156 LGDFGSASIMAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQ 228 (308)
T ss_pred ECCcccceeecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH-HHHHhh
Confidence 9999998765321 2235789999999874 34678899999999999999999999865321110 000000
Q ss_pred hhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHH
Q 012014 376 MALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLR 450 (473)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 450 (473)
...+. ......+..+.+|+.+||+.+|++|||+.+|++.-.
T Consensus 229 ~~~~~----------------------------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 229 NESPA----------------------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred cCCCC----------------------------------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 00000 001124567889999999999999999999986543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=297.41 Aligned_cols=281 Identities=16% Similarity=0.249 Sum_probs=198.9
Q ss_pred cccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccC--CCCchhHHHHHHHHHhcCCCCceeeeeeeecccc-CC
Q 012014 142 NATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY-QG 217 (473)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~ 217 (473)
...++|.+...||+|+||.||+|.. .+++.||+|++.... ......+.+|+.+++.++||||+++++++...+. ..
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 3467899999999999999999994 468899999986432 2233557789999999999999999988754432 22
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccE
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~ 297 (473)
....++|+||+ +++|.+++... .+++..+..++.|++.||.||| +.||+||||||+||+++.++.+
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~~----------~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~ 157 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKCQ----------KLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCEL 157 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCE
Confidence 33579999999 67999998753 3568899999999999999999 8999999999999999999999
Q ss_pred EEeecccccccCccccccceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 012014 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKM 376 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~ 376 (473)
||+|||++...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.+..... .+......
T Consensus 158 kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~-~~~~i~~~ 231 (343)
T cd07851 158 KILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID-QLKRIMNL 231 (343)
T ss_pred EEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHh
Confidence 99999999865332 223357889999998765 367899999999999999999999997532211 11111111
Q ss_pred hcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 377 ALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.......+........... ....... .............+..+.+++.+||+.||++|||+.||++
T Consensus 232 -~~~~~~~~~~~~~~~~~~~---~~~~~~~-~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 232 -VGTPDEELLQKISSESARN---YIQSLPQ-MPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred -cCCCCHHHHhhccchhHHH---HHHhccc-cCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 1111111111110000000 0000000 0000000111123678899999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=290.84 Aligned_cols=244 Identities=22% Similarity=0.253 Sum_probs=187.4
Q ss_pred CCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCC---CchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 147 FSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG---GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 147 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
|...+.||+|+||.||+|+. .+++.|++|.+...... ....+.+|+.+++.++|||++++++++.+. ...+
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 97 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKE-----HTAW 97 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC-----CEEE
Confidence 55667899999999999984 56899999998743322 224578899999999999999999998653 3679
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
+||||+. |+|.+++..... .+++.++..++.|++.||.||| ++|++|+||+|+||+++.++.+||+||
T Consensus 98 lv~e~~~-~~l~~~l~~~~~--------~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~df 165 (313)
T cd06633 98 LVMEYCL-GSASDLLEVHKK--------PLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADF 165 (313)
T ss_pred EEEecCC-CCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeec
Confidence 9999995 688887764321 2558889999999999999999 899999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCcccc---CCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcC
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDL---GCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP 379 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 379 (473)
|++..... .....|+..|+|||++. ...++.++||||||+++|+|++|..||........ .........+
T Consensus 166 g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~-~~~~~~~~~~ 238 (313)
T cd06633 166 GSASKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNDSP 238 (313)
T ss_pred CCCcccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhcCCC
Confidence 99864321 12345889999999974 45688899999999999999999999875322111 0000000000
Q ss_pred cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 380 QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
... ....+..+.+|+.+||+.+|.+|||+.+++..
T Consensus 239 ----~~~------------------------------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 239 ----TLQ------------------------------SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ----CCC------------------------------ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 01123467889999999999999999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=291.50 Aligned_cols=249 Identities=24% Similarity=0.378 Sum_probs=197.2
Q ss_pred CCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccC---CCCchhHHHHHHHHHhcC-CCCceeeeeeeeccccCCce
Q 012014 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 219 (473)
++|.+.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.++.+++ ||||+++++++.+ ..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-----~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD-----EE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC-----Cc
Confidence 4788999999999999999984 478999999986422 223456889999999998 9999999998754 34
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
..++||||+++++|.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l 143 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKYG---------SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKI 143 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEe
Confidence 6899999999999999997654 3668899999999999999999 999999999999999999999999
Q ss_pred eecccccccCccccc------------------cceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCC
Q 012014 300 GDFGMARFLPAIDKQ------------------NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSD 361 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~ 361 (473)
+|||++......... .......|+..|+|||...+..++.++||||||++++++++|..||.
T Consensus 144 ~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 223 (280)
T cd05581 144 TDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR 223 (280)
T ss_pred cCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCC
Confidence 999999866443211 22233457889999999988889999999999999999999999997
Q ss_pred CCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCC
Q 012014 362 GIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMK 441 (473)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt 441 (473)
...... .+.... .. ....+...+..+.+++.+||+.||.+|||
T Consensus 224 ~~~~~~-~~~~~~----~~--------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~ 266 (280)
T cd05581 224 GSNEYL-TFQKIL----KL--------------------------------EYSFPPNFPPDAKDLIEKLLVLDPQDRLG 266 (280)
T ss_pred CccHHH-HHHHHH----hc--------------------------------CCCCCCccCHHHHHHHHHHhcCCHhhCCC
Confidence 542110 000000 00 00011123567889999999999999999
Q ss_pred h----HHHHH
Q 012014 442 I----NDVES 447 (473)
Q Consensus 442 ~----~ev~~ 447 (473)
+ .+++.
T Consensus 267 ~~~~~~~ll~ 276 (280)
T cd05581 267 VNEGYDELKA 276 (280)
T ss_pred cccCHHHHhc
Confidence 9 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=287.78 Aligned_cols=275 Identities=18% Similarity=0.246 Sum_probs=193.1
Q ss_pred CCccceeecCCCeEEEEEEec-CCCEEEEEEeeccCCC-CchhHHHHHHHHHhcC-CCCceeeeeeeeccccCCceeeEE
Q 012014 147 FSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPG-GSKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQGARFKAV 223 (473)
Q Consensus 147 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l 223 (473)
|.+.+.||+|+||.||+|... +++.|++|.+...... ......+|+..+.+++ ||||+++++++.+ ....++
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-----~~~~~l 75 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-----NDELYF 75 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-----CCcEEE
Confidence 567889999999999999954 5789999998643321 2234567999999999 9999999999855 346799
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecc
Q 012014 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (473)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg 303 (473)
||||+ +|+|.+++...... .+++.++..++.|++.||.||| +++++|+||+|+||+++.++.++|+|||
T Consensus 76 v~e~~-~~~l~~~~~~~~~~-------~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~ 144 (283)
T cd07830 76 VFEYM-EGNLYQLMKDRKGK-------PFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFG 144 (283)
T ss_pred EEecC-CCCHHHHHHhcccc-------cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecc
Confidence 99999 88999988765411 3568899999999999999999 8999999999999999999999999999
Q ss_pred cccccCccccccceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcch
Q 012014 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRA 382 (473)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 382 (473)
++....... ......|+..|+|||++.+ ..++.++|+||||+++|+|++|..||......+. +........+...
T Consensus 145 ~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~-~~~~~~~~~~~~~ 220 (283)
T cd07830 145 LAREIRSRP---PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ-LYKICSVLGTPTK 220 (283)
T ss_pred cceeccCCC---CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHH-HHHHHHhcCCCCh
Confidence 998654322 1223457889999998754 4578999999999999999999999976432211 1111111000000
Q ss_pred hhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 383 EEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
....+.. .......... ...............+..+.+++.+||+.||++|||+.|++.
T Consensus 221 ~~~~~~~-----~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 221 QDWPEGY-----KLASKLGFRF-PQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred hhhhhHh-----hhhccccccc-cccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0000000 0000000000 000000001111122567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=272.62 Aligned_cols=282 Identities=20% Similarity=0.258 Sum_probs=204.4
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEee--ccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCC---
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFN--LIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG--- 217 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~--- 217 (473)
.+.|....+||+|.||.||+|+ ..+|+.||+|++- ....+......+|+++|..++|+|++.++..|.......
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 3567778899999999999998 5568889998764 233344556789999999999999999999986654332
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccE
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~ 297 (473)
....++||.+|+. +|..+|.... ..|+..++.+++.++..||.|+| +..|+|||+||+|+||+.+|.+
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn~~--------vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgil 163 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSNRK--------VRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGIL 163 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcCcc--------ccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceE
Confidence 2347999999955 8988887653 25778999999999999999999 9999999999999999999999
Q ss_pred EEeecccccccCcccc--ccceeeccCCCCcCCCccccCC-CCCcccchhhHhHHHHHHHhCCCCCCCCCCCcc--cHHH
Q 012014 298 HVGDFGMARFLPAIDK--QNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKM--NLRN 372 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~--~~~~ 372 (473)
||+|||+++.+..... ....+...-|..|.+||.+.|. .|+++.|||..|||+.||+||.+-+.+...... .+..
T Consensus 164 klADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~ 243 (376)
T KOG0669|consen 164 KLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQ 243 (376)
T ss_pred EeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHH
Confidence 9999999987654332 2233444569999999998875 599999999999999999999999887543321 1111
Q ss_pred HHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHH------HHHHHHhhhcccCCCCCCCChHHHH
Q 012014 373 FVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECF------NSICEIGVACSAERPRERMKINDVE 446 (473)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~l~~l~~~cl~~dP~~RPt~~ev~ 446 (473)
......++-+..+..-.+...++ ..+. +........+.. +..++|+..++..||.+|+++++++
T Consensus 244 LcGs~tkevWP~~d~lpL~~sie--------~ePl--~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~al 313 (376)
T KOG0669|consen 244 LCGSITKEVWPNVDNLPLYQSIE--------LEPL--PKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQAL 313 (376)
T ss_pred HhccCCcccCCCcccchHHHhcc--------CCCC--CcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhh
Confidence 11222222222222221221110 0101 111111122222 2677899999999999999999987
Q ss_pred H
Q 012014 447 S 447 (473)
Q Consensus 447 ~ 447 (473)
.
T Consensus 314 n 314 (376)
T KOG0669|consen 314 N 314 (376)
T ss_pred c
Confidence 4
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=284.81 Aligned_cols=270 Identities=20% Similarity=0.245 Sum_probs=195.9
Q ss_pred CCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccC--CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEE
Q 012014 147 FSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (473)
Q Consensus 147 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (473)
|+..+.||+|+||.||+|+. .+++.+|+|.+.... ....+.+.+|+.+++.++|+||+++++++.+. ...++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-----~~~~~ 75 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE-----RKLYL 75 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC-----CceEE
Confidence 56678899999999999994 458999999997543 33346778999999999999999999997543 47899
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecc
Q 012014 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (473)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg 303 (473)
||||++ ++|.+++..... .+++..+..++.|++.||.||| +++|+||||+|+||++++++.+||+|||
T Consensus 76 v~e~~~-~~l~~~i~~~~~--------~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g 143 (282)
T cd07829 76 VFEYCD-MDLKKYLDKRPG--------PLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFG 143 (282)
T ss_pred EecCcC-cCHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCC
Confidence 999997 599999976531 3668899999999999999999 8999999999999999999999999999
Q ss_pred cccccCccccccceeeccCCCCcCCCccccCC-CCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcC---
Q 012014 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP--- 379 (473)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~--- 379 (473)
++........ ......++..|+|||.+.+. .++.++||||||+++|||++|..||.+....+ .+.........
T Consensus 144 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 220 (282)
T cd07829 144 LARAFGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEID-QLFKIFQILGTPTE 220 (282)
T ss_pred cccccCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHH-HHHHHHHHhCCCcH
Confidence 9986643221 12223457789999998776 78999999999999999999999997633211 11111111100
Q ss_pred cchhhhcccc-chHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 380 QRAEEVVDDF-NLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 380 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.......+.. ....++ ..............+..+.+++.+||..||++||++.+++.
T Consensus 221 ~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 221 ESWPGVTKLPDYKPTFP-----------KFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred HHHHhhccccccccccc-----------ccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000000 000000 00000000111123668999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=281.16 Aligned_cols=250 Identities=20% Similarity=0.258 Sum_probs=189.3
Q ss_pred CCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccC-----CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCce
Q 012014 146 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR-----PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (473)
+|.+.+.||+|+||.||++.. ..+..+++|+++... ......+..|+.+++.++||||+++++++.+. .
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~ 75 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER-----D 75 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC-----C
Confidence 478889999999999999984 335556667665322 12233567899999999999999999987543 3
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
..++||||+++++|.+++...... ...+++.+++.++.|++.||.||| +++++|+||||+||+++. +.+||
T Consensus 76 ~~~lv~e~~~~~~l~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l 146 (260)
T cd08222 76 AFCIITEYCEGRDLDCKLEELKHT-----GKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKI 146 (260)
T ss_pred ceEEEEEeCCCCCHHHHHHHHhhc-----ccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEee
Confidence 579999999999999988643211 114668899999999999999999 999999999999999975 56999
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcC
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP 379 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 379 (473)
+|||++....... .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||..... .........
T Consensus 147 ~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-----~~~~~~~~~ 219 (260)
T cd08222 147 GDFGVSRLLMGSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-----LSVVLRIVE 219 (260)
T ss_pred cccCceeecCCCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHHc
Confidence 9999987654322 122234578899999999888889999999999999999999999864211 111110000
Q ss_pred cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 380 QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.... ..+...+..+.+++.+||+.||++||++.|+++
T Consensus 220 ~~~~-------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 220 GPTP-------------------------------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CCCC-------------------------------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 0000 011234567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=286.06 Aligned_cols=266 Identities=22% Similarity=0.306 Sum_probs=202.1
Q ss_pred hhhhhcccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC-------CCCchhHHHHHHHHHhcCCCCceeeee
Q 012014 137 FKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-------PGGSKSFKSECKAAINIKHRNIVRVFT 208 (473)
Q Consensus 137 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~~~~ 208 (473)
|.+--...++|-..++||+|||+.||+|. +...+-||||+-.... .+..+...+|.+|.+.|+||.||++|+
T Consensus 455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYD 534 (775)
T KOG1151|consen 455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYD 534 (775)
T ss_pred hccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeee
Confidence 44444455678899999999999999998 5667889999875321 122345678999999999999999999
Q ss_pred eeeccccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCc
Q 012014 209 AFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSN 288 (473)
Q Consensus 209 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~N 288 (473)
+|.-. ....|-|+|||+|.+|+-||+.+. .++++++..|+.||+.||.||... ..+|||-||||.|
T Consensus 535 yfslD----tdsFCTVLEYceGNDLDFYLKQhk---------lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgN 600 (775)
T KOG1151|consen 535 YFSLD----TDSFCTVLEYCEGNDLDFYLKQHK---------LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGN 600 (775)
T ss_pred eeeec----cccceeeeeecCCCchhHHHHhhh---------hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCcc
Confidence 98532 345699999999999999999876 467999999999999999999954 6899999999999
Q ss_pred EEec---CCccEEEeecccccccCccccc-----cceeeccCCCCcCCCccccCC----CCCcccchhhHhHHHHHHHhC
Q 012014 289 VLLD---DEMIGHVGDFGMARFLPAIDKQ-----NRFICIKGSTGYIPPEYDLGC----EASTYGDVYSFGILLLEMFTG 356 (473)
Q Consensus 289 il~~---~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwSlG~il~elltg 356 (473)
||+- ..|.+||.|||+++.+...... .......||.+|++||.+.-+ ..+.|+||||+|||+|..+.|
T Consensus 601 ILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYG 680 (775)
T KOG1151|consen 601 ILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYG 680 (775)
T ss_pred EEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhcc
Confidence 9994 4578999999999988665432 123456799999999987643 378999999999999999999
Q ss_pred CCCCCCCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCC
Q 012014 357 IRPSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERP 436 (473)
Q Consensus 357 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP 436 (473)
+.||...-.... +.+.........+..-.. +....+...+|.+||.+.-
T Consensus 681 rKPFGhnqsQQd-ILqeNTIlkAtEVqFP~K------------------------------PvVsseAkaFIRRCLaYRK 729 (775)
T KOG1151|consen 681 RKPFGHNQSQQD-ILQENTILKATEVQFPPK------------------------------PVVSSEAKAFIRRCLAYRK 729 (775)
T ss_pred CCCCCCchhHHH-HHhhhchhcceeccCCCC------------------------------CccCHHHHHHHHHHHHhhh
Confidence 999976432221 111111111111111111 1133456689999999999
Q ss_pred CCCCChHHHHH
Q 012014 437 RERMKINDVES 447 (473)
Q Consensus 437 ~~RPt~~ev~~ 447 (473)
++|....+++.
T Consensus 730 eDR~DV~qLA~ 740 (775)
T KOG1151|consen 730 EDRIDVQQLAC 740 (775)
T ss_pred hhhhhHHHHcc
Confidence 99999888764
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=290.09 Aligned_cols=195 Identities=27% Similarity=0.436 Sum_probs=165.5
Q ss_pred cceeecCCCeEEEEEE-ecCCCEEEEEEeeccC--CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEEEE
Q 012014 150 ANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYK 226 (473)
Q Consensus 150 ~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e 226 (473)
.++||+|.||+||-|+ .++|+.||||++.+.+ ......+++|+.||+++.||.||.+--.|.. ....++|||
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET-----~ervFVVME 643 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFET-----PERVFVVME 643 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecC-----CceEEEEeh
Confidence 4789999999999998 6789999999997543 3445679999999999999999999888754 347899999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCC---ccEEEeecc
Q 012014 227 FMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE---MIGHVGDFG 303 (473)
Q Consensus 227 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~---~~~kl~Dfg 303 (473)
-+ +|+..+.|-..... .+++....-++.||+.||.||| .++|+|+||||+|||+.+. -.+||||||
T Consensus 644 Kl-~GDMLEMILSsEkg-------RL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFG 712 (888)
T KOG4236|consen 644 KL-HGDMLEMILSSEKG-------RLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFG 712 (888)
T ss_pred hh-cchHHHHHHHhhcc-------cchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeecccc
Confidence 99 56766666544332 4667777788999999999999 9999999999999999543 479999999
Q ss_pred cccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCC
Q 012014 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (473)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 363 (473)
+|+.++... ...+..|||.|.|||++....|...-|+||.|||+|--++|..||...
T Consensus 713 fARiIgEks---FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd 769 (888)
T KOG4236|consen 713 FARIIGEKS---FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED 769 (888)
T ss_pred ceeecchhh---hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc
Confidence 999986533 344677999999999999999999999999999999999999999753
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=246.50 Aligned_cols=269 Identities=19% Similarity=0.260 Sum_probs=195.2
Q ss_pred CCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC--CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
+|...++||+|.||+||+|+ +.+++.||+|.++... ........+|+-+++.++|.|||+++++. .......
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvl-----hsdkklt 77 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKLT 77 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhh-----ccCceeE
Confidence 46677899999999999999 5678999999997533 33456789999999999999999999985 3345788
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
+|+||| ..+|..|.....+ .+..+.+..++.|+++||.|+| ++++.|||+||.|+||+.+|.+||+||
T Consensus 78 lvfe~c-dqdlkkyfdslng--------~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladf 145 (292)
T KOG0662|consen 78 LVFEFC-DQDLKKYFDSLNG--------DLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADF 145 (292)
T ss_pred EeHHHh-hHHHHHHHHhcCC--------cCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEeccc
Confidence 999999 5689988876543 3557788899999999999999 999999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCCC-CCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcC-
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE-ASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMALP- 379 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~- 379 (473)
|+++.++-... -.....-|..|.+|.++.+.. |++..|+||.|||+.|+.. |++.|.+..-. ..+..+.+..-.
T Consensus 146 glarafgipvr--cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvd-dqlkrif~~lg~p 222 (292)
T KOG0662|consen 146 GLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLKRIFRLLGTP 222 (292)
T ss_pred chhhhcCCceE--eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHH-HHHHHHHHHhCCC
Confidence 99997754321 122234589999999988865 8999999999999999998 66666654322 223333322211
Q ss_pred --cchh---hhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 380 --QRAE---EVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 380 --~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.++. .+.|......+.. .-...+..+.....=.+|+...+.-+|..|.++++.++
T Consensus 223 ~ed~wps~t~lpdyk~yp~ypa-------------ttswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 223 TEDQWPSMTKLPDYKPYPIYPA-------------TTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred ccccCCccccCCCCcccCCccc-------------cchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 1111 1111111111000 01112233334444456777777789999999987653
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=277.05 Aligned_cols=257 Identities=22% Similarity=0.199 Sum_probs=189.4
Q ss_pred CCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCC-CCchhHHHHHHH-HHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP-GGSKSFKSECKA-AINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
+.+....||.|+||+|++-. ...|+..|||+++.... ....++..|.+. ++.-+.||||++||.+.. ....|
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~-----EGdcW 139 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS-----EGDCW 139 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc-----CCcee
Confidence 34456679999999999987 56799999999985443 445678888876 444579999999999754 23579
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
+.||+| ..||+.+.+.-.... ...+++.-.-.|..-.+.||.||-. ...|||||+||+|||++..|.+|||||
T Consensus 140 iCMELM-d~SlDklYk~vy~vq----~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDF 212 (361)
T KOG1006|consen 140 ICMELM-DISLDKLYKRVYSVQ----KSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDF 212 (361)
T ss_pred eeHHHH-hhhHHHHHHHHHHHH----hccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecc
Confidence 999999 568876654321110 1134566666788888999999985 678999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccC--CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCc
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLG--CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQ 380 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 380 (473)
|++..+.. +...+.-.|-..|||||.+.. ..|+.+|||||||++|||+.||..||.+..+- -..+.....+
T Consensus 213 GIcGqLv~---SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv----feql~~Vv~g 285 (361)
T KOG1006|consen 213 GICGQLVD---SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV----FEQLCQVVIG 285 (361)
T ss_pred cchHhHHH---HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH----HHHHHHHHcC
Confidence 99976543 222334458889999998764 35899999999999999999999999764321 1111222222
Q ss_pred chhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 381 RAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
....+..+ ....+....+..++..||.+|-++||...++.+
T Consensus 286 dpp~l~~~--------------------------~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 286 DPPILLFD--------------------------KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred CCCeecCc--------------------------ccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 22222111 112346778999999999999999999998765
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=296.43 Aligned_cols=265 Identities=19% Similarity=0.286 Sum_probs=213.7
Q ss_pred chhhhhcccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhc-CCCCceeeeeeeecc
Q 012014 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGV 213 (473)
Q Consensus 136 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 213 (473)
.++.+-..++.|++..+||.|.+|.||+++ .++++..|+|+..... ...+++..|.++++.. .|||++.+||+|.-.
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 455566778899999999999999999999 6789999999986433 3456778888888877 699999999999877
Q ss_pred ccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecC
Q 012014 214 DYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD 293 (473)
Q Consensus 214 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~ 293 (473)
+......+|||||||.+||.-|++++..+. .+.|..+..|++.++.||.+|| .+.++|||||-.|||++.
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~-------rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~ 158 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGN-------RLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTE 158 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhccc-------chhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEec
Confidence 766777899999999999999999876632 4668889999999999999999 999999999999999999
Q ss_pred CccEEEeecccccccCccccccceeeccCCCCcCCCccccCC-----CCCcccchhhHhHHHHHHHhCCCCCCCCCCCcc
Q 012014 294 EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-----EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKM 368 (473)
Q Consensus 294 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~ 368 (473)
++.+||+|||.+..+... .....+..|||.|||||++... .|+..+|+||||++..||.-|.+|+..+.....
T Consensus 159 e~~VKLvDFGvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra 236 (953)
T KOG0587|consen 159 NAEVKLVDFGVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA 236 (953)
T ss_pred cCcEEEeeeeeeeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh
Confidence 999999999999876542 2334456799999999997643 377889999999999999999999976543221
Q ss_pred cHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 369 NLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
-..+|......+.. +..-.+++-+++..||.+|-..||++.++++
T Consensus 237 ------LF~IpRNPPPkLkr----------------------------p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 237 ------LFLIPRNPPPKLKR----------------------------PKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ------hccCCCCCCccccc----------------------------hhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 11122222111111 1234668889999999999999999988864
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=312.18 Aligned_cols=146 Identities=27% Similarity=0.350 Sum_probs=126.2
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCC---CchhHHHHHHHHHhcCCCCceeeeeeeeccccCCce
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG---GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (473)
.++|.+.++||+|+||.||+|.. .+++.||+|+++..... ....+.+|+.++..++||||+++++++.. ..
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-----~~ 77 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS-----AN 77 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE-----CC
Confidence 36799999999999999999994 46899999998743322 23568889999999999999999988754 34
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
..++||||+.+++|.+++.... .+++..++.++.||+.||.||| .++|+||||||+|||++.++.+||
T Consensus 78 ~~~lVmEy~~g~~L~~li~~~~---------~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL 145 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHIYG---------YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKL 145 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEE
Confidence 6899999999999999997543 2457788999999999999999 899999999999999999999999
Q ss_pred eeccccc
Q 012014 300 GDFGMAR 306 (473)
Q Consensus 300 ~Dfg~~~ 306 (473)
+|||+++
T Consensus 146 ~DFGls~ 152 (669)
T cd05610 146 TDFGLSK 152 (669)
T ss_pred EeCCCCc
Confidence 9999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=277.11 Aligned_cols=281 Identities=21% Similarity=0.235 Sum_probs=201.5
Q ss_pred ccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCC--C----Cceeeeeeeecccc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKH--R----NIVRVFTAFSGVDY 215 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~----niv~~~~~~~~~~~ 215 (473)
.+++|.+...+|+|.||.|-.+. ...+..||||+++... ...+...-|++++.++.+ | -+|++.++|.-
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy--- 162 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY--- 162 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc---
Confidence 47899999999999999999998 3457899999997433 234566779999999942 2 37777777632
Q ss_pred CCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecC--
Q 012014 216 QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD-- 293 (473)
Q Consensus 216 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~-- 293 (473)
..+.|||+|.+ |-|+.++|..+.-. +|+...+..++.|++++++||| +.+++|-||||+|||+.+
T Consensus 163 --rghiCivfell-G~S~~dFlk~N~y~-------~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~ 229 (415)
T KOG0671|consen 163 --RGHICIVFELL-GLSTFDFLKENNYI-------PFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSE 229 (415)
T ss_pred --cCceEEEEecc-ChhHHHHhccCCcc-------ccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccc
Confidence 34789999998 77999999887543 5779999999999999999999 999999999999999832
Q ss_pred ------------------CccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh
Q 012014 294 ------------------EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT 355 (473)
Q Consensus 294 ------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt 355 (473)
+..++++|||.|+..... ......|..|.|||++.+-.++..+||||+||||+|+.|
T Consensus 230 ~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~Elyt 304 (415)
T KOG0671|consen 230 YFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYT 304 (415)
T ss_pred eEEEeccCCccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeec
Confidence 346899999999864322 244557999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcccHHHHHHhhcCcchhhhcccc-chHHHHhhhhhhcccccCCC--Ccch--------hhHHHHHHHHH
Q 012014 356 GIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDDF-NLQEIEEGRTMCMEVSSSSG--SSAH--------ASIILECFNSI 424 (473)
Q Consensus 356 g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~--~~~~--------~~~~~~~~~~l 424 (473)
|...|.+..+.+ .+. +.+....+....++... ....+..++..+.+...... .... .........+|
T Consensus 305 G~~LFqtHen~E-HLa-MMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~L 382 (415)
T KOG0671|consen 305 GETLFQTHENLE-HLA-MMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQL 382 (415)
T ss_pred cceecccCCcHH-HHH-HHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHH
Confidence 999998755322 121 11111111112222211 22222222111222211110 0000 01112356679
Q ss_pred HHHhhhcccCCCCCCCChHHHHH
Q 012014 425 CEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 425 ~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.+|+.+||..||.+|+|+.|++.
T Consensus 383 fDLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 383 FDLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred HHHHHHHHccCccccccHHHHhc
Confidence 99999999999999999999874
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=274.03 Aligned_cols=236 Identities=26% Similarity=0.303 Sum_probs=187.4
Q ss_pred eecCCCeEEEEEEe-cCCCEEEEEEeeccCCC---CchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEEEEec
Q 012014 153 IGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG---GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFM 228 (473)
Q Consensus 153 lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 228 (473)
||.|+||.||++.. .+++.+|+|.+...... ....+.+|+.+++.++||||+++++.+.. ....+++|||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT-----EEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec-----CCeeEEEEecC
Confidence 69999999999984 45899999998753322 34578899999999999999999988743 44789999999
Q ss_pred CCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeeccccccc
Q 012014 229 PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL 308 (473)
Q Consensus 229 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 308 (473)
++++|.+++.... .+++..+..++.|++.||.||| +.+++|+||+|+||+++.++.++|+|||++...
T Consensus 76 ~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~ 143 (250)
T cd05123 76 PGGELFSHLSKEG---------RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKEL 143 (250)
T ss_pred CCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceec
Confidence 9999999997654 2558889999999999999999 899999999999999999999999999999765
Q ss_pred CccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchhhhccc
Q 012014 309 PAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDD 388 (473)
Q Consensus 309 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (473)
.... .......|+..|+|||...+...+.++|+||||+++|+|++|..||..... ...........
T Consensus 144 ~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~~~------- 209 (250)
T cd05123 144 SSEG--SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KEIYEKILKDP------- 209 (250)
T ss_pred ccCC--CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHhcCC-------
Confidence 4321 122334578899999999888889999999999999999999999965322 11111100000
Q ss_pred cchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHH
Q 012014 389 FNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKIND 444 (473)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 444 (473)
...+...+..+.+++.+||..||++|||+.+
T Consensus 210 -------------------------~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 210 -------------------------LRFPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred -------------------------CCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 0001112567789999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=290.89 Aligned_cols=242 Identities=23% Similarity=0.312 Sum_probs=196.0
Q ss_pred CCCCccceeecCCCeEEEEEEecC-CCEEEEEEeecc---CCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 145 NGFSSANLIGAGNFGSVYNGTLFD-GTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
.+++.+..||-||||.|=++.... ...+|+|++++. .....+....|-.+|...+.|.||++|..|.+ ..+
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd-----~ky 494 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD-----SKY 494 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc-----chh
Confidence 456677789999999999988433 334888888743 33455678899999999999999999999744 558
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.|++||-|-||.|...|+.++ .|....+.-++..+++|++||| ++|||+|||||+|.+++.+|.+||.
T Consensus 495 vYmLmEaClGGElWTiLrdRg---------~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLV 562 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDRG---------SFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLV 562 (732)
T ss_pred hhhhHHhhcCchhhhhhhhcC---------CcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEe
Confidence 899999999999999999887 3556777789999999999999 9999999999999999999999999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCc
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQ 380 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 380 (473)
|||+|+.+.. ...+.+++|||.|.|||++.+...+.++|.||||+++|||++|.+||.+...... +..+++..
T Consensus 563 DFGFAKki~~---g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmkt-Yn~ILkGi--- 635 (732)
T KOG0614|consen 563 DFGFAKKIGS---GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKT-YNLILKGI--- 635 (732)
T ss_pred ehhhHHHhcc---CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHH-HHHHHhhh---
Confidence 9999998865 4456678999999999999999999999999999999999999999987543321 11111100
Q ss_pred chhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCC
Q 012014 381 RAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMK 441 (473)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt 441 (473)
+ ....+...+....+|+.+.+..+|.+|..
T Consensus 636 ------d-------------------------~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 636 ------D-------------------------KIEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ------h-------------------------hhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 0 00112234455667899999999999986
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=267.20 Aligned_cols=201 Identities=22% Similarity=0.267 Sum_probs=174.8
Q ss_pred ccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeecc---CCCCchhHHHHHHHHHhc-CCCCceeeeeeeeccccCC
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI---RPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQG 217 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 217 (473)
..++|.+..+||+|+|+.|..++ ..+.+.+|+|++++. ...+.+..+.|-.+..+. +||.+|-++.+|. +
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfq-----t 322 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQ-----T 322 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhc-----c
Confidence 34789999999999999999998 567899999999853 334556677888887766 7999999999874 4
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccE
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~ 297 (473)
...+++|.||++||+|--+++... .++++.+.-+..+|+.||.||| ++|||.||||.+|+|+|..|++
T Consensus 323 esrlffvieyv~ggdlmfhmqrqr---------klpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghi 390 (593)
T KOG0695|consen 323 ESRLFFVIEYVNGGDLMFHMQRQR---------KLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHI 390 (593)
T ss_pred cceEEEEEEEecCcceeeehhhhh---------cCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCce
Confidence 557899999999999988887765 4668889999999999999999 9999999999999999999999
Q ss_pred EEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCC
Q 012014 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 362 (473)
||.|+|+++.-- .......+++|||.|.|||++.+..|...+|+|+|||+++||+.|+.||+-
T Consensus 391 kltdygmcke~l--~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 391 KLTDYGMCKEGL--GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred eecccchhhcCC--CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 999999998532 234455678899999999999999999999999999999999999999974
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=272.89 Aligned_cols=220 Identities=19% Similarity=0.107 Sum_probs=173.0
Q ss_pred CCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEEEEecCCCCHH
Q 012014 156 GNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLE 234 (473)
Q Consensus 156 G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~ 234 (473)
|.||.||++. ..+++.+|+|.+.... .+.+|...+....||||+++++++.+ ....+++|||+++|+|.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~ 73 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVS-----EDSVFLVLQHAEGGKLW 73 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheec-----CCeEEEEEecCCCCCHH
Confidence 8999999999 5678999999986432 23455556666689999999998754 34679999999999999
Q ss_pred HHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecccccccCccccc
Q 012014 235 EWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQ 314 (473)
Q Consensus 235 ~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 314 (473)
+++.... .+++..+..++.|++.||.||| +++|+||||||+||+++.++.++++|||.+......
T Consensus 74 ~~l~~~~---------~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--- 138 (237)
T cd05576 74 SHISKFL---------NIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--- 138 (237)
T ss_pred HHHHHhc---------CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc---
Confidence 9987643 2568889999999999999999 999999999999999999999999999988655331
Q ss_pred cceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchhhhccccchHHH
Q 012014 315 NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEI 394 (473)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (473)
.....++..|+|||...+..++.++||||+|+++|||++|..|+....... .....
T Consensus 139 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---------------~~~~~------- 194 (237)
T cd05576 139 --CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI---------------NTHTT------- 194 (237)
T ss_pred --cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---------------ccccc-------
Confidence 122345778999999988889999999999999999999998875321100 00000
Q ss_pred HhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChH
Q 012014 395 EEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKIN 443 (473)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 443 (473)
...+...+..+.+++.+||+.||++|||+.
T Consensus 195 -------------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 195 -------------------LNIPEWVSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred -------------------cCCcccCCHHHHHHHHHHccCCHHHhcCCC
Confidence 000112345778999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=298.71 Aligned_cols=211 Identities=19% Similarity=0.182 Sum_probs=145.0
Q ss_pred ccCCCCccceeecCCCeEEEEEEe-cC----CCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeecccc-C
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTL-FD----GTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY-Q 216 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~-~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~ 216 (473)
..++|.+.++||+|+||.||+|.. .+ +..||+|+++... ..+...++ .+....+.+++.++..+..... .
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~--~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG--AVEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc--hhHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 567899999999999999999994 44 6899999875322 11222222 1222233344433333222111 3
Q ss_pred CceeeEEEEEecCCCCHHHHhcCCCCCC-----------CCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCC
Q 012014 217 GARFKAVVYKFMPNGSLEEWLRGKDDTN-----------WRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLK 285 (473)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~-----------~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlk 285 (473)
.....++||||+++++|.+++....... ..+.........+..++.||+.||.||| +++|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence 3456899999999999999987543110 0000011223446679999999999999 8999999999
Q ss_pred CCcEEecC-CccEEEeecccccccCccccccceeeccCCCCcCCCccccCC----------------------CCCcccc
Q 012014 286 PSNVLLDD-EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC----------------------EASTYGD 342 (473)
Q Consensus 286 p~Nil~~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D 342 (473)
|+|||++. ++.+||+|||+++.+.... ........||+.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999985 5899999999998654322 1222345689999999965322 2345679
Q ss_pred hhhHhHHHHHHHhCCCCCC
Q 012014 343 VYSFGILLLEMFTGIRPSD 361 (473)
Q Consensus 343 iwSlG~il~elltg~~P~~ 361 (473)
||||||++|||+++..|++
T Consensus 362 VwSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred cHHHHHHHHHHHhCcCCCc
Confidence 9999999999999776654
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=255.66 Aligned_cols=275 Identities=17% Similarity=0.200 Sum_probs=201.0
Q ss_pred cccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcC-CCCceeeeeeeeccccCCce
Q 012014 142 NATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 219 (473)
...++|++.+++|+|.|++||.|. ..++++++||+++.. ..+.+.+|+.||..|. ||||++++++..++. +.
T Consensus 35 g~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~---Sk 108 (338)
T KOG0668|consen 35 GNQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPE---SK 108 (338)
T ss_pred cccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCcc---cc
Confidence 456789999999999999999998 567899999999743 3567899999999996 999999999987654 45
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCC-ccEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE-MIGH 298 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~-~~~k 298 (473)
.+.|++||+.+.+...+... ++...+..++.+++.||.|+| +.||+|||+||.|++||.. -.++
T Consensus 109 tpaLiFE~v~n~Dfk~ly~t------------l~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLr 173 (338)
T KOG0668|consen 109 TPSLIFEYVNNTDFKQLYPT------------LTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLR 173 (338)
T ss_pred CchhHhhhhccccHHHHhhh------------hchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceee
Confidence 67899999999888776543 446678889999999999999 9999999999999999865 4789
Q ss_pred EeecccccccCccccccceeeccCCCCcCCCccccCCC-CCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE-ASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
|+|+|+|.++...... .....+..|--||.+...+ |+.+-|+|||||++..|+..+.||-...+....+..+.+..
T Consensus 174 lIDWGLAEFYHp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVL 250 (338)
T KOG0668|consen 174 LIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVL 250 (338)
T ss_pred eeecchHhhcCCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHh
Confidence 9999999987654322 2334577889999988754 78888999999999999999999865444433333333332
Q ss_pred cCcchhhhc-------cccchHHHHhhhhhhcccccCCCCcchhhH-HHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 378 LPQRAEEVV-------DDFNLQEIEEGRTMCMEVSSSSGSSAHASI-ILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 378 ~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
....+...+ ++.....+.. .+...+....... ..-..++..+|+...|.+|-.+|||++|...
T Consensus 251 Gt~el~~Yl~KY~i~Ldp~~~~i~~~-------~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 251 GTDELYAYLNKYQIDLDPQFEDILGR-------HSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred ChHHHHHHHHHHccCCChhHhhHhhc-------cccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 222221111 1111111000 0011111111111 1112467789999999999999999999754
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=269.89 Aligned_cols=276 Identities=20% Similarity=0.234 Sum_probs=214.4
Q ss_pred hhhhhcccCCCCccceeecCCCeEEEEEEecC------CCEEEEEEeeccC-CCCchhHHHHHHHHHhcCCCCceeeeee
Q 012014 137 FKDLYNATNGFSSANLIGAGNFGSVYNGTLFD------GTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTA 209 (473)
Q Consensus 137 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~ 209 (473)
.+++.....+++...++-+|.||.||+|.|.+ .+.|-+|.++... .-....+..|...+..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 34455556778888899999999999997654 3446677665322 2234568889999999999999999999
Q ss_pred eeccccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcE
Q 012014 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNV 289 (473)
Q Consensus 210 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Ni 289 (473)
+.+ ....+++++.++.-|+|..||...+.. .......++..+...++.|++.|++||| ++++||.||...|.
T Consensus 356 ~ie----~~~~P~V~y~~~~~gNLK~FL~~Cr~~-~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNC 427 (563)
T KOG1024|consen 356 SIE----DYATPFVLYPATGVGNLKSFLQICRGD-DPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNC 427 (563)
T ss_pred Eee----ccCcceEEEeccCcchHHHHHHHhccC-CCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcc
Confidence 854 345678999999999999999844422 1222334667788899999999999999 99999999999999
Q ss_pred EecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcc
Q 012014 290 LLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKM 368 (473)
Q Consensus 290 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~ 368 (473)
+||+...+||+|-.+++.+-+.+..-..........||+||.+.+..|+.++|||||||++|||+| |+.||......++
T Consensus 428 vIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm 507 (563)
T KOG1024|consen 428 VIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM 507 (563)
T ss_pred eehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH
Confidence 999999999999999987766553333233334678999999999999999999999999999999 9999876433221
Q ss_pred cHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 369 NLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
. ..+.+|++. ..+.+||.+|..+|..||..+|++||+++|++.-
T Consensus 508 --------------~--------~ylkdGyRl--------------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~c 551 (563)
T KOG1024|consen 508 --------------E--------HYLKDGYRL--------------AQPFNCPDELFTVMACCWALLPEERPSFSQLVIC 551 (563)
T ss_pred --------------H--------HHHhcccee--------------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHH
Confidence 1 111112211 2345799999999999999999999999999999
Q ss_pred HHHHHHhh
Q 012014 449 LRLIRRKL 456 (473)
Q Consensus 449 L~~l~~~~ 456 (473)
|......+
T Consensus 552 LseF~~ql 559 (563)
T KOG1024|consen 552 LSEFHTQL 559 (563)
T ss_pred HHHHHHHH
Confidence 98876654
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=283.61 Aligned_cols=216 Identities=23% Similarity=0.238 Sum_probs=156.0
Q ss_pred ccCCCCccceeecCCCeEEEEEEe-----------------cCCCEEEEEEeeccCCCCc--------------hhHHHH
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTL-----------------FDGTTIAVKVFNLIRPGGS--------------KSFKSE 191 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~~--------------~~~~~E 191 (473)
..++|++.++||+|+||.||+|.. ..++.||||+++....... +....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 577999999999999999999963 2356799999874332222 233456
Q ss_pred HHHHHhcCCCCc-----eeeeeeeecccc---CCceeeEEEEEecCCCCHHHHhcCCCCCC---------------CCCc
Q 012014 192 CKAAINIKHRNI-----VRVFTAFSGVDY---QGARFKAVVYKFMPNGSLEEWLRGKDDTN---------------WRPL 248 (473)
Q Consensus 192 ~~~l~~l~h~ni-----v~~~~~~~~~~~---~~~~~~~lv~e~~~~g~L~~~l~~~~~~~---------------~~~~ 248 (473)
+..+.+++|.++ ++++++|..... ......+|||||+++++|.++++...... ....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766554 677777654211 11345799999999999999997542110 0001
Q ss_pred chhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecccccccCccccccceeeccCCCCcCC
Q 012014 249 NFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIP 328 (473)
Q Consensus 249 ~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a 328 (473)
...+.+..+..++.|++.||.||| +++|+||||||+|||++.++.+||+|||++........ .......+|+.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 112456778899999999999999 89999999999999999999999999999975533221 11122235889999
Q ss_pred CccccCCC--------------------C--CcccchhhHhHHHHHHHhCCC-CCCC
Q 012014 329 PEYDLGCE--------------------A--STYGDVYSFGILLLEMFTGIR-PSDG 362 (473)
Q Consensus 329 PE~~~~~~--------------------~--~~~~DiwSlG~il~elltg~~-P~~~ 362 (473)
||.+.... + ..+.||||+||++|+|++|.. ||.+
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~ 435 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVAN 435 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccc
Confidence 99875422 1 234799999999999999875 7754
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=279.91 Aligned_cols=213 Identities=22% Similarity=0.288 Sum_probs=176.2
Q ss_pred hhhcccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC---CCCchhHHHHHHHHHhcCCCCceeeeeeeeccc
Q 012014 139 DLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVD 214 (473)
Q Consensus 139 ~~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 214 (473)
.-+....-|..++.||-|+||+|.+++ ..+...+|+|.+.+.. .+.......|-.||...+.+-||+||..|.+.
T Consensus 623 RaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDk- 701 (1034)
T KOG0608|consen 623 RAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDK- 701 (1034)
T ss_pred HhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccC-
Confidence 334445668889999999999999998 4556789999987433 23345677899999999999999999988554
Q ss_pred cCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCC
Q 012014 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE 294 (473)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~ 294 (473)
..+|+||+|++||++-.+|...+ .|.+..+..++.++..|+++.| ..|+|||||||+|||||.+
T Consensus 702 ----dnLYFVMdYIPGGDmMSLLIrmg---------IFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrd 765 (1034)
T KOG0608|consen 702 ----DNLYFVMDYIPGGDMMSLLIRMG---------IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRD 765 (1034)
T ss_pred ----CceEEEEeccCCccHHHHHHHhc---------cCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccC
Confidence 47899999999999999998765 4668888889999999999999 9999999999999999999
Q ss_pred ccEEEeecccccccCc---------ccccc-------------------------------ceeeccCCCCcCCCccccC
Q 012014 295 MIGHVGDFGMARFLPA---------IDKQN-------------------------------RFICIKGSTGYIPPEYDLG 334 (473)
Q Consensus 295 ~~~kl~Dfg~~~~~~~---------~~~~~-------------------------------~~~~~~gt~~y~aPE~~~~ 334 (473)
|++||.|||+++-+.- .+... .....+||+.|+|||++..
T Consensus 766 GHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r 845 (1034)
T KOG0608|consen 766 GHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR 845 (1034)
T ss_pred CceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc
Confidence 9999999999864321 00000 0113469999999999999
Q ss_pred CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcc
Q 012014 335 CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKM 368 (473)
Q Consensus 335 ~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~ 368 (473)
..|+..+|+||.|||||||+.|+.||......+.
T Consensus 846 ~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 846 TGYTQLCDWWSVGVILYEMLVGQPPFLADTPGET 879 (1034)
T ss_pred cCccccchhhHhhHHHHHHhhCCCCccCCCCCcc
Confidence 9999999999999999999999999987655543
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=245.32 Aligned_cols=223 Identities=22% Similarity=0.258 Sum_probs=172.0
Q ss_pred hcccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC-CCCchhHHHHHHHHHhc-CCCCceeeeeeeeccccCC
Q 012014 141 YNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQG 217 (473)
Q Consensus 141 ~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 217 (473)
....++...+..||+|+||.|-+-+ ..+|+..|+|.+...- ....+++.+|+.+..+. .+|.+|++||.+..
T Consensus 42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r----- 116 (282)
T KOG0984|consen 42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR----- 116 (282)
T ss_pred ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc-----
Confidence 3445566667889999999998877 5789999999997432 33445677888875554 79999999998643
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccE
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~ 297 (473)
....++.||.| ..||+.+...--..+ ..+++.-.-+|+..++.||.|||+ ...+||||+||+|||++.+|.+
T Consensus 117 egdvwIcME~M-~tSldkfy~~v~~~g-----~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqV 188 (282)
T KOG0984|consen 117 EGDVWICMELM-DTSLDKFYRKVLKKG-----GTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQV 188 (282)
T ss_pred cccEEEeHHHh-hhhHHHHHHHHHhcC-----CcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcE
Confidence 34689999999 568887764422111 135577788999999999999996 5789999999999999999999
Q ss_pred EEeecccccccCccccccceeeccCCCCcCCCccccC----CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHH
Q 012014 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG----CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNF 373 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~ 373 (473)
|+||||++..+.+.- ..+...|-..|||||.+.. ..|+.+|||||||+++.||.++++||+.-...-..+.+.
T Consensus 189 KiCDFGIsG~L~dSi---Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqv 265 (282)
T KOG0984|consen 189 KICDFGISGYLVDSI---AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQV 265 (282)
T ss_pred EEcccccceeehhhh---HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHH
Confidence 999999998764422 2222457888999998653 369999999999999999999999998765555555555
Q ss_pred HHhhcC
Q 012014 374 VKMALP 379 (473)
Q Consensus 374 ~~~~~~ 379 (473)
++...|
T Consensus 266 Veep~P 271 (282)
T KOG0984|consen 266 VEEPSP 271 (282)
T ss_pred hcCCCC
Confidence 554444
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=258.58 Aligned_cols=238 Identities=25% Similarity=0.330 Sum_probs=188.3
Q ss_pred CCeEEEEEEec-CCCEEEEEEeeccCCCC-chhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEEEEecCCCCHH
Q 012014 157 NFGSVYNGTLF-DGTTIAVKVFNLIRPGG-SKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLE 234 (473)
Q Consensus 157 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~ 234 (473)
+||.||+|... +++.+|+|++....... .+.+.+|++.+++++|+||+++++.+... ...++++||+++++|.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~l~~e~~~~~~L~ 75 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDE-----DKLYLVMEYCDGGDLF 75 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeC-----CEEEEEEeCCCCCCHH
Confidence 58999999954 58999999997654444 67899999999999999999999997543 3679999999999999
Q ss_pred HHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecccccccCccccc
Q 012014 235 EWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQ 314 (473)
Q Consensus 235 ~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 314 (473)
+++..... ++...+..++.+++.++.||| +.+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 76 ~~~~~~~~---------~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-- 141 (244)
T smart00220 76 DLLKKRGR---------LSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-- 141 (244)
T ss_pred HHHHhccC---------CCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--
Confidence 99876531 457889999999999999999 8999999999999999999999999999998765432
Q ss_pred cceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchhhhccccchHHH
Q 012014 315 NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEI 394 (473)
Q Consensus 315 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (473)
......|+..|++||...+..++.++||||||+++++|++|..||....... ..............
T Consensus 142 -~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~----~~~~~~~~~~~~~~--------- 207 (244)
T smart00220 142 -LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL----ELFKKIGKPKPPFP--------- 207 (244)
T ss_pred -ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH----HHHHHHhccCCCCc---------
Confidence 2233457889999999988889999999999999999999999997531111 11111000000000
Q ss_pred HhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 395 EEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
......+..+.+++.+||..||++||++.++++
T Consensus 208 --------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 208 --------------------PPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred --------------------cccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 000004567889999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=287.33 Aligned_cols=246 Identities=21% Similarity=0.314 Sum_probs=185.4
Q ss_pred CCccceeecCCCeE-EEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhc-CCCCceeeeeeeeccccCCceeeEEE
Q 012014 147 FSSANLIGAGNFGS-VYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGARFKAVV 224 (473)
Q Consensus 147 ~~~~~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv 224 (473)
|...+++|.|+.|+ ||+|. .+|+.||||++-. .......+|+..|+.- +|||||++|+.- .+..+.||.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~-ye~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E-----~d~qF~YIa 581 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGV-YEGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSE-----QDRQFLYIA 581 (903)
T ss_pred eccHHHcccCCCCcEEEEEe-eCCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeec-----cCCceEEEE
Confidence 45567789998886 68897 5789999998752 2344568999999887 699999998763 446689999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecC---C--ccEEE
Q 012014 225 YKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD---E--MIGHV 299 (473)
Q Consensus 225 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~---~--~~~kl 299 (473)
.|.| ..+|.+++......... ..--..+.++.|+++||++|| +.+||||||||.||||+. + ..++|
T Consensus 582 lELC-~~sL~dlie~~~~d~~~-----~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~i 652 (903)
T KOG1027|consen 582 LELC-ACSLQDLIESSGLDVEM-----QSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKI 652 (903)
T ss_pred ehHh-hhhHHHHHhccccchhh-----cccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEe
Confidence 9999 66999999885111000 001234678899999999999 899999999999999965 2 57899
Q ss_pred eecccccccCccccc-cceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhC-CCCCCCCCCCcccHHHHHHhh
Q 012014 300 GDFGMARFLPAIDKQ-NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTG-IRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg-~~P~~~~~~~~~~~~~~~~~~ 377 (473)
+|||+++.+...... .......||-+|+|||++....-+.++||||+||++|+.++| .+||......+.++..-....
T Consensus 653 SDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L 732 (903)
T KOG1027|consen 653 SDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTL 732 (903)
T ss_pred cccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccce
Confidence 999999988664422 234456799999999999998888899999999999999995 999987544433222110000
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHH
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVE 446 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~ 446 (473)
..+ . ...++ +..+||.+|+++||..||++.+|+
T Consensus 733 -----~~L-~----------------------------~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 733 -----VHL-E----------------------------PLPDC--EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred -----eee-c----------------------------cCchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence 000 0 00112 667899999999999999999997
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=253.02 Aligned_cols=136 Identities=21% Similarity=0.327 Sum_probs=114.9
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcC-----C---CCceeeeeeeeccc
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK-----H---RNIVRVFTAFSGVD 214 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~~~~~~~~~~ 214 (473)
..+|.+.++||-|-|++||+|. ..+.+.||+|+.+... ...+....||++|++++ | .+||++++.|....
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 3689999999999999999998 5667899999987432 23456788999999983 3 46999999998765
Q ss_pred cCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEe
Q 012014 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL 291 (473)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~ 291 (473)
.++.++|+|+|++ |.+|..+|....-. .++...+.+|++||+.||.|||. ..||||-||||+|||+
T Consensus 156 -pNG~HVCMVfEvL-GdnLLklI~~s~Yr-------Glpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 -PNGQHVCMVFEVL-GDNLLKLIKYSNYR-------GLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLL 221 (590)
T ss_pred -CCCcEEEEEehhh-hhHHHHHHHHhCCC-------CCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeee
Confidence 5677899999999 88999999776533 46688999999999999999997 4599999999999998
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.9e-33 Score=262.54 Aligned_cols=199 Identities=21% Similarity=0.292 Sum_probs=168.8
Q ss_pred ccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC--------CCCchhHHHHHHHHHhcC---CCCceeeeeee
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--------PGGSKSFKSECKAAINIK---HRNIVRVFTAF 210 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---h~niv~~~~~~ 210 (473)
...+|...+.||+|+||.|+.|. ..+...|+||.+.+.+ .......-.|++||..++ |+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 34568999999999999999999 4567789999886433 122234567999999997 99999999998
Q ss_pred eccccCCceeeEEEEEec-CCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcE
Q 012014 211 SGVDYQGARFKAVVYKFM-PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNV 289 (473)
Q Consensus 211 ~~~~~~~~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Ni 289 (473)
.+.+ ++||+||-- ++-+|.++|..+. .+++.++..|+.|++.|+++|| +.||||||||-+|+
T Consensus 639 Eddd-----~yyl~te~hg~gIDLFd~IE~kp---------~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenv 701 (772)
T KOG1152|consen 639 EDDD-----YYYLETEVHGEGIDLFDFIEFKP---------RMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENV 701 (772)
T ss_pred ecCC-----eeEEEecCCCCCcchhhhhhccC---------ccchHHHHHHHHHHHhcccccc---ccCceecccccccE
Confidence 6644 789999976 4679999998776 4668899999999999999999 99999999999999
Q ss_pred EecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCC-CcccchhhHhHHHHHHHhCCCCCCC
Q 012014 290 LLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEA-STYGDVYSFGILLLEMFTGIRPSDG 362 (473)
Q Consensus 290 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~P~~~ 362 (473)
.++.+|.+||+|||.+.... ......++||..|.|||++.|..| +..-|||++|++||.++....||..
T Consensus 702 ivd~~g~~klidfgsaa~~k----sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 702 IVDSNGFVKLIDFGSAAYTK----SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred EEecCCeEEEeeccchhhhc----CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 99999999999999997653 334556789999999999999887 4556999999999999999999864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-33 Score=270.64 Aligned_cols=254 Identities=19% Similarity=0.271 Sum_probs=202.2
Q ss_pred cccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 142 NATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
...++|.....+|+|.||.||+++ ..+++..|+|+++.....+..-.++|+-+++..+|||||.+++.+.. ...
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr-----~dk 86 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLR-----RDK 86 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhh-----hcC
Confidence 345789999999999999999999 67899999999998887788888999999999999999999998754 336
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.|+.||||.+|+|.+..+..+ .+++.++...++..+.||+||| +.|-+|||||-.||++++.|.+|++
T Consensus 87 lwicMEycgggslQdiy~~Tg---------plselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvkla 154 (829)
T KOG0576|consen 87 LWICMEYCGGGSLQDIYHVTG---------PLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLA 154 (829)
T ss_pred cEEEEEecCCCcccceeeecc---------cchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeec
Confidence 799999999999999877655 4678899999999999999999 9999999999999999999999999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCccc---cCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYD---LGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
|||.+..+... -.....+.||+.|||||+. ..+.|...+|||++|++..|+-.-++|-..... ++...-+-
T Consensus 155 Dfgvsaqitat--i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp----mr~l~LmT 228 (829)
T KOG0576|consen 155 DFGVSAQITAT--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP----MRALFLMT 228 (829)
T ss_pred ccCchhhhhhh--hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch----HHHHHHhh
Confidence 99998766432 3344567799999999975 356799999999999999999887777432211 11111111
Q ss_pred cC-cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 378 LP-QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 378 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.. .+...+-|+ ..-.+.+-++++.|+..+|++|||+..++.
T Consensus 229 kS~~qpp~lkDk-----------------------------~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 229 KSGFQPPTLKDK-----------------------------TKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred ccCCCCCcccCC-----------------------------ccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 11 111111111 112446778999999999999999987653
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-34 Score=246.44 Aligned_cols=203 Identities=21% Similarity=0.298 Sum_probs=164.5
Q ss_pred CCCccceeecCCCeEEEEEE-ecCCCEEEEEEeecc--CCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI--RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
+.+..+.||-|+||.||.+. -++|+.||+|++-.. +....+.+.+|++.|..++|.|++..+++..-...+--...|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 34456789999999999998 467999999988532 223456788999999999999999998876544333334568
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
+++|+| ..+|...|-... .++...+.-+++||++||.||| +.+|.||||||.|+|++.|..+||+||
T Consensus 134 V~TELm-QSDLHKIIVSPQ---------~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDF 200 (449)
T KOG0664|consen 134 VLTELM-QSDLHKIIVSPQ---------ALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDF 200 (449)
T ss_pred HHHHHH-HhhhhheeccCC---------CCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEeccc
Confidence 899998 568988887655 3556777789999999999999 999999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCCC-CCcccchhhHhHHHHHHHhCCCCCCC
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE-ASTYGDVYSFGILLLEMFTGIRPSDG 362 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~P~~~ 362 (473)
|+++...... ....+...-|..|.|||++.|.. |+.+.||||.|||+.||+.++..|..
T Consensus 201 GLARvee~d~-~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQA 260 (449)
T KOG0664|consen 201 GLARTWDQRD-RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQA 260 (449)
T ss_pred ccccccchhh-hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhc
Confidence 9998755433 22233334588999999998864 99999999999999999999888864
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=243.02 Aligned_cols=282 Identities=18% Similarity=0.192 Sum_probs=195.6
Q ss_pred ccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC--CCCchhHHHHHHHHHhcCCCCceeeeeeeecccc-CCc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY-QGA 218 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~ 218 (473)
...+|.-.+.+|.|+- .|..|. .-.+++||+|++.... ....++..+|...+..++|+||++++.+|.-... ...
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 4567888888999988 566555 4468999999886432 2344667899999999999999999999854321 223
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...|+|||+| .++|.+.+... +.-.....|..|++.|+.||| +.||+||||||+||++..+..+|
T Consensus 94 ~e~y~v~e~m-~~nl~~vi~~e-----------lDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lK 158 (369)
T KOG0665|consen 94 QEVYLVMELM-DANLCQVILME-----------LDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLK 158 (369)
T ss_pred HhHHHHHHhh-hhHHHHHHHHh-----------cchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhhee
Confidence 4579999999 67999988733 224677889999999999999 99999999999999999999999
Q ss_pred EeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 012014 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMAL 378 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~ 378 (473)
|.|||+|+.-.. .-..+....|..|.|||++.+..+...+||||+||++.||++|..-|.| +..+.+|.+..-
T Consensus 159 i~dfg~ar~e~~---~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g----~d~idQ~~ki~~ 231 (369)
T KOG0665|consen 159 ILDFGLARTEDT---DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPG----KDHIDQWNKIIE 231 (369)
T ss_pred eccchhhcccCc---ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecC----chHHHHHHHHHH
Confidence 999999985432 2233445678999999999998899999999999999999999998875 333444433210
Q ss_pred C-cch----hhhccccchHHHHhh---h-hhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 379 P-QRA----EEVVDDFNLQEIEEG---R-TMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 379 ~-~~~----~~~~~~~~~~~~~~~---~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
. +.+ ..-+.+......... . ..-.++.+...-....+...-......+|+.+||..||++|.|+++++.
T Consensus 232 ~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 232 QLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 0 000 000000000000000 0 0000000000000000111123556778999999999999999999864
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-32 Score=254.81 Aligned_cols=283 Identities=22% Similarity=0.270 Sum_probs=201.2
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcC------CCCceeeeeeeeccccC
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK------HRNIVRVFTAFSGVDYQ 216 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~~~ 216 (473)
.++|.+....|+|-|++|.+|. ...|..||||++.... --.+.=+.|+++|++|+ --|+++++..|..
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h---- 505 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH---- 505 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh----
Confidence 4678888889999999999998 4457899999997432 12234568999999994 3478899888755
Q ss_pred CceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCC-c
Q 012014 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE-M 295 (473)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~-~ 295 (473)
.+++|||+|-+ .-+|.++|+..+.. ..+....+..++.|+.-||..|- ..||+|.||||+|||+++. .
T Consensus 506 -knHLClVFE~L-slNLRevLKKyG~n------vGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~ 574 (752)
T KOG0670|consen 506 -KNHLCLVFEPL-SLNLREVLKKYGRN------VGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKN 574 (752)
T ss_pred -cceeEEEehhh-hchHHHHHHHhCcc------cceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcc
Confidence 34899999988 56999999887643 35668888999999999999999 9999999999999999865 4
Q ss_pred cEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHH-
Q 012014 296 IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFV- 374 (473)
Q Consensus 296 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~- 374 (473)
.+||||||.|....... .+...-+..|.|||++.|.+|+...|+||.||+||||.||+..|.|..+.++ +.-+.
T Consensus 575 iLKLCDfGSA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~M-Lrl~me 649 (752)
T KOG0670|consen 575 ILKLCDFGSASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQM-LRLFME 649 (752)
T ss_pred eeeeccCcccccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHH-HHHHHH
Confidence 68999999998664322 2223346679999999999999999999999999999999999998655443 11111
Q ss_pred -HhhcCcch-------hhhccccch---HHHHhh-----hhhhccc-------ccCCCCcchhhHHHHHHHHHHHHhhhc
Q 012014 375 -KMALPQRA-------EEVVDDFNL---QEIEEG-----RTMCMEV-------SSSSGSSAHASIILECFNSICEIGVAC 431 (473)
Q Consensus 375 -~~~~~~~~-------~~~~~~~~~---~~~~~~-----~~~~~~~-------~~~~~~~~~~~~~~~~~~~l~~l~~~c 431 (473)
+..+|... .+-+|..+. ...... ..+-... +........+.........|.+|+..|
T Consensus 650 ~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkm 729 (752)
T KOG0670|consen 650 LKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKM 729 (752)
T ss_pred hcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHH
Confidence 11111100 000000000 000000 0000000 001112223344556788999999999
Q ss_pred ccCCCCCCCChHHHHH
Q 012014 432 SAERPRERMKINDVES 447 (473)
Q Consensus 432 l~~dP~~RPt~~ev~~ 447 (473)
+..||++|.|..+.+.
T Consensus 730 l~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 730 LILDPEKRITVNQALK 745 (752)
T ss_pred hccChhhcCCHHHHhc
Confidence 9999999999988764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-30 Score=228.43 Aligned_cols=210 Identities=26% Similarity=0.455 Sum_probs=177.0
Q ss_pred eecCCCeEEEEEEec-CCCEEEEEEeeccCCC-CchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEEEEecCC
Q 012014 153 IGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPG-GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPN 230 (473)
Q Consensus 153 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~ 230 (473)
||+|++|.||++... +++.+++|++...... ....+.+|+..+..+.|++|+++++++... ...++++|++++
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~~~~e~~~~ 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDE-----NHLYLVMEYCEG 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecC-----CeEEEEEecCCC
Confidence 689999999999954 4899999998754322 246789999999999999999999997543 467999999999
Q ss_pred CCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecC-CccEEEeecccccccC
Q 012014 231 GSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD-EMIGHVGDFGMARFLP 309 (473)
Q Consensus 231 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~-~~~~kl~Dfg~~~~~~ 309 (473)
++|.+++..... .++...+..++.+++.+|.+|| +.+++|+||+|.||+++. ++.++|+|||.+....
T Consensus 76 ~~l~~~~~~~~~--------~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~ 144 (215)
T cd00180 76 GSLKDLLKENEG--------KLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLT 144 (215)
T ss_pred CcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEcc
Confidence 999999976521 3558899999999999999999 899999999999999999 8999999999998664
Q ss_pred ccccccceeeccCCCCcCCCccccCC-CCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchhhhccc
Q 012014 310 AIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDD 388 (473)
Q Consensus 310 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (473)
.... ......+...|++||..... .++.++|+|++|+++++|
T Consensus 145 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------- 187 (215)
T cd00180 145 SDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------- 187 (215)
T ss_pred CCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------
Confidence 4321 12234478889999998887 788999999999999999
Q ss_pred cchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 389 FNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
..+.+++..|++.||++||++.++++.
T Consensus 188 ---------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ---------------------------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ---------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 145579999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=228.36 Aligned_cols=255 Identities=17% Similarity=0.237 Sum_probs=189.6
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhc-CCCCceeeeeeeeccccCCceee
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
.+.|.+.+.||+|.||.+-+++ ..+++.+++|.+... ......|.+|...--.| .|.||+..|++. .++....
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~va----Fqt~d~Y 97 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVA----FQTSDAY 97 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHH----hhcCceE
Confidence 4678899999999999999999 456788999987532 33567888988765555 599999988775 3445578
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEec--CCccEEE
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD--DEMIGHV 299 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~--~~~~~kl 299 (473)
++++||++.|+|.+-+...+ +-+.....++.|+++|+.|+| ++++||||||.+||||- +...+||
T Consensus 98 vF~qE~aP~gdL~snv~~~G----------igE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKl 164 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEAAG----------IGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKL 164 (378)
T ss_pred EEeeccCccchhhhhcCccc----------ccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEe
Confidence 89999999999998877654 336777889999999999999 99999999999999993 4458999
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccCC-----CCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-----EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFV 374 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~ 374 (473)
+|||.++..+..- ....-+..|.+||..... ...+.+|||.||+++|.++||.+||......+..+..|.
T Consensus 165 cDFG~t~k~g~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~ 239 (378)
T KOG1345|consen 165 CDFGLTRKVGTTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWE 239 (378)
T ss_pred eecccccccCcee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHH
Confidence 9999997653321 112236679999975432 246788999999999999999999987666665555555
Q ss_pred HhhcCc--chhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHH
Q 012014 375 KMALPQ--RAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLI 452 (473)
Q Consensus 375 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l 452 (473)
...... ......+ ...+.+.++..+-+..+|++|--..++.+.-..+
T Consensus 240 ~w~~rk~~~~P~~F~-------------------------------~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~ 288 (378)
T KOG1345|consen 240 QWLKRKNPALPKKFN-------------------------------PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCL 288 (378)
T ss_pred HHhcccCccCchhhc-------------------------------ccCHHHHHHHHHhcCCcccccchhHHHHHHHHHH
Confidence 433221 1111111 1345667788889999999995555555444433
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=236.73 Aligned_cols=282 Identities=20% Similarity=0.259 Sum_probs=198.5
Q ss_pred cCCCCccceeecCCCeEEEEEEec----CCCEEEEEEeeccCCCCchhHHHHHHHHHhc-CCCCceeeeeeeeccccCCc
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTLF----DGTTIAVKVFNLIRPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 218 (473)
.+.|...++||+|.|++||++... ..+.||+|.+...+ ...++.+|++.|..+ .+.||+++.+++.. .
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rn-----n 107 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRN-----N 107 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhcc-----C
Confidence 356888999999999999999832 46789999987543 456789999999999 59999999998743 4
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecC-CccE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD-EMIG 297 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~-~~~~ 297 (473)
....+|+||++..+..+++... +..++..+++.++.||.++| .+|||||||||+|+|.+. .+.-
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~l------------~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg 172 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRSL------------SLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRG 172 (418)
T ss_pred CeeEEEecccCccCHHHHHhcC------------CHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCc
Confidence 4689999999999999988754 37788999999999999999 999999999999999974 3567
Q ss_pred EEeecccccccCccc------------------------------------------cccceeeccCCCCcCCCccccCC
Q 012014 298 HVGDFGMARFLPAID------------------------------------------KQNRFICIKGSTGYIPPEYDLGC 335 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~ 335 (473)
.|.|||+|....... .........||++|.|||++...
T Consensus 173 ~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~ 252 (418)
T KOG1167|consen 173 VLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRC 252 (418)
T ss_pred eEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhc
Confidence 899999997211000 00001134599999999998775
Q ss_pred C-CCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchhh---hccc---------cchHHHHhhhhhh-
Q 012014 336 E-ASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEE---VVDD---------FNLQEIEEGRTMC- 401 (473)
Q Consensus 336 ~-~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~---------~~~~~~~~~~~~~- 401 (473)
+ .++++||||.|||++.++++.+||-...+.-..+...+...-+..... ..+. .............
T Consensus 253 ~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~ 332 (418)
T KOG1167|consen 253 PRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLH 332 (418)
T ss_pred cCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccC
Confidence 5 788999999999999999999999776555555555443322211111 0010 0011111101011
Q ss_pred cccccCCCC-c-chhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 402 MEVSSSSGS-S-AHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 402 ~~~~~~~~~-~-~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.+....... . .........+..+.+|+.+|+..||.+|.|++|.++
T Consensus 333 ~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 333 IESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred hhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 000000000 0 111122234558899999999999999999999864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-29 Score=228.16 Aligned_cols=199 Identities=29% Similarity=0.451 Sum_probs=168.2
Q ss_pred CCccceeecCCCeEEEEEEecC-CCEEEEEEeeccCCC-CchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEE
Q 012014 147 FSSANLIGAGNFGSVYNGTLFD-GTTIAVKVFNLIRPG-GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVV 224 (473)
Q Consensus 147 ~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 224 (473)
|.+.+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|+..+.+++|+|++++++++... ...+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-----~~~~~v 75 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDP-----EPLYLV 75 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecC-----CceEEE
Confidence 5667889999999999999554 899999999765444 567889999999999999999999987543 367999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeeccc
Q 012014 225 YKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM 304 (473)
Q Consensus 225 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~ 304 (473)
+||+++++|.+++...... +++.....++.+++.++.+|| +++++|+||+|.||+++.++.++|+|||.
T Consensus 76 ~e~~~~~~L~~~~~~~~~~--------~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~ 144 (225)
T smart00221 76 MEYCEGGDLFDYLRKKGGK--------LSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGL 144 (225)
T ss_pred EeccCCCCHHHHHHhcccC--------CCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCce
Confidence 9999999999999765421 447888999999999999999 88999999999999999999999999999
Q ss_pred ccccCccccccceeeccCCCCcCCCccc-cCCCCCcccchhhHhHHHHHHHhCCCCCCC
Q 012014 305 ARFLPAIDKQNRFICIKGSTGYIPPEYD-LGCEASTYGDVYSFGILLLEMFTGIRPSDG 362 (473)
Q Consensus 305 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~elltg~~P~~~ 362 (473)
+........ .......++..|++||.. ....++.++|+||||+++++|++|+.||..
T Consensus 145 ~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 145 ARFIHRDLA-ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred eeEecCccc-ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 987654321 122334578889999998 666788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=213.72 Aligned_cols=170 Identities=19% Similarity=0.207 Sum_probs=128.2
Q ss_pred CCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecccccccCc
Q 012014 231 GSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPA 310 (473)
Q Consensus 231 g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 310 (473)
|||.+++..... .+++.+++.++.|++.||.||| +++ ||+|||++.++.+|+ ||+++....
T Consensus 1 GsL~~~l~~~~~--------~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~ 61 (176)
T smart00750 1 VSLADILEVRGR--------PLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTP 61 (176)
T ss_pred CcHHHHHHHhCC--------CCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecc
Confidence 789999976432 3679999999999999999999 666 999999999999999 999986543
Q ss_pred cccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchhhhccccc
Q 012014 311 IDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDDFN 390 (473)
Q Consensus 311 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 390 (473)
.. ..||+.|+|||++.+..++.++|||||||++|||++|..||.........+..+.....+..... .
T Consensus 62 ~~-------~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~-- 129 (176)
T smart00750 62 EQ-------SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRD---R-- 129 (176)
T ss_pred cc-------CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccc---c--
Confidence 21 25899999999999999999999999999999999999999754322222222211111100000 0
Q ss_pred hHHHHhhhhhhcccccCCCCcchhhHHHHHH--HHHHHHhhhcccCCCCCCCChHHHHHHHHHHHHh
Q 012014 391 LQEIEEGRTMCMEVSSSSGSSAHASIILECF--NSICEIGVACSAERPRERMKINDVESRLRLIRRK 455 (473)
Q Consensus 391 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~ 455 (473)
....... ..+.+++.+||+.||.+|||+.|+++.+..+...
T Consensus 130 ------------------------~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 130 ------------------------SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred ------------------------ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 0011122 3689999999999999999999999998887543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-29 Score=265.32 Aligned_cols=201 Identities=17% Similarity=0.244 Sum_probs=138.1
Q ss_pred hcCC-CCceeeeeeeeccccCC--ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhh
Q 012014 197 NIKH-RNIVRVFTAFSGVDYQG--ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHC 273 (473)
Q Consensus 197 ~l~h-~niv~~~~~~~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~ 273 (473)
.++| +||++++++|.....+. ....+.++||+ +++|.++|..... .+++.+++.++.||+.||.|||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH- 97 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDR--------SVDAFECFHVFRQIVEIVNAAH- 97 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccc--------cccHHHHHHHHHHHHHHHHHHH-
Confidence 3455 58888888873332111 23457788887 6799999975321 3668899999999999999999
Q ss_pred CCCCCeeeccCCCCcEEecCC-------------------ccEEEeecccccccCcccc--------------ccceeec
Q 012014 274 DCQPPIAHCNLKPSNVLLDDE-------------------MIGHVGDFGMARFLPAIDK--------------QNRFICI 320 (473)
Q Consensus 274 ~~~~~iiH~Dlkp~Nil~~~~-------------------~~~kl~Dfg~~~~~~~~~~--------------~~~~~~~ 320 (473)
++||+||||||+|||++.. +.+|++|||+++....... .......
T Consensus 98 --~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (793)
T PLN00181 98 --SQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILA 175 (793)
T ss_pred --hCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCccccccc
Confidence 9999999999999999654 4456666666653211000 0001123
Q ss_pred cCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhh
Q 012014 321 KGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTM 400 (473)
Q Consensus 321 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (473)
.||+.|||||++.+..++.++|||||||+||||++|..|+.... ..+........+ +.
T Consensus 176 ~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---~~~~~~~~~~~~--------~~----------- 233 (793)
T PLN00181 176 MEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---RTMSSLRHRVLP--------PQ----------- 233 (793)
T ss_pred CCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---HHHHHHHHhhcC--------hh-----------
Confidence 58899999999999999999999999999999999988865311 001111000000 00
Q ss_pred hcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 401 CMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
..........++.+||+.||.+|||+.||++
T Consensus 234 ----------------~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 234 ----------------ILLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred ----------------hhhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 0011223457888999999999999999975
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-26 Score=203.98 Aligned_cols=269 Identities=19% Similarity=0.276 Sum_probs=205.9
Q ss_pred ccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcC-CCCceeeeeeeeccccCCcee
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 220 (473)
..-+|+++++||+|+||.++.|. +.++++||||.-. ......++..|.+..+.|. .++|..+|.+- +...+
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEP--rkS~APQLrdEYr~YKlL~g~~GIP~vYYFG-----qeG~~ 98 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEP--RKSEAPQLRDEYRTYKLLGGTEGIPQVYYFG-----QEGKY 98 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEecc--ccCCcchHHHHHHHHHHHcCCCCCCceeeec-----cccch
Confidence 34479999999999999999999 7789999999743 2234567889999988884 78999988663 44556
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCC-----c
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE-----M 295 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~-----~ 295 (473)
-.||+|++ |-||.|+..-.+. .|+.++.+.++.|++.-++|+| ++.+|.|||||+|+||... .
T Consensus 99 NiLVidLL-GPSLEDLFD~CgR--------~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n 166 (449)
T KOG1165|consen 99 NILVIDLL-GPSLEDLFDLCGR--------RFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDAN 166 (449)
T ss_pred hhhhhhhh-CcCHHHHHHHhcC--------cccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCc
Confidence 78999999 8899998865543 5889999999999999999999 9999999999999999643 4
Q ss_pred cEEEeecccccccCcccccc-----ceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccH
Q 012014 296 IGHVGDFGMARFLPAIDKQN-----RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNL 370 (473)
Q Consensus 296 ~~kl~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~ 370 (473)
.+.++|||+|+.+.+..+.. ...+..||.+||+--...+...+..-|+=|||-++.+.+.|..||.|......
T Consensus 167 ~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn-- 244 (449)
T KOG1165|consen 167 VIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN-- 244 (449)
T ss_pred eEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcch--
Confidence 68999999999886654322 23456799999999999999999999999999999999999999998643321
Q ss_pred HHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHH
Q 012014 371 RNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLR 450 (473)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 450 (473)
. ...+.+-+...... ....+...|.++..-+.-.-+.+-.+-|..+-+...+.
T Consensus 245 K--------~kYeKIGe~Kr~T~-------------------i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~ 297 (449)
T KOG1165|consen 245 K--------EKYEKIGETKRSTP-------------------IEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFD 297 (449)
T ss_pred H--------HHHHHhccccccCC-------------------HHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence 0 11111111111111 11223446777777777777788899999888777777
Q ss_pred HHHHhhccC
Q 012014 451 LIRRKLLET 459 (473)
Q Consensus 451 ~l~~~~~~~ 459 (473)
.+.+.+...
T Consensus 298 dvldr~g~t 306 (449)
T KOG1165|consen 298 DVLDRLGET 306 (449)
T ss_pred HHHHhcCCc
Confidence 776554433
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.1e-28 Score=243.54 Aligned_cols=254 Identities=20% Similarity=0.224 Sum_probs=183.6
Q ss_pred CccceeecCCCeEEEEEE-ecCCCEEEEEEeecc--CCCCc----hhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 148 SSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI--RPGGS----KSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 148 ~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
....++|.|++|.|+.+. ....+..+.|.+... ..... ..+..|.-+-..+.|||++..+..+.+.. .
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~-----~ 395 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID-----G 395 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc-----c
Confidence 456789999999888776 333444555544311 11111 12556777777889999988877765432 1
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
..-.||||++ +|..++.... .+...++-.++.|++.|+.||| +.||.|||+||+|+++..+|.+||+
T Consensus 396 ~~~~mE~~~~-Dlf~~~~~~~---------~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~ 462 (601)
T KOG0590|consen 396 ILQSMEYCPY-DLFSLVMSNG---------KLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKII 462 (601)
T ss_pred chhhhhcccH-HHHHHHhccc---------ccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEe
Confidence 2233999999 9999998763 2446778889999999999999 9999999999999999999999999
Q ss_pred ecccccccCccccc--cceeeccCCCCcCCCccccCCCCCcc-cchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 301 DFGMARFLPAIDKQ--NRFICIKGSTGYIPPEYDLGCEASTY-GDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 301 Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
|||.+..+...... ......+|+..|+|||++.+..|.+. .||||.|+++..|.+|+.||.-....+..+.. ..
T Consensus 463 Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~---~~ 539 (601)
T KOG0590|consen 463 DFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT---NN 539 (601)
T ss_pred ecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh---hc
Confidence 99999776544333 44566789999999999999998765 69999999999999999999765544432200 00
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
........ ..........+..-..++.++|+.||.+|-|+++|++
T Consensus 540 ~~~~~~~~-------------------------~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 540 YSDQRNIF-------------------------EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cccccccc-------------------------cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00000000 0011122345667778999999999999999999964
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=219.33 Aligned_cols=165 Identities=20% Similarity=0.176 Sum_probs=127.7
Q ss_pred ccCCCCccceeecCCCeEEEEEEec--CCCEEEEEEeeccC-----CCCchhHHHHHHHHHhcCCCCcee-eeeeeeccc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTLF--DGTTIAVKVFNLIR-----PGGSKSFKSECKAAINIKHRNIVR-VFTAFSGVD 214 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~-~~~~~~~~~ 214 (473)
..++|.+.++||+|+||+||+|... +++.+|||++.... ......+.+|+++|.+++|+|++. ++++
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----- 90 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----- 90 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-----
Confidence 4568999999999999999999843 57788999865321 112456899999999999999985 4432
Q ss_pred cCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccC-CCCcEEecC
Q 012014 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNL-KPSNVLLDD 293 (473)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dl-kp~Nil~~~ 293 (473)
...++||||++|++|.. +.... ...++.|++.||.||| ++||+|||| ||+|||++.
T Consensus 91 ----~~~~LVmE~~~G~~L~~-~~~~~---------------~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~ 147 (365)
T PRK09188 91 ----GKDGLVRGWTEGVPLHL-ARPHG---------------DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGP 147 (365)
T ss_pred ----CCcEEEEEccCCCCHHH-hCccc---------------hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcC
Confidence 13599999999999963 21110 1357889999999999 999999999 999999999
Q ss_pred CccEEEeecccccccCccccccc------eeeccCCCCcCCCccccCC
Q 012014 294 EMIGHVGDFGMARFLPAIDKQNR------FICIKGSTGYIPPEYDLGC 335 (473)
Q Consensus 294 ~~~~kl~Dfg~~~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~ 335 (473)
++.+||+|||+|+.+........ .....+++.|+|||.+...
T Consensus 148 ~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 148 DGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred CCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99999999999987755332111 2356688999999987643
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-26 Score=194.55 Aligned_cols=264 Identities=20% Similarity=0.258 Sum_probs=201.9
Q ss_pred ccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCC-CCceeeeeeeeccccCCcee
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKH-RNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~ 220 (473)
..+.|.++++||+|+||.+|.|. ..+|..||||+-+. .....++..|.++...|+| ..|..+..+..+ ..+
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~--~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e-----~~y 85 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESS--KAKHPQLLYESKVYRILQGGVGIPHIRHYGTE-----KDY 85 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecc--cCCCcchhHHHHHHHHhccCCCCchhhhhccc-----ccc
Confidence 45789999999999999999999 77899999998542 2344578899999999975 567777666543 345
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecC---CccE
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD---EMIG 297 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~---~~~~ 297 (473)
-.+||+++ |.||.++..-... .|+..+.+-++-|++.-++|+| .+++|||||||+|+|..- ...+
T Consensus 86 nvlVMdLL-GPsLEdLfnfC~R--------~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl 153 (341)
T KOG1163|consen 86 NVLVMDLL-GPSLEDLFNFCSR--------RFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKL 153 (341)
T ss_pred ceeeeecc-CccHHHHHHHHhh--------hhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceE
Confidence 68999999 8899998865432 5889999999999999999999 999999999999999953 3468
Q ss_pred EEeecccccccCcccccc-----ceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcc--cH
Q 012014 298 HVGDFGMARFLPAIDKQN-----RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKM--NL 370 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~--~~ 370 (473)
.|+|||+|+.+-+..... ......||..|.+--...+...+...|+=|+|.+|.++..|..||.+...... -+
T Consensus 154 ~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKy 233 (341)
T KOG1163|consen 154 YLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKY 233 (341)
T ss_pred EEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHH
Confidence 899999999876543222 23355699999998888888888999999999999999999999998644321 11
Q ss_pred HHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHH
Q 012014 371 RNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLR 450 (473)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 450 (473)
..+.+......+. ..+...|.++.-.+.-|-..--++-|...-+-+...
T Consensus 234 EkI~EkK~s~~ie-------------------------------~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr 282 (341)
T KOG1163|consen 234 EKISEKKMSTPIE-------------------------------VLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR 282 (341)
T ss_pred HHHHHhhcCCCHH-------------------------------HHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence 1111111111111 123345777888888888888888898877777777
Q ss_pred HHHHhh
Q 012014 451 LIRRKL 456 (473)
Q Consensus 451 ~l~~~~ 456 (473)
.|...+
T Consensus 283 iLfr~l 288 (341)
T KOG1163|consen 283 ILFRTL 288 (341)
T ss_pred HHHhhc
Confidence 776544
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.2e-25 Score=210.68 Aligned_cols=264 Identities=19% Similarity=0.191 Sum_probs=196.2
Q ss_pred CCCccceeecCCCeEEEEEEecC--CCEEEEEEeeccCCCCchhHHHHHHHHHhcCC----CCceeeeeeeeccccCCce
Q 012014 146 GFSSANLIGAGNFGSVYNGTLFD--GTTIAVKVFNLIRPGGSKSFKSECKAAINIKH----RNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~~~~~~~~~~~~~~~ 219 (473)
+|.+.++||+|+||.||.+.... ...+|+|............+..|..++..+.. +++.++++... ....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~ 94 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED 94 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence 89999999999999999999544 35789988775443333378899999998873 68888887753 2344
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCC-----
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE----- 294 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~----- 294 (473)
+.++||+.+ |.+|.++....... .|+..+.+.|+.|++.+|++|| +.|++||||||+|+++...
T Consensus 95 ~~~iVM~l~-G~sL~dl~~~~~~~-------~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~ 163 (322)
T KOG1164|consen 95 FNFIVMSLL-GPSLEDLRKRNPPG-------RFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEV 163 (322)
T ss_pred eeEEEEecc-CccHHHHHHhCCCC-------CcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCccc
Confidence 679999988 88999988655421 5789999999999999999999 9999999999999999754
Q ss_pred ccEEEeeccccc--ccCccccc----c-c-eeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCC
Q 012014 295 MIGHVGDFGMAR--FLPAIDKQ----N-R-FICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTG 366 (473)
Q Consensus 295 ~~~kl~Dfg~~~--~~~~~~~~----~-~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~ 366 (473)
..+.|.|||+++ .+...... . . .....||..|+++.+..+...+.+.|+||++.++.+++.|..||.+....
T Consensus 164 ~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~ 243 (322)
T KOG1164|consen 164 RTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMT 243 (322)
T ss_pred ceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccccc
Confidence 468999999998 33222211 0 1 23456999999999999999999999999999999999999999765432
Q ss_pred cccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHH
Q 012014 367 KMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVE 446 (473)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~ 446 (473)
.. ...+........... .....+..+.++...+-+.+..++|....+.
T Consensus 244 ~~-~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~ 291 (322)
T KOG1164|consen 244 DL-KSKFEKDPRKLLTDR-------------------------------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLA 291 (322)
T ss_pred ch-HHHHHHHhhhhcccc-------------------------------ccCCChHHHHHHHHHhhccCCcCCCCHHHHH
Confidence 21 111111000000000 0011344566666666668999999999999
Q ss_pred HHHHHHHHhh
Q 012014 447 SRLRLIRRKL 456 (473)
Q Consensus 447 ~~L~~l~~~~ 456 (473)
..|+.....-
T Consensus 292 ~~l~~~~~~~ 301 (322)
T KOG1164|consen 292 ELLKDVFDSE 301 (322)
T ss_pred HHHHHHHHhc
Confidence 9988876553
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.2e-27 Score=203.18 Aligned_cols=249 Identities=20% Similarity=0.277 Sum_probs=186.6
Q ss_pred CCccceeecCCCeEEEEEEecCCCEEEEEEeecc--CCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEE
Q 012014 147 FSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLI--RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVV 224 (473)
Q Consensus 147 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 224 (473)
.....+|.+...|+.|+|+|. |..++.|+++.. .....+.|..|.-.|+-+.||||..+++.|..+ ..+.++
T Consensus 192 lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp-----pnlv~i 265 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP-----PNLVII 265 (448)
T ss_pred hhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC-----CCceEe
Confidence 345567889999999999974 456667887632 334456799999999999999999999998654 467899
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe--ec
Q 012014 225 YKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG--DF 302 (473)
Q Consensus 225 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~--Df 302 (473)
..||+.|+|...|+..... -..-.++.+++.++++|++|||+- ..-|.---|.+..+++|++.+++|+ |-
T Consensus 266 sq~mp~gslynvlhe~t~v-------vvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~ 337 (448)
T KOG0195|consen 266 SQYMPFGSLYNVLHEQTSV-------VVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADT 337 (448)
T ss_pred eeeccchHHHHHHhcCccE-------EEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccc
Confidence 9999999999999887532 344678999999999999999954 3334455688999999999988774 32
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCCCC---CcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcC
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEA---STYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP 379 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 379 (473)
-++.. .....-.|.||+||.+...+- -.++|+|||.+++|||.|+..||......+-....-+...
T Consensus 338 kfsfq---------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialegl-- 406 (448)
T KOG0195|consen 338 KFSFQ---------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGL-- 406 (448)
T ss_pred eeeee---------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccc--
Confidence 22211 111123788999999987653 3568999999999999999999987654432222111111
Q ss_pred cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHH
Q 012014 380 QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIR 453 (473)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~ 453 (473)
+..+++.....+.+|+.-|++.||.+||.+..|+-.||++.
T Consensus 407 ---------------------------------rv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 407 ---------------------------------RVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ---------------------------------cccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 11122335567889999999999999999999999999874
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-24 Score=191.53 Aligned_cols=177 Identities=11% Similarity=0.094 Sum_probs=135.0
Q ss_pred ccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchh---------HHHHHHHHHhcCCCCceeeeeeeecc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKS---------FKSECKAAINIKHRNIVRVFTAFSGV 213 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h~niv~~~~~~~~~ 213 (473)
..++|+..++||.|+||.||++.. ++..+|+|++.......... +.+|+..+.++.||+|....+++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 367899999999999999999765 67789999997544333322 67999999999999999999886643
Q ss_pred ccCC---ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEE
Q 012014 214 DYQG---ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVL 290 (473)
Q Consensus 214 ~~~~---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil 290 (473)
.... ....+++|||++|.+|.++.. ++. ....+++.+|..+| +.|++|||+||+||+
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nil 167 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFI 167 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEE
Confidence 3211 235789999999999988732 112 24569999999999 999999999999999
Q ss_pred ecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh
Q 012014 291 LDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT 355 (473)
Q Consensus 291 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt 355 (473)
++.++ ++|+|||.+......... ..+.....+..++|+||||+++..+..
T Consensus 168 i~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 168 VSKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred EeCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 99988 999999988654221100 013334456678999999999876643
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.1e-23 Score=197.06 Aligned_cols=259 Identities=26% Similarity=0.369 Sum_probs=193.5
Q ss_pred CCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCC---CchhHHHHHHHHHhcCCC-CceeeeeeeeccccCCceeeE
Q 012014 147 FSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG---GSKSFKSECKAAINIKHR-NIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 147 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~~~~~~ 222 (473)
|.....||.|+||.||++... ..+++|.+...... ....+.+|+.++..+.|+ +|+++++.+... ...+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-----~~~~ 74 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDE-----GSLY 74 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecC-----CEEE
Confidence 667788999999999999855 88999998754433 356789999999999988 799999998332 2369
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCc-cEEEee
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM-IGHVGD 301 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~-~~kl~D 301 (473)
++++++.++++.+++...... ..+.......++.|++.++.|+| ..+++|||+||+||+++..+ .++++|
T Consensus 75 ~~~~~~~~~~l~~~~~~~~~~------~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~d 145 (384)
T COG0515 75 LVMEYVDGGSLEDLLKKIGRK------GPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLID 145 (384)
T ss_pred EEEecCCCCcHHHHHHhcccc------cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEec
Confidence 999999999999777655321 13557888999999999999999 89999999999999999988 799999
Q ss_pred cccccccCcccccc----ceeeccCCCCcCCCccccC---CCCCcccchhhHhHHHHHHHhCCCCCCCCCCC--cccHHH
Q 012014 302 FGMARFLPAIDKQN----RFICIKGSTGYIPPEYDLG---CEASTYGDVYSFGILLLEMFTGIRPSDGIFTG--KMNLRN 372 (473)
Q Consensus 302 fg~~~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~P~~~~~~~--~~~~~~ 372 (473)
||.++......... ......||..|+|||.+.+ ..++...|+||+|++++++++|..||...... ......
T Consensus 146 fg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~ 225 (384)
T COG0515 146 FGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK 225 (384)
T ss_pred cCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHH
Confidence 99998654433221 2355679999999999987 57888999999999999999999997654321 111111
Q ss_pred HHHhhcCc-chhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 373 FVKMALPQ-RAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 373 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
.+...... ........ ........+.+++..|+..+|..|.+..+....
T Consensus 226 ~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 226 IILELPTPSLASPLSPS---------------------------NPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred HHHhcCCcccccccCcc---------------------------ccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 11111111 00000000 001234567789999999999999998887765
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=183.00 Aligned_cols=139 Identities=15% Similarity=0.131 Sum_probs=106.3
Q ss_pred cceeecCCCeEEEEEEecCCCEEEEEEeeccCCC--C-------chh-----------------HHHHHHHHHhcCCCCc
Q 012014 150 ANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--G-------SKS-----------------FKSECKAAINIKHRNI 203 (473)
Q Consensus 150 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~-------~~~-----------------~~~E~~~l~~l~h~ni 203 (473)
...||+|+||.||+|...+|+.||+|+++..... . ... ..+|++++.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999999768999999999754221 1 112 2349999999988776
Q ss_pred eeeeeeeeccccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHH-hhCCCCCeeec
Q 012014 204 VRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYL-HCDCQPPIAHC 282 (473)
Q Consensus 204 v~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~L-H~~~~~~iiH~ 282 (473)
.....+.. ...++||||++++++...+.... .++..++..++.|++.+|.++ | +.||+||
T Consensus 82 ~~p~~~~~-------~~~~iVmE~i~g~~l~~~~~~~~---------~~~~~~~~~i~~qi~~~L~~l~H---~~giiHr 142 (190)
T cd05147 82 PCPEPILL-------KSHVLVMEFIGDDGWAAPRLKDA---------PLSESKARELYLQVIQIMRILYQ---DCRLVHA 142 (190)
T ss_pred CCCcEEEe-------cCCEEEEEEeCCCCCcchhhhcC---------CCCHHHHHHHHHHHHHHHHHHHH---hCCcccC
Confidence 43332211 12389999998887765432222 355788999999999999999 8 8899999
Q ss_pred cCCCCcEEecCCccEEEeeccccccc
Q 012014 283 NLKPSNVLLDDEMIGHVGDFGMARFL 308 (473)
Q Consensus 283 Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 308 (473)
||||+||+++ ++.++|+|||+|...
T Consensus 143 DlkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 143 DLSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCCHHHEEEE-CCcEEEEEccccccC
Confidence 9999999998 478999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.8e-22 Score=175.85 Aligned_cols=139 Identities=17% Similarity=0.143 Sum_probs=107.9
Q ss_pred cceeecCCCeEEEEEEecCCCEEEEEEeeccCCCC--------------------------chhHHHHHHHHHhcCCCCc
Q 012014 150 ANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGG--------------------------SKSFKSECKAAINIKHRNI 203 (473)
Q Consensus 150 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~h~ni 203 (473)
...||+|+||.||+|...+|+.||||+++...... ...+.+|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46799999999999996689999999998542110 1123578999999999987
Q ss_pred eeeeeeeeccccCCceeeEEEEEecCCCCHHHH-hcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCC-CCeee
Q 012014 204 VRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEW-LRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQ-PPIAH 281 (473)
Q Consensus 204 v~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~iiH 281 (473)
.....+... ..++||||++++++... +... .++..+...++.|++.+|.++| + +||+|
T Consensus 82 ~~p~~~~~~-------~~~lVmE~~~g~~~~~~~l~~~----------~~~~~~~~~i~~~l~~~l~~lH---~~~givH 141 (190)
T cd05145 82 PVPEPILLK-------KNVLVMEFIGDDGSPAPRLKDV----------PLEEEEAEELYEQVVEQMRRLY---QEAGLVH 141 (190)
T ss_pred CCceEEEec-------CCEEEEEEecCCCchhhhhhhc----------cCCHHHHHHHHHHHHHHHHHHH---HhCCEec
Confidence 544333211 23899999988855433 3322 2446788999999999999999 7 99999
Q ss_pred ccCCCCcEEecCCccEEEeecccccccC
Q 012014 282 CNLKPSNVLLDDEMIGHVGDFGMARFLP 309 (473)
Q Consensus 282 ~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 309 (473)
|||||+||+++ ++.++|+|||+++...
T Consensus 142 rDlkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 142 GDLSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCChhhEEEE-CCCEEEEEcccceecC
Confidence 99999999999 7899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.4e-22 Score=170.26 Aligned_cols=187 Identities=13% Similarity=-0.009 Sum_probs=138.6
Q ss_pred CccceeecCCCeEEEEEEecCCCEEEEEEeeccCCC----CchhHHHHHHHHHhcC-CCCceeeeeeeeccccCCceeeE
Q 012014 148 SSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG----GSKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 148 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
.+...|++|+||+||.+.. .+.+++.+.+.....- ....+.+|+++|.+|. |+++++++++. ..+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~---------~~~ 74 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD---------GRH 74 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc---------CEE
Confidence 4567899999999998764 7888888877643221 1125789999999995 58899998762 348
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccC-CCCcEEecCCccEEEee
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNL-KPSNVLLDDEMIGHVGD 301 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dl-kp~Nil~~~~~~~kl~D 301 (473)
++|||+.|.+|.+.+.. ....++.|++.+|.++| ++||+|||| ||+|||++.++.++|+|
T Consensus 75 lvmeyI~G~~L~~~~~~----------------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LID 135 (218)
T PRK12274 75 LDRSYLAGAAMYQRPPR----------------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVID 135 (218)
T ss_pred EEEeeecCccHHhhhhh----------------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEE
Confidence 99999999998754321 11347789999999999 999999999 79999999999999999
Q ss_pred cccccccCccccc----cc-------eeeccCCCCcCCCccccCC-CCC-cccchhhHhHHHHHHHhCCCCCCCC
Q 012014 302 FGMARFLPAIDKQ----NR-------FICIKGSTGYIPPEYDLGC-EAS-TYGDVYSFGILLLEMFTGIRPSDGI 363 (473)
Q Consensus 302 fg~~~~~~~~~~~----~~-------~~~~~gt~~y~aPE~~~~~-~~~-~~~DiwSlG~il~elltg~~P~~~~ 363 (473)
||++......... .. ..-...++.|++|+...-- ..+ ...+.++.|.-+|.++|+..|+-+.
T Consensus 136 FG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 136 FQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred CCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 9999865432210 00 0012257788888753321 223 4568999999999999999887554
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.7e-22 Score=182.36 Aligned_cols=203 Identities=23% Similarity=0.236 Sum_probs=143.5
Q ss_pred CCCCceeeeeeeeccc----------------------cCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHH
Q 012014 199 KHRNIVRVFTAFSGVD----------------------YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKK 256 (473)
Q Consensus 199 ~h~niv~~~~~~~~~~----------------------~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~ 256 (473)
+|||||+++++|.+.- +.....+|+||.-. ..+|.+|+-.+.. +...
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~~----------s~r~ 342 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRHR----------SYRT 342 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCCC----------chHH
Confidence 6999999999885431 22345679999988 4599999977643 3566
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEe--cCCc--cEEEeecccccccCcccc----ccceeeccCCCCcCC
Q 012014 257 KLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL--DDEM--IGHVGDFGMARFLPAIDK----QNRFICIKGSTGYIP 328 (473)
Q Consensus 257 ~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~--~~~~--~~kl~Dfg~~~~~~~~~~----~~~~~~~~gt~~y~a 328 (473)
..-++.|+++|+.||| .+||.|||+|++|||+ |+++ .+.|+|||++-.-....- .......-|...-||
T Consensus 343 ~~~~laQlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmA 419 (598)
T KOG4158|consen 343 GRVILAQLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMA 419 (598)
T ss_pred HHHHHHHHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecc
Confidence 7778999999999999 9999999999999999 4444 578999998743222111 111122347778999
Q ss_pred CccccCCC------CCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhc
Q 012014 329 PEYDLGCE------ASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCM 402 (473)
Q Consensus 329 PE~~~~~~------~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (473)
||+....+ .-.|+|.|+.|.+.||+++...||.+..........+-+...
T Consensus 420 PEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qL------------------------ 475 (598)
T KOG4158|consen 420 PEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQL------------------------ 475 (598)
T ss_pred hhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhC------------------------
Confidence 99876533 235789999999999999999999862211111111111111
Q ss_pred ccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHH
Q 012014 403 EVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLR 450 (473)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 450 (473)
+..+..++..+.+|+...|+.||++|||..=....|+
T Consensus 476 -----------Palp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 476 -----------PALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred -----------CCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence 1122346677889999999999999999765555544
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2e-23 Score=202.02 Aligned_cols=186 Identities=26% Similarity=0.266 Sum_probs=153.6
Q ss_pred eeecCCCeEEEEEEe----cCCCEEEEEEeeccCCC--CchhHHHHHHHHHhcC-CCCceeeeeeeeccccCCceeeEEE
Q 012014 152 LIGAGNFGSVYNGTL----FDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQGARFKAVV 224 (473)
Q Consensus 152 ~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv 224 (473)
++|+|+||.|++++. ..|..+|+|+++..... .......|..++...+ ||.+|++...|.. ....+++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt-----~~kl~l~ 75 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT-----DGKLYLI 75 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc-----ccchhHh
Confidence 479999999998762 34678899988753322 2225567888888886 9999999988643 4467999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeeccc
Q 012014 225 YKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM 304 (473)
Q Consensus 225 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~ 304 (473)
++|..+|+|...+.... .+.......+...++-|++++| +.+|+|||+|++||+++.+|++++.|||+
T Consensus 76 ld~~rgg~lft~l~~~~---------~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfgl 143 (612)
T KOG0603|consen 76 LDFLRGGDLFTRLSKEV---------MFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGL 143 (612)
T ss_pred hhhcccchhhhccccCC---------chHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchh
Confidence 99999999998887665 3456677778889999999999 99999999999999999999999999999
Q ss_pred ccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCC
Q 012014 305 ARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362 (473)
Q Consensus 305 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 362 (473)
++..-..... +||..|||||++. ....++|.||||++++||+||..||.+
T Consensus 144 ske~v~~~~~------cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 144 SKEAVKEKIA------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred hhHhHhhhhc------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 9876432221 7999999999998 577889999999999999999999986
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.1e-21 Score=170.63 Aligned_cols=140 Identities=23% Similarity=0.267 Sum_probs=106.0
Q ss_pred CccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhc-----CCCCceeeeeeeeccccCCceeeE
Q 012014 148 SSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-----KHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 148 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
....+||+|+||.||. ...++.. +||++........+.+.+|+.++..+ +||||+++++++.+.. .......
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~-g~g~v~~ 81 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC-GTGYVYD 81 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC-CCeEEEE
Confidence 4467899999999996 3233444 68988765444567899999999999 6799999999986642 1122244
Q ss_pred EEEEe--cCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHH-HHHhhCCCCCeeeccCCCCcEEecC----Cc
Q 012014 223 VVYKF--MPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACAL-RYLHCDCQPPIAHCNLKPSNVLLDD----EM 295 (473)
Q Consensus 223 lv~e~--~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L-~~LH~~~~~~iiH~Dlkp~Nil~~~----~~ 295 (473)
+|+|| +.+|+|.+++.... +++. ..++.|++.++ +||| +++|+||||||+|||++. ++
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~~----------~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~ 146 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQCR----------YEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEV 146 (210)
T ss_pred EEecCCCCcchhHHHHHHccc----------ccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCC
Confidence 78999 55799999996532 2233 35678888888 9999 999999999999999974 34
Q ss_pred cEEEeecccc
Q 012014 296 IGHVGDFGMA 305 (473)
Q Consensus 296 ~~kl~Dfg~~ 305 (473)
.++|+||+.+
T Consensus 147 ~~~LiDg~G~ 156 (210)
T PRK10345 147 IPVVCDNIGE 156 (210)
T ss_pred cEEEEECCCC
Confidence 7999995443
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-21 Score=189.42 Aligned_cols=219 Identities=23% Similarity=0.293 Sum_probs=157.9
Q ss_pred HHhcCCCCceeeeeeeeccccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhC
Q 012014 195 AINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCD 274 (473)
Q Consensus 195 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~ 274 (473)
|+.+.|.|+.+++|.+.+. ...++|.+||..|+|.+.+..... .+.+.-...++++|+.||.|||
T Consensus 1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~~~~--------~~d~~F~~s~~rdi~~Gl~ylh-- 65 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSNEDI--------KLDYFFILSFIRDISKGLAYLH-- 65 (484)
T ss_pred CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhcccc--------CccHHHHHHHHHHHHHHHHHHh--
Confidence 3568999999999998664 467999999999999999987432 3446667778999999999999
Q ss_pred CCCCe-eeccCCCCcEEecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCC-------CCcccchhhH
Q 012014 275 CQPPI-AHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE-------ASTYGDVYSF 346 (473)
Q Consensus 275 ~~~~i-iH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwSl 346 (473)
...| .|+.+++.|.++|....+||+|||+.................-..-|.|||.+.+.. .+.+.|||||
T Consensus 66 -~s~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~ 144 (484)
T KOG1023|consen 66 -NSPIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSF 144 (484)
T ss_pred -cCcceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehH
Confidence 4444 999999999999999999999999987764311111111112345699999987641 4667899999
Q ss_pred hHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHH
Q 012014 347 GILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICE 426 (473)
Q Consensus 347 G~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 426 (473)
|++++|+++...||+........ ...+..... .......+.+.. ..+.++.+..
T Consensus 145 ~ii~~ei~~r~~~~~~~~~~~~~-~eii~~~~~-~~~~~~rP~i~~------------------------~~e~~~~l~~ 198 (484)
T KOG1023|consen 145 GIIMYEILFRSGPFDLRNLVEDP-DEIILRVKK-GGSNPFRPSIEL------------------------LNELPPELLL 198 (484)
T ss_pred HHHHHHHHhccCccccccccCCh-HHHHHHHHh-cCCCCcCcchhh------------------------hhhcchHHHH
Confidence 99999999999999864333221 111111000 001111110000 0134557899
Q ss_pred HhhhcccCCCCCCCChHHHHHHHHHHHHh
Q 012014 427 IGVACSAERPRERMKINDVESRLRLIRRK 455 (473)
Q Consensus 427 l~~~cl~~dP~~RPt~~ev~~~L~~l~~~ 455 (473)
++.+||..+|.+||++.+|-..++.+...
T Consensus 199 l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 199 LVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred HHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 99999999999999999999999988654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.9e-22 Score=205.02 Aligned_cols=250 Identities=20% Similarity=0.234 Sum_probs=176.2
Q ss_pred CCCccceeecCCCeEEEEEEecCCCEEEEEEeeccC-CCCchhHHHHHHH--HHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 146 GFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIR-PGGSKSFKSECKA--AINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
+|...+.||++.|=.|.+|+.+.|. |+||++-+.. .-..+.+.++++- ...++|||.+.+.-+- ......|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~-----~t~kAAy 97 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVL-----VTDKAAY 97 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHH-----HhhHHHH
Confidence 5677788999999999999977777 9999997544 2334445443333 4556899999887653 3344568
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
||=+|.. -+|.|.|..+. .+..-+..-|+.|++.||..+| ..||+|||||.+||||+.-..+.|+||
T Consensus 98 lvRqyvk-hnLyDRlSTRP---------FL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDF 164 (1431)
T KOG1240|consen 98 LVRQYVK-HNLYDRLSTRP---------FLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDF 164 (1431)
T ss_pred HHHHHHh-hhhhhhhccch---------HHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcc
Confidence 8888884 48999887654 4557778889999999999999 999999999999999999999999999
Q ss_pred ccccc--cCccccccc---eeeccCCCCcCCCccccCC----------C-CCcccchhhHhHHHHHHHh-CCCCCCCCCC
Q 012014 303 GMARF--LPAIDKQNR---FICIKGSTGYIPPEYDLGC----------E-ASTYGDVYSFGILLLEMFT-GIRPSDGIFT 365 (473)
Q Consensus 303 g~~~~--~~~~~~~~~---~~~~~gt~~y~aPE~~~~~----------~-~~~~~DiwSlG~il~ellt-g~~P~~~~~~ 365 (473)
..-+. ++.+....- ..+...-..|.|||.+... . .+++.||||+||+++||++ |++||.-
T Consensus 165 AsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L--- 241 (1431)
T KOG1240|consen 165 ASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL--- 241 (1431)
T ss_pred cccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH---
Confidence 87653 222221111 1111122359999976431 2 5778899999999999999 7888852
Q ss_pred CcccHHHHHHhhc--CcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChH
Q 012014 366 GKMNLRNFVKMAL--PQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKIN 443 (473)
Q Consensus 366 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 443 (473)
.+...-.. ....+.+ +..++ ...+..|+..|++.||.+|.|++
T Consensus 242 -----SQL~aYr~~~~~~~e~~-----Le~Ie-------------------------d~~~Rnlil~Mi~rdPs~RlSAe 286 (1431)
T KOG1240|consen 242 -----SQLLAYRSGNADDPEQL-----LEKIE-------------------------DVSLRNLILSMIQRDPSKRLSAE 286 (1431)
T ss_pred -----HHHHhHhccCccCHHHH-----HHhCc-------------------------CccHHHHHHHHHccCchhccCHH
Confidence 22111100 0011111 11111 12567899999999999999999
Q ss_pred HHHHHHHHH
Q 012014 444 DVESRLRLI 452 (473)
Q Consensus 444 ev~~~L~~l 452 (473)
+.++.-+++
T Consensus 287 dyL~~yrG~ 295 (1431)
T KOG1240|consen 287 DYLQKYRGL 295 (1431)
T ss_pred HHHHhhhcc
Confidence 999885554
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.6e-21 Score=178.03 Aligned_cols=239 Identities=19% Similarity=0.224 Sum_probs=147.2
Q ss_pred CCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCC---CchhHHHHHHHHHhcCC----------CCceeeeeeee
Q 012014 146 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG---GSKSFKSECKAAINIKH----------RNIVRVFTAFS 211 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h----------~niv~~~~~~~ 211 (473)
.+.....||.|+++.||.++. .+|+.+|+|++...... ..+.+++|.-....+.+ -.++.-++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 345678899999999999994 56899999999744322 23455555544333222 11111111111
Q ss_pred c--------ccc-CCce---eeEEEEEecCCCCHHHHhcC---CCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCC
Q 012014 212 G--------VDY-QGAR---FKAVVYKFMPNGSLEEWLRG---KDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQ 276 (473)
Q Consensus 212 ~--------~~~-~~~~---~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~ 276 (473)
- ... .+.. ..+++|+-+ .+||.+++.. .... ...+....++.+..|+++.+++|| +
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~-----~~~l~~~arl~lT~Q~I~lvA~Lh---~ 163 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQT-----HSPLAFAARLSLTVQMIRLVANLH---S 163 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTT-----SHHHHHHHHHHHHHHHHHHHHHHH---H
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccc-----cchhHHHHHHHHHHHHHHHHHHHh---h
Confidence 0 000 0011 246788877 6788887643 2211 123445556778899999999999 9
Q ss_pred CCeeeccCCCCcEEecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccC--------CCCCcccchhhHhH
Q 012014 277 PPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG--------CEASTYGDVYSFGI 348 (473)
Q Consensus 277 ~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~ 348 (473)
.|++|+||+|+|++++.+|.++|+||+.....+... .....+..|.+||.... ..++.+.|.|+||+
T Consensus 164 ~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~-----~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~ 238 (288)
T PF14531_consen 164 YGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRY-----RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGI 238 (288)
T ss_dssp TTEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEE-----EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHH
T ss_pred cceEecccceeeEEEcCCCCEEEcChHHHeecCcee-----eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHH
Confidence 999999999999999999999999998876543311 11234677999997543 24788899999999
Q ss_pred HHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHh
Q 012014 349 LLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIG 428 (473)
Q Consensus 349 il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 428 (473)
++|.|++|..||........... .+ ..+.+.++.+..|+
T Consensus 239 ~ly~lWC~~lPf~~~~~~~~~~~---------------------~f--------------------~~C~~~Pe~v~~LI 277 (288)
T PF14531_consen 239 TLYSLWCGRLPFGLSSPEADPEW---------------------DF--------------------SRCRDMPEPVQFLI 277 (288)
T ss_dssp HHHHHHHSS-STCCCGGGSTSGG---------------------GG--------------------TTSS---HHHHHHH
T ss_pred HHHHHHHccCCCCCCCccccccc---------------------cc--------------------hhcCCcCHHHHHHH
Confidence 99999999999986432221000 10 11225788999999
Q ss_pred hhcccCCCCCC
Q 012014 429 VACSAERPRER 439 (473)
Q Consensus 429 ~~cl~~dP~~R 439 (473)
..+|+.||.+|
T Consensus 278 ~~lL~~~~~~R 288 (288)
T PF14531_consen 278 RGLLQRNPEDR 288 (288)
T ss_dssp HHHT-SSGGGS
T ss_pred HHHccCCcccC
Confidence 99999999988
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.1e-21 Score=196.68 Aligned_cols=197 Identities=21% Similarity=0.207 Sum_probs=152.0
Q ss_pred cccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcC---CCCceeeeeeeeccccCCc
Q 012014 142 NATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK---HRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~ 218 (473)
.....|.+.+.||+|+||.||+|...+|+.||+|+=+.. ..-+|.-=.+++.+|+ -+-|.++..++.- +
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~---~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~---~-- 766 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPP---NPWEFYICLQVMERLKPQMLPSIMHISSAHVF---Q-- 766 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCC---CceeeeehHHHHHhhchhhhcchHHHHHHHcc---C--
Confidence 334568889999999999999999777999999986532 2233333344555555 1233333333221 1
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEec------
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD------ 292 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~------ 292 (473)
..-+||+||.+.|+|.+++.... .+.+.-.+.++.|++.-+++|| ..+|||+||||+|.||.
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~~~---------~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~ 834 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINTNK---------VMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICAD 834 (974)
T ss_pred CcceeeeeccccccHHHhhccCC---------CCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCC
Confidence 23379999999999999998544 3447778889999999999999 99999999999999993
Q ss_pred -CCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCC
Q 012014 293 -DEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIR 358 (473)
Q Consensus 293 -~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~ 358 (473)
++..++|+|||.+-.+.--.........++|-.+-.+|+..|.+++...|.|.|..+++.|+.|++
T Consensus 835 ~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 835 SDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred CcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 244689999999965544344456667788999999999999999999999999999999999864
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=9e-20 Score=165.49 Aligned_cols=141 Identities=15% Similarity=0.078 Sum_probs=108.8
Q ss_pred CCCccceeecCCCeEEEEEE--ecCCCEEEEEEeeccCCCC------------------------chhHHHHHHHHHhcC
Q 012014 146 GFSSANLIGAGNFGSVYNGT--LFDGTTIAVKVFNLIRPGG------------------------SKSFKSECKAAINIK 199 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~--~~~~~~vavK~~~~~~~~~------------------------~~~~~~E~~~l~~l~ 199 (473)
.|++.+.||+|+||.||+|. ..+|+.||+|+++...... ...+.+|+.++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788999999999999998 5689999999987432110 012568999999997
Q ss_pred CC--CceeeeeeeeccccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCC
Q 012014 200 HR--NIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQP 277 (473)
Q Consensus 200 h~--niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~ 277 (473)
+. .+.++++.. ..++||||+++++|..+..... .+...+...++.|++.+|.+|| ++
T Consensus 109 ~~~i~~p~~~~~~---------~~~lV~E~~~g~~L~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~LH---~~ 167 (237)
T smart00090 109 EAGVPVPKPIAWR---------RNVLVMEFIGGDGLPAPRLKDV---------EPEEEEEFELYDDILEEMRKLY---KE 167 (237)
T ss_pred hcCCCCCeeeEec---------CceEEEEEecCCcccccccccC---------CcchHHHHHHHHHHHHHHHHHH---hc
Confidence 53 344444321 2389999999988876543222 1235567789999999999999 99
Q ss_pred C-eeeccCCCCcEEecCCccEEEeeccccccc
Q 012014 278 P-IAHCNLKPSNVLLDDEMIGHVGDFGMARFL 308 (473)
Q Consensus 278 ~-iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 308 (473)
| |+||||||+||+++ ++.++|+|||.+...
T Consensus 168 g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 168 GELVHGDLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred CCEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence 9 99999999999999 889999999998754
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.1e-21 Score=181.06 Aligned_cols=125 Identities=26% Similarity=0.425 Sum_probs=106.6
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
.++++.|++|...+|.+||........ -++...+.++.|++.|+.| ++.+|||+||.||+...+..+|
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~------~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~k 396 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEE------RSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLK 396 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccc------cchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhh
Confidence 357999999999999999986654432 3366788899999999998 5899999999999999999999
Q ss_pred EeecccccccCccc----cccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh
Q 012014 299 VGDFGMARFLPAID----KQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT 355 (473)
Q Consensus 299 l~Dfg~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt 355 (473)
|+|||+........ .....+...||..||+||.+.+..|+.++||||||++|+|++.
T Consensus 397 IgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 397 IGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 99999987665433 1223455679999999999999999999999999999999998
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1e-20 Score=192.43 Aligned_cols=213 Identities=22% Similarity=0.247 Sum_probs=145.9
Q ss_pred hhcccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 140 LYNATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 140 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
.....++|..++.|..|+||.||.++. .+.+++|+|+=+ ..-+.+ ||..+-+
T Consensus 78 ~~p~e~df~~IklisngAygavylvrh~~trqrfa~kiNk------q~lilR-----------nilt~a~---------- 130 (1205)
T KOG0606|consen 78 RAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK------QNLILR-----------NILTFAG---------- 130 (1205)
T ss_pred cCCCccccceeEeeccCCCCceeeeeccccccchhhcccc------cchhhh-----------ccccccC----------
Confidence 344567899999999999999999984 356788885422 111111 1222211
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
..+.| |+-...++..+.. + .+++.+++||| +.||+|||+||+|.+|+.-|++|
T Consensus 131 -npfvv------gDc~tllk~~g~l---------P--------vdmvla~Eylh---~ygivhrdlkpdnllIT~mGhiK 183 (1205)
T KOG0606|consen 131 -NPFVV------GDCATLLKNIGPL---------P--------VDMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIK 183 (1205)
T ss_pred -Cccee------chhhhhcccCCCC---------c--------chhhHHhHhhc---cCCeecCCCCCCcceeeeccccc
Confidence 12333 4444445443321 1 12377999999 99999999999999999999999
Q ss_pred EeecccccccCcc-------------ccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCC
Q 012014 299 VGDFGMARFLPAI-------------DKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFT 365 (473)
Q Consensus 299 l~Dfg~~~~~~~~-------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~ 365 (473)
+.|||+++..-.. ...-.....+||+.|.|||++....|+..+|+|++|+|+||.+-|..||.+...
T Consensus 184 lTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtp 263 (1205)
T KOG0606|consen 184 LTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP 263 (1205)
T ss_pred ccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCH
Confidence 9999998753211 011123456899999999999999999999999999999999999999987422
Q ss_pred CcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCC
Q 012014 366 GKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERM 440 (473)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 440 (473)
++ .+..++...+ . .++.....+.+..+++.+.|+.+|.+|-
T Consensus 264 ee-lfg~visd~i----------------~-----------------wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 264 EE-LFGQVISDDI----------------E-----------------WPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred HH-HHhhhhhhhc----------------c-----------------ccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 21 1222222111 0 0111223466778899999999999995
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=9e-19 Score=157.60 Aligned_cols=134 Identities=19% Similarity=0.278 Sum_probs=109.0
Q ss_pred ceeecCCCeEEEEEEecCCCEEEEEEeeccCCCC--------chhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGG--------SKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 151 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
+.||+|++|.||+|.. +|..+++|+........ ...+.+|+.++..+.|++|+....++... ...+
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~~ 75 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP-----ENFI 75 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC-----CCCE
Confidence 5799999999999986 77889999865332211 13577899999999999887666555332 2458
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
++|||++|++|.+++.... . ....++.+++.+|.++| +.+++|+|++|.||+++ ++.++|+||
T Consensus 76 lv~e~~~G~~L~~~~~~~~------------~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf 138 (211)
T PRK14879 76 IVMEYIEGEPLKDLINSNG------------M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDF 138 (211)
T ss_pred EEEEEeCCcCHHHHHHhcc------------H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEEC
Confidence 9999999999999986432 2 67789999999999999 99999999999999999 788999999
Q ss_pred ccccc
Q 012014 303 GMARF 307 (473)
Q Consensus 303 g~~~~ 307 (473)
|.+..
T Consensus 139 ~~a~~ 143 (211)
T PRK14879 139 GLAEF 143 (211)
T ss_pred CcccC
Confidence 98864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.2e-19 Score=156.72 Aligned_cols=138 Identities=20% Similarity=0.135 Sum_probs=108.0
Q ss_pred CCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCC----------------------CchhHHHHHHHHHhcCCCC
Q 012014 145 NGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG----------------------GSKSFKSECKAAINIKHRN 202 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~h~n 202 (473)
..|.+.+.||+|+||.||++...+|+.||||++...... .......|..++..+.|++
T Consensus 15 ~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 15 VVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred chhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 347788999999999999999778999999987643210 0113567888899888774
Q ss_pred --ceeeeeeeeccccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCee
Q 012014 203 --IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIA 280 (473)
Q Consensus 203 --iv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ii 280 (473)
++..++. ...++||||+++++|.+.... .....++.+++.++.++| ..+|+
T Consensus 95 i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~~---------------~~~~~~~~~i~~~l~~lh---~~gi~ 147 (198)
T cd05144 95 FPVPKPIDW---------NRHAVVMEYIDGVELYRVRVL---------------EDPEEVLDEILEEIVKAY---KHGII 147 (198)
T ss_pred CCCCceeec---------CCceEEEEEeCCcchhhcccc---------------ccHHHHHHHHHHHHHHHH---HCCCC
Confidence 4444432 134899999999999765431 223568889999999999 89999
Q ss_pred eccCCCCcEEecCCccEEEeecccccccC
Q 012014 281 HCNLKPSNVLLDDEMIGHVGDFGMARFLP 309 (473)
Q Consensus 281 H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 309 (473)
||||||+||+++.++.++|+|||++....
T Consensus 148 H~Dl~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 148 HGDLSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cCCCCcccEEEcCCCcEEEEECCccccCC
Confidence 99999999999999999999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.9e-18 Score=151.96 Aligned_cols=130 Identities=17% Similarity=0.249 Sum_probs=102.3
Q ss_pred eeecCCCeEEEEEEecCCCEEEEEEeeccCCCC--------chhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEE
Q 012014 152 LIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGG--------SKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (473)
Q Consensus 152 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (473)
.||+|+||.||+|. .++..+++|......... ...+.+|++++..+.|+++.....++... ...++
T Consensus 1 ~ig~G~~~~vy~~~-~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~~l 74 (199)
T TIGR03724 1 LIAKGAEAIIYLGD-FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP-----DNKTI 74 (199)
T ss_pred CCCCCceEEEEEee-cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC-----CCCEE
Confidence 48999999999998 467899999865322111 24567899999999887654433333221 23589
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecc
Q 012014 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (473)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg 303 (473)
+|||++|++|.+++.... . .++.+++.+|.+|| +.+++|+|++|.||+++ ++.++++|||
T Consensus 75 v~e~~~g~~l~~~~~~~~------------~----~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg 134 (199)
T TIGR03724 75 VMEYIEGKPLKDVIEEGN------------D----ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFG 134 (199)
T ss_pred EEEEECCccHHHHHhhcH------------H----HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECC
Confidence 999999999999875431 1 68999999999999 99999999999999999 7899999999
Q ss_pred cccc
Q 012014 304 MARF 307 (473)
Q Consensus 304 ~~~~ 307 (473)
++..
T Consensus 135 ~a~~ 138 (199)
T TIGR03724 135 LGKY 138 (199)
T ss_pred CCcC
Confidence 8864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.4e-18 Score=172.63 Aligned_cols=138 Identities=17% Similarity=0.228 Sum_probs=107.5
Q ss_pred ccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeecc--CCC------CchhHHHHHHHHHhcCCCCceeeeeeeeccc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLI--RPG------GSKSFKSECKAAINIKHRNIVRVFTAFSGVD 214 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~--~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 214 (473)
....|...+.||+|+||.||+|.+.. ..+++|+.... ... ..+.+.+|++++..++|++++....++.+.
T Consensus 331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~-~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~- 408 (535)
T PRK09605 331 VKRRKIPDHLIGKGAEADIKKGEYLG-RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP- 408 (535)
T ss_pred cccccCccceeccCCcEEEEEEeecC-ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC-
Confidence 34456778999999999999998544 34444443211 111 124578999999999999998876655432
Q ss_pred cCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCC
Q 012014 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE 294 (473)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~ 294 (473)
...++||||+++++|.+++. ....++.+++.+|.+|| +.+++||||||+||++ ++
T Consensus 409 ----~~~~lv~E~~~g~~L~~~l~-----------------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~ 463 (535)
T PRK09605 409 ----EEKTIVMEYIGGKDLKDVLE-----------------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RD 463 (535)
T ss_pred ----CCCEEEEEecCCCcHHHHHH-----------------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-EC
Confidence 24589999999999998874 23568999999999999 9999999999999999 57
Q ss_pred ccEEEeecccccc
Q 012014 295 MIGHVGDFGMARF 307 (473)
Q Consensus 295 ~~~kl~Dfg~~~~ 307 (473)
+.++|+|||+++.
T Consensus 464 ~~~~liDFGla~~ 476 (535)
T PRK09605 464 DRLYLIDFGLGKY 476 (535)
T ss_pred CcEEEEeCccccc
Confidence 7899999999974
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.9e-17 Score=143.34 Aligned_cols=135 Identities=19% Similarity=0.223 Sum_probs=96.1
Q ss_pred cceeecCCCeEEEEEEecCCCEEEEEEeeccCCC--Cchh----------------------HHHHHHHHHhcCCCC--c
Q 012014 150 ANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--GSKS----------------------FKSECKAAINIKHRN--I 203 (473)
Q Consensus 150 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l~h~n--i 203 (473)
.+.||+|+||.||+|...+++.||||+++..... .... ...|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999778999999998743221 1111 134555555554332 3
Q ss_pred eeeeeeeeccccCCceeeEEEEEecCCCCHHHH-hcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCC-CCeee
Q 012014 204 VRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEW-LRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQ-PPIAH 281 (473)
Q Consensus 204 v~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~iiH 281 (473)
.+.+++. ..++||||++++++... +.... . ..++..++.+++.++.++| . .+|+|
T Consensus 82 ~~~~~~~---------~~~lv~e~~~g~~~~~~~l~~~~----------~-~~~~~~~~~~~~~~l~~lh---~~~~ivH 138 (187)
T cd05119 82 PKPIDLN---------RHVLVMEFIGGDGIPAPRLKDVR----------L-LEDPEELYDQILELMRKLY---REAGLVH 138 (187)
T ss_pred CceEecC---------CCEEEEEEeCCCCccChhhhhhh----------h-cccHHHHHHHHHHHHHHHh---hccCcCc
Confidence 4444321 24899999998553211 11110 0 1456789999999999999 7 99999
Q ss_pred ccCCCCcEEecCCccEEEeeccccccc
Q 012014 282 CNLKPSNVLLDDEMIGHVGDFGMARFL 308 (473)
Q Consensus 282 ~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 308 (473)
+||||+||+++ ++.++|+|||.+...
T Consensus 139 ~Dl~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 139 GDLSEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred CCCChhhEEEE-CCcEEEEECcccccc
Confidence 99999999999 899999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.3e-19 Score=178.41 Aligned_cols=256 Identities=21% Similarity=0.229 Sum_probs=187.3
Q ss_pred cCCCCccceeecCCCeEEEEEEec--CCCEEEEEEeeccC--CCCchhHHHHHHHHHhcC-CCCceeeeeeeeccccCCc
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTLF--DGTTIAVKVFNLIR--PGGSKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~ 218 (473)
...|.+.+.||+|+|+.|-..... ....+|+|.+.... .........|..+-..+. |+|++++++.... .
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~-----~ 93 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS-----P 93 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC-----C
Confidence 456777888999999999888743 34456666665432 223344556777777776 9999999988544 4
Q ss_pred eeeEEEEEecCCCCHHHHhc-CCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCc-c
Q 012014 219 RFKAVVYKFMPNGSLEEWLR-GKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM-I 296 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~-~ 296 (473)
...+++++|..++++.+-+. .... ..+...+-.++.|+..++.|+|. ..++.||||||+|.+++.++ .
T Consensus 94 ~~~~~~~~~s~g~~~f~~i~~~~~~--------~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~ 163 (601)
T KOG0590|consen 94 RSYLLSLSYSDGGSLFSKISHPDST--------GTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSA 163 (601)
T ss_pred cccccccCcccccccccccccCCcc--------CCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCc
Confidence 46799999999999998883 3221 12345566789999999999995 57899999999999999999 9
Q ss_pred EEEeecccccccCc-cccccceeeccC-CCCcCCCccccCC-CCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHH
Q 012014 297 GHVGDFGMARFLPA-IDKQNRFICIKG-STGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNF 373 (473)
Q Consensus 297 ~kl~Dfg~~~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~ 373 (473)
.+++|||+|..+.. ..........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+.........+..|
T Consensus 164 l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~ 243 (601)
T KOG0590|consen 164 LKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSW 243 (601)
T ss_pred ccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceee
Confidence 99999999998776 444455556678 9999999998884 45677899999999999999999998765544332222
Q ss_pred HHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHH
Q 012014 374 VKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVE 446 (473)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~ 446 (473)
......... .. -........+++..++..+|..|.+.+++-
T Consensus 244 ~~~~~~~~~------~~--------------------------~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 244 KSNKGRFTQ------LP--------------------------WNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred ccccccccc------Cc--------------------------cccCChhhhhcccccccCCchhcccccccc
Confidence 221100000 00 011233556788889989999999988764
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.8e-16 Score=142.11 Aligned_cols=139 Identities=14% Similarity=0.104 Sum_probs=104.9
Q ss_pred cceee-cCCCeEEEEEEecCCCEEEEEEeeccC-------------CCCchhHHHHHHHHHhcCCCCc--eeeeeeeecc
Q 012014 150 ANLIG-AGNFGSVYNGTLFDGTTIAVKVFNLIR-------------PGGSKSFKSECKAAINIKHRNI--VRVFTAFSGV 213 (473)
Q Consensus 150 ~~~lg-~G~~g~V~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~ 213 (473)
...|| .||.|+||.+.. .+..++||.+.... ......+.+|+.++.++.|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45688 899999999985 47889999885311 1223467889999999998875 6666654322
Q ss_pred ccCCceeeEEEEEecCC-CCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEec
Q 012014 214 DYQGARFKAVVYKFMPN-GSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD 292 (473)
Q Consensus 214 ~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~ 292 (473)
. ......++|||+++| .+|.+++.... ++.. .+.+++.+|.+|| ++||+||||||.|||++
T Consensus 115 ~-~~~~~~~lV~e~l~G~~~L~~~l~~~~----------l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~ 176 (239)
T PRK01723 115 H-GLFYRADILIERIEGARDLVALLQEAP----------LSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLD 176 (239)
T ss_pred c-CcceeeeEEEEecCCCCCHHHHHhcCC----------CCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEc
Confidence 1 111224699999997 69999886532 2222 3678999999999 99999999999999999
Q ss_pred CCccEEEeecccccc
Q 012014 293 DEMIGHVGDFGMARF 307 (473)
Q Consensus 293 ~~~~~kl~Dfg~~~~ 307 (473)
.++.++|+|||.+..
T Consensus 177 ~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 177 PDGKFWLIDFDRGEL 191 (239)
T ss_pred CCCCEEEEECCCccc
Confidence 889999999998874
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=4.3e-17 Score=156.76 Aligned_cols=98 Identities=32% Similarity=0.481 Sum_probs=80.9
Q ss_pred CCccccccceeehhhhHHHHHhCCCCCCCCC-CCcccHHHHHHHhcCC-ccccccccccc-cchHHHHHHHhhhcccCcc
Q 012014 1 MGYVSSYGDVYSFGILLLEMFTGLRPNDDMF-NDELNLHNFVKSALPE-RAEEILDVVFF-QEIEEEETMYKKASSTCTQ 77 (473)
Q Consensus 1 ~g~~t~ksDVySfGVvllEl~tg~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~d~~~~-~~~~~~~~~~~~~~~~~~~ 77 (473)
+|++|+||||||||||||||+|||+|.|... .++.+++.|++..+.+ .+.+++|+.+. ......
T Consensus 252 ~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~------------- 318 (361)
T KOG1187|consen 252 TGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDE------------- 318 (361)
T ss_pred cCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChH-------------
Confidence 4889999999999999999999999988544 4556799999988877 67899999975 332211
Q ss_pred hhhHHHHHHHhhcccccccccccccccchhhHHHHHHHH
Q 012014 78 SSIILECLISICRTGVACSAELPNERMKINDVESRLRLI 116 (473)
Q Consensus 78 ~~~~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~ 116 (473)
+++..++.+|+.|++..+..||+|.+|...|+.+
T Consensus 319 -----~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 319 -----KEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred -----HHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 2366788899999999999999999998888544
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.3e-15 Score=129.10 Aligned_cols=135 Identities=21% Similarity=0.201 Sum_probs=108.5
Q ss_pred ccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCC--CCceeeeeeeeccccCCceeeEEEEE
Q 012014 149 SANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKH--RNIVRVFTAFSGVDYQGARFKAVVYK 226 (473)
Q Consensus 149 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~e 226 (473)
+.+.||+|.++.||++... +..+++|....... ...+.+|+.++..++| .++++++.++... ...+++||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~-----~~~~~v~e 73 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK-DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESD-----GWSYLLME 73 (155)
T ss_pred cceecccccccceEEEEec-CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC-----CccEEEEE
Confidence 4567999999999999964 47899999764332 4578999999999976 5888888776432 35799999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeeccccc
Q 012014 227 FMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMAR 306 (473)
Q Consensus 227 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~ 306 (473)
|++++++..+ +......++.+++.+|.+||.....+++|+|++|+||+++..+.++++|||.+.
T Consensus 74 ~~~g~~~~~~----------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 74 WIEGETLDEV----------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred ecCCeecccC----------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence 9988877654 144566788999999999993322579999999999999998999999999886
Q ss_pred c
Q 012014 307 F 307 (473)
Q Consensus 307 ~ 307 (473)
.
T Consensus 138 ~ 138 (155)
T cd05120 138 Y 138 (155)
T ss_pred C
Confidence 4
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.6e-15 Score=134.74 Aligned_cols=161 Identities=20% Similarity=0.353 Sum_probs=122.6
Q ss_pred HHHHhcCCCCceeeeeeeeccccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHh
Q 012014 193 KAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLH 272 (473)
Q Consensus 193 ~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH 272 (473)
.-+..+.|.|||+++.++.+..+.+.....++.|||.-|+|.++|++.... ...+....-.+|+.||+.||.|||
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~-----~~a~~~~~wkkw~tqIlsal~yLh 193 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKN-----QKALFQKAWKKWCTQILSALSYLH 193 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHh-----hhhhhHHHHHHHHHHHHhhhhhhh
Confidence 345566899999999999888777777889999999999999999875432 123556666789999999999999
Q ss_pred hCCCCCeeeccCCCCcEEecCCccEEEeecccccccCc--cccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHH
Q 012014 273 CDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPA--IDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILL 350 (473)
Q Consensus 273 ~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il 350 (473)
+. +..|+|+++..+-|++..+|-+|++--.-...... ...........|-++|.|||.-.....+.++|||+||...
T Consensus 194 s~-~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcA 272 (458)
T KOG1266|consen 194 SC-DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCA 272 (458)
T ss_pred cc-CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHH
Confidence 55 88999999999999999999888753211111100 0011112234467899999997777788899999999999
Q ss_pred HHHHhCCCC
Q 012014 351 LEMFTGIRP 359 (473)
Q Consensus 351 ~elltg~~P 359 (473)
.+|..+..-
T Consensus 273 lemailEiq 281 (458)
T KOG1266|consen 273 LEMAILEIQ 281 (458)
T ss_pred HHHHHheec
Confidence 999887543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.57 E-value=5e-15 Score=146.36 Aligned_cols=143 Identities=18% Similarity=0.209 Sum_probs=98.8
Q ss_pred cceeecCCCeEEEEEEecCCCEEEEEEeeccCCCC--------------------------c--------------hhHH
Q 012014 150 ANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGG--------------------------S--------------KSFK 189 (473)
Q Consensus 150 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--------------------------~--------------~~~~ 189 (473)
.+.||+|++|.||+|++.+|+.||||+.+..-... . -.|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 36799999999999999899999999986321000 0 0244
Q ss_pred HHHHHHHhc----CCCCceeeeeeeeccccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHH
Q 012014 190 SECKAAINI----KHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVA 265 (473)
Q Consensus 190 ~E~~~l~~l----~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~ 265 (473)
+|+..+.++ +|.+-+.+-.++.+. ....+|||||++|++|.++....... . ....++.+++
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~----~~~~vLvmE~i~G~~L~~~~~~~~~~--------~---~~~~ia~~~~ 266 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDR----TSERVLTMEWIDGIPLSDIAALDEAG--------L---DRKALAENLA 266 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhh----cCCceEEEEeECCcccccHHHHHhcC--------C---CHHHHHHHHH
Confidence 555555554 233333333333221 12358999999999998876432110 0 1234566665
Q ss_pred H-HHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecccccccCc
Q 012014 266 C-ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPA 310 (473)
Q Consensus 266 ~-~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 310 (473)
. .+..+| ..|++|+|++|.||+++.++.++++|||++..++.
T Consensus 267 ~~~l~ql~---~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 267 RSFLNQVL---RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHHHHH---hCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 5 477889 89999999999999999999999999999987643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=2.2e-14 Score=139.70 Aligned_cols=199 Identities=24% Similarity=0.249 Sum_probs=151.9
Q ss_pred CCCccceeec--CCCeEEEEEEe---cCCCEEEEEEeeccC--CCCchhHHHHHHHHHhc-CCCCceeeeeeeeccccCC
Q 012014 146 GFSSANLIGA--GNFGSVYNGTL---FDGTTIAVKVFNLIR--PGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQG 217 (473)
Q Consensus 146 ~~~~~~~lg~--G~~g~V~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 217 (473)
.|.+.+.+|. |.+|.||.+.. .++..+|+|.-+... +.....=.+|+.....+ .|+|.++.+..+ .+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~-----e~ 189 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW-----EG 189 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc-----cc
Confidence 4566788999 99999999874 457889999854322 22333445666666666 499999976665 34
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHH----HHHHHhhCCCCCeeeccCCCCcEEecC
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVAC----ALRYLHCDCQPPIAHCNLKPSNVLLDD 293 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~----~L~~LH~~~~~~iiH~Dlkp~Nil~~~ 293 (473)
....++-+|+| +.+|..+...... .++....+.+..+... ||.++| ..+++|-|+||+||+...
T Consensus 190 ~~~lfiqtE~~-~~sl~~~~~~~~~--------~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~ 257 (524)
T KOG0601|consen 190 SGILFIQTELC-GESLQSYCHTPCN--------FLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTS 257 (524)
T ss_pred CCcceeeeccc-cchhHHhhhcccc--------cCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheeccc
Confidence 55778999998 5788888776543 2445666677777777 999999 999999999999999999
Q ss_pred C-ccEEEeecccccccCccccccc---eeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCC
Q 012014 294 E-MIGHVGDFGMARFLPAIDKQNR---FICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362 (473)
Q Consensus 294 ~-~~~kl~Dfg~~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 362 (473)
+ ...+++|||+...+........ .....|...|++||...+ .++..+||||+|.++.+..++..++..
T Consensus 258 ~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~ 329 (524)
T KOG0601|consen 258 DWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSV 329 (524)
T ss_pred ccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccC
Confidence 8 8899999999988766542221 122357888999999766 688899999999999999998777643
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.45 E-value=2.4e-13 Score=135.87 Aligned_cols=147 Identities=15% Similarity=0.149 Sum_probs=94.1
Q ss_pred cCCCCccceeecCCCeEEEEEEecC-CCEEEEEEeeccCC----------------------C----C--------ch--
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTLFD-GTTIAVKVFNLIRP----------------------G----G--------SK-- 186 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~----------------------~----~--------~~-- 186 (473)
...|+. +.||+|++|.||+|++.+ |+.||||+.+..-. . . .+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345666 789999999999999776 99999999863210 0 0 01
Q ss_pred ----hHHHHHHHHHhc----CCCCceeeeeeeeccccCCceeeEEEEEecCCCCHHHHh--cCCCCCCCCCcchhhcHHH
Q 012014 187 ----SFKSECKAAINI----KHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWL--RGKDDTNWRPLNFNFLIKK 256 (473)
Q Consensus 187 ----~~~~E~~~l~~l----~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l--~~~~~~~~~~~~~~~~~~~ 256 (473)
.+.+|+..+.++ .+.+.+.+-.++.+. ....+|||||+.|+.+.++- ...+.. ...+....
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~----st~~VLvmE~i~G~~l~d~~~l~~~g~d-----~~~la~~~ 268 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDY----CSETVMVMERMYGIPVSDVAALRAAGTD-----MKLLAERG 268 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeeccc----CCCceEEEeeecCccHHhHHHHHhcCCC-----HHHHHHHH
Confidence 134455444444 233334433333221 22458999999999998752 222100 00122222
Q ss_pred HHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCc----cEEEeecccccccCc
Q 012014 257 KLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM----IGHVGDFGMARFLPA 310 (473)
Q Consensus 257 ~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~----~~kl~Dfg~~~~~~~ 310 (473)
+..++.| ++ ..|++|+|+||.||+++.++ .++++|||++..++.
T Consensus 269 v~~~~~Q-------if---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 269 VEVFFTQ-------VF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHH-------HH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 2333333 34 67999999999999999888 999999999987754
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.2e-12 Score=113.26 Aligned_cols=127 Identities=17% Similarity=0.143 Sum_probs=93.9
Q ss_pred cceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCc-eeeeeeeeccccCCceeeEEEEEec
Q 012014 150 ANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNI-VRVFTAFSGVDYQGARFKAVVYKFM 228 (473)
Q Consensus 150 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~e~~ 228 (473)
.+.|+.|.++.||++.. .+..+++|....... ....+.+|+.++..+.+.++ .+++.+..+ ..++||||+
T Consensus 3 ~~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~-------~~~lv~e~i 73 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDPE-------TGVLITEFI 73 (170)
T ss_pred eeecCCcccCceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeCC-------CCeEEEEec
Confidence 35689999999999985 478899998754321 23456889999999865554 445544211 237999999
Q ss_pred CCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCC-----eeeccCCCCcEEecCCccEEEeecc
Q 012014 229 PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPP-----IAHCNLKPSNVLLDDEMIGHVGDFG 303 (473)
Q Consensus 229 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~-----iiH~Dlkp~Nil~~~~~~~kl~Dfg 303 (473)
+|.++.+. .. ....++.+++.+|..|| ..+ ++|+|++|.||+++ ++.++++|||
T Consensus 74 ~G~~l~~~----~~-------------~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~ 132 (170)
T cd05151 74 EGSELLTE----DF-------------SDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWE 132 (170)
T ss_pred CCCccccc----cc-------------cCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEecc
Confidence 99887543 00 01235678999999999 666 59999999999999 6679999999
Q ss_pred ccc
Q 012014 304 MAR 306 (473)
Q Consensus 304 ~~~ 306 (473)
.+.
T Consensus 133 ~a~ 135 (170)
T cd05151 133 YAG 135 (170)
T ss_pred ccc
Confidence 876
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.38 E-value=8.8e-12 Score=108.36 Aligned_cols=135 Identities=16% Similarity=0.109 Sum_probs=96.4
Q ss_pred ceeecCCCeEEEEEEecC-------CCEEEEEEeeccCC----------------------CCchhH----HHHHHHHHh
Q 012014 151 NLIGAGNFGSVYNGTLFD-------GTTIAVKVFNLIRP----------------------GGSKSF----KSECKAAIN 197 (473)
Q Consensus 151 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~----------------------~~~~~~----~~E~~~l~~ 197 (473)
..||.|.=+.||.|...+ +..+|||+++.... +....+ .+|++.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998442 47999999863110 001123 389999999
Q ss_pred cC--CCCceeeeeeeeccccCCceeeEEEEEecCCCCHHH-HhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHH-hh
Q 012014 198 IK--HRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEE-WLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYL-HC 273 (473)
Q Consensus 198 l~--h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~L-H~ 273 (473)
+. .-++.+.+++. ..+|||||+.++.+.. .++.. .++..+...+..+++.+|..| |
T Consensus 83 l~~~Gv~vP~pi~~~---------~~~lvME~Ig~~~~~~~~Lkd~----------~~~~~~~~~i~~~i~~~l~~l~H- 142 (197)
T cd05146 83 MQKAGIPCPEVVVLK---------KHVLVMSFIGDDQVPAPKLKDA----------KLNDEEMKNAYYQVLSMMKQLYK- 142 (197)
T ss_pred HHHcCCCCCeEEEec---------CCEEEEEEcCCCCccchhhhcc----------ccCHHHHHHHHHHHHHHHHHHHH-
Confidence 84 35666766542 2389999996643321 22211 122455667889999999998 8
Q ss_pred CCCCCeeeccCCCCcEEecCCccEEEeeccccccc
Q 012014 274 DCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL 308 (473)
Q Consensus 274 ~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 308 (473)
..|+||+||++.||+++ ++.+.|+|||.+...
T Consensus 143 --~~glVHGDLs~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 143 --ECNLVHADLSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred --hCCeecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence 88999999999999997 467999999988754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.8e-11 Score=120.69 Aligned_cols=167 Identities=17% Similarity=0.174 Sum_probs=123.9
Q ss_pred ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEEEEecCCCCHHHHhcCCCCCCC
Q 012014 166 LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW 245 (473)
Q Consensus 166 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~ 245 (473)
..++.+|.|...+...........+-++.|+.++||||++++..+.. ....|||+|-+ -.|..+++...
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~-----~~~~ylvTErV--~Pl~~~lk~l~---- 102 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEE-----EGTLYLVTERV--RPLETVLKELG---- 102 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcc-----cCceEEEeecc--ccHHHHHHHhH----
Confidence 56788899988876554444567788899999999999999998644 34789999988 36777776543
Q ss_pred CCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecccccccCccccccceeeccCCCC
Q 012014 246 RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTG 325 (473)
Q Consensus 246 ~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~ 325 (473)
.....-.+.||+.||.|||. +.+++|++|.-+.|+++..|..||++|-++............. .---.
T Consensus 103 --------~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~--~~~~s 170 (690)
T KOG1243|consen 103 --------KEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSL--YLIES 170 (690)
T ss_pred --------HHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccc--hhhhc
Confidence 34455578899999999985 6799999999999999999999999998876543322111111 11223
Q ss_pred cCCCccccCCCCCcccchhhHhHHHHHHHhCC
Q 012014 326 YIPPEYDLGCEASTYGDVYSFGILLLEMFTGI 357 (473)
Q Consensus 326 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~ 357 (473)
|..|+.+.... -..|.|-||++++|++.|.
T Consensus 171 ~~~P~~~~~s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 171 FDDPEEIDPSE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred ccChhhcCccc--cchhhhhHHHHHHHHhCcc
Confidence 56666543322 3459999999999999993
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.28 E-value=6.9e-13 Score=136.09 Aligned_cols=207 Identities=24% Similarity=0.343 Sum_probs=147.9
Q ss_pred cccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeec---cCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCC
Q 012014 142 NATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNL---IRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (473)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (473)
...+.|.+.+-+-+|.++.++.+. ...|...+.|+... ......+....+-.++....||.++.....+ ..
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-----~~ 875 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF-----PC 875 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC-----CC
Confidence 455778888889999999999887 33454445554432 2222334444455555555667777655442 22
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccE
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~ 297 (473)
....+|+++|..+++|...|+...... .+-+...+..+..+++||| ...+.|+|++|.|+++..+++.
T Consensus 876 rsP~~L~~~~~~~~~~~Skl~~~~~~s---------aepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~ 943 (1205)
T KOG0606|consen 876 RSPLPLVGHYLNGGDLPSKLHNSGCLS---------AEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHR 943 (1205)
T ss_pred CCCcchhhHHhccCCchhhhhcCCCcc---------cccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCc
Confidence 345689999999999999988776322 2233345667788999999 7779999999999999999999
Q ss_pred EEeecccccccCccc-----------------------------cccceeeccCCCCcCCCccccCCCCCcccchhhHhH
Q 012014 298 HVGDFGMARFLPAID-----------------------------KQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGI 348 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~-----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 348 (473)
+++|||.....+-.. .........||+.|.+||...+......+|+|++|+
T Consensus 944 ~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~ 1023 (1205)
T KOG0606|consen 944 PLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGV 1023 (1205)
T ss_pred ccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhh
Confidence 999998433221100 001123456899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCC
Q 012014 349 LLLEMFTGIRPSDGIFT 365 (473)
Q Consensus 349 il~elltg~~P~~~~~~ 365 (473)
+++|.++|.+||.....
T Consensus 1024 ~l~e~l~g~pp~na~tp 1040 (1205)
T KOG0606|consen 1024 CLFEVLTGIPPFNAETP 1040 (1205)
T ss_pred hhhhhhcCCCCCCCcch
Confidence 99999999999986443
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.7e-10 Score=106.44 Aligned_cols=280 Identities=12% Similarity=0.125 Sum_probs=165.8
Q ss_pred ccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhc-CCCCceeeeeeeecc--ccCCceeeEEEE
Q 012014 149 SANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGV--DYQGARFKAVVY 225 (473)
Q Consensus 149 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~~~~~~~~lv~ 225 (473)
....||+|+-+.+|..- .-...+-|++........... +..|... .||-+-.-+.+-... ........-++|
T Consensus 15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecc--hhhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 46679999999999653 112235577765443322222 2222222 455443311110000 011222356777
Q ss_pred EecCCC-CHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeeccc
Q 012014 226 KFMPNG-SLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM 304 (473)
Q Consensus 226 e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~ 304 (473)
..+++. .+..++..... +..-..+.|.-.++.++.++.+.+-|| ..|.+-+|+.++|+|+++++.+.|.|-..
T Consensus 90 P~v~g~~pI~~~y~p~tR---Rqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 90 PKVSGKEPIHMIYSPATR---RQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred ccCCCccchhhhcCchhh---cccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccc
Confidence 777654 23333322211 111113557788999999999999999 99999999999999999999999998543
Q ss_pred ccccCccccccceeeccCCCCcCCCcccc-----CCCCCcccchhhHhHHHHHHHhC-CCCCCCCCCCcccHHHHHHhhc
Q 012014 305 ARFLPAIDKQNRFICIKGSTGYIPPEYDL-----GCEASTYGDVYSFGILLLEMFTG-IRPSDGIFTGKMNLRNFVKMAL 378 (473)
Q Consensus 305 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg-~~P~~~~~~~~~~~~~~~~~~~ 378 (473)
-... .......+..|.+.|.+||.-. +...+...|.|.||+++++++.| ++||.|+..... -
T Consensus 164 fqi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~---------a 231 (637)
T COG4248 164 FQIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISD---------A 231 (637)
T ss_pred eeec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCC---------C
Confidence 3221 2344556677999999999744 44557778999999999999986 999998643211 0
Q ss_pred Ccchh-hhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhccc--CCCCCCCChHHHHHHHHHHHHh
Q 012014 379 PQRAE-EVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSA--ERPRERMKINDVESRLRLIRRK 455 (473)
Q Consensus 379 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~--~dP~~RPt~~ev~~~L~~l~~~ 455 (473)
|+..+ .+..-... ...+ ++ .+.......++. .-.+..+..|..+|+. .++.-|||++-.+..|..++..
T Consensus 232 p~p~E~~Ia~g~f~-ya~~-~~-----~g~~p~P~~~P~-~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 232 PNPLETDIAHGRFA-YASD-QR-----RGLKPPPRSIPL-SMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred CCcchhhhhcceee-echh-cc-----CCCCCCCCCCCh-hhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 11111 00000000 0000 00 000000000000 1245677778888886 3467999999999999999988
Q ss_pred hccC
Q 012014 456 LLET 459 (473)
Q Consensus 456 ~~~~ 459 (473)
++..
T Consensus 304 L~~C 307 (637)
T COG4248 304 LKKC 307 (637)
T ss_pred hhhh
Confidence 7665
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.25 E-value=4.7e-12 Score=123.63 Aligned_cols=250 Identities=17% Similarity=0.142 Sum_probs=168.5
Q ss_pred cccCCCCccceeecCCCeEEEEEEe--cCCCEEEEEEeeccCCCCchh--HHHHHHHHHhc-CCCCceeeeeeeeccccC
Q 012014 142 NATNGFSSANLIGAGNFGSVYNGTL--FDGTTIAVKVFNLIRPGGSKS--FKSECKAAINI-KHRNIVRVFTAFSGVDYQ 216 (473)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 216 (473)
....+|..+..||.|.|+.|+.... .++..|++|.+.......... -..|+.+...+ .|.+++..+..+...
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~--- 338 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL--- 338 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc---
Confidence 3456788999999999999998873 467889999876443332222 23455555555 588888877665432
Q ss_pred CceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCC-c
Q 012014 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE-M 295 (473)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~-~ 295 (473)
...++-.|||.++++...+.... .+.....+++..|++.++.++| ++.++|+|+||+||++..+ +
T Consensus 339 --r~~~ip~e~~~~~s~~l~~~~~~---------~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~ 404 (524)
T KOG0601|consen 339 --RQGYIPLEFCEGGSSSLRSVTSQ---------MLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGF 404 (524)
T ss_pred --ccccCchhhhcCcchhhhhHHHH---------hcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchh
Confidence 24468899999999877663222 2446677889999999999999 9999999999999999876 7
Q ss_pred cEEEeecccccccCccccccceeeccCCCCc-CCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 012014 296 IGHVGDFGMARFLPAIDKQNRFICIKGSTGY-IPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFV 374 (473)
Q Consensus 296 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~ 374 (473)
..+++|||+++.+.-... ....++..| .+|.......+..+.|++|||..+.+.+++..--... .. +
T Consensus 405 ~~~~~~~~~~t~~~~~~~----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~-~~------~- 472 (524)
T KOG0601|consen 405 FSKLGDFGCWTRLAFSSG----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG-VQ------S- 472 (524)
T ss_pred hhhccccccccccceecc----cccccccccccchhhccccccccccccccccccccccccCcccCccc-cc------c-
Confidence 889999999864321110 111123334 3566666777899999999999999999975432110 00 0
Q ss_pred HhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHH
Q 012014 375 KMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLI 452 (473)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l 452 (473)
..+... ...........+..+...+...++..||.+.++....+-.
T Consensus 473 --------~~i~~~------------------------~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 473 --------LTIRSG------------------------DTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred --------eeeecc------------------------cccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 000000 0000011124556788888999999999998876554443
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.2e-10 Score=97.71 Aligned_cols=129 Identities=21% Similarity=0.265 Sum_probs=93.5
Q ss_pred ceeecCCCeEEEEEEecCCCEEEEEEeeccCCCC--------chhHHHHHHHHHhcCC--CCceeeeeeeeccccCCcee
Q 012014 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGG--------SKSFKSECKAAINIKH--RNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 151 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~ 220 (473)
..+++|+-+.+|.+.+. |.++++|.=....... .++..+|++++.++.- -+.+.++++... .
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~-------~ 73 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPD-------N 73 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCC-------C
Confidence 35789999999999753 4456666432222111 1346789999988853 344455554321 3
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
..|+|||++|-.|.+++.... ..++..+-.-+.-|| ..||+|+||.++||++..+. +.++
T Consensus 74 ~~I~me~I~G~~lkd~l~~~~----------------~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~I 133 (204)
T COG3642 74 GLIVMEYIEGELLKDALEEAR----------------PDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFI 133 (204)
T ss_pred CEEEEEEeCChhHHHHHHhcc----------------hHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEE
Confidence 479999999999998887651 236677777788899 99999999999999998665 8999
Q ss_pred ecccccc
Q 012014 301 DFGMARF 307 (473)
Q Consensus 301 Dfg~~~~ 307 (473)
|||++..
T Consensus 134 DfGLg~~ 140 (204)
T COG3642 134 DFGLGEF 140 (204)
T ss_pred ECCcccc
Confidence 9999874
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.6e-10 Score=104.63 Aligned_cols=145 Identities=15% Similarity=0.129 Sum_probs=105.1
Q ss_pred ceeecCCCeEEEEEEecCCCEEEEEEeeccCC-CCchhHHHHHHHHHhcCC--CCceeeeeeeeccccCCceeeEEEEEe
Q 012014 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKH--RNIVRVFTAFSGVDYQGARFKAVVYKF 227 (473)
Q Consensus 151 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~e~ 227 (473)
+.|+.|.++.||++...+|+.+++|....... .....+.+|++++..+.+ .++.+++.+..... .....++||||
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~e~ 81 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVMER 81 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEEEE
Confidence 56899999999999876668999998764322 235678999999999975 44577776653321 11245899999
Q ss_pred cCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhC---------------------------------
Q 012014 228 MPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCD--------------------------------- 274 (473)
Q Consensus 228 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~--------------------------------- 274 (473)
++|.++.+.+... .++..+...++.+++.+|..||+.
T Consensus 82 i~G~~l~~~~~~~----------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (223)
T cd05154 82 VDGRVLRDRLLRP----------ELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRT 151 (223)
T ss_pred eCCEecCCCCCCC----------CCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcc
Confidence 9998887655311 133556667777777777777732
Q ss_pred --------------------CCCCeeeccCCCCcEEecC--CccEEEeecccccc
Q 012014 275 --------------------CQPPIAHCNLKPSNVLLDD--EMIGHVGDFGMARF 307 (473)
Q Consensus 275 --------------------~~~~iiH~Dlkp~Nil~~~--~~~~kl~Dfg~~~~ 307 (473)
....++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 152 DEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred cccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 0246799999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.17 E-value=3e-10 Score=98.44 Aligned_cols=125 Identities=20% Similarity=0.226 Sum_probs=81.0
Q ss_pred EEEEEEecCCCEEEEEEeeccCCCC--------------------------chhHHHHHHHHHhcCCC--Cceeeeeeee
Q 012014 160 SVYNGTLFDGTTIAVKVFNLIRPGG--------------------------SKSFKSECKAAINIKHR--NIVRVFTAFS 211 (473)
Q Consensus 160 ~V~~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~h~--niv~~~~~~~ 211 (473)
.||.|...+|..+|+|+.+...... .....+|.+.|.++..- ++.+.+.+-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899998889999999986321100 02357899999999755 567776552
Q ss_pred ccccCCceeeEEEEEecC--CCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHH-HhhCCCCCeeeccCCCCc
Q 012014 212 GVDYQGARFKAVVYKFMP--NGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY-LHCDCQPPIAHCNLKPSN 288 (473)
Q Consensus 212 ~~~~~~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~-LH~~~~~~iiH~Dlkp~N 288 (473)
..+|||||++ |..+..+.... ++......++.+++..+.. +| ..||+|+||.+.|
T Consensus 80 --------~~~ivME~I~~~G~~~~~l~~~~-----------~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~N 137 (188)
T PF01163_consen 80 --------RNVIVMEYIGEDGVPLPRLKDVD-----------LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYN 137 (188)
T ss_dssp --------TTEEEEE--EETTEEGGCHHHCG-----------GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTS
T ss_pred --------CCEEEEEecCCCccchhhHHhcc-----------ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhh
Confidence 2379999998 54444333221 1123345577777775554 68 8999999999999
Q ss_pred EEecCCccEEEeeccccccc
Q 012014 289 VLLDDEMIGHVGDFGMARFL 308 (473)
Q Consensus 289 il~~~~~~~kl~Dfg~~~~~ 308 (473)
|+++++ .+.|+|||.+...
T Consensus 138 Ilv~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 138 ILVDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp EEEETT-CEEE--GTTEEET
T ss_pred EEeecc-eEEEEecCcceec
Confidence 999887 8999999988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.15 E-value=6.2e-10 Score=92.91 Aligned_cols=143 Identities=20% Similarity=0.210 Sum_probs=98.6
Q ss_pred ccceeecCCCeEEEEEEecCCCEEEEEEeeccCC--C------CchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 149 SANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRP--G------GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 149 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
...+|-+|+-+.|+++.+ .|+.+.||.--.... . ...+..+|++++.++.--.|.--.-+|.+.. .
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~-----~ 84 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY-----G 84 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC-----C
Confidence 567889999999999984 677777774321111 1 2345788999999885333322222232221 2
Q ss_pred eEEEEEecCC-CCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCc---c
Q 012014 221 KAVVYKFMPN-GSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM---I 296 (473)
Q Consensus 221 ~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~---~ 296 (473)
-.|+|||++| .++.+++........ .......++.+|-+.+.-|| .++|||+||..+||++..++ .
T Consensus 85 ~~i~ME~~~g~~~vk~~i~~~~~~~~-------~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~ 154 (229)
T KOG3087|consen 85 GQIYMEFIDGASTVKDFILSTMEDES-------EDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQIT 154 (229)
T ss_pred CeEEEEeccchhHHHHHHHHHccCcc-------cchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCc
Confidence 3799999966 478888876543321 12223678888999999999 99999999999999996554 4
Q ss_pred EEEeecccccc
Q 012014 297 GHVGDFGMARF 307 (473)
Q Consensus 297 ~kl~Dfg~~~~ 307 (473)
+.++|||++..
T Consensus 155 ~~lIdfgls~~ 165 (229)
T KOG3087|consen 155 PILIDFGLSSV 165 (229)
T ss_pred eEEEeecchhc
Confidence 58999999863
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.03 E-value=6e-09 Score=95.95 Aligned_cols=145 Identities=14% Similarity=0.009 Sum_probs=96.9
Q ss_pred ceeecCCCeEEEEEEecCCCEEEEEEeeccCC-----------CCchhHHHHHHHHHhcCCCC--ceeeeeeeeccccCC
Q 012014 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRP-----------GGSKSFKSECKAAINIKHRN--IVRVFTAFSGVDYQG 217 (473)
Q Consensus 151 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~ 217 (473)
+.+-......|++..+ +|+.+.||....... .....+.+|...+.++..-+ .+..+++........
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4444444445667654 678899997742210 11124778998888874322 223333332211111
Q ss_pred ceeeEEEEEecCCC-CHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecC---
Q 012014 218 ARFKAVVYKFMPNG-SLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD--- 293 (473)
Q Consensus 218 ~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~--- 293 (473)
....++|||++++. +|.+++...... .........++.+++..+.-|| ..||+|+|+++.|||++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~-------~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~ 176 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATN-------PPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFP 176 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhccc-------CCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEecccc
Confidence 23468999999876 899998532111 1224567789999999999999 999999999999999975
Q ss_pred ----CccEEEeeccccc
Q 012014 294 ----EMIGHVGDFGMAR 306 (473)
Q Consensus 294 ----~~~~kl~Dfg~~~ 306 (473)
++.+.|+||+.+.
T Consensus 177 ~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 177 GREEDLKLSVIDLHRAQ 193 (268)
T ss_pred CCCCCceEEEEECCccc
Confidence 4688999999875
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.6e-10 Score=125.95 Aligned_cols=100 Identities=20% Similarity=0.397 Sum_probs=73.4
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCCCCCCcccHHHHHHHhcCC-ccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPE-RAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+.+|.|+|||||||+++||+||+.|.+........+..|++..... .....+|+.+.......
T Consensus 853 ~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------- 916 (968)
T PLN00113 853 KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVN---------------- 916 (968)
T ss_pred CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCcc----------------
Confidence 4578999999999999999999999875555556788898776554 33445565543221111
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHHh
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~ 118 (473)
.+++..+..++..|+..+|.+||+|.++.+.++.+.+
T Consensus 917 -~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 917 -QNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred -HHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 1224456677889999999999999999999987654
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.01 E-value=6.8e-09 Score=99.75 Aligned_cols=180 Identities=19% Similarity=0.202 Sum_probs=132.5
Q ss_pred CCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEEEEecCC-CCHH
Q 012014 157 NFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPN-GSLE 234 (473)
Q Consensus 157 ~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-g~L~ 234 (473)
-..+.|++. ..+|..|++|+++..+.........-+++++++.|+|+|++..+|.... -+...+++|++|.++ ++|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~t-F~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYT-FGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhc-cCcceEEEEEecCCCCchHH
Confidence 445788988 6789999999995444333333445678899999999999999987443 334568999999985 6787
Q ss_pred HHhcCCCCCC------CCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeeccccccc
Q 012014 235 EWLRGKDDTN------WRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL 308 (473)
Q Consensus 235 ~~l~~~~~~~------~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 308 (473)
++........ ....+...++...+.++.|+..||.++| +.|+.-+-|.|.+|+++.+..++|+..|+...+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeee
Confidence 7664443222 1122334668899999999999999999 889999999999999999989999988887655
Q ss_pred CccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCC
Q 012014 309 PAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359 (473)
Q Consensus 309 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P 359 (473)
.... + +-+. --.+-|.=.||.+++.|.||..-
T Consensus 444 ~~d~---------~-------~~le---~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 444 QEDP---------T-------EPLE---SQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred cCCC---------C-------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence 3322 0 0111 11245888999999999998543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=4.6e-09 Score=93.59 Aligned_cols=136 Identities=20% Similarity=0.142 Sum_probs=98.1
Q ss_pred CCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCC----------------------CchhHHHHHHHHHhcCCC--
Q 012014 146 GFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG----------------------GSKSFKSECKAAINIKHR-- 201 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~l~h~-- 201 (473)
=..++..||-|.-+.||.|....|.++|||.-+..... .....++|.++|.+|...
T Consensus 92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 35567899999999999999888999999976422110 112357899999999655
Q ss_pred CceeeeeeeeccccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeee
Q 012014 202 NIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAH 281 (473)
Q Consensus 202 niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH 281 (473)
.+.+-+++ +...+||||++|-.|...-- ..+..-.++..|+.-+.-+- ..|+||
T Consensus 172 ~VP~P~~~---------nRHaVvMe~ieG~eL~~~r~--------------~~en~~~il~~il~~~~~~~---~~GiVH 225 (304)
T COG0478 172 KVPKPIAW---------NRHAVVMEYIEGVELYRLRL--------------DVENPDEILDKILEEVRKAY---RRGIVH 225 (304)
T ss_pred CCCCcccc---------ccceeeeehcccceeecccC--------------cccCHHHHHHHHHHHHHHHH---HcCccc
Confidence 67766654 24589999998866654321 01222334555555555555 679999
Q ss_pred ccCCCCcEEecCCccEEEeecccccc
Q 012014 282 CNLKPSNVLLDDEMIGHVGDFGMARF 307 (473)
Q Consensus 282 ~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 307 (473)
+|+.+=||+++++|.+.++||-.+..
T Consensus 226 GDlSefNIlV~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 226 GDLSEFNILVTEDGDIVVIDWPQAVP 251 (304)
T ss_pred cCCchheEEEecCCCEEEEeCccccc
Confidence 99999999999999999999976643
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.81 E-value=5e-08 Score=86.90 Aligned_cols=110 Identities=17% Similarity=0.177 Sum_probs=81.7
Q ss_pred chhHHHHHHHHHhcCC--CCceeeeeeeeccccCCceeeEEEEEecCCC-CHHHHhcCCCCCCCCCcchhhcHHHHHHHH
Q 012014 185 SKSFKSECKAAINIKH--RNIVRVFTAFSGVDYQGARFKAVVYKFMPNG-SLEEWLRGKDDTNWRPLNFNFLIKKKLDIA 261 (473)
Q Consensus 185 ~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~ 261 (473)
.....+|...+..|.. =.+++.+++....... ....++|+|++++. +|.+++..... .+......++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~-~~~s~lite~l~~~~~L~~~~~~~~~---------~~~~~~~~ll 124 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGG-GYRSYLITEALPGAQDLRDLLQQWEQ---------LDPSQRRELL 124 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCC-ceeEEEEEEeCCCcccHHHHHHhhcc---------cchhhHHHHH
Confidence 4467888888877742 2344444444332211 24568999999874 89999876332 2245667899
Q ss_pred HHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCc---cEEEeecccccc
Q 012014 262 IDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM---IGHVGDFGMARF 307 (473)
Q Consensus 262 ~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~---~~kl~Dfg~~~~ 307 (473)
.+++..+.-|| .+||+|+|+++.|||++.+. .+.++||+-++.
T Consensus 125 ~~l~~~i~~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 125 RALARLIAKLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHHHHHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999999 99999999999999998877 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.3e-09 Score=108.25 Aligned_cols=150 Identities=16% Similarity=0.224 Sum_probs=100.7
Q ss_pred HHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecccccccCcccc-------ccceeeccCCCCcCCCccccC
Q 012014 262 IDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDK-------QNRFICIKGSTGYIPPEYDLG 334 (473)
Q Consensus 262 ~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~ 334 (473)
.+++.||.|+|. +.++||++|.|++|.++.++.+||+.|+++........ ........-...|.|||++.+
T Consensus 106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 345589999995 67999999999999999999999999998865433111 000111123567999999999
Q ss_pred CCCCcccchhhHhHHHHHHHhCCCC-CCCCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcch
Q 012014 335 CEASTYGDVYSFGILLLEMFTGIRP-SDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAH 413 (473)
Q Consensus 335 ~~~~~~~DiwSlG~il~elltg~~P-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (473)
...+.++|+||+|+++|.+..|..+ +... .... ...+ ....+..- .
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~-~~~~-~~~~---------~~~~~~~~----------------------~ 230 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAAN-GGLL-SYSF---------SRNLLNAG----------------------A 230 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhcc-CCcc-hhhh---------hhcccccc----------------------c
Confidence 8889999999999999999954444 3321 1110 0000 00000000 0
Q ss_pred hhHHHHHHHHHHHHhhhcccCCCCCCCChHHHH
Q 012014 414 ASIILECFNSICEIGVACSAERPRERMKINDVE 446 (473)
Q Consensus 414 ~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~ 446 (473)
.....+.+.++.+=+.+.+..++.-||++.++.
T Consensus 231 ~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 231 FGYSNNLPSELRESLKKLLNGDSAVRPTLDLLL 263 (700)
T ss_pred ccccccCcHHHHHHHHHHhcCCcccCcchhhhh
Confidence 001134677888888899999999999777664
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.79 E-value=2.5e-07 Score=80.73 Aligned_cols=158 Identities=15% Similarity=0.161 Sum_probs=109.8
Q ss_pred hhhhhcccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeecc-----C-CCCchhHHHHHHHHHhcCC--CCceeeee
Q 012014 137 FKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLI-----R-PGGSKSFKSECKAAINIKH--RNIVRVFT 208 (473)
Q Consensus 137 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-----~-~~~~~~~~~E~~~l~~l~h--~niv~~~~ 208 (473)
|+.+......+...---|+||.+-|++... +|+.+-+|.-... . +.....|.+|...+.++.. -.+.+..
T Consensus 10 f~~~w~~~~~wve~pN~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv- 87 (216)
T PRK09902 10 FNHWWATEGDWVEEPNYRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV- 87 (216)
T ss_pred HHHHHhCCCceecCCCcCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-
Confidence 444444444444444457899999999764 4557888876411 1 3456789999999999853 2244444
Q ss_pred eeeccccCCceeeEEEEEecCC-CCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCC
Q 012014 209 AFSGVDYQGARFKAVVYKFMPN-GSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPS 287 (473)
Q Consensus 209 ~~~~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~ 287 (473)
++...........+||+|-+++ -||.+++...... ..+...+..++.+++..+.-|| +.|+.|+|+.+.
T Consensus 88 f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~-------~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~k 157 (216)
T PRK09902 88 FGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVS-------PYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVR 157 (216)
T ss_pred eeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcC-------CcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHh
Confidence 2221112233456899997753 6899988664322 1235667789999999999999 999999999999
Q ss_pred cEEecCCcc--EEEeeccccc
Q 012014 288 NVLLDDEMI--GHVGDFGMAR 306 (473)
Q Consensus 288 Nil~~~~~~--~kl~Dfg~~~ 306 (473)
||+++.++. ++++||--++
T Consensus 158 hIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 158 HIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred heeecCCCCeeEEEEEhhccc
Confidence 999986666 9999997654
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.5e-08 Score=97.35 Aligned_cols=87 Identities=26% Similarity=0.333 Sum_probs=55.6
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhhHH
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSIIL 82 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (473)
.+|+|+|||||||||+||+||+.|...... ..+...+.. ......+.+.
T Consensus 222 ~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--~~~~~~v~~--~~~Rp~~p~~--------------------------- 270 (362)
T KOG0192|consen 222 PYTEKSDVYSFGIVLWELLTGEIPFEDLAP--VQVASAVVV--GGLRPPIPKE--------------------------- 270 (362)
T ss_pred cCCccchhhhHHHHHHHHHHCCCCCCCCCH--HHHHHHHHh--cCCCCCCCcc---------------------------
Confidence 589999999999999999999999764432 112222111 1111111110
Q ss_pred HHHHHhhcccccccccccccccchhhHHHHHHHHHhhcc
Q 012014 83 ECLISICRTGVACSAELPNERMKINDVESRLRLIKKKLL 121 (473)
Q Consensus 83 ~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~~~~ 121 (473)
|-..+..+...|+..+|..||+..++...|+.+.....
T Consensus 271 -~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 271 -CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred -CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 01112222334999999999999999999998876544
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=98.70 E-value=6.6e-09 Score=105.39 Aligned_cols=86 Identities=24% Similarity=0.479 Sum_probs=57.7
Q ss_pred CCccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchh
Q 012014 1 MGYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSS 79 (473)
Q Consensus 1 ~g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~ 79 (473)
+|++|++||||||||||+|++| |+.|.....++| ..+.++. .++....+
T Consensus 679 y~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E--VIe~i~~---g~lL~~Pe------------------------- 728 (774)
T KOG1026|consen 679 YGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE--VIECIRA---GQLLSCPE------------------------- 728 (774)
T ss_pred cCcccchhhhhhhhhhhhhhhccccCcccccchHH--HHHHHHc---CCcccCCC-------------------------
Confidence 5899999999999999999996 667754333332 1111110 01111100
Q ss_pred hHHHHHHHhhcccccccccccccccchhhHHHHHHHHHhh
Q 012014 80 IILECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (473)
Q Consensus 80 ~~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~~ 119 (473)
.|-.++-.+.+.|++..|.+||+.+++..+|+.....
T Consensus 729 ---~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 729 ---NCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred ---CCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 2334455567789999999999999999999876543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.9e-07 Score=81.75 Aligned_cols=142 Identities=13% Similarity=0.110 Sum_probs=91.5
Q ss_pred ccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchh---------HHHHHHHHHhcCC---CCceeeeeee
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKS---------FKSECKAAINIKH---RNIVRVFTAF 210 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h---~niv~~~~~~ 210 (473)
..++|...+++-......|.+-. .+|+.+++|..+.......+. ..+.+..+.++.. .....++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIe-i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIE-IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEE-ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 35678888888887777777666 477999999876433221111 2334444444422 2222323232
Q ss_pred eccccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEE
Q 012014 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVL 290 (473)
Q Consensus 211 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil 290 (473)
.-....-....+++|||++|..|.++..-. . .++..+..++.-|| ..|+.|+|..|.|++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~i~-------------e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFl 167 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIEDID-------------E----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFL 167 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchhcC-------------H----HHHHHHHHHHHHHH---HcCCccCCCCcCcEE
Confidence 222222233457899999998887653211 1 24456778899999 999999999999999
Q ss_pred ecCCccEEEeeccccc
Q 012014 291 LDDEMIGHVGDFGMAR 306 (473)
Q Consensus 291 ~~~~~~~kl~Dfg~~~ 306 (473)
+++++ ++++||+..+
T Consensus 168 v~~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 168 VSNNG-IRIIDTQGKR 182 (229)
T ss_pred EECCc-EEEEECcccc
Confidence 98655 8999998665
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.2e-07 Score=94.68 Aligned_cols=139 Identities=21% Similarity=0.251 Sum_probs=90.4
Q ss_pred ceeecCCCeEEEEEEecCCCEEEEEEeeccC----------------------CC----Cc--------h------hHHH
Q 012014 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIR----------------------PG----GS--------K------SFKS 190 (473)
Q Consensus 151 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----------------------~~----~~--------~------~~~~ 190 (473)
.-|+.++-|.||+|++.+|+.||||+.+..- +. .. + .+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 5799999999999999999999999886311 00 00 0 1445
Q ss_pred HHHHHHhcC-----CCCceeeeeeeeccccCCceeeEEEEEecCCCCHHHHh--cCCCCCCCCCcchhhcHHHHHHHHHH
Q 012014 191 ECKAAINIK-----HRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWL--RGKDDTNWRPLNFNFLIKKKLDIAID 263 (473)
Q Consensus 191 E~~~l~~l~-----h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l--~~~~~~~~~~~~~~~~~~~~~~i~~~ 263 (473)
|+..+.+++ .|+ +++=.+|.+ -.....|+|||++|-.+.+.. +..+ +..+. ++..
T Consensus 211 EA~n~~~~~~nf~~~~~-v~VP~V~we----~t~~~VLtmE~i~Gi~i~d~~~l~~~g----------~d~k~---ia~~ 272 (517)
T COG0661 211 EAANAERFRENFKDDPD-VYVPKVYWE----YTTRRVLTMEWIDGIKISDIAALKSAG----------IDRKE---LAEL 272 (517)
T ss_pred HHHHHHHHHHHcCCCCC-eEeceeehh----ccCCcEEEEEeeCCEecccHHHHHhcC----------CCHHH---HHHH
Confidence 555555552 232 222222221 123458999999998888874 3322 11222 2222
Q ss_pred HHHH-HHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecccccccCc
Q 012014 264 VACA-LRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPA 310 (473)
Q Consensus 264 i~~~-L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 310 (473)
++.+ +..+- ..|++|.|..|.||+++.+|.+.+.|||+...++.
T Consensus 273 ~~~~f~~q~~---~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 273 LVRAFLRQLL---RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHHHHHHH---hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 2222 22333 46999999999999999999999999999987654
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.63 E-value=2.5e-08 Score=96.16 Aligned_cols=84 Identities=25% Similarity=0.300 Sum_probs=51.9
Q ss_pred CCccccccceeehhhhHHHHHhC-CCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchh
Q 012014 1 MGYVSSYGDVYSFGILLLEMFTG-LRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSS 79 (473)
Q Consensus 1 ~g~~t~ksDVySfGVvllEl~tg-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~ 79 (473)
.|++|.|||||||||+|+||+|- +-|...+ +..+-+...-.. ..+..|.
T Consensus 378 ~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m-----sn~ev~~~le~G--yRlp~P~----------------------- 427 (468)
T KOG0197|consen 378 YGKFSSKSDVWSFGVLLWELFTYGRVPYPGM-----SNEEVLELLERG--YRLPRPE----------------------- 427 (468)
T ss_pred hCCcccccceeehhhhHHHHhccCCCCCCCC-----CHHHHHHHHhcc--CcCCCCC-----------------------
Confidence 47899999999999999999984 4443322 222222221111 0111111
Q ss_pred hHHHHHHHhhcccccccccccccccchhhHHHHHHHHH
Q 012014 80 IILECLISICRTGVACSAELPNERMKINDVESRLRLIK 117 (473)
Q Consensus 80 ~~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~ 117 (473)
.|-..+-.+...|+...|++||+.......++.+.
T Consensus 428 ---~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 428 ---GCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred ---CCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 12223334556799999999999998877776654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=98.62 E-value=3.2e-08 Score=86.02 Aligned_cols=92 Identities=18% Similarity=0.222 Sum_probs=52.8
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhhH
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (473)
+..+.|+|||||||+|+||+||+.|..........+..+.....+.... +........
T Consensus 79 ~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~------------------- 136 (176)
T smart00750 79 QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPR---DRSNLESVS------------------- 136 (176)
T ss_pred CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCcc---ccccHHHHH-------------------
Confidence 3567899999999999999999999653221111222222221111000 000000000
Q ss_pred HHHHHHhhcccccccccccccccchhhHHHHHHHHH
Q 012014 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIK 117 (473)
Q Consensus 82 ~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~ 117 (473)
. ...+..+...|+..+|..||++.++...+....
T Consensus 137 -~-~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 137 -A-ARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred -h-hhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 0 012334455699999999999999988776554
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.55 E-value=7.3e-08 Score=90.73 Aligned_cols=84 Identities=21% Similarity=0.322 Sum_probs=52.3
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhhH
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (473)
+..|.|+|||||||+++||+||+.|...... ..+. ......+.. +.+....
T Consensus 197 ~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~--~~~~---~~i~~~~~~----~~~~~~~-------------------- 247 (283)
T PHA02988 197 SEYTIKDDIYSLGVVLWEIFTGKIPFENLTT--KEIY---DLIINKNNS----LKLPLDC-------------------- 247 (283)
T ss_pred ccccchhhhhHHHHHHHHHHHCCCCCCCCCH--HHHH---HHHHhcCCC----CCCCCcC--------------------
Confidence 4678999999999999999999999764321 1111 111111100 0000000
Q ss_pred HHHHHHhhcccccccccccccccchhhHHHHHHHHH
Q 012014 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIK 117 (473)
Q Consensus 82 ~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~ 117 (473)
-..+..+...|+..+|+.||++.++...|+..+
T Consensus 248 ---~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 248 ---PLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred ---cHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 011222344699999999999999999988765
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.53 E-value=4.1e-08 Score=96.81 Aligned_cols=190 Identities=14% Similarity=0.078 Sum_probs=132.9
Q ss_pred cCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCC-ceeeeeeeeccccCCceeeE
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRN-IVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~~~~~~ 222 (473)
+.-+...+-+++|+++.+++.+-...+....+.+.. .....-++++|.+++||| .+..++- ++...+.+
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~-----~l~~rl~~eLLdK~n~P~~~v~~~~d-----~~~E~~~~ 310 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ-----TLSRRLAIELLDKVNNPNPVVRYLED-----YDGEDYLW 310 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhheeceeecc-----chhhHHHHHHHHHccCCCCccccccc-----CCcccccc
Confidence 344455566889999999998732223333555432 245566889999999999 4444333 34556789
Q ss_pred EEEEecCCC-CHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEee
Q 012014 223 VVYKFMPNG-SLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (473)
Q Consensus 223 lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~D 301 (473)
+.++++.++ +-.... ......+..-+...+.+.-+++|+++| +..=+|+| ||+..+ +..|..|
T Consensus 311 i~~~i~s~~rs~~~~~--------~~se~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~ 374 (829)
T KOG0576|consen 311 IPMRICSTGRSSALEM--------TVSEIALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLD 374 (829)
T ss_pred hhhhhhcCCccccccC--------ChhhHhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-ccccccc
Confidence 999999776 211111 111223334455567777888999999 55568888 877665 6679999
Q ss_pred cccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCC
Q 012014 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362 (473)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~ 362 (473)
|+....+.... ......+|+.|+|||+.....+....|.||+|+-..++.-|.+|-..
T Consensus 375 ~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 375 FAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred ccCCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 99987765533 34456689999999999999999999999999888888888877654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.5e-06 Score=76.98 Aligned_cols=135 Identities=17% Similarity=0.168 Sum_probs=92.3
Q ss_pred eeecCCCeEEEEEEecCCCEEEEEEeeccCCCC-------------------ch-----hHHHHHHHHHhcC--CCCcee
Q 012014 152 LIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGG-------------------SK-----SFKSECKAAINIK--HRNIVR 205 (473)
Q Consensus 152 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------------------~~-----~~~~E~~~l~~l~--h~niv~ 205 (473)
.|+.|.-+.||+|...++..+|+|+++...... .. ...+|..-|.++. +-.+.+
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 466777889999987789999999997422111 11 1346777777773 445555
Q ss_pred eeeeeeccccCCceeeEEEEEecCCCC-HHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccC
Q 012014 206 VFTAFSGVDYQGARFKAVVYKFMPNGS-LEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNL 284 (473)
Q Consensus 206 ~~~~~~~~~~~~~~~~~lv~e~~~~g~-L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dl 284 (473)
-+++. .-.|||||+.... -.-.|+. ..+...++..+..++++.+.-|-. ..++||+||
T Consensus 135 Pi~~~---------~nVLvMEfIg~~g~pAP~LkD----------v~~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDL 193 (268)
T COG1718 135 PIAFR---------NNVLVMEFIGDDGLPAPRLKD----------VPLELEEAEGLYEDVVEYMRRLYK--EAGLVHGDL 193 (268)
T ss_pred ceeec---------CCeEEEEeccCCCCCCCCccc----------CCcCchhHHHHHHHHHHHHHHHHH--hcCcccccc
Confidence 55553 2379999995431 1111111 122233567778888888888872 389999999
Q ss_pred CCCcEEecCCccEEEeeccccccc
Q 012014 285 KPSNVLLDDEMIGHVGDFGMARFL 308 (473)
Q Consensus 285 kp~Nil~~~~~~~kl~Dfg~~~~~ 308 (473)
..=|||+. ++.+.++|||.|...
T Consensus 194 SEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 194 SEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred hhhheEEE-CCeEEEEECcccccc
Confidence 99999999 788999999988754
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.48 E-value=2.9e-06 Score=76.58 Aligned_cols=143 Identities=14% Similarity=0.142 Sum_probs=80.2
Q ss_pred ceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCC--ceeeeeeeeccccCCceeeEEEEEec
Q 012014 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRN--IVRVFTAFSGVDYQGARFKAVVYKFM 228 (473)
Q Consensus 151 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~e~~ 228 (473)
..||+|..+.||+. .+..+++|..... .......+|.+++..+..-. +.+.+++... .....+|||++
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~--~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~-----~~~~glv~e~i 76 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPG--FDKETIKREFDASRKVFSLGIPTPHPFDLVED-----GGRLGLIYELI 76 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCC--CCHHHHHHHHHHHHHHHHcCCCCCceEEEEec-----CCeeeeeeeec
Confidence 56899999999984 2556788887532 23456789999998885433 3555555432 22357899999
Q ss_pred CCCC-HHHHhcCC------------------CCCCCCCcchhhc--HHHHHHHHH-------HHHH-HHHHHhh-CCCCC
Q 012014 229 PNGS-LEEWLRGK------------------DDTNWRPLNFNFL--IKKKLDIAI-------DVAC-ALRYLHC-DCQPP 278 (473)
Q Consensus 229 ~~g~-L~~~l~~~------------------~~~~~~~~~~~~~--~~~~~~i~~-------~i~~-~L~~LH~-~~~~~ 278 (473)
+|.+ +...+... ........ .+. .......+. .+.. ...+|.. .....
T Consensus 77 ~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~--~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~ 154 (226)
T TIGR02172 77 VGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTS--TFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST 154 (226)
T ss_pred CCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCC--cHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence 8863 22111110 00000000 000 000000000 0111 1122221 11346
Q ss_pred eeeccCCCCcEEecCCccEEEeeccccc
Q 012014 279 IAHCNLKPSNVLLDDEMIGHVGDFGMAR 306 (473)
Q Consensus 279 iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~ 306 (473)
++|+|+.|.||++++++ +.++||+.+.
T Consensus 155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 155 CLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred eEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 78999999999999888 8999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=98.46 E-value=4.9e-08 Score=90.67 Aligned_cols=78 Identities=26% Similarity=0.361 Sum_probs=44.7
Q ss_pred ccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhhH
Q 012014 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (473)
..|.|||||||||+++||+| |+.|.... ...++.............+ ..
T Consensus 181 ~~~~ksDVysfG~~l~ei~~~~~~p~~~~-----~~~~~~~~~~~~~~~~~~~-----~~-------------------- 230 (259)
T PF07714_consen 181 EYTKKSDVYSFGMLLYEILTLGKFPFSDY-----DNEEIIEKLKQGQRLPIPD-----NC-------------------- 230 (259)
T ss_dssp EESHHHHHHHHHHHHHHHHTTSSGTTTTS-----CHHHHHHHHHTTEETTSBT-----TS--------------------
T ss_pred ccccccccccccccccccccccccccccc-----ccccccccccccccceecc-----ch--------------------
Confidence 36889999999999999999 66675432 1122222221111111000 00
Q ss_pred HHHHHHhhcccccccccccccccchhhHHHHH
Q 012014 82 LECLISICRTGVACSAELPNERMKINDVESRL 113 (473)
Q Consensus 82 ~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l 113 (473)
-..+..+...|+..+|++||++.++.+.|
T Consensus 231 ---~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 231 ---PKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---BHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---hHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 11122345679999999999999998765
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.45 E-value=8.3e-07 Score=88.39 Aligned_cols=139 Identities=17% Similarity=0.225 Sum_probs=89.2
Q ss_pred cceeecCCCeEEEEEEecCCCEEEEEEeeccCCCC-----------------------c--------h------hHHHHH
Q 012014 150 ANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGG-----------------------S--------K------SFKSEC 192 (473)
Q Consensus 150 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-----------------------~--------~------~~~~E~ 192 (473)
.+.||.-+.|.||+|++.+|+.||||+-+..-... . + .|.+|+
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 35699999999999999999999999875321100 0 0 144555
Q ss_pred HHHHhc----CCCC------ceeeeeeeeccccCCceeeEEEEEecCCCCHHHH--hcCCCCCCCCCcchhhcHHHHHHH
Q 012014 193 KAAINI----KHRN------IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEW--LRGKDDTNWRPLNFNFLIKKKLDI 260 (473)
Q Consensus 193 ~~l~~l----~h~n------iv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~--l~~~~~~~~~~~~~~~~~~~~~~i 260 (473)
+-..+. .|-+ |.++|-.+ .....|+||||+|..+.+. |.+.+ ++...+..-
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~-------st~RVLtME~~~G~~i~Dl~~i~~~g----------i~~~~i~~~ 308 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL-------STKRVLTMEYVDGIKINDLDAIDKRG----------ISPHDILNK 308 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc-------CcceEEEEEecCCccCCCHHHHHHcC----------CCHHHHHHH
Confidence 443333 4555 55555333 2245899999999876554 44433 223333332
Q ss_pred HHHHHHHHHHHhhCCCCCeeeccCCCCcEEecC----CccEEEeecccccccCc
Q 012014 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD----EMIGHVGDFGMARFLPA 310 (473)
Q Consensus 261 ~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~----~~~~kl~Dfg~~~~~~~ 310 (473)
+.+...-+-+ ..|++|+|=.|.||+++. ++.+.+-|||+...+..
T Consensus 309 l~~~~~~qIf-----~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 309 LVEAYLEQIF-----KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred HHHHHHHHHH-----hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 2232222222 458999999999999983 67899999999886644
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.43 E-value=9.7e-06 Score=70.71 Aligned_cols=102 Identities=15% Similarity=0.113 Sum_probs=80.0
Q ss_pred HHHHHHHHhcCC-CCceeeeeeeeccccCCceeeEEEEEecCCCCHHHH---hcCCCCCCCCCcchhhcHHHHHHHHHHH
Q 012014 189 KSECKAAINIKH-RNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEW---LRGKDDTNWRPLNFNFLIKKKLDIAIDV 264 (473)
Q Consensus 189 ~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~---l~~~~~~~~~~~~~~~~~~~~~~i~~~i 264 (473)
.+|.-+++.+.+ +++++++|+|- .+++.||...+++... +... ..-+|..+.+|+.++
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG---------~~~v~E~~~~~~~~~~~~~l~~~---------~~~~w~~R~~iA~~l 68 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG---------RFYVVEYVGAGSLYGIYRPLSQF---------LQSPWEQRAKIALQL 68 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC---------CEEEEEeecCccccccccccccc---------cccCHHHHHHHHHHH
Confidence 457888888876 69999999983 2789999987765422 0000 023499999999999
Q ss_pred HHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeeccccccc
Q 012014 265 ACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL 308 (473)
Q Consensus 265 ~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 308 (473)
++.+.+|+......+.-.|++|+|+-+++++.+|++|...+...
T Consensus 69 L~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 69 LELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred HHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 99999999654466888999999999999999999999877543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=98.42 E-value=6e-08 Score=91.30 Aligned_cols=96 Identities=18% Similarity=0.216 Sum_probs=52.3
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCCCCCCcccHHHHHHHhcCC-ccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPE-RAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+.++.|+|||||||+++||+||+.|..........+..+....... ...+.++... ...+..
T Consensus 185 ~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~--- 247 (283)
T cd05080 185 NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGM--------------RLPCPK--- 247 (283)
T ss_pred cCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCC--------------CCCCCC---
Confidence 4568899999999999999999998543211100011000000000 0000001000 000000
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHH
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLI 116 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~ 116 (473)
.+...+..+...|+..+|+.||++.++...++.+
T Consensus 248 --~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 248 --NCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred --CCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 0112234456789999999999999999888765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.40 E-value=1.1e-07 Score=92.10 Aligned_cols=86 Identities=21% Similarity=0.286 Sum_probs=51.4
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhhHH
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSIIL 82 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (473)
.+++|.|||||||||+|||||.-|..+...... +| -+..+...+.-|. . |
T Consensus 287 PcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI-----Iw-GVGsNsL~LpvPs---t--------------c------- 336 (904)
T KOG4721|consen 287 PCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI-----IW-GVGSNSLHLPVPS---T--------------C------- 336 (904)
T ss_pred CcccccceehhHHHHHHHHhcCCCccccchhee-----EE-eccCCcccccCcc---c--------------C-------
Confidence 478999999999999999999999654322110 00 0111111111111 0 1
Q ss_pred HHHHHhhcccccccccccccccchhhHHHHHHHHHhhc
Q 012014 83 ECLISICRTGVACSAELPNERMKINDVESRLRLIKKKL 120 (473)
Q Consensus 83 ~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~~~ 120 (473)
-..+.-+.-.|+...|..||+.+++..-|.......
T Consensus 337 --P~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pel 372 (904)
T KOG4721|consen 337 --PDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPEL 372 (904)
T ss_pred --chHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHH
Confidence 111111123599999999999999988877654433
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.36 E-value=5.9e-06 Score=75.25 Aligned_cols=152 Identities=16% Similarity=0.220 Sum_probs=84.3
Q ss_pred cceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCC--CceeeeeeeeccccCCceeeEEEEEe
Q 012014 150 ANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHR--NIVRVFTAFSGVDYQGARFKAVVYKF 227 (473)
Q Consensus 150 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~~~~~~~~~~~lv~e~ 227 (473)
++.|+.|..+.||+....+ ..+++|..... .....+.+|..++..+... .+.+++...... ......+++|++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~--~~~~~~~~~~~~ 76 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSD--EFNGFPYLLMEY 76 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEET--EETSEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccc--cccccceEEEEE
Confidence 3578999999999999655 69999996532 2346788899998888533 356666543222 222347899999
Q ss_pred cCCCCHHH----------------Hh---cCCCCCCCCCcchh-h---cHHHHHHH------------HHHHHH-HHHHH
Q 012014 228 MPNGSLEE----------------WL---RGKDDTNWRPLNFN-F---LIKKKLDI------------AIDVAC-ALRYL 271 (473)
Q Consensus 228 ~~~g~L~~----------------~l---~~~~~~~~~~~~~~-~---~~~~~~~i------------~~~i~~-~L~~L 271 (473)
++|.++.. .+ +............. . ........ ...+.. .+..+
T Consensus 77 i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (239)
T PF01636_consen 77 IPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQEL 156 (239)
T ss_dssp ESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHH
T ss_pred eccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHH
Confidence 99988877 11 11100000000000 0 00000000 111222 23333
Q ss_pred hh----CCCCCeeeccCCCCcEEec-CCccEEEeeccccc
Q 012014 272 HC----DCQPPIAHCNLKPSNVLLD-DEMIGHVGDFGMAR 306 (473)
Q Consensus 272 H~----~~~~~iiH~Dlkp~Nil~~-~~~~~kl~Dfg~~~ 306 (473)
+. .....++|+|+.|.||+++ +++.+-|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 157 EALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 31 1256799999999999999 66666899998775
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.35 E-value=2.4e-07 Score=97.73 Aligned_cols=88 Identities=25% Similarity=0.297 Sum_probs=56.3
Q ss_pred CCccccccceeehhhhHHHHHhCC-CCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchh
Q 012014 1 MGYVSSYGDVYSFGILLLEMFTGL-RPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSS 79 (473)
Q Consensus 1 ~g~~t~ksDVySfGVvllEl~tg~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~ 79 (473)
+|.+|+|||||||||+|+||+|-- .|.....+. .-+..|.. .+ -+++.-
T Consensus 878 d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~-~v~~~~~~----gg---RL~~P~---------------------- 927 (1025)
T KOG1095|consen 878 DGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF-EVLLDVLE----GG---RLDPPS---------------------- 927 (1025)
T ss_pred hcccccccchhhhHHHHHHHHhCCCCCCCCcchH-HHHHHHHh----CC---ccCCCC----------------------
Confidence 378999999999999999999854 454332221 11222222 11 111110
Q ss_pred hHHHHHHHhhcccccccccccccccchhhHHHHHHHHHhhcc
Q 012014 80 IILECLISICRTGVACSAELPNERMKINDVESRLRLIKKKLL 121 (473)
Q Consensus 80 ~~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~~~~ 121 (473)
.|-..+.++...|+...|++||+...+..++..+.....
T Consensus 928 ---~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 928 ---YCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred ---CCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 122333455678999999999999999998887765543
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.30 E-value=3.7e-06 Score=70.40 Aligned_cols=129 Identities=22% Similarity=0.237 Sum_probs=89.5
Q ss_pred CCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCce-eeeeeeeccccCCceeeEEEE
Q 012014 147 FSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIV-RVFTAFSGVDYQGARFKAVVY 225 (473)
Q Consensus 147 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~~~~~~lv~ 225 (473)
-...+.||+|.+|.||++.+ .|..+|+|+-+ .......+..|+++|..+.-.++. ++|.+- ..++.|
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr--~ds~r~~l~kEakiLeil~g~~~~p~vy~yg---------~~~i~m 91 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEW-RGGEVALKVRR--RDSPRRNLEKEAKILEILAGEGVTPEVYFYG---------EDFIRM 91 (201)
T ss_pred hhhhhhhhcccccEEEEeec-cCceEEEEEec--CCcchhhHHHHHHHHHHhhhcCCCceEEEec---------hhhhhh
Confidence 34567899999999999996 45688999855 334567899999999999766654 444331 225679
Q ss_pred EecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCC-C-cEEecCCccEEEeecc
Q 012014 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKP-S-NVLLDDEMIGHVGDFG 303 (473)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp-~-Nil~~~~~~~kl~Dfg 303 (473)
||+.|-.|.+.-.... .+ -...++++---|- ..||-|+.|.- . ||++. ++.+.|+||.
T Consensus 92 e~i~G~~L~~~~~~~~------------rk----~l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~-~~~~~iIDFd 151 (201)
T COG2112 92 EYIDGRPLGKLEIGGD------------RK----HLLRVLEKAYKLD---RLGIEHGELSRPWKNVLVN-DRDVYIIDFD 151 (201)
T ss_pred hhhcCcchhhhhhccc------------HH----HHHHHHHHHHHHH---HhccchhhhcCCceeEEec-CCcEEEEEcc
Confidence 9998888887654321 11 2334444444455 77898988864 3 55554 4489999999
Q ss_pred cccc
Q 012014 304 MARF 307 (473)
Q Consensus 304 ~~~~ 307 (473)
.|+.
T Consensus 152 ~At~ 155 (201)
T COG2112 152 SATF 155 (201)
T ss_pred chhh
Confidence 8874
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=98.28 E-value=4.4e-07 Score=85.33 Aligned_cols=81 Identities=27% Similarity=0.577 Sum_probs=51.0
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+.++.|+|||||||+|+||+| |+.|...... ..+..++.. ....... .
T Consensus 201 ~~~~~~sDv~slG~il~el~~~g~~p~~~~~~--~~~~~~i~~---~~~~~~~-----~--------------------- 249 (283)
T cd05048 201 GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN--QEVIEMIRS---RQLLPCP-----E--------------------- 249 (283)
T ss_pred CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHc---CCcCCCc-----c---------------------
Confidence 567899999999999999998 9888653221 122222211 1000000 0
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHH
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRL 115 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~ 115 (473)
.+-..+..+...|+..+|..||+++++...|+.
T Consensus 250 --~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 250 --DCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred --cCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 001122334567999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.26 E-value=2.3e-05 Score=68.69 Aligned_cols=134 Identities=18% Similarity=0.216 Sum_probs=91.8
Q ss_pred ccceeecCCCeEEEEEEecCCCEEEEEEeeccC----------------CCCchhHHHHHHHHHhcC------CCCceee
Q 012014 149 SANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIR----------------PGGSKSFKSECKAAINIK------HRNIVRV 206 (473)
Q Consensus 149 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~~ 206 (473)
....||+|+.-.||.- .++...+||+..... ....++..+|+.....+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 3567999999999953 566778899887544 223466778887777666 8899999
Q ss_pred eeeeeccccCCceeeEEEEEecCC------CCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCee
Q 012014 207 FTAFSGVDYQGARFKAVVYKFMPN------GSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIA 280 (473)
Q Consensus 207 ~~~~~~~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ii 280 (473)
+|+..+ +.-.-+|+|.+.+ -+|.+++.... ++. ...+.+. .-..||- +..|+
T Consensus 83 ~G~veT-----~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----------~~~-~~~~~L~---~f~~~l~---~~~Iv 140 (199)
T PF10707_consen 83 YGFVET-----NLGLGLVVELIRDADGNISPTLEDYLKEGG----------LTE-ELRQALD---EFKRYLL---DHHIV 140 (199)
T ss_pred eEEEec-----CCceEEEEEEEECCCCCcCccHHHHHHcCC----------ccH-HHHHHHH---HHHHHHH---HcCCe
Confidence 999644 4456788888743 36888886543 222 3333333 3345566 67899
Q ss_pred eccCCCCcEEecCC---c-cEEEee-ccccc
Q 012014 281 HCNLKPSNVLLDDE---M-IGHVGD-FGMAR 306 (473)
Q Consensus 281 H~Dlkp~Nil~~~~---~-~~kl~D-fg~~~ 306 (473)
.+|++|.||++... . .+.|+| ||...
T Consensus 141 ~~dl~~~NIv~~~~~~~~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 141 IRDLNPHNIVVQRRDSGEFRLVLIDGLGEKE 171 (199)
T ss_pred ecCCCcccEEEEecCCCceEEEEEeCCCCcc
Confidence 99999999999532 2 577887 55443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=98.26 E-value=6.9e-07 Score=84.43 Aligned_cols=84 Identities=24% Similarity=0.379 Sum_probs=52.8
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..+.|+|||||||+++||+| |+.|....... ...+.+. ........+ ..
T Consensus 200 ~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~~~~~---~~~~~~~~~-----~~------------------- 250 (291)
T cd05094 200 RKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT--EVIECIT---QGRVLERPR-----VC------------------- 250 (291)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHh---CCCCCCCCc-----cC-------------------
Confidence 346889999999999999999 88886432211 1111111 111100000 00
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHHh
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~ 118 (473)
...+..+...|+..+|++||++.++.+.+..+.+
T Consensus 251 ----~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 251 ----PKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred ----CHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 1112344567999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.2e-06 Score=82.26 Aligned_cols=84 Identities=19% Similarity=0.369 Sum_probs=52.5
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..|.++|||||||+++||+| |+.|...... ..+.+++.... ....+.. |
T Consensus 186 ~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--~~~~~~~~~~~-----~~~~~~~-----------------~----- 236 (279)
T cd05111 186 GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP--HEVPDLLEKGE-----RLAQPQI-----------------C----- 236 (279)
T ss_pred CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHCCC-----cCCCCCC-----------------C-----
Confidence 567899999999999999999 8888653221 12223322110 0011110 0
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHHh
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~ 118 (473)
...+..+...|+..+|..||++.++...+..+..
T Consensus 237 ----~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 237 ----TIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred ----CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 0111223457999999999999999988877553
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=98.21 E-value=9.3e-07 Score=85.51 Aligned_cols=84 Identities=24% Similarity=0.320 Sum_probs=51.1
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..+.|+|||||||+|+||+| |+.|.......+ .+. ........... + ...
T Consensus 251 ~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-~~~---~~~~~~~~~~~--~---~~~------------------- 302 (338)
T cd05102 251 KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-EFC---QRLKDGTRMRA--P---ENA------------------- 302 (338)
T ss_pred CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-HHH---HHHhcCCCCCC--C---CCC-------------------
Confidence 346899999999999999997 888865322111 111 11111000000 0 000
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHH
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIK 117 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~ 117 (473)
...+..+...|+..+|..||++.++.+.|+...
T Consensus 303 ----~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~ 335 (338)
T cd05102 303 ----TPEIYRIMLACWQGDPKERPTFSALVEILGDLL 335 (338)
T ss_pred ----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 011223456799999999999999999888654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.20 E-value=2.7e-05 Score=71.47 Aligned_cols=75 Identities=11% Similarity=0.017 Sum_probs=50.3
Q ss_pred eecCCC-eEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcC-CCCceeeeeeeeccccCCceeeEEEEEecCC
Q 012014 153 IGAGNF-GSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQGARFKAVVYKFMPN 230 (473)
Q Consensus 153 lg~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~ 230 (473)
|..|.+ ..||+... ++..+.+|+..... ...+.+|++++..+. +--+.+++++.... ...++|||+++|
T Consensus 6 ~~~g~~~~~v~~~~~-~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~-----~~~~lv~e~i~G 76 (244)
T cd05150 6 VTEGQSGATVYRLDG-KNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDD-----GRAWLLTSAVPG 76 (244)
T ss_pred cCCCCCcCeEEEEcC-CCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecC-----CccEEEEEeeCC
Confidence 445555 78899874 34788888865332 345778999988884 34455666664321 245899999999
Q ss_pred CCHHHH
Q 012014 231 GSLEEW 236 (473)
Q Consensus 231 g~L~~~ 236 (473)
.+|...
T Consensus 77 ~~l~~~ 82 (244)
T cd05150 77 VPAAAL 82 (244)
T ss_pred ccHhHh
Confidence 877644
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=98.19 E-value=7.4e-07 Score=83.73 Aligned_cols=87 Identities=21% Similarity=0.238 Sum_probs=51.5
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCCCCCCcc----------cHHHHHHHhcCCccccccccccccchHHHHHHHhhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDEL----------NLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKA 71 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 71 (473)
+.++.++||||||++++||+||+.|......... ....+.........
T Consensus 187 ~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------- 244 (284)
T cd05038 187 SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGER---------------------- 244 (284)
T ss_pred CCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCCc----------------------
Confidence 3567899999999999999999988543211110 01111110000000
Q ss_pred cccCcchhhHHHHHHHhhcccccccccccccccchhhHHHHHHHH
Q 012014 72 SSTCTQSSIILECLISICRTGVACSAELPNERMKINDVESRLRLI 116 (473)
Q Consensus 72 ~~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~ 116 (473)
... ...+-..+..+...|+..+|..||++.++...|..+
T Consensus 245 ---~~~---~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 245 ---LPR---PPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred ---CCC---CccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 000 000112334556689999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=98.18 E-value=1.1e-06 Score=81.62 Aligned_cols=81 Identities=20% Similarity=0.234 Sum_probs=49.2
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+.+|.++|||||||+++||+| |+.|..... ..++....... . .+......
T Consensus 180 ~~~~~~~Dv~slG~il~el~t~g~~p~~~~~-----~~~~~~~~~~~-~----~~~~~~~~------------------- 230 (263)
T cd05052 180 NKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYELLEKG-Y----RMERPEGC------------------- 230 (263)
T ss_pred CCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHHCC-C----CCCCCCCC-------------------
Confidence 456889999999999999999 887754221 11111111110 0 00000000
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHH
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRL 115 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~ 115 (473)
-..+..+...|+..+|++||++.++.+.|+.
T Consensus 231 ----~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 231 ----PPKVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred ----CHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 0112234567999999999999999988865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=98.18 E-value=1.1e-06 Score=81.93 Aligned_cols=82 Identities=26% Similarity=0.350 Sum_probs=50.8
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..+.|+|||||||+++||+| |+.|...... .++......... .+.. .
T Consensus 185 ~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-----~~~~~~i~~~~~----~~~~-~--------------------- 233 (268)
T cd05063 185 RKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-----HEVMKAINDGFR----LPAP-M--------------------- 233 (268)
T ss_pred CCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-----HHHHHHHhcCCC----CCCC-C---------------------
Confidence 456889999999999999998 9998653211 111111111000 0000 0
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHH
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLI 116 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~ 116 (473)
.+...+..+...|+..+|+.||++.++.+.|..+
T Consensus 234 --~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 234 --DCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred --CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0012233456679999999999999999888653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=98.17 E-value=1.3e-06 Score=80.83 Aligned_cols=82 Identities=27% Similarity=0.389 Sum_probs=52.1
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+.++.++|||||||+++||+| |+.|.+.... ..+..++...... ...+ ..
T Consensus 173 ~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~~~~~~---~~~~-----~~------------------- 223 (257)
T cd05060 173 GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLESGERL---PRPE-----EC------------------- 223 (257)
T ss_pred CCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHcCCcC---CCCC-----CC-------------------
Confidence 457889999999999999998 8888653321 2233333221110 0000 00
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHH
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLI 116 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~ 116 (473)
...+..+...|+..+|.+||++.++...|+.+
T Consensus 224 ----~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 224 ----PQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred ----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 01122345679999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.17 E-value=6e-07 Score=87.93 Aligned_cols=87 Identities=24% Similarity=0.233 Sum_probs=54.5
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhhHH
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSIIL 82 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (473)
.+|..|||||||+|++||+||.-|......++. -+++..+ .-..|... +..
T Consensus 569 PfS~qSDVYaFGiV~YELltg~lPysi~~~dqI------ifmVGrG-~l~pd~s~-------------~~s--------- 619 (678)
T KOG0193|consen 569 PFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI------IFMVGRG-YLMPDLSK-------------IRS--------- 619 (678)
T ss_pred CCCcccchhhhhHHHHHHHhCcCCcCCCChhhe------EEEeccc-ccCccchh-------------hhc---------
Confidence 478899999999999999999999762211111 1111111 01111110 000
Q ss_pred HHHHHhhcccccccccccccccchhhHHHHHHHHHh
Q 012014 83 ECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (473)
Q Consensus 83 ~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~ 118 (473)
.|-..+-++...|+...+++||...++...|+.+..
T Consensus 620 ~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 620 NCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred cCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 122334455678999999999999999998777654
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=98.16 E-value=1.2e-06 Score=82.49 Aligned_cols=80 Identities=28% Similarity=0.510 Sum_probs=48.9
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..+.++||||||++++||+| |..|..... ..++...........+.+ .
T Consensus 201 ~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~-----~~~~~~~i~~~~~~~~~~-----~-------------------- 250 (283)
T cd05091 201 GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-----NQDVIEMIRNRQVLPCPD-----D-------------------- 250 (283)
T ss_pred CCCCcchhHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHHcCCcCCCCC-----C--------------------
Confidence 567889999999999999999 666643221 112222211111100000 0
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHH
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLR 114 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~ 114 (473)
+-..+..+...|+...|.+||++.++...|+
T Consensus 251 ---~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 251 ---CPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred ---CCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 0111234456799999999999999988875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=98.16 E-value=1.3e-06 Score=81.52 Aligned_cols=27 Identities=30% Similarity=0.361 Sum_probs=24.0
Q ss_pred CccccccceeehhhhHHHHHhCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
+.++.|+|||||||+++||+||+.|..
T Consensus 188 ~~~~~~~Dv~slG~ll~~l~~g~~p~~ 214 (269)
T cd08528 188 EPYGEKADVWAFGCILYQMCTLQPPFY 214 (269)
T ss_pred CCCchHHHHHHHHHHHHHHHhCCCccc
Confidence 457889999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.6e-06 Score=81.93 Aligned_cols=82 Identities=24% Similarity=0.387 Sum_probs=51.1
Q ss_pred ccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhhH
Q 012014 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (473)
..+.++|||||||+++||+| |+.|..... ...+.+++...... .. + ...
T Consensus 205 ~~~~~~Di~slG~~l~el~t~g~~p~~~~~--~~~~~~~~~~~~~~---~~--~---~~~-------------------- 254 (290)
T cd05045 205 IYTTQSDVWSFGVLLWEIVTLGGNPYPGIA--PERLFNLLKTGYRM---ER--P---ENC-------------------- 254 (290)
T ss_pred CcchHhHHHHHHHHHHHHHhcCCCCCCCCC--HHHHHHHHhCCCCC---CC--C---CCC--------------------
Confidence 46889999999999999999 887764321 11222222111100 00 0 000
Q ss_pred HHHHHHhhcccccccccccccccchhhHHHHHHHHH
Q 012014 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIK 117 (473)
Q Consensus 82 ~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~ 117 (473)
...+..+...|+..+|.+||++.++...|+.+-
T Consensus 255 ---~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~ 287 (290)
T cd05045 255 ---SEEMYNLMLTCWKQEPDKRPTFADISKELEKMM 287 (290)
T ss_pred ---CHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence 111223456799999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.6e-06 Score=80.89 Aligned_cols=81 Identities=20% Similarity=0.361 Sum_probs=49.3
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..+.++||||||++++||+| |..|.....+ ..+.++... ........ .
T Consensus 190 ~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--~~~~~~~~~---~~~~~~~~-----~-------------------- 239 (273)
T cd05035 190 RVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--HEIYDYLRH---GNRLKQPE-----D-------------------- 239 (273)
T ss_pred CCCCcccchHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHc---CCCCCCCc-----C--------------------
Confidence 346789999999999999999 7777543211 112222211 10000000 0
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHH
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRL 115 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~ 115 (473)
+...+..+...|+..+|.+||++.++...|+.
T Consensus 240 ---~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~ 271 (273)
T cd05035 240 ---CLDELYDLMYSCWRADPKDRPTFTKLREVLEN 271 (273)
T ss_pred ---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 01122333456999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.4e-06 Score=81.12 Aligned_cols=84 Identities=19% Similarity=0.131 Sum_probs=50.2
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhhHH
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSIIL 82 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (473)
..+.++|||||||+++||+||+.|..... .....+........ .+..... .
T Consensus 182 ~~~~~~Di~slG~~l~el~~g~~p~~~~~---~~~~~~~~~~~~~~-----~~~~~~~--~------------------- 232 (267)
T cd08228 182 GYNFKSDIWSLGCLLYEMAALQSPFYGDK---MNLFSLCQKIEQCD-----YPPLPTE--H------------------- 232 (267)
T ss_pred CCCchhhHHHHHHHHHHHhcCCCCCcccc---ccHHHHHHHHhcCC-----CCCCChh--h-------------------
Confidence 46789999999999999999999964321 12222222111100 0000000 0
Q ss_pred HHHHHhhcccccccccccccccchhhHHHHHHHH
Q 012014 83 ECLISICRTGVACSAELPNERMKINDVESRLRLI 116 (473)
Q Consensus 83 ~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~ 116 (473)
.-..+..+...|+...|.+||++.++...++..
T Consensus 233 -~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 233 -YSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred -cCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 001122233469999999999999999888764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=98.13 E-value=1.9e-06 Score=81.72 Aligned_cols=25 Identities=16% Similarity=0.315 Sum_probs=21.3
Q ss_pred cccccccccccccccchhhHHHHHH
Q 012014 90 RTGVACSAELPNERMKINDVESRLR 114 (473)
Q Consensus 90 ~~~~~C~~~~~~~Rp~m~~v~~~l~ 114 (473)
.+...|+..+|..||++.++...|+
T Consensus 271 ~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 271 KLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHHcCCCcccCCCHHHHHHHHh
Confidence 4566899999999999999988764
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=98.13 E-value=1.6e-06 Score=80.46 Aligned_cols=84 Identities=23% Similarity=0.309 Sum_probs=50.0
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhhH
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (473)
+..+.|+|||||||+++||+||..|..... ....+..++.. .... ..+. ..
T Consensus 177 ~~~~~~~Di~slG~~l~el~~~~~~~~~~~-~~~~~~~~~~~---~~~~--~~~~---~~-------------------- 227 (262)
T cd05058 177 QKFTTKSDVWSFGVLLWELMTRGAPPYPDV-DSFDITVYLLQ---GRRL--LQPE---YC-------------------- 227 (262)
T ss_pred CccchHHHHHHHHHHHHHHHcCCCCCCCCC-CHHHHHHHHhc---CCCC--CCCC---cC--------------------
Confidence 456889999999999999999766532211 11122222211 1000 0000 00
Q ss_pred HHHHHHhhcccccccccccccccchhhHHHHHHHHH
Q 012014 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIK 117 (473)
Q Consensus 82 ~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~ 117 (473)
...+..+...|+...|++||++.++...++...
T Consensus 228 ---~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 228 ---PDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred ---CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 011223456799999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=98.13 E-value=1.7e-06 Score=79.97 Aligned_cols=78 Identities=23% Similarity=0.409 Sum_probs=48.1
Q ss_pred ccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhhH
Q 012014 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (473)
..+.|+|||||||+|+||+| |+.|..... .......+.... . ...+...
T Consensus 177 ~~~~~~Di~s~G~~l~el~~~g~~p~~~~~--~~~~~~~i~~~~--~---~~~~~~~----------------------- 226 (256)
T cd05114 177 KYSSKSDVWSFGVLMWEVFTEGKMPFEKKS--NYEVVEMISRGF--R---LYRPKLA----------------------- 226 (256)
T ss_pred ccchhhhhHHHHHHHHHHHcCCCCCCCCCC--HHHHHHHHHCCC--C---CCCCCCC-----------------------
Confidence 45789999999999999999 887764321 112222222110 0 0011000
Q ss_pred HHHHHHhhcccccccccccccccchhhHHHHH
Q 012014 82 LECLISICRTGVACSAELPNERMKINDVESRL 113 (473)
Q Consensus 82 ~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l 113 (473)
...+..+...|+..+|.+||++.++...|
T Consensus 227 ---~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 227 ---SMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ---CHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 01233456679999999999999997765
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=98.13 E-value=2.2e-06 Score=79.76 Aligned_cols=84 Identities=19% Similarity=0.124 Sum_probs=50.5
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhhHH
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSIIL 82 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (473)
..+.++|||||||+++||+||+.|.... ...+.++...........+... ..
T Consensus 182 ~~~~~~Di~slG~il~~l~~g~~p~~~~---~~~~~~~~~~~~~~~~~~~~~~----~~--------------------- 233 (267)
T cd08224 182 GYNFKSDIWSLGCLLYEMAALQSPFYGD---KMNLYSLCKKIEKCDYPPLPAD----HY--------------------- 233 (267)
T ss_pred CCCchhcHHHHHHHHHHHHHCCCCcccC---CccHHHHHhhhhcCCCCCCChh----hc---------------------
Confidence 4678999999999999999999986422 1222222221111100000000 00
Q ss_pred HHHHHhhcccccccccccccccchhhHHHHHHHH
Q 012014 83 ECLISICRTGVACSAELPNERMKINDVESRLRLI 116 (473)
Q Consensus 83 ~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~ 116 (473)
...+..+...|+..+|..||++.++...++.+
T Consensus 234 --~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 234 --SEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred --CHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 01122334569999999999999998888764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.12 E-value=6.9e-05 Score=65.07 Aligned_cols=131 Identities=24% Similarity=0.409 Sum_probs=92.4
Q ss_pred cCCCCccceeecCCC-eEEEEEEecCCCEEEEEEeecc---CC------------------CCchhHHHHHHHHHhcC--
Q 012014 144 TNGFSSANLIGAGNF-GSVYNGTLFDGTTIAVKVFNLI---RP------------------GGSKSFKSECKAAINIK-- 199 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~-g~V~~~~~~~~~~vavK~~~~~---~~------------------~~~~~~~~E~~~l~~l~-- 199 (473)
+.+++..+.||.|.- |.||+++. +|+.+|+|+++.. .. .....|..|.+...+|+
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 378889999999999 99999985 6789999995421 00 11235788999888774
Q ss_pred -CCCc--eeeeeeeeccc-------------cCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHH
Q 012014 200 -HRNI--VRVFTAFSGVD-------------YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAID 263 (473)
Q Consensus 200 -h~ni--v~~~~~~~~~~-------------~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~ 263 (473)
+.++ |+++|+..-.. ........||.||.+... .++.. -+.+
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------------~~~~~----~~~~ 172 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------------PLQIR----DIPQ 172 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------------ccchh----HHHH
Confidence 4566 99999974321 011223467888776533 01122 3456
Q ss_pred HHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecccc
Q 012014 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (473)
Q Consensus 264 i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~ 305 (473)
|.+-+..+| ..||+-+|+++.|.. .-||+|||.+
T Consensus 173 ~~~dl~~~~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 173 MLRDLKILH---KLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHH---HCCeeeccCcccccc-----CCEEEecccC
Confidence 777788899 999999999999986 2389999864
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=98.12 E-value=1.8e-06 Score=83.39 Aligned_cols=84 Identities=24% Similarity=0.333 Sum_probs=51.5
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..|.|+|||||||+|+||+| |+.|.......+ .+... .......... .
T Consensus 250 ~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~~----~~~~~~~~~~----~--------------------- 299 (337)
T cd05054 250 KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCRR----LKEGTRMRAP----E--------------------- 299 (337)
T ss_pred CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHHHH----HhccCCCCCC----c---------------------
Confidence 346889999999999999998 888864321111 11111 1111000000 0
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHH
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIK 117 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~ 117 (473)
.+...+..+...|+...|+.||++.++...|..+-
T Consensus 300 --~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~ 334 (337)
T cd05054 300 --YATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLL 334 (337)
T ss_pred --cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00122334567799999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=98.12 E-value=1.9e-06 Score=79.98 Aligned_cols=81 Identities=27% Similarity=0.362 Sum_probs=49.1
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..|.|+|||||||+++||+| |+.|...... ..+...+..... . . ....
T Consensus 179 ~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~~--~----~--~~~~-------------------- 228 (261)
T cd05068 179 NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN--AEVLQQVDQGYR--M----P--CPPG-------------------- 228 (261)
T ss_pred CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHcCCC--C----C--CCCc--------------------
Confidence 356889999999999999999 8777543211 111111111000 0 0 0000
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHH
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRL 115 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~ 115 (473)
+...+..+...|+..+|..||++.++...|+.
T Consensus 229 ---~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 229 ---CPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred ---CCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 01123344567999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=98.11 E-value=2.3e-06 Score=80.76 Aligned_cols=85 Identities=22% Similarity=0.383 Sum_probs=52.5
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..+.|+|||||||+++||+| |+.|....... .+...+. ....... . ...
T Consensus 197 ~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~--~~~~~i~---~~~~~~~-~----~~~------------------- 247 (288)
T cd05093 197 RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--EVIECIT---QGRVLQR-P----RTC------------------- 247 (288)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHH---cCCcCCC-C----CCC-------------------
Confidence 356889999999999999999 87775432211 1111111 1100000 0 000
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHHhh
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~~ 119 (473)
...+..+...|+..+|.+||++.++...++.+.+.
T Consensus 248 ----~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 248 ----PKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred ----CHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 01133445679999999999999999998877643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=98.11 E-value=2.2e-06 Score=80.67 Aligned_cols=26 Identities=31% Similarity=0.425 Sum_probs=22.7
Q ss_pred CccccccceeehhhhHHHHHhCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPN 27 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~ 27 (473)
+..+.++|||||||+++||+||+.|.
T Consensus 187 ~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 187 SKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred CCCCccccchhhhhhhhhhhcCCCCC
Confidence 35688999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=98.11 E-value=2.6e-06 Score=81.01 Aligned_cols=85 Identities=18% Similarity=0.376 Sum_probs=52.8
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..+.|+|||||||+++||+| |+.|..... ...+.+++... .. ...+.. +
T Consensus 186 ~~~~~~~DiwslG~~l~el~t~g~~p~~~~~--~~~~~~~~~~~---~~--~~~~~~-----------------~----- 236 (303)
T cd05110 186 RKFTHQSDVWSYGVTIWELMTFGGKPYDGIP--TREIPDLLEKG---ER--LPQPPI-----------------C----- 236 (303)
T ss_pred CCCChHHHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHCC---CC--CCCCCC-----------------C-----
Confidence 346889999999999999998 888864321 11233332210 00 000000 0
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHHhh
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~~ 119 (473)
...+..+...|+..+|+.||++.++...++.+...
T Consensus 237 ----~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 237 ----TIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred ----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11123345679999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 473 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 8e-34 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-32 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-22 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-21 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-21 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-21 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-21 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-17 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 8e-17 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-16 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-15 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-15 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-15 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-15 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-15 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-14 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-14 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-13 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-13 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-13 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-13 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-13 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-13 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-13 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-13 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-13 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-13 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-13 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-13 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 8e-13 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-13 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-13 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-13 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 9e-13 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 9e-13 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-12 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-12 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-12 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-12 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-12 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-12 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-12 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-12 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-12 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-12 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-12 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-12 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-12 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-12 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-12 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-12 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-12 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-12 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 3e-12 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-12 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-12 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-12 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-12 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-12 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-12 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-12 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-12 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-12 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-12 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 5e-12 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-12 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-12 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-12 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-12 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 8e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 9e-12 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 9e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 9e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-11 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-11 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-11 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-11 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 7e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-11 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-10 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-10 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-10 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-10 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-10 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-10 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-10 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-10 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-10 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-10 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-10 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-10 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-10 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-10 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 5e-10 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 8e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 8e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-09 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-09 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-09 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-09 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-09 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-09 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-09 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-09 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-09 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-09 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-09 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-09 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-09 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-09 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-09 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-09 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-09 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-09 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-09 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-09 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-09 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-09 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-09 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-09 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-09 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-09 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-09 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-09 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 4e-09 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-09 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-09 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-09 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-09 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-09 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-09 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 5e-09 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-09 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-09 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-09 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 6e-09 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-09 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-09 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-09 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-09 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 6e-09 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-09 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-09 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 6e-09 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-09 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 6e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-09 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-09 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-09 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-09 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-09 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 7e-09 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-09 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 7e-09 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-09 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-09 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 7e-09 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-09 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-09 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 7e-09 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-09 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 7e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-09 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 7e-09 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-09 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-09 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-09 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-09 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-09 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 8e-09 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 8e-09 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-09 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 9e-09 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-09 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 9e-09 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-09 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-09 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 9e-09 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-08 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-08 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-08 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-08 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-08 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-08 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-08 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-08 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-08 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-08 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-08 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-08 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-08 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-08 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-08 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-08 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-08 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-08 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-08 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-08 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-08 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-08 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-08 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-08 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-08 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-08 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-08 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-08 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-08 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-08 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-08 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-08 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-08 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-08 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-08 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-08 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-08 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-08 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-08 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 7e-08 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 7e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-08 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-08 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 8e-08 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-08 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-08 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 8e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 8e-08 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 8e-08 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 9e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 9e-08 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 9e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-08 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-07 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-07 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-07 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-07 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-07 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-07 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-07 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-07 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-07 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-07 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-07 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-07 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-07 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-07 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-07 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-07 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-07 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-07 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-07 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 4e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-07 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-07 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-07 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-07 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-07 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-07 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-07 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-07 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-07 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 7e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-07 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 7e-07 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-07 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-07 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 7e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 7e-07 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-07 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 7e-07 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-07 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 8e-07 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-07 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 8e-07 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 8e-07 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 8e-07 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 9e-07 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 9e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 9e-07 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 9e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-06 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-06 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-06 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-06 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-06 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-06 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-06 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-06 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-06 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 3e-06 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 3e-06 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-06 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-06 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-06 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-06 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-06 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-06 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-06 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-06 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-06 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-06 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-06 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 7e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-06 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 8e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-06 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-06 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 9e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 9e-06 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 9e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 9e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 9e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 9e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 9e-06 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-05 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-05 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-05 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-05 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-05 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-05 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-05 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-05 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-05 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-05 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-05 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-05 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-05 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-05 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-05 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-05 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-05 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-05 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-05 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-05 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-05 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-05 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-05 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 5e-05 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-05 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-05 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 6e-05 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-05 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-05 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-05 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-05 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-05 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-05 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 6e-05 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-05 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-05 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-05 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 6e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-05 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-05 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 6e-05 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-05 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-05 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-05 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-05 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-05 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 7e-05 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 8e-05 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 8e-05 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 8e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-05 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 8e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 8e-05 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 8e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-05 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 8e-05 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 8e-05 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 9e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 9e-05 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 9e-05 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 9e-05 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 9e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-04 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-04 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-04 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-04 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-04 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-04 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-04 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-04 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-04 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-04 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-04 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-04 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-04 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-04 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-04 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-04 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-04 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-04 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-04 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-04 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-04 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-04 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-04 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-04 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-04 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-04 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-04 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-04 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-04 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-04 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-04 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-04 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-04 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-04 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-04 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-04 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-04 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-04 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-04 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-04 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-04 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-04 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-04 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-04 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-04 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-04 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-04 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-04 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-04 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-04 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-04 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-04 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-04 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-04 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-04 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-04 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-04 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-04 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-04 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-04 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-04 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-04 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-04 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-04 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-04 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-04 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-04 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-04 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-04 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-04 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-04 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-04 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-04 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-04 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-04 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-04 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-04 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-04 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-04 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-04 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-04 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-04 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-04 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-04 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-04 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-04 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-04 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-04 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-04 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-04 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-04 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-04 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-04 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-04 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-04 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-04 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-04 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-04 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-04 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-04 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-04 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-04 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-04 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-04 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 3e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 3e-04 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-04 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-04 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-04 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-04 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-04 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-04 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-04 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-04 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-04 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-04 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-04 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-04 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-04 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-04 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-04 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-04 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-04 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-04 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-04 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-04 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-04 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-04 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-04 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-04 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-04 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-04 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-04 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-04 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-04 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-04 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-04 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 5e-04 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-04 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 5e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-04 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-04 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 5e-04 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-04 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 5e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 5e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 6e-04 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-04 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-04 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 6e-04 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 6e-04 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 6e-04 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-04 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-04 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-04 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-04 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 6e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-04 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-04 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 7e-04 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 7e-04 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-04 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 7e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 8e-04 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 8e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 8e-04 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 8e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 8e-04 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 8e-04 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 8e-04 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 8e-04 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 8e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 8e-04 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 9e-04 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 9e-04 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-04 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-04 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 1e-67
Identities = 85/277 (30%), Positives = 140/277 (50%), Gaps = 33/277 (11%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNL-IRPGGSKSFKSECKA 194
S ++L A++ FS+ N++G G FG VY G L DGT +AVK GG F++E +
Sbjct: 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEM 80
Query: 195 AINIKHRNIVRVFTAFSGVDY--QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNF 252
HRN++R+ + + +VY +M NGS+ LR + ++ PL++
Sbjct: 81 ISMAVHRNLLRL------RGFCMTPTE-RLLVYPYMANGSVASCLRERPESQ-PPLDWP- 131
Query: 253 LIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAID 312
K+ IA+ A L YLH C P I H ++K +N+LLD+E VGDFG+A+ +
Sbjct: 132 ---KRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD--Y 186
Query: 313 KQN----RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKM 368
K ++G+ G+I PEY ++S DV+ +G++LLE+ TG R D
Sbjct: 187 KDTHVTTA---VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 243
Query: 369 NLRNFVKMALP----QRAEEVVD-----DFNLQEIEE 396
+ + ++ E +VD ++ +E+E+
Sbjct: 244 DDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQ 280
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 28/84 (33%), Positives = 47/84 (55%), Gaps = 7/84 (8%)
Query: 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMF---NDELNLHNFVKSALPE-RAEEILDVVF 57
G S DV+ +G++LLE+ TG R D +D++ L ++VK L E + E ++DV
Sbjct: 210 GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDL 269
Query: 58 FQEIEEEETMYK--KASSTCTQSS 79
++EE + + + + CTQSS
Sbjct: 270 QGNYKDEE-VEQLIQVALLCTQSS 292
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 8e-59
Identities = 83/312 (26%), Positives = 135/312 (43%), Gaps = 37/312 (11%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAA 195
DL ATN F LIG G FG VY G L DG +A+K G + F++E +
Sbjct: 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETL 89
Query: 196 INIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIK 255
+H ++V + G + ++YK+M NG+L+ L G D +++ +
Sbjct: 90 SFCRHPHLVSLI----GFCDERNE-MILIYKYMENGNLKRHLYGSD-LPTMSMSW----E 139
Query: 256 KKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQN 315
++L+I I A L YLH I H ++K N+LLD+ + + DFG+++ +D+ +
Sbjct: 140 QRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTH 196
Query: 316 RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSD-GIFTGKMNLRNFV 374
+KG+ GYI PEY + + DVYSFG++L E+ + +NL +
Sbjct: 197 LSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWA 256
Query: 375 KMALPQR-AEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSA 433
+ E++VD + I E + V C A
Sbjct: 257 VESHNNGQLEQIVD----------------------PNLADKIRPESLRKFGDTAVKCLA 294
Query: 434 ERPRERMKINDV 445
+R + DV
Sbjct: 295 LSSEDRPSMGDV 306
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 3e-05
Identities = 23/103 (22%), Positives = 34/103 (33%), Gaps = 21/103 (20%)
Query: 9 DVYSFGILLLEMFTGLRPNDDMF-NDELNLHNFVKSALPER-AEEILDVVFFQEIEEEET 66
DVYSFG++L E+ + +NL + + E+I+D
Sbjct: 223 DVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD------------ 270
Query: 67 MYKKASSTCTQSSIILECLISICRTGVACSAELPNERMKINDV 109
I E L T V C A +R + DV
Sbjct: 271 -------PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDV 306
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 2e-50
Identities = 87/333 (26%), Positives = 135/333 (40%), Gaps = 74/333 (22%)
Query: 136 SFKDLYNATNGFSS------ANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG----GS 185
SF +L N TN F N +G G FG VY G + + TT+AVK +
Sbjct: 16 SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELK 74
Query: 186 KSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW 245
+ F E K +H N+V + FS +VY +MPNGSL + L D T
Sbjct: 75 QQFDQEIKVMAKCQHENLVELL-GFSSDGDD----LCLVYVYMPNGSLLDRLSCLDGT-- 127
Query: 246 RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305
PL+++ + IA A + +LH + H ++K +N+LLD+ + DFG+A
Sbjct: 128 PPLSWH----MRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLA 180
Query: 306 RFLPAIDKQ---NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
R + +R I G+T Y+ PE G E + D+YSFG++LLE+ TG+ D
Sbjct: 181 RASEKFAQTVMTSR---IVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVD- 235
Query: 363 IFT-GKMNLRNFVKMALP-----QRAEEVVD----DFNLQEIEEGRTMCMEVSSSSGSSA 412
L + + + E+ +D D + +E
Sbjct: 236 -EHREPQLL---LDIKEEIEDEEKTIEDYIDKKMNDADSTSVEA---------------- 275
Query: 413 HASIILECFNSICEIGVACSAERPRERMKINDV 445
+ + C E+ +R I V
Sbjct: 276 -----------MYSVASQCLHEKKNKRPDIKKV 297
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 9e-06
Identities = 17/55 (30%), Positives = 29/55 (52%), Gaps = 3/55 (5%)
Query: 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERA--EEILD 54
G ++ D+YSFG++LLE+ TGL D+ + L + + E E+ +D
Sbjct: 209 GEITPKSDIYSFGVVLLEIITGLPAVDEH-REPQLLLDIKEEIEDEEKTIEDYID 262
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 5e-49
Identities = 68/303 (22%), Positives = 118/303 (38%), Gaps = 40/303 (13%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAA 195
++LY + + G FG V+ +AVK+F I+ S + E +
Sbjct: 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFP-IQDKQSWQNEYEVYSL 72
Query: 196 INIKHRNIVRVFTAFSGVDYQGARFKA---VVYKFMPNGSLEEWLRGKDDTNWRPLNFNF 252
+KH NI++ F G + +G ++ F GSL ++L+ +++N
Sbjct: 73 PGMKHENILQ----FIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA------NVVSWNE 122
Query: 253 LIKKKLDIAIDVACALRYLHCD-------CQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305
L IA +A L YLH D +P I+H ++K NVLL + + + DFG+A
Sbjct: 123 LCH----IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178
Query: 306 RFLPAIDKQNRFICIKGSTGYIPPEY-----DLGCEASTYGDVYSFGILLLEMFTGIRPS 360
A G+ Y+ PE + +A D+Y+ G++L E+ + +
Sbjct: 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA 238
Query: 361 DGIFTG-KMNLRNFV--KMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASII 417
DG + + +L E VV + + +G + I
Sbjct: 239 DGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRD------YWQKHAGMAMLCETI 292
Query: 418 LEC 420
EC
Sbjct: 293 EEC 295
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 16/111 (14%), Positives = 38/111 (34%), Gaps = 13/111 (11%)
Query: 9 DVYSFGILLLEMFTGLRPNDDMFND-ELNLHNFVKSALPERAEEILDVVFFQEIEEEETM 67
D+Y+ G++L E+ + D ++ L + E++ +VV ++
Sbjct: 220 DMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSL--EDMQEVVVHKKKRPVL-- 275
Query: 68 YKKASSTCTQSSIILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118
+ + +C T C R+ V R+ +++
Sbjct: 276 ----RDYWQKH----AGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-41
Identities = 65/216 (30%), Positives = 102/216 (47%), Gaps = 23/216 (10%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGS--KSFKSECKAAINIKHRNIVRVFTAF 210
IGAG+FG+V+ + G+ +AVK+ F E ++H NIV F
Sbjct: 45 IGAGSFGTVHRAE-WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVL----F 99
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
G Q ++V +++ GSL L L+ +++L +A DVA + Y
Sbjct: 100 MGAVTQPPNL-SIVTEYLSRGSLYRLLHKSGAR--EQLDE----RRRLSMAYDVAKGMNY 152
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTG---YI 327
LH PPI H NLK N+L+D + V DFG++R K + F+ K + G ++
Sbjct: 153 LHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL-----KASTFLSSKSAAGTPEWM 206
Query: 328 PPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363
PE ++ DVYSFG++L E+ T +P +
Sbjct: 207 APEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL 242
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 4e-41
Identities = 69/324 (21%), Positives = 112/324 (34%), Gaps = 60/324 (18%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSG 212
+G G FG V + +A+K K+F E + + H NIV+++
Sbjct: 16 VGRGAFGVVCKAK-WRAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLY----- 67
Query: 213 VDYQGARFKA--VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
GA +V ++ GSL L G + + + + + + Y
Sbjct: 68 ----GACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTA------AHAMSWCLQCSQGVAY 117
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEM-IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPP 329
LH + H +LKP N+LL + + DFG A D Q KGS ++ P
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAP 172
Query: 330 EYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDDF 389
E G S DV+S+GI+L E+ T +P D I R V
Sbjct: 173 EVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGG------------PAFRIMWAV--- 217
Query: 390 NLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRL 449
G +I I + C ++ P +R + ++ +
Sbjct: 218 -----HNGTRP--------------PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIM 258
Query: 450 RLIRRKLLETPACLEVKQTTSMPP 473
+ R L+ S+PP
Sbjct: 259 THLMRYFPGADEPLQYPCQHSLPP 282
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 5e-04
Identities = 10/24 (41%), Positives = 17/24 (70%)
Query: 9 DVYSFGILLLEMFTGLRPNDDMFN 32
DV+S+GI+L E+ T +P D++
Sbjct: 185 DVFSWGIILWEVITRRKPFDEIGG 208
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-40
Identities = 60/255 (23%), Positives = 99/255 (38%), Gaps = 37/255 (14%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAA 195
+ + + LIG G +G+VY G+L D +AVKVF ++F +E
Sbjct: 4 AASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF---SFANRQNFINEKNIY 59
Query: 196 I--NIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFL 253
++H NI R V G +V ++ PNGSL ++L ++W
Sbjct: 60 RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-LHTSDW-------- 110
Query: 254 IKKKLDIAIDVACALRYLHCD------CQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF 307
+A V L YLH + +P I+H +L NVL+ ++ + DFG++
Sbjct: 111 -VSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR 169
Query: 308 L---PAIDKQNRFICIKGSTG---YIPPEY-------DLGCEASTYGDVYSFGILLLEMF 354
L + G Y+ PE A D+Y+ G++ E+F
Sbjct: 170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229
Query: 355 TGIRPSDGIFTGKMN 369
R +D +
Sbjct: 230 M--RCTDLFPGESVP 242
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 3e-39
Identities = 42/220 (19%), Positives = 83/220 (37%), Gaps = 32/220 (14%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGG--SKSFKSECKAAINIKHRNIVRVFTAF 210
+ + G ++ G + G I VKV + S+ F EC H N++
Sbjct: 18 LNENHSGELWKGR-WQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP----V 72
Query: 211 SGVDYQGARFK-AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALR 269
G ++ +MP GSL L + ++ + + A+D+A +
Sbjct: 73 LGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN---FVVDQ----SQAVKFALDMARGMA 125
Query: 270 YLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPP 329
+LH +P I L +V++D++M + + + + + ++ P
Sbjct: 126 FLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR-------MYAPAWVAP 177
Query: 330 E------YDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363
E D ++ D++SF +LL E+ T P +
Sbjct: 178 EALQKKPEDTNRRSA---DMWSFAVLLWELVTREVPFADL 214
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 6e-38
Identities = 61/223 (27%), Positives = 92/223 (41%), Gaps = 32/223 (14%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGS----KSFKSECKAAINIKHRNIVRVFT 208
IG G FG VY + G +AVK ++ + E K +KH NI+
Sbjct: 15 IGIGGFGKVYRAF-WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA--- 70
Query: 209 AFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACAL 268
GV + +V +F G L L GK ++ A+ +A +
Sbjct: 71 -LRGVCLKEPNL-CLVMEFARGGPLNRVLSGK----------RIPPDILVNWAVQIARGM 118
Query: 269 RYLHCDCQPPIAHCNLKPSNVLLDDEMIGH--------VGDFGMARFLPAIDKQNRFICI 320
YLH + PI H +LK SN+L+ ++ + DFG+AR K +
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA---- 174
Query: 321 KGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363
G+ ++ PE S DV+S+G+LL E+ TG P GI
Sbjct: 175 AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI 217
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 7e-04
Identities = 10/22 (45%), Positives = 15/22 (68%)
Query: 9 DVYSFGILLLEMFTGLRPNDDM 30
DV+S+G+LL E+ TG P +
Sbjct: 196 DVWSYGVLLWELLTGEVPFRGI 217
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 6e-38
Identities = 60/227 (26%), Positives = 97/227 (42%), Gaps = 38/227 (16%)
Query: 153 IGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGS-------KSFKSECKAAINIKHRNIV 204
IG G FG V+ G L D + +A+K L G + F+ E N+ H NIV
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 205 RVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDV 264
+ G+ + +V +F+P G L L K P+ + KL + +D+
Sbjct: 87 K----LYGLMHNP---PRMVMEFVPCGDLYHRLLDKA----HPIKW----SVKLRLMLDI 131
Query: 265 ACALRYLHCDCQPPIAHCNLKPSNVLLD-----DEMIGHVGDFGMARFLPAIDKQNRFIC 319
A + Y+ PPI H +L+ N+ L + V DFG+++ +
Sbjct: 132 ALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSG 185
Query: 320 IKGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDGI 363
+ G+ ++ PE +G E +Y D YSF ++L + TG P D
Sbjct: 186 LLGNFQWMAPET-IGAEEESYTEKADTYSFAMILYTILTGEGPFDEY 231
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 5e-04
Identities = 9/22 (40%), Positives = 13/22 (59%)
Query: 9 DVYSFGILLLEMFTGLRPNDDM 30
D YSF ++L + TG P D+
Sbjct: 210 DTYSFAMILYTILTGEGPFDEY 231
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-37
Identities = 56/237 (23%), Positives = 95/237 (40%), Gaps = 38/237 (16%)
Query: 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAI--NIKHRNIVRVFT 208
IG G +G V+ G + G +AVKVF S+ E + ++H NI+
Sbjct: 43 KQIGKGRYGEVWMGK-WRGEKVAVKVF---FTTEEASWFRETEIYQTVLMRHENILG--- 95
Query: 209 AFSGVDYQGARFKA---VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVA 265
F D +G ++ + NGSL ++L+ L+ ++K +A
Sbjct: 96 -FIAADIKGTGSWTQLYLITDYHENGSLYDYLKST------TLDAKSMLK----LAYSSV 144
Query: 266 CALRYLHCD-----CQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICI 320
L +LH + +P IAH +LK N+L+ + D G+A + D I
Sbjct: 145 SGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFIS-DTNEVDIPP 203
Query: 321 KGSTG---YIPPE------YDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKM 368
G Y+PPE ++ D+YSFG++L E+ + ++
Sbjct: 204 NTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-36
Identities = 65/216 (30%), Positives = 101/216 (46%), Gaps = 24/216 (11%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGS--KSFKSECKAAINIKHRNIVRVFTAF 210
IG+G+FG+VY G +AVK+ N+ P ++FK+E +H NI+ F
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL----F 85
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
G A+V ++ SL L + F +KK +DIA A + Y
Sbjct: 86 MGYSTAPQL--AIVTQWCEGSSLYHHLHASET--------KFEMKKLIDIARQTARGMDY 135
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPE 330
LH I H +LK +N+ L ++ +GDFG+A ++F + GS ++ PE
Sbjct: 136 LH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 192
Query: 331 YDLGCEASTYG---DVYSFGILLLEMFTGIRPSDGI 363
+++ Y DVY+FGI+L E+ TG P I
Sbjct: 193 VIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI 228
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-36
Identities = 47/229 (20%), Positives = 94/229 (41%), Gaps = 32/229 (13%)
Query: 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAI--NIKHRNIVRVFT 208
+G G +G V+ G+ + G +AVK+F KS+ E + ++H NI+
Sbjct: 14 ECVGKGRYGEVWRGS-WQGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 209 AFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACAL 268
+ + + ++ + GSL ++L+ L+ ++ I + +A L
Sbjct: 70 SDMTSRHSSTQL-WLITHYHEMGSLYDYLQLT------TLDTVSCLR----IVLSIASGL 118
Query: 269 RYLHCD-----CQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGS 323
+LH + +P IAH +LK N+L+ + D G+A Q +
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLD-VGNNPR 177
Query: 324 TG---YIPPE------YDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363
G Y+ PE ++ D+++FG++L E+ + + +
Sbjct: 178 VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV 226
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-35
Identities = 51/227 (22%), Positives = 86/227 (37%), Gaps = 33/227 (14%)
Query: 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGS--KSFKSECKAAINIKHRNIVRVFT 208
LIG G FG VY+G +A+++ ++ R K+FK E A +H N+V
Sbjct: 39 ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVL--- 93
Query: 209 AFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACAL 268
F G A++ +L +R + K IA ++ +
Sbjct: 94 -FMGACMSPPHL-AIITSLCKGRTLYSVVRDAKIV--------LDVNKTRQIAQEIVKGM 143
Query: 269 RYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF---LPAIDKQNRFICIKGSTG 325
YLH I H +LK NV D+ + + DFG+ L A ++++ G
Sbjct: 144 GYLH---AKGILHKDLKSKNVFYDNGKV-VITDFGLFSISGVLQAGRREDKLRIQNGWLC 199
Query: 326 YIPPE------YDLGCEASTYG---DVYSFGILLLEMFTGIRPSDGI 363
++ PE D + + DV++ G + E+ P
Sbjct: 200 HLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-34
Identities = 51/229 (22%), Positives = 89/229 (38%), Gaps = 32/229 (13%)
Query: 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAI--NIKHRNIVRVFT 208
IG G FG V+ G + G +AVK+F +S+ E + ++H NI+
Sbjct: 48 ESIGKGRFGEVWRGK-WRGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIA 103
Query: 209 AFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACAL 268
A + + + +V + +GSL ++L + +IK +A+ A L
Sbjct: 104 ADNKDNGTWTQL-WLVSDYHEHGSLFDYLNR------YTVTVEGMIK----LALSTASGL 152
Query: 269 RYLHCD-----CQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGS 323
+LH + +P IAH +LK N+L+ + D G+A + I
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA-TDTIDIAPNHR 211
Query: 324 TG---YIPPE------YDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363
G Y+ PE E+ D+Y+ G++ E+
Sbjct: 212 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-34
Identities = 50/225 (22%), Positives = 85/225 (37%), Gaps = 31/225 (13%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGS--KSFKSECKAAINIKHRNIVRVFTAF 210
+G G FG T T + + LIR ++F E K ++H N+++ F
Sbjct: 18 LGKGCFGQAIKVTHR-ETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLK----F 72
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
GV Y+ R + +++ G+L ++ D + +++ A D+A + Y
Sbjct: 73 IGVLYKDKRLNFIT-EYIKGGTLRGIIKSMD----SQYPW----SQRVSFAKDIASGMAY 123
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPE 330
LH I H +L N L+ + V DFG+AR + Q +
Sbjct: 124 LH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY 180
Query: 331 YDLGC------EASTYG------DVYSFGILLLEMFTGIRPSDGI 363
+G E DV+SFGI+L E+ +
Sbjct: 181 TVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY 225
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-27
Identities = 45/261 (17%), Positives = 90/261 (34%), Gaps = 49/261 (18%)
Query: 152 LIGAGNFGSVYNG--TLFDGTTIAVKVFNLIRPGGSKS----FKSECKAAINIKHRNIVR 205
I G G +Y +G + +K + G +E + + H +IV+
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKG---LVHSGDAEAQAMAMAERQFLAEVVHPSIVQ 143
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVA 265
+F D G +V +++ SL+ L + + + +++
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-------KLP----VAEAIAYLLEIL 192
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTG 325
AL YLH + + +LKP N++L +E + + D G I+ G+ G
Sbjct: 193 PALSYLH---SIGLVYNDLKPENIMLTEEQL-KLIDLGAVS---RINSFGYLY---GTPG 242
Query: 326 YIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMN-----------LRNFV 374
+ PE + D+Y+ G L + + +G + + +
Sbjct: 243 FQAPEIVRT-GPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLL 301
Query: 375 KMAL-------PQRAEEVVDD 388
+ A+ AEE+
Sbjct: 302 RRAIDPDPRQRFTTAEEMSAQ 322
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-26
Identities = 50/213 (23%), Positives = 92/213 (43%), Gaps = 22/213 (10%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNL--IRPGGSKSFKSECKAAINIKHRNIVRVFT 208
IG G+F +VY G +A + + FK E + ++H NIVR +
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 209 AFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACAL 268
++ +V + M +G+L+ +L+ ++ + +++ + L
Sbjct: 93 SWESTVKGKKCI-VLVTELMTSGTLKTYLK-----RFKVMKIK-VLRS---WCRQILKGL 142
Query: 269 RYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIKGSTGY 326
++LH PPI H +LK N+ + G V GD G+A + + + + G+ +
Sbjct: 143 QFLH-TRTPPIIHRDLKCDNIFITG-PTGSVKIGDLGLA----TLKRASFAKAVIGTPEF 196
Query: 327 IPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
+ PE + DVY+FG+ +LEM T P
Sbjct: 197 MAPEM-YEEKYDESVDVYAFGMCMLEMATSEYP 228
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 65/252 (25%), Positives = 113/252 (44%), Gaps = 34/252 (13%)
Query: 119 KLLKTPVYEGKQTINNPSFKDLY--NATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKV 176
+L+K V EG + ++ + N IG G FG V G + G +AVK
Sbjct: 166 RLIKPKVMEGTVAAQDEFYRSGWALNMKE-LKLLQTIGKGEFGDVMLGD-YRGNKVAVKC 223
Query: 177 FNLIRPGGS-KSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEE 235
I+ + ++F +E ++H N+V++ GV + +V ++M GSL +
Sbjct: 224 ---IKNDATAQAFLAEASVMTQLRHSNLVQLL----GVIVEEKGGLYIVTEYMAKGSLVD 276
Query: 236 WLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYL---HCDCQPPIAHCNLKPSNVLLD 292
+LR + L + L+ ++DV A+ YL + + H +L NVL+
Sbjct: 277 YLRSRGR---SVLGGDCLL----KFSLDVCEAMEYLEGNNF-----V-HRDLAARNVLVS 323
Query: 293 DEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLE 352
++ + V DFG+ + + + +K + PE + ST DV+SFGILL E
Sbjct: 324 EDNVAKVSDFGLTKEASSTQDTGKLP-VK----WTAPEALREKKFSTKSDVWSFGILLWE 378
Query: 353 MFT-GIRPSDGI 363
+++ G P I
Sbjct: 379 IYSFGRVPYPRI 390
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 55/224 (24%), Positives = 89/224 (39%), Gaps = 35/224 (15%)
Query: 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTA 209
LIG+G FG V+ DG T +K ++ + E KA + H NIV
Sbjct: 17 ELIGSGGFGQVFKAKHRIDGKTYVIKRVKY----NNEKAEREVKALAKLDHVNIVHYNGC 72
Query: 210 FSGVDYQGARFKAVVYK-----------FMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKL 258
+ G DY + F G+LE+W+ + L+ L
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR---RGEKLDKVLA----L 125
Query: 259 DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFI 318
++ + + Y+H + + +LKPSN+ L D +GDFG+ L K+ R
Sbjct: 126 ELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK 182
Query: 319 CIKGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
G+ Y+ PE + YG D+Y+ G++L E+
Sbjct: 183 ---GTLRYMSPEQ---ISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 2e-25
Identities = 59/219 (26%), Positives = 105/219 (47%), Gaps = 29/219 (13%)
Query: 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKS--FKSECKAAINIKHRNIVRVFT 208
+G G FG V+ GT T +A+K ++PG F E + ++H +V+++
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEAFLQEAQVMKKLRHEKLVQLY- 328
Query: 209 AFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACAL 268
V + + +V ++M GSL ++L+G+ + L L+ D+A +A +
Sbjct: 329 ---AVVSEEPIY--IVTEYMSKGSLLDFLKGETG---KYLRLPQLV----DMAAQIASGM 376
Query: 269 RYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAID---KQNRFICIKGSTG 325
Y+ + H +L+ +N+L+ + ++ V DFG+AR + + +Q IK
Sbjct: 377 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK---- 429
Query: 326 YIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363
+ PE L + DV+SFGILL E+ T G P G+
Sbjct: 430 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 468
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 56/225 (24%), Positives = 104/225 (46%), Gaps = 41/225 (18%)
Query: 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGS--KSFKSECKAAINIKHRNIVRVFT 208
+GAG FG V+ T T +AVK ++PG ++F +E ++H +V++
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKT---MKPGSMSVEAFLAEANVMKTLQHDKLVKLH- 249
Query: 209 AFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACAL 268
V + + ++ +FM GSL ++L+ + + K +D + +A +
Sbjct: 250 ---AVVTKEPIY--IITEFMAKGSLLDFLKSDEGSKQPL-------PKLIDFSAQIAEGM 297
Query: 269 RYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAID---KQNRFICIKGSTG 325
++ Q H +L+ +N+L+ ++ + DFG+AR + + ++ IK
Sbjct: 298 AFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIK---- 350
Query: 326 YIPPEYDLGCEASTYG------DVYSFGILLLEMFT-GIRPSDGI 363
+ P EA +G DV+SFGILL+E+ T G P G+
Sbjct: 351 WTAP------EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 389
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 59/219 (26%), Positives = 105/219 (47%), Gaps = 29/219 (13%)
Query: 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKS--FKSECKAAINIKHRNIVRVFT 208
+G G FG V+ GT T +A+K ++PG F E + ++H +V+++
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKT---LKPGTMSPEAFLQEAQVMKKLRHEKLVQLY- 245
Query: 209 AFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACAL 268
V + + +V ++M GSL ++L+G+ + L L+ D+A +A +
Sbjct: 246 ---AVVSEEPIY--IVTEYMSKGSLLDFLKGETG---KYLRLPQLV----DMAAQIASGM 293
Query: 269 RYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAID---KQNRFICIKGSTG 325
Y+ + H +L+ +N+L+ + ++ V DFG+AR + + +Q IK
Sbjct: 294 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIK---- 346
Query: 326 YIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363
+ PE L + DV+SFGILL E+ T G P G+
Sbjct: 347 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 385
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-25
Identities = 61/218 (27%), Positives = 86/218 (39%), Gaps = 35/218 (16%)
Query: 153 IGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKS----FKSECKAAINIKHRNIVRVF 207
IG GNFG V++G L D T +AVK R F E + H NIVR+
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKS---CRETLPPDLKAKFLQEARILKQYSHPNIVRLI 178
Query: 208 TAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACA 267
GV Q +V + + G +LR + +K L + D A
Sbjct: 179 ----GVCTQKQPI-YIVMELVQGGDFLTFLRTEGA--------RLRVKTLLQMVGDAAAG 225
Query: 268 LRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYI 327
+ YL H +L N L+ ++ + + DFGM+R + G +
Sbjct: 226 MEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREE-----ADGVYAASGGLRQV 277
Query: 328 P-----PEYDLGCEASTYGDVYSFGILLLEMFT-GIRP 359
P PE S+ DV+SFGILL E F+ G P
Sbjct: 278 PVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASP 315
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 52/235 (22%), Positives = 93/235 (39%), Gaps = 58/235 (24%)
Query: 153 IGAGNFGSVYNGTLFDG-----TTIAVKVFNLIRPGGSKSFKSE--CKAAI--NIKHRNI 203
+G+G FG+VY G +A+K +R S E +A + ++ + ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKE---LREATSPKANKEILDEAYVMASVDNPHV 79
Query: 204 VRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAID 263
R+ G+ ++ + MP G L +++R D N + L+ +
Sbjct: 80 CRLL----GICLTSTVQ--LITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQ 125
Query: 264 VACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICI 320
+A + YL H +L NVL+ + DFG+A+ L A +K
Sbjct: 126 IAKGMNYLEDRRL------VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK-----EY 174
Query: 321 KGSTGYIP-----PEYDLGCEASTYG------DVYSFGILLLEMFT-GIRPSDGI 363
G +P E+ + DV+S+G+ + E+ T G +P DGI
Sbjct: 175 HAEGGKVPIKWMAL------ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-24
Identities = 63/231 (27%), Positives = 104/231 (45%), Gaps = 57/231 (24%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGS--KSFKSECKAAINIKHRNIVRVFTAF 210
+GAG FG V+ G T +AVK ++ G +F +E ++H+ +VR++
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKS---LKQGSMSPDAFLAEANLMKQLQHQRLVRLY--- 74
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
V Q + ++ ++M NGSL ++L+ L N L+ D+A +A + +
Sbjct: 75 -AVVTQEPIY--IITEYMENGSLVDFLKTPSG---IKLTINKLL----DMAAQIAEGMAF 124
Query: 271 L------HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGST 324
+ H D L+ +N+L+ D + + DFG+AR + + N + +G
Sbjct: 125 IEERNYIHRD---------LRAANILVSDTLSCKIADFGLARLI----EDNEYTAREG-- 169
Query: 325 GYIP-----PEYDLGCEASTYG------DVYSFGILLLEMFT-GIRPSDGI 363
P P EA YG DV+SFGILL E+ T G P G+
Sbjct: 170 AKFPIKWTAP------EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 59/227 (25%), Positives = 96/227 (42%), Gaps = 49/227 (21%)
Query: 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGS-KSFKSECKAAINIKHRNIVRVFTA 209
IG G FG V G G +AVK I+ + ++F +E ++H N+V++
Sbjct: 27 QTIGKGEFGDVMLGDY-RGNKVAVKC---IKNDATAQAFLAEASVMTQLRHSNLVQLL-- 80
Query: 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALR 269
GV + +V ++M GSL ++LR + L + L+ ++DV A+
Sbjct: 81 --GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR---SVLGGDCLL----KFSLDVCEAME 131
Query: 270 YL------HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGS 323
YL H D L NVL+ ++ + V DFG+ + + + +K
Sbjct: 132 YLEGNNFVHRD---------LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP-VK-- 179
Query: 324 TGYIPPEYDLGCEASTYG------DVYSFGILLLEMFT-GIRPSDGI 363
+ PE A DV+SFGILL E+++ G P I
Sbjct: 180 --WTAPE------ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 218
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 52/226 (23%), Positives = 91/226 (40%), Gaps = 34/226 (15%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTA 209
+G G FG V+ D A+K L + E KA ++H IVR F A
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 210 F----SGVDYQGARFKAVVYKFM---PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAI 262
+ + Q + K +Y M +L++W+ G+ R L I +
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE------RSVCLHIFL 125
Query: 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKG 322
+A A+ +LH + H +LKPSN+ + + VGDFG+ + +++ +
Sbjct: 126 QIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 323 STG----------YIPPEYDLGCEASTYG---DVYSFGILLLEMFT 355
+ Y+ PE ++Y D++S G++L E+
Sbjct: 183 AYARHTGQVGTKLYMSPEQ---IHGNSYSHKVDIFSLGLILFELLY 225
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 58/220 (26%), Positives = 94/220 (42%), Gaps = 29/220 (13%)
Query: 151 NLIGAGNFGSVYNGTLFD-GTTIAVKVFNLIRPGGS--KSFKSECKAAINIKHRNIVRVF 207
+ +G G +G VY G T+AVK ++ + F E IKH N+V++
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKT---LKEDTMEVEEFLKEAAVMKEIKHPNLVQLL 282
Query: 208 TAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACA 267
GV + F ++ +FM G+L ++LR + L +A ++ A
Sbjct: 283 ----GVCTREPPFY-IITEFMTYGNLLDYLRECNRQEVSA-------VVLLYMATQISSA 330
Query: 268 LRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPA---IDKQNRFICIKGST 324
+ YL + H NL N L+ + + V DFG++R + IK
Sbjct: 331 MEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK--- 384
Query: 325 GYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363
+ PE + S DV++FG+LL E+ T G+ P GI
Sbjct: 385 -WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 423
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 55/234 (23%), Positives = 91/234 (38%), Gaps = 57/234 (24%)
Query: 151 NLIGAGNFGSVYNGTLFDG----TTIAVKVFNLIRPGGSKS----FKSECKAAINIKHRN 202
+IG G+FG VY+GTL D AVK + F +E + H N
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKS---LNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 203 IVRVFTAFSGV--DYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDI 260
++ + G+ +G+ VV +M +G L ++R + N +K +
Sbjct: 152 VLSLL----GICLRSEGSPL--VVLPYMKHGDLRNFIRNETH--------NPTVKDLIGF 197
Query: 261 AIDVACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRF 317
+ VA +++L H +L N +LD++ V DFG+AR + +
Sbjct: 198 GLQVAKGMKFLASKKF------VHRDLAARNCMLDEKFTVKVADFGLARD---MYDKEFD 248
Query: 318 ICIKGSTGYIP-----PEYDLGCEASTYG------DVYSFGILLLEMFT-GIRP 359
+ +P E+ DV+SFG+LL E+ T G P
Sbjct: 249 SVHNKTGAKLPVKWMAL------ESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 8e-24
Identities = 53/229 (23%), Positives = 85/229 (37%), Gaps = 47/229 (20%)
Query: 151 NLIGAGNFGSVYNGTLFDG----TTIAVKVFNLIRPGGSKS-FKSECKAAINIKHRNIVR 205
+IG G+FG VY+G D A+K + I F E + H N++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVA 265
+ G+ V+ +M +G L +++R N +K + + VA
Sbjct: 87 LI----GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR--------NPTVKDLISFGLQVA 134
Query: 266 CALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKG 322
+ YL H +L N +LD+ V DFG+AR I + + +
Sbjct: 135 RGMEYLAEQKF------VHRDLAARNCMLDESFTVKVADFGLARD---ILDREYYSVQQH 185
Query: 323 STGYIP-----PEYDLGCEASTYG------DVYSFGILLLEMFT-GIRP 359
+P E+ DV+SFG+LL E+ T G P
Sbjct: 186 RHARLPVKWTAL------ESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 32/259 (12%), Positives = 63/259 (24%), Gaps = 38/259 (14%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFN---LIRPGGSKSFKSECKAAINIKHRNIVRVF 207
+ G+ V+ + A+KVF + AA + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 208 TAF------------------SGVDYQGARFKAVVYKFMP--NGSLEEWLRGKDDTNWRP 247
Q A MP + LE D
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFV--YV 186
Query: 248 LNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF 307
+ I + + L + H + P N+ + + +GD
Sbjct: 187 FRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALWK 243
Query: 308 LPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDGIF 364
+ R Y P E+ L +T+ + + G+ + ++ P +
Sbjct: 244 VGT-----RGPASSVPVTYAPREF-LNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297
Query: 365 TGKMNLRNFVKMALPQRAE 383
G + +P
Sbjct: 298 PGIKGSWKRPSLRVPGTDS 316
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 3e-23
Identities = 55/232 (23%), Positives = 94/232 (40%), Gaps = 49/232 (21%)
Query: 153 IGAGNFGSVYNGTLFDG----TTIAVKVFNLIRPGGS-----KSFKSECKAAINIKHRNI 203
+G G FGSV G L +AVK ++ S + F SE + H N+
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKT---MKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 204 VRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRG-KDDTNWRPLNFNFLIKKKLDIAI 262
+R+ + QG V+ FM G L +L + +T + + L+ +
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLL----KFMV 154
Query: 263 DVACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFIC 319
D+A + YL + H +L N +L D+M V DFG+++ + + D
Sbjct: 155 DIALGMEYLSNRNF------LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD-----YY 203
Query: 320 IKGSTGYIP-----PE------YDLGCEASTYGDVYSFGILLLEMFT-GIRP 359
+G +P E Y ++ DV++FG+ + E+ T G+ P
Sbjct: 204 RQGRIAKMPVKWIAIESLADRVY------TSKSDVWAFGVTMWEIATRGMTP 249
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 3e-23
Identities = 56/222 (25%), Positives = 94/222 (42%), Gaps = 47/222 (21%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGS--KSFKSECKAAINIKHRNIVRVFTAF 210
IG+G FG V+ G + +A+K IR G + F E + + + H +V+++
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKT---IREGAMSEEDFIEEAEVMMKLSHPKLVQLY--- 69
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
GV + A +V +FM +G L ++LR + F + L + +DV + Y
Sbjct: 70 -GVCLEQAPI-CLVTEFMEHGCLSDYLRTQRGL--------FAAETLLGMCLDVCEGMAY 119
Query: 271 L---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPA---IDKQNRFICIKGST 324
L H +L N L+ + + V DFGM RF+ +K
Sbjct: 120 LEEACV------IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK--- 170
Query: 325 GYIPPEYDLGCEASTYG------DVYSFGILLLEMFT-GIRP 359
+ P E ++ DV+SFG+L+ E+F+ G P
Sbjct: 171 -WASP------EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 97.6 bits (244), Expect = 4e-23
Identities = 55/227 (24%), Positives = 93/227 (40%), Gaps = 57/227 (25%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGS--KSFKSECKAAINIKHRNIVRVFTAF 210
+G+G FG V G +AVK+ I+ G F E + + + H +V+ +
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKM---IKEGSMSEDEFFQEAQTMMKLSHPKLVKFY--- 69
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
GV + +V +++ NG L +LR + L + L+ ++ DV + +
Sbjct: 70 -GVCSKEYPI-YIVTEYISNGCLLNYLRSHG----KGLEPSQLL----EMCYDVCEGMAF 119
Query: 271 L------HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGST 324
L H D L N L+D ++ V DFGM R++ ++++ G
Sbjct: 120 LESHQFIHRD---------LAARNCLVDRDLCVKVSDFGMTRYV----LDDQYVSSVG-- 164
Query: 325 GYIP-----PEYDLGCEASTYG------DVYSFGILLLEMFT-GIRP 359
P P E Y DV++FGIL+ E+F+ G P
Sbjct: 165 TKFPVKWSAP------EVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 4e-23
Identities = 56/234 (23%), Positives = 92/234 (39%), Gaps = 57/234 (24%)
Query: 151 NLIGAGNFGSVYNGTLFDG----TTIAVKVFNLIRPGGSKS----FKSECKAAINIKHRN 202
+IG G+FG VY+GTL D AVK + F +E + H N
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKS---LNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 203 IVRVFTAFSGV--DYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDI 260
++ + G+ +G+ VV +M +G L ++R + N +K +
Sbjct: 88 VLSLL----GICLRSEGSPL--VVLPYMKHGDLRNFIRNETH--------NPTVKDLIGF 133
Query: 261 AIDVACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRF 317
+ VA ++YL H +L N +LD++ V DFG+AR + + +
Sbjct: 134 GLQVAKGMKYLASKKF------VHRDLAARNCMLDEKFTVKVADFGLARD---MYDKEYY 184
Query: 318 ICIKGSTGYIP-----PEYDLGCEASTYG------DVYSFGILLLEMFT-GIRP 359
+ +P E+ DV+SFG+LL E+ T G P
Sbjct: 185 SVHNKTGAKLPVKWMAL------ESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 5e-23
Identities = 53/225 (23%), Positives = 95/225 (42%), Gaps = 53/225 (23%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGS--KSFKSECKAAINIKHRNIVRVFTAF 210
+G G FG V G +A+K+ I+ G F E K +N+ H +V+++
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKM---IKEGSMSEDEFIEEAKVMMNLSHEKLVQLY--- 85
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
GV + ++ ++M NG L +LR F ++ L++ DV A+ Y
Sbjct: 86 -GVCTKQRPI-FIITEYMANGCLLNYLREMRHR--------FQTQQLLEMCKDVCEAMEY 135
Query: 271 L------HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAID---KQNRFICIK 321
L H D L N L++D+ + V DFG++R++ + ++
Sbjct: 136 LESKQFLHRD---------LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR 186
Query: 322 GSTGYIPPEYDLGCEASTYG------DVYSFGILLLEMFT-GIRP 359
+ PP E Y D+++FG+L+ E+++ G P
Sbjct: 187 ----WSPP------EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 1e-22
Identities = 65/235 (27%), Positives = 100/235 (42%), Gaps = 65/235 (27%)
Query: 153 IGAGNFGSVYNGTLFDG----TTIAVKVFNLIRPGGS----KSFKSECKAAI--NIKHRN 202
IG+G+ G V G L +A+K ++ G + + F SE A+I H N
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKA---LKAGYTERQRRDFLSE--ASIMGQFDHPN 111
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAI 262
I+R+ GV +G +V ++M NGSL+ +LR D F I + + +
Sbjct: 112 IIRLE----GVVTRGRLA-MIVTEYMENGSLDTFLRTHDGQ--------FTIMQLVGMLR 158
Query: 263 DVACALRYL------HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNR 316
V +RYL H D L NVL+D ++ V DFG++R L + +
Sbjct: 159 GVGAGMRYLSDLGYVHRD---------LAARNVLVDSNLVCKVSDFGLSRVL----EDDP 205
Query: 317 FICIKGSTGYIP-----PEYDLGCEASTYG------DVYSFGILLLEMFT-GIRP 359
+ G IP P EA + DV+SFG+++ E+ G RP
Sbjct: 206 DAAYTTTGGKIPIRWTAP------EAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 2e-22
Identities = 48/220 (21%), Positives = 89/220 (40%), Gaps = 32/220 (14%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKS------FKSECKAAINIKHRNIV 204
+G G +VY +A+K I + F+ E + + H+NIV
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKA---IFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 205 RVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDV 264
+ + + +V +++ +L E++ PL+ + ++ +
Sbjct: 75 SMID--VDEE-DDCYY--LVMEYIEGPTLSEYIESH-----GPLS----VDTAINFTNQI 120
Query: 265 ACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPA--IDKQNRFICIKG 322
+++ H I H ++KP N+L+D + DFG+A+ L + + N + G
Sbjct: 121 LDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL---G 174
Query: 323 STGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
+ Y PE G D+YS GI+L EM G P +G
Sbjct: 175 TVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNG 214
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 82/351 (23%), Positives = 117/351 (33%), Gaps = 99/351 (28%)
Query: 153 IGAGNFGSVYNGTLFDG------TTIAVKVFNLIRPGGSKS----FKSECKAAI--NIKH 200
+G G FG VY G + +AVK + S+ F E A I H
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT---LPEVCSEQDELDFLME--ALIISKFNH 92
Query: 201 RNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDI 260
+NIVR GV Q ++ + M G L+ +LR +P + L +
Sbjct: 93 QNIVR----CIGVSLQSLPR-FILMELMAGGDLKSFLRETRPRPSQPSSLAM--LDLLHV 145
Query: 261 AIDVACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHV---GDFGMARFLPAIDKQ 314
A D+AC +YL H H ++ N LL G V GDFGMAR +
Sbjct: 146 ARDIACGCQYLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS-- 197
Query: 315 NRFICIKGSTGYIP-----PEYDLGCEASTYG------DVYSFGILLLEMFT-GIRPSDG 362
KG +P PE A G D +SFG+LL E+F+ G P
Sbjct: 198 ---YYRKGGCAMLPVKWMPPE------AFMEGIFTSKTDTWSFGVLLWEIFSLGYMP--- 245
Query: 363 IFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFN 422
+ K N +EV L+ + G M C
Sbjct: 246 -YPSKSN-------------QEV-----LEFVTSGGRM--------------DPPKNCPG 272
Query: 423 SICEIGVACSAERPRERMKINDVESRLRLIRRKLLETPACLEVKQTTSMPP 473
+ I C +P +R + R+ + P + P
Sbjct: 273 PVYRIMTQCWQHQPEDRPNFAIILERI----EYCTQDPDVINTALPIEYGP 319
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 51/235 (21%), Positives = 90/235 (38%), Gaps = 58/235 (24%)
Query: 153 IGAGNFGSVYNGTLFDG-----TTIAVKVFNLIRPGGSKS----FKSECKAAINIKHRNI 203
+G+G FG+VY G +A+K +R S E ++ + ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKE---LREATSPKANKEILDEAYVMASVDNPHV 79
Query: 204 VRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAID 263
R+ G+ ++ + MP G L +++R D N + L+ +
Sbjct: 80 CRLL----GICLTSTVQ--LITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQ 125
Query: 264 VACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICI 320
+A + YL H +L NVL+ + DFG+A+ L A +K
Sbjct: 126 IAKGMNYLEDRRL------VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK-----EY 174
Query: 321 KGSTGYIP-----PEYDLGCEASTYG------DVYSFGILLLEMFT-GIRPSDGI 363
G +P E+ + DV+S+G+ + E+ T G +P DGI
Sbjct: 175 HAEGGKVPIKWMAL------ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 223
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-22
Identities = 62/247 (25%), Positives = 86/247 (34%), Gaps = 80/247 (32%)
Query: 153 IGAGNFGSVYNGTL--FDGTTI--AVKVFNLIRPGGSKS------FKSECKAAINIKHRN 202
+G G+FG V G G T+ AVK ++P F E A ++ HRN
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKC---LKPDVLSQPEAMDDFIREVNAMHSLDHRN 82
Query: 203 IVRVFTAFSGVDYQGARFKAVVYK--------FMPNGSLEEWLRGKDDTNWRPLNFNFLI 254
++R++ VV P GSL + LR FL+
Sbjct: 83 LIRLY--------------GVVLTPPMKMVTELAPLGSLLDRLRKHQGH--------FLL 120
Query: 255 KKKLDIAIDVACALRYL------HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL 308
A+ VA + YL H D L N+LL + +GDFG+ R L
Sbjct: 121 GTLSRYAVQVAEGMGYLESKRFIHRD---------LAARNLLLATRDLVKIGDFGLMRAL 171
Query: 309 PAIDKQNRFICIKGSTGYIP-----PEYDLGCEASTYG------DVYSFGILLLEMFT-G 356
P D +P P E+ D + FG+ L EMFT G
Sbjct: 172 PQNDDHYV----MQEHRKVPFAWCAP------ESLKTRTFSHASDTWMFGVTLWEMFTYG 221
Query: 357 IRPSDGI 363
P G+
Sbjct: 222 QEPWIGL 228
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 3e-22
Identities = 68/347 (19%), Positives = 117/347 (33%), Gaps = 85/347 (24%)
Query: 153 IGAGNFGSVYNGTLF-----DGTTIAVKVFNLIRPGGSKS---FKSECKAAINIKHRNIV 204
+G GNFGSV G +AVK ++ G F+ E + + IV
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQ---LQHSGPDQQRDFQREIQILKALHSDFIV 87
Query: 205 RVFTAFSGVDYQGARFKA-VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAID 263
+ GV Y R +V +++P+G L ++L+ + L +
Sbjct: 88 KYR----GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA--------RLDASRLLLYSSQ 135
Query: 264 VACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICI 320
+ + YL C H +L N+L++ E + DFG+A+ LP
Sbjct: 136 ICKGMEYLGSRRC------VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYV---- 185
Query: 321 KGSTGYIP-----PEYDLGCEASTYG------DVYSFGILLLEMFT-GIRPSDGIFTGKM 368
G P P E+ + DV+SFG++L E+FT + +
Sbjct: 186 VREPGQSPIFWYAP------ESLSDNIFSRQSDVWSFGVVLYELFTYCDKS----CSPSA 235
Query: 369 NLRNFVKMALPQ-RAEEVVDDFNLQEIEEGRTM-CMEVSSSSGSSAHASIILECFNSICE 426
+ + L+ +EEG+ + C + E
Sbjct: 236 EFLRMMGCERDVPALSRL-----LELLEEGQRLPAPP---------------ACPAEVHE 275
Query: 427 IGVACSAERPRERMKINDVESRLRLIRRKLLETPACLEVKQTTSMPP 473
+ C A P++R + + +L L E T+ P
Sbjct: 276 LMKLCWAPSPQDRPSFSALGPQL----DMLWSGSRGCETHAFTAHPE 318
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 3e-22
Identities = 52/232 (22%), Positives = 87/232 (37%), Gaps = 48/232 (20%)
Query: 153 IGAGNFGSVYNGTLFDG----TTIAVKVF--NLIRPGGSKSFKSECKAAINIKHRNIVR- 205
+G G FGSV L +AVK+ ++I + F E H ++ +
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 206 --VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRG-KDDTNWRPLNFNFLIKKKLDIAI 262
V V+ FM +G L +L + N L L+ +
Sbjct: 91 VGVSLRSRAKGRLPIPM--VILPFMKHGDLHAFLLASRIGENPFNLPLQTLV----RFMV 144
Query: 263 DVACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFIC 319
D+AC + YL + H +L N +L ++M V DFG++R + + D
Sbjct: 145 DIACGMEYLSSRNF------IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD-----YY 193
Query: 320 IKGSTGYIP-----PE------YDLGCEASTYGDVYSFGILLLEMFT-GIRP 359
+G +P E Y + + DV++FG+ + E+ T G P
Sbjct: 194 RQGCASKLPVKWLALESLADNLY------TVHSDVWAFGVTMWEIMTRGQTP 239
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 4e-22
Identities = 51/240 (21%), Positives = 82/240 (34%), Gaps = 77/240 (32%)
Query: 153 IGAGNFGSVYNGTLFDG---TTIAVKVFNLIRPGGSKS----FKSECKAAINIKHRNIVR 205
+G GNFGSV G +A+KV ++ G K+ E + + + IVR
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKV---LKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 206 VFTAFSGVDYQGARFKAVVYK--------FMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK 257
+ V G L ++L GK + +
Sbjct: 75 LI--------------GVCQAEALMLVMEMAGGGPLHKFLVGKREE--------IPVSNV 112
Query: 258 LDIAIDVACALRYL------HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAI 311
++ V+ ++YL H D L NVLL + + DFG+++ L A
Sbjct: 113 AELLHQVSMGMKYLEEKNFVHRD---------LAARNVLLVNRHYAKISDFGLSKALGAD 163
Query: 312 DKQNRFICIKGSTGYIP-----PEYDLGCEASTYG------DVYSFGILLLEMFT-GIRP 359
D S G P P E + DV+S+G+ + E + G +P
Sbjct: 164 DSYYT----ARSAGKWPLKWYAP------ECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 8e-22
Identities = 65/236 (27%), Positives = 102/236 (43%), Gaps = 66/236 (27%)
Query: 153 IGAGNFGSVYNGTLFDGT-----TIAVKVFNLIRPGGS----KSFKSECKAAI--NIKHR 201
IGAG FG VY G L + +A+K ++ G + F E A I H
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKT---LKAGYTEKQRVDFLGE--AGIMGQFSHH 106
Query: 202 NIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIA 261
NI+R+ GV + ++ ++M NG+L+++LR KD F + + + +
Sbjct: 107 NIIRLE----GVISKYKPM-MIITEYMENGALDKFLREKDGE--------FSVLQLVGML 153
Query: 262 IDVACALRYL------HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQN 315
+A ++YL H D L N+L++ ++ V DFG++R L +
Sbjct: 154 RGIAAGMKYLANMNYVHRD---------LAARNILVNSNLVCKVSDFGLSRVLEDDPEAT 204
Query: 316 RFICIKGSTGYIP-----PEYDLGCEASTYG------DVYSFGILLLEMFT-GIRP 359
S G IP P EA +Y DV+SFGI++ E+ T G RP
Sbjct: 205 Y----TTSGGKIPIRWTAP------EAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 9e-22
Identities = 52/258 (20%), Positives = 85/258 (32%), Gaps = 63/258 (24%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-----KHRNIVR 205
+G G++G V+ DG AVK + P ++ A + +H VR
Sbjct: 64 RLGHGSYGEVFKVRSKEDGRLYAVKR--SMSPFRGPKDRARKLAEVGSHEKVGQHPCCVR 121
Query: 206 VFTAFSGVDYQGARFKAVVYKFM--PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAID 263
+ A+ +Y SL++ + + D
Sbjct: 122 LEQAWEEGGI--------LYLQTELCGPSLQQHCEAW--------GASLPEAQVWGYLRD 165
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIK 321
AL +LH + H ++KP+N+ L G GDFG+ L
Sbjct: 166 TLLALAHLH---SQGLVHLDVKPANIFLGPR--GRCKLGDFGLLVELGTAGAGEVQE--- 217
Query: 322 GSTGYIPPE-----YDLGCEASTYGDVYSFGILLLEMFTGIR-PSDG-----IFTGKM-- 368
G Y+ PE Y DV+S G+ +LE+ + P G + G +
Sbjct: 218 GDPRYMAPELLQGSYGTAA------DVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPP 271
Query: 369 --------NLRNFVKMAL 378
LR+ + M L
Sbjct: 272 EFTAGLSSELRSVLVMML 289
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 1e-21
Identities = 56/232 (24%), Positives = 95/232 (40%), Gaps = 57/232 (24%)
Query: 153 IGAGNFGSVYNGTLFDGTT-IAVKVFNLIRPGGS--KSFKSECKAAINIKHRNIVRVFTA 209
+G G +G VY G + +AVK ++ + F E IKH N+V++
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKT---LKEDTMEVEEFLKEAAVMKEIKHPNLVQLL-- 75
Query: 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALR 269
GV + F ++ +FM G+L ++LR + + ++ L+ +A ++ A+
Sbjct: 76 --GVCTREPPF-YIITEFMTYGNLLDYLRECNR---QEVSAVVLL----YMATQISSAME 125
Query: 270 YL------HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGS 323
YL H D L N L+ + + V DFG++R + +
Sbjct: 126 YLEKKNFIHRD---------LAARNCLVGENHLVKVADFGLSRLMT--GDTYT----AHA 170
Query: 324 TGYIP-----PEYDLGCEASTYG------DVYSFGILLLEMFT-GIRPSDGI 363
P P E+ Y DV++FG+LL E+ T G+ P GI
Sbjct: 171 GAKFPIKWTAP------ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 216
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 55/232 (23%), Positives = 88/232 (37%), Gaps = 52/232 (22%)
Query: 153 IGAGNFGSVYNGTLFDG-----TTIAVKVFNLIRPGGSKS-FKSECKAAINIKHRNIVRV 206
+G+G FG+V+ G + +KV S A ++ H +IVR+
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVAC 266
G+ + +V +++P GSL + +R + L+ + +A
Sbjct: 81 L----GLCPGSSLQ--LVTQYLPLGSLLDHVRQHRG--------ALGPQLLLNWGVQIAK 126
Query: 267 ALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGS 323
+ YL H NL NVLL V DFG+A LP DKQ + S
Sbjct: 127 GMYYLEEHGM------VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ-----LLYS 175
Query: 324 TGYIP-----PEYDLGCEASTYG------DVYSFGILLLEMFT-GIRPSDGI 363
P E+ +G DV+S+G+ + E+ T G P G+
Sbjct: 176 EAKTPIKWMAL------ESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL 221
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 58/233 (24%), Positives = 94/233 (40%), Gaps = 51/233 (21%)
Query: 153 IGAGNFGSVYNGTLFDG------TTIAVKVFNLIRPGGSKS----FKSECKAAINIKHRN 202
+G G+FG VY G T +A+K + S F +E +
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKT---VNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRG-KDDTNWRPLNFNFLIKKKLDIA 261
+VR+ GV QG V+ + M G L+ +LR + P+ + K + +A
Sbjct: 90 VVRLL----GVVSQGQPT-LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 262 IDVACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFI 318
++A + YL H +L N ++ ++ +GDFGM R + D
Sbjct: 145 GEIADGMAYLNANKF------VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD-----Y 193
Query: 319 CIKGSTGYIP-----PE------YDLGCEASTYGDVYSFGILLLEMFT-GIRP 359
KG G +P PE + +TY DV+SFG++L E+ T +P
Sbjct: 194 YRKGGKGLLPVRWMSPESLKDGVF------TTYSDVWSFGVVLWEIATLAEQP 240
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 1e-21
Identities = 49/235 (20%), Positives = 86/235 (36%), Gaps = 68/235 (28%)
Query: 153 IGAGNFGSVYNGTLFDG----TTIAVKVFNLIRPGGS----KSFKSECKAAI--NIKHRN 202
IG G FG V+ G +A+K + S + F E A H +
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKT---CKNCTSDSVREKFLQE--ALTMRQFDHPH 77
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAI 262
IV++ GV + + ++ + G L +L+ + + + + A
Sbjct: 78 IVKLI----GVITENPVW--IIMELCTLGELRSFLQVRKYS--------LDLASLILYAY 123
Query: 263 DVACALRYL------HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNR 316
++ AL YL H D + NVL+ +GDFG++R++
Sbjct: 124 QLSTALAYLESKRFVHRD---------IAARNVLVSSNDCVKLGDFGLSRYMEDST---- 170
Query: 317 FICIKGSTGYIP-----PEYDLGCEASTYG------DVYSFGILLLEMFT-GIRP 359
K S G +P P E+ + DV+ FG+ + E+ G++P
Sbjct: 171 --YYKASKGKLPIKWMAP------ESINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-21
Identities = 59/214 (27%), Positives = 90/214 (42%), Gaps = 24/214 (11%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAF 210
++G G +G VY G L + IA+K S+ E ++KH+NIV+
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL--- 85
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFN-FLIKKKLDIAIDVACALR 269
G + K + + +P GSL LR K W PL N I + L+
Sbjct: 86 -GSFSENGFIK-IFMEQVPGGSLSALLRSK----WGPLKDNEQTIGF---YTKQILEGLK 136
Query: 270 YLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIKGSTGYI 327
YLH + I H ++K NVL++ G + DFG ++ L I+ G+ Y+
Sbjct: 137 YLHDNQ---IVHRDIKGDNVLINTYS-GVLKISDFGTSKRLAGINPCTE--TFTGTLQYM 190
Query: 328 PPEYDLGCE--ASTYGDVYSFGILLLEMFTGIRP 359
PE D++S G ++EM TG P
Sbjct: 191 APEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 1e-21
Identities = 67/333 (20%), Positives = 124/333 (37%), Gaps = 99/333 (29%)
Query: 153 IGAGNFGSVYNGTLFDG------TTIAVKVFNLIRPGGSKS----FKSECKAAI--NIKH 200
+G FG VY G LF +A+K ++ F+ E A + ++H
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKT---LKDKAEGPLREEFRHE--AMLRARLQH 71
Query: 201 RNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK--- 257
N+V + GV + ++++ + +G L E+L + + + K
Sbjct: 72 PNVVCLL----GVVTKDQPL-SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126
Query: 258 ----LDIAIDVACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPA 310
+ + +A + YL H H +L NVL+ D++ + D G+ R + A
Sbjct: 127 PPDFVHLVAQIAAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGLFREVYA 180
Query: 311 IDKQNRFICIKGSTGYIP-----PEYDLGCEASTYG------DVYSFGILLLEMFT-GIR 358
D +P PE A YG D++S+G++L E+F+ G++
Sbjct: 181 AD-----YYKLLGNSLLPIRWMAPE------AIMYGKFSIDSDIWSYGVVLWEVFSYGLQ 229
Query: 359 PSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTM-CMEVSSSSGSSAHASII 417
P + G N ++V ++ I + + C +
Sbjct: 230 P----YCGYSN-------------QDV-----VEMIRNRQVLPCPD-------------- 253
Query: 418 LECFNSICEIGVACSAERPRERMKINDVESRLR 450
+C + + + C E P R + D+ SRLR
Sbjct: 254 -DCPAWVYALMIECWNEFPSRRPRFKDIHSRLR 285
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 1e-21
Identities = 67/237 (28%), Positives = 91/237 (38%), Gaps = 59/237 (24%)
Query: 153 IGAGNFGSVYNGTLFDG------TTIAVKVFNLIRPGGSKS----FKSECKAAI--NIKH 200
+G G FG VY G + +AVK + S+ F E A I H
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKT---LPEVCSEQDELDFLME--ALIISKFNH 133
Query: 201 RNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDI 260
+NIVR GV Q ++ + M G L+ +LR +P + L +
Sbjct: 134 QNIVR----CIGVSLQSLPR-FILLELMAGGDLKSFLRETRPRPSQPSSLAM--LDLLHV 186
Query: 261 AIDVACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHV---GDFGMARFLPAIDKQ 314
A D+AC +YL H H ++ N LL G V GDFGMAR +
Sbjct: 187 ARDIACGCQYLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG-- 238
Query: 315 NRFICIKGSTGYIP-----PEYDLGCEASTYG------DVYSFGILLLEMFT-GIRP 359
KG +P PE A G D +SFG+LL E+F+ G P
Sbjct: 239 ---YYRKGGCAMLPVKWMPPE------AFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 76/341 (22%), Positives = 124/341 (36%), Gaps = 90/341 (26%)
Query: 153 IGAGNFGSVYNGTLFDG------TTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRV 206
+G G FG V+ + +AVK + F+ E + ++H++IVR
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKL------DI 260
F GV +G +V+++M +G L +LR + L +
Sbjct: 109 F----GVCTEGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAV 163
Query: 261 AIDVACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRF 317
A VA + YL H H +L N L+ ++ +GDFGM+R + + D
Sbjct: 164 ASQVAAGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD----- 212
Query: 318 ICIKGSTGYIP-----PEYDLGCEASTYG------DVYSFGILLLEMFT-GIRPSDGIFT 365
G +P P E+ Y DV+SFG++L E+FT G +P +
Sbjct: 213 YYRVGGRTMLPIRWMPP------ESILYRKFTTESDVWSFGVVLWEIFTYGKQP----WY 262
Query: 366 GKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTM-CMEVSSSSGSSAHASIILECFNSI 424
N E + I +GR + C +
Sbjct: 263 QLSN-------------TEA-----IDCITQGRELERPR---------------ACPPEV 289
Query: 425 CEIGVACSAERPRERMKINDVESRLRLIRRKLLETPACLEV 465
I C P++R I DV +RL+ + + P L+V
Sbjct: 290 YAIMRGCWQREPQQRHSIKDVHARLQALAQA---PPVYLDV 327
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 58/225 (25%), Positives = 94/225 (41%), Gaps = 36/225 (16%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKS------FKSECKAAINIKHRNIV 204
++G G V+ L D +AVKV +R ++ F+ E + A + H IV
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKV---LRADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 205 RVFTAFSGVDYQGARFKAVVYKFM---PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIA 261
V+ +G A + Y M +L + + + P+ K+ +++
Sbjct: 76 AVYD--TGEAETPAG--PLPYIVMEYVDGVTLRDIVHTE-----GPMT----PKRAIEVI 122
Query: 262 IDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFI--- 318
D AL + H Q I H ++KP+N+++ V DFG+AR AI +
Sbjct: 123 ADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIAR---AIADSGNSVTQT 176
Query: 319 -CIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
+ G+ Y+ PE G DVYS G +L E+ TG P G
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 3e-21
Identities = 56/220 (25%), Positives = 93/220 (42%), Gaps = 42/220 (19%)
Query: 153 IGAGNFGSVYNGTLF-----DGTTIAVKVFNLIRPGGS---KSFKSECKAAINIKHRNIV 204
+G GNFGSV G +AVK ++ + F+ E + +++H NIV
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKK---LQHSTEEHLRDFEREIEILKSLQHDNIV 105
Query: 205 RVFTAFSGVDYQGARFKA-VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAID 263
+ GV Y R ++ +++P GSL ++L+ + K L
Sbjct: 106 KYK----GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE--------RIDHIKLLQYTSQ 153
Query: 264 VACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICI 320
+ + YL H +L N+L+++E +GDFG+ + LP Q++
Sbjct: 154 ICKGMEYLGTKRY------IHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEYYK 203
Query: 321 KGSTGYIP-----PEYDLGCEASTYGDVYSFGILLLEMFT 355
G P PE + S DV+SFG++L E+FT
Sbjct: 204 VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 3e-21
Identities = 69/322 (21%), Positives = 119/322 (36%), Gaps = 64/322 (19%)
Query: 153 IGAGNFGSVYNGTLF-----DGTTIAVKVFNLIRPGGS---KSFKSECKAAINIKHRNIV 204
+G GNFGSV G +AVK ++ + F+ E + +++H NIV
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKK---LQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 205 RVFTAFSGVDYQGARFKA-VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAID 263
+ GV Y R ++ +++P GSL ++L+ + K L
Sbjct: 75 KYK----GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE--------RIDHIKLLQYTSQ 122
Query: 264 VACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICI 320
+ + YL H +L N+L+++E +GDFG+ + LP Q++
Sbjct: 123 ICKGMEYLGTKRY------IHRDLATRNILVENENRVKIGDFGLTKVLP----QDKEFFK 172
Query: 321 KGSTGYIP-----PEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVK 375
G P PE + S DV+SFG++L E+FT I S M + K
Sbjct: 173 VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDK 232
Query: 376 MALPQRAEEVVDDFNLQEIEEGRTM-CMEVSSSSGSSAHASIILECFNSICEIGVACSAE 434
+ ++ ++ + + C + I I C
Sbjct: 233 QG-QMIVFHL-----IELLKNNGRLPRPD---------------GCPDEIYMIMTECWNN 271
Query: 435 RPRERMKINDVESRLRLIRRKL 456
+R D+ R+ IR +
Sbjct: 272 NVNQRPSFRDLALRVDQIRDNM 293
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 3e-21
Identities = 51/221 (23%), Positives = 90/221 (40%), Gaps = 43/221 (19%)
Query: 153 IGAGNFGSVYNGTLF-----DGTTIAVKVFNLIRPGGSKS----FKSECKAAINIKHRNI 203
+G G+FG V G +AVK ++P + K E + N+ H NI
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKS---LKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 204 VRVFTAFSGVDYQGARFKA-VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAI 262
V+ G+ + ++ +F+P+GSL+E+L + +K++L A+
Sbjct: 86 VKYK----GICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN--------KINLKQQLKYAV 133
Query: 263 DVACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFIC 319
+ + YL H +L NVL++ E +GDFG+ + + ++
Sbjct: 134 QICKGMDYLGSRQY------VHRDLAARNVLVESEHQVKIGDFGLTKAIE----TDKEYY 183
Query: 320 IKGSTGYIP-----PEYDLGCEASTYGDVYSFGILLLEMFT 355
P PE + + DV+SFG+ L E+ T
Sbjct: 184 TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 4e-21
Identities = 71/337 (21%), Positives = 127/337 (37%), Gaps = 100/337 (29%)
Query: 153 IGAGNFGSVYNGTLFDG------TTIAVKVFNLIRPGGSKS----FKSECKAAI--NIKH 200
+G G FG V+ ++ +AVK + + F+ E A + N++H
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALK----DPTLAARKDFQRE--AELLTNLQH 76
Query: 201 RNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK--- 257
+IV+ + GV G +V+++M +G L ++LR ++ K
Sbjct: 77 EHIVKFY----GVCGDGDPL-IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131
Query: 258 ----LDIAIDVACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPA 310
L IA +A + YL H H +L N L+ ++ +GDFGM+R + +
Sbjct: 132 LSQMLHIASQIASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMSRDVYS 185
Query: 311 IDKQNRFICIKGSTGYIP-----PEYDLGCEASTYG------DVYSFGILLLEMFT-GIR 358
D G +P PE + Y DV+SFG++L E+FT G +
Sbjct: 186 TD-----YYRVGGHTMLPIRWMPPE------SIMYRKFTTESDVWSFGVILWEIFTYGKQ 234
Query: 359 PSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTM-CMEVSSSSGSSAHASII 417
P + N EV ++ I +GR +
Sbjct: 235 P----WFQLSN-------------TEV-----IECITQGRVLERPR-------------- 258
Query: 418 LECFNSICEIGVACSAERPRERMKINDVESRLRLIRR 454
C + ++ + C P++R+ I ++ L + +
Sbjct: 259 -VCPKEVYDVMLGCWQREPQQRLNIKEIYKILHALGK 294
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 5e-21
Identities = 54/244 (22%), Positives = 90/244 (36%), Gaps = 38/244 (15%)
Query: 133 NNPSFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNL--IRPGGSKSFKS 190
N F+ + +S IG+G V+ A+K NL S+++
Sbjct: 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRN 75
Query: 191 ECKAAINIKHRN--IVRVFTAFSGVDYQGARFKAVVYKFM--PNGSLEEWLRGKDDTNWR 246
E ++ + I+R++ Y +Y M N L WL+ K +
Sbjct: 76 EIAYLNKLQQHSDKIIRLYDYEITDQY--------IYMVMECGNIDLNSWLKKK-----K 122
Query: 247 PLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMAR 306
++ ++ A+ +H Q I H +LKP+N L+ D M+ + DFG+A
Sbjct: 123 SIDPWERKS----YWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIAN 174
Query: 307 FLPAIDKQNRFICIKGSTGYIPPE--------YDLGCEASTYG---DVYSFGILLLEMFT 355
+ G+ Y+PPE + G S DV+S G +L M
Sbjct: 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 234
Query: 356 GIRP 359
G P
Sbjct: 235 GKTP 238
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 5e-21
Identities = 49/238 (20%), Positives = 83/238 (34%), Gaps = 73/238 (30%)
Query: 153 IGAGNFGSVYNGTL---FDGTTIAVKVF--NLIRPGGSKSFKSECKAAINIKHRNIVRVF 207
+G+GNFG+V G T+AVK+ P +E + + IVR+
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 208 TAFSGVDYQGARFKAVVYK--------FMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLD 259
+ G L ++L+ + + ++
Sbjct: 85 --------------GICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNI---------IE 121
Query: 260 IAIDVACALRYL------HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDK 313
+ V+ ++YL H D L NVLL + + DFG+++ L A +
Sbjct: 122 LVHQVSMGMKYLEESNFVHRD---------LAARNVLLVTQHYAKISDFGLSKALRADEN 172
Query: 314 QNRFICIKGSTGYIP-----PEYDLGCEASTYG------DVYSFGILLLEMFT-GIRP 359
+ + G P P E Y DV+SFG+L+ E F+ G +P
Sbjct: 173 YYK----AQTHGKWPVKWYAP------ECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 7e-21
Identities = 53/236 (22%), Positives = 88/236 (37%), Gaps = 61/236 (25%)
Query: 153 IGAGNFGSVYNGTLFDG---TTIAVKVFNLIRPGGSKS----FKSECKAAINIKHRNIVR 205
+G GNFGSV G +A+KV ++ G K+ E + + + IVR
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKV---LKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVA 265
+ GV A +V + G L ++L GK + + ++ V+
Sbjct: 401 LI----GVCQAEALM--LVMEMAGGGPLHKFLVGKRE--------EIPVSNVAELLHQVS 446
Query: 266 CALRYL------HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFIC 319
++YL H + L NVLL + + DFG+++ L A D
Sbjct: 447 MGMKYLEEKNFVHRN---------LAARNVLLVNRHYAKISDFGLSKALGADDSYYT--- 494
Query: 320 IKGSTGYIP-----PEYDLGCEASTYG------DVYSFGILLLEMFT-GIRPSDGI 363
S G P P E + DV+S+G+ + E + G +P +
Sbjct: 495 -ARSAGKWPLKWYAP------ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM 543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 8e-21
Identities = 48/235 (20%), Positives = 90/235 (38%), Gaps = 68/235 (28%)
Query: 153 IGAGNFGSVYNGTLFDG----TTIAVKVFNLIRPGGSKS----FKSECKAAI--NIKHRN 202
+G G FG VY G + +AVK + + F SE A I N+ H +
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKT---CKKDCTLDNKEKFMSE--AVIMKNLDHPH 74
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAI 262
IV++ G+ + + ++ + P G L +L ++ + + ++
Sbjct: 75 IVKLI----GIIEEEPTW--IIMELYPYGELGHYLERNKNS--------LKVLTLVLYSL 120
Query: 263 DVACALRYL------HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNR 316
+ A+ YL H D + N+L+ +GDFG++R++ D+
Sbjct: 121 QICKAMAYLESINCVHRD---------IAVRNILVASPECVKLGDFGLSRYI--EDEDY- 168
Query: 317 FICIKGSTGYIP-----PEYDLGCEASTYG------DVYSFGILLLEMFT-GIRP 359
K S +P P E+ + DV+ F + + E+ + G +P
Sbjct: 169 ---YKASVTRLPIKWMSP------ESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 8e-21
Identities = 64/251 (25%), Positives = 100/251 (39%), Gaps = 48/251 (19%)
Query: 151 NLIGAGNFGSVYNGTLFD------GTTIAVKVFNLIRPGGSKS----FKSECKAAINI-K 199
+GAG FG V T F +AVK +++ SE K ++ +
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVK---MLKSTAHADEKEALMSELKIMSHLGQ 108
Query: 200 HRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGK-----DDTNWRPLNFNFLI 254
H NIV + G G V+ ++ G L +LR K D + N
Sbjct: 109 HENIVNLL----GACTHGGPV-LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAST 163
Query: 255 KKKLDIAIDVACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAI 311
+ L + VA + +L +C I H ++ NVLL + + +GDFG+AR +
Sbjct: 164 RDLLHFSSQVAQGMAFLASKNC-----I-HRDVAARNVLLTNGHVAKIGDFGLARDIMND 217
Query: 312 DKQNRFICIKGSTGYIP-----PEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFT 365
I +P PE C + DV+S+GILL E+F+ G+ P +
Sbjct: 218 S-----NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP----YP 268
Query: 366 GKMNLRNFVKM 376
G + F K+
Sbjct: 269 GILVNSKFYKL 279
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 8e-21
Identities = 62/235 (26%), Positives = 99/235 (42%), Gaps = 65/235 (27%)
Query: 153 IGAGNFGSVYNGTL----FDGTTIAVKVFNLIRPGGS----KSFKSECKAAI--NIKHRN 202
+GAG FG V +G L ++A+K ++ G + + F E A+I H N
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKT---LKVGYTEKQRRDFLGE--ASIMGQFDHPN 107
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAI 262
I+R+ GV + +V ++M NGSL+ +LR D F + + + +
Sbjct: 108 IIRLE----GVVTKSKPV-MIVTEYMENGSLDSFLRKHDAQ--------FTVIQLVGMLR 154
Query: 263 DVACALRYL------HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNR 316
+A ++YL H D L N+L++ ++ V DFG+ R L +
Sbjct: 155 GIASGMKYLSDMGYVHRD---------LAARNILINSNLVCKVSDFGLGRVLEDDPEAAY 205
Query: 317 FICIKGSTGYIP-----PEYDLGCEASTYG------DVYSFGILLLEMFT-GIRP 359
G IP P EA Y DV+S+GI+L E+ + G RP
Sbjct: 206 ----TTRGGKIPIRWTSP------EAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 9e-21
Identities = 52/230 (22%), Positives = 84/230 (36%), Gaps = 38/230 (16%)
Query: 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNL--IRPGGSKSFKSECKAAINIKH--RNIVRV 206
IG+G V+ A+K NL S+++E ++ I+R+
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 207 FTAFSGVDYQGARFKAVVYKFM--PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDV 264
+ Y +Y M N L WL+ K + ++ ++
Sbjct: 122 YDYEITDQY--------IYMVMECGNIDLNSWLKKK-----KSIDPWERKS----YWKNM 164
Query: 265 ACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGST 324
A+ +H Q I H +LKP+N L+ D M+ + DFG+A + G+
Sbjct: 165 LEAVHTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAV 220
Query: 325 GYIPPE--------YDLGCEASTYG---DVYSFGILLLEMFTGIRPSDGI 363
Y+PPE + G S DV+S G +L M G P I
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 270
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-20
Identities = 50/236 (21%), Positives = 89/236 (37%), Gaps = 62/236 (26%)
Query: 153 IGAGNFGSVYNGTL--------FDGTTIAVKVFNLIRPGGSKSFKSECKAAI--NIKHRN 202
+G G F ++ G T + +KV + S+SF A++ + H++
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEA--ASMMSKLSHKH 73
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAI 262
+V + GV G +V +F+ GSL+ +L+ + I KL++A
Sbjct: 74 LVLNY----GVCVCGDEN-ILVQEFVKFGSLDTYLKKNKNC--------INILWKLEVAK 120
Query: 263 DVACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGH--------VGDFGMARFLPAI 311
+A A+ +L H N+ N+LL E + D G++ + +
Sbjct: 121 QLAAAMHFLEENTL------IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV--L 172
Query: 312 DKQNRFICIKGSTGYIPPEYDLGCEASTYG-------DVYSFGILLLEMFT-GIRP 359
K I ++PPE D +SFG L E+ + G +P
Sbjct: 173 PKDILQERIP----WVPPE------CIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 38/306 (12%), Positives = 88/306 (28%), Gaps = 78/306 (25%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK----------- 199
++G + + T G + V V S + K + + ++
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 200 -----------------HRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDD 242
+ ++RV + + P G+
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERD------MWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 243 TNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--G 300
+ + + + +L + + V L LH + H L+P +++LD G V
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQR--GGVFLT 248
Query: 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYG-----------DVYSFGIL 349
F + + S G+ PPE + +Y D ++ G++
Sbjct: 249 GFEHLV------RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302
Query: 350 LLEMFTGIRPSDG---------IFTGKMNL----RNFVKMAL---PQR---AEEVVDDFN 390
+ ++ P IF N+ R ++ L + + ++
Sbjct: 303 IYWIWCADLPITKDAALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPE 362
Query: 391 LQEIEE 396
+++
Sbjct: 363 YEQLRT 368
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 55/231 (23%), Positives = 92/231 (39%), Gaps = 47/231 (20%)
Query: 153 IGAGNFGSVYNGTLFD--------GTTIAVKVFNLIRPGGSKS----FKSECKAAINI-K 199
+G G FG V T+AVK+ ++ ++ SE + I K
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM---LKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 200 HRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK-- 257
H+NI+ + G Q V+ ++ G+L E+LR + + ++
Sbjct: 100 HKNIINLL----GACTQDGPL-YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 258 -----LDIAIDVACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLP 309
+ +A + YL C I H +L NVL+ + + + DFG+AR +
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKC-----I-HRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 310 AIDKQNRFICIKGSTGYIP-----PEYDLGCEASTYGDVYSFGILLLEMFT 355
ID K + G +P PE + DV+SFG+L+ E+FT
Sbjct: 209 NID-----YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 3e-20
Identities = 60/252 (23%), Positives = 93/252 (36%), Gaps = 49/252 (19%)
Query: 153 IGAGNFGSVYNGTLFD------GTTIAVKVFNLIRPGGSKS----FKSECKAAINI-KHR 201
+GAG FG V T + T+AVK +++P + SE K + H
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVK---MLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 202 NIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGK---------DDTNWRPLNFNF 252
NIV + G G V+ ++ G L +LR K
Sbjct: 88 NIVNLL----GACTIGGPT-LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 253 LIKKKLDIAIDVACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLP 309
++ L + VA + +L +C I H +L N+LL I + DFG+AR +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNC-----I-HRDLAARNILLTHGRITKICDFGLARDIK 196
Query: 310 AIDKQNRFICIKGSTGYIP-----PEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363
+ +P PE C + DV+S+GI L E+F+ G P G+
Sbjct: 197 NDS-----NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251
Query: 364 FTGKMNLRNFVK 375
+K
Sbjct: 252 PVDS-KFYKMIK 262
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-20
Identities = 53/242 (21%), Positives = 86/242 (35%), Gaps = 38/242 (15%)
Query: 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNL--IRPGGSKSFKSECKAAINIKH--RNIVRV 206
IG+G V+ A+K NL S+++E ++ I+R+
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 207 FTAFSGVDYQGARFKAVVYKFM--PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDV 264
+ Y +Y M N L WL+ K + ++ ++
Sbjct: 75 YDYEITDQY--------IYMVMECGNIDLNSWLKKK-----KSIDPWERKS----YWKNM 117
Query: 265 ACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGST 324
A+ +H Q I H +LKP+N L+ D M+ + DFG+A + G+
Sbjct: 118 LEAVHTIH---QHGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTV 173
Query: 325 GYIPPE--------YDLGCEASTYG---DVYSFGILLLEMFTGIRPSDGIFTGKMNLRNF 373
Y+PPE + G S DV+S G +L M G P I L
Sbjct: 174 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 233
Query: 374 VK 375
+
Sbjct: 234 ID 235
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 3e-20
Identities = 59/240 (24%), Positives = 96/240 (40%), Gaps = 48/240 (20%)
Query: 153 IGAGNFGSVYNGTLFD--------GTTIAVKVFNLIRPGGSKS----FKSECKAAINI-K 199
+G G FG V T +AVK +++ ++ SE + I K
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVK---MLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 200 HRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK-- 257
H+NI+ + G Q V+ ++ G+L E+L+ + ++
Sbjct: 134 HKNIINLL----GACTQDGPL-YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 258 -----LDIAIDVACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLP 309
+ A VA + YL C H +L NVL+ ++ + + DFG+AR +
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKC------IHRDLAARNVLVTEDNVMKIADFGLARDIH 242
Query: 310 AIDKQNRFICIKGSTGYIP-----PEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363
ID K + G +P PE + DV+SFG+LL E+FT G P G+
Sbjct: 243 HID-----YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 297
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 3e-20
Identities = 66/285 (23%), Positives = 109/285 (38%), Gaps = 65/285 (22%)
Query: 115 LIKKKLLKTPVYEGKQTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDG----- 169
L+ +L P+Y+ + NP L N IG G FG V+
Sbjct: 17 LLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEP 76
Query: 170 -TTIAVKVFNLIRPGGSKS----FKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVV 224
T +AVK+ ++ S F+ E + NIV++ GV G ++
Sbjct: 77 FTMVAVKM---LKEEASADMQADFQREAALMAEFDNPNIVKLL----GVCAVGKPM-CLL 128
Query: 225 YKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK---------------LDIAIDVACALR 269
+++M G L E+LR L+ + L + L IA VA +
Sbjct: 129 FEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMA 188
Query: 270 YL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGY 326
YL H +L N L+ + M+ + DFG++R + + D
Sbjct: 189 YLSERKF------VHRDLATRNCLVGENMVVKIADFGLSRNIYSAD-----YYKADGNDA 237
Query: 327 IP-----PE------YDLGCEASTYGDVYSFGILLLEMFT-GIRP 359
IP PE Y +T DV+++G++L E+F+ G++P
Sbjct: 238 IPIRWMPPESIFYNRY------TTESDVWAYGVVLWEIFSYGLQP 276
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 4e-20
Identities = 51/233 (21%), Positives = 88/233 (37%), Gaps = 56/233 (24%)
Query: 153 IGAGNFGSVYNGTLFDG----TTIAVKVFNLIRPGGSKS----FKSECKAAI--NIKHRN 202
IG G FG V+ G +A+K + S S F E A H +
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKT---CKNCTSDSVREKFLQE--ALTMRQFDHPH 452
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAI 262
IV++ GV + + ++ + G L +L+ + + + + A
Sbjct: 453 IVKLI----GVITENPVW--IIMELCTLGELRSFLQVRKFS--------LDLASLILYAY 498
Query: 263 DVACALRYL------HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNR 316
++ AL YL H D + NVL+ +GDFG++R++
Sbjct: 499 QLSTALAYLESKRFVHRD---------IAARNVLVSSNDCVKLGDFGLSRYMEDST---- 545
Query: 317 FICIKGSTGYIP-----PEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363
K S G +P PE ++ DV+ FG+ + E+ G++P G+
Sbjct: 546 --YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 596
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 5e-20
Identities = 47/222 (21%), Positives = 83/222 (37%), Gaps = 36/222 (16%)
Query: 152 LIGAGNFGSVYNGTLFD---GTTIAVKVFNLIRPGGSKS------FKSECKAAINIKHRN 202
L+G G G VY D +A+K+ + S + E + A ++ +
Sbjct: 41 LVGRGGMGDVYEAE--DTVRERIVALKL---MSETLSSDPVFRTRMQREARTAGRLQEPH 95
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAI 262
+V + G G + V + + L LR + PL + + I
Sbjct: 96 VVPIHD--FGEI-DGQLY--VDMRLINGVDLAAMLRRQ-----GPLA----PPRAVAIVR 141
Query: 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL--PAIDKQNRFICI 320
+ AL H H ++KP N+L+ + ++ DFG+A + + +
Sbjct: 142 QIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-- 196
Query: 321 KGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
G+ Y+ PE A+ D+Y+ +L E TG P G
Sbjct: 197 -GTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQG 237
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 8e-20
Identities = 53/224 (23%), Positives = 83/224 (37%), Gaps = 25/224 (11%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFT 208
IG G++G DG + K + + SE +KH NIVR +
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 209 AFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACAL 268
+D +V ++ G L + + L + + AL
Sbjct: 73 RI--IDRTNTTLY-IVMEYCEGGDLASVIT-----KGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 269 RYLH--CDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGY 326
+ H D + H +LKP+NV LD + +GDFG+AR L + G+ Y
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV--GTPYY 182
Query: 327 IPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDGIFTGK 367
+ PE +Y D++S G LL E+ + P FT
Sbjct: 183 MSPEQ---MNRMSYNEKSDIWSLGCLLYELCALMPP----FTAF 219
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 8e-20
Identities = 55/231 (23%), Positives = 92/231 (39%), Gaps = 47/231 (20%)
Query: 153 IGAGNFGSVYNGTLFD--------GTTIAVKVFNLIRPGGSKS----FKSECKAAINI-K 199
+G G FG V T+AVK+ ++ ++ SE + I K
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKM---LKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 200 HRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK-- 257
H+NI+ + G Q V+ ++ G+L E+LR + + ++
Sbjct: 146 HKNIINLL----GACTQDGPL-YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 258 -----LDIAIDVACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLP 309
+ +A + YL C I H +L NVL+ + + + DFG+AR +
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKC-----I-HRDLAARNVLVTENNVMKIADFGLARDIN 254
Query: 310 AIDKQNRFICIKGSTGYIP-----PEYDLGCEASTYGDVYSFGILLLEMFT 355
ID K + G +P PE + DV+SFG+L+ E+FT
Sbjct: 255 NID-----YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 58/238 (24%), Positives = 95/238 (39%), Gaps = 45/238 (18%)
Query: 153 IGAGNFGSVYNGTLFD------GTTIAVKVFNLIRPGGSKS----FKSECKAAINI-KHR 201
+G G FG V F T+AVK +++ G + S SE K I+I H
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVK---MLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 202 NIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK---- 257
N+V + G + V+ +F G+L +LR K + + K
Sbjct: 92 NVVNLL----GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147
Query: 258 ---LDIAIDVACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAI 311
+ + VA + +L C H +L N+LL ++ + + DFG+AR +
Sbjct: 148 EHLICYSFQVAKGMEFLASRKC------IHRDLAARNILLSEKNVVKICDFGLARDIYKD 201
Query: 312 DKQNRFICIKGSTGYIP-----PEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363
++ +P PE + DV+SFG+LL E+F+ G P G+
Sbjct: 202 P-----DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 36/245 (14%), Positives = 75/245 (30%), Gaps = 35/245 (14%)
Query: 151 NLIGAGNFGSVY------NGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK---HR 201
+L+G G F VY + +KV +P F + +K
Sbjct: 71 HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKV---QKPANPWEFYIGTQLMERLKPSMQH 127
Query: 202 NIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIA 261
++ ++A +Q +V + G+L + +T + + +I A
Sbjct: 128 MFMKFYSAH---LFQNGSV--LVGELYSYGTLLNAINLYKNTPEKVMPQGLVIS----FA 178
Query: 262 IDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG-----------DFGMARFLPA 310
+ + + +H I H ++KP N +L + + D G + +
Sbjct: 179 MRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235
Query: 311 IDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNL 370
K F ++G+ E + D + + M G G+
Sbjct: 236 FPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKP 295
Query: 371 RNFVK 375
+
Sbjct: 296 EGLFR 300
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 53/236 (22%), Positives = 89/236 (37%), Gaps = 52/236 (22%)
Query: 153 IGAGNFGSVYNGTLFDG------TTIAVKVFNLIRPGGSKS----FKSECKAAINIKHRN 202
+G G FG V T F TT+AVK +++ S S SE + H +
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVK---MLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK----- 257
+++++ G Q ++ ++ GSL +LR L
Sbjct: 88 VIKLY----GACSQDGPL-LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 258 ----------LDIAIDVACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM 304
+ A ++ ++YL + H +L N+L+ + + DFG+
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKL-----V-HRDLAARNILVAEGRKMKISDFGL 196
Query: 305 ARFLPAIDKQNRFICIKGSTGYIP-----PEYDLGCEASTYGDVYSFGILLLEMFT 355
+R + D +K S G IP E +T DV+SFG+LL E+ T
Sbjct: 197 SRDVYEED-----SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 3e-19
Identities = 50/221 (22%), Positives = 84/221 (38%), Gaps = 45/221 (20%)
Query: 153 IGAGNFGSVYNGTL-----FDGTTIAVKVFNLIRPGGS----KSFKSECKAAINIKHRNI 203
+G G+FG V G +AVK ++ +K E + H +I
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKA---LKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 204 VRVFTAFSGVDYQGARFKA-VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAI 262
++ G +V +++P GSL ++L + + + L A
Sbjct: 96 IKYK----GCCEDAGAASLQLVMEYVPLGSLRDYLPRH----------SIGLAQLLLFAQ 141
Query: 263 DVACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFIC 319
+ + YL H H +L NVLLD++ + +GDFG+A+ +P +
Sbjct: 142 QICEGMAYLHAQHY------IHRDLAARNVLLDNDRLVKIGDFGLAKAVP----EGHEYY 191
Query: 320 IKGSTGYIP-----PEYDLGCEASTYGDVYSFGILLLEMFT 355
G P PE + DV+SFG+ L E+ T
Sbjct: 192 RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 88.6 bits (219), Expect = 3e-19
Identities = 29/243 (11%), Positives = 66/243 (27%), Gaps = 46/243 (18%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVR----- 205
++G + + T G + V V S + K + + ++ ++
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 206 -----------------VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPL 248
+ + + P G+ +
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 249 NFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMAR 306
+ + + +L + + V L LH + H L+P +++LD G V F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQR--GGVFLTGFEHLV 259
Query: 307 FLPAIDKQNRFICIKGSTGYIPPEY-------DLGCEASTYG---DVYSFGILLLEMFTG 356
+ G+ PPE + D ++ G+ + ++
Sbjct: 260 ------RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313
Query: 357 IRP 359
P
Sbjct: 314 DLP 316
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 4e-19
Identities = 63/293 (21%), Positives = 106/293 (36%), Gaps = 51/293 (17%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTA 209
++G G +V+ G G A+KVFN I E + + H+NIV++F
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK----------LD 259
+ R K ++ +F P GSL + L + L
Sbjct: 76 E---EETTTRHKVLIMEFCPCGSL----------------YTVLEEPSNAYGLPESEFLI 116
Query: 260 IAIDVACALRYLHCDCQPPIAHCNLKPSNVLL----DDEMIGHVGDFGMARFLPAIDKQN 315
+ DV + +L + I H N+KP N++ D + + + DFG AR L +
Sbjct: 117 VLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL---EDDE 170
Query: 316 RFICIKGSTGYIPPE-----YDLGCEASTYG---DVYSFGILLLEMFTGIRPSDGIFTGK 367
+F+ + G+ Y+ P+ YG D++S G+ TG P +
Sbjct: 171 QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230
Query: 368 --MNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIIL 418
+ + P A V I+ M + S S G + +L
Sbjct: 231 RNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVL 283
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 6e-19
Identities = 44/229 (19%), Positives = 83/229 (36%), Gaps = 42/229 (18%)
Query: 147 FSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-----KHR 201
F +++G G G++ +FD +AVK S + + +H
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRIL-------PECFSFADREVQLLRESDEHP 78
Query: 202 NIVRVFTAFSGVDYQGARFKAVVYKFMP--NGSLEEWLRGKDDTNWRPLNFNFLIKKKLD 259
N++R F + Y + +L+E++ KD F L + +
Sbjct: 79 NVIRYFCTEKDRQF--------QYIAIELCAATLQEYVEQKD--------FAHLGLEPIT 122
Query: 260 IAIDVACALRYLHCDCQPPIAHCNLKPSNVLL-----DDEMIGHVGDFGMARFL-PAIDK 313
+ L +LH I H +LKP N+L+ ++ + DFG+ + L
Sbjct: 123 LLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHS 179
Query: 314 QNRFICIKGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
+R + G+ G+I PE D++S G + + +
Sbjct: 180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 6e-19
Identities = 46/222 (20%), Positives = 75/222 (33%), Gaps = 26/222 (11%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAF 210
+G G F V L DG A+K + + E H NI+R+
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
++ F G+L + D + L + + + L
Sbjct: 96 LRERGAKHEAW-LLLPFFKRGTLWNEIERLKDKGNF-----LTEDQILWLLLGICRGLEA 149
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNR-------FICIKGS 323
+H AH +LKP+N+LL DE + D G + +R + + +
Sbjct: 150 IH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 324 TGYIPPE------YDLGCEASTYGDVYSFGILLLEMFTGIRP 359
Y PE + + E + DV+S G +L M G P
Sbjct: 207 ISYRAPELFSVQSHCVIDERT---DVWSLGCVLYAMMFGEGP 245
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 7e-19
Identities = 45/220 (20%), Positives = 89/220 (40%), Gaps = 35/220 (15%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI----KHRNIVRV 206
IG G F VY L DG +A+K + +K+ +++C I++ H N+++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKA-RADCIKEIDLLKQLNHPNVIKY 97
Query: 207 FTAFSGVDYQGARFKAVVYKFM---PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAID 263
+ +F + + + G L ++ +++ + +
Sbjct: 98 YASFIEDNE--------LNIVLELADAGDLSRMIK-----HFKKQKRLIPERTVWKYFVQ 144
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPA-IDKQNRFICIKG 322
+ AL ++H + H ++KP+NV + + +GD G+ RF + + + G
Sbjct: 145 LCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV---G 198
Query: 323 STGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
+ Y+ PE + Y D++S G LL EM P
Sbjct: 199 TPYYMSPER---IHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 8e-19
Identities = 64/293 (21%), Positives = 107/293 (36%), Gaps = 51/293 (17%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTA 209
++G G +V+ G G A+KVFN I E + + H+NIV++F
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK----------LD 259
+ R K ++ +F P GSL + L + L
Sbjct: 76 E---EETTTRHKVLIMEFCPCGSL----------------YTVLEEPSNAYGLPESEFLI 116
Query: 260 IAIDVACALRYLHCDCQPPIAHCNLKPSNVLL----DDEMIGHVGDFGMARFLPAIDKQN 315
+ DV + +L + I H N+KP N++ D + + + DFG AR L +
Sbjct: 117 VLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL---EDDE 170
Query: 316 RFICIKGSTGYIPPE-----YDLGCEASTYG---DVYSFGILLLEMFTGIRPSDGIFTGK 367
+F+ + G+ Y+ P+ YG D++S G+ TG P +
Sbjct: 171 QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR 230
Query: 368 MN--LRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIIL 418
N + + P A V I+ M + S S G + +L
Sbjct: 231 RNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVL 283
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 48/216 (22%), Positives = 74/216 (34%), Gaps = 31/216 (14%)
Query: 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTA 209
+G G+FG V+ G AVK L E A + IV ++
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRL-----EVFRVEELVACAGLSSPRIVPLY-- 116
Query: 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALR 269
G +G + + + GSL + ++ L + L
Sbjct: 117 --GAVREGPWVN-IFMELLEGGSLGQLIK-----QMGCLPED-RALY---YLGQALEGLE 164
Query: 270 YLHCDCQPPIAHCNLKPSNVLLDDEMIGHV---GDFGMARFLPAIDKQNRFIC---IKGS 323
YLH I H ++K NVLL + G DFG A L + I G+
Sbjct: 165 YLHTRR---ILHGDVKADNVLLSSD--GSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219
Query: 324 TGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
++ PE +G D++S ++L M G P
Sbjct: 220 ETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-18
Identities = 50/231 (21%), Positives = 83/231 (35%), Gaps = 42/231 (18%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAF 210
++G G FG V D A+K + SE ++ H+ +VR + A+
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAW 71
Query: 211 SGVDYQGARFKAVVYK--------FMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAI 262
AV K + NG+L + + + N N + +
Sbjct: 72 LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE--------NLNQQRDEYWRLFR 123
Query: 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICI 320
+ AL Y+H I H +LKP N+ +D+ +V GDFG+A+ + +
Sbjct: 124 QILEALSYIH---SQGIIHRDLKPMNIFIDES--RNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 321 K------------GSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTG 356
G+ Y+ E + Y D+YS GI+ EM
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATE--VLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 59/257 (22%), Positives = 98/257 (38%), Gaps = 54/257 (21%)
Query: 153 IGAGNFGSVYNGTLFDG------TTIAVKVFNLIRPGGS----KSFKSECKAAINI-KHR 201
+G+G FG V N T + +AVK +++ ++ SE K + H
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVK---MLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 202 NIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGK-------------DDTNWRPL 248
NIV + G +++++ G L +LR K
Sbjct: 110 NIVNLL----GACTLSGPI-YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 249 NFNFLIKKKL-DIAIDVACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM 304
+ N L + L A VA + +L C + H +L NVL+ + + DFG+
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSC-----V-HRDLAARNVLVTHGKVVKICDFGL 218
Query: 305 ARFLPAIDKQNRFICIKGSTGYIP-----PEYDLGCEASTYGDVYSFGILLLEMFT-GIR 358
AR I + ++ +P PE + DV+S+GILL E+F+ G+
Sbjct: 219 ARD---IMSDSNYV--VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 273
Query: 359 PSDGIFTGKMNLRNFVK 375
P GI N ++
Sbjct: 274 PYPGIPVDA-NFYKLIQ 289
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 3e-18
Identities = 54/243 (22%), Positives = 90/243 (37%), Gaps = 58/243 (23%)
Query: 151 NLIGAGNFGSVYNGTLFDG---TTIAVKVFNLIRPGGSKS----FKSECKAAINI-KHRN 202
++IG GNFG V + A+K ++ SK F E + + H N
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKR---MKEYASKDDHRDFAGELEVLCKLGHHPN 87
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK----- 257
I+ + G + ++ P+G+L ++LR P
Sbjct: 88 IINLL----GACEHRGYL-YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142
Query: 258 --LDIAIDVACALRYL---HCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAID 312
L A DVA + YL H +L N+L+ + + + DFG++R
Sbjct: 143 QLLHFAADVARGMDYLSQKQF------IHRDLAARNILVGENYVAKIADFGLSRGQEVY- 195
Query: 313 KQNRFICIKGSTGYIP-----PE------YDLGCEASTYGDVYSFGILLLEMFT-GIRPS 360
+K + G +P E Y +T DV+S+G+LL E+ + G P
Sbjct: 196 -------VKKTMGRLPVRWMAIESLNYSVY------TTNSDVWSYGVLLWEIVSLGGTPY 242
Query: 361 DGI 363
G+
Sbjct: 243 CGM 245
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 43/230 (18%), Positives = 83/230 (36%), Gaps = 53/230 (23%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFN---LIRPGGSKSFKSECKAAINIKHRNIVRVF 207
+G G F + + A K+ L++P + E ++ H+++V
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 208 TAFSGVDYQGARFKAVVYKFM---PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLD----- 259
F V+ + SL E + + K L
Sbjct: 108 GFFE--------DNDFVFVVLELCRRRSLLELHKRR---------------KALTEPEAR 144
Query: 260 -IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFI 318
+ +YLH + + H +LK N+ L++++ +GDFG+A + ++ + +
Sbjct: 145 YYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL 201
Query: 319 CIKGSTGYIPPE------YDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
C G+ YI PE + E DV+S G ++ + G P +
Sbjct: 202 C--GTPNYIAPEVLSKKGHS--FEV----DVWSIGCIMYTLLVGKPPFET 243
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 6e-18
Identities = 53/217 (24%), Positives = 87/217 (40%), Gaps = 32/217 (14%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFT 208
IG G+FG DG +K N+ R + + E N+KH NIV+
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 209 AFSGVDYQGARFKAVVYKFM---PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVA 265
+F + +Y M G L + + + F + LD + +
Sbjct: 91 SF--EE------NGSLYIVMDYCEGGDLFKRINAQK-------GVLFQEDQILDWFVQIC 135
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTG 325
AL+++H I H ++K N+ L + +GDFG+AR L + + R G+
Sbjct: 136 LALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI--GTPY 190
Query: 326 YIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
Y+ PE CE Y D+++ G +L E+ T
Sbjct: 191 YLSPEI---CENKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 7e-18
Identities = 43/229 (18%), Positives = 83/229 (36%), Gaps = 53/229 (23%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFN---LIRPGGSKSFKSECKAAINIKHRNIVRVF 207
+G G F + + A K+ L++P + E ++ H+++V
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 208 TAFSGVDYQGARFKAVVYKFM---PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLD----- 259
F V+ + SL E + + K L
Sbjct: 82 GFFE--------DNDFVFVVLELCRRRSLLELHKRR---------------KALTEPEAR 118
Query: 260 -IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFI 318
+ +YLH + + H +LK N+ L++++ +GDFG+A + ++ + +
Sbjct: 119 YYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL 175
Query: 319 CIKGSTGYIPPE------YDLGCEASTYGDVYSFGILLLEMFTGIRPSD 361
C G+ YI PE + E DV+S G ++ + G P +
Sbjct: 176 C--GTPNYIAPEVLSKKGHS--FEV----DVWSIGCIMYTLLVGKPPFE 216
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 8e-18
Identities = 49/295 (16%), Positives = 97/295 (32%), Gaps = 59/295 (20%)
Query: 130 QTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFK 189
+ N P+F+ + N S ++G G+ G+V F G +AVK F
Sbjct: 2 RIANIPNFEQ--SLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML-------IDFC 52
Query: 190 SECKAAINI-----KHRNIVRVFTAFSGVDYQGARFKAVVYKFMP--NGSLEEWLRGKDD 242
I + H N++R + + + + +Y + N +L++ + K+
Sbjct: 53 DIALMEIKLLTESDDHPNVIRYYCSETTDRF--------LYIALELCNLNLQDLVESKNV 104
Query: 243 TNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG-- 300
++ + + +A + +LH I H +LKP N+L+
Sbjct: 105 SDENLKLQK--EYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQ 159
Query: 301 -----------DFGMARFLPAID--KQNRFICIKGSTGYIPPEYDLGCEAST----YG-- 341
DFG+ + L + + G++G+ PE
Sbjct: 160 TGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRS 219
Query: 342 -DVYSFGILLLEMFTGIRP--------SDGIFTGKMNLRNFVKMALPQRAEEVVD 387
D++S G + + + + I G +L + E D
Sbjct: 220 IDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATD 274
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 84.7 bits (209), Expect = 1e-17
Identities = 51/232 (21%), Positives = 80/232 (34%), Gaps = 50/232 (21%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAF 210
+G G FG V G +A+K P + + E + + H N+V
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 211 -SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK----------LD 259
+ ++ G L +L + +
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDL----------------RKYLNQFENCCGLKEGPIRT 125
Query: 260 IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD---DEMIGHVGDFGMARFLPAIDKQNR 316
+ D++ ALRYLH + I H +LKP N++L +I + D G A+ L +
Sbjct: 126 LLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE 182
Query: 317 FICIKGSTGYIPPE------YDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
F G+ Y+ PE Y + D +SFG L E TG RP
Sbjct: 183 F-V--GTLQYLAPELLEQKKYTVTV------DYWSFGTLAFECITGFRPFLP 225
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 44/228 (19%), Positives = 77/228 (33%), Gaps = 24/228 (10%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK-HRNIVRVFTA 209
++ G F VY + G A+K +++ E + H NIV+ +A
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 210 FSGVDYQGARFKAVVYKFM--PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACA 267
S + +A G L + L I A
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQL------VEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 268 LRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL---PAIDKQNRFICIK--- 321
++++H +PPI H +LK N+LL ++ + DFG A + P + +
Sbjct: 149 VQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 322 ----GSTGYIPPE-YDL--GCEASTYGDVYSFGILLLEMFTGIRPSDG 362
+ Y PE DL D+++ G +L + P +
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 2e-17
Identities = 52/276 (18%), Positives = 90/276 (32%), Gaps = 79/276 (28%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGS-KSFKSECKAAINIKHRNIVRVFTA 209
+G G FG V+ D A+K L + + E KA ++H IVR F A
Sbjct: 13 CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 72
Query: 210 FSGVDYQGAR-------------------------------------------------F 220
+ + +
Sbjct: 73 WLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSP 132
Query: 221 KAVVYKFM---PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQP 277
K +Y M +L++W+ + R L I I +A A+ +LH
Sbjct: 133 KVYLYIQMQLCRKENLKDWMNRRCSLEDRE------HGVCLHIFIQIAEAVEFLH---SK 183
Query: 278 PIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIK----------GSTGYI 327
+ H +LKPSN+ + + VGDFG+ + +++ + G+ Y+
Sbjct: 184 GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243
Query: 328 PPEYDLGCEASTYG---DVYSFGILLLEMFTGIRPS 360
PE + Y D++S G++L E+
Sbjct: 244 SPEQ---IHGNNYSHKVDIFSLGLILFELLYSFSTQ 276
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 3e-17
Identities = 52/221 (23%), Positives = 90/221 (40%), Gaps = 46/221 (20%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFN---LIRPGGSKSFKSECKAAINIKHRNIVRVF 207
L+G G+F VY + G +A+K+ + + + G + ++E K +KH +I+ ++
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 208 TAFSGVDYQGARFKAVVYKFM---PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLD----- 259
F +Y VY + NG + +L+ + K
Sbjct: 78 NYFEDSNY--------VYLVLEMCHNGEMNRYLKNR--------------VKPFSENEAR 115
Query: 260 -IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFI 318
+ + YLH I H +L SN+LL M + DFG+A L +++ +
Sbjct: 116 HFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL 172
Query: 319 CIKGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTG 356
C G+ YI PE S +G DV+S G + + G
Sbjct: 173 C--GTPNYISPEI---ATRSAHGLESDVWSLGCMFYTLLIG 208
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 9e-17
Identities = 46/278 (16%), Positives = 92/278 (33%), Gaps = 72/278 (25%)
Query: 147 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-----KH 200
F IG+G FGSV+ DG A+K P + + +H
Sbjct: 13 FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKK--PLAGSVDEQNALREVYAHAVLGQH 70
Query: 201 RNIVRVFTAFSGVDYQGARFKAVVYKFM---PNGSLEEWLRGKDDTNWRPLNFNFLIKKK 257
++VR F+A++ D+ + GSL + + ++ L
Sbjct: 71 SHVVRYFSAWAEDDH--------MLIQNEYCNGGSLADAIS-ENYRIMSYFKEAEL---- 117
Query: 258 LDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV------------------ 299
D+ + V LRY+H + H ++KPSN+ + I +
Sbjct: 118 KDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 174
Query: 300 -GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFT 355
GD G + + + +G + ++ E + E T+ D+++ + ++
Sbjct: 175 IGDLGHVTRISSPQVE------EGDSRFLANE--VLQENYTHLPKADIFALALTVVCAAG 226
Query: 356 GIRPSDG------IFTGKM---------NLRNFVKMAL 378
I G++ +K+ +
Sbjct: 227 AEPLPRNGDQWHEIRQGRLPRIPQVLSQEFTELLKVMI 264
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 2e-16
Identities = 54/226 (23%), Positives = 88/226 (38%), Gaps = 51/226 (22%)
Query: 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFN---LIRPGGSKSFKSECKAAINIKHRNIVRV 206
+G G FG+VY +A+KV L + G + E + +++H NI+R+
Sbjct: 15 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 207 FTAFSGVDYQGARFKAVVY---KFMPNGSLEEWLRGKDDTNWRPLNFNFLIK-KKLD--- 259
+ F VY ++ P G++ + L K K D
Sbjct: 75 YGYFHDATR--------VYLILEYAPLGTV----------------YRELQKLSKFDEQR 110
Query: 260 ---IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNR 316
++A AL Y H + H ++KP N+LL + DFG + P +
Sbjct: 111 TATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--SSRRT 165
Query: 317 FICIKGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
+C G+ Y+PPE E + D++S G+L E G P
Sbjct: 166 DLC--GTLDYLPPEM---IEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 6e-16
Identities = 32/222 (14%), Positives = 52/222 (23%), Gaps = 66/222 (29%)
Query: 152 LIGAGNFGSVYNGTLFD---GTTIAVKVFNLIRPGGSKS------FKSECKAAINIKHRN 202
G + D +A+ + P G S I
Sbjct: 38 FHGGVPPLQFWQAL--DTALDRQVALTF---VDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAI 262
+ RV V + VV +++ GSL+E P +
Sbjct: 93 VARVLDV---VHTRAGGL--VVAEWIRGGSLQEVADT------SPS-----PVGAIRAMQ 136
Query: 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICI 320
+A A H + +A PS V + + G V
Sbjct: 137 SLAAAADAAH---RAGVALSIDHPSRVRVSID--GDVVLAYPA----------------- 174
Query: 321 KGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
+P A+ D+ G L + P
Sbjct: 175 -----TMPD-------ANPQDDIRGIGASLYALLVNRWPLPE 204
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 7e-16
Identities = 51/242 (21%), Positives = 96/242 (39%), Gaps = 42/242 (17%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFN---LIRPGGSKSFKSECKAAIN------------ 197
+ G F + D A+K + L + ++ + +
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 198 --IKHRNIVRVFTAFSGVD--YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFL 253
IK+ + + D Y ++Y++M N S+ ++ + F
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVY-------IIYEYMENDSILKFDEYFFVLDKNYTCF-IP 149
Query: 254 IKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDK 313
I+ I V + Y+H + I H ++KPSN+L+D + DFG + ++ DK
Sbjct: 150 IQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV--DK 205
Query: 314 QNRFICIKGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDGIFTGKMNL 370
+ + G+ ++PPE+ E+S G D++S GI L MF + P F+ K++L
Sbjct: 206 KIKGSR--GTYEFMPPEFFSN-ESSYNGAKVDIWSLGICLYVMFYNVVP----FSLKISL 258
Query: 371 RN 372
Sbjct: 259 VE 260
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 4e-15
Identities = 54/216 (25%), Positives = 89/216 (41%), Gaps = 32/216 (14%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHR-----NIVRV 206
IG G +GSV G +AVK IR + + + +++ R IV+
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKR---IRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQF 86
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVAC 266
+ A ++ + + M + S +++ + + L K I +
Sbjct: 87 YGAL----FREGDCW-ICMELM-STSFDKFYKYVYSVLDDVIPEEILGK----ITLATVK 136
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIKGST 324
AL +L + + I H ++KPSN+LLD G++ DFG++ L + R G
Sbjct: 137 ALNHLKENLK--IIHRDIKPSNILLDRS--GNIKLCDFGISGQLVDSIAKTRDA---GCR 189
Query: 325 GYIPPE-YDLGCEASTYG---DVYSFGILLLEMFTG 356
Y+ PE D Y DV+S GI L E+ TG
Sbjct: 190 PYMAPERIDPSASRQGYDVRSDVWSLGITLYELATG 225
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 8e-15
Identities = 49/216 (22%), Positives = 90/216 (41%), Gaps = 33/216 (15%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHR-----NIVRV 206
+G G +G V + G +AVK IR + + ++I R V
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKR---IRATVNSQEQKRLLMDLDISMRTVDCPFTVTF 71
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVAC 266
+ A ++ + + M + SL+++ + D + + + L K IA+ +
Sbjct: 72 YGAL----FREGDVW-ICMELM-DTSLDKFYKQVIDKG-QTIPEDILGK----IAVSIVK 120
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIKGST 324
AL +LH + H ++KPSNVL++ G V DFG++ +L ++ G
Sbjct: 121 ALEHLHSKLS--VIHRDVKPSNVLINAL--GQVKMCDFGISGYLVDDVAKDIDA---GCK 173
Query: 325 GYIPPE-YDLGCEASTYG---DVYSFGILLLEMFTG 356
Y+ PE + Y D++S GI ++E+
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAIL 209
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 72.6 bits (179), Expect = 2e-14
Identities = 53/222 (23%), Positives = 93/222 (41%), Gaps = 45/222 (20%)
Query: 152 LIGAGNFGSVYNG-TLFDGTTIAVKVFN---LIRPGGSKSFKSECKAAINIKHRNIVRVF 207
+G G FG+VY + +A+KV L + G + E + +++H NI+R++
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 208 TAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIK-KKLD------I 260
F + ++ +F P G L + L K + D
Sbjct: 81 NYF-----HDRKRIYLMLEFAPRGEL----------------YKELQKHGRFDEQRSATF 119
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICI 320
++A AL Y H + + H ++KP N+L+ + + DFG + P + R +C
Sbjct: 120 MEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP--SLRRRTMC- 173
Query: 321 KGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
G+ Y+PPE E T+ D++ G+L E G+ P
Sbjct: 174 -GTLDYLPPEM---IEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 32/101 (31%), Positives = 46/101 (45%), Gaps = 13/101 (12%)
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG--DFGMARFLPAIDKQNRFICIK 321
+ AL YL I H ++KP N+LLD+ GHV DF +A LP +
Sbjct: 124 LVMALDYLQ---NQRIIHRDMKPDNILLDEH--GHVHITDFNIAAMLPRETQITTM-A-- 175
Query: 322 GSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
G+ Y+ PE + + Y D +S G+ E+ G RP
Sbjct: 176 GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 3e-14
Identities = 54/218 (24%), Positives = 91/218 (41%), Gaps = 40/218 (18%)
Query: 153 IGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINI----KHRNIVRVF 207
+GAGN G V+ + G +A K+ I + +++ + + IV
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKL---IHLEIKPAIRNQIIRELQVLHECNSPYIVG-- 95
Query: 208 TAFSGVDYQGARFKA----VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAID 263
+ GA + + + M GSL++ L+ + L K ++I
Sbjct: 96 -------FYGAFYSDGEISICMEHMDGGSLDQVLKKA-----GRIPEQILGK----VSIA 139
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIK 321
V L YL + I H ++KPSN+L++ G + DFG++ L N F+
Sbjct: 140 VIKGLTYLREKHK--IMHRDVKPSNILVNSR--GEIKLCDFGVSGQLID-SMANSFV--- 191
Query: 322 GSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
G+ Y+ PE G S D++S G+ L+EM G P
Sbjct: 192 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 229
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 9e-14
Identities = 49/231 (21%), Positives = 84/231 (36%), Gaps = 49/231 (21%)
Query: 147 FSSANLIGAGNFGSVY------NGTLFDGTTIAVKVFN---LIRPGGSKSFKSECKAAIN 197
F ++G G+F +V + A+K+ +I+ E
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREY-----AIKILEKRHIIKENKVPYVTRERDVMSR 86
Query: 198 IKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIK-K 256
+ H V+++ F Q + NG L ++ K
Sbjct: 87 LDHPFFVKLYFTF-----QDDEKLYFGLSYAKNGEL----------------LKYIRKIG 125
Query: 257 KLDI------AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFL 308
D ++ AL YLH I H +LKP N+LL+++ H+ DFG A+ L
Sbjct: 126 SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNED--MHIQITDFGTAKVL 180
Query: 309 PAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
KQ R G+ Y+ PE A D+++ G ++ ++ G+ P
Sbjct: 181 SPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-13
Identities = 56/252 (22%), Positives = 90/252 (35%), Gaps = 62/252 (24%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFN--LIRPGGSKSFKSECKAAINI--------KH 200
L+G G FG+V+ G L D +A+KV + S C + + H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 201 RNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKK-KLD 259
++R+ F + + E L +D L F+++ +K L
Sbjct: 98 PGVIRLLDWFE--------TQEGFMLVL-----ERPLPAQD------L-FDYITEKGPLG 137
Query: 260 ------IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAI 311
V A+++ H + H ++K N+L+D G DFG L
Sbjct: 138 EGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRR-GCAKLIDFGSGALLH-- 191
Query: 312 DKQNRFICIKGSTGYIPPE------YDLGCEASTYGDVYSFGILLLEMFTGIRPSDG--- 362
D+ G+ Y PPE Y A V+S GILL +M G P +
Sbjct: 192 DEPYTDFD--GTRVYSPPEWISRHQYH-ALPA----TVWSLGILLYDMVCGDIPFERDQE 244
Query: 363 IFTGKMNLRNFV 374
I +++ V
Sbjct: 245 ILEAELHFPAHV 256
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 66/334 (19%), Positives = 111/334 (33%), Gaps = 48/334 (14%)
Query: 47 ERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI--ILECLISICRTGVACSAELPNERM 104
R LD V E+ ++ + + + + R V + +
Sbjct: 78 SRCVAFLDGVAEYEVTPDDKRKACGRNLTQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGP 137
Query: 105 KINDVESRLRLIKKKLLKTPVYEGKQTINNPSFKDLYNATNG------FSSANLIGAGNF 158
+ + RL + L P + +I F F ++G G F
Sbjct: 138 CKDLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGF 197
Query: 159 GSVY------NGTLFDGTTIAVKVFN---LIRPGGSKSFKSECKAAINIKHRNIVRVFTA 209
G V G ++ A K + + G +E + + R +V + A
Sbjct: 198 GEVCACQVRATGKMY-----ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYA 252
Query: 210 FSGVD--YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACA 267
+ D +V M G L+ + F + + A ++ C
Sbjct: 253 YETKDALC-------LVLTLMNGGDLKFHIY-------HMGQAGFPEARAVFYAAEICCG 298
Query: 268 LRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIKGSTG 325
L LH + I + +LKP N+LLDD GH+ D G+A +P G+ G
Sbjct: 299 LEDLH---RERIVYRDLKPENILLDDH--GHIRISDLGLAVHVPEGQTIKGR-V--GTVG 350
Query: 326 YIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
Y+ PE + D ++ G LL EM G P
Sbjct: 351 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 53/238 (22%), Positives = 86/238 (36%), Gaps = 58/238 (24%)
Query: 147 FSSANLIGAGNFGSVY------NGTLFDGTTIAVKVFN---LIRPGGSKSFKSECKAAIN 197
F +IG G FG V +F A+K+ N +++ + F+ E +N
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVF-----AMKILNKWEMLKRAETACFREERDVLVN 130
Query: 198 IKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK 257
+ I + AF Q +V + G L L K +
Sbjct: 131 GDSKWITTLHYAF-----QDDNNLYLVMDYYVGGDL----------------LTLLSKFE 169
Query: 258 LDIAIDVA--------CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMA-R 306
+ ++A A+ +H Q H ++KP N+L+D GH+ DFG +
Sbjct: 170 DRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMN--GHIRLADFGSCLK 224
Query: 307 FLPAIDKQNRFICIKGSTGYIPPE--YDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
+ Q+ G+ YI PE + YG D +S G+ + EM G P
Sbjct: 225 LMEDGTVQSSVAV--GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 4e-13
Identities = 62/248 (25%), Positives = 105/248 (42%), Gaps = 41/248 (16%)
Query: 127 EGKQTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGS 185
++++ L + F L+G G +G VY G + G A+KV ++ +
Sbjct: 6 SPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-----T 60
Query: 186 KSFKSECKAAINI-----KHRNIVRVFTAFSGVDYQGARFKA-VVYKFMPNGSLEEWLRG 239
+ E K IN+ HRNI + AF + G + +V +F GS+ + ++
Sbjct: 61 GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN 120
Query: 240 KDDTNWRPLNFNFLIKKKLDIAI---DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI 296
T L K+ IA ++ L +LH + H ++K NVLL +
Sbjct: 121 ---TKGNTL-------KEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTEN-- 165
Query: 297 GHV--GDFGMARFL-PAIDKQNRFICIKGSTGYIPPE--YDLGCEASTYG---DVYSFGI 348
V DFG++ L + ++N FI G+ ++ PE +TY D++S GI
Sbjct: 166 AEVKLVDFGVSAQLDRTVGRRNTFI---GTPYWMAPEVIACDENPDATYDFKSDLWSLGI 222
Query: 349 LLLEMFTG 356
+EM G
Sbjct: 223 TAIEMAEG 230
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 6e-13
Identities = 55/235 (23%), Positives = 84/235 (35%), Gaps = 55/235 (23%)
Query: 147 FSSANLIGAGNFGSVY------NGTLFDGTTIAVKVFN---LIRPGGSKSFKSECKAAIN 197
+ +IG G FG V ++ A+K+ + +I+ S F E
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVY-----AMKLLSKFEMIKRSDSAFFWEERDIMAF 125
Query: 198 IKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK 257
+V++F AF Q R+ +V ++MP G L N +
Sbjct: 126 ANSPWVVQLFYAF-----QDDRYLYMVMEYMPGGDL----------------VNLMSNYD 164
Query: 258 LDI------AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMA-RFL 308
+ +V AL +H H ++KP N+LLD GH+ DFG +
Sbjct: 165 VPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMN 219
Query: 309 PAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYG---DVYSFGILLLEMFTGIRP 359
+ G+ YI PE YG D +S G+ L EM G P
Sbjct: 220 KEGMVRCDTAV--GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 6e-13
Identities = 49/235 (20%), Positives = 87/235 (37%), Gaps = 55/235 (23%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFN----LIRPGGSKSFKSECKAAINIKHRNIVRV 206
L+G G++G V AVK+ P G + K E + ++H+N++++
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 207 FTAFSGVDYQGARFKA-VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVA 265
V Y + K +V ++ G E + + + +K+ + A
Sbjct: 72 VD----VLYNEEKQKMYMVMEYCVCGMQE-------------M-LDSVPEKRFPV--CQA 111
Query: 266 C--------ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRF 317
L YLH I H ++KP N+LL + G+A +
Sbjct: 112 HGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAE-ALHPFAADDT 167
Query: 318 I---CIKGSTGYIPPE-------YDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
GS + PPE + G + D++S G+ L + TG+ P +G
Sbjct: 168 CRTSQ--GSPAFQPPEIANGLDTFS-GFKV----DIWSAGVTLYNITTGLYPFEG 215
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 7e-13
Identities = 49/233 (21%), Positives = 80/233 (34%), Gaps = 53/233 (22%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFN--------LIRPGGSKSFKSECKAAINIKHRNI 203
+G+G FG V+ + VK I E ++H NI
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 204 VRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKK-KLD--- 259
++V F + M E+ G D L F F+ + +LD
Sbjct: 92 IKVLDIFENQGF--------FQLVM-----EKHGSGLD------L-FAFIDRHPRLDEPL 131
Query: 260 ---IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNR 316
I + A+ YL I H ++K N+++ ++ + DFG A +L
Sbjct: 132 ASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT 188
Query: 317 FICIKGSTGYIPPE------YDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363
F C G+ Y PE Y G E +++S G+ L + P +
Sbjct: 189 F-C--GTIEYCAPEVLMGNPYR-GPEL----EMWSLGVTLYTLVFEENPFCEL 233
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 9e-13
Identities = 49/271 (18%), Positives = 96/271 (35%), Gaps = 49/271 (18%)
Query: 100 PNERMKINDVESRLRLIKKKLLKTPVYEGKQTINNPSFKDLYNATNGFSSANLIGAGNFG 159
+ KIND + I KK + PV + S D Y+ +G+G FG
Sbjct: 17 KYDGPKINDYDKFYEDIWKKYVPQPV-----EVKQGSVYDYYDI------LEELGSGAFG 65
Query: 160 SVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218
V+ G K N P + K+E + H ++ + A ++
Sbjct: 66 VVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA-----FEDK 120
Query: 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK-----LDIAI---DVACALRY 270
++ +F+ G L F+ + + ++ L++
Sbjct: 121 YEMVLILEFLSGGEL----------------FDRIAAEDYKMSEAEVINYMRQACEGLKH 164
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIKGSTGYIP 328
+H + I H ++KP N++ + + V DFG+A ++ + +
Sbjct: 165 MH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATK---LNPDEIVKVTTATAEFAA 218
Query: 329 PEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
PE Y D+++ G+L + +G+ P
Sbjct: 219 PEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 47/231 (20%), Positives = 74/231 (32%), Gaps = 55/231 (23%)
Query: 154 GAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI----KHRNIVRVFT 208
G + +V G + V+ NL S + + +++ H NIV
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEA--CSNEMVTFLQGELHVSKLFNHPNIVPYRA 93
Query: 209 AFSGVDYQGARFKA----VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLD---IA 261
F VV FM GS ++ + ++ IA
Sbjct: 94 TF---------IADNELWVVTSFMAYGSAKDLIC-------------THFMDGMNELAIA 131
Query: 262 I---DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFG-MARFLPAIDKQN 315
V AL Y+H + H ++K S++L+ + G V + +Q
Sbjct: 132 YILQGVLKALDYIHHMGY--V-HRSVKASHILISVD--GKVYLSGLRSNLSMISHGQRQR 186
Query: 316 -RFICIKGSTGYIP---PEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
K S +P PE L Y D+YS GI E+ G P
Sbjct: 187 VVHDFPKYSVKVLPWLSPEV-LQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 46/253 (18%), Positives = 97/253 (38%), Gaps = 56/253 (22%)
Query: 129 KQTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKS 187
Q++ + +D Y + +G+G G V +A+++ + + +
Sbjct: 125 DQSVYPKALRDEYIMSK------TLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSA 178
Query: 188 FKSECKAAI--------NIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRG 239
+++ + + H I+++ F DY +V + M G L
Sbjct: 179 READPALNVETEIEILKKLNHPCIIKIKNFFDAEDYY------IVLELMEGGEL------ 226
Query: 240 KDDTNWRPLNFNFLIKKKL-------DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL- 291
F+ ++ K + A++YLH + I H +LKP NVLL
Sbjct: 227 ----------FDKVVGNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLS 273
Query: 292 --DDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYG---DVYSF 346
+++ + + DFG ++ + + + + G+ Y+ PE + + Y D +S
Sbjct: 274 SQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSL 330
Query: 347 GILLLEMFTGIRP 359
G++L +G P
Sbjct: 331 GVILFICLSGYPP 343
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 1e-12
Identities = 51/240 (21%), Positives = 83/240 (34%), Gaps = 60/240 (25%)
Query: 147 FSSANLIGAGNFGSVY------NGTLFDGTTIAVKVFN---LIRPGGSKSFKSECKAAIN 197
F +IG G F V G ++ A+K+ N +++ G F+ E +N
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVY-----AMKIMNKWDMLKRGEVSCFREERDVLVN 117
Query: 198 IKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK 257
R I ++ AF Q + +V ++ G L L K
Sbjct: 118 GDRRWITQLHFAF-----QDENYLYLVMEYYVGGDL----------------LTLLSKFG 156
Query: 258 LDIAIDVA--------CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMA-R 306
I ++A A+ +H + H ++KP N+LLD GH+ DFG +
Sbjct: 157 ERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRC--GHIRLADFGSCLK 211
Query: 307 FLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVY-------SFGILLLEMFTGIRP 359
++ G+ Y+ PE Y + G+ EMF G P
Sbjct: 212 LRADGTVRSLVAV--GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 52/246 (21%), Positives = 84/246 (34%), Gaps = 43/246 (17%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFN-----LIRPGGSKSFKSECKAAINIKHRNIVRV 206
IG G++G V A+K+ N I P + K+E + + H NI R+
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 207 FTAFSGVDY--------------------------QGARFKAVVYKFMPNGSLEEWLRGK 240
+ + Y + A EE + G
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 241 DDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV- 299
L+F K +I + AL YLH I H ++KP N L +
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIK 210
Query: 300 -GDFGMARFLPAIDKQNRFICIK--GSTGYIPPEYDLGCEASTYG---DVYSFGILLLEM 353
DFG+++ ++ + G+ ++ PE L +YG D +S G+LL +
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEV-LNTTNESYGPKCDAWSAGVLLHLL 269
Query: 354 FTGIRP 359
G P
Sbjct: 270 LMGAVP 275
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 59/230 (25%), Positives = 90/230 (39%), Gaps = 49/230 (21%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKS-FKSECKAAINIKHRNIVRVFTAF 210
IG+G V +A+K NL + S E +A H NIV +T+F
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLD---IAI---DV 264
+V K + GS+ + ++ LD IA +V
Sbjct: 83 ----VVKDEL-WLVMKLLSGGSVLDIIKHIVAKGEHK-------SGVLDESTIATILREV 130
Query: 265 ACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFL------PAIDKQNR 316
L YLH + Q I H ++K N+LL ++ G V DFG++ FL +
Sbjct: 131 LEGLEYLHKNGQ--I-HRDVKAGNILLGED--GSVQIADFGVSAFLATGGDITRNKVRKT 185
Query: 317 FICIKGSTGYIPPE-------YDLGCEASTYGDVYSFGILLLEMFTGIRP 359
F+ G+ ++ PE YD D++SFGI +E+ TG P
Sbjct: 186 FV---GTPCWMAPEVMEQVRGYDFKA------DIWSFGITAIELATGAAP 226
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-12
Identities = 54/220 (24%), Positives = 86/220 (39%), Gaps = 37/220 (16%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-----KHRNIVRV 206
+G+G G V+ G IAVK +R G+K +++ IV+
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQ---MRRSGNKEENKRILMDLDVVLKSHDCPYIVQC 89
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVAC 266
F F + + M + + R + P+ L K + + +
Sbjct: 90 FGTF----ITNTDVF-IAMELMGTCAEKLKKRMQ-----GPIPERILGK----MTVAIVK 135
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIKGST 324
AL YL + H ++KPSN+LLD+ G + DFG++ L ++R G
Sbjct: 136 ALYYLKEKHG--VIHRDVKPSNILLDER--GQIKLCDFGISGRLVDDKAKDRSA---GCA 188
Query: 325 GYIPPE--YDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
Y+ PE Y DV+S GI L+E+ TG P
Sbjct: 189 AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 54/247 (21%), Positives = 94/247 (38%), Gaps = 48/247 (19%)
Query: 133 NNPSFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFN---LIRPGGSKSF 188
+ F D Y ++G G+FG V G AVKV + + + +S
Sbjct: 20 STAIFSDRYKG------QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESL 73
Query: 189 KSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPL 248
E + + H NI++++ ++ + +V + G L + + +
Sbjct: 74 LREVQLLKQLDHPNIMKLYEF-----FEDKGYFYLVGEVYTGGELFDEIISRK------- 121
Query: 249 NFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH---VGDFGMA 305
F I V + Y+H + I H +LKP N+LL+ + + DFG++
Sbjct: 122 --RFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS 176
Query: 306 RFLPAIDKQNRFICIKGSTGYIPPE-----YDLGCEASTYGDVYSFGILLLEMFTGIRPS 360
+ + G+ YI PE YD C DV+S G++L + +G P
Sbjct: 177 TH---FEASKKMKDKIGTAYYIAPEVLHGTYDEKC------DVWSTGVILYILLSGCPP- 226
Query: 361 DGIFTGK 367
F G
Sbjct: 227 ---FNGA 230
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 3e-12
Identities = 55/229 (24%), Positives = 91/229 (39%), Gaps = 54/229 (23%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFN--LIRPGGSKSFKSECKAAINIKHRNIVRVFTA 209
IG GNF V + G +A+K+ + + P + E + + H NIV++
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL--- 79
Query: 210 FSGVDYQGARFKAVVYKFM---PNGSLEEWLRGKDDTNWRPLNFNFLIKK-KLD------ 259
++ + +Y M G + F++L+ ++
Sbjct: 80 -----FEVIETEKTLYLIMEYASGGEV----------------FDYLVAHGRMKEKEARS 118
Query: 260 IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFIC 319
+ A++Y H I H +LK N+LLD +M + DFG + K + F C
Sbjct: 119 KFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF-C 174
Query: 320 IKGSTGYIPPE------YDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
G+ Y PE YD G E DV+S G++L + +G P DG
Sbjct: 175 --GAPPYAAPELFQGKKYD-GPEV----DVWSLGVILYTLVSGSLPFDG 216
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 51/246 (20%), Positives = 87/246 (35%), Gaps = 47/246 (19%)
Query: 133 NNPSFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSK--SFK 189
++Y +G+G +G V A+K+ S
Sbjct: 31 KKGHLSEMY------QRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLL 84
Query: 190 SECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLN 249
E + H NI++++ ++ R +V + G L + + +
Sbjct: 85 EEVAVLKLLDHPNIMKLYDF-----FEDKRNYYLVMECYKGGELFDEIIHRM-------- 131
Query: 250 FNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH---VGDFGMAR 306
F I V + YLH + I H +LKP N+LL+ + + DFG++
Sbjct: 132 -KFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187
Query: 307 FLPAIDKQNRFICIKGSTGYIPPE-----YDLGCEASTYGDVYSFGILLLEMFTGIRPSD 361
+ Q + G+ YI PE YD C DV+S G++L + G P
Sbjct: 188 V---FENQKKMKERLGTAYYIAPEVLRKKYDEKC------DVWSIGVILFILLAGYPP-- 236
Query: 362 GIFTGK 367
F G+
Sbjct: 237 --FGGQ 240
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 4e-12
Identities = 57/254 (22%), Positives = 86/254 (33%), Gaps = 68/254 (26%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFN------LIRPGGSKSFKSECKAAINIKHR--N 202
L+G+G FGSVY+G + D +A+K E +
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFM----PNGSLEEWLRGKDDTNWRPLNFNFLIKK-K 257
++R+ F D + P L F+F+ ++
Sbjct: 110 VIRLLDWFERPDS--------FVLILERPEPVQDL----------------FDFITERGA 145
Query: 258 LD------IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLP 309
L V A+R+ H + H ++K N+L+D G + DFG L
Sbjct: 146 LQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNR-GELKLIDFGSGALLK 201
Query: 310 AIDKQNRFICIKGSTGYIPPE------YDLGCEASTYGDVYSFGILLLEMFTGIRPSDG- 362
D G+ Y PPE Y G A V+S GILL +M G P +
Sbjct: 202 --DTVYTDFD--GTRVYSPPEWIRYHRYH-GRSA----AVWSLGILLYDMVCGDIPFEHD 252
Query: 363 --IFTGKMNLRNFV 374
I G++ R V
Sbjct: 253 EEIIRGQVFFRQRV 266
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 6e-12
Identities = 48/231 (20%), Positives = 83/231 (35%), Gaps = 51/231 (22%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFN-----LIRPGGSKSFKSECKAAINI-----KHR 201
+G G V AVK+ + + + ++I H
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 202 NIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKL--- 258
NI+++ Y+ F +V+ M G L F++L +K
Sbjct: 85 NIIQLKDT-----YETNTFFFLVFDLMKKGEL----------------FDYLTEKVTLSE 123
Query: 259 ----DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQ 314
I + + LH I H +LKP N+LLDD+M + DFG + +D
Sbjct: 124 KETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ---LDPG 177
Query: 315 NRFICIKGSTGYIPPE---YDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
+ + G+ Y+ PE + YG D++S G+++ + G P
Sbjct: 178 EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 51/245 (20%), Positives = 90/245 (36%), Gaps = 61/245 (24%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAA---INI--------- 198
+G G+F +V+ + + T +A+K+ + K +AA I +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIV--------RGDKVYTEAAEDEIKLLQRVNDADN 77
Query: 199 ------KHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNG-SLEEWLRGKDDTNWRPLNFN 251
+I+++ F +++G VV F G +L ++ R +
Sbjct: 78 TKEDSMGANHILKLLDHF---NHKGPNGVHVVMVFEVLGENLLALIK---KYEHRGIPLI 131
Query: 252 FLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH------VGDFGMA 305
+K+ I+ + L Y+H C I H ++KP NVL++ + D G A
Sbjct: 132 -YVKQ---ISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185
Query: 306 RFLPAI---DKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
+ Q R Y PE LG D++S L+ E+ TG D
Sbjct: 186 CWYDEHYTNSIQTRE--------YRSPEVLLGAPWGCGADIWSTACLIFELITG----DF 233
Query: 363 IFTGK 367
+F
Sbjct: 234 LFEPD 238
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 1e-11
Identities = 56/236 (23%), Positives = 86/236 (36%), Gaps = 65/236 (27%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFN---LIRPGGSKSFKSECKAAINIKHRNIVRVF 207
+G G FG V G G +AVK+ N + K E + +H +I+++
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL- 76
Query: 208 TAFSGVDYQGARFKAVVYKFM---PNGSLEEWLRGKDDTNWRPLNFNFLIKK-KLDIAID 263
YQ + M G L F+++ K +++
Sbjct: 77 -------YQVISTPTDFFMVMEYVSGGEL----------------FDYICKHGRVEE--M 111
Query: 264 VAC--------ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQN 315
A A+ Y H + H +LKP NVLLD M + DFG++ +
Sbjct: 112 EARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLS----NMMSDG 164
Query: 316 RFI---CIKGSTGYIPPE------YDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
F+ C GS Y PE Y G E D++S G++L + G P D
Sbjct: 165 EFLRTSC--GSPNYAAPEVISGRLYA-GPEV----DIWSCGVILYALLCGTLPFDD 213
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 60/226 (26%), Positives = 89/226 (39%), Gaps = 37/226 (16%)
Query: 147 FSSANLIGAGNFGSVY------NGTLFDGTTIAVKVFN---LIRPGGSKSFKSECKAAIN 197
F ++G G FG V+ G L+ A K N L + G + E K
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLY-----ACKKLNKKRLKKRKGYQGAMVEKKILAK 241
Query: 198 IKHRNIVRVFTAFSGVD--YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIK 255
+ R IV + AF +V M G + + D+ N F
Sbjct: 242 VHSRFIVSLAYAFETKTDLC-------LVMTIMNGGDIRYHIYNVDEDNPG-----FQEP 289
Query: 256 KKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDK 313
+ + + L +LH Q I + +LKP NVLLDD+ G+V D G+A L A
Sbjct: 290 RAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDD--GNVRISDLGLAVELKAGQT 344
Query: 314 QNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
+ + G+ G++ PE LG E D ++ G+ L EM P
Sbjct: 345 KTKGYA--GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 51/231 (22%), Positives = 86/231 (37%), Gaps = 61/231 (26%)
Query: 147 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI----KHR 201
S IG G+ G V G +AVK+ +L + + + I +H
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDL----RKQQRRELLFNEVVIMRDYQHF 102
Query: 202 NIVRVFTAFSGVDYQGARFKA----VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK 257
N+V + V+ +F+ G+L + + LN +
Sbjct: 103 NVVE---------MYKSYLVGEELWVLMEFLQGGALTDIVSQV------RLN-------E 140
Query: 258 LDIAI---DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGM-ARFLPAI 311
IA V AL YLH + H ++K ++LL + G V DFG A+ +
Sbjct: 141 EQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLD--GRVKLSDFGFCAQISKDV 195
Query: 312 DKQNRFICIKGSTGYIPPE------YDLGCEASTYGDVYSFGILLLEMFTG 356
K+ + G+ ++ PE Y D++S GI+++EM G
Sbjct: 196 PKRKSLV---GTPYWMAPEVISRSLYATEV------DIWSLGIMVIEMVDG 237
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 50/224 (22%), Positives = 90/224 (40%), Gaps = 46/224 (20%)
Query: 147 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKS-FKSECKAAINIKHRNIV 204
F+ IG G+FG V+ G +A+K+ +L + E +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 205 RVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAI-- 262
+ + ++ + + ++ +++ GS + L PL+ + IA
Sbjct: 84 KYYGSY----LKDTKL-WIIMEYLGGGSALDLLEPG------PLD-------ETQIATIL 125
Query: 263 -DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFL-PAIDKQNRFI 318
++ L YLH + H ++K +NVLL + G V DFG+A L K+N F+
Sbjct: 126 REILKGLDYLHSE---KKIHRDIKAANVLLSEH--GEVKLADFGVAGQLTDTQIKRNTFV 180
Query: 319 CIKGSTGYIPPE------YDLGCEASTYGDVYSFGILLLEMFTG 356
G+ ++ PE YD D++S GI +E+ G
Sbjct: 181 ---GTPFWMAPEVIKQSAYDSKA------DIWSLGITAIELARG 215
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 67/351 (19%), Positives = 113/351 (32%), Gaps = 59/351 (16%)
Query: 40 FVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSIILECLISICRTGVA----- 94
F L E V F++EI++ E + + I ++
Sbjct: 68 FRDFCLKHLEEAKPLVEFYEEIKKYEKLETEEERLVCSREIFDTYIMKELLACSHPFSKS 127
Query: 95 ----CSAELPNERMKINDVESRLRLIKKKLLKTPVYEGKQTINNPSFKDLYNAT------ 144
L +++ + + + I + L + ++ F N
Sbjct: 128 AIEHVQGHLVKKQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLT 187
Query: 145 -NGFSSANLIGAGNFGSVY------NGTLFDGTTIAVKVFN---LIRPGGSKSFKSE--- 191
N FS +IG G FG VY G ++ A+K + + G +E
Sbjct: 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMY-----AMKCLDKKRIKMKQGETLALNERIM 242
Query: 192 CKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFN 251
IV + AF + + M G L L
Sbjct: 243 LSLVSTGDCPFIVCMSYAF-----HTPDKLSFILDLMNGGDLHYHLSQHG---------V 288
Query: 252 FLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLP 309
F A ++ L ++H + + +LKP+N+LLD+ GHV D G+A
Sbjct: 289 FSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEH--GHVRISDLGLACDFS 343
Query: 310 AIDKQNRFICIKGSTGYIPPEYDLGCEASTYG-DVYSFGILLLEMFTGIRP 359
K+ G+ GY+ PE A D +S G +L ++ G P
Sbjct: 344 --KKKPHASV--GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 63/282 (22%), Positives = 102/282 (36%), Gaps = 60/282 (21%)
Query: 96 SAELPNERMKINDVESRLRLIKKKLLKTPVYEGKQTINNPSFKDLYNATNGFSSANLIGA 155
SA L E K+ND + + P E F Y+ ++IG
Sbjct: 51 SANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDP------KDVIGR 104
Query: 156 GNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAA----INI-----KHRNIVR 205
G V G AVK+ + S E + A +I H +I+
Sbjct: 105 GVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKL------- 258
+ + Y+ + F +V+ M G L F++L +K
Sbjct: 165 LIDS-----YESSSFMFLVFDLMRKGEL----------------FDYLTEKVALSEKETR 203
Query: 259 DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFI 318
I + A+ +LH + I H +LKP N+LLDD M + DFG + ++ +
Sbjct: 204 SIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCH---LEPGEKLR 257
Query: 319 CIKGSTGYIPPE---YDLGCEASTYG---DVYSFG----ILL 350
+ G+ GY+ PE + YG D+++ G LL
Sbjct: 258 ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLL 299
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 2e-11
Identities = 53/253 (20%), Positives = 86/253 (33%), Gaps = 70/253 (27%)
Query: 132 INNPSFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKS 190
+ + F Y+ +G G+F AVK+ + K ++
Sbjct: 1 MKDSPFYQHYDL---DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIIS-------KRMEA 50
Query: 191 ECKAAINI-----KHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW 245
+ I H NIV++ + +V + + G L
Sbjct: 51 NTQKEITALKLCEGHPNIVKLHEV-----FHDQLHTFLVMELLNGGEL------------ 93
Query: 246 RPLNFNFLIKKKL-------DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE---- 294
F + KKK I + A+ ++H + H +LKP N+L DE
Sbjct: 94 ----FERIKKKKHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNL 146
Query: 295 --MIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPE------YDLGCEASTYGDVYSF 346
I DFG AR P ++ + C + Y PE YD C D++S
Sbjct: 147 EIKI---IDFGFARLKPPDNQPLKTPC--FTLHYAAPELLNQNGYDESC------DLWSL 195
Query: 347 GILLLEMFTGIRP 359
G++L M +G P
Sbjct: 196 GVILYTMLSGQVP 208
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-11
Identities = 50/264 (18%), Positives = 99/264 (37%), Gaps = 28/264 (10%)
Query: 100 PNERMKINDVESRLRLIKKKLLKTPVYEGKQTINNPSFKDLYNATNGFSSANLIGAGNFG 159
ERM + + + P T + Y S ++G G FG
Sbjct: 48 LTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYT----VSKTEILGGGRFG 103
Query: 160 SVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218
V+ G +A K+ + K+E + H N+++++ A ++
Sbjct: 104 QVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA-----FESK 158
Query: 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPP 278
+V +++ G L + + + +N + + +R++H Q
Sbjct: 159 NDIVLVMEYVDGGELFDRIIDES--------YNLTELDTILFMKQICEGIRHMH---QMY 207
Query: 279 IAHCNLKPSNVLL---DDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC 335
I H +LKP N+L D + I + DFG+AR + + G+ ++ PE
Sbjct: 208 ILHLDLKPENILCVNRDAKQI-KIIDFGLARR---YKPREKLKVNFGTPEFLAPEVVNYD 263
Query: 336 EASTYGDVYSFGILLLEMFTGIRP 359
S D++S G++ + +G+ P
Sbjct: 264 FVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 3e-11
Identities = 53/233 (22%), Positives = 87/233 (37%), Gaps = 58/233 (24%)
Query: 147 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI----KHR 201
+ +G G FG VY G A KV + + E I I H
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVE----IEILATCDHP 76
Query: 202 NIVRVFTAFSGVDYQGARFKA----VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK 257
IV+ GA + ++ +F P G+++ + + +
Sbjct: 77 YIVK---------LLGAYYHDGKLWIMIEFCPGGAVDAIML--------------ELDRG 113
Query: 258 LD---IAI---DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFL- 308
L I + + AL +LH I H +LK NVL+ E G + DFG++
Sbjct: 114 LTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLE--GDIRLADFGVSAKNL 168
Query: 309 PAIDKQNRFICIKGSTGYIPPE--YDLGCEASTYG---DVYSFGILLLEMFTG 356
+ K++ FI G+ ++ PE + + Y D++S GI L+EM
Sbjct: 169 KTLQKRDSFI---GTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 4e-11
Identities = 48/242 (19%), Positives = 89/242 (36%), Gaps = 63/242 (26%)
Query: 131 TINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFK 189
++ + + + ++G+G F V+ G A+K S +
Sbjct: 1 SMQTTNIRKTFI------FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE 54
Query: 190 SECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLN 249
+E IKH NIV + + + Y M + + G + L
Sbjct: 55 NEIAVLKKIKHENIVTLEDIYESTTH--------YYLVM------QLVSGGE------L- 93
Query: 250 FNFLIKKKL-------DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL----DDEMIGH 298
F+ ++++ + + V A++YLH + I H +LKP N+L ++ I
Sbjct: 94 FDRILERGVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKI-M 149
Query: 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPE------YDLGCEASTYGDVYSFG----I 348
+ DFG+++ ++ G+ GY+ PE Y D +S G I
Sbjct: 150 ITDFGLSKM----EQNGIMSTACGTPGYVAPEVLAQKPYSKAV------DCWSIGVITYI 199
Query: 349 LL 350
LL
Sbjct: 200 LL 201
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 55/250 (22%), Positives = 94/250 (37%), Gaps = 47/250 (18%)
Query: 129 KQTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNL--IRPGGS 185
+ +F + YN ++G G+FG V AVKV N + +
Sbjct: 12 ENLYFQGTFAERYNIVC------MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT 65
Query: 186 KSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW 245
+ E + + H NI+++F + + +V + G L + + +
Sbjct: 66 STILREVELLKKLDHPNIMKLFEI-----LEDSSSFYIVGELYTGGELFDEIIKRK---- 116
Query: 246 RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH---VGDF 302
F I V + Y+H + I H +LKP N+LL+ + + DF
Sbjct: 117 -----RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDF 168
Query: 303 GMARFLPAIDKQNRFICIKGSTGYIPPE-----YDLGCEASTYGDVYSFGILLLEMFTGI 357
G++ + + G+ YI PE YD C DV+S G++L + +G
Sbjct: 169 GLSTC---FQQNTKMKDRIGTAYYIAPEVLRGTYDEKC------DVWSAGVILYILLSGT 219
Query: 358 RPSDGIFTGK 367
P F GK
Sbjct: 220 PP----FYGK 225
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 5e-11
Identities = 52/230 (22%), Positives = 90/230 (39%), Gaps = 59/230 (25%)
Query: 147 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVR 205
++ IG G G+VY + G +A++ NL + + +E K+ NIV
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 206 VFTAFSGVDYQGARFKA----VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLD-- 259
Y + VV +++ GSL + + + +D
Sbjct: 82 ---------YLDSYLVGDELWVVMEYLAGGSLTDVVT----------------ETCMDEG 116
Query: 260 -IAI---DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGM-ARFLPAID 312
IA + AL +LH + + H ++K N+LL + G V DFG A+ P
Sbjct: 117 QIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMD--GSVKLTDFGFCAQITPEQS 171
Query: 313 KQNRFICIKGSTGYIPPE------YDLGCEASTYGDVYSFGILLLEMFTG 356
K++ + G+ ++ PE Y D++S GI+ +EM G
Sbjct: 172 KRSTMV---GTPYWMAPEVVTRKAYGPKV------DIWSLGIMAIEMIEG 212
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 6e-11
Identities = 54/241 (22%), Positives = 86/241 (35%), Gaps = 69/241 (28%)
Query: 133 NNPSFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSE 191
N+ F D Y IG G++ AVK+ + KS K +
Sbjct: 16 NSIQFTDGYEVKE------DIGVGSYSVCKRCIHKATNMEFAVKIID-------KS-KRD 61
Query: 192 CKAAINI-----KHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWR 246
I I +H NI+ + Y ++ VV + M G L
Sbjct: 62 PTEEIEILLRYGQHPNIITLKDV-----YDDGKYVYVVTELMKGGEL------------- 103
Query: 247 PLNFNFLIKKKL-------DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH- 298
+ ++++K + + + YLH + H +LKPSN+L DE
Sbjct: 104 ---LDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPE 157
Query: 299 ---VGDFGMARFLPAIDKQNRFICIKGSTGYIPPE------YDLGCEASTYGDVYSFGIL 349
+ DFG A+ L A + C + ++ PE YD C D++S G+L
Sbjct: 158 SIRICDFGFAKQLRAENGLLMTPC--YTANFVAPEVLERQGYDAAC------DIWSLGVL 209
Query: 350 L 350
L
Sbjct: 210 L 210
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 6e-11
Identities = 42/220 (19%), Positives = 86/220 (39%), Gaps = 50/220 (22%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAI--------NIKHRNI 203
+G+G G V +A+K+ + + + +++ + + H I
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 204 VRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKL----- 258
+++ F DY +V + M G L F+ ++ K
Sbjct: 78 IKIKNFFDAEDYY------IVLELMEGGEL----------------FDKVVGNKRLKEAT 115
Query: 259 --DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL---DDEMIGHVGDFGMARFLPAIDK 313
+ A++YLH + I H +LKP NVLL +++ + + DFG ++ + +
Sbjct: 116 CKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGE 169
Query: 314 QNRFICIKGSTGYIPPEYDLGCEASTYG---DVYSFGILL 350
+ + G+ Y+ PE + + Y D +S G++L
Sbjct: 170 TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 6e-11
Identities = 55/258 (21%), Positives = 98/258 (37%), Gaps = 48/258 (18%)
Query: 129 KQTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGTLFD-GTTIAVK-VFNLIRPGGSK 186
+ + + F + G G FG+V G G ++A+K V
Sbjct: 7 SLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQ------DP 60
Query: 187 SFK----SECKAAINIKHRNIVRVFTAF--SGVDYQGARFKAVVYKFMPNGSLEEWLRGK 240
F+ + + H NIV++ + F G + + VV +++P+ +L R
Sbjct: 61 RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCR-- 117
Query: 241 DDTNWRPLNFNFLIKKKLDIAID--------VACALRYLHCDCQPPIAHCNLKPSNVLLD 292
++++ + ++ LH + H ++KP NVL++
Sbjct: 118 -----------NYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVN 165
Query: 293 DEMIGH--VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEA-STYGDVYSFGIL 349
+ G + DFG A+ L + +IC S Y PE G + +T D++S G +
Sbjct: 166 EAD-GTLKLCDFGSAKKLSPSEPNVAYIC---SRYYRAPELIFGNQHYTTAVDIWSVGCI 221
Query: 350 LLEMFTGIRPSDGIFTGK 367
EM G P IF G
Sbjct: 222 FAEMMLG-EP---IFRGD 235
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 8e-11
Identities = 52/242 (21%), Positives = 91/242 (37%), Gaps = 43/242 (17%)
Query: 129 KQTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFN--LIRPGGS 185
+ +F + YN ++G G+FG V AVKV N + +
Sbjct: 12 ENLYFQGTFAERYNIVC------MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT 65
Query: 186 KSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW 245
+ E + + H NI+++F + + +V + G L + + +
Sbjct: 66 STILREVELLKKLDHPNIMKLFEI-----LEDSSSFYIVGELYTGGELFDEIIKRK---- 116
Query: 246 RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL---DDEMIGHVGDF 302
F I V + Y+H + I H +LKP N+LL + + + DF
Sbjct: 117 -----RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDF 168
Query: 303 GMARFLPAIDKQNRFICIKGSTGYIPPE-----YDLGCEASTYGDVYSFGILLLEMFTGI 357
G++ + + G+ YI PE YD C DV+S G++L + +G
Sbjct: 169 GLSTC---FQQNTKMKDRIGTAYYIAPEVLRGTYDEKC------DVWSAGVILYILLSGT 219
Query: 358 RP 359
P
Sbjct: 220 PP 221
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 9e-11
Identities = 57/256 (22%), Positives = 96/256 (37%), Gaps = 59/256 (23%)
Query: 124 PVYEGKQTINNPSFKDLYNATN---GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNL 179
P ++ +P +L+ + FS IG G+FG+VY + + +A+K +
Sbjct: 30 PAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSY 89
Query: 180 IRPGGSKSFKSECKAAINI----KHRNIVRVFTAFSGVDYQGARFKA----VVYKFMPNG 231
S + + +H N ++ Y+G + +V ++ G
Sbjct: 90 -SGKQSNEKWQDIIKEVRFLQKLRHPNTIQ---------YRGCYLREHTAWLVMEYCL-G 138
Query: 232 SLEEWLRGKDDTNWRPLNFNFLIKKKLD---IAI---DVACALRYLHCDCQPPIAHCNLK 285
S + L + KK L IA L YLH + H ++K
Sbjct: 139 SASDLLE--------------VHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVK 181
Query: 286 PSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYG-- 341
N+LL + G V GDFG A + N F+ G+ ++ PE L + Y
Sbjct: 182 AGNILLSEP--GLVKLGDFGSASIM---APANSFV---GTPYWMAPEVILAMDEGQYDGK 233
Query: 342 -DVYSFGILLLEMFTG 356
DV+S GI +E+
Sbjct: 234 VDVWSLGITCIELAER 249
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 55/236 (23%), Positives = 87/236 (36%), Gaps = 65/236 (27%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFN---LIRPGGSKSFKSECKAAINIKHRNIVRVF 207
+G G FG V G G +AVK+ N + + E + +H +I+++
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL- 81
Query: 208 TAFSGVDYQGARFKAVVYKFM---PNGSLEEWLRGKDDTNWRPLNFNFLIKK-KLDIAID 263
YQ + ++ M G L F+++ K +LD
Sbjct: 82 -------YQVISTPSDIFMVMEYVSGGEL----------------FDYICKNGRLDE--K 116
Query: 264 VA--------CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQN 315
+ + Y H + H +LKP NVLLD M + DFG++ +
Sbjct: 117 ESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLS----NMMSDG 169
Query: 316 RFI---CIKGSTGYIPPE------YDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
F+ C GS Y PE Y G E D++S G++L + G P D
Sbjct: 170 EFLRTSC--GSPNYAAPEVISGRLYA-GPEV----DIWSSGVILYALLCGTLPFDD 218
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 1e-10
Identities = 55/235 (23%), Positives = 87/235 (37%), Gaps = 64/235 (27%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFN---LIRPGGSKSFKSECKAAINIKHRNIVRVF 207
+G G+FG V T +A+K + L + + E ++H +I+++
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL- 74
Query: 208 TAFSGVDYQGARFKAVVYKFM--PNGSLEEWLRGKDDTNWRPLNFNFLIKK-KLDIAIDV 264
Y + + G L F+++++K ++ D
Sbjct: 75 -------YDVITTPTDIVMVIEYAGGEL----------------FDYIVEKKRMTE--DE 109
Query: 265 AC--------ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNR 316
A+ Y H I H +LKP N+LLDD + + DFG++ I
Sbjct: 110 GRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLS----NIMTDGN 162
Query: 317 FI---CIKGSTGYIPPE------YDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
F+ C GS Y PE Y G E DV+S GI+L M G P D
Sbjct: 163 FLKTSC--GSPNYAAPEVINGKLYA-GPEV----DVWSCGIVLYVMLVGRLPFDD 210
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 1e-10
Identities = 47/250 (18%), Positives = 80/250 (32%), Gaps = 78/250 (31%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFN------------LIRPGGSKSFKSECKAAIN- 197
IG G++G V D T A+KV + P G++ C
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 198 -------------IKHRNIVRVF----TAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGK 240
+ H N+V++ Y +V++ + G +
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLY-------MVFELVNQGPV------- 125
Query: 241 DDTNWRPLNFNFLIKKKL--DIAI----DVACALRYLHCDCQPPIAHCNLKPSNVLLDDE 294
K L D A D+ + YLH I H ++KPSN+L+ ++
Sbjct: 126 ---------MEVPTLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGED 173
Query: 295 MIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPE--------YDLGCEASTYGDVYSF 346
+ DFG++ D G+ ++ PE + G DV++
Sbjct: 174 GHIKIADFGVSNEFKGSDALLSNTV--GTPAFMAPESLSETRKIFS-GKAL----DVWAM 226
Query: 347 GILLLEMFTG 356
G+ L G
Sbjct: 227 GVTLYCFVFG 236
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 1e-10
Identities = 49/223 (21%), Positives = 77/223 (34%), Gaps = 49/223 (21%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFS 211
IG G++G V A K FK E + ++ H NI+R++ F
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 212 GVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK-------LDIAIDV 264
+Y M E G + L F ++ K+ I DV
Sbjct: 77 DNTD--------IYLVM------ELCTGGE------L-FERVVHKRVFRESDAARIMKDV 115
Query: 265 ACALRYLHCDCQPPIAHCNLKPSNVLL---DDEMIGHVGDFGMARFLPAIDKQNRFICIK 321
A+ Y H + +AH +LKP N L + + DFG+A
Sbjct: 116 LSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR---FKPGKMMRTKV 169
Query: 322 GSTGYIPPE-----YDLGCEASTYGDVYSFGILLLEMFTGIRP 359
G+ Y+ P+ Y C D +S G+++ + G P
Sbjct: 170 GTPYYVSPQVLEGLYGPEC------DEWSAGVMMYVLLCGYPP 206
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 51/257 (19%), Positives = 94/257 (36%), Gaps = 58/257 (22%)
Query: 133 NNPSFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKV-------------FN 178
+ Y +G+G +G V + A+KV N
Sbjct: 30 KEGKIGESYFKVR------KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDN 83
Query: 179 LIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLR 238
+ +E ++ H NI+++F ++ ++ +V +F G L E +
Sbjct: 84 KNIEKFHEEIYNEISLLKSLDHPNIIKLFDV-----FEDKKYFYLVTEFYEGGELFEQII 138
Query: 239 GKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298
+ F +I + + YLH + I H ++KP N+LL+++
Sbjct: 139 NRH---------KFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLL 186
Query: 299 ---VGDFGMARFLPAIDKQNRFICIKGSTGYIPPE-----YDLGCEASTYGDVYSFGILL 350
+ DFG++ F K + G+ YI PE Y+ C DV+S G+++
Sbjct: 187 NIKIVDFGLSSF---FSKDYKLRDRLGTAYYIAPEVLKKKYNEKC------DVWSCGVIM 237
Query: 351 LEMFTGIRPSDGIFTGK 367
+ G P F G+
Sbjct: 238 YILLCGYPP----FGGQ 250
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 46/247 (18%), Positives = 85/247 (34%), Gaps = 44/247 (17%)
Query: 124 PVYEGKQTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP 182
Y I + D Y+ +G G FG V+ T G A K
Sbjct: 142 QYYPQPVEIKHDHVLDHYDI------HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE 195
Query: 183 GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDD 242
++ + E + ++H +V + A ++ ++Y+FM G L
Sbjct: 196 SDKETVRKEIQTMSVLRHPTLVNLHDA-----FEDDNEMVMIYEFMSGGEL--------- 241
Query: 243 TNWRPLNFNFLIKKK-----LDIAI---DVACALRYLHCDCQPPIAHCNLKPSNVLLDDE 294
F + + + V L ++H + H +LKP N++ +
Sbjct: 242 -------FEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTK 291
Query: 295 MIGHV--GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLE 352
+ DFG+ +D + G+ + PE G Y D++S G+L
Sbjct: 292 RSNELKLIDFGLTAH---LDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYI 348
Query: 353 MFTGIRP 359
+ +G+ P
Sbjct: 349 LLSGLSP 355
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 53/256 (20%), Positives = 92/256 (35%), Gaps = 63/256 (24%)
Query: 128 GKQTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSK 186
G +T +D Y+ +G+G F V G A K + S+
Sbjct: 1 GMETFKQQKVEDFYDI------GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASR 54
Query: 187 SF--KSECKAAINI----KHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGK 240
+ E + ++I H NI+ + Y+ ++ + + G L
Sbjct: 55 RGVCREEIEREVSILRQVLHPNIITLHDV-----YENRTDVVLILELVSGGEL------- 102
Query: 241 DDTNWRPLNFNFLIKKKL-------DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD 293
F+FL +K+ + + YLH IAH +LKP N++L D
Sbjct: 103 ---------FDFLAQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLD 150
Query: 294 EMIGH----VGDFGMARFLPAIDKQNRFICIKGSTGYIPPE------YDLGCEASTYGDV 343
+ I + DFG+A I+ F I G+ ++ PE L D+
Sbjct: 151 KNIPIPHIKLIDFGLAHE---IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEA------DM 201
Query: 344 YSFGILLLEMFTGIRP 359
+S G++ + +G P
Sbjct: 202 WSIGVITYILLSGASP 217
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 51/252 (20%), Positives = 87/252 (34%), Gaps = 65/252 (25%)
Query: 128 GKQTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSK 186
G + F+D+Y +++G G V L AVK+
Sbjct: 1 GSTDSFSGRFEDVYQLQE-----DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRS 55
Query: 187 SFKSECKAAINI-----KHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKD 241
E + + HRN++ + ++ +V++ M GS+
Sbjct: 56 RVFRE----VEMLYQCQGHRNVLELIEF-----FEEEDRFYLVFEKMRGGSI-------- 98
Query: 242 DTNWRPLNFNFLIKKKL-------DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE 294
+ + K++ + DVA AL +LH IAH +LKP N+L +
Sbjct: 99 --------LSHIHKRRHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHP 147
Query: 295 ------MIGHVGDFGMARFLPAIDKQNRFICIK-----GSTGYIPPE--YDLGCEASTYG 341
I DF + + + + GS Y+ PE EAS Y
Sbjct: 148 NQVSPVKI---CDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYD 204
Query: 342 ---DVYSFGILL 350
D++S G++L
Sbjct: 205 KRCDLWSLGVIL 216
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 33/121 (27%), Positives = 56/121 (46%), Gaps = 22/121 (18%)
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMA-RFLPAIDKQNRFICI 320
+ AL +LH + I + ++K N+LLD GHV DFG++ F+ ++ C
Sbjct: 168 IVLALEHLH---KLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFVADETERAYDFC- 221
Query: 321 KGSTGYIPPEYDLGCEASTYG-----DVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVK 375
G+ Y+ P+ G + G D +S G+L+ E+ TG P FT + +
Sbjct: 222 -GTIEYMAPDIVRGGD---SGHDKAVDWWSLGVLMYELLTGASP----FTVDGEKNSQAE 273
Query: 376 M 376
+
Sbjct: 274 I 274
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 4e-10
Identities = 48/265 (18%), Positives = 88/265 (33%), Gaps = 72/265 (27%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKA 194
+ D Y + ++G G G V G A+K+ S + E
Sbjct: 25 AVTDDYQLSK-----QVLGLGVNGKVLECFHRRTGQKCALKLLY-----DSPKARQE--- 71
Query: 195 AINI-----KHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLN 249
++ +IV + + + + ++ + M G L
Sbjct: 72 -VDHHWQASGGPHIVCILDVYENMHHGKRCL-LIIMECMEGGEL---------------- 113
Query: 250 FNFLIKKKL---------DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH-- 298
F+ + ++ +I D+ A+++LH IAH ++KP N+L +
Sbjct: 114 FSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVL 170
Query: 299 -VGDFGMARFLPAIDKQNRFICIKGSTGYIPPE------YDLGCEASTYGDVYSFGILLL 351
+ DFG A+ QN + Y+ PE YD C D++S G+++
Sbjct: 171 KLTDFGFAKET----TQNALQTPCYTPYYVAPEVLGPEKYDKSC------DMWSLGVIMY 220
Query: 352 EMFTGIRPSDGIFTGKMNLRNFVKM 376
+ G P F M
Sbjct: 221 ILLCGFPP----FYSNTGQAISPGM 241
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 59.5 bits (145), Expect = 4e-10
Identities = 47/221 (21%), Positives = 79/221 (35%), Gaps = 56/221 (25%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFN--LIRPGGSKSFKSECKAAINIKHRNIVRVFTA 209
+G G F V G A K+ N + + + E + ++H NIVR+ +
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKL-------DIAI 262
Q F +V+ + G L F ++ ++
Sbjct: 74 -----IQEESFHYLVFDLVTGGEL----------------FEDIVAREFYSEADASHCIQ 112
Query: 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH---VGDFGMARFLPAIDKQNRFIC 319
+ ++ Y H I H NLKP N+LL + G + DFG+A ++ +
Sbjct: 113 QILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE---VNDSEAWHG 166
Query: 320 IKGSTGYIPPE------YDLGCEASTYGDVYSFG----ILL 350
G+ GY+ PE Y D+++ G ILL
Sbjct: 167 FAGTPGYLSPEVLKKDPYSKPV------DIWACGVILYILL 201
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 4e-10
Identities = 52/245 (21%), Positives = 86/245 (35%), Gaps = 65/245 (26%)
Query: 131 TINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFN--LIRPGGSKS 187
TI F + Y +G G F V + G A + N + +
Sbjct: 3 TITCTRFTEEYQL------FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQK 56
Query: 188 FKSECKAAI--NIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW 245
+ E A I +KH NIVR+ + S + Y + + G +
Sbjct: 57 LERE--ARICRLLKHPNIVRLHDSISEEGH--------HYLIF------DLVTGGE---- 96
Query: 246 RPLNFNFLIKKKL-------DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298
L F ++ ++ + A+ + H Q + H NLKP N+LL ++ G
Sbjct: 97 --L-FEDIVAREYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGA 150
Query: 299 ---VGDFGMARFLPAIDKQNRFICIKGSTGYIPPE------YDLGCEASTYGDVYSFG-- 347
+ DFG+A + + G+ GY+ PE Y D+++ G
Sbjct: 151 AVKLADFGLAIEVEGEQQAWFGFA--GTPGYLSPEVLRKDPYGKPV------DLWACGVI 202
Query: 348 --ILL 350
ILL
Sbjct: 203 LYILL 207
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 5e-10
Identities = 55/264 (20%), Positives = 89/264 (33%), Gaps = 72/264 (27%)
Query: 133 NNPSFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKV-----FNLIRPGGSK 186
++ F+D+Y +IG G F V G AVK+ F ++
Sbjct: 18 DDVLFEDVYEL------CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTE 71
Query: 187 SFKSECKAAI--NIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTN 244
K E A+I +KH +IV + Y +V++FM L
Sbjct: 72 DLKRE--ASICHMLKHPHIVELLET-----YSSDGMLYMVFEFMDGADL----------- 113
Query: 245 WRPLNFNFLIKKKL-----------DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD 293
++K+ + ALRY H I H ++KP VLL
Sbjct: 114 -----CFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLAS 165
Query: 294 EMIGH---VGDFGMARFLPAIDKQNRFICIKGSTGYIPPE------YDLGCEASTYGDVY 344
+ +G FG+A L G+ ++ PE Y DV+
Sbjct: 166 KENSAPVKLGGFGVAIQLGESGLVAGGRV--GTPHFMAPEVVKREPYGKPV------DVW 217
Query: 345 SFGILLLEMFTGIRP----SDGIF 364
G++L + +G P + +F
Sbjct: 218 GCGVILFILLSGCLPFYGTKERLF 241
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 5e-10
Identities = 57/231 (24%), Positives = 94/231 (40%), Gaps = 61/231 (26%)
Query: 147 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI----KHR 201
F +G G++GSVY G +A+K + +S E I+I
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV------ESDLQEIIKEISIMQQCDSP 84
Query: 202 NIVRVFTAFSGVDYQGARFKA----VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK 257
++V+ Y G+ FK +V ++ GS+ + +R ++ + L +
Sbjct: 85 HVVK---------YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN----KTLT-------E 124
Query: 258 LDIAI---DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFL-PAI 311
+IA L YLH H ++K N+LL+ E GH DFG+A L +
Sbjct: 125 DEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTE--GHAKLADFGVAGQLTDTM 179
Query: 312 DKQNRFICIKGSTGYIPPE------YDLGCEASTYGDVYSFGILLLEMFTG 356
K+N I G+ ++ PE Y+ D++S GI +EM G
Sbjct: 180 AKRNTVI---GTPFWMAPEVIQEIGYNCVA------DIWSLGITAIEMAEG 221
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 5e-10
Identities = 51/256 (19%), Positives = 92/256 (35%), Gaps = 63/256 (24%)
Query: 128 GKQTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSK 186
G + +D Y+ +G+G F V G A K + S+
Sbjct: 1 GMEPFKQQKVEDFYDI------GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASR 54
Query: 187 SF--KSECKAAINI----KHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGK 240
+ E + ++I H N++ + Y+ ++ + + G L
Sbjct: 55 RGVSREEIEREVSILRQVLHHNVITLHDV-----YENRTDVVLILELVSGGEL------- 102
Query: 241 DDTNWRPLNFNFLIKKK----LDIAI---DVACALRYLHCDCQPPIAHCNLKPSNVLLDD 293
F+FL +K+ + + + YLH IAH +LKP N++L D
Sbjct: 103 ---------FDFLAQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLD 150
Query: 294 EMIGH----VGDFGMARFLPAIDKQNRFICIKGSTGYIPPE------YDLGCEASTYGDV 343
+ I + DFG+A I+ F I G+ ++ PE L D+
Sbjct: 151 KNIPIPHIKLIDFGLAHE---IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEA------DM 201
Query: 344 YSFGILLLEMFTGIRP 359
+S G++ + +G P
Sbjct: 202 WSIGVITYILLSGASP 217
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 5e-10
Identities = 32/135 (23%), Positives = 54/135 (40%), Gaps = 19/135 (14%)
Query: 258 LDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRF 317
+ + VA + +L H +L N+LL ++ + + DFG+AR D
Sbjct: 196 ICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLAR-----DIYKDP 247
Query: 318 ICIKGSTGYIP-----PEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLR 371
++ +P PE + DV+SFG+LL E+F+ G P G+ +
Sbjct: 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFC 306
Query: 372 NFVK----MALPQRA 382
+K M P
Sbjct: 307 RRLKEGTRMRAPDYT 321
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 5e-10
Identities = 47/221 (21%), Positives = 79/221 (35%), Gaps = 56/221 (25%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFN--LIRPGGSKSFKSECKAAINIKHRNIVRVFTA 209
+G G F V G A K+ N + + + E + ++H NIVR+ +
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKL-------DIAI 262
Q F +V+ + G L F ++ ++
Sbjct: 97 -----IQEESFHYLVFDLVTGGEL----------------FEDIVAREFYSEADASHCIQ 135
Query: 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH---VGDFGMARFLPAIDKQNRFIC 319
+ ++ Y H I H NLKP N+LL + G + DFG+A ++ +
Sbjct: 136 QILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE---VNDSEAWHG 189
Query: 320 IKGSTGYIPPE------YDLGCEASTYGDVYSFG----ILL 350
G+ GY+ PE Y D+++ G ILL
Sbjct: 190 FAGTPGYLSPEVLKKDPYSKPV------DIWACGVILYILL 224
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 6e-10
Identities = 54/237 (22%), Positives = 93/237 (39%), Gaps = 53/237 (22%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHR--------- 201
+IG G+FG V +A+K+ +R K F + I I
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKM---VRN--EKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 202 -NIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDI 260
N++ + F ++ + ++ + + +L E ++ ++ + L++K
Sbjct: 159 MNVIHMLENF---TFRN--HICMTFELL-SMNLYELIK---KNKFQGFSLP-LVRK---F 205
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH--VGDFGMARFL-----PAIDK 313
A + L LH + I HC+LKP N+LL + V DFG + + I
Sbjct: 206 AHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYI-- 260
Query: 314 QNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNL 370
Q+RF Y PE LG D++S G +L E+ TG P + G+
Sbjct: 261 QSRF--------YRAPEVILGARYGMPIDMWSLGCILAELLTG-YP---LLPGEDEG 305
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 8e-10
Identities = 51/248 (20%), Positives = 90/248 (36%), Gaps = 50/248 (20%)
Query: 153 IGAGNFGSVYNGTLFD-GTTIAVK-VFNLIRPGGSKSFKS-ECKAAINIKHRNIVRVFTA 209
+G G+FG V + G A+K V +K+ E + H NI+++
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDIMKVLDHVNIIKLVDY 68
Query: 210 F-SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFL--------------- 253
F + D + + G P +L
Sbjct: 69 FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128
Query: 254 ---IKKKLDIAID--------VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--G 300
I+ I ++ + A+ ++H I H ++KP N+L++ + +
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKD-NTLKLC 184
Query: 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYG-DVYSFGILLLEMFTGIRP 359
DFG A+ L + +IC S Y PE LG T D++S G + E+ G +P
Sbjct: 185 DFGSAKKLIPSEPSVAYIC---SRFYRAPELMLGATEYTPSIDLWSIGCVFGELILG-KP 240
Query: 360 SDGIFTGK 367
+F+G+
Sbjct: 241 ---LFSGE 245
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 36/105 (34%), Positives = 49/105 (46%), Gaps = 17/105 (16%)
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMAR-FLPAIDKQNRFICI 320
+A L +L I + +LK NV+LD E GH+ DFGM + + F C
Sbjct: 130 IAIGLFFLQ---SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCKENIWDGVTTKTF-C- 182
Query: 321 KGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDG 362
G+ YI PE YG D ++FG+LL EM G P +G
Sbjct: 183 -GTPDYIAPEIIAY---QPYGKSVDWWAFGVLLYEMLAGQAPFEG 223
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 1e-09
Identities = 52/247 (21%), Positives = 87/247 (35%), Gaps = 60/247 (24%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTA 209
+G G +G V +AVK+ ++ R ++ K E + H N+V+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF--- 70
Query: 210 FSGVDYQGARFKAVVYKFM---PNGSLEEWLRGKDDTNWRPLNFNFLIKK-KLDIAIDVA 265
Y R + Y F+ G L F+ + + A
Sbjct: 71 -----YGHRREGNIQYLFLEYCSGGEL----------------FDRIEPDIGMPE--PDA 107
Query: 266 --------CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRF 317
+ YLH I H ++KP N+LLD+ + DFG+A + + + R
Sbjct: 108 QRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERL 163
Query: 318 I---CIKGSTGYIPPE------YDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKM 368
+ C G+ Y+ PE + DV+S GI+L M G P D
Sbjct: 164 LNKMC--GTLPYVAPELLKRREFH-AEPV----DVWSCGIVLTAMLAGELPWDQPSDSCQ 216
Query: 369 NLRNFVK 375
++ +
Sbjct: 217 EYSDWKE 223
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 36/107 (33%), Positives = 50/107 (46%), Gaps = 15/107 (14%)
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFI 318
A ++A L +L I + +LK NV+LD E GH+ DFGM + +
Sbjct: 448 AAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSE--GHIKIADFGMCKENIWDGVTTKTF 502
Query: 319 CIKGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDG 362
C G+ YI PE YG D ++FG+LL EM G P +G
Sbjct: 503 C--GTPDYIAPEIIAYQP---YGKSVDWWAFGVLLYEMLAGQAPFEG 544
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 1e-09
Identities = 36/105 (34%), Positives = 47/105 (44%), Gaps = 17/105 (16%)
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMAR-FLPAIDKQNRFICI 320
+ AL +LH I + +LK NVLLD E GH DFGM + + F C
Sbjct: 133 IISALMFLH---DKGIIYRDLKLDNVLLDHE--GHCKLADFGMCKEGICNGVTTATF-C- 185
Query: 321 KGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDG 362
G+ YI PE YG D ++ G+LL EM G P +
Sbjct: 186 -GTPDYIAPEILQE---MLYGPAVDWWAMGVLLYEMLCGHAPFEA 226
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 1e-09
Identities = 59/232 (25%), Positives = 88/232 (37%), Gaps = 41/232 (17%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSK-SFKS----ECKAAINIKHRNIVRV 206
IG G FG V+ G +A+K + K F E K +KH N+V +
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKK---VLMENEKEGFPITALREIKILQLLKHENVVNL 81
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVAC 266
R K +Y E L G + IK+ + +
Sbjct: 82 IEICRTKASPYNRCKGSIYLVFD--FCEHDLAGLLSNVLVKFTLS-EIKR---VMQMLLN 135
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF--LPAIDKQNRFICIKGST 324
L Y+H + I H ++K +NVL+ + + + DFG+AR L + NR+ T
Sbjct: 136 GLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY------T 186
Query: 325 G------YIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDGIFTGK 367
Y PPE LG YG D++ G ++ EM+T P I G
Sbjct: 187 NRVVTLWYRPPELLLGER--DYGPPIDLWGAGCIMAEMWTR-SP---IMQGN 232
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 28/101 (27%), Positives = 47/101 (46%), Gaps = 14/101 (13%)
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIK 321
+ AL YLH + + + +LK N++LD + GH+ DFG+ + + C
Sbjct: 257 IVSALDYLHSEKN--VVYRDLKLENLMLDKD--GHIKITDFGLCKEGIKDGATMKTFC-- 310
Query: 322 GSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
G+ Y+ PE + YG D + G+++ EM G P
Sbjct: 311 GTPEYLAPEVLED---NDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 38/102 (37%), Positives = 52/102 (50%), Gaps = 17/102 (16%)
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMAR-FLPAIDKQNRFICI 320
++ AL YLH + I + +LK NVLLD E GH+ D+GM + L D + F C
Sbjct: 119 ISLALNYLH---ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTTSTF-C- 171
Query: 321 KGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
G+ YI PE G YG D ++ G+L+ EM G P
Sbjct: 172 -GTPNYIAPEILRG---EDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 38/102 (37%), Positives = 52/102 (50%), Gaps = 17/102 (16%)
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMAR-FLPAIDKQNRFICI 320
++ AL YLH + I + +LK NVLLD E GH+ D+GM + L D + F C
Sbjct: 162 ISLALNYLH---ERGIIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTTSTF-C- 214
Query: 321 KGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
G+ YI PE G YG D ++ G+L+ EM G P
Sbjct: 215 -GTPNYIAPEILRG---EDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 27/101 (26%), Positives = 45/101 (44%), Gaps = 18/101 (17%)
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIK 321
+ YLH + + +LKP N+L+D + G++ DFG A+ + + C
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQ--GYIQVTDFGFAKRVK--GRTWTL-C-- 199
Query: 322 GSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
G+ + PE L Y D ++ G+L+ EM G P
Sbjct: 200 GTPEALAPEIILS---KGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 63/239 (26%), Positives = 108/239 (45%), Gaps = 53/239 (22%)
Query: 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI----------- 198
+LIG G+FG V + +A+K+ I+ K+F ++ + + +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKI---IK--NKKAFLNQAQIEVRLLELMNKHDTEM 114
Query: 199 KHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKL 258
K+ IV + F ++ +V++ + + +L + LR +TN+R ++ N L +K
Sbjct: 115 KY-YIVHLKRHF---MFRNHLC--LVFEML-SYNLYDLLR---NTNFRGVSLN-LTRK-- 161
Query: 259 DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH--VGDFGMARFL-----PAI 311
A + AL +L + I HC+LKP N+LL + + DFG + L I
Sbjct: 162 -FAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYI 219
Query: 312 DKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNL 370
Q+RF Y PE LG D++S G +L+EM TG P +F+G +
Sbjct: 220 --QSRF--------YRSPEVLLGMPYDLAIDMWSLGCILVEMHTG-EP---LFSGANEV 264
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 47/251 (18%), Positives = 89/251 (35%), Gaps = 47/251 (18%)
Query: 137 FKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVK--VFNLIRPGGSKSFKS---- 190
+L+ + ++ I +G++G+V G +G +A+K +
Sbjct: 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73
Query: 191 -----ECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV--VYKFMPNGSLEEWLRGKDDT 243
E + + H NI+ + F + + V + M L + + +
Sbjct: 74 KRVLREIRLLNHFHHPNILGLRDIFVHFEEPA--MHKLYLVTELMRT-DLAQVIHDQRIV 130
Query: 244 NWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303
P + + + L L LH + + H +L P N+LL D + DF
Sbjct: 131 -ISPQHIQYFMYHIL-------LGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFN 179
Query: 304 MARFLPAIDKQNRFICIKGSTGYI------PPEYDLGCEASTYG-DVYSFGILLLEMFTG 356
+AR D + T Y+ PE + + T D++S G ++ EMF
Sbjct: 180 LAR----EDTADANK-----THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR 230
Query: 357 IRPSDGIFTGK 367
+ +F G
Sbjct: 231 -KA---LFRGS 237
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 3e-09
Identities = 38/109 (34%), Positives = 56/109 (51%), Gaps = 19/109 (17%)
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIK 321
+A AL +LH I + +LKP N+LLD+E GH+ DFG+++ +K+ C
Sbjct: 135 LALALDHLH---SLGIIYRDLKPENILLDEE--GHIKLTDFGLSKESIDHEKKAYSFC-- 187
Query: 322 GSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDGIFTGK 367
G+ Y+ PE + D +SFG+L+ EM TG P F GK
Sbjct: 188 GTVEYMAPEVVNR---RGHTQSADWWSFGVLMFEMLTGTLP----FQGK 229
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 3e-09
Identities = 38/102 (37%), Positives = 53/102 (51%), Gaps = 11/102 (10%)
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMAR-FLPAIDKQNRFICI 320
+ L++LH I + +LK N+LLD + GH+ DFGM + + K N F C
Sbjct: 127 IILGLQFLH---SKGIVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDAKTNTF-C- 179
Query: 321 KGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
G+ YI PE LG + + D +SFG+LL EM G P G
Sbjct: 180 -GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 220
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 3e-09
Identities = 28/102 (27%), Positives = 47/102 (46%), Gaps = 17/102 (16%)
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMAR-FLPAIDKQNRFICI 320
+ AL YLH + + ++K N++LD + GH+ DFG+ + + F C
Sbjct: 114 IVSALEYLH---SRDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTF-C- 166
Query: 321 KGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
G+ Y+ PE + YG D + G+++ EM G P
Sbjct: 167 -GTPEYLAPEVLED---NDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 3e-09
Identities = 39/101 (38%), Positives = 49/101 (48%), Gaps = 18/101 (17%)
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIK 321
V AL YLH I + +LKP N+LLD GH+ DFG A+++P D C
Sbjct: 115 VCLALEYLH---SKDIIYRDLKPENILLDKN--GHIKITDFGFAKYVP--DVTYTL-C-- 164
Query: 322 GSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
G+ YI PE Y D +SFGIL+ EM G P
Sbjct: 165 GTPDYIAPEVVST---KPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 3e-09
Identities = 34/109 (31%), Positives = 53/109 (48%), Gaps = 19/109 (17%)
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIK 321
++ AL +LH Q I + +LKP N++L+ + GHV DFG+ + C
Sbjct: 130 ISMALGHLH---QKGIIYRDLKPENIMLNHQ--GHVKLTDFGLCKESIHDGTVTHTFC-- 182
Query: 322 GSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDGIFTGK 367
G+ Y+ PE + S + D +S G L+ +M TG P FTG+
Sbjct: 183 GTIEYMAPEILMR---SGHNRAVDWWSLGALMYDMLTGAPP----FTGE 224
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 3e-09
Identities = 33/102 (32%), Positives = 47/102 (46%), Gaps = 17/102 (16%)
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMA-RFLPAIDKQNRFICI 320
+A AL YLH I + +LKP N+LLD + GH+ DFG+ + + F C
Sbjct: 148 IASALGYLH---SLNIVYRDLKPENILLDSQ--GHIVLTDFGLCKENIEHNSTTSTF-C- 200
Query: 321 KGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRP 359
G+ Y+ PE Y D + G +L EM G+ P
Sbjct: 201 -GTPEYLAPEVLHK---QPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 4e-09
Identities = 52/247 (21%), Positives = 87/247 (35%), Gaps = 60/247 (24%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTA 209
+G G +G V +AVK+ ++ R ++ K E + H N+V+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKF--- 70
Query: 210 FSGVDYQGARFKAVVYKFM---PNGSLEEWLRGKDDTNWRPLNFNFLIKK-KLDIAIDVA 265
Y R + Y F+ G L F+ + + A
Sbjct: 71 -----YGHRREGNIQYLFLEYCSGGEL----------------FDRIEPDIGMPE--PDA 107
Query: 266 --------CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRF 317
+ YLH I H ++KP N+LLD+ + DFG+A + + + R
Sbjct: 108 QRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLAT-VFRYNNRERL 163
Query: 318 I---CIKGSTGYIPPE------YDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKM 368
+ C G+ Y+ PE + DV+S GI+L M G P D
Sbjct: 164 LNKMC--GTLPYVAPELLKRREFH-AEPV----DVWSCGIVLTAMLAGELPWDQPSDSCQ 216
Query: 369 NLRNFVK 375
++ +
Sbjct: 217 EYSDWKE 223
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 55/253 (21%), Positives = 92/253 (36%), Gaps = 62/253 (24%)
Query: 137 FKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKS----E 191
+ + + IG+G G V +A+K L RP +++ E
Sbjct: 17 GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIK--KLSRPFQNQTHAKRAYRE 74
Query: 192 CKAAINIKHRNIVR---VFTAFSGVDYQGARFKAV--VYKFMPNGSLEEWLRGKDDTNWR 246
+ H+NI+ VFT ++ F+ V V + M D N
Sbjct: 75 LVLMKCVNHKNIIGLLNVFTPQKSLE----EFQDVYIVMELM-------------DAN-- 115
Query: 247 PLNFNFLIKKKLD------IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300
+I+ +LD + + C +++LH I H +LKPSN+++ + +
Sbjct: 116 ---LCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKIL 169
Query: 301 DFGMARFLPAIDKQNRFICIKGSTGYI------PPEYDLGCEASTYGDVYSFGILLLEMF 354
DFG+AR T Y+ PE LG D++S G ++ EM
Sbjct: 170 DFGLARTAGTSF---------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 220
Query: 355 TGIRPSDGIFTGK 367
G +F G
Sbjct: 221 KG-GV---LFPGT 229
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 4e-09
Identities = 47/234 (20%), Positives = 79/234 (33%), Gaps = 54/234 (23%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAF 210
+G+G FG V+ G +K N R + ++E + ++ H NI+++F F
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 211 SGVDYQ---------GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIA 261
G + +V +L E ++
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKALSE-------------------GYVAELM 130
Query: 262 IDVACALRYLHCDCQPPIAHCNLKPSNVLL---DDEMIGHVGDFGMARFLPAIDKQNRFI 318
+ AL Y H + H +LKP N+L + DFG+A
Sbjct: 131 KQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL---FKSDEHST 184
Query: 319 CIKGSTGYIPPE-----YDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGK 367
G+ Y+ PE C D++S G+++ + TG P FTG
Sbjct: 185 NAAGTALYMAPEVFKRDVTFKC------DIWSAGVVMYFLLTGCLP----FTGT 228
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 57.9 bits (139), Expect = 4e-09
Identities = 80/499 (16%), Positives = 164/499 (32%), Gaps = 109/499 (21%)
Query: 17 LLEMFTGLRPNDDMFNDELNLHN---FVKSALPERAEEILDVVFFQEIEEEETMYKKA-- 71
LLE LRP ++ + K+ + LDV +++ + M K
Sbjct: 144 LLE----LRPAKNVL-----IDGVLGSGKTWV------ALDVCLSYKVQCK--MDFKIFW 186
Query: 72 --SSTCTQSSIILECLISICRTGVACSAELP----NERMKINDVESRLRLIKKKLLKTPV 125
C +LE L + N +++I+ +++ LR +LLK+
Sbjct: 187 LNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELR----RLLKSKP 242
Query: 126 YEGKQTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGS 185
YE + ++ N A A N L TT +V + + +
Sbjct: 243 YENCLLV----LLNVQN-------AKAWNAFNLSC---KILL--TTRFKQVTDFLSAATT 286
Query: 186 KSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPN--GSLEEWLRGKDDT 243
+ ++ + + + + Q + + P + E +R T
Sbjct: 287 THISLD-HHSMTLTPDEVKSLLLKYLDCRPQDLPREVL--TTNPRRLSIIAESIRDGLAT 343
Query: 244 --NWRPLNFNFLIKKKLDIAIDV--ACALRYLHCDCQ--PPIAHCNLK-PSNVL------ 290
NW+ +N + L ++ +++V R + PP + P+ +L
Sbjct: 344 WDNWKHVNCDKL-TTIIESSLNVLEPAEYRKMFDRLSVFPP----SAHIPTILLSLIWFD 398
Query: 291 LDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEY-DLGCEASTYGDVYSFGIL 349
+ + V + L ++KQ K ST IP Y +L + ++
Sbjct: 399 VIKSDVMVVVNKLHKYSL--VEKQP-----KESTISIPSIYLELKVKLENEYALHR---S 448
Query: 350 LLEMFTGIRPSDGIFTGKMNLRNFV------KMALPQRAEEVVD------DFNL--QEIE 395
+++ + + D L + + + E + DF Q+I
Sbjct: 449 IVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIR 508
Query: 396 EGRTMCMEVSSSSGSSAHASIILECFNS-ICEIGVACSAERPRERMKINDVESRLRLIRR 454
T ++SGS + L+ + IC+ + ER+ +N + L I
Sbjct: 509 HDSTAW----NASGSILNTLQQLKFYKPYICDN------DPKYERL-VNAILDFLPKIEE 557
Query: 455 KLLETPACLEVKQTTSMPP 473
L+ + ++ + M
Sbjct: 558 NLICSK-YTDLLRIALMAE 575
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 61/228 (26%), Positives = 96/228 (42%), Gaps = 42/228 (18%)
Query: 153 IGAGNFGSVYNGTLFD-GTTIAVK-VFNLIRPGGSKSFKS-ECKAAINIKHRNIVRVFTA 209
IG G+FG VY L D G +A+K V K FK+ E + + H NIVR+
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKVLQ------DKRFKNRELQIMRKLDHCNIVRLRYF 115
Query: 210 F-SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACAL 268
F S + + + +V ++P ++ R + L +K + +L
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAK-QTLP-VIYVKL---YMYQLFRSL 169
Query: 269 RYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIKGSTGY 326
Y+H I H ++KP N+LLD + + DFG A+ L + + Y
Sbjct: 170 AYIHSFG---ICHRDIKPQNLLLDPDT-AVLKLCDFGSAKQL----VRGEP-----NVSY 216
Query: 327 I------PPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGK 367
I PE G + ++ DV+S G +L E+ G +P IF G
Sbjct: 217 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QP---IFPGD 260
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 56.0 bits (136), Expect = 7e-09
Identities = 55/235 (23%), Positives = 84/235 (35%), Gaps = 45/235 (19%)
Query: 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNL-IRPGGSKSFKS----------ECKAAINI 198
IG G +G+VY G +A+K + GG +A
Sbjct: 15 AEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAF--- 71
Query: 199 KHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKL 258
+H N+VR+ + +V++ + L +L D L IK
Sbjct: 72 EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL---DKAPPPGLPAE-TIKD-- 124
Query: 259 DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFI 318
+ L +LH +C I H +LKP N+L+ + DFG+AR Q
Sbjct: 125 -LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR---IYSYQMAL- 176
Query: 319 CIKGSTG------YIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGK 367
T Y PE L +T D++S G + EMF +P +F G
Sbjct: 177 -----TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR-KP---LFCGN 222
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 8e-09
Identities = 42/218 (19%), Positives = 78/218 (35%), Gaps = 39/218 (17%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFS 211
+G G FG V+ T K ++ K E +HRNI+ + +
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHES-- 69
Query: 212 GVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKL-----DIAI---D 263
++ ++++F+ + F + +I
Sbjct: 70 ---FESMEELVMIFEFISGLDI----------------FERINTSAFELNEREIVSYVHQ 110
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIK 321
V AL++LH I H +++P N++ + +FG AR + + F +
Sbjct: 111 VCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ---LKPGDNFRLLF 164
Query: 322 GSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
+ Y PE ST D++S G L+ + +GI P
Sbjct: 165 TAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 8e-09
Identities = 52/255 (20%), Positives = 89/255 (34%), Gaps = 67/255 (26%)
Query: 131 TINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFK 189
+ D Y+ +G+G F V G A K R S+ +
Sbjct: 3 VFRQENVDDYYDT------GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSR--R 54
Query: 190 SECKAAI--------NIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKD 241
+ I I+H N++ + Y+ ++ + + G L
Sbjct: 55 GVSREDIEREVSILKEIQHPNVITLHEV-----YENKTDVILILELVAGGEL-------- 101
Query: 242 DTNWRPLNFNFLIKKKL-------DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE 294
F+FL +K+ + + + YLH IAH +LKP N++L D
Sbjct: 102 --------FDFLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDR 150
Query: 295 MIGH----VGDFGMARFLPAIDKQNRFICIKGSTGYIPPE------YDLGCEASTYGDVY 344
+ + DFG+A ID N F I G+ ++ PE L D++
Sbjct: 151 NVPKPRIKIIDFGLAHK---IDFGNEFKNIFGTPEFVAPEIVNYEPLGLEA------DMW 201
Query: 345 SFGILLLEMFTGIRP 359
S G++ + +G P
Sbjct: 202 SIGVITYILLSGASP 216
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 9e-09
Identities = 55/256 (21%), Positives = 94/256 (36%), Gaps = 68/256 (26%)
Query: 137 FKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAA 195
+ + + IG+G G V +A+K L RP +++ K A
Sbjct: 54 GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK--KLSRPFQNQTH---AKRA 108
Query: 196 I-------NIKHRNIVR---VFTAFSGVDYQGARFKAV--VYKFMPNGSLEEWLRGKDDT 243
+ H+NI+ VFT ++ F+ V V + M D
Sbjct: 109 YRELVLMKCVNHKNIISLLNVFTPQKTLE----EFQDVYLVMELM-------------DA 151
Query: 244 NWRPLNFNFLIKKKLD------IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297
N +I+ +LD + + C +++LH I H +LKPSN+++ +
Sbjct: 152 N-----LCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 203
Query: 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYI------PPEYDLGCEASTYGDVYSFGILLL 351
+ DFG+AR T Y+ PE LG D++S G ++
Sbjct: 204 KILDFGLARTAGTSF---------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 254
Query: 352 EMFTGIRPSDGIFTGK 367
EM + +F G+
Sbjct: 255 EMVRH-KI---LFPGR 266
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 1e-08
Identities = 46/251 (18%), Positives = 81/251 (32%), Gaps = 64/251 (25%)
Query: 133 NNPSFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSE 191
+ +F + Y T+ +G G F V G A K R G ++E
Sbjct: 22 SMENFNNFYILTS-----KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC--RAE 74
Query: 192 CKAAINI-----KHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWR 246
I + ++ + Y+ ++ ++ G +
Sbjct: 75 ILHEIAVLELAKSCPRVINLHEV-----YENTSEIILILEYAAGGEI------------- 116
Query: 247 PLNFNFLIKKKLDI-----AIDVAC----ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297
F+ + + ++ I + + YLH Q I H +LKP N+LL
Sbjct: 117 ---FSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPL 170
Query: 298 H---VGDFGMARFLPAIDKQNRFICIKGSTGYIPPE------YDLGCEASTYGDVYSFGI 348
+ DFGM+R I I G+ Y+ PE D+++ GI
Sbjct: 171 GDIKIVDFGMSRK---IGHACELREIMGTPEYLAPEILNYDPITTAT------DMWNIGI 221
Query: 349 LLLEMFTGIRP 359
+ + T P
Sbjct: 222 IAYMLLTHTSP 232
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 50/232 (21%), Positives = 75/232 (32%), Gaps = 59/232 (25%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAF 210
IG+GNFG +AVK ++ + E +++H NIVR
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIER-GAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKK-KLDIAIDVA---- 265
+ A++ ++ G L + + + D A
Sbjct: 86 LTPTHL-----AIIMEYASGGEL----------------YERICNAGRFSE--DEARFFF 122
Query: 266 ----CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH--VGDFGMARFLPAIDKQNRFI- 318
+ Y H I H +LK N LLD + DFG + +
Sbjct: 123 QQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYS----KSSVLHSQPK 175
Query: 319 --CIKGSTGYIPPE------YDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
G+ YI PE YD G A DV+S G+ L M G P +
Sbjct: 176 STV--GTPAYIAPEVLLRQEYD-GKIA----DVWSCGVTLYVMLVGAYPFED 220
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 60/227 (26%), Positives = 98/227 (43%), Gaps = 41/227 (18%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVK-VFNLIRPGGSKSFKS-ECKAAINIKHRNIVRVFTAF 210
IG G+FG V+ L + +A+K V K FK+ E + +KH N+V + F
Sbjct: 48 IGNGSFGVVFQAKLVESDEVAIKKVLQ------DKRFKNRELQIMRIVKHPNVVDLKAFF 101
Query: 211 -SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALR 269
S D + F +V +++P ++ R + + LIK + +L
Sbjct: 102 YSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLK-QTMP-MLLIKL---YMYQLLRSLA 155
Query: 270 YLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIKGSTGYI 327
Y+H I H ++KP N+LLD G + DFG A+ L A + + YI
Sbjct: 156 YIHSIG---ICHRDIKPQNLLLDPPS-GVLKLIDFGSAKILIAGEP---------NVSYI 202
Query: 328 ------PPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGK 367
PE G +T D++S G ++ E+ G +P +F G+
Sbjct: 203 CSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG-QP---LFPGE 245
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 53/251 (21%), Positives = 92/251 (36%), Gaps = 41/251 (16%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKA 194
S + + + +G G + V+ + + + VK+ ++P K K E K
Sbjct: 27 SHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI---LKPVKKKKIKREIKI 83
Query: 195 AINIK-HRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFL 253
N++ NI+ + + + F E + D F L
Sbjct: 84 LENLRGGPNIITLADIV-----KDPVSRTPALVF-------EHVNNTD--------FKQL 123
Query: 254 IKKKLDIAI-----DVACALRYLHCDCQPPIAHCNLKPSNVLLDDE-MIGHVGDFGMARF 307
+ D I ++ AL Y H I H ++KP NV++D E + D+G+A F
Sbjct: 124 YQTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 180
Query: 308 LPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYG-DVYSFGILLLEMFTGIRPSDGIFTG 366
+ N + S + PE + + Y D++S G +L M P F G
Sbjct: 181 YHPGQEYNVRV---ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP---FFHG 234
Query: 367 KMNLRNFVKMA 377
N V++A
Sbjct: 235 HDNYDQLVRIA 245
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 2e-08
Identities = 33/112 (29%), Positives = 51/112 (45%), Gaps = 18/112 (16%)
Query: 266 CALRYLH-CDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGS- 323
A++ LH + + H +LKPSN+L++ V DFG+AR + N + S
Sbjct: 123 RAVKVLHGSN----VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSG 178
Query: 324 -TGYI------PPEYDLGCEASTYG-DVYSFGILLLEMFTGIRPSDGIFTGK 367
++ PE L + DV+S G +L E+F RP IF G+
Sbjct: 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR-RP---IFPGR 226
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 35/109 (32%), Positives = 50/109 (45%), Gaps = 19/109 (17%)
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTG 325
L+Y+H + H +LKPSN+LL+ + DFG+AR F+ T
Sbjct: 139 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL-----TE 190
Query: 326 YI------PPEYDLGCEASTYG-DVYSFGILLLEMFTGIRPSDGIFTGK 367
Y+ PE L + T D++S G +L EM + RP IF GK
Sbjct: 191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN-RP---IFPGK 235
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 2e-08
Identities = 50/231 (21%), Positives = 88/231 (38%), Gaps = 57/231 (24%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSF--KSECKAAINI----KHRNIVR 205
+G+G F V G A K R S+ + E + +NI +H NI+
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKL------- 258
+ ++ ++ + + G L F+FL +K+
Sbjct: 73 LHDI-----FENKTDVVLILELVSGGEL----------------FDFLAEKESLTEDEAT 111
Query: 259 DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH----VGDFGMARFLPAIDKQ 314
+ + YLH IAH +LKP N++L D+ + + + DFG+A I+
Sbjct: 112 QFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK---IEAG 165
Query: 315 NRFICIKGSTGYIPPE------YDLGCEASTYGDVYSFGILLLEMFTGIRP 359
N F I G+ ++ PE L D++S G++ + +G P
Sbjct: 166 NEFKNIFGTPEFVAPEIVNYEPLGLEA------DMWSIGVITYILLSGASP 210
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 3e-08
Identities = 56/237 (23%), Positives = 89/237 (37%), Gaps = 64/237 (27%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNL-----------IRPGGSKSFKSECKAAINIKHR 201
+G G +G VY G +A+K L IR E + H
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIR---------EISLLKELHHP 79
Query: 202 NIVRVFTAFSGVD--YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLD 259
NIV + +V++FM L++ L D N L + IK
Sbjct: 80 NIVSLIDVIHSERCLT-------LVFEFMEK-DLKKVL----DENKTGLQDS-QIKI--- 123
Query: 260 IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF--LPAIDKQNRF 317
+ + + H I H +LKP N+L++ + + DFG+AR +P
Sbjct: 124 YLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP-------- 172
Query: 318 ICIKGSTG------YIPPEYDLGCEA-STYGDVYSFGILLLEMFTGIRPSDGIFTGK 367
++ T Y P+ +G + ST D++S G + EM TG +P +F G
Sbjct: 173 --VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG-KP---LFPGV 223
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 45/223 (20%), Positives = 77/223 (34%), Gaps = 62/223 (27%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAF 210
+G G VY A+KV + K ++E + + H NI+++ F
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 211 SGVDYQGARFKAVVYKFM---PNGSLEEWLRGKDDTNWRPLNFNFLIKKKL-------DI 260
+ + G L F+ +++K D
Sbjct: 118 ETPTE--------ISLVLELVTGGEL----------------FDRIVEKGYYSERDAADA 153
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLL---DDEMIGHVGDFGMARFLPAIDKQNRF 317
+ A+ YLH + I H +LKP N+L + + DFG+++ ++ Q
Sbjct: 154 VKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKI---VEHQVLM 207
Query: 318 ICIKGSTGYIPPE------YDLGCEASTYGDVYSFG----ILL 350
+ G+ GY PE Y D++S G ILL
Sbjct: 208 KTVCGTPGYCAPEILRGCAYGPEV------DMWSVGIITYILL 244
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 4e-08
Identities = 30/108 (27%), Positives = 43/108 (39%), Gaps = 22/108 (20%)
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTG 325
L +LH + H +LKP N+L+ + DFG+AR Q T
Sbjct: 131 RGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMAL------TS 178
Query: 326 ------YIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGK 367
Y PE L +T D++S G + EMF +P +F G
Sbjct: 179 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR-KP---LFRGS 222
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 5e-08
Identities = 26/110 (23%), Positives = 47/110 (42%), Gaps = 20/110 (18%)
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG-HVGDFGMARFLPAIDKQNRFICIKGST 324
L+Y+H + H +LKP+N+ ++ E + +GDFG+AR + + +
Sbjct: 131 RGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL-----S 182
Query: 325 GYI------PPEYDLGCEASTYG-DVYSFGILLLEMFTGIRPSDGIFTGK 367
+ P L T D+++ G + EM TG + +F G
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KT---LFAGA 228
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 6e-08
Identities = 52/271 (19%), Positives = 92/271 (33%), Gaps = 82/271 (30%)
Query: 131 TINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFK 189
I + D Y T+ ++G G G V A+K+ ++ +
Sbjct: 53 QIKKNAIIDDYKVTS-----QVLGLGINGKVLQIFNKRTQEKFALKM---LQD--CPKAR 102
Query: 190 SECKAAINI-----KHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTN 244
E + + + +IVR+ + + R + M E L G +
Sbjct: 103 RE----VELHWRASQCPHIVRIVDVYE--NLYAGRKC--LLIVM------ECLDGGE--- 145
Query: 245 WRPLNFNFLIKKKL---------DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE- 294
L F+ + + +I + A++YLH IAH ++KP N+L +
Sbjct: 146 ---L-FSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKR 198
Query: 295 -----MIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPE------YDLGCEASTYGDV 343
+ DFG A+ N + Y+ PE YD C D+
Sbjct: 199 PNAILKL---TDFGFAKE---TTSHNSLTTPCYTPYYVAPEVLGPEKYDKSC------DM 246
Query: 344 YSFGILLLEMFTGIRP---------SDGIFT 365
+S G+++ + G P S G+ T
Sbjct: 247 WSLGVIMYILLCGYPPFYSNHGLAISPGMKT 277
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 7e-08
Identities = 34/157 (21%), Positives = 63/157 (40%), Gaps = 36/157 (22%)
Query: 232 SLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL 291
+ E+L+ + N++P ++ +A + ALR+LH + Q + H +LKP N+L
Sbjct: 107 NTFEFLK---ENNFQPYPLP-HVRH---MAYQLCHALRFLH-ENQ--LTHTDLKPENILF 156
Query: 292 DDEMIGHVGDFGMARFLPAIDKQNRFICIK----GS--------TGYI------PPEYDL 333
+ + + + ++ + I+ GS T + PPE L
Sbjct: 157 VNSEFETLYNEHKSCEEKSVKNTS----IRVADFGSATFDHEHHTTIVATRHYRPPEVIL 212
Query: 334 GCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNL 370
+ DV+S G +L E + G +F N
Sbjct: 213 ELGWAQPCDVWSIGCILFEYYRG----FTLFQTHENR 245
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 52.5 bits (127), Expect = 1e-07
Identities = 49/238 (20%), Positives = 89/238 (37%), Gaps = 64/238 (26%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNL-----------IRPGGSKSFKSECKAAINIKH 200
IG G +G+V+ +A+K L +R E +KH
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---------EICLLKELKH 60
Query: 201 RNIVRVFTAFSGVD--YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKL 258
+NIVR+ +V++F L+++ D+ L+ ++K
Sbjct: 61 KNIVRLHDVLHSDKKLT-------LVFEFCDQ-DLKKYF----DSCNGDLDPE-IVKS-- 105
Query: 259 DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF--LPAIDKQNR 316
+ L + H + H +LKP N+L++ + +FG+AR +P
Sbjct: 106 -FLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP------- 154
Query: 317 FICIKGSTG------YIPPEYDLGCEA-STYGDVYSFGILLLEMFTGIRPSDGIFTGK 367
++ + Y PP+ G + ST D++S G + E+ RP +F G
Sbjct: 155 ---VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP---LFPGN 206
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 57/254 (22%), Positives = 95/254 (37%), Gaps = 65/254 (25%)
Query: 137 FKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKS----E 191
K + + S +G+G +GSV + G +A+K L RP S+ F E
Sbjct: 16 NKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK--KLSRPFQSEIFAKRAYRE 73
Query: 192 CKAAINIKHRNIVR---VFTAFSGVDYQGARFKAV--VYKFMPNGSLEEWLRGKDDTNWR 246
+++H N++ VFT S + F V FM T+
Sbjct: 74 LLLLKHMQHENVIGLLDVFTPASSLR----NFYDFYLVMPFM-------------QTD-- 114
Query: 247 PLNFNFLIKKKLD------IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300
++ K + + L+Y+H + H +LKP N+ ++++ +
Sbjct: 115 ---LQKIMGLKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKIL 168
Query: 301 DFGMARFLPAIDKQNRFICIKGSTGYI------PPEYDLGCEASTYG-DVYSFGILLLEM 353
DFG+AR TGY+ PE L D++S G ++ EM
Sbjct: 169 DFGLAR-----------HADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEM 217
Query: 354 FTGIRPSDGIFTGK 367
TG + +F GK
Sbjct: 218 LTG-KT---LFKGK 227
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 1e-07
Identities = 58/243 (23%), Positives = 91/243 (37%), Gaps = 71/243 (29%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNL----------IRPGGSKSFKSECKAAINIKHR 201
+G G + +VY G G +A+K L IR E +KH
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIR---------EISLMKELKHE 63
Query: 202 NIVRVFTAFSGVD--YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNF---LIKK 256
NIVR++ + +V++FM N L++++ D L+K
Sbjct: 64 NIVRLYDVIHTENKLT-------LVFEFMDN-DLKKYM---DSRTVGNTPRGLELNLVKY 112
Query: 257 KLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNR 316
+ L + H + I H +LKP N+L++ +GDFG+AR
Sbjct: 113 ---FQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARA--------- 157
Query: 317 FICIKGSTG-----------YIPPEYDLGCEA-STYGDVYSFGILLLEMFTGIRPSDGIF 364
G Y P+ +G ST D++S G +L EM TG +P +F
Sbjct: 158 ----FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITG-KP---LF 209
Query: 365 TGK 367
G
Sbjct: 210 PGT 212
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 2e-07
Identities = 47/235 (20%), Positives = 87/235 (37%), Gaps = 44/235 (18%)
Query: 153 IGAGNFGSVYNGTLFDGTT---IAVKVFNLIRPGGSKSFKSECKAAI--NIKHRNIVRVF 207
+G G +G VY DG A+K G S + + A+ +KH N++ +
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIE----GTGISMSACREIALLRELKHPNVISLQ 84
Query: 208 TAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNF---LIKKKLDIAIDV 264
F + + + +++ + + L ++ + ++K + +
Sbjct: 85 KVF--LSHADRKV-WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKS---LLYQI 137
Query: 265 ACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH----VGDFGMARFL-----PAIDKQN 315
+ YLH + + H +LKP+N+L+ E + D G AR P D
Sbjct: 138 LDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 194
Query: 316 RFICIKGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDGIFTGK 367
+ Y PE LG Y D+++ G + E+ T P IF +
Sbjct: 195 VVVTF----WYRAPELLLGAR--HYTKAIDIWAIGCIFAELLTS-EP---IFHCR 239
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 37/159 (23%), Positives = 54/159 (33%), Gaps = 34/159 (21%)
Query: 232 SLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL 291
SL E + N+ + IK I++ AL YL + H +LKP N+LL
Sbjct: 121 SLYEIIT---RNNYNGFHIE-DIKL---YCIEILKALNYLR-KMS--LTHTDLKPENILL 170
Query: 292 DDEMIGHVGDFGMARFLPAIDKQNRFIC--IK----GS--------TGYI------PPEY 331
DD + R IK G I PE
Sbjct: 171 DDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEV 230
Query: 332 DLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNL 370
L D++SFG +L E++TG +F ++
Sbjct: 231 ILNLGWDVSSDMWSFGCVLAELYTG----SLLFRTHEHM 265
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 56/238 (23%), Positives = 94/238 (39%), Gaps = 54/238 (22%)
Query: 147 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNL----------IRPGGSKSFKSECKAA 195
+ + +G G + +VY G +A+K L IR E
Sbjct: 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIR---------EVSLL 54
Query: 196 INIKHRNIVRVFTAFSGVD--YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFL 253
++KH NIV + +V++++ L+++L D +N +
Sbjct: 55 KDLKHANIVTLHDIIHTEKSLT-------LVFEYLDK-DLKQYL----DDCGNIINMH-N 101
Query: 254 IKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF--LPAI 311
+K + L Y H + + H +LKP N+L+++ + DFG+AR +P
Sbjct: 102 VKL---FLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155
Query: 312 DKQNRFICIKGSTG-YIPPEYDLGCEA-STYGDVYSFGILLLEMFTGIRPSDGIFTGK 367
N + T Y PP+ LG ST D++ G + EM TG RP +F G
Sbjct: 156 TYDNEVV-----TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATG-RP---LFPGS 204
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 61/248 (24%), Positives = 100/248 (40%), Gaps = 52/248 (20%)
Query: 137 FKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKS----E 191
K ++ + + + +G+G +GSV G +AVK L RP S E
Sbjct: 21 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK--KLSRPFQSIIHAKRTYRE 78
Query: 192 CKAAINIKHRNIVR---VFTAFSGVDYQGARFKAV--VYKFMPNGSLEEWLRGKDDTNWR 246
+ ++KH N++ VFT ++ F V V M L ++ + T+
Sbjct: 79 LRLLKHMKHENVIGLLDVFTPARSLE----EFNDVYLVTHLMGA-DLNNIVKCQKLTDDH 133
Query: 247 PLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMAR 306
FLI + L L+Y+H I H +LKPSN+ ++++ + DFG+AR
Sbjct: 134 ---VQFLIYQIL-------RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR 180
Query: 307 FLPAIDKQNRFICIKGSTGYI------PPEYDLGCEASTYG-DVYSFGILLLEMFTGIRP 359
+ TGY+ PE L D++S G ++ E+ TG R
Sbjct: 181 ------HTADEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG-RT 228
Query: 360 SDGIFTGK 367
+F G
Sbjct: 229 ---LFPGT 233
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-07
Identities = 36/122 (29%), Positives = 54/122 (44%), Gaps = 27/122 (22%)
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGS-- 323
++YLH + H ++KPSN+LL+ E V DFG++R I + I + +
Sbjct: 120 KVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 324 -----------TGYI------PPEYDLGCEASTYG-DVYSFGILLLEMFTGIRPSDGIFT 365
T Y+ PE LG T G D++S G +L E+ G +P IF
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG-KP---IFP 232
Query: 366 GK 367
G
Sbjct: 233 GS 234
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 6e-07
Identities = 31/157 (19%), Positives = 58/157 (36%), Gaps = 36/157 (22%)
Query: 232 SLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL 291
S ++++ + + P + I+K +A + ++ +LH + + H +LKP N+L
Sbjct: 102 STYDFIK---ENGFLPFRLD-HIRK---MAYQICKSVNFLH-SNK--LTHTDLKPENILF 151
Query: 292 DDEMIGHVGDFGMARFLPAIDKQNRFICIK----GSTGYI--------------PPEYDL 333
+ + R + + IK GS Y PE L
Sbjct: 152 VQSDYTEAYNPKIKRDERTLINPD----IKVVDFGSATYDDEHHSTLVSTRHYRAPEVIL 207
Query: 334 GCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNL 370
S DV+S G +L+E + G +F +
Sbjct: 208 ALGWSQPCDVWSIGCILIEYYLG----FTVFPTHDSK 240
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 6e-07
Identities = 31/109 (28%), Positives = 47/109 (43%), Gaps = 25/109 (22%)
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTG 325
LRY+H I H +LKP N+ ++++ + DFG+AR TG
Sbjct: 139 KGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----------QADSEMTG 184
Query: 326 YI------PPEYDLGCEASTYG-DVYSFGILLLEMFTGIRPSDGIFTGK 367
Y+ PE L T D++S G ++ EM TG + +F G
Sbjct: 185 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG-KT---LFKGS 229
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 49.8 bits (120), Expect = 6e-07
Identities = 55/237 (23%), Positives = 87/237 (36%), Gaps = 64/237 (27%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNL-----------IRPGGSKSFKSECKAAINIKHR 201
IG G +G VY G T A+K L IR E +KH
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR---------EISILKELKHS 60
Query: 202 NIVRVFTAFSGVD--YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLD 259
NIV+++ +V++ + L++ L D L K
Sbjct: 61 NIVKLYDVIHTKKRLV-------LVFEHLDQ-DLKKLL----DVCEGGLESV-TAKS--- 104
Query: 260 IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF--LPAIDKQNRF 317
+ + + Y H + H +LKP N+L++ E + DFG+AR +P
Sbjct: 105 FLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP-------- 153
Query: 318 ICIKGSTG------YIPPEYDLGCEA-STYGDVYSFGILLLEMFTGIRPSDGIFTGK 367
++ T Y P+ +G + ST D++S G + EM G P +F G
Sbjct: 154 --VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG-TP---LFPGV 204
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 8e-07
Identities = 53/238 (22%), Positives = 87/238 (36%), Gaps = 61/238 (25%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNL-----------IRPGGSKSFKSECKAAINIKH 200
+G G +G VY T+A+K L IR E ++H
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR---------EVSLLKELQH 92
Query: 201 RNIVRVFTAFSGVD--YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKL 258
RNI+ + + + +++++ N L++++ D N ++ +IK
Sbjct: 93 RNIIELKSVIHHNHRLH-------LIFEYAEN-DLKKYM----DKN-PDVSMR-VIKS-- 136
Query: 259 DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG-----DFGMARF--LPAI 311
+ + + H H +LKP N+LL DFG+AR +P
Sbjct: 137 -FLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR 192
Query: 312 DKQNRFICIKGSTG-YIPPEYDLGCEA-STYGDVYSFGILLLEMFTGIRPSDGIFTGK 367
+ I T Y PPE LG ST D++S + EM P +F G
Sbjct: 193 QFTHEII-----TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMK-TP---LFPGD 241
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 9e-07
Identities = 57/240 (23%), Positives = 83/240 (34%), Gaps = 66/240 (27%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKS--------ECKAAINIKHRNI 203
+G G F +VY +A+K I+ G K E K + H NI
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKK---IKLGHRSEAKDGINRTALREIKLLQELSHPNI 74
Query: 204 VRVFTAFSGVD--YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIA 261
+ + AF +V+ FM LE + N L + IK
Sbjct: 75 IGLLDAFGHKSNIS-------LVFDFMET-DLEVII----KDNSLVLTPS-HIKA---YM 118
Query: 262 IDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIK 321
+ L YLH I H +LKP+N+LLD+ + + DFG+A+
Sbjct: 119 LMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS-------------F 162
Query: 322 GSTG-----------YIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDGIFTGK 367
GS Y PE G YG D+++ G +L E+ P G
Sbjct: 163 GSPNRAYTHQVVTRWYRAPELLFGAR--MYGVGVDMWAVGCILAELLLR-VP---FLPGD 216
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 1e-06
Identities = 50/240 (20%), Positives = 90/240 (37%), Gaps = 65/240 (27%)
Query: 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNL-----------IRPGGSKSFKSECKAAINI 198
L+G G++G V G +A+K F +R E K +
Sbjct: 31 GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR---------EIKLLKQL 81
Query: 199 KHRNIVRVFTAFSGVD--YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKK 256
+H N+V + Y +V++F+ + ++ + L + L++ +++K
Sbjct: 82 RHENLVNLLEVCKKKKRWY-------LVFEFVDH-TILDDL----ELFPNGLDYQ-VVQK 128
Query: 257 KLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNR 316
+ + + H I H ++KP N+L+ + + DFG AR L
Sbjct: 129 ---YLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLA--APGEV 180
Query: 317 FICIKGSTGYI------PPEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDGIFTGK 367
+ + PE +G YG DV++ G L+ EMF G P +F G
Sbjct: 181 Y------DDEVATRWYRAPELLVGDV--KYGKAVDVWAIGCLVTEMFMG-EP---LFPGD 228
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 2e-06
Identities = 49/238 (20%), Positives = 88/238 (36%), Gaps = 65/238 (27%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNL-----------IRPGGSKSFKSECKAAINIKH 200
IG G++G V+ G +A+K F +R E + +KH
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR---------EIRMLKQLKH 61
Query: 201 RNIVRVFTAFSGVD--YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKL 258
N+V + F + +V+++ + ++ L D R + + L+K
Sbjct: 62 PNLVNLLEVFRRKRRLH-------LVFEYCDH-TVLHEL----DRYQRGVPEH-LVKS-- 106
Query: 259 DIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFI 318
I A+ + H + H ++KP N+L+ + + DFG AR L
Sbjct: 107 -ITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY--- 159
Query: 319 CIKGSTGYI------PPEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDGIFTGK 367
+ PE +G YG DV++ G + E+ +G P ++ GK
Sbjct: 160 -----DDEVATRWYRSPELLVGDT--QYGPPVDVWAIGCVFAELLSG-VP---LWPGK 206
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 27/124 (21%), Positives = 48/124 (38%), Gaps = 26/124 (20%)
Query: 266 CALRYLH-CDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGS- 323
++H I H +LKP+N LL+ + V DFG+AR + + N ++ +
Sbjct: 140 LGENFIHESG----IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195
Query: 324 -------------TGYI------PPEYDLGCEASTYG-DVYSFGILLLEMFTGIRPSDGI 363
T ++ PE L E T D++S G + E+ ++
Sbjct: 196 EPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255
Query: 364 FTGK 367
T +
Sbjct: 256 PTNR 259
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 42/234 (17%), Positives = 83/234 (35%), Gaps = 41/234 (17%)
Query: 152 LIGAGNFGSVYNGTLFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTA 209
IG G FG +Y + ++ +++ P + +E K ++ +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 210 FSGVDYQG---------ARFKAVVYKFM------PNGSLEEWLRGKDDTNWRPLNFNFLI 254
+ Y G Y+FM L++ F
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS--DLQKIYEANAKR--------FSR 151
Query: 255 KKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD--DEMIGHVGDFGMA-RFLPAI 311
K L +++ + L Y+H H ++K SN+LL+ + ++ D+G+A R+ P
Sbjct: 152 KTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCP-- 206
Query: 312 DKQNRFI------CIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
+ ++ C G+ + + G S GD+ G +++ TG P
Sbjct: 207 EGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 4e-05
Identities = 33/160 (20%), Positives = 54/160 (33%), Gaps = 36/160 (22%)
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGS-- 323
++Y+H I H +LKP+N L++ + V DFG+AR + + N + I
Sbjct: 167 VGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223
Query: 324 -----------------TGYI------PPEYDLGCEASTYG-DVYSFGILLLEMFTGIRP 359
TG++ PE L E T DV+S G + E+ I+
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283
Query: 360 SDG-------IFTGKMNLRNFVKMALPQRAEEVVDDFNLQ 392
+ +F G + Q
Sbjct: 284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQ 323
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 36/162 (22%), Positives = 68/162 (41%), Gaps = 28/162 (17%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAA-INIKHRNIVRVFTAF 210
IG GNFG + G L+ +A+K+ + E + I +V+ +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKL--EPMKSRAPQLHLEYRFYKQLGSGDGIPQVY--Y 72
Query: 211 SGVDYQGARFKAVVYKFMPNG-SLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALR 269
G ++ A+V + + G SLE+ + + F +K L IAI + +
Sbjct: 73 FGPC---GKYNAMVLELL--GPSLEDL--------FDLCDRTFSLKTVLMIAIQLISRME 119
Query: 270 YLHCDCQPPIAHCNLKPSNVLL-----DDEMIGHVGDFGMAR 306
Y+H + + ++KP N L+ + + H+ DF +A+
Sbjct: 120 YVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 42.2 bits (98), Expect = 3e-04
Identities = 40/255 (15%), Positives = 67/255 (26%), Gaps = 49/255 (19%)
Query: 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRP----GGSKSFKSE 191
F T IG G FG V+ D T +A+K+ + P G + E
Sbjct: 12 PFSHCL-PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEE 69
Query: 192 CKAAINI-KHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGK-------DDT 243
I I K +++ + G V P L+ W D
Sbjct: 70 ILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRP 129
Query: 244 NWRPLNFNFLI--------------------KKKLDIAIDVACALRYLHCDCQPPIAHCN 283
++ + F++ I + +L + H +
Sbjct: 130 DFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRD 187
Query: 284 LKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGD- 342
L NVLL + + + I G D
Sbjct: 188 LHWGNVLLKKTSLKKLHYTL----------NGKSSTIPSC-GLQVSIIDYTLSRLERDGI 236
Query: 343 -VYSFGILLLEMFTG 356
V+ + ++FTG
Sbjct: 237 VVFCDVSMDEDLFTG 251
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 41.0 bits (96), Expect = 5e-04
Identities = 28/146 (19%), Positives = 45/146 (30%), Gaps = 56/146 (38%)
Query: 260 IAIDVACALRYLHCDCQPPIAHCNLKPSNVLL--DDEMIGH------------------- 298
I V L YLH C+ I H ++KP N+LL +++ I
Sbjct: 151 IIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208
Query: 299 ----------------------------VGDFGMARFLPAIDKQNRFICIKGSTGYIPPE 330
+ D G A ++ K + Y E
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWV---HKHFTEDI--QTRQYRSLE 263
Query: 331 YDLGCEASTYGDVYSFGILLLEMFTG 356
+G +T D++S + E+ TG
Sbjct: 264 VLIGSGYNTPADIWSTACMAFELATG 289
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 7e-04
Identities = 47/231 (20%), Positives = 82/231 (35%), Gaps = 38/231 (16%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAF 210
IG+G FG +Y A V + + SE K + ++ ++ +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVK-VEYQENGPLFSELKFYQRVAKKDCIKKWIER 102
Query: 211 SGVDYQG---------ARFKAVVYKFM------PNGSLEEWLRGKDDTNWRPLNFNFLIK 255
+DY G FK Y+FM L++ N F
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGI--DLQKISG---------QNGTFKKS 151
Query: 256 KKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD--DEMIGHVGDFGMA-RFLPAID 312
L + I + L Y+H + H ++K +N+LL + ++ D+G++ R+ P +
Sbjct: 152 TVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGN 208
Query: 313 KQN-RFICIKGSTG---YIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
+ + KG G + + G S DV G +L G P
Sbjct: 209 HKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 8e-04
Identities = 45/254 (17%), Positives = 81/254 (31%), Gaps = 76/254 (29%)
Query: 124 PVYEGKQTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP 182
P + I + D Y ++ ++G G G V A+K+
Sbjct: 2 PHVKSGLQIKKNAIIDDY-----KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ---- 52
Query: 183 GGSKSFKSECKAAINI-----KHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWL 237
+ E + + + +IVR+ + + + M E L
Sbjct: 53 -DCPKARRE----VELHWRASQCPHIVRIVDVYE----NLYAGRKCLLIVM------ECL 97
Query: 238 RGKDDTNWRPLNFNFLIKKKL---------DIAIDVACALRYLHCDCQPPIAHCNLKPSN 288
G + L F+ + + +I + A++YLH IAH ++KP N
Sbjct: 98 DGGE------L-FSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPEN 147
Query: 289 VLL---DDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYS 345
+L I + DFG A + YD C D++S
Sbjct: 148 LLYTSKRPNAILKLTDFGFA---KETTGEK---------------YDKSC------DMWS 183
Query: 346 FGILLLEMFTGIRP 359
G+++ + G P
Sbjct: 184 LGVIMYILLCGYPP 197
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 473 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.85 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.76 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.41 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.32 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.12 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.1 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.03 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.01 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 98.98 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 98.92 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 98.89 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 98.75 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 98.73 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.73 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 98.7 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.64 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 98.51 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 98.49 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.47 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 98.47 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.47 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 98.45 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 98.42 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 98.41 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 98.4 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 98.36 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 98.36 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 98.33 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 98.31 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 98.31 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 98.3 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 98.29 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.29 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.27 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 98.27 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 98.25 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 98.23 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 98.23 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.22 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 98.2 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 98.19 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 98.19 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 98.19 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 98.18 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 98.17 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 98.16 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 98.16 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 98.13 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 98.13 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 98.13 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 98.11 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 98.11 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 98.11 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 98.1 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 98.1 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 98.1 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 98.1 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 98.1 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 98.09 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 98.08 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 98.08 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 98.08 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 98.08 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 98.07 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 98.07 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 98.07 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 98.06 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 98.06 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.06 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 98.06 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 98.05 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 98.05 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 98.05 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 98.05 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 98.04 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 98.04 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 98.03 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 98.03 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 98.03 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 98.03 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 98.03 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 98.02 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 98.02 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 98.02 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 98.01 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 98.01 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 98.01 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 98.01 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 98.01 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 98.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 98.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 98.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 97.99 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 97.99 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 97.99 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 97.99 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.98 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 97.98 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 97.98 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 97.97 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 97.97 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 97.97 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 97.96 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 97.95 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 97.94 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 97.92 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 97.92 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 97.92 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 97.91 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 97.9 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 97.9 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 97.89 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 97.89 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 97.88 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 97.87 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 97.86 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 97.86 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 97.84 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 97.84 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 97.83 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 97.83 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 97.83 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 97.82 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 97.82 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 97.82 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 97.8 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 97.79 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 97.78 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 97.78 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 97.77 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.76 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 97.76 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 97.76 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 97.75 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 97.74 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 97.74 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 97.74 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 97.73 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 97.73 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 97.72 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 97.72 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 97.72 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 97.72 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 97.7 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.7 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 97.7 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 97.69 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 97.69 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 97.68 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 97.68 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 97.68 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 97.67 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 97.67 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 97.67 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 97.67 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 97.66 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 97.66 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 97.65 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 97.65 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 97.65 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 97.64 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 97.63 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 97.63 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 97.63 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 97.63 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 97.62 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.61 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 97.61 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 97.61 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 97.61 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 97.6 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 97.6 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 97.59 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 97.59 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 97.59 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 97.59 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 97.58 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 97.57 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 97.57 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 97.57 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 97.57 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 97.57 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 97.56 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 97.56 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 97.55 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 97.54 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 97.54 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 97.53 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 97.52 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 97.52 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 97.52 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 97.51 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 97.5 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 97.5 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 97.5 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 97.49 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 97.49 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 97.49 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 97.48 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 97.48 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.48 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 97.47 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 97.47 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 97.46 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 97.46 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 97.46 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 97.46 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 97.45 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 97.45 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 97.45 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 97.45 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 97.44 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 97.44 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 97.43 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 97.43 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 97.42 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 97.42 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 97.41 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 97.41 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 97.41 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 97.4 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 97.4 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 97.4 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.39 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 97.36 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 97.35 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 97.34 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 97.34 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 97.34 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 97.34 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.33 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 97.33 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 97.31 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 97.3 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 97.29 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.29 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.28 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 97.27 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 97.27 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 97.27 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 97.26 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 97.26 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 97.24 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 97.19 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 97.19 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 97.19 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 97.16 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-61 Score=449.73 Aligned_cols=267 Identities=24% Similarity=0.373 Sum_probs=207.5
Q ss_pred hhhcccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCC--CCchhHHHHHHHHHhcCCCCceeeeeeeeccccC
Q 012014 139 DLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQ 216 (473)
Q Consensus 139 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 216 (473)
.|+...++|.+.++||+|+||+||+|++. ..||||+++.... ...+.|.+|+.++++++|||||++++++.+
T Consensus 30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~---- 103 (307)
T 3omv_A 30 YWEIEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK---- 103 (307)
T ss_dssp CCBCCTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----
T ss_pred CcEEcHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC----
Confidence 34556678899999999999999999853 4699999874432 234578999999999999999999998743
Q ss_pred CceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCcc
Q 012014 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI 296 (473)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~ 296 (473)
...+||||||++|+|.++|..... .+++.+++.|+.||+.||.||| +++||||||||+|||+++++.
T Consensus 104 --~~~~iVmEy~~gGsL~~~l~~~~~--------~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~ 170 (307)
T 3omv_A 104 --DNLAIVTQWCEGSSLYKHLHVQET--------KFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLT 170 (307)
T ss_dssp --SSCEEEEECCSSCBHHHHHHTSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEE
T ss_pred --CeEEEEEEcCCCCCHHHHHhhcCC--------CCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCc
Confidence 246899999999999999976532 3679999999999999999999 899999999999999999999
Q ss_pred EEEeecccccccCccccccceeeccCCCCcCCCccccC---CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHH
Q 012014 297 GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG---CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNF 373 (473)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~ 373 (473)
+||+|||+|+..............+||+.|||||++.+ ..|+.++|||||||++|||+||+.||.+...... +...
T Consensus 171 ~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~-~~~~ 249 (307)
T 3omv_A 171 VKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ-IIFM 249 (307)
T ss_dssp EEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HHHH
T ss_pred EEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH-HHHH
Confidence 99999999987655443444556789999999999864 4589999999999999999999999986433221 1111
Q ss_pred HHh-hcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHH
Q 012014 374 VKM-ALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLI 452 (473)
Q Consensus 374 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l 452 (473)
+.. ..+.... ....+++..+.+|+.+||+.||++||||.||++.|+.|
T Consensus 250 ~~~~~~~p~~~-------------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 250 VGRGYASPDLS-------------------------------KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp HHTTCCCCCST-------------------------------TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred HhcCCCCCCcc-------------------------------cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111 1111100 01123567889999999999999999999999999999
Q ss_pred HHhh
Q 012014 453 RRKL 456 (473)
Q Consensus 453 ~~~~ 456 (473)
+..+
T Consensus 299 ~~~l 302 (307)
T 3omv_A 299 QHSL 302 (307)
T ss_dssp HTTC
T ss_pred hccC
Confidence 7654
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-61 Score=450.60 Aligned_cols=267 Identities=23% Similarity=0.377 Sum_probs=210.8
Q ss_pred CCCCccceeecCCCeEEEEEEec------CCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 145 NGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
++|.+.+.||+|+||.||+|++. +++.||||+++.......+.|.+|+++|++++|||||+++++|.+.
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~----- 87 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG----- 87 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC-----
Confidence 56888999999999999999853 4678999999865545567899999999999999999999998653
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCC----CCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCC
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDT----NWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE 294 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~----~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~ 294 (473)
...+||||||++|+|.++|+..... ........+++.+++.|+.||+.||.||| +++||||||||+|||++.+
T Consensus 88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGEN 164 (299)
T ss_dssp SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCC
Confidence 3679999999999999999765310 00011124779999999999999999999 8999999999999999999
Q ss_pred ccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHH
Q 012014 295 MIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNF 373 (473)
Q Consensus 295 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~ 373 (473)
+.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.+....+ +...
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~--~~~~ 242 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--VIEC 242 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHHH
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHH
Confidence 9999999999987654433222333458999999999999999999999999999999999 899998643211 1111
Q ss_pred HHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHH
Q 012014 374 VKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIR 453 (473)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~ 453 (473)
+... .. .+.+..++.++.+|+.+||+.||++|||++||++.|+.+.
T Consensus 243 i~~~--------------------~~--------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 243 ITQG--------------------RV--------------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp HHHT--------------------CC--------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHcC--------------------CC--------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1000 00 0011235678899999999999999999999999999886
Q ss_pred Hh
Q 012014 454 RK 455 (473)
Q Consensus 454 ~~ 455 (473)
+.
T Consensus 289 ~~ 290 (299)
T 4asz_A 289 KA 290 (299)
T ss_dssp HH
T ss_pred hc
Confidence 53
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-60 Score=451.40 Aligned_cols=267 Identities=25% Similarity=0.372 Sum_probs=205.3
Q ss_pred CCCCccceeecCCCeEEEEEEec------CCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 145 NGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
++|.+.++||+|+||.||+|++. +++.||||+++.......+.|.+|+++|++++|||||+++++|.+.
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~----- 115 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEG----- 115 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----
Confidence 46778899999999999999853 4788999999765544567899999999999999999999998653
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCC------CCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEec
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNW------RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD 292 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~------~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~ 292 (473)
...+||||||++|+|.++++....... ......+++.+++.|+.||+.||.||| +++||||||||+|||++
T Consensus 116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVG 192 (329)
T ss_dssp SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEEC
Confidence 367999999999999999987543210 011224779999999999999999999 89999999999999999
Q ss_pred CCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHH
Q 012014 293 DEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLR 371 (473)
Q Consensus 293 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~ 371 (473)
.++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||.+....+ +.
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~--~~ 270 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE--AI 270 (329)
T ss_dssp TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH--HH
T ss_pred CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH--HH
Confidence 999999999999987655443334445679999999999999999999999999999999999 899998643211 11
Q ss_pred HHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHH
Q 012014 372 NFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRL 451 (473)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 451 (473)
..+... .+ .+.+..+++++.+|+.+||+.||++||||.||++.|+.
T Consensus 271 ~~i~~g--------------------~~--------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~ 316 (329)
T 4aoj_A 271 DCITQG--------------------RE--------------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQA 316 (329)
T ss_dssp HHHHHT--------------------CC--------------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHH
T ss_pred HHHHcC--------------------CC--------------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence 111000 00 00112356788999999999999999999999999999
Q ss_pred HHHh
Q 012014 452 IRRK 455 (473)
Q Consensus 452 l~~~ 455 (473)
+.+.
T Consensus 317 l~~~ 320 (329)
T 4aoj_A 317 LAQA 320 (329)
T ss_dssp HHHS
T ss_pred HhhC
Confidence 8653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-59 Score=441.08 Aligned_cols=264 Identities=21% Similarity=0.361 Sum_probs=210.1
Q ss_pred CCCCccceeecCCCeEEEEEEec------CCCEEEEEEeeccC-CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCC
Q 012014 145 NGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (473)
.++++.++||+|+||.||+|.+. +++.||||+++... ....+.|.+|+.++++++|||||+++|+|.+.
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~---- 101 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD---- 101 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS----
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC----
Confidence 45667889999999999999852 46789999997443 23456899999999999999999999998653
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCC-------CCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEE
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTN-------WRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVL 290 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~-------~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil 290 (473)
...+||||||++|||.++|....... .......+++.+++.|+.||+.||.||| +++||||||||+|||
T Consensus 102 -~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NIL 177 (308)
T 4gt4_A 102 -QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVL 177 (308)
T ss_dssp -SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred -CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceE
Confidence 35799999999999999997653221 1112235789999999999999999999 899999999999999
Q ss_pred ecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCccc
Q 012014 291 LDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMN 369 (473)
Q Consensus 291 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~ 369 (473)
+++++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |..||.+....+
T Consensus 178 l~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~-- 255 (308)
T 4gt4_A 178 VYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD-- 255 (308)
T ss_dssp ECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH--
T ss_pred ECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH--
Confidence 99999999999999987655443344445679999999999999999999999999999999998 899998643211
Q ss_pred HHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHH
Q 012014 370 LRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRL 449 (473)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L 449 (473)
+...+.. +.. .+.+.+++..+.+|+.+||+.||++||||.||++.|
T Consensus 256 ~~~~i~~---~~~-------------------------------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L 301 (308)
T 4gt4_A 256 VVEMIRN---RQV-------------------------------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 301 (308)
T ss_dssp HHHHHHT---TCC-------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHc---CCC-------------------------------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 1111110 000 011224667899999999999999999999999999
Q ss_pred HHH
Q 012014 450 RLI 452 (473)
Q Consensus 450 ~~l 452 (473)
+.+
T Consensus 302 ~a~ 304 (308)
T 4gt4_A 302 RAW 304 (308)
T ss_dssp HTS
T ss_pred Hhc
Confidence 864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-58 Score=438.01 Aligned_cols=249 Identities=20% Similarity=0.262 Sum_probs=206.4
Q ss_pred CCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEE
Q 012014 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (473)
..|++.++||+|+||.||+|+. .+|+.||||+++.......+.+.+|+.+|+.++|||||+++++|.+. ...||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-----~~~~i 148 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DELWV 148 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEEE
Confidence 4688899999999999999994 57999999999876666778899999999999999999999998653 37899
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecc
Q 012014 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (473)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg 303 (473)
|||||+||+|.+++... .+++.++..++.||+.||.||| +++||||||||+|||++.+|.+||+|||
T Consensus 149 vmEy~~gg~L~~~l~~~----------~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFG 215 (346)
T 4fih_A 149 VMEFLEGGALTDIVTHT----------RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFG 215 (346)
T ss_dssp EECCCTTEEHHHHHHHS----------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCT
T ss_pred EEeCCCCCcHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCc
Confidence 99999999999999754 3668999999999999999999 9999999999999999999999999999
Q ss_pred cccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchh
Q 012014 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAE 383 (473)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 383 (473)
+|+.+.... ......+||+.|||||++.+..|+.++|||||||++|||++|..||.+....+ ....+....+....
T Consensus 216 la~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~--~~~~i~~~~~~~~~ 291 (346)
T 4fih_A 216 FCAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--AMKMIRDNLPPRLK 291 (346)
T ss_dssp TCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHSSCCCCS
T ss_pred CceecCCCC--CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--HHHHHHcCCCCCCC
Confidence 998765432 23345679999999999999999999999999999999999999997632111 11111111111000
Q ss_pred hhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 384 EVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.....+.++.+|+.+||..||++|||+.|+++
T Consensus 292 --------------------------------~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 292 --------------------------------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp --------------------------------CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --------------------------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 01124567889999999999999999999865
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-59 Score=438.33 Aligned_cols=250 Identities=21% Similarity=0.345 Sum_probs=207.5
Q ss_pred CCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeecc---CCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
++|++.++||+|+||+||+|+ ..+|+.||||++++. .....+.+.+|+++|++++|||||+++++|.+ ...
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~ 106 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-----DEK 106 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----CCE
Confidence 579999999999999999999 567999999999742 23456779999999999999999999999865 347
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.|+|||||+||+|.+++.... .+++.++..++.||+.||.||| +++|+||||||+|||++.++.+||+
T Consensus 107 ~yivmEy~~gG~L~~~i~~~~---------~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~ 174 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRKIG---------SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQIT 174 (311)
T ss_dssp EEEEECCCTTEEHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEEC
T ss_pred EEEEEecCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEE
Confidence 899999999999999997654 4679999999999999999999 9999999999999999999999999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCc
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQ 380 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 380 (473)
|||+|+.+..........+.+||+.|||||++.+..|+.++|||||||++|||++|..||.+..... .+........
T Consensus 175 DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-~~~~i~~~~~-- 251 (311)
T 4aw0_A 175 DFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL-IFAKIIKLEY-- 251 (311)
T ss_dssp CCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCC--
T ss_pred EcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHcCCC--
Confidence 9999998765444445566789999999999999999999999999999999999999997632111 1111111100
Q ss_pred chhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 381 RAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
. .+...++++.+|+.+||..||++|||+.|++..
T Consensus 252 ~----------------------------------~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~ 285 (311)
T 4aw0_A 252 D----------------------------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 285 (311)
T ss_dssp C----------------------------------CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred C----------------------------------CCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence 0 001134567899999999999999999997544
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-58 Score=433.77 Aligned_cols=264 Identities=20% Similarity=0.231 Sum_probs=210.1
Q ss_pred ccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
..+.|...++||+|+||.||+|+ ..+|+.||||+++... ...+|+.+++.++|||||+++++|.+. ...
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~-----~~~ 125 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREG-----PWV 125 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEET-----TEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEE
Confidence 34568889999999999999999 4579999999997532 235799999999999999999998653 368
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCc-cEEEe
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM-IGHVG 300 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~-~~kl~ 300 (473)
|||||||+||+|.++|+... .+++.++..++.||+.||.||| +++||||||||+|||++.+| .+||+
T Consensus 126 ~ivmEy~~gg~L~~~l~~~~---------~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~ 193 (336)
T 4g3f_A 126 NIFMELLEGGSLGQLIKQMG---------CLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALC 193 (336)
T ss_dssp EEEECCCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEEC
T ss_pred EEEEeccCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEe
Confidence 99999999999999997654 3679999999999999999999 99999999999999999987 69999
Q ss_pred ecccccccCcccccc---ceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 301 DFGMARFLPAIDKQN---RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
|||+|+.+....... .....+||+.|||||++.+..|+.++|||||||++|||++|.+||.+...... +.......
T Consensus 194 DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~i~~~~ 272 (336)
T 4g3f_A 194 DFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL-CLKIASEP 272 (336)
T ss_dssp CCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC-HHHHHHSC
T ss_pred eCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHHHcCC
Confidence 999998775432211 22345799999999999999999999999999999999999999987544332 22221111
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHHhhc
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRKLL 457 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~~~ 457 (473)
. ... ..+..++..+.+|+.+||+.||++|||+.||++.|........
T Consensus 273 ~--~~~-------------------------------~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 273 P--PIR-------------------------------EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp C--GGG-------------------------------GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred C--Cch-------------------------------hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 0 000 0112345678899999999999999999999999988876643
Q ss_pred --cCCcc
Q 012014 458 --ETPAC 462 (473)
Q Consensus 458 --~~~~~ 462 (473)
.+|+-
T Consensus 320 ~l~hPw~ 326 (336)
T 4g3f_A 320 GLKSPWK 326 (336)
T ss_dssp SSCSCSS
T ss_pred hccCCCc
Confidence 34443
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-58 Score=426.17 Aligned_cols=248 Identities=23% Similarity=0.333 Sum_probs=196.5
Q ss_pred CccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCC--CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEE
Q 012014 148 SSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVV 224 (473)
Q Consensus 148 ~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 224 (473)
++.++||+|+||.||+|. ..++..||+|++..... ...+.|.+|+.++++++|||||+++++|.+.. ......+||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~~~~lv 107 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVLV 107 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCcEEEEE
Confidence 566789999999999998 45689999999974332 23456899999999999999999999986532 334568999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCC--eeeccCCCCcEEecC-CccEEEee
Q 012014 225 YKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPP--IAHCNLKPSNVLLDD-EMIGHVGD 301 (473)
Q Consensus 225 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~Dlkp~Nil~~~-~~~~kl~D 301 (473)
||||++|+|.+++.... .+++..+..++.||+.||.||| +++ ||||||||+|||++. ++.+||+|
T Consensus 108 mEy~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~D 175 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFK---------VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGD 175 (290)
T ss_dssp EECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECC
T ss_pred EeCCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEe
Confidence 99999999999997654 3668999999999999999999 777 999999999999974 79999999
Q ss_pred cccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcc
Q 012014 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQR 381 (473)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 381 (473)
||+|+.... ......+||+.|||||++.+ .|+.++|||||||++|||+||..||.+..... ..........
T Consensus 176 FGla~~~~~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~----~~~~~i~~~~ 246 (290)
T 3fpq_A 176 LGLATLKRA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA----QIYRRVTSGV 246 (290)
T ss_dssp TTGGGGCCT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH----HHHHHHTTTC
T ss_pred CcCCEeCCC----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH----HHHHHHHcCC
Confidence 999986432 23345689999999999875 69999999999999999999999997532221 1111111100
Q ss_pred hhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 382 AEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
... ..+...++++.+|+.+||..||++|||++|+++
T Consensus 247 ~~~------------------------------~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 247 KPA------------------------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CCG------------------------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCC------------------------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 001113446789999999999999999999864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-59 Score=443.28 Aligned_cols=251 Identities=22% Similarity=0.308 Sum_probs=198.9
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCC--CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
-++|++.+.||+|+||.||+|+ ..+|+.||||+++.... ...+.+.+|+.+|++++|||||+++++|.+. ..
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~-----~~ 97 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEEN-----GS 97 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC-----CE
Confidence 3689999999999999999999 46799999999975432 2345789999999999999999999998653 46
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.|||||||+||+|.++|...... .+++.+++.|+.||+.||.||| ++|||||||||+|||++.++.+||+
T Consensus 98 ~yiVmEy~~gg~L~~~i~~~~~~-------~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~ 167 (350)
T 4b9d_A 98 LYIVMDYCEGGDLFKRINAQKGV-------LFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLG 167 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHTTTC-------CCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEEC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCC-------CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEc
Confidence 89999999999999999755422 3568899999999999999999 9999999999999999999999999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCc
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQ 380 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 380 (473)
|||+|+.+.... ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+....+ .+........+.
T Consensus 168 DFGla~~~~~~~--~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-~~~~i~~~~~~~ 244 (350)
T 4b9d_A 168 DFGIARVLNSTV--ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN-LVLKIISGSFPP 244 (350)
T ss_dssp STTEESCCCHHH--HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHTCCCC
T ss_pred ccccceeecCCc--ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-HHHHHHcCCCCC
Confidence 999998764321 22334579999999999999999999999999999999999999997632211 111111111110
Q ss_pred chhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 381 RAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.....+.++.+|+.+||+.||++|||+.|+++
T Consensus 245 -----------------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 245 -----------------------------------VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp -----------------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----------------------------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01123557889999999999999999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-57 Score=439.48 Aligned_cols=250 Identities=20% Similarity=0.255 Sum_probs=207.1
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
.+.|++.++||+|+||.||+|+ ..+|+.||||+++.......+.+.+|+.+|+.++|||||+++++|.+. ...|
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-----~~~~ 224 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-----DELW 224 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEEC-----CEEE
Confidence 3569999999999999999999 457999999999877767778899999999999999999999998653 3789
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
||||||+||+|.+++... .+++.++..++.||+.||.||| ++|||||||||+|||++.+|.+||+||
T Consensus 225 iVmEy~~gG~L~~~i~~~----------~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DF 291 (423)
T 4fie_A 225 VVMEFLEGGALTDIVTHT----------RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDF 291 (423)
T ss_dssp EEEECCTTEEHHHHHHHS----------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCC
T ss_pred EEEeCCCCCcHHHHHhcc----------CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecC
Confidence 999999999999999754 3668999999999999999999 899999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcch
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRA 382 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 382 (473)
|+|+.+.... ......+||+.|||||++.+..|+.++|||||||++|||++|..||.+....+ ....+....+...
T Consensus 292 Gla~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~--~~~~i~~~~~~~~ 367 (423)
T 4fie_A 292 GFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--AMKMIRDNLPPRL 367 (423)
T ss_dssp TTCEECCSSC--CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHSCCCCC
T ss_pred ccceECCCCC--ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--HHHHHHcCCCCCC
Confidence 9998765432 23345679999999999999999999999999999999999999997632111 1111111111100
Q ss_pred hhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 383 EEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
. .....+..+.+|+.+||..||++|||+.|+++
T Consensus 368 ~--------------------------------~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 368 K--------------------------------NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp S--------------------------------CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred c--------------------------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 00123457889999999999999999999865
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-57 Score=436.11 Aligned_cols=277 Identities=21% Similarity=0.273 Sum_probs=217.2
Q ss_pred hhhhhcccCCCCccceeecCCCeEEEEEEecC------CCEEEEEEeeccCC-CCchhHHHHHHHHHhcCC-CCceeeee
Q 012014 137 FKDLYNATNGFSSANLIGAGNFGSVYNGTLFD------GTTIAVKVFNLIRP-GGSKSFKSECKAAINIKH-RNIVRVFT 208 (473)
Q Consensus 137 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h-~niv~~~~ 208 (473)
..+|+...++|++.+.||+|+||.||+|.+.. ++.||||+++.... ...+.|.+|+.+|.+++| ||||++++
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 34566677899999999999999999998432 35799999975332 234568999999999965 99999999
Q ss_pred eeeccccCCceeeEEEEEecCCCCHHHHhcCCCCCC-------CCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeee
Q 012014 209 AFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTN-------WRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAH 281 (473)
Q Consensus 209 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~-------~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH 281 (473)
+|... ....+||||||++|+|.++|+...... .......+++.+++.++.||+.||.||| +++|||
T Consensus 136 ~~~~~----~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiH 208 (353)
T 4ase_A 136 ACTKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIH 208 (353)
T ss_dssp EECCT----TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCC
T ss_pred EEEec----CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeec
Confidence 98542 235799999999999999997643210 0011224779999999999999999999 899999
Q ss_pred ccCCCCcEEecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCC
Q 012014 282 CNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPS 360 (473)
Q Consensus 282 ~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~ 360 (473)
|||||+|||+++++.+||+|||+|+.+.............||+.|||||++.+..|+.++|||||||++|||+| |..||
T Consensus 209 RDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf 288 (353)
T 4ase_A 209 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 288 (353)
T ss_dssp SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCC
Confidence 99999999999999999999999997755443333445668999999999999999999999999999999998 99999
Q ss_pred CCCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCC
Q 012014 361 DGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERM 440 (473)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 440 (473)
.+...... +...+...... ..+..+++++.+|+.+||+.||++||
T Consensus 289 ~~~~~~~~-~~~~i~~g~~~----------------------------------~~p~~~~~~~~~li~~c~~~dP~~RP 333 (353)
T 4ase_A 289 PGVKIDEE-FCRRLKEGTRM----------------------------------RAPDYTTPEMYQTMLDCWHGEPSQRP 333 (353)
T ss_dssp TTCCCSHH-HHHHHHHTCCC----------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred CCCCHHHH-HHHHHHcCCCC----------------------------------CCCccCCHHHHHHHHHHcCcChhHCc
Confidence 87543321 11111111000 01123456788999999999999999
Q ss_pred ChHHHHHHHHHHHHh
Q 012014 441 KINDVESRLRLIRRK 455 (473)
Q Consensus 441 t~~ev~~~L~~l~~~ 455 (473)
|+.||++.|+.+.+.
T Consensus 334 t~~eil~~L~~llq~ 348 (353)
T 4ase_A 334 TFSELVEHLGNLLQA 348 (353)
T ss_dssp CHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHH
Confidence 999999999988653
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-57 Score=426.20 Aligned_cols=270 Identities=20% Similarity=0.284 Sum_probs=200.0
Q ss_pred CCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHH--HHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 145 NGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFK--SECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~--~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
++|.+.++||+|+||+||+|++ +|+.||||+++.. ....+. .|+..+.+++|||||+++++|.+.+ ......+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~~ 77 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLW 77 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEEE
Confidence 4577889999999999999986 6899999998643 233343 4555567889999999999987643 2234679
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhC-----CCCCeeeccCCCCcEEecCCccE
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCD-----CQPPIAHCNLKPSNVLLDDEMIG 297 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~-----~~~~iiH~Dlkp~Nil~~~~~~~ 297 (473)
||||||++|+|.++|+.. .+++..+.+++.|++.||+|||+. ...+||||||||+|||++.++++
T Consensus 78 lV~Ey~~~gsL~~~l~~~----------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~ 147 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNRY----------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 147 (303)
T ss_dssp EEEECCTTCBHHHHHHHC----------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred EEecCCCCCcHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCE
Confidence 999999999999999765 366899999999999999999932 01299999999999999999999
Q ss_pred EEeecccccccCccccc--cceeeccCCCCcCCCccccCC------CCCcccchhhHhHHHHHHHhCCCCCCCCCCCcc-
Q 012014 298 HVGDFGMARFLPAIDKQ--NRFICIKGSTGYIPPEYDLGC------EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKM- 368 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~- 368 (473)
||+|||+|+........ .......||+.|||||++.+. .++.++|||||||++|||+||..||........
T Consensus 148 Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p 227 (303)
T 3hmm_A 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227 (303)
T ss_dssp EECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred EEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc
Confidence 99999999876443221 122345799999999998764 367899999999999999999888754332221
Q ss_pred ---------cHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCC
Q 012014 369 ---------NLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRER 439 (473)
Q Consensus 369 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 439 (473)
.............. ++.. + ......+++..+.+|+.+||+.||++|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~----rp~~-------------------p--~~~~~~~~~~~l~~li~~cl~~dP~~R 282 (303)
T 3hmm_A 228 YYDLVPSDPSVEEMRKVVCEQKL----RPNI-------------------P--NRWQSCEALRVMAKIMRECWYANGAAR 282 (303)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCC----CCCC-------------------C--GGGGSSHHHHHHHHHHHTTCCSSGGGS
T ss_pred chhcccccchHHHHHHHHhcccC----CCCC-------------------C--ccccchHHHHHHHHHHHHHcccCHhHC
Confidence 11111111100000 0000 0 000123467789999999999999999
Q ss_pred CChHHHHHHHHHHHH
Q 012014 440 MKINDVESRLRLIRR 454 (473)
Q Consensus 440 Pt~~ev~~~L~~l~~ 454 (473)
|||.||++.|+.|.+
T Consensus 283 Pt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 283 LTALRIKKTLSQLSQ 297 (303)
T ss_dssp CCHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHHH
Confidence 999999999999865
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-57 Score=418.19 Aligned_cols=245 Identities=20% Similarity=0.280 Sum_probs=187.1
Q ss_pred CCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC---CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
++|++.+.||+|+||+||+|+ ..+|+.||||+++... ......+.+|+.++++++|||||+++++|.+ ...
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~ 87 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS-----KDE 87 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----CCE
Confidence 689999999999999999998 4679999999997432 2334578999999999999999999999855 347
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.|+||||| +|+|.+++.... .+++.++..++.||+.||+||| +++|+||||||+|||++.++.+||+
T Consensus 88 ~~ivmEy~-~g~L~~~l~~~~---------~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~ 154 (275)
T 3hyh_A 88 IIMVIEYA-GNELFDYIVQRD---------KMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIA 154 (275)
T ss_dssp EEEEEECC-CEEHHHHHHHSC---------SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEEC
T ss_pred EEEEEeCC-CCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEe
Confidence 89999999 789999997654 3679999999999999999999 8999999999999999999999999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCccccCCCC-CcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcC
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEA-STYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP 379 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 379 (473)
|||+|+..... ....+.+||+.|||||++.+..+ +.++|||||||++|+|++|+.||.+... .........
T Consensus 155 DFGla~~~~~~---~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~-----~~~~~~i~~ 226 (275)
T 3hyh_A 155 DFGLSNIMTDG---NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI-----PVLFKNISN 226 (275)
T ss_dssp CSSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHH
T ss_pred ecCCCeecCCC---CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHc
Confidence 99999865432 22345679999999999998876 5799999999999999999999975321 111111000
Q ss_pred cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 380 QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
... ..+...++++.+|+.+||+.||++|||++|+++
T Consensus 227 ~~~--------------------------------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 227 GVY--------------------------------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp TCC--------------------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCC--------------------------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 000 000123456789999999999999999999875
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-57 Score=422.60 Aligned_cols=243 Identities=23% Similarity=0.279 Sum_probs=190.5
Q ss_pred cCCCCccceeecCCCeEEEEEEe----cCCCEEEEEEeeccC--CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCC
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL----FDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (473)
.++|++.+.||+|+||+||+|+. .+++.||||+++... ......+.+|+.+|++++|||||+++++|.+.
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~---- 98 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTE---- 98 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEET----
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC----
Confidence 36799999999999999999984 246899999997432 22344688999999999999999999998653
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccE
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~ 297 (473)
...|+|||||+||+|.+++.... .+++.++..++.||+.||.||| +++|+||||||+|||++.++.+
T Consensus 99 -~~~~ivmEy~~gg~L~~~l~~~~---------~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~v 165 (304)
T 3ubd_A 99 -GKLYLILDFLRGGDLFTRLSKEV---------MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHI 165 (304)
T ss_dssp -TEEEEEECCCTTCEEHHHHHHHC---------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCE
T ss_pred -CEEEEEEEcCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCE
Confidence 47899999999999999998654 3668999999999999999999 8999999999999999999999
Q ss_pred EEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
||+|||+|+...... ....+.+||+.|||||++.+..|+.++|||||||++|||++|..||.+....+ .+....+..
T Consensus 166 Kl~DFGla~~~~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~-~~~~i~~~~ 242 (304)
T 3ubd_A 166 KLTDFGLSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE-TMTMILKAK 242 (304)
T ss_dssp EEESSEEEEC-------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCC
T ss_pred EecccccceeccCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH-HHHHHHcCC
Confidence 999999998654322 23345679999999999999999999999999999999999999998632211 111111100
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCCh
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKI 442 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 442 (473)
. . .+...++++.+|+.+||+.||++|||+
T Consensus 243 ~-~-----------------------------------~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 243 L-G-----------------------------------MPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp C-C-----------------------------------CCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred C-C-----------------------------------CCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 0 0 011234578899999999999999996
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-55 Score=415.60 Aligned_cols=256 Identities=21% Similarity=0.348 Sum_probs=188.7
Q ss_pred CCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeecccc-------
Q 012014 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY------- 215 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------- 215 (473)
++|++.+.||+|+||+||+|+ ..+|+.||||+++.... ...+.+.+|+.+|++++|||||+++++|.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 358899999999999999998 45799999999975432 233568899999999999999999999875431
Q ss_pred CCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCc
Q 012014 216 QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM 295 (473)
Q Consensus 216 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~ 295 (473)
....+.|+|||||++|+|.+++....... ...+..++.++.||+.||.||| +++||||||||+|||++.++
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~------~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~ 155 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIE------ERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDD 155 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGG------GSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCC------hhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCC
Confidence 12345799999999999999998764321 2335668899999999999999 89999999999999999999
Q ss_pred cEEEeecccccccCccccc----------cceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCC
Q 012014 296 IGHVGDFGMARFLPAIDKQ----------NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFT 365 (473)
Q Consensus 296 ~~kl~Dfg~~~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~ 365 (473)
.+||+|||+|+.+...... ......+||+.|||||++.+..|+.++|||||||++|||++ ||.+...
T Consensus 156 ~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~ 232 (299)
T 4g31_A 156 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME 232 (299)
T ss_dssp CEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred cEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH
Confidence 9999999999876543211 12234579999999999999999999999999999999996 7753110
Q ss_pred CcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHH
Q 012014 366 GKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDV 445 (473)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev 445 (473)
............ .++......+.+.+|+.+||+.||++|||+.|+
T Consensus 233 ----~~~~~~~~~~~~-------------------------------~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~ei 277 (299)
T 4g31_A 233 ----RVRTLTDVRNLK-------------------------------FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINI 277 (299)
T ss_dssp ----HHHHHHHHHTTC-------------------------------CCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred ----HHHHHHHHhcCC-------------------------------CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHH
Confidence 000000000000 011122344566789999999999999999998
Q ss_pred HH
Q 012014 446 ES 447 (473)
Q Consensus 446 ~~ 447 (473)
++
T Consensus 278 l~ 279 (299)
T 4g31_A 278 IE 279 (299)
T ss_dssp HT
T ss_pred hc
Confidence 75
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-53 Score=410.99 Aligned_cols=284 Identities=19% Similarity=0.217 Sum_probs=205.9
Q ss_pred ccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCC--CchhHHHHHHHHHhcCCCCceeeeeeeeccc-cCCc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAFSGVD-YQGA 218 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~~ 218 (473)
..++|++.+.||+|+||.||+|+ ..+|+.||||+++..... ..+.+.+|+.+|+.++|||||++++++.... +...
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 131 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF 131 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence 34689999999999999999999 467999999999743322 2356789999999999999999999986532 2344
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...|||||||+ |+|.+++.... .+++.++..++.||+.||.||| ++|||||||||+|||++.++.+|
T Consensus 132 ~~~~ivmE~~~-g~L~~~i~~~~---------~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~K 198 (398)
T 4b99_A 132 KSVYVVLDLME-SDLHQIIHSSQ---------PLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELK 198 (398)
T ss_dssp CCEEEEEECCS-EEHHHHHTSSS---------CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEE
T ss_pred CEEEEEEeCCC-CCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEE
Confidence 67899999995 78999998654 4678999999999999999999 99999999999999999999999
Q ss_pred EeecccccccCccc--cccceeeccCCCCcCCCccccCC-CCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 012014 299 VGDFGMARFLPAID--KQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVK 375 (473)
Q Consensus 299 l~Dfg~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~ 375 (473)
|+|||+|+.+.... ........+||+.|||||++.+. .++.++||||+||++|||++|.+||.+....+ .+..+..
T Consensus 199 i~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~-~l~~I~~ 277 (398)
T 4b99_A 199 IGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH-QLQLIMM 277 (398)
T ss_dssp ECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHH
T ss_pred EeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH-HHHHHHH
Confidence 99999998764432 12234457899999999998875 46999999999999999999999998743221 1222222
Q ss_pred hhcCcchh--hhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 376 MALPQRAE--EVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 376 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
........ ............. . ..................++.+|+.+||..||++|||+.|+++
T Consensus 278 ~~g~p~~~~~~~~~~~~~~~~~~---~----~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 278 VLGTPSPAVIQAVGAERVRAYIQ---S----LPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp HHCCCCGGGTC-----CHHHHHH---S----SCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred hcCCCChHHhhhhhhhhhhhhhh---c----CCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 22111111 0000000000000 0 0000000011111224567889999999999999999999865
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=397.37 Aligned_cols=202 Identities=23% Similarity=0.306 Sum_probs=168.4
Q ss_pred ccCCCCccceeecCCCeEEEEEEe----cCCCEEEEEEeeccCCCCchhHHHHHHHHHhc-CCCCceeeeeeeeccccCC
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTL----FDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQG 217 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 217 (473)
..++|++.++||+|+||+||+|+. .+++.||+|++... .....+.+|+++|..+ +|||||+++++|.+.
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~---- 92 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKN---- 92 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEET----
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEEC----
Confidence 456899999999999999999973 24678999998643 3456788999999998 699999999998653
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCC-cc
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE-MI 296 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~-~~ 296 (473)
...++|||||++|+|.+++.. +++.++..++.||+.||.||| ++||+||||||+|||++.+ +.
T Consensus 93 -~~~~lvmE~~~g~~L~~~~~~------------l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~ 156 (361)
T 4f9c_A 93 -DHVVIAMPYLEHESFLDILNS------------LSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKK 156 (361)
T ss_dssp -TEEEEEEECCCCCCHHHHHTT------------CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTE
T ss_pred -CEEEEEEeCCCcccHHHHHcC------------CCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCe
Confidence 478999999999999999842 558899999999999999999 9999999999999999876 79
Q ss_pred EEEeecccccccCcccc--------------------------ccceeeccCCCCcCCCccccCC-CCCcccchhhHhHH
Q 012014 297 GHVGDFGMARFLPAIDK--------------------------QNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGIL 349 (473)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~i 349 (473)
+||+|||+|+....... .......+||+.|+|||++.+. .|+.++||||+||+
T Consensus 157 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~i 236 (361)
T 4f9c_A 157 YALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVI 236 (361)
T ss_dssp EEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHH
T ss_pred EEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHH
Confidence 99999999986543211 1112345799999999999876 48999999999999
Q ss_pred HHHHHhCCCCCCCCCCC
Q 012014 350 LLEMFTGIRPSDGIFTG 366 (473)
Q Consensus 350 l~elltg~~P~~~~~~~ 366 (473)
+|||++|+.||....+.
T Consensus 237 l~ell~G~~Pf~~~~~~ 253 (361)
T 4f9c_A 237 FLSLLSGRYPFYKASDD 253 (361)
T ss_dssp HHHHHHTCSSSSCCSSH
T ss_pred HHHHHHCCCCCCCCCCH
Confidence 99999999999764443
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=413.97 Aligned_cols=252 Identities=21% Similarity=0.331 Sum_probs=205.1
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
.++|++.+.||+|+||.||+|+ ..+|+.||+|++........+.+.+|+.+|+.++|||||+++++|.+ ....+
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-----~~~~~ 230 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-----DNEMV 230 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC-----SSEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----CCEEE
Confidence 3689999999999999999999 46799999999976554456678999999999999999999999865 34789
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCC--ccEEEe
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE--MIGHVG 300 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~--~~~kl~ 300 (473)
||||||+||+|.++|..... .+++.++..++.||+.||.||| +++|+||||||+|||++.+ +.+||+
T Consensus 231 iv~E~~~gg~L~~~i~~~~~--------~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~ 299 (573)
T 3uto_A 231 MIYEFMSGGELFEKVADEHN--------KMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLI 299 (573)
T ss_dssp EEEECCCCCBHHHHHTCTTS--------CEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEEC
T ss_pred EEEeecCCCcHHHHHHHhCC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEe
Confidence 99999999999999975432 4779999999999999999999 9999999999999999854 899999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCc
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQ 380 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 380 (473)
|||+|+.+.. .......+||+.|||||++.+..|+.++|||||||++|||++|..||.+....+. +.........
T Consensus 300 DFG~a~~~~~---~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~-~~~i~~~~~~- 374 (573)
T 3uto_A 300 DFGLTAHLDP---KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-LRNVKSCDWN- 374 (573)
T ss_dssp CCSSCEECCT---TSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-HHHHHTTCCC-
T ss_pred eccceeEccC---CCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-HHHHHhCCCC-
Confidence 9999997754 2334456799999999999999999999999999999999999999986432111 1111110000
Q ss_pred chhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 381 RAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
. .. ......+..+.+|+.+||..||.+|||+.|+++
T Consensus 375 -~----~~--------------------------~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 375 -M----DD--------------------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp -C----CS--------------------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -C----Cc--------------------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00 001123456789999999999999999999975
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=411.73 Aligned_cols=249 Identities=22% Similarity=0.262 Sum_probs=196.0
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC---CCCchhHHHH---HHHHHhcCCCCceeeeeeeeccccC
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSE---CKAAINIKHRNIVRVFTAFSGVDYQ 216 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E---~~~l~~l~h~niv~~~~~~~~~~~~ 216 (473)
-++|++.++||+|+||.||+|+ ..+|+.||||++++.. ........+| +.++..++|||||+++++|.+.
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~--- 264 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--- 264 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS---
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC---
Confidence 4689999999999999999999 4579999999997421 2223334444 5566777999999999998653
Q ss_pred CceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCcc
Q 012014 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI 296 (473)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~ 296 (473)
..+|+|||||+||+|.++|.... .|++..+..++.||+.||.||| ++|||||||||+|||++.+|+
T Consensus 265 --~~lylVmEy~~GGdL~~~l~~~~---------~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~ 330 (689)
T 3v5w_A 265 --DKLSFILDLMNGGDLHYHLSQHG---------VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGH 330 (689)
T ss_dssp --SEEEEEECCCCSCBHHHHHHHHC---------CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSC
T ss_pred --CEEEEEEecCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCC
Confidence 47899999999999999998654 4679999999999999999999 999999999999999999999
Q ss_pred EEEeecccccccCccccccceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 012014 297 GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVK 375 (473)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~ 375 (473)
+||+|||+|+.+... ...+.+||+.|||||++.+ ..|+.++|||||||++|||++|.+||.+...... .....
T Consensus 331 vKL~DFGlA~~~~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~--~~i~~ 404 (689)
T 3v5w_A 331 VRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDR 404 (689)
T ss_dssp EEECCCTTCEECSSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH--HHHHH
T ss_pred EEecccceeeecCCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHH
Confidence 999999999876432 2345679999999999964 5799999999999999999999999976432221 11111
Q ss_pred hhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCC-----hHHHHH
Q 012014 376 MALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMK-----INDVES 447 (473)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~ 447 (473)
....... ..+...+.++.+|+.+||..||.+|++ ++||++
T Consensus 405 ~i~~~~~--------------------------------~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 405 MTLTMAV--------------------------------ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp HHHHCCC--------------------------------CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred hhcCCCC--------------------------------CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 1000000 001123457789999999999999998 566653
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=378.07 Aligned_cols=285 Identities=30% Similarity=0.469 Sum_probs=227.0
Q ss_pred CchhhhhcccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccc
Q 012014 135 PSFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVD 214 (473)
Q Consensus 135 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 214 (473)
..+.++...+++|++.+.||+|+||.||+|...+++.||+|++........+.+.+|+.++..++||||+++++++..
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-- 106 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE-- 106 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC--
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC--
Confidence 445667778899999999999999999999987899999999876655556789999999999999999999999854
Q ss_pred cCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCC
Q 012014 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE 294 (473)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~ 294 (473)
....++||||+++|+|.+++...... ...+++.+++.++.|++.||.||| +++|+||||||+||+++.+
T Consensus 107 ---~~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~ 175 (321)
T 2qkw_B 107 ---RNEMILIYKYMENGNLKRHLYGSDLP-----TMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDEN 175 (321)
T ss_dssp ---TTCCEEEEECCTTCBTGGGSSSSCCC-----SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTT
T ss_pred ---CCeEEEEEEcCCCCcHHHHHhccCCC-----ccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCC
Confidence 33679999999999999999765422 113668999999999999999999 8999999999999999999
Q ss_pred ccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcc-cHHHH
Q 012014 295 MIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKM-NLRNF 373 (473)
Q Consensus 295 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~-~~~~~ 373 (473)
+.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|+|++|+.||.+...... ....+
T Consensus 176 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~ 255 (321)
T 2qkw_B 176 FVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEW 255 (321)
T ss_dssp CCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHH
T ss_pred CCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHH
Confidence 99999999999865443333333445589999999999888999999999999999999999999986543321 22222
Q ss_pred HHh-hcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHH
Q 012014 374 VKM-ALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLI 452 (473)
Q Consensus 374 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l 452 (473)
... ..........+... ......+.+..+.+++.+||+.||++|||+.||++.|+.+
T Consensus 256 ~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 256 AVESHNNGQLEQIVDPNL----------------------ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp THHHHTTTCCCSSSSSSC----------------------TTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hhhccccccHHHhcChhh----------------------ccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 111 11111222222111 1112346788999999999999999999999999999998
Q ss_pred HH
Q 012014 453 RR 454 (473)
Q Consensus 453 ~~ 454 (473)
.+
T Consensus 314 l~ 315 (321)
T 2qkw_B 314 LR 315 (321)
T ss_dssp HH
T ss_pred hh
Confidence 65
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-49 Score=376.17 Aligned_cols=289 Identities=22% Similarity=0.262 Sum_probs=214.8
Q ss_pred hhhhhcccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccC
Q 012014 137 FKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQ 216 (473)
Q Consensus 137 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 216 (473)
..++....++|++.++||+|+||.||+|+. .++.||||++.... .......+|+.++.+++||||+++++++.... .
T Consensus 16 ~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~-~ 92 (322)
T 3soc_A 16 TENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGT-S 92 (322)
T ss_dssp CCCEEETTEEEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-S
T ss_pred ccccccchhhchhhheecccCceEEEEEEE-CCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCC-C
Confidence 344556678899999999999999999985 47999999986432 22334567888899999999999999987643 2
Q ss_pred CceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCC----------CeeeccCCC
Q 012014 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQP----------PIAHCNLKP 286 (473)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~----------~iiH~Dlkp 286 (473)
.....++||||+++|+|.+++... .+++..+..++.|++.||.||| +. +|+||||||
T Consensus 93 ~~~~~~lv~e~~~~g~L~~~l~~~----------~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp 159 (322)
T 3soc_A 93 VDVDLWLITAFHEKGSLSDFLKAN----------VVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKS 159 (322)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHHC----------CBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSG
T ss_pred CCceEEEEEecCCCCCHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCCh
Confidence 234579999999999999999764 2668999999999999999999 88 999999999
Q ss_pred CcEEecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCC-----CCCcccchhhHhHHHHHHHhCCCCCC
Q 012014 287 SNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-----EASTYGDVYSFGILLLEMFTGIRPSD 361 (473)
Q Consensus 287 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~il~elltg~~P~~ 361 (473)
+|||++.++.+||+|||+++...............||+.|+|||++.+. .++.++|||||||++|||++|..||.
T Consensus 160 ~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~ 239 (322)
T 3soc_A 160 KNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239 (322)
T ss_dssp GGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSS
T ss_pred HhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999876554433333445699999999998873 46678899999999999999999998
Q ss_pred CCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCC
Q 012014 362 GIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMK 441 (473)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt 441 (473)
+................ .....+... ... ........ ..-....++..+.+|+.+||+.||++|||
T Consensus 240 ~~~~~~~~~~~~~~~~~-~~~~~~~~~---------~~~--~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps 305 (322)
T 3soc_A 240 GPVDEYMLPFEEEIGQH-PSLEDMQEV---------VVH--KKKRPVLR--DYWQKHAGMAMLCETIEECWDHDAEARLS 305 (322)
T ss_dssp SCCCCCCCTTHHHHCSS-CCHHHHHHH---------HTT--SCCCCCCC--GGGGSSHHHHHHHHHHHHHTCSSGGGSCC
T ss_pred CCcchhccchhhhhccC-Cchhhhhhh---------hhc--ccCCCCcc--ccccccchHHHHHHHHHHHccCChhhCcC
Confidence 75433211000000000 000000000 000 00000000 00011246678999999999999999999
Q ss_pred hHHHHHHHHHHHHh
Q 012014 442 INDVESRLRLIRRK 455 (473)
Q Consensus 442 ~~ev~~~L~~l~~~ 455 (473)
+.||++.|+.|++.
T Consensus 306 ~~ell~~L~~l~~~ 319 (322)
T 3soc_A 306 AGCVGERITQMQRL 319 (322)
T ss_dssp HHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHH
Confidence 99999999999764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=373.51 Aligned_cols=286 Identities=32% Similarity=0.499 Sum_probs=225.7
Q ss_pred ccCCCchhhhhcccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeee
Q 012014 131 TINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTA 209 (473)
Q Consensus 131 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~ 209 (473)
....+++.++....++|.+.+.||+|+||.||+|...+++.||+|++..... .....+.+|+.++..++||||++++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 95 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF 95 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence 3456788899999999999999999999999999977899999999975432 234478999999999999999999999
Q ss_pred eeccccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCC---CeeeccCCC
Q 012014 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQP---PIAHCNLKP 286 (473)
Q Consensus 210 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~---~iiH~Dlkp 286 (473)
+... ...++||||+++|+|.+++....... ..+++..+..++.|++.||.||| ++ +|+||||||
T Consensus 96 ~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~ivH~Dlkp 162 (326)
T 3uim_A 96 CMTP-----TERLLVYPYMANGSVASCLRERPESQ-----PPLDWPKRQRIALGSARGLAYLH---DHCDPKIIHRDVKA 162 (326)
T ss_dssp ECCS-----SCCEEEEECCTTCBHHHHHHCCSTTC-----CCCCHHHHHHHHHHHHHHHHHHH---HSSSSCEECCCCSG
T ss_pred EecC-----CceEEEEEeccCCCHHHHHHhccccC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCCCCeEeCCCch
Confidence 8543 35689999999999999998764321 13668999999999999999999 66 999999999
Q ss_pred CcEEecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCC---
Q 012014 287 SNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI--- 363 (473)
Q Consensus 287 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~--- 363 (473)
+|||++.++.+||+|||+++...... ........||+.|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 163 ~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 241 (326)
T 3uim_A 163 ANILLDEEFEAVVGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA 241 (326)
T ss_dssp GGEEECTTCCEEECCCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHT
T ss_pred hhEEECCCCCEEeccCccccccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccc
Confidence 99999999999999999998764432 22334456999999999998888999999999999999999999999632
Q ss_pred CCCcccHHHHHHhhcCc-chhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCCh
Q 012014 364 FTGKMNLRNFVKMALPQ-RAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKI 442 (473)
Q Consensus 364 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 442 (473)
.........+....... ....+.+... ........+..+.+++.+||+.||.+|||+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~ 299 (326)
T 3uim_A 242 NDDDVMLLDWVKGLLKEKKLEALVDVDL----------------------QGNYKDEEVEQLIQVALLCTQSSPMERPKM 299 (326)
T ss_dssp TTSCSBHHHHHTTTTSSCCSTTSSCTTC----------------------TTSCCHHHHHHHHHHHHHHTCSCGGGSCCH
T ss_pred cccchhHHHHHHHHhhchhhhhhcChhh----------------------ccccCHHHHHHHHHHHHHHhCcCCccCCCH
Confidence 12222333333322221 1122222111 112234577899999999999999999999
Q ss_pred HHHHHHHHHH
Q 012014 443 NDVESRLRLI 452 (473)
Q Consensus 443 ~ev~~~L~~l 452 (473)
.||++.|++.
T Consensus 300 ~ell~~L~~~ 309 (326)
T 3uim_A 300 SEVVRMLEGD 309 (326)
T ss_dssp HHHHHHHHTS
T ss_pred HHHHHHhcCc
Confidence 9999999863
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=370.50 Aligned_cols=264 Identities=22% Similarity=0.373 Sum_probs=213.7
Q ss_pred ccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
..++|.+.++||+|+||.||+|.. .+++.||+|++........+.+.+|+.++.+++||||+++++++.+. ...
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~ 82 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD-----KRL 82 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEE
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC-----Cee
Confidence 346799999999999999999994 56899999998655445567799999999999999999999998653 367
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEee
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~D 301 (473)
++||||+++|+|.+++..... .+++.++..++.|++.||.||| +++|+||||||+||+++.++.+||+|
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~D 151 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKSMDS--------QYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVAD 151 (310)
T ss_dssp EEEEECCTTCBHHHHHHHCCT--------TSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECC
T ss_pred EEEEEecCCCcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEee
Confidence 999999999999999986432 3668999999999999999999 89999999999999999999999999
Q ss_pred cccccccCcccccc------------ceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCccc
Q 012014 302 FGMARFLPAIDKQN------------RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMN 369 (473)
Q Consensus 302 fg~~~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~ 369 (473)
||+++......... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.........
T Consensus 152 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~ 231 (310)
T 3s95_A 152 FGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD 231 (310)
T ss_dssp CTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTT
T ss_pred cccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHH
Confidence 99998764432211 112456999999999999999999999999999999999999998764332211
Q ss_pred ----HHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHH
Q 012014 370 ----LRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDV 445 (473)
Q Consensus 370 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev 445 (473)
........ .+..++..+.+|+.+||+.||++|||+.||
T Consensus 232 ~~~~~~~~~~~~--------------------------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l 273 (310)
T 3s95_A 232 FGLNVRGFLDRY--------------------------------------CPPNCPPSFFPITVRCCDLDPEKRPSFVKL 273 (310)
T ss_dssp SSBCHHHHHHHT--------------------------------------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHH
T ss_pred Hhhhhhcccccc--------------------------------------CCCCCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 11111000 011234567889999999999999999999
Q ss_pred HHHHHHHHHhhccCC
Q 012014 446 ESRLRLIRRKLLETP 460 (473)
Q Consensus 446 ~~~L~~l~~~~~~~~ 460 (473)
++.|+.++..+....
T Consensus 274 ~~~L~~l~~~~~~~~ 288 (310)
T 3s95_A 274 EHWLETLRMHLAGHL 288 (310)
T ss_dssp HHHHHHHHHHHHHCC
T ss_pred HHHHHHHHHhccCcc
Confidence 999999998776543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-48 Score=363.98 Aligned_cols=250 Identities=19% Similarity=0.242 Sum_probs=204.9
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
.++|++.+.||+|+||.||+|. ..+++.||+|++........+.+.+|+.+++.++||||++++++|... ...+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~ 93 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELW 93 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC-----CEEE
Confidence 4579999999999999999998 467899999999876666677899999999999999999999998653 3679
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
+||||+++|+|.+++.... +++.++..++.|++.||.||| ++||+||||||+|||++.++.+||+||
T Consensus 94 lv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Df 160 (297)
T 3fxz_A 94 VVMEYLAGGSLTDVVTETC----------MDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDF 160 (297)
T ss_dssp EEEECCTTCBHHHHHHHSC----------CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCC
T ss_pred EEEECCCCCCHHHHHhhcC----------CCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeC
Confidence 9999999999999997652 558899999999999999999 899999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcch
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRA 382 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 382 (473)
|++....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+...... +........+.
T Consensus 161 g~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~-- 235 (297)
T 3fxz_A 161 GFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTPE-- 235 (297)
T ss_dssp TTCEECCSTT--CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHHCSCC--
T ss_pred CCceecCCcc--cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhCCCCC--
Confidence 9998765432 223345699999999999999999999999999999999999999975322111 00000000000
Q ss_pred hhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 383 EEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
. ..+...+..+.+|+.+||+.||++|||+.|+++
T Consensus 236 --~-----------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 236 --L-----------------------------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp --C-----------------------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --C-----------------------------CCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0 001224567889999999999999999999975
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=365.02 Aligned_cols=269 Identities=25% Similarity=0.338 Sum_probs=201.7
Q ss_pred hhcccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCC--CchhHHHHHHHHHhcCCCCceeeeeeeeccccCC
Q 012014 140 LYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (473)
Q Consensus 140 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (473)
+....++|++.+.||+|+||.||+|+. +++.||+|++...... ..+.+.+|+.++.+++||||+++++++...
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~---- 106 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP---- 106 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST----
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC----
Confidence 344567899999999999999999985 6889999998754322 234688999999999999999999998543
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCC--eeeccCCCCcEEecCCc
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPP--IAHCNLKPSNVLLDDEM 295 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~Dlkp~Nil~~~~~ 295 (473)
...++||||+++|+|.+++..... ...+++..++.++.|++.||.||| +++ |+||||||+||+++.++
T Consensus 107 -~~~~lv~e~~~~~~L~~~l~~~~~------~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~ 176 (309)
T 3p86_A 107 -PNLSIVTEYLSRGSLYRLLHKSGA------REQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKY 176 (309)
T ss_dssp -TCCEEEEECCTTCBHHHHHHSTTH------HHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTC
T ss_pred -CceEEEEecCCCCcHHHHHhhcCC------CCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCC
Confidence 357999999999999999986531 113678999999999999999999 888 99999999999999999
Q ss_pred cEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 012014 296 IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVK 375 (473)
Q Consensus 296 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~ 375 (473)
.+||+|||+++...... .......||+.|+|||++.+..++.++||||||+++|+|++|..||.+...... .....
T Consensus 177 ~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~--~~~~~ 252 (309)
T 3p86_A 177 TVKVCDFGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV--VAAVG 252 (309)
T ss_dssp CEEECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH--HHHHH
T ss_pred cEEECCCCCCccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH
Confidence 99999999997543321 223345699999999999999999999999999999999999999976422110 00000
Q ss_pred hhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHHh
Q 012014 376 MALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRK 455 (473)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~ 455 (473)
.. .... ..+..++..+.+|+.+||+.||.+|||+.||++.|+.+.+.
T Consensus 253 ~~--~~~~-------------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 253 FK--CKRL-------------------------------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp HS--CCCC-------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred hc--CCCC-------------------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 00 0000 00112455788999999999999999999999999999776
Q ss_pred hccCC
Q 012014 456 LLETP 460 (473)
Q Consensus 456 ~~~~~ 460 (473)
....+
T Consensus 300 ~~p~~ 304 (309)
T 3p86_A 300 AVPPP 304 (309)
T ss_dssp -----
T ss_pred CCCCC
Confidence 54443
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=360.40 Aligned_cols=270 Identities=20% Similarity=0.319 Sum_probs=208.6
Q ss_pred ccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHh--cCCCCceeeeeeeeccccCCcee
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAIN--IKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
..++|++.+.||+|+||.||+|+. +++.||||++... ....+.+|.+++.. ++||||+++++++.... .....
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~~~~ 80 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSR-HSSTQ 80 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TTEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CCCce
Confidence 356899999999999999999986 7899999998642 34566777777776 79999999999876542 33456
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCC-----CCCeeeccCCCCcEEecCCc
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDC-----QPPIAHCNLKPSNVLLDDEM 295 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~-----~~~iiH~Dlkp~Nil~~~~~ 295 (473)
.++||||+++|+|.++++.. .+++..++.++.|++.||.|||+.. +++|+||||||+|||++.++
T Consensus 81 ~~lv~e~~~~g~L~~~l~~~----------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~ 150 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQLT----------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG 150 (301)
T ss_dssp EEEEECCCTTCBHHHHHTTC----------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTS
T ss_pred eEEehhhccCCCHHHHHhhc----------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCC
Confidence 89999999999999999654 3668999999999999999999321 56999999999999999999
Q ss_pred cEEEeecccccccCcccccc--ceeeccCCCCcCCCccccCC------CCCcccchhhHhHHHHHHHhC----------C
Q 012014 296 IGHVGDFGMARFLPAIDKQN--RFICIKGSTGYIPPEYDLGC------EASTYGDVYSFGILLLEMFTG----------I 357 (473)
Q Consensus 296 ~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~elltg----------~ 357 (473)
.+||+|||+++......... ......||+.|+|||++.+. .++.++|||||||++|||++| .
T Consensus 151 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~ 230 (301)
T 3q4u_A 151 QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230 (301)
T ss_dssp CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccc
Confidence 99999999997654332111 12234699999999999876 455789999999999999999 8
Q ss_pred CCCCCCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCC
Q 012014 358 RPSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPR 437 (473)
Q Consensus 358 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~ 437 (473)
.||........................... ........+..+.+|+.+||+.||+
T Consensus 231 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~l~~li~~cl~~dP~ 285 (301)
T 3q4u_A 231 PPFYDVVPNDPSFEDMRKVVCVDQQRPNIP-------------------------NRWFSDPTLTSLAKLMKECWYQNPS 285 (301)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSCCCCCCC-------------------------GGGGGSHHHHHHHHHHHHHCCSSGG
T ss_pred ccccccCCCCcchhhhhHHHhccCCCCCCC-------------------------hhhccCccHHHHHHHHHHHhhcChh
Confidence 888765554443333332221111100000 0011234678899999999999999
Q ss_pred CCCChHHHHHHHHHH
Q 012014 438 ERMKINDVESRLRLI 452 (473)
Q Consensus 438 ~RPt~~ev~~~L~~l 452 (473)
+|||+.||++.|+.|
T Consensus 286 ~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 286 ARLTALRIKKTLTKI 300 (301)
T ss_dssp GSCCHHHHHHHHHHH
T ss_pred hCCCHHHHHHHHhcc
Confidence 999999999999986
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=358.80 Aligned_cols=284 Identities=29% Similarity=0.437 Sum_probs=221.2
Q ss_pred ccCCCchhhhhcccCCCCcc------ceeecCCCeEEEEEEecCCCEEEEEEeeccC----CCCchhHHHHHHHHHhcCC
Q 012014 131 TINNPSFKDLYNATNGFSSA------NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIR----PGGSKSFKSECKAAINIKH 200 (473)
Q Consensus 131 ~~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h 200 (473)
....+++.++...+++|... +.||+|+||.||+|.. +++.||+|++.... ....+.+.+|+.++..++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34557788888888888776 8999999999999985 78999999987432 2234578899999999999
Q ss_pred CCceeeeeeeeccccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCee
Q 012014 201 RNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIA 280 (473)
Q Consensus 201 ~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ii 280 (473)
|||+++++++.+. ...++||||+++|+|.+++...... ..+++..++.++.|++.||.||| +++|+
T Consensus 90 ~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH---~~~i~ 155 (307)
T 2nru_A 90 ENLVELLGFSSDG-----DDLCLVYVYMPNGSLLDRLSCLDGT------PPLSWHMRCKIAQGAANGINFLH---ENHHI 155 (307)
T ss_dssp TTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHTGGGC------CCCCHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred CCeEEEEEEEecC-----CceEEEEEecCCCcHHHHHHhccCC------CCCCHHHHHHHHHHHHHHHHHHh---cCCee
Confidence 9999999998543 3679999999999999999754321 13668899999999999999999 89999
Q ss_pred eccCCCCcEEecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCC
Q 012014 281 HCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPS 360 (473)
Q Consensus 281 H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~ 360 (473)
||||||+||+++.++.+||+|||+++...............||+.|+|||.+.+ .++.++||||||+++|+|++|..||
T Consensus 156 H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~ 234 (307)
T 2nru_A 156 HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAV 234 (307)
T ss_dssp CSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSB
T ss_pred cCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCc
Confidence 999999999999999999999999987654332323334568999999999875 5899999999999999999999999
Q ss_pred CCCCCCcccHHHHHHhh--cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCC
Q 012014 361 DGIFTGKMNLRNFVKMA--LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRE 438 (473)
Q Consensus 361 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~ 438 (473)
........ +..+.... ........++... .......+..+.+++.+||+.||.+
T Consensus 235 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~l~~li~~cl~~~p~~ 290 (307)
T 2nru_A 235 DEHREPQL-LLDIKEEIEDEEKTIEDYIDKKM-----------------------NDADSTSVEAMYSVASQCLHEKKNK 290 (307)
T ss_dssp CTTBSSSB-TTHHHHHHHTTSCCHHHHSCSSC-----------------------SCCCHHHHHHHHHHHHHHTCSSTTT
T ss_pred ccCcchHH-HHHHHHHhhhhhhhhhhhccccc-----------------------cccchHHHHHHHHHHHHHcCCCccc
Confidence 87543322 11111111 1111122222111 0112356788999999999999999
Q ss_pred CCChHHHHHHHHHHHH
Q 012014 439 RMKINDVESRLRLIRR 454 (473)
Q Consensus 439 RPt~~ev~~~L~~l~~ 454 (473)
|||+.+|++.|+.+..
T Consensus 291 Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 291 RPDIKKVQQLLQEMTA 306 (307)
T ss_dssp SCCHHHHHHHHHHHC-
T ss_pred CcCHHHHHHHHHHHhc
Confidence 9999999999999854
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=365.83 Aligned_cols=279 Identities=23% Similarity=0.327 Sum_probs=207.9
Q ss_pred cCCCCccceeecCCCeEEEEEEe-----cCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-----FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
.++|++.+.||+|+||.||+|+. .+++.||+|++........+.+.+|+.++.+++||||+++++++...+ .
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~ 85 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---R 85 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH---H
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---C
Confidence 46789999999999999999973 368899999987554444567899999999999999999999985432 2
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...++||||+++|+|.+++..... .+++.+++.++.|++.||.||| +++|+||||||+||+++.++.+|
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~k 154 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHKE--------RIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVK 154 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCGG--------GCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEE
T ss_pred CceEEEEEeCCCCCHHHHHHhccc--------ccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEE
Confidence 357999999999999999976532 3668899999999999999999 89999999999999999999999
Q ss_pred EeecccccccCccccc-cceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 299 VGDFGMARFLPAIDKQ-NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
|+|||+++........ .......||..|+|||++.+..++.++||||||+++|+|++|..||..... .+....
T Consensus 155 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~------~~~~~~ 228 (295)
T 3ugc_A 155 IGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA------EFMRMI 228 (295)
T ss_dssp ECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH------HHHHHH
T ss_pred EccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChH------HHHhhh
Confidence 9999999876443221 122234477789999999998999999999999999999999999865211 111111
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHHhh
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRKL 456 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~~ 456 (473)
..................... ....+..++..+.+|+.+||+.||++|||+.||++.|+.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 229 GNDKQGQMIVFHLIELLKNNG--------------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp CTTCCTHHHHHHHHHHHHTTC--------------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred cCccccchhHHHHHHHHhccC--------------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 110000000000000100000 00112235678999999999999999999999999999998765
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=371.88 Aligned_cols=280 Identities=21% Similarity=0.256 Sum_probs=217.3
Q ss_pred CchhhhhcccCCCCccceeecCCCeEEEEEEe------cCCCEEEEEEeeccCC-CCchhHHHHHHHHHhc-CCCCceee
Q 012014 135 PSFKDLYNATNGFSSANLIGAGNFGSVYNGTL------FDGTTIAVKVFNLIRP-GGSKSFKSECKAAINI-KHRNIVRV 206 (473)
Q Consensus 135 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~ 206 (473)
.....+....++|.+.+.||+|+||.||+|.+ .+++.||||+++.... ...+.+.+|+.++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 44566677788999999999999999999973 2457899999974322 2235689999999999 79999999
Q ss_pred eeeeeccccCCceeeEEEEEecCCCCHHHHhcCCCCCCC-----------------------------------------
Q 012014 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW----------------------------------------- 245 (473)
Q Consensus 207 ~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~----------------------------------------- 245 (473)
++++.+. ....++||||+++|+|.+++........
T Consensus 92 ~~~~~~~----~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (359)
T 3vhe_A 92 LGACTKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGF 167 (359)
T ss_dssp EEEECST----TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------
T ss_pred eeeeecC----CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccc
Confidence 9998543 2357999999999999999987643100
Q ss_pred ----------------CCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecccccccC
Q 012014 246 ----------------RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLP 309 (473)
Q Consensus 246 ----------------~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 309 (473)
......+++..++.++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++...
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 244 (359)
T 3vhe_A 168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 244 (359)
T ss_dssp ----------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTT
T ss_pred ccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeec
Confidence 000112778999999999999999999 8999999999999999999999999999998765
Q ss_pred ccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcCcchhhhccc
Q 012014 310 AIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDD 388 (473)
Q Consensus 310 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 388 (473)
............||+.|+|||++.+..++.++||||||+++|||++ |..||.+....... ...........
T Consensus 245 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-~~~~~~~~~~~------- 316 (359)
T 3vhe_A 245 KDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF-CRRLKEGTRMR------- 316 (359)
T ss_dssp SCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH-HHHHHHTCCCC-------
T ss_pred ccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH-HHHHHcCCCCC-------
Confidence 4433333444568999999999998899999999999999999998 99999764333211 11111110000
Q ss_pred cchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHHhh
Q 012014 389 FNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRKL 456 (473)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~~ 456 (473)
.+...+..+.+|+.+||+.||.+|||+.||++.|+.+....
T Consensus 317 ---------------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 317 ---------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp ---------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---------------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 00123457889999999999999999999999999997653
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-48 Score=374.92 Aligned_cols=270 Identities=24% Similarity=0.339 Sum_probs=210.7
Q ss_pred ccCCCCccceeecCCCeEEEEEEec--------CCCEEEEEEeeccCC-CCchhHHHHHHHHHhc-CCCCceeeeeeeec
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTLF--------DGTTIAVKVFNLIRP-GGSKSFKSECKAAINI-KHRNIVRVFTAFSG 212 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~ 212 (473)
..++|.+.+.||+|+||.||+|... ++..||+|+++.... ...+.+.+|+.++..+ +||||++++++|..
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 4578999999999999999999842 345799999874321 2235688999999999 89999999999854
Q ss_pred cccCCceeeEEEEEecCCCCHHHHhcCCCCCCC-------CCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCC
Q 012014 213 VDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW-------RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLK 285 (473)
Q Consensus 213 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~-------~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlk 285 (473)
. ...++||||+++|+|.+++........ ......+++.+++.++.||+.||.||| +++|+|||||
T Consensus 159 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlk 230 (370)
T 2psq_A 159 D-----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLA 230 (370)
T ss_dssp S-----SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCC
T ss_pred C-----CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccc
Confidence 3 367999999999999999987542110 000113668899999999999999999 8999999999
Q ss_pred CCcEEecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCC
Q 012014 286 PSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIF 364 (473)
Q Consensus 286 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~ 364 (473)
|+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus 231 p~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~ 310 (370)
T 2psq_A 231 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP 310 (370)
T ss_dssp GGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999999999999999999987654433333344557889999999999999999999999999999999 999997643
Q ss_pred CCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHH
Q 012014 365 TGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKIND 444 (473)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 444 (473)
... +...+...... ..+..++..+.+|+.+||+.||.+|||+.|
T Consensus 311 ~~~--~~~~~~~~~~~----------------------------------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~e 354 (370)
T 2psq_A 311 VEE--LFKLLKEGHRM----------------------------------DKPANCTNELYMMMRDCWHAVPSQRPTFKQ 354 (370)
T ss_dssp GGG--HHHHHHTTCCC----------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHH--HHHHHhcCCCC----------------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 211 11111000000 001234567889999999999999999999
Q ss_pred HHHHHHHHHHhh
Q 012014 445 VESRLRLIRRKL 456 (473)
Q Consensus 445 v~~~L~~l~~~~ 456 (473)
|++.|+.+....
T Consensus 355 ll~~L~~il~~~ 366 (370)
T 2psq_A 355 LVEDLDRILTLT 366 (370)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHh
Confidence 999999997644
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-48 Score=369.88 Aligned_cols=250 Identities=21% Similarity=0.318 Sum_probs=201.8
Q ss_pred hcccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCC--CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCC
Q 012014 141 YNATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (473)
Q Consensus 141 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (473)
....++|.+.+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|+.+++.++||||+++++++..
T Consensus 11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----- 85 (328)
T 3fe3_A 11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET----- 85 (328)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----
Confidence 34567899999999999999999994 6899999999975432 234568899999999999999999999854
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccE
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~ 297 (473)
....++||||+++|+|.+++.... .+++.++..++.|++.||.||| +++|+||||||+|||++.++.+
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~---------~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~ 153 (328)
T 3fe3_A 86 EKTLYLIMEYASGGEVFDYLVAHG---------RMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNI 153 (328)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHC---------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCE
T ss_pred CCEEEEEEECCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCE
Confidence 346899999999999999997654 3568899999999999999999 8999999999999999999999
Q ss_pred EEeecccccccCccccccceeeccCCCCcCCCccccCCCCC-cccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 012014 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEAS-TYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKM 376 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~ 376 (473)
||+|||++...... .......||+.|+|||++.+..++ .++|||||||++|+|++|..||.+... ......
T Consensus 154 kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~ 225 (328)
T 3fe3_A 154 KIADFGFSNEFTVG---GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL-----KELRER 225 (328)
T ss_dssp EECSTTCCGGGSSS---CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH
T ss_pred EEeeccCceecCCC---CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH-----HHHHHH
Confidence 99999999866432 223445799999999999888765 789999999999999999999976321 111111
Q ss_pred hcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 377 ALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
...... ..+...+..+.+|+.+||+.||.+|||+.|+++
T Consensus 226 i~~~~~--------------------------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 226 VLRGKY--------------------------------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp HHHCCC--------------------------------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred HHhCCC--------------------------------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000000 000113456788999999999999999999875
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=364.11 Aligned_cols=253 Identities=20% Similarity=0.282 Sum_probs=201.8
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
.++|++.+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+ ....
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~~~ 80 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNIQ 80 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEEC-----SSEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEec-----CCeE
Confidence 46899999999999999999984 4789999999974332 234678999999999999999999999854 3467
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEee
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~D 301 (473)
++||||+++|+|.+++.... .+++.++..++.||+.||.||| ++||+||||||+|||++.++.+||+|
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~D 148 (323)
T 3tki_A 81 YLFLEYCSGGELFDRIEPDI---------GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISD 148 (323)
T ss_dssp EEEEECCTTEEGGGGSBTTT---------BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECC
T ss_pred EEEEEcCCCCcHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEE
Confidence 99999999999999997654 3668999999999999999999 89999999999999999999999999
Q ss_pred cccccccCccccccceeeccCCCCcCCCccccCCCC-CcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCc
Q 012014 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEA-STYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQ 380 (473)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 380 (473)
||+++.+.............||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.......+..+.......
T Consensus 149 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 228 (323)
T 3tki_A 149 FGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL 228 (323)
T ss_dssp CTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTS
T ss_pred eeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccC
Confidence 999987644333333345679999999999987775 7789999999999999999999986544332222221111000
Q ss_pred chhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 381 RAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
. .....+..+.+|+.+||+.||++|||+.|+++
T Consensus 229 ~----------------------------------~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 229 N----------------------------------PWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp T----------------------------------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred C----------------------------------ccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 0 00123456788999999999999999999865
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=357.58 Aligned_cols=264 Identities=23% Similarity=0.327 Sum_probs=202.3
Q ss_pred cCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEE
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (473)
.++|++.+.||+|+||.||+|.. .++.||+|++.. ....+.+.+|+.++++++||||+++++++.+ ..++
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-------~~~l 76 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACLN-------PVCL 76 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT-------TTEE
T ss_pred HhHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-------CcEE
Confidence 45788999999999999999986 578999999863 2345678999999999999999999998753 2589
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCcc-EEEeec
Q 012014 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI-GHVGDF 302 (473)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~-~kl~Df 302 (473)
||||+++|+|.+++...... ..++...++.++.|++.||.|||+...++|+||||||+||+++.++. +||+||
T Consensus 77 v~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Df 150 (307)
T 2eva_A 77 VMEYAEGGSLYNVLHGAEPL------PYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDF 150 (307)
T ss_dssp EEECCTTCBHHHHHHCSSSE------ECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCC
T ss_pred EEEcCCCCCHHHHHhccCCC------CccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccc
Confidence 99999999999999865421 12557889999999999999999221189999999999999988886 799999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcch
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRA 382 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 382 (473)
|++...... .....||+.|+|||++.+..++.++||||||+++|+|++|..||................ ...
T Consensus 151 g~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---~~~ 222 (307)
T 2eva_A 151 GTACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN---GTR 222 (307)
T ss_dssp CC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT---TCC
T ss_pred ccccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc---CCC
Confidence 999755321 223458999999999999899999999999999999999999997543221111100000 000
Q ss_pred hhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHHhhccCCcc
Q 012014 383 EEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRKLLETPAC 462 (473)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~~~~~~~~ 462 (473)
. .....++..+.+|+.+||+.||++|||+.||++.|+.+...+......
T Consensus 223 ~-------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~ 271 (307)
T 2eva_A 223 P-------------------------------PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEP 271 (307)
T ss_dssp C-------------------------------CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTTSC
T ss_pred C-------------------------------CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCCCc
Confidence 0 001124557889999999999999999999999999998776554443
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=366.59 Aligned_cols=252 Identities=19% Similarity=0.284 Sum_probs=202.6
Q ss_pred ccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCC------CchhHHHHHHHHHhcCCCCceeeeeeeecccc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG------GSKSFKSECKAAINIKHRNIVRVFTAFSGVDY 215 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 215 (473)
..++|.+.+.||+|+||.||+|.. .+|+.||+|+++..... ..+.+.+|+.++..++||||++++++|.+
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--- 86 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN--- 86 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC---
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe---
Confidence 346799999999999999999994 56899999999754322 23678999999999999999999999854
Q ss_pred CCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCc
Q 012014 216 QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM 295 (473)
Q Consensus 216 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~ 295 (473)
....++||||+++|+|.+++.... .+++..+..++.||+.||.||| ++||+||||||+|||++.++
T Consensus 87 --~~~~~lv~e~~~gg~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~ 152 (361)
T 2yab_A 87 --RTDVVLILELVSGGELFDFLAQKE---------SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKN 152 (361)
T ss_dssp --SSEEEEEEECCCSCBHHHHHTTCS---------CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTT
T ss_pred --CCEEEEEEEcCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCC
Confidence 347899999999999999997653 3679999999999999999999 89999999999999998776
Q ss_pred ----cEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHH
Q 012014 296 ----IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLR 371 (473)
Q Consensus 296 ----~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~ 371 (473)
.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+..... .+.
T Consensus 153 ~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~-~~~ 228 (361)
T 2yab_A 153 IPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLA 228 (361)
T ss_dssp SSSCCEEECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHH
T ss_pred CCccCEEEEecCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-HHH
Confidence 79999999998765422 2334569999999999999899999999999999999999999997632211 011
Q ss_pred HHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 372 NFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.+...... . ........+..+.+|+.+||..||.+|||+.|+++
T Consensus 229 ~i~~~~~~---------~-----------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 229 NITAVSYD---------F-----------------------DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp HHHTTCCC---------C-----------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHhcCCC---------C-----------------------CchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11000000 0 00111234567889999999999999999999874
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=366.04 Aligned_cols=265 Identities=24% Similarity=0.357 Sum_probs=206.1
Q ss_pred ccCCCCccceeecCCCeEEEEEEec----CCCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCC
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTLF----DGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (473)
..++|.+.+.||+|+||.||+|... .+..||||+++.... ...+.+.+|+.++.+++||||+++++++.+.
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---- 122 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG---- 122 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG----
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC----
Confidence 3467999999999999999999953 344699999974322 2345689999999999999999999998543
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccE
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~ 297 (473)
...++||||+++|+|.+++..... .+++.+++.++.|++.||.||| +++|+||||||+|||++.++.+
T Consensus 123 -~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~ 190 (325)
T 3kul_A 123 -RLAMIVTEYMENGSLDTFLRTHDG--------QFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVC 190 (325)
T ss_dssp -GCCEEEEECCTTCBHHHHHHTTTT--------CSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCE
T ss_pred -CccEEEeeCCCCCcHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCE
Confidence 367999999999999999975532 3668999999999999999999 8999999999999999999999
Q ss_pred EEeecccccccCcccccc-ceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHH
Q 012014 298 HVGDFGMARFLPAIDKQN-RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVK 375 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~ 375 (473)
||+|||+++......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+..... ...
T Consensus 191 kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-----~~~ 265 (325)
T 3kul_A 191 KVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD-----VIS 265 (325)
T ss_dssp EECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-----HHH
T ss_pred EECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH-----HHH
Confidence 999999998765432211 2223346788999999998899999999999999999999 999997642211 111
Q ss_pred hhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHHh
Q 012014 376 MALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRK 455 (473)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~ 455 (473)
...... . ...+..++..+.+|+.+||+.||++|||+.||++.|+.+.+.
T Consensus 266 ~~~~~~-----~--------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 266 SVEEGY-----R--------------------------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp HHHTTC-----C--------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHcCC-----C--------------------------CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 000000 0 000113456788999999999999999999999999999765
Q ss_pred hccC
Q 012014 456 LLET 459 (473)
Q Consensus 456 ~~~~ 459 (473)
....
T Consensus 315 ~~~~ 318 (325)
T 3kul_A 315 PESL 318 (325)
T ss_dssp CC--
T ss_pred cccc
Confidence 4443
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=359.26 Aligned_cols=265 Identities=18% Similarity=0.252 Sum_probs=210.6
Q ss_pred ccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhc-CCCCceeeeeeeeccccCCcee
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 220 (473)
..++|.+.+.||+|+||.||+|. ..+++.||||++.... ....+.+|+.++..+ +||||+++++++... ..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-----~~ 79 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCG-----KY 79 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEET-----TE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecC-----Cc
Confidence 34689999999999999999999 4678999999987432 345789999999999 999999999997553 36
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCcc----
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI---- 296 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~---- 296 (473)
.++||||+ +++|.+++..... .+++..++.++.|++.||.||| +++|+||||||+|||++.++.
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~ 147 (330)
T 2izr_A 80 NAMVLELL-GPSLEDLFDLCDR--------TFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQ 147 (330)
T ss_dssp EEEEEECC-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTT
T ss_pred cEEEEEeC-CCCHHHHHHHcCC--------CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCc
Confidence 79999999 9999999986421 3678999999999999999999 899999999999999998887
Q ss_pred -EEEeecccccccCcccccc-----ceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCccc-
Q 012014 297 -GHVGDFGMARFLPAIDKQN-----RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMN- 369 (473)
Q Consensus 297 -~kl~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~- 369 (473)
+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+.......
T Consensus 148 ~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~ 227 (330)
T 2izr_A 148 VIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKE 227 (330)
T ss_dssp SEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHH
T ss_pred eEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHH
Confidence 9999999998764432211 123567999999999999999999999999999999999999999875322210
Q ss_pred -HHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 370 -LRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 370 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
+..+.....+.... ......+ .+.+|+..||+.||.+|||+.+|.+.
T Consensus 228 ~~~~i~~~~~~~~~~-------------------------------~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~ 275 (330)
T 2izr_A 228 RYQKIGDTKRATPIE-------------------------------VLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKL 275 (330)
T ss_dssp HHHHHHHHHHHSCHH-------------------------------HHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred HHHHHHhhhccCCHH-------------------------------HHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHH
Confidence 11110000000000 0011134 88999999999999999999999999
Q ss_pred HHHHHHhhcc
Q 012014 449 LRLIRRKLLE 458 (473)
Q Consensus 449 L~~l~~~~~~ 458 (473)
|+.+......
T Consensus 276 l~~~~~~~~~ 285 (330)
T 2izr_A 276 FTDLFDRKGY 285 (330)
T ss_dssp HHHHHHHTTC
T ss_pred HHHHHHHcCC
Confidence 9999876533
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=372.79 Aligned_cols=265 Identities=25% Similarity=0.340 Sum_probs=209.3
Q ss_pred hhhcccCCCCccceeecCCCeEEEEEEec-CCCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccccC
Q 012014 139 DLYNATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQ 216 (473)
Q Consensus 139 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 216 (473)
.+....++|.+.+.||+|+||.||+|... +++.||||+++.... .....+.+|+.++++++||||+++++++...
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--- 184 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK--- 184 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS---
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC---
Confidence 44556678999999999999999999954 789999999874321 2234688999999999999999999998543
Q ss_pred CceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCcc
Q 012014 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI 296 (473)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~ 296 (473)
...++||||+++|+|.+++..... .+++.+++.++.||+.||.||| +++|+||||||+|||++.++.
T Consensus 185 --~~~~lv~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~ 251 (377)
T 3cbl_A 185 --QPIYIVMELVQGGDFLTFLRTEGA--------RLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNV 251 (377)
T ss_dssp --SSCEEEEECCTTCBHHHHHHHHGG--------GCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCC
T ss_pred --CCcEEEEEcCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCc
Confidence 357999999999999999975421 3668899999999999999999 899999999999999999999
Q ss_pred EEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHH
Q 012014 297 GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVK 375 (473)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~ 375 (473)
+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.+..... ....+.
T Consensus 252 ~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~--~~~~~~ 329 (377)
T 3cbl_A 252 LKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ--TREFVE 329 (377)
T ss_dssp EEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH--HHHHHH
T ss_pred EEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHH
Confidence 99999999986533211111111224678999999998889999999999999999998 999997643211 111111
Q ss_pred hhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHHh
Q 012014 376 MALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRK 455 (473)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~ 455 (473)
... + ...+..++..+.+|+.+||+.||++|||+.+|++.|+.++++
T Consensus 330 ~~~--------------------~--------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 330 KGG--------------------R--------------LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp TTC--------------------C--------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCC--------------------C--------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 000 0 000112456788999999999999999999999999999765
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=359.75 Aligned_cols=262 Identities=19% Similarity=0.358 Sum_probs=203.0
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCC---chhHHHHHHHHHhcCCCCceeeeeeeeccccCCce
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGG---SKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (473)
.++|++.+.||+|+||.||+|. ..+++.||+|++....... .+.+.+|+.++.+++||||+++++++.+ ..
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~~ 84 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE-----DD 84 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC-----SS
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee-----CC
Confidence 4689999999999999999998 4578999999986433322 3568899999999999999999999754 34
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
..++||||+++++|.+++.... .+++..+..++.|++.||.||| +++|+||||||+||+++.++.+||
T Consensus 85 ~~~lv~e~~~g~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl 152 (294)
T 4eqm_A 85 CYYLVMEYIEGPTLSEYIESHG---------PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKI 152 (294)
T ss_dssp EEEEEEECCCSCBHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEE
T ss_pred eEEEEEeCCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEE
Confidence 6899999999999999997654 3568999999999999999999 899999999999999999999999
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcC
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP 379 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 379 (473)
+|||+++...... ........||+.|+|||++.+..++.++||||||+++|+|++|..||.+...... ... ...
T Consensus 153 ~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~----~~~-~~~ 226 (294)
T 4eqm_A 153 FDFGIAKALSETS-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI----AIK-HIQ 226 (294)
T ss_dssp CCCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH----HHH-HHS
T ss_pred EeCCCcccccccc-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH----HHH-Hhh
Confidence 9999998764322 1223345699999999999999999999999999999999999999976422111 000 000
Q ss_pred cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCC-ChHHHHHHHHHHHHh
Q 012014 380 QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERM-KINDVESRLRLIRRK 455 (473)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~ev~~~L~~l~~~ 455 (473)
...... ........+..+.+++.+||+.||.+|| +++++.+.|+.+...
T Consensus 227 ~~~~~~---------------------------~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 227 DSVPNV---------------------------TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp SCCCCH---------------------------HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred ccCCCc---------------------------chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 000000 0011123466788999999999999998 899998888876443
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=350.70 Aligned_cols=260 Identities=23% Similarity=0.341 Sum_probs=209.3
Q ss_pred cccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 142 NATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
...++|++.+.||+|+||.||+|...+++.||+|++.... ...+.+.+|+.++.+++||||+++++++.+ ....
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~ 80 (269)
T 4hcu_A 7 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPI 80 (269)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECS-----SSSE
T ss_pred eChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CCce
Confidence 3456899999999999999999998788999999997432 345679999999999999999999999854 3357
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEee
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~D 301 (473)
++||||+++++|.+++..... .+++..+..++.|++.||.||| +++|+||||||+||+++.++.+||+|
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~D 149 (269)
T 4hcu_A 81 CLVFEFMEHGCLSDYLRTQRG--------LFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSD 149 (269)
T ss_dssp EEEEECCTTCBHHHHHHTTTT--------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECC
T ss_pred EEEEEeCCCCcHHHHHHhcCc--------ccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEecc
Confidence 999999999999999976532 3668899999999999999999 89999999999999999999999999
Q ss_pred cccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcCc
Q 012014 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMALPQ 380 (473)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~ 380 (473)
||+++...... ........||+.|+|||++.+..++.++||||||+++|+|++ |..||.+..... ........
T Consensus 150 fg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~-----~~~~~~~~ 223 (269)
T 4hcu_A 150 FGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-----VVEDISTG 223 (269)
T ss_dssp TTGGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----HHHHHHTT
T ss_pred ccccccccccc-cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH-----HHHHHhcC
Confidence 99998654322 112223446788999999998899999999999999999999 999997532211 11110000
Q ss_pred chhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHHh
Q 012014 381 RAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRK 455 (473)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~ 455 (473)
. .. ..+...+..+.+|+.+||+.||++|||+.|+++.|+.+.++
T Consensus 224 ~-----~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 224 F-----RL--------------------------YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp C-----CC--------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred c-----cC--------------------------CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 0 00 00011345688999999999999999999999999999764
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-47 Score=368.04 Aligned_cols=278 Identities=15% Similarity=0.187 Sum_probs=208.9
Q ss_pred ccCCCCccceeecCCCeEEEEEEecC------CCEEEEEEeeccCCC-----------CchhHHHHHHHHHhcCCCCcee
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTLFD------GTTIAVKVFNLIRPG-----------GSKSFKSECKAAINIKHRNIVR 205 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~ 205 (473)
..++|.+.++||+|+||.||+|.... ++.||||++...... ....+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999998543 478999998743210 1112344555666778999999
Q ss_pred eeeeeeccccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCC
Q 012014 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLK 285 (473)
Q Consensus 206 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlk 285 (473)
+++++.... .+....++||||+ +++|.+++..... .+++.+++.++.||+.||.||| +++|+|||||
T Consensus 113 ~~~~~~~~~-~~~~~~~lv~e~~-g~~L~~~~~~~~~--------~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlk 179 (364)
T 3op5_A 113 YWGSGLHDK-NGKSYRFMIMDRF-GSDLQKIYEANAK--------RFSRKTVLQLSLRILDILEYIH---EHEYVHGDIK 179 (364)
T ss_dssp EEEEEEEEE-TTEEEEEEEEECE-EEEHHHHHHHTTS--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCC
T ss_pred EEeeeeecc-CCcceEEEEEeCC-CCCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCC
Confidence 999987643 3345689999999 9999999976432 3678999999999999999999 8999999999
Q ss_pred CCcEEec--CCccEEEeecccccccCcccccc-----ceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCC
Q 012014 286 PSNVLLD--DEMIGHVGDFGMARFLPAIDKQN-----RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIR 358 (473)
Q Consensus 286 p~Nil~~--~~~~~kl~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~ 358 (473)
|+|||++ .++.+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||++|..
T Consensus 180 p~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~ 259 (364)
T 3op5_A 180 ASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHL 259 (364)
T ss_dssp GGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCC
T ss_pred HHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999 88999999999998765432211 1134459999999999999999999999999999999999999
Q ss_pred CCCCCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCC
Q 012014 359 PSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRE 438 (473)
Q Consensus 359 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~ 438 (473)
||.+...... +..............+++..+. ...++..+.+|+..||+.||.+
T Consensus 260 Pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~li~~cl~~~p~~ 313 (364)
T 3op5_A 260 PWEDNLKDPK-YVRDSKIRYRENIASLMDKCFP-------------------------AANAPGEIAKYMETVKLLDYTE 313 (364)
T ss_dssp TTGGGTTCHH-HHHHHHHHHHHCHHHHHHHHSC-------------------------TTCCCHHHHHHHHHHHTCCTTC
T ss_pred CccccccCHH-HHHHHHHHhhhhHHHHHHHhcc-------------------------cccCHHHHHHHHHHHhcCCCCC
Confidence 9986433221 1111111111111111111000 0124678899999999999999
Q ss_pred CCChHHHHHHHHHHHHhhccC
Q 012014 439 RMKINDVESRLRLIRRKLLET 459 (473)
Q Consensus 439 RPt~~ev~~~L~~l~~~~~~~ 459 (473)
|||+.+|++.|+.+.......
T Consensus 314 RP~~~~l~~~l~~~~~~~~~~ 334 (364)
T 3op5_A 314 KPLYENLRDILLQGLKAIGSK 334 (364)
T ss_dssp CCCHHHHHHHHHHHHHHTTCC
T ss_pred CCCHHHHHHHHHHHHHHcCCC
Confidence 999999999999998765443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-47 Score=363.07 Aligned_cols=248 Identities=19% Similarity=0.237 Sum_probs=200.9
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeecc---CCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCce
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (473)
.++|++.+.||+|+||.||+|+. .+|+.||+|+++.. .......+.+|+.++..++||||++++++|.+. .
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-----~ 78 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-----D 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS-----S
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC-----C
Confidence 46799999999999999999994 57899999999743 234556788999999999999999999998553 3
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
..++||||+++|+|.+++.... .+++..+..++.||+.||.||| ++||+||||||+|||++.++.+||
T Consensus 79 ~~~lv~E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL 146 (337)
T 1o6l_A 79 RLCFVMEYANGGELFFHLSRER---------VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKI 146 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEE
T ss_pred EEEEEEeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEE
Confidence 6899999999999999997643 3568899999999999999999 899999999999999999999999
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcC
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP 379 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 379 (473)
+|||+++..... .......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.... ........
T Consensus 147 ~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-----~~~~~i~~ 219 (337)
T 1o6l_A 147 TDFGLCKEGISD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----RLFELILM 219 (337)
T ss_dssp CCCTTCBCSCCT--TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHH
T ss_pred eeccchhhcccC--CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH-----HHHHHHHc
Confidence 999999864322 22234456999999999999999999999999999999999999999753211 11110000
Q ss_pred cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCC-----ChHHHHH
Q 012014 380 QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERM-----KINDVES 447 (473)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~ 447 (473)
... ..+...+..+.+|+.+||+.||++|| ++.||++
T Consensus 220 ~~~--------------------------------~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 220 EEI--------------------------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp CCC--------------------------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCC--------------------------------CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 000 00012345788999999999999999 8888865
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=360.52 Aligned_cols=252 Identities=19% Similarity=0.254 Sum_probs=202.8
Q ss_pred ccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
..++|.+.+.||+|+||.||+|.. .+++.||+|.++.. ......+.+|+.++..++||||+++++++.+. ...
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~ 76 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESM-----EEL 76 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEET-----TEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecC-----CEE
Confidence 357899999999999999999984 46889999998643 23345688999999999999999999998653 368
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecC--CccEEE
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD--EMIGHV 299 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~--~~~~kl 299 (473)
++||||+++|+|.+++..... .+++.++..++.||+.||.||| ++||+||||||+|||++. ++.+||
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl 145 (321)
T 1tki_A 77 VMIFEFISGLDIFERINTSAF--------ELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKI 145 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSSC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEE
T ss_pred EEEEEeCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEE
Confidence 999999999999999976432 3668999999999999999999 899999999999999987 789999
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcC
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP 379 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 379 (473)
+|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+..... .+.........
T Consensus 146 ~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~ 221 (321)
T 1tki_A 146 IEFGQARQLKPG---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-IIENIMNAEYT 221 (321)
T ss_dssp CCCTTCEECCTT---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTCCC
T ss_pred EECCCCeECCCC---CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH-HHHHHHcCCCC
Confidence 999999876442 23344569999999999999889999999999999999999999997632211 11111111000
Q ss_pred cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 380 QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
. ........+..+.+|+.+||..||.+|||+.|+++
T Consensus 222 ~--------------------------------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 222 F--------------------------------DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp C--------------------------------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C--------------------------------ChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0 00011234567889999999999999999999987
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=353.85 Aligned_cols=264 Identities=26% Similarity=0.399 Sum_probs=196.8
Q ss_pred hhcccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCC--CchhHHHHHHHHHhcCCCCceeeeeeeeccccCC
Q 012014 140 LYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (473)
Q Consensus 140 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (473)
.....++|++.++||+|+||.||+|+. ...||+|+++..... ..+.+.+|+.++++++||||+++++++..
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----- 91 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA----- 91 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEES--SSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----
T ss_pred CccCccceeeeeEecCCCCeEEEEEEE--cCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC-----
Confidence 345567899999999999999999984 346999999754332 23568899999999999999999997532
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccE
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~ 297 (473)
...++||||+++++|.+++..... .+++.+++.++.|++.||.||| +++|+||||||+||+++.++.+
T Consensus 92 -~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~ 159 (289)
T 3og7_A 92 -PQLAIVTQWCEGSSLYHHLHASET--------KFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTV 159 (289)
T ss_dssp -SSCEEEEECCCEEEHHHHHTTC-----------CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEE
T ss_pred -CccEEEEEecCCCcHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCE
Confidence 246899999999999999965432 3668899999999999999999 8999999999999999999999
Q ss_pred EEeecccccccCccccccceeeccCCCCcCCCcccc---CCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 012014 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDL---GCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFV 374 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~ 374 (473)
||+|||+++...............||+.|+|||++. +..++.++||||||+++|+|++|..||.+............
T Consensus 160 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~ 239 (289)
T 3og7_A 160 KIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG 239 (289)
T ss_dssp EECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHH
T ss_pred EEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhc
Confidence 999999998665433333344556999999999986 56688899999999999999999999976433221111111
Q ss_pred HhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHH
Q 012014 375 KMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIR 453 (473)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~ 453 (473)
..........+ ...++..+.+|+.+||+.||.+|||+.||++.|+.+.
T Consensus 240 ~~~~~~~~~~~-------------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 240 RGSLSPDLSKV-------------------------------RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp HTSCCCCTTSS-------------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ccccCcchhhc-------------------------------cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 11111111110 1134568899999999999999999999999999874
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=350.24 Aligned_cols=267 Identities=17% Similarity=0.225 Sum_probs=213.0
Q ss_pred ccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhc-CCCCceeeeeeeeccccCCcee
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 220 (473)
..++|.+.+.||+|+||.||+|. ..+++.||+|++... .....+.+|+.++..+ +|+|++++++++.. ...
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-----~~~ 80 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE-----GLH 80 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE-----TTE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCC-----Cce
Confidence 45689999999999999999999 467899999998643 3456789999999999 79999999998754 346
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCcc----
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI---- 296 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~---- 296 (473)
.++||||+ +++|.+++..... .+++.++..++.||+.||.||| +++|+||||||+||+++.++.
T Consensus 81 ~~lv~e~~-~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~ 148 (298)
T 1csn_A 81 NVLVIDLL-GPSLEDLLDLCGR--------KFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNAN 148 (298)
T ss_dssp EEEEEECC-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTT
T ss_pred eEEEEEec-CCCHHHHHHHhcc--------CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCC
Confidence 79999999 9999999986532 3668999999999999999999 999999999999999987765
Q ss_pred -EEEeecccccccCccccc-----cceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCccc-
Q 012014 297 -GHVGDFGMARFLPAIDKQ-----NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMN- 369 (473)
Q Consensus 297 -~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~- 369 (473)
+||+|||+++........ .......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.......
T Consensus 149 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 228 (298)
T 1csn_A 149 MIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ 228 (298)
T ss_dssp CEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHH
T ss_pred eEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHH
Confidence 999999999876543321 1234456999999999999999999999999999999999999999875332210
Q ss_pred -HHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 370 -LRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 370 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
+........+... ......++..+.+|+.+||+.||++|||+.+|++.
T Consensus 229 ~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 229 KYERIGEKKQSTPL-------------------------------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp HHHHHHHHHHHSCH-------------------------------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred HHHHHHhhccCccH-------------------------------HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 1111100000000 01112356788999999999999999999999999
Q ss_pred HHHHHHhhccC
Q 012014 449 LRLIRRKLLET 459 (473)
Q Consensus 449 L~~l~~~~~~~ 459 (473)
|+.+.+.+...
T Consensus 278 l~~~~~~~~~~ 288 (298)
T 1csn_A 278 FSKVLERLNTT 288 (298)
T ss_dssp HHHHHHHTTCC
T ss_pred HHHHHHhcCCC
Confidence 99998876544
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=352.34 Aligned_cols=281 Identities=20% Similarity=0.239 Sum_probs=205.1
Q ss_pred hcccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCC--CchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 141 YNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 141 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
....++|++.+.||+|+||.||+|...+++.||+|++...... ....+.+|+.++++++||||+++++++.+ .
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~ 91 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS-----E 91 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC-----S
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc-----C
Confidence 4456889999999999999999999878999999999743322 23568899999999999999999999854 3
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...++||||++ |+|.+++..... .+++..+..++.|++.||.||| ++||+||||||+|||++.++.+|
T Consensus 92 ~~~~lv~e~~~-~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~k 159 (311)
T 3niz_A 92 RCLTLVFEFME-KDLKKVLDENKT--------GLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALK 159 (311)
T ss_dssp SCEEEEEECCS-EEHHHHHHTCTT--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEE
T ss_pred CEEEEEEcCCC-CCHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEE
Confidence 46799999997 588888876532 3668899999999999999999 89999999999999999999999
Q ss_pred EeecccccccCccccccceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
|+|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+. +..+....
T Consensus 160 l~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~i~~~~ 236 (311)
T 3niz_A 160 LADFGLARAFGIPV--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ-LPKIFSIL 236 (311)
T ss_dssp ECCCTTCEETTSCC--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH-HHHHHHHH
T ss_pred EccCcCceecCCCc--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHH
Confidence 99999998764322 22334568999999999876 5689999999999999999999999987544432 22222222
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
................+.. ..................+.++.+|+.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 237 GTPNPREWPQVQELPLWKQ------RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp CCCCTTTSGGGTTSHHHHS------CCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCCChHHhhhhhccchhhh------cccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1111111100000000000 000000011111222334567889999999999999999999875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=374.37 Aligned_cols=259 Identities=24% Similarity=0.331 Sum_probs=209.4
Q ss_pred hhhcccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 139 DLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 139 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
.+....++|.+.+.||+|+||.||+|.. .++.||||+++... ..+.+.+|+.++++++||||+++++++... .
T Consensus 187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~ 259 (450)
T 1k9a_A 187 GWALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEE----K 259 (450)
T ss_dssp TCBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECT----T
T ss_pred ccccChHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcC----C
Confidence 3445667899999999999999999986 47899999997533 567899999999999999999999997542 2
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...++||||+++|+|.+++...... .+++..++.++.||+.||.||| +++|+||||||+|||++.++.+|
T Consensus 260 ~~~~iv~e~~~~g~L~~~l~~~~~~-------~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~k 329 (450)
T 1k9a_A 260 GGLYIVTEYMAKGSLVDYLRSRGRS-------VLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAK 329 (450)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHCTT-------TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEE
T ss_pred CceEEEEEecCCCcHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEE
Confidence 3579999999999999999865421 2568889999999999999999 89999999999999999999999
Q ss_pred EeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhh
Q 012014 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~ 377 (473)
|+|||+++..... .....+++.|+|||++.+..++.++||||||+++|||++ |..||.+....+. ...+...
T Consensus 330 l~DfG~a~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~--~~~i~~~ 402 (450)
T 1k9a_A 330 VSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--VPRVEKG 402 (450)
T ss_dssp ECCCTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH--HHHHHTT
T ss_pred EeeCCCccccccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHHcC
Confidence 9999999854321 122357889999999999999999999999999999998 9999986533221 1111100
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHHh
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRK 455 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~ 455 (473)
.+ ...+..++..+.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus 403 --------------------~~--------------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 403 --------------------YK--------------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp --------------------CC--------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred --------------------CC--------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 00 001123567889999999999999999999999999998754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=355.36 Aligned_cols=247 Identities=19% Similarity=0.240 Sum_probs=200.8
Q ss_pred CCccceeecCCCeEEEEEEec-CCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEEE
Q 012014 147 FSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVY 225 (473)
Q Consensus 147 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (473)
|...+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++..++||||+++++++... ...++||
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~ 121 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVG-----EELWVLM 121 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEEEEE
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEEC-----CEEEEEE
Confidence 566678999999999999954 7999999999876666677899999999999999999999998653 3679999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecccc
Q 012014 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (473)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~ 305 (473)
||+++|+|.+++... .+++..+..++.|++.||.||| +++|+||||||+||+++.++.+||+|||++
T Consensus 122 e~~~~~~L~~~l~~~----------~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~ 188 (321)
T 2c30_A 122 EFLQGGALTDIVSQV----------RLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFC 188 (321)
T ss_dssp CCCCSCBHHHHHTTC----------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred ecCCCCCHHHHHHhc----------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCcEEEeeeeee
Confidence 999999999998754 2568999999999999999999 899999999999999999999999999999
Q ss_pred cccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchhhh
Q 012014 306 RFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEV 385 (473)
Q Consensus 306 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (473)
....... .......||+.|+|||++.+..++.++||||||+++|+|++|..||.+..... ....+....+...
T Consensus 189 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~--- 261 (321)
T 2c30_A 189 AQISKDV--PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--AMKRLRDSPPPKL--- 261 (321)
T ss_dssp EECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHSSCCCC---
T ss_pred eecccCc--cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHhcCCCCCc---
Confidence 8764422 12234569999999999999899999999999999999999999997532111 0111110000000
Q ss_pred ccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 386 VDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
......+..+.+|+.+||+.||++|||+.|+++
T Consensus 262 -----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 262 -----------------------------KNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp -----------------------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -----------------------------CccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001123557889999999999999999999976
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=349.36 Aligned_cols=253 Identities=26% Similarity=0.414 Sum_probs=202.3
Q ss_pred ccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCc-------hhHHHHHHHHHhcCCCCceeeeeeeeccc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGS-------KSFKSECKAAINIKHRNIVRVFTAFSGVD 214 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 214 (473)
..++|++.+.||+|+||.||+|+. .+++.||+|++........ +.+.+|+.++.+++||||+++++++.+..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 357899999999999999999994 5789999999875433222 57889999999999999999999985422
Q ss_pred cCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCC--eeeccCCCCcEEec
Q 012014 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPP--IAHCNLKPSNVLLD 292 (473)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~Dlkp~Nil~~ 292 (473)
++||||+++|+|.+++..... .+++..++.++.|++.||.||| +++ |+||||||+||+++
T Consensus 97 -------~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~ 158 (287)
T 4f0f_A 97 -------RMVMEFVPCGDLYHRLLDKAH--------PIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQ 158 (287)
T ss_dssp -------EEEEECCTTCBHHHHHHCTTS--------CCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEES
T ss_pred -------eEEEEecCCCCHHHHHhcccC--------CccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEe
Confidence 799999999999998866532 3668999999999999999999 888 99999999999998
Q ss_pred CCcc-----EEEeecccccccCccccccceeeccCCCCcCCCcccc--CCCCCcccchhhHhHHHHHHHhCCCCCCCCCC
Q 012014 293 DEMI-----GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDL--GCEASTYGDVYSFGILLLEMFTGIRPSDGIFT 365 (473)
Q Consensus 293 ~~~~-----~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~il~elltg~~P~~~~~~ 365 (473)
.++. +||+|||+++.... ......||+.|+|||++. ...++.++||||||+++|+|++|..||.....
T Consensus 159 ~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 233 (287)
T 4f0f_A 159 SLDENAPVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY 233 (287)
T ss_dssp CCCTTCSCCEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred ccCCCCceeEEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc
Confidence 7776 99999999975432 234456999999999984 45578999999999999999999999976543
Q ss_pred CcccHHHHHHhh-cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHH
Q 012014 366 GKMNLRNFVKMA-LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKIND 444 (473)
Q Consensus 366 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 444 (473)
............ ... ..+..++..+.+|+.+||+.||.+|||+.|
T Consensus 234 ~~~~~~~~~~~~~~~~----------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 279 (287)
T 4f0f_A 234 GKIKFINMIREEGLRP----------------------------------TIPEDCPPRLRNVIELCWSGDPKKRPHFSY 279 (287)
T ss_dssp CHHHHHHHHHHSCCCC----------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred cHHHHHHHHhccCCCC----------------------------------CCCcccCHHHHHHHHHHhcCChhhCcCHHH
Confidence 332211111110 000 001124567889999999999999999999
Q ss_pred HHHHHHHH
Q 012014 445 VESRLRLI 452 (473)
Q Consensus 445 v~~~L~~l 452 (473)
|++.|+.|
T Consensus 280 ll~~L~~l 287 (287)
T 4f0f_A 280 IVKELSEL 287 (287)
T ss_dssp HHHHHHTC
T ss_pred HHHHHHhC
Confidence 99999753
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=358.03 Aligned_cols=251 Identities=20% Similarity=0.300 Sum_probs=201.6
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCC------CchhHHHHHHHHHhcCCCCceeeeeeeeccccC
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG------GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQ 216 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 216 (473)
.++|.+.+.||+|+||.||+|.. .+++.||+|+++..... ..+.+.+|+.++..++||||+++++++.+
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---- 85 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN---- 85 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe----
Confidence 35688999999999999999994 46899999999754322 34678999999999999999999999854
Q ss_pred CceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCc-
Q 012014 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM- 295 (473)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~- 295 (473)
....++||||+++|+|.+++.... .+++.++..++.||+.||.||| +++|+||||||+|||++.++
T Consensus 86 -~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~ 152 (326)
T 2y0a_A 86 -KTDVILILELVAGGELFDFLAEKE---------SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNV 152 (326)
T ss_dssp -SSEEEEEEECCCSCBHHHHHTTSS---------CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSS
T ss_pred -CCEEEEEEEcCCCCCHHHHHHhcC---------CcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCC
Confidence 346899999999999999997643 3668999999999999999999 89999999999999998877
Q ss_pred ---cEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHH
Q 012014 296 ---IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRN 372 (473)
Q Consensus 296 ---~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~ 372 (473)
.+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+..... .+..
T Consensus 153 ~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~ 228 (326)
T 2y0a_A 153 PKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE-TLAN 228 (326)
T ss_dssp SSCCEEECCCTTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHH
T ss_pred CCCCEEEEECCCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-HHHH
Confidence 89999999998764322 2234569999999999998899999999999999999999999997632211 0111
Q ss_pred HHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 373 FVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
...... .. ........+..+.+|+.+||+.||++|||+.|+++
T Consensus 229 ~~~~~~-~~-------------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 229 VSAVNY-EF-------------------------------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp HHHTCC-CC-------------------------------CHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHhcCC-Cc-------------------------------CccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 100000 00 00111234567889999999999999999999986
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=358.87 Aligned_cols=259 Identities=23% Similarity=0.368 Sum_probs=200.6
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCE----EEEEEeeccC-CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCC
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTT----IAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (473)
.++|++.++||+|+||.||+|.. .+++. ||+|.++... ....+.+.+|+.++.+++||||++++++|...
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---- 89 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---- 89 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS----
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC----
Confidence 35799999999999999999984 34443 5888775322 34456799999999999999999999998642
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccE
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~ 297 (473)
..++++||+.+|+|.+++..... .+++..++.++.||+.||.||| +++|+||||||+|||++.++.+
T Consensus 90 --~~~~v~e~~~~g~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~ 156 (327)
T 3poz_A 90 --TVQLITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHV 156 (327)
T ss_dssp --SEEEEEECCTTCBHHHHHHHSTT--------SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEE
T ss_pred --CeEEEEEecCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCE
Confidence 35899999999999999976532 3668899999999999999999 8999999999999999999999
Q ss_pred EEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHh
Q 012014 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKM 376 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~ 376 (473)
||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||.+..... +...+..
T Consensus 157 kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~~ 234 (327)
T 3poz_A 157 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEK 234 (327)
T ss_dssp EECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHT
T ss_pred EEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH--HHHHHHc
Confidence 9999999987755443334444557889999999999999999999999999999999 999997643221 1111111
Q ss_pred hcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHHh
Q 012014 377 ALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRK 455 (473)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~ 455 (473)
.... ..+..++..+.+|+.+||+.||.+|||+.||++.|+.+...
T Consensus 235 ~~~~----------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~ 279 (327)
T 3poz_A 235 GERL----------------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp TCCC----------------------------------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred CCCC----------------------------------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence 1000 00112345788999999999999999999999999998754
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-47 Score=352.88 Aligned_cols=259 Identities=23% Similarity=0.339 Sum_probs=207.8
Q ss_pred ccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
..++|++.+.||+|+||.||+|...++..||+|+++... ...+.+.+|+.++.+++||||+++++++.. ....+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 79 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSK-----EYPIY 79 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSEE
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----CCceE
Confidence 456899999999999999999998888899999997533 345678999999999999999999999854 34679
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
+||||+++++|.+++..... .+++.+++.++.|++.||.||| +++|+||||||+||+++.++.+||+||
T Consensus 80 lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Df 148 (268)
T 3sxs_A 80 IVTEYISNGCLLNYLRSHGK--------GLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDF 148 (268)
T ss_dssp EEEECCTTCBHHHHHHHHGG--------GCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCT
T ss_pred EEEEccCCCcHHHHHHHcCC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccC
Confidence 99999999999999976421 3668999999999999999999 899999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcCcc
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMALPQR 381 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 381 (473)
|++....... ........||+.|+|||++.+..++.++||||||+++|+|++ |..||........ ........
T Consensus 149 g~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-----~~~~~~~~ 222 (268)
T 3sxs_A 149 GMTRYVLDDQ-YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV-----VLKVSQGH 222 (268)
T ss_dssp TCEEECCTTC-EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-----HHHHHTTC
T ss_pred ccceecchhh-hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH-----HHHHHcCC
Confidence 9998664432 122233446778999999998889999999999999999999 9999975422111 00000000
Q ss_pred hhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHHh
Q 012014 382 AEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRK 455 (473)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~ 455 (473)
. .. .+...+..+.+++.+||+.||.+|||+.|+++.|+.++++
T Consensus 223 ~--~~-----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 223 R--LY-----------------------------RPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp C--CC-----------------------------CCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred C--CC-----------------------------CCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 0 00 0011245688999999999999999999999999988654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=364.28 Aligned_cols=276 Identities=23% Similarity=0.304 Sum_probs=214.7
Q ss_pred hhcccCCCCccceeecCCCeEEEEEEec--------CCCEEEEEEeeccCC-CCchhHHHHHHHHHhc-CCCCceeeeee
Q 012014 140 LYNATNGFSSANLIGAGNFGSVYNGTLF--------DGTTIAVKVFNLIRP-GGSKSFKSECKAAINI-KHRNIVRVFTA 209 (473)
Q Consensus 140 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~ 209 (473)
+....++|.+.+.||+|+||.||+|... .+..||+|+++.... .....+.+|++++.++ +||||++++++
T Consensus 64 ~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 143 (382)
T 3tt0_A 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 143 (382)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence 3445678999999999999999999842 235799999875322 2235688999999999 99999999999
Q ss_pred eeccccCCceeeEEEEEecCCCCHHHHhcCCCCCCCC-------CcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeec
Q 012014 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWR-------PLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHC 282 (473)
Q Consensus 210 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~-------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~ 282 (473)
+... ...++||||+++|+|.+++......... .....+++.+++.++.||+.||.||| +++|+||
T Consensus 144 ~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~ 215 (382)
T 3tt0_A 144 CTQD-----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHR 215 (382)
T ss_dssp ECSS-----SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred eccC-----CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecC
Confidence 8543 3579999999999999999875421100 01124779999999999999999999 8999999
Q ss_pred cCCCCcEEecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCC
Q 012014 283 NLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSD 361 (473)
Q Consensus 283 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~ 361 (473)
||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 216 Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~ 295 (382)
T 3tt0_A 216 DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 295 (382)
T ss_dssp CCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999987655433333344557889999999999999999999999999999999 999997
Q ss_pred CCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCC
Q 012014 362 GIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMK 441 (473)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt 441 (473)
+.... ............ ..+..++..+.+|+.+||+.||++|||
T Consensus 296 ~~~~~-----~~~~~~~~~~~~-------------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps 339 (382)
T 3tt0_A 296 GVPVE-----ELFKLLKEGHRM-------------------------------DKPSNCTNELYMMMRDCWHAVPSQRPT 339 (382)
T ss_dssp TCCHH-----HHHHHHHTTCCC-------------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCHH-----HHHHHHHcCCCC-------------------------------CCCccCCHHHHHHHHHHcCCChhhCcC
Confidence 53211 111111000000 001124567889999999999999999
Q ss_pred hHHHHHHHHHHHHhhccC
Q 012014 442 INDVESRLRLIRRKLLET 459 (473)
Q Consensus 442 ~~ev~~~L~~l~~~~~~~ 459 (473)
+.||++.|+.+.......
T Consensus 340 ~~ell~~L~~~~~~~~~~ 357 (382)
T 3tt0_A 340 FKQLVEDLDRIVALTSNQ 357 (382)
T ss_dssp HHHHHHHHHHHHHHSCSC
T ss_pred HHHHHHHHHHHHHHHhcC
Confidence 999999999998765443
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=368.06 Aligned_cols=267 Identities=23% Similarity=0.359 Sum_probs=208.5
Q ss_pred cCCCCccceeecCCCeEEEEEEec------CCCEEEEEEeeccC-CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccC
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQ 216 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 216 (473)
.++|.+.+.||+|+||.||+|.+. +++.||||+++... ......+.+|+.++.+++||||+++++++...
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--- 146 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS--- 146 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC---
Confidence 467999999999999999999842 45689999986432 22334688999999999999999999998543
Q ss_pred CceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCc-
Q 012014 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM- 295 (473)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~- 295 (473)
...++||||+++|+|.+++......... ...+++.+++.++.||+.||.||| ++||+||||||+|||++.++
T Consensus 147 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~ 219 (367)
T 3l9p_A 147 --LPRFILLELMAGGDLKSFLRETRPRPSQ--PSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGP 219 (367)
T ss_dssp --SSCEEEEECCTTEEHHHHHHHHSCCSSS--CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSST
T ss_pred --CCCEEEEEeCCCCCHHHHHHhhccccCc--cccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCC
Confidence 3569999999999999999765432211 124678999999999999999999 89999999999999998555
Q ss_pred --cEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHH
Q 012014 296 --IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRN 372 (473)
Q Consensus 296 --~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~ 372 (473)
.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||.+..... +..
T Consensus 220 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~--~~~ 297 (367)
T 3l9p_A 220 GRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE--VLE 297 (367)
T ss_dssp TCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHH
T ss_pred CceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH
Confidence 599999999986543333333444568999999999998899999999999999999998 999997632211 111
Q ss_pred HHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHH
Q 012014 373 FVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLI 452 (473)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l 452 (473)
.+...... ..+..++..+.+|+.+||+.||.+|||+.||++.|+.+
T Consensus 298 ~i~~~~~~----------------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 298 FVTSGGRM----------------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp HHHTTCCC----------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHcCCCC----------------------------------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11000000 00112455788999999999999999999999999999
Q ss_pred HHhh
Q 012014 453 RRKL 456 (473)
Q Consensus 453 ~~~~ 456 (473)
....
T Consensus 344 ~~~~ 347 (367)
T 3l9p_A 344 TQDP 347 (367)
T ss_dssp HHCH
T ss_pred hhCh
Confidence 8654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=360.66 Aligned_cols=275 Identities=22% Similarity=0.266 Sum_probs=210.2
Q ss_pred hhhcccCCCCccceeecCCCeEEEEEEe------cCCCEEEEEEeecc-CCCCchhHHHHHHHHHhc-CCCCceeeeeee
Q 012014 139 DLYNATNGFSSANLIGAGNFGSVYNGTL------FDGTTIAVKVFNLI-RPGGSKSFKSECKAAINI-KHRNIVRVFTAF 210 (473)
Q Consensus 139 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 210 (473)
++....++|.+.+.||+|+||.||+|.. .++..||+|+++.. .....+.+.+|+.++.++ +||||+++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 3445667899999999999999999984 23568999999743 233457799999999999 899999999998
Q ss_pred eccccCCceeeEEEEEecCCCCHHHHhcCCCCCCC--------------CCcchhhcHHHHHHHHHHHHHHHHHHhhCCC
Q 012014 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW--------------RPLNFNFLIKKKLDIAIDVACALRYLHCDCQ 276 (473)
Q Consensus 211 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~--------------~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~ 276 (473)
... ...++||||+++|+|.+++........ ......+++..++.++.||+.||.||| +
T Consensus 119 ~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~ 190 (344)
T 1rjb_A 119 TLS-----GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---F 190 (344)
T ss_dssp CSS-----SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---H
T ss_pred eeC-----CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---h
Confidence 543 357999999999999999987543100 000123678999999999999999999 8
Q ss_pred CCeeeccCCCCcEEecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-
Q 012014 277 PPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT- 355 (473)
Q Consensus 277 ~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt- 355 (473)
+||+||||||+||+++.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++
T Consensus 191 ~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 270 (344)
T 1rjb_A 191 KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 270 (344)
T ss_dssp TTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred CCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcC
Confidence 9999999999999999999999999999987654332222334457889999999988899999999999999999998
Q ss_pred CCCCCCCCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCC
Q 012014 356 GIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAER 435 (473)
Q Consensus 356 g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~d 435 (473)
|..||.+...... +........... .+..++..+.+|+.+||+.|
T Consensus 271 g~~p~~~~~~~~~-~~~~~~~~~~~~----------------------------------~~~~~~~~l~~li~~~l~~d 315 (344)
T 1rjb_A 271 GVNPYPGIPVDAN-FYKLIQNGFKMD----------------------------------QPFYATEEIYIIMQSCWAFD 315 (344)
T ss_dssp SCCSSTTCCCSHH-HHHHHHTTCCCC----------------------------------CCTTCCHHHHHHHHHHTCSS
T ss_pred CCCCcccCCcHHH-HHHHHhcCCCCC----------------------------------CCCCCCHHHHHHHHHHcCCC
Confidence 9999976533221 111111110000 01123567889999999999
Q ss_pred CCCCCChHHHHHHHHHHHHhh
Q 012014 436 PRERMKINDVESRLRLIRRKL 456 (473)
Q Consensus 436 P~~RPt~~ev~~~L~~l~~~~ 456 (473)
|.+|||+.||++.|+.+....
T Consensus 316 p~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 316 SRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp GGGSCCHHHHHHHHHHHC---
T ss_pred chhCcCHHHHHHHHHHHHHHH
Confidence 999999999999999986544
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=360.09 Aligned_cols=291 Identities=23% Similarity=0.275 Sum_probs=207.2
Q ss_pred ccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHH--HhcCCCCceeeeeeeeccccCCcee
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAA--INIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l--~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
..++|++.+.||+|+||.||+|+. +++.||||+++.. ....+..|.+++ ..++||||+++++.+......+...
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 457899999999999999999975 7899999998743 234455555554 4589999999998776555556667
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCC---------CeeeccCCCCcEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQP---------PIAHCNLKPSNVLL 291 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~---------~iiH~Dlkp~Nil~ 291 (473)
.++||||+++|+|.+++.... +++..+..++.||+.||.||| ++ +|+||||||+|||+
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~~----------~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill 153 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLHT----------SDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLV 153 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHCC----------BCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEE
T ss_pred EEEEEecCCCCcHHHHHhhcc----------cchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEE
Confidence 899999999999999997653 347888999999999999999 88 99999999999999
Q ss_pred cCCccEEEeecccccccCcccc------ccceeeccCCCCcCCCccccC-------CCCCcccchhhHhHHHHHHHhCCC
Q 012014 292 DDEMIGHVGDFGMARFLPAIDK------QNRFICIKGSTGYIPPEYDLG-------CEASTYGDVYSFGILLLEMFTGIR 358 (473)
Q Consensus 292 ~~~~~~kl~Dfg~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~elltg~~ 358 (473)
+.++.+||+|||+++.+..... ........||+.|+|||++.+ ..++.++|||||||++|||++|..
T Consensus 154 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~ 233 (336)
T 3g2f_A 154 KNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233 (336)
T ss_dssp CTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBG
T ss_pred cCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCC
Confidence 9999999999999987643221 122234569999999999887 456778999999999999999977
Q ss_pred CCCCCCCCcccHHHHHHhhc-CcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCC
Q 012014 359 PSDGIFTGKMNLRNFVKMAL-PQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPR 437 (473)
Q Consensus 359 P~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~ 437 (473)
||............+..... ...... .............. ...+.....++..+.+|+.+||+.||+
T Consensus 234 p~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~ 301 (336)
T 3g2f_A 234 DLFPGESVPEYQMAFQTEVGNHPTFED---------MQVLVSREKQRPKF---PEAWKENSLAVRSLKETIEDCWDQDAE 301 (336)
T ss_dssp GGSTTSCCCCCCCTTHHHHCSSCCHHH---------HHHHHTTSCCCCCC---CTTCCCCSHHHHHHHHHHHHHSCSSGG
T ss_pred cCCCccchhHHHHhhhcccCCCchHHH---------HHhhhcccccCCCC---CcccccccchHHHHHHHHHHHhcCChh
Confidence 76443221111000000000 000000 00000000000000 000111234677899999999999999
Q ss_pred CCCChHHHHHHHHHHHHhhccCCcc
Q 012014 438 ERMKINDVESRLRLIRRKLLETPAC 462 (473)
Q Consensus 438 ~RPt~~ev~~~L~~l~~~~~~~~~~ 462 (473)
+|||+.|+++.|+.+...+..+...
T Consensus 302 ~Rps~~e~l~~L~~ll~~~~~~~~~ 326 (336)
T 3g2f_A 302 ARLTAQXAEERMAELMMIWERNKSV 326 (336)
T ss_dssp GSCCHHHHHHHHHHHHHCCCC----
T ss_pred hCcchHHHHHHHHHHHHHHHhcccC
Confidence 9999999999999999887665443
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=354.22 Aligned_cols=270 Identities=22% Similarity=0.321 Sum_probs=204.9
Q ss_pred ccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhc--CCCCceeeeeeeeccccCCcee
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI--KHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~~~~~~~~~~~~~~~~ 220 (473)
..++|++.+.||+|+||.||+|+. +++.||||++... ....+.+|.+++..+ +||||+++++++.... .....
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~ 109 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGT-GSWTQ 109 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-GGGCE
T ss_pred cccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC-CCCCc
Confidence 446899999999999999999985 4899999998632 234556666666654 8999999999986542 22256
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCC--------CeeeccCCCCcEEec
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQP--------PIAHCNLKPSNVLLD 292 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~--------~iiH~Dlkp~Nil~~ 292 (473)
.++||||+++|+|.+++... .+++..++.++.|++.||.||| ++ +|+||||||+|||++
T Consensus 110 ~~lv~e~~~~g~L~~~l~~~----------~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~ 176 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKST----------TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVK 176 (337)
T ss_dssp EEEEECCCTTCBHHHHHHHC----------CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEEC
T ss_pred eEEEEeccCCCcHHHHhhcc----------CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEEC
Confidence 89999999999999999754 2668999999999999999999 77 999999999999999
Q ss_pred CCccEEEeecccccccCccccccc--eeeccCCCCcCCCccccCCCCCcc------cchhhHhHHHHHHHhC--------
Q 012014 293 DEMIGHVGDFGMARFLPAIDKQNR--FICIKGSTGYIPPEYDLGCEASTY------GDVYSFGILLLEMFTG-------- 356 (473)
Q Consensus 293 ~~~~~kl~Dfg~~~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~------~DiwSlG~il~elltg-------- 356 (473)
.++.+||+|||+++.......... .....||+.|+|||++.+..++.. +|||||||++|||++|
T Consensus 177 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~ 256 (337)
T 3mdy_A 177 KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256 (337)
T ss_dssp TTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccc
Confidence 999999999999976644322211 124569999999999988776665 9999999999999999
Q ss_pred --CCCCCCCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccC
Q 012014 357 --IRPSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAE 434 (473)
Q Consensus 357 --~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~ 434 (473)
..||........................... .......++..+.+|+.+||+.
T Consensus 257 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~l~~li~~~l~~ 311 (337)
T 3mdy_A 257 EYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFP-------------------------NRWSSDECLRQMGKLMTECWAH 311 (337)
T ss_dssp CCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCC-------------------------GGGGGSHHHHHHHHHHHHHSCS
T ss_pred cccccHhhhcCCCCchhhhHHHHhhhccCcccc-------------------------ccchhhHHHHHHHHHHHHhhhh
Confidence 6666554433333322222111111100000 0011235788999999999999
Q ss_pred CCCCCCChHHHHHHHHHHHHh
Q 012014 435 RPRERMKINDVESRLRLIRRK 455 (473)
Q Consensus 435 dP~~RPt~~ev~~~L~~l~~~ 455 (473)
||++|||+.||++.|+.+.+.
T Consensus 312 dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 312 NPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp SGGGSCCHHHHHHHHHHHHHT
T ss_pred ChhhCCCHHHHHHHHHHHHhh
Confidence 999999999999999999764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=367.33 Aligned_cols=261 Identities=23% Similarity=0.375 Sum_probs=195.7
Q ss_pred cCCCCccceeecCCCeEEEEEEec----CCCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTLF----DGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
.++|.+.+.||+|+||.||+|+.. ++..||||+++.... ...+.+.+|+.++.+++||||+++++++...
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----- 118 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS----- 118 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-----
Confidence 457999999999999999999853 577899999875322 2345689999999999999999999998543
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...++||||+++|+|.+++..... .+++.+++.++.||+.||.||| +++|+||||||+|||++.++.+|
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~k 187 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHDA--------QFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCK 187 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTT--------CSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEE
T ss_pred CceEEEEeCCCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEE
Confidence 367999999999999999976532 3668899999999999999999 89999999999999999999999
Q ss_pred EeecccccccCccccc-cceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHh
Q 012014 299 VGDFGMARFLPAIDKQ-NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKM 376 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~ 376 (473)
|+|||+++........ .......+|+.|+|||++.+..++.++||||||+++|||++ |..||.+....+ ....
T Consensus 188 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~-----~~~~ 262 (373)
T 2qol_A 188 VSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD-----VIKA 262 (373)
T ss_dssp ECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH-----HHHH
T ss_pred ECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHHH
Confidence 9999999876543211 11222335788999999998899999999999999999998 999997542211 1110
Q ss_pred hcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHHhh
Q 012014 377 ALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRKL 456 (473)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~~ 456 (473)
..... . ...+..++..+.+|+.+||+.||++|||+.||++.|+.+....
T Consensus 263 i~~~~-----------------~--------------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 263 VDEGY-----------------R--------------LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp HHTTE-----------------E--------------CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred HHcCC-----------------C--------------CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 00000 0 0001134567889999999999999999999999999997653
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=352.92 Aligned_cols=283 Identities=20% Similarity=0.261 Sum_probs=211.6
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccC-CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
.++|.+.++||+|+||.||+|.. .+++.||||+++... ....+.+.+|+.++++++||||+++++++... .....
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~~ 84 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTRHK 84 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTCCE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecC---CCceE
Confidence 45799999999999999999994 458999999997433 23456788999999999999999999998643 23467
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEe----cCCccE
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL----DDEMIG 297 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~----~~~~~~ 297 (473)
++||||+++|+|.+++...... ..+++.+++.++.||+.||.||| +++|+||||||+|||+ +.++.+
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~ 155 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNA------YGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVY 155 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGT------TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEE
T ss_pred EEEEeCCCCCCHHHHHHHhccc------cCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceE
Confidence 9999999999999999865321 12678999999999999999999 8999999999999999 888899
Q ss_pred EEeecccccccCccccccceeeccCCCCcCCCcccc--------CCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCccc
Q 012014 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDL--------GCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMN 369 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~ 369 (473)
||+|||+++...... ......||+.|+|||++. +..++.++|||||||++|||++|..||.........
T Consensus 156 kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 232 (319)
T 4euu_A 156 KLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232 (319)
T ss_dssp EECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC
T ss_pred EEccCCCceecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh
Confidence 999999998765432 223456999999999876 567899999999999999999999999765443322
Q ss_pred HHH---HHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHH
Q 012014 370 LRN---FVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVE 446 (473)
Q Consensus 370 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~ 446 (473)
... ......+.....+.... ...+. .. ... ..........+..+.+|+.+||+.||++|||++|++
T Consensus 233 ~~~~~~~~~~~p~~~~~~~~~~~-~~~~~-----~~--~~~---~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell 301 (319)
T 4euu_A 233 KEVMYKIITGKPSGAISGVQKAE-NGPID-----WS--GDM---PVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFF 301 (319)
T ss_dssp HHHHHHHHHHCCTTCCEEEECST-TCCEE-----EE--SSC---CTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHH
T ss_pred HHHHHHHhcCCCcccchhhhccc-CCccc-----cC--ccC---CcccccchhHHHHhHHHHHHhccCChhhhccHHHhh
Confidence 222 11211111111111100 00000 00 000 000112346788899999999999999999999998
Q ss_pred HHHHHH
Q 012014 447 SRLRLI 452 (473)
Q Consensus 447 ~~L~~l 452 (473)
+.....
T Consensus 302 ~h~~d~ 307 (319)
T 4euu_A 302 AETSDI 307 (319)
T ss_dssp HHHHHH
T ss_pred hccHHH
Confidence 877643
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=358.64 Aligned_cols=280 Identities=22% Similarity=0.361 Sum_probs=198.7
Q ss_pred chhhhhcccCCCCccceeecCCCeEEEEEEecC-C---CEEEEEEeecc--CCCCchhHHHHHHHHHhcCCCCceeeeee
Q 012014 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTLFD-G---TTIAVKVFNLI--RPGGSKSFKSECKAAINIKHRNIVRVFTA 209 (473)
Q Consensus 136 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~ 209 (473)
.+.++....++|++.+.||+|+||.||+|.... + ..||+|+++.. .....+.+.+|+.++++++||||++++++
T Consensus 14 ~~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 93 (323)
T 3qup_A 14 KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGV 93 (323)
T ss_dssp --CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEE
T ss_pred HhhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhce
Confidence 344556677899999999999999999998433 3 27999998753 22345678999999999999999999999
Q ss_pred eeccccCC-ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCc
Q 012014 210 FSGVDYQG-ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSN 288 (473)
Q Consensus 210 ~~~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~N 288 (473)
+......+ ....++||||+++|+|.+++....... ....+++.+++.++.|++.||.||| ++||+||||||+|
T Consensus 94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~N 167 (323)
T 3qup_A 94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGE---NPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARN 167 (323)
T ss_dssp EECC-------CEEEEEECCTTCBHHHHHHHHHC------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGG
T ss_pred eeccccccCCCccEEEEEeccCCcHHHHHHhhhccc---cccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcce
Confidence 86543211 123489999999999999996543211 0113668999999999999999999 8999999999999
Q ss_pred EEecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCc
Q 012014 289 VLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGK 367 (473)
Q Consensus 289 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~ 367 (473)
||++.++.+||+|||+++...............+|+.|+|||.+.+..++.++|||||||++|+|++ |..||.+.....
T Consensus 168 Ili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~ 247 (323)
T 3qup_A 168 CMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247 (323)
T ss_dssp EEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred EEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH
Confidence 9999999999999999987654433333334457889999999999899999999999999999999 999998643221
Q ss_pred ccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 368 MNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
. .......... ..+...+..+.+|+.+||+.||++|||+.++++
T Consensus 248 ~--~~~~~~~~~~----------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 291 (323)
T 3qup_A 248 I--YNYLIGGNRL----------------------------------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRM 291 (323)
T ss_dssp H--HHHHHTTCCC----------------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred H--HHHHhcCCCC----------------------------------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1 1111000000 001124457889999999999999999999999
Q ss_pred HHHHHHHhhc
Q 012014 448 RLRLIRRKLL 457 (473)
Q Consensus 448 ~L~~l~~~~~ 457 (473)
.|+.+.....
T Consensus 292 ~l~~~l~~~~ 301 (323)
T 3qup_A 292 ELENILGHLS 301 (323)
T ss_dssp HHHHHHHC--
T ss_pred HHHHHHHHhh
Confidence 9999976543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=362.88 Aligned_cols=278 Identities=21% Similarity=0.321 Sum_probs=212.1
Q ss_pred hhhhhcccCCCCccceeecCCCeEEEEEEec------CCCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeee
Q 012014 137 FKDLYNATNGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTA 209 (473)
Q Consensus 137 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~ 209 (473)
+..+....++|.+.+.||+|+||.||+|+.. +++.||+|+++.... ...+.+.+|+.++.+++||||++++++
T Consensus 39 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 118 (343)
T 1luf_A 39 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 118 (343)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred cceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 4445556788999999999999999999853 347899999874332 224568899999999999999999999
Q ss_pred eeccccCCceeeEEEEEecCCCCHHHHhcCCCCCCC---------------CCcchhhcHHHHHHHHHHHHHHHHHHhhC
Q 012014 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW---------------RPLNFNFLIKKKLDIAIDVACALRYLHCD 274 (473)
Q Consensus 210 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~---------------~~~~~~~~~~~~~~i~~~i~~~L~~LH~~ 274 (473)
+.. ....++||||+++|+|.+++........ ......+++.+++.++.||+.||.|||
T Consensus 119 ~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH-- 191 (343)
T 1luf_A 119 CAV-----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS-- 191 (343)
T ss_dssp ECS-----SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH--
T ss_pred Ecc-----CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH--
Confidence 854 3367999999999999999976532110 000124778999999999999999999
Q ss_pred CCCCeeeccCCCCcEEecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHH
Q 012014 275 CQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMF 354 (473)
Q Consensus 275 ~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 354 (473)
+++|+||||||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|+|+
T Consensus 192 -~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 270 (343)
T 1luf_A 192 -ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270 (343)
T ss_dssp -HTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred -hCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHH
Confidence 8999999999999999999999999999998765433333334456899999999999889999999999999999999
Q ss_pred h-CCCCCCCCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhccc
Q 012014 355 T-GIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSA 433 (473)
Q Consensus 355 t-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~ 433 (473)
+ |..||.+..... ............ .+..++..+.+|+.+||+
T Consensus 271 t~g~~p~~~~~~~~-----~~~~~~~~~~~~-------------------------------~~~~~~~~l~~li~~~l~ 314 (343)
T 1luf_A 271 SYGLQPYYGMAHEE-----VIYYVRDGNILA-------------------------------CPENCPLELYNLMRLCWS 314 (343)
T ss_dssp TTTCCTTTTSCHHH-----HHHHHHTTCCCC-------------------------------CCTTCCHHHHHHHHHHTC
T ss_pred hcCCCcCCCCChHH-----HHHHHhCCCcCC-------------------------------CCCCCCHHHHHHHHHHcc
Confidence 9 999997632211 111100000000 011245678899999999
Q ss_pred CCCCCCCChHHHHHHHHHHHHhhcc
Q 012014 434 ERPRERMKINDVESRLRLIRRKLLE 458 (473)
Q Consensus 434 ~dP~~RPt~~ev~~~L~~l~~~~~~ 458 (473)
.||++|||+.+|++.|+.+.+.+..
T Consensus 315 ~~p~~Rps~~~~~~~L~~~~~~~~~ 339 (343)
T 1luf_A 315 KLPADRPSFCSIHRILQRMCERAEG 339 (343)
T ss_dssp SSGGGSCCHHHHHHHHHHTTC----
T ss_pred cCcccCCCHHHHHHHHHHHHhhhhh
Confidence 9999999999999999998766543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=354.63 Aligned_cols=277 Identities=22% Similarity=0.282 Sum_probs=214.9
Q ss_pred hhhhcccCCCCccceeecCCCeEEEEEEe------cCCCEEEEEEeeccCC-CCchhHHHHHHHHHhc-CCCCceeeeee
Q 012014 138 KDLYNATNGFSSANLIGAGNFGSVYNGTL------FDGTTIAVKVFNLIRP-GGSKSFKSECKAAINI-KHRNIVRVFTA 209 (473)
Q Consensus 138 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~ 209 (473)
..+....++|.+.+.||+|+||.||+|.. .+++.||+|+++.... ...+.+.+|+.++.++ +||||++++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 95 (313)
T 1t46_A 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (313)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence 33445567899999999999999999984 3467899999974332 2346788999999999 99999999999
Q ss_pred eeccccCCceeeEEEEEecCCCCHHHHhcCCCCCCC---------CCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCee
Q 012014 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW---------RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIA 280 (473)
Q Consensus 210 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~---------~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ii 280 (473)
+... ...++||||+++|+|.+++........ ......+++.+++.++.||+.||.||| +++|+
T Consensus 96 ~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~ 167 (313)
T 1t46_A 96 CTIG-----GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCI 167 (313)
T ss_dssp ECSS-----SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCC
T ss_pred EecC-----CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCee
Confidence 8543 357999999999999999976542100 001123678999999999999999999 89999
Q ss_pred eccCCCCcEEecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCC
Q 012014 281 HCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRP 359 (473)
Q Consensus 281 H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P 359 (473)
||||||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|+|++ |..|
T Consensus 168 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p 247 (313)
T 1t46_A 168 HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247 (313)
T ss_dssp CSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred cCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999987655433222333457889999999988899999999999999999999 9999
Q ss_pred CCCCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCC
Q 012014 360 SDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRER 439 (473)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 439 (473)
|.+...... +........... .+...+..+.+|+.+||+.||.+|
T Consensus 248 ~~~~~~~~~-~~~~~~~~~~~~----------------------------------~~~~~~~~l~~li~~~l~~dp~~R 292 (313)
T 1t46_A 248 YPGMPVDSK-FYKMIKEGFRML----------------------------------SPEHAPAEMYDIMKTCWDADPLKR 292 (313)
T ss_dssp STTCCSSHH-HHHHHHHTCCCC----------------------------------CCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred CCcccchhH-HHHHhccCCCCC----------------------------------CcccCCHHHHHHHHHHcCCCchhC
Confidence 976433221 111111110000 001235678899999999999999
Q ss_pred CChHHHHHHHHHHHHhhc
Q 012014 440 MKINDVESRLRLIRRKLL 457 (473)
Q Consensus 440 Pt~~ev~~~L~~l~~~~~ 457 (473)
||+.||++.|+.+.....
T Consensus 293 ps~~ell~~L~~~~~~~~ 310 (313)
T 1t46_A 293 PTFKQIVQLIEKQISEST 310 (313)
T ss_dssp CCHHHHHHHHHHHHHHTC
T ss_pred cCHHHHHHHHHHHHHHhh
Confidence 999999999999876543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=359.83 Aligned_cols=249 Identities=22% Similarity=0.289 Sum_probs=199.3
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeecc---CCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCce
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (473)
.++|.+.+.||+|+||.||+|. ..+++.||+|++... .......+.+|+.++..++|||||+++++|.+. .
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~ 88 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE-----E 88 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----S
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-----C
Confidence 4679999999999999999998 456899999999742 234456788999999999999999999998643 3
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
..++||||+.+|+|.+++.... .+++..+..++.||+.||.||| ++||+||||||+|||++.++.+||
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL 156 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQNV---------HFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHI 156 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTTC---------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEE
T ss_pred EEEEEEecCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEE
Confidence 6899999999999999998654 3668999999999999999999 899999999999999999999999
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccC---CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG---CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKM 376 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~ 376 (473)
+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||....... .......
T Consensus 157 ~DFG~a~~~~~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~--~~~~~~~ 231 (384)
T 4fr4_A 157 TDFNIAAMLPRE---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS--SKEIVHT 231 (384)
T ss_dssp CCCTTCEECCTT---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC--HHHHHHH
T ss_pred eccceeeeccCC---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc--HHHHHHH
Confidence 999999876432 23345679999999999864 458999999999999999999999997543222 1111111
Q ss_pred hcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCC-hHHHH
Q 012014 377 ALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMK-INDVE 446 (473)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-~~ev~ 446 (473)
...... ..+...+..+.+|+.+||+.||.+||+ +++|.
T Consensus 232 ~~~~~~--------------------------------~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~ 270 (384)
T 4fr4_A 232 FETTVV--------------------------------TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ 270 (384)
T ss_dssp HHHCCC--------------------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHH
T ss_pred Hhhccc--------------------------------CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHH
Confidence 000000 001123457889999999999999998 55554
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=366.80 Aligned_cols=248 Identities=21% Similarity=0.242 Sum_probs=195.3
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccC---CCCchhHHHHHHHHHhc-CCCCceeeeeeeeccccCCc
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 218 (473)
.++|++.++||+|+||.||+|+. .+++.||+|+++... ......+.+|..++.++ +||||++++++|.+ .
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~-----~ 125 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----E 125 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC-----S
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE-----C
Confidence 45799999999999999999994 468899999997532 23445688999999887 89999999999854 3
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...++||||+++|+|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|||++.++.+|
T Consensus 126 ~~~~lV~E~~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ik 193 (396)
T 4dc2_A 126 SRLFFVIEYVNGGDLMFHMQRQR---------KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIK 193 (396)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEE
T ss_pred CEEEEEEEcCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEE
Confidence 47899999999999999997654 3668999999999999999999 89999999999999999999999
Q ss_pred EeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCccc----HHHHH
Q 012014 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMN----LRNFV 374 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~----~~~~~ 374 (473)
|+|||+++..... .......+||+.|+|||++.+..++.++|||||||++|||++|..||......... .....
T Consensus 194 L~DFGla~~~~~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~ 271 (396)
T 4dc2_A 194 LTDYGMCKEGLRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF 271 (396)
T ss_dssp ECCCTTCBCCCCT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHH
T ss_pred EeecceeeecccC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHH
Confidence 9999999853221 22344567999999999999999999999999999999999999999754322110 00000
Q ss_pred HhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCCh
Q 012014 375 KMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKI 442 (473)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 442 (473)
........ ..+...+..+.+|+.+||+.||.+||++
T Consensus 272 ~~i~~~~~--------------------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 272 QVILEKQI--------------------------------RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp HHHHHCCC--------------------------------CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred HHHhcccc--------------------------------CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 00000000 0011234577899999999999999997
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=360.84 Aligned_cols=247 Identities=21% Similarity=0.306 Sum_probs=199.7
Q ss_pred ccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeecc---CCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
..++|.+.+.||+|+||.||+|.. .+++.||+|++... .......+.+|+.+++.++||||+++++++...
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~----- 81 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP----- 81 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS-----
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----
Confidence 346899999999999999999994 67899999998642 233456789999999999999999999998653
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...++||||+ +|+|.+++.... .+++.++..++.||+.||.||| ++||+||||||+|||++.++.+|
T Consensus 82 ~~~~lv~E~~-~g~l~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~k 148 (336)
T 3h4j_B 82 TDIVMVIEYA-GGELFDYIVEKK---------RMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVK 148 (336)
T ss_dssp SEEEEEECCC-CEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEE
T ss_pred CEEEEEEECC-CCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEE
Confidence 3679999999 789999987654 3668999999999999999999 89999999999999999999999
Q ss_pred EeecccccccCccccccceeeccCCCCcCCCccccCCCC-CcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEA-STYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
|+|||++....... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+......
T Consensus 149 l~DFG~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~--------- 216 (336)
T 3h4j_B 149 IADFGLSNIMTDGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL--------- 216 (336)
T ss_dssp ECCSSCTBTTTTSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC---------
T ss_pred EEEeccceeccCCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH---------
Confidence 99999998664422 2334569999999999988776 7899999999999999999999976322211
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
...+... ....+...+..+.+|+.+||+.||.+|||+.|+++
T Consensus 217 ----~~~i~~~------------------------~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 217 ----FKKVNSC------------------------VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp ----BCCCCSS------------------------CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred ----HHHHHcC------------------------CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 0000000 00001123457789999999999999999999975
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=354.71 Aligned_cols=272 Identities=22% Similarity=0.308 Sum_probs=211.7
Q ss_pred hhcccCCCCccceeecCCCeEEEEEEe------cCCCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeec
Q 012014 140 LYNATNGFSSANLIGAGNFGSVYNGTL------FDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSG 212 (473)
Q Consensus 140 ~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 212 (473)
+....++|.+.+.||+|+||.||+|.. .+++.||+|+++.... ...+.+.+|+.+++.++||||+++++++.+
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 97 (314)
T 2ivs_A 18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ 97 (314)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec
Confidence 344567899999999999999999984 2357899999874322 233568899999999999999999999854
Q ss_pred cccCCceeeEEEEEecCCCCHHHHhcCCCCCCC---------------CCcchhhcHHHHHHHHHHHHHHHHHHhhCCCC
Q 012014 213 VDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW---------------RPLNFNFLIKKKLDIAIDVACALRYLHCDCQP 277 (473)
Q Consensus 213 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~---------------~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~ 277 (473)
. ...++||||+++|+|.+++........ ......+++.+++.++.||+.||.||| ++
T Consensus 98 ~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~ 169 (314)
T 2ivs_A 98 D-----GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EM 169 (314)
T ss_dssp S-----SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HT
T ss_pred C-----CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HC
Confidence 3 357999999999999999986543110 001123778999999999999999999 89
Q ss_pred CeeeccCCCCcEEecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-C
Q 012014 278 PIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-G 356 (473)
Q Consensus 278 ~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g 356 (473)
+|+||||||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|+|++ |
T Consensus 170 ~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 249 (314)
T 2ivs_A 170 KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG 249 (314)
T ss_dssp TEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTS
T ss_pred CCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999987654333223334457889999999998889999999999999999999 9
Q ss_pred CCCCCCCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCC
Q 012014 357 IRPSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERP 436 (473)
Q Consensus 357 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP 436 (473)
..||.+..... +...+...... ..+..++..+.+|+.+||+.||
T Consensus 250 ~~p~~~~~~~~--~~~~~~~~~~~----------------------------------~~~~~~~~~~~~li~~~l~~dp 293 (314)
T 2ivs_A 250 GNPYPGIPPER--LFNLLKTGHRM----------------------------------ERPDNCSEEMYRLMLQCWKQEP 293 (314)
T ss_dssp CCSSTTCCGGG--HHHHHHTTCCC----------------------------------CCCTTCCHHHHHHHHHHTCSSG
T ss_pred CCCCCCCCHHH--HHHHhhcCCcC----------------------------------CCCccCCHHHHHHHHHHccCCh
Confidence 99997643221 11111110000 0011245678899999999999
Q ss_pred CCCCChHHHHHHHHHHHHh
Q 012014 437 RERMKINDVESRLRLIRRK 455 (473)
Q Consensus 437 ~~RPt~~ev~~~L~~l~~~ 455 (473)
++|||+.||++.|+.+..+
T Consensus 294 ~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 294 DKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp GGSCCHHHHHHHHHHHHHT
T ss_pred hhCcCHHHHHHHHHHHHhh
Confidence 9999999999999998654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=356.12 Aligned_cols=259 Identities=22% Similarity=0.343 Sum_probs=203.2
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCE----EEEEEeeccC-CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCC
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTT----IAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (473)
.++|++.++||+|+||.||+|.. .+++. ||+|.+.... ......+.+|+.++..++||||+++++++.+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----- 86 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG----- 86 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-----
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-----
Confidence 46799999999999999999984 44554 7788775332 3344678899999999999999999998743
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccE
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~ 297 (473)
...++||||+++|+|.+++..... .+++..++.++.||+.||.||| +++|+||||||+|||++.++.+
T Consensus 87 -~~~~~v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~ 154 (325)
T 3kex_A 87 -SSLQLVTQYLPLGSLLDHVRQHRG--------ALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQV 154 (325)
T ss_dssp -SSEEEEEECCTTCBSHHHHHSSGG--------GSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCE
T ss_pred -CccEEEEEeCCCCCHHHHHHHccc--------cCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeE
Confidence 247899999999999999976521 3567889999999999999999 8999999999999999999999
Q ss_pred EEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHh
Q 012014 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKM 376 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~ 376 (473)
||+|||+++...............||+.|+|||++.+..++.++||||||+++|+|++ |..||.+..... +...+..
T Consensus 155 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~ 232 (325)
T 3kex_A 155 QVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE--VPDLLEK 232 (325)
T ss_dssp EECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH--HHHHHHT
T ss_pred EECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH--HHHHHHc
Confidence 9999999998765544444455668889999999998899999999999999999999 999998643221 1111111
Q ss_pred hcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHHh
Q 012014 377 ALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRK 455 (473)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~ 455 (473)
...... +..++..+.+|+.+||+.||.+|||+.||++.|+.+...
T Consensus 233 ~~~~~~----------------------------------~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~ 277 (325)
T 3kex_A 233 GERLAQ----------------------------------PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277 (325)
T ss_dssp TCBCCC----------------------------------CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred CCCCCC----------------------------------CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 000000 001233566899999999999999999999999998643
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=349.29 Aligned_cols=264 Identities=22% Similarity=0.356 Sum_probs=208.6
Q ss_pred hhhhhcccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccC
Q 012014 137 FKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQ 216 (473)
Q Consensus 137 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 216 (473)
+..+....++|++.+.||+|+||.||+|...++..||+|+++... ...+.+.+|+.++.+++||||+++++++.+
T Consensus 16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---- 90 (283)
T 3gen_A 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK---- 90 (283)
T ss_dssp CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECS----
T ss_pred CCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEec----
Confidence 344555677899999999999999999998888899999997433 345679999999999999999999999854
Q ss_pred CceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCcc
Q 012014 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI 296 (473)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~ 296 (473)
....++||||+++|+|.+++..... .+++.+++.++.|++.||.||| +++|+||||||+||+++.++.
T Consensus 91 -~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~ 158 (283)
T 3gen_A 91 -QRPIFIITEYMANGCLLNYLREMRH--------RFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGV 158 (283)
T ss_dssp -SSSEEEEECCCTTCBHHHHHHCGGG--------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSC
T ss_pred -CCCeEEEEeccCCCcHHHHHHHhcc--------CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCC
Confidence 3467999999999999999976321 3668999999999999999999 899999999999999999999
Q ss_pred EEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHH
Q 012014 297 GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVK 375 (473)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~ 375 (473)
+||+|||+++...... ........||+.|+|||++.+..++.++||||||+++|+|++ |..||........ ...+.
T Consensus 159 ~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~--~~~~~ 235 (283)
T 3gen_A 159 VKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET--AEHIA 235 (283)
T ss_dssp EEECSTTGGGGBCCHH-HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH--HHHHH
T ss_pred EEEccccccccccccc-cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH--HHHHh
Confidence 9999999998664322 112223446788999999998889999999999999999998 9999976432110 00000
Q ss_pred hhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHH
Q 012014 376 MALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRR 454 (473)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~ 454 (473)
...... .+...+..+.+|+.+||+.||.+|||+.|+++.|+.+..
T Consensus 236 ~~~~~~----------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 236 QGLRLY----------------------------------RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp TTCCCC----------------------------------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccCCC----------------------------------CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 000000 001124578899999999999999999999999999865
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=379.81 Aligned_cols=264 Identities=23% Similarity=0.347 Sum_probs=212.1
Q ss_pred hhhhhcccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccC
Q 012014 137 FKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQ 216 (473)
Q Consensus 137 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 216 (473)
...+....++|.+.+.||+|+||.||+|...++..||||+++... ...+.+.+|+.++++++||||+++++++..
T Consensus 180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~---- 254 (454)
T 1qcf_A 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK---- 254 (454)
T ss_dssp TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEECS----
T ss_pred ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEeC----
Confidence 455666778899999999999999999998788899999997533 356789999999999999999999999742
Q ss_pred CceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCcc
Q 012014 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI 296 (473)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~ 296 (473)
...++||||+++|+|.+++..... ..+++..++.++.||+.||.||| +++|+||||||+|||++.++.
T Consensus 255 --~~~~lv~e~~~~g~L~~~l~~~~~-------~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~ 322 (454)
T 1qcf_A 255 --EPIYIITEFMAKGSLLDFLKSDEG-------SKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLV 322 (454)
T ss_dssp --SSCEEEECCCTTCBHHHHHHSHHH-------HTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCC
T ss_pred --CccEEEEeecCCCcHHHHHHhccC-------CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCc
Confidence 246999999999999999975421 13557889999999999999999 899999999999999999999
Q ss_pred EEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHH
Q 012014 297 GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVK 375 (473)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~ 375 (473)
+||+|||+++....... .......+|+.|+|||++....++.++|||||||++|||++ |..||.+....+ +...+.
T Consensus 323 ~kl~DFG~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~--~~~~i~ 399 (454)
T 1qcf_A 323 CKIADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE--VIRALE 399 (454)
T ss_dssp EEECSTTGGGGBCCHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHHH
T ss_pred EEEeeCCCceEcCCCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHHH
Confidence 99999999987643221 11223346788999999998899999999999999999999 999997642211 011110
Q ss_pred hhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHH
Q 012014 376 MALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRR 454 (473)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~ 454 (473)
.. .+. +.+..++..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 400 ~~--------------------~~~--------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 400 RG--------------------YRM--------------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp HT--------------------CCC--------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred cC--------------------CCC--------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 00 000 0012356688999999999999999999999999988743
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=351.38 Aligned_cols=281 Identities=21% Similarity=0.257 Sum_probs=206.1
Q ss_pred ccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCC-----CCchhHHHHHHHHHhcC---CCCceeeeeeeecc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP-----GGSKSFKSECKAAINIK---HRNIVRVFTAFSGV 213 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~ 213 (473)
..++|++.+.||+|+||.||+|+ ..+++.||+|++..... .....+.+|+.+++.++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 35789999999999999999999 46789999999974332 22346778888887775 99999999998765
Q ss_pred ccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecC
Q 012014 214 DYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD 293 (473)
Q Consensus 214 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~ 293 (473)
........++||||+. |+|.+++...... .+++.++..++.||+.||.||| +++|+||||||+|||++.
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~-------~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~ 155 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPP-------GLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTS 155 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTT-------CSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECT
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCC-------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcC
Confidence 5444456899999996 6999999876532 2668999999999999999999 899999999999999999
Q ss_pred CccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHH
Q 012014 294 EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNF 373 (473)
Q Consensus 294 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~ 373 (473)
++.+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+..... .+..+
T Consensus 156 ~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i 231 (308)
T 3g33_A 156 GGTVKLADFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKI 231 (308)
T ss_dssp TSCEEECSCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH-HHHHH
T ss_pred CCCEEEeeCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHH
Confidence 999999999999866432 22234568999999999999999999999999999999999999998643322 12222
Q ss_pred HHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 374 VKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
...........+........ ................+.+..+.+|+.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 232 FDLIGLPPEDDWPRDVSLPR---------GAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp HHHHCCCCTTTSCSSCSSCG---------GGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhCCCChhhccchhhccc---------cccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 22111111111000000000 000000011111222345678899999999999999999999874
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=355.49 Aligned_cols=245 Identities=26% Similarity=0.340 Sum_probs=199.9
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeecc---CCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCce
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (473)
.++|++.+.||+|+||.||+|+. .+|+.||+|+++.. .....+.+.+|+.++..++||||+++++++.+ ..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-----~~ 79 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-----AQ 79 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-----SS
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe-----CC
Confidence 35799999999999999999994 57999999999743 23445678899999999999999999999854 34
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
..++||||+++|+|.+++.... .+++..+..++.||+.||.||| ++||+||||||+|||++.++.+||
T Consensus 80 ~~~lv~e~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL 147 (318)
T 1fot_A 80 QIFMIMDYIEGGELFSLLRKSQ---------RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKI 147 (318)
T ss_dssp EEEEEECCCCSCBHHHHHHHTS---------SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEE
T ss_pred EEEEEEeCCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEE
Confidence 6899999999999999998654 3568899999999999999999 999999999999999999999999
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcC
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP 379 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 379 (473)
+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+..... .+........
T Consensus 148 ~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~- 220 (318)
T 1fot_A 148 TDFGFAKYVPD-----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-TYEKILNAEL- 220 (318)
T ss_dssp CCCSSCEECSS-----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHCCC-
T ss_pred eecCcceecCC-----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCC-
Confidence 99999986543 2234579999999999999999999999999999999999999997532111 0111111000
Q ss_pred cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCC-----ChHHHHH
Q 012014 380 QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERM-----KINDVES 447 (473)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~ 447 (473)
. .+...+..+.+|+.+||..||++|| ++.||++
T Consensus 221 -~----------------------------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 221 -R----------------------------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp -C----------------------------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred -C----------------------------------CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 0 0012345778999999999999999 8888863
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=351.48 Aligned_cols=279 Identities=23% Similarity=0.349 Sum_probs=203.8
Q ss_pred chhhhhcccCCCCccceeecCCCeEEEEEEec----CCCEEEEEEeeccCCC--CchhHHHHHHHHHhcCCCCceeeeee
Q 012014 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTLF----DGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTA 209 (473)
Q Consensus 136 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~ 209 (473)
.+.++....++|.+.+.||+|+||.||+|... ++..||+|+++..... ..+.+.+|+.++.+++||||++++++
T Consensus 25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 104 (313)
T 3brb_A 25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGV 104 (313)
T ss_dssp CTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred hHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence 34555566788999999999999999999843 3458999998754322 23568899999999999999999999
Q ss_pred eeccccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcE
Q 012014 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNV 289 (473)
Q Consensus 210 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Ni 289 (473)
+...........++||||+++|+|.+++....... ....+++..++.++.||+.||.||| +++|+||||||+||
T Consensus 105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NI 178 (313)
T 3brb_A 105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLET---GPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNC 178 (313)
T ss_dssp EEC-------CEEEEEECCTTCBHHHHHHHTTBTT---SCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGE
T ss_pred EeeccccCCcccEEEEecccCCCHHHHHHHhhhhc---CCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceE
Confidence 87654333345799999999999999985432110 0114678999999999999999999 99999999999999
Q ss_pred EecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcc
Q 012014 290 LLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKM 368 (473)
Q Consensus 290 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~ 368 (473)
+++.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+.....
T Consensus 179 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~- 257 (313)
T 3brb_A 179 MLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE- 257 (313)
T ss_dssp EECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-
T ss_pred EEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH-
Confidence 999999999999999987654332233334457889999999999999999999999999999999 899997643221
Q ss_pred cHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 369 NLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
+.......... ..+..++..+.+|+.+||+.||.+|||+.+|++.
T Consensus 258 -~~~~~~~~~~~----------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 258 -MYDYLLHGHRL----------------------------------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp -HHHHHHTTCCC----------------------------------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -HHHHHHcCCCC----------------------------------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11111000000 0011245678899999999999999999999999
Q ss_pred HHHHHHhh
Q 012014 449 LRLIRRKL 456 (473)
Q Consensus 449 L~~l~~~~ 456 (473)
|+.+.+.+
T Consensus 303 L~~l~~~l 310 (313)
T 3brb_A 303 LEKLLESL 310 (313)
T ss_dssp HHHHHHHC
T ss_pred HHHHHHhc
Confidence 99998765
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-46 Score=349.55 Aligned_cols=277 Identities=17% Similarity=0.217 Sum_probs=200.4
Q ss_pred CCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCC--CchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
++|++.+.||+|+||.||+|.. .+++.||+|+++..... ....+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 76 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-----KKL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeC-----CEE
Confidence 5799999999999999999994 56899999999754332 236788999999999999999999998643 367
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEee
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~D 301 (473)
++||||+++ +|.+++..... .+++..+..++.|++.||.||| ++||+||||||+||+++.++.+||+|
T Consensus 77 ~lv~e~~~~-~l~~~~~~~~~--------~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~D 144 (292)
T 3o0g_A 77 TLVFEFCDQ-DLKKYFDSCNG--------DLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLAN 144 (292)
T ss_dssp EEEEECCSE-EHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECC
T ss_pred EEEEecCCC-CHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEee
Confidence 999999965 66666654321 3668999999999999999999 89999999999999999999999999
Q ss_pred cccccccCccccccceeeccCCCCcCCCccccCCC-CCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCc
Q 012014 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE-ASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQ 380 (473)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 380 (473)
||+++...... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.........+..........
T Consensus 145 fg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~ 222 (292)
T 3o0g_A 145 FGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP 222 (292)
T ss_dssp CTTCEECCSCC--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCC
T ss_pred cccceecCCcc--ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCC
Confidence 99998764322 2223456899999999988766 89999999999999999998888654333333333333222111
Q ss_pred chhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 381 RAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
............ . .... ................+..+.+|+.+||+.||++|||+.|+++
T Consensus 223 ~~~~~~~~~~~~---~---~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 223 TEEQWPSMTKLP---D---YKPY-PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CTTTCTTGGGST---T---CCCC-CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred Chhhhhhhcccc---c---cccc-ccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 111100000000 0 0000 0000000011112235667889999999999999999999874
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-47 Score=365.11 Aligned_cols=249 Identities=22% Similarity=0.246 Sum_probs=195.5
Q ss_pred ccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeecc---CCCCchhHHHHHHHHHhc-CCCCceeeeeeeeccccCC
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQG 217 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 217 (473)
..++|++.++||+|+||.||+|+. .+++.||+|+++.. .......+.+|..++..+ +||||++++++|.+.
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~---- 96 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP---- 96 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS----
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC----
Confidence 357899999999999999999994 56899999999742 233456688999999988 799999999998543
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccE
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~ 297 (473)
...++||||+++|+|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|||++.++.+
T Consensus 97 -~~~~lv~E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~i 163 (353)
T 3txo_A 97 -DRLFFVMEFVNGGDLMFHIQKSR---------RFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHC 163 (353)
T ss_dssp -SEEEEEEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCE
T ss_pred -CEEEEEEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCE
Confidence 36899999999999999997654 3668999999999999999999 8999999999999999999999
Q ss_pred EEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
||+|||+++..... .......+||+.|+|||++.+..++.++|||||||++|||++|..||.+....+ .+.......
T Consensus 164 kL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-~~~~i~~~~ 240 (353)
T 3txo_A 164 KLADFGMCKEGICN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD-LFEAILNDE 240 (353)
T ss_dssp EECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCC
T ss_pred EEccccceeecccC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH-HHHHHHcCC
Confidence 99999999854322 223345679999999999998889999999999999999999999997642211 111111100
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCCh------HHHHH
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKI------NDVES 447 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~------~ev~~ 447 (473)
.. .+...+..+.+|+.+||+.||.+||++ .||++
T Consensus 241 ~~------------------------------------~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 241 VV------------------------------------YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp CC------------------------------------CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CC------------------------------------CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 00 001134567889999999999999998 66654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-46 Score=354.37 Aligned_cols=280 Identities=21% Similarity=0.268 Sum_probs=215.9
Q ss_pred chhhhhcccCCCCccceeecCCCeEEEEEEe------cCCCEEEEEEeeccCC-CCchhHHHHHHHHHhc-CCCCceeee
Q 012014 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTL------FDGTTIAVKVFNLIRP-GGSKSFKSECKAAINI-KHRNIVRVF 207 (473)
Q Consensus 136 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~ 207 (473)
....+....++|.+.+.||+|+||.||+|.. .+++.||+|+++.... .....+.+|+.++.++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3445556678999999999999999999973 3468899999875332 1234688999999999 799999999
Q ss_pred eeeeccccCCceeeEEEEEecCCCCHHHHhcCCCCCCCC-------CcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCee
Q 012014 208 TAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWR-------PLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIA 280 (473)
Q Consensus 208 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~-------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ii 280 (473)
+++... ....++||||+++|+|.+++......... .....+++..+..++.|++.||.||| +++|+
T Consensus 98 ~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~ 170 (316)
T 2xir_A 98 GACTKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCI 170 (316)
T ss_dssp EEECCT----TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCC
T ss_pred EEEecC----CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcc
Confidence 998542 23579999999999999999876431100 00112678999999999999999999 89999
Q ss_pred eccCCCCcEEecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCC
Q 012014 281 HCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRP 359 (473)
Q Consensus 281 H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P 359 (473)
||||||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|+|++ |..|
T Consensus 171 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p 250 (316)
T 2xir_A 171 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250 (316)
T ss_dssp CSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred cccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999987654332223334457899999999998899999999999999999998 9999
Q ss_pred CCCCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCC
Q 012014 360 SDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRER 439 (473)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 439 (473)
|.+........... ....... .+...+..+.+++.+||+.||.+|
T Consensus 251 ~~~~~~~~~~~~~~-~~~~~~~----------------------------------~~~~~~~~l~~li~~~l~~dp~~R 295 (316)
T 2xir_A 251 YPGVKIDEEFCRRL-KEGTRMR----------------------------------APDYTTPEMYQTMLDCWHGEPSQR 295 (316)
T ss_dssp STTCCCSHHHHHHH-HHTCCCC----------------------------------CCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred CcccchhHHHHHHh-ccCccCC----------------------------------CCCCCCHHHHHHHHHHcCCChhhC
Confidence 97643322111111 1100000 001134578899999999999999
Q ss_pred CChHHHHHHHHHHHHhhc
Q 012014 440 MKINDVESRLRLIRRKLL 457 (473)
Q Consensus 440 Pt~~ev~~~L~~l~~~~~ 457 (473)
||+.||++.|+.+.....
T Consensus 296 ps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 296 PTFSELVEHLGNLLQANA 313 (316)
T ss_dssp CCHHHHHHHHHHHHHHHC
T ss_pred cCHHHHHHHHHHHHhhhc
Confidence 999999999999976543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=368.24 Aligned_cols=258 Identities=21% Similarity=0.242 Sum_probs=203.6
Q ss_pred hhhhcccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeecc---CCCCchhHHHHHHHHHhcCCCCceeeeeeeecc
Q 012014 138 KDLYNATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGV 213 (473)
Q Consensus 138 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 213 (473)
.++....++|.+.++||+|+||.||+|+. .+++.||+|+++.. .......+.+|+.++..++||||++++++|.+
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~- 140 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD- 140 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE-
Confidence 34555678899999999999999999994 46899999999742 23445678999999999999999999999864
Q ss_pred ccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecC
Q 012014 214 DYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD 293 (473)
Q Consensus 214 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~ 293 (473)
....++||||+++|+|.+++... .+++..+..++.||+.||.||| +++|+||||||+|||++.
T Consensus 141 ----~~~~~lV~E~~~gg~L~~~l~~~----------~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~ 203 (410)
T 3v8s_A 141 ----DRYLYMVMEYMPGGDLVNLMSNY----------DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDK 203 (410)
T ss_dssp ----SSEEEEEECCCTTEEHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECT
T ss_pred ----CCEEEEEEeCCCCCcHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECC
Confidence 34789999999999999999754 2568899999999999999999 899999999999999999
Q ss_pred CccEEEeecccccccCccccccceeeccCCCCcCCCccccCCC----CCcccchhhHhHHHHHHHhCCCCCCCCCCCccc
Q 012014 294 EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE----ASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMN 369 (473)
Q Consensus 294 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~ 369 (473)
++.+||+|||+++...... .......+||+.|+|||++.+.. ++.++|||||||++|||++|..||.+..... .
T Consensus 204 ~g~ikL~DFG~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~ 281 (410)
T 3v8s_A 204 SGHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-T 281 (410)
T ss_dssp TSCEEECCCTTCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH-H
T ss_pred CCCEEEeccceeEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh-H
Confidence 9999999999998764422 12233567999999999988765 7899999999999999999999997532111 1
Q ss_pred HHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCC--CCChHHHHH
Q 012014 370 LRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRE--RMKINDVES 447 (473)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~ev~~ 447 (473)
+..+......... +.....+..+.+|+.+||..+|.+ ||++.||++
T Consensus 282 ~~~i~~~~~~~~~--------------------------------p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 282 YSKIMNHKNSLTF--------------------------------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp HHHHHTHHHHCCC--------------------------------CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred HHHHHhccccccC--------------------------------CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 1111110000000 000123457789999999999998 999999875
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=357.97 Aligned_cols=251 Identities=20% Similarity=0.288 Sum_probs=186.4
Q ss_pred ccCCCCccceeecCCCeEEEEEEec-CCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
..++|.+.+.||+|+||.||+|... +++.||||+++... ..+.+.+|+.++.+++||||++++++|... ...
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~ 123 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETP-----TEI 123 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECS-----SEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecC-----CeE
Confidence 4567999999999999999999954 58899999997432 346788999999999999999999998543 367
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecC---CccEE
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD---EMIGH 298 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~---~~~~k 298 (473)
++||||+++|+|.+++.... .+++.++..++.||+.||.||| +++|+||||||+|||++. ++.+|
T Consensus 124 ~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~k 191 (349)
T 2w4o_A 124 SLVLELVTGGELFDRIVEKG---------YYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLK 191 (349)
T ss_dssp EEEECCCCSCBHHHHHTTCS---------SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEE
T ss_pred EEEEEeCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEE
Confidence 99999999999999997654 3568899999999999999999 899999999999999975 88999
Q ss_pred EeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 012014 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMAL 378 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~ 378 (473)
|+|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.........+..+.....
T Consensus 192 l~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~ 268 (349)
T 2w4o_A 192 IADFGLSKIVEHQ---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEY 268 (349)
T ss_dssp ECCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCC
T ss_pred EccCccccccCcc---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCC
Confidence 9999999865432 2223456899999999999989999999999999999999999999754322211111111000
Q ss_pred CcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 379 PQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
. .. . +.....+..+.+|+.+||+.||++|||+.|+++
T Consensus 269 ~-~~----~---------------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 269 Y-FI----S---------------------------PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp C-CC----T---------------------------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred c-cC----C---------------------------chhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00 0 000124557889999999999999999999875
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=359.89 Aligned_cols=252 Identities=18% Similarity=0.291 Sum_probs=201.7
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
.++|.+.+.||+|+||.||+|.. .+++.||+|++..........+.+|+.++..++||||+++++++.+ ....+
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~~~ 124 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED-----KYEMV 124 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-----SSEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe-----CCEEE
Confidence 45799999999999999999984 5789999999975443345578999999999999999999999854 34689
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecC--CccEEEe
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD--EMIGHVG 300 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~--~~~~kl~ 300 (473)
+||||+++|+|.+++..... .+++.++..++.||+.||.||| +++|+||||||+|||++. ++.+||+
T Consensus 125 lv~E~~~gg~L~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~ 193 (387)
T 1kob_A 125 LILEFLSGGELFDRIAAEDY--------KMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKII 193 (387)
T ss_dssp EEEECCCCCBHHHHTTCTTC--------CBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEEC
T ss_pred EEEEcCCCCcHHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEE
Confidence 99999999999999976432 3678999999999999999999 899999999999999974 5789999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCc
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQ 380 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 380 (473)
|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+..... .+.........
T Consensus 194 DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-~~~~i~~~~~~- 268 (387)
T 1kob_A 194 DFGLATKLNPD---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-TLQNVKRCDWE- 268 (387)
T ss_dssp CCTTCEECCTT---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHHCCCC-
T ss_pred ecccceecCCC---cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCC-
Confidence 99999876442 22334569999999999999899999999999999999999999997632111 01111000000
Q ss_pred chhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 381 RAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.+. ......+..+.+|+.+||+.||++|||+.|+++
T Consensus 269 -----~~~--------------------------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 269 -----FDE--------------------------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp -----CCS--------------------------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred -----CCc--------------------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 000 000124567889999999999999999999986
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=357.60 Aligned_cols=251 Identities=20% Similarity=0.286 Sum_probs=199.5
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCC--CchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
.++|.+.+.||+|+||.||+|.. .+++.||+|++...... ..+.+.+|+.++..++||||+++++++.+. ..
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~ 102 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-----SF 102 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-----CE
Confidence 45799999999999999999984 56899999999754322 235688999999999999999999998543 46
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCC---ccE
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE---MIG 297 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~---~~~ 297 (473)
.++||||+++|+|.+++.... .+++.++..++.||+.||.||| +++|+||||||+|||++.+ +.+
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~ 170 (362)
T 2bdw_A 103 HYLVFDLVTGGELFEDIVARE---------FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAV 170 (362)
T ss_dssp EEEEECCCCSCBHHHHHTTCS---------CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCE
T ss_pred EEEEEecCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCE
Confidence 799999999999999997654 3668999999999999999999 8999999999999999765 459
Q ss_pred EEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+..... +...+...
T Consensus 171 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~--~~~~i~~~ 245 (362)
T 2bdw_A 171 KLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--LYAQIKAG 245 (362)
T ss_dssp EECCCTTCBCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHT
T ss_pred EEeecCcceEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHhC
Confidence 999999998765322 2234569999999999999899999999999999999999999997632111 11111100
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
...... ......+..+.+|+.+||+.||++|||+.|+++
T Consensus 246 ~~~~~~-------------------------------~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 246 AYDYPS-------------------------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp CCCCCT-------------------------------TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCCCCc-------------------------------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000000 000124567889999999999999999999875
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=367.71 Aligned_cols=252 Identities=19% Similarity=0.246 Sum_probs=198.9
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCC--CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
.++|++.+.||+|+||.||+|. ..+|+.+|+|++..... ...+.+.+|+.+++.++||||+++++++.+ ...
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-----~~~ 84 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE-----EGH 84 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC-----SSE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE-----CCE
Confidence 4578999999999999999998 45789999999975432 223568899999999999999999999854 347
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEec---CCccE
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD---DEMIG 297 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~---~~~~~ 297 (473)
.++||||+++|+|.+++.... .+++.++..++.||+.||.||| ++||+||||||+|||++ .++.+
T Consensus 85 ~~lv~E~~~gg~L~~~i~~~~---------~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~v 152 (444)
T 3soa_A 85 HYLIFDLVTGGELFEDIVARE---------YYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAV 152 (444)
T ss_dssp EEEEECCCBCCBHHHHHHHCS---------CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCE
T ss_pred EEEEEEeCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcE
Confidence 799999999999999997654 3668999999999999999999 89999999999999998 46789
Q ss_pred EEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+..... .+.......
T Consensus 153 kL~DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~~~ 229 (444)
T 3soa_A 153 KLADFGLAIEVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR-LYQQIKAGA 229 (444)
T ss_dssp EECCCSSCBCCCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHTC
T ss_pred EEccCceeEEecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH-HHHHHHhCC
Confidence 999999998764422 22334579999999999999899999999999999999999999997532111 011111100
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.... . +.....+..+.+|+.+||+.||++|||+.|+++
T Consensus 230 ~~~~-~-------------------------------~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 230 YDFP-S-------------------------------PEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp CCCC-T-------------------------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCC-c-------------------------------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000 0 000123557889999999999999999999976
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-46 Score=367.55 Aligned_cols=262 Identities=19% Similarity=0.218 Sum_probs=204.2
Q ss_pred hhhhhcccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeecc---CCCCchhHHHHHHHHHhcCCCCceeeeeeeec
Q 012014 137 FKDLYNATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSG 212 (473)
Q Consensus 137 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 212 (473)
+.++....++|++.++||+|+||.||+|+. .+++.||+|+++.. .......+.+|..++..++||||++++++|.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 445566678999999999999999999995 45789999999742 22344568999999999999999999999865
Q ss_pred cccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEec
Q 012014 213 VDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD 292 (473)
Q Consensus 213 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~ 292 (473)
....++|||||++|+|.+++..... .+++..+..++.||+.||.||| +++|+||||||+|||++
T Consensus 146 -----~~~~~lV~Ey~~gg~L~~~l~~~~~--------~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~ 209 (437)
T 4aw2_A 146 -----DNNLYLVMDYYVGGDLLTLLSKFED--------RLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMD 209 (437)
T ss_dssp -----SSEEEEEECCCTTCBHHHHHHTTTT--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEC
T ss_pred -----CCEEEEEEecCCCCcHHHHHHHccC--------CCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEc
Confidence 3468999999999999999986422 3668999999999999999999 89999999999999999
Q ss_pred CCccEEEeecccccccCccccccceeeccCCCCcCCCcccc-----CCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCc
Q 012014 293 DEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDL-----GCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGK 367 (473)
Q Consensus 293 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~ 367 (473)
.++.+||+|||+++...... .......+||+.|+|||++. ...++.++|||||||++|||++|..||.+....+
T Consensus 210 ~~g~vkL~DFGla~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~ 288 (437)
T 4aw2_A 210 MNGHIRLADFGSCLKLMEDG-TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 288 (437)
T ss_dssp TTSCEEECCCTTCEECCTTS-CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred CCCCEEEcchhhhhhcccCC-CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH
Confidence 99999999999998664422 22233457999999999987 5568999999999999999999999997632211
Q ss_pred ccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCC--CCChHHH
Q 012014 368 MNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRE--RMKINDV 445 (473)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~--RPt~~ev 445 (473)
.+..+........... .....+..+.+|+.+||..+|++ ||++.||
T Consensus 289 -~~~~i~~~~~~~~~p~-------------------------------~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~ei 336 (437)
T 4aw2_A 289 -TYGKIMNHKERFQFPT-------------------------------QVTDVSENAKDLIRRLICSREHRLGQNGIEDF 336 (437)
T ss_dssp -HHHHHHTHHHHCCCCS-------------------------------SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHH
T ss_pred -HHHhhhhccccccCCc-------------------------------ccccCCHHHHHHHHHHhcccccccCCCCHHHH
Confidence 1111110000000000 00113456788999999988888 9999998
Q ss_pred HH
Q 012014 446 ES 447 (473)
Q Consensus 446 ~~ 447 (473)
++
T Consensus 337 l~ 338 (437)
T 4aw2_A 337 KK 338 (437)
T ss_dssp HT
T ss_pred hC
Confidence 65
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-46 Score=357.87 Aligned_cols=253 Identities=22% Similarity=0.289 Sum_probs=192.4
Q ss_pred ccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCC--CchhHHHHHHHHHhcCC--CCceeeeeeeeccccCCc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKH--RNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~ 218 (473)
..++|++.+.||+|+||.||+|...+++.||||++...... ..+.+.+|+.++.+++| |||+++++++...
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~----- 81 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD----- 81 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC-----
Confidence 45679999999999999999999878999999999754322 23568899999999986 9999999998643
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...++||| +.+|+|.+++.... .+++.++..++.||+.||.||| +++|+||||||+|||++ ++.+|
T Consensus 82 ~~~~lv~e-~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~k 147 (343)
T 3dbq_A 82 QYIYMVME-CGNIDLNSWLKKKK---------SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLK 147 (343)
T ss_dssp SEEEEEEC-CCSEEHHHHHHHSC---------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEE
T ss_pred CEEEEEEe-CCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEE
Confidence 47899999 45889999998754 3568899999999999999999 89999999999999997 57899
Q ss_pred EeecccccccCccccccceeeccCCCCcCCCccccC-----------CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCc
Q 012014 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-----------CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGK 367 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~ 367 (473)
|+|||+++...............||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......
T Consensus 148 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 227 (343)
T 3dbq_A 148 LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 227 (343)
T ss_dssp ECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH
T ss_pred EeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH
Confidence 999999987654433333345679999999999864 678999999999999999999999997543221
Q ss_pred ccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 368 MNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
..+..... +...... +...+..+.+|+.+||+.||.+|||+.|+++
T Consensus 228 ~~~~~~~~---~~~~~~~-------------------------------~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 228 SKLHAIID---PNHEIEF-------------------------------PDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp HHHHHHHC---TTSCCCC-------------------------------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHhc---CCcccCC-------------------------------cccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 11111110 0000000 0012346789999999999999999999975
Q ss_pred H
Q 012014 448 R 448 (473)
Q Consensus 448 ~ 448 (473)
.
T Consensus 274 h 274 (343)
T 3dbq_A 274 H 274 (343)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=348.92 Aligned_cols=251 Identities=19% Similarity=0.247 Sum_probs=193.9
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCC--------------------------CCchhHHHHHHHHH
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--------------------------GGSKSFKSECKAAI 196 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~ 196 (473)
.++|.+.+.||+|+||.||+|. ..+++.||||++..... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 4689999999999999999998 45689999999974321 12356899999999
Q ss_pred hcCCCCceeeeeeeeccccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCC
Q 012014 197 NIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQ 276 (473)
Q Consensus 197 ~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~ 276 (473)
+++||||+++++++.+. .....++||||+++++|.+++... .+++.++..++.||+.||.||| +
T Consensus 92 ~l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~l~~~~~~~----------~~~~~~~~~~~~qi~~~l~~lH---~ 155 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDP---NEDHLYMVFELVNQGPVMEVPTLK----------PLSEDQARFYFQDLIKGIEYLH---Y 155 (298)
T ss_dssp TCCCTTBCCEEEEEECS---SSSEEEEEEECCTTCBSCCSSCSS----------CCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred hCCCCCCCeEEEEEEcC---CCCEEEEEEecCCCCcHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHH---H
Confidence 99999999999998652 245689999999999998765432 3668999999999999999999 8
Q ss_pred CCeeeccCCCCcEEecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCC---CCcccchhhHhHHHHHH
Q 012014 277 PPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE---ASTYGDVYSFGILLLEM 353 (473)
Q Consensus 277 ~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~el 353 (473)
++|+||||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+.. ++.++|||||||++|+|
T Consensus 156 ~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l 233 (298)
T 2zv2_A 156 QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCF 233 (298)
T ss_dssp TTEECCCCCGGGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHH
T ss_pred CCeeccCCCHHHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHH
Confidence 999999999999999999999999999998764322 2233456999999999998765 47889999999999999
Q ss_pred HhCCCCCCCCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhccc
Q 012014 354 FTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSA 433 (473)
Q Consensus 354 ltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~ 433 (473)
++|..||.+... ............ .. +.....+..+.+|+.+||+
T Consensus 234 ~~g~~pf~~~~~-----~~~~~~~~~~~~-~~-----------------------------~~~~~~~~~l~~li~~~l~ 278 (298)
T 2zv2_A 234 VFGQCPFMDERI-----MCLHSKIKSQAL-EF-----------------------------PDQPDIAEDLKDLITRMLD 278 (298)
T ss_dssp HHSSCSSCCSSH-----HHHHHHHHHCCC-CC-----------------------------CSSSCCCHHHHHHHHHHTC
T ss_pred HHCCCCCCCccH-----HHHHHHHhcccC-CC-----------------------------CCccccCHHHHHHHHHHhh
Confidence 999999975321 111100000000 00 0001234578899999999
Q ss_pred CCCCCCCChHHHHH
Q 012014 434 ERPRERMKINDVES 447 (473)
Q Consensus 434 ~dP~~RPt~~ev~~ 447 (473)
.||++|||+.||++
T Consensus 279 ~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 279 KNPESRIVVPEIKL 292 (298)
T ss_dssp SCTTTSCCHHHHTT
T ss_pred cChhhCCCHHHHhc
Confidence 99999999999864
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=345.29 Aligned_cols=268 Identities=19% Similarity=0.258 Sum_probs=208.3
Q ss_pred ccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
..++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+|+.++..++|++++..+..+.. .....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~ 80 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYN 80 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecC----CCCce
Confidence 457899999999999999999994 678999999876432 34568999999999999988888777643 23467
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEe---cCCccEE
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL---DDEMIGH 298 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~---~~~~~~k 298 (473)
++||||+ +++|.+++..... .+++.++..++.||+.||.||| +++|+||||||+|||+ +.++.+|
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~k 148 (296)
T 4hgt_A 81 VMVMELL-GPSLEDLFNFCSR--------KFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVY 148 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTTS--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEE
T ss_pred EEEEEcc-CCCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEE
Confidence 9999999 9999999975332 3668999999999999999999 8999999999999999 7889999
Q ss_pred EeecccccccCccccc-----cceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcc--cHH
Q 012014 299 VGDFGMARFLPAIDKQ-----NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKM--NLR 371 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~--~~~ 371 (473)
|+|||+++........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+...... .+.
T Consensus 149 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 228 (296)
T 4hgt_A 149 IIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE 228 (296)
T ss_dssp ECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHH
T ss_pred EecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhh
Confidence 9999999876543321 122345689999999999999999999999999999999999999987543321 111
Q ss_pred HHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHH
Q 012014 372 NFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRL 451 (473)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 451 (473)
.......+.... ......+..+.+|+.+||+.||++|||+.+|++.|+.
T Consensus 229 ~~~~~~~~~~~~-------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (296)
T 4hgt_A 229 RISEKKMSTPIE-------------------------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp HHHHHHHHSCHH-------------------------------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred hhhcccccchhh-------------------------------hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHH
Confidence 111111000000 0011235688999999999999999999999999999
Q ss_pred HHHhhccC
Q 012014 452 IRRKLLET 459 (473)
Q Consensus 452 l~~~~~~~ 459 (473)
+......+
T Consensus 278 ~~~~~~~~ 285 (296)
T 4hgt_A 278 LFHRQGFS 285 (296)
T ss_dssp HHHHHTCC
T ss_pred HHHHhCCC
Confidence 98876543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=356.78 Aligned_cols=254 Identities=21% Similarity=0.273 Sum_probs=191.9
Q ss_pred ccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
..++|.+.+.||+|+||.||+++. .+++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+. ...
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~~ 91 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTP-----THL 91 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECS-----SEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeC-----CEE
Confidence 457899999999999999999994 478999999997533 3456789999999999999999999998643 368
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCcc--EEE
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI--GHV 299 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~--~kl 299 (473)
++||||+++|+|.+++.... .+++..+..++.|++.||.||| ++||+||||||+|||++.++. +||
T Consensus 92 ~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl 159 (361)
T 3uc3_A 92 AIIMEYASGGELYERICNAG---------RFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKI 159 (361)
T ss_dssp EEEEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEE
T ss_pred EEEEEeCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEE
Confidence 99999999999999997543 3668999999999999999999 899999999999999987765 999
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccCCCCCcc-cchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTY-GDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMAL 378 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~ 378 (473)
+|||+++.... ........||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+...... +........
T Consensus 160 ~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~~~~~~~ 235 (361)
T 3uc3_A 160 CDFGYSKSSVL---HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD-YRKTIQRIL 235 (361)
T ss_dssp CCCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC-HHHHHHHHH
T ss_pred eecCccccccc---cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH-HHHHHHHHh
Confidence 99999974322 122234569999999999988887665 8999999999999999999986433222 122111111
Q ss_pred CcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 379 PQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
..... . +.....+..+.+|+.+||+.||++|||+.|+++.
T Consensus 236 ~~~~~-~-----------------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 236 SVKYS-I-----------------------------PDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp TTCCC-C-----------------------------CTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred cCCCC-C-----------------------------CCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 10000 0 0000134577899999999999999999999764
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=344.16 Aligned_cols=268 Identities=19% Similarity=0.259 Sum_probs=211.8
Q ss_pred ccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
..++|.+.+.||+|+||.||+|+. .+++.||+|++.... ....+.+|+.++..++|++++..+..+.. .....
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~ 80 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYN 80 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccC----CCCce
Confidence 457899999999999999999994 678999999987433 34678999999999999988877766643 23467
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEe---cCCccEE
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL---DDEMIGH 298 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~---~~~~~~k 298 (473)
++||||+ +++|.+++..... .+++.++..++.|++.||.||| +++|+||||||+|||+ +.++.+|
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~k 148 (296)
T 3uzp_A 81 VMVMELL-GPSLEDLFNFCSR--------KFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVY 148 (296)
T ss_dssp EEEEECC-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEE
T ss_pred EEEEEec-CCCHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEE
Confidence 9999999 9999999974332 3668999999999999999999 8999999999999999 4888999
Q ss_pred EeecccccccCcccccc-----ceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCc--ccHH
Q 012014 299 VGDFGMARFLPAIDKQN-----RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGK--MNLR 371 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~--~~~~ 371 (473)
|+|||+++......... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+..... ..+.
T Consensus 149 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 228 (296)
T 3uzp_A 149 IIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE 228 (296)
T ss_dssp ECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHH
T ss_pred EeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhh
Confidence 99999998765433211 1234569999999999999999999999999999999999999998753322 1111
Q ss_pred HHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHH
Q 012014 372 NFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRL 451 (473)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 451 (473)
.......+.... .....++..+.+|+.+||+.||++|||+.+|++.|+.
T Consensus 229 ~~~~~~~~~~~~-------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~ 277 (296)
T 3uzp_A 229 RISEKKMSTPIE-------------------------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN 277 (296)
T ss_dssp HHHHHHHHSCHH-------------------------------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHH
T ss_pred hhcccccCCchH-------------------------------HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHH
Confidence 111111100000 0112345678999999999999999999999999999
Q ss_pred HHHhhccC
Q 012014 452 IRRKLLET 459 (473)
Q Consensus 452 l~~~~~~~ 459 (473)
+......+
T Consensus 278 ~~~~~~~~ 285 (296)
T 3uzp_A 278 LFHRQGFS 285 (296)
T ss_dssp HHHHTTCC
T ss_pred HHHhcCCc
Confidence 98776544
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=353.29 Aligned_cols=276 Identities=23% Similarity=0.315 Sum_probs=212.0
Q ss_pred hhhhcccCCCCccceeecCCCeEEEEEEe--------cCCCEEEEEEeeccCC-CCchhHHHHHHHHHhc-CCCCceeee
Q 012014 138 KDLYNATNGFSSANLIGAGNFGSVYNGTL--------FDGTTIAVKVFNLIRP-GGSKSFKSECKAAINI-KHRNIVRVF 207 (473)
Q Consensus 138 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~--------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~ 207 (473)
..+....++|.+.+.||+|+||.||+|.. .++..||+|+++.... .....+.+|+.++.++ +||||++++
T Consensus 28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 107 (334)
T 2pvf_A 28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLL 107 (334)
T ss_dssp TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEE
Confidence 33445567899999999999999999985 2467899999874322 2235688999999999 899999999
Q ss_pred eeeeccccCCceeeEEEEEecCCCCHHHHhcCCCCCCCC-------CcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCee
Q 012014 208 TAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWR-------PLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIA 280 (473)
Q Consensus 208 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~-------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ii 280 (473)
+++... ...++||||+++|+|.+++......... .....+++.+++.++.||+.||.||| +++|+
T Consensus 108 ~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~iv 179 (334)
T 2pvf_A 108 GACTQD-----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCI 179 (334)
T ss_dssp EEECSS-----SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred EEEccC-----CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCee
Confidence 998543 3679999999999999999876431100 00113678899999999999999999 89999
Q ss_pred eccCCCCcEEecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCC
Q 012014 281 HCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRP 359 (473)
Q Consensus 281 H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P 359 (473)
||||||+||+++.++.+||+|||+++...............+|+.|+|||++.+..++.++||||||+++|+|++ |..|
T Consensus 180 H~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p 259 (334)
T 2pvf_A 180 HRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259 (334)
T ss_dssp CSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999987654332223334457889999999988889999999999999999999 9999
Q ss_pred CCCCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCC
Q 012014 360 SDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRER 439 (473)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 439 (473)
|.+..... +...+...... ..+..++..+.+|+.+||+.||.+|
T Consensus 260 ~~~~~~~~--~~~~~~~~~~~----------------------------------~~~~~~~~~l~~li~~~l~~dp~~R 303 (334)
T 2pvf_A 260 YPGIPVEE--LFKLLKEGHRM----------------------------------DKPANCTNELYMMMRDCWHAVPSQR 303 (334)
T ss_dssp STTCCHHH--HHHHHHHTCCC----------------------------------CCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred cCcCCHHH--HHHHHhcCCCC----------------------------------CCCccCCHHHHHHHHHHccCChhhC
Confidence 97632111 11111000000 0011245678899999999999999
Q ss_pred CChHHHHHHHHHHHHhhc
Q 012014 440 MKINDVESRLRLIRRKLL 457 (473)
Q Consensus 440 Pt~~ev~~~L~~l~~~~~ 457 (473)
||+.||++.|+.+.....
T Consensus 304 ps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 304 PTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp CCHHHHHHHHHHHHHHHC
T ss_pred cCHHHHHHHHHHHHhccc
Confidence 999999999999976543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=355.21 Aligned_cols=254 Identities=21% Similarity=0.263 Sum_probs=199.2
Q ss_pred CCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccC-----CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR-----PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
++|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++..++||||+++++++.+.
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~----- 98 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD----- 98 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-----
Confidence 4688999999999999999984 578999999986321 22456789999999999999999999998653
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCcc--
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI-- 296 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~-- 296 (473)
...++|||||++|+|.+++...... ...+++..+..++.||+.||.||| +++|+||||||+|||++.++.
T Consensus 99 ~~~~lv~e~~~g~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~ 170 (351)
T 3c0i_A 99 GMLYMVFEFMDGADLCFEIVKRADA-----GFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSA 170 (351)
T ss_dssp TEEEEEEECCSSCBHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTC
T ss_pred CEEEEEEeCCCCCCHHHHHHHhccc-----CCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCC
Confidence 3689999999999999888643211 113668899999999999999999 899999999999999976654
Q ss_pred -EEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 012014 297 -GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVK 375 (473)
Q Consensus 297 -~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~ 375 (473)
+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+... ..+.....
T Consensus 171 ~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~~~~i~~ 246 (351)
T 3c0i_A 171 PVKLGGFGVAIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--RLFEGIIK 246 (351)
T ss_dssp CEEECCCTTCEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--HHHHHHHH
T ss_pred cEEEecCcceeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--HHHHHHHc
Confidence 9999999998765422 122345699999999999998999999999999999999999999976311 10111111
Q ss_pred hhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 376 MALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
..... ........+..+.+|+.+||+.||++|||+.|+++
T Consensus 247 ~~~~~--------------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 247 GKYKM--------------------------------NPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp TCCCC--------------------------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCC--------------------------------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00000 00011124567889999999999999999999975
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=373.46 Aligned_cols=264 Identities=23% Similarity=0.345 Sum_probs=211.9
Q ss_pred hhhhhcccCCCCccceeecCCCeEEEEEEec-CCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeecccc
Q 012014 137 FKDLYNATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY 215 (473)
Q Consensus 137 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 215 (473)
+..+....++|.+.++||+|+||.||+|.+. ++..||||+++... ...+.+.+|+.++++++||||++++++|...
T Consensus 212 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-- 288 (495)
T 1opk_A 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-- 288 (495)
T ss_dssp SSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred ccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecC--
Confidence 4556666778999999999999999999954 48899999987533 3467899999999999999999999998543
Q ss_pred CCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCc
Q 012014 216 QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM 295 (473)
Q Consensus 216 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~ 295 (473)
...++||||+++|+|.+++...... .+++..++.++.||+.||.||| +++|+||||||+|||++.++
T Consensus 289 ---~~~~lv~E~~~~g~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~ 355 (495)
T 1opk_A 289 ---PPFYIITEFMTYGNLLDYLRECNRQ-------EVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENH 355 (495)
T ss_dssp ---SSCEEEEECCTTCBHHHHHHHSCTT-------TSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGG
T ss_pred ---CcEEEEEEccCCCCHHHHHHhcCcC-------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCC
Confidence 3579999999999999999764322 3668899999999999999999 89999999999999999999
Q ss_pred cEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHH
Q 012014 296 IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFV 374 (473)
Q Consensus 296 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~ 374 (473)
.+||+|||+++...... ........+++.|+|||++.+..++.++|||||||++|||++ |..||.+..... +...+
T Consensus 356 ~~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~--~~~~~ 432 (495)
T 1opk_A 356 LVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELL 432 (495)
T ss_dssp CEEECCTTCEECCTTCC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHHHH
T ss_pred cEEEeecccceeccCCc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH--HHHHH
Confidence 99999999998764322 111223346788999999998889999999999999999999 999997643221 11111
Q ss_pred HhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHH
Q 012014 375 KMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIR 453 (473)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~ 453 (473)
..... ...+..++..+.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus 433 ~~~~~----------------------------------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 433 EKDYR----------------------------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp HTTCC----------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HcCCC----------------------------------CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 10000 0011235668889999999999999999999999998763
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=360.04 Aligned_cols=268 Identities=17% Similarity=0.164 Sum_probs=202.0
Q ss_pred cCCCCccceeecCCCeEEEEEEec----CCCEEEEEEeeccCCC-----------CchhHHHHHHHHHhcCCCCceeeee
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTLF----DGTTIAVKVFNLIRPG-----------GSKSFKSECKAAINIKHRNIVRVFT 208 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~~~~ 208 (473)
.++|.+.+.||+|+||.||+|... ++..+|+|++...... ....+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 467999999999999999999954 5788999998754321 1234667888899999999999999
Q ss_pred eeeccccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCc
Q 012014 209 AFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSN 288 (473)
Q Consensus 209 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~N 288 (473)
++.... .+....++||||+ +++|.+++.... .+++.+++.++.||+.||.||| +++|+||||||+|
T Consensus 116 ~~~~~~-~~~~~~~lv~e~~-~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~N 181 (345)
T 2v62_A 116 SGLTEF-KGRSYRFMVMERL-GIDLQKISGQNG---------TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAAN 181 (345)
T ss_dssp EEEEES-SSCEEEEEEEECE-EEEHHHHCBGGG---------BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGG
T ss_pred cccccc-CCCcEEEEEEecc-CCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHH
Confidence 986532 3356789999999 999999997653 3668999999999999999999 8999999999999
Q ss_pred EEecCCc--cEEEeecccccccCccccc-----cceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCC
Q 012014 289 VLLDDEM--IGHVGDFGMARFLPAIDKQ-----NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSD 361 (473)
Q Consensus 289 il~~~~~--~~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~ 361 (473)
||++.++ .+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||++|||++|..||.
T Consensus 182 Ill~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~ 261 (345)
T 2v62_A 182 LLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWE 261 (345)
T ss_dssp EEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTG
T ss_pred EEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9998877 9999999999876543211 11234569999999999999899999999999999999999999996
Q ss_pred CCCCCcccHHHHHHhh---cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCC
Q 012014 362 GIFTGKMNLRNFVKMA---LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRE 438 (473)
Q Consensus 362 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~ 438 (473)
+............... .+........ ...++..+.+|+.+||+.||++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~l~~li~~~l~~dp~~ 312 (345)
T 2v62_A 262 QNLKDPVAVQTAKTNLLDELPQSVLKWAP-----------------------------SGSSCCEIAQFLVCAHSLAYDE 312 (345)
T ss_dssp GGTTCHHHHHHHHHHHHHTTTHHHHHHSC-----------------------------TTSCCHHHHHHHHHHHTCCTTC
T ss_pred ccccccHHHHHHHHhhcccccHHHHhhcc-----------------------------ccccHHHHHHHHHHHhhcCccc
Confidence 5332222111111111 1110000000 0134568899999999999999
Q ss_pred CCChHHHHHHHHHHHH
Q 012014 439 RMKINDVESRLRLIRR 454 (473)
Q Consensus 439 RPt~~ev~~~L~~l~~ 454 (473)
|||+.+|++.|+.+..
T Consensus 313 Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 313 KPNYQALKKILNPHGI 328 (345)
T ss_dssp CCCHHHHHHHHCTTCC
T ss_pred CCCHHHHHHHHhccCC
Confidence 9999999999988754
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=345.27 Aligned_cols=252 Identities=26% Similarity=0.370 Sum_probs=192.2
Q ss_pred ccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCC----CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRP----GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
..++|++.+.||+|+||.||+|.. .++.||+|+++.... ...+.+.+|+.++..++||||+++++++...
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 78 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE----- 78 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC-----
T ss_pred chhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC-----
Confidence 356899999999999999999985 589999999874332 2346788999999999999999999998543
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCC---eeeccCCCCcEEecC--
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPP---IAHCNLKPSNVLLDD-- 293 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~---iiH~Dlkp~Nil~~~-- 293 (473)
...++||||+++++|.+++... .+++..+..++.|++.||.||| +++ |+||||||+||+++.
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~ 145 (271)
T 3dtc_A 79 PNLCLVMEFARGGPLNRVLSGK----------RIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKV 145 (271)
T ss_dssp --CEEEEECCTTEEHHHHHTSS----------CCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCC
T ss_pred CceEEEEEcCCCCCHHHHhhcC----------CCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEeccc
Confidence 3679999999999999999644 3568899999999999999999 777 999999999999986
Q ss_pred ------CccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCc
Q 012014 294 ------EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGK 367 (473)
Q Consensus 294 ------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~ 367 (473)
++.+||+|||+++...... .....||+.|+|||.+.+..++.++||||||+++|+|++|..||.+.....
T Consensus 146 ~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~ 221 (271)
T 3dtc_A 146 ENGDLSNKILKITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA 221 (271)
T ss_dssp SSSCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH
T ss_pred ccccccCcceEEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 7789999999998654322 223468999999999998889999999999999999999999997642211
Q ss_pred ccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 368 MNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
. ...... .... ...+..++..+.+|+.+||+.||.+|||+.|+++
T Consensus 222 ~----~~~~~~-~~~~------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 266 (271)
T 3dtc_A 222 V----AYGVAM-NKLA------------------------------LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILD 266 (271)
T ss_dssp H----HHHHHT-SCCC------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred H----HHhhhc-CCCC------------------------------CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 1 000000 0000 0001124567889999999999999999999999
Q ss_pred HHHHH
Q 012014 448 RLRLI 452 (473)
Q Consensus 448 ~L~~l 452 (473)
.|+.|
T Consensus 267 ~L~~l 271 (271)
T 3dtc_A 267 QLTTI 271 (271)
T ss_dssp HHHC-
T ss_pred HHhcC
Confidence 99864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=353.16 Aligned_cols=256 Identities=21% Similarity=0.328 Sum_probs=197.8
Q ss_pred CCCCccceeecCCCeEEEEEEec-CCCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeecccc-------
Q 012014 145 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY------- 215 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------- 215 (473)
++|++.+.||+|+||.||+|+.. +++.||||+++.... ...+.+.+|+.++++++||||++++++|.+...
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 46889999999999999999954 799999999975432 344678999999999999999999999865321
Q ss_pred ---------------------------------------------CCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcch
Q 012014 216 ---------------------------------------------QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNF 250 (473)
Q Consensus 216 ---------------------------------------------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 250 (473)
......++|||||++|+|.+++.......
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~------ 159 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLE------ 159 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGG------
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCcc------
Confidence 11224799999999999999998765321
Q ss_pred hhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecccccccCccccc----------cceeec
Q 012014 251 NFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQ----------NRFICI 320 (473)
Q Consensus 251 ~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~----------~~~~~~ 320 (473)
...+..++.++.||+.||.||| +++|+||||||+|||++.++.+||+|||+++........ ......
T Consensus 160 ~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T 3qd2_B 160 DREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQ 236 (332)
T ss_dssp GSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSC
T ss_pred chhhHHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccccccccccccccc
Confidence 2346678999999999999999 899999999999999999999999999999876543211 122335
Q ss_pred cCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhh
Q 012014 321 KGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTM 400 (473)
Q Consensus 321 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 400 (473)
.||+.|+|||++.+..++.++||||||+++|+|++|..|+... ...........
T Consensus 237 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-------~~~~~~~~~~~------------------- 290 (332)
T 3qd2_B 237 VGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-------VRIITDVRNLK------------------- 290 (332)
T ss_dssp C-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-------HHHHHHHHTTC-------------------
T ss_pred CCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-------HHHHHHhhccC-------------------
Confidence 6999999999999999999999999999999999987764210 00000000000
Q ss_pred hcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 401 CMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.+......+..+.+|+.+||+.||++|||+.|+++
T Consensus 291 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 291 ------------FPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp ------------CCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred ------------CCcccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 01112335567789999999999999999999975
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=356.07 Aligned_cols=265 Identities=22% Similarity=0.341 Sum_probs=197.9
Q ss_pred ccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCC---chhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGG---SKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
..++|++.+.||+|+||.||+|+ ..+++.||+|+++...... ...+.+|+.++.+++||||+++++++.... ...
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 88 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAG 88 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TTE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CCC
Confidence 45789999999999999999999 4678999999997543332 246789999999999999999999986543 223
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...++||||+++|+|.+++.... .+++.+++.++.|++.||.||| +++|+||||||+|||++.++.+|
T Consensus 89 ~~~~lv~e~~~g~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~k 156 (311)
T 3ork_A 89 PLPYIVMEYVDGVTLRDIVHTEG---------PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVK 156 (311)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEE
T ss_pred cccEEEEecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEE
Confidence 45699999999999999997643 3568899999999999999999 89999999999999999999999
Q ss_pred EeecccccccCccccc-cceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 299 VGDFGMARFLPAIDKQ-NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
|+|||+++........ .......||+.|+|||++.+..++.++||||||+++|+|++|..||.+........ ......
T Consensus 157 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~-~~~~~~ 235 (311)
T 3ork_A 157 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY-QHVRED 235 (311)
T ss_dssp ECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-HHHHCC
T ss_pred EeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHhcCC
Confidence 9999999876443221 22234568999999999999999999999999999999999999997643211100 000000
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHH-HHHHHHHHH
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKIND-VESRLRLIR 453 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e-v~~~L~~l~ 453 (473)
+.. ........+..+.+|+.+||+.||++||++.+ +...|..+.
T Consensus 236 -~~~-------------------------------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 236 -PIP-------------------------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp -CCC-------------------------------HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -CCC-------------------------------cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 000 00011124567889999999999999996555 555555553
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=351.79 Aligned_cols=259 Identities=22% Similarity=0.361 Sum_probs=198.7
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCE----EEEEEeecc-CCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCC
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTT----IAVKVFNLI-RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (473)
.++|++.++||+|+||.||+|.. .+++. ||+|.+... .......+.+|+.++.+++||||+++++++...
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~---- 89 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---- 89 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS----
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC----
Confidence 46899999999999999999984 45554 577766532 234557799999999999999999999998642
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccE
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~ 297 (473)
..++++||+.+|+|.+++..... .+++..++.++.||+.||.||| +++|+||||||+|||++.++.+
T Consensus 90 --~~~~v~~~~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~ 156 (327)
T 3lzb_A 90 --TVQLITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHV 156 (327)
T ss_dssp --SEEEEECCCSSCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEE
T ss_pred --CceEEEEecCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCE
Confidence 36899999999999999976532 3668899999999999999999 8999999999999999999999
Q ss_pred EEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHh
Q 012014 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKM 376 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~ 376 (473)
||+|||+++...............||+.|+|||++.+..++.++||||||+++|+|++ |..||.+..... +...+..
T Consensus 157 kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~--~~~~~~~ 234 (327)
T 3lzb_A 157 KITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEK 234 (327)
T ss_dssp EECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHHHT
T ss_pred EEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHc
Confidence 9999999987655443333444557889999999999999999999999999999999 999997643222 1111111
Q ss_pred hcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHHh
Q 012014 377 ALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRK 455 (473)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~ 455 (473)
.... ..+..++..+.+|+.+||+.||.+|||+.||++.|+.+...
T Consensus 235 ~~~~----------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 279 (327)
T 3lzb_A 235 GERL----------------------------------PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279 (327)
T ss_dssp TCCC----------------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred CCCC----------------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 1000 00112345788999999999999999999999999999743
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=348.66 Aligned_cols=262 Identities=19% Similarity=0.314 Sum_probs=196.7
Q ss_pred hhcccCCCCccceeecCCCeEEEEEEecC----CCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccc
Q 012014 140 LYNATNGFSSANLIGAGNFGSVYNGTLFD----GTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVD 214 (473)
Q Consensus 140 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 214 (473)
+....++|++.+.||+|+||.||+|.... +..||+|+++.... ...+.+.+|+.++.+++||||+++++++.+
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-- 87 (281)
T 1mp8_A 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-- 87 (281)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS--
T ss_pred eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEcc--
Confidence 34455789999999999999999998532 45699999864322 224568899999999999999999999732
Q ss_pred cCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCC
Q 012014 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE 294 (473)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~ 294 (473)
...++||||+++|+|.+++..... .+++..+..++.|++.||.||| +++|+||||||+||+++.+
T Consensus 88 ----~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~ 152 (281)
T 1mp8_A 88 ----NPVWIIMELCTLGELRSFLQVRKY--------SLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSN 152 (281)
T ss_dssp ----SSCEEEEECCTTEEHHHHHHHTTT--------TSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEET
T ss_pred ----CccEEEEecCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCC
Confidence 246899999999999999975532 3668899999999999999999 8999999999999999999
Q ss_pred ccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHH
Q 012014 295 MIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNF 373 (473)
Q Consensus 295 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~ 373 (473)
+.+||+|||+++...... ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+....+. ...
T Consensus 153 ~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~--~~~ 229 (281)
T 1mp8_A 153 DCVKLGDFGLSRYMEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--IGR 229 (281)
T ss_dssp TEEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HHH
T ss_pred CCEEECccccccccCccc-ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH--HHH
Confidence 999999999998764432 112233446789999999998889999999999999999997 9999986432211 111
Q ss_pred HHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHH
Q 012014 374 VKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIR 453 (473)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~ 453 (473)
+...... ..+..++..+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 230 i~~~~~~----------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 230 IENGERL----------------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp HHTTCCC----------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHcCCCC----------------------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 1000000 001124567889999999999999999999999999987
Q ss_pred Hh
Q 012014 454 RK 455 (473)
Q Consensus 454 ~~ 455 (473)
+.
T Consensus 276 ~~ 277 (281)
T 1mp8_A 276 EE 277 (281)
T ss_dssp HH
T ss_pred HH
Confidence 64
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=359.96 Aligned_cols=249 Identities=22% Similarity=0.305 Sum_probs=199.2
Q ss_pred cccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccC---CCCchhHHHHHHHHHhc-CCCCceeeeeeeeccccC
Q 012014 142 NATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQ 216 (473)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 216 (473)
...++|.+.++||+|+||.||+|+. .+++.||+|+++... ......+.+|..++..+ +||||++++++|.+
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~---- 89 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT---- 89 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC----
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe----
Confidence 3457899999999999999999995 468999999997432 34456788999999877 99999999999854
Q ss_pred CceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCcc
Q 012014 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI 296 (473)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~ 296 (473)
....++||||+++|+|.+++.... .+++.++..++.||+.||.||| ++||+||||||+|||++.++.
T Consensus 90 -~~~~~lv~E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~ 156 (345)
T 1xjd_A 90 -KENLFFVMEYLNGGDLMYHIQSCH---------KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGH 156 (345)
T ss_dssp -SSEEEEEEECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSC
T ss_pred -CCEEEEEEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCC
Confidence 346899999999999999997643 3568899999999999999999 899999999999999999999
Q ss_pred EEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 012014 297 GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKM 376 (473)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~ 376 (473)
+||+|||+++..... .......+||+.|+|||++.+..++.++|||||||++|||++|..||.+..... +...+..
T Consensus 157 vkL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~i~~ 232 (345)
T 1xjd_A 157 IKIADFGMCKENMLG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--LFHSIRM 232 (345)
T ss_dssp EEECCCTTCBCCCCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH
T ss_pred EEEeEChhhhhcccC--CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHHh
Confidence 999999999854322 122345679999999999999999999999999999999999999997632211 0110000
Q ss_pred hcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChH-HHH
Q 012014 377 ALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKIN-DVE 446 (473)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-ev~ 446 (473)
..+. .+...+..+.+|+.+||..||++||++. ||+
T Consensus 233 ~~~~-----------------------------------~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 233 DNPF-----------------------------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp CCCC-----------------------------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred CCCC-----------------------------------CCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 0000 0011345778999999999999999997 654
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=345.00 Aligned_cols=256 Identities=20% Similarity=0.286 Sum_probs=203.1
Q ss_pred ccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCC--CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
..++|.+.+.||+|+||.||+|+. +++.||+|+++.... ...+.+.+|+.++.+++||||+++++++.+.. ...
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~ 83 (271)
T 3kmu_A 8 DFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP---APH 83 (271)
T ss_dssp CGGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT---SSS
T ss_pred CHHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC---CCC
Confidence 346799999999999999999996 589999999975432 22356889999999999999999999986532 346
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCC--eeeccCCCCcEEecCCccEE
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPP--IAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~Dlkp~Nil~~~~~~~k 298 (473)
.++||||+++|+|.+++...... .+++.+++.++.|++.||.||| +++ |+||||||+||+++.++.++
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~ 153 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGTNF-------VVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTAR 153 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCSSC-------CCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEE
T ss_pred eEeeecccCCCcHHHHHhhcccC-------CCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCccee
Confidence 79999999999999999875432 3668999999999999999999 888 99999999999999999999
Q ss_pred EeecccccccCccccccceeeccCCCCcCCCccccCCCCCc---ccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 012014 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEAST---YGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVK 375 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~ 375 (473)
|+|||++..... ....||+.|+|||++.+..++. ++||||||+++|+|++|..||.+....... .....
T Consensus 154 l~~~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~ 225 (271)
T 3kmu_A 154 ISMADVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG-MKVAL 225 (271)
T ss_dssp EEGGGSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHH-HHHHH
T ss_pred EEeccceeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHH-HHHHh
Confidence 999988764322 1235899999999998765544 799999999999999999999764321110 00000
Q ss_pred hhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHH
Q 012014 376 MALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRR 454 (473)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~ 454 (473)
..... ..+..++..+.+++.+||+.||++|||+.|+++.|+.+.+
T Consensus 226 ~~~~~----------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 226 EGLRP----------------------------------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp SCCCC----------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred cCCCC----------------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 00000 0011245578899999999999999999999999999854
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-45 Score=357.37 Aligned_cols=255 Identities=19% Similarity=0.275 Sum_probs=192.8
Q ss_pred cCCCCcc-ceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHHHHHHh-cCCCCceeeeeeeeccccCCcee
Q 012014 144 TNGFSSA-NLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAIN-IKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 144 ~~~~~~~-~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
.++|.+. ++||+|+||.||+|.. .+++.||||+++. ...+.+|+.++.+ .+||||++++++|.... .+...
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~~~~~ 133 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLY-AGRKC 133 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecc-cCCcE
Confidence 3566665 7899999999999984 5689999999862 4567889998754 58999999999985422 33457
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecC---CccE
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD---EMIG 297 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~---~~~~ 297 (473)
.++|||||++|+|.+++...... .+++.++..++.||+.||.||| +++|+||||||+|||++. ++.+
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~~-------~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~ 203 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGDQ-------AFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAIL 203 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC----------CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCE
T ss_pred EEEEEEeCCCCcHHHHHHHhCCC-------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccE
Confidence 89999999999999999875421 3679999999999999999999 899999999999999987 7899
Q ss_pred EEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcc--cHHHHHH
Q 012014 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKM--NLRNFVK 375 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~--~~~~~~~ 375 (473)
||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+...... .....+.
T Consensus 204 kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~ 280 (400)
T 1nxk_A 204 KLTDFGFAKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 280 (400)
T ss_dssp EECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH
T ss_pred EEEecccccccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH
Confidence 99999999865432 223455689999999999999999999999999999999999999976433221 0111111
Q ss_pred hhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 376 MALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
...... .. ......+..+.+|+.+||+.||++|||+.||++.
T Consensus 281 ~~~~~~-----------------------~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 281 MGQYEF-----------------------PN--------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp HTCCCC-----------------------CT--------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cCcccC-----------------------CC--------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000000 00 0001245678899999999999999999999864
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=373.46 Aligned_cols=264 Identities=24% Similarity=0.392 Sum_probs=206.3
Q ss_pred hhhhhcccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccC
Q 012014 137 FKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQ 216 (473)
Q Consensus 137 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 216 (473)
...+....++|.+.+.||+|+||.||+|.+.++..||||+++... ...+.+.+|+.++++++||||+++++++.+
T Consensus 176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---- 250 (452)
T 1fmk_A 176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE---- 250 (452)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred ccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC----
Confidence 345566678899999999999999999998777889999997533 345789999999999999999999999753
Q ss_pred CceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCcc
Q 012014 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI 296 (473)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~ 296 (473)
...++||||+++|+|.+++...... .+++.+++.++.||+.||.||| +++|+||||||+|||++.++.
T Consensus 251 --~~~~iv~e~~~~gsL~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~ 318 (452)
T 1fmk_A 251 --EPIYIVTEYMSKGSLLDFLKGETGK-------YLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLV 318 (452)
T ss_dssp --SSCEEEECCCTTCBHHHHHSHHHHT-------TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGC
T ss_pred --CceEEEehhhcCCCHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCC
Confidence 2468999999999999999753211 3568899999999999999999 899999999999999999999
Q ss_pred EEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHH
Q 012014 297 GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVK 375 (473)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~ 375 (473)
+||+|||+++...... ........+|+.|+|||++.+..++.++||||||+++|||++ |..||.+....+ ...
T Consensus 319 ~kl~DfG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-----~~~ 392 (452)
T 1fmk_A 319 CKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-----VLD 392 (452)
T ss_dssp EEECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----HHH
T ss_pred EEECCCccceecCCCc-eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH-----HHH
Confidence 9999999998764322 112223446889999999998899999999999999999999 999997642211 111
Q ss_pred hhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHH
Q 012014 376 MALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRR 454 (473)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~ 454 (473)
.. ..+.+ .+.+..++..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 393 ~i-----------------~~~~~--------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 393 QV-----------------ERGYR--------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp HH-----------------HTTCC--------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred HH-----------------HcCCC--------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 00 00000 00112356688899999999999999999999999988743
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=346.11 Aligned_cols=269 Identities=22% Similarity=0.350 Sum_probs=216.1
Q ss_pred CchhhhhcccCCCCccceeecCCCeEEEEEEec-CCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeecc
Q 012014 135 PSFKDLYNATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGV 213 (473)
Q Consensus 135 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 213 (473)
+.+.++....++|++.+.||+|+||.||+|... ++..||+|++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 3 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~- 80 (288)
T 3kfa_A 3 PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR- 80 (288)
T ss_dssp TTCCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CchhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc-
Confidence 345667778889999999999999999999954 5889999998743 2345678999999999999999999999854
Q ss_pred ccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecC
Q 012014 214 DYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD 293 (473)
Q Consensus 214 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~ 293 (473)
....++||||+++++|.+++...... .+++..++.++.|++.||.||| +++|+||||||+||+++.
T Consensus 81 ----~~~~~~v~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~ 146 (288)
T 3kfa_A 81 ----EPPFYIITEFMTYGNLLDYLRECNRQ-------EVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGE 146 (288)
T ss_dssp ----SSSEEEEEECCTTEEHHHHHHHCCTT-------TSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECG
T ss_pred ----CCCEEEEEEcCCCCcHHHHHHhcccC-------CccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcC
Confidence 33679999999999999999765432 3668899999999999999999 899999999999999999
Q ss_pred CccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHH
Q 012014 294 EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRN 372 (473)
Q Consensus 294 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~ 372 (473)
++.+||+|||++....... ........||+.|+|||++.+..++.++||||||+++|+|++ |..||.+..... ...
T Consensus 147 ~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~--~~~ 223 (288)
T 3kfa_A 147 NHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYE 223 (288)
T ss_dssp GGCEEECCCCGGGTSCSSS-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--HHH
T ss_pred CCCEEEccCccceeccCCc-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH
Confidence 9999999999998765432 222233446889999999998899999999999999999999 999997643221 111
Q ss_pred HHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHH
Q 012014 373 FVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLI 452 (473)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l 452 (473)
........ ..+..++..+.+|+.+||+.||.+|||+.||++.|+.+
T Consensus 224 ~~~~~~~~----------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 224 LLEKDYRM----------------------------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp HHHTTCCC----------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhccCCC----------------------------------CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 11110000 00112456788999999999999999999999999998
Q ss_pred HHhh
Q 012014 453 RRKL 456 (473)
Q Consensus 453 ~~~~ 456 (473)
....
T Consensus 270 ~~~~ 273 (288)
T 3kfa_A 270 FQES 273 (288)
T ss_dssp HHHH
T ss_pred HHhc
Confidence 7654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=358.68 Aligned_cols=245 Identities=20% Similarity=0.248 Sum_probs=199.6
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeecc---CCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCce
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (473)
.++|++.+.||+|+||.||+|+. .+|+.||+|+++.. .....+.+.+|+.++..++||||+++++++.+ ..
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~ 114 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-----NS 114 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-----CC
Confidence 36799999999999999999994 47899999999742 23445678899999999999999999999854 34
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
..++||||+++|+|.+++.... .+++..+..++.||+.||.||| ++||+||||||+|||++.++.+||
T Consensus 115 ~~~lv~e~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL 182 (350)
T 1rdq_E 115 NLYMVMEYVAGGEMFSHLRRIG---------RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQV 182 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHHC---------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEE
T ss_pred EEEEEEcCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEE
Confidence 6899999999999999997653 3668899999999999999999 899999999999999999999999
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcC
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP 379 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 379 (473)
+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|..||.+..... .+..+.....
T Consensus 183 ~DFg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-~~~~i~~~~~- 255 (350)
T 1rdq_E 183 TDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-IYEKIVSGKV- 255 (350)
T ss_dssp CCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCCC-
T ss_pred cccccceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH-HHHHHHcCCC-
Confidence 999999866432 234568999999999999999999999999999999999999997532111 0111110000
Q ss_pred cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCC-----hHHHHH
Q 012014 380 QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMK-----INDVES 447 (473)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~ 447 (473)
. .+...+..+.+|+.+||+.||.+||+ +.||++
T Consensus 256 -~----------------------------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 256 -R----------------------------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -C----------------------------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -C----------------------------------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 0 00123457889999999999999998 777754
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=351.11 Aligned_cols=275 Identities=21% Similarity=0.316 Sum_probs=206.0
Q ss_pred cCCCCccceeecCCCeEEEEEEe-----cCCCEEEEEEeeccC-CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCC
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-----FDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (473)
.+.|++.+.||+|+||.||+|++ .+++.||+|+++... ......+.+|+.++..++||||+++++++....
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--- 96 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDG--- 96 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC---
Confidence 34588999999999999999983 468899999997433 334467899999999999999999999986532
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccE
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~ 297 (473)
....++||||+++|+|.+++..... .+++.+++.++.|++.||.||| +++|+||||||+||+++.++.+
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~ 165 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPKNKN--------KINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQV 165 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHHHTT--------TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEE
T ss_pred CceEEEEEEeCCCCcHHHHHHhccc--------cCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCE
Confidence 3457999999999999999955432 3668899999999999999999 8999999999999999999999
Q ss_pred EEeecccccccCccccc-cceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 012014 298 HVGDFGMARFLPAIDKQ-NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKM 376 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~ 376 (473)
||+|||++......... .......||..|+|||++.+..++.++||||||+++|+|++|..|+... ...+...
T Consensus 166 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~------~~~~~~~ 239 (302)
T 4e5w_A 166 KIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSP------MALFLKM 239 (302)
T ss_dssp EECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH------HHHHHHH
T ss_pred EECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcch------hhHHhhc
Confidence 99999999876543221 1223455788899999999888999999999999999999999986532 1111111
Q ss_pred hcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHH
Q 012014 377 ALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIR 453 (473)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~ 453 (473)
..+..... ...........+. ....+..++..+.+|+.+||+.||.+|||+.|+++.|+.+.
T Consensus 240 ~~~~~~~~-~~~~~~~~~~~~~--------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 240 IGPTHGQM-TVTRLVNTLKEGK--------------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HCSCCGGG-HHHHHHHHHHTTC--------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCCccccc-CHHHHHHHHhccC--------------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 11110000 0000000100000 00011234568899999999999999999999999999874
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=341.61 Aligned_cols=259 Identities=23% Similarity=0.337 Sum_probs=208.0
Q ss_pred ccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
..++|++.+.||+|+||.||+|...+++.||+|++.... ...+.+.+|+.++..++||||+++++++.+. ...+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 79 (267)
T 3t9t_A 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----APIC 79 (267)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSS-----SSCE
T ss_pred chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccC-----CCeE
Confidence 456899999999999999999998788899999997533 2456799999999999999999999998543 3579
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
+||||+++++|.+++..... .+++..+..++.|++.||.||| +++++||||||+||+++.++.+||+||
T Consensus 80 lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~df 148 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQRG--------LFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDF 148 (267)
T ss_dssp EEECCCTTCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCT
T ss_pred EEEeCCCCCcHHHHHhhCcc--------cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccc
Confidence 99999999999999976532 3568899999999999999999 899999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcCcc
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMALPQR 381 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 381 (473)
|++....... ........||+.|+|||++.+..++.++||||||+++|+|++ |..||...... ..........
T Consensus 149 g~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~i~~~~ 222 (267)
T 3t9t_A 149 GMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----EVVEDISTGF 222 (267)
T ss_dssp TGGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHHHHTTC
T ss_pred cccccccccc-ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH-----HHHHHHhcCC
Confidence 9998654321 111223447788999999998889999999999999999999 89999753211 1111100000
Q ss_pred hhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHHh
Q 012014 382 AEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRK 455 (473)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~ 455 (473)
. .. .+...+..+.+|+.+||+.||++|||+.|+++.|+.+.+.
T Consensus 223 ~-~~------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 223 R-LY------------------------------KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp C-CC------------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred c-CC------------------------------CCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 0 00 0011345788999999999999999999999999999763
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=345.94 Aligned_cols=276 Identities=19% Similarity=0.273 Sum_probs=198.2
Q ss_pred CCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccC--CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 145 NGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
++|.+.+.||+|+||.||+|+..+++.||+|++.... ......+.+|+.++++++||||+++++++... ...+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 76 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----KRLV 76 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-----SCEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccC-----CeEE
Confidence 5789999999999999999998779999999986433 22346788999999999999999999998543 3679
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
+||||+++ +|.+++..... .+++..+..++.||+.||.||| ++||+||||||+||+++.++.+||+||
T Consensus 77 lv~e~~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Df 144 (288)
T 1ob3_A 77 LVFEHLDQ-DLKKLLDVCEG--------GLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADF 144 (288)
T ss_dssp EEEECCSE-EHHHHHHTSTT--------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCT
T ss_pred EEEEecCC-CHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeEC
Confidence 99999965 99999876432 3568889999999999999999 899999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCC-CCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcc
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQR 381 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 381 (473)
|+++...... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+....+ .+....+......
T Consensus 145 g~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~ 221 (288)
T 1ob3_A 145 GLARAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTPN 221 (288)
T ss_dssp THHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCC
T ss_pred ccccccCccc--cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHHCCCC
Confidence 9998654321 222334689999999998764 58999999999999999999999998643222 1122221111100
Q ss_pred hhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 382 AEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
............+. ... ...............+..+.+|+.+||+.||++|||+.|+++
T Consensus 222 ~~~~~~~~~~~~~~------~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 222 SKNWPNVTELPKYD------PNF-TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TTTSTTGGGSTTCC------TTC-CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhchhhhcccccc------ccc-ccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000000000000 000 000000000111234567889999999999999999999875
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=343.50 Aligned_cols=265 Identities=23% Similarity=0.350 Sum_probs=211.2
Q ss_pred hhhcccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 139 DLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 139 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
++....++|++.+.||+|+||.||+|...++..||+|+++... ...+.+.+|+.++..++||||+++++++.+
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~------ 79 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ------ 79 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC------
Confidence 4555667899999999999999999998778899999987433 346789999999999999999999998743
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...++||||+++++|.+++..... ..+++.++..++.|++.||.||| +++|+||||||+||+++.++.+|
T Consensus 80 ~~~~~v~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~k 149 (279)
T 1qpc_A 80 EPIYIITEYMENGSLVDFLKTPSG-------IKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCK 149 (279)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHH-------HTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEE
T ss_pred CCcEEEEecCCCCCHHHHHhcCCC-------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEE
Confidence 246899999999999999975421 13668899999999999999999 89999999999999999999999
Q ss_pred EeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhh
Q 012014 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~ 377 (473)
|+|||++........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+..... .....
T Consensus 150 l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-----~~~~~ 223 (279)
T 1qpc_A 150 IADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-----VIQNL 223 (279)
T ss_dssp ECCCTTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----HHHHH
T ss_pred ECCCcccccccCccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH-----HHHHH
Confidence 999999987654221 11223346889999999988889999999999999999999 999997632211 11100
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHHhhc
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRKLL 457 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~~~ 457 (473)
.... .. ..+..++..+.+|+.+||+.||++|||+.+|++.|+.+.....
T Consensus 224 ~~~~-----~~--------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 224 ERGY-----RM--------------------------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp HTTC-----CC--------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred hccc-----CC--------------------------CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 0000 00 0011245678899999999999999999999999999976654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=367.06 Aligned_cols=201 Identities=20% Similarity=0.292 Sum_probs=158.0
Q ss_pred ccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCC--CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCce
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (473)
..++|.+.++||+|+||.||+|. ..+++.||||++..... ...+.+.+|+.++.+++||||+++++++.....+...
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 45789999999999999999998 45789999999864322 2235688999999999999999999999765555556
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
..++||||+ +|+|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~~---------~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl 197 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFRTPV---------YLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKV 197 (458)
T ss_dssp CEEEEECCC-SEEHHHHHHSSC---------CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEE
T ss_pred eEEEEEecc-ccchhhhcccCC---------CCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEee
Confidence 789999998 679999997654 3668999999999999999999 899999999999999999999999
Q ss_pred eecccccccCccccc-------------------------cceeeccCCCCcCCCccc-cCCCCCcccchhhHhHHHHHH
Q 012014 300 GDFGMARFLPAIDKQ-------------------------NRFICIKGSTGYIPPEYD-LGCEASTYGDVYSFGILLLEM 353 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~el 353 (473)
+|||+++........ .......||+.|+|||++ .+..++.++|||||||++|||
T Consensus 198 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~el 277 (458)
T 3rp9_A 198 CDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277 (458)
T ss_dssp CCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred cccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHH
Confidence 999999876432211 123445689999999976 456799999999999999999
Q ss_pred HhC
Q 012014 354 FTG 356 (473)
Q Consensus 354 ltg 356 (473)
++|
T Consensus 278 ltg 280 (458)
T 3rp9_A 278 LNM 280 (458)
T ss_dssp HTT
T ss_pred HHh
Confidence 993
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=359.32 Aligned_cols=250 Identities=21% Similarity=0.266 Sum_probs=191.5
Q ss_pred CCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCC--CchhHHHHHHHHHhcC--CCCceeeeeeeeccccCCcee
Q 012014 145 NGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIK--HRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~~ 220 (473)
.+|.+.+.||+|+||.||+|...+++.||||++...... ..+.+.+|+.++.+++ ||||+++++++... ..
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~-----~~ 130 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-----QY 130 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----SE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC-----CE
Confidence 469999999999999999999777999999999754322 3357899999999996 59999999998653 36
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.++||| +.+++|.+++.... .+++.++..++.||+.||.||| +++|+||||||+|||++ ++.+||+
T Consensus 131 ~~lv~E-~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~ 196 (390)
T 2zmd_A 131 IYMVME-CGNIDLNSWLKKKK---------SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLI 196 (390)
T ss_dssp EEEEEE-CCSEEHHHHHHHCS---------SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEEC
T ss_pred EEEEEe-cCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEE
Confidence 899999 56889999998654 3557889999999999999999 99999999999999995 5889999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCccccC-----------CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCccc
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-----------CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMN 369 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~ 369 (473)
|||+++.+.............||+.|+|||++.+ ..++.++|||||||++|||++|..||.........
T Consensus 197 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~ 276 (390)
T 2zmd_A 197 DFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 276 (390)
T ss_dssp CCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH
T ss_pred ecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHH
Confidence 9999987654332323345679999999999865 36889999999999999999999999754321111
Q ss_pred HHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 370 LRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
+............ +...+..+.+|+.+||+.||.+|||+.||++
T Consensus 277 ~~~~~~~~~~~~~----------------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 277 LHAIIDPNHEIEF----------------------------------PDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp HHHHHCTTSCCCC----------------------------------CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHhCccccCCC----------------------------------CccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 1111100000000 0011346789999999999999999999975
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=345.29 Aligned_cols=263 Identities=25% Similarity=0.369 Sum_probs=202.8
Q ss_pred CCCCccceeecCCCeEEEEEEecC----CCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCce
Q 012014 145 NGFSSANLIGAGNFGSVYNGTLFD----GTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (473)
.+|.+.++||+|+||.||+|...+ ...+|+|.++.... ...+.+.+|+.++++++||||+++++++.. ...
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~ 100 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SEG 100 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC----SSS
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc----CCC
Confidence 468889999999999999998432 23589998864322 233568899999999999999999998643 234
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
..++||||+++|+|.+++..... .+++..++.++.|++.||.||| +++|+||||||+||+++.++.+||
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl 169 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKV 169 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTC--------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEE
T ss_pred ceEEEEeCCCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEE
Confidence 67899999999999999976432 3568899999999999999999 899999999999999999999999
Q ss_pred eecccccccCcccc--ccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHh
Q 012014 300 GDFGMARFLPAIDK--QNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKM 376 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~ 376 (473)
+|||+++....... ........||+.|+|||.+.+..++.++||||||+++|+|++ |.+||.+....+. ......
T Consensus 170 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~--~~~~~~ 247 (298)
T 3f66_A 170 ADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TVYLLQ 247 (298)
T ss_dssp CSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH--HHHHHT
T ss_pred CcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH--HHHHhc
Confidence 99999987644321 122334457889999999998899999999999999999999 5666654322221 111100
Q ss_pred hcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHHhh
Q 012014 377 ALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRKL 456 (473)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~~ 456 (473)
..... .+..++..+.+++.+||+.||++|||+.|+++.|+.+...+
T Consensus 248 ~~~~~----------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~ 293 (298)
T 3f66_A 248 GRRLL----------------------------------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 293 (298)
T ss_dssp TCCCC----------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred CCCCC----------------------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 00000 00113457889999999999999999999999999998776
Q ss_pred cc
Q 012014 457 LE 458 (473)
Q Consensus 457 ~~ 458 (473)
..
T Consensus 294 ~~ 295 (298)
T 3f66_A 294 IG 295 (298)
T ss_dssp CC
T ss_pred cc
Confidence 54
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=342.87 Aligned_cols=265 Identities=23% Similarity=0.330 Sum_probs=205.1
Q ss_pred CCCccceeecCCCeEEEEEEec-CCC---EEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 146 GFSSANLIGAGNFGSVYNGTLF-DGT---TIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~~~-~~~---~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
.|...++||+|+||.||+|... ++. .||+|+++.... ...+.+.+|+.+++.++||||+++++++.+. ...
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~ 97 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP----EGL 97 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS----SSC
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecC----CCC
Confidence 4566789999999999999843 333 799999874332 2345788999999999999999999998543 234
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.++||||+.+|+|.+++..... .+++.++..++.|++.||.||| ++||+||||||+||+++.++.+||+
T Consensus 98 ~~~v~e~~~~~~L~~~~~~~~~--------~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~ 166 (298)
T 3pls_A 98 PHVLLPYMCHGDLLQFIRSPQR--------NPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVA 166 (298)
T ss_dssp CEEEECCCTTCBHHHHHHCTTC--------CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEEC
T ss_pred cEEEEecccCCCHHHHHhcccc--------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeC
Confidence 5899999999999999976432 3568899999999999999999 8999999999999999999999999
Q ss_pred ecccccccCccc--cccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 012014 301 DFGMARFLPAID--KQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMAL 378 (473)
Q Consensus 301 Dfg~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~ 378 (473)
|||+++...... .........||+.|+|||.+.+..++.++||||||+++|+|++|..|+....... .+........
T Consensus 167 Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~-~~~~~~~~~~ 245 (298)
T 3pls_A 167 DFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF-DLTHFLAQGR 245 (298)
T ss_dssp CTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG-GHHHHHHTTC
T ss_pred cCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH-HHHHHhhcCC
Confidence 999998654432 1222334567899999999999999999999999999999999655543322211 1111111110
Q ss_pred CcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHHhhcc
Q 012014 379 PQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRKLLE 458 (473)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~~~~ 458 (473)
... .+..++..+.+|+.+||+.||.+|||+.++++.|+.+...+..
T Consensus 246 ~~~----------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 246 RLP----------------------------------QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp CCC----------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred CCC----------------------------------CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 000 0112345788999999999999999999999999999888765
Q ss_pred CC
Q 012014 459 TP 460 (473)
Q Consensus 459 ~~ 460 (473)
..
T Consensus 292 ~~ 293 (298)
T 3pls_A 292 DH 293 (298)
T ss_dssp CC
T ss_pred cc
Confidence 44
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=367.95 Aligned_cols=285 Identities=17% Similarity=0.165 Sum_probs=200.5
Q ss_pred cccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeecc--CCCCchhHHHHHHHHHhcCCCCceeeeeeeecccc-CC
Q 012014 142 NATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI--RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY-QG 217 (473)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~ 217 (473)
...++|++.+.||+|+||.||+|. ..+++.||||++... .....+.+.+|+.+++.++||||++++++|..... ..
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 346789999999999999999998 456899999999743 22234568899999999999999999999865432 23
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccE
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~ 297 (473)
....++||||+++ +|.+.+... +++..+..++.||+.||.||| ++||+||||||+|||++.++.+
T Consensus 139 ~~~~~lv~E~~~~-~l~~~~~~~-----------l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~ 203 (464)
T 3ttj_A 139 FQDVYLVMELMDA-NLCQVIQME-----------LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTL 203 (464)
T ss_dssp CCEEEEEEECCSE-EHHHHHTSC-----------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCE
T ss_pred CCeEEEEEeCCCC-CHHHHHhhc-----------CCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCE
Confidence 4567999999965 577777532 458889999999999999999 8999999999999999999999
Q ss_pred EEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+ .+..+....
T Consensus 204 kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~-~~~~i~~~l 279 (464)
T 3ttj_A 204 KILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQL 279 (464)
T ss_dssp EECCCCCC-----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHH
T ss_pred EEEEEEeeeecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhc
Confidence 99999999865432 22344579999999999999999999999999999999999999998743221 122222221
Q ss_pred cCcchhhhccccchHHHHhhhhhhcc--------cccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCME--------VSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
..... +...... ............ ....................+.+|+.+||..||++|||+.|+++
T Consensus 280 g~p~~-~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 280 GTPCP-EFMKKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp CSCCH-HHHTTSC-HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCH-HHHHHcc-hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 11111 1111000 000000000000 00000000011122334678999999999999999999999875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=350.88 Aligned_cols=277 Identities=22% Similarity=0.279 Sum_probs=208.2
Q ss_pred CCccceeecCCCeEEEEEEe-----cCCCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 147 FSSANLIGAGNFGSVYNGTL-----FDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 147 ~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
|++.+.||+|+||.||++.+ .+++.||||+++.... .....+.+|+.++++++||||+++++++.+. +...
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~ 109 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA---GAAS 109 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET---TTTE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC---CCce
Confidence 48899999999999998863 2678999999975432 2245689999999999999999999998653 2346
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.++||||+++|+|.+++.... +++.+++.++.|++.||.||| +++|+||||||+||+++.++.+||+
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~ 176 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRHS----------IGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIG 176 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGSC----------CCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEecccCCcHHHHHhhCC----------CCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEEC
Confidence 799999999999999997653 558899999999999999999 8999999999999999999999999
Q ss_pred ecccccccCccccc-cceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcC
Q 012014 301 DFGMARFLPAIDKQ-NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP 379 (473)
Q Consensus 301 Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 379 (473)
|||++......... .......||+.|+|||++.+..++.++||||||+++|+|++|..||....... ... ....
T Consensus 177 Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~---~~~--~~~~ 251 (318)
T 3lxp_A 177 DFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF---LEL--IGIA 251 (318)
T ss_dssp CGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH---HHH--HCSC
T ss_pred CccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh---hhh--hccc
Confidence 99999876543221 12233457888999999998889999999999999999999999986421110 000 0000
Q ss_pred cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHHhhccC
Q 012014 380 QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRKLLET 459 (473)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~~~~~ 459 (473)
...... .........+. ....+..++..+.+|+.+||+.||++|||+.||++.|+.+.+++...
T Consensus 252 ~~~~~~--~~~~~~~~~~~--------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 315 (318)
T 3lxp_A 252 QGQMTV--LRLTELLERGE--------------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315 (318)
T ss_dssp CHHHHH--HHHHHHHHTTC--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred ccchhH--HHHHHHHhccc--------------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence 000000 00000000000 00011234678899999999999999999999999999999888654
Q ss_pred C
Q 012014 460 P 460 (473)
Q Consensus 460 ~ 460 (473)
.
T Consensus 316 ~ 316 (318)
T 3lxp_A 316 A 316 (318)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=355.95 Aligned_cols=201 Identities=23% Similarity=0.287 Sum_probs=173.0
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCC---CchhHHHHHHHHHhc-CCCCceeeeeeeeccccCCc
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG---GSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 218 (473)
.++|++.+.||+|+||.||+|+. .+++.||+|+++..... ....+.+|..++.++ +||||++++++|.+ .
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-----~ 82 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----E 82 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----S
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe-----C
Confidence 35799999999999999999994 46899999999854322 234578899999988 89999999999854 3
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...++||||+++|+|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|||++.++.+|
T Consensus 83 ~~~~lv~e~~~gg~L~~~l~~~~---------~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~k 150 (345)
T 3a8x_A 83 SRLFFVIEYVNGGDLMFHMQRQR---------KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIK 150 (345)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEE
T ss_pred CEEEEEEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEE
Confidence 47899999999999999997643 3668999999999999999999 89999999999999999999999
Q ss_pred EeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCC
Q 012014 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 363 (473)
|+|||+++..... .......+||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 151 L~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 213 (345)
T 3a8x_A 151 LTDYGMCKEGLRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 213 (345)
T ss_dssp ECCGGGCBCSCCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTT
T ss_pred EEeccccccccCC--CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCc
Confidence 9999999854322 22234567999999999999999999999999999999999999999753
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=354.44 Aligned_cols=280 Identities=23% Similarity=0.322 Sum_probs=210.8
Q ss_pred cCCCCccceeecCCCeEEEEEEe-----cCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-----FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
.++|++.+.||+|+||.||+|.. .+++.||+|++........+.+.+|+.++.+++||||+++++++...+ .
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~ 116 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---R 116 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC------
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC---C
Confidence 35688999999999999999983 368899999997655445567899999999999999999999875432 3
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...++||||+++++|.+++..... .+++.+++.++.|++.||.||| +++|+||||||+||+++.++.+|
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~k 185 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKHKE--------RIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVK 185 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHSTT--------SSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEE
T ss_pred CceEEEEECCCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEE
Confidence 457999999999999999976532 3568899999999999999999 89999999999999999999999
Q ss_pred EeecccccccCcccccc-ceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 299 VGDFGMARFLPAIDKQN-RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
|+|||++.......... ......++..|+|||++.+..++.++||||||+++|+|++|..||.... ..+....
T Consensus 186 L~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~------~~~~~~~ 259 (326)
T 2w1i_A 186 IGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP------AEFMRMI 259 (326)
T ss_dssp ECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHH------HHHHHHH
T ss_pred EecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCH------HHHHHhh
Confidence 99999998765432211 1123346778999999988889999999999999999999999986421 1111111
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHHhhc
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRKLL 457 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~~~ 457 (473)
............+...+..... ...+..++..+.+|+.+||+.||++|||+.||++.|+.+++.+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l~ 325 (326)
T 2w1i_A 260 GNDKQGQMIVFHLIELLKNNGR--------------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325 (326)
T ss_dssp CTTCCTHHHHHHHHHHHHTTCC--------------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ccccchhhhHHHHHHHhhcCCC--------------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence 0000000000000000000000 00112356788999999999999999999999999999988764
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=357.31 Aligned_cols=270 Identities=15% Similarity=0.140 Sum_probs=206.6
Q ss_pred cCCCCccceeecCCCeEEEEEEec---------CCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceee--------
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTLF---------DGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRV-------- 206 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~~---------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~-------- 206 (473)
.++|.+.+.||+|+||.||+|... +++.||+|++... ..+.+|+.++.+++||||+++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 468999999999999999999854 3789999998742 578999999999999999984
Q ss_pred -------eeeeeccccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 012014 207 -------FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPI 279 (473)
Q Consensus 207 -------~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i 279 (473)
++++.. .....++||||+ +++|.+++..... ..+++.+++.++.||+.||.||| +++|
T Consensus 116 ~~~i~~~~~~~~~----~~~~~~lv~e~~-~~~L~~~l~~~~~-------~~l~~~~~~~i~~qi~~~L~~LH---~~~i 180 (352)
T 2jii_A 116 LLAIPTCMGFGVH----QDKYRFLVLPSL-GRSLQSALDVSPK-------HVLSERSVLQVACRLLDALEFLH---ENEY 180 (352)
T ss_dssp TCSCCCCCEEEEE----TTTEEEEEEECC-CEEHHHHHHHSGG-------GCCCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred ccCccchhhcccc----CCcEEEEEecCC-CcCHHHHHHhCCc-------CCCCHHHHHHHHHHHHHHHHHHH---hCCc
Confidence 344322 235789999999 9999999986521 14679999999999999999999 8999
Q ss_pred eeccCCCCcEEecCCc--cEEEeecccccccCcccccc-----ceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHH
Q 012014 280 AHCNLKPSNVLLDDEM--IGHVGDFGMARFLPAIDKQN-----RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLE 352 (473)
Q Consensus 280 iH~Dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 352 (473)
+||||||+|||++.++ .+||+|||+++.+....... ......||+.|+|||++.+..++.++||||||+++|+
T Consensus 181 vH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~e 260 (352)
T 2jii_A 181 VHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLK 260 (352)
T ss_dssp BCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred cCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHH
Confidence 9999999999999998 99999999998765432211 1233469999999999999899999999999999999
Q ss_pred HHhCCCCCCCCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcc
Q 012014 353 MFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACS 432 (473)
Q Consensus 353 lltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl 432 (473)
|++|..||.+.......+........ ........... .....+..+.+|+.+||
T Consensus 261 l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-------------------------~~~~~~~~l~~li~~~l 314 (352)
T 2jii_A 261 WLYGFLPWTNCLPNTEDIMKQKQKFV-DKPGPFVGPCG-------------------------HWIRPSETLQKYLKVVM 314 (352)
T ss_dssp HHHSCCTTGGGTTCHHHHHHHHHHHH-HSCCCEECTTS-------------------------CEECCCHHHHHHHHHHH
T ss_pred HHhCCCCcccCCcCHHHHHHHHHhcc-CChhhhhhhcc-------------------------ccCCCcHHHHHHHHHHH
Confidence 99999999865422222222111110 00000000000 00113567889999999
Q ss_pred cCCCCCCCChHHHHHHHHHHHHhhccC
Q 012014 433 AERPRERMKINDVESRLRLIRRKLLET 459 (473)
Q Consensus 433 ~~dP~~RPt~~ev~~~L~~l~~~~~~~ 459 (473)
+.||++|||+.+|++.|+.+.......
T Consensus 315 ~~dp~~Rps~~~l~~~L~~~~~~~~~~ 341 (352)
T 2jii_A 315 ALTYEEKPPYAMLRNNLEALLQDLRVS 341 (352)
T ss_dssp TCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred hCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence 999999999999999999998876544
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=352.79 Aligned_cols=276 Identities=25% Similarity=0.339 Sum_probs=211.5
Q ss_pred hhhhcccCCCCccceeecCCCeEEEEEEec-CC-----CEEEEEEeeccCC-CCchhHHHHHHHHHhc-CCCCceeeeee
Q 012014 138 KDLYNATNGFSSANLIGAGNFGSVYNGTLF-DG-----TTIAVKVFNLIRP-GGSKSFKSECKAAINI-KHRNIVRVFTA 209 (473)
Q Consensus 138 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~ 209 (473)
..+....++|.+.+.||+|+||.||+|... ++ ..||+|.++.... ...+.+.+|+.++..+ +||||++++++
T Consensus 39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 345566789999999999999999999843 22 4799999875332 2345688999999999 89999999999
Q ss_pred eeccccCCceeeEEEEEecCCCCHHHHhcCCCCC-----CCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccC
Q 012014 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDT-----NWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNL 284 (473)
Q Consensus 210 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-----~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dl 284 (473)
+... ...++||||+++|+|.+++...... ........+++..++.++.||+.||.||| +++|+||||
T Consensus 119 ~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dl 190 (333)
T 2i1m_A 119 CTHG-----GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDV 190 (333)
T ss_dssp ECSS-----SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCC
T ss_pred EecC-----CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCc
Confidence 8543 3579999999999999999753210 00000113568899999999999999999 899999999
Q ss_pred CCCcEEecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCC
Q 012014 285 KPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGI 363 (473)
Q Consensus 285 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~ 363 (473)
||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|+|++ |..||.+.
T Consensus 191 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 270 (333)
T 2i1m_A 191 AARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGI 270 (333)
T ss_dssp SGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCccc
Confidence 99999999999999999999986644332222233457889999999998899999999999999999999 99999764
Q ss_pred CCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChH
Q 012014 364 FTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKIN 443 (473)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ 443 (473)
..... +........... .+...+..+.+|+.+||+.||.+|||+.
T Consensus 271 ~~~~~-~~~~~~~~~~~~----------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ 315 (333)
T 2i1m_A 271 LVNSK-FYKLVKDGYQMA----------------------------------QPAFAPKNIYSIMQACWALEPTHRPTFQ 315 (333)
T ss_dssp CSSHH-HHHHHHHTCCCC----------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred chhHH-HHHHHhcCCCCC----------------------------------CCCCCCHHHHHHHHHHhccChhhCcCHH
Confidence 33221 111111110000 0011345788999999999999999999
Q ss_pred HHHHHHHHHHHhh
Q 012014 444 DVESRLRLIRRKL 456 (473)
Q Consensus 444 ev~~~L~~l~~~~ 456 (473)
||++.|+.+....
T Consensus 316 ~l~~~L~~~~~~~ 328 (333)
T 2i1m_A 316 QICSFLQEQAQED 328 (333)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhh
Confidence 9999999987654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=346.85 Aligned_cols=273 Identities=18% Similarity=0.257 Sum_probs=198.6
Q ss_pred ccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCC---CchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG---GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
..++|++.+.||+|+||.||+|.. .+++.||+|+++..... ....+.+|+.++.+++||||+++++++...
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~----- 104 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED----- 104 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-----
Confidence 446799999999999999999984 57899999999753322 235688999999999999999999998653
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...++||||+++|+|.+++...... ...+++..++.++.|++.||.||| +++++||||||+||+++.++.+|
T Consensus 105 ~~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~k 176 (310)
T 2wqm_A 105 NELNIVLELADAGDLSRMIKHFKKQ-----KRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVK 176 (310)
T ss_dssp TEEEEEEECCCSCBHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEE
T ss_pred CcEEEEEecCCCCCHHHHHHHhccc-----ccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEE
Confidence 3679999999999999998642110 013568899999999999999999 89999999999999999999999
Q ss_pred EeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 012014 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMAL 378 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~ 378 (473)
|+|||++....... .......||+.|+|||++.+..++.++||||||+++|+|++|..||.+..... ........
T Consensus 177 l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~ 251 (310)
T 2wqm_A 177 LGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL---YSLCKKIE 251 (310)
T ss_dssp ECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH---HHHHHHHH
T ss_pred EEeccceeeecCCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH---HHHHHHhh
Confidence 99999998654322 12233458999999999999899999999999999999999999997532221 11111110
Q ss_pred CcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHHhhcc
Q 012014 379 PQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRKLLE 458 (473)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~~~~ 458 (473)
........ ....+..+.+|+.+||+.||++|||+.+|++.|+.+.+....
T Consensus 252 ~~~~~~~~------------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 252 QCDYPPLP------------------------------SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp TTCSCCCC------------------------------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred cccCCCCc------------------------------ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 00000000 012355788999999999999999999999999999998877
Q ss_pred CCccc
Q 012014 459 TPACL 463 (473)
Q Consensus 459 ~~~~~ 463 (473)
++.+.
T Consensus 302 ~~~~~ 306 (310)
T 2wqm_A 302 SLEHH 306 (310)
T ss_dssp -----
T ss_pred hhhhh
Confidence 76543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=359.91 Aligned_cols=286 Identities=18% Similarity=0.160 Sum_probs=203.1
Q ss_pred hcccCCCCccceeecC--CCeEEEEEEe-cCCCEEEEEEeeccCC--CCchhHHHHHHHHHhcCCCCceeeeeeeecccc
Q 012014 141 YNATNGFSSANLIGAG--NFGSVYNGTL-FDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY 215 (473)
Q Consensus 141 ~~~~~~~~~~~~lg~G--~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 215 (473)
....++|++.++||+| +||.||+|+. .+++.||||+++.... .....+.+|+.+++.++||||++++++|.+.
T Consensus 21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-- 98 (389)
T 3gni_B 21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-- 98 (389)
T ss_dssp CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET--
T ss_pred cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC--
Confidence 3456789999999999 9999999994 4799999999975432 2235678899999999999999999998653
Q ss_pred CCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCc
Q 012014 216 QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM 295 (473)
Q Consensus 216 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~ 295 (473)
...++||||+++|+|.+++...... .+++..+..++.||+.||.||| +++|+||||||+|||++.++
T Consensus 99 ---~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~ 165 (389)
T 3gni_B 99 ---NELWVVTSFMAYGSAKDLICTHFMD-------GMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDG 165 (389)
T ss_dssp ---TEEEEEEECCTTCBHHHHHHHTCTT-------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTC
T ss_pred ---CEEEEEEEccCCCCHHHHHhhhccc-------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCC
Confidence 3689999999999999999765322 3668899999999999999999 89999999999999999999
Q ss_pred cEEEeecccccccCcccc-----ccceeeccCCCCcCCCccccC--CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcc
Q 012014 296 IGHVGDFGMARFLPAIDK-----QNRFICIKGSTGYIPPEYDLG--CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKM 368 (473)
Q Consensus 296 ~~kl~Dfg~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~ 368 (473)
.+||+|||.+........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+......
T Consensus 166 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~ 245 (389)
T 3gni_B 166 KVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM 245 (389)
T ss_dssp CEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH
T ss_pred CEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence 999999999865432211 111123468999999999987 5799999999999999999999999987544332
Q ss_pred cHHHHHHhhcCcchhhhccccchH---------------HHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhccc
Q 012014 369 NLRNFVKMALPQRAEEVVDDFNLQ---------------EIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSA 433 (473)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~ 433 (473)
..... ....+ .+.+..... ........ ...................+..+.+|+.+||+
T Consensus 246 ~~~~~-~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~ 319 (389)
T 3gni_B 246 LLEKL-NGTVP----CLLDTSTIPAEELTMSPSRSVANSGLSDSLTT-STPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQ 319 (389)
T ss_dssp HHHC--------------------------------------------------------------CCHHHHHHHHHHTC
T ss_pred HHHHh-cCCCC----cccccccccccccccccccccccccccccccc-CccccccCCCCCCccccccCHHHHHHHHHHhh
Confidence 11111 11000 000000000 00000000 00000000001111233456789999999999
Q ss_pred CCCCCCCChHHHHH
Q 012014 434 ERPRERMKINDVES 447 (473)
Q Consensus 434 ~dP~~RPt~~ev~~ 447 (473)
.||++|||+.|+++
T Consensus 320 ~dP~~Rpta~ell~ 333 (389)
T 3gni_B 320 RNPDARPSASTLLN 333 (389)
T ss_dssp SCTTTSCCHHHHTT
T ss_pred cCcccCCCHHHHhc
Confidence 99999999999984
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=355.34 Aligned_cols=264 Identities=25% Similarity=0.373 Sum_probs=197.4
Q ss_pred CCCccceeecCCCeEEEEEEec--CC--CEEEEEEeeccC-CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 146 GFSSANLIGAGNFGSVYNGTLF--DG--TTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
.|.+.++||+|+||.||+|... ++ ..||+|.++... ....+.+.+|+.++++++||||+++++++... ...
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~----~~~ 165 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----EGS 165 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC----SSC
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC----CCC
Confidence 4677889999999999999843 22 368999886432 22346789999999999999999999987432 235
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.++||||+++|+|.+++..... .+++.+++.++.||+.||.||| +++|+||||||+|||++.++.+||+
T Consensus 166 ~~lv~e~~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~ 234 (373)
T 3c1x_A 166 PLVVLPYMKHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVA 234 (373)
T ss_dssp CEEEEECCTTCBHHHHHHCTTC--------CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEEC
T ss_pred eEEEEECCCCCCHHHHHhhccc--------CCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEe
Confidence 6899999999999999976532 3568889999999999999999 8999999999999999999999999
Q ss_pred ecccccccCccccc--cceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhh
Q 012014 301 DFGMARFLPAIDKQ--NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 301 Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~ 377 (473)
|||+++........ .......||+.|+|||++.+..++.++||||||+++|||++ |.+||.+....+. .......
T Consensus 235 DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~--~~~~~~~ 312 (373)
T 3c1x_A 235 DFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TVYLLQG 312 (373)
T ss_dssp CC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH--HHHHHTT
T ss_pred eccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH--HHHHHcC
Confidence 99999865432211 12233457889999999999899999999999999999999 7778865433221 1111100
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHHhhc
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRKLL 457 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~~~ 457 (473)
... ..+..++..+.+++.+||+.||++|||+.||++.|+.+...+.
T Consensus 313 ~~~----------------------------------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 313 RRL----------------------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp CCC----------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred CCC----------------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 000 0011245678899999999999999999999999999988776
Q ss_pred cCC
Q 012014 458 ETP 460 (473)
Q Consensus 458 ~~~ 460 (473)
...
T Consensus 359 ~~~ 361 (373)
T 3c1x_A 359 GEH 361 (373)
T ss_dssp SCC
T ss_pred ccc
Confidence 543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=361.23 Aligned_cols=286 Identities=21% Similarity=0.267 Sum_probs=214.5
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccC-CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
.++|.+.++||+|+||.||+|.. .+++.||||+++... ....+.+.+|+.++.+++||||+++++++.... ....
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---~~~~ 84 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETT---TRHK 84 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTT---TCCE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCC---CCee
Confidence 45799999999999999999994 458999999997433 234567889999999999999999999986532 3467
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEe----cCCccE
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL----DDEMIG 297 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~----~~~~~~ 297 (473)
++||||+++|+|.+++...... ..+++..++.++.||+.||.||| +++|+||||||+|||+ +.++.+
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~ 155 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNA------YGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVY 155 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGT------TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEE
T ss_pred EEEEecCCCCCHHHHHHhhhcc------cCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeE
Confidence 9999999999999999765321 12678999999999999999999 8999999999999999 788889
Q ss_pred EEeecccccccCccccccceeeccCCCCcCCCccccC--------CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCccc
Q 012014 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG--------CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMN 369 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~ 369 (473)
||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||.........
T Consensus 156 kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~ 232 (396)
T 4eut_A 156 KLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232 (396)
T ss_dssp EECCGGGCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC
T ss_pred EEecCCCceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch
Confidence 999999998765432 2234569999999999865 46788999999999999999999999765443332
Q ss_pred HHHHHHhh--cC-cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHH
Q 012014 370 LRNFVKMA--LP-QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVE 446 (473)
Q Consensus 370 ~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~ 446 (473)
...+.... .+ .....+.... ...+ .+.. .. ..........+..+.+++.+||+.||++|||+.|++
T Consensus 233 ~~~~~~~~~~~p~~~~~~~~~~~-~~~~-----~~~~--~~---~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l 301 (396)
T 4eut_A 233 KEVMYKIITGKPSGAISGVQKAE-NGPI-----DWSG--DM---PVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFF 301 (396)
T ss_dssp HHHHHHHHHSCCTTCCEEEECST-TCCE-----EEES--SC---CTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHH
T ss_pred HHHHHHHhcCCCcccchhheecc-CCCc-----ccCc--cC---CcccccchHHHhhchHHHHHhhccChhhhccHHHHH
Confidence 22222111 11 1111110000 0000 0000 00 001112346788899999999999999999999999
Q ss_pred HHHHHHHHh
Q 012014 447 SRLRLIRRK 455 (473)
Q Consensus 447 ~~L~~l~~~ 455 (473)
+.|+.+...
T Consensus 302 ~~l~~il~~ 310 (396)
T 4eut_A 302 AETSDILHR 310 (396)
T ss_dssp HHHHHHHTC
T ss_pred HHHHHHhhc
Confidence 999988754
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=341.03 Aligned_cols=252 Identities=20% Similarity=0.282 Sum_probs=202.0
Q ss_pred CCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccC-CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
++|++.+.||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+. ...+
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~~ 81 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG-----NIQY 81 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC-----CEEE
Confidence 5688999999999999999995 478999999997443 23346789999999999999999999998543 3679
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
+||||+++++|.+++.... .+++..+..++.|++.||.||| +++|+||||||+||+++.++.+||+||
T Consensus 82 lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~df 149 (276)
T 2yex_A 82 LFLEYCSGGELFDRIEPDI---------GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDF 149 (276)
T ss_dssp EEEECCTTEEGGGGSBTTT---------BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred EEEEecCCCcHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeC
Confidence 9999999999999987543 3668899999999999999999 899999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCCCC-CcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcc
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEA-STYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQR 381 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 381 (473)
|++................||+.|+|||++.+..+ +.++||||||+++|+|++|..||.........+..+......
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-- 227 (276)
T 2yex_A 150 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-- 227 (276)
T ss_dssp TTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTT--
T ss_pred CCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccc--
Confidence 99986643332223344568999999999987765 778999999999999999999998754433222222111000
Q ss_pred hhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 382 AEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.. .....+..+.+|+.+||+.||++|||+.||++
T Consensus 228 ----~~----------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 228 ----LN----------------------------PWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp ----ST----------------------------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----cC----------------------------chhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 00 00123557789999999999999999999865
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=367.27 Aligned_cols=248 Identities=21% Similarity=0.316 Sum_probs=201.2
Q ss_pred ccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccC---CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
..++|.+.+.||+|+||.||+|+. .+|+.||||+++... ......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~----- 88 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP----- 88 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----
Confidence 346899999999999999999994 479999999997432 23456789999999999999999999998553
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...++||||+++|+|.+++.... .+++.++..++.||+.||.||| +++|+||||||+|||++.++.+|
T Consensus 89 ~~~~lv~E~~~gg~L~~~l~~~~---------~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vk 156 (476)
T 2y94_A 89 SDIFMVMEYVSGGELFDYICKNG---------RLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAK 156 (476)
T ss_dssp SEEEEEEECCSSEEHHHHTTSSS---------SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEE
T ss_pred CEEEEEEeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeE
Confidence 36899999999999999997654 3668999999999999999999 99999999999999999999999
Q ss_pred EeecccccccCccccccceeeccCCCCcCCCccccCCCC-CcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEA-STYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
|+|||+++...... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.... ......
T Consensus 157 L~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-----~~~~~i 228 (476)
T 2y94_A 157 IADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP-----TLFKKI 228 (476)
T ss_dssp ECCCSSCEECCTTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH-----HHHHHH
T ss_pred EEeccchhhccccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH-----HHHHHH
Confidence 99999998764422 2334569999999999988765 68999999999999999999999753211 111110
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
..... . .+...+..+.+|+.+||+.||.+|||+.||++
T Consensus 229 ~~~~~----~----------------------------~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 229 CDGIF----Y----------------------------TPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp HTTCC----C----------------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hcCCc----C----------------------------CCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 00000 0 00113456789999999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=359.87 Aligned_cols=252 Identities=18% Similarity=0.275 Sum_probs=191.8
Q ss_pred ccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC--------CCCchhHHHHHHHHHhcCCCCceeeeeeeecc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--------PGGSKSFKSECKAAINIKHRNIVRVFTAFSGV 213 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 213 (473)
..++|.+.+.||+|+||.||+|. ..+++.||+|++.... ......+.+|+.++.+++||||+++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 45789999999999999999998 4568999999997432 1223458899999999999999999999743
Q ss_pred ccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecC
Q 012014 214 DYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD 293 (473)
Q Consensus 214 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~ 293 (473)
...++||||+++|+|.+++.... .+++.++..++.|++.||.||| +++|+||||||+|||++.
T Consensus 212 -----~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~ 274 (419)
T 3i6u_A 212 -----EDYYIVLELMEGGELFDKVVGNK---------RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSS 274 (419)
T ss_dssp -----SEEEEEEECCTTCBGGGGTSSSC---------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESS
T ss_pred -----CceEEEEEcCCCCcHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEec
Confidence 23689999999999999987654 3668999999999999999999 899999999999999965
Q ss_pred Cc---cEEEeecccccccCccccccceeeccCCCCcCCCccccC---CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCc
Q 012014 294 EM---IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG---CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGK 367 (473)
Q Consensus 294 ~~---~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~ 367 (473)
++ .+||+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.....
T Consensus 275 ~~~~~~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~ 351 (419)
T 3i6u_A 275 QEEDCLIKITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 351 (419)
T ss_dssp SSSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC
T ss_pred CCCcceEEEeecccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH
Confidence 44 5999999999876432 22334569999999999863 568889999999999999999999998643332
Q ss_pred ccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 368 MNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
. +...+........ +......+..+.+|+.+||+.||++|||+.|+++
T Consensus 352 ~-~~~~i~~~~~~~~-------------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 352 S-LKDQITSGKYNFI-------------------------------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp C-HHHHHHTTCCCCC-------------------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred H-HHHHHhcCCCCCC-------------------------------chhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 2 1111111100000 0111234567889999999999999999999875
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=357.34 Aligned_cols=244 Identities=20% Similarity=0.227 Sum_probs=196.1
Q ss_pred ccCCCCccceeecCCCeEEEEEEec-CCCEEEEEEeecc---CCCCchhHHHHHHHHHhc-CCCCceeeeeeeeccccCC
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLI---RPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQG 217 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 217 (473)
..++|.+.++||+|+||.||+|+.. +++.||+|+++.. .....+.+.+|..++..+ +||||+++++++.+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~----- 92 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT----- 92 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC-----
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc-----
Confidence 3568999999999999999999954 5789999999743 234456788999999988 79999999999854
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccE
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~ 297 (473)
....++||||+++|+|.+++.... .+++..+..++.||+.||.||| ++||+||||||+|||++.++.+
T Consensus 93 ~~~~~lv~E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~v 160 (353)
T 2i0e_A 93 MDRLYFVMEYVNGGDLMYHIQQVG---------RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHI 160 (353)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCE
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcE
Confidence 347899999999999999997643 3668999999999999999999 8999999999999999999999
Q ss_pred EEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
||+|||+++..... .......+||+.|+|||++.+..++.++|||||||++|||++|..||.+..... .+..+....
T Consensus 161 kL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-~~~~i~~~~ 237 (353)
T 2i0e_A 161 KIADFGMCKENIWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE-LFQSIMEHN 237 (353)
T ss_dssp EECCCTTCBCCCCT--TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCC
T ss_pred EEEeCCcccccccC--CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH-HHHHHHhCC
Confidence 99999999854322 223345679999999999999999999999999999999999999997632111 011111100
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCCh
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKI 442 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 442 (473)
. . .+...+..+.+|+.+||+.||.+||++
T Consensus 238 ~-~-----------------------------------~p~~~s~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 238 V-A-----------------------------------YPKSMSKEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp C-C-----------------------------------CCTTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred C-C-----------------------------------CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 0 0 001234578899999999999999964
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=352.61 Aligned_cols=212 Identities=28% Similarity=0.333 Sum_probs=180.5
Q ss_pred cccCCCchhhhhcccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHHHHHHhcC-----CCCc
Q 012014 130 QTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK-----HRNI 203 (473)
Q Consensus 130 ~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~ni 203 (473)
.....+++.+.....++|.+.++||+|+||.||+|+. .+++.||||+++.. ......+..|+.++..+. ||||
T Consensus 20 ~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~i 98 (360)
T 3llt_A 20 DEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNI 98 (360)
T ss_dssp CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGB
T ss_pred ccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCe
Confidence 3445567777778889999999999999999999994 57899999998632 123456778999999996 9999
Q ss_pred eeeeeeeeccccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeecc
Q 012014 204 VRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCN 283 (473)
Q Consensus 204 v~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~D 283 (473)
+++++++... ...++||||+ +++|.+++...... .+++.++..++.||+.||.||| +++|+|||
T Consensus 99 v~~~~~~~~~-----~~~~lv~e~~-~~~L~~~~~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrD 162 (360)
T 3llt_A 99 VKYHGKFMYY-----DHMCLIFEPL-GPSLYEIITRNNYN-------GFHIEDIKLYCIEILKALNYLR---KMSLTHTD 162 (360)
T ss_dssp CCEEEEEEET-----TEEEEEECCC-CCBHHHHHHHTTTC-------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSC
T ss_pred ecccceeeEC-----CeeEEEEcCC-CCCHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCC
Confidence 9999998653 3679999999 99999999865432 3668899999999999999999 89999999
Q ss_pred CCCCcEEecC-------------------------CccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCC
Q 012014 284 LKPSNVLLDD-------------------------EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEAS 338 (473)
Q Consensus 284 lkp~Nil~~~-------------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 338 (473)
|||+|||++. ++.+||+|||+++..... .....||+.|+|||++.+..++
T Consensus 163 lkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~ 237 (360)
T 3llt_A 163 LKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWD 237 (360)
T ss_dssp CSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCC
T ss_pred CCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCC
Confidence 9999999975 789999999999865332 2235689999999999999999
Q ss_pred cccchhhHhHHHHHHHhCCCCCCCC
Q 012014 339 TYGDVYSFGILLLEMFTGIRPSDGI 363 (473)
Q Consensus 339 ~~~DiwSlG~il~elltg~~P~~~~ 363 (473)
.++|||||||++|+|++|..||.+.
T Consensus 238 ~~~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 238 VSSDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp TTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CccchHHHHHHHHHHHHCCCCCCCC
Confidence 9999999999999999999999864
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=356.74 Aligned_cols=252 Identities=19% Similarity=0.270 Sum_probs=195.2
Q ss_pred ccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEEEEe
Q 012014 149 SANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKF 227 (473)
Q Consensus 149 ~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~ 227 (473)
..+.||+|+||.||+|.. .+|+.||+|+++.......+.+.+|+.++.+++||||+++++++.+. ...++||||
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~~~~lv~E~ 167 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESK-----NDIVLVMEY 167 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SEEEEEEEC
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-----CEEEEEEeC
Confidence 367899999999999984 57899999999865444566799999999999999999999998653 368999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEe--cCCccEEEeecccc
Q 012014 228 MPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL--DDEMIGHVGDFGMA 305 (473)
Q Consensus 228 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~--~~~~~~kl~Dfg~~ 305 (473)
+++|+|.+++.... ..+++..+..++.||+.||.||| +++|+||||||+|||+ +.++.+||+|||++
T Consensus 168 ~~~~~L~~~l~~~~--------~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a 236 (373)
T 2x4f_A 168 VDGGELFDRIIDES--------YNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLA 236 (373)
T ss_dssp CTTCEEHHHHHHTG--------GGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSC
T ss_pred CCCCcHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCc
Confidence 99999999886542 14668899999999999999999 8999999999999999 56789999999999
Q ss_pred cccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchhhh
Q 012014 306 RFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEV 385 (473)
Q Consensus 306 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 385 (473)
+...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+..... .+..+........
T Consensus 237 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~i~~~~~~~~---- 308 (373)
T 2x4f_A 237 RRYKPRE---KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE-TLNNILACRWDLE---- 308 (373)
T ss_dssp EECCTTC---BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTCCCSC----
T ss_pred eecCCcc---ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhccCCCC----
Confidence 8765432 2233469999999999998899999999999999999999999997643211 1111111100000
Q ss_pred ccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH--HHHHH
Q 012014 386 VDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES--RLRLI 452 (473)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~--~L~~l 452 (473)
.......+..+.+|+.+||+.||.+|||+.|+++ .+...
T Consensus 309 ----------------------------~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 309 ----------------------------DEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp ----------------------------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred ----------------------------hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 0001124567889999999999999999999987 44443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=362.66 Aligned_cols=260 Identities=21% Similarity=0.255 Sum_probs=201.3
Q ss_pred hhhhcccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeecc---CCCCchhHHHHHHHHHhcCCCCceeeeeeeecc
Q 012014 138 KDLYNATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGV 213 (473)
Q Consensus 138 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 213 (473)
.+.....++|++.++||+|+||.||+|+. .+++.||+|+++.. .......+.+|..++..++||||++++++|.+
T Consensus 54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~- 132 (412)
T 2vd5_A 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD- 132 (412)
T ss_dssp HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC-
T ss_pred hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee-
Confidence 34455667899999999999999999995 57999999999742 12234568899999999999999999999854
Q ss_pred ccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecC
Q 012014 214 DYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD 293 (473)
Q Consensus 214 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~ 293 (473)
....++||||+++|+|.+++..... .+++..+..++.||+.||.||| +++|+||||||+|||++.
T Consensus 133 ----~~~~~lVmE~~~gg~L~~~l~~~~~--------~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~ 197 (412)
T 2vd5_A 133 ----ENYLYLVMEYYVGGDLLTLLSKFGE--------RIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDR 197 (412)
T ss_dssp ----SSEEEEEECCCCSCBHHHHHHHHSS--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECT
T ss_pred ----CCEEEEEEcCCCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecC
Confidence 3478999999999999999976421 3668899999999999999999 899999999999999999
Q ss_pred CccEEEeecccccccCccccccceeeccCCCCcCCCcccc-------CCCCCcccchhhHhHHHHHHHhCCCCCCCCCCC
Q 012014 294 EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDL-------GCEASTYGDVYSFGILLLEMFTGIRPSDGIFTG 366 (473)
Q Consensus 294 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~ 366 (473)
++++||+|||+++...... .......+||+.|+|||++. +..++.++|||||||++|||++|..||.+....
T Consensus 198 ~g~vkL~DFGla~~~~~~~-~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~ 276 (412)
T 2vd5_A 198 CGHIRLADFGSCLKLRADG-TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA 276 (412)
T ss_dssp TSCEEECCCTTCEECCTTS-CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred CCCEEEeechhheeccCCC-ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH
Confidence 9999999999998764422 11223457999999999987 356899999999999999999999999763221
Q ss_pred cccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCC---CChH
Q 012014 367 KMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRER---MKIN 443 (473)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R---Pt~~ 443 (473)
. .+..+..... ...- +......+..+.+|+.+||. +|.+| |++.
T Consensus 277 ~-~~~~i~~~~~-----~~~~--------------------------p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ 323 (412)
T 2vd5_A 277 E-TYGKIVHYKE-----HLSL--------------------------PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAG 323 (412)
T ss_dssp H-HHHHHHTHHH-----HCCC--------------------------C----CCCHHHHHHHHTTSS-CGGGCTTTTTHH
T ss_pred H-HHHHHHhccc-----CcCC--------------------------CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHH
Confidence 1 1111110000 0000 00011245678899999999 99998 5888
Q ss_pred HHHH
Q 012014 444 DVES 447 (473)
Q Consensus 444 ev~~ 447 (473)
||++
T Consensus 324 ei~~ 327 (412)
T 2vd5_A 324 DFRT 327 (412)
T ss_dssp HHHT
T ss_pred HHhc
Confidence 8753
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=347.32 Aligned_cols=283 Identities=20% Similarity=0.277 Sum_probs=188.6
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC-CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
.++|++.+.||+|+||.||+|. ..+++.||+|+++... ......+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~ 78 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT-----ENKL 78 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC-----TTEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE-----CCeE
Confidence 4689999999999999999998 4568999999997543 3345678999999999999999999999854 3468
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEee
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~D 301 (473)
++||||++ |+|.+++........ ...+++..+..++.||+.||.||| ++||+||||||+|||++.++.+||+|
T Consensus 79 ~lv~e~~~-~~L~~~l~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~D 151 (317)
T 2pmi_A 79 TLVFEFMD-NDLKKYMDSRTVGNT---PRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGD 151 (317)
T ss_dssp EEEEECCC-CBHHHHHHHHHSSSC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECC
T ss_pred EEEEEecC-CCHHHHHHhcccccc---ccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECc
Confidence 99999997 699999865421110 113668899999999999999999 89999999999999999999999999
Q ss_pred cccccccCccccccceeeccCCCCcCCCccccCC-CCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCc
Q 012014 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQ 380 (473)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 380 (473)
||+++...... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+..... .+..+.......
T Consensus 152 fg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~ 228 (317)
T 2pmi_A 152 FGLARAFGIPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE-QLKLIFDIMGTP 228 (317)
T ss_dssp CSSCEETTSCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSC
T ss_pred CccceecCCCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCC
Confidence 99998764322 222345689999999998764 58999999999999999999999998643321 122221111100
Q ss_pred chhhhccccchHHHHhhhhhhcccccCCCCcc----hhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 381 RAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSA----HASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
. ...... ................... ........+..+.+|+.+||+.||++|||+.|+++
T Consensus 229 ~-~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 229 N-ESLWPS-----VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp C-TTTCGG-----GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred C-hhHhhh-----hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0 000000 0000000000000000000 00001124567899999999999999999999864
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=356.20 Aligned_cols=279 Identities=23% Similarity=0.316 Sum_probs=209.2
Q ss_pred cCCCCccceeecCCCeEEEEEEe-----cCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-----FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
.++|++.+.||+|+||.||+|+. .+++.||+|++........+.+.+|+.++.+++||||+++++++... ..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~ 98 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGP---GR 98 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS---SS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC---CC
Confidence 35799999999999999999983 46789999999765444556789999999999999999999988642 34
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...++||||+++++|.+++..... .+++..++.++.|++.||.||| +++|+||||||+||+++.++.+|
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~k 167 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHRA--------RLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVK 167 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHGG--------GCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEE
T ss_pred ceEEEEEeecCCCCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEE
Confidence 568999999999999999976421 3668999999999999999999 89999999999999999999999
Q ss_pred EeecccccccCccccc-cceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 299 VGDFGMARFLPAIDKQ-NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
|+|||+++........ .......||+.|+|||++.+..++.++||||||+++|+|++|..||...... .....
T Consensus 168 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~------~~~~~ 241 (327)
T 3lxl_A 168 IADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE------FLRMM 241 (327)
T ss_dssp ECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH------HHHHC
T ss_pred EcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccch------hhhhc
Confidence 9999999876443221 1222345788899999999888999999999999999999999998652111 11000
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHHhhc
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRKLL 457 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~~~ 457 (473)
.......... ........+. ....+..++..+.+|+.+||+.||++|||+.||++.|+.+.....
T Consensus 242 ~~~~~~~~~~-~~~~~~~~~~--------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 242 GCERDVPALS-RLLELLEEGQ--------------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp C----CCHHH-HHHHHHHTTC--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred ccccccccHH-HHHHHhhccc--------------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 0000000000 0000000000 000112356788999999999999999999999999999876543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=349.26 Aligned_cols=274 Identities=20% Similarity=0.297 Sum_probs=210.8
Q ss_pred ccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHh--cCCCCceeeeeeeeccccCCcee
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAIN--IKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
..++|.+.+.||+|+||.||+|+. +++.||||+++.. ....+.+|++++.. ++||||+++++++.... .....
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~~~~~ 114 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQ 114 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-SSCCC
T ss_pred ccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-Cccce
Confidence 446799999999999999999986 6899999998632 34667889999887 79999999999986543 22236
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCC-----CCCeeeccCCCCcEEecCCc
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDC-----QPPIAHCNLKPSNVLLDDEM 295 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~-----~~~iiH~Dlkp~Nil~~~~~ 295 (473)
.++||||+++|+|.+++... .+++.+++.++.|++.||.|||+.. +++|+||||||+||+++.++
T Consensus 115 ~~lv~e~~~~g~L~~~l~~~----------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~ 184 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNRY----------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 184 (342)
T ss_dssp EEEEECCCTTCBHHHHHHHC----------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS
T ss_pred eEEEEeecCCCcHHHHHhcc----------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC
Confidence 79999999999999999764 2568999999999999999999321 36899999999999999999
Q ss_pred cEEEeecccccccCcccccc--ceeeccCCCCcCCCccccCCC------CCcccchhhHhHHHHHHHhC----------C
Q 012014 296 IGHVGDFGMARFLPAIDKQN--RFICIKGSTGYIPPEYDLGCE------ASTYGDVYSFGILLLEMFTG----------I 357 (473)
Q Consensus 296 ~~kl~Dfg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwSlG~il~elltg----------~ 357 (473)
.+||+|||++.......... ......||+.|+|||++.+.. ++.++||||||+++|||++| .
T Consensus 185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~ 264 (342)
T 1b6c_B 185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264 (342)
T ss_dssp CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence 99999999997664432111 123446899999999987752 34689999999999999999 7
Q ss_pred CCCCCCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCC
Q 012014 358 RPSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPR 437 (473)
Q Consensus 358 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~ 437 (473)
.||............+............... . -...+++..+.+|+.+||+.||+
T Consensus 265 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~---------------------~~~~~~~~~l~~li~~cl~~dp~ 319 (342)
T 1b6c_B 265 LPYYDLVPSDPSVEEMRKVVCEQKLRPNIPN----R---------------------WQSCEALRVMAKIMRECWYANGA 319 (342)
T ss_dssp CTTTTTSCSSCCHHHHHHHHTTSCCCCCCCG----G---------------------GGTSHHHHHHHHHHHHHCCSSGG
T ss_pred cCccccCcCcccHHHHHHHHHHHHhCCCCcc----c---------------------ccchhHHHHHHHHHHHHhccChh
Confidence 7887654444333333322211111000000 0 01135678899999999999999
Q ss_pred CCCChHHHHHHHHHHHHhh
Q 012014 438 ERMKINDVESRLRLIRRKL 456 (473)
Q Consensus 438 ~RPt~~ev~~~L~~l~~~~ 456 (473)
+|||+.||++.|+.+.++.
T Consensus 320 ~Rps~~~i~~~L~~i~~~~ 338 (342)
T 1b6c_B 320 ARLTALRIKKTLSQLSQQE 338 (342)
T ss_dssp GSCCHHHHHHHHHHHHHTT
T ss_pred hCCCHHHHHHHHHHHHHHh
Confidence 9999999999999997653
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=360.42 Aligned_cols=206 Identities=20% Similarity=0.279 Sum_probs=169.1
Q ss_pred ccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCC--CchhHHHHHHHHHhcCCCCceeeeeeeeccccCCce
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (473)
..++|.+.++||+|+||.||+|. ..+++.||||+++..... ..+.+.+|+.++++++||||+++++++.........
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 46789999999999999999998 456889999999743222 235788999999999999999999998765444446
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
..++||||+. |+|.+++.... .+++..+..++.||+.||.||| ++||+||||||+|||++.++.+||
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~~~---------~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL 170 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKTPI---------FLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKV 170 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHSSC---------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEE
T ss_pred eEEEEEecCC-cCHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEE
Confidence 7899999995 69999998654 3668999999999999999999 899999999999999999999999
Q ss_pred eecccccccCccccc--------------------cceeeccCCCCcCCCccc-cCCCCCcccchhhHhHHHHHHHhCCC
Q 012014 300 GDFGMARFLPAIDKQ--------------------NRFICIKGSTGYIPPEYD-LGCEASTYGDVYSFGILLLEMFTGIR 358 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~elltg~~ 358 (473)
+|||+++........ .......||+.|+|||++ .+..++.++|||||||++|||++|..
T Consensus 171 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~ 250 (432)
T 3n9x_A 171 CDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250 (432)
T ss_dssp CCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCT
T ss_pred ccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccc
Confidence 999999876443211 123556799999999986 55669999999999999999998666
Q ss_pred CCC
Q 012014 359 PSD 361 (473)
Q Consensus 359 P~~ 361 (473)
||.
T Consensus 251 p~~ 253 (432)
T 3n9x_A 251 SHI 253 (432)
T ss_dssp TTC
T ss_pred ccc
Confidence 554
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=346.42 Aligned_cols=269 Identities=20% Similarity=0.249 Sum_probs=196.0
Q ss_pred cCCCCcc-ceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhc-CCCCceeeeeeeeccccCCcee
Q 012014 144 TNGFSSA-NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 144 ~~~~~~~-~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 220 (473)
.+.|.+. ++||+|+||.||+|. ..+++.||||++..........+.+|+.++.++ +||||+++++++.+. ..
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~-----~~ 85 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE-----DR 85 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC-----CE
Confidence 3567774 789999999999998 557899999999866555667899999999985 799999999998653 36
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCcc---E
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI---G 297 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~---~ 297 (473)
.++||||+++|+|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|||++.++. +
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~ 153 (316)
T 2ac3_A 86 FYLVFEKMRGGSILSHIHKRR---------HFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPV 153 (316)
T ss_dssp EEEEEECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSE
T ss_pred EEEEEEcCCCCcHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCce
Confidence 899999999999999997643 3568899999999999999999 899999999999999988775 9
Q ss_pred EEeecccccccCcccc-----ccceeeccCCCCcCCCccccC-----CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCc
Q 012014 298 HVGDFGMARFLPAIDK-----QNRFICIKGSTGYIPPEYDLG-----CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGK 367 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~ 367 (473)
||+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+
T Consensus 154 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 233 (316)
T 2ac3_A 154 KICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD 233 (316)
T ss_dssp EECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSC
T ss_pred EEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccc
Confidence 9999999976542211 112234459999999999875 458899999999999999999999998754332
Q ss_pred ccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 368 MNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
....... ..+..... +...+..+.. ..........+..+.+|+.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~--~~~~~~~~-----~~~~i~~~~~-----------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 234 CGWDRGE--ACPACQNM-----LFESIQEGKY-----------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp SCC------CCHHHHHH-----HHHHHHHCCC-----------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ccccccc--cchhHHHH-----HHHHHhccCc-----------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 1111000 00000000 0000000000 0000011224567889999999999999999999976
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=352.26 Aligned_cols=249 Identities=21% Similarity=0.287 Sum_probs=189.8
Q ss_pred ccCCCCccceeecCCCeEEEEEEe----cCCCEEEEEEeeccC----CCCchhHHHHHHHHHhcCCCCceeeeeeeeccc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTL----FDGTTIAVKVFNLIR----PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVD 214 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 214 (473)
..++|++.+.||+|+||.||+|+. .+++.||+|+++... ......+.+|+.++..++||||+++++++..
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-- 92 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT-- 92 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC--
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc--
Confidence 346799999999999999999985 478999999997532 2234567899999999999999999999854
Q ss_pred cCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCC
Q 012014 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE 294 (473)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~ 294 (473)
....++||||+++|+|.+++.... .+++..+..++.||+.||.||| ++||+||||||+|||++.+
T Consensus 93 ---~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~ 157 (327)
T 3a62_A 93 ---GGKLYLILEYLSGGELFMQLEREG---------IFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQ 157 (327)
T ss_dssp ---SSCEEEEEECCTTEEHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTT
T ss_pred ---CCEEEEEEeCCCCCcHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCC
Confidence 346799999999999999997643 3558889999999999999999 8999999999999999999
Q ss_pred ccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 012014 295 MIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFV 374 (473)
Q Consensus 295 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~ 374 (473)
+.+||+|||+++...... .......||+.|+|||++.+..++.++||||||+++|+|++|..||.+..... .+....
T Consensus 158 ~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~ 234 (327)
T 3a62_A 158 GHVKLTDFGLCKESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK-TIDKIL 234 (327)
T ss_dssp SCEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHH
T ss_pred CcEEEEeCCcccccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH-HHHHHH
Confidence 999999999997543221 22334569999999999999899999999999999999999999997632211 011111
Q ss_pred HhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCC-----ChHHHHH
Q 012014 375 KMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERM-----KINDVES 447 (473)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~ 447 (473)
.... ..+...+..+.+|+.+||+.||++|| ++.|+++
T Consensus 235 ~~~~------------------------------------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 235 KCKL------------------------------------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp HTCC------------------------------------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred hCCC------------------------------------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 0000 00012345788999999999999999 6667654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=348.10 Aligned_cols=251 Identities=18% Similarity=0.256 Sum_probs=201.6
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCC------CchhHHHHHHHHHhcCCCCceeeeeeeeccccC
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG------GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQ 216 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 216 (473)
.++|.+.+.||+|+||.||+|.. .+|+.||+|+++..... ..+.+.+|+.++.+++||||+++++++.+
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 86 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN---- 86 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC----
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec----
Confidence 45689999999999999999994 46899999999754322 24568999999999999999999999854
Q ss_pred CceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCc-
Q 012014 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM- 295 (473)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~- 295 (473)
....++||||+++++|.+++.... .+++..+..++.|++.||.||| +++|+||||||+||+++.++
T Consensus 87 -~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~ 153 (321)
T 2a2a_A 87 -RTDVVLILELVSGGELFDFLAQKE---------SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNI 153 (321)
T ss_dssp -SSEEEEEECCCCSCBHHHHHHTCS---------CEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTS
T ss_pred -CCEEEEEEEcCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCC
Confidence 346899999999999999997653 3678999999999999999999 89999999999999999887
Q ss_pred ---cEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHH
Q 012014 296 ---IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRN 372 (473)
Q Consensus 296 ---~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~ 372 (473)
.+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.....
T Consensus 154 ~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----- 225 (321)
T 2a2a_A 154 PIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE----- 225 (321)
T ss_dssp SSCCEEECCCTTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH-----
T ss_pred CcCCEEEccCccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH-----
Confidence 79999999998765422 2234568999999999999899999999999999999999999997632211
Q ss_pred HHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 373 FVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
......... .. .........+..+.+|+.+||+.||++|||+.|+++
T Consensus 226 ~~~~i~~~~-----~~-----------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 226 TLANITSVS-----YD-----------------------FDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp HHHHHHTTC-----CC-----------------------CCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred HHHHHHhcc-----cc-----------------------cChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 111000000 00 000111234567889999999999999999999975
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=349.95 Aligned_cols=269 Identities=19% Similarity=0.185 Sum_probs=206.5
Q ss_pred ccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
..++|++.+.||+|+||.||+|.. .+++.||+|++........+.+.+|+.++..++||||+++++++.... ......
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~ 105 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHEA 105 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCcee
Confidence 456899999999999999999994 679999999987654445667899999999999999999999986432 234577
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEee
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~D 301 (473)
++||||+++|+|.+++...... ...+++.+++.++.||+.||.||| +++|+||||||+||+++.++.+||+|
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~d 177 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDK-----GNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMD 177 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTT-----TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECC
T ss_pred EEEEEeCCCCcHHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEe
Confidence 9999999999999998753111 013668999999999999999999 89999999999999999999999999
Q ss_pred cccccccCcccccc-------ceeeccCCCCcCCCccccCCC---CCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHH
Q 012014 302 FGMARFLPAIDKQN-------RFICIKGSTGYIPPEYDLGCE---ASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLR 371 (473)
Q Consensus 302 fg~~~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~ 371 (473)
||++.......... ......||+.|+|||++.+.. ++.++||||||+++|+|++|..||.........+.
T Consensus 178 fg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~ 257 (317)
T 2buj_A 178 LGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA 257 (317)
T ss_dssp CSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHH
T ss_pred cCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhh
Confidence 99987653221110 112345799999999987654 68999999999999999999999964222111111
Q ss_pred HHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHH
Q 012014 372 NFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRL 451 (473)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 451 (473)
......... +.....+..+.+|+.+||+.||.+|||+.||++.|+.
T Consensus 258 ~~~~~~~~~----------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 303 (317)
T 2buj_A 258 LAVQNQLSI----------------------------------PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEA 303 (317)
T ss_dssp HHHHCC--C----------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHhhccCCC----------------------------------CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhh
Confidence 111100000 0001235578899999999999999999999999998
Q ss_pred HHH
Q 012014 452 IRR 454 (473)
Q Consensus 452 l~~ 454 (473)
+..
T Consensus 304 ~~~ 306 (317)
T 2buj_A 304 LQP 306 (317)
T ss_dssp TCC
T ss_pred cCC
Confidence 753
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=340.39 Aligned_cols=251 Identities=23% Similarity=0.318 Sum_probs=197.9
Q ss_pred CCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCC--CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
..|.+.+.||+|+||.||+|.. .++..||+|++..... .....+.+|+.+++.++||||+++++++.... ......
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~ 104 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCI 104 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCCceE
Confidence 3478888999999999999984 5688999999874332 23456889999999999999999999986542 345678
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCC--eeeccCCCCcEEec-CCccEE
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPP--IAHCNLKPSNVLLD-DEMIGH 298 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~Dlkp~Nil~~-~~~~~k 298 (473)
++||||+++|+|.+++.... .+++..+..++.||+.||.||| +++ |+||||||+||+++ .++.+|
T Consensus 105 ~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~k 172 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRFK---------VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVK 172 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEE
T ss_pred EEEEEecCCCCHHHHHHHcc---------CCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEE
Confidence 99999999999999997643 3558899999999999999999 888 99999999999997 789999
Q ss_pred EeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 012014 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMAL 378 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~ 378 (473)
|+|||++..... .......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+...... ......
T Consensus 173 l~Dfg~~~~~~~----~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~~~ 243 (290)
T 1t4h_A 173 IGDLGLATLKRA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ----IYRRVT 243 (290)
T ss_dssp ECCTTGGGGCCT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH----HHHHHT
T ss_pred EeeCCCcccccc----cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH----HHHHHh
Confidence 999999975433 22334569999999998875 599999999999999999999999976432211 111111
Q ss_pred CcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 379 PQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
...... ......+..+.+|+.+||+.||.+|||+.||++
T Consensus 244 ~~~~~~------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 244 SGVKPA------------------------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp TTCCCG------------------------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCCcc------------------------------ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 100000 001112356889999999999999999999875
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=351.07 Aligned_cols=267 Identities=20% Similarity=0.261 Sum_probs=200.9
Q ss_pred hhcccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeecc-----CCCCchhHHHHHHHHHhcCCCCceeeeeeeecc
Q 012014 140 LYNATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI-----RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGV 213 (473)
Q Consensus 140 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 213 (473)
+....++|.+.+.||+|+||.||+|.. .+++.||+|++... .....+.+.+|+.++++++||||+++++++.+
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~- 99 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED- 99 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc-
Confidence 344567899999999999999999984 56889999998643 23445678999999999999999999999854
Q ss_pred ccCCceeeEEEEEecCCCCHHHHhcCCCCCC-------------------------------CCCcchhhcHHHHHHHHH
Q 012014 214 DYQGARFKAVVYKFMPNGSLEEWLRGKDDTN-------------------------------WRPLNFNFLIKKKLDIAI 262 (473)
Q Consensus 214 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~-------------------------------~~~~~~~~~~~~~~~i~~ 262 (473)
....++||||+++|+|.+++....... .......+++..+..++.
T Consensus 100 ----~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 175 (345)
T 3hko_A 100 ----EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMR 175 (345)
T ss_dssp ----SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHH
T ss_pred ----CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHH
Confidence 346899999999999999996311100 011133466888899999
Q ss_pred HHHHHHHHHhhCCCCCeeeccCCCCcEEecCCc--cEEEeecccccccCccccc--cceeeccCCCCcCCCccccC--CC
Q 012014 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM--IGHVGDFGMARFLPAIDKQ--NRFICIKGSTGYIPPEYDLG--CE 336 (473)
Q Consensus 263 ~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~--~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~ 336 (473)
||+.||.||| +++|+||||||+||+++.++ .+||+|||+++.+...... .......||+.|+|||++.+ ..
T Consensus 176 qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~ 252 (345)
T 3hko_A 176 QIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNES 252 (345)
T ss_dssp HHHHHHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSC
T ss_pred HHHHHHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCC
Confidence 9999999999 89999999999999998766 8999999999865432211 12345569999999999875 67
Q ss_pred CCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhH
Q 012014 337 ASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASI 416 (473)
Q Consensus 337 ~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (473)
++.++||||||+++|+|++|..||.+....+. +........... .+.
T Consensus 253 ~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~--------------------------------~~~ 299 (345)
T 3hko_A 253 YGPKCDAWSAGVLLHLLLMGAVPFPGVNDADT-ISQVLNKKLCFE--------------------------------NPN 299 (345)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCCCTT--------------------------------SGG
T ss_pred CCcHHHHHHHHHHHHHHHHCCCCCCCCChHHH-HHHHHhcccccC--------------------------------Ccc
Confidence 89999999999999999999999976432211 111111000000 000
Q ss_pred HHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 417 ILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 417 ~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
....+..+.+|+.+||+.||.+|||+.|+++
T Consensus 300 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 300 YNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp GGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred cccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1124567889999999999999999999976
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=358.57 Aligned_cols=286 Identities=22% Similarity=0.282 Sum_probs=193.3
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC--CCCchhHHHHHHHHHhcC-CCCceeeeeeeeccccCCce
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 219 (473)
.++|++.+.||+|+||.||+|. ..+++.||||++.... ......+.+|+.++..+. ||||+++++++... +..
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~~~ 84 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD---NDR 84 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT---TSS
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC---CCC
Confidence 4689999999999999999998 4578999999986432 223356789999999997 99999999998642 234
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
..++|||||+ |+|.+++... .++...+..++.||+.||.||| ++||+||||||+|||++.++.+||
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~~----------~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl 150 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRAN----------ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKV 150 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHHT----------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEE
T ss_pred EEEEEecccC-cCHHHHHHcC----------CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEe
Confidence 6899999996 6999999764 2558889999999999999999 899999999999999999999999
Q ss_pred eecccccccCccc-------------------cccceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHHhCCCC
Q 012014 300 GDFGMARFLPAID-------------------KQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRP 359 (473)
Q Consensus 300 ~Dfg~~~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P 359 (473)
+|||+++.+.... .........||+.|+|||++.+ ..++.++|||||||++|||++|.+|
T Consensus 151 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~p 230 (388)
T 3oz6_A 151 ADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPI 230 (388)
T ss_dssp CCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCC
Confidence 9999998654311 1112334579999999999886 5789999999999999999999999
Q ss_pred CCCCCCCcccHHHHHHhhcCcc---hhhhccccchHHHHhhhhhhcccccCCCCcchhhH---------HHHHHHHHHHH
Q 012014 360 SDGIFTGKMNLRNFVKMALPQR---AEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASI---------ILECFNSICEI 427 (473)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~l~~l 427 (473)
|.+..... .+..+........ ...+..+.....+..... ................ ...++..+.+|
T Consensus 231 f~~~~~~~-~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 308 (388)
T 3oz6_A 231 FPGSSTMN-QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKE-KVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDL 308 (388)
T ss_dssp CCCSSHHH-HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHH-HCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHH
T ss_pred CCCCCHHH-HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcc-cccccCCCHHHhCcchhhhcccccccccCCHHHHHH
Confidence 98743222 1222222111111 111111111111000000 0000000000000000 01235678999
Q ss_pred hhhcccCCCCCCCChHHHHHH
Q 012014 428 GVACSAERPRERMKINDVESR 448 (473)
Q Consensus 428 ~~~cl~~dP~~RPt~~ev~~~ 448 (473)
+.+||+.||++|||+.|+++.
T Consensus 309 l~~~L~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 309 LDKLLQFNPNKRISANDALKH 329 (388)
T ss_dssp HHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHhhccCcccCCCHHHHhCC
Confidence 999999999999999998753
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=339.08 Aligned_cols=250 Identities=20% Similarity=0.239 Sum_probs=201.6
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
.++|++.+.||+|+||.||+|.. .++..+|+|++........+.+.+|+.++.+++||||+++++++.+ ....+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 82 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFED-----NTDIY 82 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEec-----CCeEE
Confidence 45689999999999999999994 4578999999987666667889999999999999999999999854 34679
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEe---cCCccEEE
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL---DDEMIGHV 299 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~---~~~~~~kl 299 (473)
+||||+++++|.+++.... .+++.++..++.|++.||.||| +++|+||||||+||++ +.++.+||
T Consensus 83 lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l 150 (277)
T 3f3z_A 83 LVMELCTGGELFERVVHKR---------VFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKL 150 (277)
T ss_dssp EEEECCCSCBHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEE
T ss_pred EEEeccCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEE
Confidence 9999999999999987654 3568899999999999999999 8999999999999999 78899999
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcC
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP 379 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 379 (473)
+|||++....... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+...... ..........
T Consensus 151 ~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~ 225 (277)
T 3f3z_A 151 IDFGLAARFKPGK---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV-MLKIREGTFT 225 (277)
T ss_dssp CCCTTCEECCTTS---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHCCCC
T ss_pred EecccceeccCcc---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHH-HHHHHhCCCC
Confidence 9999998764322 2234568999999999876 489999999999999999999999976432110 1111000000
Q ss_pred cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 380 QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
. ........+..+.+|+.+||+.||++|||+.|+++
T Consensus 226 ~--------------------------------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 226 F--------------------------------PEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp C--------------------------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred C--------------------------------CchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00001124567889999999999999999999975
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=348.00 Aligned_cols=254 Identities=19% Similarity=0.262 Sum_probs=198.3
Q ss_pred cCCCCccceeecCCCeEEEEEEec-CC-------CEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeecccc
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTLF-DG-------TTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY 215 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 215 (473)
.++|.+.+.||+|+||.||+|... ++ ..||+|++........+.+.+|+.++.+++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG-- 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT--
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC--
Confidence 457899999999999999999843 33 47999999765555667899999999999999999999998643
Q ss_pred CCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCc
Q 012014 216 QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM 295 (473)
Q Consensus 216 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~ 295 (473)
...++||||+++|+|.+++..... .+++..+..++.||+.||.||| +++|+||||||+|||++.++
T Consensus 85 ---~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~ 150 (289)
T 4fvq_A 85 ---DENILVQEFVKFGSLDTYLKKNKN--------CINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREE 150 (289)
T ss_dssp ---TCCEEEEECCTTCBHHHHHHHTGG--------GCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECC
T ss_pred ---CCCEEEEECCCCCCHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCC
Confidence 356899999999999999976531 3668899999999999999999 89999999999999998887
Q ss_pred c--------EEEeecccccccCccccccceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHHhCCCCCCCCCCC
Q 012014 296 I--------GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFTG 366 (473)
Q Consensus 296 ~--------~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~ 366 (473)
. +||+|||++...... ....||+.|+|||++.+ ..++.++||||||+++|+|++|..|+......
T Consensus 151 ~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~ 224 (289)
T 4fvq_A 151 DRKTGNPPFIKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS 224 (289)
T ss_dssp BGGGTBCCEEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred cccccccceeeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch
Confidence 6 999999999754321 22347899999999987 67999999999999999999965544322111
Q ss_pred cccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHH
Q 012014 367 KMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVE 446 (473)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~ 446 (473)
... ...... ..... ...+..+.+|+.+||+.||++|||+.|++
T Consensus 225 ~~~-~~~~~~--~~~~~----------------------------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll 267 (289)
T 4fvq_A 225 QRK-LQFYED--RHQLP----------------------------------APKAAELANLINNCMDYEPDHRPSFRAII 267 (289)
T ss_dssp HHH-HHHHHT--TCCCC----------------------------------CCSSCTTHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHH-HHHhhc--cCCCC----------------------------------CCCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 110 000000 00000 01123567899999999999999999999
Q ss_pred HHHHHHHHhh
Q 012014 447 SRLRLIRRKL 456 (473)
Q Consensus 447 ~~L~~l~~~~ 456 (473)
+.|+.+...-
T Consensus 268 ~~l~~l~~p~ 277 (289)
T 4fvq_A 268 RDLNSLFTPD 277 (289)
T ss_dssp HHHHTCC---
T ss_pred HHHHHhcCCC
Confidence 9999885543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=339.91 Aligned_cols=259 Identities=19% Similarity=0.290 Sum_probs=202.2
Q ss_pred ccCCCCccceeecCCCeEEEEEEecC----CCEEEEEEeeccC-CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCC
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTLFD----GTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (473)
..++|.+.+.||+|+||.||+|...+ +..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---- 85 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE---- 85 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS----
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC----
Confidence 45689999999999999999998432 2359999987532 22346788999999999999999999997432
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccE
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~ 297 (473)
..++||||+++++|.+++..... .+++..+..++.|++.||.||| +++|+||||||+||+++.++.+
T Consensus 86 --~~~~v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~ 152 (281)
T 3cc6_A 86 --PTWIIMELYPYGELGHYLERNKN--------SLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECV 152 (281)
T ss_dssp --SCEEEEECCTTCBHHHHHHHHTT--------TCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEE
T ss_pred --CCEEEEecCCCCCHHHHHHhccc--------cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcE
Confidence 35899999999999999975432 3568899999999999999999 8999999999999999999999
Q ss_pred EEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHh
Q 012014 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKM 376 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~ 376 (473)
||+|||++....... ........||+.|+|||++.+..++.++||||||+++|+|++ |..||....... ....+..
T Consensus 153 kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~--~~~~~~~ 229 (281)
T 3cc6_A 153 KLGDFGLSRYIEDED-YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD--VIGVLEK 229 (281)
T ss_dssp EECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG--HHHHHHH
T ss_pred EeCccCCCccccccc-ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH--HHHHHhc
Confidence 999999998764432 112233457889999999988889999999999999999998 999997543221 1111111
Q ss_pred hcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHHh
Q 012014 377 ALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRK 455 (473)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~ 455 (473)
..... .+..++..+.+|+.+||+.||++|||+.||++.|+.+...
T Consensus 230 ~~~~~----------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 274 (281)
T 3cc6_A 230 GDRLP----------------------------------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM 274 (281)
T ss_dssp TCCCC----------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCC----------------------------------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence 00000 0012345788999999999999999999999999998653
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=345.99 Aligned_cols=244 Identities=20% Similarity=0.238 Sum_probs=189.0
Q ss_pred CCCCccceeecCCCeEEEEEEec-CCCEEEEEEeeccCCCC--chhHHHHHHHHHhc-CCCCceeeeeeeeccccCCcee
Q 012014 145 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGG--SKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 220 (473)
++|++.++||+|+||+||+|... +++.||||++....... ......|+..+.++ +||||++++++|.+. ..
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~-----~~ 131 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG-----GI 131 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC-----CE
Confidence 57999999999999999999954 79999999986433222 22345556555555 899999999998643 46
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.++||||+ +++|.+++..... .+++..+..++.||+.||.||| +++|+||||||+|||++.++.+||+
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~~--------~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~ 199 (311)
T 3p1a_A 132 LYLQTELC-GPSLQQHCEAWGA--------SLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLG 199 (311)
T ss_dssp EEEEEECC-CCBHHHHHHHHCS--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEEC
T ss_pred EEEEEecc-CCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEc
Confidence 89999999 7799998876532 3678999999999999999999 8999999999999999999999999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCc
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQ 380 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 380 (473)
|||++....... ......||+.|+|||++.+ .++.++|||||||++|||++|..|+.+.. ....
T Consensus 200 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----~~~~-------- 263 (311)
T 3p1a_A 200 DFGLLVELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----GWQQ-------- 263 (311)
T ss_dssp CCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----HHHH--------
T ss_pred cceeeeecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----HHHH--------
Confidence 999998764322 2334569999999999876 79999999999999999999977764310 0110
Q ss_pred chhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 381 RAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
+...... .......+..+.+|+.+||+.||++|||+.|+++
T Consensus 264 ----~~~~~~~----------------------~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 264 ----LRQGYLP----------------------PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ----HTTTCCC----------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ----HhccCCC----------------------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 0000000 1112234668899999999999999999999975
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=351.66 Aligned_cols=275 Identities=21% Similarity=0.315 Sum_probs=210.3
Q ss_pred chhhhhcccCCCCccceeecCCCeEEEEEEec------CCCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeee
Q 012014 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFT 208 (473)
Q Consensus 136 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~ 208 (473)
...++....++|.+.+.||+|+||.||+|... +++.||+|++..... .....+.+|+.+++.++||||+++++
T Consensus 16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 34566667789999999999999999999843 367899999874322 22346889999999999999999999
Q ss_pred eeeccccCCceeeEEEEEecCCCCHHHHhcCCCCCC-CCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCC
Q 012014 209 AFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTN-WRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPS 287 (473)
Q Consensus 209 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~ 287 (473)
++.+ ....++||||+++|+|.+++....... .......+++..++.++.||+.||.||| ++||+||||||+
T Consensus 96 ~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~ 167 (322)
T 1p4o_A 96 VVSQ-----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAAR 167 (322)
T ss_dssp EECS-----SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGG
T ss_pred EEcc-----CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccc
Confidence 9854 336799999999999999997532100 0000012468899999999999999999 899999999999
Q ss_pred cEEecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCC
Q 012014 288 NVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTG 366 (473)
Q Consensus 288 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~ 366 (473)
||+++.++.+||+|||+++...............||+.|+|||++.+..++.++||||||+++|+|++ |..||.+....
T Consensus 168 NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 247 (322)
T 1p4o_A 168 NCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 247 (322)
T ss_dssp GEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH
T ss_pred eEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH
Confidence 99999999999999999986544332222233446889999999998889999999999999999999 89999764221
Q ss_pred cccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHH
Q 012014 367 KMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVE 446 (473)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~ 446 (473)
............. .+..++..+.+|+.+||+.||.+|||+.|++
T Consensus 248 -----~~~~~~~~~~~~~-------------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l 291 (322)
T 1p4o_A 248 -----QVLRFVMEGGLLD-------------------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLEII 291 (322)
T ss_dssp -----HHHHHHHTTCCCC-------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred -----HHHHHHHcCCcCC-------------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHH
Confidence 1111110000000 0112456788999999999999999999999
Q ss_pred HHHHHHHH
Q 012014 447 SRLRLIRR 454 (473)
Q Consensus 447 ~~L~~l~~ 454 (473)
+.|+.+..
T Consensus 292 ~~L~~~~~ 299 (322)
T 1p4o_A 292 SSIKEEME 299 (322)
T ss_dssp HHHGGGSC
T ss_pred HHHHHhhc
Confidence 99987744
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=350.65 Aligned_cols=263 Identities=14% Similarity=0.119 Sum_probs=208.8
Q ss_pred hhhhcccCCCCccceeecCCCeEEEEEE------ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcC---CCCceeeee
Q 012014 138 KDLYNATNGFSSANLIGAGNFGSVYNGT------LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK---HRNIVRVFT 208 (473)
Q Consensus 138 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~ 208 (473)
.++....++|.+.++||+|+||.||+|. ..+++.||+|+++. .....+.+|+.++..++ |+||+++++
T Consensus 58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP---ANPWEFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESS---CCHHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCC---CChhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 4455567889999999999999999993 45689999999864 34567888999998886 999999999
Q ss_pred eeeccccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCc
Q 012014 209 AFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSN 288 (473)
Q Consensus 209 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~N 288 (473)
++... ...++||||+++|+|.+++....... ...+++..++.++.||+.||.||| +++|+||||||+|
T Consensus 135 ~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~N 202 (365)
T 3e7e_A 135 AHLFQ-----NGSVLVGELYSYGTLLNAINLYKNTP----EKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDN 202 (365)
T ss_dssp EEECS-----SCEEEEECCCCSCBHHHHHHHHHTST----TCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGG
T ss_pred eeecC-----CCcEEEEeccCCCcHHHHHHHhhccc----ccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHH
Confidence 98653 36799999999999999997432111 114679999999999999999999 9999999999999
Q ss_pred EEecC-----------CccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCC
Q 012014 289 VLLDD-----------EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGI 357 (473)
Q Consensus 289 il~~~-----------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~ 357 (473)
||++. ++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 203 Ill~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~ 282 (365)
T 3e7e_A 203 FILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282 (365)
T ss_dssp EEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSS
T ss_pred EEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCC
Confidence 99998 8999999999997654433344455667999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCC
Q 012014 358 RPSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPR 437 (473)
Q Consensus 358 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~ 437 (473)
.||......... ........ .....+.+++..|++.+|.
T Consensus 283 ~pf~~~~~~~~~------------~~~~~~~~-----------------------------~~~~~~~~~~~~~l~~~p~ 321 (365)
T 3e7e_A 283 YMKVKNEGGECK------------PEGLFRRL-----------------------------PHLDMWNEFFHVMLNIPDC 321 (365)
T ss_dssp CCCEEEETTEEE------------ECSCCTTC-----------------------------SSHHHHHHHHHHHHCCCCT
T ss_pred CccccCCCCcee------------echhcccc-----------------------------CcHHHHHHHHHHHcCCCCC
Confidence 999643222110 00000000 0234566799999999999
Q ss_pred CC-CChHHHHHHHHHHHHhh
Q 012014 438 ER-MKINDVESRLRLIRRKL 456 (473)
Q Consensus 438 ~R-Pt~~ev~~~L~~l~~~~ 456 (473)
+| |+++++.+.|+.+....
T Consensus 322 ~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 322 HHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp TCCCCHHHHHHHHHHHHHHH
T ss_pred CcchHHHHHHHHHHHHHHHh
Confidence 99 67899999999887654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=350.57 Aligned_cols=287 Identities=17% Similarity=0.226 Sum_probs=208.6
Q ss_pred hcccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 141 YNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 141 ~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
....++|++.+.||+|+||.||+|. ..+++.||+|++..... .....+.+|+.++.+++||||+++++++........
T Consensus 23 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 102 (364)
T 3qyz_A 23 FDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 102 (364)
T ss_dssp CCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred ccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcccc
Confidence 3455789999999999999999998 45788999999874332 223568899999999999999999999876554555
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...++||||+. |+|.+++... .+++.++..++.||+.||.||| ++||+||||||+|||++.++.+|
T Consensus 103 ~~~~iv~e~~~-~~L~~~l~~~----------~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~k 168 (364)
T 3qyz_A 103 KDVYIVQDLME-TDLYKLLKTQ----------HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLK 168 (364)
T ss_dssp CCEEEEEECCS-EEHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEE
T ss_pred ceEEEEEcccC-cCHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEE
Confidence 67899999996 6999999764 2568899999999999999999 89999999999999999999999
Q ss_pred EeecccccccCccccc-cceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 012014 299 VGDFGMARFLPAIDKQ-NRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKM 376 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~ 376 (473)
|+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+ .+......
T Consensus 169 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~ 247 (364)
T 3qyz_A 169 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-QLNHILGI 247 (364)
T ss_dssp ECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG-HHHHHHHH
T ss_pred EEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHHH
Confidence 9999999876543221 12234579999999998655 458999999999999999999999998754332 22222222
Q ss_pred hcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 377 ALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
........+........ ..... .................+..+.+|+.+||+.||++|||+.|+++
T Consensus 248 ~~~~~~~~~~~~~~~~~-~~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 248 LGSPSQEDLNCIINLKA-RNYLL----SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HCSCCHHHHHTCCCHHH-HHHHH----TSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hCCCCHHHHHHhhhhhH-HHHHH----hcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 21111111100000000 00000 00000000111122234667899999999999999999999975
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=340.64 Aligned_cols=256 Identities=22% Similarity=0.345 Sum_probs=204.0
Q ss_pred CCCCccceeecCCCeEEEEEEec-CCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeecccc--------
Q 012014 145 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY-------- 215 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-------- 215 (473)
++|++.+.||+|+||.||+|... +++.||+|+++.. .+.+.+|+.++.+++||||+++++++....+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 86 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN----NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN 86 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECC----SGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccc----cHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence 46889999999999999999954 7999999998743 3567899999999999999999998865322
Q ss_pred ---CCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEec
Q 012014 216 ---QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD 292 (473)
Q Consensus 216 ---~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~ 292 (473)
......++||||+++|+|.+++...... .+++..++.++.||+.||.||| +++|+||||||+||+++
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~ 156 (284)
T 2a19_B 87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE-------KLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLV 156 (284)
T ss_dssp --CCEEEEEEEEECCCCSCBHHHHHHHGGGS-------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEE
T ss_pred ccccCcceEEEEEeccCCCCHHHHHhhccCC-------CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEc
Confidence 1244579999999999999999754211 3668899999999999999999 89999999999999999
Q ss_pred CCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHH
Q 012014 293 DEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRN 372 (473)
Q Consensus 293 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~ 372 (473)
.++.+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||... ..
T Consensus 157 ~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-------~~ 226 (284)
T 2a19_B 157 DTKQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-------SK 226 (284)
T ss_dssp ETTEEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-------HH
T ss_pred CCCCEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-------HH
Confidence 99999999999998765432 223345899999999999989999999999999999999999886421 01
Q ss_pred HHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHH
Q 012014 373 FVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLI 452 (473)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l 452 (473)
.......... ....+..+.+|+.+||+.||.+|||+.|+++.|+.+
T Consensus 227 ~~~~~~~~~~----------------------------------~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~ 272 (284)
T 2a19_B 227 FFTDLRDGII----------------------------------SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVW 272 (284)
T ss_dssp HHHHHHTTCC----------------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHHhhcccc----------------------------------cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1100000000 011344678899999999999999999999999999
Q ss_pred HHhhcc
Q 012014 453 RRKLLE 458 (473)
Q Consensus 453 ~~~~~~ 458 (473)
+.....
T Consensus 273 ~~~~~~ 278 (284)
T 2a19_B 273 KKSPEK 278 (284)
T ss_dssp TC----
T ss_pred hhCCCc
Confidence 765543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=349.56 Aligned_cols=247 Identities=20% Similarity=0.248 Sum_probs=176.3
Q ss_pred cceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHHHHHHhcC-CCCceeeeeeeeccccCCceeeEEEEEe
Q 012014 150 ANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQGARFKAVVYKF 227 (473)
Q Consensus 150 ~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~ 227 (473)
.+.||+|+||.||+|.. .+++.||||++... ....+.+|+.++..+. ||||+++++++.+ ....++||||
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~-----~~~~~lv~e~ 87 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHD-----QLHTFLVMEL 87 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----SSEEEEEECC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc-----CCEEEEEEEc
Confidence 47899999999999994 56899999998642 3467889999999997 9999999999854 3467999999
Q ss_pred cCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCc---cEEEeeccc
Q 012014 228 MPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM---IGHVGDFGM 304 (473)
Q Consensus 228 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~---~~kl~Dfg~ 304 (473)
+++|+|.+++.... .+++.++..++.||+.||.||| +++|+||||||+|||++.++ .+||+|||+
T Consensus 88 ~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~ 155 (325)
T 3kn6_A 88 LNGGELFERIKKKK---------HFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGF 155 (325)
T ss_dssp CCSCBHHHHHHHCS---------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTT
T ss_pred cCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEecccc
Confidence 99999999998754 3668999999999999999999 89999999999999997665 899999999
Q ss_pred ccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCc--ccHHHHHHhhcCcch
Q 012014 305 ARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGK--MNLRNFVKMALPQRA 382 (473)
Q Consensus 305 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~--~~~~~~~~~~~~~~~ 382 (473)
++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+..... ...............
T Consensus 156 a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~ 233 (325)
T 3kn6_A 156 ARLKPPDN--QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF 233 (325)
T ss_dssp CEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC
T ss_pred ceecCCCC--CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC
Confidence 98654322 22334568999999999999999999999999999999999999998643221 111111111111000
Q ss_pred hhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHH
Q 012014 383 EEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVE 446 (473)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~ 446 (473)
. .........+..+.+|+.+||+.||.+|||+.|++
T Consensus 234 ~----------------------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell 269 (325)
T 3kn6_A 234 S----------------------------FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLR 269 (325)
T ss_dssp C----------------------------CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTST
T ss_pred C----------------------------CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHh
Confidence 0 00011123567889999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=349.69 Aligned_cols=291 Identities=18% Similarity=0.193 Sum_probs=205.3
Q ss_pred hhhhhcccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCC-----------chhHHHHHHHHHhcCCCCcee
Q 012014 137 FKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGG-----------SKSFKSECKAAINIKHRNIVR 205 (473)
Q Consensus 137 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~ 205 (473)
+.++....++|.+.+.||+|+||.||+|...+++.||||++....... .+.+.+|+.++.+++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 455666788999999999999999999997789999999996433221 167899999999999999999
Q ss_pred eeeeeeccccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCC
Q 012014 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLK 285 (473)
Q Consensus 206 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlk 285 (473)
+++++...+.......++||||+. |+|.+++..... .+++..+..++.||+.||.||| +++|+|||||
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlk 161 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRI--------VISPQHIQYFMYHILLGLHVLH---EAGVVHRDLH 161 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTS--------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCC
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhccc--------CCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCC
Confidence 999987655445567899999996 689888875432 3668999999999999999999 8999999999
Q ss_pred CCcEEecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHHhCCCCCCCCC
Q 012014 286 PSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (473)
Q Consensus 286 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~ 364 (473)
|+||+++.++.+||+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..
T Consensus 162 p~NIl~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 238 (362)
T 3pg1_A 162 PGNILLADNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST 238 (362)
T ss_dssp GGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hHHEEEcCCCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999754332 22234568999999999877 678999999999999999999999998643
Q ss_pred CCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHH
Q 012014 365 TGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKIND 444 (473)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 444 (473)
... .+.................... ........ ..................+..+.+|+.+||+.||++|||+.|
T Consensus 239 ~~~-~~~~i~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 313 (362)
T 3pg1_A 239 FYN-QLNKIVEVVGTPKIEDVVMFSS-PSARDYLR---NSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQ 313 (362)
T ss_dssp HHH-HHHHHHHHHCCCCHHHHHHTSC-HHHHHHTT---TCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHH-HHHHHHHHcCCCChHHhhhccc-hhhhHHHH---hhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHH
Confidence 221 1222222111111111100000 00000000 000000011112222344677899999999999999999999
Q ss_pred HHH
Q 012014 445 VES 447 (473)
Q Consensus 445 v~~ 447 (473)
+++
T Consensus 314 ll~ 316 (362)
T 3pg1_A 314 ALR 316 (362)
T ss_dssp HHT
T ss_pred HHc
Confidence 875
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=339.13 Aligned_cols=264 Identities=22% Similarity=0.328 Sum_probs=208.2
Q ss_pred ccCCCCccc-eeecCCCeEEEEEEec---CCCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCC
Q 012014 143 ATNGFSSAN-LIGAGNFGSVYNGTLF---DGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (473)
Q Consensus 143 ~~~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (473)
..++|.+.. .||+|+||.||+|... ++..||+|+++.... ...+.+.+|+.++..++||||+++++++..
T Consensus 7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----- 81 (287)
T 1u59_A 7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA----- 81 (287)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-----
T ss_pred cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecC-----
Confidence 345676666 9999999999999742 577899999975432 234568899999999999999999999832
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccE
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~ 297 (473)
...++||||+++++|.+++..... .+++..+..++.|++.||.||| +++|+||||||+||+++.++.+
T Consensus 82 -~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~ 149 (287)
T 1u59_A 82 -EALMLVMEMAGGGPLHKFLVGKRE--------EIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYA 149 (287)
T ss_dssp -SSEEEEEECCTTEEHHHHHTTCTT--------TSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEE
T ss_pred -CCcEEEEEeCCCCCHHHHHHhCCc--------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCE
Confidence 247999999999999999975432 3668999999999999999999 8999999999999999999999
Q ss_pred EEeecccccccCccccc-cceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHH
Q 012014 298 HVGDFGMARFLPAIDKQ-NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVK 375 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~ 375 (473)
||+|||++......... .......||+.|+|||++.+..++.++||||||+++|+|++ |..||.+..... +...+.
T Consensus 150 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~i~ 227 (287)
T 1u59_A 150 KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFIE 227 (287)
T ss_dssp EECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--HHHHHH
T ss_pred EECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--HHHHHh
Confidence 99999999876443221 11223446889999999988889999999999999999998 999997643211 111111
Q ss_pred hhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHHh
Q 012014 376 MALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRK 455 (473)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~ 455 (473)
..... ..+..++..+.+|+.+||+.||++|||+.||++.|+.+..+
T Consensus 228 ~~~~~----------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 273 (287)
T 1u59_A 228 QGKRM----------------------------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273 (287)
T ss_dssp TTCCC----------------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCcC----------------------------------CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 00000 00113456888999999999999999999999999999876
Q ss_pred hccC
Q 012014 456 LLET 459 (473)
Q Consensus 456 ~~~~ 459 (473)
....
T Consensus 274 ~~~~ 277 (287)
T 1u59_A 274 LASK 277 (287)
T ss_dssp HHTT
T ss_pred cCCc
Confidence 6443
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=341.81 Aligned_cols=257 Identities=24% Similarity=0.325 Sum_probs=199.9
Q ss_pred hcccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 141 YNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 141 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
....++|++.+.||+|+||.||+|.. +++.||+|+++.. ...+.+.+|+.++.+++||||+++++++... ...
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~----~~~ 89 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGG 89 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC------C
T ss_pred cCChhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC----CCc
Confidence 34457899999999999999999985 5889999998743 3567799999999999999999999987432 335
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.++||||+++|+|.+++..... ..+++..+..++.|++.||.||| +++|+||||||+||+++.++.+||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~ 159 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVS 159 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHHH-------HHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEEC
T ss_pred eEEEEecCCCCCHHHHHHhccc-------ccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEe
Confidence 7999999999999999975421 12568889999999999999999 8999999999999999999999999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcC
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMALP 379 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 379 (473)
|||++...... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||....... +...+. .
T Consensus 160 Dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~~~~~---~ 229 (278)
T 1byg_A 160 DFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVE---K 229 (278)
T ss_dssp CCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--HHHHHT---T
T ss_pred ecccccccccc-----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHh---c
Confidence 99999755332 122347889999999998889999999999999999998 999997642211 111000 0
Q ss_pred cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHHh
Q 012014 380 QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRK 455 (473)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~ 455 (473)
... ...+..++..+.+++.+||+.||++|||+.|+++.|+.++..
T Consensus 230 ~~~-------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 230 GYK-------------------------------MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp TCC-------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCC-------------------------------CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 000 000112456788999999999999999999999999999764
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=369.63 Aligned_cols=264 Identities=22% Similarity=0.336 Sum_probs=204.9
Q ss_pred cCCCCccc-eeecCCCeEEEEEEec---CCCEEEEEEeeccC-CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 144 TNGFSSAN-LIGAGNFGSVYNGTLF---DGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 144 ~~~~~~~~-~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
.+++.+.+ .||+|+||.||+|... ++..||||+++... ....+.+.+|+.++.+++|||||+++++|..
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~------ 407 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------ 407 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES------
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc------
Confidence 34444444 7999999999999853 45679999997543 2355789999999999999999999999853
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...++||||+++|+|.+++..... .+++.++..++.||+.||.||| +++|+||||||+|||++.++.+|
T Consensus 408 ~~~~lv~E~~~~g~L~~~l~~~~~--------~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vk 476 (613)
T 2ozo_A 408 EALMLVMEMAGGGPLHKFLVGKRE--------EIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAK 476 (613)
T ss_dssp SSEEEEEECCTTCBHHHHHTTCTT--------TSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEE
T ss_pred CCeEEEEEeCCCCcHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEE
Confidence 247999999999999999975432 3668999999999999999999 89999999999999999999999
Q ss_pred EeecccccccCccccc-cceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHh
Q 012014 299 VGDFGMARFLPAIDKQ-NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKM 376 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~ 376 (473)
|+|||+++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+....+ +...+..
T Consensus 477 L~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~~~i~~ 554 (613)
T 2ozo_A 477 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFIEQ 554 (613)
T ss_dssp ECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH--HHHHHHT
T ss_pred EeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHc
Confidence 9999999876443211 11223346789999999998899999999999999999998 999998643221 1111110
Q ss_pred hcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHHhh
Q 012014 377 ALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRKL 456 (473)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~~ 456 (473)
. .+ ...+..++..+.+|+.+||+.||++|||+.+|++.|+.+...+
T Consensus 555 ~--------------------~~--------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~ 600 (613)
T 2ozo_A 555 G--------------------KR--------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 600 (613)
T ss_dssp T--------------------CC--------------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred C--------------------CC--------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence 0 00 0011235678899999999999999999999999999998776
Q ss_pred ccCC
Q 012014 457 LETP 460 (473)
Q Consensus 457 ~~~~ 460 (473)
....
T Consensus 601 ~~~~ 604 (613)
T 2ozo_A 601 ASKV 604 (613)
T ss_dssp SCSC
T ss_pred cccc
Confidence 5443
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=349.57 Aligned_cols=285 Identities=19% Similarity=0.255 Sum_probs=200.3
Q ss_pred CCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
++|.+.+.||+|+||.||+|.. .+++.||+|+++.... .....+.+|+.+++.++||||+++++++... ...+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 76 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE-----KSLT 76 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECS-----SCEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeC-----CEEE
Confidence 5799999999999999999995 4789999999874332 2223456899999999999999999998543 3679
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
+||||++ |+|.+++..... .+++..+..++.||+.||.||| ++||+||||||+||+++.++.+||+||
T Consensus 77 lv~e~~~-~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Df 144 (324)
T 3mtl_A 77 LVFEYLD-KDLKQYLDDCGN--------IINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADF 144 (324)
T ss_dssp EEEECCS-EEHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSS
T ss_pred EEecccc-cCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccC
Confidence 9999996 699999876532 3568899999999999999999 899999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcC--
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP-- 379 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~-- 379 (473)
|+++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+ .+.........
T Consensus 145 g~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~~~ 221 (324)
T 3mtl_A 145 GLARAKSIPT--KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE-QLHFIFRILGTPT 221 (324)
T ss_dssp SEEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCC
T ss_pred cccccccCCc--cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCC
Confidence 9998654322 22234468999999999876 568999999999999999999999998743222 12222221111
Q ss_pred -cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH--HHHHHHHhh
Q 012014 380 -QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES--RLRLIRRKL 456 (473)
Q Consensus 380 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~--~L~~l~~~~ 456 (473)
.......... .+.. ..................+..+.+|+.+||+.||++|||+.|+++ .+..+.+..
T Consensus 222 ~~~~~~~~~~~---~~~~------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 292 (324)
T 3mtl_A 222 EETWPGILSNE---EFKT------YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERI 292 (324)
T ss_dssp TTTSTTGGGCH---HHHH------TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTT
T ss_pred hHhchhhhcch---hhcc------cccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccccc
Confidence 1111111110 0000 000000011111222335677889999999999999999999976 444444433
Q ss_pred cc
Q 012014 457 LE 458 (473)
Q Consensus 457 ~~ 458 (473)
..
T Consensus 293 ~~ 294 (324)
T 3mtl_A 293 HK 294 (324)
T ss_dssp SS
T ss_pred cc
Confidence 33
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-45 Score=345.87 Aligned_cols=261 Identities=18% Similarity=0.248 Sum_probs=195.9
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCC---chhHHHHHHHHHhcCCCCceeeeeeeeccccCCce
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGG---SKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (473)
.++|.+.+.||+|+||.||+|.. .+++.||+|++....... .+.+.+|+.++.+++||||+++++++... .
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----~ 107 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID-----G 107 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----T
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC-----C
Confidence 47899999999999999999994 478899999987533222 35688999999999999999999998653 3
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
..++||||+++++|.+++.... .+++.++..++.|++.||.||| +++|+||||||+||+++.++.+||
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl 175 (309)
T 2h34_A 108 QLYVDMRLINGVDLAAMLRRQG---------PLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYL 175 (309)
T ss_dssp EEEEEEECCCCEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEE
T ss_pred eEEEEEEecCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEE
Confidence 6799999999999999997643 3568899999999999999999 899999999999999999999999
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcC
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP 379 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 379 (473)
+|||++....... ........||+.|+|||++.+..++.++||||||+++|+|++|..||.+.... .+........+
T Consensus 176 ~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~ 252 (309)
T 2h34_A 176 VDFGIASATTDEK-LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS--VMGAHINQAIP 252 (309)
T ss_dssp CSCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH--HHHHHHHSCCC
T ss_pred ecCccCccccccc-cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH--HHHHHhccCCC
Confidence 9999997654322 12223456899999999999989999999999999999999999999753211 11111111000
Q ss_pred cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCC-ChHHHHHHHHHHHHhh
Q 012014 380 QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERM-KINDVESRLRLIRRKL 456 (473)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~ev~~~L~~l~~~~ 456 (473)
. . .......+..+.+|+.+||+.||++|| |++++++.|+.+....
T Consensus 253 ~-~-------------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 253 R-P-------------------------------STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp C-G-------------------------------GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred C-c-------------------------------cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 0 0 001122455788999999999999999 9999999998775443
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=345.60 Aligned_cols=277 Identities=19% Similarity=0.242 Sum_probs=196.5
Q ss_pred CCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCC--CchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
++|++.+.||+|+||.||+|.. .+++.||+|++...... ..+.+.+|+.++.+++||||+++++++... ...
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-----~~~ 77 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK-----RRL 77 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecC-----CeE
Confidence 5799999999999999999995 45899999998643322 135678999999999999999999998643 367
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEee
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~D 301 (473)
++||||+++++|.+++.... .+++..+..++.|++.||.||| ++||+||||||+||+++.++.+||+|
T Consensus 78 ~lv~e~~~~~~l~~~~~~~~---------~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~D 145 (311)
T 4agu_A 78 HLVFEYCDHTVLHELDRYQR---------GVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCD 145 (311)
T ss_dssp EEEEECCSEEHHHHHHHTSS---------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECC
T ss_pred EEEEEeCCCchHHHHHhhhc---------CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEee
Confidence 99999999999999887654 3568899999999999999999 89999999999999999999999999
Q ss_pred cccccccCccccccceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCc
Q 012014 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQ 380 (473)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 380 (473)
||++....... .......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+....+. +....... ..
T Consensus 146 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~-~~ 221 (311)
T 4agu_A 146 FGFARLLTGPS--DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQ-LYLIRKTL-GD 221 (311)
T ss_dssp CTTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHH-CS
T ss_pred CCCchhccCcc--cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHh-cc
Confidence 99998764322 22234468999999999876 5689999999999999999999999986433221 11111110 00
Q ss_pred chhhhccccchHHHHhhhhh-hcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 381 RAEEVVDDFNLQEIEEGRTM-CMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
..... ...+...... ....................+..+.+|+.+||+.||++|||+.|+++
T Consensus 222 ~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 222 LIPRH-----QQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp CCHHH-----HHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred ccccc-----ccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000 0000000000 00000000000011111235667899999999999999999999974
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=356.95 Aligned_cols=249 Identities=25% Similarity=0.274 Sum_probs=189.8
Q ss_pred ccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccC---CCCchhHHHHHHH-HHhcCCCCceeeeeeeeccccCC
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGSKSFKSECKA-AINIKHRNIVRVFTAFSGVDYQG 217 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~ 217 (473)
..++|++.++||+|+||.||+|+. .+++.||+|+++... ......+.+|..+ ++.++||||++++++|.+
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~----- 110 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT----- 110 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC-----
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe-----
Confidence 456899999999999999999994 468899999997533 2233456677776 567899999999999855
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccE
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~ 297 (473)
....++||||+++|+|.+++.... .+++..+..++.||+.||.||| ++||+||||||+|||++.++.+
T Consensus 111 ~~~~~lv~E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~i 178 (373)
T 2r5t_A 111 ADKLYFVLDYINGGELFYHLQRER---------CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHI 178 (373)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCE
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCE
Confidence 347899999999999999997643 3568889999999999999999 8999999999999999999999
Q ss_pred EEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
||+|||+++..... .......+||+.|+|||++.+..++.++|||||||++|||++|..||.+..... .+..+....
T Consensus 179 kL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~-~~~~i~~~~ 255 (373)
T 2r5t_A 179 VLTDFGLCKENIEH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE-MYDNILNKP 255 (373)
T ss_dssp EECCCCBCGGGBCC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH-HHHHHHHSC
T ss_pred EEeeCccccccccC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHhcc
Confidence 99999999864322 223345679999999999999999999999999999999999999997632111 111111100
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
. . .+...+..+.+|+.+||+.||.+||++.+.++
T Consensus 256 ~--~----------------------------------~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~ 289 (373)
T 2r5t_A 256 L--Q----------------------------------LKPNITNSARHLLEGLLQKDRTKRLGAKDDFM 289 (373)
T ss_dssp C--C----------------------------------CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHH
T ss_pred c--C----------------------------------CCCCCCHHHHHHHHHHcccCHHhCCCCCCCHH
Confidence 0 0 00123456789999999999999999864433
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=369.03 Aligned_cols=249 Identities=19% Similarity=0.222 Sum_probs=191.3
Q ss_pred ccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeecc---CCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
..++|++.++||+|+||.||+|. ..+++.||||+++.. .......+.+|+.++..++||||++++++|...
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~----- 220 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH----- 220 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEET-----
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC-----
Confidence 34679999999999999999998 457899999999742 333446678999999999999999999998653
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCC-CCeeeccCCCCcEEecCCccE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQ-PPIAHCNLKPSNVLLDDEMIG 297 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~iiH~Dlkp~Nil~~~~~~~ 297 (473)
...++||||+++|+|.+++.... .+++..+..++.||+.||.||| + +||+||||||+|||++.++.+
T Consensus 221 ~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~ 288 (446)
T 4ejn_A 221 DRLCFVMEYANGGELFFHLSRER---------VFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHI 288 (446)
T ss_dssp TEEEEEECCCSSCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCE
T ss_pred CEEEEEEeeCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCE
Confidence 36799999999999999997654 3668899999999999999999 7 899999999999999999999
Q ss_pred EEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|..||.+..... +...+...
T Consensus 289 kl~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~i~~~ 364 (446)
T 4ejn_A 289 KITDFGLCKEGIKD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFELILME 364 (446)
T ss_dssp EECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHC
T ss_pred EEccCCCceeccCC--CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH--HHHHHHhC
Confidence 99999999854322 222344679999999999999999999999999999999999999997632211 11100000
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCC-----ChHHHHH
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERM-----KINDVES 447 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~ 447 (473)
... .+...+..+.+|+.+||+.||.+|| |+.|+++
T Consensus 365 ~~~-----------------------------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 365 EIR-----------------------------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp CCC-----------------------------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred CCC-----------------------------------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 000 0012345788999999999999999 9999875
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=351.10 Aligned_cols=242 Identities=18% Similarity=0.260 Sum_probs=198.4
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCC--------CchhHHHHHHHHHhcCCCCceeeeeeeeccc
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPG--------GSKSFKSECKAAINIKHRNIVRVFTAFSGVD 214 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 214 (473)
.++|.+.+.||+|+||.||+|. ..+++.||||+++..... ....+.+|+.++.+++||||++++++|.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~-- 100 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN-- 100 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC--
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee--
Confidence 4578999999999999999998 467899999999754321 33467889999999999999999999854
Q ss_pred cCCceeeEEEEEecCCC-CHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecC
Q 012014 215 YQGARFKAVVYKFMPNG-SLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD 293 (473)
Q Consensus 215 ~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~ 293 (473)
....++||||+.+| +|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|||++.
T Consensus 101 ---~~~~~lv~e~~~~g~~l~~~~~~~~---------~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~ 165 (335)
T 3dls_A 101 ---QGFFQLVMEKHGSGLDLFAFIDRHP---------RLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAE 165 (335)
T ss_dssp ---SSEEEEEEECCTTSCBHHHHHHTCC---------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECT
T ss_pred ---CCEEEEEEEeCCCCccHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcC
Confidence 34679999999777 9999998764 3568899999999999999999 899999999999999999
Q ss_pred CccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCC-CcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHH
Q 012014 294 EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEA-STYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRN 372 (473)
Q Consensus 294 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~ 372 (473)
++.+||+|||+++...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.......
T Consensus 166 ~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----- 237 (335)
T 3dls_A 166 DFTIKLIDFGSAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV----- 237 (335)
T ss_dssp TSCEEECCCTTCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT-----
T ss_pred CCcEEEeecccceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH-----
Confidence 9999999999998765432 2334569999999999988776 889999999999999999999996521100
Q ss_pred HHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 373 FVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
...... +...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 238 ----------~~~~~~----------------------------~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 238 ----------EAAIHP----------------------------PYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ----------TTCCCC----------------------------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ----------hhccCC----------------------------CcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 01134568899999999999999999999764
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=365.09 Aligned_cols=253 Identities=22% Similarity=0.312 Sum_probs=203.7
Q ss_pred cccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeecc---CCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCC
Q 012014 142 NATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (473)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (473)
...++|.+.++||+|+||.||+|+. .+|+.||+|++... .......+.+|+.++..++||||++++++|.+
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~----- 255 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET----- 255 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee-----
Confidence 3457799999999999999999994 57999999999742 23345668899999999999999999999854
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccE
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~ 297 (473)
....++||||+++|+|.+++...... .+++..+..++.||+.||.||| ++||+||||||+|||++.++.+
T Consensus 256 ~~~l~lVmEy~~gg~L~~~l~~~~~~-------~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~v 325 (576)
T 2acx_A 256 KDALCLVLTLMNGGDLKFHIYHMGQA-------GFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHI 325 (576)
T ss_dssp SSEEEEEECCCCSCBHHHHHHSSSSC-------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCe
Confidence 34789999999999999999765422 3668999999999999999999 8999999999999999999999
Q ss_pred EEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|..||.+...... ...+....
T Consensus 326 KL~DFGla~~~~~~---~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~-~~~i~~~i 401 (576)
T 2acx_A 326 RISDLGLAVHVPEG---QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-REEVERLV 401 (576)
T ss_dssp EECCCTTCEECCTT---CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC-HHHHHHHH
T ss_pred EEEecccceecccC---ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh-HHHHHHHh
Confidence 99999999876432 223445799999999999998999999999999999999999999986432211 11111000
Q ss_pred --cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCC-----ChHHHHH
Q 012014 378 --LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERM-----KINDVES 447 (473)
Q Consensus 378 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~ 447 (473)
.+... +...+..+.+|+.+||+.||.+|| ++.||++
T Consensus 402 ~~~~~~~----------------------------------p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 402 KEVPEEY----------------------------------SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp HHCCCCC----------------------------------CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred hcccccC----------------------------------CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 00000 012345788999999999999999 6778764
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=375.49 Aligned_cols=263 Identities=24% Similarity=0.400 Sum_probs=210.6
Q ss_pred hhhhhcccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccC
Q 012014 137 FKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQ 216 (473)
Q Consensus 137 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 216 (473)
...+....++|.+.++||+|+||.||+|.+.++..||||+++... ...+.|.+|+.+|++++||||+++++++.+
T Consensus 259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~---- 333 (535)
T 2h8h_A 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE---- 333 (535)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred ccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee----
Confidence 445666778899999999999999999998777889999997543 345789999999999999999999999743
Q ss_pred CceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCcc
Q 012014 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI 296 (473)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~ 296 (473)
...++||||+++|+|.+++...... .+++.+++.++.||+.||.||| +++|+||||||+|||++.++.
T Consensus 334 --~~~~lv~e~~~~gsL~~~l~~~~~~-------~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~ 401 (535)
T 2h8h_A 334 --EPIYIVTEYMSKGSLLDFLKGETGK-------YLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLV 401 (535)
T ss_dssp --SSCEEEECCCTTEEHHHHHSHHHHT-------TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGC
T ss_pred --ccceEeeehhcCCcHHHHHhhcCCC-------CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCc
Confidence 2469999999999999999753211 3568899999999999999999 899999999999999999999
Q ss_pred EEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHH
Q 012014 297 GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVK 375 (473)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~ 375 (473)
+||+|||+++...... ........++..|+|||++.+..++.++|||||||++|||++ |..||.+....+ ...
T Consensus 402 ~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~-----~~~ 475 (535)
T 2h8h_A 402 CKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-----VLD 475 (535)
T ss_dssp EEECCTTSTTTCCCHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH-----HHH
T ss_pred EEEcccccceecCCCc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-----HHH
Confidence 9999999998764321 111223346788999999998899999999999999999999 999997642211 111
Q ss_pred hhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHH
Q 012014 376 MALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIR 453 (473)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~ 453 (473)
.. ..+.++ ..+..++..+.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus 476 ~i-----------------~~~~~~--------------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~ 522 (535)
T 2h8h_A 476 QV-----------------ERGYRM--------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 522 (535)
T ss_dssp HH-----------------HTTCCC--------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred HH-----------------HcCCCC--------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 00 000000 001235667889999999999999999999999998774
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=350.33 Aligned_cols=251 Identities=20% Similarity=0.291 Sum_probs=195.5
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHHHHHHhc-CCCCceeeeeeeeccccCCceee
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
.++|.+.+.||+|+||.||+|.. .+++.||+|+++... ....+|++++.++ +||||+++++++.+ ....
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~E~~~l~~~~~hp~iv~~~~~~~~-----~~~~ 91 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEIEILLRYGQHPNIITLKDVYDD-----GKYV 91 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT----CCCHHHHHHHHHHTTSTTBCCEEEEEEC-----SSEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc----CChHHHHHHHHHhcCCCCcCeEEEEEEc-----CCEE
Confidence 45689999999999999999984 468999999997533 2346788888888 79999999999854 3478
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCC----ccE
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE----MIG 297 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~----~~~ 297 (473)
++||||+++|+|.+++.... .+++.++..++.||+.||.||| ++||+||||||+|||+.++ +.+
T Consensus 92 ~lv~E~~~gg~L~~~i~~~~---------~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~ 159 (342)
T 2qr7_A 92 YVVTELMKGGELLDKILRQK---------FFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESI 159 (342)
T ss_dssp EEEECCCCSCBHHHHHHTCT---------TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGE
T ss_pred EEEEeCCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeE
Confidence 99999999999999997654 3668999999999999999999 8999999999999998433 359
Q ss_pred EEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+..... ...+....
T Consensus 160 kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~i 235 (342)
T 2qr7_A 160 RICDFGFAKQLRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT--PEEILARI 235 (342)
T ss_dssp EECCCTTCEECBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC--HHHHHHHH
T ss_pred EEEECCCcccCcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC--HHHHHHHH
Confidence 999999998764422 22334578999999999988889999999999999999999999997532211 11111110
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
...... . . .......+..+.+|+.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~-~-~--------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 236 GSGKFS-L-S--------------------------GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp HHCCCC-C-C--------------------------STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ccCCcc-c-C--------------------------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000000 0 0 0000124567889999999999999999999876
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=339.59 Aligned_cols=263 Identities=22% Similarity=0.320 Sum_probs=205.0
Q ss_pred hcccCCCCccc-eeecCCCeEEEEEEe---cCCCEEEEEEeeccCCC--CchhHHHHHHHHHhcCCCCceeeeeeeeccc
Q 012014 141 YNATNGFSSAN-LIGAGNFGSVYNGTL---FDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAFSGVD 214 (473)
Q Consensus 141 ~~~~~~~~~~~-~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 214 (473)
....++|.+.+ .||+|+||.||+|.. .+++.||||+++..... ..+.+.+|+.++..++||||+++++++..
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-- 89 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-- 89 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES--
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECC--
Confidence 34456788888 999999999999963 34688999999754322 24678999999999999999999999832
Q ss_pred cCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCC
Q 012014 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE 294 (473)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~ 294 (473)
...++||||+++++|.+++.... .+++..++.++.|++.||.||| +++|+||||||+||+++.+
T Consensus 90 ----~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~ 153 (291)
T 1xbb_A 90 ----ESWMLVMEMAELGPLNKYLQQNR---------HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQ 153 (291)
T ss_dssp ----SSEEEEEECCTTEEHHHHHHHCT---------TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEET
T ss_pred ----CCcEEEEEeCCCCCHHHHHHhCc---------CCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCC
Confidence 24689999999999999998654 3568899999999999999999 8999999999999999999
Q ss_pred ccEEEeecccccccCccccc-cceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHH
Q 012014 295 MIGHVGDFGMARFLPAIDKQ-NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRN 372 (473)
Q Consensus 295 ~~~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~ 372 (473)
+.+||+|||++......... .......||+.|+|||.+.+..++.++||||||+++|+|++ |..||.+..... +..
T Consensus 154 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~ 231 (291)
T 1xbb_A 154 HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTA 231 (291)
T ss_dssp TEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHH
T ss_pred CcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHH
Confidence 99999999999876443221 11223346788999999988889999999999999999999 999997632211 111
Q ss_pred HHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHH
Q 012014 373 FVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLI 452 (473)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l 452 (473)
.+...... ..+..++..+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 232 ~~~~~~~~----------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 232 MLEKGERM----------------------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp HHHTTCCC----------------------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHcCCCC----------------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11100000 00112456788999999999999999999999999999
Q ss_pred HHhhc
Q 012014 453 RRKLL 457 (473)
Q Consensus 453 ~~~~~ 457 (473)
.....
T Consensus 278 ~~~~~ 282 (291)
T 1xbb_A 278 YYDVV 282 (291)
T ss_dssp HHHHH
T ss_pred HHHHh
Confidence 76654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=337.29 Aligned_cols=251 Identities=20% Similarity=0.287 Sum_probs=199.4
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCC--CchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
.++|++.+.||+|+||.||+|.. .+++.||+|++...... ....+.+|+.++.+++||||+++++++.. ...
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 79 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-----ESF 79 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc-----CCE
Confidence 57899999999999999999984 56899999999754322 23568899999999999999999999854 336
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCcc---E
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI---G 297 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~---~ 297 (473)
.++||||+++++|.+++.... .+++..+..++.|++.||.||| +++|+||||||+||+++.++. +
T Consensus 80 ~~~v~e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~ 147 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIVARE---------FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAV 147 (284)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCE
T ss_pred EEEEEecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcE
Confidence 799999999999999887653 3568899999999999999999 899999999999999976655 9
Q ss_pred EEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+..... ........
T Consensus 148 kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~ 222 (284)
T 3kk8_A 148 KLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--LYAQIKAG 222 (284)
T ss_dssp EECCCTTCEECCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHT
T ss_pred EEeeceeeEEcccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH--HHHHHHhc
Confidence 999999997664422 2234568999999999999999999999999999999999999997532211 11111000
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
...... ......+..+.+|+.+||+.||++|||+.|+++
T Consensus 223 ~~~~~~-------------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 223 AYDYPS-------------------------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp CCCCCT-------------------------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccCCc-------------------------------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 000000 000123457889999999999999999999977
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-44 Score=335.23 Aligned_cols=258 Identities=21% Similarity=0.313 Sum_probs=202.5
Q ss_pred CCCCccceeecCCCeEEEEEEec-CCCEEEEEEeeccCCC------CchhHHHHHHHHHhcCCCCceeeeeeeeccccCC
Q 012014 145 NGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPG------GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (473)
++|.+.+.||+|+||.||+|... +++.||+|+++..... ..+.+.+|+.++.+++||||+++++++.+.
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---- 80 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK---- 80 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS----
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC----
Confidence 46889999999999999999954 6899999999754321 346789999999999999999999998543
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCc--
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM-- 295 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~-- 295 (473)
...++||||+++++|.+++.... .+++.++..++.||+.||.||| +++|+||||||+||+++.++
T Consensus 81 -~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~ 147 (283)
T 3bhy_A 81 -TDVVLILELVSGGELFDFLAEKE---------SLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVP 147 (283)
T ss_dssp -SEEEEEEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSS
T ss_pred -CeEEEEEeecCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCC
Confidence 36799999999999999997543 3668999999999999999999 89999999999999998877
Q ss_pred --cEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHH
Q 012014 296 --IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNF 373 (473)
Q Consensus 296 --~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~ 373 (473)
.+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+..... .+..+
T Consensus 148 ~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~ 223 (283)
T 3bhy_A 148 NPRIKLIDFGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE-TLTNI 223 (283)
T ss_dssp SCCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHH
T ss_pred CCceEEEecccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH-HHHHh
Confidence 89999999998664322 2234458999999999998899999999999999999999999997632211 00000
Q ss_pred HHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH--HHHH
Q 012014 374 VKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES--RLRL 451 (473)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~--~L~~ 451 (473)
. ..... .........+..+.+|+.+||+.||++|||+.|+++ .++.
T Consensus 224 ~-~~~~~-------------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 224 S-AVNYD-------------------------------FDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp H-TTCCC-------------------------------CCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred H-hcccC-------------------------------CcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 0 00000 000111234567889999999999999999999997 5666
Q ss_pred HHHh
Q 012014 452 IRRK 455 (473)
Q Consensus 452 l~~~ 455 (473)
++..
T Consensus 272 ~~~~ 275 (283)
T 3bhy_A 272 IRRR 275 (283)
T ss_dssp HHHC
T ss_pred HHHH
Confidence 6544
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=346.37 Aligned_cols=269 Identities=22% Similarity=0.337 Sum_probs=204.6
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEE--EEEEeecc-CCCCchhHHHHHHHHHhc-CCCCceeeeeeeeccccCCc
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTI--AVKVFNLI-RPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~v--avK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 218 (473)
.++|.+.+.||+|+||.||+|+. .++..+ |+|.++.. .....+.+.+|+.++.++ +||||+++++++.+.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~----- 98 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR----- 98 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-----
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeC-----
Confidence 36799999999999999999984 456644 99988743 233456789999999999 899999999998553
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCC-------CcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEe
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWR-------PLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL 291 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~-------~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~ 291 (473)
...++||||+++|+|.+++......... .....+++.+++.++.||+.||.||| ++||+||||||+||++
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~ 175 (327)
T 1fvr_A 99 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILV 175 (327)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEE
Confidence 3689999999999999999865310000 00113668999999999999999999 8999999999999999
Q ss_pred cCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccH
Q 012014 292 DDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNL 370 (473)
Q Consensus 292 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~ 370 (473)
+.++.+||+|||+++..... .......+++.|+|||++.+..++.++||||||+++|+|++ |..||.+....
T Consensus 176 ~~~~~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---- 248 (327)
T 1fvr_A 176 GENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---- 248 (327)
T ss_dssp CGGGCEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----
T ss_pred cCCCeEEEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH----
Confidence 99999999999999744321 11223447889999999988889999999999999999998 99999763211
Q ss_pred HHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHH
Q 012014 371 RNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLR 450 (473)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 450 (473)
.......... . ...+..++..+.+|+.+||+.||.+|||+.|+++.|+
T Consensus 249 -~~~~~~~~~~-----~--------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~ 296 (327)
T 1fvr_A 249 -ELYEKLPQGY-----R--------------------------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 296 (327)
T ss_dssp -HHHHHGGGTC-----C--------------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -HHHHHhhcCC-----C--------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 1111110000 0 0001123567889999999999999999999999999
Q ss_pred HHHHhhccC
Q 012014 451 LIRRKLLET 459 (473)
Q Consensus 451 ~l~~~~~~~ 459 (473)
.+.+.....
T Consensus 297 ~~~~~~~~~ 305 (327)
T 1fvr_A 297 RMLEERKTY 305 (327)
T ss_dssp HHHHSSSCS
T ss_pred HHHHhhcCc
Confidence 998765443
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=345.53 Aligned_cols=278 Identities=17% Similarity=0.184 Sum_probs=203.0
Q ss_pred ccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcC-CCCceeeeeeeeccccCCcee
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 220 (473)
..++|++.+.||+|+||.||+|. ..+++.||+|+++. ...+.+.+|+.++.+++ ||||+++++++.+. ....
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~---~~~~ 107 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDP---VSRT 107 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCC
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccC---CCCc
Confidence 34679999999999999999998 46789999999863 34678999999999997 99999999998652 2446
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCc-cEEE
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM-IGHV 299 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~-~~kl 299 (473)
.++||||+++++|.+++.. ++..++..++.||+.||.||| +++|+||||||+|||++.++ .+||
T Consensus 108 ~~lv~e~~~~~~l~~~~~~------------~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl 172 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQT------------LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRL 172 (330)
T ss_dssp EEEEEECCCCCCHHHHGGG------------CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEE
T ss_pred eEEEEeccCchhHHHHHHh------------CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEE
Confidence 7999999999999999853 447889999999999999999 89999999999999999776 8999
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMAL 378 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~ 378 (473)
+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.........+........
T Consensus 173 ~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~ 249 (330)
T 3nsz_A 173 IDWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 249 (330)
T ss_dssp CCCTTCEECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHC
T ss_pred EeCCCceEcCCCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcC
Confidence 9999998764432 2234468999999999877 56899999999999999999999999654333222222222211
Q ss_pred Ccchhhhccccc---hHHHHhhhhhhcccccCCC-CcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 379 PQRAEEVVDDFN---LQEIEEGRTMCMEVSSSSG-SSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 379 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.......++... ...+.... ........ ...........+..+.+|+.+||+.||++|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 250 TEDLYDYIDKYNIELDPRFNDIL---GRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HHHHHHHHHHTTCCCCTHHHHHH---CCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CchhhhHHHHhccccccchhhhh---hhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 111111100000 00000000 00000000 00001111225678899999999999999999999975
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=347.86 Aligned_cols=263 Identities=25% Similarity=0.371 Sum_probs=199.7
Q ss_pred ccCCCCccceeecCCCeEEEEEEecC-----CCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccccC
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTLFD-----GTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQ 216 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 216 (473)
..++|.+.+.||+|+||.||+|.... +..||+|+++.... .....+.+|+.++.+++||||+++++++..
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---- 117 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK---- 117 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS----
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec----
Confidence 34678889999999999999998432 23599999874322 223468899999999999999999999854
Q ss_pred CceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCcc
Q 012014 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI 296 (473)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~ 296 (473)
....++||||+++|+|.+++..... .+++.+++.++.||+.||.||| +++|+||||||+||+++.++.
T Consensus 118 -~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~ 185 (333)
T 1mqb_A 118 -YKPMMIITEYMENGALDKFLREKDG--------EFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLV 185 (333)
T ss_dssp -SSSEEEEEECCTTEEHHHHHHHTTT--------CSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCC
T ss_pred -CCCcEEEEeCCCCCcHHHHHHhCCC--------CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCc
Confidence 3467999999999999999976432 3668899999999999999999 899999999999999999999
Q ss_pred EEEeecccccccCccccc-cceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHH
Q 012014 297 GHVGDFGMARFLPAIDKQ-NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFV 374 (473)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~ 374 (473)
+||+|||+++........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+..... ..
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-----~~ 260 (333)
T 1mqb_A 186 CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-----VM 260 (333)
T ss_dssp EEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----HH
T ss_pred EEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH-----HH
Confidence 999999999876443211 11223346788999999998899999999999999999999 999997532211 11
Q ss_pred HhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHH
Q 012014 375 KMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRR 454 (473)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~ 454 (473)
........ ...+..++..+.+|+.+||+.||++|||+.||++.|+.+..
T Consensus 261 ~~~~~~~~-------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 309 (333)
T 1mqb_A 261 KAINDGFR-------------------------------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309 (333)
T ss_dssp HHHHTTCC-------------------------------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHCCCc-------------------------------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 10000000 00011245678899999999999999999999999999976
Q ss_pred hhc
Q 012014 455 KLL 457 (473)
Q Consensus 455 ~~~ 457 (473)
...
T Consensus 310 ~~~ 312 (333)
T 1mqb_A 310 APD 312 (333)
T ss_dssp SGG
T ss_pred cch
Confidence 543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=356.29 Aligned_cols=265 Identities=19% Similarity=0.275 Sum_probs=206.7
Q ss_pred ccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
..++|.+.++||+|+||.||+|. ..+++.||||+++... ....+.+|+.++..++|++.+..+.++.. .....
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~----~~~~~ 78 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGV----EGDYN 78 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEE----ETTEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEe----eCCEE
Confidence 35789999999999999999999 4678999999887433 34568999999999987555444444322 23467
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEe---cCCccEE
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL---DDEMIGH 298 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~---~~~~~~k 298 (473)
++||||+ +++|.+++..... .+++.+++.|+.||+.||.||| +++|+||||||+|||+ +.++.+|
T Consensus 79 ~lvme~~-g~sL~~ll~~~~~--------~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vk 146 (483)
T 3sv0_A 79 VLVMDLL-GPSLEDLFNFCSR--------KLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVY 146 (483)
T ss_dssp EEEEECC-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEE
T ss_pred EEEEECC-CCCHHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEE
Confidence 9999999 9999999975332 3678999999999999999999 8999999999999999 6889999
Q ss_pred EeecccccccCcccccc-----ceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcc--cHH
Q 012014 299 VGDFGMARFLPAIDKQN-----RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKM--NLR 371 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~--~~~ 371 (473)
|+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+...... .+.
T Consensus 147 L~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~ 226 (483)
T 3sv0_A 147 IIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYE 226 (483)
T ss_dssp ECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHH
T ss_pred EEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHH
Confidence 99999998765433211 12256799999999999999999999999999999999999999987543321 111
Q ss_pred HHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHH
Q 012014 372 NFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRL 451 (473)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 451 (473)
.+.......... .....++.++.+|+..||+.||++||++.+|++.|+.
T Consensus 227 ~i~~~~~~~~~~-------------------------------~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~ 275 (483)
T 3sv0_A 227 KISEKKVATSIE-------------------------------ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRD 275 (483)
T ss_dssp HHHHHHHHSCHH-------------------------------HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred HHhhccccccHH-------------------------------HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 111111101000 1112346789999999999999999999999999999
Q ss_pred HHHhh
Q 012014 452 IRRKL 456 (473)
Q Consensus 452 l~~~~ 456 (473)
+....
T Consensus 276 l~~~~ 280 (483)
T 3sv0_A 276 LFIRE 280 (483)
T ss_dssp HHHHT
T ss_pred HHHHc
Confidence 97654
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=339.49 Aligned_cols=249 Identities=22% Similarity=0.366 Sum_probs=179.9
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccC---CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCce
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (473)
.++|.+.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.++.+++||||+++++++.+ ..
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 84 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED-----SN 84 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC-----SS
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc-----CC
Confidence 45799999999999999999984 578999999996422 2334678999999999999999999999854 34
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
..++||||+++++|.+++..... .+++..+..++.|++.||.||| +++|+||||||+||+++.++.+||
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl 153 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKNRVK--------PFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKI 153 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHTCSS--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEE
T ss_pred eEEEEEecCCCCcHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEE
Confidence 67999999999999999986532 3668999999999999999999 899999999999999999999999
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcC
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP 379 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 379 (473)
+|||++....... .......||+.|+|||.+.+..++.++||||||+++|+|++|..||........ ......
T Consensus 154 ~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~ 226 (278)
T 3cok_A 154 ADFGLATQLKMPH--EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-----LNKVVL 226 (278)
T ss_dssp CCCTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------CCS
T ss_pred EeecceeeccCCC--CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-----HHHHhh
Confidence 9999998664322 122335689999999999988899999999999999999999999976332111 000000
Q ss_pred cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 380 QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
... ..+...+..+.+|+.+||+.||++|||+.++++
T Consensus 227 ~~~--------------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 227 ADY--------------------------------EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp SCC--------------------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccc--------------------------------CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 000 000123457789999999999999999999875
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=347.74 Aligned_cols=277 Identities=19% Similarity=0.262 Sum_probs=193.4
Q ss_pred ccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCC--CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCce
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (473)
..++|.+.++||+|+||.||+|. ..+++.||||+++.... .....+.+|+.++++++||||+++++++.+. .
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~ 106 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN-----H 106 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEET-----T
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecC-----C
Confidence 44689999999999999999998 45789999999974332 2245678999999999999999999998653 3
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEe-----cCC
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL-----DDE 294 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~-----~~~ 294 (473)
..++||||++ |+|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|||+ +.+
T Consensus 107 ~~~lv~e~~~-~~L~~~~~~~~---------~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~ 173 (329)
T 3gbz_A 107 RLHLIFEYAE-NDLKKYMDKNP---------DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASET 173 (329)
T ss_dssp EEEEEEECCS-EEHHHHHHHCT---------TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----C
T ss_pred EEEEEEecCC-CCHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCcc
Confidence 6799999996 59999998764 3568899999999999999999 8999999999999999 455
Q ss_pred ccEEEeecccccccCccccccceeeccCCCCcCCCccccCC-CCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHH
Q 012014 295 MIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNF 373 (473)
Q Consensus 295 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~ 373 (473)
+.+||+|||+++...... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+....+. +...
T Consensus 174 ~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~ 250 (329)
T 3gbz_A 174 PVLKIGDFGLARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ-LFKI 250 (329)
T ss_dssp CEEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHH
T ss_pred ceEEECcCCCccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH-HHHH
Confidence 569999999998664322 223344689999999999875 489999999999999999999999976433221 1111
Q ss_pred HHhh-cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 374 VKMA-LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 374 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.... .+.. ........... .....................+..+.+|+.+||+.||++|||+.|+++
T Consensus 251 ~~~~~~~~~-~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 251 FEVLGLPDD-TTWPGVTALPD------WKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp HHHHCCCCT-TTSTTGGGSTT------CCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHhCCCch-hhhhhhhhhhh------hhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 1111 1100 00000000000 000000000111111122235678899999999999999999999864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=339.93 Aligned_cols=248 Identities=22% Similarity=0.331 Sum_probs=197.1
Q ss_pred ccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC---CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
..++|++.+.||+|+||.||+|. ..+++.||+|++.... ......+.+|+.++.+++||||+++++++.+.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 81 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA----- 81 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC-----
Confidence 45679999999999999999998 4567899999986321 23346788999999999999999999998543
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...++||||+++|+|.+++.... .+++..+..++.|++.||.||| ++||+||||||+||+++.++.+|
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~ 149 (279)
T 3fdn_A 82 TRVYLILEYAPLGTVYRELQKLS---------KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELK 149 (279)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEE
T ss_pred CEEEEEEecCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEE
Confidence 36799999999999999997653 3568899999999999999999 99999999999999999999999
Q ss_pred EeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 012014 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMAL 378 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~ 378 (473)
|+|||++...... ......||+.|+|||.+.+..++.++||||||+++|+|++|..||........ .... ....
T Consensus 150 l~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~-~~~~ 223 (279)
T 3fdn_A 150 IADFGWSVHAPSS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-YKRI-SRVE 223 (279)
T ss_dssp ECSCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHH-HHTC
T ss_pred EEeccccccCCcc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH-HHHH-HhCC
Confidence 9999998654322 22345689999999999998999999999999999999999999975321110 0000 0000
Q ss_pred CcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 379 PQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
.. .+...+..+.+|+.+||+.||++|||+.||++.
T Consensus 224 -~~----------------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 224 -FT----------------------------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp -CC----------------------------------CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred -CC----------------------------------CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 001134567899999999999999999999874
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=337.94 Aligned_cols=253 Identities=20% Similarity=0.256 Sum_probs=193.1
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccC-CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
.++|.+.+.||+|+||.||+|.. .++..+|+|++.... ....+.+.+|++++++++||||+++++++.+ ....
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~ 95 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFED-----YHNM 95 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheec-----CCeE
Confidence 35788999999999999999984 568999999997543 3345788999999999999999999999854 3367
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEe---cCCccEE
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL---DDEMIGH 298 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~---~~~~~~k 298 (473)
++||||+++|+|.+++...... ...+++..+..++.|++.||.||| +++|+||||||+||++ +.++.+|
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~k 167 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSAQAR-----GKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIK 167 (285)
T ss_dssp EEEECCCSCCBHHHHHHHHHHH-----TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEE
T ss_pred EEEEEeCCCCcHHHHHHhhhhc-----ccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEE
Confidence 9999999999999998543110 013668899999999999999999 8999999999999999 4567899
Q ss_pred EeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 012014 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMAL 378 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~ 378 (473)
|+|||++....... ......||+.|+|||++. ..++.++||||||+++|+|++|..||.+...... ........
T Consensus 168 l~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~--~~~~~~~~ 241 (285)
T 3is5_A 168 IIDFGLAELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV--QQKATYKE 241 (285)
T ss_dssp ECCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHCC
T ss_pred EEeeecceecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH--HhhhccCC
Confidence 99999998654322 233456899999999986 4689999999999999999999999976422110 00000000
Q ss_pred CcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 379 PQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
+.... .....+..+.+|+.+||+.||++|||+.||++
T Consensus 242 ~~~~~--------------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 242 PNYAV--------------------------------ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CCCCC----------------------------------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ccccc--------------------------------ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 00012456789999999999999999999974
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=349.18 Aligned_cols=279 Identities=18% Similarity=0.222 Sum_probs=198.4
Q ss_pred cccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCC--CchhHHHHHHHHHhcCCCCceeeeeeeecccc-CC
Q 012014 142 NATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAFSGVDY-QG 217 (473)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~ 217 (473)
...++|.+.+.||+|+||.||+|.. .+|+.||||++...... ..+.+.+|+.+++.++||||+++++++..... ..
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 101 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 101 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence 3467899999999999999999984 57999999998643221 23567899999999999999999999865421 12
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccE
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~ 297 (473)
....++||||+ +++|.+++... .+++..+..++.||+.||.||| ++||+||||||+|||++.++.+
T Consensus 102 ~~~~~lv~e~~-~~~L~~~~~~~----------~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~ 167 (367)
T 1cm8_A 102 FTDFYLVMPFM-GTDLGKLMKHE----------KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCEL 167 (367)
T ss_dssp CCCCEEEEECC-SEEHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCE
T ss_pred CceEEEEEecC-CCCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCE
Confidence 24569999999 88999999763 2568899999999999999999 8999999999999999999999
Q ss_pred EEeecccccccCccccccceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 012014 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKM 376 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~ 376 (473)
||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+ .+......
T Consensus 168 kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~l~~i~~~ 241 (367)
T 1cm8_A 168 KILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMKV 241 (367)
T ss_dssp EECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHH
T ss_pred EEEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHh
Confidence 99999999865432 233568999999999877 679999999999999999999999998643221 12222221
Q ss_pred hcCc--chhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 377 ALPQ--RAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 377 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.... .....+.......+.. ...... ...........+..+.+|+.+||..||++|||+.|+++
T Consensus 242 ~g~~~~~~~~~~~~~~~~~~~~---~~~~~~----~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 242 TGTPPAEFVQRLQSDEAKNYMK---GLPELE----KKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HCCCCHHHHHTCSCHHHHHHHH---HSCCCC----CCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred cCCCCHHHHHHhhhHHHHHHHH---hCCCCC----CCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 1111 1101111000000000 000000 00011111234567889999999999999999999876
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=359.60 Aligned_cols=262 Identities=15% Similarity=0.144 Sum_probs=196.6
Q ss_pred cccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeecc---CCCCchhHHHHH---HHHHhcCCCCceeeee------
Q 012014 142 NATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI---RPGGSKSFKSEC---KAAINIKHRNIVRVFT------ 208 (473)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~h~niv~~~~------ 208 (473)
...++|.+.+.||+|+||.||+|. ..+|+.||||++... .....+.+.+|+ ++++.++|||||++++
T Consensus 70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~ 149 (377)
T 3byv_A 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 149 (377)
T ss_dssp CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence 345789999999999999999999 467999999999743 233446788999 4555568999999984
Q ss_pred -eeecccc-------CCc-----eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCC
Q 012014 209 -AFSGVDY-------QGA-----RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDC 275 (473)
Q Consensus 209 -~~~~~~~-------~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~ 275 (473)
++...+. .+. ...++||||+ +|+|.+++........ ....+++..++.++.||+.||.|||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH--- 223 (377)
T 3byv_A 150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSS--THKSLVHHARLQLTLQVIRLLASLH--- 223 (377)
T ss_dssp EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTT--TTHHHHHHHHHHHHHHHHHHHHHHH---
T ss_pred hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhcccccc--ccccccHHHHHHHHHHHHHHHHHHH---
Confidence 4332210 000 1368999999 6899999976432211 1224667888899999999999999
Q ss_pred CCCeeeccCCCCcEEecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCC-----------CCCcccchh
Q 012014 276 QPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-----------EASTYGDVY 344 (473)
Q Consensus 276 ~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Diw 344 (473)
+++|+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||
T Consensus 224 ~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dvw 297 (377)
T 3byv_A 224 HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAW 297 (377)
T ss_dssp HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHH
T ss_pred hCCeecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHH
Confidence 89999999999999999999999999999985322 3344567 999999999887 799999999
Q ss_pred hHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHH
Q 012014 345 SFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSI 424 (473)
Q Consensus 345 SlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 424 (473)
||||++|||++|..||.+...... ...+... ....+..+
T Consensus 298 SlG~il~elltg~~Pf~~~~~~~~-------------~~~~~~~----------------------------~~~~~~~~ 336 (377)
T 3byv_A 298 ALGLVIYWIWCADLPITKDAALGG-------------SEWIFRS----------------------------CKNIPQPV 336 (377)
T ss_dssp HHHHHHHHHHHSSCCC------CC-------------SGGGGSS----------------------------CCCCCHHH
T ss_pred HHHHHHHHHHHCCCCCcccccccc-------------hhhhhhh----------------------------ccCCCHHH
Confidence 999999999999999975322111 0000000 01234578
Q ss_pred HHHhhhcccCCCCCCCChHHHHH--HHHHHHHhh
Q 012014 425 CEIGVACSAERPRERMKINDVES--RLRLIRRKL 456 (473)
Q Consensus 425 ~~l~~~cl~~dP~~RPt~~ev~~--~L~~l~~~~ 456 (473)
.+|+.+||+.||++|||+.|+++ .++.++..+
T Consensus 337 ~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~ 370 (377)
T 3byv_A 337 RALLEGFLRYPKEDRLLPLQAMETPEYEQLRTEL 370 (377)
T ss_dssp HHHHHHHTCSSGGGCCCHHHHHTSHHHHHHHHHH
T ss_pred HHHHHHHcCCCchhCCCHHHHhhChHHHHHHHHH
Confidence 89999999999999999999986 666665543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=346.77 Aligned_cols=272 Identities=19% Similarity=0.186 Sum_probs=194.2
Q ss_pred hhhcccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHHHHHHhcC-CCCceeeeeeeecccc-
Q 012014 139 DLYNATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK-HRNIVRVFTAFSGVDY- 215 (473)
Q Consensus 139 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~- 215 (473)
.+.....+|++.++||+|+||.||+|+. .+++.||+|++..........+.+|+.++.++. ||||+++++++.....
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 101 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE 101 (337)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence 3444556899999999999999999994 578999999987554445567889999999996 9999999999853221
Q ss_pred --CCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCC--eeeccCCCCcEEe
Q 012014 216 --QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPP--IAHCNLKPSNVLL 291 (473)
Q Consensus 216 --~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~Dlkp~Nil~ 291 (473)
......+++|||+. |+|.+++....... .+++.+++.++.||+.||.||| +++ |+||||||+|||+
T Consensus 102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~------~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~ 171 (337)
T 3ll6_A 102 SDTGQAEFLLLTELCK-GQLVEFLKKMESRG------PLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLL 171 (337)
T ss_dssp STTSSEEEEEEEECCS-EEHHHHHHHHHTTC------SCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEE
T ss_pred cccCCceEEEEEEecC-CCHHHHHHHhhccC------CCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEE
Confidence 34556899999995 79999886522111 3668999999999999999999 888 9999999999999
Q ss_pred cCCccEEEeecccccccCcccccc----------ceeeccCCCCcCCCccc---cCCCCCcccchhhHhHHHHHHHhCCC
Q 012014 292 DDEMIGHVGDFGMARFLPAIDKQN----------RFICIKGSTGYIPPEYD---LGCEASTYGDVYSFGILLLEMFTGIR 358 (473)
Q Consensus 292 ~~~~~~kl~Dfg~~~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwSlG~il~elltg~~ 358 (473)
+.++.+||+|||+++......... ......||+.|+|||++ .+..++.++||||||+++|+|++|..
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~ 251 (337)
T 3ll6_A 172 SNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH 251 (337)
T ss_dssp CTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSC
T ss_pred CCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCC
Confidence 999999999999998765432111 11234589999999998 56678999999999999999999999
Q ss_pred CCCCCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCC
Q 012014 359 PSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRE 438 (473)
Q Consensus 359 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~ 438 (473)
||....... .......... ....+..+.+|+.+||+.||.+
T Consensus 252 p~~~~~~~~-----~~~~~~~~~~----------------------------------~~~~~~~~~~li~~~l~~~p~~ 292 (337)
T 3ll6_A 252 PFEDGAKLR-----IVNGKYSIPP----------------------------------HDTQYTVFHSLIRAMLQVNPEE 292 (337)
T ss_dssp CC-----------------CCCCT----------------------------------TCCSSGGGHHHHHHHSCSSGGG
T ss_pred CCcchhHHH-----hhcCcccCCc----------------------------------ccccchHHHHHHHHHccCChhh
Confidence 996532111 0000000000 0012234678999999999999
Q ss_pred CCChHHHHHHHHHHHHhhccC
Q 012014 439 RMKINDVESRLRLIRRKLLET 459 (473)
Q Consensus 439 RPt~~ev~~~L~~l~~~~~~~ 459 (473)
|||+.|+++.|+.+.......
T Consensus 293 Rps~~e~l~~l~~~~~~~~~~ 313 (337)
T 3ll6_A 293 RLSIAEVVHQLQEIAAARNVN 313 (337)
T ss_dssp SCCHHHHHHHHHHHHHHTTCC
T ss_pred CcCHHHHHHHHHHHHhccCCC
Confidence 999999999999998765433
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=371.19 Aligned_cols=253 Identities=23% Similarity=0.328 Sum_probs=198.8
Q ss_pred ceeecCCCeEEEEEEe---cCCCEEEEEEeeccCC--CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEEE
Q 012014 151 NLIGAGNFGSVYNGTL---FDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVY 225 (473)
Q Consensus 151 ~~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (473)
+.||+|+||.||+|.+ .+++.||||+++.... ...+.+.+|+.++.+++|||||++++++.. ...++||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~------~~~~lv~ 448 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA------ESWMLVM 448 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES------SSEEEEE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------CCEEEEE
Confidence 4799999999999964 3467899999975322 234679999999999999999999999843 2368999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecccc
Q 012014 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (473)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~ 305 (473)
||+++|+|.+++.... .+++.+++.++.||+.||.||| +++|+||||||+|||++.++.+||+|||++
T Consensus 449 E~~~~g~L~~~l~~~~---------~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla 516 (635)
T 4fl3_A 449 EMAELGPLNKYLQQNR---------HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLS 516 (635)
T ss_dssp ECCTTEEHHHHHHHCT---------TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHH
T ss_pred EccCCCCHHHHHhhCC---------CCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCc
Confidence 9999999999997654 3568899999999999999999 899999999999999999999999999999
Q ss_pred cccCccccc-cceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcCcchh
Q 012014 306 RFLPAIDKQ-NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMALPQRAE 383 (473)
Q Consensus 306 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 383 (473)
+.+...... .......||+.|+|||++.+..++.++|||||||++|||++ |..||.+....+ +...+.....
T Consensus 517 ~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~--~~~~i~~~~~---- 590 (635)
T 4fl3_A 517 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAMLEKGER---- 590 (635)
T ss_dssp HHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTTCC----
T ss_pred cccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCC----
Confidence 876543221 22233446889999999999899999999999999999998 999997643211 1111110000
Q ss_pred hhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHHhhc
Q 012014 384 EVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRKLL 457 (473)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~~~ 457 (473)
...+..++..+.+|+..||+.||++|||+.+|++.|+.+..++.
T Consensus 591 ------------------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l~ 634 (635)
T 4fl3_A 591 ------------------------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 634 (635)
T ss_dssp ------------------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHC
T ss_pred ------------------------------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhc
Confidence 00112356688999999999999999999999999999987653
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=345.66 Aligned_cols=268 Identities=23% Similarity=0.359 Sum_probs=203.4
Q ss_pred ccCCCCccceeecCCCeEEEEEEe------cCCCEEEEEEeeccC-CCCchhHHHHHHHHHhcCCCCceeeeeeeecccc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTL------FDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY 215 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 215 (473)
..++|.+.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.++.+++||||+++++++...
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 105 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS-- 105 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC--
Confidence 457899999999999999999983 346789999986432 22345688999999999999999999998543
Q ss_pred CCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecC--
Q 012014 216 QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD-- 293 (473)
Q Consensus 216 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~-- 293 (473)
...++||||+++|+|.+++......... ...+++.+++.++.||+.||.||| +++|+||||||+|||++.
T Consensus 106 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~ 177 (327)
T 2yfx_A 106 ---LPRFILMELMAGGDLKSFLRETRPRPSQ--PSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPG 177 (327)
T ss_dssp ---SSCEEEEECCTTEEHHHHHHHTSCCSSS--TTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSS
T ss_pred ---CCcEEEEecCCCCcHHHHHHhhcccccc--cccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCC
Confidence 3569999999999999999876432211 124668899999999999999999 899999999999999984
Q ss_pred -CccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHH
Q 012014 294 -EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLR 371 (473)
Q Consensus 294 -~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~ 371 (473)
+..+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||.+..... +.
T Consensus 178 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~ 255 (327)
T 2yfx_A 178 PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE--VL 255 (327)
T ss_dssp TTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HH
T ss_pred CcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH--HH
Confidence 45699999999976543332223334557899999999988899999999999999999998 999997532111 11
Q ss_pred HHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHH
Q 012014 372 NFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRL 451 (473)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 451 (473)
..+...... ..+..++..+.+|+.+||+.||.+|||+.||++.|+.
T Consensus 256 ~~~~~~~~~----------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~ 301 (327)
T 2yfx_A 256 EFVTSGGRM----------------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY 301 (327)
T ss_dssp HHHHTTCCC----------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHhcCCCC----------------------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence 111000000 0011245578899999999999999999999999999
Q ss_pred HHHhh
Q 012014 452 IRRKL 456 (473)
Q Consensus 452 l~~~~ 456 (473)
+....
T Consensus 302 ~~~~~ 306 (327)
T 2yfx_A 302 CTQDP 306 (327)
T ss_dssp HHHCH
T ss_pred HhcCH
Confidence 97643
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=335.50 Aligned_cols=254 Identities=24% Similarity=0.308 Sum_probs=196.0
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
.++|....+||+|+||.||+|. ..+++.||+|.+........+.+.+|+.++..++||||+++++++... ...+
T Consensus 21 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-----~~~~ 95 (295)
T 2clq_A 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN-----GFIK 95 (295)
T ss_dssp BCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEE
T ss_pred ccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC-----CcEE
Confidence 4456666799999999999999 457889999999866655667899999999999999999999998543 3679
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecC-CccEEEee
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD-EMIGHVGD 301 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~-~~~~kl~D 301 (473)
+||||+++++|.+++...... ..+++..+..++.|++.||.||| +++|+||||||+||+++. ++.+||+|
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~D 166 (295)
T 2clq_A 96 IFMEQVPGGSLSALLRSKWGP------LKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISD 166 (295)
T ss_dssp EEEECCSEEEHHHHHHHTTCC------CTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccC------CCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEee
Confidence 999999999999999765321 13457888899999999999999 899999999999999987 89999999
Q ss_pred cccccccCccccccceeeccCCCCcCCCccccCCC--CCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcC
Q 012014 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE--ASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP 379 (473)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 379 (473)
||++....... .......||+.|+|||++.+.. ++.++||||||+++|+|++|..||...................
T Consensus 167 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 244 (295)
T 2clq_A 167 FGTSKRLAGIN--PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVH 244 (295)
T ss_dssp TTTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCC
T ss_pred cccccccCCCC--CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccc
Confidence 99998664322 1223456899999999987643 8899999999999999999999996432211100000000000
Q ss_pred cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 380 QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
. ..+...+..+.+|+.+||+.||++|||+.|+++
T Consensus 245 ~----------------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 245 P----------------------------------EIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp C----------------------------------CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred c----------------------------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 001124557889999999999999999999864
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=349.44 Aligned_cols=288 Identities=18% Similarity=0.217 Sum_probs=202.4
Q ss_pred hcccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeecccc----
Q 012014 141 YNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY---- 215 (473)
Q Consensus 141 ~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---- 215 (473)
....++|.+.+.||+|+||.||+|. ..+|+.||+|++.... ....+|+.+++.++||||++++++|.....
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 3456789999999999999999998 4679999999986432 233479999999999999999999865331
Q ss_pred -----------------------------CCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHH
Q 012014 216 -----------------------------QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVAC 266 (473)
Q Consensus 216 -----------------------------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~ 266 (473)
....+.++||||++ |+|.+.+...... ...+++..+..++.||+.
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-----~~~l~~~~~~~i~~qi~~ 152 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS-----GRSIPMNLISIYIYQLFR 152 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc-----CCCCCHHHHHHHHHHHHH
Confidence 23445889999997 5887777532110 013668899999999999
Q ss_pred HHHHHhhCCCCCeeeccCCCCcEEec-CCccEEEeecccccccCccccccceeeccCCCCcCCCccccCC-CCCcccchh
Q 012014 267 ALRYLHCDCQPPIAHCNLKPSNVLLD-DEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVY 344 (473)
Q Consensus 267 ~L~~LH~~~~~~iiH~Dlkp~Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Diw 344 (473)
||.||| ++||+||||||+|||++ .++.+||+|||+++...... ......||+.|+|||++.+. .++.++|||
T Consensus 153 aL~~LH---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw 226 (383)
T 3eb0_A 153 AVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLW 226 (383)
T ss_dssp HHHHHH---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHH
T ss_pred HHHHHH---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhh
Confidence 999999 99999999999999997 68899999999998764432 22344689999999998775 489999999
Q ss_pred hHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccc--cCCCCcchhhHHHHHHH
Q 012014 345 SFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVS--SSSGSSAHASIILECFN 422 (473)
Q Consensus 345 SlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 422 (473)
||||++|+|++|..||.+....+ .+..++..........+... ........ ...........+...+.
T Consensus 227 slG~il~ell~g~~pf~~~~~~~-~~~~i~~~~g~p~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (383)
T 3eb0_A 227 SIGCVFGELILGKPLFSGETSID-QLVRIIQIMGTPTKEQMIRM---------NPHYTEVRFPTLKAKDWRKILPEGTPS 296 (383)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHHHH---------CTTC--CCCCCCCCCCHHHHSCTTCCH
T ss_pred hHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHHHh---------CcccccccCCccCcccHHhhCCCCCCH
Confidence 99999999999999998743222 22222222211111111000 00000000 00001111112223566
Q ss_pred HHHHHhhhcccCCCCCCCChHHHHH--HHHHHHH
Q 012014 423 SICEIGVACSAERPRERMKINDVES--RLRLIRR 454 (473)
Q Consensus 423 ~l~~l~~~cl~~dP~~RPt~~ev~~--~L~~l~~ 454 (473)
.+.+|+.+||+.||.+|||+.|+++ .++.++.
T Consensus 297 ~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 297 LAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcCHHHHHHHh
Confidence 7899999999999999999999984 4565554
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=358.88 Aligned_cols=252 Identities=25% Similarity=0.300 Sum_probs=200.0
Q ss_pred ccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccC---CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
..++|.+.++||+|+||.||+|+. .+|+.||+|+++... ......+.+|+.++.+++||||++++++|.+ .
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-----~ 257 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET-----K 257 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----S
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee-----C
Confidence 346799999999999999999995 569999999997422 2345678899999999999999999999854 3
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...++||||++||+|.+++...... ...+++..+..++.||+.||.||| ++||+||||||+|||++.+|.+|
T Consensus 258 ~~l~lVmE~~~gg~L~~~l~~~~~~-----~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vk 329 (543)
T 3c4z_A 258 TDLCLVMTIMNGGDIRYHIYNVDED-----NPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVR 329 (543)
T ss_dssp SEEEEEECCCTTCBHHHHHHTSSTT-----SCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEE
T ss_pred CEEEEEEEeccCCCHHHHHHHhhcc-----cccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEE
Confidence 4689999999999999999765321 113678999999999999999999 89999999999999999999999
Q ss_pred EeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 012014 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMAL 378 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~ 378 (473)
|+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+...... ...+.....
T Consensus 330 L~DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~-~~~~~~~i~ 406 (543)
T 3c4z_A 330 ISDLGLAVELKAGQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKELKQRVL 406 (543)
T ss_dssp ECCCTTCEECCTTC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC-HHHHHHHHH
T ss_pred EeecceeeeccCCC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh-HHHHHHHHh
Confidence 99999998764432 122345799999999999999999999999999999999999999986432211 111111100
Q ss_pred CcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCCh
Q 012014 379 PQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKI 442 (473)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 442 (473)
.... ..+...+..+.+|+.+||+.||.+||++
T Consensus 407 ~~~~--------------------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 407 EQAV--------------------------------TYPDKFSPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp HCCC--------------------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred hccc--------------------------------CCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence 0000 0011235578899999999999999976
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=339.03 Aligned_cols=250 Identities=21% Similarity=0.275 Sum_probs=197.2
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
.++|.+.+.||+|+||.||+|+. .+|+.||+|+++.........+.+|+.++..++||||+++++++.+ ....+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~ 82 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYES-----TTHYY 82 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEEC-----SSEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhccc-----CCEEE
Confidence 35788999999999999999994 4789999999986554455678999999999999999999999854 34679
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEe---cCCccEEE
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL---DDEMIGHV 299 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~---~~~~~~kl 299 (473)
+||||+++++|.+++.... .+++..+..++.|++.||.||| +++|+||||||+||++ +.++.+||
T Consensus 83 lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl 150 (304)
T 2jam_A 83 LVMQLVSGGELFDRILERG---------VYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMI 150 (304)
T ss_dssp EEECCCCSCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEB
T ss_pred EEEEcCCCccHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEE
Confidence 9999999999999987543 3568899999999999999999 8999999999999999 78899999
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcC
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP 379 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 379 (473)
+|||++...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+..... .+..+......
T Consensus 151 ~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~~~~~~ 225 (304)
T 2jam_A 151 TDFGLSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK-LFEKIKEGYYE 225 (304)
T ss_dssp CSCSTTCCCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHCCCC
T ss_pred ccCCcceecCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHcCCCC
Confidence 999999754322 1223458999999999999899999999999999999999999997532111 00111000000
Q ss_pred cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 380 QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.. .......+..+.+|+.+||+.||++|||+.|+++
T Consensus 226 -~~-------------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 226 -FE-------------------------------SPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp -CC-------------------------------TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred -CC-------------------------------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00 0001124567889999999999999999999976
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=360.59 Aligned_cols=250 Identities=20% Similarity=0.281 Sum_probs=197.8
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeecc--CCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI--RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
.++|.+.++||+|+||.||+|.. .+++.||||++... .......+.+|+.++++++||||+++++++.+ ...
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~ 95 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-----SSS 95 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----SSE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc-----CCE
Confidence 35789999999999999999994 47899999999642 23445778999999999999999999999854 346
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEec---CCccE
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD---DEMIG 297 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~---~~~~~ 297 (473)
.++|||||.+|+|.+++.... .+++.++..++.||+.||.||| ++||+||||||+|||++ .++.+
T Consensus 96 ~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~ 163 (486)
T 3mwu_A 96 FYIVGELYTGGELFDEIIKRK---------RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDI 163 (486)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCE
T ss_pred EEEEEEcCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCE
Confidence 899999999999999887653 3668999999999999999999 89999999999999995 45679
Q ss_pred EEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
||+|||+++..... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+..... .+.......
T Consensus 164 kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~ 238 (486)
T 3mwu_A 164 KIIDFGLSTCFQQN---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-ILKRVETGK 238 (486)
T ss_dssp EECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTC
T ss_pred EEEECCcCeECCCC---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCC
Confidence 99999999866432 22334569999999999876 59999999999999999999999997642211 111111110
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.+... +.....+..+.+|+.+||+.||.+|||+.|+++
T Consensus 239 ~~~~~--------------------------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 239 YAFDL--------------------------------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp CCSCS--------------------------------GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCCC--------------------------------cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00000 001124567889999999999999999999986
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=345.50 Aligned_cols=246 Identities=20% Similarity=0.266 Sum_probs=194.1
Q ss_pred CCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCC---chhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGG---SKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
+.|...+.||+|+||.||+|+ ..+++.||||++....... .+.+.+|+.++.+++||||+++++++... ..
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-----~~ 128 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HT 128 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-----Ce
Confidence 458889999999999999998 4678999999997543222 24688999999999999999999998653 36
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.++||||+. |+|.+++..... .+++.++..++.|++.||.||| +++|+||||||+|||++.++.+||+
T Consensus 129 ~~lv~e~~~-g~l~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~ 196 (348)
T 1u5q_A 129 AWLVMEYCL-GSASDLLEVHKK--------PLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLG 196 (348)
T ss_dssp EEEEEECCS-EEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEEC
T ss_pred EEEEEecCC-CCHHHHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEe
Confidence 799999996 688888854321 3668899999999999999999 8999999999999999999999999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCcccc---CCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDL---GCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
|||+++..... ....||+.|+|||++. +..++.++|||||||++|||++|..||.+...... +.......
T Consensus 197 DfG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-~~~~~~~~ 269 (348)
T 1u5q_A 197 DFGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNE 269 (348)
T ss_dssp CCTTCBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHSC
T ss_pred eccCceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHhcC
Confidence 99999865432 2346899999999984 56789999999999999999999999975321110 11111100
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
.+. .. ....+..+.+|+.+||+.||++|||+.++++.
T Consensus 270 ~~~----~~------------------------------~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 270 SPA----LQ------------------------------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp CCC----CC------------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCC----CC------------------------------CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000 00 01134567899999999999999999999753
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=362.54 Aligned_cols=250 Identities=22% Similarity=0.316 Sum_probs=200.4
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccC---CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCce
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (473)
.++|++.++||+|+||.||+|.. .+++.||||++.... ......+.+|+.++++++||||+++++++.+ ..
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~ 99 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED-----KG 99 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-----CC
Confidence 35789999999999999999994 478999999997433 2345678999999999999999999999854 34
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEe---cCCcc
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL---DDEMI 296 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~---~~~~~ 296 (473)
..++||||+.+|+|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|||+ +.++.
T Consensus 100 ~~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~ 167 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEIISRK---------RFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDAN 167 (484)
T ss_dssp EEEEEECCCCSCBHHHHHHTCS---------CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCC
T ss_pred EEEEEEecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCc
Confidence 7899999999999999997654 3668999999999999999999 8999999999999999 56789
Q ss_pred EEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 012014 297 GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKM 376 (473)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~ 376 (473)
+||+|||+++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+..... .+......
T Consensus 168 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~ 242 (484)
T 3nyv_A 168 IRIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD-ILKKVEKG 242 (484)
T ss_dssp EEECCTTHHHHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHC
T ss_pred EEEEeeeeeEEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHcC
Confidence 9999999998764422 2334569999999999876 69999999999999999999999997642211 01111110
Q ss_pred hcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 377 ALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
...... +.....+..+.+|+.+||+.||.+|||+.|+++
T Consensus 243 ~~~~~~--------------------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 243 KYTFEL--------------------------------PQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp CCCCCS--------------------------------GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCC--------------------------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 000000 001124567889999999999999999999986
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=347.34 Aligned_cols=254 Identities=19% Similarity=0.265 Sum_probs=198.2
Q ss_pred cCCCCccceeecCCCeEEEEEEe----cCCCEEEEEEeeccC----CCCchhHHHHHHHHHhc-CCCCceeeeeeeeccc
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL----FDGTTIAVKVFNLIR----PGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVD 214 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~ 214 (473)
.++|.+.+.||+|+||.||+|+. .+++.||||+++... ....+.+.+|+.++.++ +||||+++++++...
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~- 131 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE- 131 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC-
Confidence 46799999999999999999985 378999999986422 23456678899999999 699999999998543
Q ss_pred cCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCC
Q 012014 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE 294 (473)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~ 294 (473)
...++||||+++|+|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|||++.+
T Consensus 132 ----~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~ 195 (355)
T 1vzo_A 132 ----TKLHLILDYINGGELFTHLSQRE---------RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSN 195 (355)
T ss_dssp ----TEEEEEECCCCSCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTT
T ss_pred ----ceEEEEeecCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCC
Confidence 36799999999999999997643 3568899999999999999999 8999999999999999999
Q ss_pred ccEEEeecccccccCccccccceeeccCCCCcCCCccccC--CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHH
Q 012014 295 MIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG--CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRN 372 (473)
Q Consensus 295 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~ 372 (473)
+.+||+|||+++...... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ ...
T Consensus 196 ~~~kl~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-~~~ 273 (355)
T 1vzo_A 196 GHVVLTDFGLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAE 273 (355)
T ss_dssp SCEEESCSSEEEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHH
T ss_pred CcEEEeeCCCCeecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch-HHH
Confidence 999999999998664322 222334569999999999986 3478999999999999999999999975432221 111
Q ss_pred HHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCC-----ChHHHHH
Q 012014 373 FVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERM-----KINDVES 447 (473)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~ 447 (473)
+........ ...+...+..+.+|+.+||..||.+|| |+.|+++
T Consensus 274 ~~~~~~~~~--------------------------------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~ 321 (355)
T 1vzo_A 274 ISRRILKSE--------------------------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 321 (355)
T ss_dssp HHHHHHHCC--------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred HHHHHhccC--------------------------------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence 111110000 000112345678999999999999999 8888876
Q ss_pred H
Q 012014 448 R 448 (473)
Q Consensus 448 ~ 448 (473)
.
T Consensus 322 h 322 (355)
T 1vzo_A 322 H 322 (355)
T ss_dssp S
T ss_pred C
Confidence 4
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=340.46 Aligned_cols=251 Identities=19% Similarity=0.257 Sum_probs=194.8
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCC--------CCchhHHHHHHHHHhcCCCCceeeeeeeeccc
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--------GGSKSFKSECKAAINIKHRNIVRVFTAFSGVD 214 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 214 (473)
.++|.+.+.||+|+||.||+|.. .+++.||||++..... .....+.+|+.++.+++||||+++++++...
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 87 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE- 87 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC-
Confidence 35789999999999999999984 5688999999864321 2234688999999999999999999997432
Q ss_pred cCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCC
Q 012014 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE 294 (473)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~ 294 (473)
..++||||+++|+|.+++.... .+++..+..++.||+.||.||| +++|+||||||+||+++.+
T Consensus 88 -----~~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~ 150 (322)
T 2ycf_A 88 -----DYYIVLELMEGGELFDKVVGNK---------RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQ 150 (322)
T ss_dssp -----SEEEEEECCTTEETHHHHSTTC---------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSS
T ss_pred -----ceEEEEecCCCCcHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecC
Confidence 2699999999999999997654 3568899999999999999999 8999999999999999876
Q ss_pred cc---EEEeecccccccCccccccceeeccCCCCcCCCcccc---CCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcc
Q 012014 295 MI---GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDL---GCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKM 368 (473)
Q Consensus 295 ~~---~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~ 368 (473)
+. +||+|||+++...... ......||+.|+|||++. ...++.++|||||||++|+|++|..||........
T Consensus 151 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 227 (322)
T 2ycf_A 151 EEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS 227 (322)
T ss_dssp SSSCCEEECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC
T ss_pred CCCCeEEEccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH
Confidence 54 9999999998764321 223345899999999973 46689999999999999999999999976433322
Q ss_pred cHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 369 NLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
+...+....... .+......+..+.+|+.+||+.||++|||+.|+++
T Consensus 228 -~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 228 -LKDQITSGKYNF-------------------------------IPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp -HHHHHHHTCCCC-------------------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred -HHHHHHhCcccc-------------------------------CchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 111111110000 00111234567889999999999999999999984
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=359.64 Aligned_cols=251 Identities=20% Similarity=0.262 Sum_probs=197.2
Q ss_pred ccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCC-------------CCchhHHHHHHHHHhcCCCCceeeee
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP-------------GGSKSFKSECKAAINIKHRNIVRVFT 208 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~~~~ 208 (473)
..++|.+.++||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 457899999999999999999994 5688999999974331 23457889999999999999999999
Q ss_pred eeeccccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCc
Q 012014 209 AFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSN 288 (473)
Q Consensus 209 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~N 288 (473)
+|.+ ....++|||||++|+|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|
T Consensus 114 ~~~~-----~~~~~lv~e~~~gg~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~N 176 (504)
T 3q5i_A 114 VFED-----KKYFYLVTEFYEGGELFEQIINRH---------KFDECDAANIMKQILSGICYLH---KHNIVHRDIKPEN 176 (504)
T ss_dssp EEEC-----SSEEEEEEECCTTCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGG
T ss_pred EEEc-----CCEEEEEEecCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHH
Confidence 9854 347899999999999999987643 3668999999999999999999 8999999999999
Q ss_pred EEecCCc---cEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCC
Q 012014 289 VLLDDEM---IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFT 365 (473)
Q Consensus 289 il~~~~~---~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~ 365 (473)
||++.++ .+||+|||+++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+...
T Consensus 177 il~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 252 (504)
T 3q5i_A 177 ILLENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQND 252 (504)
T ss_dssp EEESSTTCCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred EEEecCCCCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9998776 69999999998765422 2334569999999999874 699999999999999999999999986422
Q ss_pred CcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHH
Q 012014 366 GKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDV 445 (473)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev 445 (473)
.. .+........... .......+..+.+|+.+||+.||.+|||+.|+
T Consensus 253 ~~-~~~~i~~~~~~~~--------------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~ 299 (504)
T 3q5i_A 253 QD-IIKKVEKGKYYFD--------------------------------FNDWKNISDEAKELIKLMLTYDYNKRCTAEEA 299 (504)
T ss_dssp HH-HHHHHHHCCCCCC--------------------------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HH-HHHHHHcCCCCCC--------------------------------ccccCCCCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 11 0111100000000 00112245678899999999999999999998
Q ss_pred HH
Q 012014 446 ES 447 (473)
Q Consensus 446 ~~ 447 (473)
++
T Consensus 300 l~ 301 (504)
T 3q5i_A 300 LN 301 (504)
T ss_dssp HT
T ss_pred hc
Confidence 75
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=358.46 Aligned_cols=250 Identities=20% Similarity=0.274 Sum_probs=194.3
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccC--CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
.++|++.++||+|+||.||+|+. .++..||+|++.... ......+.+|+.+++.++||||++++++|.+ ...
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~ 110 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED-----KRN 110 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SSE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-----CCE
Confidence 34689999999999999999994 478999999997543 3345678999999999999999999999854 346
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecC---CccE
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD---EMIG 297 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~---~~~~ 297 (473)
.++|||||++|+|.+++.... .+++..+..++.||+.||.||| ++||+||||||+|||++. ++.+
T Consensus 111 ~~lv~e~~~~g~L~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~ 178 (494)
T 3lij_A 111 YYLVMECYKGGELFDEIIHRM---------KFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALI 178 (494)
T ss_dssp EEEEEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCE
T ss_pred EEEEEecCCCCcHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcE
Confidence 799999999999999887653 3568899999999999999999 899999999999999976 4559
Q ss_pred EEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
||+|||+++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+..... .+.......
T Consensus 179 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~ 253 (494)
T 3lij_A 179 KIVDFGLSAVFENQK---KMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQE-ILRKVEKGK 253 (494)
T ss_dssp EECCCTTCEECBTTB---CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTC
T ss_pred EEEECCCCeECCCCc---cccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCC
Confidence 999999998764422 2334569999999999864 69999999999999999999999997643211 011111100
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
..... +.....+..+.+|+.+||+.||.+|||+.|+++
T Consensus 254 ~~~~~--------------------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 254 YTFDS--------------------------------PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp CCCCS--------------------------------GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCCc--------------------------------hhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 00000 000123557889999999999999999999985
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=343.56 Aligned_cols=283 Identities=19% Similarity=0.224 Sum_probs=201.4
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCC--CCchhHHHHHHHHHhcCCCCceeeeeeeecccc---CC
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY---QG 217 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~ 217 (473)
.++|++.+.||+|+||.||+|+. .+|+.||+|++..... .....+.+|+.++..++||||+++++++..... ..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 46899999999999999999995 6789999999864332 234578899999999999999999999865431 11
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccE
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~ 297 (473)
....++||||++ |+|.+.+..... .+++.++..++.||+.||.||| ++||+||||||+|||++.++.+
T Consensus 96 ~~~~~lv~e~~~-~~l~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~ 163 (351)
T 3mi9_A 96 KGSIYLVFDFCE-HDLAGLLSNVLV--------KFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVL 163 (351)
T ss_dssp -CEEEEEEECCS-EEHHHHHHCTTS--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCE
T ss_pred CceEEEEEeccC-CCHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCE
Confidence 346799999996 588887765432 3668999999999999999999 8999999999999999999999
Q ss_pred EEeecccccccCcccc--ccceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 012014 298 HVGDFGMARFLPAIDK--QNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFV 374 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~ 374 (473)
||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..... .+....
T Consensus 164 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~ 242 (351)
T 3mi9_A 164 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-QLALIS 242 (351)
T ss_dssp EECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHH
T ss_pred EEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHH
Confidence 9999999987643221 222344568999999999876 458999999999999999999999998643221 111111
Q ss_pred Hhhc--Cc-chhhhccccchHHHHhhhhhhcccccCCCCcch-hhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 375 KMAL--PQ-RAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAH-ASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 375 ~~~~--~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.... +. ............. ............ .-........+.+|+.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 243 QLCGSITPEVWPNVDNYELYEK--------LELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp HHHCCCCTTTSTTGGGCGGGTS--------SCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhCCCChhhccccccchhhcc--------cccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 1111 11 0000000000000 000000000000 0000112456889999999999999999999876
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=343.91 Aligned_cols=277 Identities=21% Similarity=0.262 Sum_probs=195.5
Q ss_pred cccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCC-----CCchhHHHHHHHHHhcCCCCceeeeeeeecccc
Q 012014 142 NATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP-----GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY 215 (473)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 215 (473)
...++|.+.+.||+|+||.||+|.. .+|+.||+|+++.... .....+.+|+.++..++||||+++++++.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-- 84 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK-- 84 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT--
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC--
Confidence 3457899999999999999999994 4689999999974322 1235688999999999999999999998543
Q ss_pred CCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCc
Q 012014 216 QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM 295 (473)
Q Consensus 216 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~ 295 (473)
...++||||+++ +|.+++..... .+++.++..++.|++.||.||| +++|+||||||+|||++.++
T Consensus 85 ---~~~~lv~e~~~~-~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~ 149 (346)
T 1ua2_A 85 ---SNISLVFDFMET-DLEVIIKDNSL--------VLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENG 149 (346)
T ss_dssp ---TCCEEEEECCSE-EHHHHHTTCCS--------SCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTC
T ss_pred ---CceEEEEEcCCC-CHHHHHHhcCc--------CCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCC
Confidence 367999999975 89999876532 3557788999999999999999 89999999999999999999
Q ss_pred cEEEeecccccccCccccccceeeccCCCCcCCCccccCC-CCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 012014 296 IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFV 374 (473)
Q Consensus 296 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~ 374 (473)
.+||+|||+++...... .......||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+....+ .+....
T Consensus 150 ~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~-~~~~i~ 226 (346)
T 1ua2_A 150 VLKLADFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIF 226 (346)
T ss_dssp CEEECCCGGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHH
T ss_pred CEEEEecccceeccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHH
Confidence 99999999998764322 223345689999999998764 48999999999999999999999997643221 122222
Q ss_pred HhhcCcchhhhccccchHHHHhhhhhhccccc-CCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 375 KMALPQRAEEVVDDFNLQEIEEGRTMCMEVSS-SSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
............+...... .... ..............+..+.+|+.+||+.||++|||+.|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 227 ETLGTPTEEQWPDMCSLPD---------YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp HHHCCCCTTTSSSTTSSTT---------CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred HHcCCCChhhhhhhccCcc---------cccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 2111111000000000000 0000 00000000111234578899999999999999999999876
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=345.92 Aligned_cols=285 Identities=16% Similarity=0.170 Sum_probs=195.1
Q ss_pred ccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCC--CCchhHHHHHHHHHhcCCCCceeeeeeeecccc-CCc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY-QGA 218 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~ 218 (473)
..++|.+.+.||+|+||.||+|. ..+++.||||++..... .....+.+|+.+++.++||||+++++++..... ...
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 35789999999999999999998 45689999999974322 223567899999999999999999999865431 223
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...++||||++ |+|.+++... +++..+..++.||+.||.||| ++||+||||||+|||++.++.+|
T Consensus 103 ~~~~lv~e~~~-~~l~~~~~~~-----------~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~k 167 (371)
T 2xrw_A 103 QDVYIVMELMD-ANLCQVIQME-----------LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLK 167 (371)
T ss_dssp CEEEEEEECCS-EEHHHHHHSC-----------CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEE
T ss_pred cceEEEEEcCC-CCHHHHHhhc-----------cCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEE
Confidence 46799999996 5898888632 458889999999999999999 89999999999999999999999
Q ss_pred EeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 012014 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMAL 378 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~ 378 (473)
|+|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+..... .+.......
T Consensus 168 l~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~- 242 (371)
T 2xrw_A 168 ILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQL- 242 (371)
T ss_dssp ECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHC-C-
T ss_pred EEEeecccccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHh-
Confidence 9999999865432 12234568999999999999899999999999999999999999998643211 111111111
Q ss_pred Ccchhhhccc---cchHHHHhhhhhh---c-ccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 379 PQRAEEVVDD---FNLQEIEEGRTMC---M-EVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 379 ~~~~~~~~~~---~~~~~~~~~~~~~---~-~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.....+.... ............. . ..................+..+.+|+.+||..||++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 243 GTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp CCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 0001111100 0000000000000 0 000000000011122345778999999999999999999999976
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=339.64 Aligned_cols=263 Identities=22% Similarity=0.274 Sum_probs=196.6
Q ss_pred CCCchhhhhcccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCC--CchhHHHHHHHHHhcC--CCCceeeee
Q 012014 133 NNPSFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIK--HRNIVRVFT 208 (473)
Q Consensus 133 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~--h~niv~~~~ 208 (473)
.+..++.+....++|++.+.||+|+||.||+|...+++.||+|++...... ..+.+.+|+.++.+++ ||||+++++
T Consensus 16 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~ 95 (313)
T 3cek_A 16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95 (313)
T ss_dssp ----CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred CCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEE
Confidence 445666677777889999999999999999999778999999999754322 3457889999999997 599999999
Q ss_pred eeeccccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCc
Q 012014 209 AFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSN 288 (473)
Q Consensus 209 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~N 288 (473)
++... ...++||| +.+++|.+++.... .+++.++..++.|++.||.||| +++|+||||||+|
T Consensus 96 ~~~~~-----~~~~lv~e-~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~N 157 (313)
T 3cek_A 96 YEITD-----QYIYMVME-CGNIDLNSWLKKKK---------SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPAN 157 (313)
T ss_dssp EEECS-----SEEEEEEC-CCSEEHHHHHHHCS---------SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGG
T ss_pred EeecC-----CEEEEEEe-cCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCccc
Confidence 98543 36899999 55889999998654 3558889999999999999999 8999999999999
Q ss_pred EEecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccC-----------CCCCcccchhhHhHHHHHHHhCC
Q 012014 289 VLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-----------CEASTYGDVYSFGILLLEMFTGI 357 (473)
Q Consensus 289 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwSlG~il~elltg~ 357 (473)
|++++ +.+||+|||+++...............||+.|+|||++.+ ..++.++||||||+++|+|++|.
T Consensus 158 Il~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~ 236 (313)
T 3cek_A 158 FLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236 (313)
T ss_dssp EEEET-TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSS
T ss_pred EEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCC
Confidence 99964 8999999999987654332222334568999999999875 46888999999999999999999
Q ss_pred CCCCCCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCC
Q 012014 358 RPSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPR 437 (473)
Q Consensus 358 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~ 437 (473)
.||.........+.......... . .+...+..+.+|+.+||+.||+
T Consensus 237 ~pf~~~~~~~~~~~~~~~~~~~~---~-------------------------------~~~~~~~~l~~li~~~l~~dp~ 282 (313)
T 3cek_A 237 TPFQQIINQISKLHAIIDPNHEI---E-------------------------------FPDIPEKDLQDVLKCCLKRDPK 282 (313)
T ss_dssp CTTTTCCSHHHHHHHHHCTTSCC---C-------------------------------CCCCSCHHHHHHHHHHTCSSTT
T ss_pred CchhhHHHHHHHHHHHHhccccc---C-------------------------------CcccchHHHHHHHHHHccCCcc
Confidence 99975432211111111000000 0 0001245788999999999999
Q ss_pred CCCChHHHHHH
Q 012014 438 ERMKINDVESR 448 (473)
Q Consensus 438 ~RPt~~ev~~~ 448 (473)
+|||+.|+++.
T Consensus 283 ~Rps~~ell~h 293 (313)
T 3cek_A 283 QRISIPELLAH 293 (313)
T ss_dssp TSCCHHHHHTS
T ss_pred cCcCHHHHhcC
Confidence 99999999763
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=341.07 Aligned_cols=267 Identities=21% Similarity=0.282 Sum_probs=200.1
Q ss_pred CCCchhhhhcccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHHHHHHhc-CCCCceeeeeee
Q 012014 133 NNPSFKDLYNATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-KHRNIVRVFTAF 210 (473)
Q Consensus 133 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 210 (473)
....+.++....++|++.+.||+|+||.||+|.. .+++.||+|++.... .....+.+|+.++.++ +||||+++++++
T Consensus 12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 90 (326)
T 2x7f_A 12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAF 90 (326)
T ss_dssp ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence 3445666777889999999999999999999994 578999999987433 3457889999999999 799999999998
Q ss_pred eccccC-CceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcE
Q 012014 211 SGVDYQ-GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNV 289 (473)
Q Consensus 211 ~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Ni 289 (473)
...... .....++||||+++|+|.+++..... ..+++..+..++.||+.||.||| ++||+||||||+||
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NI 160 (326)
T 2x7f_A 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-------NTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNV 160 (326)
T ss_dssp EECC--CCCCEEEEEEECCTTEEHHHHHHHSGG-------GCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGE
T ss_pred eeccCccccceEEEEEEcCCCCcHHHHHHhccc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHE
Confidence 653321 13467999999999999999976431 13668889999999999999999 89999999999999
Q ss_pred EecCCccEEEeecccccccCccccccceeeccCCCCcCCCcccc-----CCCCCcccchhhHhHHHHHHHhCCCCCCCCC
Q 012014 290 LLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDL-----GCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (473)
Q Consensus 290 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~P~~~~~ 364 (473)
+++.++.+||+|||++....... .......||+.|+|||++. +..++.++||||||+++|+|++|..||.+..
T Consensus 161 l~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 238 (326)
T 2x7f_A 161 LLTENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 238 (326)
T ss_dssp EECTTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred EEcCCCCEEEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 99999999999999998654321 1223346899999999987 5568999999999999999999999997532
Q ss_pred CCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHH
Q 012014 365 TGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKIND 444 (473)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 444 (473)
.... +........+ ... ....+..+.+|+.+||..||.+|||+.|
T Consensus 239 ~~~~-~~~~~~~~~~----~~~------------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ 283 (326)
T 2x7f_A 239 PMRA-LFLIPRNPAP----RLK------------------------------SKKWSKKFQSFIESCLVKNHSQRPATEQ 283 (326)
T ss_dssp HHHH-HHHHHHSCCC----CCS------------------------------CSCSCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred HHHH-HHHhhcCccc----cCC------------------------------ccccCHHHHHHHHHHhccChhhCCCHHH
Confidence 1110 0000000000 000 0113457889999999999999999999
Q ss_pred HHH
Q 012014 445 VES 447 (473)
Q Consensus 445 v~~ 447 (473)
+++
T Consensus 284 ll~ 286 (326)
T 2x7f_A 284 LMK 286 (326)
T ss_dssp HHT
T ss_pred Hhh
Confidence 976
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=333.28 Aligned_cols=251 Identities=19% Similarity=0.274 Sum_probs=202.6
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC-CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
.+.|.+.+.||+|+||.||+|. ..+++.||+|++.... ....+.+.+|+.++..++||||+++++++... ...
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 95 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-----TKL 95 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-----CeE
Confidence 4568999999999999999998 4578999999997543 23457789999999999999999999998653 367
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEee
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~D 301 (473)
++||||+++++|.+++... .+++..+..++.|++.||.||| ++||+||||||+||+++.++.+||+|
T Consensus 96 ~lv~e~~~~~~L~~~~~~~----------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~D 162 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLEPG----------PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLAD 162 (303)
T ss_dssp EEEEECCTTEEHHHHHTTS----------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECC
T ss_pred EEEEEeCCCCcHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEee
Confidence 9999999999999999753 3568899999999999999999 89999999999999999999999999
Q ss_pred cccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcc
Q 012014 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQR 381 (473)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 381 (473)
||++....... .......||+.|+|||++.+..++.++||||||+++|+|++|..||....... ....+....+..
T Consensus 163 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~ 238 (303)
T 3a7i_A 163 FGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK--VLFLIPKNNPPT 238 (303)
T ss_dssp CTTCEECBTTB--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHHHHHSCCCC
T ss_pred cccceecCccc--cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH--HHHHhhcCCCCC
Confidence 99998764322 12234568999999999999899999999999999999999999997532111 000000000000
Q ss_pred hhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHH
Q 012014 382 AEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLR 450 (473)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 450 (473)
.....+..+.+|+.+||+.||++|||+.||++..-
T Consensus 239 ----------------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~ 273 (303)
T 3a7i_A 239 ----------------------------------LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF 273 (303)
T ss_dssp ----------------------------------CCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred ----------------------------------CccccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence 00123457889999999999999999999987543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=343.54 Aligned_cols=277 Identities=18% Similarity=0.244 Sum_probs=198.6
Q ss_pred ccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCC--chhHHHHHHHHHhcCCCCceeeeeeeeccccCCce
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGG--SKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (473)
..++|++.+.||+|+||.||+|.. .+++.||+|++....... .+.+.+|+.++.+++||||+++++++.+. .
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~ 97 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK-----K 97 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----T
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC-----C
Confidence 346899999999999999999994 458999999986443221 34577999999999999999999998643 3
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
..++||||+++++|.+++.... .+++..+..++.||+.||.||| ++||+||||||+||+++.++.+||
T Consensus 98 ~~~lv~e~~~~~~l~~~~~~~~---------~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl 165 (331)
T 4aaa_A 98 RWYLVFEFVDHTILDDLELFPN---------GLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKL 165 (331)
T ss_dssp EEEEEEECCSEEHHHHHHHSTT---------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEE
T ss_pred EEEEEEecCCcchHHHHHhhcc---------CCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEE
Confidence 6799999999999998876544 3568899999999999999999 899999999999999999999999
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccCC-CCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMAL 378 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~ 378 (473)
+|||+++...... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||.+...... +........
T Consensus 166 ~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~ 242 (331)
T 4aaa_A 166 CDFGFARTLAAPG--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ-LYHIMMCLG 242 (331)
T ss_dssp CCCTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHC
T ss_pred EeCCCceeecCCc--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhC
Confidence 9999998654322 222345689999999998875 689999999999999999999999986433221 111111110
Q ss_pred C--cchhhhccccchHHHHhhhhh-hcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 379 P--QRAEEVVDDFNLQEIEEGRTM-CMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 379 ~--~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
. ........ ..... ....................+..+.+|+.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 243 NLIPRHQELFN--------KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp SCCHHHHHHHH--------HCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCChhhhhHhh--------hccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0 00000000 00000 00000000011111122345778999999999999999999999875
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=337.07 Aligned_cols=282 Identities=20% Similarity=0.258 Sum_probs=206.1
Q ss_pred cccCCCCccceeecCCCeEEEEEEe--cCCCEEEEEEeeccC--CCCchhHHHHHHHHHhc---CCCCceeeeeeeeccc
Q 012014 142 NATNGFSSANLIGAGNFGSVYNGTL--FDGTTIAVKVFNLIR--PGGSKSFKSECKAAINI---KHRNIVRVFTAFSGVD 214 (473)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~ 214 (473)
...++|.+.+.||+|+||.||+|.. .+++.||+|+++... ......+.+|+.+++.+ +||||+++++++....
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 3457899999999999999999995 467899999997432 23345678888888776 8999999999986433
Q ss_pred cCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCC
Q 012014 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE 294 (473)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~ 294 (473)
.......++||||+. |+|.+++...... .+++..+..++.||+.||.||| ++||+||||||+||+++.+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~ 156 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEP-------GVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSS 156 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTT-------CSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTT
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccC-------CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCC
Confidence 334567899999997 6999999765422 3668899999999999999999 8999999999999999999
Q ss_pred ccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 012014 295 MIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFV 374 (473)
Q Consensus 295 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~ 374 (473)
+.+||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+..... .+....
T Consensus 157 ~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~i~ 232 (326)
T 1blx_A 157 GQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKIL 232 (326)
T ss_dssp CCEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHH
T ss_pred CCEEEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHH
Confidence 999999999998664322 2334568999999999999899999999999999999999999998643221 112222
Q ss_pred HhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 375 KMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
................... ... ...............+..+.+|+.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~-------~~~--~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 233 DVIGLPGEEDWPRDVALPR-------QAF--HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp HHHCCCCGGGSCTTCSSCG-------GGS--CCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHcCCCCcccCccccccch-------hhh--cccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1111110000000000000 000 000000011112235667889999999999999999999974
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=337.81 Aligned_cols=254 Identities=20% Similarity=0.333 Sum_probs=198.3
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccC----CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR----PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
.++|.+.+.||+|+||.||+|.. .+++.||+|+++... ......+.+|+.++..++||||+++++++.. ...
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~ 80 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN---EEK 80 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC---C--
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc---CCC
Confidence 46899999999999999999994 568999999997432 2345678999999999999999999999853 223
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...++||||++++ |.+++...... .+++..+..++.||+.||.||| +++|+||||||+||+++.++.+|
T Consensus 81 ~~~~lv~e~~~~~-l~~~~~~~~~~-------~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~k 149 (305)
T 2wtk_C 81 QKMYMVMEYCVCG-MQEMLDSVPEK-------RFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLK 149 (305)
T ss_dssp -CEEEEEECCSEE-HHHHHHHSTTC-------SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEE
T ss_pred CeEEEEehhccCC-HHHHHHhCccc-------ccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEE
Confidence 4679999999776 77777654322 3668899999999999999999 89999999999999999999999
Q ss_pred EeecccccccCccccccceeeccCCCCcCCCccccCCC--CCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 012014 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE--ASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKM 376 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~ 376 (473)
|+|||++................||+.|+|||++.+.. ++.++||||||+++|+|++|..||.+... ......
T Consensus 150 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~ 224 (305)
T 2wtk_C 150 ISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI-----YKLFEN 224 (305)
T ss_dssp ECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHH
T ss_pred eeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH-----HHHHHH
Confidence 99999998765433333444566999999999987644 47899999999999999999999975321 111110
Q ss_pred hcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 377 ALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
...... ..+..++..+.+|+.+||+.||.+|||+.|+++.
T Consensus 225 i~~~~~--------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 225 IGKGSY--------------------------------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp HHHCCC--------------------------------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred HhcCCC--------------------------------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000000 0011235578899999999999999999999864
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=341.50 Aligned_cols=264 Identities=18% Similarity=0.202 Sum_probs=202.2
Q ss_pred CCCchhhhhcccCCCCcc-ceeecCCCeEEEEEEe-cCCCEEEEEEeeccCC--CCchhHHHHHHHHHhc-CCCCceeee
Q 012014 133 NNPSFKDLYNATNGFSSA-NLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--GGSKSFKSECKAAINI-KHRNIVRVF 207 (473)
Q Consensus 133 ~~~~~~~~~~~~~~~~~~-~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~ 207 (473)
.+..|+......+.|.+. +.||+|+||.||+|.. .+++.||+|+++.... .....+.+|+.++..+ +||||++++
T Consensus 16 ~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~ 95 (327)
T 3lm5_A 16 ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH 95 (327)
T ss_dssp CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred hhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence 344555555566677777 8899999999999984 4689999999975332 2346788999999999 469999999
Q ss_pred eeeeccccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCC
Q 012014 208 TAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPS 287 (473)
Q Consensus 208 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~ 287 (473)
+++.. ....++||||+++|+|.+++...... .+++.++..++.|++.||.||| ++||+||||||+
T Consensus 96 ~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~-------~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~ 160 (327)
T 3lm5_A 96 EVYEN-----TSEIILILEYAAGGEIFSLCLPELAE-------MVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQ 160 (327)
T ss_dssp EEEEC-----SSEEEEEEECCTTEEGGGGGSSCC-C-------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGG
T ss_pred EEEEe-----CCeEEEEEEecCCCcHHHHHHHhccc-------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChH
Confidence 99854 34689999999999999998654322 3668999999999999999999 899999999999
Q ss_pred cEEecC---CccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCC
Q 012014 288 NVLLDD---EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (473)
Q Consensus 288 Nil~~~---~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~ 364 (473)
||+++. ++.+||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+..
T Consensus 161 NIl~~~~~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 237 (327)
T 3lm5_A 161 NILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED 237 (327)
T ss_dssp GEEESCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HEEEecCCCCCcEEEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999987 7899999999998764322 2234569999999999999999999999999999999999999997643
Q ss_pred CCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHH
Q 012014 365 TGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKIND 444 (473)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 444 (473)
.... +........ .... ......+..+.+|+.+||+.||++|||+.|
T Consensus 238 ~~~~-~~~i~~~~~-~~~~-------------------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ 284 (327)
T 3lm5_A 238 NQET-YLNISQVNV-DYSE-------------------------------ETFSSVSQLATDFIQSLLVKNPEKRPTAEI 284 (327)
T ss_dssp HHHH-HHHHHHTCC-CCCT-------------------------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred chHH-HHHHHhccc-ccCc-------------------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHH
Confidence 2111 011100000 0000 001124557889999999999999999999
Q ss_pred HHH
Q 012014 445 VES 447 (473)
Q Consensus 445 v~~ 447 (473)
+++
T Consensus 285 ll~ 287 (327)
T 3lm5_A 285 CLS 287 (327)
T ss_dssp HTT
T ss_pred HhC
Confidence 875
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=339.45 Aligned_cols=249 Identities=19% Similarity=0.229 Sum_probs=200.2
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCC---CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCce
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP---GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (473)
.++|.+.+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+ ..
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~ 88 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-----ND 88 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc-----CC
Confidence 45799999999999999999994 4688999999875332 234568899999999999999999999854 34
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
..++||||+++++|.+++.... .+++.++..++.|++.||.||| +++|+||||||+||+++.++.+||
T Consensus 89 ~~~lv~e~~~~~~L~~~~~~~~---------~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl 156 (294)
T 2rku_A 89 FVFVVLELCRRRSLLELHKRRK---------ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKI 156 (294)
T ss_dssp EEEEEEECCTTCBHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEE
T ss_pred EEEEEEecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEE
Confidence 6799999999999999987643 3568899999999999999999 899999999999999999999999
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcC
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP 379 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 379 (473)
+|||++....... .......||+.|+|||++.+..++.++||||||+++|+|++|..||......+ .......
T Consensus 157 ~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~ 229 (294)
T 2rku_A 157 GDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE-----TYLRIKK 229 (294)
T ss_dssp CCCTTCEECCSTT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH-----HHHHHHT
T ss_pred EeccCceecccCc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHhh
Confidence 9999998764322 22234568999999999999889999999999999999999999997532111 1000000
Q ss_pred cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 380 QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
... ..+...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 230 ~~~--------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 230 NEY--------------------------------SIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp TCC--------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccC--------------------------------CCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 000 0001234567889999999999999999999874
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=344.36 Aligned_cols=249 Identities=19% Similarity=0.236 Sum_probs=200.2
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCC---CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCce
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP---GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (473)
.++|.+.+.||+|+||.||++.. .+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+. .
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~ 114 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN-----D 114 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----S
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-----C
Confidence 45799999999999999999994 4588999999875322 2345688999999999999999999998643 4
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
..++||||+++++|.+++.... .+++.+++.++.||+.||.||| +++|+||||||+||+++.++.+||
T Consensus 115 ~~~lv~e~~~~~~L~~~~~~~~---------~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl 182 (335)
T 2owb_A 115 FVFVVLELCRRRSLLELHKRRK---------ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKI 182 (335)
T ss_dssp EEEEEECCCTTCBHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEE
T ss_pred eEEEEEecCCCCCHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEE
Confidence 6899999999999999987643 3568899999999999999999 899999999999999999999999
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcC
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP 379 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 379 (473)
+|||+++...... .......||+.|+|||++.+..++.++||||||+++|+|++|..||........ +........
T Consensus 183 ~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~- 258 (335)
T 2owb_A 183 GDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET-YLRIKKNEY- 258 (335)
T ss_dssp CCCTTCEECCSTT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-HHHHHHTCC-
T ss_pred eeccCceecccCc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH-HHHHhcCCC-
Confidence 9999998764322 222345689999999999998899999999999999999999999975321110 000000000
Q ss_pred cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHH
Q 012014 380 QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
. .+...+..+.+|+.+||+.||++|||+.|+++.
T Consensus 259 -~----------------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 259 -S----------------------------------IPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp -C----------------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -C----------------------------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 001234567889999999999999999999863
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=335.90 Aligned_cols=246 Identities=22% Similarity=0.343 Sum_probs=199.3
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeecc---CCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCce
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (473)
.++|.+.+.||+|+||.||+|.. .+++.||+|++... .......+.+|+.++..++||||+++++++.+ ..
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~ 87 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD-----RK 87 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SS
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc-----CC
Confidence 46799999999999999999994 46789999998642 22345678999999999999999999999854 34
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
..++||||+++|+|.+++.... .+++..+..++.|++.||.||| +++|+||||||+||+++.++.+||
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl 155 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQKHG---------RFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKI 155 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEE
T ss_pred EEEEEEEeCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEE
Confidence 6799999999999999997653 3568899999999999999999 999999999999999999999999
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcC
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP 379 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 379 (473)
+|||++....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||....... .......
T Consensus 156 ~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~ 226 (284)
T 2vgo_A 156 ADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE-----THRRIVN 226 (284)
T ss_dssp CCCTTCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-----HHHHHHT
T ss_pred ecccccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH-----HHHHHhc
Confidence 9999987654321 234568999999999999899999999999999999999999997532111 1100000
Q ss_pred cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 380 QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
... ..+...+..+.+|+.+||+.||.+|||+.|+++
T Consensus 227 ~~~--------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 227 VDL--------------------------------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp TCC--------------------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccc--------------------------------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 000 000123457789999999999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=342.58 Aligned_cols=254 Identities=20% Similarity=0.294 Sum_probs=199.3
Q ss_pred hcccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCC--------chhHHHHHHHHHhc-CCCCceeeeeee
Q 012014 141 YNATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGG--------SKSFKSECKAAINI-KHRNIVRVFTAF 210 (473)
Q Consensus 141 ~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l-~h~niv~~~~~~ 210 (473)
....++|.+.+.||+|+||.||+|.. .+|+.||||++....... .+.+.+|+.++.++ +||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 33456799999999999999999995 479999999997543211 34578999999999 799999999998
Q ss_pred eccccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEE
Q 012014 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVL 290 (473)
Q Consensus 211 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil 290 (473)
.. ....++||||+++++|.+++.... .+++..+..++.||+.||.||| +.||+||||||+||+
T Consensus 170 ~~-----~~~~~lv~e~~~g~~L~~~l~~~~---------~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl 232 (365)
T 2y7j_A 170 ES-----SSFMFLVFDLMRKGELFDYLTEKV---------ALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENIL 232 (365)
T ss_dssp EB-----SSEEEEEECCCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEE
T ss_pred ee-----CCEEEEEEEeCCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEE
Confidence 54 346899999999999999997543 3668899999999999999999 899999999999999
Q ss_pred ecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccC------CCCCcccchhhHhHHHHHHHhCCCCCCCCC
Q 012014 291 LDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG------CEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (473)
Q Consensus 291 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwSlG~il~elltg~~P~~~~~ 364 (473)
++.++.+||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..
T Consensus 233 ~~~~~~ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 309 (365)
T 2y7j_A 233 LDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR 309 (365)
T ss_dssp ECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ECCCCCEEEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC
Confidence 9999999999999998765422 2334569999999998863 358899999999999999999999997532
Q ss_pred CCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHH
Q 012014 365 TGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKIND 444 (473)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e 444 (473)
... .+........... .+.....+..+.+|+.+||+.||++|||+.|
T Consensus 310 ~~~-~~~~i~~~~~~~~--------------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e 356 (365)
T 2y7j_A 310 QIL-MLRMIMEGQYQFS--------------------------------SPEWDDRSSTVKDLISRLLQVDPEARLTAEQ 356 (365)
T ss_dssp HHH-HHHHHHHTCCCCC--------------------------------HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred HHH-HHHHHHhCCCCCC--------------------------------CcccccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 110 0000000000000 0001123567889999999999999999999
Q ss_pred HHH
Q 012014 445 VES 447 (473)
Q Consensus 445 v~~ 447 (473)
+++
T Consensus 357 ll~ 359 (365)
T 2y7j_A 357 ALQ 359 (365)
T ss_dssp HHH
T ss_pred Hhc
Confidence 975
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=347.00 Aligned_cols=281 Identities=17% Similarity=0.237 Sum_probs=187.5
Q ss_pred cccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCC--CCchhHHHHHHHHHhcCCCCceeeeeeeeccc-cCC
Q 012014 142 NATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVD-YQG 217 (473)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~ 217 (473)
...++|.+.+.||+|+||.||+|. ..+|+.||||++..... .....+.+|+.+++.++||||+++++++.... ...
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 105 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 105 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence 445889999999999999999998 46789999999864322 22356789999999999999999999986532 122
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccE
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~ 297 (473)
....++||||+ +++|.+++... .+++..+..++.||+.||.||| ++||+||||||+|||++.++.+
T Consensus 106 ~~~~~lv~e~~-~~~L~~~~~~~----------~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~ 171 (367)
T 2fst_X 106 FNDVYLVTHLM-GADLNNIVKCQ----------KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCEL 171 (367)
T ss_dssp CCCCEEEEECC-CEECC-----C----------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCE
T ss_pred CCeEEEEeccc-CCCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCE
Confidence 34579999999 78999988753 3668899999999999999999 8999999999999999999999
Q ss_pred EEeecccccccCccccccceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 012014 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKM 376 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~ 376 (473)
||+|||+++.... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||.+....+ .+..+...
T Consensus 172 kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~l~~i~~~ 245 (367)
T 2fst_X 172 KILDFGLARHTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRL 245 (367)
T ss_dssp EECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHH
T ss_pred EEeeccccccccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHH
Confidence 9999999986532 1234568999999999887 678999999999999999999999998643211 12222221
Q ss_pred hcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 377 ALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.... ..+................... .............+..+.+|+.+||..||++|||+.|+++
T Consensus 246 ~g~p-~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 246 VGTP-GAELLKKISSESARNYIQSLTQ----MPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HCSC-CHHHHTTCCCHHHHHHHHTSCC----CCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hCCC-CHHHHHHhhhHHHHHHHhccCC----CCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 1111 1111111100000000000000 0000011111234567889999999999999999999875
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=372.64 Aligned_cols=244 Identities=20% Similarity=0.226 Sum_probs=198.1
Q ss_pred ccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeecc---CCCCchhHHHHHHHHHhc-CCCCceeeeeeeeccccCC
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI---RPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQG 217 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 217 (473)
..++|.+.++||+|+||.||+|+ ..+++.||||+++.. .....+.+..|..++..+ +||||++++++|.+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~----- 413 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT----- 413 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC-----
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe-----
Confidence 45789999999999999999999 456889999999742 334566788999999987 79999999999754
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccE
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~ 297 (473)
....++||||+++|+|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|||++.++.+
T Consensus 414 ~~~~~lV~E~~~gg~L~~~l~~~~---------~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~i 481 (674)
T 3pfq_A 414 MDRLYFVMEYVNGGDLMYHIQQVG---------RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHI 481 (674)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCE
T ss_pred CCEEEEEEeCcCCCcHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcE
Confidence 347899999999999999998654 3668999999999999999999 8999999999999999999999
Q ss_pred EEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
||+|||+++..... ........||+.|+|||++.+..++.++|||||||++|||++|..||.+.... ......
T Consensus 482 kL~DFGla~~~~~~--~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~-----~~~~~i 554 (674)
T 3pfq_A 482 KIADFGMCKENIWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-----ELFQSI 554 (674)
T ss_dssp EECCCTTCEECCCT--TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHH
T ss_pred EEeecceeeccccC--CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH-----HHHHHH
Confidence 99999999864322 22344567999999999999999999999999999999999999999863221 111111
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCCh
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKI 442 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 442 (473)
..... ..+...+.++.+|+.+||+.||++||++
T Consensus 555 ~~~~~--------------------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 555 MEHNV--------------------------------AYPKSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp HSSCC--------------------------------CCCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred HhCCC--------------------------------CCCccCCHHHHHHHHHHccCCHHHCCCC
Confidence 11000 0011234578899999999999999998
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=343.01 Aligned_cols=287 Identities=19% Similarity=0.205 Sum_probs=203.7
Q ss_pred cccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCce
Q 012014 142 NATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (473)
...++|.+.+.||+|+||.||+|.. .+|+.||||+++.... .....+.+|+.++++++||||+++++++.........
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 3467899999999999999999994 4689999999864321 1234678999999999999999999998665444456
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
..++||||+. |+|.+++... .+++..+..++.|++.||.||| ++||+||||||+||+++.++.+||
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~~----------~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl 153 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVISTQ----------MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKV 153 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEE
T ss_pred eEEEEEeccC-ccHHHHHhhc----------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEE
Confidence 7899999996 6999998764 2568899999999999999999 899999999999999999999999
Q ss_pred eecccccccCcccccc--------ceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccH
Q 012014 300 GDFGMARFLPAIDKQN--------RFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNL 370 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~ 370 (473)
+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+..... .+
T Consensus 154 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~ 232 (353)
T 2b9h_A 154 CDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH-QL 232 (353)
T ss_dssp CCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HH
T ss_pred EecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HH
Confidence 9999998764322111 1223468999999998764 678999999999999999999999998643221 11
Q ss_pred HHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 371 RNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
..+........................... .... ............+..+.+|+.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 233 LLIFGIIGTPHSDNDLRCIESPRAREYIKS---LPMY-PAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp HHHHHHHCCCCSTTTTTTCCCHHHHHHHHT---SCCC-CCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhCCCchhccccccccchhhHHhhc---ccCC-CCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 111111111000000000000000000000 0000 000011112245678899999999999999999999876
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=338.15 Aligned_cols=254 Identities=20% Similarity=0.238 Sum_probs=196.2
Q ss_pred cccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 142 NATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
...++|++.+.||+|+||.||+|.. .+++.||+|++........+.+.+|+.++..++||||+++++++... ..
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~ 90 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHD-----GK 90 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC------C
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC-----Ce
Confidence 3456899999999999999999995 45899999999866666678899999999999999999999998643 36
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.++||||+++++|.+++..... .+++..+..++.|++.||.||| ++|++||||||+||+++.++.+||+
T Consensus 91 ~~lv~e~~~~~~l~~~~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~ 159 (302)
T 2j7t_A 91 LWIMIEFCPGGAVDAIMLELDR--------GLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLA 159 (302)
T ss_dssp EEEEEECCTTEEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEEC
T ss_pred EEEEEEeCCCCcHHHHHHhhcc--------CCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEE
Confidence 7999999999999999865321 3668899999999999999999 8999999999999999999999999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCccc-----cCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYD-----LGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVK 375 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~ 375 (473)
|||++....... .......||+.|+|||++ .+..++.++||||||+++|+|++|..||........ +.....
T Consensus 160 Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~ 236 (302)
T 2j7t_A 160 DFGVSAKNLKTL--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-LLKIAK 236 (302)
T ss_dssp CCHHHHHHHHHH--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHH
T ss_pred ECCCCccccccc--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH-HHHHhc
Confidence 999976432111 112234589999999997 466789999999999999999999999976422110 011100
Q ss_pred hhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 376 MALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
...+ ... .+...+..+.+|+.+||+.||++|||+.|+++
T Consensus 237 ~~~~----~~~-----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 237 SDPP----TLL-----------------------------TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp SCCC----CCS-----------------------------SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred cCCc----ccC-----------------------------CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0000 000 01123557889999999999999999999875
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=348.02 Aligned_cols=199 Identities=26% Similarity=0.330 Sum_probs=170.4
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
.++|.+.+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+.++..++||||+++++++... ...
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-----~~~ 106 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GEI 106 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET-----TEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC-----CEE
Confidence 35799999999999999999994 4689999999975422 2345688999999999999999999998653 367
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCC-CeeeccCCCCcEEecCCccEEEe
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQP-PIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~-~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
++||||+++|+|.+++.... .+++..+..++.|++.||.||| ++ +|+||||||+||+++.++.+||+
T Consensus 107 ~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~ 174 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKKAG---------RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLC 174 (360)
T ss_dssp EEEECCCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEEC
T ss_pred EEEEECCCCCCHHHHHHHcC---------CCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEE
Confidence 99999999999999997653 3558889999999999999999 75 99999999999999999999999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCC
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 363 (473)
|||++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 175 Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 175 DFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp CCCCCHHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred ECCCCcccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999755321 223356899999999999999999999999999999999999999764
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=334.81 Aligned_cols=251 Identities=19% Similarity=0.273 Sum_probs=195.5
Q ss_pred ccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
..++|++.+.||+|+||.||+|.. .+|+.||+|++... .....+.+|+.++..++||||+++++++... ...
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~~ 99 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKN-----TDL 99 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEET-----TEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeC-----CEE
Confidence 456799999999999999999985 45899999999753 3467899999999999999999999998643 367
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEee
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~D 301 (473)
++||||+++++|.+++..... .+++..+..++.|++.||.||| +++++|+||||+||+++.++.+||+|
T Consensus 100 ~lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~d 168 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRLRNK--------TLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLAD 168 (314)
T ss_dssp EEEEECCTTEEHHHHHHHHTC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECC
T ss_pred EEEeecCCCCCHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEee
Confidence 999999999999999863221 3668999999999999999999 89999999999999999999999999
Q ss_pred cccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcc
Q 012014 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQR 381 (473)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 381 (473)
||++....... .......||+.|+|||++.+..++.++||||||+++|+|++|..||........ ........+..
T Consensus 169 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~ 244 (314)
T 3com_A 169 FGVAGQLTDTM--AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA--IFMIPTNPPPT 244 (314)
T ss_dssp CTTCEECBTTB--SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHHSCCCC
T ss_pred cccchhhhhhc--cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHhcCCCcc
Confidence 99998664322 122345689999999999998999999999999999999999999975321110 00000000000
Q ss_pred hhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 382 AEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
. ..+...+..+.+|+.+||+.||.+|||+.++++
T Consensus 245 ~--------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 245 F--------------------------------RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp C--------------------------------SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred c--------------------------------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0 001123557889999999999999999999976
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=334.88 Aligned_cols=257 Identities=21% Similarity=0.273 Sum_probs=199.3
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCC--CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
.++|++.+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+.++++++||||+++++++.+. ....
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~ 81 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTT 81 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG---GGTE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC---CCce
Confidence 46799999999999999999994 4789999999975432 2345688999999999999999999987542 2346
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCC-----eeeccCCCCcEEecCCc
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPP-----IAHCNLKPSNVLLDDEM 295 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~-----iiH~Dlkp~Nil~~~~~ 295 (473)
.++||||+++|+|.+++...... ...+++..++.++.|++.||.||| +++ |+||||||+||+++.++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~ 153 (279)
T 2w5a_A 82 LYIVMEYCEGGDLASVITKGTKE-----RQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQ 153 (279)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSS
T ss_pred EEEEEeCCCCCCHHHHHHhhccc-----CCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCC
Confidence 79999999999999999754211 012668999999999999999999 777 99999999999999999
Q ss_pred cEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 012014 296 IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVK 375 (473)
Q Consensus 296 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~ 375 (473)
.+||+|||+++...... .......||+.|+|||++.+..++.++||||||+++|+|++|..||....... +...+.
T Consensus 154 ~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~i~ 229 (279)
T 2w5a_A 154 NVKLGDFGLARILNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--LAGKIR 229 (279)
T ss_dssp CEEECCCCHHHHC---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHH
T ss_pred CEEEecCchheeecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH--HHHHHh
Confidence 99999999998654322 11223458999999999999899999999999999999999999997642111 111110
Q ss_pred hhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHH
Q 012014 376 MALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRL 449 (473)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L 449 (473)
.. .... .+...+..+.+|+.+||+.||++|||+.||++.+
T Consensus 230 ~~---~~~~-------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~ 269 (279)
T 2w5a_A 230 EG---KFRR-------------------------------IPYRYSDELNEIITRMLNLKDYHRPSVEEILENP 269 (279)
T ss_dssp HT---CCCC-------------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred hc---cccc-------------------------------CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence 00 0000 0112456788999999999999999999998754
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=332.57 Aligned_cols=248 Identities=22% Similarity=0.328 Sum_probs=191.7
Q ss_pred ccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeecc---CCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
..++|.+.+.||+|+||.||+|.. .+++.||+|++... .......+.+|+.+++.++||||+++++++...
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 83 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP----- 83 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC-----
Confidence 346899999999999999999995 47899999999742 233456789999999999999999999998543
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...++||||+++++|.+++.... .+++..+..++.|++.||.||| +++|+||||||+||+++.++.+|
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~ 151 (276)
T 2h6d_A 84 TDFFMVMEYVSGGELFDYICKHG---------RVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAK 151 (276)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEE
T ss_pred CeEEEEEeccCCCcHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEE
Confidence 36799999999999999997653 3568899999999999999999 89999999999999999999999
Q ss_pred EeecccccccCccccccceeeccCCCCcCCCccccCCCC-CcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEA-STYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
|+|||++....... ......||+.|+|||.+.+..+ +.++||||||+++|+|++|..||....... +...+...
T Consensus 152 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~ 226 (276)
T 2h6d_A 152 IADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT--LFKKIRGG 226 (276)
T ss_dssp ECCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHC
T ss_pred EeecccccccCCCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH--HHHHhhcC
Confidence 99999998764322 2233458999999999988765 689999999999999999999997532110 00000000
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
... .+...+..+.+++.+||+.||++|||+.||++
T Consensus 227 ~~~-----------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 227 VFY-----------------------------------IPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp CCC-----------------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccc-----------------------------------CchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 000 00113456789999999999999999999986
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=348.12 Aligned_cols=285 Identities=15% Similarity=0.177 Sum_probs=201.4
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcC--------CCCceeeeeeeeccc
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK--------HRNIVRVFTAFSGVD 214 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~~~~~~~~~~ 214 (473)
.++|.+.++||+|+||.||+|+ ..+++.||||+++.. ....+.+.+|+.++..++ ||||++++++|....
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 4789999999999999999998 456889999998632 223456889999999985 788999999986432
Q ss_pred cCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCC-CeeeccCCCCcEEecC
Q 012014 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQP-PIAHCNLKPSNVLLDD 293 (473)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~-~iiH~Dlkp~Nil~~~ 293 (473)
......++||||+ +++|.+++...... .+++..+..++.||+.||.||| ++ ||+||||||+|||++.
T Consensus 115 -~~~~~~~lv~e~~-~~~l~~~~~~~~~~-------~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~ 182 (397)
T 1wak_A 115 -VNGTHICMVFEVL-GHHLLKWIIKSNYQ-------GLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSV 182 (397)
T ss_dssp -TTEEEEEEEECCC-CCBHHHHHHHTTTS-------CCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECC
T ss_pred -CCCceEEEEEecc-CccHHHHHHhcccC-------CCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEec
Confidence 2345789999999 66777776544321 3668999999999999999999 87 9999999999999987
Q ss_pred Cc-------------------------------------------------cEEEeecccccccCccccccceeeccCCC
Q 012014 294 EM-------------------------------------------------IGHVGDFGMARFLPAIDKQNRFICIKGST 324 (473)
Q Consensus 294 ~~-------------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~ 324 (473)
++ .+||+|||+++..... .....||+
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~ 257 (397)
T 1wak_A 183 NEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTR 257 (397)
T ss_dssp CHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCG
T ss_pred cchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCC
Confidence 75 7999999999876432 23346899
Q ss_pred CcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCccc-----HHHHHHhhcCcchhhhc-cccchHH-HHhh
Q 012014 325 GYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMN-----LRNFVKMALPQRAEEVV-DDFNLQE-IEEG 397 (473)
Q Consensus 325 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~-----~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~ 397 (473)
.|+|||++.+..++.++|||||||++|+|++|..||.+....... +......... ...... ....... +...
T Consensus 258 ~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~p~~~~~~~~~~~~~~~~~ 336 (397)
T 1wak_A 258 QYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGK-VPRKLIVAGKYSKEFFTKK 336 (397)
T ss_dssp GGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCS-CCHHHHHHCTTGGGTBCTT
T ss_pred cccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCC-CChHHhhcccccccccCCc
Confidence 999999999999999999999999999999999999875443321 1111111100 000000 0000000 0000
Q ss_pred hhhhcccccCCCCc-----chhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 398 RTMCMEVSSSSGSS-----AHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 398 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.............. .........+..+.+|+.+||+.||++|||+.|+++
T Consensus 337 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 337 GDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp SSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred cccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 00000000000000 000123456788999999999999999999999975
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=349.20 Aligned_cols=209 Identities=20% Similarity=0.248 Sum_probs=155.2
Q ss_pred CCc-cceeecCCCeEEEEEEec---CCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 147 FSS-ANLIGAGNFGSVYNGTLF---DGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 147 ~~~-~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
|.+ .++||+|+||.||+|+.. +++.||+|++... .....+.+|+.++++++||||++++++|... .....+
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---~~~~~~ 96 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSH---ADRKVW 96 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEET---TTTEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecC---CCCeEE
Confidence 444 568999999999999854 5789999998643 3456788999999999999999999998542 244789
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEe----cCCccEE
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL----DDEMIGH 298 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~----~~~~~~k 298 (473)
+||||+. |+|.+++..............+++..+..++.||+.||.||| +++|+||||||+|||+ +.++.+|
T Consensus 97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEE
Confidence 9999995 688888753321110111123678999999999999999999 8999999999999999 6778999
Q ss_pred EeecccccccCcccc-ccceeeccCCCCcCCCccccCC-CCCcccchhhHhHHHHHHHhCCCCCCCCC
Q 012014 299 VGDFGMARFLPAIDK-QNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~ 364 (473)
|+|||+++....... ........||+.|+|||++.+. .++.++|||||||++|+|++|..||.+..
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 999999987643221 1223446789999999998874 58999999999999999999999997643
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=347.17 Aligned_cols=278 Identities=20% Similarity=0.234 Sum_probs=196.2
Q ss_pred cCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeecccc-CCceeeE
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY-QGARFKA 222 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~ 222 (473)
..+|.+.++||+|+||.||+|+...+..+|+|++.... ....+|+.+++.++||||++++++|..... ....+.+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 35699999999999999999997677779999886432 223479999999999999999999865442 3345578
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEec-CCccEEEee
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD-DEMIGHVGD 301 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~-~~~~~kl~D 301 (473)
+||||++++ +.+.+...... ...+++..+..++.||+.||.||| ++||+||||||+|||++ .++.+||+|
T Consensus 115 lv~e~~~~~-l~~~~~~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~D 185 (394)
T 4e7w_A 115 LVLEYVPET-VYRASRHYAKL-----KQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLID 185 (394)
T ss_dssp EEEECCSEE-HHHHHHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECC
T ss_pred EEeeccCcc-HHHHHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEee
Confidence 999999764 44433211000 013668889999999999999999 89999999999999999 799999999
Q ss_pred cccccccCccccccceeeccCCCCcCCCccccCC-CCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCc
Q 012014 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQ 380 (473)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 380 (473)
||+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|..||.+....+ .+..+.......
T Consensus 186 FG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~l~~i~~~~g~p 261 (394)
T 4e7w_A 186 FGSAKILIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID-QLVEIIKVLGTP 261 (394)
T ss_dssp CTTCEECCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCC
T ss_pred CCCcccccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCC
Confidence 99998764322 22345689999999998765 58999999999999999999999998743222 222222221111
Q ss_pred chhhhccccchHHHHhhhhhhcccc--cCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 381 RAEEVVDDFNLQEIEEGRTMCMEVS--SSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
....+.. . ........ ...............+..+.+|+.+||+.||.+|||+.|+++
T Consensus 262 ~~~~~~~-~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 262 SREQIKT-M--------NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp CHHHHHH-H--------CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CHHHHHh-h--------ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 1111000 0 00000000 000000011111224568899999999999999999999875
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=350.87 Aligned_cols=200 Identities=23% Similarity=0.303 Sum_probs=169.3
Q ss_pred ccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHHHHHHhc------CCCCceeeeeeeecccc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINI------KHRNIVRVFTAFSGVDY 215 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~~ 215 (473)
...+|++.++||+|+||.||+|.. .+++.||||+++.. ......+.+|+.++..+ +|+||+++++++...
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~-- 171 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR-- 171 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET--
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC--
Confidence 456899999999999999999984 46899999998642 12235677888888887 577999999998653
Q ss_pred CCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCc
Q 012014 216 QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM 295 (473)
Q Consensus 216 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~ 295 (473)
...++||||+. ++|.+++...... .+++..+..++.||+.||.||| +++|+||||||+|||++.++
T Consensus 172 ---~~~~lv~e~~~-~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~ 237 (429)
T 3kvw_A 172 ---NHICMTFELLS-MNLYELIKKNKFQ-------GFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQG 237 (429)
T ss_dssp ---TEEEEEECCCC-CBHHHHHHHTTTC-------CCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTT
T ss_pred ---CeEEEEEeccC-CCHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCC
Confidence 36899999995 6999999775432 3668899999999999999999 89999999999999999988
Q ss_pred c--EEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCC
Q 012014 296 I--GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (473)
Q Consensus 296 ~--~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~ 364 (473)
. +||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||++|.+||.+..
T Consensus 238 ~~~vkL~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 238 RSGIKVIDFGSSCYEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp SCCEEECCCTTCEETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CcceEEeecccceecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 7 99999999976432 2234568999999999999999999999999999999999999998753
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=338.91 Aligned_cols=271 Identities=21% Similarity=0.236 Sum_probs=182.8
Q ss_pred hcccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC-CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 141 YNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 141 ~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
....++|.+.+.||+|+||.||+|. ..+++.||+|++.... ....+.+.+|+.++.+++||||+++++++...
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~----- 85 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK----- 85 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESS-----
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeec-----
Confidence 3456789999999999999999998 4578999999986432 23456788999999999999999999998653
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...++||||+++++|.+++........ .....+++..+..++.||+.||.||| +++|+||||||+||+++.++.+|
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~-~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~k 161 (303)
T 2vwi_A 86 DELWLVMKLLSGGSVLDIIKHIVAKGE-HKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQ 161 (303)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHHHTTT-TTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEE
T ss_pred CCcEEEehhccCCchHHHHHHHhhccc-cccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEE
Confidence 357999999999999999864210000 00113668999999999999999999 89999999999999999999999
Q ss_pred EeecccccccCcccc---ccceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 012014 299 VGDFGMARFLPAIDK---QNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFV 374 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~ 374 (473)
|+|||++........ ........||+.|+|||++.+ ..++.++||||||+++|+|++|..||......... ....
T Consensus 162 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~ 240 (303)
T 2vwi_A 162 IADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL-MLTL 240 (303)
T ss_dssp ECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH-HHHH
T ss_pred EEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH-HHHh
Confidence 999999976643221 112234568999999999876 46899999999999999999999999764332211 0000
Q ss_pred HhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 375 KMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.. .+........ ........+..+.+|+.+||+.||.+|||+.|+++
T Consensus 241 ~~-~~~~~~~~~~-------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 241 QN-DPPSLETGVQ-------------------------DKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp TS-SCCCTTC------------------------------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred cc-CCCccccccc-------------------------cchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 00 0000000000 00001123457889999999999999999999975
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=334.88 Aligned_cols=254 Identities=20% Similarity=0.206 Sum_probs=182.6
Q ss_pred ccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCC-C-chhHHHHHHHHHhcCCCCceeeeeeeeccccCCce
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG-G-SKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (473)
..++|++.+.||+|+||.||+|.. .+++.||+|+++..... . ...+.++...++.++||||+++++++.+. .
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~-----~ 79 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE-----G 79 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----S
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc-----C
Confidence 456899999999999999999994 57899999998743221 1 12344455557888999999999998643 3
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCC-CeeeccCCCCcEEecCCccEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQP-PIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~-~iiH~Dlkp~Nil~~~~~~~k 298 (473)
..++||||++ |+|.+++...... ...+++..+..++.|++.||.||| ++ ||+||||||+||+++.++.+|
T Consensus 80 ~~~lv~e~~~-~~l~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~k 150 (290)
T 3fme_A 80 DVWICMELMD-TSLDKFYKQVIDK-----GQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVK 150 (290)
T ss_dssp SEEEEEECCS-EEHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEE
T ss_pred CEEEEEehhc-cchHHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEE
Confidence 6799999996 5888877542110 013668999999999999999999 87 999999999999999999999
Q ss_pred EeecccccccCccccccceeeccCCCCcCCCccc----cCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 012014 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYD----LGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFV 374 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~ 374 (473)
|+|||+++...... ......||+.|+|||++ .+..++.++||||||+++|+|++|..||.........+....
T Consensus 151 l~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 227 (290)
T 3fme_A 151 MCDFGISGYLVDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV 227 (290)
T ss_dssp BCCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHH
T ss_pred EeecCCcccccccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHh
Confidence 99999998664422 22234589999999996 556789999999999999999999999975332222122111
Q ss_pred HhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 375 KMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
....+... ....+..+.+|+.+||+.||++|||+.|+++
T Consensus 228 ~~~~~~~~----------------------------------~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 228 EEPSPQLP----------------------------------ADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HSCCCCCC----------------------------------TTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ccCCCCcc----------------------------------cccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 11111000 0123457889999999999999999999987
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=335.66 Aligned_cols=260 Identities=26% Similarity=0.374 Sum_probs=194.9
Q ss_pred ccCCCCccceeecCCCeEEEEEEec--CCC--EEEEEEeeccC---CCCchhHHHHHHHHHhcCCCCceeeeeeeecccc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTLF--DGT--TIAVKVFNLIR---PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY 215 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 215 (473)
..++|++.+.||+|+||.||+|.+. +++ .||+|+++... ....+.+.+|+.++.+++||||+++++++...
T Consensus 16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-- 93 (291)
T 1u46_A 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-- 93 (291)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--
T ss_pred chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC--
Confidence 3467999999999999999999842 333 68999987432 22346788999999999999999999998542
Q ss_pred CCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCc
Q 012014 216 QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM 295 (473)
Q Consensus 216 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~ 295 (473)
..++||||+++|+|.+++..... .+++..+..++.|++.||.||| +++|+||||||+||+++.++
T Consensus 94 ----~~~~v~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~ 158 (291)
T 1u46_A 94 ----PMKMVTELAPLGSLLDRLRKHQG--------HFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRD 158 (291)
T ss_dssp ----SCEEEEECCTTCBHHHHHHHHGG--------GSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETT
T ss_pred ----CceeeEecccCCCHHHHHHhccC--------CcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCC
Confidence 26899999999999999975421 3668899999999999999999 89999999999999999999
Q ss_pred cEEEeecccccccCcccccc-ceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHH
Q 012014 296 IGHVGDFGMARFLPAIDKQN-RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNF 373 (473)
Q Consensus 296 ~~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~ 373 (473)
.+||+|||++.......... ......||+.|+|||++.+..++.++||||||+++|+|++ |..||.+.... ..
T Consensus 159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~ 233 (291)
T 1u46_A 159 LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS-----QI 233 (291)
T ss_dssp EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HH
T ss_pred CEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH-----HH
Confidence 99999999998765432211 1223457888999999988889999999999999999999 99999764221 11
Q ss_pred HHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHH
Q 012014 374 VKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIR 453 (473)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~ 453 (473)
.......... ......++..+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus 234 ~~~~~~~~~~------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 234 LHKIDKEGER------------------------------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp HHHHHTSCCC------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred HHHHHccCCC------------------------------CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 1110000000 0001124567889999999999999999999999999885
Q ss_pred H
Q 012014 454 R 454 (473)
Q Consensus 454 ~ 454 (473)
.
T Consensus 284 ~ 284 (291)
T 1u46_A 284 P 284 (291)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=352.87 Aligned_cols=267 Identities=10% Similarity=0.027 Sum_probs=182.6
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCC---CCchhHHHHHHHHHhc--CCCCceeeeeeee------
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP---GGSKSFKSECKAAINI--KHRNIVRVFTAFS------ 211 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~h~niv~~~~~~~------ 211 (473)
..+|.+.+.||+|+||.||+|.. .+++.||+|+++.... ...+.+.+|+.++..+ +||||++++..+.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 44589999999999999999994 5789999999986443 2234567885554444 6999888664332
Q ss_pred -cccc------------CCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHH------HHHHHHHHHHHHHHh
Q 012014 212 -GVDY------------QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK------LDIAIDVACALRYLH 272 (473)
Q Consensus 212 -~~~~------------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~------~~i~~~i~~~L~~LH 272 (473)
.... ......++||||++ |+|.+++...... +....+ ..++.||+.||.|||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~--------~~~~~~~~~~vk~~i~~qi~~aL~~LH 211 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFV--------YVFRGDEGILALHILTAQLIRLAANLQ 211 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHS--------CCCCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccc--------cchhhhhhhhhHHHHHHHHHHHHHHHH
Confidence 1110 00145799999998 8999999764211 112233 677799999999999
Q ss_pred hCCCCCeeeccCCCCcEEecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccC--CCCCcccchhhHhHHH
Q 012014 273 CDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG--CEASTYGDVYSFGILL 350 (473)
Q Consensus 273 ~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il 350 (473)
+++|+||||||+|||++.++.+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++
T Consensus 212 ---~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il 283 (371)
T 3q60_A 212 ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSI 283 (371)
T ss_dssp ---HTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHH
T ss_pred ---HCCCccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHH
Confidence 899999999999999999999999999999865321 223457899999999987 6799999999999999
Q ss_pred HHHHhCCCCCCCCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhh
Q 012014 351 LEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVA 430 (473)
Q Consensus 351 ~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 430 (473)
|||++|..||.+.......... .......... ..........+..+.+|+.+
T Consensus 284 ~elltg~~Pf~~~~~~~~~~~~------~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~li~~ 335 (371)
T 3q60_A 284 YRVWCLFLPFGLVTPGIKGSWK------RPSLRVPGTD----------------------SLAFGSCTPLPDFVKTLIGR 335 (371)
T ss_dssp HHHHHSSCSTTBCCTTCTTCCC------BCCTTSCCCC----------------------SCCCTTSSCCCHHHHHHHHH
T ss_pred HHHHhCCCCCCCcCcccccchh------hhhhhhcccc----------------------ccchhhccCCCHHHHHHHHH
Confidence 9999999999865332110000 0000000000 00000011345688899999
Q ss_pred cccCCCCCCCChHHHHH--HHHHHHHh
Q 012014 431 CSAERPRERMKINDVES--RLRLIRRK 455 (473)
Q Consensus 431 cl~~dP~~RPt~~ev~~--~L~~l~~~ 455 (473)
||+.||++|||+.|+++ .++.+...
T Consensus 336 ~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 362 (371)
T 3q60_A 336 FLNFDRRRRLLPLEAMETPEFLQLQNE 362 (371)
T ss_dssp HTCSSTTTCCCHHHHTTSHHHHHHHHH
T ss_pred HcCCChhhCCCHHHHhcCHHHHHHHHH
Confidence 99999999999999975 45555443
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=345.83 Aligned_cols=277 Identities=21% Similarity=0.236 Sum_probs=195.9
Q ss_pred CCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeecccc-CCceeeE
Q 012014 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY-QGARFKA 222 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~ 222 (473)
.+|.+.++||+|+||.||+|+. .+++.||||++.... ....+|+++++.++||||++++++|..... ....+.+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 4689999999999999999995 468999999986432 234579999999999999999999865432 2344578
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCC-ccEEEee
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE-MIGHVGD 301 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~-~~~kl~D 301 (473)
+||||+++ +|.+++...... ...+++..+..++.||+.||.||| +++|+||||||+|||++.+ +.+||+|
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~D 200 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRA-----KQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCD 200 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECC
T ss_pred eehhcccc-cHHHHHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEecc
Confidence 99999965 676665431100 013668899999999999999999 9999999999999999955 6789999
Q ss_pred cccccccCccccccceeeccCCCCcCCCccccCC-CCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCc
Q 012014 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQ 380 (473)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 380 (473)
||+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.... ..+..++......
T Consensus 201 FG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~-~~l~~i~~~lg~p 276 (420)
T 1j1b_A 201 FGSAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV-DQLVEIIKVLGTP 276 (420)
T ss_dssp CTTCEECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCSC
T ss_pred chhhhhcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCC
Confidence 99998764322 22335689999999998765 6999999999999999999999999874322 1222222222111
Q ss_pred chhhhccccchHHHHhhhhhhcccccCC--CCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 381 RAEEVVDDFNLQEIEEGRTMCMEVSSSS--GSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
....+. ............. ............+..+.+|+.+||..||.+|||+.|+++
T Consensus 277 ~~~~~~---------~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 277 TREQIR---------EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp CHHHHH---------HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CHHHHH---------hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 111110 0000000000000 000000111234568899999999999999999999875
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=340.44 Aligned_cols=266 Identities=19% Similarity=0.251 Sum_probs=201.5
Q ss_pred ccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCc-----------------hhHHHHHHHHHhcCCCCcee
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGS-----------------KSFKSECKAAINIKHRNIVR 205 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-----------------~~~~~E~~~l~~l~h~niv~ 205 (473)
..++|.+.+.||+|+||.||+|.. +++.||+|++........ +.+.+|+.++.+++||||++
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 357899999999999999999998 899999999974321111 78999999999999999999
Q ss_pred eeeeeeccccCCceeeEEEEEecCCCCHHHH------hcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCC-CC
Q 012014 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEW------LRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQ-PP 278 (473)
Q Consensus 206 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~ 278 (473)
+++++.+. ...++||||+++|+|.++ +..... ..+++..+..++.|++.||.||| + +|
T Consensus 108 ~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH---~~~~ 172 (348)
T 2pml_X 108 CEGIITNY-----DEVYIIYEYMENDSILKFDEYFFVLDKNYT-------CFIPIQVIKCIIKSVLNSFSYIH---NEKN 172 (348)
T ss_dssp CSEEEESS-----SEEEEEEECCTTCBSSEESSSEESSCSSSC-------CCCCHHHHHHHHHHHHHHHHHHH---HTSC
T ss_pred EEEEEeeC-----CeEEEEEeccCCCcHHHHHHHhhhhhhccc-------cCCCHHHHHHHHHHHHHHHHHHh---ccCC
Confidence 99998653 368999999999999998 544211 14678999999999999999999 7 99
Q ss_pred eeeccCCCCcEEecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCC-CCCc-ccchhhHhHHHHHHHhC
Q 012014 279 IAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EAST-YGDVYSFGILLLEMFTG 356 (473)
Q Consensus 279 iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DiwSlG~il~elltg 356 (473)
|+||||||+||+++.++.+||+|||++...... ......||+.|+|||++.+. .++. ++||||||+++|+|++|
T Consensus 173 i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g 248 (348)
T 2pml_X 173 ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYN 248 (348)
T ss_dssp EECCCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHS
T ss_pred EeecCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhC
Confidence 999999999999999999999999999865432 23345689999999999887 5666 99999999999999999
Q ss_pred CCCCCCCCCCcccHHHHHHhhc--CcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccC
Q 012014 357 IRPSDGIFTGKMNLRNFVKMAL--PQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAE 434 (473)
Q Consensus 357 ~~P~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~ 434 (473)
..||.................. +........... ...........+..+.+|+.+||+.
T Consensus 249 ~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~~l~~li~~~L~~ 309 (348)
T 2pml_X 249 VVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLT-------------------NKKSTCSNNFLSNEDIDFLKLFLRK 309 (348)
T ss_dssp SCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTC-------------------C--------CCCHHHHHHHHHHCCS
T ss_pred CCCCCCCCcHHHHHHHHhccCcCCccchhhhhcccc-------------------ccccccchhhcCHHHHHHHHHHccC
Confidence 9999865432211111111000 000000000000 0000011123566889999999999
Q ss_pred CCCCCCChHHHHH
Q 012014 435 RPRERMKINDVES 447 (473)
Q Consensus 435 dP~~RPt~~ev~~ 447 (473)
||.+|||+.|+++
T Consensus 310 dP~~Rps~~e~l~ 322 (348)
T 2pml_X 310 NPAERITSEDALK 322 (348)
T ss_dssp SGGGSCCHHHHHT
T ss_pred ChhhCCCHHHHhc
Confidence 9999999999976
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=340.27 Aligned_cols=278 Identities=18% Similarity=0.227 Sum_probs=199.5
Q ss_pred cccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCC--CchhHHHHHHHHHhcCCCCceeeeeeeeccccC-C
Q 012014 142 NATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQ-G 217 (473)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~ 217 (473)
...++|.+.+.||+|+||.||+|. ..+|+.||||++...... ....+.+|+.+++.++||||+++++++...+.. .
T Consensus 39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 118 (371)
T 4exu_A 39 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN 118 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred cccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence 345789999999999999999998 457899999999753322 235688999999999999999999998654321 1
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccE
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~ 297 (473)
....++||||+. ++|.+++... +++..+..++.||+.||.||| ++||+||||||+|||++.++.+
T Consensus 119 ~~~~~lv~e~~~-~~l~~~~~~~-----------~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~ 183 (371)
T 4exu_A 119 FYDFYLVMPFMQ-TDLQKIMGME-----------FSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCEL 183 (371)
T ss_dssp CCCCEEEEECCC-EEHHHHTTSC-----------CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCE
T ss_pred ceeEEEEEcccc-ccHHHHhhcC-----------CCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCE
Confidence 123489999996 6998887432 558899999999999999999 8999999999999999999999
Q ss_pred EEeecccccccCccccccceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 012014 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKM 376 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~ 376 (473)
||+|||+++.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+....+ .+......
T Consensus 184 kL~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~ 257 (371)
T 4exu_A 184 KILDFGLARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKV 257 (371)
T ss_dssp EECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHH
T ss_pred EEEecCccccccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHH
Confidence 9999999986532 2234568999999999887 678999999999999999999999998643221 12222211
Q ss_pred hcCc--chhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 377 ALPQ--RAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 377 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.... .............+.. . . ...............+..+.+|+.+||+.||++|||+.|+++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~---~---~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 258 TGVPGTEFVQKLNDKAAKSYIQ---S---L-PQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp HCCCCHHHHTTCSCHHHHHHHH---H---S-CCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hCCCcHHHHHHhhhhhhhhhhh---c---c-CCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 1111 1111111110000000 0 0 000001111122335678999999999999999999999875
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=366.63 Aligned_cols=266 Identities=19% Similarity=0.317 Sum_probs=205.6
Q ss_pred chhhhhcccCCCCccceeecCCCeEEEEEEecC----CCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeee
Q 012014 136 SFKDLYNATNGFSSANLIGAGNFGSVYNGTLFD----GTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAF 210 (473)
Q Consensus 136 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~ 210 (473)
...+.....++|.+.+.||+|+||.||+|.... +..||+|.++.... ...+.+.+|+.++.+++||||+++++++
T Consensus 381 ~~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~ 460 (656)
T 2j0j_A 381 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI 460 (656)
T ss_dssp CGGGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 334455556789999999999999999998532 45799998864322 2235788999999999999999999997
Q ss_pred eccccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEE
Q 012014 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVL 290 (473)
Q Consensus 211 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil 290 (473)
.+ ...++||||+++|+|.+++..... .+++..++.++.|++.||.||| +++|+||||||+|||
T Consensus 461 ~~------~~~~lv~E~~~~g~L~~~l~~~~~--------~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NIL 523 (656)
T 2j0j_A 461 TE------NPVWIIMELCTLGELRSFLQVRKF--------SLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVL 523 (656)
T ss_dssp CS------SSCEEEEECCTTCBHHHHHHHTTT--------TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEE
T ss_pred ec------CceEEEEEcCCCCcHHHHHHhccC--------CCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEE
Confidence 43 246899999999999999975432 3568899999999999999999 899999999999999
Q ss_pred ecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCccc
Q 012014 291 LDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMN 369 (473)
Q Consensus 291 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~ 369 (473)
++.++.+||+|||+++...... ........||+.|+|||++.+..++.++||||||+++|||++ |..||.+....+
T Consensus 524 l~~~~~vkL~DFG~a~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-- 600 (656)
T 2j0j_A 524 VSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-- 600 (656)
T ss_dssp EEETTEEEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--
T ss_pred EeCCCCEEEEecCCCeecCCCc-ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH--
Confidence 9999999999999998764432 122233457889999999998899999999999999999997 999997643211
Q ss_pred HHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHH
Q 012014 370 LRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRL 449 (473)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L 449 (473)
....+...... ..+..++..+.+|+.+||+.||++|||+.||++.|
T Consensus 601 ~~~~i~~~~~~----------------------------------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L 646 (656)
T 2j0j_A 601 VIGRIENGERL----------------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 646 (656)
T ss_dssp HHHHHHHTCCC----------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHcCCCC----------------------------------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 00000000000 00113456788999999999999999999999999
Q ss_pred HHHHHh
Q 012014 450 RLIRRK 455 (473)
Q Consensus 450 ~~l~~~ 455 (473)
+.+.+.
T Consensus 647 ~~il~~ 652 (656)
T 2j0j_A 647 STILEE 652 (656)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 998653
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=339.88 Aligned_cols=269 Identities=20% Similarity=0.269 Sum_probs=201.6
Q ss_pred CchhhhhcccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccC--CCCchhHHHHHHHHHhcCCCCceeeeeeeec
Q 012014 135 PSFKDLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSG 212 (473)
Q Consensus 135 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 212 (473)
....++....++|.+.+.||+|+||.||+|... ..+|+|+++... ....+.+.+|+.++.+++||||+++++++.+
T Consensus 23 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 100 (319)
T 2y4i_B 23 IFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100 (319)
T ss_dssp CCGGGSSSCCSCEECCCBCCCSSSSEEEEEEES--SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC
T ss_pred cccccccCCHHHeEEeeEeccCCceEEEEEEEc--CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence 345666677889999999999999999999853 359999987433 2344668899999999999999999999865
Q ss_pred cccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEec
Q 012014 213 VDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD 292 (473)
Q Consensus 213 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~ 292 (473)
. ...++||||+++++|.+++..... .+++.++..++.||+.||.||| +++|+||||||+||+++
T Consensus 101 ~-----~~~~iv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~ 164 (319)
T 2y4i_B 101 P-----PHLAIITSLCKGRTLYSVVRDAKI--------VLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD 164 (319)
T ss_dssp S-----SCEEEECBCCCSEEHHHHTTSSCC--------CCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC
T ss_pred C-----CceEEEeecccCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe
Confidence 3 357999999999999999976532 3567899999999999999999 89999999999999998
Q ss_pred CCccEEEeecccccccCccc---cccceeeccCCCCcCCCccccC---------CCCCcccchhhHhHHHHHHHhCCCCC
Q 012014 293 DEMIGHVGDFGMARFLPAID---KQNRFICIKGSTGYIPPEYDLG---------CEASTYGDVYSFGILLLEMFTGIRPS 360 (473)
Q Consensus 293 ~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwSlG~il~elltg~~P~ 360 (473)
++.+||+|||+++...... .........||+.|+|||++.+ ..++.++||||||+++|+|++|..||
T Consensus 165 -~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~ 243 (319)
T 2y4i_B 165 -NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF 243 (319)
T ss_dssp ---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred -CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 6799999999987653221 1122234458999999999874 35788999999999999999999999
Q ss_pred CCCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCC
Q 012014 361 DGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERM 440 (473)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 440 (473)
....... ............... ...+..+.+|+.+||+.||++||
T Consensus 244 ~~~~~~~-----~~~~~~~~~~~~~~~------------------------------~~~~~~l~~li~~~l~~~p~~Rp 288 (319)
T 2y4i_B 244 KTQPAEA-----IIWQMGTGMKPNLSQ------------------------------IGMGKEISDILLFCWAFEQEERP 288 (319)
T ss_dssp SSCCHHH-----HHHHHHTTCCCCCCC------------------------------SSCCTTHHHHHHHHHCSSTTTSC
T ss_pred CCCCHHH-----HHHHhccCCCCCCCc------------------------------CCCCHHHHHHHHHHhcCChhhCc
Confidence 7532211 111000000000000 01234678899999999999999
Q ss_pred ChHHHHHHHHHHHHhhc
Q 012014 441 KINDVESRLRLIRRKLL 457 (473)
Q Consensus 441 t~~ev~~~L~~l~~~~~ 457 (473)
|+.+|++.|+.+.....
T Consensus 289 t~~~l~~~l~~l~~~~~ 305 (319)
T 2y4i_B 289 TFTKLMDMLEKLPKRNR 305 (319)
T ss_dssp CHHHHHHHHTTC-----
T ss_pred CHHHHHHHHHHHHHhhc
Confidence 99999999999976643
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=330.49 Aligned_cols=246 Identities=20% Similarity=0.283 Sum_probs=192.2
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCC--CchhHHHHHHHHHhc-CCCCceeeeeeeeccccCCce
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG--GSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 219 (473)
.++|++.+.||+|+||.||+|.. .+++.||+|+++..... ....+.+|+..+..+ +||||+++++++.+. .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~-----~ 84 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED-----D 84 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET-----T
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC-----C
Confidence 35789999999999999999995 47999999999754322 345678899999999 999999999998653 3
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCC-----
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE----- 294 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~----- 294 (473)
..++||||+++|+|.+++...... ...+++.++..++.||+.||.||| +++|+||||||+||+++.+
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~-----~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~ 156 (289)
T 1x8b_A 85 HMLIQNEYCNGGSLADAISENYRI-----MSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNA 156 (289)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHHH-----TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC-------
T ss_pred eEEEEEEecCCCcHHHHHHhhccc-----ccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCcc
Confidence 679999999999999999754210 013668999999999999999999 8999999999999999844
Q ss_pred --------------ccEEEeecccccccCccccccceeeccCCCCcCCCccccCC-CCCcccchhhHhHHHHHHHhCCCC
Q 012014 295 --------------MIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRP 359 (473)
Q Consensus 295 --------------~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P 359 (473)
..+||+|||++....... ...||+.|+|||++.+. .++.++||||||+++|+|++|.+|
T Consensus 157 ~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~ 230 (289)
T 1x8b_A 157 ASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230 (289)
T ss_dssp -------------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCC
T ss_pred cccccccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCC
Confidence 479999999998764322 23489999999998876 567899999999999999999887
Q ss_pred CCCCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCC
Q 012014 360 SDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRER 439 (473)
Q Consensus 360 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 439 (473)
+... ...........+ . .+...+..+.+|+.+||+.||++|
T Consensus 231 ~~~~----~~~~~~~~~~~~----~-------------------------------~~~~~~~~~~~li~~~l~~dp~~R 271 (289)
T 1x8b_A 231 PRNG----DQWHEIRQGRLP----R-------------------------------IPQVLSQEFTELLKVMIHPDPERR 271 (289)
T ss_dssp CSSS----HHHHHHHTTCCC----C-------------------------------CSSCCCHHHHHHHHHHTCSSGGGS
T ss_pred Ccch----hHHHHHHcCCCC----C-------------------------------CCcccCHHHHHHHHHHhCCCcccC
Confidence 6431 111111110000 0 011234578899999999999999
Q ss_pred CChHHHHH
Q 012014 440 MKINDVES 447 (473)
Q Consensus 440 Pt~~ev~~ 447 (473)
||+.|+++
T Consensus 272 ps~~~ll~ 279 (289)
T 1x8b_A 272 PSAMALVK 279 (289)
T ss_dssp CCHHHHHT
T ss_pred CCHHHHhh
Confidence 99999875
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=335.17 Aligned_cols=280 Identities=19% Similarity=0.279 Sum_probs=196.5
Q ss_pred ccCCCCccceeecCCCeEEEEEEec-CCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccc-------
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTLF-DGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVD------- 214 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------- 214 (473)
..++|.+.+.||+|+||.||+|... +++.||+|++........+.+.+|+.++++++||||+++++++....
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 3578999999999999999999954 58999999997654445567899999999999999999999874321
Q ss_pred --cCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEec
Q 012014 215 --YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD 292 (473)
Q Consensus 215 --~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~ 292 (473)
.......++||||++ |+|.+++... .+++..+..++.|++.||.||| ++||+||||||+||+++
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~----------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~ 154 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQG----------PLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFIN 154 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTTC----------CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEE
T ss_pred ccccccCceeEEeeccC-CCHHHHhhcC----------CccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEc
Confidence 123356799999997 6999999753 2558889999999999999999 89999999999999997
Q ss_pred -CCccEEEeecccccccCcccc-ccceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCccc
Q 012014 293 -DEMIGHVGDFGMARFLPAIDK-QNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMN 369 (473)
Q Consensus 293 -~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~ 369 (473)
.++.+||+|||+++....... ........||+.|+|||.+.+ ..++.++||||||+++|+|++|..||.+..... .
T Consensus 155 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~ 233 (320)
T 2i6l_A 155 TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE-Q 233 (320)
T ss_dssp TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-H
T ss_pred CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH-H
Confidence 567999999999987643211 122233457999999998765 678999999999999999999999998643211 1
Q ss_pred HHHHHHhhcCcc----hhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHH
Q 012014 370 LRNFVKMALPQR----AEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDV 445 (473)
Q Consensus 370 ~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev 445 (473)
+..... ..+.. ..++...... ..... ...............+..+.+|+.+||+.||++|||+.|+
T Consensus 234 ~~~~~~-~~~~~~~~~~~~~~~~~~~-~~~~~--------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 303 (320)
T 2i6l_A 234 MQLILE-SIPVVHEEDRQELLSVIPV-YIRND--------MTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEA 303 (320)
T ss_dssp HHHHHH-HSCCCCHHHHHHHHTTSCH-HHHHH--------TTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred HHHHHH-hcCCCchhhhhhhhhcCcc-ccccc--------ccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHH
Confidence 111111 11100 0000000000 00000 0000000111122356789999999999999999999999
Q ss_pred HH
Q 012014 446 ES 447 (473)
Q Consensus 446 ~~ 447 (473)
++
T Consensus 304 l~ 305 (320)
T 2i6l_A 304 LS 305 (320)
T ss_dssp HT
T ss_pred hC
Confidence 75
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=330.73 Aligned_cols=252 Identities=20% Similarity=0.260 Sum_probs=198.5
Q ss_pred ccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCC---------CchhHHHHHHHHHhcC-CCCceeeeeeee
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG---------GSKSFKSECKAAINIK-HRNIVRVFTAFS 211 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 211 (473)
..++|.+.+.||+|+||.||+|.. .+++.||+|+++..... ..+.+.+|+.++.++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 357899999999999999999995 46899999999754321 1245789999999995 999999999985
Q ss_pred ccccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEe
Q 012014 212 GVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL 291 (473)
Q Consensus 212 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~ 291 (473)
. ....++||||+++++|.+++.... .+++..+..++.||+.||.||| ++|++||||||+||++
T Consensus 95 ~-----~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~ 157 (298)
T 1phk_A 95 T-----NTFFFLVFDLMKKGELFDYLTEKV---------TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILL 157 (298)
T ss_dssp C-----SSEEEEEEECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred c-----CCeEEEEEeccCCCcHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEE
Confidence 4 346899999999999999997643 3568899999999999999999 8999999999999999
Q ss_pred cCCccEEEeecccccccCccccccceeeccCCCCcCCCcccc------CCCCCcccchhhHhHHHHHHHhCCCCCCCCCC
Q 012014 292 DDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDL------GCEASTYGDVYSFGILLLEMFTGIRPSDGIFT 365 (473)
Q Consensus 292 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwSlG~il~elltg~~P~~~~~~ 365 (473)
+.++.+||+|||++....... ......||+.|+|||++. ...++.++||||||+++|+|++|..||.+...
T Consensus 158 ~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 234 (298)
T 1phk_A 158 DDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ 234 (298)
T ss_dssp CTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cCCCcEEEecccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH
Confidence 999999999999998764322 223456899999999875 45688999999999999999999999975321
Q ss_pred CcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHH
Q 012014 366 GKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDV 445 (473)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev 445 (473)
.. ............. .+.....+..+.+|+.+||+.||++|||+.|+
T Consensus 235 ~~-~~~~~~~~~~~~~--------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l 281 (298)
T 1phk_A 235 ML-MLRMIMSGNYQFG--------------------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 281 (298)
T ss_dssp HH-HHHHHHHTCCCCC--------------------------------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred HH-HHHHHhcCCcccC--------------------------------cccccccCHHHHHHHHHHccCCcccCCCHHHH
Confidence 11 0000000000000 00011345678899999999999999999998
Q ss_pred HH
Q 012014 446 ES 447 (473)
Q Consensus 446 ~~ 447 (473)
++
T Consensus 282 l~ 283 (298)
T 1phk_A 282 LA 283 (298)
T ss_dssp TT
T ss_pred Hh
Confidence 65
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=333.84 Aligned_cols=257 Identities=19% Similarity=0.253 Sum_probs=174.5
Q ss_pred cccCCCCccc-eeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHH-HHHHhcCCCCceeeeeeeeccccCCc
Q 012014 142 NATNGFSSAN-LIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSEC-KAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 142 ~~~~~~~~~~-~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
...++|.+.+ +||+|+||.||+|.. .+++.||||++.. .....+|+ ..+..++||||+++++++.... .+.
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~ 98 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD-----SPKARQEVDHHWQASGGPHIVCILDVYENMH-HGK 98 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEES-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTE
T ss_pred cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecC-----cHHHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCC
Confidence 4567888854 699999999999994 4789999999863 22333444 3466779999999999986533 334
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecC---Cc
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD---EM 295 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~---~~ 295 (473)
...++||||+++|+|.+++...... .+++.+++.++.||+.||.||| +++|+||||||+||+++. ++
T Consensus 99 ~~~~lv~e~~~gg~L~~~l~~~~~~-------~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~ 168 (336)
T 3fhr_A 99 RCLLIIMECMEGGELFSRIQERGDQ-------AFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDA 168 (336)
T ss_dssp EEEEEEEECCTTEEHHHHHHTC-CC-------CCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTC
T ss_pred ceEEEEEeccCCCCHHHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCc
Confidence 5689999999999999999876432 3678999999999999999999 899999999999999976 45
Q ss_pred cEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 012014 296 IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVK 375 (473)
Q Consensus 296 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~ 375 (473)
.+||+|||+++..... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.......... ..
T Consensus 169 ~~kl~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~ 243 (336)
T 3fhr_A 169 VLKLTDFGFAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM-KR 243 (336)
T ss_dssp CEEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------
T ss_pred eEEEeccccceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH-HH
Confidence 6999999999865432 223456899999999998888999999999999999999999999764322110000 00
Q ss_pred hhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 376 MALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
....... .. ........+..+.+|+.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~-~~---------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 244 RIRLGQY-GF---------------------------PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp --------CC---------------------------CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hhhcccc-cc---------------------------CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000000 00 00000124567889999999999999999999987
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=335.14 Aligned_cols=289 Identities=20% Similarity=0.219 Sum_probs=191.2
Q ss_pred hhcccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeecccc--C
Q 012014 140 LYNATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY--Q 216 (473)
Q Consensus 140 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--~ 216 (473)
.....++|.+.+.||+|+||.||+|.. .+++.||||++... ........++++.+..++||||++++++|..... .
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCT
T ss_pred chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccc
Confidence 344567899999999999999999995 56899999998643 3345567888889999999999999999865432 2
Q ss_pred CceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecC-Cc
Q 012014 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD-EM 295 (473)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~-~~ 295 (473)
...+.++||||+++ +|.+.+...... ...+++..+..++.|++.||.|||.. +++|+||||||+|||++. ++
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 97 RDIYLNVVMEYVPD-TLHRCCRNYYRR-----QVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp TCEEEEEEEECCSC-BHHHHHHHHHTT-----TCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTT
T ss_pred cceeEEEEeecccc-cHHHHHHHHhhc-----ccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCC
Confidence 23457899999975 555444321100 01355788899999999999999954 679999999999999996 89
Q ss_pred cEEEeecccccccCccccccceeeccCCCCcCCCccccCCC-CCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 012014 296 IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE-ASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFV 374 (473)
Q Consensus 296 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~ 374 (473)
.+||+|||+++...... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+..... .+..+.
T Consensus 170 ~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-~~~~~~ 245 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG-QLHEIV 245 (360)
T ss_dssp EEEECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHH
T ss_pred cEEEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH-HHHHHH
Confidence 99999999998765432 223456899999999987654 8999999999999999999999998743221 222222
Q ss_pred HhhcCcchh--hhccccc-hHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 375 KMALPQRAE--EVVDDFN-LQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 375 ~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
+........ ...++.. ..... ..................+..+.+|+.+||+.||.+|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 246 RVLGCPSREVLRKLNPSHTDVDLY-------NSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHCCCCHHHHHHHCTTCCCGGGG-------CCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHcCCCCHHHHHhcccchhhcccc-------ccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 211111000 0000000 00000 000000000000111225678999999999999999999999975
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=329.83 Aligned_cols=257 Identities=21% Similarity=0.283 Sum_probs=190.0
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccc--------
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVD-------- 214 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-------- 214 (473)
.++|++.+.||+|+||.||+|+. .+++.||+|++... ....+.+.+|+.++.+++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 35788999999999999999994 57899999998642 223456889999999999999999999886532
Q ss_pred cCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCC
Q 012014 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE 294 (473)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~ 294 (473)
.......++||||+++|+|.+++..... .+++..++.++.|++.||.||| +++|+||||||+||+++.+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~ 152 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSENL--------NQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDES 152 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSCG--------GGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTT
T ss_pred cccCCceEEEEecCCCCCHHHhhhcccc--------ccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCC
Confidence 1234578999999999999999975431 4667889999999999999999 8999999999999999999
Q ss_pred ccEEEeecccccccCcccc------------ccceeeccCCCCcCCCccccCC-CCCcccchhhHhHHHHHHHhCCCCCC
Q 012014 295 MIGHVGDFGMARFLPAIDK------------QNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSD 361 (473)
Q Consensus 295 ~~~kl~Dfg~~~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~ 361 (473)
+.+||+|||++........ ........||+.|+|||++.+. .++.++||||||+++|+|++ ||.
T Consensus 153 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~ 229 (303)
T 1zy4_A 153 RNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFS 229 (303)
T ss_dssp SCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCS
T ss_pred CCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccC
Confidence 9999999999986543210 1122345689999999998864 68999999999999999998 554
Q ss_pred CCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCC
Q 012014 362 GIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMK 441 (473)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt 441 (473)
..... ............ .. ........+..+.+|+.+||+.||.+|||
T Consensus 230 ~~~~~----~~~~~~~~~~~~-~~---------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps 277 (303)
T 1zy4_A 230 TGMER----VNILKKLRSVSI-EF---------------------------PPDFDDNKMKVEKKIIRLLIDHDPNKRPG 277 (303)
T ss_dssp SHHHH----HHHHHHHHSTTC-CC---------------------------CTTCCTTTSHHHHHHHHHHTCSSGGGSCC
T ss_pred CchhH----HHHHHhcccccc-cc---------------------------CccccccchHHHHHHHHHHHhcCcccCcC
Confidence 21110 011100000000 00 00011224556789999999999999999
Q ss_pred hHHHHH
Q 012014 442 INDVES 447 (473)
Q Consensus 442 ~~ev~~ 447 (473)
+.|+++
T Consensus 278 ~~~ll~ 283 (303)
T 1zy4_A 278 ARTLLN 283 (303)
T ss_dssp HHHHHH
T ss_pred HHHHhC
Confidence 999975
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=337.81 Aligned_cols=286 Identities=15% Similarity=0.210 Sum_probs=199.9
Q ss_pred ccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHHHHHHhcC-----------CCCceeeeeee
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK-----------HRNIVRVFTAF 210 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~ 210 (473)
..++|.+.+.||+|+||.||+|.. .+++.||||++... ......+.+|+.++.+++ ||||+++++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 346899999999999999999994 67899999998632 123456889999999886 89999999998
Q ss_pred eccccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCC-CeeeccCCCCcE
Q 012014 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQP-PIAHCNLKPSNV 289 (473)
Q Consensus 211 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~-~iiH~Dlkp~Ni 289 (473)
.... ......++||||+ +++|.+++...... .+++..+..++.||+.||.||| ++ ||+||||||+||
T Consensus 96 ~~~~-~~~~~~~lv~e~~-~~~L~~~~~~~~~~-------~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NI 163 (373)
T 1q8y_A 96 NHKG-PNGVHVVMVFEVL-GENLLALIKKYEHR-------GIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENV 163 (373)
T ss_dssp EEEE-TTEEEEEEEECCC-CEEHHHHHHHTTTS-------CCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGE
T ss_pred hccC-CCCceEEEEEecC-CCCHHHHHHHhhcc-------CCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHe
Confidence 7543 2344789999999 99999999765422 3568899999999999999999 87 999999999999
Q ss_pred Eec------CCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCC
Q 012014 290 LLD------DEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363 (473)
Q Consensus 290 l~~------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 363 (473)
|++ ..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 164 ll~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 238 (373)
T 1q8y_A 164 LMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 238 (373)
T ss_dssp EEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred EEeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 994 4458999999999866432 22346899999999999999999999999999999999999999865
Q ss_pred CCCc-----ccHHHHHHhhcCcchhhhccc-cchHHHHhhhhhhccccc-CCCC-----cchhhHHHHHHHHHHHHhhhc
Q 012014 364 FTGK-----MNLRNFVKMALPQRAEEVVDD-FNLQEIEEGRTMCMEVSS-SSGS-----SAHASIILECFNSICEIGVAC 431 (473)
Q Consensus 364 ~~~~-----~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~-~~~~-----~~~~~~~~~~~~~l~~l~~~c 431 (473)
.... ..+........+ ........ .....+-........... .... ......+...+..+.+|+.+|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 317 (373)
T 1q8y_A 239 EGHSYTKDDDHIAQIIELLGE-LPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM 317 (373)
T ss_dssp ------CHHHHHHHHHHHHCS-CCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGG
T ss_pred cccccCChHHHHHHHHHhcCC-CCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHH
Confidence 3221 111111111110 00000000 000000000000000000 0000 000112345788999999999
Q ss_pred ccCCCCCCCChHHHHH
Q 012014 432 SAERPRERMKINDVES 447 (473)
Q Consensus 432 l~~dP~~RPt~~ev~~ 447 (473)
|+.||++|||+.||++
T Consensus 318 L~~dP~~Rpt~~ell~ 333 (373)
T 1q8y_A 318 LQLDPRKRADAGGLVN 333 (373)
T ss_dssp GCSSTTTCBCHHHHHT
T ss_pred hccCccccCCHHHHhh
Confidence 9999999999999975
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=325.69 Aligned_cols=250 Identities=20% Similarity=0.274 Sum_probs=196.7
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccC--CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
.++|++.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.++++++||||+++++++.. ...
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~ 95 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-----SSS 95 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-----SSE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC-----CCe
Confidence 45799999999999999999995 478999999997432 3345678999999999999999999999854 346
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCC---ccE
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE---MIG 297 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~---~~~ 297 (473)
.++||||+++++|.+++.... .+++.++..++.||+.||.||| +++++||||||+||+++.+ +.+
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~ 163 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRK---------RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDI 163 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred EEEEEEccCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccE
Confidence 799999999999999886543 3568899999999999999999 8999999999999999654 479
Q ss_pred EEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
||+|||++....... ......||+.|+|||.+.+ .++.++||||||+++|+|++|..||.+..... .........
T Consensus 164 kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~ 238 (287)
T 2wei_A 164 KIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-ILKRVETGK 238 (287)
T ss_dssp EECSTTGGGTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCC
T ss_pred EEeccCcceeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHcCC
Confidence 999999998654322 1223347899999999876 48999999999999999999999997632211 000000000
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.+... +.....+..+.+|+.+||+.||++|||+.|+++
T Consensus 239 ~~~~~--------------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 239 YAFDL--------------------------------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CCCCS--------------------------------GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCc--------------------------------hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 00000 001124567889999999999999999999987
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=339.44 Aligned_cols=207 Identities=25% Similarity=0.295 Sum_probs=169.6
Q ss_pred hhhhcccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHHHHHHhcC-CC-----Cceeeeeee
Q 012014 138 KDLYNATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK-HR-----NIVRVFTAF 210 (473)
Q Consensus 138 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~~~~~~ 210 (473)
.......++|.+.+.||+|+||.||+|.. .+++.||||+++... .....+.+|+.++..++ |+ +|+++++++
T Consensus 47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~ 125 (382)
T 2vx3_A 47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF 125 (382)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence 33344568999999999999999999984 468899999986321 22356778888888885 55 489999987
Q ss_pred eccccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEE
Q 012014 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVL 290 (473)
Q Consensus 211 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil 290 (473)
... ...++||||+. |+|.+++...... .+++..+..++.|++.||.|||+. ..||+||||||+|||
T Consensus 126 ~~~-----~~~~lv~e~~~-~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIl 191 (382)
T 2vx3_A 126 MFR-----NHLCLVFEMLS-YNLYDLLRNTNFR-------GVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENIL 191 (382)
T ss_dssp EET-----TEEEEEEECCC-CBHHHHHHHTTTS-------CCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEE
T ss_pred ccC-----CceEEEEecCC-CCHHHHHhhcCcC-------CCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEE
Confidence 543 36899999995 6999999765422 366889999999999999999943 468999999999999
Q ss_pred ec--CCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCC
Q 012014 291 LD--DEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (473)
Q Consensus 291 ~~--~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~ 364 (473)
++ .++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|..||.+..
T Consensus 192 l~~~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 192 LCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp ESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EecCCCCcEEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 94 4788999999999876432 234568999999999999999999999999999999999999998643
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=329.77 Aligned_cols=276 Identities=17% Similarity=0.246 Sum_probs=199.4
Q ss_pred ccCCCCccceeecCCCeEEEEEEe--cCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCC------Cceeeeeeeeccc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTL--FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHR------NIVRVFTAFSGVD 214 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~~~~~~~~~~ 214 (473)
..++|++.+.||+|+||.||+|.. .+++.||+|+++... ...+.+.+|+.++..++|+ +++++++++...
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~- 89 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH- 89 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET-
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC-
Confidence 356899999999999999999984 368899999986321 2345688999999998665 499999988543
Q ss_pred cCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecC-
Q 012014 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD- 293 (473)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~- 293 (473)
...++||||+ +++|.+++...... .+++.++..++.||+.||.||| +++|+||||||+|||++.
T Consensus 90 ----~~~~lv~e~~-~~~l~~~l~~~~~~-------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~ 154 (339)
T 1z57_A 90 ----GHICIVFELL-GLSTYDFIKENGFL-------PFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQS 154 (339)
T ss_dssp ----TEEEEEEECC-CCBHHHHHHHTTTC-------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCC
T ss_pred ----CcEEEEEcCC-CCCHHHHHHhcCCC-------CCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEecc
Confidence 3789999999 89999999766432 3568899999999999999999 899999999999999987
Q ss_pred ------------------CccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh
Q 012014 294 ------------------EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT 355 (473)
Q Consensus 294 ------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt 355 (473)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 229 (339)
T 1z57_A 155 DYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL 229 (339)
T ss_dssp CEEEEEC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHH
T ss_pred ccccccCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHh
Confidence 668999999999864332 233468999999999999899999999999999999999
Q ss_pred CCCCCCCCCCCcccHHHHHHhh--cCcchhhhccccc--------h----HHHHhhhhhhcccccCCCCcchhhHHHHHH
Q 012014 356 GIRPSDGIFTGKMNLRNFVKMA--LPQRAEEVVDDFN--------L----QEIEEGRTMCMEVSSSSGSSAHASIILECF 421 (473)
Q Consensus 356 g~~P~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~--------~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (473)
|..||.+....+ .+..+.... .+........... . .........+.... .........+
T Consensus 230 g~~pf~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~ 302 (339)
T 1z57_A 230 GFTVFPTHDSKE-HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLK------EFMLSQDVEH 302 (339)
T ss_dssp SSCSCCCSCHHH-HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGG------GGCSCCSHHH
T ss_pred CCCCCCCCChHH-HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchh------hhcccchhhH
Confidence 999998643221 111111111 1111000000000 0 00000000000000 0000122457
Q ss_pred HHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 422 NSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 422 ~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
..+.+|+.+||+.||.+|||+.|+++
T Consensus 303 ~~l~~li~~~L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 303 ERLFDLIQKMLEYDPAKRITLREALK 328 (339)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred HHHHHHHHHHhCcCcccccCHHHHhc
Confidence 88999999999999999999999874
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=341.78 Aligned_cols=257 Identities=19% Similarity=0.243 Sum_probs=185.1
Q ss_pred CCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhc-CCCCceeeeeeeeccccCCceeeEE
Q 012014 145 NGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGARFKAV 223 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~l 223 (473)
+.|...++||+|+||+||.+...+|+.||||++... ..+.+.+|+.++.++ +||||+++++++.+ ....++
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-----~~~~~l 86 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETT-----DRFLYI 86 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEEC-----SSEEEE
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEec-----CCeEEE
Confidence 345667889999999998776678999999998642 245678999999876 89999999998754 347899
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCC---------
Q 012014 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE--------- 294 (473)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~--------- 294 (473)
|||||. |+|.+++.......... ....+..++.++.||+.||.||| +++|+||||||+|||++.+
T Consensus 87 v~E~~~-gsL~~~l~~~~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~ 160 (434)
T 2rio_A 87 ALELCN-LNLQDLVESKNVSDENL--KLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQT 160 (434)
T ss_dssp EECCCS-EEHHHHHHTC--------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTT
T ss_pred EEecCC-CCHHHHHhccCCCchhh--hhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCccccccccc
Confidence 999995 69999998764321110 00123345789999999999999 8999999999999999754
Q ss_pred ----ccEEEeecccccccCccccc--cceeeccCCCCcCCCccccC-------CCCCcccchhhHhHHHHHHHh-CCCCC
Q 012014 295 ----MIGHVGDFGMARFLPAIDKQ--NRFICIKGSTGYIPPEYDLG-------CEASTYGDVYSFGILLLEMFT-GIRPS 360 (473)
Q Consensus 295 ----~~~kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ellt-g~~P~ 360 (473)
+.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++ |..||
T Consensus 161 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf 240 (434)
T 2rio_A 161 GAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF 240 (434)
T ss_dssp CCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCC
Confidence 48999999999876543221 12234569999999999875 568999999999999999999 99999
Q ss_pred CCCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCC
Q 012014 361 DGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERM 440 (473)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 440 (473)
....... ........... .. . .......+..+.+|+.+||+.||.+||
T Consensus 241 ~~~~~~~---~~i~~~~~~~~--~~-~--------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rp 288 (434)
T 2rio_A 241 GDKYSRE---SNIIRGIFSLD--EM-K--------------------------CLHDRSLIAEATDLISQMIDHDPLKRP 288 (434)
T ss_dssp CSTTTHH---HHHHHTCCCCC--CC-T--------------------------TCCCHHHHHHHHHHHHHHTCSSGGGSC
T ss_pred CCchhhH---HHHhcCCCCcc--cc-c--------------------------ccccccchHHHHHHHHHHhhCChhhCC
Confidence 7532211 11111110000 00 0 000124567889999999999999999
Q ss_pred ChHHHHH
Q 012014 441 KINDVES 447 (473)
Q Consensus 441 t~~ev~~ 447 (473)
|+.||++
T Consensus 289 s~~eil~ 295 (434)
T 2rio_A 289 TAMKVLR 295 (434)
T ss_dssp CHHHHHT
T ss_pred CHHHHHh
Confidence 9999975
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-43 Score=334.46 Aligned_cols=261 Identities=20% Similarity=0.168 Sum_probs=175.2
Q ss_pred hhcccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCC-CCchhHHHHHH-HHHhcCCCCceeeeeeeeccccC
Q 012014 140 LYNATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP-GGSKSFKSECK-AAINIKHRNIVRVFTAFSGVDYQ 216 (473)
Q Consensus 140 ~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~ 216 (473)
+....++|.+.+.||+|+||.||+|.. .+++.||||+++.... .....+..|+. +++.++||||+++++++...
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~--- 93 (327)
T 3aln_A 17 WDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE--- 93 (327)
T ss_dssp ECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS---
T ss_pred cccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC---
Confidence 344567899999999999999999995 5789999999975432 12234556665 67778999999999998653
Q ss_pred CceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCC-CeeeccCCCCcEEecCCc
Q 012014 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQP-PIAHCNLKPSNVLLDDEM 295 (473)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~-~iiH~Dlkp~Nil~~~~~ 295 (473)
...++||||++ |+|.+++....... ...+++..+..++.|++.||.||| ++ +|+||||||+||+++.++
T Consensus 94 --~~~~lv~e~~~-~~l~~~~~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~ 163 (327)
T 3aln_A 94 --GDCWICMELMS-TSFDKFYKYVYSVL----DDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSG 163 (327)
T ss_dssp --SEEEEEECCCS-EEHHHHHHHHHHTT----CCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTT
T ss_pred --CceEEEEeecC-CChHHHHHHHHhhh----cccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCC
Confidence 36799999997 48888776311000 013568889999999999999999 87 999999999999999999
Q ss_pred cEEEeecccccccCccccccceeeccCCCCcCCCccc----cCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHH
Q 012014 296 IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYD----LGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLR 371 (473)
Q Consensus 296 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~ 371 (473)
.+||+|||+++...... ......||+.|+|||++ .+..++.++||||||+++|+|++|..||.+.......
T Consensus 164 ~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-- 238 (327)
T 3aln_A 164 NIKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ-- 238 (327)
T ss_dssp EEEECCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------
T ss_pred CEEEccCCCceeccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH--
Confidence 99999999998664322 22233589999999998 4566899999999999999999999999753221100
Q ss_pred HHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 372 NFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
...........+.. ......+..+.+|+.+||+.||++|||+.||++
T Consensus 239 --~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 239 --LTQVVKGDPPQLSN---------------------------SEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp ---CCCCCSCCCCCCC---------------------------CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred --HHHHhcCCCCCCCC---------------------------cccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 00000000000000 000123557889999999999999999999976
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=329.54 Aligned_cols=277 Identities=18% Similarity=0.218 Sum_probs=197.0
Q ss_pred ccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCC--CchhHHHHHHHHHhcCCCCceeeeeeeecccc-CCc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAFSGVDY-QGA 218 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~ 218 (473)
..++|.+.+.||+|+||.||+|.. .+|+.||||++...... ....+.+|+.++..++||||+++++++..... ...
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 357899999999999999999984 56899999998743222 23567899999999999999999999865431 111
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...++||||+. ++|.+++.. .+++.++..++.||+.||.||| ++||+||||||+||+++.++.+|
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~-----------~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~k 166 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMGL-----------KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELK 166 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTTS-----------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEE
T ss_pred eeEEEEecccc-CCHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEE
Confidence 24599999996 688887643 2568899999999999999999 89999999999999999999999
Q ss_pred EeecccccccCccccccceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
|+|||+++..... .....||+.|+|||++.+ ..++.++||||||+++|+|++|..||.+....+ .+.......
T Consensus 167 l~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~i~~~~ 240 (353)
T 3coi_A 167 ILDFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVT 240 (353)
T ss_dssp ECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH-HHHHHHHHH
T ss_pred EeecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHh
Confidence 9999999865321 233468999999999877 678999999999999999999999997643211 122222111
Q ss_pred cC--cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 378 LP--QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 378 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.. ......+.......+.. ........ .........+..+.+|+.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~----~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 241 GVPGTEFVQKLNDKAAKSYIQ---SLPQTPRK----DFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp CBCCHHHHTTCSCHHHHHHHH---TSCBCSSC----CTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred CCCCHHHHHHHhhHHHHHHHH---hCcCCCCc----cHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 11 01111111100000000 00000000 000111234678899999999999999999999875
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=330.12 Aligned_cols=243 Identities=20% Similarity=0.286 Sum_probs=195.5
Q ss_pred hcccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCC------CchhHHHHHHHHHhcC--CCCceeeeeeee
Q 012014 141 YNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPG------GSKSFKSECKAAINIK--HRNIVRVFTAFS 211 (473)
Q Consensus 141 ~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~~~~~~~ 211 (473)
....++|.+.+.||+|+||.||+|. ..+++.||||+++..... ....+.+|+.++.+++ ||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 3456789999999999999999998 457899999999754322 2356788999999996 599999999986
Q ss_pred ccccCCceeeEEEEEecCC-CCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEE
Q 012014 212 GVDYQGARFKAVVYKFMPN-GSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVL 290 (473)
Q Consensus 212 ~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil 290 (473)
.. ...++|||++.+ ++|.+++.... .+++..+..++.||+.||.||| +++|+||||||+|||
T Consensus 119 ~~-----~~~~lv~e~~~~~~~L~~~l~~~~---------~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIl 181 (320)
T 3a99_A 119 RP-----DSFVLILERPEPVQDLFDFITERG---------ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENIL 181 (320)
T ss_dssp CS-----SEEEEEEECCSSEEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEE
T ss_pred cC-----CcEEEEEEcCCCCccHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEE
Confidence 43 367999999976 89999997643 3568899999999999999999 899999999999999
Q ss_pred ec-CCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCC-CcccchhhHhHHHHHHHhCCCCCCCCCCCcc
Q 012014 291 LD-DEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEA-STYGDVYSFGILLLEMFTGIRPSDGIFTGKM 368 (473)
Q Consensus 291 ~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~P~~~~~~~~~ 368 (473)
++ +++.+||+|||+++..... ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||....
T Consensus 182 l~~~~~~~kL~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~---- 253 (320)
T 3a99_A 182 IDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---- 253 (320)
T ss_dssp EETTTTEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----
T ss_pred EeCCCCCEEEeeCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh----
Confidence 99 7899999999999876432 2233568999999999887665 678899999999999999999996421
Q ss_pred cHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 369 NLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
....... .. ....+..+.+|+.+||+.||++|||+.||++
T Consensus 254 ---~~~~~~~------~~------------------------------~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 254 ---EIIRGQV------FF------------------------------RQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp ---HHHHCCC------CC------------------------------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---hhhcccc------cc------------------------------cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1100000 00 0113457889999999999999999999975
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=327.28 Aligned_cols=200 Identities=23% Similarity=0.342 Sum_probs=166.2
Q ss_pred ccCCCCccceeecCCCeEEEEEEe-cCC-CEEEEEEeeccCCCCchhHHHHHHHHHhcCCCC------ceeeeeeeeccc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTL-FDG-TTIAVKVFNLIRPGGSKSFKSECKAAINIKHRN------IVRVFTAFSGVD 214 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~ 214 (473)
..++|.+.+.||+|+||.||+|.. .++ +.||+|+++.. ....+.+.+|+.++..++|++ ++.+++++...
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~- 94 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH- 94 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET-
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC-
Confidence 357899999999999999999984 344 68999998632 123456888999999997665 88888887543
Q ss_pred cCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEe---
Q 012014 215 YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL--- 291 (473)
Q Consensus 215 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~--- 291 (473)
...++||||+ +++|.+++...... .+++.++..++.||+.||.||| +++|+||||||+|||+
T Consensus 95 ----~~~~lv~e~~-~~~l~~~l~~~~~~-------~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~ 159 (355)
T 2eu9_A 95 ----GHMCIAFELL-GKNTFEFLKENNFQ-------PYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNS 159 (355)
T ss_dssp ----TEEEEEEECC-CCBHHHHHHHTTTC-------CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCC
T ss_pred ----CeEEEEEecc-CCChHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecc
Confidence 3679999999 67787877654322 3668899999999999999999 9999999999999999
Q ss_pred ----------------cCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh
Q 012014 292 ----------------DDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT 355 (473)
Q Consensus 292 ----------------~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt 355 (473)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 234 (355)
T 2eu9_A 160 EFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234 (355)
T ss_dssp CEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHh
Confidence 56789999999999864332 233568999999999999999999999999999999999
Q ss_pred CCCCCCCCC
Q 012014 356 GIRPSDGIF 364 (473)
Q Consensus 356 g~~P~~~~~ 364 (473)
|..||.+..
T Consensus 235 g~~pf~~~~ 243 (355)
T 2eu9_A 235 GFTLFQTHE 243 (355)
T ss_dssp SSCSCCCSS
T ss_pred CCCCCCCCC
Confidence 999998643
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=327.00 Aligned_cols=244 Identities=22% Similarity=0.321 Sum_probs=189.1
Q ss_pred hhcccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCC------CCchhHHHHHHHHHhc----CCCCceeeee
Q 012014 140 LYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP------GGSKSFKSECKAAINI----KHRNIVRVFT 208 (473)
Q Consensus 140 ~~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~h~niv~~~~ 208 (473)
.....++|.+.+.||+|+||.||+|. ..+++.||+|++..... .....+.+|+.++.++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 34456789999999999999999998 45789999999975432 1234567899999998 8999999999
Q ss_pred eeeccccCCceeeEEEEEe-cCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCC
Q 012014 209 AFSGVDYQGARFKAVVYKF-MPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPS 287 (473)
Q Consensus 209 ~~~~~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~ 287 (473)
++... ...++|||+ +.+++|.+++.... .+++..++.++.||+.||.||| +++|+||||||+
T Consensus 106 ~~~~~-----~~~~~v~e~~~~~~~L~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~ 168 (312)
T 2iwi_A 106 WFETQ-----EGFMLVLERPLPAQDLFDYITEKG---------PLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDE 168 (312)
T ss_dssp EC----------CEEEEECCSSEEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGG
T ss_pred EEecC-----CeEEEEEEecCCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChh
Confidence 97543 357899999 78999999997643 3568999999999999999999 899999999999
Q ss_pred cEEec-CCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCC-cccchhhHhHHHHHHHhCCCCCCCCCC
Q 012014 288 NVLLD-DEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEAS-TYGDVYSFGILLLEMFTGIRPSDGIFT 365 (473)
Q Consensus 288 Nil~~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~P~~~~~~ 365 (473)
||+++ .++.+||+|||++....... .....||+.|+|||++.+..+. .++||||||+++|+|++|..||....
T Consensus 169 Nil~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~- 243 (312)
T 2iwi_A 169 NILIDLRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ- 243 (312)
T ss_dssp GEEEETTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-
T ss_pred hEEEeCCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-
Confidence 99999 88999999999998764322 2345589999999998776664 58999999999999999999996420
Q ss_pred CcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHH
Q 012014 366 GKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDV 445 (473)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev 445 (473)
........ .....+..+.+|+.+||+.||++|||+.|+
T Consensus 244 ------~~~~~~~~------------------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~ 281 (312)
T 2iwi_A 244 ------EILEAELH------------------------------------FPAHVSPDCCALIRRCLAPKPSSRPSLEEI 281 (312)
T ss_dssp ------HHHHTCCC------------------------------------CCTTSCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred ------HHhhhccC------------------------------------CcccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence 11000000 001234567899999999999999999999
Q ss_pred HH
Q 012014 446 ES 447 (473)
Q Consensus 446 ~~ 447 (473)
++
T Consensus 282 l~ 283 (312)
T 2iwi_A 282 LL 283 (312)
T ss_dssp HH
T ss_pred hc
Confidence 76
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=336.78 Aligned_cols=251 Identities=20% Similarity=0.278 Sum_probs=184.1
Q ss_pred cccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhc-CCCCceeeeeeeeccccCCcee
Q 012014 142 NATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 220 (473)
....+|...++||+|+||+||.....+++.||||++.. .....+.+|+.+++.+ +|||||++++++.+ ...
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~---~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~-----~~~ 92 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDEHPNVIRYFCTEKD-----RQF 92 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECT---TTEEECHHHHHHHHHSCCCTTBCCEEEEEEE-----TTE
T ss_pred EccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECH---HHHHHHHHHHHHHHhccCCCCcCeEEEEEec-----CCE
Confidence 34456899999999999997655567899999999863 2345577999999999 79999999998754 346
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecC-----Cc
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD-----EM 295 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~-----~~ 295 (473)
.++|||||. |+|.+++...... +...++..++.||+.||.||| +++|+||||||+|||++. ..
T Consensus 93 ~~lv~E~~~-g~L~~~l~~~~~~--------~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~ 160 (432)
T 3p23_A 93 QYIAIELCA-ATLQEYVEQKDFA--------HLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKI 160 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSSCC--------CCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBC
T ss_pred EEEEEECCC-CCHHHHHHhcCCC--------ccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCce
Confidence 799999995 6999999866432 223345689999999999999 899999999999999943 23
Q ss_pred cEEEeecccccccCcccc-ccceeeccCCCCcCCCcccc---CCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccH
Q 012014 296 IGHVGDFGMARFLPAIDK-QNRFICIKGSTGYIPPEYDL---GCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNL 370 (473)
Q Consensus 296 ~~kl~Dfg~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~ 370 (473)
.+||+|||+++....... ........||+.|+|||++. ...++.++|||||||++|||++ |..||.......
T Consensus 161 ~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~--- 237 (432)
T 3p23_A 161 KAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ--- 237 (432)
T ss_dssp CEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH---
T ss_pred eEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH---
Confidence 688999999987654321 12234466999999999987 4567889999999999999999 999985422111
Q ss_pred HHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHH
Q 012014 371 RNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVE 446 (473)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~ 446 (473)
.............. ........+.+|+.+||+.||.+|||+.||+
T Consensus 238 ---~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~evl 282 (432)
T 3p23_A 238 ---ANILLGACSLDCLH----------------------------PEKHEDVIARELIEKMIAMDPQKRPSAKHVL 282 (432)
T ss_dssp ---HHHHTTCCCCTTSC----------------------------TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred ---HHHHhccCCccccC----------------------------ccccccHHHHHHHHHHHhCCHhhCCCHHHHH
Confidence 00000000000000 0112455678999999999999999999998
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=349.13 Aligned_cols=285 Identities=20% Similarity=0.210 Sum_probs=200.4
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccC-CCCchhHHHHHHHHHhcCCCCceeeeeeeecccc-CCcee
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY-QGARF 220 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~ 220 (473)
.++|.+.+.||+|+||.||+|.. .+|+.||||+++... ....+.+.+|+.++.+++||||+++++++..... .....
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 36899999999999999999984 568999999986432 2234568899999999999999999998755221 22456
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCcc---E
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI---G 297 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~---~ 297 (473)
.++||||+++|+|.+++....... .+++..+..++.|++.||.||| ++||+||||||+||+++.++. +
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~------~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~v 163 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCC------GLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIH 163 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTT------CCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEE
T ss_pred EEEEEEeCCCCCHHHHHHhcccCC------CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeE
Confidence 799999999999999998754221 3557788999999999999999 899999999999999987664 9
Q ss_pred EEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.+.... ..+....
T Consensus 164 KL~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~----~~~~~~i 236 (676)
T 3qa8_A 164 KIIDLGYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP----VQWHGKV 236 (676)
T ss_dssp EECSCCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH----HHSSTTC
T ss_pred EEccccccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch----hhhhhhh
Confidence 999999998764432 223456899999999999999999999999999999999999999753111 0000000
Q ss_pred cCcchhh-hccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHH-----HHHHHHH
Q 012014 378 LPQRAEE-VVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKIND-----VESRLRL 451 (473)
Q Consensus 378 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~e-----v~~~L~~ 451 (473)
....... .......... ........ ........+..+.+|+.+||..||++|||+.| ..+.++.
T Consensus 237 ~~~~~~~~~~~~~l~g~~-------~~~~~lp~---p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~ 306 (676)
T 3qa8_A 237 REKSNEHIVVYDDLTGAV-------KFSSVLPT---PNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDS 306 (676)
T ss_dssp C------CCSCCCCSSSC-------CCCSSSCC---SCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHH
T ss_pred hcccchhhhhhhhhcccc-------ccccccCC---chhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHH
Confidence 0000000 0000000000 00000000 00112235778999999999999999999988 4566666
Q ss_pred HHH
Q 012014 452 IRR 454 (473)
Q Consensus 452 l~~ 454 (473)
+..
T Consensus 307 iL~ 309 (676)
T 3qa8_A 307 ILS 309 (676)
T ss_dssp HHC
T ss_pred HHh
Confidence 543
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=324.47 Aligned_cols=253 Identities=21% Similarity=0.235 Sum_probs=176.9
Q ss_pred cccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCC--chhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 142 NATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGG--SKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
...++|++.+.||+|+||.||+|.. .+++.||||++....... .+.+.++..++..++||||+++++++...
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~----- 96 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN----- 96 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-----
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-----
Confidence 3456899999999999999999995 478999999997543211 12344455568888999999999998653
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCC-CeeeccCCCCcEEecCCccE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQP-PIAHCNLKPSNVLLDDEMIG 297 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~-~iiH~Dlkp~Nil~~~~~~~ 297 (473)
...++||||+ ++.+..+...... .+++..+..++.|++.||.||| ++ ||+||||||+||+++.++.+
T Consensus 97 ~~~~lv~e~~-~~~~~~l~~~~~~--------~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~ 164 (318)
T 2dyl_A 97 TDVFIAMELM-GTCAEKLKKRMQG--------PIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQI 164 (318)
T ss_dssp SEEEEEECCC-SEEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCE
T ss_pred CcEEEEEecc-CCcHHHHHHHhcc--------CCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCE
Confidence 3689999999 6666666543221 3568899999999999999999 75 99999999999999999999
Q ss_pred EEeecccccccCccccccceeeccCCCCcCCCcccc-----CCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHH
Q 012014 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDL-----GCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRN 372 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~ 372 (473)
||+|||++....... ......||+.|+|||++. +..++.++||||||+++|+|++|..||.........+..
T Consensus 165 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 241 (318)
T 2dyl_A 165 KLCDFGISGRLVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTK 241 (318)
T ss_dssp EECCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHH
T ss_pred EEEECCCchhccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHH
Confidence 999999997654322 223345899999999984 456889999999999999999999999753222111111
Q ss_pred HHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 373 FVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
......+ . ... ....+..+.+|+.+||+.||.+|||+.||++
T Consensus 242 ~~~~~~~-~---~~~-----------------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 242 VLQEEPP-L---LPG-----------------------------HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp HHHSCCC-C---CCS-----------------------------SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HhccCCC-C---CCc-----------------------------cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1111000 0 000 0113457889999999999999999999986
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-41 Score=313.90 Aligned_cols=235 Identities=13% Similarity=0.019 Sum_probs=182.3
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCC---chhHHHHHHHHHhcCCCCceeeeeeeeccccCCce
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGG---SKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (473)
.++|++.+.||+|+||.||+|.. .+++.||||++....... ...+.+|+.++.+++||||+++++++.+. .
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-----~ 104 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR-----A 104 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-----T
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC-----C
Confidence 46799999999999999999995 458999999997543322 26789999999999999999999998653 3
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
..++||||+++++|.+++.... ...++..++.|++.||.||| ++||+||||||+|||++.++.+||
T Consensus 105 ~~~lv~e~~~g~~L~~~l~~~~-----------~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl 170 (286)
T 3uqc_A 105 GGLVVAEWIRGGSLQEVADTSP-----------SPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVL 170 (286)
T ss_dssp EEEEEEECCCEEEHHHHHTTCC-----------CHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEE
T ss_pred cEEEEEEecCCCCHHHHHhcCC-----------ChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEE
Confidence 6799999999999999996431 24568889999999999999 899999999999999999999999
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcC
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP 379 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 379 (473)
+++| |++ .++.++|||||||++|+|++|..||.+.........
T Consensus 171 ~~~~----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~-------- 213 (286)
T 3uqc_A 171 AYPA----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP-------- 213 (286)
T ss_dssp CSCC----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE--------
T ss_pred Eecc----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH--------
Confidence 8543 333 378899999999999999999999987533221000
Q ss_pred cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHHhhc
Q 012014 380 QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRKLL 457 (473)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~~~ 457 (473)
.......... .........+..+.+|+.+||+.||++| |+.|+++.|+.+.....
T Consensus 214 --~~~~~~~~~~--------------------~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 214 --AERDTAGQPI--------------------EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp --CCBCTTSCBC--------------------CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred --HHHHhccCCC--------------------ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 0000000000 0001112356678999999999999999 99999999999875543
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-41 Score=351.92 Aligned_cols=249 Identities=19% Similarity=0.327 Sum_probs=197.6
Q ss_pred ccCCCCccceeecCCCeEEEEEEec--CCCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCce
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTLF--DGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (473)
..++|.+.+.||+|+||.||+|... +++.||||++..... .....+.+|+.++.+++||||++++++|...+..+..
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 4578999999999999999999854 689999999864322 2334678999999999999999999999775543344
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
..|+||||+++++|.+++.. .+++.+++.++.||+.||.||| ++||+||||||+|||++.+ .+||
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~-----------~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl 222 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ-----------KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKL 222 (681)
T ss_dssp EEEEEEECCCCEECC----C-----------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEE
T ss_pred eeEEEEEeCCCCcHHHHHhC-----------CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEE
Confidence 47999999999999887654 2568999999999999999999 8999999999999999875 8999
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcC
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP 379 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 379 (473)
+|||+++..... ....||+.|+|||++.+. ++.++|||||||++|+|++|..||.+...... +
T Consensus 223 ~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------~ 285 (681)
T 2pzi_A 223 IDLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------P 285 (681)
T ss_dssp CCCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------C
T ss_pred EecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc----------c
Confidence 999999876432 334699999999998765 48899999999999999999999875321110 0
Q ss_pred cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCC-ChHHHHHHHHHHHHhh
Q 012014 380 QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERM-KINDVESRLRLIRRKL 456 (473)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~ev~~~L~~l~~~~ 456 (473)
.. ......+..+.+|+.+||+.||++|| +++++...|..+....
T Consensus 286 -------~~--------------------------~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~~ 330 (681)
T 2pzi_A 286 -------ED--------------------------DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREV 330 (681)
T ss_dssp -------TT--------------------------CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHHH
T ss_pred -------cc--------------------------ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHHh
Confidence 00 00112346788999999999999999 5777888888776443
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=333.79 Aligned_cols=255 Identities=13% Similarity=0.091 Sum_probs=184.7
Q ss_pred hcccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCC---CCchhHHHHHHHHHhcCC-CCceeeeee------
Q 012014 141 YNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP---GGSKSFKSECKAAINIKH-RNIVRVFTA------ 209 (473)
Q Consensus 141 ~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~niv~~~~~------ 209 (473)
...+.+|...++||+|+||.||+|. ..+|+.||||+++.... ...+.+.+|+.++..++| +|...+..+
T Consensus 74 ~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~ 153 (413)
T 3dzo_A 74 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 153 (413)
T ss_dssp SSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCC
T ss_pred CCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccc
Confidence 3445568888999999999999999 55799999999873332 235779999999999987 322211111
Q ss_pred ---------------eeccccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhC
Q 012014 210 ---------------FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCD 274 (473)
Q Consensus 210 ---------------~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~ 274 (473)
+...........+++|+++ +++|.+++....... .....+++..++.++.||+.||.|||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~--~~~~~l~~~~~~~i~~qi~~aL~~LH-- 228 (413)
T 3dzo_A 154 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHS--STHKSLVHHARLQLTLQVIRLLASLH-- 228 (413)
T ss_dssp CEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHT--TTSHHHHHHHHHHHHHHHHHHHHHHH--
T ss_pred hhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhccc--ccCCCCCHHHHHHHHHHHHHHHHHHH--
Confidence 1110000122356777766 789999985211000 00125778899999999999999999
Q ss_pred CCCCeeeccCCCCcEEecCCccEEEeecccccccCccccccceeeccCCCCcCCCccc----------cCCCCCcccchh
Q 012014 275 CQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYD----------LGCEASTYGDVY 344 (473)
Q Consensus 275 ~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Diw 344 (473)
+++|+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||
T Consensus 229 -~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dvw 301 (413)
T 3dzo_A 229 -HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTW 301 (413)
T ss_dssp -HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHH
T ss_pred -hCCcccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHH
Confidence 899999999999999999999999999999865432 344567 999999998 556688999999
Q ss_pred hHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHH
Q 012014 345 SFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSI 424 (473)
Q Consensus 345 SlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 424 (473)
||||++|||++|+.||.+...... ...++.. ....+..+
T Consensus 302 SlGvil~elltg~~Pf~~~~~~~~-------------~~~~~~~----------------------------~~~~~~~~ 340 (413)
T 3dzo_A 302 TLGLAIYWIWCADLPNTDDAALGG-------------SEWIFRS----------------------------CKNIPQPV 340 (413)
T ss_dssp HHHHHHHHHHHSSCCCCTTGGGSC-------------SGGGGSS----------------------------CCCCCHHH
T ss_pred HHHHHHHHHHHCCCCCCCcchhhh-------------HHHHHhh----------------------------cccCCHHH
Confidence 999999999999999976422110 0001000 00134678
Q ss_pred HHHhhhcccCCCCCCCChHHHHHH
Q 012014 425 CEIGVACSAERPRERMKINDVESR 448 (473)
Q Consensus 425 ~~l~~~cl~~dP~~RPt~~ev~~~ 448 (473)
.+|+.+||+.||++|||+.|+++.
T Consensus 341 ~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 341 RALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHccCChhhCcCHHHHHhC
Confidence 899999999999999998888653
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=308.24 Aligned_cols=235 Identities=19% Similarity=0.279 Sum_probs=179.9
Q ss_pred cCCCCcc-ceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHHHHH-HhcCCCCceeeeeeeeccccCCcee
Q 012014 144 TNGFSSA-NLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAA-INIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 144 ~~~~~~~-~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
.++|.+. ++||+|+||.||+|.. .+++.||+|+++. ...+.+|+.++ +.++||||+++++++.... .....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~ 89 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLY-AGRKC 89 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhc-CCCce
Confidence 3567776 7899999999999984 5789999999863 45678899988 5569999999999986522 33457
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecC---CccE
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD---EMIG 297 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~---~~~~ 297 (473)
.++||||+++|+|.+++...... .+++..+..++.|++.||.||| +++|+||||||+||+++. ++.+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~ 159 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGDQ-------AFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAIL 159 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTTC-------CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCE
T ss_pred EEEEEeecCCCcHHHHHHhccCC-------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcE
Confidence 89999999999999999875422 3678999999999999999999 899999999999999998 7899
Q ss_pred EEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
||+|||++.... +..++.++|||||||++|+|++|..||.+......
T Consensus 160 kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~--------- 206 (299)
T 3m2w_A 160 KLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--------- 206 (299)
T ss_dssp EECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC---------------
T ss_pred EEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh---------
Confidence 999999986432 23567889999999999999999999975422110
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.......+.... ...........+..+.+|+.+||+.||++|||+.|+++
T Consensus 207 ~~~~~~~~~~~~--------------------~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 207 SPGMKTRIRMGQ--------------------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp -CCSCCSSCTTC--------------------CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hHHHHHHHhhcc--------------------ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 000000000000 00001111235678899999999999999999999986
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=314.57 Aligned_cols=197 Identities=17% Similarity=0.177 Sum_probs=157.7
Q ss_pred cCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCC--------CCchhHHHHHHHHHhcC---------CCCceee
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRP--------GGSKSFKSECKAAINIK---------HRNIVRV 206 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---------h~niv~~ 206 (473)
.++|++.+.||+|+||.||+|+. +|+.||||+++.... ...+.+.+|+.+++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 45789999999999999999986 789999999985432 22367899999999886 6565555
Q ss_pred eee-----------------eeccc--------cCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHH
Q 012014 207 FTA-----------------FSGVD--------YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIA 261 (473)
Q Consensus 207 ~~~-----------------~~~~~--------~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~ 261 (473)
.++ |.+.. .......++|||||++|++.+.+... .+++.++..++
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~----------~~~~~~~~~i~ 167 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK----------LSSLATAKSIL 167 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTT----------CCCHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhc----------CCCHHHHHHHH
Confidence 554 33200 01245789999999999776666442 25689999999
Q ss_pred HHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCc--------------------cEEEeecccccccCccccccceeecc
Q 012014 262 IDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM--------------------IGHVGDFGMARFLPAIDKQNRFICIK 321 (473)
Q Consensus 262 ~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~ 321 (473)
.||+.||.|||+ +++|+||||||+|||++.++ .+||+|||+|+..... ...
T Consensus 168 ~qi~~aL~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~ 238 (336)
T 2vuw_A 168 HQLTASLAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVV 238 (336)
T ss_dssp HHHHHHHHHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEE
T ss_pred HHHHHHHHHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEE
Confidence 999999999993 36899999999999999887 8999999999865431 236
Q ss_pred CCCCcCCCccccCCCCCcccchhhHhHH-HHHHHhCCCCCC
Q 012014 322 GSTGYIPPEYDLGCEASTYGDVYSFGIL-LLEMFTGIRPSD 361 (473)
Q Consensus 322 gt~~y~aPE~~~~~~~~~~~DiwSlG~i-l~elltg~~P~~ 361 (473)
||+.|+|||++.+.. +.++||||||++ .+++++|..||.
T Consensus 239 gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 239 FCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp CCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred EeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence 999999999998766 889999998777 778888999984
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-33 Score=284.03 Aligned_cols=185 Identities=17% Similarity=0.047 Sum_probs=127.7
Q ss_pred eecCCCeEEEEEE-ecCCCEEEEEEeeccCC----------CCchhHHHHHHHHHhc-CCCCceeeeeeeeccccCCcee
Q 012014 153 IGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP----------GGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 153 lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 220 (473)
.+.|++|.+..++ ...|+.+|+|++..... ...+.|.+|+++|+++ .|+||+++++++.+ ...
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed-----~~~ 316 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN-----AQS 316 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC-----SSE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE-----CCE
Confidence 4566777666655 55689999999974321 1224689999999999 79999999999854 447
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.||||||++|++|.++|..... ++. .+|+.||+.||.|+| ++|||||||||+|||++.+|.+||+
T Consensus 317 ~yLVMEyv~G~~L~d~i~~~~~---------l~~---~~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~ 381 (569)
T 4azs_A 317 GWLVMEKLPGRLLSDMLAAGEE---------IDR---EKILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLI 381 (569)
T ss_dssp EEEEEECCCSEEHHHHHHTTCC---------CCH---HHHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEEC
T ss_pred EEEEEecCCCCcHHHHHHhCCC---------CCH---HHHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEe
Confidence 8999999999999999987653 223 258999999999999 9999999999999999999999999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCC
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPS 360 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~ 360 (473)
|||+|+...... ....+.+||+.|||||++.+ .+..++|+||+|++++++.++..|+
T Consensus 382 DFGlAr~~~~~~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 382 DFGSIVTTPQDC--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp CCTTEESCC-----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred ecccCeeCCCCC--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 999998765432 22344679999999999876 4677899999999988876665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-29 Score=256.06 Aligned_cols=186 Identities=14% Similarity=0.095 Sum_probs=142.4
Q ss_pred CccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCC--------chhHHHHHHHHHhcCCCCceeeeeeeeccccCCce
Q 012014 148 SSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGG--------SKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 148 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (473)
...++||+|+||.||+|. ..++.+++|+........ .+.+.+|++++++++||||+++..++... .
T Consensus 339 ~~~~~LG~G~fg~Vy~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~-----~ 412 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS-YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDL-----D 412 (540)
T ss_dssp ---------CCEEEEEEE-CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET-----T
T ss_pred CCCCEEeeCCCEEEEEEE-ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC-----C
Confidence 446789999999999995 567899999875432221 23478999999999999999544444322 2
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
..++||||+++++|.+++.. +..++.|++.||.||| +++|+||||||+|||++. .+||
T Consensus 413 ~~~lVmE~~~ggsL~~~l~~-----------------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL 470 (540)
T 3en9_A 413 NKRIMMSYINGKLAKDVIED-----------------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYI 470 (540)
T ss_dssp TTEEEEECCCSEEHHHHSTT-----------------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEE
T ss_pred ccEEEEECCCCCCHHHHHHH-----------------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEE
Confidence 45999999999999999875 2358999999999999 899999999999999998 9999
Q ss_pred eecccccccCcccccc-----ceeeccCCCCcCCCccccC--CCCCcccchhhHhHHHHHHHhCCCCCC
Q 012014 300 GDFGMARFLPAIDKQN-----RFICIKGSTGYIPPEYDLG--CEASTYGDVYSFGILLLEMFTGIRPSD 361 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~P~~ 361 (473)
+|||+++......... ......||+.|||||++.. ..|+..+|+||..+-..+-+.++.+|.
T Consensus 471 ~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 471 IDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred EECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 9999999875432211 1235679999999999987 568888999999999999888877764
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.4e-26 Score=212.77 Aligned_cols=150 Identities=17% Similarity=0.078 Sum_probs=118.9
Q ss_pred hcccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCC------------------CchhHHHHHHHHHhcCCCC
Q 012014 141 YNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG------------------GSKSFKSECKAAINIKHRN 202 (473)
Q Consensus 141 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l~h~n 202 (473)
......|.+.+.||+|+||.||+|...+|+.||+|+++..... ....+.+|+.++.+++ |
T Consensus 86 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~ 163 (282)
T 1zar_A 86 VRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G 163 (282)
T ss_dssp HHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T
T ss_pred HhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C
Confidence 3344567777999999999999999877999999999643221 1345889999999999 4
Q ss_pred ceeeeeeeeccccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeec
Q 012014 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHC 282 (473)
Q Consensus 203 iv~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~ 282 (473)
+++++++.. ...++||||+++|+|.+ +... +...++.|++.||.||| ++||+||
T Consensus 164 -~~v~~~~~~------~~~~lvmE~~~g~~L~~-l~~~---------------~~~~i~~qi~~~l~~lH---~~giiHr 217 (282)
T 1zar_A 164 -LAVPKVYAW------EGNAVLMELIDAKELYR-VRVE---------------NPDEVLDMILEEVAKFY---HRGIVHG 217 (282)
T ss_dssp -SSSCCEEEE------ETTEEEEECCCCEEGGG-CCCS---------------CHHHHHHHHHHHHHHHH---HTTEECS
T ss_pred -CCcCeEEec------cceEEEEEecCCCcHHH-cchh---------------hHHHHHHHHHHHHHHHH---HCCCEeC
Confidence 666665422 24599999999999988 4221 23359999999999999 9999999
Q ss_pred cCCCCcEEecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccC
Q 012014 283 NLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG 334 (473)
Q Consensus 283 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 334 (473)
||||+|||++ ++.+||+|||+++. +..|+|||++..
T Consensus 218 Dlkp~NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 218 DLSQYNVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILER 253 (282)
T ss_dssp CCSTTSEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred CCCHHHEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence 9999999999 99999999999863 445789998754
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=3e-21 Score=177.90 Aligned_cols=137 Identities=20% Similarity=0.213 Sum_probs=105.1
Q ss_pred CCccceeecCCCeEEEEEEe-cCCCE--EEEEEeeccCCCC------------------------chhHHHHHHHHHhcC
Q 012014 147 FSSANLIGAGNFGSVYNGTL-FDGTT--IAVKVFNLIRPGG------------------------SKSFKSECKAAINIK 199 (473)
Q Consensus 147 ~~~~~~lg~G~~g~V~~~~~-~~~~~--vavK~~~~~~~~~------------------------~~~~~~E~~~l~~l~ 199 (473)
|.+.+.||+|+||.||+|.. .+|+. ||||+++...... ...+.+|+.++.++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999996 68889 9999975432110 025789999999998
Q ss_pred CCCc--eeeeeeeeccccCCceeeEEEEEecCC-C----CHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHh
Q 012014 200 HRNI--VRVFTAFSGVDYQGARFKAVVYKFMPN-G----SLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLH 272 (473)
Q Consensus 200 h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH 272 (473)
|+++ +..+.. ...+|||||+.+ | +|.++... .++..+..++.|++.||.|||
T Consensus 129 ~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~~------------~~~~~~~~i~~qi~~~l~~lH 187 (258)
T 1zth_A 129 EAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGRE------------LKELDVEGIFNDVVENVKRLY 187 (258)
T ss_dssp HTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGGG------------GGGSCHHHHHHHHHHHHHHHH
T ss_pred hCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhhc------------cChHHHHHHHHHHHHHHHHHH
Confidence 8764 333332 135899999942 3 77776532 113456789999999999999
Q ss_pred hCCCCCeeeccCCCCcEEecCCccEEEeeccccccc
Q 012014 273 CDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL 308 (473)
Q Consensus 273 ~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 308 (473)
. +.||+||||||+|||++. .++|+|||+|...
T Consensus 188 ~--~~givHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 188 Q--EAELVHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp H--TSCEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred H--HCCEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 4 469999999999999998 8999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.76 E-value=6.7e-19 Score=168.30 Aligned_cols=150 Identities=13% Similarity=0.090 Sum_probs=100.1
Q ss_pred hcccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCC--------------CchhHHHHHHHHHhcCCCCceee
Q 012014 141 YNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG--------------GSKSFKSECKAAINIKHRNIVRV 206 (473)
Q Consensus 141 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--------------~~~~~~~E~~~l~~l~h~niv~~ 206 (473)
.....-|++...||+|+||.||+|...+|+.||||+++..... .......+.++.....|+|++++
T Consensus 91 ~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL 170 (397)
T 4gyi_A 91 AARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL 170 (397)
T ss_dssp HHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH
Confidence 3333458999999999999999999888999999998632110 01112222333223334444444
Q ss_pred eeeeecccc-CCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCC
Q 012014 207 FTAFSGVDY-QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLK 285 (473)
Q Consensus 207 ~~~~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlk 285 (473)
+........ -.....+|||||++|++|.++... .....++.|++.+|.+|| +.||||||||
T Consensus 171 ~~~gv~vp~p~~~~~~~LVME~i~G~~L~~l~~~---------------~~~~~l~~qll~~l~~lH---~~gIVHrDLK 232 (397)
T 4gyi_A 171 YEEGFPVPEPIAQSRHTIVMSLVDALPMRQVSSV---------------PDPASLYADLIALILRLA---KHGLIHGDFN 232 (397)
T ss_dssp HHTTCSCCCEEEEETTEEEEECCSCEEGGGCCCC---------------SCHHHHHHHHHHHHHHHH---HTTEECSCCS
T ss_pred HhcCCCCCeeeeccCceEEEEecCCccHhhhccc---------------HHHHHHHHHHHHHHHHHH---HCCCcCCCCC
Confidence 322111000 001123799999999888654321 123457899999999999 8999999999
Q ss_pred CCcEEecCCc----------cEEEeeccccccc
Q 012014 286 PSNVLLDDEM----------IGHVGDFGMARFL 308 (473)
Q Consensus 286 p~Nil~~~~~----------~~kl~Dfg~~~~~ 308 (473)
|.|||+++++ .+.|+||+.+...
T Consensus 233 p~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 233 EFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp TTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred HHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 9999998776 4899999987643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=1.2e-12 Score=120.62 Aligned_cols=143 Identities=13% Similarity=0.097 Sum_probs=109.8
Q ss_pred cCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcC-CCCceeeeeeeeccccCCceeeE
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
..+|.+...++.|+.+.||++.. ++..+++|+...........+.+|+.+++.+. +.++.++++++.. ....+
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-----~~~~~ 86 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH-----DGWSN 86 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-----TTEEE
T ss_pred hccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec-----CCceE
Confidence 34677788888899999999974 47899999986432234457999999999984 6778888888653 23579
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCC---------------------------
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDC--------------------------- 275 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~--------------------------- 275 (473)
+||||++|.+|.+.+... .....++.+++.+|..||+..
T Consensus 87 lv~e~i~G~~l~~~~~~~--------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYEDE--------------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLAD 152 (263)
T ss_dssp EEEECCSSEEHHHHCCTT--------------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSC
T ss_pred EEEEecCCeehhhccCCc--------------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccc
Confidence 999999999998864211 122357889999999999510
Q ss_pred -----------------------------CCCeeeccCCCCcEEecCCccEEEeeccccc
Q 012014 276 -----------------------------QPPIAHCNLKPSNVLLDDEMIGHVGDFGMAR 306 (473)
Q Consensus 276 -----------------------------~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~ 306 (473)
...++|+|++|.||+++++..+.|+||+.+.
T Consensus 153 ~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 153 VDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1459999999999999876667899998775
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.32 E-value=9.8e-12 Score=114.25 Aligned_cols=138 Identities=14% Similarity=0.045 Sum_probs=98.0
Q ss_pred cCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCC--ceeeeeeeeccccCCceee
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRN--IVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~ 221 (473)
..+|.+..+.+.|..+.||++...+|..+++|+.... ....+.+|+.+++.+.+.+ +.+++++... ....
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~-----~~~~ 90 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTE-----AGRD 90 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-----SSCE
T ss_pred cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccC-----CCCC
Confidence 3445544444466679999998767788999997532 3456889999999986544 5567776543 2346
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCC--------------------------
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDC-------------------------- 275 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~-------------------------- 275 (473)
++||||++|.+|. .... ....++.+++..|..||+..
T Consensus 91 ~~v~e~i~G~~l~--~~~~---------------~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (264)
T 1nd4_A 91 WLLLGEVPGQDLL--SSHL---------------APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLV 153 (264)
T ss_dssp EEEEECCSSEETT--TSCC---------------CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCC
T ss_pred EEEEEecCCcccC--cCcC---------------CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCc
Confidence 9999999998884 2111 01246777888888888321
Q ss_pred -----------------------------CCCeeeccCCCCcEEecCCccEEEeeccccc
Q 012014 276 -----------------------------QPPIAHCNLKPSNVLLDDEMIGHVGDFGMAR 306 (473)
Q Consensus 276 -----------------------------~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~ 306 (473)
...++|+|++|.||++++++.+.|+|||.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 154 DQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999887777899999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.12 E-value=1.7e-10 Score=111.21 Aligned_cols=144 Identities=9% Similarity=0.109 Sum_probs=102.9
Q ss_pred cceeecCCCeEEEEEEecCCCEEEEEEee--ccC-CCCchhHHHHHHHHHhcC--CCCceeeeeeeeccccCCceeeEEE
Q 012014 150 ANLIGAGNFGSVYNGTLFDGTTIAVKVFN--LIR-PGGSKSFKSECKAAINIK--HRNIVRVFTAFSGVDYQGARFKAVV 224 (473)
Q Consensus 150 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~~~~~~lv 224 (473)
.+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+.+++.+. +..+++++.++.+.+. ....++|
T Consensus 43 ~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~--~g~~~~v 119 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESV--IGRAFYI 119 (359)
T ss_dssp EEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTT--TSSCEEE
T ss_pred EEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCc--cCCeEEE
Confidence 567899999999998854 5688888765 221 123457889999999996 4567888888754321 1346899
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCC-----------------------------
Q 012014 225 YKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDC----------------------------- 275 (473)
Q Consensus 225 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~----------------------------- 275 (473)
|||++|.++.+.... .++..+...++.+++..|..||+..
T Consensus 120 me~v~G~~l~~~~~~-----------~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (359)
T 3dxp_A 120 MEFVSGRVLWDQSLP-----------GMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKL 188 (359)
T ss_dssp EECCCCBCCCCTTCT-----------TCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHH
T ss_pred EEecCCeecCCCccc-----------cCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHh
Confidence 999998776431110 2446778889999999999999520
Q ss_pred --------------------------CCCeeeccCCCCcEEecCCc--cEEEeecccccc
Q 012014 276 --------------------------QPPIAHCNLKPSNVLLDDEM--IGHVGDFGMARF 307 (473)
Q Consensus 276 --------------------------~~~iiH~Dlkp~Nil~~~~~--~~kl~Dfg~~~~ 307 (473)
...++|+|++|.||+++.++ .+.|+||+.+..
T Consensus 189 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 189 SETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred cCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 25799999999999998765 368999998874
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.10 E-value=1.6e-11 Score=114.83 Aligned_cols=90 Identities=23% Similarity=0.337 Sum_probs=55.3
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhhH
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (473)
|.+|.|||||||||||+||+||+.|...... ...+...+..... .+.+.... ..|
T Consensus 212 ~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~-~~~~~~~~~~~~~-------~p~~~~~~-----------~~~------ 266 (307)
T 3omv_A 212 NPFSFQSDVYSYGIVLYELMTGELPYSHINN-RDQIIFMVGRGYA-------SPDLSKLY-----------KNC------ 266 (307)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-HHHHHHHHHTTCC-------CCCSTTSC-----------TTS------
T ss_pred CCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh-HHHHHHHHhcCCC-------CCCccccc-----------ccc------
Confidence 4589999999999999999999999753221 1111122211111 11100000 000
Q ss_pred HHHHHHhhcccccccccccccccchhhHHHHHHHHHhh
Q 012014 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (473)
Q Consensus 82 ~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~~ 119 (473)
-..+..+...|+..+|.+||++.++...|+.++..
T Consensus 267 ---~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 267 ---PKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp ---CHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred ---hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 11122345679999999999999999999887654
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.03 E-value=4.1e-11 Score=112.77 Aligned_cols=189 Identities=17% Similarity=0.124 Sum_probs=117.5
Q ss_pred cceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcC-CCC--ceeeeeeeeccccCCceeeEEEEE
Q 012014 150 ANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK-HRN--IVRVFTAFSGVDYQGARFKAVVYK 226 (473)
Q Consensus 150 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~~~~~~~~~~~~~~~~~~lv~e 226 (473)
.+.++.|.+..||+.. ..+++|+.... .....+.+|..++..+. +.. +.+++...... ......|+||+
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~--~~~~~~~~vm~ 96 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPS--ETYQMSFAGFT 96 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCC--SSCSCSCEEEE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCC--CCCCcceEEEc
Confidence 4568999999999763 56888985421 23457889999998883 322 34444432211 11123589999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhC--------------------------------
Q 012014 227 FMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCD-------------------------------- 274 (473)
Q Consensus 227 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~-------------------------------- 274 (473)
+++|.+|.+.... .++..++..++.+++..|..||+.
T Consensus 97 ~i~G~~l~~~~~~-----------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (304)
T 3sg8_A 97 KIKGVPLTPLLLN-----------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSREL 165 (304)
T ss_dssp CCCCEECCHHHHH-----------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTS
T ss_pred ccCCeECCccccc-----------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccC
Confidence 9999887653221 233566677777888777777741
Q ss_pred -----------------------CCCCeeeccCCCCcEEecC--CccEEEeecccccccCccccccceeeccCCCCcCCC
Q 012014 275 -----------------------CQPPIAHCNLKPSNVLLDD--EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPP 329 (473)
Q Consensus 275 -----------------------~~~~iiH~Dlkp~Nil~~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP 329 (473)
....++|+|++|.||++++ ...+.|+||+.+........-..... ...-..|
T Consensus 166 ~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~---~~~~~~~ 242 (304)
T 3sg8_A 166 KGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLME---DDEEYGM 242 (304)
T ss_dssp CHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCC---TTTSCCH
T ss_pred CcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHh---hccccCH
Confidence 0135899999999999988 56788999998865322110000000 0000122
Q ss_pred cccc----CC----------CCCcccchhhHhHHHHHHHhCCCCC
Q 012014 330 EYDL----GC----------EASTYGDVYSFGILLLEMFTGIRPS 360 (473)
Q Consensus 330 E~~~----~~----------~~~~~~DiwSlG~il~elltg~~P~ 360 (473)
+... .. ......+.|++|.++|.+.+|..+|
T Consensus 243 ~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 243 EFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 2111 00 0112258999999999999998775
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=99.01 E-value=2e-10 Score=107.71 Aligned_cols=94 Identities=12% Similarity=0.127 Sum_probs=57.0
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCCCCCC----------cccHHHHHHHhcCCccccccccccccchHHHHHHHhhhc
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFND----------ELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKAS 72 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~ 72 (473)
..|.|||||||||||+||+||+.|....... ......+........ ++|.+.....
T Consensus 194 ~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~----~rp~~p~~~~---------- 259 (303)
T 3hmm_A 194 ESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK----LRPNIPNRWQ---------- 259 (303)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSC----CCCCCCGGGG----------
T ss_pred ccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhccc----CCCCCCcccc----------
Confidence 4678999999999999999998875321111 111222222111111 1222111100
Q ss_pred ccCcchhhHHHHHHHhhcccccccccccccccchhhHHHHHHHHHh
Q 012014 73 STCTQSSIILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (473)
Q Consensus 73 ~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~ 118 (473)
..++...+..+...|+..+|.+||++.++.+.|+.+.+
T Consensus 260 --------~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 260 --------SCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp --------SSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------chHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 01223445566788999999999999999999987754
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=98.98 E-value=1.1e-10 Score=109.43 Aligned_cols=81 Identities=27% Similarity=0.548 Sum_probs=52.5
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..|.|||||||||||+||+| |+.|..... ...+...+.. .......+ . |
T Consensus 222 ~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~--~~~~~~~i~~---~~~~~~p~-----~--------------~----- 272 (308)
T 4gt4_A 222 GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS--NQDVVEMIRN---RQVLPCPD-----D--------------C----- 272 (308)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC--HHHHHHHHHT---TCCCCCCT-----T--------------C-----
T ss_pred CCCCccchhhhHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHc---CCCCCCcc-----c--------------c-----
Confidence 568999999999999999999 888865322 1123332221 11111100 0 1
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHH
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRL 115 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~ 115 (473)
-..+..+...|+..+|.+||++.++...|+.
T Consensus 273 ----~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 273 ----PAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ----hHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 1112234567999999999999999988874
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=98.92 E-value=3e-10 Score=105.99 Aligned_cols=85 Identities=22% Similarity=0.383 Sum_probs=54.4
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..|.|||||||||||+||+| |+.|...... ..+...+.. ...... | .. |
T Consensus 205 ~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~--~~~~~~i~~---~~~~~~--p---~~--------------~----- 255 (299)
T 4asz_A 205 RKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--NEVIECITQ---GRVLQR--P---RT--------------C----- 255 (299)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--HHHHHHHHH---TCCCCC--C---TT--------------C-----
T ss_pred CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHHc---CCCCCC--C---cc--------------c-----
Confidence 567999999999999999999 8999753321 122222221 111000 0 00 0
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHHhh
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~~ 119 (473)
-..+..+...|+..+|++||++.++...|+.+.+.
T Consensus 256 ----~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 256 ----PQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 01122345579999999999999999998877653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.89 E-value=4.4e-10 Score=106.35 Aligned_cols=84 Identities=26% Similarity=0.440 Sum_probs=54.1
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..|.|||||||||||+||+| |+.|...... ..+...+.... ... .| .. |
T Consensus 235 ~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~--~~~~~~i~~g~---~~~--~p---~~--------------~----- 285 (329)
T 4aoj_A 235 RKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN--TEAIDCITQGR---ELE--RP---RA--------------C----- 285 (329)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH--HHHHHHHHHTC---CCC--CC---TT--------------C-----
T ss_pred CCCCccccccchHHHHHHHHcCCCCCCCCCCH--HHHHHHHHcCC---CCC--Cc---cc--------------c-----
Confidence 467999999999999999999 8999753321 11222222110 000 01 00 0
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHHh
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~ 118 (473)
-..+..+...|+..+|++||++.++...|+.+.+
T Consensus 286 ----~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 286 ----PPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp ----CHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ----cHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 0112234567999999999999999999988764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=98.75 E-value=1.7e-09 Score=103.21 Aligned_cols=85 Identities=24% Similarity=0.340 Sum_probs=52.9
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..|.|||||||||+|+||+| |+.|.......+ .+...+..-. .....+ . |
T Consensus 262 ~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~-~~~~~i~~g~---~~~~p~-----~--------------~----- 313 (353)
T 4ase_A 262 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCRRLKEGT---RMRAPD-----Y--------------T----- 313 (353)
T ss_dssp CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-HHHHHHHHTC---CCCCCT-----T--------------C-----
T ss_pred CCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH-HHHHHHHcCC---CCCCCc-----c--------------C-----
Confidence 457899999999999999999 899875432221 1222221110 001100 0 0
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHHh
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~ 118 (473)
-..+..+...|+..+|.+||++.++...|+.+-+
T Consensus 314 ----~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 314 ----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 0011223457999999999999999998877643
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=98.73 E-value=7.3e-09 Score=98.07 Aligned_cols=98 Identities=26% Similarity=0.389 Sum_probs=66.8
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCCCCC-CcccHHHHHHHhcCC-ccccccccccccchHHHHHHHhhhcccCcchh
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFN-DELNLHNFVKSALPE-RAEEILDVVFFQEIEEEETMYKKASSTCTQSS 79 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~ 79 (473)
+..+.++|||||||+|+||+||+.|...... ....+..|....... ....++++.+......
T Consensus 216 ~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------- 279 (321)
T 2qkw_B 216 GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRP---------------- 279 (321)
T ss_dssp CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCH----------------
T ss_pred CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCH----------------
Confidence 4568899999999999999999999764332 334566676544333 3444555544322211
Q ss_pred hHHHHHHHhhcccccccccccccccchhhHHHHHHHHHh
Q 012014 80 IILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (473)
Q Consensus 80 ~~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~ 118 (473)
.+...+..+...|+..+|.+||++.++...|+...+
T Consensus 280 ---~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 280 ---ESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp ---HHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 112334455668999999999999999999987654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=98.70 E-value=5.6e-09 Score=99.07 Aligned_cols=95 Identities=31% Similarity=0.486 Sum_probs=67.3
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCC---CCCCcccHHHHHHHhcCC-ccccccccccccchHHHHHHHhhhcccCcc
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD---MFNDELNLHNFVKSALPE-RAEEILDVVFFQEIEEEETMYKKASSTCTQ 77 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~---~~~~~~~~~~~~~~~~~~-~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~ 77 (473)
+..+.++|||||||+++||+||+.|.+. .......+.+|+...... ....+.+..+.......
T Consensus 210 ~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------- 276 (326)
T 3uim_A 210 GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDE------------- 276 (326)
T ss_dssp SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHH-------------
T ss_pred CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHH-------------
Confidence 3468899999999999999999999752 123345677888776655 34455555443332211
Q ss_pred hhhHHHHHHHhhcccccccccccccccchhhHHHHHHH
Q 012014 78 SSIILECLISICRTGVACSAELPNERMKINDVESRLRL 115 (473)
Q Consensus 78 ~~~~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~ 115 (473)
+...+..+...|+..+|.+||++.++...|+.
T Consensus 277 ------~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 277 ------EVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp ------HHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred ------HHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 13344556678999999999999999988874
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=98.51 E-value=3.5e-08 Score=91.33 Aligned_cols=27 Identities=37% Similarity=0.501 Sum_probs=24.8
Q ss_pred CccccccceeehhhhHHHHHhCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
|+.+.|+|||||||+|+||+||+.|..
T Consensus 204 ~~y~~~~DiwSlGvilyelltg~~Pf~ 230 (290)
T 3fpq_A 204 EKYDESVDVYAFGMCMLEMATSEYPYS 230 (290)
T ss_dssp TCCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 567899999999999999999999975
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=98.49 E-value=6.9e-08 Score=91.38 Aligned_cols=95 Identities=15% Similarity=0.248 Sum_probs=56.0
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCCCCCCc-----------ccHHHHHHHhcCCccccccccccccchHHHHHHHhhh
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDE-----------LNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKA 71 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~ 71 (473)
..|.|+|||||||+|+||+||+.|........ .....+............+......
T Consensus 214 ~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------ 281 (322)
T 3soc_A 214 DAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQK------------ 281 (322)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGS------------
T ss_pred CCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccc------------
Confidence 35678999999999999999999975322111 1112222211111111111100000
Q ss_pred cccCcchhhHHHHHHHhhcccccccccccccccchhhHHHHHHHHHhh
Q 012014 72 SSTCTQSSIILECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (473)
Q Consensus 72 ~~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~~ 119 (473)
..+...+..+...|+..+|.+||++.++...|+.+.+.
T Consensus 282 ----------~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 282 ----------HAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp ----------SHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------cchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 01122244456679999999999999999999988653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.47 E-value=9.9e-07 Score=81.07 Aligned_cols=134 Identities=13% Similarity=0.058 Sum_probs=91.8
Q ss_pred eeecCCCe-EEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHHHHHHhcC-CCCceeeeeeeeccccCCceeeEEEEEec
Q 012014 152 LIGAGNFG-SVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQGARFKAVVYKFM 228 (473)
Q Consensus 152 ~lg~G~~g-~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 228 (473)
.+..|..| .||+... .++..+++|+-.. .....+.+|...|+.+. +--+.+++.++.+. ...++|||++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~-----~~~~lvme~l 102 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTP-----DDAWLLTTAI 102 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEET-----TEEEEEEECC
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEEC-----CeEEEEEEee
Confidence 34556555 6898773 4567899998652 23456888999998884 33366777776443 2569999999
Q ss_pred CCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhC----------------------------------
Q 012014 229 PNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCD---------------------------------- 274 (473)
Q Consensus 229 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~---------------------------------- 274 (473)
+|.++.+..... ......+..+++..|..||+.
T Consensus 103 ~G~~~~~~~~~~-------------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (272)
T 4gkh_A 103 PGKTAFQVLEEY-------------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDD 169 (272)
T ss_dssp CSEEHHHHHHHC-------------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCG
T ss_pred CCccccccccCC-------------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccc
Confidence 998887765322 112234555666666666631
Q ss_pred ---------------------CCCCeeeccCCCCcEEecCCccEEEeeccccc
Q 012014 275 ---------------------CQPPIAHCNLKPSNVLLDDEMIGHVGDFGMAR 306 (473)
Q Consensus 275 ---------------------~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~ 306 (473)
....++|+|+.|.||++++++.+-|+||+.+.
T Consensus 170 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 170 ERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp GGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 01137999999999999988777899999875
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=98.47 E-value=1.1e-07 Score=88.95 Aligned_cols=91 Identities=19% Similarity=0.297 Sum_probs=53.3
Q ss_pred ccccccceeehhhhHHHHHhC----------CCCCCCCCCCcccHHHHHHHhcCCcc-ccccccccccchHHHHHHHhhh
Q 012014 3 YVSSYGDVYSFGILLLEMFTG----------LRPNDDMFNDELNLHNFVKSALPERA-EEILDVVFFQEIEEEETMYKKA 71 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg----------~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~~~ 71 (473)
..|.|+|||||||+++||+|| +.|....................... ..+....+ ..
T Consensus 199 ~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~----------- 266 (301)
T 3q4u_A 199 DSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWF-SD----------- 266 (301)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGG-GS-----------
T ss_pred cCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhc-cC-----------
Confidence 356799999999999999999 66654332222223322222211111 11110000 00
Q ss_pred cccCcchhhHHHHHHHhhcccccccccccccccchhhHHHHHHHH
Q 012014 72 SSTCTQSSIILECLISICRTGVACSAELPNERMKINDVESRLRLI 116 (473)
Q Consensus 72 ~~~~~~~~~~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~ 116 (473)
.+...+..+...|+..+|.+||++.++...|+.+
T Consensus 267 -----------~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 267 -----------PTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp -----------HHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred -----------ccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 1122334456679999999999999999998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.47 E-value=5e-07 Score=84.69 Aligned_cols=137 Identities=17% Similarity=0.092 Sum_probs=88.9
Q ss_pred cceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCC---CceeeeeeeeccccCCceeeEEEEE
Q 012014 150 ANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHR---NIVRVFTAFSGVDYQGARFKAVVYK 226 (473)
Q Consensus 150 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~~~~~~~~~~~~lv~e 226 (473)
...++.|....||+. +..+++|+.. .......+.+|..+|..+.+. .+.+++.+... .....++|||
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~----~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR----SDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC----TTSCEEEEEE
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc----CCCceEEEEe
Confidence 456888998999987 5778888843 112345788999999999652 35566555431 1234689999
Q ss_pred ecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhC--------------------------------
Q 012014 227 FMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCD-------------------------------- 274 (473)
Q Consensus 227 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~-------------------------------- 274 (473)
|++|.+|.+..-.. ++..+...++.+++..|..||+.
T Consensus 94 ~i~G~~l~~~~~~~-----------l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~ 162 (306)
T 3tdw_A 94 KVQGQILGEDGMAV-----------LPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFP 162 (306)
T ss_dssp CCCSEECHHHHHTT-----------SCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGG
T ss_pred ccCCeECchhhhhh-----------CCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhccc
Confidence 99998876532111 11233334444444444444421
Q ss_pred -------------------------CCCCeeeccCCCCcEEecC---Ccc-EEEeecccccc
Q 012014 275 -------------------------CQPPIAHCNLKPSNVLLDD---EMI-GHVGDFGMARF 307 (473)
Q Consensus 275 -------------------------~~~~iiH~Dlkp~Nil~~~---~~~-~kl~Dfg~~~~ 307 (473)
....++|+|++|.||+++. ++. +.|+||+.+..
T Consensus 163 ~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 163 LLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp GSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred ccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 1346799999999999987 344 58999998763
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=98.42 E-value=1.1e-07 Score=89.15 Aligned_cols=95 Identities=25% Similarity=0.382 Sum_probs=58.1
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCCCCCCcccHHHHHHHhcCC--ccccccccccccchHHHHHHHhhhcccCcchh
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPE--RAEEILDVVFFQEIEEEETMYKKASSTCTQSS 79 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~ 79 (473)
|..+.++|||||||+++||+||+.|.+..... ..+..+....... ...+.++..+.....
T Consensus 209 ~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------- 270 (307)
T 2nru_A 209 GEITPKSDIYSFGVVLLEIITGLPAVDEHREP-QLLLDIKEEIEDEEKTIEDYIDKKMNDADS----------------- 270 (307)
T ss_dssp TEECTHHHHHHHHHHHHHHHHCCCSBCTTBSS-SBTTHHHHHHHTTSCCHHHHSCSSCSCCCH-----------------
T ss_pred CCCCccchhHHHHHHHHHHHHCCCCcccCcch-HHHHHHHHHhhhhhhhhhhhccccccccch-----------------
Confidence 45688999999999999999999997643222 1222232221111 122223322211111
Q ss_pred hHHHHHHHhhcccccccccccccccchhhHHHHHHHHH
Q 012014 80 IILECLISICRTGVACSAELPNERMKINDVESRLRLIK 117 (473)
Q Consensus 80 ~~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~ 117 (473)
.+...+..+...|+..+|..||++.++...|+.+.
T Consensus 271 ---~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 271 ---TSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp ---HHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred ---HHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 11223344566799999999999999999988764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=98.41 E-value=2.1e-07 Score=88.73 Aligned_cols=94 Identities=13% Similarity=0.195 Sum_probs=56.2
Q ss_pred cccccceeehhhhHHHHHhC----------CCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcc
Q 012014 4 VSSYGDVYSFGILLLEMFTG----------LRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASS 73 (473)
Q Consensus 4 ~t~ksDVySfGVvllEl~tg----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~ 73 (473)
.+.|+|||||||+|+||+|| +.|.............+......... .+.+.....
T Consensus 234 ~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~----------- 298 (342)
T 1b6c_B 234 SFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKL----RPNIPNRWQ----------- 298 (342)
T ss_dssp HHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCC----CCCCCGGGG-----------
T ss_pred cCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHh----CCCCccccc-----------
Confidence 34789999999999999999 44543322222233333333222211 111111000
Q ss_pred cCcchhhHHHHHHHhhcccccccccccccccchhhHHHHHHHHHhh
Q 012014 74 TCTQSSIILECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (473)
Q Consensus 74 ~~~~~~~~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~~ 119 (473)
...+...+..+...|+..+|.+||++.++...|+.+.+.
T Consensus 299 -------~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 299 -------SCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp -------TSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -------chhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 001223344556689999999999999999999987653
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=98.40 E-value=2.4e-07 Score=88.07 Aligned_cols=34 Identities=18% Similarity=0.246 Sum_probs=27.5
Q ss_pred HHhhcccccccccccccccchhhHHHHHHHHHhh
Q 012014 86 ISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (473)
Q Consensus 86 ~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~~ 119 (473)
..+..+...|+..+|.+||++.++...|+.+...
T Consensus 299 ~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 299 RQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 3344556789999999999999999999887653
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.36 E-value=2.8e-07 Score=86.50 Aligned_cols=88 Identities=17% Similarity=0.271 Sum_probs=54.4
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhhH
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (473)
+..+.++|||||||+++||+||+.|.+........ ..|.. ..... +.+.....
T Consensus 178 ~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~--~~~~~-----~~~~~~~~------------------- 230 (307)
T 2eva_A 178 SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR-IMWAV--HNGTR-----PPLIKNLP------------------- 230 (307)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH-HHHHH--HTTCC-----CCCBTTCC-------------------
T ss_pred CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH-HHHHH--hcCCC-----CCcccccC-------------------
Confidence 35788999999999999999999997643222111 11111 11100 00001100
Q ss_pred HHHHHHhhcccccccccccccccchhhHHHHHHHHHhhc
Q 012014 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKKKL 120 (473)
Q Consensus 82 ~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~~~ 120 (473)
..+..+...|+..+|.+||++.++...|+.+....
T Consensus 231 ----~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 231 ----KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp ----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred ----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 01112344699999999999999999999886544
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=98.36 E-value=6.8e-08 Score=93.12 Aligned_cols=94 Identities=18% Similarity=0.124 Sum_probs=56.1
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhhHH
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSIIL 82 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (473)
..+.|+|||||||+|+||+||+.|........ .+..+..........+++++.+... .+
T Consensus 237 ~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~------- 295 (364)
T 3op5_A 237 APSRRGDLEILGYCMIQWLTGHLPWEDNLKDP-KYVRDSKIRYRENIASLMDKCFPAA-------------NA------- 295 (364)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH-HHHHHHHHHHHHCHHHHHHHHSCTT-------------CC-------
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCccccccCH-HHHHHHHHHhhhhHHHHHHHhcccc-------------cC-------
Confidence 46889999999999999999999976432221 2222222221111222222111000 00
Q ss_pred HHHHHhhcccccccccccccccchhhHHHHHHHHHhh
Q 012014 83 ECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (473)
Q Consensus 83 ~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~~ 119 (473)
-..+..+...|+..+|.+||++.++...|+.+...
T Consensus 296 --~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~ 330 (364)
T 3op5_A 296 --PGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA 330 (364)
T ss_dssp --CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred --HHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence 01122334569999999999999999998877553
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=98.31 E-value=1.1e-07 Score=88.36 Aligned_cols=86 Identities=21% Similarity=0.293 Sum_probs=51.9
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCCCCCCcccHHHHHHHhc-CCccccccccccccchHHHHHHHhhhcccCcchhhH
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSAL-PERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (473)
..|.++|||||||+++||+||+.|....... ..+...+.... ......+. ...
T Consensus 201 ~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~-----~~~-------------------- 254 (289)
T 3og7_A 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNR-DQIIEMVGRGSLSPDLSKVR-----SNC-------------------- 254 (289)
T ss_dssp CSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH-HHHHHHHHHTSCCCCTTSSC-----TTS--------------------
T ss_pred CCCcccchHHHHHHHHHHHHCCCCccccchH-HHHHHHhcccccCcchhhcc-----ccC--------------------
Confidence 4677999999999999999999997643221 12222222111 11110000 000
Q ss_pred HHHHHHhhcccccccccccccccchhhHHHHHHHHH
Q 012014 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIK 117 (473)
Q Consensus 82 ~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~ 117 (473)
-..+..+...|+..+|.+||++.++...|+.+.
T Consensus 255 ---~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 255 ---PKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ---CHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 011223345699999999999999999887653
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=98.31 E-value=4.1e-07 Score=86.23 Aligned_cols=84 Identities=17% Similarity=0.258 Sum_probs=53.6
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..|.|+|||||||+|+||+| |+.|.+.... ..+...+....... .+. ..
T Consensus 194 ~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~~~~~~~~~~-----~~~---~~------------------- 244 (327)
T 3poz_A 194 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGERLP-----QPP---IC------------------- 244 (327)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHHHHHTTCCCC-----CCT---TB-------------------
T ss_pred CCCCchhhhhhhHHHHHHHHhcCCCCccCCCH--HHHHHHHHcCCCCC-----CCc---cC-------------------
Confidence 356889999999999999999 9988764322 22333222111000 000 00
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHHh
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~ 118 (473)
...+..+...|+..+|.+||++.++...|+.+..
T Consensus 245 ----~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 245 ----TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp ----CHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred ----CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0112234557999999999999999998887654
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=98.30 E-value=1.8e-07 Score=87.17 Aligned_cols=90 Identities=12% Similarity=0.130 Sum_probs=53.8
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCCCCC-Cc-ccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFN-DE-LNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
..+.++|||||||+|+||+||+.|...... .. ..+..............+ +...
T Consensus 191 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~-- 246 (296)
T 3uzp_A 191 EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL----------------------CKGY-- 246 (296)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH----------------------TTTS--
T ss_pred CCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHH----------------------HhhC--
Confidence 468899999999999999999999764321 11 111111111100000000 0000
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHHhhc
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKKKL 120 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~~~ 120 (473)
-..+..+...|+..+|.+||++.++...|+.+....
T Consensus 247 ----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 247 ----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp ----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ----CHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 011223345699999999999999999998876543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=98.29 E-value=5.4e-07 Score=84.98 Aligned_cols=85 Identities=13% Similarity=0.128 Sum_probs=50.3
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhhHH
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSIIL 82 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (473)
..+.|+|||||||+|+||+||+.|.......+ -+...... -+ ...+ +...+...
T Consensus 232 ~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~i~~~-~~-~~~~-----~~~~~s~~------------------ 285 (336)
T 4g3f_A 232 PCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP-LCLKIASE-PP-PIRE-----IPPSCAPL------------------ 285 (336)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC-CHHHHHHS-CC-GGGG-----SCTTSCHH------------------
T ss_pred CCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHHHcC-CC-Cchh-----cCccCCHH------------------
Confidence 46889999999999999999999976432222 11111110 00 0000 00111000
Q ss_pred HHHHHhhcccccccccccccccchhhHHHHHHHHHh
Q 012014 83 ECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (473)
Q Consensus 83 ~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~ 118 (473)
+ ..+-..|+..+|.+||+..++...+.....
T Consensus 286 --~---~~li~~~L~~dP~~R~sa~el~~~l~~~l~ 316 (336)
T 4g3f_A 286 --T---AQAIQEGLRKEPVHRASAMELRRKVGKALQ 316 (336)
T ss_dssp --H---HHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --H---HHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 1 112345899999999999999887765543
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=2.2e-06 Score=82.20 Aligned_cols=83 Identities=7% Similarity=-0.110 Sum_probs=55.5
Q ss_pred ccee-ecCCCeEEEEEEec-------CCCEEEEEEeeccC---CCCchhHHHHHHHHHhcC-C--CCceeeeeeeecccc
Q 012014 150 ANLI-GAGNFGSVYNGTLF-------DGTTIAVKVFNLIR---PGGSKSFKSECKAAINIK-H--RNIVRVFTAFSGVDY 215 (473)
Q Consensus 150 ~~~l-g~G~~g~V~~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~~~ 215 (473)
.+.| +.|....+|+.... ++..+++|+..... ......+.+|+.+++.+. + -.+.+++.++.+.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88889999988743 26788999865322 112356889999998884 2 357777777543221
Q ss_pred CCceeeEEEEEecCCCCHH
Q 012014 216 QGARFKAVVYKFMPNGSLE 234 (473)
Q Consensus 216 ~~~~~~~lv~e~~~~g~L~ 234 (473)
....++||||++|.++.
T Consensus 105 --~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 --LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp --TSSCEEEEECCCCBCCC
T ss_pred --cCCceEEEEecCCCChh
Confidence 12458999999886654
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.27 E-value=3.2e-07 Score=87.95 Aligned_cols=94 Identities=12% Similarity=0.083 Sum_probs=55.6
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCCCCCCcccHHHHHHHhcCCccccccccccc-cchHHHHHHHhhhcccCcchhhH
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFF-QEIEEEETMYKKASSTCTQSSII 81 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 81 (473)
..+.++|||||||+|+||+||+.|..........+......... ....+.+.... ....
T Consensus 244 ~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~------------------- 303 (352)
T 2jii_A 244 GPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVD-KPGPFVGPCGHWIRPS------------------- 303 (352)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHH-SCCCEECTTSCEECCC-------------------
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccC-ChhhhhhhccccCCCc-------------------
Confidence 56889999999999999999999976433222222222221111 11111111000 0000
Q ss_pred HHHHHHhhcccccccccccccccchhhHHHHHHHHHhhc
Q 012014 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKKKL 120 (473)
Q Consensus 82 ~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~~~ 120 (473)
..+..+...|+..+|.+||++.++...|+.+....
T Consensus 304 ----~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 338 (352)
T 2jii_A 304 ----ETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL 338 (352)
T ss_dssp ----HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ----HHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence 11122344688999999999999999998876543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=98.25 E-value=2.7e-07 Score=85.85 Aligned_cols=90 Identities=12% Similarity=0.129 Sum_probs=53.5
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCCCCCC-c-ccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFND-E-LNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
..+.++|||||||+|+||+||+.|....... . ..+............... +...
T Consensus 191 ~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~-- 246 (296)
T 4hgt_A 191 EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL----------------------CKGY-- 246 (296)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHH----------------------TTTS--
T ss_pred CCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhh----------------------hccC--
Confidence 4678999999999999999999997643221 1 111111111100000000 0000
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHHhhc
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKKKL 120 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~~~ 120 (473)
-..+..+...|+..+|.+||++.++...++.+....
T Consensus 247 ----~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~ 282 (296)
T 4hgt_A 247 ----PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp ----CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ----CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence 011223345699999999999999999998876543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=98.23 E-value=4.1e-07 Score=88.04 Aligned_cols=85 Identities=32% Similarity=0.430 Sum_probs=53.1
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..|.|+|||||||+|+||+| |+.|...... .....++.... ... .+. . |
T Consensus 290 ~~~~~~~DvwslG~il~el~t~g~~p~~~~~~--~~~~~~~~~~~---~~~--~~~---~--------------~----- 340 (377)
T 3cbl_A 290 GRYSSESDVWSFGILLWETFSLGASPYPNLSN--QQTREFVEKGG---RLP--CPE---L--------------C----- 340 (377)
T ss_dssp CEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH--HHHHHHHHTTC---CCC--CCT---T--------------C-----
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCC---CCC--CCC---C--------------C-----
Confidence 456889999999999999999 8888653221 11222222110 000 000 0 0
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHHhh
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~~ 119 (473)
-..+..+...|+..+|.+||++.++...|+.+.+.
T Consensus 341 ----~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 341 ----PDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 01112234569999999999999999999987653
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=98.23 E-value=3.2e-07 Score=85.53 Aligned_cols=89 Identities=7% Similarity=0.008 Sum_probs=52.9
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCCCCCCc-ccHHHHHHH-hcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDE-LNLHNFVKS-ALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
..+.++|||||||+|+||+||+.|........ ......+.. ........+ ... +
T Consensus 194 ~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~--------------~----- 249 (298)
T 1csn_A 194 EQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL-----CAG--------------F----- 249 (298)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHH-----TTT--------------S-----
T ss_pred CCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHH-----Hhh--------------C-----
Confidence 46889999999999999999999976432111 111111100 000000000 000 0
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHHhh
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~~ 119 (473)
-..+..+...|+..+|.+||++.++...|+.+...
T Consensus 250 ----~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~ 284 (298)
T 1csn_A 250 ----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER 284 (298)
T ss_dssp ----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred ----cHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence 01122334569999999999999999999987654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=7.5e-06 Score=79.70 Aligned_cols=75 Identities=19% Similarity=0.139 Sum_probs=48.8
Q ss_pred cceeecCCCeEEEEEEe-cCCCEEEEEEeeccC-------CCCchhHHHHHHHHHhcCC--C-CceeeeeeeeccccCCc
Q 012014 150 ANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR-------PGGSKSFKSECKAAINIKH--R-NIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 150 ~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~h--~-niv~~~~~~~~~~~~~~ 218 (473)
.+.||.|.++.||++.. .+++.+++|...... ......+..|.+++..+.. | .+.+++.+..
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d~------- 107 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDT------- 107 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEET-------
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEcC-------
Confidence 45789999999999974 356889999864211 1234567889999888742 3 3445654421
Q ss_pred eeeEEEEEecCCC
Q 012014 219 RFKAVVYKFMPNG 231 (473)
Q Consensus 219 ~~~~lv~e~~~~g 231 (473)
...++|||++++.
T Consensus 108 ~~~~lvmE~l~g~ 120 (397)
T 2olc_A 108 EMAVTVMEDLSHL 120 (397)
T ss_dssp TTTEEEECCCTTS
T ss_pred CccEEEEEeCCCc
Confidence 1247999999764
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=98.20 E-value=4.1e-07 Score=83.44 Aligned_cols=81 Identities=22% Similarity=0.256 Sum_probs=48.5
Q ss_pred ccccceeehhhhHHHHHhCCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhhHHHH
Q 012014 5 SSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSIILEC 84 (473)
Q Consensus 5 t~ksDVySfGVvllEl~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 84 (473)
+.|+|||||||+++||+||+.|...... ............ .+.+.....
T Consensus 189 ~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~~----~~~~~~~~~---------------------- 237 (271)
T 3kmu_A 189 RRSADMWSFAVLLWELVTREVPFADLSN-----MEIGMKVALEGL----RPTIPPGIS---------------------- 237 (271)
T ss_dssp HHHHHHHHHHHHHHHHHHCSCTTTTSCH-----HHHHHHHHHSCC----CCCCCTTCC----------------------
T ss_pred CchhhHHHHHHHHHHHHhCCCCccccCh-----HHHHHHHHhcCC----CCCCCCCCC----------------------
Confidence 4489999999999999999999753221 111111111110 000000000
Q ss_pred HHHhhcccccccccccccccchhhHHHHHHHHH
Q 012014 85 LISICRTGVACSAELPNERMKINDVESRLRLIK 117 (473)
Q Consensus 85 ~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~ 117 (473)
..+..+...|+..+|.+||++.++...|+.+.
T Consensus 238 -~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 238 -PHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp -HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred -HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 01112234699999999999999999988764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=98.19 E-value=5.2e-07 Score=83.61 Aligned_cols=83 Identities=18% Similarity=0.285 Sum_probs=50.0
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhhHH
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSIIL 82 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (473)
..+.++|||||||+++||+||+.|................. ... .+.+.....
T Consensus 204 ~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~---~~~----~~~~~~~~~-------------------- 256 (287)
T 4f0f_A 204 SYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE---EGL----RPTIPEDCP-------------------- 256 (287)
T ss_dssp EECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHH---SCC----CCCCCTTSC--------------------
T ss_pred CcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhc---cCC----CCCCCcccC--------------------
Confidence 35789999999999999999999976433222111221111 100 000101100
Q ss_pred HHHHHhhcccccccccccccccchhhHHHHHHH
Q 012014 83 ECLISICRTGVACSAELPNERMKINDVESRLRL 115 (473)
Q Consensus 83 ~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~ 115 (473)
..+..+...|+..+|.+||++.++...|+.
T Consensus 257 ---~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 257 ---PRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp ---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ---HHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 011223446899999999999999988763
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.19 E-value=3.1e-07 Score=86.30 Aligned_cols=83 Identities=27% Similarity=0.443 Sum_probs=53.5
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCCCCCCc----ccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcch
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDE----LNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQS 78 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~ 78 (473)
..+.|+|||||||+|+||+||+.|........ .....+.....+.. +.
T Consensus 198 ~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~-- 249 (310)
T 3s95_A 198 SYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPN--------------------------CP-- 249 (310)
T ss_dssp CCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHTCCTT--------------------------CC--
T ss_pred CCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccccCCCC--------------------------CC--
Confidence 46889999999999999999998854322111 11122211111110 00
Q ss_pred hhHHHHHHHhhcccccccccccccccchhhHHHHHHHHHhhc
Q 012014 79 SIILECLISICRTGVACSAELPNERMKINDVESRLRLIKKKL 120 (473)
Q Consensus 79 ~~~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~~~ 120 (473)
..+..+...|+..+|.+||++.++...|+.++...
T Consensus 250 -------~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 250 -------PSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp -------TTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 11222345699999999999999999999887654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.19 E-value=2.2e-07 Score=88.79 Aligned_cols=88 Identities=16% Similarity=0.166 Sum_probs=50.8
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCCCCCCcccHHHHHHHhc---CCccccccccccccchHHHHHHHhhhcccCcchh
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSAL---PERAEEILDVVFFQEIEEEETMYKKASSTCTQSS 79 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~ 79 (473)
..+.++|||||||+|+||+||+.|..........+........ +......... . .+
T Consensus 236 ~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~--------------~~---- 294 (345)
T 2v62_A 236 ALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPS---G--------------SS---- 294 (345)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCT---T--------------SC----
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhhccc---c--------------cc----
Confidence 4688999999999999999999997532222211111111110 0000000000 0 00
Q ss_pred hHHHHHHHhhcccccccccccccccchhhHHHHHHHH
Q 012014 80 IILECLISICRTGVACSAELPNERMKINDVESRLRLI 116 (473)
Q Consensus 80 ~~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~ 116 (473)
-..+..+...|+..+|.+||++.++...|+..
T Consensus 295 -----~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 326 (345)
T 2v62_A 295 -----CCEIAQFLVCAHSLAYDEKPNYQALKKILNPH 326 (345)
T ss_dssp -----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred -----HHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence 01122334579999999999999999888654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=98.18 E-value=8.7e-07 Score=83.15 Aligned_cols=91 Identities=16% Similarity=0.091 Sum_probs=53.8
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhhH
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (473)
+..+.++|||||||+++||+||+.|...... ....+.............. ....
T Consensus 211 ~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~~~~~~~~----~~~~------------------- 264 (310)
T 2wqm_A 211 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLYSLCKKIEQCDYPPLPS----DHYS------------------- 264 (310)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHSSCTTC---C---CHHHHHHHHHTTCSCCCCT----TTSC-------------------
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCcccch---hHHHHHHHhhcccCCCCcc----cccC-------------------
Confidence 3468899999999999999999998653211 2222222111111000000 0000
Q ss_pred HHHHHHhhcccccccccccccccchhhHHHHHHHHHhhccc
Q 012014 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKKKLLK 122 (473)
Q Consensus 82 ~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~~~~~ 122 (473)
..+..+...|+..+|.+||++.++...++.+......
T Consensus 265 ----~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 265 ----EELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp ----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred ----HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 0112234469999999999999999999888765443
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=98.17 E-value=7.9e-07 Score=82.77 Aligned_cols=30 Identities=20% Similarity=0.273 Sum_probs=25.2
Q ss_pred cccccccccccccccchhhHHHHHHHHHhh
Q 012014 90 RTGVACSAELPNERMKINDVESRLRLIKKK 119 (473)
Q Consensus 90 ~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~~ 119 (473)
.+...|+..+|.+||++.++...|+.+...
T Consensus 263 ~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 263 MIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 345579999999999999999999987653
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=98.16 E-value=7.6e-07 Score=83.60 Aligned_cols=85 Identities=22% Similarity=0.253 Sum_probs=51.7
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhhHH
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSIIL 82 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (473)
..+.|+|||||||+|+||+||+.|...... ......+..... ...+. ....
T Consensus 215 ~~~~~~DiwslG~il~elltg~~Pf~~~~~--~~~~~~~~~~~~--~~~~~-----~~~~-------------------- 265 (309)
T 3p86_A 215 PSNEKSDVYSFGVILWELATLQQPWGNLNP--AQVVAAVGFKCK--RLEIP-----RNLN-------------------- 265 (309)
T ss_dssp CCCTTHHHHHHHHHHHHHHHCCCTTTTSCH--HHHHHHHHHSCC--CCCCC-----TTSC--------------------
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhcCC--CCCCC-----ccCC--------------------
Confidence 468899999999999999999999753221 111111111110 00000 0000
Q ss_pred HHHHHhhcccccccccccccccchhhHHHHHHHHHhh
Q 012014 83 ECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (473)
Q Consensus 83 ~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~~ 119 (473)
..+..+...|+..+|.+||++.++...|+...+.
T Consensus 266 ---~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 266 ---PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp ---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred ---HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0111233469999999999999999999877654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=98.16 E-value=1.4e-06 Score=86.44 Aligned_cols=85 Identities=21% Similarity=0.300 Sum_probs=53.6
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..|.|+|||||||+|+||+| |+.|....... .+...+..... .. .+ .. |
T Consensus 361 ~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--~~~~~i~~~~~---~~--~p---~~--------------~----- 411 (450)
T 1k9a_A 361 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEKGYK---MD--AP---DG--------------C----- 411 (450)
T ss_dssp SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT--THHHHHHTTCC---CC--CC---TT--------------C-----
T ss_pred CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCCC---CC--CC---Cc--------------C-----
Confidence 457899999999999999999 98886543222 22222221110 00 00 00 0
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHHhh
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~~ 119 (473)
-..+..+...|+..+|.+||++.++...|+.+...
T Consensus 412 ----~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 412 ----PPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 01112233469999999999999999999887643
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=98.13 E-value=7.6e-07 Score=86.01 Aligned_cols=84 Identities=25% Similarity=0.371 Sum_probs=51.9
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..+.|+|||||||+|+||+| |+.|...... ..+...+..... . . .+ ..
T Consensus 225 ~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~--~~~~~~i~~~~~--~-~--~~---~~-------------------- 274 (373)
T 2qol_A 225 RKFTSASDVWSYGIVLWEVMSYGERPYWEMSN--QDVIKAVDEGYR--L-P--PP---MD-------------------- 274 (373)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH--HHHHHHHHTTEE--C-C--CC---TT--------------------
T ss_pred CCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCC--C-C--CC---cc--------------------
Confidence 357889999999999999998 9998653221 111111111000 0 0 00 00
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHHh
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~ 118 (473)
+...+..+...|+..+|..||++.++...|+.+..
T Consensus 275 ---~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 275 ---CPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp ---CBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---ccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 01112234567999999999999999999988754
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.13 E-value=1.3e-06 Score=82.96 Aligned_cols=33 Identities=15% Similarity=0.166 Sum_probs=26.7
Q ss_pred hhcccccccccccccccchhhHHHHHHHHHhhc
Q 012014 88 ICRTGVACSAELPNERMKINDVESRLRLIKKKL 120 (473)
Q Consensus 88 ~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~~~ 120 (473)
+..+...|+..+|.+||++.++...|+.+....
T Consensus 288 l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~ 320 (336)
T 3g2f_A 288 LKETIEDCWDQDAEARLTAQXAEERMAELMMIW 320 (336)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred HHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence 334456799999999999999999999876543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.13 E-value=1.3e-06 Score=82.63 Aligned_cols=83 Identities=16% Similarity=0.249 Sum_probs=52.6
Q ss_pred ccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhhH
Q 012014 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (473)
..+.++|||||||+|+||+| |+.|.+.... ..+...+....... .+ ...
T Consensus 195 ~~~~~~Di~slG~il~ell~~g~~p~~~~~~--~~~~~~~~~~~~~~-----~~---~~~-------------------- 244 (327)
T 3lzb_A 195 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPA--SEISSILEKGERLP-----QP---PIC-------------------- 244 (327)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHHHHHTTCCCC-----CC---TTB--------------------
T ss_pred CCChHHHHHHHHHHHHHHHHCCCCCCCCCCH--HHHHHHHHcCCCCC-----CC---ccC--------------------
Confidence 46889999999999999999 9988764322 22332222111000 00 000
Q ss_pred HHHHHHhhcccccccccccccccchhhHHHHHHHHHh
Q 012014 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (473)
Q Consensus 82 ~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~ 118 (473)
-..+..+...|+..+|.+||++.++...|+.+..
T Consensus 245 ---~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 245 ---TIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred ---CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 0011223446999999999999999999988754
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=98.11 E-value=1.9e-06 Score=79.51 Aligned_cols=84 Identities=13% Similarity=0.159 Sum_probs=52.2
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..+.++||||||++++||+| |+.|....... .+...+....... .+. ...
T Consensus 189 ~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~--~~~~~~~~~~~~~-----~~~---~~~------------------ 240 (281)
T 3cc6_A 189 RRFTTASDVWMFAVCMWEILSFGKQPFFWLENK--DVIGVLEKGDRLP-----KPD---LCP------------------ 240 (281)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG--GHHHHHHHTCCCC-----CCT---TCC------------------
T ss_pred CCCCchhccHHHHHHHHHHHhCCCCCcccCChH--HHHHHHhcCCCCC-----CCC---CCC------------------
Confidence 356789999999999999999 99987533221 2222222111000 000 000
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHHh
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~ 118 (473)
..+..+...|+..+|.+||++.++...|+.+..
T Consensus 241 -----~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 241 -----PVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp -----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----HHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 011223346999999999999999999887654
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=98.11 E-value=1.5e-06 Score=82.18 Aligned_cols=84 Identities=18% Similarity=0.309 Sum_probs=53.2
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..|.++|||||||+++||+| |+.|....... .+...+.............
T Consensus 192 ~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~-------------------------- 243 (325)
T 3kex_A 192 GKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA--EVPDLLEKGERLAQPQICT-------------------------- 243 (325)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT--HHHHHHHTTCBCCCCTTBC--------------------------
T ss_pred CCCChhhHhHHhHHHHHHHHhCCCCCccccCHH--HHHHHHHcCCCCCCCCcCc--------------------------
Confidence 457889999999999999999 99997643211 2222222211100000000
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHHh
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~ 118 (473)
..+..+...|+..+|.+||++.++...|+.+..
T Consensus 244 -----~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 244 -----IDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp -----TTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred -----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 012233456999999999999999999887643
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=98.11 E-value=6.6e-07 Score=89.29 Aligned_cols=88 Identities=11% Similarity=0.098 Sum_probs=53.0
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCCCCCCc-cc-HHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDE-LN-LHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
..+.|+|||||||||+||+||+.|........ .. +..+...........+.. .+
T Consensus 189 ~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~-------------------~~----- 244 (483)
T 3sv0_A 189 EQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCR-------------------GY----- 244 (483)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHT-------------------TS-----
T ss_pred CCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhc-------------------CC-----
Confidence 46789999999999999999999976432211 11 111111100000000000 00
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHHh
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~ 118 (473)
-..+..+...|+..+|.+||++.++...|+.+..
T Consensus 245 ----p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~ 278 (483)
T 3sv0_A 245 ----PTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI 278 (483)
T ss_dssp ----CHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred ----cHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 1122334557999999999999999999887754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=98.10 E-value=1.3e-06 Score=83.76 Aligned_cols=86 Identities=24% Similarity=0.354 Sum_probs=52.6
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..+.|+|||||||+++||+| |+.|.......+ .+...+........ + ....
T Consensus 270 ~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-~~~~~~~~~~~~~~-----~---~~~~------------------ 322 (359)
T 3vhe_A 270 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCRRLKEGTRMRA-----P---DYTT------------------ 322 (359)
T ss_dssp CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-HHHHHHHHTCCCCC-----C---TTCC------------------
T ss_pred CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH-HHHHHHHcCCCCCC-----C---CCCC------------------
Confidence 356889999999999999999 988865322211 11111111110000 0 0000
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHHhh
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~~ 119 (473)
..+..+...|+..+|.+||++.++...|+.+...
T Consensus 323 -----~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 323 -----PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp -----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----HHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 0112234569999999999999999999877543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.10 E-value=6.6e-07 Score=85.39 Aligned_cols=28 Identities=32% Similarity=0.466 Sum_probs=23.9
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
+..+.|+|||||||+|+||+||+.|...
T Consensus 195 ~~~~~~~DiwslG~il~ell~g~~pf~~ 222 (343)
T 3dbq_A 195 SKISPKSDVWSLGCILYYMTYGKTPFQQ 222 (343)
T ss_dssp --CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cCCCchhhHHHHHHHHHHHHhCCCcchh
Confidence 4578899999999999999999999754
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=98.10 E-value=3e-06 Score=78.88 Aligned_cols=87 Identities=22% Similarity=0.283 Sum_probs=53.9
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhhHH
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSIIL 82 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (473)
..+.++||||||++++||+||..|...... ...+...+........ + ....
T Consensus 204 ~~~~~~Di~slG~il~~l~~g~~~~~~~~~-~~~~~~~~~~~~~~~~-----~---~~~~-------------------- 254 (298)
T 3pls_A 204 RFTTKSDVWSFGVLLWELLTRGAPPYRHID-PFDLTHFLAQGRRLPQ-----P---EYCP-------------------- 254 (298)
T ss_dssp CCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-GGGHHHHHHTTCCCCC-----C---TTCC--------------------
T ss_pred CCChhhchhhHHHHHHHHhhCCCCCCccCC-HHHHHHHhhcCCCCCC-----C---ccch--------------------
Confidence 468899999999999999998777432221 2223333222111000 0 0000
Q ss_pred HHHHHhhcccccccccccccccchhhHHHHHHHHHhhcc
Q 012014 83 ECLISICRTGVACSAELPNERMKINDVESRLRLIKKKLL 121 (473)
Q Consensus 83 ~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~~~~ 121 (473)
..+..+...|+..+|.+||++.++...++.+.....
T Consensus 255 ---~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 255 ---DSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp ---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred ---HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 011223446999999999999999999998876543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.10 E-value=7e-07 Score=84.11 Aligned_cols=85 Identities=15% Similarity=0.130 Sum_probs=50.3
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhhHH
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSIIL 82 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (473)
..+.++|||||||+++||+||+.|...... ...................+.
T Consensus 219 ~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~------------------------ 269 (319)
T 2y4i_B 219 PFSKHSDVFALGTIWYELHAREWPFKTQPA-----EAIIWQMGTGMKPNLSQIGMG------------------------ 269 (319)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCSSSSCCH-----HHHHHHHHTTCCCCCCCSSCC------------------------
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHhccCCCCCCCcCCCC------------------------
Confidence 468899999999999999999999753221 111111111100000000000
Q ss_pred HHHHHhhcccccccccccccccchhhHHHHHHHHHhh
Q 012014 83 ECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (473)
Q Consensus 83 ~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~~ 119 (473)
..+..+...|+..+|.+||++.++...|+.+...
T Consensus 270 ---~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 270 ---KEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp ---TTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred ---HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 0112234568999999999999999998876543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=98.10 E-value=7.6e-07 Score=88.45 Aligned_cols=83 Identities=27% Similarity=0.374 Sum_probs=51.6
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..|.|+|||||||+|+||+| |+.|...... ..+...+..... ...+. . |
T Consensus 360 ~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~--~~~~~~i~~~~~-----~~~~~---~--------------~----- 410 (454)
T 1qcf_A 360 GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN--PEVIRALERGYR-----MPRPE---N--------------C----- 410 (454)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHHHHTCC-----CCCCT---T--------------S-----
T ss_pred CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCC-----CCCCC---C--------------C-----
Confidence 457899999999999999999 9888653221 112222111100 00000 0 0
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHH
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIK 117 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~ 117 (473)
-..+..+...|+..+|.+||++.++...|+.+.
T Consensus 411 ----~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~ 443 (454)
T 1qcf_A 411 ----PEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY 443 (454)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred ----CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 011223345799999999999999998887653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=98.09 E-value=1.8e-06 Score=79.19 Aligned_cols=85 Identities=22% Similarity=0.360 Sum_probs=52.0
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..+.++|||||||+++||+| |+.|...... ..+...+..... ...+.. ..
T Consensus 182 ~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~--~~~~~~~~~~~~-----~~~~~~---~~------------------ 233 (269)
T 4hcu_A 182 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--SEVVEDISTGFR-----LYKPRL---AS------------------ 233 (269)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHHTTCC-----CCCCTT---SC------------------
T ss_pred CCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH--HHHHHHHhcCcc-----CCCCCc---CC------------------
Confidence 356889999999999999999 8888653211 111111111100 001100 00
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHHhh
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~~ 119 (473)
..+..+...|+..+|.+||++.++...|+.+.+.
T Consensus 234 -----~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 234 -----THVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp -----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -----HHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 0111233469999999999999999999887653
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=98.08 E-value=9.1e-07 Score=81.17 Aligned_cols=27 Identities=41% Similarity=0.644 Sum_probs=24.1
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
..+.++||||||++++||+||+.|...
T Consensus 190 ~~~~~~Di~slG~~l~~l~~g~~p~~~ 216 (271)
T 3dtc_A 190 MFSKGSDVWSYGVLLWELLTGEVPFRG 216 (271)
T ss_dssp CCSHHHHHHHHHHHHHHHHHCCCTTTT
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 468899999999999999999999753
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.08 E-value=1.5e-06 Score=82.29 Aligned_cols=85 Identities=21% Similarity=0.263 Sum_probs=52.8
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..+.++|||||||+|+||+| |+.|...... ..+...+...... . .....
T Consensus 229 ~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--~~~~~~~~~~~~~---~-----~~~~~------------------- 279 (325)
T 3kul_A 229 RTFSSASDVWSFGVVMWEVLAYGERPYWNMTN--RDVISSVEEGYRL---P-----APMGC------------------- 279 (325)
T ss_dssp CEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH--HHHHHHHHTTCCC---C-----CCTTC-------------------
T ss_pred CCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHcCCCC---C-----CCCCc-------------------
Confidence 346789999999999999999 9988653221 1111111111000 0 00000
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHHhh
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~~ 119 (473)
-..+..+...|+..+|.+||++.++...|+.+...
T Consensus 280 ----~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 280 ----PHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 01122334579999999999999999999987653
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.08 E-value=5.4e-07 Score=84.83 Aligned_cols=83 Identities=22% Similarity=0.264 Sum_probs=50.1
Q ss_pred cccccceeehhhhHHHHHhCCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhhHHH
Q 012014 4 VSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSIILE 83 (473)
Q Consensus 4 ~t~ksDVySfGVvllEl~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 83 (473)
.+.++|||||||+++||+||+.|.+........+......... ...+ ....
T Consensus 223 ~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-----~~~~---~~~~--------------------- 273 (317)
T 2buj_A 223 IDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS-----IPQS---PRHS--------------------- 273 (317)
T ss_dssp ECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC-------CCCC---TTSC---------------------
T ss_pred CCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCC-----CCcc---ccCC---------------------
Confidence 5789999999999999999999965321111122211111000 0000 0000
Q ss_pred HHHHhhcccccccccccccccchhhHHHHHHHHH
Q 012014 84 CLISICRTGVACSAELPNERMKINDVESRLRLIK 117 (473)
Q Consensus 84 ~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~ 117 (473)
..+..+...|+..+|.+||++.++...|+.+.
T Consensus 274 --~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 274 --SALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp --HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred --HHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 01122344689999999999999999988764
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=98.08 E-value=2.4e-06 Score=82.42 Aligned_cols=87 Identities=20% Similarity=0.332 Sum_probs=52.4
Q ss_pred CccccccceeehhhhHHHHHhCCC-CCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLR-PNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..|.|+|||||||+|+||+||.. |...... ..+...+.... ....+.. .
T Consensus 271 ~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~--~~~~~~~~~~~-----~~~~p~~---~------------------- 321 (373)
T 3c1x_A 271 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYLLQGR-----RLLQPEY---C------------------- 321 (373)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS--SCHHHHHHTTC-----CCCCCTT---C-------------------
T ss_pred CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH--HHHHHHHHcCC-----CCCCCCC---C-------------------
Confidence 356889999999999999999544 4432211 12222222110 0001100 0
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHHhhcc
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKKKLL 121 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~~~~ 121 (473)
-..+..+...|+..+|.+||++.++...|+.+.....
T Consensus 322 ----~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 322 ----PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred ----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 0011223456999999999999999999998765443
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=98.07 E-value=7.8e-07 Score=86.47 Aligned_cols=27 Identities=33% Similarity=0.479 Sum_probs=24.0
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
..+.|+|||||||+|+||+||+.|...
T Consensus 243 ~~~~~~DiwSlGvil~ell~G~~Pf~~ 269 (390)
T 2zmd_A 243 KISPKSDVWSLGCILYYMTYGKTPFQQ 269 (390)
T ss_dssp -CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCCChhhHHHHHHHHHHHHHCCCcchh
Confidence 578899999999999999999999753
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=98.07 E-value=2e-06 Score=78.57 Aligned_cols=84 Identities=23% Similarity=0.342 Sum_probs=51.4
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..+.++||||||++++||+| |+.|...... ..+...+...... ..+.. ..
T Consensus 180 ~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~i~~~~~~-----~~~~~---~~------------------ 231 (267)
T 3t9t_A 180 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--SEVVEDISTGFRL-----YKPRL---AS------------------ 231 (267)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHHTTCCC-----CCCTT---SC------------------
T ss_pred CCccchhchhhhHHHHHHHhccCCCCCCCCCH--HHHHHHHhcCCcC-----CCCcc---Cc------------------
Confidence 346789999999999999999 7887653211 1111111111000 00000 00
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHHh
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~ 118 (473)
..+..+...|+..+|.+||++.++...|+.+.+
T Consensus 232 -----~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 232 -----THVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp -----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 011223456999999999999999999988765
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=98.07 E-value=2.2e-06 Score=82.64 Aligned_cols=84 Identities=21% Similarity=0.295 Sum_probs=52.0
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..+.++|||||||+|+||+| |+.|...... ..+...+..... ... ....
T Consensus 280 ~~~~~~~DvwslG~il~ellt~g~~p~~~~~~--~~~~~~~~~~~~---~~~-----~~~~------------------- 330 (370)
T 2psq_A 280 RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV--EELFKLLKEGHR---MDK-----PANC------------------- 330 (370)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--GGHHHHHHTTCC---CCC-----CTTS-------------------
T ss_pred CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHhcCCC---CCC-----CCCC-------------------
Confidence 346889999999999999999 8888653221 122222211110 000 0000
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHHh
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~ 118 (473)
-..+..+...|+..+|.+||++.++...|+.+..
T Consensus 331 ----~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 331 ----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0111223446999999999999999999987654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.06 E-value=1.3e-06 Score=84.06 Aligned_cols=85 Identities=24% Similarity=0.366 Sum_probs=52.7
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..+.++|||||||+|+||+| |+.|..... ...+...+.... ..... ...
T Consensus 261 ~~~~~~~DvwslG~il~ellt~g~~pf~~~~--~~~~~~~i~~~~---~~~~~-----~~~------------------- 311 (367)
T 3l9p_A 261 GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS--NQEVLEFVTSGG---RMDPP-----KNC------------------- 311 (367)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHHHHHHHTTC---CCCCC-----TTC-------------------
T ss_pred CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCC---CCCCC-----ccC-------------------
Confidence 346889999999999999998 888865321 112222222111 00000 000
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHHhh
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~~ 119 (473)
-..+..+...|+..+|.+||++.++...++.....
T Consensus 312 ----~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 312 ----PGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ----CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 01122334569999999999999999999887653
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.06 E-value=3.9e-05 Score=70.98 Aligned_cols=75 Identities=16% Similarity=0.117 Sum_probs=56.1
Q ss_pred ccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCC---CCceeeeeeeeccccCCceeeEEEE
Q 012014 149 SANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKH---RNIVRVFTAFSGVDYQGARFKAVVY 225 (473)
Q Consensus 149 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~~~~~~~~~~~lv~ 225 (473)
....+|.|..+.||+.+..+|+.|++|+...........|..|+..|+.|.- -.+++++++. ..++||
T Consensus 19 ~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~---------~~~lv~ 89 (288)
T 3f7w_A 19 AVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD---------DRTLAM 89 (288)
T ss_dssp EEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE---------TTEEEE
T ss_pred EEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc---------CceEEE
Confidence 3567899999999999999999999998764444445678899999998842 2345555442 237899
Q ss_pred EecCCCC
Q 012014 226 KFMPNGS 232 (473)
Q Consensus 226 e~~~~g~ 232 (473)
||++++.
T Consensus 90 e~l~~~~ 96 (288)
T 3f7w_A 90 EWVDERP 96 (288)
T ss_dssp ECCCCCC
T ss_pred EeecccC
Confidence 9998764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.06 E-value=1.6e-06 Score=84.07 Aligned_cols=86 Identities=22% Similarity=0.286 Sum_probs=53.1
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..+.|+|||||||+|+||+| |+.|..... ...+...+..... .... ...
T Consensus 268 ~~~~~~~DiwslG~il~ellt~g~~p~~~~~--~~~~~~~~~~~~~---~~~~-----~~~------------------- 318 (382)
T 3tt0_A 268 RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--VEELFKLLKEGHR---MDKP-----SNC------------------- 318 (382)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHHHHHHHTTCC---CCCC-----SSC-------------------
T ss_pred CCCCchhHHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCCC---CCCC-----ccC-------------------
Confidence 346889999999999999999 888865321 1112222221110 0000 000
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHHhhc
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKKKL 120 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~~~ 120 (473)
-..+..+...|+..+|.+||++.++...|+.+....
T Consensus 319 ----~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 319 ----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354 (382)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred ----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 011122344699999999999999999998876543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=98.05 E-value=2.6e-06 Score=80.78 Aligned_cols=85 Identities=27% Similarity=0.383 Sum_probs=52.1
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..+.++|||||||+++||+| |+.|....... ..+...+....... .+.. ..
T Consensus 241 ~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-~~~~~~~~~~~~~~-----~~~~---~~------------------ 293 (333)
T 2i1m_A 241 CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN-SKFYKLVKDGYQMA-----QPAF---AP------------------ 293 (333)
T ss_dssp CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS-HHHHHHHHHTCCCC-----CCTT---CC------------------
T ss_pred CCCChHHHHHHHHHHHHHHHcCCCCCCcccchh-HHHHHHHhcCCCCC-----CCCC---CC------------------
Confidence 356889999999999999999 88886532211 11222222211110 0000 00
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHHh
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~ 118 (473)
..+..+...|+..+|..||++.++...|+....
T Consensus 294 -----~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 294 -----KNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp -----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----HHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 011223446999999999999999998887654
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.05 E-value=2e-06 Score=88.60 Aligned_cols=85 Identities=22% Similarity=0.267 Sum_probs=54.2
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..|.|+|||||||+|+||+| |+.|...... ..+...+.... .... + ...
T Consensus 514 ~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--~~~~~~i~~~~---~~~~--p---~~~------------------- 564 (613)
T 2ozo_A 514 RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFIEQGK---RMEC--P---PEC------------------- 564 (613)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS--HHHHHHHHTTC---CCCC--C---TTC-------------------
T ss_pred CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH--HHHHHHHHcCC---CCCC--C---CcC-------------------
Confidence 457899999999999999998 9998754322 12222222111 0000 0 000
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHHhh
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~~ 119 (473)
-..+..+...|+..+|.+||++.++...|+.....
T Consensus 565 ----~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 565 ----PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp ----CHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 01122334579999999999999999999876543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=98.05 E-value=1.1e-06 Score=81.37 Aligned_cols=27 Identities=30% Similarity=0.378 Sum_probs=23.8
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
..|.++|||||||+++||+||+.|.+.
T Consensus 189 ~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (290)
T 3fme_A 189 GYSVKSDIWSLGITMIELAILRFPYDS 215 (290)
T ss_dssp -CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCccc
Confidence 468899999999999999999999764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=98.05 E-value=8.2e-07 Score=84.16 Aligned_cols=26 Identities=19% Similarity=0.313 Sum_probs=23.9
Q ss_pred ccccccceeehhhhHHHHHhCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
..+.|+|||||||+|+||+||+.|+.
T Consensus 201 ~y~~~~DiwSlGvilyemltG~~PF~ 226 (350)
T 4b9d_A 201 PYNNKSDIWALGCVLYELCTLKHAFE 226 (350)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 46889999999999999999999975
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.04 E-value=2.3e-06 Score=81.16 Aligned_cols=82 Identities=17% Similarity=0.152 Sum_probs=49.3
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhhHH
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSIIL 82 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (473)
..+.++|||||||+++||+||+.|....... ........... ....
T Consensus 229 ~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~----~~~~------------------------- 274 (337)
T 3ll6_A 229 PIGEKQDIWALGCILYLLCFRQHPFEDGAKL-----RIVNGKYSIPP----HDTQ------------------------- 274 (337)
T ss_dssp CSSHHHHHHHHHHHHHHHHHSSCCC-----------------CCCCT----TCCS-------------------------
T ss_pred CCChHHhHHHHHHHHHHHHhCCCCCcchhHH-----HhhcCcccCCc----cccc-------------------------
Confidence 4678999999999999999999996532110 01110000000 0000
Q ss_pred HHHHHhhcccccccccccccccchhhHHHHHHHHHhhc
Q 012014 83 ECLISICRTGVACSAELPNERMKINDVESRLRLIKKKL 120 (473)
Q Consensus 83 ~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~~~ 120 (473)
...+..+...|+..+|.+||++.++...|+.+....
T Consensus 275 --~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 275 --YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp --SGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred --chHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 000112334688999999999999999998887643
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=98.04 E-value=3.3e-06 Score=79.27 Aligned_cols=84 Identities=18% Similarity=0.283 Sum_probs=51.8
Q ss_pred ccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhhH
Q 012014 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (473)
..+.++||||||++|+||+| |+.|...... ..+...+...... . .....
T Consensus 225 ~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~~~~~---~-----~~~~~-------------------- 274 (313)
T 3brb_A 225 VYTSKSDVWAFGVTMWEIATRGMTPYPGVQN--HEMYDYLLHGHRL---K-----QPEDC-------------------- 274 (313)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG--GGHHHHHHTTCCC---C-----CBTTC--------------------
T ss_pred CccchhhhHHHHHHHHHHHhcCCCCCccCCH--HHHHHHHHcCCCC---C-----CCccc--------------------
Confidence 46789999999999999999 7777543221 1222222211100 0 00000
Q ss_pred HHHHHHhhcccccccccccccccchhhHHHHHHHHHhh
Q 012014 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (473)
Q Consensus 82 ~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~~ 119 (473)
...+..+...|+..+|..||++.++...|+.+...
T Consensus 275 ---~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~ 309 (313)
T 3brb_A 275 ---LDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLES 309 (313)
T ss_dssp ---CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 01122234569999999999999999999887653
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=98.03 E-value=3.3e-06 Score=77.98 Aligned_cols=83 Identities=18% Similarity=0.303 Sum_probs=51.2
Q ss_pred ccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhhH
Q 012014 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (473)
..+.++|||||||+++||+| |+.|...... ..+...+..... .. +.....
T Consensus 193 ~~~~~~Di~slG~~l~ell~~g~~pf~~~~~--~~~~~~i~~~~~---~~-----~~~~~~------------------- 243 (281)
T 1mp8_A 193 RFTSASDVWMFGVCMWEILMHGVKPFQGVKN--NDVIGRIENGER---LP-----MPPNCP------------------- 243 (281)
T ss_dssp CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHHHHHTTCC---CC-----CCTTCC-------------------
T ss_pred CCCCccCchHHHHHHHHHHhcCCCCCCcCCH--HHHHHHHHcCCC---CC-----CCCCCC-------------------
Confidence 46789999999999999997 8888653321 122222221100 00 000000
Q ss_pred HHHHHHhhcccccccccccccccchhhHHHHHHHHHh
Q 012014 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (473)
Q Consensus 82 ~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~ 118 (473)
..+..+...|+..+|.+||++.++...|+.+..
T Consensus 244 ----~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 244 ----PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp ----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 011123446899999999999999999887654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=98.03 E-value=2.8e-06 Score=79.70 Aligned_cols=83 Identities=25% Similarity=0.360 Sum_probs=51.9
Q ss_pred ccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhhH
Q 012014 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (473)
..+.++|||||||+++||+| |+.|...... ..+...+...... . ......
T Consensus 228 ~~~~~~Di~slG~il~el~t~g~~p~~~~~~--~~~~~~~~~~~~~---~-----~~~~~~------------------- 278 (314)
T 2ivs_A 228 IYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP--ERLFNLLKTGHRM---E-----RPDNCS------------------- 278 (314)
T ss_dssp EECHHHHHHHHHHHHHHHHTTSCCSSTTCCG--GGHHHHHHTTCCC---C-----CCTTCC-------------------
T ss_pred CcCchhhHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHhhcCCcC---C-----CCccCC-------------------
Confidence 46889999999999999999 9888653321 1222222211100 0 000000
Q ss_pred HHHHHHhhcccccccccccccccchhhHHHHHHHHHh
Q 012014 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (473)
Q Consensus 82 ~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~ 118 (473)
..+..+...|+..+|.+||++.++...|+.+..
T Consensus 279 ----~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 279 ----EEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp ----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 111223456999999999999999999887654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=98.03 E-value=2.1e-06 Score=86.22 Aligned_cols=82 Identities=20% Similarity=0.290 Sum_probs=50.4
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..+.|+|||||||+|+||+| |+.|...... ..+...+...... . .+ ...
T Consensus 394 ~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~--~~~~~~~~~~~~~---~--~~---~~~------------------- 444 (495)
T 1opk_A 394 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYELLEKDYRM---E--RP---EGC------------------- 444 (495)
T ss_dssp CEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG--GGHHHHHHTTCCC---C--CC---TTC-------------------
T ss_pred CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCCCC---C--CC---CCC-------------------
Confidence 346889999999999999999 8888653221 1222222211100 0 00 000
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHH
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLI 116 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~ 116 (473)
-..+..+...|+..+|.+||++.++...|+.+
T Consensus 445 ----~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~ 476 (495)
T 1opk_A 445 ----PEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476 (495)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ----CHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 01122234569999999999999999888754
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=98.03 E-value=1.6e-06 Score=82.25 Aligned_cols=90 Identities=11% Similarity=0.034 Sum_probs=52.7
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhhHH
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSIIL 82 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (473)
..+.++|||||||+|+||+||+.|....... .+............ ...... .+...
T Consensus 193 ~~~~~~Di~slG~il~ell~g~~Pf~~~~~~--~~~~~~~~i~~~~~-~~~~~~-----------------~~~~~---- 248 (330)
T 2izr_A 193 EQSRRDDLEALGHMFMYFLRGSLPWQGLKAD--TLKERYQKIGDTKR-ATPIEV-----------------LCENF---- 248 (330)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS--SHHHHHHHHHHHHH-HSCHHH-----------------HTTTC----
T ss_pred CCCchhHHHHHHHHHHHHhcCCCCccccccc--cHHHHHHHHHhhhc-cCCHHH-----------------HhccC----
Confidence 4688999999999999999999997643221 12111111000000 000000 00000
Q ss_pred HHHHHhhcccccccccccccccchhhHHHHHHHHHhh
Q 012014 83 ECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (473)
Q Consensus 83 ~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~~ 119 (473)
- .+..+...|+..+|..||++.++...++.....
T Consensus 249 --p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~ 282 (330)
T 2izr_A 249 --P-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR 282 (330)
T ss_dssp --H-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred --h-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence 0 222334569999999999999999999876554
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=98.03 E-value=3.1e-06 Score=78.38 Aligned_cols=85 Identities=24% Similarity=0.287 Sum_probs=53.0
Q ss_pred ccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhhH
Q 012014 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (473)
..+.++|||||||+++||+| |+.|...... ..+...+.... ... +.....
T Consensus 189 ~~~~~~Di~slG~il~ellt~g~~p~~~~~~--~~~~~~i~~~~---~~~-----~~~~~~------------------- 239 (287)
T 1u59_A 189 KFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFIEQGK---RME-----CPPECP------------------- 239 (287)
T ss_dssp EECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--HHHHHHHHTTC---CCC-----CCTTCC-------------------
T ss_pred CCCchhhHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHhcCC---cCC-----CCCCcC-------------------
Confidence 46789999999999999999 9998653221 12222222110 000 000000
Q ss_pred HHHHHHhhcccccccccccccccchhhHHHHHHHHHhhc
Q 012014 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKKKL 120 (473)
Q Consensus 82 ~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~~~ 120 (473)
..+..+...|+..+|.+||++.++...++.+....
T Consensus 240 ----~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 274 (287)
T 1u59_A 240 ----PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 274 (287)
T ss_dssp ----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 11122345699999999999999999998876543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=98.02 E-value=3.6e-06 Score=78.86 Aligned_cols=86 Identities=19% Similarity=0.259 Sum_probs=52.4
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..+.++|||||||+|+||+| |+.|....... ..+...+....... .. ....
T Consensus 222 ~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~~~~~~~~~~~~----~~----~~~~------------------ 274 (313)
T 1t46_A 222 CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD-SKFYKMIKEGFRML----SP----EHAP------------------ 274 (313)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS-HHHHHHHHHTCCCC----CC----TTSC------------------
T ss_pred CCCChHHHHHHHHHHHHHHHhCCCCCCCcccch-hHHHHHhccCCCCC----Cc----ccCC------------------
Confidence 346889999999999999999 88886533211 11222222111100 00 0000
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHHhh
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~~ 119 (473)
..+..+...|+..+|.+||++.++...|+.....
T Consensus 275 -----~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 275 -----AEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp -----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----HHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 0112234469999999999999999998876543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=98.02 E-value=1.1e-06 Score=82.61 Aligned_cols=27 Identities=33% Similarity=0.479 Sum_probs=24.4
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
..+.++|||||||+|+||+||+.|...
T Consensus 215 ~~~~~~Di~slG~il~el~~g~~pf~~ 241 (313)
T 3cek_A 215 KISPKSDVWSLGCILYYMTYGKTPFQQ 241 (313)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cCCchHHHHHHHHHHHHHHhCCCchhh
Confidence 578899999999999999999999754
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=98.02 E-value=2.1e-06 Score=79.71 Aligned_cols=28 Identities=36% Similarity=0.515 Sum_probs=24.8
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
+..+.++|||||||+++||+||+.|...
T Consensus 204 ~~~~~~~Di~slG~~l~~l~~g~~pf~~ 231 (290)
T 1t4h_A 204 EKYDESVDVYAFGMCMLEMATSEYPYSE 231 (290)
T ss_dssp TCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred ccCCCcchHHHHHHHHHHHHhCCCCCCC
Confidence 4578899999999999999999999753
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=98.01 E-value=1.4e-06 Score=82.86 Aligned_cols=84 Identities=19% Similarity=0.376 Sum_probs=51.5
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..+.++|||||||+++||+| |+.|...... ..+...+. ........ ....
T Consensus 251 ~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--~~~~~~~~---~~~~~~~~-----~~~~------------------ 302 (343)
T 1luf_A 251 NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH--EEVIYYVR---DGNILACP-----ENCP------------------ 302 (343)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH--HHHHHHHH---TTCCCCCC-----TTCC------------------
T ss_pred CCcCcccccHHHHHHHHHHHhcCCCcCCCCCh--HHHHHHHh---CCCcCCCC-----CCCC------------------
Confidence 356889999999999999999 9888653211 11111111 11110000 0000
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHHh
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~ 118 (473)
..+..+...|+..+|.+||++.++...|+.+..
T Consensus 303 -----~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 303 -----LELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp -----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred -----HHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 011223456999999999999999999887654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=98.01 E-value=3.3e-06 Score=77.79 Aligned_cols=85 Identities=21% Similarity=0.207 Sum_probs=52.3
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..+.++||||||++++||+| |+.|...... ..+...+. .... ........
T Consensus 189 ~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--~~~~~~~~---~~~~-----~~~~~~~~------------------ 240 (278)
T 1byg_A 189 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVE---KGYK-----MDAPDGCP------------------ 240 (278)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--GGHHHHHT---TTCC-----CCCCTTCC------------------
T ss_pred CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHh---cCCC-----CCCcccCC------------------
Confidence 346889999999999999999 8888653221 12221111 1100 00000000
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHHhh
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~~ 119 (473)
..+..+...|+..+|.+||++.++...|+.++..
T Consensus 241 -----~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 241 -----PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp -----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----HHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 0111223469999999999999999999987654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=98.01 E-value=2e-06 Score=79.88 Aligned_cols=83 Identities=24% Similarity=0.242 Sum_probs=51.3
Q ss_pred ccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhhH
Q 012014 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (473)
..+.++||||||++++||+| |+.|...... ..+...+.... ... .....
T Consensus 196 ~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--~~~~~~~~~~~---~~~-----~~~~~-------------------- 245 (291)
T 1xbb_A 196 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEKGE---RMG-----CPAGC-------------------- 245 (291)
T ss_dssp EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHTTC---CCC-----CCTTC--------------------
T ss_pred CCChhhhHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHHcCC---CCC-----CCCCC--------------------
Confidence 35789999999999999999 9988653221 11222221110 000 00000
Q ss_pred HHHHHHhhcccccccccccccccchhhHHHHHHHHHh
Q 012014 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (473)
Q Consensus 82 ~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~ 118 (473)
-..+..+...|+..+|..||++.++...|+.+-.
T Consensus 246 ---~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 246 ---PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp ---CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0112223456999999999999999999887643
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=98.01 E-value=1.7e-06 Score=81.85 Aligned_cols=30 Identities=20% Similarity=0.280 Sum_probs=25.2
Q ss_pred cccccccccccccccchhhHHHHHHHHHhh
Q 012014 90 RTGVACSAELPNERMKINDVESRLRLIKKK 119 (473)
Q Consensus 90 ~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~~ 119 (473)
.+...|+..+|.+||++.++...|+.+...
T Consensus 294 ~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 294 MIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 344579999999999999999999987654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=98.01 E-value=3.2e-06 Score=78.75 Aligned_cols=85 Identities=20% Similarity=0.285 Sum_probs=51.1
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhhHH
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSIIL 82 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (473)
..+.|+||||||++++||+||..|....... ..+.......... ..+.. ..
T Consensus 208 ~~~~~~Di~slG~il~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~-----~~~~~---~~-------------------- 258 (298)
T 3f66_A 208 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQGRRL-----LQPEY---CP-------------------- 258 (298)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT-TTHHHHHHTTCCC-----CCCTT---CC--------------------
T ss_pred CCChHHHHHHHHHHHHHHHhCCCCCCccCCH-HHHHHHHhcCCCC-----CCCcc---CC--------------------
Confidence 4688999999999999999976654322221 1222221111100 00000 00
Q ss_pred HHHHHhhcccccccccccccccchhhHHHHHHHHHhh
Q 012014 83 ECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (473)
Q Consensus 83 ~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~~ 119 (473)
..+..+...|+..+|.+||++.++...|+.+...
T Consensus 259 ---~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 259 ---DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp ---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 0112234469999999999999999999887654
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=98.00 E-value=3e-06 Score=80.74 Aligned_cols=85 Identities=24% Similarity=0.294 Sum_probs=52.0
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..+.++|||||||+|+||+| |+.|....... ..+...+....... .+ ....
T Consensus 249 ~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-~~~~~~~~~~~~~~-----~~---~~~~------------------ 301 (344)
T 1rjb_A 249 GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD-ANFYKLIQNGFKMD-----QP---FYAT------------------ 301 (344)
T ss_dssp CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-HHHHHHHHTTCCCC-----CC---TTCC------------------
T ss_pred CCCChhHhHHHHHHHHHHHHcCCCCCcccCCcH-HHHHHHHhcCCCCC-----CC---CCCC------------------
Confidence 456889999999999999999 98886543221 12222222111100 00 0000
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHHh
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~ 118 (473)
..+..+...|+..+|.+||++.++...|+.+..
T Consensus 302 -----~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 302 -----EEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp -----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred -----HHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 011223456999999999999999999887643
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=98.00 E-value=2.9e-06 Score=79.65 Aligned_cols=86 Identities=24% Similarity=0.352 Sum_probs=52.2
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..+.++|||||||+++||+| |+.|.......+ .+...+........ . ....
T Consensus 225 ~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~---~-----~~~~------------------ 277 (316)
T 2xir_A 225 RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCRRLKEGTRMRA---P-----DYTT------------------ 277 (316)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH-HHHHHHHHTCCCCC---C-----TTCC------------------
T ss_pred ccccchhHHHHHHHHHHHHHhCCCCCCcccchhH-HHHHHhccCccCCC---C-----CCCC------------------
Confidence 346889999999999999999 888865332211 11111111110000 0 0000
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHHhh
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~~ 119 (473)
..+..+...|+..+|.+||++.++...|+.+...
T Consensus 278 -----~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 278 -----PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp -----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 0112233469999999999999999999877543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=98.00 E-value=1.5e-06 Score=86.23 Aligned_cols=83 Identities=29% Similarity=0.351 Sum_probs=50.6
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..|.|+|||||||+|+||+| |+.|....... .+...+.... ... .+ .. |
T Consensus 356 ~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~--~~~~~i~~~~---~~~--~~---~~--------------~----- 406 (452)
T 1fmk_A 356 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLDQVERGY---RMP--CP---PE--------------C----- 406 (452)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTTC---CCC--CC---TT--------------S-----
T ss_pred CCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCC---CCC--CC---CC--------------C-----
Confidence 457899999999999999999 88886432111 1111111110 000 00 00 0
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHH
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIK 117 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~ 117 (473)
-..+..+...|+..+|.+||++.++...|+.+.
T Consensus 407 ----~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~ 439 (452)
T 1fmk_A 407 ----PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 439 (452)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred ----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 011222345699999999999999998887653
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=97.99 E-value=3.2e-06 Score=78.03 Aligned_cols=84 Identities=19% Similarity=0.306 Sum_probs=51.1
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..+.++|||||||+++||+| |+.|....... .....+...... ..+.. ..
T Consensus 196 ~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~~~-----~~~~~---~~------------------ 247 (283)
T 3gen_A 196 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEHIAQGLRL-----YRPHL---AS------------------ 247 (283)
T ss_dssp CCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHHHHHTTCCC-----CCCTT---CC------------------
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCccccChh--HHHHHHhcccCC-----CCCCc---CC------------------
Confidence 346889999999999999999 98886532211 111111111000 00000 00
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHHh
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~ 118 (473)
..+..+...|+..+|.+||++.++...|..+..
T Consensus 248 -----~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 248 -----EKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp -----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----HHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 011223446999999999999999999887653
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=97.99 E-value=2e-06 Score=78.83 Aligned_cols=82 Identities=27% Similarity=0.393 Sum_probs=49.8
Q ss_pred ccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhhH
Q 012014 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (473)
..+.++||||||++++||+| |+.|.+..... .......... ....+....
T Consensus 181 ~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~~~~~~~~~~--~~~~~~~~~---------------------- 231 (268)
T 3sxs_A 181 KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS-----EVVLKVSQGH--RLYRPHLAS---------------------- 231 (268)
T ss_dssp EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH-----HHHHHHHTTC--CCCCCTTSC----------------------
T ss_pred CCchhhhhHHHHHHHHHHHcCCCCCccccChH-----HHHHHHHcCC--CCCCCCcCh----------------------
Confidence 46789999999999999999 88886532211 1111111110 000110000
Q ss_pred HHHHHHhhcccccccccccccccchhhHHHHHHHHH
Q 012014 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIK 117 (473)
Q Consensus 82 ~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~ 117 (473)
..+..+...|+..+|.+||++.++.+.|+.++
T Consensus 232 ----~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (268)
T 3sxs_A 232 ----DTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263 (268)
T ss_dssp ----HHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred ----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 01112344699999999999999999887664
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=97.99 E-value=9.5e-08 Score=90.21 Aligned_cols=30 Identities=13% Similarity=0.145 Sum_probs=25.2
Q ss_pred ccccccccccccccchhhHHHHHHHHHhhc
Q 012014 91 TGVACSAELPNERMKINDVESRLRLIKKKL 120 (473)
Q Consensus 91 ~~~~C~~~~~~~Rp~m~~v~~~l~~~~~~~ 120 (473)
+...|+..+|.+||++.++...|+.+....
T Consensus 283 li~~~l~~dP~~Rps~~ell~~L~~l~~~~ 312 (318)
T 3lxp_A 283 LMKNCWETEASFRPTFENLIPILKTVHEKY 312 (318)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence 345799999999999999999998876544
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=97.99 E-value=2.8e-06 Score=78.23 Aligned_cols=85 Identities=25% Similarity=0.301 Sum_probs=51.5
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..+.++|||||||+++||+| |+.|...... ..+...+...... ..+ ....
T Consensus 185 ~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--~~~~~~~~~~~~~-----~~~---~~~~------------------ 236 (279)
T 1qpc_A 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PEVIQNLERGYRM-----VRP---DNCP------------------ 236 (279)
T ss_dssp CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHTTCCC-----CCC---TTCC------------------
T ss_pred CCCCchhhhHHHHHHHHHHHhCCCCCCcccCH--HHHHHHHhcccCC-----CCc---cccc------------------
Confidence 346789999999999999999 8877643211 1111111111000 000 0000
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHHhh
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~~ 119 (473)
..+..+...|+..+|.+||++.++...|+.+...
T Consensus 237 -----~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 237 -----EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp -----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----HHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 1122234569999999999999999998877543
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.98 E-value=5e-05 Score=72.09 Aligned_cols=151 Identities=17% Similarity=0.126 Sum_probs=78.9
Q ss_pred ceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcC--CCCceeeeeeeecccc-CCceeeEEEEEe
Q 012014 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK--HRNIVRVFTAFSGVDY-QGARFKAVVYKF 227 (473)
Q Consensus 151 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~-~~~~~~~lv~e~ 227 (473)
..|+.|..+.||+....+| .+++|+... ....+..|..++..|. .-.+++++....+... ......+++|+|
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~----~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHR----PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECS----CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCC----CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677899999986444 589998763 2344556666666653 1133444432100000 012346899999
Q ss_pred cCCCCHH---------------H---HhcCCC-CCCC----CCcchhhcHHH---------------------------H
Q 012014 228 MPNGSLE---------------E---WLRGKD-DTNW----RPLNFNFLIKK---------------------------K 257 (473)
Q Consensus 228 ~~~g~L~---------------~---~l~~~~-~~~~----~~~~~~~~~~~---------------------------~ 257 (473)
++|.++. . ...... .... ....+.-.+.. .
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9886431 1 111110 0000 00000000000 1
Q ss_pred HHHHHHHHHHHHHHhh----------CCCCCeeeccCCCCcEEecCCccEEEeeccccc
Q 012014 258 LDIAIDVACALRYLHC----------DCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMAR 306 (473)
Q Consensus 258 ~~i~~~i~~~L~~LH~----------~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~ 306 (473)
..+..++..++.+|+. .....++|+|+++.||+++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1122234445666652 015789999999999999888889999999764
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=97.98 E-value=2.4e-06 Score=81.03 Aligned_cols=85 Identities=24% Similarity=0.294 Sum_probs=52.4
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..+.++|||||||+|+||+| |+.|...... ..+...+.. ..... .+ ...
T Consensus 225 ~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--~~~~~~~~~---~~~~~--~~---~~~------------------- 275 (333)
T 1mqb_A 225 RKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVMKAIND---GFRLP--TP---MDC------------------- 275 (333)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHHT---TCCCC--CC---TTC-------------------
T ss_pred CCCCchhhhHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHC---CCcCC--Cc---ccC-------------------
Confidence 456889999999999999999 9988653211 111111111 10000 00 000
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHHhh
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~~ 119 (473)
-..+..+...|+..+|..||++.++...|+.+...
T Consensus 276 ----~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 276 ----PSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp ----BHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 01122334579999999999999999999877543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=97.98 E-value=2.2e-06 Score=81.93 Aligned_cols=27 Identities=30% Similarity=0.327 Sum_probs=24.4
Q ss_pred CccccccceeehhhhHHHHHhCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
+..+.|+|||||||+|+||+||+.|..
T Consensus 228 ~~~~~~~DiwslG~il~ell~g~~p~~ 254 (348)
T 1u5q_A 228 GQYDGKVDVWSLGITCIELAERKPPLF 254 (348)
T ss_dssp CCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 457889999999999999999999965
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=97.97 E-value=4.8e-06 Score=78.52 Aligned_cols=83 Identities=19% Similarity=0.291 Sum_probs=51.7
Q ss_pred ccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhhH
Q 012014 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (473)
..+.|+|||||||+++||+| |+.|...... ..+...+.... .... . ...
T Consensus 215 ~~~~~~Di~slG~il~ell~~g~~p~~~~~~--~~~~~~~~~~~---~~~~-~----~~~-------------------- 264 (323)
T 3qup_A 215 LYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN--AEIYNYLIGGN---RLKQ-P----PEC-------------------- 264 (323)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHHHHHTTC---CCCC-C----TTC--------------------
T ss_pred CCCCccchhhHHHHHHHHHhCCCCCccccCh--HHHHHHHhcCC---CCCC-C----Ccc--------------------
Confidence 46889999999999999999 8888653321 12222211110 0000 0 000
Q ss_pred HHHHHHhhcccccccccccccccchhhHHHHHHHHHh
Q 012014 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (473)
Q Consensus 82 ~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~ 118 (473)
...+..+...|+..+|.+||++.++...++.+..
T Consensus 265 ---~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~ 298 (323)
T 3qup_A 265 ---MEEVYDLMYQCWSADPKQRPSFTCLRMELENILG 298 (323)
T ss_dssp ---CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0112233456999999999999999999987754
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=97.97 E-value=2e-06 Score=81.63 Aligned_cols=84 Identities=21% Similarity=0.304 Sum_probs=51.7
Q ss_pred ccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhhH
Q 012014 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (473)
..+.++|||||||+|+||+| |+.|..... ...+...+...... .. . ...
T Consensus 235 ~~~~~~Di~slG~il~ellt~g~~p~~~~~--~~~~~~~~~~~~~~---~~-~----~~~-------------------- 284 (334)
T 2pvf_A 235 VYTHQSDVWSFGVLMWEIFTLGGSPYPGIP--VEELFKLLKEGHRM---DK-P----ANC-------------------- 284 (334)
T ss_dssp EECHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHHHHHHHHTCCC---CC-C----TTC--------------------
T ss_pred CcChHHHHHHHHHHHHHHHhCCCCCcCcCC--HHHHHHHHhcCCCC---CC-C----ccC--------------------
Confidence 46789999999999999999 888865321 11122221111100 00 0 000
Q ss_pred HHHHHHhhcccccccccccccccchhhHHHHHHHHHhh
Q 012014 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (473)
Q Consensus 82 ~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~~ 119 (473)
-..+..+...|+..+|.+||++.++...|+.+...
T Consensus 285 ---~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~ 319 (334)
T 2pvf_A 285 ---TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319 (334)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 00112234469999999999999999999887654
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=97.97 E-value=2.8e-06 Score=78.79 Aligned_cols=84 Identities=23% Similarity=0.281 Sum_probs=50.2
Q ss_pred ccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhhH
Q 012014 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (473)
..+.++|||||||+++||+| |+.|...... ............. ...+ ...
T Consensus 200 ~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~~~~~~~~~-~~~~---~~~-------------------- 250 (291)
T 1u46_A 200 TFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-----SQILHKIDKEGER-LPRP---EDC-------------------- 250 (291)
T ss_dssp EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHHHHTSCCC-CCCC---TTC--------------------
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCcccCCH-----HHHHHHHHccCCC-CCCC---cCc--------------------
Confidence 35789999999999999999 8888653211 1111111111000 0000 000
Q ss_pred HHHHHHhhcccccccccccccccchhhHHHHHHHHHh
Q 012014 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (473)
Q Consensus 82 ~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~ 118 (473)
-..+..+...|+..+|.+||++.++...|+....
T Consensus 251 ---~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 251 ---PQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred ---CHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 0112223456999999999999999998887643
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=97.96 E-value=2.7e-06 Score=80.50 Aligned_cols=26 Identities=31% Similarity=0.479 Sum_probs=23.8
Q ss_pred ccccccceeehhhhHHHHHhCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
..+.|+|||||||+|+||+||+.|+.
T Consensus 246 ~y~~~~DiWSlGvilyeml~G~~PF~ 271 (346)
T 4fih_A 246 PYGPEVDIWSLGIMVIEMVDGEPPYF 271 (346)
T ss_dssp CBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 46889999999999999999999975
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=97.95 E-value=4.6e-06 Score=78.86 Aligned_cols=84 Identities=24% Similarity=0.382 Sum_probs=51.7
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..+.++||||||++|+||+| |+.|..... ...+..++.... .... . ....
T Consensus 220 ~~~~~~~Di~slG~il~ellt~g~~p~~~~~--~~~~~~~~~~~~---~~~~-~----~~~~------------------ 271 (327)
T 2yfx_A 220 GIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS--NQEVLEFVTSGG---RMDP-P----KNCP------------------ 271 (327)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHHHHHHHTTC---CCCC-C----TTCC------------------
T ss_pred CCCCchhhHHHHHHHHHHHHcCCCCCCCCcC--HHHHHHHHhcCC---CCCC-C----CCCC------------------
Confidence 346889999999999999999 888764321 112222222110 0000 0 0000
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHHh
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~ 118 (473)
..+..+...|+..+|..||++.++...+.....
T Consensus 272 -----~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 272 -----GPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp -----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 011223456999999999999999999887754
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=97.94 E-value=2.7e-06 Score=88.01 Aligned_cols=83 Identities=24% Similarity=0.239 Sum_probs=51.9
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..+.|+|||||||+|+||+| |+.|...... ..+...+.... ..... ...
T Consensus 547 ~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--~~~~~~i~~~~---~~~~p-----~~~------------------- 597 (635)
T 4fl3_A 547 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEKGE---RMGCP-----AGC------------------- 597 (635)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHTTC---CCCCC-----TTC-------------------
T ss_pred CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--HHHHHHHHcCC---CCCCC-----CCC-------------------
Confidence 357889999999999999999 9998653221 11222221110 00000 000
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHH
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIK 117 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~ 117 (473)
-..+..+...|+..+|.+||++.++...|+.+-
T Consensus 598 ----~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 598 ----PREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp ----CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ----CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 011222345699999999999999999998764
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=97.92 E-value=3.2e-06 Score=77.64 Aligned_cols=26 Identities=38% Similarity=0.505 Sum_probs=23.4
Q ss_pred ccccceeehhhhHHHHHhCCCCCCCC
Q 012014 5 SSYGDVYSFGILLLEMFTGLRPNDDM 30 (473)
Q Consensus 5 t~ksDVySfGVvllEl~tg~~~~~~~ 30 (473)
+.++||||||++++||+||+.|.+..
T Consensus 186 ~~~~Di~slG~il~~l~~g~~p~~~~ 211 (276)
T 2yex_A 186 AEPVDVWSCGIVLTAMLAGELPWDQP 211 (276)
T ss_dssp HHHHHHHHHHHHHHHHHHSSCCCSCS
T ss_pred CCcchHHHHHHHHHHHHhCCCCCCCC
Confidence 67899999999999999999997643
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=97.92 E-value=4e-06 Score=76.81 Aligned_cols=25 Identities=32% Similarity=0.437 Sum_probs=22.8
Q ss_pred cccccceeehhhhHHHHHhCCCCCC
Q 012014 4 VSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 4 ~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
.+.|+||||+||+|+||+||+.|..
T Consensus 189 ~~~~~DiwSlGvily~lltg~~PF~ 213 (275)
T 3hyh_A 189 AGPEVDVWSCGVILYVMLCRRLPFD 213 (275)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCChhhhHHHHHHHHHHHHCCCCCC
Confidence 4679999999999999999999975
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=97.92 E-value=6.9e-06 Score=75.98 Aligned_cols=84 Identities=18% Similarity=0.270 Sum_probs=51.5
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..+.++|||||||+++||+| |+.|..... ...+...+........ + ....
T Consensus 187 ~~~~~~~Di~slG~il~~ll~~g~~p~~~~~--~~~~~~~~~~~~~~~~-----~---~~~~------------------ 238 (288)
T 3kfa_A 187 NKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYELLEKDYRMER-----P---EGCP------------------ 238 (288)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--GGGHHHHHHTTCCCCC-----C---TTCC------------------
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--HHHHHHHHhccCCCCC-----C---CCCC------------------
Confidence 356789999999999999999 887765322 1122222221111000 0 0000
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHHh
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~ 118 (473)
..+..+...|+..+|.+||++.++.+.|+....
T Consensus 239 -----~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 239 -----EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp -----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----HHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 011223446899999999999999998887654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=97.91 E-value=3.6e-06 Score=79.45 Aligned_cols=28 Identities=29% Similarity=0.514 Sum_probs=24.7
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
+..+.++|||||||+|+||+||+.|...
T Consensus 216 ~~~~~~~Dv~slG~il~el~~g~~pf~~ 243 (321)
T 2c30_A 216 SLYATEVDIWSLGIMVIEMVDGEPPYFS 243 (321)
T ss_dssp CCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 4568899999999999999999999753
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=97.90 E-value=4.4e-06 Score=77.07 Aligned_cols=79 Identities=16% Similarity=0.190 Sum_probs=49.1
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhhH
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (473)
+..+.++|||||||+|+||+||+.|... ...+............++ .
T Consensus 196 ~~~~~~~Di~slG~il~~l~~~~~~~~~-------~~~~~~~~~~~~~~~~~~--------~------------------ 242 (284)
T 2a19_B 196 QDYGKEVDLYALGLILAELLHVCDTAFE-------TSKFFTDLRDGIISDIFD--------K------------------ 242 (284)
T ss_dssp SCCCTHHHHHHHHHHHHHHHSCCSSHHH-------HHHHHHHHHTTCCCTTSC--------H------------------
T ss_pred CCCcchhhhHHHHHHHHHHHhcCCcchh-------HHHHHHHhhcccccccCC--------H------------------
Confidence 3468899999999999999999887421 011111111100000000 0
Q ss_pred HHHHHHhhcccccccccccccccchhhHHHHHHHHHh
Q 012014 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (473)
Q Consensus 82 ~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~ 118 (473)
.+ ..+...|+..+|.+||++.++...+..+.+
T Consensus 243 --~~---~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 243 --KE---KTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp --HH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred --HH---HHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 01 122346889999999999999999887754
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=97.90 E-value=3e-06 Score=85.95 Aligned_cols=82 Identities=29% Similarity=0.369 Sum_probs=50.0
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..+.|+|||||||+|+||+| |+.|....... .+...+.... ... .+ .. |
T Consensus 439 ~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~--~~~~~i~~~~---~~~--~~---~~--------------~----- 489 (535)
T 2h8h_A 439 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLDQVERGY---RMP--CP---PE--------------C----- 489 (535)
T ss_dssp CCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH--HHHHHHHTTC---CCC--CC---TT--------------C-----
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcCC---CCC--CC---CC--------------C-----
Confidence 457899999999999999999 88886532211 1111111110 000 00 00 0
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHH
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLI 116 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~ 116 (473)
-..+..+...|+..+|++||++.++...|+.+
T Consensus 490 ----~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~ 521 (535)
T 2h8h_A 490 ----PESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521 (535)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 01112234569999999999999999888754
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=97.89 E-value=1.7e-06 Score=80.15 Aligned_cols=82 Identities=15% Similarity=0.163 Sum_probs=48.6
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhhH
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (473)
+..+.++|||||||+++||+||..|........ .......... .......
T Consensus 193 ~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~--------------------------- 242 (289)
T 4fvq_A 193 KNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ-RKLQFYEDRH--QLPAPKA--------------------------- 242 (289)
T ss_dssp GGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-HHHHHHHTTC--CCCCCSS---------------------------
T ss_pred CCCCchhHHHHHHHHHHHHHcCCCCCccccchH-HHHHHhhccC--CCCCCCC---------------------------
Confidence 347889999999999999999766543221111 1111111100 0000000
Q ss_pred HHHHHHhhcccccccccccccccchhhHHHHHHHHH
Q 012014 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIK 117 (473)
Q Consensus 82 ~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~ 117 (473)
..+..+...|+..+|.+||++.++...|+.+.
T Consensus 243 ----~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~ 274 (289)
T 4fvq_A 243 ----AELANLINNCMDYEPDHRPSFRAIIRDLNSLF 274 (289)
T ss_dssp ----CTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred ----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 00112234699999999999999999887653
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=97.89 E-value=6.9e-06 Score=77.61 Aligned_cols=84 Identities=20% Similarity=0.233 Sum_probs=51.5
Q ss_pred ccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhhH
Q 012014 3 YVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (473)
..+.++|||||||+++||+| |+.|..... ............... ......
T Consensus 217 ~~~~~~Di~slG~il~ellt~g~~pf~~~~-----~~~~~~~~~~~~~~~-----~~~~~~------------------- 267 (327)
T 1fvr_A 217 VYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-----CAELYEKLPQGYRLE-----KPLNCD------------------- 267 (327)
T ss_dssp EECHHHHHHHHHHHHHHHHTTSCCTTTTCC-----HHHHHHHGGGTCCCC-----CCTTBC-------------------
T ss_pred cCCchhcchHHHHHHHHHHcCCCCCCCCCc-----HHHHHHHhhcCCCCC-----CCCCCC-------------------
Confidence 35789999999999999999 998865321 111211111110000 000000
Q ss_pred HHHHHHhhcccccccccccccccchhhHHHHHHHHHhh
Q 012014 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (473)
Q Consensus 82 ~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~~ 119 (473)
..+..+...|+..+|.+||++.++...|..+...
T Consensus 268 ----~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 268 ----DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp ----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0112234468999999999999999999877654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=97.88 E-value=4.1e-06 Score=79.07 Aligned_cols=26 Identities=38% Similarity=0.505 Sum_probs=23.4
Q ss_pred ccccceeehhhhHHHHHhCCCCCCCC
Q 012014 5 SSYGDVYSFGILLLEMFTGLRPNDDM 30 (473)
Q Consensus 5 t~ksDVySfGVvllEl~tg~~~~~~~ 30 (473)
+.++|||||||+|+||+||+.|.+..
T Consensus 186 ~~~~DiwslG~il~~ll~g~~pf~~~ 211 (323)
T 3tki_A 186 AEPVDVWSCGIVLTAMLAGELPWDQP 211 (323)
T ss_dssp HHHHHHHHHHHHHHHHHHSSCSCSSS
T ss_pred CCcccHHHHHHHHHHHHhCCCCCCCC
Confidence 67899999999999999999997643
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=97.87 E-value=4e-06 Score=78.16 Aligned_cols=25 Identities=32% Similarity=0.429 Sum_probs=22.3
Q ss_pred ccccccceeehhhhHHHHHhCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPN 27 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~ 27 (473)
..+.++||||||++++||+||+.|.
T Consensus 205 ~~~~~~Di~slG~il~~l~~g~~p~ 229 (302)
T 4e5w_A 205 KFYIASDVWSFGVTLHELLTYCDSD 229 (302)
T ss_dssp EEEHHHHHHHHHHHHHHHHTTTCGG
T ss_pred CCCcchhHHHHHHHHHHHHHccCCC
Confidence 4577999999999999999998874
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.86 E-value=2.4e-06 Score=80.25 Aligned_cols=26 Identities=27% Similarity=0.499 Sum_probs=23.1
Q ss_pred CccccccceeehhhhHHHHHhCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPN 27 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~ 27 (473)
|..+.|+|||||||+|+||+||+.+.
T Consensus 230 ~~~~~~~DiwslG~il~el~~g~~~~ 255 (311)
T 3p1a_A 230 GSYGTAADVFSLGLTILEVACNMELP 255 (311)
T ss_dssp TCCSTHHHHHHHHHHHHHHHHTCCCC
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 45788999999999999999998764
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=97.86 E-value=3e-06 Score=79.83 Aligned_cols=82 Identities=21% Similarity=0.285 Sum_probs=48.9
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..+.++|||||||+++||+| |+.|..... ...+...+. ........ ....
T Consensus 215 ~~~~~~~Di~slG~il~el~~~g~~p~~~~~--~~~~~~~~~---~~~~~~~~-----~~~~------------------ 266 (322)
T 1p4o_A 215 GVFTTYSDVWSFGVVLWEIATLAEQPYQGLS--NEQVLRFVM---EGGLLDKP-----DNCP------------------ 266 (322)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--HHHHHHHHH---TTCCCCCC-----TTCC------------------
T ss_pred CCCCchhhHHHHHHHHHHHHhcCCCccccCC--HHHHHHHHH---cCCcCCCC-----CCCC------------------
Confidence 356889999999999999999 777754321 111111111 11110000 0000
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHH
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLI 116 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~ 116 (473)
..+..+...|+..+|..||++.++...|+..
T Consensus 267 -----~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~ 297 (322)
T 1p4o_A 267 -----DMLFELMRMCWQYNPKMRPSFLEIISSIKEE 297 (322)
T ss_dssp -----HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred -----HHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence 0111233468999999999999999888754
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=97.84 E-value=2.5e-06 Score=80.69 Aligned_cols=26 Identities=38% Similarity=0.567 Sum_probs=23.0
Q ss_pred ccccccceeehhhhHHHHHhCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
..+.++|||||||+++||+||+.|..
T Consensus 206 ~~~~~~Di~slG~il~~ll~g~~p~~ 231 (327)
T 3lxl_A 206 IFSRQSDVWSFGVVLYELFTYCDKSC 231 (327)
T ss_dssp EEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred CCChHHhHHHHHHHHHHHHhCCCCCc
Confidence 35789999999999999999999854
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.84 E-value=8.4e-06 Score=76.73 Aligned_cols=28 Identities=21% Similarity=0.262 Sum_probs=24.9
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
+..|.++|||||||+|+||+||+.|...
T Consensus 198 ~~~~~~~DiwslG~il~el~~g~~pf~~ 225 (319)
T 4euu_A 198 KKYGATVDLWSIGVTFYHAATGSLPFRP 225 (319)
T ss_dssp CCBCTTHHHHHHHHHHHHHHHSSCSEEC
T ss_pred CCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 4578899999999999999999999753
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=97.83 E-value=4.1e-06 Score=78.06 Aligned_cols=27 Identities=33% Similarity=0.513 Sum_probs=24.2
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
..+.++|||||||+|+||+||+.|...
T Consensus 203 ~~~~~~Di~slG~il~~l~~g~~pf~~ 229 (303)
T 2vwi_A 203 GYDFKADIWSFGITAIELATGAAPYHK 229 (303)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 368899999999999999999999764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=97.83 E-value=5.1e-06 Score=77.40 Aligned_cols=27 Identities=30% Similarity=0.446 Sum_probs=24.2
Q ss_pred CccccccceeehhhhHHHHHhCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
+..+.++|||||||+|+||+||+.|..
T Consensus 191 ~~~~~~~DiwslG~il~ell~g~~pf~ 217 (297)
T 3fxz_A 191 KAYGPKVDIWSLGIMAIEMIEGEPPYL 217 (297)
T ss_dssp SCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 346889999999999999999999965
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.83 E-value=4.9e-06 Score=78.15 Aligned_cols=27 Identities=37% Similarity=0.513 Sum_probs=23.6
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
..+.++|||||||+|+||+||+.|...
T Consensus 205 ~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (318)
T 2dyl_A 205 DYDIRADVWSLGISLVELATGQFPYKN 231 (318)
T ss_dssp -CCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCccccchhhHHHHHHHHHhCCCCCCC
Confidence 467899999999999999999998754
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=97.82 E-value=6.5e-06 Score=75.76 Aligned_cols=27 Identities=26% Similarity=0.420 Sum_probs=23.6
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
..+.++||||||++++||+||+.|...
T Consensus 192 ~~~~~~Di~slG~il~~l~~g~~p~~~ 218 (279)
T 2w5a_A 192 SYNEKSDIWSLGCLLYELCALMPPFTA 218 (279)
T ss_dssp -CCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCchhhHHHHHHHHHHHHHCCCCCcc
Confidence 468899999999999999999998653
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.82 E-value=5.2e-06 Score=77.04 Aligned_cols=26 Identities=31% Similarity=0.510 Sum_probs=23.6
Q ss_pred cccccceeehhhhHHHHHhCCCCCCC
Q 012014 4 VSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 4 ~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
.+.++|||||||+++||+||+.|...
T Consensus 202 ~~~~~Di~slG~il~~l~~g~~pf~~ 227 (295)
T 2clq_A 202 YGKAADIWSLGCTIIEMATGKPPFYE 227 (295)
T ss_dssp CSHHHHHHHHHHHHHHHHHTSCTTGG
T ss_pred CCcHHHHHHHHHHHHHHHHCCCCccC
Confidence 67899999999999999999999753
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=97.82 E-value=6e-06 Score=81.41 Aligned_cols=28 Identities=21% Similarity=0.449 Sum_probs=24.6
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDD 29 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~ 29 (473)
+..|.++|||||||+|+||+| |+.|...
T Consensus 214 ~~~~~~~DiwSlG~il~ellt~g~~Pf~~ 242 (434)
T 2rio_A 214 RRLTRSIDIFSMGCVFYYILSKGKHPFGD 242 (434)
T ss_dssp CCCCTHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred cCcchhhhhHhHHHHHHHHHhCCCCCCCC
Confidence 457899999999999999999 8888753
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=97.80 E-value=5.1e-06 Score=78.34 Aligned_cols=28 Identities=21% Similarity=0.422 Sum_probs=24.6
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
+..+.++|||||||+|+||+||+.|...
T Consensus 194 ~~~~~~~Di~slG~il~~l~~g~~pf~~ 221 (322)
T 2ycf_A 194 AGYNRAVDCWSLGVILFICLSGYPPFSE 221 (322)
T ss_dssp TTCTTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 3467899999999999999999999754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.79 E-value=6e-06 Score=78.87 Aligned_cols=28 Identities=25% Similarity=0.374 Sum_probs=24.7
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
+..+.++|||||||+|+||+||+.|...
T Consensus 225 ~~~~~~~DiwslG~il~ell~g~~pf~~ 252 (349)
T 2w4o_A 225 CAYGPEVDMWSVGIITYILLCGFEPFYD 252 (349)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence 3578899999999999999999999753
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=97.78 E-value=4.5e-06 Score=78.88 Aligned_cols=27 Identities=37% Similarity=0.452 Sum_probs=23.6
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
..+.++|||||||+++||+||+.|...
T Consensus 205 ~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (327)
T 3aln_A 205 GYDVRSDVWSLGITLYELATGRFPYPK 231 (327)
T ss_dssp -CCSHHHHHHHHHHHHHHHHSCCCSSC
T ss_pred CCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 468899999999999999999999653
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.78 E-value=8e-06 Score=79.34 Aligned_cols=26 Identities=31% Similarity=0.479 Sum_probs=23.8
Q ss_pred ccccccceeehhhhHHHHHhCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
..+.|+|||||||+|+||+||+.|+.
T Consensus 323 ~y~~~~DiWSlGvilyeml~G~~PF~ 348 (423)
T 4fie_A 323 PYGPEVDIWSLGIMVIEMVDGEPPYF 348 (423)
T ss_dssp CBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 46889999999999999999999975
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=97.77 E-value=2.9e-06 Score=80.31 Aligned_cols=28 Identities=21% Similarity=0.201 Sum_probs=24.7
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
+..+.++|||||||+|+||+||+.|...
T Consensus 206 ~~~~~~~DiwslG~il~~ll~g~~p~~~ 233 (330)
T 3nsz_A 206 QMYDYSLDMWSLGCMLASMIFRKEPFFH 233 (330)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 3578899999999999999999999753
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.76 E-value=0.00013 Score=71.50 Aligned_cols=79 Identities=9% Similarity=0.030 Sum_probs=47.3
Q ss_pred CCCeeeccCCCCcEEecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCC---CCCcccchhhHhHHHHH
Q 012014 276 QPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC---EASTYGDVYSFGILLLE 352 (473)
Q Consensus 276 ~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~e 352 (473)
...++|+|++|.||+++.++ ++++||+.+..-.....-...... -...|.+|+..... ......++.+....+|+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGN-LILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHH-HHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHH-HHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 78899999999999998776 899999988753321110000000 01235555544311 11122455677777887
Q ss_pred HHhC
Q 012014 353 MFTG 356 (473)
Q Consensus 353 lltg 356 (473)
.+++
T Consensus 309 ~y~~ 312 (420)
T 2pyw_A 309 LFNK 312 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7764
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=97.76 E-value=1.1e-05 Score=75.32 Aligned_cols=28 Identities=29% Similarity=0.525 Sum_probs=24.4
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
+..+.++||||||++|+||+||+.|...
T Consensus 194 ~~~~~~~Di~slG~il~~l~~g~~p~~~ 221 (303)
T 3a7i_A 194 SAYDSKADIWSLGITAIELARGEPPHSE 221 (303)
T ss_dssp CCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCCCchhhhHHHHHHHHHHccCCCCCCC
Confidence 3468899999999999999999998653
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=97.76 E-value=8.6e-06 Score=75.32 Aligned_cols=28 Identities=25% Similarity=0.373 Sum_probs=24.7
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
+..+.++|||||||+++||+||+.|...
T Consensus 200 ~~~~~~~Di~slG~il~~ll~g~~pf~~ 227 (285)
T 3is5_A 200 RDVTFKCDIWSAGVVMYFLLTGCLPFTG 227 (285)
T ss_dssp TCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCCCcccCeehHHHHHHHHHhCCCCCCC
Confidence 4568899999999999999999999653
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=97.75 E-value=9.2e-06 Score=77.30 Aligned_cols=28 Identities=25% Similarity=0.313 Sum_probs=24.8
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
+..+.++|||||||+|+||+||+.|...
T Consensus 251 ~~~~~~~DiwslG~il~el~~g~~pf~~ 278 (345)
T 3hko_A 251 ESYGPKCDAWSAGVLLHLLLMGAVPFPG 278 (345)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 4578899999999999999999999653
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=97.74 E-value=6.2e-06 Score=80.88 Aligned_cols=28 Identities=21% Similarity=0.422 Sum_probs=24.5
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
+..+.|+|||||||+|+||+||+.|...
T Consensus 319 ~~~~~~~DiwslG~il~~lltg~~pf~~ 346 (419)
T 3i6u_A 319 AGYNRAVDCWSLGVILFICLSGYPPFSE 346 (419)
T ss_dssp CTTHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 3467899999999999999999999754
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=97.74 E-value=1.5e-05 Score=74.60 Aligned_cols=26 Identities=27% Similarity=0.467 Sum_probs=21.7
Q ss_pred ccccccceeehhhhHHHHHhCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
..+.++||||||++|+||+||+.|..
T Consensus 211 ~~~~~~Di~slG~il~~l~~g~~pf~ 236 (309)
T 2h34_A 211 HATYRADIYALTCVLYECLTGSPPYQ 236 (309)
T ss_dssp ---CCCHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCchHhHHHHHHHHHHHHHCCCCCC
Confidence 45789999999999999999999865
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=97.74 E-value=6.3e-06 Score=77.75 Aligned_cols=27 Identities=30% Similarity=0.536 Sum_probs=24.0
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
..+.++|||||||+|+||+||+.|...
T Consensus 179 ~~~~~~DiwslG~il~~ll~g~~pf~~ 205 (321)
T 1tki_A 179 VVSTATDMWSLGTLVYVLLSGINPFLA 205 (321)
T ss_dssp EECHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCcC
Confidence 358899999999999999999999753
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=97.73 E-value=1.5e-05 Score=74.12 Aligned_cols=27 Identities=37% Similarity=0.639 Sum_probs=24.0
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
..+.++|||||||+++||+||+.|.+.
T Consensus 188 ~~~~~~Di~slG~~l~~ll~g~~pf~~ 214 (294)
T 4eqm_A 188 ATDECTDIYSIGIVLYEMLVGEPPFNG 214 (294)
T ss_dssp CCCTTHHHHHHHHHHHHHHHSSCSSCS
T ss_pred CCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 467899999999999999999999753
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=97.73 E-value=6.5e-06 Score=76.25 Aligned_cols=27 Identities=15% Similarity=0.250 Sum_probs=24.3
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
..+.++|||||||+|+||+||+.|...
T Consensus 178 ~~~~~~Di~slG~il~elltg~~Pf~~ 204 (286)
T 3uqc_A 178 DANPQDDIRGIGASLYALLVNRWPLPE 204 (286)
T ss_dssp TCCHHHHHHHHHHHHHHHHHSEECSCC
T ss_pred CCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 468899999999999999999999753
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=97.72 E-value=1.3e-05 Score=77.97 Aligned_cols=28 Identities=18% Similarity=0.383 Sum_probs=24.8
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
+..+.++|||||||+|+||+||+.|...
T Consensus 238 ~~~~~~~DiwslG~il~ell~g~~pf~~ 265 (400)
T 1nxk_A 238 EKYDKSCDMWSLGVIMYILLCGYPPFYS 265 (400)
T ss_dssp CCSSSHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCCCcccHHHHHHHHHHHHhCCCCCCC
Confidence 4568899999999999999999999753
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=97.72 E-value=7.5e-06 Score=75.48 Aligned_cols=28 Identities=18% Similarity=0.337 Sum_probs=24.6
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
+..+.++||||||++++||+||+.|...
T Consensus 186 ~~~~~~~Di~slG~il~~l~~g~~p~~~ 213 (283)
T 3bhy_A 186 EPLGLEADMWSIGVITYILLSGASPFLG 213 (283)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCCCcchhhhhHHHHHHHHHHCCCCCCC
Confidence 4568899999999999999999998653
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=97.72 E-value=5.5e-06 Score=80.03 Aligned_cols=26 Identities=12% Similarity=0.253 Sum_probs=23.5
Q ss_pred ccccccceeehhhhHHHHHhCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
..|.|+|||||||+|+||+||+.|..
T Consensus 289 ~~~~~~DvwSlG~il~elltg~~Pf~ 314 (377)
T 3byv_A 289 LMTFSFDAWALGLVIYWIWCADLPIT 314 (377)
T ss_dssp ECCHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred cCChhhhHHHHHHHHHHHHHCCCCCc
Confidence 57899999999999999999999964
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=97.72 E-value=1.1e-05 Score=78.36 Aligned_cols=27 Identities=19% Similarity=0.170 Sum_probs=24.4
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
..+.++|||||||+|+||+||+.|...
T Consensus 269 ~~~~~~DiwslG~il~elltg~~pf~~ 295 (397)
T 1wak_A 269 GYNTPADIWSTACMAFELATGDYLFEP 295 (397)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCcHHHHHHHHHHHHHHhhCCCCCCC
Confidence 468899999999999999999999764
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=97.70 E-value=6.2e-06 Score=76.86 Aligned_cols=27 Identities=19% Similarity=0.391 Sum_probs=24.2
Q ss_pred CccccccceeehhhhHHHHHhCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
+..+.++|||||||+|+||+||+.|..
T Consensus 173 ~~~~~~~DiwslG~il~el~tg~~pf~ 199 (299)
T 3m2w_A 173 EKYDKSCDMWSLGVIMYILLCGYPPFY 199 (299)
T ss_dssp CGGGGHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 356889999999999999999999965
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.70 E-value=0.00011 Score=68.29 Aligned_cols=71 Identities=10% Similarity=0.047 Sum_probs=44.8
Q ss_pred cceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCc-eeeeeeeeccccCCceeeEEEEEec
Q 012014 150 ANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNI-VRVFTAFSGVDYQGARFKAVVYKFM 228 (473)
Q Consensus 150 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~e~~ 228 (473)
.+.|+.|....+|+. ..+++|+...... ......+|+.++..+...++ .++++.+.+ .-++++||+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~-~~~~r~~E~~~l~~l~~~g~~P~~~~~~~~-------~~~~v~e~i 89 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTE-EYINRANEAVAAREAAKAGVSPEVLHVDPA-------TGVMVTRYI 89 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEECTT-------TCCEEEECC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCcc-ceeCHHHHHHHHHHHHHcCCCCceEEEECC-------CCEEEEeec
Confidence 677999999999998 5688898764321 12234678888877742222 466654321 137899999
Q ss_pred -CCCCH
Q 012014 229 -PNGSL 233 (473)
Q Consensus 229 -~~g~L 233 (473)
++.+|
T Consensus 90 ~~g~~l 95 (301)
T 3dxq_A 90 AGAQTM 95 (301)
T ss_dssp TTCEEC
T ss_pred CCCccC
Confidence 65443
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.70 E-value=8.6e-06 Score=76.96 Aligned_cols=27 Identities=19% Similarity=0.348 Sum_probs=24.2
Q ss_pred CccccccceeehhhhHHHHHhCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
+..+.++|||||||+|+||+||+.|..
T Consensus 192 ~~~~~~~DiwslG~il~~ll~g~~pf~ 218 (326)
T 2y0a_A 192 EPLGLEADMWSIGVITYILLSGASPFL 218 (326)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred CCCCcHHHHHHHHHHHHHHHHCcCCCC
Confidence 356889999999999999999999965
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=97.69 E-value=9.8e-06 Score=76.60 Aligned_cols=28 Identities=18% Similarity=0.339 Sum_probs=24.6
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
+..+.++|||||||+|+||+||+.|...
T Consensus 208 ~~~~~~~DiwslG~il~~ll~g~~pf~~ 235 (327)
T 3lm5_A 208 DPITTATDMWNIGIIAYMLLTHTSPFVG 235 (327)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 4568899999999999999999999653
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=97.69 E-value=1.9e-05 Score=81.94 Aligned_cols=83 Identities=18% Similarity=0.287 Sum_probs=50.9
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..+.++|||||||+|+||+| |+.|...... ..+...+..... .. +....
T Consensus 567 ~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~--~~~~~~i~~~~~---~~-----~~~~~------------------- 617 (656)
T 2j0j_A 567 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--NDVIGRIENGER---LP-----MPPNC------------------- 617 (656)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHHHTCC---CC-----CCTTC-------------------
T ss_pred CCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHHcCCC---CC-----CCccc-------------------
Confidence 346889999999999999997 8888653211 112222211100 00 00000
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHH
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIK 117 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~ 117 (473)
-..+..+...|+..+|.+||++.++...|+.+.
T Consensus 618 ----~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 618 ----PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----cHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 011122345699999999999999999988764
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.68 E-value=1.2e-05 Score=75.74 Aligned_cols=28 Identities=32% Similarity=0.421 Sum_probs=23.7
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
+..+.++|||||||+++||+||+.|...
T Consensus 209 ~~~~~~~Di~slG~il~~l~~g~~p~~~ 236 (326)
T 2x7f_A 209 ATYDFKSDLWSLGITAIEMAEGAPPLCD 236 (326)
T ss_dssp --CCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 3468899999999999999999998753
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=97.68 E-value=1.5e-05 Score=74.14 Aligned_cols=27 Identities=30% Similarity=0.424 Sum_probs=24.0
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
..+.++|||||||+++||+||+.|...
T Consensus 198 ~~~~~~Di~slG~il~~l~~g~~p~~~ 224 (302)
T 2j7t_A 198 PYDYKADIWSLGITLIEMAQIEPPHHE 224 (302)
T ss_dssp TTTTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCchhhhHHHHHHHHHHHhcCCCCCcc
Confidence 467899999999999999999998653
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.68 E-value=1.3e-05 Score=77.18 Aligned_cols=27 Identities=30% Similarity=0.532 Sum_probs=24.2
Q ss_pred CccccccceeehhhhHHHHHhCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
+..+.++|||||||+|+||+||+.|..
T Consensus 263 ~~~~~~~DiwslG~il~elltg~~pf~ 289 (373)
T 2x4f_A 263 DFVSFPTDMWSVGVIAYMLLSGLSPFL 289 (373)
T ss_dssp CBCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CCCCcHHhHHHHHHHHHHHHhCCCCCC
Confidence 456789999999999999999999965
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=97.67 E-value=1.4e-05 Score=76.58 Aligned_cols=28 Identities=29% Similarity=0.326 Sum_probs=24.8
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
+..+.++|||||||+|+||+||+.|...
T Consensus 234 ~~~~~~~DiwslG~il~ell~g~~pf~~ 261 (360)
T 3llt_A 234 LGWDVSSDMWSFGCVLAELYTGSLLFRT 261 (360)
T ss_dssp CCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCCCccchHHHHHHHHHHHHCCCCCCC
Confidence 3578999999999999999999999753
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=97.67 E-value=1.1e-05 Score=74.38 Aligned_cols=27 Identities=26% Similarity=0.399 Sum_probs=24.1
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
..+.++||||||++++||+||+.|...
T Consensus 183 ~~~~~~Di~slG~~l~~l~~g~~pf~~ 209 (284)
T 3kk8_A 183 PYSKPVDIWACGVILYILLVGYPPFWD 209 (284)
T ss_dssp CBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCcccchHHHHHHHHHHHHCCCCCCC
Confidence 468899999999999999999999653
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.67 E-value=1.1e-05 Score=74.96 Aligned_cols=25 Identities=24% Similarity=0.282 Sum_probs=22.6
Q ss_pred cccccceeehhhhHHHHHhCCCCCC
Q 012014 4 VSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 4 ~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
.+.++|||||||+|+||+||+.|..
T Consensus 217 ~~~~~Di~slG~~l~~l~~g~~pf~ 241 (298)
T 2zv2_A 217 SGKALDVWAMGVTLYCFVFGQCPFM 241 (298)
T ss_dssp ESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCchhhhHhHHHHHHHHHHCCCCCC
Confidence 3678999999999999999999965
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=97.67 E-value=4.5e-06 Score=80.47 Aligned_cols=27 Identities=7% Similarity=0.159 Sum_probs=24.5
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
..+.|+|||||||+|+||+||+.|...
T Consensus 269 ~~~~~~DiwSlG~il~elltg~~Pf~~ 295 (371)
T 3q60_A 269 TFTHALNAWQLGLSIYRVWCLFLPFGL 295 (371)
T ss_dssp ECCHHHHHHHHHHHHHHHHHSSCSTTB
T ss_pred CcCccccHHHHHHHHHHHHhCCCCCCC
Confidence 468999999999999999999999764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.66 E-value=1.5e-05 Score=77.50 Aligned_cols=27 Identities=22% Similarity=0.286 Sum_probs=23.8
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
..+.++|||||||+++||+||+.|...
T Consensus 199 ~~~~~~DiwSlG~il~el~tg~~Pf~~ 225 (396)
T 4eut_A 199 KYGATVDLWSIGVTFYHAATGSLPFRP 225 (396)
T ss_dssp HHHHHHHHHHHHHHHHHHHHSSCSEEC
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 457799999999999999999999754
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=97.66 E-value=1e-05 Score=77.73 Aligned_cols=27 Identities=19% Similarity=0.340 Sum_probs=24.0
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
..+.++|||||||+|+||+||+.|...
T Consensus 281 ~~~~~~Di~slG~il~ell~g~~pf~~ 307 (365)
T 2y7j_A 281 GYGKEVDLWACGVILFTLLAGSPPFWH 307 (365)
T ss_dssp CBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCchhhHHhHHHHHHHHHHCCCCCCC
Confidence 467899999999999999999999653
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=97.65 E-value=7.8e-06 Score=77.63 Aligned_cols=27 Identities=19% Similarity=0.432 Sum_probs=22.9
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
..+.++|||||||+++||+||+.|...
T Consensus 205 ~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (336)
T 3fhr_A 205 KYDKSCDMWSLGVIMYILLCGFPPFYS 231 (336)
T ss_dssp HHHHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred CCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 457899999999999999999999753
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=97.65 E-value=6.4e-06 Score=80.66 Aligned_cols=26 Identities=19% Similarity=0.359 Sum_probs=23.6
Q ss_pred cccccceeehhhhHHHHHhCCCCCCC
Q 012014 4 VSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 4 ~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
.|.|+|||||||+|+||+||+.|...
T Consensus 294 ~~~~~DvwSlGvil~elltg~~Pf~~ 319 (413)
T 3dzo_A 294 MTFAFDTWTLGLAIYWIWCADLPNTD 319 (413)
T ss_dssp ECHHHHHHHHHHHHHHHHHSSCCCCT
T ss_pred CCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 67799999999999999999999753
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=97.65 E-value=1.6e-05 Score=75.71 Aligned_cols=28 Identities=25% Similarity=0.324 Sum_probs=24.8
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
+..+.++|||||||+|+||+||+.|...
T Consensus 214 ~~~~~~~Di~slG~il~el~~g~~pf~~ 241 (355)
T 2eu9_A 214 LGWAQPCDVWSIGCILFEYYRGFTLFQT 241 (355)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 3568899999999999999999999753
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=97.64 E-value=1.7e-05 Score=72.77 Aligned_cols=28 Identities=21% Similarity=0.436 Sum_probs=24.8
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
|..+.++||||||++++||+||+.|...
T Consensus 182 ~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (277)
T 3f3z_A 182 GLYGPECDEWSAGVMMYVLLCGYPPFSA 209 (277)
T ss_dssp TCBCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccCCchhhehhHHHHHHHHHHCCCCCCC
Confidence 4578899999999999999999999753
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=97.63 E-value=1.5e-05 Score=73.72 Aligned_cols=28 Identities=29% Similarity=0.461 Sum_probs=24.7
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
|..+.++||||||++++||+||+.|...
T Consensus 197 ~~~~~~~Di~slG~~l~~l~~g~~p~~~ 224 (287)
T 2wei_A 197 GTYDEKCDVWSAGVILYILLSGTPPFYG 224 (287)
T ss_dssp TCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCCCchhhHhHHHHHHHHHhCCCCCCC
Confidence 4578899999999999999999998653
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=97.63 E-value=1.3e-05 Score=77.70 Aligned_cols=28 Identities=29% Similarity=0.533 Sum_probs=24.5
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
+..+.++|||||||+|+||+||+.|...
T Consensus 225 ~~~~~~~DiwSlG~il~elltg~~Pf~~ 252 (387)
T 1kob_A 225 EPVGFYTDMWAIGVLGYVLLSGLSPFAG 252 (387)
T ss_dssp CCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred CCCCCcccEeeHhHHHHHHHhCCCCCCC
Confidence 3468899999999999999999999653
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=97.63 E-value=1.2e-05 Score=75.64 Aligned_cols=27 Identities=19% Similarity=0.348 Sum_probs=24.2
Q ss_pred CccccccceeehhhhHHHHHhCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
+..+.++|||||||+|+||+||+.|..
T Consensus 193 ~~~~~~~Di~slG~il~~l~~g~~pf~ 219 (321)
T 2a2a_A 193 EPLGLEADMWSIGVITYILLSGASPFL 219 (321)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred CCCCCccccHHHHHHHHHHHHCCCCCC
Confidence 356889999999999999999999965
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=97.63 E-value=9.8e-06 Score=76.08 Aligned_cols=27 Identities=22% Similarity=0.461 Sum_probs=24.0
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
..+.++|||||||+++||+||+.|...
T Consensus 202 ~~~~~~DiwslG~il~~l~~g~~pf~~ 228 (316)
T 2ac3_A 202 IYDKRCDLWSLGVILYILLSGYPPFVG 228 (316)
T ss_dssp HHTTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCcccccHhHHHHHHHHHHCCCCCcc
Confidence 357899999999999999999999754
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=97.62 E-value=1.4e-05 Score=74.99 Aligned_cols=27 Identities=30% Similarity=0.353 Sum_probs=24.3
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
..+.++|||||||+++||+||+.|...
T Consensus 196 ~~~~~~DiwslG~il~~ll~g~~pf~~ 222 (311)
T 3niz_A 196 KYSTSVDIWSIGCIFAEMITGKPLFPG 222 (311)
T ss_dssp SCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCchHHhHHHHHHHHHHHhCCCCCCC
Confidence 468899999999999999999999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00054 Score=63.82 Aligned_cols=75 Identities=11% Similarity=0.090 Sum_probs=56.4
Q ss_pred cceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcC---CCCceeeeeeeeccccCCceeeEEEEE
Q 012014 150 ANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK---HRNIVRVFTAFSGVDYQGARFKAVVYK 226 (473)
Q Consensus 150 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~~~~~lv~e 226 (473)
.+.|+.|....+|+... ++..+++|+.... ....+..|...|+.|. ...+++++.+... ....++|||
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-----~g~~~lvme 111 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNS-----QGHSFLLLE 111 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-----SSEEEEEEE
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-----CCceEEEEE
Confidence 45689999999999874 5778999987532 3566889999988883 3567788777543 235799999
Q ss_pred ecCCCCH
Q 012014 227 FMPNGSL 233 (473)
Q Consensus 227 ~~~~g~L 233 (473)
|+++..+
T Consensus 112 ~l~G~~~ 118 (312)
T 3jr1_A 112 ALNKSKN 118 (312)
T ss_dssp CCCCCCC
T ss_pred eccCCCC
Confidence 9998754
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=97.61 E-value=1.6e-05 Score=76.28 Aligned_cols=26 Identities=23% Similarity=0.354 Sum_probs=23.8
Q ss_pred ccccccceeehhhhHHHHHhCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
..+.++|||||||+|+||+||+.|..
T Consensus 206 ~~~~~~DiwslG~il~~ll~g~~Pf~ 231 (362)
T 2bdw_A 206 PYSKPVDIWACGVILYILLVGYPPFW 231 (362)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 46889999999999999999999965
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=97.61 E-value=1.2e-05 Score=75.98 Aligned_cols=27 Identities=26% Similarity=0.490 Sum_probs=23.7
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
..+.++|||||||+++||+||+.|...
T Consensus 185 ~~~~~~DiwslG~il~~ll~g~~pf~~ 211 (325)
T 3kn6_A 185 GYDESCDLWSLGVILYTMLSGQVPFQS 211 (325)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCTTC-
T ss_pred CCCCccchHHHHHHHHHHHhCCCCCCC
Confidence 467899999999999999999999753
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=97.61 E-value=1.6e-05 Score=76.19 Aligned_cols=28 Identities=32% Similarity=0.428 Sum_probs=24.7
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
+..+.++|||||||+++||+||+.|...
T Consensus 205 ~~~~~~~Di~slG~il~~l~~g~~pf~~ 232 (360)
T 3eqc_A 205 THYSVQSDIWSMGLSLVEMAVGRYPIPP 232 (360)
T ss_dssp CCCSHHHHHHHHHHHHHHHHHTSCCSSC
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 3468899999999999999999999753
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=97.60 E-value=2.9e-05 Score=73.47 Aligned_cols=27 Identities=30% Similarity=0.386 Sum_probs=24.3
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
..+.++|||||||+|+||+||+.|...
T Consensus 210 ~~~~~~Di~slG~il~el~~g~~pf~~ 236 (339)
T 1z57_A 210 GWSQPCDVWSIGCILIEYYLGFTVFPT 236 (339)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 568899999999999999999999753
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=97.60 E-value=8.3e-06 Score=75.10 Aligned_cols=26 Identities=27% Similarity=0.489 Sum_probs=23.6
Q ss_pred ccccccceeehhhhHHHHHhCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
..+.++|||||||+++||+||+.|..
T Consensus 183 ~~~~~~Di~slG~il~~l~~g~~p~~ 208 (279)
T 3fdn_A 183 MHDEKVDLWSLGVLCYEFLVGKPPFE 208 (279)
T ss_dssp CCCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred CCCccchhHhHHHHHHHHHHCCCCCC
Confidence 45789999999999999999999965
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=97.59 E-value=3.3e-05 Score=74.24 Aligned_cols=28 Identities=21% Similarity=0.214 Sum_probs=23.8
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
+..+.++|||||||+|+||+||+.|...
T Consensus 210 ~~~~~~~Di~slG~il~el~~g~~pf~~ 237 (373)
T 1q8y_A 210 APWGCGADIWSTACLIFELITGDFLFEP 237 (373)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred CCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 3468899999999999999999999763
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=97.59 E-value=1.1e-05 Score=75.66 Aligned_cols=28 Identities=39% Similarity=0.600 Sum_probs=24.5
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
+..+.++|||||||+|+||+||+.|...
T Consensus 194 ~~~~~~~Di~slG~~l~~ll~g~~pf~~ 221 (311)
T 3ork_A 194 DSVDARSDVYSLGCVLYEVLTGEPPFTG 221 (311)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 3568899999999999999999999753
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=97.59 E-value=1.7e-05 Score=75.65 Aligned_cols=28 Identities=29% Similarity=0.240 Sum_probs=24.6
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
+..+.++|||||||+|+||+||+.|...
T Consensus 198 ~~~~~~~Di~slG~il~~l~~g~~pf~~ 225 (353)
T 2b9h_A 198 AKYSRAMDVWSCGCILAELFLRRPIFPG 225 (353)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCccchhhHHHHHHHHHHHHhCCCCCCC
Confidence 4578899999999999999999998653
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=97.59 E-value=1.6e-05 Score=75.15 Aligned_cols=27 Identities=19% Similarity=0.133 Sum_probs=24.1
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
..+.++|||||||+|+||+||+.|...
T Consensus 214 ~~~~~~DiwslG~il~ell~g~~pf~~ 240 (329)
T 3gbz_A 214 HYSTSVDIWSIACIWAEMLMKTPLFPG 240 (329)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 368999999999999999999998653
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=97.58 E-value=4.4e-05 Score=70.75 Aligned_cols=27 Identities=26% Similarity=0.364 Sum_probs=24.0
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
..+.++||||||++++||+||+.|...
T Consensus 191 ~~~~~~Di~slG~~l~~l~~g~~p~~~ 217 (294)
T 2rku_A 191 GHSFEVDVWSIGCIMYTLLVGKPPFET 217 (294)
T ss_dssp CBCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 467899999999999999999999753
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=97.57 E-value=2.3e-05 Score=72.91 Aligned_cols=26 Identities=19% Similarity=0.524 Sum_probs=23.6
Q ss_pred ccccccceeehhhhHHHHHhCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
..+.++||||+||+|+||+||+.|+.
T Consensus 210 ~y~~~~DiWSlGvilyeml~G~~PF~ 235 (311)
T 4aw0_A 210 SACKSSDLWALGCIIYQLVAGLPPFR 235 (311)
T ss_dssp CBCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 35789999999999999999999975
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=97.57 E-value=2e-05 Score=74.03 Aligned_cols=27 Identities=33% Similarity=0.343 Sum_probs=24.1
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
..+.++|||||||+++||+||+.|...
T Consensus 185 ~~~~~~DiwslG~il~el~~g~~pf~~ 211 (317)
T 2pmi_A 185 TYSTSIDIWSCGCILAEMITGKPLFPG 211 (317)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 468899999999999999999998753
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=97.57 E-value=2e-05 Score=73.22 Aligned_cols=27 Identities=19% Similarity=0.294 Sum_probs=23.9
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
..+.++||||||++|+||+||+.|...
T Consensus 205 ~~~~~~Di~slG~~l~~l~~g~~p~~~ 231 (298)
T 1phk_A 205 GYGKEVDMWSTGVIMYTLLAGSPPFWH 231 (298)
T ss_dssp CBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCCcccccHhHHHHHHHHHHCCCCCcC
Confidence 467899999999999999999998653
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=97.57 E-value=1.3e-05 Score=77.62 Aligned_cols=27 Identities=33% Similarity=0.449 Sum_probs=24.5
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
..+.++|||||||+|+||+||+.|...
T Consensus 213 ~~~~~~DiwslG~il~el~~g~~pf~~ 239 (389)
T 3gni_B 213 GYDAKSDIYSVGITACELANGHVPFKD 239 (389)
T ss_dssp CBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 578899999999999999999999754
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=97.56 E-value=1.7e-05 Score=73.95 Aligned_cols=27 Identities=22% Similarity=0.341 Sum_probs=24.0
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
..+.++|||||||+++||+||+.|...
T Consensus 183 ~~~~~~Di~slG~il~~l~~g~~pf~~ 209 (304)
T 2jam_A 183 PYSKAVDCWSIGVITYILLCGYPPFYE 209 (304)
T ss_dssp SCCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 467899999999999999999998653
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=97.55 E-value=3.4e-05 Score=73.82 Aligned_cols=27 Identities=22% Similarity=0.282 Sum_probs=24.2
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
..+.++|||||||+|+||+||+.|...
T Consensus 208 ~~~~~~Di~slG~il~ell~g~~pf~~ 234 (360)
T 3e3p_A 208 HYTTAVDIWSVGCIFAEMMLGEPIFRG 234 (360)
T ss_dssp SCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCcCC
Confidence 368999999999999999999998653
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=97.54 E-value=2.2e-05 Score=75.91 Aligned_cols=27 Identities=30% Similarity=0.305 Sum_probs=24.3
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
..+.++|||||||+|+||+||+.|...
T Consensus 234 ~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 234 PYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 578999999999999999999999753
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.54 E-value=1.7e-05 Score=74.43 Aligned_cols=28 Identities=21% Similarity=0.266 Sum_probs=24.7
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
+..+.++|||||||+|+||+||+.|...
T Consensus 200 ~~~~~~~Di~slG~il~el~~g~~pf~~ 227 (320)
T 2i6l_A 200 NNYTKAIDMWAAGCIFAEMLTGKTLFAG 227 (320)
T ss_dssp TCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccCCchhhhHhHHHHHHHHHhCCCCCCC
Confidence 4578899999999999999999999753
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.53 E-value=2.5e-05 Score=77.07 Aligned_cols=26 Identities=19% Similarity=0.314 Sum_probs=23.8
Q ss_pred ccccccceeehhhhHHHHHhCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
..+.++|||||||+|+||+||+.|..
T Consensus 189 ~~~~~~DIwSlGvilyell~G~~Pf~ 214 (444)
T 3soa_A 189 PYGKPVDLWACGVILYILLVGYPPFW 214 (444)
T ss_dssp CBCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCCCccccHHHHHHHHHHHhCCCCCC
Confidence 46889999999999999999999965
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.52 E-value=2.1e-05 Score=72.30 Aligned_cols=27 Identities=26% Similarity=0.437 Sum_probs=21.3
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
..+.++||||||++++||+||+.|...
T Consensus 188 ~~~~~~Di~slG~il~~l~~g~~p~~~ 214 (278)
T 3cok_A 188 AHGLESDVWSLGCMFYTLLIGRPPFDT 214 (278)
T ss_dssp ----CTHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 357899999999999999999999653
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.52 E-value=2.7e-05 Score=72.75 Aligned_cols=28 Identities=21% Similarity=0.211 Sum_probs=24.7
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
+..+.++|||||||+++||+||+.|...
T Consensus 194 ~~~~~~~DiwslG~il~~l~~g~~pf~~ 221 (308)
T 3g33_A 194 STYATPVDMWSVGCIFAEMFRRKPLFCG 221 (308)
T ss_dssp SCCCSTHHHHHHHHHHHHTTTSSCSCCC
T ss_pred CCCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 4568899999999999999999999753
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.52 E-value=3.9e-05 Score=71.83 Aligned_cols=27 Identities=33% Similarity=0.519 Sum_probs=24.1
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
..+.++||||||++++||+||+.|...
T Consensus 201 ~~~~~~Di~slG~il~~l~~g~~p~~~ 227 (314)
T 3com_A 201 GYNCVADIWSLGITAIEMAEGKPPYAD 227 (314)
T ss_dssp CBCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 468899999999999999999998653
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.51 E-value=2.6e-05 Score=73.59 Aligned_cols=27 Identities=26% Similarity=0.254 Sum_probs=24.2
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
..+.++|||||||+++||+||+.|...
T Consensus 177 ~~~~~~DiwslG~il~~l~~g~~pf~~ 203 (324)
T 3mtl_A 177 DYSTQIDMWGVGCIFYEMATGRPLFPG 203 (324)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 468899999999999999999998753
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.50 E-value=2.1e-05 Score=73.63 Aligned_cols=28 Identities=18% Similarity=0.285 Sum_probs=24.5
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
+..+.++|||||||+++||+||+.|...
T Consensus 178 ~~~~~~~Di~slG~il~~l~~g~~p~~~ 205 (311)
T 4agu_A 178 TQYGPPVDVWAIGCVFAELLSGVPLWPG 205 (311)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 3468899999999999999999998653
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=97.50 E-value=3.4e-05 Score=73.96 Aligned_cols=24 Identities=38% Similarity=0.636 Sum_probs=21.0
Q ss_pred cccceeehhhhHHHHHhCCCCCCC
Q 012014 6 SYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 6 ~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
.++|||||||+|+||+||+.|...
T Consensus 197 ~~~DiwslG~il~ell~g~~Pf~~ 220 (361)
T 3uc3_A 197 KIADVWSCGVTLYVMLVGAYPFED 220 (361)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSCC-
T ss_pred CeeeeehhHHHHHHHHhCCCCCCC
Confidence 449999999999999999999754
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=97.50 E-value=3.5e-05 Score=72.52 Aligned_cols=28 Identities=21% Similarity=0.248 Sum_probs=24.6
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
+..+.++|||||||+++||+||+.|...
T Consensus 194 ~~~~~~~Di~slG~il~~l~~g~~pf~~ 221 (326)
T 1blx_A 194 SSYATPVDLWSVGCIFAEMFRRKPLFRG 221 (326)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCCcchhHHHHHHHHHHHHcCCCCCCC
Confidence 4568899999999999999999998653
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=97.49 E-value=3.1e-05 Score=74.04 Aligned_cols=26 Identities=31% Similarity=0.484 Sum_probs=23.0
Q ss_pred cccccceeehhhhHHHHHhCCCCCCC
Q 012014 4 VSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 4 ~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
.+.++|||||||+|+||+||+.|...
T Consensus 239 ~~~~~DvwslG~il~ell~g~~pf~~ 264 (355)
T 1vzo_A 239 HDKAVDWWSLGVLMYELLTGASPFTV 264 (355)
T ss_dssp -CTHHHHHHHHHHHHHHHHSSCTTSC
T ss_pred CCchhhHHHHHHHHHHHHHCCCCCcc
Confidence 57899999999999999999999753
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=97.49 E-value=2.2e-05 Score=73.00 Aligned_cols=20 Identities=30% Similarity=0.590 Sum_probs=18.6
Q ss_pred ccccccceeehhhhHHHHHh
Q 012014 3 YVSSYGDVYSFGILLLEMFT 22 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~t 22 (473)
..+.|+|||||||+|+||++
T Consensus 206 ~y~~~~DiwSlGvilyell~ 225 (299)
T 4g31_A 206 SYSHKVDIFSLGLILFELLY 225 (299)
T ss_dssp CCCTHHHHHHHHHHHHHHHS
T ss_pred CCCCHHHHHHHHHHHHHHcc
Confidence 46899999999999999997
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=97.49 E-value=3.3e-05 Score=71.54 Aligned_cols=25 Identities=28% Similarity=0.283 Sum_probs=22.9
Q ss_pred cccccceeehhhhHHHHHhCCCCCC
Q 012014 4 VSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 4 ~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
.+.++|||||||+++||+||+.|..
T Consensus 179 ~~~~~DiwslG~il~~l~~~~~p~~ 203 (292)
T 3o0g_A 179 YSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp CCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred cCchHHHHHHHHHHHHHHHcCCCCc
Confidence 6899999999999999999999854
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=97.48 E-value=2.6e-05 Score=72.09 Aligned_cols=27 Identities=26% Similarity=0.302 Sum_probs=24.2
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
..+.++|||||||+++||+||+.|...
T Consensus 177 ~~~~~~DiwslG~il~~l~~g~~pf~~ 203 (288)
T 1ob3_A 177 KYSTTIDIWSVGCIFAEMVNGTPLFPG 203 (288)
T ss_dssp SCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 468899999999999999999998753
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=97.48 E-value=1.6e-05 Score=75.96 Aligned_cols=27 Identities=19% Similarity=0.176 Sum_probs=24.0
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
..+.++|||||||+++||+||+.|...
T Consensus 205 ~~~~~~DiwslG~il~ell~g~~pf~~ 231 (351)
T 3mi9_A 205 DYGPPIDLWGAGCIMAEMWTRSPIMQG 231 (351)
T ss_dssp SCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCcHhHHHHHHHHHHHHHhCCCCCCC
Confidence 368899999999999999999998653
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.48 E-value=0.001 Score=62.76 Aligned_cols=147 Identities=10% Similarity=0.031 Sum_probs=73.2
Q ss_pred ceeecCCCeE-EEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCC--CCceeeeeeeeccccCCceeeEEEEEe
Q 012014 151 NLIGAGNFGS-VYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKH--RNIVRVFTAFSGVDYQGARFKAVVYKF 227 (473)
Q Consensus 151 ~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~e~ 227 (473)
+.|+.|+... +|+....++..+++|..... ....+..|+.++..+.. -.+.+++.+.. . . .+++||+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~---~~~~~~~e~~~l~~L~~~g~~vP~v~~~d~----~-~--g~ll~e~ 93 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPE---EGGDTQPFVDLAQYLRNLDISAPEIYAEEH----A-R--GLLLIED 93 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTT---TTCCSHHHHHHHHHHHHTTCBCCCEEEEET----T-T--TEEEECC
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCC---CCccccHHHHHHHHHHhCCCCCCceeeecC----C-C--CEEEEee
Confidence 3465565544 66776434677888764322 11445677777777642 23556665421 1 1 1689999
Q ss_pred cCCCCHHHHhcCCCC---------------------CCCCCcchhhcH------H-----HHH-----HHHHHHHHHHHH
Q 012014 228 MPNGSLEEWLRGKDD---------------------TNWRPLNFNFLI------K-----KKL-----DIAIDVACALRY 270 (473)
Q Consensus 228 ~~~g~L~~~l~~~~~---------------------~~~~~~~~~~~~------~-----~~~-----~i~~~i~~~L~~ 270 (473)
+.+.++.+++..... ............ . ..+ .....+...+..
T Consensus 94 l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~ 173 (333)
T 3csv_A 94 LGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQ 173 (333)
T ss_dssp CCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHH
T ss_pred CCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence 977777655432110 000000000000 0 000 000011112222
Q ss_pred Hh---hCCCCCeeeccCCCCcEEecCC----ccEEEeecccccc
Q 012014 271 LH---CDCQPPIAHCNLKPSNVLLDDE----MIGHVGDFGMARF 307 (473)
Q Consensus 271 LH---~~~~~~iiH~Dlkp~Nil~~~~----~~~kl~Dfg~~~~ 307 (473)
+. ......++|+|+.+.||+++.+ +.+.|+||+.+..
T Consensus 174 l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 174 ILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred HHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 21 1115689999999999999874 6889999998864
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=97.47 E-value=6e-06 Score=78.21 Aligned_cols=27 Identities=30% Similarity=0.338 Sum_probs=24.0
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
..+.++|||||||+++||+||+.|...
T Consensus 201 ~~~~~~Di~slG~il~~l~~g~~pf~~ 227 (331)
T 4aaa_A 201 KYGKAVDVWAIGCLVTEMFMGEPLFPG 227 (331)
T ss_dssp TCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CcchHHHHHHHHHHHHHHHhCCCCCCC
Confidence 468899999999999999999998653
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=97.47 E-value=1.7e-05 Score=75.19 Aligned_cols=25 Identities=44% Similarity=0.604 Sum_probs=22.9
Q ss_pred ccccceeehhhhHHHHHhCCCCCCC
Q 012014 5 SSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 5 t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
+.++|||||||+|+||+||+.|.+.
T Consensus 186 ~~~~DiwslG~il~~ll~g~~Pf~~ 210 (336)
T 3h4j_B 186 GPEVDVWSCGIVLYVMLVGRLPFDD 210 (336)
T ss_dssp CHHHHHHHHHHHHHHHHHSSCSSBC
T ss_pred CCccchhHHHHHHHHHHhCCCCCCC
Confidence 6789999999999999999999763
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.46 E-value=3.6e-05 Score=71.73 Aligned_cols=25 Identities=32% Similarity=0.469 Sum_probs=22.7
Q ss_pred cccccceeehhhhHHHHHhCCCCCC
Q 012014 4 VSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 4 ~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
.+.++|||||||+++||+||+.|..
T Consensus 190 ~~~~~Di~slG~il~~l~~g~~p~~ 214 (305)
T 2wtk_C 190 SGFKVDIWSAGVTLYNITTGLYPFE 214 (305)
T ss_dssp ESHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CcchhhHHHHHHHHHHHHhCCCCCC
Confidence 3679999999999999999999965
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=97.46 E-value=6.8e-05 Score=69.05 Aligned_cols=28 Identities=25% Similarity=0.433 Sum_probs=24.6
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
+..+.++||||||++++||+||+.|.+.
T Consensus 187 ~~~~~~~Di~slG~il~~l~~g~~pf~~ 214 (284)
T 2vgo_A 187 KTHDEKVDLWCAGVLCYEFLVGMPPFDS 214 (284)
T ss_dssp CCBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCCCcccchhhHHHHHHHHHHCCCCCCC
Confidence 3468899999999999999999999753
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=97.46 E-value=2.3e-05 Score=74.84 Aligned_cols=27 Identities=22% Similarity=0.353 Sum_probs=24.1
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
..+.++|||||||+|+||+||+.|...
T Consensus 209 ~~~~~~DiwslG~il~~ll~g~~pf~~ 235 (351)
T 3c0i_A 209 PYGKPVDVWGCGVILFILLSGCLPFYG 235 (351)
T ss_dssp CBCTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred CCCchHhhHHHHHHHHHHHHCCCCCCC
Confidence 468899999999999999999999653
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=97.46 E-value=3.6e-05 Score=70.55 Aligned_cols=25 Identities=32% Similarity=0.612 Sum_probs=22.7
Q ss_pred ccccceeehhhhHHHHHhCCCCCCC
Q 012014 5 SSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 5 t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
+.++||||||++++||+||+.|.+.
T Consensus 189 ~~~~Di~slG~~l~~l~~g~~p~~~ 213 (276)
T 2h6d_A 189 GPEVDIWSCGVILYALLCGTLPFDD 213 (276)
T ss_dssp HHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CccchHHHHHHHHHHHHhCCCCCCC
Confidence 6799999999999999999998653
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=97.45 E-value=2.8e-05 Score=76.49 Aligned_cols=27 Identities=26% Similarity=0.314 Sum_probs=24.1
Q ss_pred CccccccceeehhhhHHHHHhCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
+..+.++|||||||+|+||+||+.|..
T Consensus 274 ~~~~~~~DiwSlG~il~elltG~~pf~ 300 (429)
T 3kvw_A 274 ARYGMPIDMWSLGCILAELLTGYPLLP 300 (429)
T ss_dssp BCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCCchHHHHhHHHHHHHHHhCCCCCC
Confidence 357899999999999999999998865
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.45 E-value=4.6e-05 Score=74.96 Aligned_cols=26 Identities=19% Similarity=0.314 Sum_probs=22.5
Q ss_pred ccccccceeehhhhHHHHHh-CCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFT-GLRPND 28 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~t-g~~~~~ 28 (473)
..|.++|||||||+|+||+| |+.|..
T Consensus 205 ~~t~~~DiwSlG~il~ellt~g~~pf~ 231 (432)
T 3p23_A 205 NPTYTVDIFSAGCVFYYVISEGSHPFG 231 (432)
T ss_dssp CCCTHHHHHHHHHHHHHHHTTSCBTTB
T ss_pred CCCcHHHHHHHHHHHHHHHcCCCCCcc
Confidence 45679999999999999999 887764
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=97.45 E-value=5.1e-05 Score=71.88 Aligned_cols=27 Identities=26% Similarity=0.364 Sum_probs=23.9
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
..+.++|||||||+|+||+||+.|...
T Consensus 217 ~~~~~~Di~slG~il~~l~~g~~pf~~ 243 (335)
T 2owb_A 217 GHSFEVDVWSIGCIMYTLLVGKPPFET 243 (335)
T ss_dssp CBCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCCchhhHHHHHHHHHHHHHCcCCCCC
Confidence 467899999999999999999999753
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=97.45 E-value=3.5e-05 Score=77.08 Aligned_cols=28 Identities=29% Similarity=0.519 Sum_probs=24.8
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
|..+.++|||||||+++||+||+.|...
T Consensus 202 ~~~~~~~DiwslG~il~~ll~g~~pf~~ 229 (484)
T 3nyv_A 202 GTYDEKCDVWSTGVILYILLSGCPPFNG 229 (484)
T ss_dssp TCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCCCcceeHHHHHHHHHHHHCCCCCCC
Confidence 4578899999999999999999999653
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.44 E-value=0.00014 Score=70.72 Aligned_cols=26 Identities=15% Similarity=0.220 Sum_probs=23.8
Q ss_pred ccccccceeehhhhHHHHHhCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
..+.++|||||||+|+||+||+.|..
T Consensus 212 ~~~~~~DiwSlG~il~ell~g~~pf~ 237 (405)
T 3rgf_A 212 HYTKAIDIWAIGCIFAELLTSEPIFH 237 (405)
T ss_dssp SCCHHHHHHHHHHHHHHHHHSSCTTC
T ss_pred cccchhhhHHHHHHHHHHHhCCCCCC
Confidence 47889999999999999999999975
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=97.44 E-value=2.6e-05 Score=74.17 Aligned_cols=26 Identities=35% Similarity=0.662 Sum_probs=23.3
Q ss_pred cccccceeehhhhHHHHHhCCCCCCC
Q 012014 4 VSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 4 ~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
.+.++|||||||+|+||+||+.|...
T Consensus 197 ~~~~~DiwslG~il~ell~g~~Pf~~ 222 (342)
T 2qr7_A 197 YDAACDIWSLGVLLYTMLTGYTPFAN 222 (342)
T ss_dssp HHHHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred CCCccCeeeHhHHHHHHhcCCCCCCC
Confidence 46789999999999999999999763
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=97.43 E-value=2.8e-05 Score=74.40 Aligned_cols=26 Identities=23% Similarity=0.448 Sum_probs=23.5
Q ss_pred cccccceeehhhhHHHHHhCCCCCCC
Q 012014 4 VSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 4 ~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
.+.++||||+||+|+||+||+.|...
T Consensus 224 y~~~~DiWSlG~il~ell~G~~Pf~~ 249 (361)
T 4f9c_A 224 QTTAIDMWSAGVIFLSLLSGRYPFYK 249 (361)
T ss_dssp CCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CCCccchhhhHHHHHHHHHCCCCCCC
Confidence 67889999999999999999999753
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=97.43 E-value=3.3e-05 Score=72.87 Aligned_cols=24 Identities=25% Similarity=0.531 Sum_probs=21.6
Q ss_pred ccccccceeehhhhHHHHHhCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRP 26 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~ 26 (473)
..+.++|||||||+++||+||..|
T Consensus 252 ~~~~~~Di~slG~il~el~~~~~~ 275 (332)
T 3qd2_B 252 NYSHKVDIFSLGLILFELLYSFST 275 (332)
T ss_dssp CCCTHHHHHHHHHHHHHHHSCCCC
T ss_pred CCcchhhHHHHHHHHHHHHHcCCC
Confidence 568899999999999999999665
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=97.42 E-value=3e-05 Score=71.41 Aligned_cols=25 Identities=4% Similarity=0.014 Sum_probs=21.7
Q ss_pred ccccccceeehhhhHHHHHhCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPN 27 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~ 27 (473)
..+.++|||||||+++||+||+.+.
T Consensus 207 ~~~~~~Di~slG~il~~l~~~~~~~ 231 (289)
T 1x8b_A 207 THLPKADIFALALTVVCAAGAEPLP 231 (289)
T ss_dssp TTHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred CCCchhhHHHHHHHHHHHhcCCCCC
Confidence 3457999999999999999998764
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.42 E-value=3.9e-05 Score=72.71 Aligned_cols=25 Identities=16% Similarity=0.268 Sum_probs=22.7
Q ss_pred ccccceeehhhhHHHHHhCCCCCCC
Q 012014 5 SSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 5 t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
+.++|||||||+++||+||+.|...
T Consensus 208 ~~~~DiwslG~il~el~~g~~pf~~ 232 (335)
T 3dls_A 208 GPELEMWSLGVTLYTLVFEENPFCE 232 (335)
T ss_dssp SHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred CCcccchhHHHHHHHHHhCCCchhh
Confidence 7789999999999999999999653
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.41 E-value=8.6e-05 Score=71.68 Aligned_cols=26 Identities=31% Similarity=0.392 Sum_probs=23.7
Q ss_pred cccccceeehhhhHHHHHhCCCCCCC
Q 012014 4 VSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 4 ~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
.+.++|||||||+|+||+||+.|...
T Consensus 194 ~~~~~DiwSlG~il~elltG~~Pf~~ 219 (384)
T 4fr4_A 194 YSFAVDWWSLGVTAYELLRGRRPYHI 219 (384)
T ss_dssp BCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCccceeechHHHHHHHHhCCCCCCC
Confidence 68899999999999999999999753
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00016 Score=70.01 Aligned_cols=26 Identities=23% Similarity=0.222 Sum_probs=23.7
Q ss_pred ccccccceeehhhhHHHHHhCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
..|.++|||||||+|+||+||+.|..
T Consensus 207 ~~~~~~DiwSlG~il~ell~g~~pf~ 232 (388)
T 3oz6_A 207 KYTKGIDMWSLGCILGEILCGKPIFP 232 (388)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCCChhhHHHHHHHHHHHHhCCCCCC
Confidence 56889999999999999999999864
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=97.41 E-value=3e-05 Score=72.02 Aligned_cols=26 Identities=38% Similarity=0.630 Sum_probs=23.9
Q ss_pred ccccccceeehhhhHHHHHhCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
..+.++|||||||+|+||+||+.|..
T Consensus 202 ~y~~~~DiwSlGvilyemltG~~PF~ 227 (304)
T 3ubd_A 202 GHTQSADWWSFGVLMFEMLTGTLPFQ 227 (304)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCCCCcccchHHHHHHHHhCCCCCC
Confidence 46889999999999999999999975
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=97.40 E-value=3.2e-05 Score=74.11 Aligned_cols=28 Identities=21% Similarity=0.223 Sum_probs=24.7
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
+..+.++|||||||+++||+||+.|...
T Consensus 209 ~~~~~~~DiwslG~il~~l~~g~~pf~~ 236 (362)
T 3pg1_A 209 KGFTKLVDMWSAGCVMAEMFNRKALFRG 236 (362)
T ss_dssp TTCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCCcHhHHHhHHHHHHHHHhCCCCCCC
Confidence 3578899999999999999999999753
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=97.40 E-value=3.3e-05 Score=74.00 Aligned_cols=26 Identities=19% Similarity=0.372 Sum_probs=23.8
Q ss_pred ccccccceeehhhhHHHHHhCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
..+.++|||||||+++||+||+.|..
T Consensus 194 ~~~~~~DiwslGvil~~ll~g~~Pf~ 219 (361)
T 2yab_A 194 PLGLEADMWSIGVITYILLSGASPFL 219 (361)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred CCCccccHHHHHHHHHHHHhCCCCCC
Confidence 46889999999999999999999965
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=97.40 E-value=4.2e-05 Score=72.29 Aligned_cols=25 Identities=32% Similarity=0.582 Sum_probs=22.5
Q ss_pred ccccceeehhhhHHHHHhCCCCCCC
Q 012014 5 SSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 5 t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
+.++|||||||+|+||+||+.|.+.
T Consensus 192 ~~~~DiwslG~il~ell~g~~pf~~ 216 (328)
T 3fe3_A 192 GPEVDVWSLGVILYTLVSGSLPFDG 216 (328)
T ss_dssp SHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CchhhhhhhHHHHHHHHhCCCCCCC
Confidence 4789999999999999999999753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.39 E-value=0.00038 Score=68.15 Aligned_cols=72 Identities=14% Similarity=0.225 Sum_probs=49.2
Q ss_pred cceeecCCCeEEEEEEecC--------CCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCC-ceeeeeeeeccccCCcee
Q 012014 150 ANLIGAGNFGSVYNGTLFD--------GTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRN-IVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 150 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~~~~ 220 (473)
.+.|+.|....+|++...+ +..+++|+.... .....+.+|..++..+...+ .+++++.+.+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~-------- 147 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG-------- 147 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT--------
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC--------
Confidence 4568888889999998543 578999987421 12256778999998885333 3667765421
Q ss_pred eEEEEEecCCCC
Q 012014 221 KAVVYKFMPNGS 232 (473)
Q Consensus 221 ~~lv~e~~~~g~ 232 (473)
.+|+||++|.+
T Consensus 148 -g~v~e~l~G~~ 158 (429)
T 1nw1_A 148 -GRLEEYIPSRP 158 (429)
T ss_dssp -EEEECCCCEEE
T ss_pred -CEEEEEeCCcc
Confidence 38999997633
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=97.36 E-value=5.1e-05 Score=74.35 Aligned_cols=26 Identities=31% Similarity=0.263 Sum_probs=23.8
Q ss_pred ccccccceeehhhhHHHHHhCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
..+.++|||||||+|+||+||+.|..
T Consensus 233 ~~~~~~DiwSlG~il~ell~G~~pf~ 258 (420)
T 1j1b_A 233 DYTSSIDVWSAGCVLAELLLGQPIFP 258 (420)
T ss_dssp SCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCchhhhHHHHHHHHHHHhCCCCCC
Confidence 47889999999999999999999865
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00015 Score=70.20 Aligned_cols=26 Identities=19% Similarity=0.165 Sum_probs=23.6
Q ss_pred ccccccceeehhhhHHHHHhCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
..+.++||||+||+|+||+||+.|+.
T Consensus 239 ~~~~~~DiWSlG~il~ell~G~~pF~ 264 (398)
T 4b99_A 239 EYTQAIDLWSVGCIFGEMLARRQLFP 264 (398)
T ss_dssp CCCTHHHHHHHHHHHHHHHHTSCSSC
T ss_pred CCCChhheehhHHHHHHHHHCCCCCC
Confidence 46889999999999999999999964
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=97.34 E-value=4.7e-05 Score=71.60 Aligned_cols=24 Identities=38% Similarity=0.595 Sum_probs=22.1
Q ss_pred ccccceeehhhhHHHHHhCCCCCC
Q 012014 5 SSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 5 t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
+.++|||||||+++||+||+.|..
T Consensus 227 ~~~~Di~slG~il~el~~g~~pf~ 250 (320)
T 3a99_A 227 GRSAAVWSLGILLYDMVCGDIPFE 250 (320)
T ss_dssp HHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CccchHHhHHHHHHHHHHCCCCCC
Confidence 678999999999999999999864
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=97.34 E-value=4.4e-05 Score=73.46 Aligned_cols=28 Identities=25% Similarity=0.300 Sum_probs=24.8
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
...+.++|||||||+|+||+||+.|...
T Consensus 217 ~~~~~~~DiwslG~il~el~~g~~pf~~ 244 (371)
T 4exu_A 217 MHYNQTVDIWSVGCIMAEMLTGKTLFKG 244 (371)
T ss_dssp SCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCCcHHhHHHHHHHHHHHHhCCCCCCC
Confidence 3578899999999999999999999753
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=97.34 E-value=5.3e-05 Score=75.98 Aligned_cols=28 Identities=25% Similarity=0.469 Sum_probs=24.8
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
+..+.++|||||||+|+||+||+.|...
T Consensus 212 ~~~~~~~DiwslG~il~~ll~g~~pf~~ 239 (494)
T 3lij_A 212 KKYDEKCDVWSIGVILFILLAGYPPFGG 239 (494)
T ss_dssp TCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ccCCCchhHHHHHHHHHHHHhCCCCCCC
Confidence 4578899999999999999999999653
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=97.34 E-value=4.1e-05 Score=71.07 Aligned_cols=26 Identities=27% Similarity=0.296 Sum_probs=23.6
Q ss_pred cccccceeehhhhHHHHHhCCCCCCC
Q 012014 4 VSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 4 ~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
.+.++|||||||+++||+||+.|...
T Consensus 181 ~~~~~Di~slG~~l~~l~~g~~pf~~ 206 (299)
T 2r3i_A 181 YSTAVDIWSLGCIFAEMVTRRALFPG 206 (299)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 68899999999999999999998653
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.33 E-value=0.001 Score=65.56 Aligned_cols=74 Identities=14% Similarity=0.201 Sum_probs=47.6
Q ss_pred cceeecCCCeEEEEEEecC-CCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCc-eeeeeeeeccccCCceeeEEEEEe
Q 012014 150 ANLIGAGNFGSVYNGTLFD-GTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNI-VRVFTAFSGVDYQGARFKAVVYKF 227 (473)
Q Consensus 150 ~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~e~ 227 (473)
.+.|+.|-...+|+....+ +..+++|+..... ...-...+|..++..|...++ .++++.+. + .+||||
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~-----~----G~v~e~ 182 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT-----N----GRIEEF 182 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET-----T----EEEEEC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC-----C----eEEEEe
Confidence 4568888889999998654 4788999874322 112223689999998864444 56776652 1 359999
Q ss_pred cCCCCH
Q 012014 228 MPNGSL 233 (473)
Q Consensus 228 ~~~g~L 233 (473)
++|.+|
T Consensus 183 I~G~~l 188 (458)
T 2qg7_A 183 MDGYAL 188 (458)
T ss_dssp CCSEEC
T ss_pred eCCccC
Confidence 987443
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=97.33 E-value=6e-05 Score=75.37 Aligned_cols=27 Identities=30% Similarity=0.476 Sum_probs=24.3
Q ss_pred CccccccceeehhhhHHHHHhCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
|..+.++|||||||+|+||+||+.|..
T Consensus 197 ~~~~~~~DiwslG~il~~ll~g~~pf~ 223 (486)
T 3mwu_A 197 GTYDEKCDVWSAGVILYILLSGTPPFY 223 (486)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 456889999999999999999999965
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=97.31 E-value=5.5e-05 Score=73.44 Aligned_cols=26 Identities=19% Similarity=0.276 Sum_probs=23.8
Q ss_pred ccccccceeehhhhHHHHHhCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
..|.++|||||||+|+||+||+.|..
T Consensus 218 ~~~~~~DiwSlG~il~ell~g~~pf~ 243 (394)
T 4e7w_A 218 NYTTNIDIWSTGCVMAELMQGQPLFP 243 (394)
T ss_dssp SCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 46889999999999999999999865
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=97.30 E-value=4.6e-05 Score=73.71 Aligned_cols=27 Identities=19% Similarity=0.191 Sum_probs=24.1
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
..|.++|||||||+++||+||+.|...
T Consensus 218 ~~~~~~DiwslG~il~ell~g~~pf~~ 244 (383)
T 3eb0_A 218 EYTPSIDLWSIGCVFGELILGKPLFSG 244 (383)
T ss_dssp SCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCcchhhhhHHHHHHHHHhCCCCCCC
Confidence 468999999999999999999998653
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=97.29 E-value=6.2e-05 Score=72.19 Aligned_cols=26 Identities=23% Similarity=0.281 Sum_probs=23.6
Q ss_pred cccccceeehhhhHHHHHhCCCCCCC
Q 012014 4 VSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 4 ~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
.+.++|||||||+|+||+||+.|...
T Consensus 209 ~~~~~DiwslG~il~ell~g~~pf~~ 234 (364)
T 3qyz_A 209 YTKSIDIWSVGCILAEMLSNRPIFPG 234 (364)
T ss_dssp CSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCcchhHHHHHHHHHHHHHCCCCCCC
Confidence 68899999999999999999998753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.29 E-value=0.0018 Score=60.82 Aligned_cols=79 Identities=14% Similarity=0.115 Sum_probs=49.1
Q ss_pred ceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCC--Cceeeeeeeecccc-CCceeeEEEEEe
Q 012014 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHR--NIVRVFTAFSGVDY-QGARFKAVVYKF 227 (473)
Q Consensus 151 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~~~~-~~~~~~~lv~e~ 227 (473)
..|+ |....||+....+|+.+++|...... .....+..|..++..+... .+++++.. .+... ......+++|+|
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~-~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAF-NGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCB-TTBSCEEETTEEEEEEEC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeec-CCcEEEEECCEEEEEEEe
Confidence 3466 78889998876667789999986321 2345677888888887422 24444443 11100 012345789999
Q ss_pred cCCCC
Q 012014 228 MPNGS 232 (473)
Q Consensus 228 ~~~g~ 232 (473)
++|.+
T Consensus 109 i~G~~ 113 (328)
T 1zyl_A 109 VGGRQ 113 (328)
T ss_dssp CCCEE
T ss_pred cCCCC
Confidence 98743
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.28 E-value=0.0019 Score=60.49 Aligned_cols=154 Identities=12% Similarity=0.058 Sum_probs=79.6
Q ss_pred cceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCC--ceeeeeeeecccc-CCceeeEEEEE
Q 012014 150 ANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRN--IVRVFTAFSGVDY-QGARFKAVVYK 226 (473)
Q Consensus 150 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~-~~~~~~~lv~e 226 (473)
.+.|+.|....+|+....++ .+++|+.... .....+..|..++..+...+ +.+++....+... ......+++|+
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~ 103 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS 103 (322)
T ss_dssp EEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred eeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence 34577788899999986555 6889987642 23456778888888774222 3344322100000 00124589999
Q ss_pred ecCCCCHHH--------------HhcCC-CCCCCCC-cchh-hcHHHHHH------------HHHHHHHHHHHHhh----
Q 012014 227 FMPNGSLEE--------------WLRGK-DDTNWRP-LNFN-FLIKKKLD------------IAIDVACALRYLHC---- 273 (473)
Q Consensus 227 ~~~~g~L~~--------------~l~~~-~~~~~~~-~~~~-~~~~~~~~------------i~~~i~~~L~~LH~---- 273 (473)
|++|..+.. .++.. ....... .... ..|..... +...+...+.+++.
T Consensus 104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~ 183 (322)
T 2ppq_A 104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 183 (322)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence 998754210 01110 0000000 0000 11211000 01123344455542
Q ss_pred CCCCCeeeccCCCCcEEecCCccEEEeeccccc
Q 012014 274 DCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMAR 306 (473)
Q Consensus 274 ~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~ 306 (473)
....+++|+|+.+.||+++++..+.|+||+.+.
T Consensus 184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 113579999999999999987666899998775
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=97.27 E-value=7.9e-05 Score=75.91 Aligned_cols=26 Identities=35% Similarity=0.621 Sum_probs=23.5
Q ss_pred ccccccceeehhhhHHHHHhCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
..+.++||||+||+|+||+||+.|+.
T Consensus 332 ~y~~~~DiWSlGvilyeml~G~~Pf~ 357 (573)
T 3uto_A 332 PVGYYTDMWSVGVLSYILLSGLSPFG 357 (573)
T ss_dssp CBCHHHHHHHHHHHHHHHHHSCCSSC
T ss_pred CCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 35789999999999999999999975
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=97.27 E-value=0.00024 Score=68.22 Aligned_cols=26 Identities=23% Similarity=0.188 Sum_probs=23.6
Q ss_pred ccccccceeehhhhHHHHHhCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
..+.++|||||||+|+||+||+.|..
T Consensus 202 ~~~~~~DiwslG~il~el~~g~~pf~ 227 (371)
T 2xrw_A 202 GYKENVDIWSVGCIMGEMIKGGVLFP 227 (371)
T ss_dssp CCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCchHhHHHHHHHHHHHHhCCCCCC
Confidence 46889999999999999999999865
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=97.27 E-value=0.00012 Score=70.23 Aligned_cols=27 Identities=22% Similarity=0.276 Sum_probs=24.2
Q ss_pred CccccccceeehhhhHHHHHhCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
+..+.++|||||||+++||+||+.|..
T Consensus 205 ~~~~~~~DiwslG~il~ell~g~~pf~ 231 (367)
T 2fst_X 205 MHYNQTVDIWSVGCIMAELLTGRTLFP 231 (367)
T ss_dssp CSCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred cCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 357889999999999999999999865
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=97.26 E-value=7.4e-05 Score=71.04 Aligned_cols=26 Identities=31% Similarity=0.420 Sum_probs=22.7
Q ss_pred ccc-ccceeehhhhHHHHHhCCCCCCC
Q 012014 4 VSS-YGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 4 ~t~-ksDVySfGVvllEl~tg~~~~~~ 29 (473)
.+. ++|||||||+++||+||+.|...
T Consensus 228 ~~~~~~Di~slG~il~~l~~g~~pf~~ 254 (348)
T 2pml_X 228 YNGAKVDIWSLGICLYVMFYNVVPFSL 254 (348)
T ss_dssp EEHHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCcchhhHHHHHHHHHHHHhCCCCCCC
Confidence 344 99999999999999999999764
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=97.26 E-value=5.8e-05 Score=75.86 Aligned_cols=28 Identities=21% Similarity=0.401 Sum_probs=24.8
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
+..+.++|||||||+++||+||+.|...
T Consensus 222 ~~~~~~~DiwslG~il~~ll~g~~pf~~ 249 (504)
T 3q5i_A 222 KKYNEKCDVWSCGVIMYILLCGYPPFGG 249 (504)
T ss_dssp TCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cCCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 4578899999999999999999999753
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=97.24 E-value=8.4e-05 Score=70.73 Aligned_cols=25 Identities=16% Similarity=0.178 Sum_probs=22.6
Q ss_pred cccccceeehhhhHHHHHhCCCCCC
Q 012014 4 VSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 4 ~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
.+.++|||||||+|+||+||+.|..
T Consensus 190 ~~~~~DiwslG~il~ell~g~~~~~ 214 (346)
T 1ua2_A 190 YGVGVDMWAVGCILAELLLRVPFLP 214 (346)
T ss_dssp CCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCchhhhHhHHHHHHHHHHCCCCCC
Confidence 6789999999999999999988754
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=97.19 E-value=0.00015 Score=71.70 Aligned_cols=27 Identities=22% Similarity=0.335 Sum_probs=24.4
Q ss_pred CccccccceeehhhhHHHHHhCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
+..+.++|||||||+|+||+||+.|..
T Consensus 324 ~~~~~~~DiwslG~il~ell~g~~Pf~ 350 (446)
T 4ejn_A 324 NDYGRAVDWWGLGVVMYEMMCGRLPFY 350 (446)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCCCccchhhhHHHHHHHhhCCCCCC
Confidence 456889999999999999999999975
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.19 E-value=5.9e-05 Score=70.53 Aligned_cols=24 Identities=38% Similarity=0.566 Sum_probs=21.7
Q ss_pred ccccceeehhhhHHHHHhCCCCCC
Q 012014 5 SSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 5 t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
+.++|||||||+++||+||+.|..
T Consensus 217 ~~~~Di~slG~il~~l~~g~~pf~ 240 (312)
T 2iwi_A 217 ALPATVWSLGILLYDMVCGDIPFE 240 (312)
T ss_dssp HHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CccchHHHHHHHHHHHHHCCCCCC
Confidence 458999999999999999999864
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.19 E-value=0.00021 Score=68.15 Aligned_cols=28 Identities=25% Similarity=0.300 Sum_probs=24.6
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
+..+.++|||||||+++||+||+.|...
T Consensus 199 ~~~~~~~Di~slG~il~el~~g~~pf~~ 226 (353)
T 3coi_A 199 MHYNQTVDIWSVGCIMAEMLTGKTLFKG 226 (353)
T ss_dssp SCCCTTHHHHHHHHHHHHHHHSSCSSBS
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 3568899999999999999999998653
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=97.16 E-value=0.00012 Score=72.66 Aligned_cols=26 Identities=19% Similarity=0.095 Sum_probs=23.6
Q ss_pred ccccccceeehhhhHHHHHhCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
..+.++|||||||+|+||+||+.|..
T Consensus 239 ~~~~~~DiwSlG~il~ell~g~~pF~ 264 (464)
T 3ttj_A 239 GYKENVDIWSVGCIMGEMVRHKILFP 264 (464)
T ss_dssp CCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCHHHHHHHHHHHHHHHHhCCCCCC
Confidence 46789999999999999999999864
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 473 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-50 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-06 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-42 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 0.002 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-42 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-05 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-41 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 0.002 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-41 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-40 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-40 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-40 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-39 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 0.003 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-38 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 0.004 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-38 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 0.001 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-37 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-37 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-37 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-04 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-37 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-36 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-36 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-36 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-36 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-35 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-35 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-35 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-35 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-35 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-34 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-34 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-34 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-34 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 0.003 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-33 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-33 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-32 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-32 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-31 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-30 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-30 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-29 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-29 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 8e-29 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-28 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-28 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-28 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-28 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-27 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-27 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-27 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-27 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 0.003 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-27 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-26 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-26 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-26 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-25 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-24 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-24 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-24 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-23 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-23 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-22 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-22 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-22 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 9e-22 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-21 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-21 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-15 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (433), Expect = 2e-50
Identities = 73/311 (23%), Positives = 122/311 (39%), Gaps = 55/311 (17%)
Query: 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNL--IRPGGSKSFKSECKAAINIKHRNIVRVFT 208
IG+G+FG+VY G +AVK+ N+ P ++FK+E +H NI+
Sbjct: 14 QRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM- 70
Query: 209 AFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACAL 268
Y A A+V ++ SL L + F + K +DIA A +
Sbjct: 71 -----GYSTAPQLAIVTQWCEGSSLYHHLHIIET--------KFEMIKLIDIARQTAQGM 117
Query: 269 RYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIP 328
YLH I H +LK +N+ L +++ +GDFG+A ++F + GS ++
Sbjct: 118 DYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174
Query: 329 PEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEV 385
PE + + Y DVY+FGI+L E+ TG P I + + L +V
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV 234
Query: 386 VDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDV 445
+ C ++ + C ++ ER +
Sbjct: 235 RSN-------------------------------CPKAMKRLMAECLKKKRDERPLFPQI 263
Query: 446 ESRLRLIRRKL 456
+ + L+ R L
Sbjct: 264 LASIELLARSL 274
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (111), Expect = 2e-06
Identities = 22/119 (18%), Positives = 43/119 (36%), Gaps = 28/119 (23%)
Query: 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEI 61
S DVY+FGI+L E+ TG P ++ N + + + L ++
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS------- 236
Query: 62 EEEETMYKKASSTCTQSSIILECLISICRTGVACSAELPNERMKINDVESRLRLIKKKL 120
+ M + ++ ECL + +ER + + + L+ + L
Sbjct: 237 NCPKAMKR----------LMAECL-----------KKKRDERPLFPQILASIELLARSL 274
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 1e-42
Identities = 57/239 (23%), Positives = 103/239 (43%), Gaps = 18/239 (7%)
Query: 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAF 210
+GAG FG V+ G T +AVK +F +E ++H+ +VR++
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLY--- 74
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
V Q + ++ ++M NGSL ++L+ I K LD+A +A + +
Sbjct: 75 -AVVTQEPIY--IITEYMENGSLVDFLKTPS-------GIKLTINKLLDMAAQIAEGMAF 124
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPE 330
+ + H +L+ +N+L+ D + + DFG+AR + ++ K + PE
Sbjct: 125 IE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTAPE 180
Query: 331 YDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDDF 389
+ DV+SFGILL E+ T R T ++N + R + ++
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEEL 239
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.7 bits (87), Expect = 0.002
Identities = 14/53 (26%), Positives = 22/53 (41%)
Query: 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILD 54
G + DV+SFGILL E+ T R + + N + R + +
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE 237
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 7e-42
Identities = 57/317 (17%), Positives = 113/317 (35%), Gaps = 45/317 (14%)
Query: 153 IGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSG 212
IG G FG V+ G G +AVK+F+ R S ++E + ++H NI+ A +
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSS-REERSWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 213 VDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLH 272
+ + +V + +GSL ++L + ++ + +A+ A L +LH
Sbjct: 69 DNGTWTQL-WLVSDYHEHGSLFDYLN----------RYTVTVEGMIKLALSTASGLAHLH 117
Query: 273 CDC-----QPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFIC--IKGSTG 325
+ +P IAH +LK N+L+ + D G+A + G+
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177
Query: 326 YIPPEYDLGCEASTYG------DVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKM--A 377
Y+ PE + D+Y+ G++ E+ ++ + V +
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237
Query: 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPR 437
+ + + V + I C E + +I C
Sbjct: 238 VEEMRKVVCEQKLRPNIPNRWQSC-----------------EALRVMAKIMRECWYANGA 280
Query: 438 ERMKINDVESRLRLIRR 454
R+ ++ L + +
Sbjct: 281 ARLTALRIKKTLSQLSQ 297
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.5 bits (99), Expect = 6e-05
Identities = 17/117 (14%), Positives = 36/117 (30%), Gaps = 12/117 (10%)
Query: 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEI 61
D+Y+ G++ E+ + +L ++ V S EE+ VV Q++
Sbjct: 193 FESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP--SVEEMRKVVCEQKL 250
Query: 62 EEEETMYKKASSTCTQSSIILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118
E L + + C R+ ++ L + +
Sbjct: 251 RPN----------IPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 4e-41
Identities = 54/222 (24%), Positives = 89/222 (40%), Gaps = 22/222 (9%)
Query: 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNL-IRPGGSKSFKSECKAAINIKH 200
+ F + +GAGN G V+ + G +A K+ +L I+P E +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 201 RNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDI 260
IV + AF ++ + M GSL++ L+ + L +
Sbjct: 64 PYIVGFYGAF-----YSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL---------GKV 109
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICI 320
+I V L YL I H ++KPSN+L++ + DFG++ L +
Sbjct: 110 SIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSF 163
Query: 321 KGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
G+ Y+ PE G S D++S G+ L+EM G P
Sbjct: 164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.7 bits (87), Expect = 0.002
Identities = 12/36 (33%), Positives = 17/36 (47%)
Query: 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNL 37
+ S D++S G+ L+EM G P EL L
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 8e-41
Identities = 63/329 (19%), Positives = 111/329 (33%), Gaps = 58/329 (17%)
Query: 138 KDLYNATNGFSSANL-IGAGNFGSVYNGTLF---DGTTIAVKVFNL-IRPGGSKSFKSEC 192
K L+ + A++ +G GNFGSV G +A+KV ++ E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 193 KAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNF 252
+ + + IVR+ +V + G L ++L GK +
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAEAL------MLVMEMAGGGPLHKFLVGKRE--------EI 106
Query: 253 LIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAID 312
+ ++ V+ ++YL H +L NVLL + + DFG+++ L A D
Sbjct: 107 PVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163
Query: 313 KQ-NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLR 371
K + PE + S+ DV+S+G+ + E + + +
Sbjct: 164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK---PYKKMKG-- 218
Query: 372 NFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVAC 431
EV + IE+G+ M EC + + C
Sbjct: 219 -----------PEV-----MAFIEQGKRM--------------ECPPECPPELYALMSDC 248
Query: 432 SAERPRERMKINDVESRLRLIRRKLLETP 460
+ +R VE R+R L
Sbjct: 249 WIYKWEDRPDFLTVEQRMRACYYSLASKV 277
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 4e-40
Identities = 54/239 (22%), Positives = 99/239 (41%), Gaps = 18/239 (7%)
Query: 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAF 210
+G G FG V+ GT T +A+K ++F E + ++H +V+++
Sbjct: 23 VKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 81
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
S +V ++M GSL ++L+G+ R + +D+A +A + Y
Sbjct: 82 SEEPI------YIVTEYMSKGSLLDFLKGETGKYLRL-------PQLVDMAAQIASGMAY 128
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPE 330
+ H +L+ +N+L+ + ++ V DFG+AR + ++ K + PE
Sbjct: 129 VERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPE 184
Query: 331 YDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDDF 389
L + DV+SFGILL E+ T R + L + E +
Sbjct: 185 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL 243
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 143 bits (362), Expect = 6e-40
Identities = 62/346 (17%), Positives = 124/346 (35%), Gaps = 72/346 (20%)
Query: 136 SFKDLYNATNGFSSA---------NLIGAGNFGSVYNGTLF----DGTTIAVKVFNL-IR 181
+F+D A F+ +IGAG FG V +G L +A+K
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 182 PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKD 241
+ F SE H N++ + + ++ +FM NGSL+ +
Sbjct: 68 EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP-----VMIITEFMENGSLDSF----- 117
Query: 242 DTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301
R + F + + + + +A ++YL H +L N+L++ ++ V D
Sbjct: 118 ---LRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSD 171
Query: 302 FGMARFLP---AIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIR 358
FG++RFL + + K + PE + ++ DV+S+GI++ E+ +
Sbjct: 172 FGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231
Query: 359 PSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIIL 418
+ M + D+ L +
Sbjct: 232 RP------------YWDMTNQDVINAIEQDYRLP-----------------------PPM 256
Query: 419 ECFNSICEIGVACSAERPRERMKINDVESRLRLIRRKLLETPACLE 464
+C +++ ++ + C + R K + + L K++ P L+
Sbjct: 257 DCPSALHQLMLDCWQKDRNHRPKFGQIVNTL----DKMIRNPNSLK 298
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 143 bits (362), Expect = 6e-40
Identities = 60/347 (17%), Positives = 111/347 (31%), Gaps = 69/347 (19%)
Query: 134 NPSFKDLYNATNGFSSANLIGAGNFGSVYNGTL------FDGTTIAVKVFNL-IRPGGSK 186
NP L N IG G FG V+ T +AVK+
Sbjct: 2 NPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA 61
Query: 187 SFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWR 246
F+ E + NIV++ + +++++M G L E+LR
Sbjct: 62 DFQREAALMAEFDNPNIVKLLGVCAVGKP-----MCLLFEYMAYGDLNEFLRSMSPHTVC 116
Query: 247 PLNFNFL---------------IKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL 291
L+ + L ++L IA VA + YL + H +L N L+
Sbjct: 117 SLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLV 173
Query: 292 DDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLL 351
+ M+ + DFG++R + + D ++PPE +T DV+++G++L
Sbjct: 174 GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLW 233
Query: 352 EMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSS 411
E+F+ + + + E +
Sbjct: 234 EIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLEL---------------------- 271
Query: 412 AHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRKLLE 458
+ C ++ P +R + L +++ E
Sbjct: 272 -------------YNLMRLCWSKLPADRPSFCSIHRIL----QRMCE 301
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 9e-39
Identities = 52/244 (21%), Positives = 87/244 (35%), Gaps = 16/244 (6%)
Query: 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNL--IRPGGSKSFKSECKAAINIKHRNIVRVF 207
IG G++G DG + K + + + SE +KH NIVR +
Sbjct: 10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69
Query: 208 TAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACA 267
+ +V ++ G L + + L + + A
Sbjct: 70 DRIID---RTNTTLYIVMEYCEGGDLASVITKG-----TKERQYLDEEFVLRVMTQLTLA 121
Query: 268 LRYLH--CDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTG 325
L+ H D + H +LKP+NV LD + +GDFG+AR L + G+
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN--HDTSFAKAFVGTPY 179
Query: 326 YIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEV 385
Y+ PE + D++S G LL E+ + P F+ K + +
Sbjct: 180 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTA-FSQKELAGKIREGKFRRIPYRY 238
Query: 386 VDDF 389
D+
Sbjct: 239 SDEL 242
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.3 bits (86), Expect = 0.003
Identities = 9/44 (20%), Positives = 14/44 (31%), Gaps = 1/44 (2%)
Query: 9 DVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEI 52
D++S G LL E+ + P EL +
Sbjct: 196 DIWSLGCLLYELCALMPPFTAFSQKEL-AGKIREGKFRRIPYRY 238
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (350), Expect = 1e-38
Identities = 63/304 (20%), Positives = 108/304 (35%), Gaps = 57/304 (18%)
Query: 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAF 210
IG G FG V G G +AVK +++F +E ++H N+V++
Sbjct: 13 QTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLL--- 66
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
GV + +V ++M GSL ++LR + L + L+K ++DV A+ Y
Sbjct: 67 -GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR---SVLGGDCLLK----FSLDVCEAMEY 118
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPE 330
L H +L NVL+ ++ + V DFG+ + + K + PE
Sbjct: 119 LE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPE 170
Query: 331 YDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDDFN 390
+ ST DV+SFGILL E+++ R K + K +
Sbjct: 171 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAV- 229
Query: 391 LQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLR 450
++ C++ R + +L
Sbjct: 230 -----------------------YEVMKNCWH-----------LDAAMRPSFLQLREQLE 255
Query: 451 LIRR 454
I+
Sbjct: 256 HIKT 259
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.5 bits (84), Expect = 0.004
Identities = 18/117 (15%), Positives = 32/117 (27%), Gaps = 32/117 (27%)
Query: 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEI 61
S+ DV+SFGILL E+++ R + + K + + V+
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY---- 230
Query: 62 EEEETMYKKASSTCTQSSIILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118
++ C R + +L IK
Sbjct: 231 -----------------EVMKNCW-----------HLDAAMRPSFLQLREQLEHIKT 259
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 6e-38
Identities = 55/241 (22%), Positives = 94/241 (39%), Gaps = 22/241 (9%)
Query: 153 IGAGNFGSVYNGTL-FDGTTIAVKVFNL--IRPGGSKSFKSECKAAINIKHRNIVRVFTA 209
IG G+F +VY G +A + + FK E + ++H NIVR + +
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALR 269
+ +G + +V + M +G+L+ +L+ + L + L+
Sbjct: 77 WESTV-KGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVL---------RSWCRQILKGLQ 126
Query: 270 YLHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIKGSTGYI 327
+LH PPI H +LK N+ + G V GD G+A + + G+ ++
Sbjct: 127 FLHTRT-PPIIHRDLKCDNIFITGPT-GSVKIGDLGLATLKR--ASFAKAVI--GTPEFM 180
Query: 328 PPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVVD 387
PE + DVY+FG+ +LEM T P R P ++V
Sbjct: 181 APEM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 239
Query: 388 D 388
Sbjct: 240 P 240
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (89), Expect = 0.001
Identities = 12/46 (26%), Positives = 19/46 (41%)
Query: 9 DVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILD 54
DVY+FG+ +LEM T P + N P +++
Sbjct: 194 DVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI 239
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 1e-37
Identities = 49/239 (20%), Positives = 92/239 (38%), Gaps = 18/239 (7%)
Query: 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAF 210
IG+G FG V+ G + +A+K + F E + + + H +V+++
Sbjct: 11 QEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
+V++FM +G L ++ R F + L + +DV + Y
Sbjct: 70 LEQAP-----ICLVFEFMEHGCLSDY--------LRTQRGLFAAETLLGMCLDVCEGMAY 116
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPE 330
L + + H +L N L+ + + V DFGM RF+ D+ K + PE
Sbjct: 117 L---EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPE 172
Query: 331 YDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDDF 389
S+ DV+SFG+L+ E+F+ + + + + +
Sbjct: 173 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHV 231
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 3e-37
Identities = 51/239 (21%), Positives = 99/239 (41%), Gaps = 18/239 (7%)
Query: 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAF 210
+G G FG V G +A+K+ F E K +N+ H +V+++
Sbjct: 10 KELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
+ ++ ++M NG L +LR F ++ L++ DV A+ Y
Sbjct: 69 TKQRPI-----FIITEYMANGCLLNYLREM--------RHRFQTQQLLEMCKDVCEAMEY 115
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPE 330
L H +L N L++D+ + V DFG++R++ D+ + K + PPE
Sbjct: 116 LES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPE 171
Query: 331 YDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDDF 389
+ + S+ D+++FG+L+ E+++ + FT + + R +
Sbjct: 172 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKV 230
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 3e-37
Identities = 66/314 (21%), Positives = 113/314 (35%), Gaps = 57/314 (18%)
Query: 151 NLIGAGNFGSVYNGTLFD----GTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVR 205
+IG G+FG VY+GTL D AVK N I G F +E + H N++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVA 265
+ G+ + VV +M +G L + R N +K + + VA
Sbjct: 93 LL----GICLRSEGSPLVVLPYMKHGDLRNF--------IRNETHNPTVKDLIGFGLQVA 140
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFIC--IKGS 323
+ H +L N +LD++ V DFG+AR + + + K
Sbjct: 141 KGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 197
Query: 324 TGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAE 383
++ E + +T DV+SFG+LL E+ T P +N +
Sbjct: 198 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP----PYPDVNTFDITVY------- 246
Query: 384 EVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKIN 443
+ +GR + C + + E+ + C + R +
Sbjct: 247 ----------LLQGRRL--------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFS 282
Query: 444 DVESRLRLIRRKLL 457
++ SR+ I +
Sbjct: 283 ELVSRISAIFSTFI 296
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.1 bits (93), Expect = 4e-04
Identities = 19/121 (15%), Positives = 37/121 (30%), Gaps = 32/121 (26%)
Query: 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEI 61
++ DV+SFG+LL E+ T P N ++ + E D ++
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY---- 264
Query: 62 EEEETMYKKASSTCTQSSIILECLISICRTGVACSAELPNERMKINDVESRLRLIKKKLL 121
++L+C R +++ SR+ I +
Sbjct: 265 -----------------EVMLKCW-----------HPKAEMRPSFSELVSRISAIFSTFI 296
Query: 122 K 122
Sbjct: 297 G 297
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 135 bits (340), Expect = 9e-37
Identities = 48/264 (18%), Positives = 92/264 (34%), Gaps = 34/264 (12%)
Query: 135 PSFKDLY---NATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNL---IRPGGSKS 187
P +L+ + FS IG G+FG+VY + + +A+K + +
Sbjct: 2 PDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD 61
Query: 188 FKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRP 247
E + ++H N ++ + +V ++ + + K
Sbjct: 62 IIKEVRFLQKLRHPNTIQYRGCYLREHT-----AWLVMEYCLGSASDLLEVHKKPLQE-- 114
Query: 248 LNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARF 307
+ + L YLH + H ++K N+LL + + +GDFG A
Sbjct: 115 -------VEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI 164
Query: 308 LPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYG---DVYSFGILLLEMFTGIRPSDGIF 364
+ N F+ G+ ++ PE L + Y DV+S GI +E+ P +
Sbjct: 165 ---MAPANSFV---GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218
Query: 365 TGKMNLRNFVKMALPQRAEEVVDD 388
L + + P +
Sbjct: 219 AMSA-LYHIAQNESPALQSGHWSE 241
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 2e-36
Identities = 50/216 (23%), Positives = 89/216 (41%), Gaps = 25/216 (11%)
Query: 151 NLIGAGNFGSVYNGTL-FDGTTIAVKVFN---LIRPGGSKSFKSECKAAINIKHRNIVRV 206
+G G FG+VY +A+KV L + G + E + +++H NI+R+
Sbjct: 12 RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVAC 266
+ F A ++ ++ P G++ L+ + ++ ++A
Sbjct: 72 YGYF-----HDATRVYLILEYAPLGTVYRELQ-----KLSKFD----EQRTATYITELAN 117
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGY 326
AL Y H + H ++KP N+LL + DFG + P +R + G+ Y
Sbjct: 118 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDY 170
Query: 327 IPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
+PPE G D++S G+L E G P +
Sbjct: 171 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 206
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 6e-36
Identities = 47/218 (21%), Positives = 81/218 (37%), Gaps = 24/218 (11%)
Query: 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTA 209
+G G FG VY A KV + + + E + H NIV++ A
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALR 269
F + ++ +F G+++ + + RPL + + + AL
Sbjct: 78 FYYENN-----LWILIEFCAGGAVDAVMLELE----RPLTESQIQV----VCKQTLDALN 124
Query: 270 YLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPP 329
YLH I H +LK N+L + + DFG++ ++ G+ ++ P
Sbjct: 125 YLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI--GTPYWMAP 179
Query: 330 EYDLGCEASTYG-----DVYSFGILLLEMFTGIRPSDG 362
E + + DV+S GI L+EM P
Sbjct: 180 EVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHE 217
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 7e-36
Identities = 54/255 (21%), Positives = 89/255 (34%), Gaps = 25/255 (9%)
Query: 151 NLIGAGNFGSVYNGTLF------DGTTIAVKVFNL-IRPGGSKSFKSECKAAINIK-HRN 202
+GAG FG V T + T+AVK+ ++ SE K + H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLI-------- 254
IV + A + V+ ++ G L +LR K D+ ++
Sbjct: 89 IVNLLGACTIGGP-----TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 255 -KKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDK 313
+ L + VA + +L H +L N+LL I + DFG+AR +
Sbjct: 144 LEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 314 QNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNF 373
+ ++ PE C + DV+S+GI L E+F+
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260
Query: 374 VKMALPQRAEEVVDD 388
+K + E
Sbjct: 261 IKEGFRMLSPEHAPA 275
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 9e-36
Identities = 60/307 (19%), Positives = 106/307 (34%), Gaps = 61/307 (19%)
Query: 151 NLIGAGNFGSVYNGTLFD---GTTIAVKVFN--LIRPGGSKSFKSECKAAINIKHRNIVR 205
+G+GNFG+V G T+AVK+ P +E + + IVR
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVA 265
+ + +V + G L ++L+ + + +++ V+
Sbjct: 73 MIGICEAESW------MLVMEMAELGPLNKYLQQNRHVKDKNI---------IELVHQVS 117
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPA-IDKQNRFICIKGST 324
++YL H +L NVLL + + DFG+++ L A + K
Sbjct: 118 MGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 174
Query: 325 GYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMALPQRAE 383
+ PE + S+ DV+SFG+L+ E F+ G +P G+ ++
Sbjct: 175 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV--------------- 219
Query: 384 EVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKIN 443
+E+G M C + ++ C R
Sbjct: 220 -------TAMLEKGERM--------------GCPAGCPREMYDLMNLCWTYDVENRPGFA 258
Query: 444 DVESRLR 450
VE RLR
Sbjct: 259 AVELRLR 265
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (329), Expect = 1e-35
Identities = 46/241 (19%), Positives = 86/241 (35%), Gaps = 20/241 (8%)
Query: 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFT 208
+G G +G V +AVK+ ++ R ++ K E + H N+V+ +
Sbjct: 11 QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 209 AFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACAL 268
+ + + ++ G L + + + +
Sbjct: 71 HR-----REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDA---------QRFFHQLMAGV 116
Query: 269 RYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIP 328
YLH I H ++KP N+LLD+ + DFG+A +++ + G+ Y+
Sbjct: 117 VYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 173
Query: 329 PEYDLGCEASTYG-DVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVVD 387
PE E DV+S GI+L M G P D ++ + + +D
Sbjct: 174 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKID 233
Query: 388 D 388
Sbjct: 234 S 234
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (329), Expect = 2e-35
Identities = 45/216 (20%), Positives = 80/216 (37%), Gaps = 21/216 (9%)
Query: 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFN---LIRPGGSKSFKSECKAAINIKHRNIVRV 206
++G G+F +V L A+K+ +I+ E + H V++
Sbjct: 14 KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVAC 266
+ F Q + NG L +++R + A
Sbjct: 74 YFTF-----QDDEKLYFGLSYAKNGELLKYIR-----KIGSFDET-------CTRFYTAE 116
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGY 326
+ L I H +LKP N+LL+++M + DFG A+ L KQ R G+ Y
Sbjct: 117 IVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 176
Query: 327 IPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
+ PE A D+++ G ++ ++ G+ P
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 212
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 132 bits (333), Expect = 3e-35
Identities = 50/260 (19%), Positives = 97/260 (37%), Gaps = 33/260 (12%)
Query: 106 INDVESRLRLIKKKLLKTPVYEGKQTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGT 165
IND + I KK + PV + S D Y+ +G+G FG V+
Sbjct: 1 INDYDKFYEDIWKKYVPQPV-----EVKQGSVYDYYDILE------ELGSGAFGVVHRCV 49
Query: 166 -LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVV 224
G K N P + K+E + H ++ + AF + ++
Sbjct: 50 EKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEMVLI 104
Query: 225 YKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNL 284
+F+ G L + + + ++ + ++ L+++H + I H ++
Sbjct: 105 LEFLSGGELFDRIAAE--------DYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDI 153
Query: 285 KPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGD 342
KP N++ + + V DFG+A L + + + PE Y D
Sbjct: 154 KPENIMCETKKASSVKIIDFGLATKL---NPDEIVKVTTATAEFAAPEIVDREPVGFYTD 210
Query: 343 VYSFGILLLEMFTGIRPSDG 362
+++ G+L + +G+ P G
Sbjct: 211 MWAIGVLGYVLLSGLSPFAG 230
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 3e-35
Identities = 53/247 (21%), Positives = 91/247 (36%), Gaps = 33/247 (13%)
Query: 152 LIGAGNFGSVYNGTLFD------GTTIAVKVFNL-IRPGGSKSFKSECKAAINI-KHRNI 203
++G+G FG V N T + +AVK+ ++ SE K + H NI
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 204 VRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDT--------------NWRPLN 249
V + A + +++++ G L +LR K +
Sbjct: 104 VNLLGACTLSGPI-----YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 158
Query: 250 FNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLP 309
+ L A VA + +L H +L NVL+ + + DFG+AR +
Sbjct: 159 NVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215
Query: 310 AIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMN 369
+ + ++ PE + DV+S+GILL E+F+ + G
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN---PYPGIPV 272
Query: 370 LRNFVKM 376
NF K+
Sbjct: 273 DANFYKL 279
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 131 bits (331), Expect = 4e-35
Identities = 46/248 (18%), Positives = 93/248 (37%), Gaps = 31/248 (12%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAF 210
+G G FG V+ T G A K ++ + E + ++H +V + AF
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
+ ++Y+FM G L E + + + + ++ V L +
Sbjct: 93 -----EDDNEMVMIYEFMSGGELFEKVADE--------HNKMSEDEAVEYMRQVCKGLCH 139
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIKGSTGYIP 328
+H + H +LKP N++ + + DFG+ L D + G+ +
Sbjct: 140 MHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAA 193
Query: 329 PEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG---------IFTGKMNLRNFVKMALP 379
PE G Y D++S G+L + +G+ P G + + N+ + +
Sbjct: 194 PEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGIS 253
Query: 380 QRAEEVVD 387
+ ++ +
Sbjct: 254 EDGKDFIR 261
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 128 bits (323), Expect = 2e-34
Identities = 59/322 (18%), Positives = 108/322 (33%), Gaps = 53/322 (16%)
Query: 135 PSFKDLYNATNGFSSANLIGAGNFGSVYNGTLFD-GTTIAVKVFNLIRPGGSKSFKSECK 193
P++ + + +G G +G VY G T+AVK + F E
Sbjct: 7 PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAA 65
Query: 194 AAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFL 253
IKH N+V++ ++ +FM G+L ++L
Sbjct: 66 VMKEIKHPNLVQLLGVC-----TREPPFYIITEFMTYGNLLDYL-------RECNRQEVS 113
Query: 254 IKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDK 313
L +A ++ A+ YL + H +L N L+ + + V DFG++R + D
Sbjct: 114 AVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DT 169
Query: 314 QNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNF 373
K + PE + S DV++FG+LL E+ T ++L
Sbjct: 170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS----PYPGIDLSQV 225
Query: 374 VKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSA 433
++ +E+ M C + E+ AC
Sbjct: 226 YEL-----------------LEKDYRM--------------ERPEGCPEKVYELMRACWQ 254
Query: 434 ERPRERMKINDVESRLRLIRRK 455
P +R ++ + ++
Sbjct: 255 WNPSDRPSFAEIHQAFETMFQE 276
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (324), Expect = 2e-34
Identities = 60/323 (18%), Positives = 109/323 (33%), Gaps = 58/323 (17%)
Query: 145 NGFSSANLIGAGNFGSVYNGTLFDG---TTIAVKVFNLI-RPGGSKSFKSECKAAINI-K 199
N ++IG GNFG V + A+K + F E + +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 200 HRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK-- 257
H NI+ + A Y + ++ P+G+L ++LR P
Sbjct: 70 HPNIINLLGACEHRGY-----LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124
Query: 258 -----LDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAID 312
L A DVA + YL Q H +L N+L+ + + + DFG++R
Sbjct: 125 SSQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 181
Query: 313 KQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRN 372
K+ + ++ E +T DV+S+G+LL E+ +
Sbjct: 182 KKT---MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP------------ 226
Query: 373 FVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACS 432
+ M + E++ + L+ L C + + ++ C
Sbjct: 227 YCGMTCAELYEKLPQGYRLE-----------------------KPLNCDDEVYDLMRQCW 263
Query: 433 AERPRERMKINDVESRLRLIRRK 455
E+P ER + L + +
Sbjct: 264 REKPYERPSFAQILVSLNRMLEE 286
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 2e-34
Identities = 45/213 (21%), Positives = 83/213 (38%), Gaps = 21/213 (9%)
Query: 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTA 209
IG G G+VY + G +A++ NL + + +E K+ NIV +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALR 269
+ D VV +++ GSL + + + + + AL
Sbjct: 86 YLVGDE-----LWVVMEYLAGGSLTDVVTETCMDE----------GQIAAVCRECLQALE 130
Query: 270 YLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPP 329
+LH + H ++K N+LL + + DFG + +Q++ + G+ ++ P
Sbjct: 131 FLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT--PEQSKRSTMVGTPYWMAP 185
Query: 330 EYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
E D++S GI+ +EM G P
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 6e-34
Identities = 67/325 (20%), Positives = 124/325 (38%), Gaps = 62/325 (19%)
Query: 147 FSSANLIGAGNFGSVYNGTLFDGT-----TIAVKVFNL-IRPGGSKSFKSECKAAINIKH 200
+ +IGAG FG VY G L + +A+K F E H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 201 RNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDI 260
NI+R+ S ++ ++M NG+L+++LR KD F + + + +
Sbjct: 69 HNIIRLEGVISKYKP-----MMIITEYMENGALDKFLREKDG--------EFSVLQLVGM 115
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPA-IDKQNRFIC 319
+A ++YL H +L N+L++ ++ V DFG++R L +
Sbjct: 116 LRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSG 172
Query: 320 IKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP 379
K + PE + ++ DV+SFGI++ E+ T + +++
Sbjct: 173 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER------------PYWELSNH 220
Query: 380 QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRER 439
+ + + D F L ++C ++I ++ + C + R
Sbjct: 221 EVMKAINDGFRL-----------------------PTPMDCPSAIYQLMMQCWQQERARR 257
Query: 440 MKINDVESRLRLIRRKLLETPACLE 464
K D+ S L KL+ P L+
Sbjct: 258 PKFADIVSIL----DKLIRAPDSLK 278
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.1 bits (85), Expect = 0.003
Identities = 17/116 (14%), Positives = 35/116 (30%), Gaps = 36/116 (31%)
Query: 9 DVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMY 68
DV+SFGI++ E+ T ++ + + ++
Sbjct: 195 DVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIY----------- 243
Query: 69 KKASSTCTQSSIILECLISICRTGVACSAELPNERMKINDVESRLRLIKKKLLKTP 124
++++C + R K D+ S L KL++ P
Sbjct: 244 ----------QLMMQCW-----------QQERARRPKFADIVSIL----DKLIRAP 274
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 2e-33
Identities = 54/247 (21%), Positives = 95/247 (38%), Gaps = 16/247 (6%)
Query: 151 NLIGAGNFGSVYNGTL------FDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNI 203
+G G+FG VY G T +A+K N F +E ++
Sbjct: 26 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85
Query: 204 VRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRG-KDDTNWRPLNFNFLIKKKLDIAI 262
VR+ S V+ + M G L+ +LR + P+ + K + +A
Sbjct: 86 VRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140
Query: 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKG 322
++A + YL H +L N ++ ++ +GDFGM R + D +
Sbjct: 141 EIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 197
Query: 323 STGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRA 382
++ PE +TY DV+SFG++L E+ T + + LR ++ L +
Sbjct: 198 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP 257
Query: 383 EEVVDDF 389
+ D
Sbjct: 258 DNCPDML 264
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 4e-33
Identities = 56/315 (17%), Positives = 106/315 (33%), Gaps = 60/315 (19%)
Query: 147 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKV-----FNLIRPGGSKSFKSECKAAINIKH 200
F ++G+G FG+VY G + +G + + V P +K E ++ +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 201 RNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSL-EEWLRGKDDTNWRPLNFNFLIKKKLD 259
++ R+ Q ++ + MP G L + KD+ + L L+
Sbjct: 71 PHVCRLLGICLTSTVQ------LITQLMPFGCLLDYVREHKDNIGSQYL---------LN 115
Query: 260 IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFIC 319
+ +A + YL + H +L NVL+ + DFG+A+ L A +K+
Sbjct: 116 WCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 172
Query: 320 IKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP 379
K ++ E L + DV+S+G+ + E+ T + +
Sbjct: 173 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK----PYDGIPASEISSI--- 225
Query: 380 QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRER 439
+E+G + C + I V C R
Sbjct: 226 --------------LEKGERL--------------PQPPICTIDVYMIMVKCWMIDADSR 257
Query: 440 MKINDVESRLRLIRR 454
K ++ + R
Sbjct: 258 PKFRELIIEFSKMAR 272
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 122 bits (308), Expect = 1e-32
Identities = 62/279 (22%), Positives = 102/279 (36%), Gaps = 48/279 (17%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFN---LIRPGGSKSFKSECKAAINIKHRNIVRVF 207
++G G V+ L +AVKV P F+ E + A + H IV V+
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 208 TAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACA 267
G +V +++ +L + + P+ K+ +++ D A
Sbjct: 74 DTGEAETPAGPLP-YIVMEYVDGVTLRDIVH-----TEGPMT----PKRAIEVIADACQA 123
Query: 268 LRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL-PAIDKQNRFICIKGSTGY 326
L + Q I H ++KP+N+++ V DFG+AR + + + + + G+ Y
Sbjct: 124 LNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180
Query: 327 IPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG---------IFTGKM--------- 368
+ PE G DVYS G +L E+ TG P G
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG 240
Query: 369 ---NLRNFVKMAL-------PQRAEEVVDDFNLQEIEEG 397
+L V AL Q A E+ D L + G
Sbjct: 241 LSADLDAVVLKALAKNPENRYQTAAEMRAD--LVRVHNG 277
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 4e-32
Identities = 57/215 (26%), Positives = 85/215 (39%), Gaps = 25/215 (11%)
Query: 153 IGAGNFGSVYNGTLF----DGTTIAVKVFN---LIRPGGSKSFKSECKAAINIKHRNIVR 205
+G G+FG V G ++AVK L +P F E A ++ HRN++R
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVA 265
++ + +V + P GSL + LR +FL+ A+ VA
Sbjct: 76 LYGVVLTPPMK------MVTELAPLGSLLDRLRKHQG--------HFLLGTLSRYAVQVA 121
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRF-ICIKGST 324
+ YL H +L N+LL + +GDFG+ R LP D K
Sbjct: 122 EGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 178
Query: 325 GYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRP 359
+ PE S D + FG+ L EMFT +
Sbjct: 179 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 213
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 6e-31
Identities = 44/246 (17%), Positives = 87/246 (35%), Gaps = 26/246 (10%)
Query: 152 LIGAGNFGSVYNGTLFD----GTTIAVKVFNLI-RPGGSKSFKSECKAAINIKHRNIVRV 206
IG G FG V+ G +A+K + F E H +IV++
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVAC 266
+ ++ + G L + L+ + + A ++
Sbjct: 74 IGVITE------NPVWIIMELCTLGELRSF----LQVRKYSLD----LASLILYAYQLST 119
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGY 326
AL YL H ++ NVL+ +GDFG++R++ + K +
Sbjct: 120 ALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKW 175
Query: 327 IPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKM--NLRNFVKMALPQRAE 383
+ PE ++ DV+ FG+ + E+ G++P G+ + + N ++ +P
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCP 235
Query: 384 EVVDDF 389
+
Sbjct: 236 PTLYSL 241
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (298), Expect = 1e-30
Identities = 44/214 (20%), Positives = 81/214 (37%), Gaps = 23/214 (10%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAF 210
+G G FG V+ T K ++ K E +HRNI+ + +F
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHESF 70
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
++ ++++F+ + E + F ++ + V AL++
Sbjct: 71 ESMEE-----LVMIFEFISGLDIFERINTS--------AFELNEREIVSYVHQVCEALQF 117
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHV--GDFGMARFLPAIDKQNRFICIKGSTGYIP 328
LH I H +++P N++ + +FG AR L + F + + Y
Sbjct: 118 LH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL---KPGDNFRLLFTAPEYYA 171
Query: 329 PEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
PE ST D++S G L+ + +GI P
Sbjct: 172 PEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA 205
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (295), Expect = 2e-30
Identities = 63/325 (19%), Positives = 111/325 (34%), Gaps = 58/325 (17%)
Query: 151 NLIGAGNFGSVYNGTLF------DGTTIAVKVFNL-IRPGGSKSFKSECKAAINIKHRNI 203
+G G FG V F T+AVK+ ++ SE K I+I H
Sbjct: 19 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78
Query: 204 VRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK------ 257
V G + V+ +F G+L +LR K + + K
Sbjct: 79 VVNLL---GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 135
Query: 258 -LDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNR 316
+ + VA + +L H +L N+LL ++ + + DFG+AR + R
Sbjct: 136 LICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192
Query: 317 FICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKM 376
+ ++ PE + DV+SFG+LL E+F+
Sbjct: 193 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS----------------- 235
Query: 377 ALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERP 436
P ++ ++F + ++EG M + + + C P
Sbjct: 236 --PYPGVKIDEEF-CRRLKEGTRM--------------RAPDYTTPEMYQTMLDCWHGEP 278
Query: 437 RERMKINDVESRLRLIRRKLLETPA 461
+R +++ L LL+ A
Sbjct: 279 SQRPTFSELVEHL----GNLLQANA 299
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 1e-29
Identities = 52/256 (20%), Positives = 90/256 (35%), Gaps = 25/256 (9%)
Query: 151 NLIGAGNFGSVYNGTL--------FDGTTIAVKVFNL-IRPGGSKSFKSECKAAINI-KH 200
+G G FG V T +AVK+ SE + I KH
Sbjct: 19 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78
Query: 201 RNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGK-------DDTNWRPLNFNFL 253
+NI+ + A V+ ++ G+L E+L+ +
Sbjct: 79 KNIINLLGAC-----TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 254 IKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDK 313
K + A VA + YL H +L NVL+ ++ + + DFG+AR + ID
Sbjct: 134 SKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 314 QNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNF 373
+ + ++ PE + DV+SFG+LL E+FT + +
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250
Query: 374 VKMALPQRAEEVVDDF 389
+ + ++
Sbjct: 251 KEGHRMDKPSNCTNEL 266
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 114 bits (287), Expect = 3e-29
Identities = 53/216 (24%), Positives = 87/216 (40%), Gaps = 26/216 (12%)
Query: 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFN---LIRPGGSKSFKSECKAAINIKHRNIVRV 206
+G G+FG V+ +G A+KV ++R + E + H I+R+
Sbjct: 10 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69
Query: 207 FTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVAC 266
+ F ++ M +++ G + + + F A +V
Sbjct: 70 WGTFQDAQQ--------IFMIM------DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL 115
Query: 267 ALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGY 326
AL YLH I + +LKP N+LLD + DFG A+++P + + G+ Y
Sbjct: 116 ALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCGTPDY 167
Query: 327 IPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
I PE + D +SFGIL+ EM G P
Sbjct: 168 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD 203
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 113 bits (283), Expect = 8e-29
Identities = 42/228 (18%), Positives = 78/228 (34%), Gaps = 19/228 (8%)
Query: 137 FKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNL-IRPGGSKSFKSECKA 194
+K + + + +++G G F V +A+K G S ++E
Sbjct: 1 WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60
Query: 195 AINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLI 254
IKH NIV + + + ++ + + G L + + K R
Sbjct: 61 LHKIKHPNIVALDDIY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTER-------- 107
Query: 255 KKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQ 314
+ V A++YLH LD++ + DFG+++ D
Sbjct: 108 -DASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPG 163
Query: 315 NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
+ G+ GY+ PE S D +S G++ + G P
Sbjct: 164 SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD 211
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 1e-28
Identities = 52/244 (21%), Positives = 95/244 (38%), Gaps = 26/244 (10%)
Query: 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFN---LIRPGGSKSFKSECKA-AINIKHRNIVR 205
++G G+FG V+ A+K ++ + E + ++ +H +
Sbjct: 8 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67
Query: 206 VFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVA 265
+F F Q V +++ G L ++ + + A ++
Sbjct: 68 MFCTF-----QTKENLFFVMEYLNGGDLMYHIQSCHKFDLS---------RATFYAAEII 113
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTG 325
L++L I + +LK N+LLD + + DFGM + D + C G+
Sbjct: 114 LGLQFL---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC--GTPD 168
Query: 326 YIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEV 385
YI PE LG + + D +SFG+LL EM G P G + L + ++M P +
Sbjct: 169 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG--QDEEELFHSIRMDNPFYPRWL 226
Query: 386 VDDF 389
+
Sbjct: 227 EKEA 230
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 3e-28
Identities = 43/216 (19%), Positives = 82/216 (37%), Gaps = 24/216 (11%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-KHRNIVRVFTA 209
++G G G V A+K+ + E + + +IVR+
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIVDV 73
Query: 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALR 269
+ + Y G + +V + + G L ++ + D F ++ +I + A++
Sbjct: 74 YENL-YAGRKCLLIVMECLDGGELFSRIQDRGDQA-------FTEREASEIMKSIGEAIQ 125
Query: 270 YLHCDCQPPIAHCNLKPSNVLLDDEM---IGHVGDFGMARFLPAIDKQNRFICIKGSTGY 326
YLH IAH ++KP N+L + I + DFG A+ N + Y
Sbjct: 126 YLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE---TTSHNSLTTPCYTPYY 179
Query: 327 IPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
+ PE + D++S G+++ + G P
Sbjct: 180 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS 215
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 5e-28
Identities = 56/234 (23%), Positives = 90/234 (38%), Gaps = 24/234 (10%)
Query: 147 FSSANLIGAGNFGSVYNGTLFD-GTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVR 205
++ +IG G+FG VY L D G +A+K + E + + H NIVR
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ----DKRFKNRELQIMRKLDHCNIVR 77
Query: 206 VFTAF-SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDV 264
+ F S + + + +V ++P + +
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRA------KQTLPVIYVKLYMYQL 131
Query: 265 ACALRYLHCDCQPPIAHCNLKPSNVLLD-DEMIGHVGDFGMARFLPAIDKQNRFICIKGS 323
+L Y+H I H ++KP N+LLD D + + DFG A+ L + +IC
Sbjct: 132 FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS--- 185
Query: 324 TGYIPPEYDLGCEASTYG-DVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKM 376
Y PE G T DV+S G +L E+ G F G + V++
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI----FPGDSGVDQLVEI 235
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 112 bits (281), Expect = 5e-28
Identities = 51/226 (22%), Positives = 81/226 (35%), Gaps = 29/226 (12%)
Query: 145 NGFSSANLIGAGNFGSVYNGTLFD-GTTIAVKVFN---LIRPGGSKSFKSECKAA---IN 197
N FS +IG G FG VY D G A+K + + G +E
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 198 IKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK 257
IV + AF D + + M G L L + + F
Sbjct: 64 GDCPFIVCMSYAFHTPDKL-----SFILDLMNGGDLHYHLSQHGVFSEADMRF------- 111
Query: 258 LDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRF 317
A ++ L ++H + + +LKP+N+LLD+ + D G+A + +
Sbjct: 112 --YAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKP 162
Query: 318 ICIKGSTGYIPPEYDLGCEASTY-GDVYSFGILLLEMFTGIRPSDG 362
G+ GY+ PE A D +S G +L ++ G P
Sbjct: 163 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 208
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 1e-27
Identities = 45/219 (20%), Positives = 81/219 (36%), Gaps = 26/219 (11%)
Query: 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNL-----IRPGGSKSFKSECKAAINIKHRNIV 204
+ +G G F +VY +A+K L + G +++ E K + H NI+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 205 RVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDV 264
+ A + ++V+ FM I +
Sbjct: 64 GLLDA-----FGHKSNISLVFDFMETDLEVIIKDNSLVLTPS------------HIKAYM 106
Query: 265 ACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGST 324
L+ L Q I H +LKP+N+LLD+ + + DFG+A+ + ++ +
Sbjct: 107 LMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV--VTR 164
Query: 325 GYIPPEYDLGCEASTYG-DVYSFGILLLEMFTGIRPSDG 362
Y PE G G D+++ G +L E+ + G
Sbjct: 165 WYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG 203
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 2e-27
Identities = 51/302 (16%), Positives = 99/302 (32%), Gaps = 31/302 (10%)
Query: 151 NLIGAGNFGSVYNGT--LFDGTTIAVKVFNL--IRPGGSKSFKSE---CKAAINIKHRNI 203
IG G +G V+ G +A+K + G S E + +H N+
Sbjct: 13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72
Query: 204 VRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAID 263
VR+F + +V++ + + + D+
Sbjct: 73 VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP--------EPGVPTETIKDMMFQ 124
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGS 323
+ L +LH + H +LKP N+L+ + DFG+AR + +
Sbjct: 125 LLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV---VT 178
Query: 324 TGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAE 383
Y PE L +T D++S G + EMF F G ++ K+
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL----FRGSSDVDQLGKIL------ 228
Query: 384 EVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKIN 443
+V+ ++ + + S + + + ++ + C P +R+
Sbjct: 229 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAY 288
Query: 444 DV 445
Sbjct: 289 SA 290
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 2e-27
Identities = 53/312 (16%), Positives = 109/312 (34%), Gaps = 28/312 (8%)
Query: 140 LYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAIN 197
+++ +++ + IG G +G V + + +A+K + + E K +
Sbjct: 3 VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLR 62
Query: 198 IKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKK 257
+H NI+ + + + +V M L + L+ + +
Sbjct: 63 FRHENIIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLLKTQ----------HLSNDHI 111
Query: 258 LDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL-PAIDKQNR 316
+ L+Y+H + H +LKPSN+LL+ + DFG+AR P D
Sbjct: 112 CYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 168
Query: 317 FICIKGSTGYIPPEYDLGCEASTY-GDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVK 375
+ Y PE L + T D++S G +L EM + F GK L
Sbjct: 169 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI----FPGKHYLDQLNH 224
Query: 376 M--ALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSA 433
+ L ++E ++ + + + + + + +
Sbjct: 225 ILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLD----KMLT 280
Query: 434 ERPRERMKINDV 445
P +R+++
Sbjct: 281 FNPHKRIEVEQA 292
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (269), Expect = 5e-27
Identities = 45/222 (20%), Positives = 80/222 (36%), Gaps = 31/222 (13%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGS------KSFKSECKAAINIKHRNIV 204
+G+G F V G A K R S + + E I+H N++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 205 RVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDV 264
+ + + ++ + + G L ++L K+ +
Sbjct: 77 TLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEE------------ATEFL 119
Query: 265 ACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG----HVGDFGMARFLPAIDKQNRFICI 320
L ++ IAH +LKP N++L D + + DFG+A ID N F I
Sbjct: 120 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFGNEFKNI 176
Query: 321 KGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
G+ ++ PE D++S G++ + +G P G
Sbjct: 177 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 218
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.0 bits (85), Expect = 0.003
Identities = 11/99 (11%), Positives = 31/99 (31%), Gaps = 27/99 (27%)
Query: 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDEL---------------------NLHNF 40
+ D++S G++ + +G P E +F
Sbjct: 191 EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDF 250
Query: 41 VKSAL---PER---AEEILDVVFFQEIEEEETMYKKASS 73
++ L P++ ++ L + + + ++ + S
Sbjct: 251 IRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWSH 289
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 107 bits (267), Expect = 8e-27
Identities = 47/229 (20%), Positives = 85/229 (37%), Gaps = 37/229 (16%)
Query: 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGS---------KSFKSECKAAINIK- 199
++G G V AVK+ ++ G ++ E +
Sbjct: 9 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68
Query: 200 HRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLD 259
H NI+++ + + F +V+ M G L ++L K + K+
Sbjct: 69 HPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSE---------KETRK 114
Query: 260 IAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFIC 319
I + + LH + I H +LKP N+LLDD+M + DFG + L D +
Sbjct: 115 IMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLRE 168
Query: 320 IKGSTGYIPPEYDLGCEASTYG------DVYSFGILLLEMFTGIRPSDG 362
+ G+ Y+ PE + D++S G+++ + G P
Sbjct: 169 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH 217
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 106 bits (265), Expect = 2e-26
Identities = 50/298 (16%), Positives = 95/298 (31%), Gaps = 30/298 (10%)
Query: 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFT 208
IG G +G VY G T A+K L + G + E +KH NIV+++
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67
Query: 209 AFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACAL 268
+ +V++ + + + + L
Sbjct: 68 VI-----HTKKRLVLVFEHLDQDLKKLLDVCEGGLESV------------TAKSFLLQLL 110
Query: 269 RYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIP 328
+ + H +LKP N+L++ E + DFG+AR ++ + Y
Sbjct: 111 NGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVT--LWYRA 168
Query: 329 PEYDLGCEA-STYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVVD 387
P+ +G + ST D++S G + EM G F G +++ +
Sbjct: 169 PDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL----FPGVSEADQLMRIFRILGTPNSKN 224
Query: 388 DFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDV 445
N+ E+ + S + + + P +R+
Sbjct: 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLS----KMLKLDPNQRITAKQA 278
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 3e-26
Identities = 48/235 (20%), Positives = 80/235 (34%), Gaps = 25/235 (10%)
Query: 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNL--IRPGGSKSFKSECKAAINIKHRNIVRVF 207
IG G FG V+ G +A+K + + G + E K +KH N+V +
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75
Query: 208 TAFSGVDYQGARFKAVVY---KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDV 264
R K +Y F + +I +
Sbjct: 76 EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS------------EIKRVM 123
Query: 265 ACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAI--DKQNRFICIKG 322
L L+ + I H ++K +NVL+ + + + DFG+AR + NR+
Sbjct: 124 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 323 STGYIPPEYDLGCEASTYG-DVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKM 376
+ Y PPE LG D++ G ++ EM+T G +
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI----MQGNTEQHQLALI 234
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 105 bits (263), Expect = 7e-26
Identities = 61/335 (18%), Positives = 117/335 (34%), Gaps = 41/335 (12%)
Query: 125 VYEGKQTINNPSFKDLYNATNGFSSAN------LIGAGNFGSVYNGT-LFDGTTIAVKVF 177
VY T + D + + + + +G G + V+ + + + VK+
Sbjct: 9 VYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI- 67
Query: 178 NLIRPGGSKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEW 236
++P K K E K N++ NI+ + +R A+V++ + N ++
Sbjct: 68 --LKPVKKKKIKREIKILENLRGGPNIITLADIV---KDPVSRTPALVFEHVNNTDFKQL 122
Query: 237 LRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE-M 295
+ D + R ++ AL Y H I H ++KP NV++D E
Sbjct: 123 YQTLTDYDIR------------FYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHR 167
Query: 296 IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYG-DVYSFGILLLEMF 354
+ D+G+A F + S + PE + + Y D++S G +L M
Sbjct: 168 KLRLIDWGLAEF---YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 224
Query: 355 TGIRPSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHA 414
P F G N V++A E++ D + IE + S
Sbjct: 225 FRKEP---FFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER 281
Query: 415 SIILECFNSICEIGV----ACSAERPRERMKINDV 445
+ E + + + + R+ +
Sbjct: 282 FVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 5e-25
Identities = 47/220 (21%), Positives = 76/220 (34%), Gaps = 22/220 (10%)
Query: 147 FSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNL--IRPGGSKSFKSECKAAINIKHRNI 203
F IG G +G VY G +A+K L G + E + H NI
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 204 VRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAID 263
V++ D K + + L++++ T
Sbjct: 64 VKLL------DVIHTENKLYLVFEFLHQDLKKFMDASALTGIPL-------PLIKSYLFQ 110
Query: 264 VACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGS 323
+ L + + H +LKP N+L++ E + DFG+AR + +
Sbjct: 111 LLQGLAFC---HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEV--VT 165
Query: 324 TGYIPPEYDLGCEASTYG-DVYSFGILLLEMFTGIRPSDG 362
Y PE LGC+ + D++S G + EM T G
Sbjct: 166 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG 205
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 2e-24
Identities = 41/222 (18%), Positives = 74/222 (33%), Gaps = 23/222 (10%)
Query: 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFN---LIRPGGSKSFKSECKAAINIKH 200
N F L+G G FG V G A+K+ +I +E + N +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 201 RNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDI 260
+ + A +Q V ++ G L L +
Sbjct: 65 PFLTALKYA-----FQTHDRLCFVMEYANGGELFFHLSRERVFTEE------------RA 107
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICI 320
A + L + + ++K N++LD + + DFG+ + + + C
Sbjct: 108 RFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC- 166
Query: 321 KGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
G+ Y+ PE + D + G+++ EM G P
Sbjct: 167 -GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 207
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 99 bits (248), Expect = 4e-24
Identities = 43/249 (17%), Positives = 84/249 (33%), Gaps = 29/249 (11%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAF 210
IG+G+FG +Y GT + G +A+K+ E K ++ +
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKL--ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
+ +V + + + + + + + L +A + + Y
Sbjct: 72 ----GAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTV---------LLLADQMISRIEY 118
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHV---GDFGMARFLP-----AIDKQNRFICIKG 322
+H H ++KP N L+ G++ DFG+A+ + G
Sbjct: 119 IH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 175
Query: 323 STGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF--TGKMNLRNFVKMALPQ 380
+ Y LG E S D+ S G +L+ G P G+ T + + +
Sbjct: 176 TARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 235
Query: 381 RAEEVVDDF 389
E + +
Sbjct: 236 PIEVLCKGY 244
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.6 bits (247), Expect = 5e-24
Identities = 47/298 (15%), Positives = 96/298 (32%), Gaps = 28/298 (9%)
Query: 151 NLIGAGNFGSVYNGT-LFDGTTIAVKVFNL--IRPGGSKSFKSECKAAINIKHRNIVRVF 207
IG G +G+V+ +A+K L G S E +KH+NIVR+
Sbjct: 8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67
Query: 208 TAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACA 267
+ + E+ + N + + +
Sbjct: 68 DVL--------------HSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKG 113
Query: 268 LRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYI 327
L + H + H +LKP N+L++ + +FG+AR I + +
Sbjct: 114 LGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVVTLWYRP 169
Query: 328 PPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVVD 387
P ST D++S G + E+ RP +F G ++
Sbjct: 170 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRP---LFPGNDVDDQLKRIFRLLGTPTEEQ 226
Query: 388 DFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDV 445
++ ++ + + M +++S + + + + P +R+ +
Sbjct: 227 WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQ----NLLKCNPVQRISAEEA 280
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.5 bits (242), Expect = 2e-23
Identities = 49/237 (20%), Positives = 86/237 (36%), Gaps = 34/237 (14%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR------PGGSKSFKSECK--AAINIKHRN 202
L+G+G FGSVY+G + D +A+K R E ++
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAI 262
++R+ + F ++ + P L +++ + +
Sbjct: 71 VIRLL----DWFERPDSFVLILERPEPVQDLFDFITERGALQE---------ELARSFFW 117
Query: 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLD-DEMIGHVGDFGMARFLPAIDKQNRFICIK 321
V A+R+ + H ++K N+L+D + + DFG L K +
Sbjct: 118 QVLEAVRHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFD 170
Query: 322 GSTGYIPPEYDLGCEASTYG-DVYSFGILLLEMFTGIRPSDG---IFTGKMNLRNFV 374
G+ Y PPE+ V+S GILL +M G P + I G++ R V
Sbjct: 171 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRV 227
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 97.2 bits (241), Expect = 3e-23
Identities = 37/223 (16%), Positives = 75/223 (33%), Gaps = 29/223 (13%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAF 210
IG G+FG ++ GT L + +A+K R + + E + + + F
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEP--RRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRY 270
Q +V + + + + + A + ++
Sbjct: 70 ----GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTV---------AMAAKQMLARVQS 116
Query: 271 LHCDCQPPIAHCNLKPSNVLLDDEMIGHVG-----DFGMARFLPAIDKQNRFIC-----I 320
+H + + + ++KP N L+ + DFGM +F + +
Sbjct: 117 IH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL 173
Query: 321 KGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGI 363
G+ Y+ LG E S D+ + G + + G P G+
Sbjct: 174 SGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 97.0 bits (240), Expect = 1e-22
Identities = 38/218 (17%), Positives = 78/218 (35%), Gaps = 13/218 (5%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAF 210
+G G+F +V+ + + T +A+K+ +++ + E K + + + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 211 SGVDYQGARFKAVVYKFMPNGSL-----EEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVA 265
+ + PNG E + + + I+ +
Sbjct: 79 A---NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135
Query: 266 CALRYLHCDCQPPIAHCNLKPSNVLLD-DEMIGHVGDFGMARFLPAIDKQNRFICIKGST 324
L Y+H C I H ++KP NVL++ + ++ +A A + +
Sbjct: 136 LGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTR 193
Query: 325 GYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
Y PE LG D++S L+ E+ TG +
Sbjct: 194 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 231
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 96.8 bits (240), Expect = 1e-22
Identities = 42/214 (19%), Positives = 81/214 (37%), Gaps = 26/214 (12%)
Query: 153 IGAGNFGSVYNGT-LFDGTTIAVKVFN---LIRPGGSKSFKSECKAAINIKHRNIVRVFT 208
+G G+FG V G A+K+ + +++ + +E + + +V++
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 209 AFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACAL 268
++ +V +++ G + LR F A +
Sbjct: 109 -----SFKDNSNLYMVMEYVAGGEMFSHLRRIG---------RFSEPHARFYAAQIVLTF 154
Query: 269 RYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIP 328
YLH + + +LKP N+L+D + V DFG A+ + R + G+ +
Sbjct: 155 EYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWTLCGTPEALA 206
Query: 329 PEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDG 362
PE L + D ++ G+L+ EM G P
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.6 bits (234), Expect = 5e-22
Identities = 45/238 (18%), Positives = 90/238 (37%), Gaps = 26/238 (10%)
Query: 129 KQTINNPSFKDLYNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFN--LIRPGGS 185
+Q +N K ++ + + + +G+G +GSV G +AVK + +
Sbjct: 6 RQELN----KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 61
Query: 186 KSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW 245
K E + ++KH N++ + F+ + + L ++ + T+
Sbjct: 62 KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 121
Query: 246 RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305
+ + L+Y+H H +LKPSN+ ++++ + DFG+A
Sbjct: 122 HVQFLIY----------QILRGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLA 168
Query: 306 RFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYG-DVYSFGILLLEMFTGIRPSDG 362
R + + Y PE L D++S G ++ E+ TG G
Sbjct: 169 RHT-----DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.1 bits (233), Expect = 9e-22
Identities = 51/299 (17%), Positives = 100/299 (33%), Gaps = 30/299 (10%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFN--LIRPGGSKSFKSECKAAINIKHRNIVRVFT 208
+G+G +G+V + G +A+K +K E + +++H N++ +
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 209 AFSGVDYQGARFK-AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACA 267
F+ + +V FM + K + + +
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI-----------QFLVYQMLKG 133
Query: 268 LRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYI 327
LRY+H I H +LKP N+ ++++ + DFG+AR + + Y
Sbjct: 134 LRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA-----DSEMTGYVVTRWYR 185
Query: 328 PPEYDLGCEASTYG-DVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAEEVV 386
PE L T D++S G ++ EM TG G + ++ + E V
Sbjct: 186 APEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG--SDHLDQLKEIMKVTGTPPAEFV 243
Query: 387 DDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDV 445
E + E+ +S + N + +R+ +
Sbjct: 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLE----KMLVLDAEQRVTAGEA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.1 bits (230), Expect = 2e-21
Identities = 43/229 (18%), Positives = 79/229 (34%), Gaps = 26/229 (11%)
Query: 152 LIGAGNFGSVYNGT-LFDGTTIAVKVFN--LIRPGGSKSFKSECKAAINIKHRNIVRVFT 208
IG+G G V +A+K + +K E + H+NI+ +
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 209 AFSGVD-YQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACA 267
F+ + + +V + M + D + + C
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS------------YLLYQMLCG 131
Query: 268 LRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYI 327
+++LH H +LKPSN+++ + + DFG+AR + Y
Sbjct: 132 IKHLHSAGI---IHRDLKPSNIVVKSDCTLKILDFGLART---AGTSFMMTPYVVTRYYR 185
Query: 328 PPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKM 376
PE LG D++S G ++ EM F G+ + + K+
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKIL----FPGRDYIDQWNKV 230
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.2 bits (228), Expect = 2e-21
Identities = 41/237 (17%), Positives = 90/237 (37%), Gaps = 31/237 (13%)
Query: 151 NLIGAGNFGSVYNGTLF----DGTTIAVKVFNLI----RPGGSKSFKSECKAAINIKHRN 202
++G G +G V+ G A+KV + ++ ++E + +I+
Sbjct: 30 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89
Query: 203 IVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAI 262
+ +Q ++ ++ G L L ++ ++ I
Sbjct: 90 FLVTLHYA----FQTETKLHLILDYINGGELFTHLSQRERFTEH------------EVQI 133
Query: 263 DVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKG 322
V + L + I + ++K N+LLD + DFG+++ A + + + G
Sbjct: 134 YVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-G 192
Query: 323 STGYIPPEYDLGCEA--STYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377
+ Y+ P+ G ++ D +S G+L+ E+ TG P FT + +++
Sbjct: 193 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP----FTVDGEKNSQAEIS 245
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 71.4 bits (174), Expect = 4e-15
Identities = 25/168 (14%), Positives = 49/168 (29%), Gaps = 31/168 (18%)
Query: 151 NLIGAGNFGSVYNGTLFDGTTIAVKVFNL----------IRPGGSKSFKSECKAAINIKH 200
L+G G +V+N VK + R G F + +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 201 RNIVRVFTAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDI 260
R + ++ Y + N L E + ++ ++
Sbjct: 66 RALQKLQGLAVPKVYA----------WEGNAVLMEL-------IDAKELYRVRVENPDEV 108
Query: 261 AIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFL 308
+ + + I H +L NVL+ +E I + DF + +
Sbjct: 109 LDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEGI-WIIDFPQSVEV 152
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 473 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 98.84 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 98.81 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 98.78 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 98.75 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 98.73 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 98.73 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 98.72 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 98.72 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 98.7 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 98.68 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 98.66 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 98.62 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 98.61 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 98.61 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 98.6 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.59 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 98.59 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 98.58 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 98.55 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 98.53 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 98.53 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 98.52 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 98.5 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 98.43 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 98.32 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 98.29 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 98.25 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 98.21 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 98.2 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.16 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 98.13 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 98.13 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 98.11 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 98.11 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 98.03 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 98.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 97.98 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 97.97 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 97.92 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 97.88 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 97.87 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 97.85 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 97.84 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 97.82 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 97.8 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 97.8 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 97.8 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 97.77 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.77 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 97.77 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 97.76 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 97.72 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 97.56 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 97.38 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 97.34 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.34 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 97.29 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 97.26 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 97.24 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 97.23 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 97.17 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 97.14 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 97.07 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 97.06 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.95 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 96.73 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.24 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-59 Score=432.46 Aligned_cols=268 Identities=26% Similarity=0.401 Sum_probs=208.1
Q ss_pred hhhcccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccC--CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccC
Q 012014 139 DLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQ 216 (473)
Q Consensus 139 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 216 (473)
+|+...++|++.+.||+|+||+||+|++. ..||||+++... ....+.|.+|+.++.+++|||||++++++.+
T Consensus 2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~---- 75 (276)
T d1uwha_ 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA---- 75 (276)
T ss_dssp CCBCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS----
T ss_pred CcccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec----
Confidence 44556788999999999999999999843 469999997433 3344678999999999999999999998643
Q ss_pred CceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCcc
Q 012014 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI 296 (473)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~ 296 (473)
...++|||||++|+|.+++..... .+++.+++.++.||+.||+||| +++||||||||+|||++.++.
T Consensus 76 --~~~~lv~Ey~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~ 142 (276)
T d1uwha_ 76 --PQLAIVTQWCEGSSLYHHLHIIET--------KFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLT 142 (276)
T ss_dssp --SSCEEEEECCCEEEHHHHHHTSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSS
T ss_pred --cEEEEEEecCCCCCHHHHHhhccC--------CCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCC
Confidence 246899999999999999976532 3668999999999999999999 899999999999999999999
Q ss_pred EEEeecccccccCccccccceeeccCCCCcCCCccccC---CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHH
Q 012014 297 GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG---CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNF 373 (473)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~ 373 (473)
+||+|||+|+...............||+.|||||++.+ ..++.++|||||||++|||+||+.||.+...........
T Consensus 143 ~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~ 222 (276)
T d1uwha_ 143 VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222 (276)
T ss_dssp EEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH
T ss_pred EEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHH
Confidence 99999999987755444444556679999999999864 358999999999999999999999998643322111111
Q ss_pred HHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHH
Q 012014 374 VKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIR 453 (473)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~ 453 (473)
.+...+..... ...++++.+.+|+.+||+.||++|||++||++.|+.|.
T Consensus 223 ~~~~~~p~~~~-------------------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 223 GRGYLSPDLSK-------------------------------VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp HHTSCCCCGGG-------------------------------SCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcCCCCCcchh-------------------------------ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11111111111 11235678899999999999999999999999999998
Q ss_pred Hhh
Q 012014 454 RKL 456 (473)
Q Consensus 454 ~~~ 456 (473)
+.+
T Consensus 272 ~~~ 274 (276)
T d1uwha_ 272 RSL 274 (276)
T ss_dssp HTC
T ss_pred HcC
Confidence 754
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-57 Score=421.03 Aligned_cols=252 Identities=20% Similarity=0.275 Sum_probs=202.8
Q ss_pred CCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccC-CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
++|++.++||+|+||+||+|+. .+|+.||||+++... ....+.+.+|+.++++++|||||++++++.+. ...+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~-----~~~~ 79 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG-----NIQY 79 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEET-----TEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-----ceeE
Confidence 5799999999999999999994 579999999997543 23446789999999999999999999998653 3789
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
+|||||++|+|.+++.... .+++.++..++.||+.||.||| ++||+||||||+|||+++++.+||+||
T Consensus 80 ivmEy~~gg~L~~~l~~~~---------~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DF 147 (271)
T d1nvra_ 80 LFLEYCSGGELFDRIEPDI---------GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDF 147 (271)
T ss_dssp EEEECCTTEEGGGGSBTTT---------BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCC
T ss_pred EEEeccCCCcHHHHHhcCC---------CCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccc
Confidence 9999999999999997654 4678999999999999999999 899999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCCCC-CcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcc
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEA-STYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQR 381 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 381 (473)
|+|+..............+||+.|||||++.+..+ +.++|||||||++|||++|+.||.........+...........
T Consensus 148 G~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~ 227 (271)
T d1nvra_ 148 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 227 (271)
T ss_dssp TTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTST
T ss_pred hhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCC
Confidence 99987755443344455679999999999988776 57899999999999999999999765433322222111100000
Q ss_pred hhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 382 AEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.....+.++.+|+.+||+.||++|||++|+++
T Consensus 228 ----------------------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 228 ----------------------------------PWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp ----------------------------------TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----------------------------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00123456788999999999999999999854
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-56 Score=413.96 Aligned_cols=258 Identities=22% Similarity=0.349 Sum_probs=199.0
Q ss_pred cCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEE
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (473)
.++|++.+.||+|+||+||+|.+.+++.||||+++.. ....+.|.+|++++.+++|||||+++++|... ...++
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-----~~~~l 77 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-----APICL 77 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-----SSCEE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccC-----CceEE
Confidence 4679999999999999999999888889999998753 34457899999999999999999999998653 35799
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecc
Q 012014 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (473)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg 303 (473)
|||||++|+|.+++..... .+++..++.++.||+.||.||| +++|+||||||+|||+++++.+||+|||
T Consensus 78 v~E~~~~g~L~~~l~~~~~--------~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFG 146 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRTQRG--------LFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFG 146 (263)
T ss_dssp EEECCTTCBHHHHHHTTTT--------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC
T ss_pred EEEecCCCcHHHHhhcccc--------CCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccc
Confidence 9999999999999876532 3568899999999999999999 8999999999999999999999999999
Q ss_pred cccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhC-CCCCCCCCCCcccHHHHHHhhcCcch
Q 012014 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTG-IRPSDGIFTGKMNLRNFVKMALPQRA 382 (473)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg-~~P~~~~~~~~~~~~~~~~~~~~~~~ 382 (473)
+++....... .......||+.|+|||++.+..++.++|||||||++|||+|+ .+||... .... +...+......
T Consensus 147 la~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~-~~~~-~~~~i~~~~~~-- 221 (263)
T d1sm2a_ 147 MTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-SNSE-VVEDISTGFRL-- 221 (263)
T ss_dssp -------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC-CHHH-HHHHHHHTCCC--
T ss_pred hheeccCCCc-eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC-CHHH-HHHHHHhcCCC--
Confidence 9987654332 223345689999999999999999999999999999999995 5555432 1111 11111110000
Q ss_pred hhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHHh
Q 012014 383 EEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRK 455 (473)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~ 455 (473)
..+..+++++.+|+.+||+.||++|||++||++.|+.|.++
T Consensus 222 --------------------------------~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 222 --------------------------------YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp --------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------------------------------CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 00112456788999999999999999999999999999764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-56 Score=416.52 Aligned_cols=249 Identities=19% Similarity=0.244 Sum_probs=205.6
Q ss_pred CCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEE
Q 012014 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (473)
++|++.+.||+|+||+||+|. ..+|+.||||+++.......+.+.+|+.++++++|||||+++++|.+. ...++
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~i 94 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELWV 94 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEEC-----CEEEE
Confidence 579999999999999999998 467999999999876666677899999999999999999999998653 36899
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecc
Q 012014 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (473)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg 303 (473)
|||||++|+|.+++... .+++.++..++.||+.||.||| ++||+||||||+|||++.++.+||+|||
T Consensus 95 vmEy~~gg~L~~~~~~~----------~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG 161 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVTET----------CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFG 161 (293)
T ss_dssp EEECCTTCBHHHHHHHS----------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCT
T ss_pred EEEecCCCcHHHHhhcc----------CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccch
Confidence 99999999999988754 3668999999999999999999 8999999999999999999999999999
Q ss_pred cccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcchh
Q 012014 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRAE 383 (473)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 383 (473)
+|+.+.... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+...... +........+.
T Consensus 162 ~a~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~~~~~~~~~--- 235 (293)
T d1yhwa1 162 FCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTPE--- 235 (293)
T ss_dssp TCEECCSTT--CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHHHHCSCC---
T ss_pred hheeecccc--ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH-HHHHHhCCCCC---
Confidence 998765432 233455799999999999999999999999999999999999999975322111 11111110000
Q ss_pred hhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 384 EVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
. ..+...+..+.+|+.+||+.||++|||+.|+++
T Consensus 236 -~-----------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 236 -L-----------------------------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp -C-----------------------------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred -C-----------------------------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 001224567889999999999999999999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.7e-57 Score=420.25 Aligned_cols=268 Identities=21% Similarity=0.296 Sum_probs=214.8
Q ss_pred CCchhhhhcccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeec
Q 012014 134 NPSFKDLYNATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSG 212 (473)
Q Consensus 134 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 212 (473)
.+.+++++...++|++.+.||+|+||+||+|.+ .+++.||||+++.. ....+.+.+|+.+|++++|||||+++++|.+
T Consensus 6 ~p~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 84 (287)
T d1opja_ 6 SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 84 (287)
T ss_dssp STTCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCCCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEee
Confidence 456677777788999999999999999999995 46889999998743 3456789999999999999999999999864
Q ss_pred cccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEec
Q 012014 213 VDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD 292 (473)
Q Consensus 213 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~ 292 (473)
. ...++|||||++|+|.+++...... .+++..++.++.||+.||.||| +++|+||||||+|||++
T Consensus 85 ~-----~~~~iv~E~~~~g~l~~~l~~~~~~-------~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~ 149 (287)
T d1opja_ 85 E-----PPFYIITEFMTYGNLLDYLRECNRQ-------EVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVG 149 (287)
T ss_dssp S-----SSCEEEEECCTTCBHHHHHHHSCTT-------TSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEC
T ss_pred C-----CeeEEEeecccCcchHHHhhhcccc-------chHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEEC
Confidence 3 3679999999999999999764322 4678999999999999999999 89999999999999999
Q ss_pred CCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHH
Q 012014 293 DEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRN 372 (473)
Q Consensus 293 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~ 372 (473)
.++.+||+|||+|+...... ........||+.|+|||++.+..++.++|||||||++|||++|..||........ +..
T Consensus 150 ~~~~~Kl~DFG~a~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~-~~~ 227 (287)
T d1opja_ 150 ENHLVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYE 227 (287)
T ss_dssp GGGCEEECCCCCTTTCCSSS-SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-HHH
T ss_pred CCCcEEEccccceeecCCCC-ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH-HHH
Confidence 99999999999998765432 2223334589999999999999999999999999999999997776643222111 111
Q ss_pred HHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHH
Q 012014 373 FVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLI 452 (473)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l 452 (473)
.+..... .+.+..++..+.+|+.+||+.||++|||++||++.|+.+
T Consensus 228 ~i~~~~~----------------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 228 LLEKDYR----------------------------------MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp HHHTTCC----------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred HHhcCCC----------------------------------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1111000 001123456788999999999999999999999998876
Q ss_pred H
Q 012014 453 R 453 (473)
Q Consensus 453 ~ 453 (473)
.
T Consensus 274 ~ 274 (287)
T d1opja_ 274 F 274 (287)
T ss_dssp T
T ss_pred H
Confidence 3
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-56 Score=415.24 Aligned_cols=263 Identities=24% Similarity=0.347 Sum_probs=209.4
Q ss_pred hhhcccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 139 DLYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 139 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
+++...++|++.+.||+|+||.||+|.+.+++.||||+++... ...+.|.+|+.++.+++|||||++++++.+
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~------ 79 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ------ 79 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS------
T ss_pred CeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc------
Confidence 3445567899999999999999999998888899999997533 346789999999999999999999998743
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...++|||||++|+|.+++..... ..+++.+++.|+.||+.||.||| +++|+||||||+|||+++++.+|
T Consensus 80 ~~~~iv~Ey~~~g~L~~~~~~~~~-------~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~K 149 (272)
T d1qpca_ 80 EPIYIITEYMENGSLVDFLKTPSG-------IKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCK 149 (272)
T ss_dssp SSCEEEEECCTTCBHHHHTTSHHH-------HTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEE
T ss_pred CCeEEEEEeCCCCcHHHHHhhcCC-------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeeccccee
Confidence 235899999999999998765431 23679999999999999999999 89999999999999999999999
Q ss_pred EeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 012014 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMAL 378 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~ 378 (473)
|+|||+|+...... ........||+.|+|||++.+..++.++|||||||++|||+||..|+.........+.. +....
T Consensus 150 l~DFGla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~-i~~~~ 227 (272)
T d1qpca_ 150 IADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN-LERGY 227 (272)
T ss_dssp ECCCTTCEECSSSC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTTC
T ss_pred eccccceEEccCCc-cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHH-HHhcC
Confidence 99999998775432 22223456899999999999889999999999999999999966655432221111111 10000
Q ss_pred CcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHH
Q 012014 379 PQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRR 454 (473)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~ 454 (473)
. ...+..+++.+.+|+.+||+.||++|||++||++.|+.+..
T Consensus 228 ~----------------------------------~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 228 R----------------------------------MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp C----------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C----------------------------------CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 0 00011245678899999999999999999999999998743
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-56 Score=412.26 Aligned_cols=245 Identities=22% Similarity=0.336 Sum_probs=202.2
Q ss_pred CCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeecc---CCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
++|++.+.||+|+||.||+|+. .+++.||+|++... .......+.+|+.++++++|||||++++++.+. ..
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~ 80 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-----TR 80 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-----SE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC-----CE
Confidence 5799999999999999999995 57899999998632 234556789999999999999999999998653 46
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.++|||||++|+|.+++.... .+++.++..++.||+.||.||| +++|+||||||+|||++.++.+||+
T Consensus 81 ~~ivmEy~~~g~L~~~l~~~~---------~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~ 148 (263)
T d2j4za1 81 VYLILEYAPLGTVYRELQKLS---------KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIA 148 (263)
T ss_dssp EEEEEECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEEC
T ss_pred EEEEEeecCCCcHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeec
Confidence 899999999999999997654 3668999999999999999999 8999999999999999999999999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCc
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQ 380 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 380 (473)
|||+|+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... .........
T Consensus 149 DFG~a~~~~~----~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-----~~~~~i~~~ 219 (263)
T d2j4za1 149 DFGWSVHAPS----SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ-----ETYKRISRV 219 (263)
T ss_dssp CCCSCSCCCC----CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHHTT
T ss_pred ccceeeecCC----CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH-----HHHHHHHcC
Confidence 9999986543 2234567999999999999999999999999999999999999999763211 111110000
Q ss_pred chhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 381 RAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.. ..+...++++.+|+.+||+.||++|||++|+++
T Consensus 220 ~~--------------------------------~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 220 EF--------------------------------TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CC--------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CC--------------------------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 00 001123557889999999999999999999975
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-55 Score=405.82 Aligned_cols=248 Identities=24% Similarity=0.333 Sum_probs=196.3
Q ss_pred CccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCC--CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEE
Q 012014 148 SSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVV 224 (473)
Q Consensus 148 ~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 224 (473)
+..++||+|+||+||+|.. .+++.||+|++..... ...+.+.+|+++|++++|||||+++++|.+.. .+....++|
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~~~iv 90 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVLV 90 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCEEEEE
Confidence 5667899999999999994 5688999999875432 23456889999999999999999999986532 335578999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCC--eeeccCCCCcEEec-CCccEEEee
Q 012014 225 YKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPP--IAHCNLKPSNVLLD-DEMIGHVGD 301 (473)
Q Consensus 225 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--iiH~Dlkp~Nil~~-~~~~~kl~D 301 (473)
||||++|+|.+++.... .+++.++..++.||+.||.||| +++ |+||||||+|||++ +++.+||+|
T Consensus 91 mE~~~~g~L~~~l~~~~---------~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~D 158 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFK---------VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGD 158 (270)
T ss_dssp EECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECC
T ss_pred EeCCCCCcHHHHHhccc---------cccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEee
Confidence 99999999999997654 3668899999999999999999 777 99999999999996 578999999
Q ss_pred cccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcc
Q 012014 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQR 381 (473)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 381 (473)
||+|+.... .......||+.|||||++.+ .++.++|||||||++|||++|+.||.+................+..
T Consensus 159 FGla~~~~~----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~ 233 (270)
T d1t4ha_ 159 LGLATLKRA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS 233 (270)
T ss_dssp TTGGGGCCT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGG
T ss_pred cCcceeccC----CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcc
Confidence 999986432 22345679999999999876 6999999999999999999999999754322211111110000000
Q ss_pred hhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 382 AEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.....++++.+|+.+||+.||++|||+.|+++
T Consensus 234 ----------------------------------~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 234 ----------------------------------FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ----------------------------------GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----------------------------------cCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 01123456789999999999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-55 Score=411.47 Aligned_cols=252 Identities=20% Similarity=0.241 Sum_probs=203.7
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
.+.|++.+.||+|+||.||+|+. .+++.||||+++.......+.+.+|+++|++++|||||++++++.+. ...+
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~~~~ 85 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-----NNLW 85 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEET-----TEEE
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-----CeEE
Confidence 35689999999999999999994 57899999999876666678899999999999999999999998653 3679
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
+|||||++|+|.+++..... .+++.++..++.||+.||.||| +++|+||||||+|||++.++.+||+||
T Consensus 86 lvmEy~~~g~L~~~~~~~~~--------~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DF 154 (288)
T d2jfla1 86 ILIEFCAGGAVDAVMLELER--------PLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADF 154 (288)
T ss_dssp EEEECCTTEEHHHHHHHHTS--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCC
T ss_pred EEEecCCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEec
Confidence 99999999999999765321 3668999999999999999999 899999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCcccc-----CCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDL-----GCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
|+|+...... .......||+.|+|||++. +..|+.++|||||||++|||++|..||.+....+. +.......
T Consensus 155 G~a~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~-~~~i~~~~ 231 (288)
T d2jfla1 155 GVSAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-LLKIAKSE 231 (288)
T ss_dssp TTCEECHHHH--HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-HHHHHHSC
T ss_pred hhhhccCCCc--ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH-HHHHHcCC
Confidence 9997653321 1223456999999999974 45689999999999999999999999986433221 11111111
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.+ .. ..+...+.++.+|+.+||+.||++|||++|+++
T Consensus 232 ~~----~~-----------------------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 232 PP----TL-----------------------------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp CC----CC-----------------------------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CC----CC-----------------------------CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00 00 001234567889999999999999999999865
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-56 Score=416.02 Aligned_cols=253 Identities=20% Similarity=0.295 Sum_probs=202.6
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeecc---CCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCce
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (473)
.++|++.+.||+|+||.||+|+. .+|+.||||+++.. .....+.+.+|++++++++||||++++++|.+. .
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-----~ 81 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD-----E 81 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS-----S
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC-----C
Confidence 35799999999999999999994 57999999999742 234557799999999999999999999998643 4
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
..|+|||||++|+|.+++.... .+++..+..++.|++.||.||| +++|+||||||+|||+++++.+||
T Consensus 82 ~~~ivmEy~~gg~L~~~~~~~~---------~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl 149 (288)
T d1uu3a_ 82 KLYFGLSYAKNGELLKYIRKIG---------SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQI 149 (288)
T ss_dssp EEEEEECCCTTEEHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEE
T ss_pred EEEEEEEccCCCCHHHhhhccC---------CCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEe
Confidence 6899999999999999987654 3668999999999999999999 899999999999999999999999
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcC
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP 379 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 379 (473)
+|||+|+.+.............||+.|+|||++.+..++.++|||||||++|||++|..||.+.... ........
T Consensus 150 ~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-----~~~~~i~~ 224 (288)
T d1uu3a_ 150 TDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY-----LIFQKIIK 224 (288)
T ss_dssp CCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHT
T ss_pred cccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH-----HHHHHHHc
Confidence 9999999876544444455567999999999999999999999999999999999999999763211 11111000
Q ss_pred cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHH
Q 012014 380 QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLR 450 (473)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 450 (473)
... ..+...++++.+|+.+||+.||++|||++|++..-.
T Consensus 225 ~~~--------------------------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~ 263 (288)
T d1uu3a_ 225 LEY--------------------------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263 (288)
T ss_dssp TCC--------------------------------CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHH
T ss_pred CCC--------------------------------CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHH
Confidence 000 000123456789999999999999999999866443
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-55 Score=407.58 Aligned_cols=268 Identities=22% Similarity=0.321 Sum_probs=212.5
Q ss_pred ccCCCCccce-eecCCCeEEEEEEec---CCCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCC
Q 012014 143 ATNGFSSANL-IGAGNFGSVYNGTLF---DGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQG 217 (473)
Q Consensus 143 ~~~~~~~~~~-lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 217 (473)
..++|.+.+. ||+|+||.||+|... ++..||||+++.... ...+.|.+|+++|++++|||||++++++.+.
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~---- 81 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE---- 81 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS----
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC----
Confidence 3456777774 999999999999743 355799999975332 2346799999999999999999999998532
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccE
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~ 297 (473)
..++|||||++|+|.+++..... .+++.+++.++.||+.||.||| +++|+||||||+|||++.++.+
T Consensus 82 --~~~lvmE~~~~g~L~~~l~~~~~--------~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~ 148 (285)
T d1u59a_ 82 --ALMLVMEMAGGGPLHKFLVGKRE--------EIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYA 148 (285)
T ss_dssp --SEEEEEECCTTEEHHHHHTTCTT--------TSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEE
T ss_pred --eEEEEEEeCCCCcHHHHhhcccc--------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCce
Confidence 46899999999999999865432 3678999999999999999999 8999999999999999999999
Q ss_pred EEeecccccccCccccc-cceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHH
Q 012014 298 HVGDFGMARFLPAIDKQ-NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVK 375 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~ 375 (473)
||+|||+|+.+...... .......||+.|+|||++.+..++.++|||||||++|||+| |..||.+....+ +...+.
T Consensus 149 Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~--~~~~i~ 226 (285)
T d1u59a_ 149 KISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--VMAFIE 226 (285)
T ss_dssp EECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH--HHHHHH
T ss_pred eeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH--HHHHHH
Confidence 99999999877543322 22334568999999999998899999999999999999998 999998643221 111111
Q ss_pred hhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHHh
Q 012014 376 MALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRK 455 (473)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~ 455 (473)
.... .+.+..++.++.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus 227 ~~~~----------------------------------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 227 QGKR----------------------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp TTCC----------------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cCCC----------------------------------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 1000 001123566888999999999999999999999999998877
Q ss_pred hccCCccc
Q 012014 456 LLETPACL 463 (473)
Q Consensus 456 ~~~~~~~~ 463 (473)
+.+.....
T Consensus 273 ~~~~~~~~ 280 (285)
T d1u59a_ 273 LASKVEGH 280 (285)
T ss_dssp HHTTCSSC
T ss_pred hhhccchh
Confidence 76655443
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.9e-56 Score=414.78 Aligned_cols=259 Identities=23% Similarity=0.390 Sum_probs=194.3
Q ss_pred cCCCCccceeecCCCeEEEEEEec-CCC---EEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTLF-DGT---TIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~---~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
.++|++.++||+|+||+||+|... +++ .||||.+..... ...+.|.+|+.+|++++|||||+++++|.+.
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~----- 99 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS----- 99 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-----
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC-----
Confidence 356888899999999999999853 333 588888764322 2345789999999999999999999998543
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...++|||||++|+|.+++..... .+++.+++.++.||+.||.||| +++|+||||||+|||++.++.+|
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~~~--------~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~K 168 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQNDG--------QFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCK 168 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTTTT--------CSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEE
T ss_pred CEEEEEEEecCCCcceeeeccccC--------CCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEE
Confidence 367999999999999999876532 3668999999999999999999 89999999999999999999999
Q ss_pred EeecccccccCcccccc---ceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHH
Q 012014 299 VGDFGMARFLPAIDKQN---RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFV 374 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~ 374 (473)
|+|||+|+.+....... ......||+.|||||++.+..++.++|||||||++|||+| |..||.+....+ +...+
T Consensus 169 l~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~--~~~~i 246 (299)
T d1jpaa_ 169 VSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD--VINAI 246 (299)
T ss_dssp ECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHH
T ss_pred ECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH--HHHHH
Confidence 99999998765433221 1223457999999999999999999999999999999998 899997643211 11111
Q ss_pred HhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHH
Q 012014 375 KMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRR 454 (473)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~ 454 (473)
..... .+.+.+++..+.+|+.+||+.||++|||+.||++.|+.+.+
T Consensus 247 ~~~~~----------------------------------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 247 EQDYR----------------------------------LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp HTTCC----------------------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HcCCC----------------------------------CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 10000 00112356678899999999999999999999999988754
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-55 Score=413.81 Aligned_cols=267 Identities=23% Similarity=0.302 Sum_probs=207.2
Q ss_pred cccCCCCccceeecCCCeEEEEEEecC-C-----CEEEEEEeecc-CCCCchhHHHHHHHHHhc-CCCCceeeeeeeecc
Q 012014 142 NATNGFSSANLIGAGNFGSVYNGTLFD-G-----TTIAVKVFNLI-RPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGV 213 (473)
Q Consensus 142 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~ 213 (473)
...++|++.++||+|+||+||+|+... + ..||+|.+... .......+.+|+.++.++ +|||||+++++|.+.
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 345789999999999999999998532 2 36999998643 334556789999999998 899999999998653
Q ss_pred ccCCceeeEEEEEecCCCCHHHHhcCCCCCCC--------------CCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCe
Q 012014 214 DYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW--------------RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPI 279 (473)
Q Consensus 214 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~--------------~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~i 279 (473)
...++|||||++|+|.++|+....... ......+++.+++.++.||+.||.||| +++|
T Consensus 114 -----~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~I 185 (325)
T d1rjba_ 114 -----GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSC 185 (325)
T ss_dssp -----SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred -----CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCe
Confidence 367999999999999999976542110 011124678999999999999999999 8999
Q ss_pred eeccCCCCcEEecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCC
Q 012014 280 AHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIR 358 (473)
Q Consensus 280 iH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~ 358 (473)
|||||||+|||++.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||++|||+| |..
T Consensus 186 iHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~ 265 (325)
T d1rjba_ 186 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 265 (325)
T ss_dssp EETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred eeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCC
Confidence 9999999999999999999999999987655443333344568999999999999999999999999999999998 899
Q ss_pred CCCCCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCC
Q 012014 359 PSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRE 438 (473)
Q Consensus 359 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~ 438 (473)
||.+...... +...+...... +.+..+++.+.+|+.+||+.||++
T Consensus 266 Pf~~~~~~~~-~~~~~~~~~~~----------------------------------~~p~~~~~~l~~li~~cl~~dP~~ 310 (325)
T d1rjba_ 266 PYPGIPVDAN-FYKLIQNGFKM----------------------------------DQPFYATEEIYIIMQSCWAFDSRK 310 (325)
T ss_dssp SSTTCCCSHH-HHHHHHTTCCC----------------------------------CCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred CCCCCCHHHH-HHHHHhcCCCC----------------------------------CCCCcCCHHHHHHHHHHcCCChhH
Confidence 9986543321 22222111100 011234567889999999999999
Q ss_pred CCChHHHHHHHHH
Q 012014 439 RMKINDVESRLRL 451 (473)
Q Consensus 439 RPt~~ev~~~L~~ 451 (473)
|||++||++.|..
T Consensus 311 RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 311 RPSFPNLTSFLGC 323 (325)
T ss_dssp SCCHHHHHHHHHH
T ss_pred CcCHHHHHHHHhC
Confidence 9999999999863
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-56 Score=409.13 Aligned_cols=258 Identities=20% Similarity=0.250 Sum_probs=190.0
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCC--CchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
.++|++.+.||+|+||.||+|+ ..+|+.||+|+++..... ..+.+.+|++++++++|||||++++++.+. ....
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~---~~~~ 79 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTT 79 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------C
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeC---CCCE
Confidence 3579999999999999999998 457899999999754322 235688999999999999999999998642 2345
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCC--CCCeeeccCCCCcEEecCCccEE
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDC--QPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~--~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
.++|||||++|+|.+++...... ...+++..++.++.||+.||.|||+.. ..+|+||||||+|||++.++.+|
T Consensus 80 ~~ivmEy~~~g~L~~~i~~~~~~-----~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vk 154 (269)
T d2java1 80 LYIVMEYCEGGDLASVITKGTKE-----RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVK 154 (269)
T ss_dssp EEEEEECCTTEEHHHHHHHHHHH-----TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEE
T ss_pred EEEEEecCCCCcHHHHHHhcccc-----CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEE
Confidence 79999999999999998643210 013678999999999999999999321 13499999999999999999999
Q ss_pred EeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 012014 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMAL 378 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~ 378 (473)
|+|||+|+.+.... .......||+.|+|||++.+..++.++|||||||++|||++|..||.+....+ ..........
T Consensus 155 l~DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~-~~~~i~~~~~ 231 (269)
T d2java1 155 LGDFGLARILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-LAGKIREGKF 231 (269)
T ss_dssp ECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHTCC
T ss_pred EeeccceeecccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH-HHHHHHcCCC
Confidence 99999998765422 22345679999999999999999999999999999999999999997632211 0111111000
Q ss_pred CcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 379 PQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
+ . .+..+++++.+|+.+||+.||++|||+.||++
T Consensus 232 ~----~-------------------------------~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 232 R----R-------------------------------IPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp C----C-------------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C----C-------------------------------CCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 0 0 01123557889999999999999999999864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-54 Score=397.52 Aligned_cols=254 Identities=22% Similarity=0.369 Sum_probs=208.6
Q ss_pred cCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEE
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (473)
.++|++.++||+|+||+||+|+..+++.||||+++... ...+.|.+|+.++.+++||||++++++|.+. ...++
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~-----~~~~i 76 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-----RPIFI 76 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCS-----SSEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeC-----CceEE
Confidence 47899999999999999999998888899999998543 3467899999999999999999999998543 36799
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecc
Q 012014 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFG 303 (473)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg 303 (473)
||||+++|+|.+++..... .+++..+..++.|+++||.||| ++||+||||||+||++++++.+||+|||
T Consensus 77 v~Ey~~~g~l~~~~~~~~~--------~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG 145 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREMRH--------RFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFG 145 (258)
T ss_dssp EEECCTTEEHHHHHHSGGG--------CCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCS
T ss_pred EEEccCCCcHHHhhhcccc--------CCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcch
Confidence 9999999999999766532 3568899999999999999999 8999999999999999999999999999
Q ss_pred cccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcCcch
Q 012014 304 MARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMALPQRA 382 (473)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 382 (473)
+++...... ........||+.|+|||.+.+..++.++|||||||++|||+| |+.||.+....+ +...+......
T Consensus 146 ~a~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~--~~~~i~~~~~~-- 220 (258)
T d1k2pa_ 146 LSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--TAEHIAQGLRL-- 220 (258)
T ss_dssp SCCBCSSSS-CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHHHHHTTCCC--
T ss_pred hheeccCCC-ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH--HHHHHHhCCCC--
Confidence 998765433 223334568999999999999999999999999999999998 899998653221 11111110000
Q ss_pred hhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHH
Q 012014 383 EEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRL 451 (473)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~ 451 (473)
..+..++..+.+|+.+||+.||++|||++||++.|..
T Consensus 221 --------------------------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 221 --------------------------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp --------------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred --------------------------------CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 0011245678899999999999999999999998853
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-54 Score=403.96 Aligned_cols=262 Identities=23% Similarity=0.361 Sum_probs=198.4
Q ss_pred ccCCCCccceeecCCCeEEEEEEecCC-----CEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccccC
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTLFDG-----TTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQ 216 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 216 (473)
..+.|+..++||+|+||.||+|.+.+. ..||||+++.... .....|.+|+.++.+++|||||++++++.+.
T Consensus 5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~--- 81 (283)
T d1mqba_ 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY--- 81 (283)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS---
T ss_pred CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC---
Confidence 346788999999999999999985432 3799999864332 2234688999999999999999999998543
Q ss_pred CceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCcc
Q 012014 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI 296 (473)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~ 296 (473)
...++|||||.+|++.+++..... .+++.+++.++.||+.||.||| +++|+||||||+|||++.++.
T Consensus 82 --~~~~~v~e~~~~~~l~~~~~~~~~--------~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~ 148 (283)
T d1mqba_ 82 --KPMMIITEYMENGALDKFLREKDG--------EFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLV 148 (283)
T ss_dssp --SSEEEEEECCTTEEHHHHHHHTTT--------CSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCC
T ss_pred --CceEEEEEecccCcchhhhhcccc--------cccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCe
Confidence 367999999999999998876532 3668999999999999999999 899999999999999999999
Q ss_pred EEEeecccccccCccccc-cceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 012014 297 GHVGDFGMARFLPAIDKQ-NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVK 375 (473)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~ 375 (473)
+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|..||.........+ ..+.
T Consensus 149 ~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~-~~i~ 227 (283)
T d1mqba_ 149 CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM-KAIN 227 (283)
T ss_dssp EEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-HHHH
T ss_pred EEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHH-HHHh
Confidence 999999999876543222 22334568999999999999999999999999999999999766654322211111 1111
Q ss_pred hhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHHh
Q 012014 376 MALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRK 455 (473)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~ 455 (473)
.... .+.+.+++..+.+|+.+||+.||++||||.||++.|+.+.+.
T Consensus 228 ~~~~----------------------------------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 228 DGFR----------------------------------LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp TTCC----------------------------------CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ccCC----------------------------------CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 0000 001123456788999999999999999999999999988653
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.6e-55 Score=412.91 Aligned_cols=252 Identities=19% Similarity=0.260 Sum_probs=187.3
Q ss_pred ccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
..+.|++.++||+|+||+||+|+. .+++.||||++..... .....+.+|+.+|++++|||||+++++|.+. ..
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~ 81 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESG-----GH 81 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECS-----SE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CE
Confidence 346799999999999999999994 5789999999975432 3345688999999999999999999998543 46
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEec---CCccE
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD---DEMIG 297 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~---~~~~~ 297 (473)
.++|||||+||+|.+++.... .+++.++..++.||+.||.||| +++|+||||||+|||+. +++.+
T Consensus 82 ~~lvmE~~~gg~L~~~l~~~~---------~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~v 149 (307)
T d1a06a_ 82 LYLIMQLVSGGELFDRIVEKG---------FYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKI 149 (307)
T ss_dssp EEEEECCCCSCBHHHHHHTCS---------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCE
T ss_pred EEEEEeccCCCcHHHhhhccc---------CCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceE
Confidence 899999999999999997654 3679999999999999999999 89999999999999994 57899
Q ss_pred EEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
||+|||+|+..... .......||+.|||||++.+..|+.++|||||||++|||++|..||.+..... .........
T Consensus 150 kl~DFG~a~~~~~~---~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-~~~~i~~~~ 225 (307)
T d1a06a_ 150 MISDFGLSKMEDPG---SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK-LFEQILKAE 225 (307)
T ss_dssp EECCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHTTC
T ss_pred EEeccceeEEccCC---CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH-HHHHHhccC
Confidence 99999999865432 22334679999999999999999999999999999999999999997632211 011111100
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.+.. .+.....++.+.+|+.+||+.||++|||++|+++
T Consensus 226 ~~~~--------------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 226 YEFD--------------------------------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp CCCC--------------------------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCC--------------------------------CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0000 0001124567889999999999999999999976
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-55 Score=405.10 Aligned_cols=252 Identities=23% Similarity=0.325 Sum_probs=198.8
Q ss_pred ceeecCCCeEEEEEEec---CCCEEEEEEeeccCC--CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEEE
Q 012014 151 NLIGAGNFGSVYNGTLF---DGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVVY 225 (473)
Q Consensus 151 ~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~ 225 (473)
++||+|+||.||+|.+. .++.||||+++.... ...+.+.+|+.+|++++|||||+++++|.+. ..++||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~------~~~lvm 86 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE------SWMLVM 86 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS------SEEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC------CEEEEE
Confidence 47999999999999853 346899999964322 2345799999999999999999999998432 358999
Q ss_pred EecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeecccc
Q 012014 226 KFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMA 305 (473)
Q Consensus 226 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~ 305 (473)
|||++|+|.+++.... .+++.+++.++.||+.||.||| +++|+||||||+|||++.++.+||+|||++
T Consensus 87 E~~~~g~L~~~l~~~~---------~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla 154 (277)
T d1xbba_ 87 EMAELGPLNKYLQQNR---------HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLS 154 (277)
T ss_dssp ECCTTEEHHHHHHHCT---------TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred EcCCCCcHHHHHhhcc---------CCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhh
Confidence 9999999999998654 3668999999999999999999 899999999999999999999999999999
Q ss_pred cccCccccc-cceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcCcchh
Q 012014 306 RFLPAIDKQ-NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMALPQRAE 383 (473)
Q Consensus 306 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 383 (473)
+.+...... .......||+.|+|||++.+..++.++|||||||++|||+| |..||.+....+ +...+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~--~~~~i~~~~~---- 228 (277)
T d1xbba_ 155 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE--VTAMLEKGER---- 228 (277)
T ss_dssp EECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHTTCC----
T ss_pred hhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH--HHHHHHcCCC----
Confidence 876543322 22234568999999999999999999999999999999998 899998643211 1111111000
Q ss_pred hhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHHhh
Q 012014 384 EVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRKL 456 (473)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~~ 456 (473)
.+.+..++.++.+|+.+||+.||++|||+++|++.|+....+.
T Consensus 229 ------------------------------~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 271 (277)
T d1xbba_ 229 ------------------------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271 (277)
T ss_dssp ------------------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred ------------------------------CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhhc
Confidence 0011234668889999999999999999999999998875443
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-55 Score=413.33 Aligned_cols=201 Identities=26% Similarity=0.331 Sum_probs=174.5
Q ss_pred ccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC-CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
..++|++.++||+|+||+||+|+ ..+|+.||+|+++... ......+.+|+.+|++++|||||+++++|.+. ..
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-----~~ 78 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-----GE 78 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS-----SE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CE
Confidence 45689999999999999999999 4578999999997543 23346789999999999999999999998653 36
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCC-CCeeeccCCCCcEEecCCccEEE
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQ-PPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~-~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
.++|||||++|+|.+++.... .+++..+..++.|++.||.||| + ++|+||||||+|||++.++.+||
T Consensus 79 ~~iVmEy~~gg~L~~~l~~~~---------~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl 146 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKKAG---------RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKL 146 (322)
T ss_dssp EEEEEECCTTEEHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEE
T ss_pred EEEEEEcCCCCcHHHHHhhcC---------CCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEE
Confidence 899999999999999997654 3668999999999999999999 6 48999999999999999999999
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCC
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIF 364 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~ 364 (473)
+|||+|+..... ......||+.|+|||++.+..|+.++||||+||++|||++|+.||.+..
T Consensus 147 ~DFGla~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 147 CDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp CCCCCCHHHHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred eeCCCccccCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 999999865332 2234579999999999999999999999999999999999999998643
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-54 Score=408.30 Aligned_cols=275 Identities=22% Similarity=0.324 Sum_probs=214.2
Q ss_pred CchhhhhcccCCCCccceeecCCCeEEEEEEec------CCCEEEEEEeeccCCC-CchhHHHHHHHHHhcCCCCceeee
Q 012014 135 PSFKDLYNATNGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRPG-GSKSFKSECKAAINIKHRNIVRVF 207 (473)
Q Consensus 135 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~ 207 (473)
+.+.+++...++|++.+.||+|+||.||+|+.. +++.||||+++..... ..+.+.+|+.++++++||||++++
T Consensus 3 p~~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~ 82 (301)
T d1lufa_ 3 PKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLL 82 (301)
T ss_dssp HHHHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred cchhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccce
Confidence 456677778889999999999999999999853 3578999998743322 245699999999999999999999
Q ss_pred eeeeccccCCceeeEEEEEecCCCCHHHHhcCCCCCCC---------------CCcchhhcHHHHHHHHHHHHHHHHHHh
Q 012014 208 TAFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW---------------RPLNFNFLIKKKLDIAIDVACALRYLH 272 (473)
Q Consensus 208 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~---------------~~~~~~~~~~~~~~i~~~i~~~L~~LH 272 (473)
++|... ...+++|||+++|+|.+++........ ......+++.+++.|+.|++.||+|||
T Consensus 83 ~~~~~~-----~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH 157 (301)
T d1lufa_ 83 GVCAVG-----KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS 157 (301)
T ss_dssp EEECSS-----SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred eeeccC-----CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc
Confidence 998543 367999999999999999975432111 011123678899999999999999999
Q ss_pred hCCCCCeeeccCCCCcEEecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHH
Q 012014 273 CDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLE 352 (473)
Q Consensus 273 ~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 352 (473)
+++||||||||+|||++.++.+||+|||+|+...............||+.|+|||.+.+..++.++|||||||++||
T Consensus 158 ---~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~e 234 (301)
T d1lufa_ 158 ---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE 234 (301)
T ss_dssp ---HTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred ---cCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHH
Confidence 89999999999999999999999999999987655544444455678999999999999999999999999999999
Q ss_pred HHhCC-CCCCCCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhc
Q 012014 353 MFTGI-RPSDGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVAC 431 (473)
Q Consensus 353 lltg~-~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c 431 (473)
|++|. +||.+....+ +...+. .+... +.+..++.++.+|+.+|
T Consensus 235 ll~~~~~p~~~~~~~e--~~~~v~---~~~~~-------------------------------~~p~~~~~~~~~li~~c 278 (301)
T d1lufa_ 235 IFSYGLQPYYGMAHEE--VIYYVR---DGNIL-------------------------------ACPENCPLELYNLMRLC 278 (301)
T ss_dssp HHTTTCCTTTTSCHHH--HHHHHH---TTCCC-------------------------------CCCTTCCHHHHHHHHHH
T ss_pred HHccCCCCCCCCCHHH--HHHHHH---cCCCC-------------------------------CCCccchHHHHHHHHHH
Confidence 99985 5676532211 111111 00000 01123456788999999
Q ss_pred ccCCCCCCCChHHHHHHHHHHH
Q 012014 432 SAERPRERMKINDVESRLRLIR 453 (473)
Q Consensus 432 l~~dP~~RPt~~ev~~~L~~l~ 453 (473)
|+.||++||||.||++.|+.|.
T Consensus 279 l~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 279 WSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TCSSGGGSCCHHHHHHHHHHTT
T ss_pred cCCChhHCcCHHHHHHHHHHhc
Confidence 9999999999999999999874
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=6.2e-54 Score=410.30 Aligned_cols=251 Identities=21% Similarity=0.318 Sum_probs=203.6
Q ss_pred CCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEE
Q 012014 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAV 223 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l 223 (473)
++|++.+.||+|+||.||+|+. .+|+.||||++........+.+.+|+.+|++++|||||+++++|.+. ...++
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~i 100 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD-----NEMVM 100 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET-----TEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-----CEEEE
Confidence 5799999999999999999994 57999999999765444556789999999999999999999998653 47899
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEec--CCccEEEee
Q 012014 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD--DEMIGHVGD 301 (473)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~--~~~~~kl~D 301 (473)
|||||++|+|.+++..... .+++.++..++.||+.||.||| ++|||||||||+|||++ .++.+||+|
T Consensus 101 vmE~~~gg~L~~~l~~~~~--------~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~D 169 (350)
T d1koaa2 101 IYEFMSGGELFEKVADEHN--------KMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLID 169 (350)
T ss_dssp EECCCCSCBHHHHHTCTTS--------CBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECC
T ss_pred EEEcCCCCCHHHHHHhhcC--------CCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEee
Confidence 9999999999999965432 3679999999999999999999 99999999999999995 467899999
Q ss_pred cccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcc
Q 012014 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQR 381 (473)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 381 (473)
||+|+.+... .......||+.|||||++.+..++.++|||||||++|+|++|..||.+....+ .+..........
T Consensus 170 FG~a~~~~~~---~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~i~~~~~~~- 244 (350)
T d1koaa2 170 FGLTAHLDPK---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-TLRNVKSCDWNM- 244 (350)
T ss_dssp CTTCEECCTT---SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHTCCCS-
T ss_pred cchheecccc---cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCCC-
Confidence 9999876542 33445679999999999999999999999999999999999999997642211 111111110000
Q ss_pred hhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 382 AEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
. .......++.+.+|+.+||+.||++|||++|+++
T Consensus 245 -----~--------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 245 -----D--------------------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp -----C--------------------------CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred -----C--------------------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0001124557889999999999999999999976
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-54 Score=399.81 Aligned_cols=261 Identities=23% Similarity=0.361 Sum_probs=202.3
Q ss_pred hhcccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCce
Q 012014 140 LYNATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 140 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (473)
+....++|++.+.||+|+||.||+|+..+++.||||+++.. ....+.|.+|+.++++++|||||++++++.+ .
T Consensus 12 ~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~------~ 84 (285)
T d1fmka3 12 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------E 84 (285)
T ss_dssp SBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------S
T ss_pred eEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec------C
Confidence 33445689999999999999999999888889999999743 3345789999999999999999999999743 2
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
..++|||||++|+|..++...... .+++.+++.++.||+.||.||| +++|+||||||+|||++.++.+||
T Consensus 85 ~~~lv~Ey~~~g~l~~~~~~~~~~-------~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl 154 (285)
T d1fmka3 85 PIYIVTEYMSKGSLLDFLKGETGK-------YLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKV 154 (285)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHT-------TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred CeEEEEEecCCCchhhhhhhcccc-------cchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEE
Confidence 358999999999999998764311 3679999999999999999999 899999999999999999999999
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcC
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP 379 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 379 (473)
+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++|..||.........+.. +.....
T Consensus 155 ~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~-i~~~~~ 232 (285)
T d1fmka3 155 ADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYR 232 (285)
T ss_dssp CCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTTCC
T ss_pred cccchhhhccCCC-ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHH-HHhcCC
Confidence 9999998764432 22233456899999999999999999999999999999999976665442221111111 110000
Q ss_pred cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHH
Q 012014 380 QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIR 453 (473)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~ 453 (473)
. +.+..+++++.+|+.+||+.||++|||+++|++.|+...
T Consensus 233 ~----------------------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 233 M----------------------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp C----------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred C----------------------------------CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 0 011234567889999999999999999999998887753
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.3e-53 Score=408.40 Aligned_cols=252 Identities=18% Similarity=0.283 Sum_probs=204.2
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
.++|++.+.||+|+||.||+|+ ..+|+.||||+++.........+.+|+.+|++++|||||+++++|.+ ....+
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~~~ 102 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED-----KYEMV 102 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-----SSEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEE
Confidence 3579999999999999999999 45799999999976544445678899999999999999999999864 34789
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEec--CCccEEEe
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD--DEMIGHVG 300 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~--~~~~~kl~ 300 (473)
+|||||++|+|.+++..... .+++.++..|+.||+.||.||| ++||+||||||+|||++ .++.+||+
T Consensus 103 ivmE~~~gg~L~~~~~~~~~--------~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~ 171 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAEDY--------KMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKII 171 (352)
T ss_dssp EEEECCCCCBHHHHTTCTTC--------CBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEEC
T ss_pred EEEEcCCCChHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEe
Confidence 99999999999998865532 3779999999999999999999 99999999999999997 67899999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCc
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQ 380 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 380 (473)
|||+|+.+... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+..... .+........+
T Consensus 172 DFGla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~i~~~~~~- 246 (352)
T d1koba_ 172 DFGLATKLNPD---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-TLQNVKRCDWE- 246 (352)
T ss_dssp CCTTCEECCTT---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHHCCCC-
T ss_pred ecccceecCCC---CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCC-
Confidence 99999877542 23445679999999999999999999999999999999999999997642211 11111111000
Q ss_pred chhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 381 RAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
... ......+.++.+|+.+||+.||.+|||+.|+++
T Consensus 247 ~~~-------------------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 247 FDE-------------------------------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp CCS-------------------------------STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCc-------------------------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 001124557889999999999999999999975
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=400.39 Aligned_cols=251 Identities=20% Similarity=0.295 Sum_probs=202.5
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCC------CCchhHHHHHHHHHhcCCCCceeeeeeeeccccC
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRP------GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQ 216 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 216 (473)
.++|++.+.||+|+||+||+|+. .+|+.||||+++.... ...+.+.+|+.+|++++|||||+++++|.+.
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--- 85 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK--- 85 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS---
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC---
Confidence 46799999999999999999994 5799999999974332 1245789999999999999999999998653
Q ss_pred CceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCc-
Q 012014 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM- 295 (473)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~- 295 (473)
...++|||||++|+|.+++.... .+++..+..++.|++.||.||| +++|+||||||+|||++.++
T Consensus 86 --~~~~iv~E~~~gg~L~~~i~~~~---------~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~ 151 (293)
T d1jksa_ 86 --TDVILILELVAGGELFDFLAEKE---------SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNV 151 (293)
T ss_dssp --SEEEEEEECCCSCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSS
T ss_pred --CEEEEEEEcCCCccccchhcccc---------ccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCC
Confidence 47899999999999999997654 3668999999999999999999 99999999999999998776
Q ss_pred ---cEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHH
Q 012014 296 ---IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRN 372 (473)
Q Consensus 296 ---~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~ 372 (473)
.+||+|||+|+...... ......||+.|+|||++.+..++.++|||||||++|||++|..||.+....+. +..
T Consensus 152 ~~~~vkl~DfG~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-~~~ 227 (293)
T d1jksa_ 152 PKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-LAN 227 (293)
T ss_dssp SSCCEEECCCTTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHH
T ss_pred cccceEecchhhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH-HHH
Confidence 59999999998764432 23345689999999999999999999999999999999999999986422110 111
Q ss_pred HHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 373 FVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
...... . .........+..+.+|+.+||+.||++|||++|+++
T Consensus 228 i~~~~~-~-------------------------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 228 VSAVNY-E-------------------------------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HHTTCC-C-------------------------------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHhcCC-C-------------------------------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 100000 0 001112235667889999999999999999999864
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.4e-54 Score=402.62 Aligned_cols=244 Identities=19% Similarity=0.245 Sum_probs=196.3
Q ss_pred CCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCC---chhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 146 GFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGG---SKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
.|+..+.||+|+||.||+|+ ..+++.||||+++...... .+.+.+|+.+|++++|||||+++++|.+. ...
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~~ 90 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-----HTA 90 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC-----CEE
Confidence 48889999999999999998 4678999999997543322 24688999999999999999999998653 368
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEee
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~D 301 (473)
++|||||.+|+|..++.... .+++.++..++.||+.||.||| ++||+||||||+|||++.++.+||+|
T Consensus 91 ~iv~E~~~~g~l~~~~~~~~---------~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~D 158 (309)
T d1u5ra_ 91 WLVMEYCLGSASDLLEVHKK---------PLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGD 158 (309)
T ss_dssp EEEEECCSEEHHHHHHHHTS---------CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECC
T ss_pred EEEEEecCCCchHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEee
Confidence 99999999999987776543 3668999999999999999999 89999999999999999999999999
Q ss_pred cccccccCccccccceeeccCCCCcCCCccccC---CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 012014 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG---CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMAL 378 (473)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~ 378 (473)
||+|+.... .....||+.|||||++.+ ..|+.++|||||||++|||++|..||.+..... .+........
T Consensus 159 FG~a~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~-~~~~i~~~~~ 231 (309)
T d1u5ra_ 159 FGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNES 231 (309)
T ss_dssp CTTCBSSSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCC
T ss_pred cccccccCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhCCC
Confidence 999986533 223569999999999864 458999999999999999999999997532211 1111111100
Q ss_pred CcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 379 PQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
+. .. ....++.+.+|+.+||+.||++|||++|+++
T Consensus 232 ~~----~~------------------------------~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 232 PA----LQ------------------------------SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CC----CS------------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CC----CC------------------------------CCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 00 00 0123457889999999999999999999875
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-53 Score=401.02 Aligned_cols=258 Identities=23% Similarity=0.370 Sum_probs=203.2
Q ss_pred CCCCccceeecCCCeEEEEEEe-cCCC----EEEEEEeecc-CCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 145 NGFSSANLIGAGNFGSVYNGTL-FDGT----TIAVKVFNLI-RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~-~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
++|++.++||+|+||+||+|.+ .+|+ +||+|.++.. .....+.+.+|+.++++++|||||+++++|.+.
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~----- 83 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----- 83 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-----
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----
Confidence 4699999999999999999984 3444 6888988643 334567899999999999999999999998653
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
..++++||+.+|+|.+++..... .+++..++.++.||+.||.||| +++|+||||||+|||++.++.+|
T Consensus 84 -~~~~v~e~~~~~~l~~~~~~~~~--------~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~k 151 (317)
T d1xkka_ 84 -TVQLITQLMPFGCLLDYVREHKD--------NIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVK 151 (317)
T ss_dssp -SEEEEEECCTTCBHHHHHHHTSS--------SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEE
T ss_pred -CeeEEEEeccCCccccccccccc--------CCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeE
Confidence 35789999999999998876532 3668999999999999999999 89999999999999999999999
Q ss_pred EeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhh
Q 012014 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~ 377 (473)
|+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+| |.+||.+....+ +...+...
T Consensus 152 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--~~~~i~~~ 229 (317)
T d1xkka_ 152 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEKG 229 (317)
T ss_dssp ECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--HHHHHHHT
T ss_pred eeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHcC
Confidence 999999998765444444445568999999999999999999999999999999998 789987643222 12222111
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHHh
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRK 455 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~ 455 (473)
... +.+..++..+.+|+.+||+.||++|||+.||++.|+.+...
T Consensus 230 ~~~----------------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 230 ERL----------------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp CCC----------------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CCC----------------------------------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 000 01123456788999999999999999999999999988643
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.8e-53 Score=396.17 Aligned_cols=264 Identities=21% Similarity=0.317 Sum_probs=203.8
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCC---chhHHHHHHHHHhcCCCCceeeeeeeeccccCCce
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGG---SKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (473)
.++|++.+.||+|+||.||+|+ ..+|+.||||+++...... ...+.+|+.+++.++|||||++++++...+ ....
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~~ 84 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAGP 84 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSSE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCCc
Confidence 4679999999999999999998 4679999999997543332 346889999999999999999999987643 3344
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
..|+|||||+||+|.+++.... .+++.++..++.||+.||.||| ++||+||||||+|||++.++..+|
T Consensus 85 ~~~lvmE~~~g~~L~~~~~~~~---------~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l 152 (277)
T d1o6ya_ 85 LPYIVMEYVDGVTLRDIVHTEG---------PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKV 152 (277)
T ss_dssp EEEEEEECCCEEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEE
T ss_pred eEEEEEECCCCCEehhhhcccC---------CCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCcccccee
Confidence 6799999999999999987654 3668999999999999999999 899999999999999999999999
Q ss_pred eecccccccCccc-cccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 012014 300 GDFGMARFLPAID-KQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMAL 378 (473)
Q Consensus 300 ~Dfg~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~ 378 (473)
+|||.++...... .........||+.|+|||++.+..++.++|||||||++|||+||.+||.+....+. +........
T Consensus 153 ~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-~~~~~~~~~ 231 (277)
T d1o6ya_ 153 MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-AYQHVREDP 231 (277)
T ss_dssp CCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHCCC
T ss_pred ehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH-HHHHHhcCC
Confidence 9999987654332 22234456799999999999999999999999999999999999999976322111 111111000
Q ss_pred CcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCC-ChHHHHHHHHHHH
Q 012014 379 PQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERM-KINDVESRLRLIR 453 (473)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-t~~ev~~~L~~l~ 453 (473)
. ... ......++.+.+|+.+||+.||++|| |++++++.|..++
T Consensus 232 -~-~~~------------------------------~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 232 -I-PPS------------------------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp -C-CGG------------------------------GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -C-CCc------------------------------hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 0 000 00112456788999999999999999 8999999998875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-54 Score=399.65 Aligned_cols=261 Identities=19% Similarity=0.315 Sum_probs=197.0
Q ss_pred hcccCCCCccceeecCCCeEEEEEEecC----CCEEEEEEeeccCCC-CchhHHHHHHHHHhcCCCCceeeeeeeecccc
Q 012014 141 YNATNGFSSANLIGAGNFGSVYNGTLFD----GTTIAVKVFNLIRPG-GSKSFKSECKAAINIKHRNIVRVFTAFSGVDY 215 (473)
Q Consensus 141 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 215 (473)
+...++|++.+.||+|+||.||+|+... +..||||.++..... ..+.+.+|+.++++++|||||++++++.+
T Consensus 3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~--- 79 (273)
T d1mp8a_ 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE--- 79 (273)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS---
T ss_pred CcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---
Confidence 3445689999999999999999998532 346888887643322 23568999999999999999999999843
Q ss_pred CCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCc
Q 012014 216 QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM 295 (473)
Q Consensus 216 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~ 295 (473)
...++||||+++|+|.+++..... .+++..++.++.||+.||.||| +++|+||||||+||+++.++
T Consensus 80 ---~~~~iv~E~~~~g~l~~~~~~~~~--------~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~ 145 (273)
T d1mp8a_ 80 ---NPVWIIMELCTLGELRSFLQVRKY--------SLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSND 145 (273)
T ss_dssp ---SSCEEEEECCTTEEHHHHHHHTTT--------TSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETT
T ss_pred ---CeEEEEEEeccCCcHHhhhhccCC--------CCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCC
Confidence 246999999999999998765432 3668999999999999999999 89999999999999999999
Q ss_pred cEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHH
Q 012014 296 IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFV 374 (473)
Q Consensus 296 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~ 374 (473)
.+||+|||+|+...... ........||+.|+|||++.+..++.++|||||||++|||++ |.+||.+....+ +...+
T Consensus 146 ~~Kl~DfG~a~~~~~~~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~--~~~~i 222 (273)
T d1mp8a_ 146 CVKLGDFGLSRYMEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VIGRI 222 (273)
T ss_dssp EEEECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG--HHHHH
T ss_pred cEEEccchhheeccCCc-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH--HHHHH
Confidence 99999999998765432 223344568999999999999999999999999999999998 899997643322 11111
Q ss_pred HhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHH
Q 012014 375 KMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRR 454 (473)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~ 454 (473)
..... .+.+..+++.+.+|+.+||+.||++|||+.||++.|+.+.+
T Consensus 223 ~~~~~----------------------------------~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 223 ENGER----------------------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp HTTCC----------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcCCC----------------------------------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 10000 00112345688999999999999999999999999999865
Q ss_pred h
Q 012014 455 K 455 (473)
Q Consensus 455 ~ 455 (473)
.
T Consensus 269 ~ 269 (273)
T d1mp8a_ 269 E 269 (273)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-53 Score=391.28 Aligned_cols=254 Identities=24% Similarity=0.345 Sum_probs=199.1
Q ss_pred ccCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
..++|++.++||+|+||.||+|+. .|+.||||+++. ....+.+.+|++++++++||||++++++|.+ .....+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~~~~ 77 (262)
T d1byga_ 5 NMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLY 77 (262)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCC--CC--HHHHHTHHHHTTCCCTTBCCEEEEECC----C--CCE
T ss_pred CHHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEe----cCCcEE
Confidence 446788899999999999999996 578999999864 3456789999999999999999999998853 223569
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
+||||+++|+|.+++..... ..+++..++.|+.||+.||.||| +++|+||||||+|||++.++.+||+||
T Consensus 78 lv~ey~~~g~L~~~l~~~~~-------~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~df 147 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRGR-------SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDF 147 (262)
T ss_dssp EEECCCTTEEHHHHHHHHHH-------HHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCC
T ss_pred EEEeccCCCCHHHHHHhcCC-------CCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeeccc
Confidence 99999999999999975421 13678999999999999999999 899999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHHHhhcCcc
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFVKMALPQR 381 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 381 (473)
|+++..... .....+|+.|+|||++.+..++.++|||||||++|||+| |.+||......+ +...+....
T Consensus 148 g~s~~~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~--~~~~i~~~~--- 217 (262)
T d1byga_ 148 GLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVEKGY--- 217 (262)
T ss_dssp CC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--HHHHHTTTC---
T ss_pred ccceecCCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHcCC---
Confidence 999865332 223457999999999998999999999999999999998 788876542221 111111000
Q ss_pred hhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHH
Q 012014 382 AEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRR 454 (473)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~ 454 (473)
.++.+..+++.+.+|+.+||+.||.+|||+.||++.|+.++.
T Consensus 218 -------------------------------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 218 -------------------------------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp -------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------------------------------CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 001112345678899999999999999999999999999864
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-53 Score=403.28 Aligned_cols=248 Identities=19% Similarity=0.220 Sum_probs=202.9
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeecc---CCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCce
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (473)
-++|++.+.||+|+||.||+|+ ..+|+.||||++++. .....+.+.+|+.+|++++||||++++++|.+. .
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~ 78 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-----D 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS-----S
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccc-----c
Confidence 3579999999999999999999 467999999999742 234567789999999999999999999998653 4
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
..++|||||++|+|.+++.... .+++..+..++.||+.||+||| ++||+||||||+|||++.+|.+||
T Consensus 79 ~~~iv~ey~~gg~L~~~~~~~~---------~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl 146 (337)
T d1o6la_ 79 RLCFVMEYANGGELFFHLSRER---------VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKI 146 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS---------CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEE
T ss_pred ccccceeccCCCchhhhhhccc---------CCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEE
Confidence 7899999999999999998765 3668899999999999999999 999999999999999999999999
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcC
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP 379 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 379 (473)
+|||+|+...... ......+||+.|+|||++.+..|+.++|||||||++|||++|++||.+..... .+....... .
T Consensus 147 ~DFG~a~~~~~~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~-~~~~i~~~~-~ 222 (337)
T d1o6la_ 147 TDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-LFELILMEE-I 222 (337)
T ss_dssp CCCTTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCC-C
T ss_pred eecccccccccCC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH-HHHHHhcCC-C
Confidence 9999998654322 23344679999999999999999999999999999999999999998643211 011110000 0
Q ss_pred cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCC-----hHHHHH
Q 012014 380 QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMK-----INDVES 447 (473)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~ 447 (473)
..+...+.++.+|+.+||+.||.+||+ ++|+++
T Consensus 223 -----------------------------------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 -----------------------------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -----------------------------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -----------------------------------CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 001123456789999999999999995 777765
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-53 Score=396.74 Aligned_cols=274 Identities=22% Similarity=0.277 Sum_probs=202.3
Q ss_pred hhhcccCCCCccceeecCCCeEEEEEEec------CCCEEEEEEeeccCC-CCchhHHHHHHHHHhc-CCCCceeeeeee
Q 012014 139 DLYNATNGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRP-GGSKSFKSECKAAINI-KHRNIVRVFTAF 210 (473)
Q Consensus 139 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 210 (473)
.+....++|++.++||+|+||.||+|... +++.||||+++.... ...+.+.+|..++.++ +|+||+.+++++
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~ 86 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 86 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence 34445578999999999999999999843 246899999874322 2345677888888777 689999999987
Q ss_pred eccccCCceeeEEEEEecCCCCHHHHhcCCCCCC-------CCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeecc
Q 012014 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTN-------WRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCN 283 (473)
Q Consensus 211 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~-------~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~D 283 (473)
... ....++|||||++|+|.+++....... .......+++.+++.++.||+.||.||| +++|+|||
T Consensus 87 ~~~----~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrD 159 (299)
T d1ywna1 87 TKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD 159 (299)
T ss_dssp CST----TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred ccC----CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCc
Confidence 542 345799999999999999997653210 0011224778999999999999999999 89999999
Q ss_pred CCCCcEEecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhC-CCCCCC
Q 012014 284 LKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTG-IRPSDG 362 (473)
Q Consensus 284 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg-~~P~~~ 362 (473)
|||+|||+++++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++| .+||.+
T Consensus 160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~ 239 (299)
T d1ywna1 160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239 (299)
T ss_dssp CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999876554444444456799999999999999999999999999999999996 567765
Q ss_pred CCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCCh
Q 012014 363 IFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKI 442 (473)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~ 442 (473)
..... .+...+....... .+..+++++.+|+.+||+.||++|||+
T Consensus 240 ~~~~~-~~~~~~~~~~~~~----------------------------------~~~~~~~~l~~li~~cl~~dP~~Rpt~ 284 (299)
T d1ywna1 240 VKIDE-EFCRRLKEGTRMR----------------------------------APDYTTPEMYQTMLDCWHGEPSQRPTF 284 (299)
T ss_dssp CCCSH-HHHHHHHHTCCCC----------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred CCHHH-HHHHHHhcCCCCC----------------------------------CCccCCHHHHHHHHHHcCCChhHCcCH
Confidence 43322 1122111111000 011245578899999999999999999
Q ss_pred HHHHHHHHHHHH
Q 012014 443 NDVESRLRLIRR 454 (473)
Q Consensus 443 ~ev~~~L~~l~~ 454 (473)
.||++.|+.+.+
T Consensus 285 ~eil~~L~~ilq 296 (299)
T d1ywna1 285 SELVEHLGNLLQ 296 (299)
T ss_dssp HHHHHHHHHHHH
T ss_pred HHHHHHHHHHHh
Confidence 999999998854
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.2e-53 Score=398.80 Aligned_cols=244 Identities=25% Similarity=0.339 Sum_probs=200.7
Q ss_pred CCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeecc---CCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
++|++.+.||+|+||+||+|+. .+|+.||||+++.. .....+.+.+|+.++++++|||||++++++.+. ..
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA-----QQ 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS-----SE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeC-----Ce
Confidence 4699999999999999999994 67999999999732 334567789999999999999999999998653 47
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.++|||||+||+|..++..... +++..+..++.||+.||.||| ++||+||||||+|||++.++.+||+
T Consensus 79 ~~ivmE~~~gg~l~~~~~~~~~---------~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~ 146 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLRKSQR---------FPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKIT 146 (316)
T ss_dssp EEEEECCCCSCBHHHHHHHTSS---------CCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEEC
T ss_pred eeeEeeecCCcccccccccccc---------ccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEe
Confidence 8999999999999999987653 457888899999999999999 9999999999999999999999999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCc
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQ 380 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 380 (473)
|||+|+..... ....+||+.|||||++.+..|+.++|||||||++|+|++|..||.+..... .+........
T Consensus 147 DFG~a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~i~~~~~-- 218 (316)
T d1fota_ 147 DFGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK-TYEKILNAEL-- 218 (316)
T ss_dssp CCSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHCCC--
T ss_pred cCccceEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH-HHHHHHcCCC--
Confidence 99999876432 234679999999999999999999999999999999999999997632111 0111110000
Q ss_pred chhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCC-----ChHHHHH
Q 012014 381 RAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERM-----KINDVES 447 (473)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~ 447 (473)
..+...++++.+++.+||..||.+|| |++||++
T Consensus 219 ----------------------------------~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 219 ----------------------------------RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp ----------------------------------CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ----------------------------------CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 00112345688999999999999996 8999875
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-52 Score=396.81 Aligned_cols=256 Identities=18% Similarity=0.248 Sum_probs=200.3
Q ss_pred cCCCCccc-eeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhc-CCCCceeeeeeeeccccCCcee
Q 012014 144 TNGFSSAN-LIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 144 ~~~~~~~~-~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 220 (473)
.++|.+.. +||+|+||.||+|+ ..+++.||||+++. ...+.+|+.++.++ +|||||+++++|.+.. .....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~~~~ 83 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLY-AGRKC 83 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cCCCE
Confidence 35788765 69999999999998 46799999999863 46788999987655 8999999999986532 33457
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecC---CccE
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD---EMIG 297 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~---~~~~ 297 (473)
.|+|||||+||+|.++|...... .+++.++..++.||+.||+||| ++||+||||||+|||++. ++.+
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~-------~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~ 153 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQ-------AFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAIL 153 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCC-------CEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCE
T ss_pred EEEEEECCCCCcHHHHHHhcCCC-------CcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccc
Confidence 89999999999999999865322 4789999999999999999999 999999999999999975 5679
Q ss_pred EEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 298 HVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
||+|||+|+...... ......||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+...... ...+....
T Consensus 154 Kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~-~~~~~~~i 229 (335)
T d2ozaa1 154 KLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-SPGMKTRI 229 (335)
T ss_dssp EECCCTTCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------CC
T ss_pred cccccceeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH-HHHHHHHH
Confidence 999999998765432 23445799999999999999999999999999999999999999976432211 00000000
Q ss_pred cCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 378 LPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
..... . .........++++.+|+.+||+.||++|||+.|+++
T Consensus 230 ~~~~~-~---------------------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 230 RMGQY-E---------------------------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp CSCSS-S---------------------------CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hcCCC-C---------------------------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 00000 0 000112345678899999999999999999999976
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=389.27 Aligned_cols=260 Identities=24% Similarity=0.342 Sum_probs=202.9
Q ss_pred cceeecCCCeEEEEEEecCC----CEEEEEEeeccC-CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeEEE
Q 012014 150 ANLIGAGNFGSVYNGTLFDG----TTIAVKVFNLIR-PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKAVV 224 (473)
Q Consensus 150 ~~~lg~G~~g~V~~~~~~~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 224 (473)
.++||+|+||+||+|++.++ ..||||+++... ....+.|.+|+++|.+++|||||+++|++... ....++|
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~~~lv 107 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----EGSPLVV 107 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET----TTEEEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec----CCceEEE
Confidence 46799999999999985332 258999987432 23346799999999999999999999998543 2357999
Q ss_pred EEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeeccc
Q 012014 225 YKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDFGM 304 (473)
Q Consensus 225 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~ 304 (473)
||||++|+|.+++..... .+++..++.++.|++.||.||| +++|+||||||+|||+++++.+||+|||+
T Consensus 108 ~E~~~~g~l~~~~~~~~~--------~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~ 176 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGL 176 (311)
T ss_dssp EECCTTCBHHHHHHCTTC--------CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGG
T ss_pred EEEeecCchhhhhccccc--------cchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccc
Confidence 999999999999886543 2457888999999999999999 89999999999999999999999999999
Q ss_pred ccccCccccc--cceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcch
Q 012014 305 ARFLPAIDKQ--NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQRA 382 (473)
Q Consensus 305 ~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 382 (473)
++........ .......||+.|+|||.+.+..++.++||||||+++|||+||..||..................+
T Consensus 177 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~--- 253 (311)
T d1r0pa_ 177 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL--- 253 (311)
T ss_dssp GCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCC---
T ss_pred hhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---
Confidence 9876543221 12233568999999999999999999999999999999999888876533222111111110000
Q ss_pred hhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHHHHhhccC
Q 012014 383 EEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLIRRKLLET 459 (473)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l~~~~~~~ 459 (473)
..+..+++.+.+|+.+||+.||++|||+.||++.|+.+...+...
T Consensus 254 --------------------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~ 298 (311)
T d1r0pa_ 254 --------------------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298 (311)
T ss_dssp --------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred --------------------------------CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence 001124567889999999999999999999999999998775554
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-52 Score=389.10 Aligned_cols=271 Identities=20% Similarity=0.270 Sum_probs=201.8
Q ss_pred CCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHH--HHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 145 NGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSEC--KAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~--~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
.+|.+.+.||+|+||.||+|+. +|+.||||+++.. ....+.+|. ..+..++|||||++++++.+.+ ......+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEEE
Confidence 3577788999999999999985 7899999998642 233444444 4456789999999999997654 3345689
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhC-----CCCCeeeccCCCCcEEecCCccE
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCD-----CQPPIAHCNLKPSNVLLDDEMIG 297 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~-----~~~~iiH~Dlkp~Nil~~~~~~~ 297 (473)
+|||||++|+|.++++.. .+++.+++.++.|++.||.|||+. .+++|+||||||+|||++.++.+
T Consensus 78 lv~Ey~~~g~L~~~l~~~----------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~ 147 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRY----------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 147 (303)
T ss_dssp EEEECCTTCBHHHHHHHC----------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCE
T ss_pred EEEecccCCCHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCe
Confidence 999999999999999865 266899999999999999999932 13699999999999999999999
Q ss_pred EEeecccccccCccccc--cceeeccCCCCcCCCccccCCC------CCcccchhhHhHHHHHHHhCCCCCCCCCCCccc
Q 012014 298 HVGDFGMARFLPAIDKQ--NRFICIKGSTGYIPPEYDLGCE------ASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMN 369 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~ 369 (473)
||+|||+++........ .......||+.|+|||++.+.. ++.++|||||||++|||+||..||.........
T Consensus 148 Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~ 227 (303)
T d1vjya_ 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227 (303)
T ss_dssp EECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred EEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccc
Confidence 99999999876543321 2234567999999999987643 577899999999999999999887643322211
Q ss_pred HH----------HHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCC
Q 012014 370 LR----------NFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRER 439 (473)
Q Consensus 370 ~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~R 439 (473)
.. ........... ++.. .......+.+..+.+|+.+||+.||++|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~----~p~~---------------------~~~~~~~~~~~~l~~li~~cl~~dp~~R 282 (303)
T d1vjya_ 228 YYDLVPSDPSVEEMRKVVCEQKL----RPNI---------------------PNRWQSCEALRVMAKIMRECWYANGAAR 282 (303)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCC----CCCC---------------------CGGGGGCHHHHHHHHHHHTTCCSSGGGS
T ss_pred hhhcccccchHHHHHHHHhcccc----CCCC---------------------CcccCChHHHHHHHHHHHHHcccCHhHC
Confidence 11 11110000000 0000 0011123467789999999999999999
Q ss_pred CChHHHHHHHHHHHHh
Q 012014 440 MKINDVESRLRLIRRK 455 (473)
Q Consensus 440 Pt~~ev~~~L~~l~~~ 455 (473)
||+.||++.|+.|.+.
T Consensus 283 ps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 283 LTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CCHHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHHHHh
Confidence 9999999999999753
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=6.4e-52 Score=383.84 Aligned_cols=250 Identities=20% Similarity=0.277 Sum_probs=200.5
Q ss_pred CCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCC---------chhHHHHHHHHHhcC-CCCceeeeeeeecc
Q 012014 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGG---------SKSFKSECKAAINIK-HRNIVRVFTAFSGV 213 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 213 (473)
++|++.+.||+|+||+||+|+. .+|+.||||+++...... .+.+.+|+.++++++ ||||++++++|.+
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~- 81 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET- 81 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc-
Confidence 5899999999999999999994 578999999997544322 135789999999997 9999999999865
Q ss_pred ccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecC
Q 012014 214 DYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD 293 (473)
Q Consensus 214 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~ 293 (473)
....|+|||||++|+|.+++.... .+++.++..++.||+.||+||| +++|+||||||+|||++.
T Consensus 82 ----~~~~~ivmE~~~~g~L~~~l~~~~---------~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~ 145 (277)
T d1phka_ 82 ----NTFFFLVFDLMKKGELFDYLTEKV---------TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDD 145 (277)
T ss_dssp ----SSEEEEEEECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECT
T ss_pred ----CcceEEEEEcCCCchHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcC
Confidence 347899999999999999997654 3679999999999999999999 899999999999999999
Q ss_pred CccEEEeecccccccCccccccceeeccCCCCcCCCccccC------CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCc
Q 012014 294 EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG------CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGK 367 (473)
Q Consensus 294 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~ 367 (473)
++.+||+|||+++.+.... ......||+.|+|||.+.+ ..++.++||||+||++|+|++|..||.+.....
T Consensus 146 ~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~ 222 (277)
T d1phka_ 146 DMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML 222 (277)
T ss_dssp TCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred CCCeEEccchheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH
Confidence 9999999999998775422 2344569999999998753 347889999999999999999999998643211
Q ss_pred ccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 368 MNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.+......... . ........++++.+|+.+||+.||++|||+.||++
T Consensus 223 -~~~~i~~~~~~-----~---------------------------~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 223 -MLRMIMSGNYQ-----F---------------------------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp -HHHHHHHTCCC-----C---------------------------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred -HHHHHHhCCCC-----C---------------------------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11111111000 0 00011235568889999999999999999999854
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-53 Score=390.36 Aligned_cols=257 Identities=27% Similarity=0.373 Sum_probs=194.0
Q ss_pred cCCCCccceeecCCCeEEEEEEec--CC--CEEEEEEeeccCC---CCchhHHHHHHHHHhcCCCCceeeeeeeeccccC
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTLF--DG--TTIAVKVFNLIRP---GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQ 216 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 216 (473)
.++|++.+.||+|+||.||+|+.. ++ ..||||+++.... ...+.|.+|+.++++++|||||+++++|.+.
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~--- 83 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--- 83 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS---
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec---
Confidence 357999999999999999999843 22 3689999874322 2345789999999999999999999998542
Q ss_pred CceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCcc
Q 012014 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI 296 (473)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~ 296 (473)
..++|||||++|+|.+++..... .+++..++.++.||+.||.||| +++|+||||||+||+++.++.
T Consensus 84 ---~~~lv~e~~~~~~l~~~~~~~~~--------~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~ 149 (273)
T d1u46a_ 84 ---PMKMVTELAPLGSLLDRLRKHQG--------HFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDL 149 (273)
T ss_dssp ---SCEEEEECCTTCBHHHHHHHHGG--------GSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTE
T ss_pred ---chheeeeeecCcchhhhhhcccC--------CCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccc
Confidence 35899999999999998865432 4779999999999999999999 899999999999999999999
Q ss_pred EEEeecccccccCcccccc-ceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCCCCCCCcccHHHHH
Q 012014 297 GHVGDFGMARFLPAIDKQN-RFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSDGIFTGKMNLRNFV 374 (473)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~ 374 (473)
+||+|||+++......... ......||..|+|||++.+..++.++|||||||++|||+| |..||.+....+. +....
T Consensus 150 vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~-~~~i~ 228 (273)
T d1u46a_ 150 VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI-LHKID 228 (273)
T ss_dssp EEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-HHHHH
T ss_pred eeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH-HHHHH
Confidence 9999999999775443222 2233457889999999999999999999999999999998 8999976422211 11111
Q ss_pred HhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHH
Q 012014 375 KMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLI 452 (473)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l 452 (473)
+.... .+.+..++..+.+|+.+||+.||++||||+||.+.|+..
T Consensus 229 ~~~~~----------------------------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 229 KEGER----------------------------------LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp TSCCC----------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hCCCC----------------------------------CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 00000 001112456788999999999999999999999988865
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-52 Score=391.51 Aligned_cols=273 Identities=23% Similarity=0.285 Sum_probs=213.0
Q ss_pred hhhcccCCCCccceeecCCCeEEEEEEe------cCCCEEEEEEeeccCC-CCchhHHHHHHHHHhc-CCCCceeeeeee
Q 012014 139 DLYNATNGFSSANLIGAGNFGSVYNGTL------FDGTTIAVKVFNLIRP-GGSKSFKSECKAAINI-KHRNIVRVFTAF 210 (473)
Q Consensus 139 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~ 210 (473)
.+....++|++.++||+|+||.||+|++ .+++.||||+++.... .....+.+|+.++.++ +|||||+++++|
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 3445668999999999999999999984 2456899999975432 2344688999999999 699999999998
Q ss_pred eccccCCceeeEEEEEecCCCCHHHHhcCCCCCCC---------CCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeee
Q 012014 211 SGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW---------RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAH 281 (473)
Q Consensus 211 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~---------~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH 281 (473)
.+. ...++|||||++|+|.+++........ ......+++..+..++.||+.||.||| +++++|
T Consensus 97 ~~~-----~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivH 168 (311)
T d1t46a_ 97 TIG-----GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIH 168 (311)
T ss_dssp CSS-----SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCC
T ss_pred eeC-----CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeee
Confidence 553 357999999999999999976543211 011224778999999999999999999 899999
Q ss_pred ccCCCCcEEecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCC
Q 012014 282 CNLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPS 360 (473)
Q Consensus 282 ~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~ 360 (473)
|||||+||+++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+| |.+||
T Consensus 169 rDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~ 248 (311)
T d1t46a_ 169 RDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248 (311)
T ss_dssp SCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred cccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCC
Confidence 99999999999999999999999998765444444455678999999999999999999999999999999999 55555
Q ss_pred CCCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCC
Q 012014 361 DGIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERM 440 (473)
Q Consensus 361 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP 440 (473)
.+.. ....+...+....+.. .+...+..+.+|+.+||+.||++||
T Consensus 249 ~~~~-~~~~~~~~i~~~~~~~----------------------------------~~~~~~~~l~~Li~~cl~~dP~~RP 293 (311)
T d1t46a_ 249 PGMP-VDSKFYKMIKEGFRML----------------------------------SPEHAPAEMYDIMKTCWDADPLKRP 293 (311)
T ss_dssp TTCC-SSHHHHHHHHHTCCCC----------------------------------CCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred CCCC-HHHHHHHHHhcCCCCC----------------------------------CcccccHHHHHHHHHHcCCChhHCc
Confidence 4432 2222222222211110 0112456788999999999999999
Q ss_pred ChHHHHHHHHHHHH
Q 012014 441 KINDVESRLRLIRR 454 (473)
Q Consensus 441 t~~ev~~~L~~l~~ 454 (473)
||.||++.|+++..
T Consensus 294 s~~~il~~L~~~i~ 307 (311)
T d1t46a_ 294 TFKQIVQLIEKQIS 307 (311)
T ss_dssp CHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHhhc
Confidence 99999999987644
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=390.02 Aligned_cols=268 Identities=22% Similarity=0.322 Sum_probs=203.6
Q ss_pred cCCCCccceeecCCCeEEEEEEec-CCC--EEEEEEeecc-CCCCchhHHHHHHHHHhc-CCCCceeeeeeeeccccCCc
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTLF-DGT--TIAVKVFNLI-RPGGSKSFKSECKAAINI-KHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 218 (473)
.++|++.++||+|+||.||+|.+. +|. .||||+++.. .....+.+.+|+++|.++ +|||||+++++|.+.
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~----- 83 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR----- 83 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-----
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC-----
Confidence 367888999999999999999853 444 4778887643 334566899999999999 799999999998653
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCC-------CCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEe
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNW-------RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL 291 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~-------~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~ 291 (473)
...++||||+++|+|.++|+....... ......+++.+++.++.||+.||.||| +++|+||||||+|||+
T Consensus 84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~ 160 (309)
T d1fvra_ 84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILV 160 (309)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEE
T ss_pred CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEE
Confidence 368999999999999999976521000 000114678999999999999999999 8999999999999999
Q ss_pred cCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCC-CCCCCCCCCcccH
Q 012014 292 DDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGI-RPSDGIFTGKMNL 370 (473)
Q Consensus 292 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~-~P~~~~~~~~~~~ 370 (473)
+.++.+||+|||+++....... .....||..|+|||.+.+..++.++|||||||++|||++|. +||.+.. .
T Consensus 161 ~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~-----~ 232 (309)
T d1fvra_ 161 GENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-----C 232 (309)
T ss_dssp CGGGCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC-----H
T ss_pred cCCCceEEcccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC-----H
Confidence 9999999999999986543222 22345899999999999999999999999999999999975 5665432 1
Q ss_pred HHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHH
Q 012014 371 RNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLR 450 (473)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~ 450 (473)
........... ..+.+..+++++.+|+.+||+.||++||||.||++.|+
T Consensus 233 ~~~~~~i~~~~-------------------------------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~ 281 (309)
T d1fvra_ 233 AELYEKLPQGY-------------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281 (309)
T ss_dssp HHHHHHGGGTC-------------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHhcC-------------------------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 11111110000 00011234568899999999999999999999999999
Q ss_pred HHHHhhcc
Q 012014 451 LIRRKLLE 458 (473)
Q Consensus 451 ~l~~~~~~ 458 (473)
.+.+....
T Consensus 282 ~i~~~~~~ 289 (309)
T d1fvra_ 282 RMLEERKT 289 (309)
T ss_dssp HHHHSSSC
T ss_pred HHHhcCcC
Confidence 99765443
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.5e-52 Score=399.49 Aligned_cols=244 Identities=19% Similarity=0.239 Sum_probs=200.7
Q ss_pred CCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeecc---CCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCcee
Q 012014 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI---RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 220 (473)
++|++.+.||+|+||.||+|+. .+|+.||||+++.. .....+.+.+|+.+|+.++|||||++++++.+. ..
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~ 115 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN-----SN 115 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-----SE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccc-----cc
Confidence 5799999999999999999984 57999999998632 234556789999999999999999999998653 36
Q ss_pred eEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEe
Q 012014 221 KAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVG 300 (473)
Q Consensus 221 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~ 300 (473)
.++||||+.+|+|.+++.... .+++.++..++.||+.||.||| +++||||||||+|||++.++.+||+
T Consensus 116 ~~~v~e~~~~g~l~~~l~~~~---------~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~ 183 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLRRIG---------RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVT 183 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHC---------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred cccccccccccchhhhHhhcC---------CCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEee
Confidence 799999999999999997654 3668999999999999999999 8999999999999999999999999
Q ss_pred ecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCc
Q 012014 301 DFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQ 380 (473)
Q Consensus 301 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 380 (473)
|||+|+..... .....||+.|||||++.+..++.++|||||||++|||++|..||.+..... .+....... +.
T Consensus 184 DFG~a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~i~~~~-~~ 256 (350)
T d1rdqe_ 184 DFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-IYEKIVSGK-VR 256 (350)
T ss_dssp CCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHCC-CC
T ss_pred eceeeeecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH-HHHHHhcCC-CC
Confidence 99999876432 234569999999999999999999999999999999999999997632111 011110000 00
Q ss_pred chhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCC-----ChHHHHH
Q 012014 381 RAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERM-----KINDVES 447 (473)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RP-----t~~ev~~ 447 (473)
.+...++++.+|+.+||+.||.+|+ |++||++
T Consensus 257 -----------------------------------~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 257 -----------------------------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -----------------------------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -----------------------------------CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 0112355788999999999999994 8999875
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-52 Score=391.78 Aligned_cols=252 Identities=19% Similarity=0.259 Sum_probs=202.3
Q ss_pred ccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
..++|.+.+.||+|+||+||+|.. .+++.||||+++... .....+.+|+++|+.++|||||+++++|.+. ...
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-----~~~ 76 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESM-----EEL 76 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET-----TEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-----CEE
Confidence 356899999999999999999994 578899999997532 2345688999999999999999999998653 368
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCC--ccEEE
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDE--MIGHV 299 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~--~~~kl 299 (473)
|+|||||+||+|.+++..... .+++.++..++.||+.||.||| ++||+||||||+|||++.+ ..+||
T Consensus 77 ~lvmE~~~gg~L~~~i~~~~~--------~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl 145 (321)
T d1tkia_ 77 VMIFEFISGLDIFERINTSAF--------ELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKI 145 (321)
T ss_dssp EEEECCCCCCBHHHHHTSSSC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEE
T ss_pred EEEEecCCCCcHHHHHHhcCC--------CCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEE
Confidence 999999999999999976532 3679999999999999999999 8999999999999999754 58999
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcC
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP 379 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 379 (473)
+|||+++.... ........||+.|+|||.+.+..++.++|||||||++|+|++|..||.+....+ .+.........
T Consensus 146 ~DFG~~~~~~~---~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~-~~~~i~~~~~~ 221 (321)
T d1tkia_ 146 IEFGQARQLKP---GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-IIENIMNAEYT 221 (321)
T ss_dssp CCCTTCEECCT---TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH-HHHHHHHTCCC
T ss_pred cccchhhcccc---CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH-HHHHHHhCCCC
Confidence 99999987643 223344568999999999999999999999999999999999999997642211 11111111000
Q ss_pred cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 380 QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
. ........+.++.+|+.+||..||.+|||+.|+++
T Consensus 222 ~--------------------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 222 F--------------------------------DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp C--------------------------------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C--------------------------------ChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00111124567889999999999999999999986
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.4e-51 Score=396.38 Aligned_cols=249 Identities=22% Similarity=0.265 Sum_probs=195.2
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccC---CCCchhHHHH---HHHHHhcCCCCceeeeeeeeccccC
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIR---PGGSKSFKSE---CKAAINIKHRNIVRVFTAFSGVDYQ 216 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E---~~~l~~l~h~niv~~~~~~~~~~~~ 216 (473)
-++|++.++||+|+||.||+|+. .+|+.||||++.... ......+.+| +.+++.++|||||+++++|.+.
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~--- 79 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--- 79 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS---
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC---
Confidence 36899999999999999999994 579999999986321 1222334444 6667777899999999998653
Q ss_pred CceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCcc
Q 012014 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI 296 (473)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~ 296 (473)
...|+|||||++|+|.+++.... .+++.++..++.||+.||.||| +++||||||||+|||++.++.
T Consensus 80 --~~~~ivmE~~~gg~L~~~l~~~~---------~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~ 145 (364)
T d1omwa3 80 --DKLSFILDLMNGGDLHYHLSQHG---------VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGH 145 (364)
T ss_dssp --SEEEEEECCCCSCBHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSC
T ss_pred --CEEEEEEEecCCCcHHHHHHhcc---------cccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCc
Confidence 36899999999999999997654 3558899999999999999999 999999999999999999999
Q ss_pred EEEeecccccccCccccccceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHH
Q 012014 297 GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVK 375 (473)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~ 375 (473)
+||+|||+|+.+... ......||+.|+|||++.+ ..|+.++|||||||++|||+||..||.+...... ....+
T Consensus 146 iKl~DFGla~~~~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~~~~ 219 (364)
T d1omwa3 146 VRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDR 219 (364)
T ss_dssp EEECCCTTCEECSSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH--HHHHH
T ss_pred EEEeeeceeeecCCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH
Confidence 999999999876542 2234569999999999875 5689999999999999999999999986433221 11111
Q ss_pred hhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCC-----hHHHHH
Q 012014 376 MALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMK-----INDVES 447 (473)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~ 447 (473)
....... . .+...++++.+|+.+||+.||++||| ++|+++
T Consensus 220 ~~~~~~~-~-------------------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 220 MTLTMAV-E-------------------------------LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp HSSSCCC-C-------------------------------CCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred hcccCCC-C-------------------------------CCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 1111000 0 00123457889999999999999999 577764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-52 Score=393.02 Aligned_cols=247 Identities=23% Similarity=0.314 Sum_probs=199.1
Q ss_pred CCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeecc---CCCCchhHHHHHHHHH-hcCCCCceeeeeeeeccccCCce
Q 012014 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLI---RPGGSKSFKSECKAAI-NIKHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~~~ 219 (473)
++|.+.+.||+|+||+||+|+ ..+|+.||||+++.. .....+.+..|..++. .++|||||++++++.+. .
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~-----~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK-----E 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS-----S
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC-----C
Confidence 579999999999999999999 457999999999742 2344556777777765 68999999999998653 4
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
..|+|||||++|+|.+++.... .+++.++..++.||+.||.||| +++|+||||||+|||++.++.+||
T Consensus 77 ~~yivmEy~~~g~L~~~i~~~~---------~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl 144 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQSCH---------KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKI 144 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHHHS---------SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEE
T ss_pred ceeEEEeecCCCcHHHHhhccC---------CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceec
Confidence 6899999999999999997654 3568899999999999999999 899999999999999999999999
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcC
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALP 379 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 379 (473)
+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|..||.+..... +...+....+
T Consensus 145 ~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~--~~~~i~~~~~ 220 (320)
T d1xjda_ 145 ADFGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--LFHSIRMDNP 220 (320)
T ss_dssp CCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHCCC
T ss_pred cccchhhhccccc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH--HHHHHHcCCC
Confidence 9999998654322 22334579999999999999999999999999999999999999998632211 1111110000
Q ss_pred cchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChH-HHHH
Q 012014 380 QRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKIN-DVES 447 (473)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~-ev~~ 447 (473)
. .+...+..+.+|+.+||..||++|||+. ||++
T Consensus 221 ~-----------------------------------~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 F-----------------------------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp C-----------------------------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred C-----------------------------------CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 0 0112355788999999999999999995 6753
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-51 Score=383.91 Aligned_cols=271 Identities=24% Similarity=0.319 Sum_probs=206.6
Q ss_pred hhcccCCCCccceeecCCCeEEEEEEecC--------CCEEEEEEeeccCC-CCchhHHHHHHHHHhc-CCCCceeeeee
Q 012014 140 LYNATNGFSSANLIGAGNFGSVYNGTLFD--------GTTIAVKVFNLIRP-GGSKSFKSECKAAINI-KHRNIVRVFTA 209 (473)
Q Consensus 140 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~~~~~ 209 (473)
+....++|.+.+.||+|+||.||+|+... +..||||+++.... .....+.+|...+.++ +|||||+++++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 33455789999999999999999998322 24799999875432 2335688899999888 79999999999
Q ss_pred eeccccCCceeeEEEEEecCCCCHHHHhcCCCCCCC-------CCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeec
Q 012014 210 FSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNW-------RPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHC 282 (473)
Q Consensus 210 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~-------~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~ 282 (473)
|.+. ...++|||||++|+|.++|........ ......+++.+++.++.||+.||.||| +++||||
T Consensus 88 ~~~~-----~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHr 159 (299)
T d1fgka_ 88 CTQD-----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHR 159 (299)
T ss_dssp ECSS-----SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred cccC-----CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEee
Confidence 8653 367999999999999999976642210 011124779999999999999999999 9999999
Q ss_pred cCCCCcEEecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHh-CCCCCC
Q 012014 283 NLKPSNVLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFT-GIRPSD 361 (473)
Q Consensus 283 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~ 361 (473)
||||+|||++.++.+||+|||+++...............||+.|+|||.+.+..|+.++|||||||++|||++ |.+||.
T Consensus 160 DiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~ 239 (299)
T d1fgka_ 160 DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 239 (299)
T ss_dssp CCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred eecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCC
Confidence 9999999999999999999999997766554444555678999999999999999999999999999999998 788886
Q ss_pred CCCCCcccHHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCC
Q 012014 362 GIFTGKMNLRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMK 441 (473)
Q Consensus 362 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt 441 (473)
+..... +...+...... ..+..+++.+.+|+.+||+.||++|||
T Consensus 240 ~~~~~~--~~~~i~~~~~~----------------------------------~~p~~~~~~l~~li~~cl~~dP~~Rps 283 (299)
T d1fgka_ 240 GVPVEE--LFKLLKEGHRM----------------------------------DKPSNCTNELYMMMRDCWHAVPSQRPT 283 (299)
T ss_dssp TCCHHH--HHHHHHTTCCC----------------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCHHH--HHHHHHcCCCC----------------------------------CCCccchHHHHHHHHHHccCCHhHCcC
Confidence 532211 11111100000 001124567889999999999999999
Q ss_pred hHHHHHHHHHHHH
Q 012014 442 INDVESRLRLIRR 454 (473)
Q Consensus 442 ~~ev~~~L~~l~~ 454 (473)
+.||++.|+.|.+
T Consensus 284 ~~eil~~L~~i~a 296 (299)
T d1fgka_ 284 FKQLVEDLDRIVA 296 (299)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhh
Confidence 9999999999844
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=382.82 Aligned_cols=280 Identities=19% Similarity=0.244 Sum_probs=204.2
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cC-CCEEEEEEeecc--CCCCchhHHHHHHHHHhc---CCCCceeeeeeeeccccC
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FD-GTTIAVKVFNLI--RPGGSKSFKSECKAAINI---KHRNIVRVFTAFSGVDYQ 216 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~ 216 (473)
.++|++.++||+|+||+||+|+. .+ ++.||||+++.. .......+.+|+.+++.+ +||||++++++|......
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 46899999999999999999985 34 567999999743 233445677888887776 799999999998765555
Q ss_pred CceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCcc
Q 012014 217 GARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMI 296 (473)
Q Consensus 217 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~ 296 (473)
.....+++|||+.++++......... .+++..+..++.|++.||+||| +++|+||||||+|||++.++.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~ 154 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEP--------GVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQ 154 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTT--------CSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCC--------CCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCC
Confidence 56678999999988777655443322 3668899999999999999999 899999999999999999999
Q ss_pred EEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 012014 297 GHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKM 376 (473)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~ 376 (473)
+||+|||+++..... .......||+.|+|||++.+..|+.++||||+||++|||++|..||.+....+ .+..+...
T Consensus 155 ~kl~dfg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~ 230 (305)
T d1blxa_ 155 IKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDV 230 (305)
T ss_dssp EEECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHH
T ss_pred eeecchhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH-HHHHHHHh
Confidence 999999999865432 23345679999999999999999999999999999999999999998643222 22222222
Q ss_pred hcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 377 ALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
................. ..................++.+.+|+.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 231 IGLPGEEDWPRDVALPR---------QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp HCCCCGGGSCTTCSSCG---------GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hCCCchhcccccccchh---------hhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 21111111100000000 000000000111112234567889999999999999999999864
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-51 Score=383.40 Aligned_cols=271 Identities=20% Similarity=0.220 Sum_probs=193.7
Q ss_pred ccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCC-----CchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 149 SANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPG-----GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 149 ~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
.+++||+|+||+||+|+ ..+|+.||||+++..... ..+.+.+|+.++++++|||||+++++|... ...+
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~-----~~~~ 76 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK-----SNIS 76 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT-----TCCE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccC-----Ccee
Confidence 35789999999999999 457999999998743321 235688999999999999999999998653 3679
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
+||||+.++++..+..... .+++.++..++.||+.||+||| ++||+||||||+|||++.++.+||+||
T Consensus 77 ivmE~~~~~~~~~~~~~~~---------~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DF 144 (299)
T d1ua2a_ 77 LVFDFMETDLEVIIKDNSL---------VLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADF 144 (299)
T ss_dssp EEEECCSEEHHHHHTTCCS---------SCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred ehhhhhcchHHhhhhhccc---------CCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccC
Confidence 9999998887776665443 3557889999999999999999 999999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCC-CCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcc
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQR 381 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 381 (473)
|+|+...... .......||+.|+|||++.+. .++.++|||||||++|||++|.+||.+....+ .+..+.+......
T Consensus 145 G~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~l~~i~~~~~~~~ 221 (299)
T d1ua2a_ 145 GLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFETLGTPT 221 (299)
T ss_dssp GGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCC
T ss_pred ccccccCCCc--ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH-HHHHHHHhcCCCC
Confidence 9998765432 222345699999999998754 57999999999999999999999997643322 1222222211111
Q ss_pred hhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 382 AEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.....+...... ....................+.+.+|+.+||+.||++|||++|+++
T Consensus 222 ~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 222 EEQWPDMCSLPD--------YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TTTSSSTTSSTT--------CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhccchhccch--------hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 111100000000 0000000000001111234567889999999999999999999864
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=381.13 Aligned_cols=276 Identities=20% Similarity=0.241 Sum_probs=198.6
Q ss_pred CCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccC--CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
++|++.+.||+|+||.||+|+ ..+|+.||||+++... ......+.+|++++++++|||||+++++|.+. ...
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~-----~~~ 76 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE-----NKL 76 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccc-----cce
Confidence 589999999999999999999 4679999999996433 23457889999999999999999999998653 368
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEee
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~D 301 (473)
++||||+.+ ++.+++...... .+++.++..++.||+.||.||| ++|||||||||+|||++.++.+||+|
T Consensus 77 ~iv~e~~~~-~~~~~~~~~~~~-------~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~D 145 (298)
T d1gz8a_ 77 YLVFEFLHQ-DLKKFMDASALT-------GIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLAD 145 (298)
T ss_dssp EEEEECCSE-EHHHHHHHTTTT-------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECS
T ss_pred eEEEeecCC-chhhhhhhhccc-------CCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceecc
Confidence 999999965 555555433221 3679999999999999999999 89999999999999999999999999
Q ss_pred cccccccCccccccceeeccCCCCcCCCccccCCC-CCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCc
Q 012014 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE-ASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQ 380 (473)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 380 (473)
||+|+...... .......||+.|+|||++.... ++.++|||||||++|+|++|+.||.+....+ .+..........
T Consensus 146 FG~a~~~~~~~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~-~~~~i~~~~~~~ 222 (298)
T d1gz8a_ 146 FGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTP 222 (298)
T ss_dssp TTHHHHHCCCS--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCC
T ss_pred CCcceeccCCc--ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH-HHHHHHHhcCCC
Confidence 99998764422 2223346999999999877765 5789999999999999999999998643222 122222111110
Q ss_pred chhhhccccchHHHHhhhhhhccccc-CCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 381 RAEEVVDDFNLQEIEEGRTMCMEVSS-SSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.. .... ..... . ...... ................++.+|+.+||+.||++|||++|+++
T Consensus 223 ~~-~~~~-~~~~~-~-----~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 223 DE-VVWP-GVTSM-P-----DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp CT-TTST-TGGGS-T-----TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ch-hhcc-ccccc-c-----ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 00 0000 00000 0 000000 00001111122234568889999999999999999999975
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-51 Score=388.49 Aligned_cols=273 Identities=22% Similarity=0.311 Sum_probs=210.1
Q ss_pred hhhcccCCCCccceeecCCCeEEEEEEec------CCCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeee
Q 012014 139 DLYNATNGFSSANLIGAGNFGSVYNGTLF------DGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFS 211 (473)
Q Consensus 139 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 211 (473)
+|....++|.+.+.||+|+||.||+|.+. +++.||||+++.... .....+.+|+.++++++|||||+++++|.
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 93 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence 45556688999999999999999999842 357899999874322 22345889999999999999999999985
Q ss_pred ccccCCceeeEEEEEecCCCCHHHHhcCCCCCC-CCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEE
Q 012014 212 GVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTN-WRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVL 290 (473)
Q Consensus 212 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil 290 (473)
.. ...++|||||++|+|.+++....... .......+++..+..++.|++.||.||| +++|+||||||+|||
T Consensus 94 ~~-----~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiL 165 (308)
T d1p4oa_ 94 QG-----QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCM 165 (308)
T ss_dssp SS-----SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEE
T ss_pred cC-----CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCcee
Confidence 43 35799999999999999986532100 0000113568899999999999999999 899999999999999
Q ss_pred ecCCccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCC-CCCCCCCCCccc
Q 012014 291 LDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGI-RPSDGIFTGKMN 369 (473)
Q Consensus 291 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~-~P~~~~~~~~~~ 369 (473)
++.++++||+|||+++...............||+.|+|||.+.+..++.++||||||+++|||+||. .||.+....
T Consensus 166 ld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~--- 242 (308)
T d1p4oa_ 166 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE--- 242 (308)
T ss_dssp ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH---
T ss_pred ecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH---
Confidence 9999999999999998775544333344456899999999999999999999999999999999984 677553221
Q ss_pred HHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHH
Q 012014 370 LRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRL 449 (473)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L 449 (473)
+.......+... ..+..++..+.+|+.+||+.||++|||+.||++.|
T Consensus 243 --~~~~~i~~~~~~-------------------------------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L 289 (308)
T d1p4oa_ 243 --QVLRFVMEGGLL-------------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289 (308)
T ss_dssp --HHHHHHHTTCCC-------------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred --HHHHHHHhCCCC-------------------------------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 111111110000 01123456799999999999999999999999998
Q ss_pred HHHHHh
Q 012014 450 RLIRRK 455 (473)
Q Consensus 450 ~~l~~~ 455 (473)
+...+.
T Consensus 290 ~~~~~~ 295 (308)
T d1p4oa_ 290 KEEMEP 295 (308)
T ss_dssp GGGSCT
T ss_pred HHhcCC
Confidence 776443
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-51 Score=377.93 Aligned_cols=240 Identities=20% Similarity=0.288 Sum_probs=193.2
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCC------CchhHHHHHHHHHhcC--CCCceeeeeeeeccc
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPG------GSKSFKSECKAAINIK--HRNIVRVFTAFSGVD 214 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~ 214 (473)
.++|++.++||+|+||.||+|+ ..+|+.||||+++..... ....+.+|+.++++++ |||||+++++|.+.
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~- 81 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP- 81 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS-
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC-
Confidence 4679999999999999999999 457999999999743321 2345779999999996 89999999998653
Q ss_pred cCCceeeEEEEEecCC-CCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecC
Q 012014 215 YQGARFKAVVYKFMPN-GSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD 293 (473)
Q Consensus 215 ~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~ 293 (473)
...++||||+.+ +++.+++.... .+++.++..++.||+.||.||| +++|+||||||+|||++.
T Consensus 82 ----~~~~lv~e~~~~~~~l~~~~~~~~---------~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~ 145 (273)
T d1xwsa_ 82 ----DSFVLILERPEPVQDLFDFITERG---------ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDL 145 (273)
T ss_dssp ----SEEEEEEECCSSEEEHHHHHHHHC---------SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEET
T ss_pred ----CeEEEEEEeccCcchHHHHHhccC---------CCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEec
Confidence 367999999975 68888887654 3668999999999999999999 999999999999999985
Q ss_pred -CccEEEeecccccccCccccccceeeccCCCCcCCCccccCCCC-CcccchhhHhHHHHHHHhCCCCCCCCCCCcccHH
Q 012014 294 -EMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEA-STYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLR 371 (473)
Q Consensus 294 -~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~ 371 (473)
++.+||+|||+|+..... ......||+.|+|||++.+..+ +.++|||||||++|||++|..||.+..
T Consensus 146 ~~~~vkl~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------- 214 (273)
T d1xwsa_ 146 NRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------- 214 (273)
T ss_dssp TTTEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------
T ss_pred CCCeEEECccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------
Confidence 579999999999865432 2334679999999999987665 567899999999999999999997521
Q ss_pred HHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 372 NFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
...+... .. ....+.++.+|+.+||+.||++|||++|+++
T Consensus 215 ~i~~~~~------~~------------------------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 215 EIIRGQV------FF------------------------------RQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp HHHHCCC------CC------------------------------SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHhhccc------CC------------------------------CCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 1111000 00 0113457889999999999999999999865
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.2e-50 Score=375.49 Aligned_cols=276 Identities=18% Similarity=0.240 Sum_probs=200.6
Q ss_pred CCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccC--CCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 145 NGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIR--PGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
++|++.++||+|+||+||+|+..+|+.||||+++... ....+.+.+|+.+|++++|||||+++++|.+. ...+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-----~~~~ 76 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-----KRLV 76 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-----SCEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccC-----Ccee
Confidence 5899999999999999999998889999999996533 23356899999999999999999999998653 3679
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEeec
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGDF 302 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~Df 302 (473)
++|||+.++.+..+..... .+++..+..++.||+.||+||| +++|+||||||+|||++.++.+||+||
T Consensus 77 i~~e~~~~~~~~~~~~~~~---------~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~Df 144 (286)
T d1ob3a_ 77 LVFEHLDQDLKKLLDVCEG---------GLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADF 144 (286)
T ss_dssp EEEECCSEEHHHHHHTSTT---------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCT
T ss_pred EEEEeehhhhHHHHHhhcC---------CcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEeccc
Confidence 9999998777777765543 4679999999999999999999 899999999999999999999999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccCC-CCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcc
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQR 381 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 381 (473)
|.+....... .......|++.|+|||.+.+. .++.++|||||||++|||++|+.||.+....+ .+...........
T Consensus 145 G~a~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~-~~~~i~~~~~~~~ 221 (286)
T d1ob3a_ 145 GLARAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTPN 221 (286)
T ss_dssp THHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCC
T ss_pred ccceecccCc--cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH-HHHHHHHhhCCCC
Confidence 9998764432 222344589999999998764 57999999999999999999999998643222 1222222221111
Q ss_pred hhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 382 AEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.....+.... ....... ...............++.+.+|+.+||+.||++|||++|+++
T Consensus 222 ~~~~~~~~~~------~~~~~~~-~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 222 SKNWPNVTEL------PKYDPNF-TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TTTSTTGGGS------TTCCTTC-CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhccchhhh------hhccccc-ccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1111000000 0000000 000000111112234567889999999999999999999973
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-49 Score=377.89 Aligned_cols=287 Identities=17% Similarity=0.223 Sum_probs=202.2
Q ss_pred hcccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCC-CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCc
Q 012014 141 YNATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP-GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 141 ~~~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 218 (473)
...+++|++.++||+|+||+||+|. ..+|+.||||+++.... ...+.+.+|+.+|++++||||+++++++........
T Consensus 4 ~~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~ 83 (345)
T d1pmea_ 4 FDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 83 (345)
T ss_dssp CCCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred cCcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccccc
Confidence 3456789999999999999999998 46899999999974332 223568899999999999999999999876554444
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...+++ +|+.+|+|.+++... .+++..+..++.||+.||+||| ++|||||||||+|||++.++.+|
T Consensus 84 ~~~~l~-~~~~~g~L~~~l~~~----------~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~k 149 (345)
T d1pmea_ 84 KDVYLV-THLMGADLYKLLKTQ----------HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLK 149 (345)
T ss_dssp CCEEEE-EECCCEEHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEE
T ss_pred ceEEEE-EeecCCchhhhhhcC----------CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEE
Confidence 444555 556699999999754 3668999999999999999999 89999999999999999999999
Q ss_pred EeecccccccCccccc-cceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHh
Q 012014 299 VGDFGMARFLPAIDKQ-NRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKM 376 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~ 376 (473)
|+|||+++........ .......||+.|+|||++.. ..++.++||||+||++|+|++|..||.+....+. .......
T Consensus 150 l~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~-~~~~~~~ 228 (345)
T d1pmea_ 150 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ-LNHILGI 228 (345)
T ss_dssp ECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHH
T ss_pred EcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH-HHHHhhh
Confidence 9999999876543322 22344669999999999855 4578999999999999999999999976433221 1111111
Q ss_pred hcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 377 ALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
................. ...... ..... .............++.+|+.+||+.||.+|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~-~~~~~~---~~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 229 LGSPSQEDLNCIINLKA-RNYLLS---LPHKN-KVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp HCSCCHHHHHTCCCHHH-HHHHHT---SCCCC-CCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccCCChhhhhhhhhhhh-hccccc---CCccC-CCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11111111100000000 000000 00000 00001111223457889999999999999999999975
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-48 Score=367.56 Aligned_cols=263 Identities=19% Similarity=0.278 Sum_probs=201.0
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceeeE
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
.++|++.+.||+|+||.||+|+ ..+|+.||||++.... ....+..|+++++.++|+|++..+..+.. .....+
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~----~~~~~~ 79 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNV 79 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEE----ETTEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEe----cCCEEE
Confidence 3579999999999999999998 4578999999987533 34568899999999988877666655532 234678
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEec---CCccEEE
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLD---DEMIGHV 299 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~---~~~~~kl 299 (473)
+||||+ +++|.+.+..... .+++..+..++.|++.||+||| +++|+||||||+|||++ .+..+||
T Consensus 80 ivme~~-~~~l~~~~~~~~~--------~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl 147 (299)
T d1ckia_ 80 MVMELL-GPSLEDLFNFCSR--------KFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYI 147 (299)
T ss_dssp EEEECC-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEE
T ss_pred EEEEEc-CCchhhhhhhccC--------CCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeee
Confidence 999999 6677776654432 3668999999999999999999 89999999999999985 3557999
Q ss_pred eecccccccCccccc-----cceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHH--H
Q 012014 300 GDFGMARFLPAIDKQ-----NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLR--N 372 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~--~ 372 (473)
+|||+|+.+...... .......||+.|+|||++.+..++.++|||||||++|||++|..||........... .
T Consensus 148 ~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~ 227 (299)
T d1ckia_ 148 IDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER 227 (299)
T ss_dssp CCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHH
T ss_pred eccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHH
Confidence 999999977543321 123455799999999999999999999999999999999999999987543322111 1
Q ss_pred HHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHHHHH
Q 012014 373 FVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRLRLI 452 (473)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L~~l 452 (473)
......+... ......+++++.+|+..||+.||++||++++|.+.|+.+
T Consensus 228 ~~~~~~~~~~-------------------------------~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 228 ISEKKMSTPI-------------------------------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp HHHHHHHSCH-------------------------------HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred hhcccCCCCh-------------------------------hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 1110000000 011123567889999999999999999999999999887
Q ss_pred HHh
Q 012014 453 RRK 455 (473)
Q Consensus 453 ~~~ 455 (473)
..+
T Consensus 277 ~~~ 279 (299)
T d1ckia_ 277 FHR 279 (299)
T ss_dssp HHH
T ss_pred HHH
Confidence 543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.9e-48 Score=360.39 Aligned_cols=266 Identities=17% Similarity=0.234 Sum_probs=209.2
Q ss_pred cCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCC-CCceeeeeeeeccccCCceee
Q 012014 144 TNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKH-RNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~ 221 (473)
.++|++.++||+|+||+||+|+ ..+|+.||||+++.. .....+.+|++++..++| +|++.+++++.. ....
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-----~~~~ 76 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE-----GLHN 76 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE-----TTEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccc--cCcHHHHHHHHHHHHhcCCCCCCEEEEEeec-----CCcc
Confidence 4689999999999999999999 457899999998643 345678899999999975 899999988754 3367
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecC-----Ccc
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDD-----EMI 296 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~-----~~~ 296 (473)
++||||+ +++|.+++..... .++..++..++.|++.||.||| ++||+||||||+|||++. ++.
T Consensus 77 ~~vme~~-~~~l~~~~~~~~~--------~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~ 144 (293)
T d1csna_ 77 VLVIDLL-GPSLEDLLDLCGR--------KFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANM 144 (293)
T ss_dssp EEEEECC-CCBHHHHHHHTTT--------CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTC
T ss_pred EEEEEec-CCCHHHHHHhhcc--------chhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCc
Confidence 9999999 7899999876542 3668899999999999999999 999999999999999964 578
Q ss_pred EEEeecccccccCccccc-----cceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCccc--
Q 012014 297 GHVGDFGMARFLPAIDKQ-----NRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMN-- 369 (473)
Q Consensus 297 ~kl~Dfg~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~-- 369 (473)
+||+|||+|+.+...... .......||+.|||||++.+..++.++|||||||++|||++|..||.+.......
T Consensus 145 vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~ 224 (293)
T d1csna_ 145 IYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK 224 (293)
T ss_dssp EEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHH
T ss_pred eEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHH
Confidence 999999999876543211 2233567999999999999999999999999999999999999999865433211
Q ss_pred HHHHHHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHHHH
Q 012014 370 LRNFVKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVESRL 449 (473)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~~L 449 (473)
+............. +....+++++.+++..|++.+|++||+++.+.+.|
T Consensus 225 ~~~i~~~~~~~~~~-------------------------------~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l 273 (293)
T d1csna_ 225 YERIGEKKQSTPLR-------------------------------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLF 273 (293)
T ss_dssp HHHHHHHHHHSCHH-------------------------------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHH
T ss_pred HHHHHhccCCCChH-------------------------------HhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence 11111100000000 11123567889999999999999999999999999
Q ss_pred HHHHHhhccC
Q 012014 450 RLIRRKLLET 459 (473)
Q Consensus 450 ~~l~~~~~~~ 459 (473)
+.+.++....
T Consensus 274 ~~~~~~~~~~ 283 (293)
T d1csna_ 274 SKVLERLNTT 283 (293)
T ss_dssp HHHHHHTTCC
T ss_pred HHHHHHcCCC
Confidence 9887665433
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-48 Score=369.09 Aligned_cols=284 Identities=19% Similarity=0.215 Sum_probs=197.3
Q ss_pred cCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeecc--CCCCchhHHHHHHHHHhcCCCCceeeeeeeecccc---CC
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLI--RPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY---QG 217 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~ 217 (473)
.++|++.+.||+|+||+||+|+. .+|+.||||++... .......+.+|+.+|++++||||+++++++..... ..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 47899999999999999999994 57999999998643 23445678999999999999999999999865321 12
Q ss_pred ceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccE
Q 012014 218 ARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIG 297 (473)
Q Consensus 218 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~ 297 (473)
....++||||+.++++..+..... .+++..+..++.||+.||.||| ++||+||||||+|||++.++.+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~---------~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~ 156 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLV---------KFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVL 156 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTC---------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCE
T ss_pred CceEEEEEeccCCCccchhhhccc---------ccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcE
Confidence 345799999998776665544333 3568889999999999999999 8999999999999999999999
Q ss_pred EEeecccccccCcccc--ccceeeccCCCCcCCCccccCC-CCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHH
Q 012014 298 HVGDFGMARFLPAIDK--QNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFV 374 (473)
Q Consensus 298 kl~Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~ 374 (473)
||+|||+++.+..... ........||+.|+|||++.+. .++.++|||||||++|||++|+.||.+..... .+....
T Consensus 157 kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~-~~~~i~ 235 (318)
T d3blha1 157 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH-QLALIS 235 (318)
T ss_dssp EECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHH
T ss_pred EeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH-HHHHHH
Confidence 9999999987654322 1223345699999999998765 68999999999999999999999997643221 111111
Q ss_pred HhhcC--cch-hhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 375 KMALP--QRA-EEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 375 ~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
..... ... ...........+.. ...........-........+.+|+.+||+.||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 236 QLCGSITPEVWPNVDNYELYEKLEL-------VKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp HHHCCCCTTTSTTCCCC-------C-------CSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HhcCCCChhhccccchhhhhhhhcc-------cccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 11111 111 11111000000000 00000000000001123456778999999999999999999873
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-48 Score=375.15 Aligned_cols=285 Identities=20% Similarity=0.238 Sum_probs=197.2
Q ss_pred CCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCceeeeeeeecccc-CCceeeEE
Q 012014 146 GFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNIVRVFTAFSGVDY-QGARFKAV 223 (473)
Q Consensus 146 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~l 223 (473)
+|+..++||+|+||+||+|+. .+|+.||||+++... ....+|+.+|++++||||++++++|..... .+..+.++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 688899999999999999994 579999999997532 233579999999999999999999865432 33456799
Q ss_pred EEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCc-cEEEeec
Q 012014 224 VYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM-IGHVGDF 302 (473)
Q Consensus 224 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~-~~kl~Df 302 (473)
|||||+++.+..+...... ...+++.++..++.||+.||+||| ++||+||||||+|||++.++ .+||+||
T Consensus 97 v~Ey~~~~~~~~l~~~~~~------~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DF 167 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRA------KQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDF 167 (350)
T ss_dssp EEECCSEEHHHHHHHHHHT------TCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCC
T ss_pred EEeccCCccHHHHHhhhhc------cCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecc
Confidence 9999976543333221110 114678999999999999999999 99999999999999999775 8999999
Q ss_pred ccccccCccccccceeeccCCCCcCCCccccC-CCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCcc
Q 012014 303 GMARFLPAIDKQNRFICIKGSTGYIPPEYDLG-CEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQR 381 (473)
Q Consensus 303 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 381 (473)
|+++...... ......||+.|+|||.+.+ ..++.++||||+||++|||++|..||......+ .+..+.+......
T Consensus 168 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~-~l~~i~~~~g~~~ 243 (350)
T d1q5ka_ 168 GSAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLGTPT 243 (350)
T ss_dssp TTCEECCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHHHCCCC
T ss_pred cchhhccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH-HHHHHHHHhCCCh
Confidence 9998764432 2334569999999998765 468999999999999999999999997643221 1222222111111
Q ss_pred hhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH--HHHHHHH
Q 012014 382 AEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES--RLRLIRR 454 (473)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~--~L~~l~~ 454 (473)
...+ ....... .. ...................++++.+|+.+||..||++|||+.|+++ .++.++.
T Consensus 244 ~~~~-~~~~~~~-~~-----~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 244 REQI-REMNPNY-TE-----FKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp HHHH-HHHCC----C-----CCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred HHhh-hhhccch-hh-----ccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 0000 0000000 00 0000000000000011124567889999999999999999999985 3555543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-48 Score=371.78 Aligned_cols=278 Identities=18% Similarity=0.225 Sum_probs=198.0
Q ss_pred ccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCC--CchhHHHHHHHHHhcCCCCceeeeeeeecccc-CCc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAFSGVDY-QGA 218 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~ 218 (473)
..++|++.++||+|+||+||+|. ..+|+.||||+++..... ..+.+.+|+++|++++|||||+++++|...+. ...
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 45789999999999999999999 457999999999743222 23468899999999999999999999876442 233
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...++||||| +++|..+++.. .+++..+..++.||+.||.||| ++||+||||||+|||++.++.+|
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~~----------~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~k 161 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKHE----------KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELK 161 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC----------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEE
T ss_pred ceEEEEEecc-cccHHHHHHhc----------cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhcccccccc
Confidence 4579999999 67888887654 3679999999999999999999 99999999999999999999999
Q ss_pred EeecccccccCccccccceeeccCCCCcCCCccccCC-CCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhh
Q 012014 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMA 377 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~ 377 (473)
|+|||+|+.... ......||+.|+|||++.+. .++.++||||+||++|+|++|.+||.+..... .+.......
T Consensus 162 l~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~-~~~~~~~~~ 235 (346)
T d1cm8a_ 162 ILDFGLARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMKVT 235 (346)
T ss_dssp ECCCTTCEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHH
T ss_pred cccccceeccCC-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH-HHHHHHhcc
Confidence 999999987543 22345699999999998764 57899999999999999999999998643221 122222211
Q ss_pred cCc--chhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 378 LPQ--RAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 378 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
... ................ ...... ............+.+.+|+.+||..||++|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~----~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 236 GTPPAEFVQRLQSDEAKNYMK---GLPELE----KKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp CCCCHHHHHTCSCHHHHHHHH---HSCCCC----CCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCcHHHHhhhcchhhhhhhc---cCCccc----ccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 111 1111111100000000 000000 00011111234557789999999999999999999986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-48 Score=361.88 Aligned_cols=277 Identities=17% Similarity=0.213 Sum_probs=203.0
Q ss_pred CCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCC--CCchhHHHHHHHHHhcCCCCceeeeeeeeccccCCceee
Q 012014 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRP--GGSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGARFK 221 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 221 (473)
++|++.++||+|+||+||+|+ ..+++.||||+++.... .....+.+|+.+++.++||||++++++|.+.. ..
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~-----~~ 76 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDK-----KL 76 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS-----EE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccccc-----ce
Confidence 579999999999999999999 46789999999975432 23467899999999999999999999986543 67
Q ss_pred EEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEEee
Q 012014 222 AVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHVGD 301 (473)
Q Consensus 222 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl~D 301 (473)
+++++++.+++|..++.... .+++..+..++.|++.||+||| +++|+||||||+|||++.++.+||+|
T Consensus 77 ~iv~~~~~~~~l~~~~~~~~---------~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~D 144 (292)
T d1unla_ 77 TLVFEFCDQDLKKYFDSCNG---------DLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLAN 144 (292)
T ss_dssp EEEEECCSEEHHHHHHHTTT---------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECC
T ss_pred eEEeeecccccccccccccc---------ccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeee
Confidence 99999999999988887654 3558889999999999999999 89999999999999999999999999
Q ss_pred cccccccCccccccceeeccCCCCcCCCccccCCC-CCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCc
Q 012014 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE-ASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQ 380 (473)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 380 (473)
||.++....... ......+++.|+|||.+.+.. ++.++|||||||++|||++|..||....+....+..+.....+.
T Consensus 145 FG~a~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~ 222 (292)
T d1unla_ 145 FGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP 222 (292)
T ss_dssp CTTCEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCC
T ss_pred cchhhcccCCCc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCC
Confidence 999987654332 222344788899999987665 68999999999999999999999754333222222222222111
Q ss_pred chhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 381 RAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
..... .... .... ... ..................+.+.+|+.+||+.||.+|||++||++
T Consensus 223 ~~~~~-~~~~--~~~~---~~~-~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 223 TEEQW-PSMT--KLPD---YKP-YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CTTTC-TTGG--GSTT---CCC-CCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred Chhhh-hhhh--hccc---ccc-cccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11000 0000 0000 000 00000001111122234567889999999999999999999864
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4e-48 Score=369.20 Aligned_cols=276 Identities=17% Similarity=0.169 Sum_probs=197.9
Q ss_pred CCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCCCchhHHHHHHHHHhcC-CCCceeeeeeeeccccCCceeeE
Q 012014 145 NGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
++|++.++||+|+||+||+|+. .+|+.||||+++. ...+.+.+|+.+|..++ ||||++++++|... .....+
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~---~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~---~~~~~~ 108 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDP---VSRTPA 108 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCSEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECH---HHHHHHHHHHHHHHhccCCCCCcEEEEEEEec---CCCcee
Confidence 5799999999999999999994 6789999999864 34578899999999995 99999999998642 244689
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCc-cEEEee
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM-IGHVGD 301 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~-~~kl~D 301 (473)
+|||||.+++|..+.+ .+++.++..++.||+.||.||| ++||+||||||+|||++.++ .+||+|
T Consensus 109 ~v~e~~~~~~L~~~~~------------~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~D 173 (328)
T d3bqca1 109 LVFEHVNNTDFKQLYQ------------TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLID 173 (328)
T ss_dssp EEEECCCSCBGGGTTT------------SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECC
T ss_pred EEEeecCCCcHHHHhc------------CCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecc
Confidence 9999999999976642 3568899999999999999999 99999999999999998655 699999
Q ss_pred cccccccCccccccceeeccCCCCcCCCccccCC-CCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhcCc
Q 012014 302 FGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC-EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMALPQ 380 (473)
Q Consensus 302 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 380 (473)
||+|+...... ......||+.|+|||.+.+. .++.++||||+||++|+|++|..||....................
T Consensus 174 FG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~ 250 (328)
T d3bqca1 174 WGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 250 (328)
T ss_dssp GGGCEECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHH
T ss_pred cccceeccCCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCc
Confidence 99998765432 23345689999999998765 479999999999999999999999976433222111111111100
Q ss_pred chhhhc---cccchHHHHhhhhhhcccccCC-CCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 381 RAEEVV---DDFNLQEIEEGRTMCMEVSSSS-GSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 381 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
...... .......+.. ......... ............++++.+|+.+||+.||++|||++|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 251 DLYDYIDKYNIELDPRFND---ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHHHHHHHTTCCCCGGGGG---TCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhcccccCcccch---hcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 0000000000 000000000 000000111234567889999999999999999999864
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=369.87 Aligned_cols=285 Identities=17% Similarity=0.165 Sum_probs=196.0
Q ss_pred ccCCCCccceeecCCCeEEEEEEe-cCCCEEEEEEeeccCCC--CchhHHHHHHHHHhcCCCCceeeeeeeecccc-CCc
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGTL-FDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAFSGVDY-QGA 218 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~~ 218 (473)
..++|++.++||+|+||+||+|+. .+|+.||||+++..... ....+.+|+.++++++|||||+++++|..... +..
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence 347899999999999999999994 57999999999754322 23468899999999999999999999865432 345
Q ss_pred eeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEE
Q 012014 219 RFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGH 298 (473)
Q Consensus 219 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~k 298 (473)
...|+|||||.++ +.+.+.. .+++..+..++.||+.||.||| ++||+||||||+|||++.++.+|
T Consensus 95 ~~~~iv~Ey~~~~-l~~~~~~-----------~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~k 159 (355)
T d2b1pa1 95 QDVYLVMELMDAN-LCQVIQM-----------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLK 159 (355)
T ss_dssp CEEEEEEECCSEE-HHHHHTS-----------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEE
T ss_pred ceeEEEEeccchH-HHHhhhc-----------CCCHHHHHHHHHHHHHHHHHhh---hcccccccCCcccccccccccee
Confidence 6889999999654 5555532 2568899999999999999999 99999999999999999999999
Q ss_pred EeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 012014 299 VGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMAL 378 (473)
Q Consensus 299 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~ 378 (473)
++|||+++..... .......||+.|+|||++.+..++.++||||+||++|+|++|+.||.+..... ..........
T Consensus 160 l~df~~~~~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~-~~~~i~~~~~ 235 (355)
T d2b1pa1 160 ILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLG 235 (355)
T ss_dssp ECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHC
T ss_pred eechhhhhccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHH-HHHHHHHhcc
Confidence 9999998865432 23344568999999999999999999999999999999999999997643211 1122222111
Q ss_pred Ccchhhhccccc---hHHHHhhhh----hhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 379 PQRAEEVVDDFN---LQEIEEGRT----MCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 379 ~~~~~~~~~~~~---~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
... .+...... ......... .....................+..+.+|+.+||..||++|||++||++
T Consensus 236 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 236 TPC-PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp CCC-HHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCC-HHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 111 11111000 000000000 000000000011122234456788999999999999999999999973
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=362.60 Aligned_cols=252 Identities=19% Similarity=0.265 Sum_probs=198.2
Q ss_pred CCCCccceeecCCCeEEEEEEe----cCCCEEEEEEeeccC----CCCchhHHHHHHHHHhcCC-CCceeeeeeeecccc
Q 012014 145 NGFSSANLIGAGNFGSVYNGTL----FDGTTIAVKVFNLIR----PGGSKSFKSECKAAINIKH-RNIVRVFTAFSGVDY 215 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~ 215 (473)
++|++.+.||+|+||+||+|.. .+|+.||||+++... ....+.+.+|++++++++| |||+++++++.+.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~-- 101 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-- 101 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET--
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC--
Confidence 6799999999999999999983 247899999986422 2345678899999999977 8999999998654
Q ss_pred CCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCc
Q 012014 216 QGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEM 295 (473)
Q Consensus 216 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~ 295 (473)
...+++|||+.+|+|.+++..... +++..+..++.||+.||.||| +++|+||||||+|||++.++
T Consensus 102 ---~~~~~v~e~~~~~~L~~~i~~~~~---------~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~ 166 (322)
T d1vzoa_ 102 ---TKLHLILDYINGGELFTHLSQRER---------FTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNG 166 (322)
T ss_dssp ---TEEEEEECCCCSCBHHHHHHHHSC---------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTS
T ss_pred ---CceeeeeecccccHHHHHHHhccc---------ccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCC
Confidence 368999999999999999977652 447888999999999999999 89999999999999999999
Q ss_pred cEEEeecccccccCccccccceeeccCCCCcCCCccccCC--CCCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHH
Q 012014 296 IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGC--EASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNF 373 (473)
Q Consensus 296 ~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~ 373 (473)
.+||+|||+++.+.... ........||+.|+|||.+.+. .++.++|||||||++|+|++|..||.+...... ....
T Consensus 167 ~vkL~DFG~a~~~~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~-~~~i 244 (322)
T d1vzoa_ 167 HVVLTDFGLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS-QAEI 244 (322)
T ss_dssp CEEESCSSEEEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC-HHHH
T ss_pred CEEEeeccchhhhcccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHH
Confidence 99999999998765433 2233446799999999998764 468899999999999999999999987543322 1111
Q ss_pred HHhhcCcchhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCC-----hHHHHH
Q 012014 374 VKMALPQRAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMK-----INDVES 447 (473)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt-----~~ev~~ 447 (473)
.+....... ..+...+.++.+|+.+||++||++||| ++|+++
T Consensus 245 ~~~~~~~~~--------------------------------~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 245 SRRILKSEP--------------------------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp HHHHHHCCC--------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred HHhcccCCC--------------------------------CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 111100000 001134568889999999999999995 677764
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-47 Score=365.66 Aligned_cols=279 Identities=16% Similarity=0.222 Sum_probs=198.7
Q ss_pred ccCCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCC--CchhHHHHHHHHHhcCCCCceeeeeeeeccccCCce
Q 012014 143 ATNGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPG--GSKSFKSECKAAINIKHRNIVRVFTAFSGVDYQGAR 219 (473)
Q Consensus 143 ~~~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 219 (473)
.+++|++.++||+|+||+||+|+ ..+|+.||||+++..... ..+.+.+|+.+|++++|||||++++++.........
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 46789999999999999999999 467999999999754322 234678999999999999999999998654432333
Q ss_pred eeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEecCCccEEE
Q 012014 220 FKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLLDDEMIGHV 299 (473)
Q Consensus 220 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~~~~~~~kl 299 (473)
..+++|+|+.+|+|.+++... .+++.++..++.||+.||.||| ++||+||||||+|||++.++.+|+
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~~----------~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl 162 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKCQ----------KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKI 162 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTTC----------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEE
T ss_pred ceEEEEEeecCCchhhhcccc----------cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccc
Confidence 446677788899999999654 3668999999999999999999 899999999999999999999999
Q ss_pred eecccccccCccccccceeeccCCCCcCCCccccCCC-CCcccchhhHhHHHHHHHhCCCCCCCCCCCcccHHHHHHhhc
Q 012014 300 GDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCE-ASTYGDVYSFGILLLEMFTGIRPSDGIFTGKMNLRNFVKMAL 378 (473)
Q Consensus 300 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~ 378 (473)
+|||++..... ......||+.|+|||.+.+.. ++.++|||||||++|+|++|..||.+..... ....+.....
T Consensus 163 ~dfg~a~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~-~~~~i~~~~~ 236 (348)
T d2gfsa1 163 LDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVG 236 (348)
T ss_dssp CCC----CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHC
T ss_pred cccchhcccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcC
Confidence 99999976533 223456899999999877654 6889999999999999999999998643221 1111111111
Q ss_pred Cc--chhhhccccchHHHHhhhhhhcccccCCCCcchhhHHHHHHHHHHHHhhhcccCCCCCCCChHHHHH
Q 012014 379 PQ--RAEEVVDDFNLQEIEEGRTMCMEVSSSSGSSAHASIILECFNSICEIGVACSAERPRERMKINDVES 447 (473)
Q Consensus 379 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~cl~~dP~~RPt~~ev~~ 447 (473)
.. ................ . . ...............+..+.+|+.+||..||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~---~---~-~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 237 TPGAELLKKISSESARNYIQ---S---L-TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp CCCHHHHTTCCCHHHHHHHT---T---S-CCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCChHHhhhccchhhhhhhh---h---c-ccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 11 0000000000000000 0 0 000000011111234567889999999999999999999976
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.8e-41 Score=327.97 Aligned_cols=284 Identities=17% Similarity=0.194 Sum_probs=186.4
Q ss_pred CCCCccceeecCCCeEEEEEE-ecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcC-----------CCCceeeeeeeec
Q 012014 145 NGFSSANLIGAGNFGSVYNGT-LFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK-----------HRNIVRVFTAFSG 212 (473)
Q Consensus 145 ~~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~~ 212 (473)
++|++.++||+|+||+||+|+ ..+|+.||||+++... ...+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 359999999999999999999 4679999999997422 22356788999988875 5789999988754
Q ss_pred cccCCceeeEEEEEecCCCC-HHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCcEEe
Q 012014 213 VDYQGARFKAVVYKFMPNGS-LEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSNVLL 291 (473)
Q Consensus 213 ~~~~~~~~~~lv~e~~~~g~-L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~Nil~ 291 (473)
.. ....+++|+++..+. ........... .+++..+..++.||+.||.|||+ ..||+||||||+|||+
T Consensus 92 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll 159 (362)
T d1q8ya_ 92 KG---PNGVHVVMVFEVLGENLLALIKKYEHR-------GIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLM 159 (362)
T ss_dssp EE---TTEEEEEEEECCCCEEHHHHHHHTTTS-------CCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEE
T ss_pred cc---ccceeeeeeeccccccccccccccccc-------CCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeee
Confidence 32 234556666665443 33333222211 35588899999999999999993 2899999999999999
Q ss_pred cCCc------cEEEeecccccccCccccccceeeccCCCCcCCCccccCCCCCcccchhhHhHHHHHHHhCCCCCCCCCC
Q 012014 292 DDEM------IGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPPEYDLGCEASTYGDVYSFGILLLEMFTGIRPSDGIFT 365 (473)
Q Consensus 292 ~~~~------~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~ 365 (473)
+.++ .++++|||.+...... .....||+.|+|||++.+..++.++||||+||++++|++|+.||.....
T Consensus 160 ~~~~~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~ 234 (362)
T d1q8ya_ 160 EIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG 234 (362)
T ss_dssp EEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred eccCcccccceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcc
Confidence 7665 4899999999865332 2345699999999999999999999999999999999999999976432
Q ss_pred Ccc-----cHHHHHHhhcCcchhhhcc-ccchHHHHhhhhhhcccccCCCCc------chhhHHHHHHHHHHHHhhhccc
Q 012014 366 GKM-----NLRNFVKMALPQRAEEVVD-DFNLQEIEEGRTMCMEVSSSSGSS------AHASIILECFNSICEIGVACSA 433 (473)
Q Consensus 366 ~~~-----~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~l~~~cl~ 433 (473)
... .+.......... ..+... ........................ .........++.+.+|+.+||.
T Consensus 235 ~~~~~~~~~~~~~~~~lg~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~ 313 (362)
T d1q8ya_ 235 HSYTKDDDHIAQIIELLGEL-PSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQ 313 (362)
T ss_dssp ----CHHHHHHHHHHHHCSC-CHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGC
T ss_pred ccccchhHHHHHHHHHhCCC-CHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCC
Confidence 211 111111111100 000000 000000000000000000000000 0111224567889999999999
Q ss_pred CCCCCCCChHHHHH
Q 012014 434 ERPRERMKINDVES 447 (473)
Q Consensus 434 ~dP~~RPt~~ev~~ 447 (473)
.||.+|||++|+++
T Consensus 314 ~dP~~Rpta~e~L~ 327 (362)
T d1q8ya_ 314 LDPRKRADAGGLVN 327 (362)
T ss_dssp SSTTTCBCHHHHHT
T ss_pred CChhHCcCHHHHhc
Confidence 99999999999853
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=3.5e-26 Score=198.89 Aligned_cols=164 Identities=16% Similarity=0.098 Sum_probs=118.9
Q ss_pred CCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCC-----C-------------chhHHHHHHHHHhcCCCCceeeee
Q 012014 147 FSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPG-----G-------------SKSFKSECKAAINIKHRNIVRVFT 208 (473)
Q Consensus 147 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-----~-------------~~~~~~E~~~l~~l~h~niv~~~~ 208 (473)
+.+.++||+|+||+||+|...+|+.||||+++..... . .....+|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 3567899999999999999888999999987632110 0 122456888899999999999876
Q ss_pred eeeccccCCceeeEEEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhCCCCCeeeccCCCCc
Q 012014 209 AFSGVDYQGARFKAVVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCDCQPPIAHCNLKPSN 288 (473)
Q Consensus 209 ~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~iiH~Dlkp~N 288 (473)
+. ..+++|||+++..+.++ +...+..++.|++.||.||| ++||+||||||+|
T Consensus 82 ~~---------~~~lvme~~~~~~~~~l----------------~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~N 133 (191)
T d1zara2 82 WE---------GNAVLMELIDAKELYRV----------------RVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYN 133 (191)
T ss_dssp EE---------TTEEEEECCCCEEGGGC----------------CCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTS
T ss_pred ec---------CCEEEEEeeccccccch----------------hhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhh
Confidence 53 12799999987654331 12345578999999999999 8999999999999
Q ss_pred EEecCCccEEEeecccccccCccccccceeeccCCCCcCCC------ccccCCCCCcccchhhHhHHH
Q 012014 289 VLLDDEMIGHVGDFGMARFLPAIDKQNRFICIKGSTGYIPP------EYDLGCEASTYGDVYSFGILL 350 (473)
Q Consensus 289 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~DiwSlG~il 350 (473)
||+++++ ++|+|||+|......... .|... +.+ ...|+.++|+||+.--+
T Consensus 134 ILv~~~~-~~liDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 134 VLVSEEG-IWIIDFPQSVEVGEEGWR----------EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp EEEETTE-EEECCCTTCEETTSTTHH----------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred eeeeCCC-EEEEECCCcccCCCCCcH----------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 9999765 899999999765322110 01110 111 24678899999976443
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.00 E-value=4.8e-11 Score=108.16 Aligned_cols=89 Identities=22% Similarity=0.351 Sum_probs=54.9
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCCCCCCcccHHHHHHHhcCC-ccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPE-RAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..|.|||||||||+|+||+||+.|...... ...+...+...... ...++ ... |
T Consensus 184 ~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~-~~~~~~~~~~~~~~p~~~~~-----~~~--------------~----- 238 (276)
T d1uwha_ 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNINN-RDQIIFMVGRGYLSPDLSKV-----RSN--------------C----- 238 (276)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-HHHHHHHHHHTSCCCCGGGS-----CTT--------------C-----
T ss_pred CCCCchhhhhhhHHHHHHHHHCCCCCCCCCh-HHHHHHHHhcCCCCCcchhc-----ccc--------------c-----
Confidence 3578999999999999999999999754321 11111112211110 00000 000 0
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHHhh
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~~ 119 (473)
-..+..+...|+..+|.+||++.++...|+.+.+.
T Consensus 239 ----~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 239 ----PKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ----hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 01122334679999999999999999999887654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.84 E-value=4.4e-10 Score=103.56 Aligned_cols=86 Identities=21% Similarity=0.316 Sum_probs=54.2
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhhH
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (473)
+..|.|||||||||+|+||+||+.|....... ..+..++.. ... ...+.. .
T Consensus 209 ~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-~~~~~~i~~---g~~--~~~p~~---~-------------------- 259 (311)
T d1r0pa_ 209 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQ---GRR--LLQPEY---C-------------------- 259 (311)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHT---TCC--CCCCTT---C--------------------
T ss_pred CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH-HHHHHHHHc---CCC--CCCccc---C--------------------
Confidence 56799999999999999999998885432211 122222221 110 111110 0
Q ss_pred HHHHHHhhcccccccccccccccchhhHHHHHHHHHhh
Q 012014 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKKK 119 (473)
Q Consensus 82 ~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~~ 119 (473)
-..+..+...|+..+|++||++.+|.+.|+.+...
T Consensus 260 ---~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 260 ---PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ---cHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 01122345689999999999999999999888654
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.81 E-value=1.1e-09 Score=98.29 Aligned_cols=85 Identities=19% Similarity=0.270 Sum_probs=52.9
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhhH
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (473)
+..|.|||||||||+|+||+||.+|...... ...+...+..... ...+.. |
T Consensus 177 ~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~-~~~~~~~i~~~~~-----~~~p~~-----------------~------ 227 (263)
T d1sm2a_ 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRS-NSEVVEDISTGFR-----LYKPRL-----------------A------ 227 (263)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC-HHHHHHHHHHTCC-----CCCCTT-----------------S------
T ss_pred CCCCchhhhcchHHHHHHHHHCCCCCCCCCC-HHHHHHHHHhcCC-----CCCccc-----------------c------
Confidence 4678999999999999999997666432211 1122222222111 111110 0
Q ss_pred HHHHHHhhcccccccccccccccchhhHHHHHHHHHh
Q 012014 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (473)
Q Consensus 82 ~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~ 118 (473)
-..+..+...|+..+|++||++.++.+.|+.+.+
T Consensus 228 ---~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 228 ---STHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 0112234567999999999999999999987754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.78 E-value=1.8e-09 Score=99.04 Aligned_cols=93 Identities=12% Similarity=0.125 Sum_probs=55.7
Q ss_pred cccccceeehhhhHHHHHhCCCCCCCCCCC----------cccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcc
Q 012014 4 VSSYGDVYSFGILLLEMFTGLRPNDDMFND----------ELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASS 73 (473)
Q Consensus 4 ~t~ksDVySfGVvllEl~tg~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~ 73 (473)
.|.|+|||||||+|+||+||+.|....... ............... .+|.+....
T Consensus 195 ~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~p~~~~~~------------ 258 (303)
T d1vjya_ 195 SFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQK----LRPNIPNRW------------ 258 (303)
T ss_dssp HHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSC----CCCCCCGGG------------
T ss_pred cCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccc----cCCCCCccc------------
Confidence 678999999999999999998775321111 111111111111111 111111110
Q ss_pred cCcchhhHHHHHHHhhcccccccccccccccchhhHHHHHHHHHh
Q 012014 74 TCTQSSIILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (473)
Q Consensus 74 ~~~~~~~~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~ 118 (473)
....+...+..+...|+..+|.+||++.++...|+.+..
T Consensus 259 ------~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 259 ------QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp ------GGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 001223445566788999999999999999999988764
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.75 E-value=9.7e-10 Score=100.83 Aligned_cols=83 Identities=16% Similarity=0.256 Sum_probs=51.8
Q ss_pred CccccccceeehhhhHHHHHhCCCC-CCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRP-NDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..|.|||||||||||+||+||..| .... . ...+...+.. .....+. ...
T Consensus 217 ~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~-~-~~e~~~~v~~---~~~~~~p-----~~~------------------- 267 (301)
T d1lufa_ 217 NRYTTESDVWAYGVVLWEIFSYGLQPYYGM-A-HEEVIYYVRD---GNILACP-----ENC------------------- 267 (301)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTTCCTTTTS-C-HHHHHHHHHT---TCCCCCC-----TTC-------------------
T ss_pred CCCChhhhhccchhhHHHHHccCCCCCCCC-C-HHHHHHHHHc---CCCCCCC-----ccc-------------------
Confidence 3578999999999999999999764 3322 1 1122222221 1111110 000
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHH
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIK 117 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~ 117 (473)
...+..+...|+..+|.+||++.+|.+.|+.+.
T Consensus 268 ----~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 268 ----PLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ----hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 111233456799999999999999999888653
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.73 E-value=1.6e-09 Score=98.31 Aligned_cols=85 Identities=19% Similarity=0.198 Sum_probs=52.8
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhhH
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (473)
+..+.|||||||||+|+||+||..|....... ..+...+.... . +......
T Consensus 188 ~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-~~~~~~i~~~~---~-----~~~~~~~-------------------- 238 (283)
T d1mqba_ 188 RKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVMKAINDGF---R-----LPTPMDC-------------------- 238 (283)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHHHHTTC---C-----CCCCTTC--------------------
T ss_pred CCCCCcccccccHHHHHHHHhCCCCccccCCH-HHHHHHHhccC---C-----CCCchhh--------------------
Confidence 56789999999999999999987764422211 11222222110 0 0000000
Q ss_pred HHHHHHhhcccccccccccccccchhhHHHHHHHHHh
Q 012014 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (473)
Q Consensus 82 ~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~ 118 (473)
...+..+...|+..+|++||++.++...|+.+.+
T Consensus 239 ---~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 239 ---PSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp ---BHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---HHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 1112234567999999999999999998887654
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.73 E-value=1.4e-09 Score=98.24 Aligned_cols=83 Identities=22% Similarity=0.230 Sum_probs=51.1
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhhH
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (473)
+..|.|||||||||+|+||+||.+|...... ...+.+.+..... ...+. ..
T Consensus 185 ~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-~~~~~~~i~~~~~-----~~~p~---~~-------------------- 235 (272)
T d1qpca_ 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-NPEVIQNLERGYR-----MVRPD---NC-------------------- 235 (272)
T ss_dssp CEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-HHHHHHHHHTTCC-----CCCCT---TC--------------------
T ss_pred CCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-HHHHHHHHHhcCC-----CCCcc---cC--------------------
Confidence 4578999999999999999998777543221 1122222221100 00110 00
Q ss_pred HHHHHHhhcccccccccccccccchhhHHHHHHHH
Q 012014 82 LECLISICRTGVACSAELPNERMKINDVESRLRLI 116 (473)
Q Consensus 82 ~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~ 116 (473)
-..+..+...|+..+|++||++.++.+.|+..
T Consensus 236 ---~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 236 ---PEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---hHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 01122334579999999999999999888754
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.72 E-value=2.9e-09 Score=95.30 Aligned_cols=84 Identities=20% Similarity=0.208 Sum_probs=52.9
Q ss_pred CccccccceeehhhhHHHHHhC-CCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFTG-LRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+.+|.|||||||||+++||+|+ +.|.... ....+..++.... ..++. ....
T Consensus 175 ~~~t~~sDIwSfG~il~el~t~~~~p~~~~--~~~~~~~~i~~~~---~~~~~-----~~~~------------------ 226 (262)
T d1byga_ 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPRVEKGY---KMDAP-----DGCP------------------ 226 (262)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCSCTTS--CGGGHHHHHTTTC---CCCCC-----TTCC------------------
T ss_pred CCCChHHHHHhHHHHHHHHHHCCCCCCCCC--CHHHHHHHHHcCC---CCCCC-----ccCC------------------
Confidence 5689999999999999999995 5454322 2223444433211 11111 1110
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHHh
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~ 118 (473)
..+..+...|+..+|.+||++.++.+.|+.++.
T Consensus 227 -----~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 227 -----PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp -----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----HHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 011123456999999999999999999987754
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.72 E-value=2e-09 Score=98.45 Aligned_cols=83 Identities=22% Similarity=0.284 Sum_probs=52.6
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..|.|||||||||+|+||+| |+.|..... ...+...+..-. ... .....
T Consensus 208 ~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~--~~~~~~~i~~~~---~~~-----~~~~~------------------- 258 (299)
T d1jpaa_ 208 RKFTSASDVWSYGIVMWEVMSYGERPYWDMT--NQDVINAIEQDY---RLP-----PPMDC------------------- 258 (299)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHHHTTC---CCC-----CCTTC-------------------
T ss_pred CCCCcccccccchHHHHHHHhCCCCCCCCCC--HHHHHHHHHcCC---CCC-----CCccc-------------------
Confidence 567899999999999999998 888865322 112222222110 000 00000
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHH
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIK 117 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~ 117 (473)
-..+..+...|+..+|.+||++.++...|+.+.
T Consensus 259 ----~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l 291 (299)
T d1jpaa_ 259 ----PSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMI 291 (299)
T ss_dssp ----CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ----hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 011223456799999999999999999987654
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.70 E-value=3.6e-09 Score=97.30 Aligned_cols=85 Identities=16% Similarity=0.133 Sum_probs=51.7
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhhH
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (473)
+..|.|||||||||+|+||+||..|.... .+..+...........+ ......
T Consensus 201 ~~~~~~sDvwSfGvil~ell~~~~~p~~~----~~~~~~~~~i~~~~~~~-----~~~~~~------------------- 252 (309)
T d1fvra_ 201 SVYTTNSDVWSYGVLLWEIVSLGGTPYCG----MTCAELYEKLPQGYRLE-----KPLNCD------------------- 252 (309)
T ss_dssp CEECHHHHHHHHHHHHHHHHTTSCCTTTT----CCHHHHHHHGGGTCCCC-----CCTTBC-------------------
T ss_pred CCCCccceeehhHHHHHHHHhcCCCCCCC----CCHHHHHHHHHhcCCCC-----CCccCC-------------------
Confidence 46789999999999999999987753211 11222222211111101 000100
Q ss_pred HHHHHHhhcccccccccccccccchhhHHHHHHHHHh
Q 012014 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (473)
Q Consensus 82 ~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~ 118 (473)
..+..+...|+..+|++||++.++...|+.+.+
T Consensus 253 ----~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 253 ----DEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp ----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 111223456999999999999999999987754
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.68 E-value=2.6e-09 Score=96.89 Aligned_cols=84 Identities=23% Similarity=0.289 Sum_probs=53.0
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..|.|||||||||+|+||+| |+.|...... ..+...+.. ....++. ....
T Consensus 187 ~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~--~~~~~~i~~---~~~~~~p-----~~~~------------------ 238 (285)
T d1u59a_ 187 RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--PEVMAFIEQ---GKRMECP-----PECP------------------ 238 (285)
T ss_dssp CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--HHHHHHHHT---TCCCCCC-----TTCC------------------
T ss_pred CCCCccchhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHHHc---CCCCCCC-----CcCC------------------
Confidence 457899999999999999998 8999754321 122222221 1111110 0000
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHHh
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~ 118 (473)
..+..+...|+..+|++||++.++.+.|+....
T Consensus 239 -----~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 239 -----PELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp -----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 111233457999999999999999999886644
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.66 E-value=5.9e-09 Score=95.92 Aligned_cols=85 Identities=14% Similarity=0.129 Sum_probs=53.0
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhhH
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (473)
+..|.|+|||||||+|+||+|+..|..........+...+..-.... .+. ..
T Consensus 222 ~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~-----~~~---~~-------------------- 273 (311)
T d1t46a_ 222 CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRML-----SPE---HA-------------------- 273 (311)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCC-----CCT---TS--------------------
T ss_pred CCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC-----Ccc---cc--------------------
Confidence 56799999999999999999976664433222222333333221110 000 00
Q ss_pred HHHHHHhhcccccccccccccccchhhHHHHHHHHH
Q 012014 82 LECLISICRTGVACSAELPNERMKINDVESRLRLIK 117 (473)
Q Consensus 82 ~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~ 117 (473)
-..+..+...|+..+|.+||++.++...|+.+-
T Consensus 274 ---~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 274 ---PAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---cHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 011223345799999999999999999887653
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.62 E-value=3.8e-09 Score=95.42 Aligned_cols=82 Identities=24% Similarity=0.267 Sum_probs=50.7
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..|.|||||||||+|+||+| |+.|...... ..+...+.. ...... + ....
T Consensus 185 ~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~--~~~~~~i~~---~~~~~~--p---~~~~------------------ 236 (277)
T d1xbba_ 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--SEVTAMLEK---GERMGC--P---AGCP------------------ 236 (277)
T ss_dssp CEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHT---TCCCCC--C---TTCC------------------
T ss_pred CCCCchhhhccchhhhhHHhhCCCCCCCCCCH--HHHHHHHHc---CCCCCC--C---cccC------------------
Confidence 457899999999999999998 8888653211 122222221 100000 0 0000
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHH
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLI 116 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~ 116 (473)
..+..+...|+..+|.+||++.++...|+..
T Consensus 237 -----~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 237 -----REMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp -----HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -----HHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 1112334579999999999999998887754
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.61 E-value=5.2e-09 Score=94.82 Aligned_cols=82 Identities=24% Similarity=0.219 Sum_probs=51.2
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhhH
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (473)
+..|.|||||||||+|+||+||.+|....... ..+..++...... . ......
T Consensus 189 ~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-~~~~~~i~~~~~~---~-----~~~~~~------------------- 240 (285)
T d1fmka3 189 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REVLDQVERGYRM---P-----CPPECP------------------- 240 (285)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHHHTTCCC---C-----CCTTSC-------------------
T ss_pred CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-HHHHHHHHhcCCC---C-----CCcccC-------------------
Confidence 57899999999999999999988875432221 1222332221110 0 111110
Q ss_pred HHHHHHhhcccccccccccccccchhhHHHHHHH
Q 012014 82 LECLISICRTGVACSAELPNERMKINDVESRLRL 115 (473)
Q Consensus 82 ~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~ 115 (473)
..+..+...|+..+|++||++.+|...|+.
T Consensus 241 ----~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 270 (285)
T d1fmka3 241 ----ESLHDLMCQCWRKEPEERPTFEYLQAFLED 270 (285)
T ss_dssp ----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred ----HHHHHHHHHHcccCHhHCcCHHHHHHHHhh
Confidence 112233567999999999999999877764
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.61 E-value=6e-09 Score=93.89 Aligned_cols=82 Identities=23% Similarity=0.284 Sum_probs=50.0
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCcc-ccccccccccchHHHHHHHhhhcccCcchh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERA-EEILDVVFFQEIEEEETMYKKASSTCTQSS 79 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~ 79 (473)
+..|.|||||||||+|+||+| |+.|.... ....+..++. ..+. .... ....
T Consensus 189 ~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~--~~~~~~~~i~---~~~~~~~~~-----~~~~----------------- 241 (273)
T d1u46a_ 189 RTFSHASDTWMFGVTLWEMFTYGQEPWIGL--NGSQILHKID---KEGERLPRP-----EDCP----------------- 241 (273)
T ss_dssp CEEEHHHHHHHHHHHHHHHHTTSCCTTTTC--CHHHHHHHHH---TSCCCCCCC-----TTCC-----------------
T ss_pred CCCCcchhhhhhHHHHHHHHhCCCCCCCCc--CHHHHHHHHH---hCCCCCCCc-----cccc-----------------
Confidence 346789999999999999999 78885422 1112222222 1110 0100 0000
Q ss_pred hHHHHHHHhhcccccccccccccccchhhHHHHHHHH
Q 012014 80 IILECLISICRTGVACSAELPNERMKINDVESRLRLI 116 (473)
Q Consensus 80 ~~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~ 116 (473)
..+..+...|+..+|++||++.++...|...
T Consensus 242 ------~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 242 ------QDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp ------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------HHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1122334569999999999999998877653
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.60 E-value=1.3e-08 Score=93.11 Aligned_cols=84 Identities=19% Similarity=0.234 Sum_probs=50.7
Q ss_pred CccccccceeehhhhHHHHHhCCCC-CCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRP-NDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..|.|||||||||+|+||+||..| .... .....+...+..... ..+.+ ...
T Consensus 211 ~~~~~~sDiwS~Gvil~ellt~~~~p~~~~-~~~~~~~~~~~~~~~---~~~~~-----~~~------------------ 263 (299)
T d1ywna1 211 RVYTIQSDVWSFGVLLWEIFSLGASPYPGV-KIDEEFCRRLKEGTR---MRAPD-----YTT------------------ 263 (299)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCSSTTC-CCSHHHHHHHHHTCC---CCCCT-----TCC------------------
T ss_pred CCCCcccceeehHHHHHHHHhCCCCCCCCC-CHHHHHHHHHhcCCC---CCCCc-----cCC------------------
Confidence 4578999999999999999998764 3322 111112222221110 01111 000
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHH
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIK 117 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~ 117 (473)
..+..+...|+..+|.+||++.++...|+.+.
T Consensus 264 -----~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 264 -----PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp -----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 01123345799999999999999999888664
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.59 E-value=2.1e-07 Score=82.92 Aligned_cols=143 Identities=13% Similarity=0.095 Sum_probs=94.2
Q ss_pred cCCCCccceeecCCCeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcC-CCCceeeeeeeeccccCCceeeE
Q 012014 144 TNGFSSANLIGAGNFGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQGARFKA 222 (473)
Q Consensus 144 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~ 222 (473)
...|+..+..+.++.+.||+.. .+++.+++|+...........+.+|...+..+. +--+.+++.+..+ ....+
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~-~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~-----~~~~~ 86 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLV-GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH-----DGWSN 86 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEE-CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-----TTEEE
T ss_pred hhceEEEEcCCCCCCCcEEEEE-eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEec-----CCceE
Confidence 3455555554445557899886 467778899887555555667888999888774 3335666665433 23568
Q ss_pred EEEEecCCCCHHHHhcCCCCCCCCCcchhhcHHHHHHHHHHHHHHHHHHhhC----------------------------
Q 012014 223 VVYKFMPNGSLEEWLRGKDDTNWRPLNFNFLIKKKLDIAIDVACALRYLHCD---------------------------- 274 (473)
Q Consensus 223 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~L~~LH~~---------------------------- 274 (473)
+||++++|.++.+...... ....++.+++..+..||+.
T Consensus 87 lv~~~l~G~~~~~~~~~~~--------------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDEQ--------------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLAD 152 (263)
T ss_dssp EEEECCSSEEHHHHTTTCS--------------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSC
T ss_pred EEEEecccccccccccccc--------------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhh
Confidence 9999999988866543221 1112344455555555521
Q ss_pred ----------------------------CCCCeeeccCCCCcEEecCCccEEEeeccccc
Q 012014 275 ----------------------------CQPPIAHCNLKPSNVLLDDEMIGHVGDFGMAR 306 (473)
Q Consensus 275 ----------------------------~~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~ 306 (473)
....++|+|+.|.||++++++..-|+||+.+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 153 VDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 01237999999999999987777799998775
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.59 E-value=5.1e-09 Score=96.18 Aligned_cols=83 Identities=19% Similarity=0.216 Sum_probs=51.1
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhhH
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (473)
+..+.|+|||||||+|+||+||+++.... .+..++...........+.+ ..
T Consensus 210 ~~~~~~~Dv~S~G~il~El~t~~~~p~~~----~~~~~~~~~i~~~~~~~~p~-----~~-------------------- 260 (308)
T d1p4oa_ 210 GVFTTYSDVWSFGVVLWEIATLAEQPYQG----LSNEQVLRFVMEGGLLDKPD-----NC-------------------- 260 (308)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHTSCCTTTT----SCHHHHHHHHHTTCCCCCCT-----TC--------------------
T ss_pred CCCCcccccccHHHHHHHHHhCCCCCCCC----CCHHHHHHHHHhCCCCCCcc-----cc--------------------
Confidence 45788999999999999999997653221 12223322222211111111 00
Q ss_pred HHHHHHhhcccccccccccccccchhhHHHHHHHH
Q 012014 82 LECLISICRTGVACSAELPNERMKINDVESRLRLI 116 (473)
Q Consensus 82 ~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~ 116 (473)
-..+..+...|+..+|+.||++.++.+.|+..
T Consensus 261 ---~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 261 ---PDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred ---hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 01133445679999999999999998887543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.58 E-value=1.6e-08 Score=93.26 Aligned_cols=84 Identities=18% Similarity=0.334 Sum_probs=52.2
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..|.|||||||||+|+||+| |+.|.+..... .+...+..... ...+. . |
T Consensus 188 ~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~--~~~~~i~~~~~-----~~~p~---~--------------~----- 238 (317)
T d1xkka_ 188 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKGER-----LPQPP---I--------------C----- 238 (317)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG--GHHHHHHHTCC-----CCCCT---T--------------B-----
T ss_pred CCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHcCCC-----CCCCc---c--------------c-----
Confidence 567999999999999999999 67776533221 22222222110 00000 0 0
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHHh
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~ 118 (473)
-..+..+...|+..+|.+||++.++...+..+.+
T Consensus 239 ----~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 239 ----TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 0112233457999999999999999988876643
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.55 E-value=1.9e-08 Score=90.55 Aligned_cols=84 Identities=18% Similarity=0.296 Sum_probs=52.6
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..+.|+|||||||+|+||+| |+.|...... ..+...+..... .. +.....
T Consensus 184 ~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~--~~~~~~i~~~~~---~~-----~~~~~~------------------ 235 (273)
T d1mp8a_ 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--NDVIGRIENGER---LP-----MPPNCP------------------ 235 (273)
T ss_dssp CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG--GGHHHHHHTTCC---CC-----CCTTCC------------------
T ss_pred CCCCCccccccchHHHHHHHhcCCCCCCCCCH--HHHHHHHHcCCC---CC-----CCCCCC------------------
Confidence 467889999999999999998 7777654322 223322222110 00 001110
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHHh
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIKK 118 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~~ 118 (473)
..+..+...|+..+|.+||++.++...|+.+.+
T Consensus 236 -----~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 236 -----PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp -----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 011223457999999999999999998887643
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.53 E-value=1.2e-08 Score=92.66 Aligned_cols=83 Identities=17% Similarity=0.159 Sum_probs=50.5
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhhH
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSII 81 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (473)
+..|.|||||||||+|+||+||..|...... ...+.+.+..-.. .. .....
T Consensus 191 ~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-~~~~~~~i~~~~~---~~-----~~~~~-------------------- 241 (287)
T d1opja_ 191 NKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKDYR---ME-----RPEGC-------------------- 241 (287)
T ss_dssp CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-HHHHHHHHHTTCC---CC-----CCTTC--------------------
T ss_pred CCCCchhhhhhHHHHHHHHHhCCCCCCCcch-HHHHHHHHhcCCC---CC-----CCccc--------------------
Confidence 4678999999999999999998877542211 1112222221110 00 00000
Q ss_pred HHHHHHhhcccccccccccccccchhhHHHHHHHH
Q 012014 82 LECLISICRTGVACSAELPNERMKINDVESRLRLI 116 (473)
Q Consensus 82 ~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~ 116 (473)
-..+..+...|+..+|.+||++.++.+.|+.+
T Consensus 242 ---~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 242 ---PEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred ---hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 01122345679999999999999998877654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.53 E-value=1.7e-08 Score=93.31 Aligned_cols=81 Identities=25% Similarity=0.315 Sum_probs=50.1
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..|.|||||||||+|+||+| |+.|....... ..+...+..... +.......
T Consensus 241 ~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~-~~~~~~~~~~~~--------~~~p~~~~------------------ 293 (325)
T d1rjba_ 241 GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD-ANFYKLIQNGFK--------MDQPFYAT------------------ 293 (325)
T ss_dssp CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-HHHHHHHHTTCC--------CCCCTTCC------------------
T ss_pred CCCCcceeccchhHHHHHHHhCCCCCCCCCCHH-HHHHHHHhcCCC--------CCCCCcCC------------------
Confidence 567899999999999999998 88886532221 122222222111 00000000
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHH
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLR 114 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~ 114 (473)
..+..+...|+..+|++||++.++.+.|.
T Consensus 294 -----~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 294 -----EEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp -----HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred -----HHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 01122345799999999999999988774
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.52 E-value=1.9e-08 Score=91.81 Aligned_cols=83 Identities=22% Similarity=0.257 Sum_probs=51.4
Q ss_pred CccccccceeehhhhHHHHHhC-CCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFTG-LRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..|.|+|||||||||+||+|+ +.|..... ...+..++.... ... .....
T Consensus 212 ~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~--~~~~~~~i~~~~---~~~-----~p~~~------------------- 262 (299)
T d1fgka_ 212 RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP--VEELFKLLKEGH---RMD-----KPSNC------------------- 262 (299)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHHHHHHHTTC---CCC-----CCSSC-------------------
T ss_pred CCCCchhhhHHhHHHHHHhccCCCCCCCCCC--HHHHHHHHHcCC---CCC-----CCccc-------------------
Confidence 5678999999999999999995 55543221 112222222110 000 00000
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHHHHH
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLRLIK 117 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~~~~ 117 (473)
...+..+...|+..+|.+||++.++.+.|+.+.
T Consensus 263 ----~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 263 ----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----hHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 011223456799999999999999999998764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.50 E-value=1.5e-08 Score=90.35 Aligned_cols=80 Identities=19% Similarity=0.323 Sum_probs=48.7
Q ss_pred CccccccceeehhhhHHHHHh-CCCCCCCCCCCcccHHHHHHHhcCCccccccccccccchHHHHHHHhhhcccCcchhh
Q 012014 2 GYVSSYGDVYSFGILLLEMFT-GLRPNDDMFNDELNLHNFVKSALPERAEEILDVVFFQEIEEEETMYKKASSTCTQSSI 80 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~t-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (473)
+..|.|||||||||+++||+| |+.|....... .+..-+.. +. ....+....
T Consensus 176 ~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~--~~~~~i~~----~~-~~~~p~~~~--------------------- 227 (258)
T d1k2pa_ 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS--ETAEHIAQ----GL-RLYRPHLAS--------------------- 227 (258)
T ss_dssp CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH--HHHHHHHT----TC-CCCCCTTCC---------------------
T ss_pred CCCCcceeecccchhhHhHHhcCCCCCCCCCHH--HHHHHHHh----CC-CCCCccccc---------------------
Confidence 457899999999999999999 77776533211 12211111 10 111111100
Q ss_pred HHHHHHHhhcccccccccccccccchhhHHHHHH
Q 012014 81 ILECLISICRTGVACSAELPNERMKINDVESRLR 114 (473)
Q Consensus 81 ~~~~~~~~~~~~~~C~~~~~~~Rp~m~~v~~~l~ 114 (473)
..+..+...|+..+|++||++.++...|.
T Consensus 228 -----~~l~~li~~cl~~dP~~RPt~~eil~~L~ 256 (258)
T d1k2pa_ 228 -----EKVYTIMYSCWHEKADERPTFKILLSNIL 256 (258)
T ss_dssp -----HHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred -----HHHHHHHHHHccCCHhHCcCHHHHHHHhh
Confidence 11223345699999999999999988764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.43 E-value=3.6e-08 Score=88.42 Aligned_cols=27 Identities=37% Similarity=0.501 Sum_probs=24.7
Q ss_pred CccccccceeehhhhHHHHHhCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
++.+.|+|||||||+|+||+||+.|..
T Consensus 187 ~~~~~~~DIwSlGvilyel~~g~~Pf~ 213 (270)
T d1t4ha_ 187 EKYDESVDVYAFGMCMLEMATSEYPYS 213 (270)
T ss_dssp TCCCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CCCCCcCchhhHHHHHHHHHHCCCCCC
Confidence 467899999999999999999999975
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.32 E-value=4.6e-08 Score=87.64 Aligned_cols=28 Identities=25% Similarity=0.363 Sum_probs=24.9
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
+..+.|||||||||+|+||+||+.|...
T Consensus 189 ~~~~~~~DIwSlGvilyel~tg~~Pf~~ 216 (269)
T d2java1 189 MSYNEKSDIWSLGCLLYELCALMPPFTA 216 (269)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCChHHHHHhhCHHHHHHhhCCCCCCC
Confidence 4578999999999999999999999753
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=98.29 E-value=1.8e-07 Score=84.25 Aligned_cols=27 Identities=41% Similarity=0.621 Sum_probs=24.4
Q ss_pred CccccccceeehhhhHHHHHhCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
+..+.|+|||||||+|+||+||+.|..
T Consensus 189 ~~~~~~~DiwSlGvilyelltG~~Pf~ 215 (277)
T d1o6ya_ 189 DSVDARSDVYSLGCVLYEVLTGEPPFT 215 (277)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCCCcceecccchHHHHHHHhCCCCCC
Confidence 357899999999999999999999975
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.25 E-value=1.5e-07 Score=84.29 Aligned_cols=26 Identities=38% Similarity=0.510 Sum_probs=23.2
Q ss_pred cccccceeehhhhHHHHHhCCCCCCC
Q 012014 4 VSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 4 ~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
.+.++|||||||+|+||+||+.|.+.
T Consensus 183 ~~~~~DiwSlGvilyeml~G~~pf~~ 208 (271)
T d1nvra_ 183 HAEPVDVWSCGIVLTAMLAGELPWDQ 208 (271)
T ss_dssp CHHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred CCCceeeeHhHHHHHHHHhCCCCCCC
Confidence 36789999999999999999999764
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.21 E-value=1.9e-07 Score=85.27 Aligned_cols=27 Identities=30% Similarity=0.327 Sum_probs=24.4
Q ss_pred CccccccceeehhhhHHHHHhCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
+..|.|+|||||||+|+||+||+.|..
T Consensus 189 ~~y~~~~DiwSlGvilyel~~g~~Pf~ 215 (309)
T d1u5ra_ 189 GQYDGKVDVWSLGITCIELAERKPPLF 215 (309)
T ss_dssp CCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CCcCchhhhhhHHHHHHHHHHCCCCCC
Confidence 457899999999999999999999964
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.20 E-value=1.5e-07 Score=85.71 Aligned_cols=27 Identities=26% Similarity=0.254 Sum_probs=24.4
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
..+.|+|||||||+++||+||+.|...
T Consensus 189 ~~~~~~DiwSlG~~l~el~tg~~P~~~ 215 (299)
T d1ckia_ 189 EQSRRDDLESLGYVLMYFNLGSLPWQG 215 (299)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCCChhhEEecCHHHHHHHhCCCcccc
Confidence 468999999999999999999999754
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.16 E-value=3.1e-06 Score=74.70 Aligned_cols=74 Identities=14% Similarity=0.059 Sum_probs=50.0
Q ss_pred eeecCC-CeEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCC--CCceeeeeeeeccccCCceeeEEEEEec
Q 012014 152 LIGAGN-FGSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKH--RNIVRVFTAFSGVDYQGARFKAVVYKFM 228 (473)
Q Consensus 152 ~lg~G~-~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~e~~ 228 (473)
.+..|. .+.||+....++..+++|.... .....+..|...++.+.. -.+.+++.+..+ ....++||+++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~---~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~-----~~~~~~v~~~i 88 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLS---GALNELQDEAARLSWLATTGVPCAAVLDVVTE-----AGRDWLLLGEV 88 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECS---CTTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-----SSCEEEEEECC
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCc---cCHhHHHHHHHHHHHHHhcCCCCCceeeeccc-----ccceEEEEEee
Confidence 344454 3679999877788889997643 234467889988887743 335666665433 23568999999
Q ss_pred CCCCH
Q 012014 229 PNGSL 233 (473)
Q Consensus 229 ~~g~L 233 (473)
+|.++
T Consensus 89 ~G~~~ 93 (255)
T d1nd4a_ 89 PGQDL 93 (255)
T ss_dssp SSEET
T ss_pred ecccc
Confidence 87654
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.13 E-value=5.4e-07 Score=80.19 Aligned_cols=26 Identities=27% Similarity=0.489 Sum_probs=23.8
Q ss_pred ccccccceeehhhhHHHHHhCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
..+.|+|||||||+|+||+||+.|..
T Consensus 180 ~~~~~~DiwSlGvilyell~G~~Pf~ 205 (263)
T d2j4za1 180 MHDEKVDLWSLGVLCYEFLVGKPPFE 205 (263)
T ss_dssp CCCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred CCCchhhhhhHhHHHHHHhcCCCCCC
Confidence 46889999999999999999999975
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.13 E-value=5e-07 Score=81.54 Aligned_cols=27 Identities=33% Similarity=0.427 Sum_probs=24.0
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
..|.|+|||||||+|+||+||+.|...
T Consensus 191 ~y~~k~DiwSlGvilyemltg~~Pf~~ 217 (288)
T d2jfla1 191 PYDYKADVWSLGITLIEMAEIEPPHHE 217 (288)
T ss_dssp STTTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCChhhhHHHHHHHHHHHhhCCCCCCC
Confidence 357899999999999999999999753
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=98.11 E-value=3.3e-07 Score=83.59 Aligned_cols=28 Identities=25% Similarity=0.341 Sum_probs=24.8
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
+..+.|+|||||||+|+||+||+.|...
T Consensus 184 ~~~~~~~DiwSlGvilyell~g~~Pf~~ 211 (307)
T d1a06a_ 184 KPYSKAVDCWSIGVIAYILLCGYPPFYD 211 (307)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCCcHHHhhhhhHHHHHHHhCCCCCCC
Confidence 3468999999999999999999999753
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.11 E-value=3e-07 Score=83.46 Aligned_cols=27 Identities=19% Similarity=0.348 Sum_probs=24.4
Q ss_pred CccccccceeehhhhHHHHHhCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
+..+.|+|||||||+|+||+||+.|..
T Consensus 191 ~~~~~~~DiwSlGvilyell~g~~Pf~ 217 (293)
T d1jksa_ 191 EPLGLEADMWSIGVITYILLSGASPFL 217 (293)
T ss_dssp CCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCCCcccchhhhHHHHHHHcCCCCCC
Confidence 357899999999999999999999965
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.03 E-value=6.5e-07 Score=80.93 Aligned_cols=27 Identities=30% Similarity=0.446 Sum_probs=24.3
Q ss_pred CccccccceeehhhhHHHHHhCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
+..+.|+|||||||+|+||+||+.|..
T Consensus 191 ~~~~~~~DiwSlGvilyemltG~~Pf~ 217 (293)
T d1yhwa1 191 KAYGPKVDIWSLGIMAIEMIEGEPPYL 217 (293)
T ss_dssp SCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CCCCchhceehHhHHHHHHhhCCCCCC
Confidence 356899999999999999999999964
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.00 E-value=8e-07 Score=81.02 Aligned_cols=28 Identities=21% Similarity=0.248 Sum_probs=24.8
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
+..+.|+||||+||+|+||+||+.|...
T Consensus 190 ~~y~~~~DiwSlG~il~ell~g~~pf~~ 217 (305)
T d1blxa_ 190 SSYATPVDLWSVGCIFAEMFRRKPLFRG 217 (305)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCChhehhhchHHHHHHHHHCCCCCCC
Confidence 3568999999999999999999999753
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.98 E-value=1.5e-06 Score=79.82 Aligned_cols=28 Identities=32% Similarity=0.428 Sum_probs=25.1
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
+..+.|+|||||||+|+||+||+.|...
T Consensus 178 ~~y~~~~DiWSlGvil~ell~G~~Pf~~ 205 (322)
T d1s9ja_ 178 THYSVQSDIWSMGLSLVEMAVGRYPIPP 205 (322)
T ss_dssp SCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred CCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 4678999999999999999999999753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.97 E-value=1.1e-06 Score=81.07 Aligned_cols=26 Identities=19% Similarity=0.416 Sum_probs=23.7
Q ss_pred ccccccceeehhhhHHHHHhCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
..+.|+|||||||+|+||+||+.|..
T Consensus 189 ~y~~~~DiwSlGvily~lltg~~Pf~ 214 (335)
T d2ozaa1 189 KYDKSCDMWSLGVIMYILLCGYPPFY 214 (335)
T ss_dssp GGSHHHHHHHHHHHHHHHTTSSCSCE
T ss_pred CCCHHHHHHhhchhHHHHhhCCCCCC
Confidence 46789999999999999999999975
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=97.92 E-value=1.2e-06 Score=78.54 Aligned_cols=26 Identities=19% Similarity=0.357 Sum_probs=23.6
Q ss_pred cccccceeehhhhHHHHHhCCCCCCC
Q 012014 4 VSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 4 ~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
.|.|+||||+||||+||+||+.|...
T Consensus 192 ~~~~~DiwslGvilyeml~g~~Pf~~ 217 (277)
T d1phka_ 192 YGKEVDMWSTGVIMYTLLAGSPPFWH 217 (277)
T ss_dssp BCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCchheEcccchhhhhhccCCCCCCC
Confidence 57899999999999999999999753
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.88 E-value=3.1e-06 Score=76.16 Aligned_cols=27 Identities=19% Similarity=0.491 Sum_probs=24.2
Q ss_pred CccccccceeehhhhHHHHHhCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
...+.|+|||||||+|+||+||+.|..
T Consensus 185 ~~~~~~~DiwSlGvilyell~g~~Pf~ 211 (288)
T d1uu3a_ 185 KSACKSSDLWALGCIIYQLVAGLPPFR 211 (288)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCCcccceehhhHHHHHHhhCCCCCC
Confidence 346889999999999999999999965
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=97.87 E-value=1.6e-06 Score=80.41 Aligned_cols=27 Identities=30% Similarity=0.551 Sum_probs=24.3
Q ss_pred CccccccceeehhhhHHHHHhCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
+..+.|+||||+||+|+||+||+.|..
T Consensus 203 ~~~~~~~DiwSlGvilyelltG~~Pf~ 229 (352)
T d1koba_ 203 EPVGFYTDMWAIGVLGYVLLSGLSPFA 229 (352)
T ss_dssp CCBCHHHHHHHHHHHHHHHHHSCCSSC
T ss_pred CCCCCccchHHHHHHHHHHHhCCCCCC
Confidence 347899999999999999999999965
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=97.85 E-value=2e-06 Score=79.77 Aligned_cols=26 Identities=35% Similarity=0.621 Sum_probs=23.6
Q ss_pred ccccccceeehhhhHHHHHhCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
..+.|+|||||||+|+||+||+.|..
T Consensus 201 ~~~~~~DiwSlGvilyell~G~~Pf~ 226 (350)
T d1koaa2 201 PVGYYTDMWSVGVLSYILLSGLSPFG 226 (350)
T ss_dssp CBCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCChhHhhhhhhHHHHHHHhCCCCCC
Confidence 46789999999999999999999965
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.84 E-value=1.9e-06 Score=77.89 Aligned_cols=26 Identities=27% Similarity=0.272 Sum_probs=23.6
Q ss_pred ccccccceeehhhhHHHHHhCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
..|.|+|||||||+++||+||+.|..
T Consensus 178 ~~~~~~DiwSlG~il~ell~g~~p~~ 203 (292)
T d1unla_ 178 LYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_dssp CCCTHHHHHHHHHHHHHHTTTSCCSC
T ss_pred CCCchhhccccchHHHHHhhCCCCCC
Confidence 36899999999999999999999964
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=97.82 E-value=2.4e-06 Score=77.29 Aligned_cols=27 Identities=19% Similarity=0.273 Sum_probs=24.4
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
..|.|+|||||||+++||+||+.|...
T Consensus 189 ~~~~~~DiwSlG~~l~elltg~~Pf~~ 215 (293)
T d1csna_ 189 EQSRRDDLEALGHVFMYFLRGSLPWQG 215 (293)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCTTSS
T ss_pred CCChHHHHHHhhHHHHHHHhCCCcCCC
Confidence 478999999999999999999999753
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=97.80 E-value=2.4e-06 Score=76.94 Aligned_cols=27 Identities=26% Similarity=0.302 Sum_probs=24.3
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
..|.|+|||||||||+||+||+.|...
T Consensus 177 ~~~~~~DiwslGv~l~el~~G~~pf~~ 203 (286)
T d1ob3a_ 177 KYSTTIDIWSVGCIFAEMVNGTPLFPG 203 (286)
T ss_dssp SCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCcceeehhcCcHHHHHHHCCCCCCC
Confidence 468999999999999999999999753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=97.80 E-value=3.1e-06 Score=78.91 Aligned_cols=27 Identities=26% Similarity=0.484 Sum_probs=24.3
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
..+.|+|||||||+|+||+||+.|...
T Consensus 182 ~~~~~~DiwSlGvilyemltG~~Pf~~ 208 (364)
T d1omwa3 182 AYDSSADWFSLGCMLFKLLRGHSPFRQ 208 (364)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred CCCcccchhHHHHHHHHHHhCCCCCCC
Confidence 368899999999999999999999764
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.80 E-value=2.5e-06 Score=78.16 Aligned_cols=27 Identities=19% Similarity=0.176 Sum_probs=23.9
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
..+.|+|||||||+++||+||+.|.+.
T Consensus 198 ~~~~k~DiwSlGvil~el~~g~~pf~~ 224 (318)
T d3blha1 198 DYGPPIDLWGAGCIMAEMWTRSPIMQG 224 (318)
T ss_dssp SCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCCcHHHcccCCceeeeHhhCCCCCCC
Confidence 357899999999999999999998753
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.77 E-value=5.2e-06 Score=75.98 Aligned_cols=27 Identities=30% Similarity=0.417 Sum_probs=23.1
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
..+.|||||||||+|+||+||+.|...
T Consensus 208 ~~~~ksDIWSlG~iLyelltG~~PF~~ 234 (322)
T d1vzoa_ 208 GHDKAVDWWSLGVLMYELLTGASPFTV 234 (322)
T ss_dssp --CTHHHHHHHHHHHHHHHHSSCTTSC
T ss_pred CCCchhhhHHHHHHHHHHHhCCCCCCC
Confidence 357899999999999999999999753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.77 E-value=5.1e-05 Score=71.21 Aligned_cols=76 Identities=18% Similarity=0.150 Sum_probs=48.5
Q ss_pred cceeecCCCeEEEEEEec-CCCEEEEEEeec----c---CCCCchhHHHHHHHHHhcC---CCCceeeeeeeeccccCCc
Q 012014 150 ANLIGAGNFGSVYNGTLF-DGTTIAVKVFNL----I---RPGGSKSFKSECKAAINIK---HRNIVRVFTAFSGVDYQGA 218 (473)
Q Consensus 150 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~----~---~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~~ 218 (473)
.+.||.|....||+.... +++.+++|.-.. . .+....+...|...|..+. ...+++++.+..+
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~------ 104 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTE------ 104 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETT------
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcCC------
Confidence 346899999999999843 467899996531 1 1123455677888887663 2456667655322
Q ss_pred eeeEEEEEecCCCC
Q 012014 219 RFKAVVYKFMPNGS 232 (473)
Q Consensus 219 ~~~~lv~e~~~~g~ 232 (473)
..++|||++.+..
T Consensus 105 -~~~lvmE~L~~~~ 117 (392)
T d2pula1 105 -MAVTVMEDLSHLK 117 (392)
T ss_dssp -TTEEEECCCTTSE
T ss_pred -CCEEEEeccCCcc
Confidence 2378999997643
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.77 E-value=1.8e-06 Score=78.27 Aligned_cols=27 Identities=30% Similarity=0.367 Sum_probs=24.2
Q ss_pred CccccccceeehhhhHHHHHhCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
+..+.|+|||||||+|+||+||+.|..
T Consensus 178 ~~~~~~~DiwSlGvily~m~~G~~Pf~ 204 (298)
T d1gz8a_ 178 KYYSTAVDIWSLGCIFAEMVTRRALFP 204 (298)
T ss_dssp SSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cCCCccccccccchhhhHHhhCCCCCC
Confidence 346889999999999999999999975
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.76 E-value=2.6e-06 Score=78.07 Aligned_cols=28 Identities=29% Similarity=0.519 Sum_probs=24.4
Q ss_pred CccccccceeehhhhHHHHHhCCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
+..+.|+||||+||+|+||+||+.|...
T Consensus 178 ~~~~~~~DiWSlGvily~ll~G~~Pf~~ 205 (321)
T d1tkia_ 178 DVVSTATDMWSLGTLVYVLLSGINPFLA 205 (321)
T ss_dssp CEECHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCCCchhhcccHHHHHHHHHhCCCCCCC
Confidence 3467899999999999999999999653
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.72 E-value=6.4e-06 Score=73.50 Aligned_cols=25 Identities=36% Similarity=0.545 Sum_probs=22.3
Q ss_pred cccccceeehhhhHHHHHhCCCCCC
Q 012014 4 VSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 4 ~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
.+.++|||||||+|+||+||+.|..
T Consensus 187 ~~~~~DiwSlGvilyell~g~~Pf~ 211 (273)
T d1xwsa_ 187 HGRSAAVWSLGILLYDMVCGDIPFE 211 (273)
T ss_dssp CHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCcccccccceeeehhHhhCCCCCC
Confidence 3577999999999999999999964
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.56 E-value=3.7e-05 Score=70.94 Aligned_cols=27 Identities=26% Similarity=0.354 Sum_probs=24.0
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
..+.++||||+||+|+||+||+.|...
T Consensus 195 ~~~~~~DiwSlGvil~ell~g~~pf~~ 221 (346)
T d1cm8a_ 195 RYTQTVDIWSVGCIMAEMITGKTLFKG 221 (346)
T ss_dssp CCCTTHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCccchhhcchHHHHHHHHCcCCCCC
Confidence 468899999999999999999998653
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.38 E-value=1.1e-05 Score=74.75 Aligned_cols=26 Identities=31% Similarity=0.263 Sum_probs=23.6
Q ss_pred ccccccceeehhhhHHHHHhCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
..+.|+||||+||+++||+||+.|..
T Consensus 199 ~~~~~~DIwSlG~il~el~~g~~pf~ 224 (350)
T d1q5ka_ 199 DYTSSIDVWSAGCVLAELLLGQPIFP 224 (350)
T ss_dssp SCCTHHHHHHHHHHHHHHHHTSCSSC
T ss_pred CCCcceeecccceEEEehhhCCCCCC
Confidence 46899999999999999999999865
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.34 E-value=1.9e-05 Score=72.08 Aligned_cols=27 Identities=37% Similarity=0.536 Sum_probs=24.5
Q ss_pred CccccccceeehhhhHHHHHhCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
+..+.|+|||||||+|+||+||+.|..
T Consensus 178 ~~~~~~~DiwSlGvilyemltG~~PF~ 204 (320)
T d1xjda_ 178 QKYNHSVDWWSFGVLLYEMLIGQSPFH 204 (320)
T ss_dssp CCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCCchhhhhhhhHHHHHHHhCCCCCC
Confidence 457899999999999999999999975
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.34 E-value=0.00019 Score=65.38 Aligned_cols=72 Identities=14% Similarity=0.086 Sum_probs=44.8
Q ss_pred eEEEEEEecCCCEEEEEEeeccCCCCchhHHHHHHHHHhcCCCCc--eeeeeeeeccccCCceeeEEEEEecCCC
Q 012014 159 GSVYNGTLFDGTTIAVKVFNLIRPGGSKSFKSECKAAINIKHRNI--VRVFTAFSGVDYQGARFKAVVYKFMPNG 231 (473)
Q Consensus 159 g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~~~g 231 (473)
-.||++...+|+.+++|+.+... ...+++..|...+..|...++ +..+..-...........+.++++++|.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred ceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 57999998899999999976432 245678889998888743222 1111111011112234568899998763
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.29 E-value=2.9e-05 Score=71.61 Aligned_cols=26 Identities=23% Similarity=0.281 Sum_probs=23.2
Q ss_pred cccccceeehhhhHHHHHhCCCCCCC
Q 012014 4 VSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 4 ~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
.+.|+||||+||+++||+||+.|...
T Consensus 190 ~~~~~DiwSlG~il~eml~g~~pf~~ 215 (345)
T d1pmea_ 190 YTKSIDIWSVGCILAEMLSNRPIFPG 215 (345)
T ss_dssp CSTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCchhhhhccCceehHHhhCCCCCCC
Confidence 47889999999999999999999753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=97.26 E-value=2.8e-05 Score=70.67 Aligned_cols=27 Identities=41% Similarity=0.575 Sum_probs=24.3
Q ss_pred ccccccceeehhhhHHHHHhCCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
..+.++|||||||+|+||+||+.|...
T Consensus 177 ~y~~~~DiwSlGvilyemltG~~Pf~~ 203 (316)
T d1fota_ 177 PYNKSIDWWSFGILIYEMLAGYTPFYD 203 (316)
T ss_dssp CBCTTHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCCchhhccccchhHHHHHhCCCCCCC
Confidence 468899999999999999999999753
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.24 E-value=9.3e-05 Score=68.18 Aligned_cols=26 Identities=23% Similarity=0.331 Sum_probs=23.6
Q ss_pred ccccccceeehhhhHHHHHhCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
..+.++|||||||+++||+||+.|..
T Consensus 195 ~~~~~~DiwSlGv~l~~ll~g~~pF~ 220 (348)
T d2gfsa1 195 HYNQTVDIWSVGCIMAELLTGRTLFP 220 (348)
T ss_dssp CCCTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred cCCcccchhhhhHHHHHHHhCCCCCC
Confidence 46889999999999999999999864
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=97.23 E-value=3e-05 Score=72.08 Aligned_cols=27 Identities=22% Similarity=0.230 Sum_probs=23.6
Q ss_pred CccccccceeehhhhHHHHHhCCCCCC
Q 012014 2 GYVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 2 g~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
+..+.|+||||+||+|+||+||+.|..
T Consensus 204 ~~~~~~~DiwSlG~il~el~~g~~pF~ 230 (362)
T d1q8ya_ 204 APWGCGADIWSTACLIFELITGDFLFE 230 (362)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred cCCCccccccchHHHHHHHHHCCCCCC
Confidence 346889999999999999999999965
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.17 E-value=3.4e-05 Score=69.56 Aligned_cols=25 Identities=16% Similarity=0.178 Sum_probs=22.8
Q ss_pred cccccceeehhhhHHHHHhCCCCCC
Q 012014 4 VSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 4 ~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
.|.|+|||||||+|+||+||+.|..
T Consensus 178 ~~~~~DiwSlGvil~el~~g~~pf~ 202 (299)
T d1ua2a_ 178 YGVGVDMWAVGCILAELLLRVPFLP 202 (299)
T ss_dssp CCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CChhhhhhhcchHHHHHHhCcCCCC
Confidence 5889999999999999999988864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=97.14 E-value=4.1e-05 Score=70.62 Aligned_cols=26 Identities=27% Similarity=0.362 Sum_probs=23.7
Q ss_pred ccccccceeehhhhHHHHHhCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
..+.|+|||||||+|+||+||+.|..
T Consensus 214 ~~~~~~DiwSlGvilyemltG~~Pf~ 239 (350)
T d1rdqe_ 214 GYNKAVDWWALGVLIYEMAAGYPPFF 239 (350)
T ss_dssp CBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCccccccchhHHHHHHHhCCCCCC
Confidence 46889999999999999999999964
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.07 E-value=9.2e-05 Score=68.43 Aligned_cols=26 Identities=19% Similarity=0.095 Sum_probs=23.3
Q ss_pred ccccccceeehhhhHHHHHhCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
..+.++||||+||+++||+||+.|..
T Consensus 194 ~~~~~~DiwSlG~~l~ell~g~~pF~ 219 (355)
T d2b1pa1 194 GYKENVDIWSVGCIMGEMVRHKILFP 219 (355)
T ss_dssp CCCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCCCcccccccchHHHHhhCCCCCC
Confidence 46889999999999999999998853
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.06 E-value=5.6e-05 Score=69.23 Aligned_cols=26 Identities=23% Similarity=0.342 Sum_probs=23.7
Q ss_pred ccccccceeehhhhHHHHHhCCCCCC
Q 012014 3 YVSSYGDVYSFGILLLEMFTGLRPND 28 (473)
Q Consensus 3 ~~t~ksDVySfGVvllEl~tg~~~~~ 28 (473)
..+.++||||+||+|+||+||+.|..
T Consensus 181 ~y~~~~DiwSlGvilyeml~G~~pf~ 206 (337)
T d1o6la_ 181 DYGRAVDWWGLGVVMYEMMCGRLPFY 206 (337)
T ss_dssp CBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCChhhcccchhhHHHHHHHCCCCCC
Confidence 46899999999999999999999865
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.95 E-value=0.0012 Score=61.69 Aligned_cols=72 Identities=14% Similarity=0.235 Sum_probs=48.8
Q ss_pred cceeecCCCeEEEEEEecC--------CCEEEEEEeeccCCCCchhHHHHHHHHHhcC-CCCceeeeeeeeccccCCcee
Q 012014 150 ANLIGAGNFGSVYNGTLFD--------GTTIAVKVFNLIRPGGSKSFKSECKAAINIK-HRNIVRVFTAFSGVDYQGARF 220 (473)
Q Consensus 150 ~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~ 220 (473)
.+.|+.|-.-.+|++...+ .+.|.+++.-. ........+|..+++.+. +.-..+++++|.+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~-------- 116 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG-------- 116 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT--------
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC--------
Confidence 4568888889999988543 34677776542 223345668999988884 4444577877632
Q ss_pred eEEEEEecCCCC
Q 012014 221 KAVVYKFMPNGS 232 (473)
Q Consensus 221 ~~lv~e~~~~g~ 232 (473)
.+|+||++|.+
T Consensus 117 -g~I~efi~g~~ 127 (395)
T d1nw1a_ 117 -GRLEEYIPSRP 127 (395)
T ss_dssp -EEEECCCCEEE
T ss_pred -ceEEEEecccc
Confidence 68999997643
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=96.73 E-value=0.00031 Score=63.92 Aligned_cols=26 Identities=23% Similarity=0.231 Sum_probs=23.5
Q ss_pred cccccceeehhhhHHHHHhCCCCCCC
Q 012014 4 VSSYGDVYSFGILLLEMFTGLRPNDD 29 (473)
Q Consensus 4 ~t~ksDVySfGVvllEl~tg~~~~~~ 29 (473)
.+.++||||+||+++||++|+.|...
T Consensus 207 ~~~~~DiwslG~~l~e~~~g~~pf~~ 232 (328)
T d3bqca1 207 YDYSLDMWSLGCMLASMIFRKEPFFH 232 (328)
T ss_dssp CCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred CCcccchhhhhhhhHHhccCCCCCCC
Confidence 58899999999999999999999653
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.24 E-value=0.0096 Score=53.22 Aligned_cols=31 Identities=23% Similarity=0.293 Sum_probs=27.9
Q ss_pred CCCeeeccCCCCcEEecCCccEEEeeccccc
Q 012014 276 QPPIAHCNLKPSNVLLDDEMIGHVGDFGMAR 306 (473)
Q Consensus 276 ~~~iiH~Dlkp~Nil~~~~~~~kl~Dfg~~~ 306 (473)
..|+||+|+.++||+++++...-+.||+.+.
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccccccCCcchhhhhcccccceeEecccccc
Confidence 4689999999999999998877899999875
|